Citrus Sinensis ID: 014363
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 426 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LTC0 | 410 | Probable receptor-like pr | no | no | 0.828 | 0.860 | 0.486 | 1e-94 | |
| Q9LFP7 | 493 | Probable receptor-like pr | no | no | 0.762 | 0.659 | 0.491 | 2e-91 | |
| Q9SRH7 | 490 | Receptor-like serine/thre | no | no | 0.779 | 0.677 | 0.484 | 4e-91 | |
| O49839 | 426 | Protein kinase 2A, chloro | no | no | 0.767 | 0.767 | 0.487 | 8e-86 | |
| O49840 | 426 | Protein kinase 2B, chloro | no | no | 0.767 | 0.767 | 0.482 | 9e-85 | |
| Q06548 | 410 | Protein kinase APK1A, chl | no | no | 0.784 | 0.814 | 0.457 | 3e-84 | |
| Q8GXZ3 | 410 | Serine/threonine-protein | no | no | 0.791 | 0.821 | 0.474 | 4e-84 | |
| P43293 | 389 | Probable serine/threonine | no | no | 0.718 | 0.786 | 0.478 | 5e-84 | |
| P46573 | 412 | Protein kinase APK1B, chl | no | no | 0.690 | 0.713 | 0.491 | 8e-83 | |
| O48814 | 395 | Serine/threonine-protein | no | no | 0.807 | 0.870 | 0.431 | 1e-77 |
| >sp|Q9LTC0|Y5707_ARATH Probable receptor-like protein kinase At5g47070 OS=Arabidopsis thaliana GN=At5g47070 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 347 bits (889), Expect = 1e-94, Method: Compositional matrix adjust.
Identities = 183/376 (48%), Positives = 248/376 (65%), Gaps = 23/376 (6%)
Query: 33 NDNEVGRIGSELTSQNVSAISVESEARP-------SYPS-------MSQRPSNLKEFTIA 78
++N+ R G EL + ++ SE S PS ++R NL+ F+
Sbjct: 18 DNNKNKRKGKELLQNSAPELTNRSETSSFNLQTPRSLPSPRSIKDLYTEREQNLRVFSYE 77
Query: 79 ELKSATKNFSRSVVIGEGGFGCVYKG-LIKNSEDPSQKVEVAVKQLGRRG--GHKEWMTE 135
EL AT FSR +VIGEGGFG VYKG ++ N + + VA+K+L R+G GHK+W+ E
Sbjct: 78 ELSKATYVFSRKLVIGEGGFGIVYKGKILSNGDSSDPPLVVAIKKLNRQGLQGHKQWLAE 137
Query: 136 VNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLK 195
V FLG+V H N+VKL+GYC++D E GI+RLLVYEYM N S++ +L P+ L W RL+
Sbjct: 138 VQFLGVVNHPNVVKLIGYCSEDGETGIERLLVYEYMSNRSLEDHLFPRRSHTLPWKKRLE 197
Query: 196 IAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTA 255
I AA GL YLH D ++I RDFKSSN+LLD+Q+ KLSDFGLAR GP THV+TA
Sbjct: 198 IMLGAAEGLTYLH---DLKVIYRDFKSSNVLLDDQFCPKLSDFGLAREGPDGDNTHVTTA 254
Query: 256 VVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYL 315
VGT GYAAPEYVQTG L +SDV+S+GV LYE+ITGRR I+RN+P +E++LL WVK Y
Sbjct: 255 RVGTHGYAAPEYVQTGHLRLKSDVYSFGVVLYEIITGRRTIERNKPVAERRLLDWVKEYP 314
Query: 316 SDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASAE 375
+D+++F IVDPRL Y L+ +A+LCL KN + RP M V+E + KI++ E
Sbjct: 315 ADSQRFSMIVDPRLRNNYPAAGARSLAKLADLCLKKNDKERPTMEIVVERLKKIIE---E 371
Query: 376 AGSPRRPLRSSTSRET 391
+ S P+ ++T++E+
Sbjct: 372 SDSEDYPMATTTTKES 387
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9LFP7|Y5158_ARATH Probable receptor-like protein kinase At5g15080 OS=Arabidopsis thaliana GN=At5g15080 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 336 bits (861), Expect = 2e-91, Method: Compositional matrix adjust.
Identities = 170/346 (49%), Positives = 239/346 (69%), Gaps = 21/346 (6%)
Query: 33 NDNEVGRIGSELTSQNVSAISVESEARPSYPSMSQR---PSNLKEFTIAELKSATKNFSR 89
ND VG++ S T+ N +E+ S P +S+ S+L++FT +LK +T+NF
Sbjct: 92 NDQPVGQVSSTTTTSN-------AESSSSTPVISEELNISSHLRKFTFNDLKLSTRNFRP 144
Query: 90 SVVIGEGGFGCVYKGLIKNSE----DPSQKVEVAVKQLGRRG--GHKEWMTEVNFLGIVE 143
++GEGGFGCV+KG I+ + P + VAVK L G GHKEW+ E+NFLG +
Sbjct: 145 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNPDGLQGHKEWLAEINFLGNLL 204
Query: 144 HQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARG 203
H NLVKLVGYC +DD QRLLVYE+MP GS++ +L +S L W++R+KIA AA+G
Sbjct: 205 HPNLVKLVGYCIEDD----QRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKG 259
Query: 204 LAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYA 263
L++LHE +I RDFK+SNILLD +NAKLSDFGLA+ P EG THVST V+GT GYA
Sbjct: 260 LSFLHEEALKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPDEGKTHVSTRVMGTYGYA 319
Query: 264 APEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQ 323
APEYV TG L ++SDV+S+GV L E++TGRR +D+NRP E L++W +P+L D ++F +
Sbjct: 320 APEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLLDKRRFYR 379
Query: 324 IVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 369
++DPRLEG +S++ K++ +A CL ++ + RPKMS+V+E + +
Sbjct: 380 LLDPRLEGHFSIKGAQKVTQLAAQCLSRDPKIRPKMSDVVEALKPL 425
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SRH7|Y3130_ARATH Receptor-like serine/threonine-protein kinase At3g01300 OS=Arabidopsis thaliana GN=At3g01300 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 335 bits (859), Expect = 4e-91, Method: Compositional matrix adjust.
Identities = 171/353 (48%), Positives = 244/353 (69%), Gaps = 21/353 (5%)
Query: 26 RSSCATFNDNEVGRIGSELTSQNVSAISVESEARPSYPSMSQRP---SNLKEFTIAELKS 82
+S+ ND VG + S T+ N +E+ S P +S+ S+LK+F+ +LK
Sbjct: 79 QSAIVQSNDQPVGPVSSTTTTSN-------AESSLSTPIISEELNIYSHLKKFSFIDLKL 131
Query: 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSE----DPSQKVEVAVKQLGRRG--GHKEWMTEV 136
AT+NF ++GEGGFGCV+KG ++ + P + VAVK L G GHKEW+ E+
Sbjct: 132 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNPDGLQGHKEWLAEI 191
Query: 137 NFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKI 196
N+LG + H NLVKLVGYC +DD QRLLVYE+MP GS++ +L +S L W++R+KI
Sbjct: 192 NYLGNLLHPNLVKLVGYCIEDD----QRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKI 246
Query: 197 AQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAV 256
A AA+GL++LHE +I RDFK+SNILLD ++NAKLSDFGLA+ P EG THVST V
Sbjct: 247 ALGAAKGLSFLHEEALKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDAPDEGKTHVSTRV 306
Query: 257 VGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS 316
+GT GYAAPEYV TG L ++SDV+S+GV L E++TGRR +D+NRP E L++W +P+L
Sbjct: 307 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLL 366
Query: 317 DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 369
D ++F +++DPRLEG +S++ K++ +A CL ++++ RPKMSEV+E++ +
Sbjct: 367 DKRRFYRLLDPRLEGHFSVKGAQKVTQLAAQCLSRDSKIRPKMSEVVEVLKPL 419
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49839|APK2A_ARATH Protein kinase 2A, chloroplastic OS=Arabidopsis thaliana GN=APK2A PE=2 SV=1 | Back alignment and function description |
|---|
Score = 317 bits (813), Expect = 8e-86, Method: Compositional matrix adjust.
Identities = 169/347 (48%), Positives = 225/347 (64%), Gaps = 20/347 (5%)
Query: 71 NLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIK----NSEDPSQKVEVAVKQLGRR 126
NLK FT ELK+ATKNF + ++GEGGFGCV+KG I + P + VAVKQL
Sbjct: 70 NLKAFTFNELKNATKNFRQDNLLGEGGFGCVFKGWIDQTSLTASRPGSGIVVAVKQLKPE 129
Query: 127 G--GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKS 184
G GHKEW+TEVN+LG + H NLV LVGYCA+ G RLLVYE+MP GS++ +L +
Sbjct: 130 GFQGHKEWLTEVNYLGQLSHPNLVLLVGYCAE----GENRLLVYEFMPKGSLENHLFRRG 185
Query: 185 ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLG 244
LTWA+R+K+A AA+GL +LHE Q+I RDFK++NILLD +NAKLSDFGLA+ G
Sbjct: 186 AQPLTWAIRMKVAVGAAKGLTFLHEAKS-QVIYRDFKAANILLDADFNAKLSDFGLAKAG 244
Query: 245 PSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSE 304
P+ THVST V+GT GYAAPEYV TGRL A+SDV+S+GV L ELI+GRR +D + +E
Sbjct: 245 PTGDNTHVSTKVIGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELISGRRAMDNSNGGNE 304
Query: 305 QKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 364
L+ W PYL D ++ +I+D +L G+Y + +++A CL +A+ RPKMSEVL
Sbjct: 305 YSLVDWATPYLGDKRKLFRIMDTKLGGQYPQKGAFTAANLALQCLNPDAKLRPKMSEVLV 364
Query: 365 MVNKIVDASAEAGSPRRPLRSSTSRETP--DHTKTKHKRRIIESKTR 409
+ ++ + +P T E+P H+ K + S R
Sbjct: 365 TLEQLESVA-------KPGTKHTQMESPRFHHSSVMQKSPVRYSHDR 404
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49840|APK2B_ARATH Protein kinase 2B, chloroplastic OS=Arabidopsis thaliana GN=APK2B PE=1 SV=1 | Back alignment and function description |
|---|
Score = 314 bits (804), Expect = 9e-85, Method: Compositional matrix adjust.
Identities = 163/338 (48%), Positives = 222/338 (65%), Gaps = 11/338 (3%)
Query: 71 NLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNS----EDPSQKVEVAVKQLGRR 126
NLK FT ELK+AT+NF ++GEGGFG V+KG I + P + VAVK+L
Sbjct: 67 NLKAFTFNELKNATRNFRPDSLLGEGGFGYVFKGWIDGTTLTASKPGSGIVVAVKKLKTE 126
Query: 127 G--GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKS 184
G GHKEW+TEVN+LG + H NLVKLVGYC + G RLLVYE+MP GS++ +L +
Sbjct: 127 GYQGHKEWLTEVNYLGQLSHPNLVKLVGYCVE----GENRLLVYEFMPKGSLENHLFRRG 182
Query: 185 ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLG 244
LTWA+R+K+A AA+GL +LH+ Q+I RDFK++NILLD ++N+KLSDFGLA+ G
Sbjct: 183 AQPLTWAIRMKVAIGAAKGLTFLHDAKS-QVIYRDFKAANILLDAEFNSKLSDFGLAKAG 241
Query: 245 PSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSE 304
P+ THVST V+GT GYAAPEYV TGRL A+SDV+S+GV L EL++GRR +D+++ E
Sbjct: 242 PTGDKTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKSKVGME 301
Query: 305 QKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 364
Q L+ W PYL D ++ +I+D RL G+Y + + +A CL +A+ RPKMSEVL
Sbjct: 302 QSLVDWATPYLGDKRKLFRIMDTRLGGQYPQKGAYTAASLALQCLNPDAKLRPKMSEVLA 361
Query: 365 MVNKIVDASAEAGSPRRPLRSSTSRETPDHTKTKHKRR 402
++++ G R + + R + K RR
Sbjct: 362 KLDQLESTKPGTGVGNRQAQIDSPRGSNGSIVQKSPRR 399
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q06548|APK1A_ARATH Protein kinase APK1A, chloroplastic OS=Arabidopsis thaliana GN=APK1A PE=2 SV=1 | Back alignment and function description |
|---|
Score = 312 bits (800), Expect = 3e-84, Method: Compositional matrix adjust.
Identities = 162/354 (45%), Positives = 236/354 (66%), Gaps = 20/354 (5%)
Query: 32 FNDNEVGRIGSELTSQNVSAISVESEARPSYPSMSQRPSNLKEFTIAELKSATKNFSRSV 91
++ ++G +GS+ S++SV R + + Q P NLK F+ AELKSAT+NF
Sbjct: 20 YDAKDIGSLGSK-----ASSVSVRPSPR-TEGEILQSP-NLKSFSFAELKSATRNFRPDS 72
Query: 92 VIGEGGFGCVYKGLIK----NSEDPSQKVEVAVKQLGRRG--GHKEWMTEVNFLGIVEHQ 145
V+GEGGFGCV+KG I + P + +AVK+L + G GH+EW+ EVN+LG H+
Sbjct: 73 VLGEGGFGCVFKGWIDEKSLTASRPGTGLVIAVKKLNQDGWQGHQEWLAEVNYLGQFSHR 132
Query: 146 NLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETI--LTWAMRLKIAQDAARG 203
+LVKL+GYC +D+ RLLVYE+MP GS++ +L + L+W +RLK+A AA+G
Sbjct: 133 HLVKLIGYCLEDE----HRLLVYEFMPRGSLENHLFRRGLYFQPLSWKLRLKVALGAAKG 188
Query: 204 LAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYA 263
LA+LH + ++I RDFK+SNILLD ++NAKLSDFGLA+ GP +HVST V+GT GYA
Sbjct: 189 LAFLHSS-ETRVIYRDFKTSNILLDSEYNAKLSDFGLAKDGPIGDKSHVSTRVMGTHGYA 247
Query: 264 APEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQ 323
APEY+ TG L +SDV+S+GV L EL++GRR +D+NRP E+ L++W KPYL + ++ +
Sbjct: 248 APEYLATGHLTTKSDVYSFGVVLLELLSGRRAVDKNRPSGERNLVEWAKPYLVNKRKIFR 307
Query: 324 IVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASAEAG 377
++D RL+ +YS+ K++ ++ CL + RP MSEV+ + I +A G
Sbjct: 308 VIDNRLQDQYSMEEACKVATLSLRCLTTEIKLRPNMSEVVSHLEHIQSLNAAIG 361
|
Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GXZ3|Y5102_ARATH Serine/threonine-protein kinase At5g01020 OS=Arabidopsis thaliana GN=At5g01020 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 311 bits (798), Expect = 4e-84, Method: Compositional matrix adjust.
Identities = 166/350 (47%), Positives = 228/350 (65%), Gaps = 13/350 (3%)
Query: 26 RSSCATFNDNEVGRIGSELTSQNVSAISVESEARPSYPSMSQRP---SNLKEFTIAELKS 82
R A F + + S++VS +S S P + S+ P + + FT+ EL++
Sbjct: 7 RDEAAVFTPQAQAQQLQKKHSRSVSDLSDPST--PRFRDDSRTPISYAQVIPFTLFELET 64
Query: 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQK-VEVAVKQLGRRG--GHKEWMTEVNFL 139
TK+F ++GEGGFG VYKG I ++ K + VAVK L + G GH+EW+TEVNFL
Sbjct: 65 ITKSFRPDYILGEGGFGTVYKGYIDDNLRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFL 124
Query: 140 GIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQD 199
G + H NLVKL+GYC +DD RLLVYE+M GS++ +L K+ L+W+ R+ IA
Sbjct: 125 GQLRHPNLVKLIGYCCEDD----HRLLVYEFMLRGSLENHLFRKTTAPLSWSRRMMIALG 180
Query: 200 AARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGT 259
AA+GLA+LH + +I RDFK+SNILLD + AKLSDFGLA+ GP THVST V+GT
Sbjct: 181 AAKGLAFLHNA-ERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGT 239
Query: 260 MGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 319
GYAAPEYV TG L ARSDV+S+GV L E++TGR+ +D+ RP EQ L+ W +P L+D +
Sbjct: 240 YGYAAPEYVMTGHLTARSDVYSFGVVLLEMLTGRKSVDKTRPSKEQNLVDWARPKLNDKR 299
Query: 320 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 369
+ QI+DPRLE +YS+R K +A CL +N + RP MS+V+E + +
Sbjct: 300 KLLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL 349
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43293|NAK_ARATH Probable serine/threonine-protein kinase NAK OS=Arabidopsis thaliana GN=NAK PE=2 SV=2 | Back alignment and function description |
|---|
Score = 311 bits (798), Expect = 5e-84, Method: Compositional matrix adjust.
Identities = 154/322 (47%), Positives = 227/322 (70%), Gaps = 16/322 (4%)
Query: 70 SNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSE----DPSQKVEVAVKQLGR 125
+NLK F+++ELKSAT+NF V+GEGGFGCV+KG I S P + +AVK+L +
Sbjct: 51 ANLKNFSLSELKSATRNFRPDSVVGEGGFGCVFKGWIDESSLAPSKPGTGIVIAVKRLNQ 110
Query: 126 RG--GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPK 183
G GH+EW+ E+N+LG ++H NLVKL+GYC +++ RLLVYE+M GS++ +L +
Sbjct: 111 EGFQGHREWLAEINYLGQLDHPNLVKLIGYCLEEE----HRLLVYEFMTRGSLENHLFRR 166
Query: 184 SETI--LTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 241
L+W R+++A AARGLA+LH Q+I RDFK+SNILLD +NAKLSDFGLA
Sbjct: 167 GTFYQPLSWNTRVRMALGAARGLAFLHNAQP-QVIYRDFKASNILLDSNYNAKLSDFGLA 225
Query: 242 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRP 301
R GP +HVST V+GT GYAAPEY+ TG L+ +SDV+S+GV L EL++GRR ID+N+P
Sbjct: 226 RDGPMGDNSHVSTRVMGTQGYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRAIDKNQP 285
Query: 302 RSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSE 361
E L+ W +PYL++ ++ +++DPRL+G+YSL K++ +A C+ +A++RP M+E
Sbjct: 286 VGEHNLVDWARPYLTNKRRLLRVMDPRLQGQYSLTRALKIAVLALDCISIDAKSRPTMNE 345
Query: 362 VLEMVNKI---VDASAEAGSPR 380
+++ + ++ +AS E +P+
Sbjct: 346 IVKTMEELHIQKEASKEQQNPQ 367
|
May play a role in the regulation of plant growth and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P46573|APK1B_ARATH Protein kinase APK1B, chloroplastic OS=Arabidopsis thaliana GN=APK1B PE=2 SV=2 | Back alignment and function description |
|---|
Score = 307 bits (787), Expect = 8e-83, Method: Compositional matrix adjust.
Identities = 151/307 (49%), Positives = 213/307 (69%), Gaps = 13/307 (4%)
Query: 71 NLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIK----NSEDPSQKVEVAVKQLGRR 126
NLK FT AELK+AT+NF V+GEGGFG V+KG I + P V +AVK+L +
Sbjct: 53 NLKSFTFAELKAATRNFRPDSVLGEGGFGSVFKGWIDEQTLTASKPGTGVVIAVKKLNQD 112
Query: 127 G--GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKS 184
G GH+EW+ EVN+LG H NLVKL+GYC +D+ RLLVYE+MP GS++ +L +
Sbjct: 113 GWQGHQEWLAEVNYLGQFSHPNLVKLIGYCLEDE----HRLLVYEFMPRGSLENHLFRRG 168
Query: 185 ETI--LTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 242
L+W +RLK+A AA+GLA+LH + +I RDFK+SNILLD ++NAKLSDFGLA+
Sbjct: 169 SYFQPLSWTLRLKVALGAAKGLAFLHNA-ETSVIYRDFKTSNILLDSEYNAKLSDFGLAK 227
Query: 243 LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPR 302
GP+ +HVST ++GT GYAAPEY+ TG L +SDV+SYGV L E+++GRR +D+NRP
Sbjct: 228 DGPTGDKSHVSTRIMGTYGYAAPEYLATGHLTTKSDVYSYGVVLLEVLSGRRAVDKNRPP 287
Query: 303 SEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEV 362
EQKL++W +P L++ ++ +++D RL+ +YS+ K++ +A CL + RP M+EV
Sbjct: 288 GEQKLVEWARPLLANKRKLFRVIDNRLQDQYSMEEACKVATLALRCLTFEIKLRPNMNEV 347
Query: 363 LEMVNKI 369
+ + I
Sbjct: 348 VSHLEHI 354
|
Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O48814|BIK1_ARATH Serine/threonine-protein kinase BIK1 OS=Arabidopsis thaliana GN=BIK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 290 bits (742), Expect = 1e-77, Method: Compositional matrix adjust.
Identities = 155/359 (43%), Positives = 224/359 (62%), Gaps = 15/359 (4%)
Query: 21 SLFSIRSSCATFNDNEVGRIGSELTSQNVSAISVESEARPSYPSMSQRPSNLKEFTIAEL 80
S FS R F++ + + S S+ +V + + +S P +K FT EL
Sbjct: 3 SCFSSRVKADIFHNGKSSDLYGLSLSSRKSSSTVAAAQKTEGEILSSTP--VKSFTFNEL 60
Query: 81 KSATKNFSRSVVIGEGGFGCVYKGLIKNSE----DPSQKVEVAVKQLGRRG--GHKEWMT 134
K AT+NF VIGEGGFGCV+KG + S P + +AVK+L + G GH+EW+T
Sbjct: 61 KLATRNFRPDSVIGEGGFGCVFKGWLDESTLTPTKPGTGLVIAVKKLNQEGFQGHREWLT 120
Query: 135 EVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETI--LTWAM 192
E+N+LG + H NLVKL+GYC +D+ RLLVYE+M GS++ +L + L W +
Sbjct: 121 EINYLGQLSHPNLVKLIGYCLEDE----HRLLVYEFMQKGSLENHLFRRGAYFKPLPWFL 176
Query: 193 RLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHV 252
R+ +A DAA+GLA+LH ++I RD K+SNILLD +NAKLSDFGLAR GP ++V
Sbjct: 177 RVNVALDAAKGLAFLHSD-PVKVIYRDIKASNILLDADYNAKLSDFGLARDGPMGDLSYV 235
Query: 253 STAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK 312
ST V+GT GYAAPEY+ +G L ARSDV+S+GV L E+++G+R +D NRP E+ L+ W +
Sbjct: 236 STRVMGTYGYAAPEYMSSGHLNARSDVYSFGVLLLEILSGKRALDHNRPAKEENLVDWAR 295
Query: 313 PYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVD 371
PYL+ ++ IVD RL+ +Y +++ VA CL ++RP M +V+ + ++ D
Sbjct: 296 PYLTSKRKVLLIVDNRLDTQYLPEEAVRMASVAVQCLSFEPKSRPTMDQVVRALQQLQD 354
|
Required to activate the resistance responses to necrotrophic pathogens. Phosphorylates FLS2 and BAK1. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 426 | ||||||
| 255556958 | 422 | Protein kinase APK1A, chloroplast precur | 0.981 | 0.990 | 0.723 | 1e-177 | |
| 224068749 | 424 | predicted protein [Populus trichocarpa] | 0.995 | 1.0 | 0.704 | 1e-174 | |
| 359481541 | 437 | PREDICTED: probable receptor-like protei | 0.995 | 0.970 | 0.678 | 1e-173 | |
| 297741627 | 460 | unnamed protein product [Vitis vinifera] | 0.985 | 0.913 | 0.695 | 1e-172 | |
| 359486879 | 2201 | PREDICTED: uncharacterized protein LOC10 | 0.988 | 0.191 | 0.666 | 1e-165 | |
| 356572460 | 428 | PREDICTED: probable receptor-like protei | 0.997 | 0.992 | 0.671 | 1e-162 | |
| 356505240 | 428 | PREDICTED: probable receptor-like protei | 0.997 | 0.992 | 0.671 | 1e-162 | |
| 357510763 | 434 | Protein kinase [Medicago truncatula] gi| | 0.990 | 0.972 | 0.662 | 1e-160 | |
| 357440361 | 427 | Protein kinase 2A [Medicago truncatula] | 0.992 | 0.990 | 0.648 | 1e-159 | |
| 297829514 | 418 | hypothetical protein ARALYDRAFT_478307 [ | 0.892 | 0.909 | 0.705 | 1e-158 |
| >gi|255556958|ref|XP_002519512.1| Protein kinase APK1A, chloroplast precursor, putative [Ricinus communis] gi|223541375|gb|EEF42926.1| Protein kinase APK1A, chloroplast precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 627 bits (1616), Expect = e-177, Method: Compositional matrix adjust.
Identities = 306/423 (72%), Positives = 355/423 (83%), Gaps = 5/423 (1%)
Query: 6 FTNWDKKDEPPTTPKSLFSIRSSCATFNDNEVGRIGSELTSQNVSAISVESEARPSYPSM 65
++ DKKDEP TT L S++S+ + F D EVGR SE +VS S+ES RPS+PSM
Sbjct: 3 LSHGDKKDEPKTT--KLVSVQSTNSAFTDREVGR-SSEFNYPDVSGTSIESIDRPSFPSM 59
Query: 66 SQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGR 125
SQRPSNL+ FT+AELKSAT+NFSRSV++GEGGFGCVY+G IK+ EDP++K+EVAVKQLG+
Sbjct: 60 SQRPSNLRVFTVAELKSATRNFSRSVMLGEGGFGCVYRGSIKSLEDPTKKLEVAVKQLGK 119
Query: 126 RG--GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPK 183
RG GHKEW+TEVN LG+VEH NLVKLVGYCADDDERGIQRLL+YE+MPNGSV+ +LS +
Sbjct: 120 RGMQGHKEWVTEVNVLGVVEHPNLVKLVGYCADDDERGIQRLLIYEFMPNGSVEDHLSAR 179
Query: 184 SETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL 243
S+ + WAMRL+IAQDAARGL YLHE M FQII RDFKSSNILLDEQWNAKLSDFGLARL
Sbjct: 180 SDAPIPWAMRLRIAQDAARGLTYLHEEMGFQIIFRDFKSSNILLDEQWNAKLSDFGLARL 239
Query: 244 GPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRS 303
GPSEG THVSTAVVGTMGYAAPEYVQTGRL ++SDVWSYGVFLYELITGRRP+DRNRPRS
Sbjct: 240 GPSEGLTHVSTAVVGTMGYAAPEYVQTGRLTSKSDVWSYGVFLYELITGRRPLDRNRPRS 299
Query: 304 EQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVL 363
EQKLL+WVKPYL+DAK+F QI+DPRLEGKY LR KL+ +AN CLV+N + RPKMSEVL
Sbjct: 300 EQKLLEWVKPYLADAKKFPQILDPRLEGKYPLRSAQKLATIANRCLVRNPKARPKMSEVL 359
Query: 364 EMVNKIVDASAEAGSPRRPLRSSTSRETPDHTKTKHKRRIIESKTRESGTLFWKWRQKLI 423
EMVN+IVDAS+EA SP+ +SS + ET KTK+KRR ++ K RESG W KLI
Sbjct: 360 EMVNRIVDASSEASSPQLSFKSSITMETSRDHKTKNKRRKVDLKGRESGWFSRMWAPKLI 419
Query: 424 RTC 426
RTC
Sbjct: 420 RTC 422
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224068749|ref|XP_002326190.1| predicted protein [Populus trichocarpa] gi|222833383|gb|EEE71860.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 618 bits (1593), Expect = e-174, Method: Compositional matrix adjust.
Identities = 300/426 (70%), Positives = 353/426 (82%), Gaps = 2/426 (0%)
Query: 1 MKCFPFTNWDKKDEPPTTPKSLFSIRSSCATFNDNEVGRIGSELTSQNVSAISVESEARP 60
MKCF F + DK DEP TPKS+ S++S + D E+GR GSEL SQNVS S ES RP
Sbjct: 1 MKCFSFHSGDKTDEP-KTPKSV-SVQSVNSPGADREIGRSGSELNSQNVSGTSTESMVRP 58
Query: 61 SYPSMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAV 120
S PSMSQRPSNL+ FT++ELKSATKNFSRSV+IGEGGFGCVYKG IK++EDP+ K+E+AV
Sbjct: 59 SLPSMSQRPSNLRVFTVSELKSATKNFSRSVMIGEGGFGCVYKGSIKSTEDPTTKLEIAV 118
Query: 121 KQLGRRGGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYL 180
KQLG+RGGHKEW+TEVN LG+VEH NLVKLVGYCAD+DERG+QRLL+YE+M GSV+ +L
Sbjct: 119 KQLGKRGGHKEWVTEVNVLGVVEHPNLVKLVGYCADEDERGMQRLLIYEFMSKGSVEDHL 178
Query: 181 SPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 240
S +S+ L WAMRL+IAQDAARGL YLHE MDFQII RDFKSSNILLDEQWNAKLSDFGL
Sbjct: 179 SIRSDKPLPWAMRLRIAQDAARGLKYLHEEMDFQIIFRDFKSSNILLDEQWNAKLSDFGL 238
Query: 241 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNR 300
ARLGPSEG THVSTAVVGTMGYAAPEYVQTGRL ++SDVWSYGVFLYELITGRRP+DRNR
Sbjct: 239 ARLGPSEGLTHVSTAVVGTMGYAAPEYVQTGRLTSKSDVWSYGVFLYELITGRRPLDRNR 298
Query: 301 PRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMS 360
P+SEQKLL+W++PYLSDAK+F+QIVDPRLE K L+ KL+++AN CLV+N + RPKMS
Sbjct: 299 PKSEQKLLEWIRPYLSDAKKFKQIVDPRLEQKDILKSAHKLANIANRCLVRNPKLRPKMS 358
Query: 361 EVLEMVNKIVDASAEAGSPRRPLRSSTSRETPDHTKTKHKRRIIESKTRESGTLFWKWRQ 420
EVLE +N+IVDAS S ++ ++S +T T K+KRR ++ KT ESG W W
Sbjct: 359 EVLEKMNQIVDASTGTESAQQSSKNSAPIKTSHGTTAKNKRRNVDLKTGESGWFGWMWNP 418
Query: 421 KLIRTC 426
K +RTC
Sbjct: 419 KHVRTC 424
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359481541|ref|XP_002276673.2| PREDICTED: probable receptor-like protein kinase At5g15080-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 613 bits (1582), Expect = e-173, Method: Compositional matrix adjust.
Identities = 298/439 (67%), Positives = 355/439 (80%), Gaps = 15/439 (3%)
Query: 1 MKCFPFTNWDKKDEPPTTPKSLFSIRSSCATFNDNEVGRIGSELTSQNVSAISVESEARP 60
MKCF F DKK+EP T+ + S++S+ +T + E+ R SEL+SQNVS +S ES ARP
Sbjct: 1 MKCFTFYYGDKKEEPKTSKWT--SVQSNNSTLTEQEMKRFASELSSQNVSNVSTESLARP 58
Query: 61 SYPSMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAV 120
++PS+SQR SNL+ FT +ELKS TKNFSRS +IGEGGFGCVYKG+IK+S+DP K++VAV
Sbjct: 59 TFPSLSQRVSNLRVFTFSELKSVTKNFSRSAMIGEGGFGCVYKGMIKSSDDPPSKLDVAV 118
Query: 121 KQLGRRG-------------GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLV 167
KQLG+RG GHKEW+TEV LG+VEH NLVKLVGYCA+DDERGIQRLL+
Sbjct: 119 KQLGKRGMQARFLHDVFLVMGHKEWVTEVKVLGVVEHPNLVKLVGYCAEDDERGIQRLLI 178
Query: 168 YEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL 227
YEYMPNGSV+ +LS +S+T L+WAMRLKIAQDAA+GLAYLHE MDFQII RDFKSSNILL
Sbjct: 179 YEYMPNGSVESHLSSQSQTPLSWAMRLKIAQDAAQGLAYLHEEMDFQIIFRDFKSSNILL 238
Query: 228 DEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLY 287
DE+WNAKLSDFGLARLGPSEG THVSTAVVGTMGYAAPEYVQTGRL ++SDVWSYGVF+Y
Sbjct: 239 DEEWNAKLSDFGLARLGPSEGLTHVSTAVVGTMGYAAPEYVQTGRLTSKSDVWSYGVFIY 298
Query: 288 ELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANL 347
ELITGRRP DRNRP+SEQKLL WVKP+LSD K+F I+DPRLEG Y L+ V +L+ VAN
Sbjct: 299 ELITGRRPFDRNRPKSEQKLLSWVKPFLSDIKKFNLILDPRLEGNYHLKSVQRLAIVANR 358
Query: 348 CLVKNARTRPKMSEVLEMVNKIVDASAEAGSPRRPLRSSTSRETPDHTKTKHKRRIIESK 407
CLV+N ++RPKMSEVLEMVN+IVDA E GSP+ P++ S ET T+ K KR I + +
Sbjct: 359 CLVRNPKSRPKMSEVLEMVNRIVDAPRETGSPQPPVKRLLSIETSQITELKKKRNIKDLR 418
Query: 408 TRESGTLFWKWRQKLIRTC 426
E G L WKW +++RTC
Sbjct: 419 IGEGGWLPWKWTSRVVRTC 437
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297741627|emb|CBI32759.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 609 bits (1571), Expect = e-172, Method: Compositional matrix adjust.
Identities = 295/424 (69%), Positives = 351/424 (82%), Gaps = 4/424 (0%)
Query: 1 MKCFPFTNWDKKDEPPTTPKSLFSIRSSCATFNDNEVGRIGSELTSQNVSAISVESEARP 60
MKCF F DKK+EP T+ + S++S+ +T + E+ R SEL+SQNVS +S ES ARP
Sbjct: 1 MKCFTFYYGDKKEEPKTSKWT--SVQSNNSTLTEQEMKRFASELSSQNVSNVSTESLARP 58
Query: 61 SYPSMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAV 120
++PS+SQR SNL+ FT +ELKS TKNFSRS +IGEGGFGCVYKG+IK+S+DP K++VAV
Sbjct: 59 TFPSLSQRVSNLRVFTFSELKSVTKNFSRSAMIGEGGFGCVYKGMIKSSDDPPSKLDVAV 118
Query: 121 KQLGRRG--GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQ 178
KQLG+RG GHKEW+TEV LG+VEH NLVKLVGYCA+DDERGIQRLL+YEYMPNGSV+
Sbjct: 119 KQLGKRGMQGHKEWVTEVKVLGVVEHPNLVKLVGYCAEDDERGIQRLLIYEYMPNGSVES 178
Query: 179 YLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 238
+LS +S+T L+WAMRLKIAQDAA+GLAYLHE MDFQII RDFKSSNILLDE+WNAKLSDF
Sbjct: 179 HLSSQSQTPLSWAMRLKIAQDAAQGLAYLHEEMDFQIIFRDFKSSNILLDEEWNAKLSDF 238
Query: 239 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDR 298
GLARLGPSEG THVSTAVVGTMGYAAPEYVQTGRL ++SDVWSYGVF+YELITGRRP DR
Sbjct: 239 GLARLGPSEGLTHVSTAVVGTMGYAAPEYVQTGRLTSKSDVWSYGVFIYELITGRRPFDR 298
Query: 299 NRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPK 358
NRP+SEQKLL WVKP+LSD K+F I+DPRLEG Y L+ V +L+ VAN CLV+N ++RPK
Sbjct: 299 NRPKSEQKLLSWVKPFLSDIKKFNLILDPRLEGNYHLKSVQRLAIVANRCLVRNPKSRPK 358
Query: 359 MSEVLEMVNKIVDASAEAGSPRRPLRSSTSRETPDHTKTKHKRRIIESKTRESGTLFWKW 418
MSEVLEMVN+IVDA E GSP+ P++ S ET T+ K KR I + + E G L WKW
Sbjct: 359 MSEVLEMVNRIVDAPRETGSPQPPVKRLLSIETSQITELKKKRNIKDLRIGEGGWLPWKW 418
Query: 419 RQKL 422
++
Sbjct: 419 TSRV 422
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359486879|ref|XP_002273591.2| PREDICTED: uncharacterized protein LOC100254784 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 586 bits (1510), Expect = e-165, Method: Compositional matrix adjust.
Identities = 284/426 (66%), Positives = 349/426 (81%), Gaps = 5/426 (1%)
Query: 1 MKCFPFTNWDKKDEPPTTPKSLFSIRSSCATFNDNEVGRIGSELTSQNVSAISVESEARP 60
M CFPF +K DEP T + +S + D+EV R GSE SQN S IS ES A+
Sbjct: 1 MTCFPFHKGEKNDEPKATKSTSVRSSTSISMSTDHEVRRSGSEFNSQNASDISTESSAKT 60
Query: 61 SYPSMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAV 120
S+ S+ QRPSNLK FT +ELKSATKNFSRS++IGEGGFG VY+G+I+++EDP +K+++AV
Sbjct: 61 SFTSLQQRPSNLKVFTFSELKSATKNFSRSLMIGEGGFGGVYRGVIRSTEDPHKKIDIAV 120
Query: 121 KQLGRRG--GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQ 178
KQL RRG GHKEW+TEVN LG+VEH+NLVKLVGYCA+DDERGIQRLL+YEYMPN SV
Sbjct: 121 KQLSRRGLQGHKEWVTEVNVLGVVEHENLVKLVGYCAEDDERGIQRLLIYEYMPNRSVQD 180
Query: 179 YLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 238
+L+ + ET L+W+ RL+IAQDAARGLAYLHEGM+FQII RDFKSSNILLDEQWNAKLSDF
Sbjct: 181 HLTNRFETPLSWSTRLRIAQDAARGLAYLHEGMEFQIIFRDFKSSNILLDEQWNAKLSDF 240
Query: 239 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDR 298
GLARLGPS+G +HVSTAVVGT+GYAAPEY+QTGRL A+SDVWSYGVFLYELITGRRP+DR
Sbjct: 241 GLARLGPSDGLSHVSTAVVGTIGYAAPEYIQTGRLTAKSDVWSYGVFLYELITGRRPLDR 300
Query: 299 NRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPK 358
NRP++EQKLL+W++P+LSD K+F+ I+DPRLEGKY+L+ KL+ VAN CLV+ +TRPK
Sbjct: 301 NRPKNEQKLLEWIRPHLSDVKKFQLILDPRLEGKYTLKSAQKLAAVANKCLVRQIKTRPK 360
Query: 359 MSEVLEMVNKIVDASAEAGSPRRPLRSSTSRETPDHTKTKH-KRRIIESKTRESGTLFW- 416
MSE+L+MVN+IV+A AE GSP+ P++SST R+ P+ +K K K ++ E+ L W
Sbjct: 361 MSEILDMVNRIVEA-AETGSPQPPIKSSTPRDAPEESKRKRLKTMFVDPIIGENRRLVWQ 419
Query: 417 KWRQKL 422
KWR KL
Sbjct: 420 KWRPKL 425
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356572460|ref|XP_003554386.1| PREDICTED: probable receptor-like protein kinase At5g47070-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 578 bits (1489), Expect = e-162, Method: Compositional matrix adjust.
Identities = 288/429 (67%), Positives = 341/429 (79%), Gaps = 4/429 (0%)
Query: 1 MKCFPFTNWDKKDEPPTTPKSLFSIRSSCATFNDNEVGRIGSELTSQNVSAI-SVESEAR 59
MKCFPF+ +KKDEP S RS +T + EV R GS L SQ+VS S ES R
Sbjct: 1 MKCFPFSYGEKKDEPKGLQLQSTSGRSDNSTCVEAEVRRSGSALNSQDVSDNGSSESLRR 60
Query: 60 PSYPSMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVA 119
+ PS+SQRP NL+ FT++ELKSATKNFSRSV+IGEGGFGCVY GLI+++EDPS++ EVA
Sbjct: 61 NAIPSLSQRPCNLRVFTVSELKSATKNFSRSVMIGEGGFGCVYLGLIRSAEDPSRRTEVA 120
Query: 120 VKQLGRRG--GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVD 177
VKQL +RG GH+EW+TEVN LGIVEH NLVKLVGYCADDDERGIQRLL+YEYMPN SV+
Sbjct: 121 VKQLSKRGMQGHREWVTEVNVLGIVEHPNLVKLVGYCADDDERGIQRLLIYEYMPNRSVE 180
Query: 178 QYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 237
+LS +SET L W+ RLKIA+DAA GL YLHE MDFQII RDFKSSNILLDEQWNAKLSD
Sbjct: 181 HHLSHRSETPLPWSRRLKIARDAASGLTYLHEEMDFQIIFRDFKSSNILLDEQWNAKLSD 240
Query: 238 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPID 297
FGLARLGPS+G THVSTAVVGTMGYAAPEYVQTGRL +++DVWSYGVFLYELITGRRP+D
Sbjct: 241 FGLARLGPSDGLTHVSTAVVGTMGYAAPEYVQTGRLTSKNDVWSYGVFLYELITGRRPLD 300
Query: 298 RNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRP 357
RNRPR EQKLL+W++PYLSD K+F+ I+DPRL+ K + +L+ +AN CLVKN + RP
Sbjct: 301 RNRPRGEQKLLEWIRPYLSDGKKFQLILDPRLDKKQVFKSAQRLATIANRCLVKNPKNRP 360
Query: 358 KMSEVLEMVNKIVDASAEAGSPRRPLRSSTSRETPDHTKTKHKRRIIESKTRESGTLFWK 417
KMSEVLEMVN +V+ S + SP+ PLRS + E T+T +K+R ++ K ES
Sbjct: 361 KMSEVLEMVNGMVE-SISSSSPQLPLRSVATLEASQDTETNNKKRTMDHKPGESNWFVRM 419
Query: 418 WRQKLIRTC 426
WR KL+RTC
Sbjct: 420 WRPKLVRTC 428
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356505240|ref|XP_003521400.1| PREDICTED: probable receptor-like protein kinase At5g47070-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 577 bits (1488), Expect = e-162, Method: Compositional matrix adjust.
Identities = 288/429 (67%), Positives = 344/429 (80%), Gaps = 4/429 (0%)
Query: 1 MKCFPFTNWDKKDEPPTTPKSLFSIRSSCATFNDNEVGRIGSELTSQNVSAI-SVESEAR 59
MKCFPF+ +KKDEP S RS + + EV R GSEL SQ+VS S ES+ R
Sbjct: 1 MKCFPFSYGEKKDEPKGLQLQSTSGRSDNSMCVEAEVRRSGSELNSQDVSDNGSSESQRR 60
Query: 60 PSYPSMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVA 119
+ PS+SQRPSNL+ FT++ELKSATKNFSRSV+IGEGGFGCVY GLI+++ED S+++EVA
Sbjct: 61 NAIPSLSQRPSNLRVFTVSELKSATKNFSRSVMIGEGGFGCVYLGLIRSAEDSSRRIEVA 120
Query: 120 VKQLGRRG--GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVD 177
VKQL +RG GH+EW+TEVN LGIVEH NLVKLVGYCADDDERGIQRLL+YEYMPN SV+
Sbjct: 121 VKQLSKRGMQGHREWVTEVNVLGIVEHPNLVKLVGYCADDDERGIQRLLIYEYMPNRSVE 180
Query: 178 QYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 237
+LS +SET L W RLKIA+DAARGL YLHE MDFQII RDFKSSNILLDEQWNAKLSD
Sbjct: 181 HHLSHRSETPLPWTRRLKIARDAARGLTYLHEEMDFQIIFRDFKSSNILLDEQWNAKLSD 240
Query: 238 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPID 297
FGLARLGPS+G THVSTAVVGTMGYAAPEYVQTGRL +++DVWSYGVFLYELITGRRP+D
Sbjct: 241 FGLARLGPSDGLTHVSTAVVGTMGYAAPEYVQTGRLTSKNDVWSYGVFLYELITGRRPLD 300
Query: 298 RNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRP 357
RNRPR EQKLL+W++PYLSD K+F+ I+DPRL+ K + +L+ +AN CL KN + RP
Sbjct: 301 RNRPRREQKLLEWIRPYLSDGKKFQLILDPRLDKKQVFKSAQRLAMIANQCLAKNPKNRP 360
Query: 358 KMSEVLEMVNKIVDASAEAGSPRRPLRSSTSRETPDHTKTKHKRRIIESKTRESGTLFWK 417
KMSEVLEMVN +V++S+ + SP+ PLRS + E T+T +K+R ++ K ES
Sbjct: 361 KMSEVLEMVNGMVESSSSS-SPQLPLRSVVTLEASQDTETNNKKRTMDQKLGESNWFVRM 419
Query: 418 WRQKLIRTC 426
WR KL+RTC
Sbjct: 420 WRPKLVRTC 428
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357510763|ref|XP_003625670.1| Protein kinase [Medicago truncatula] gi|355500685|gb|AES81888.1| Protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 572 bits (1473), Expect = e-160, Method: Compositional matrix adjust.
Identities = 284/429 (66%), Positives = 348/429 (81%), Gaps = 7/429 (1%)
Query: 1 MKCFPFTNWDKKDEPPTTPKSLFSIRSSCATFNDNEVGRIGSELTSQNVS-AISVESEAR 59
MKCFPF + DKKDEP + S RS +T+ D E R GSEL SQ++S + SVES R
Sbjct: 9 MKCFPFHSSDKKDEPKGLQSA--SGRSDSSTYVDVEGRRCGSELNSQDISDSGSVESLRR 66
Query: 60 PSYPSMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVA 119
+ P++SQRPSNL+ FT++ELKSATKNFSRSV++GEGGFGCVY+G+I++ +DPS+++EVA
Sbjct: 67 NAPPNLSQRPSNLRVFTVSELKSATKNFSRSVMLGEGGFGCVYQGVIRSVDDPSRRIEVA 126
Query: 120 VKQLGRRG--GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVD 177
VKQL +RG GH+EW+TEVN LGIVEH NLVKLVGYCADDDERGIQRLL+YEYMPN SV+
Sbjct: 127 VKQLSKRGVQGHREWVTEVNVLGIVEHPNLVKLVGYCADDDERGIQRLLIYEYMPNRSVE 186
Query: 178 QYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 237
+LS ++ET L W RLKIA DAARGL YLHE MDFQII RDFKSSNILLD+QWNAKLSD
Sbjct: 187 HHLSHRAETPLPWNRRLKIAHDAARGLTYLHEEMDFQIIFRDFKSSNILLDDQWNAKLSD 246
Query: 238 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPID 297
FGLARLGPS+G THVSTAVVGTMGYAAPEY+QTGRL +++DVWSYGVFLYELITGRRP+D
Sbjct: 247 FGLARLGPSDGLTHVSTAVVGTMGYAAPEYLQTGRLTSKNDVWSYGVFLYELITGRRPLD 306
Query: 298 RNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRP 357
RNRP+ EQKLL+W+KPYLSD K+F+ I+DPRL+ K +R +L+ +AN CLVKN + RP
Sbjct: 307 RNRPKGEQKLLEWIKPYLSDTKKFQLILDPRLDKKQVIRSAQRLATIANRCLVKNPKNRP 366
Query: 358 KMSEVLEMVNKIVDASAEAGSPRRPLRSSTSRETPDHTKTKH-KRRIIESKTRESGTLFW 416
KMSEVLEMVN IV++S++ S + PL++ + E T+ ++ K+R ++ K RES
Sbjct: 367 KMSEVLEMVNGIVESSSDTNS-QLPLKNVSRIEVSHETEMRNTKKRTMDQKPRESNWFVR 425
Query: 417 KWRQKLIRT 425
WR KLIRT
Sbjct: 426 LWRPKLIRT 434
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357440361|ref|XP_003590458.1| Protein kinase 2A [Medicago truncatula] gi|355479506|gb|AES60709.1| Protein kinase 2A [Medicago truncatula] gi|388509014|gb|AFK42573.1| unknown [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 566 bits (1459), Expect = e-159, Method: Compositional matrix adjust.
Identities = 279/430 (64%), Positives = 341/430 (79%), Gaps = 7/430 (1%)
Query: 1 MKCFPFTNW--DKKDEPPTTPKSLFSIRSSCATFNDNEVGRIGSELTSQNVSAISVESEA 58
M CFPF + +KK + S S+ +T+ ++V R GSEL S + S S +S
Sbjct: 1 MNCFPFNIYYGEKKGDAKGLQMQSLSGLSNNSTYGGSDVRRTGSELNSLDASDNSSDSLR 60
Query: 59 RPSYPSMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEV 118
R ++P++SQRPSNL+ FT++ELKSATKNF RSV++GEGGFGCVYKGLIK+ +DP++K+E+
Sbjct: 61 RNAFPNLSQRPSNLRVFTVSELKSATKNFGRSVMLGEGGFGCVYKGLIKSVDDPAKKIEI 120
Query: 119 AVKQLGRRG--GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSV 176
AVKQLG+RG GHKEW+TEVN LGIVEH NLVKLVGYCADDDERGIQRLLVYEYMPN S+
Sbjct: 121 AVKQLGKRGIQGHKEWVTEVNVLGIVEHPNLVKLVGYCADDDERGIQRLLVYEYMPNRSL 180
Query: 177 DQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLS 236
+ +LSP+SET L W+ RLKIAQDAARGL YLHE MDFQII RDFKSSNILLDEQWNAKLS
Sbjct: 181 EHHLSPRSETPLPWSRRLKIAQDAARGLTYLHEEMDFQIIFRDFKSSNILLDEQWNAKLS 240
Query: 237 DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPI 296
DFGLARLGPS+G THVSTAVVGTMGYAAPEY+QTGRL ++ DVWSYGVFLYELITGRRP+
Sbjct: 241 DFGLARLGPSDGLTHVSTAVVGTMGYAAPEYIQTGRLTSKIDVWSYGVFLYELITGRRPL 300
Query: 297 DRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTR 356
DRNRP+ EQ+LL+W++PYLSD K+F+ I+DPRLE K+ L+ KL+ VAN CLV+N + R
Sbjct: 301 DRNRPKGEQQLLEWIRPYLSDVKKFQIILDPRLERKHLLKSAQKLAIVANRCLVRNPKNR 360
Query: 357 PKMSEVLEMVNKIVDASAEAGSPRRPLRSSTSRETPDHTKTKHKRRIIESKTRESGTLFW 416
PKMSEVLEMV++IV++S + PL S S + T+ +K+RI++ K F
Sbjct: 361 PKMSEVLEMVDRIVESSVSTNQ-QPPLNSVASADDSQDTEINNKKRIMDPKP--DCNWFR 417
Query: 417 KWRQKLIRTC 426
WR KL+RTC
Sbjct: 418 LWRPKLLRTC 427
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297829514|ref|XP_002882639.1| hypothetical protein ARALYDRAFT_478307 [Arabidopsis lyrata subsp. lyrata] gi|297328479|gb|EFH58898.1| hypothetical protein ARALYDRAFT_478307 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 565 bits (1457), Expect = e-158, Method: Compositional matrix adjust.
Identities = 275/390 (70%), Positives = 326/390 (83%), Gaps = 10/390 (2%)
Query: 1 MKCFPFTNWDKKDEPPTTPKSLFSIRSSCATFNDNEVGRIGSELTSQNVSAISVESEA-- 58
MKCF F+ DKK E TP S+ S + F+D E+ R GSE S++VS S ES
Sbjct: 1 MKCFLFSGGDKKGEQ-KTPISV----SLTSNFSDREINRSGSEFNSRDVSGTSTESSMGR 55
Query: 59 RPSYPSMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEV 118
+ SYP+MS R SN++EF+I +LKSATKNFSRSV+IGEGGFGCV++G ++N EDPS K+EV
Sbjct: 56 KNSYPTMSTRASNIREFSITDLKSATKNFSRSVMIGEGGFGCVFRGTVRNLEDPSNKIEV 115
Query: 119 AVKQLGRRG--GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSV 176
AVKQLG+RG GHKEW+TEVNFLGIVEH+NLVKL+GYCA+DDERGIQRLLVYEYMPN SV
Sbjct: 116 AVKQLGKRGLQGHKEWVTEVNFLGIVEHKNLVKLLGYCAEDDERGIQRLLVYEYMPNRSV 175
Query: 177 DQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLS 236
+ +LSP+S T+LTW +RL+IAQDAARGL YLHE M+FQII RDFKSSNILLDE W AKLS
Sbjct: 176 EFHLSPRSLTVLTWDLRLRIAQDAARGLTYLHEEMEFQIIFRDFKSSNILLDEDWKAKLS 235
Query: 237 DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPI 296
DFGLARLGPSEG THVST VVGTMGYAAPEY+QTGRL ++SDVW YGVFLYELITGRRP+
Sbjct: 236 DFGLARLGPSEGLTHVSTDVVGTMGYAAPEYIQTGRLTSKSDVWGYGVFLYELITGRRPV 295
Query: 297 DRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTR 356
DRNRP+ EQKLL+WV+PYLSD ++F+ I+DPRLEGKY ++ V KL+ VAN CLV+N++ R
Sbjct: 296 DRNRPKGEQKLLEWVRPYLSDTRKFKLILDPRLEGKYPIKSVQKLAVVANRCLVRNSKAR 355
Query: 357 PKMSEVLEMVNKIVDASAEAGSPRR-PLRS 385
PKMSEVLEMV KIV+AS+ GSP+ PL S
Sbjct: 356 PKMSEVLEMVTKIVEASSGNGSPQLVPLNS 385
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 426 | ||||||
| TAIR|locus:2085069 | 418 | AT3G09830 [Arabidopsis thalian | 0.873 | 0.889 | 0.708 | 4.8e-142 | |
| TAIR|locus:2142639 | 420 | AT5G03320 [Arabidopsis thalian | 0.978 | 0.992 | 0.634 | 1e-139 | |
| TAIR|locus:2064920 | 435 | AT2G39110 [Arabidopsis thalian | 0.962 | 0.942 | 0.567 | 3.7e-119 | |
| TAIR|locus:2053250 | 462 | AT2G28940 [Arabidopsis thalian | 0.751 | 0.692 | 0.640 | 7e-109 | |
| TAIR|locus:2151992 | 410 | AT5G47070 [Arabidopsis thalian | 0.769 | 0.8 | 0.517 | 2.6e-86 | |
| TAIR|locus:2100282 | 490 | AT3G01300 [Arabidopsis thalian | 0.807 | 0.702 | 0.476 | 1.2e-83 | |
| TAIR|locus:2147805 | 493 | AT5G15080 [Arabidopsis thalian | 0.769 | 0.665 | 0.489 | 1.9e-83 | |
| TAIR|locus:2095517 | 453 | AT3G28690 [Arabidopsis thalian | 0.725 | 0.682 | 0.510 | 4.1e-81 | |
| TAIR|locus:2150019 | 410 | AT5G01020 [Arabidopsis thalian | 0.791 | 0.821 | 0.474 | 4.2e-79 | |
| TAIR|locus:2012492 | 426 | APK2A "protein kinase 2A" [Ara | 0.706 | 0.706 | 0.520 | 1.8e-78 |
| TAIR|locus:2085069 AT3G09830 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1389 (494.0 bits), Expect = 4.8e-142, P = 4.8e-142
Identities = 270/381 (70%), Positives = 319/381 (83%)
Query: 1 MKCFPFTNWDKKDEPPTTPKSLFSIRSSCATFNDNEVGRIGSELTSQNVSAISVESEA-- 58
MKCF F+ DK+ E T P S+ S+ S F+D E+ R GSE S++VS S ES
Sbjct: 1 MKCFLFSGGDKRGEQKT-PISV-SLTS---IFSDREINRSGSEFNSRDVSGTSTESSMGR 55
Query: 59 RPSYPSMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEV 118
+ SYP +S R SNL+EF+I +LKSATKNFSRSV+IGEGGFGCV++G ++N ED S K+EV
Sbjct: 56 KNSYPPVSTRASNLREFSITDLKSATKNFSRSVMIGEGGFGCVFRGTVRNLEDSSVKIEV 115
Query: 119 AVKQLGRRG--GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSV 176
AVKQLG+RG GHKEW+TEVNFLGIVEH NLVKL+GYCA+DDERGIQRLLVYEYMPN SV
Sbjct: 116 AVKQLGKRGLQGHKEWVTEVNFLGIVEHTNLVKLLGYCAEDDERGIQRLLVYEYMPNRSV 175
Query: 177 DQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLS 236
+ +LSP+S T+LTW +RL+IAQDAARGL YLHE M+FQII RDFKSSNILLDE W AKLS
Sbjct: 176 EFHLSPRSLTVLTWDLRLRIAQDAARGLTYLHEEMEFQIIFRDFKSSNILLDEDWKAKLS 235
Query: 237 DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPI 296
DFGLARLGPSEG THVST VVGTMGYAAPEY+QTGRL ++SDVW YGVFLYELITGRRP+
Sbjct: 236 DFGLARLGPSEGLTHVSTDVVGTMGYAAPEYIQTGRLTSKSDVWGYGVFLYELITGRRPV 295
Query: 297 DRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTR 356
DRNRP+ EQKLL+WV+PYLSD ++F+ I+DPRLEGKY ++ V KL+ VAN CLV+N++ R
Sbjct: 296 DRNRPKGEQKLLEWVRPYLSDTRKFKLILDPRLEGKYPIKSVQKLAVVANRCLVRNSKAR 355
Query: 357 PKMSEVLEMVNKIVDASAEAG 377
PKMSEVLEMVNKIV+AS+ G
Sbjct: 356 PKMSEVLEMVNKIVEASSGNG 376
|
|
| TAIR|locus:2142639 AT5G03320 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1367 (486.3 bits), Expect = 1.0e-139, P = 1.0e-139
Identities = 272/429 (63%), Positives = 327/429 (76%)
Query: 1 MKCFPFTNWDKKDEPPTTPKSLFSIRSSCATFNDNEVGRIGSELTSQNVSAIS-VESEAR 59
MKCF F DKKDE +PK + S + F+D V + GS+ + ++VS S V S R
Sbjct: 1 MKCFLFPLGDKKDEQ-RSPKPV----SPTSNFSD--VNKSGSDFSPRDVSGTSTVSSTGR 53
Query: 60 PSYPSMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVA 119
S SMS R +NL+EFTI +LKSAT+NFSRS +IGEGGFGCV+ G IKN EDPS+K+EVA
Sbjct: 54 NSNTSMSARENNLREFTIGDLKSATRNFSRSGMIGEGGFGCVFWGTIKNLEDPSKKIEVA 113
Query: 120 VKQLGRRG--GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVD 177
VKQLG+RG GHKEW+TEVNFLG+VEH NLVKL+G+CA+DDERGIQRLLVYEYMPN SV+
Sbjct: 114 VKQLGKRGLQGHKEWVTEVNFLGVVEHSNLVKLLGHCAEDDERGIQRLLVYEYMPNQSVE 173
Query: 178 QYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 237
+LSP+S T+LTW +RL+IAQDAARGL YLHE MDFQII RDFKSSNILLDE W AKLSD
Sbjct: 174 FHLSPRSPTVLTWDLRLRIAQDAARGLTYLHEEMDFQIIFRDFKSSNILLDENWTAKLSD 233
Query: 238 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPID 297
FGLARLGPS G +HVST VVGTMGYAAPEY+QTGRL ++SDVW YGVF+YELITGRRP+D
Sbjct: 234 FGLARLGPSPGSSHVSTDVVGTMGYAAPEYIQTGRLTSKSDVWGYGVFIYELITGRRPLD 293
Query: 298 RNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRP 357
RN+P+ EQKLL+WV+PYLSD ++FR IVDPRLEGKY ++ V KL+ VANLCL +NA+ RP
Sbjct: 294 RNKPKGEQKLLEWVRPYLSDTRRFRLIVDPRLEGKYMIKSVQKLAVVANLCLTRNAKARP 353
Query: 358 KMSEVLEMVNKIVDASAEAGXXXXXXXXXXXXXXXDHTKTKHKRRIIESKTRESGTLFWK 417
KMSEVLEMV KIV+AS+ + +++++ E G L
Sbjct: 354 KMSEVLEMVTKIVEASSPGNGGKKPQLVPLKSQETSRVEEGKNKKVLDGA--EGGWLEKL 411
Query: 418 WRQKLIRTC 426
W K +R C
Sbjct: 412 WNPKNVRAC 420
|
|
| TAIR|locus:2064920 AT2G39110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1173 (418.0 bits), Expect = 3.7e-119, P = 3.7e-119
Identities = 244/430 (56%), Positives = 307/430 (71%)
Query: 1 MKCFPFTNWDKKDEPPTTPKSLFSIRSSCATFNDNEVGRIGSELTSQNVSAISVESEARP 60
MKCF F+ +D+ T K F AT G GSE S +A S+ S
Sbjct: 16 MKCFYFSKDKTQDDEAKTRK--FG----SATMAR---GGSGSEFNSDTSTATSITS---- 62
Query: 61 SYPSMSQRPSN-LKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVA 119
S +S+ SN LK F + +LK+ATKNFSRS++IGEGGFG V++G+I+N +D +K+++A
Sbjct: 63 SLHVLSETHSNNLKVFVLDDLKTATKNFSRSLMIGEGGFGGVFRGVIQNPQDSRKKIDIA 122
Query: 120 VKQLGRRG--GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVD 177
VKQL RRG GHKEW+TEVN LG+VEH NLVKL+GYCA+DDERGIQRLLVYEY+ N SV
Sbjct: 123 VKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLVYEYVQNRSVQ 182
Query: 178 QYLSPKS-ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLS 236
+LS + T L W+ RLKIAQD ARGLAYLH+GM+FQII RDFKSSNILLDE WNAKLS
Sbjct: 183 DHLSNRFIVTPLPWSTRLKIAQDTARGLAYLHQGMEFQIIFRDFKSSNILLDENWNAKLS 242
Query: 237 DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPI 296
DFGLAR+GPS+G THVSTAVVGT+GYAAPEY+QTG L A+SDVWSYG+FLYELITGRRP
Sbjct: 243 DFGLARMGPSDGITHVSTAVVGTIGYAAPEYIQTGHLTAKSDVWSYGIFLYELITGRRPF 302
Query: 297 DRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTR 356
DRNRPR+EQ +L+W++P+LSD K+F+ I+DPRLEG Y L+ KL+ VAN CL+ A+ R
Sbjct: 303 DRNRPRNEQNILEWIRPHLSDIKKFKMIIDPRLEGNYYLKSALKLAAVANRCLMVKAKAR 362
Query: 357 PKMSEVLEMVNKIVDASAE-AGXXXXXXXXXXXXXXXDHTKTKH-KRRIIESKTRESGTL 414
P MS+V EM+ +IV+ S++ A + ++ + KRR +E E+G
Sbjct: 363 PTMSQVSEMLERIVETSSDGAPSGLPLMKSLTPKDAFEASRRERVKRRFVELLIGENGCP 422
Query: 415 -FWKWRQKLI 423
W KL+
Sbjct: 423 NLPTWSHKLV 432
|
|
| TAIR|locus:2053250 AT2G28940 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1076 (383.8 bits), Expect = 7.0e-109, P = 7.0e-109
Identities = 214/334 (64%), Positives = 264/334 (79%)
Query: 56 SEARPSYPS-MSQR------PSN-LKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIK 107
S R ++P +SQR P N LK FT ELK ATK F+R ++IGEGGFGCVY+G++
Sbjct: 63 SPERLTFPKPLSQRWIGGLVPENDLKVFTFKELKIATKGFNRGLLIGEGGFGCVYRGVVD 122
Query: 108 NSEDPS--QKVEVAVKQLGRRG--GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQ 163
S+ K+ VAVKQL R+G GHKEW+ EVNFLG+V H NLVKLVGYCADDDERG+Q
Sbjct: 123 VSDSNGFDSKINVAVKQLNRQGLQGHKEWINEVNFLGVVNHPNLVKLVGYCADDDERGMQ 182
Query: 164 RLLVYEYMPNGSVDQYLSPKSETI-LTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKS 222
RLLVYE M N S++ +L + ++ L W MRLKIAQDAA+GLAYLHE MDFQ+I RDFKS
Sbjct: 183 RLLVYELMCNKSLEDHLVGRVVSVSLPWMMRLKIAQDAAQGLAYLHEEMDFQLIFRDFKS 242
Query: 223 SNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSY 282
SNILLDE++ AKLSDFGLAR GP EG HVST+VVGT+GYAAPEYVQTG+L A+SDVWS+
Sbjct: 243 SNILLDERFGAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGKLTAKSDVWSF 302
Query: 283 GVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKY-SLRLVSKL 341
GV LYELITGRR +DRNRPR EQKLL+WVKPY+SD+K+F IVDPRLEG+Y ++ V ++
Sbjct: 303 GVVLYELITGRRAVDRNRPRGEQKLLEWVKPYVSDSKKFHLIVDPRLEGQYYCMKSVQRV 362
Query: 342 SHVANLCLVKNARTRPKMSEVLEMVNKIVDASAE 375
+ +AN CL+K ++RPKMSEV+ ++ +I+D AE
Sbjct: 363 AALANKCLMKQPKSRPKMSEVVSLLGRIIDEEAE 396
|
|
| TAIR|locus:2151992 AT5G47070 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 863 (308.9 bits), Expect = 2.6e-86, P = 2.6e-86
Identities = 176/340 (51%), Positives = 238/340 (70%)
Query: 43 ELTSQN-VSAISVES-EARPSYPSM----SQRPSNLKEFTIAELKSATKNFSRSVVIGEG 96
ELT+++ S+ ++++ + PS S+ ++R NL+ F+ EL AT FSR +VIGEG
Sbjct: 36 ELTNRSETSSFNLQTPRSLPSPRSIKDLYTEREQNLRVFSYEELSKATYVFSRKLVIGEG 95
Query: 97 GFGCVYKG-LIKNSEDPSQKVEVAVKQLGRRG--GHKEWMTEVNFLGIVEHQNLVKLVGY 153
GFG VYKG ++ N + + VA+K+L R+G GHK+W+ EV FLG+V H N+VKL+GY
Sbjct: 96 GFGIVYKGKILSNGDSSDPPLVVAIKKLNRQGLQGHKQWLAEVQFLGVVNHPNVVKLIGY 155
Query: 154 CADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDF 213
C++D E GI+RLLVYEYM N S++ +L P+ L W RL+I AA GL YLH D
Sbjct: 156 CSEDGETGIERLLVYEYMSNRSLEDHLFPRRSHTLPWKKRLEIMLGAAEGLTYLH---DL 212
Query: 214 QIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRL 273
++I RDFKSSN+LLD+Q+ KLSDFGLAR GP THV+TA VGT GYAAPEYVQTG L
Sbjct: 213 KVIYRDFKSSNVLLDDQFCPKLSDFGLAREGPDGDNTHVTTARVGTHGYAAPEYVQTGHL 272
Query: 274 AARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKY 333
+SDV+S+GV LYE+ITGRR I+RN+P +E++LL WVK Y +D+++F IVDPRL Y
Sbjct: 273 RLKSDVYSFGVVLYEIITGRRTIERNKPVAERRLLDWVKEYPADSQRFSMIVDPRLRNNY 332
Query: 334 SLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 373
L+ +A+LCL KN + RP M V+E + KI++ S
Sbjct: 333 PAAGARSLAKLADLCLKKNDKERPTMEIVVERLKKIIEES 372
|
|
| TAIR|locus:2100282 AT3G01300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 838 (300.0 bits), Expect = 1.2e-83, P = 1.2e-83
Identities = 171/359 (47%), Positives = 242/359 (67%)
Query: 17 TTPKSLFSIRSSCATFNDNEVGRIGSELTSQNVSAISVESEARPSYPSMSQRPSNLKEFT 76
T S +S+ ND VG + S T+ N + S + P S+LK+F+
Sbjct: 70 TLSTSTVGSQSAIVQSNDQPVGPVSSTTTTSNAES----SLSTPIISEELNIYSHLKKFS 125
Query: 77 IAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSED----PSQKVEVAVKQLGRRG--GHK 130
+LK AT+NF ++GEGGFGCV+KG ++ + P + VAVK L G GHK
Sbjct: 126 FIDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNPDGLQGHK 185
Query: 131 EWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTW 190
EW+ E+N+LG + H NLVKLVGYC +DD QRLLVYE+MP GS++ +L +S L W
Sbjct: 186 EWLAEINYLGNLLHPNLVKLVGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLP-LPW 240
Query: 191 AMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFT 250
++R+KIA AA+GL++LHE +I RDFK+SNILLD ++NAKLSDFGLA+ P EG T
Sbjct: 241 SIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDAPDEGKT 300
Query: 251 HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQW 310
HVST V+GT GYAAPEYV TG L ++SDV+S+GV L E++TGRR +D+NRP E L++W
Sbjct: 301 HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 360
Query: 311 VKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 369
+P+L D ++F +++DPRLEG +S++ K++ +A CL ++++ RPKMSEV+E++ +
Sbjct: 361 ARPHLLDKRRFYRLLDPRLEGHFSVKGAQKVTQLAAQCLSRDSKIRPKMSEVVEVLKPL 419
|
|
| TAIR|locus:2147805 AT5G15080 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 836 (299.3 bits), Expect = 1.9e-83, P = 1.9e-83
Identities = 168/343 (48%), Positives = 235/343 (68%)
Query: 33 NDNEVGRIGSELTSQNVSAISVESEARPSYPSMSQRPSNLKEFTIAELKSATKNFSRSVV 92
ND VG++ S T+ N + S + P S+L++FT +LK +T+NF +
Sbjct: 92 NDQPVGQVSSTTTTSNAES----SSSTPVISEELNISSHLRKFTFNDLKLSTRNFRPESL 147
Query: 93 IGEGGFGCVYKGLIKNSED----PSQKVEVAVKQLGRRG--GHKEWMTEVNFLGIVEHQN 146
+GEGGFGCV+KG I+ + P + VAVK L G GHKEW+ E+NFLG + H N
Sbjct: 148 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNPDGLQGHKEWLAEINFLGNLLHPN 207
Query: 147 LVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAY 206
LVKLVGYC +DD QRLLVYE+MP GS++ +L +S L W++R+KIA AA+GL++
Sbjct: 208 LVKLVGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALGAAKGLSF 262
Query: 207 LHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPE 266
LHE +I RDFK+SNILLD +NAKLSDFGLA+ P EG THVST V+GT GYAAPE
Sbjct: 263 LHEEALKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPDEGKTHVSTRVMGTYGYAAPE 322
Query: 267 YVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVD 326
YV TG L ++SDV+S+GV L E++TGRR +D+NRP E L++W +P+L D ++F +++D
Sbjct: 323 YVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLLDKRRFYRLLD 382
Query: 327 PRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 369
PRLEG +S++ K++ +A CL ++ + RPKMS+V+E + +
Sbjct: 383 PRLEGHFSIKGAQKVTQLAAQCLSRDPKIRPKMSDVVEALKPL 425
|
|
| TAIR|locus:2095517 AT3G28690 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 814 (291.6 bits), Expect = 4.1e-81, P = 4.1e-81
Identities = 165/323 (51%), Positives = 228/323 (70%)
Query: 56 SEARPSYPSMS---QRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSED- 111
+E+ S P MS + S L+ F +LK AT+NF ++GEGGFGCV+KG I+ +
Sbjct: 69 AESGSSTPLMSGELKYSSKLRIFMFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTA 128
Query: 112 ---PSQKVEVAVKQLGRRG--GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLL 166
P + VAVK L G GHKEW+ E+NFLG + H +LVKLVGYC ++D QRLL
Sbjct: 129 PVKPGTGLTVAVKTLNPDGLQGHKEWLAEINFLGNLVHPSLVKLVGYCMEED----QRLL 184
Query: 167 VYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNIL 226
VYE+MP GS++ +L ++ L W++R+KIA AA+GLA+LHE + +I RDFK+SNIL
Sbjct: 185 VYEFMPRGSLENHLFRRTLP-LPWSVRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNIL 243
Query: 227 LDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFL 286
LD ++NAKLSDFGLA+ P E +HVST V+GT GYAAPEYV TG L +SDV+S+GV L
Sbjct: 244 LDGEYNAKLSDFGLAKDAPDEKKSHVSTRVMGTYGYAAPEYVMTGHLTTKSDVYSFGVVL 303
Query: 287 YELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVAN 346
E++TGRR +D++RP EQ L++WV+P+L D K+F +++DPRLEG YS++ K + VA
Sbjct: 304 LEILTGRRSVDKSRPNGEQNLVEWVRPHLLDKKRFYRLLDPRLEGHYSIKGAQKATQVAA 363
Query: 347 LCLVKNARTRPKMSEVLEMVNKI 369
CL ++++ RPKMSEV+E + +
Sbjct: 364 QCLNRDSKARPKMSEVVEALKPL 386
|
|
| TAIR|locus:2150019 AT5G01020 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 795 (284.9 bits), Expect = 4.2e-79, P = 4.2e-79
Identities = 166/350 (47%), Positives = 228/350 (65%)
Query: 26 RSSCATFNDNEVGRIGSELTSQNVSAISVESEARPSYPSMSQRPSNLKE---FTIAELKS 82
R A F + + S++VS +S S P + S+ P + + FT+ EL++
Sbjct: 7 RDEAAVFTPQAQAQQLQKKHSRSVSDLSDPST--PRFRDDSRTPISYAQVIPFTLFELET 64
Query: 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQK-VEVAVKQLGRRG--GHKEWMTEVNFL 139
TK+F ++GEGGFG VYKG I ++ K + VAVK L + G GH+EW+TEVNFL
Sbjct: 65 ITKSFRPDYILGEGGFGTVYKGYIDDNLRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFL 124
Query: 140 GIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQD 199
G + H NLVKL+GYC +DD R LLVYE+M GS++ +L K+ L+W+ R+ IA
Sbjct: 125 GQLRHPNLVKLIGYCCEDDHR----LLVYEFMLRGSLENHLFRKTTAPLSWSRRMMIALG 180
Query: 200 AARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGT 259
AA+GLA+LH + +I RDFK+SNILLD + AKLSDFGLA+ GP THVST V+GT
Sbjct: 181 AAKGLAFLHNA-ERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGT 239
Query: 260 MGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 319
GYAAPEYV TG L ARSDV+S+GV L E++TGR+ +D+ RP EQ L+ W +P L+D +
Sbjct: 240 YGYAAPEYVMTGHLTARSDVYSFGVVLLEMLTGRKSVDKTRPSKEQNLVDWARPKLNDKR 299
Query: 320 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 369
+ QI+DPRLE +YS+R K +A CL +N + RP MS+V+E + +
Sbjct: 300 KLLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL 349
|
|
| TAIR|locus:2012492 APK2A "protein kinase 2A" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 789 (282.8 bits), Expect = 1.8e-78, P = 1.8e-78
Identities = 163/313 (52%), Positives = 217/313 (69%)
Query: 71 NLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSE----DPSQKVEVAVKQLGRR 126
NLK FT ELK+ATKNF + ++GEGGFGCV+KG I + P + VAVKQL
Sbjct: 70 NLKAFTFNELKNATKNFRQDNLLGEGGFGCVFKGWIDQTSLTASRPGSGIVVAVKQLKPE 129
Query: 127 G--GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKS 184
G GHKEW+TEVN+LG + H NLV LVGYCA+ G RLLVYE+MP GS++ +L +
Sbjct: 130 GFQGHKEWLTEVNYLGQLSHPNLVLLVGYCAE----GENRLLVYEFMPKGSLENHLFRRG 185
Query: 185 ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLG 244
LTWA+R+K+A AA+GL +LHE Q+I RDFK++NILLD +NAKLSDFGLA+ G
Sbjct: 186 AQPLTWAIRMKVAVGAAKGLTFLHEAKS-QVIYRDFKAANILLDADFNAKLSDFGLAKAG 244
Query: 245 PSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSE 304
P+ THVST V+GT GYAAPEYV TGRL A+SDV+S+GV L ELI+GRR +D + +E
Sbjct: 245 PTGDNTHVSTKVIGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELISGRRAMDNSNGGNE 304
Query: 305 QKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 364
L+ W PYL D ++ +I+D +L G+Y + +++A CL +A+ RPKMSEVL
Sbjct: 305 YSLVDWATPYLGDKRKLFRIMDTKLGGQYPQKGAFTAANLALQCLNPDAKLRPKMSEVLV 364
Query: 365 MVNKIVDASAEAG 377
+ ++ ++ A+ G
Sbjct: 365 TLEQL-ESVAKPG 376
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 426 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-47 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-47 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 6e-47 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-46 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-46 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-45 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-45 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-34 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-34 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-34 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-32 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-32 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-31 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-29 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-29 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-28 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-28 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-28 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-28 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 7e-28 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 8e-28 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-27 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-26 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-26 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-26 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 6e-26 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-25 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-24 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-24 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-24 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-23 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-23 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-23 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-23 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-23 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 7e-23 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-22 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-22 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-22 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-22 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-22 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-22 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-22 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-22 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-22 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-21 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-21 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-21 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-21 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-21 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-21 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-21 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 5e-21 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-21 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 7e-21 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-20 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-20 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-20 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-20 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-20 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-20 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-20 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-20 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-20 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-20 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 8e-20 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 9e-20 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 9e-20 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-19 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-19 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-19 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-19 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-19 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-19 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-19 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-19 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-19 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-19 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-19 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-19 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-19 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-19 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-19 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-19 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 6e-19 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 6e-19 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 8e-19 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-18 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-18 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-18 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-18 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-18 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-18 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-18 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-18 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-18 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 7e-18 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 7e-18 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 7e-18 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 8e-18 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-17 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-17 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-17 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-17 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-17 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-17 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-17 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-17 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-17 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-17 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 5e-17 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 6e-17 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-17 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-17 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-17 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 8e-17 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 9e-17 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-16 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-16 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-16 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-16 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-16 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-16 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-16 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-16 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-16 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-16 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 5e-16 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 7e-16 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 9e-16 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 9e-16 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-15 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-15 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-15 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-15 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-15 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-15 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-15 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-15 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-15 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-15 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-15 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-15 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-15 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-15 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-15 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 5e-15 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 5e-15 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-15 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 6e-15 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 7e-15 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 8e-15 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 8e-15 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-14 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-14 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-14 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-14 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-14 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-14 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-14 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-14 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-14 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-14 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-14 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-14 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-14 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-14 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-14 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-14 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 6e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-14 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 7e-14 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 8e-14 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 8e-14 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 9e-14 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-13 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-13 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-13 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-13 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-13 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-13 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-13 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-13 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-13 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 4e-13 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-13 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-13 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-13 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-13 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 5e-13 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-13 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 6e-13 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 7e-13 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 7e-13 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 7e-13 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 7e-13 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 7e-13 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 8e-13 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 9e-13 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-12 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-12 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-12 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-12 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-12 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-12 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 8e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 9e-12 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-11 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-11 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-11 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-11 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-11 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-11 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-11 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-11 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 5e-11 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 6e-11 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 7e-11 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 7e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 8e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-10 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-10 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-10 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-10 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-10 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-10 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-10 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-10 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-10 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-10 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 5e-10 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 6e-10 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 6e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 6e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 6e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 7e-10 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 7e-10 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 9e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-09 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-09 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-09 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-09 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 5e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 6e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 8e-09 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-08 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-08 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-08 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-08 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-08 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-08 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-08 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 4e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 7e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 7e-08 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 7e-08 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 8e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 8e-08 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-07 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 7e-07 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 8e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 9e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 9e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 9e-07 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 4e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 5e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 6e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 9e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 9e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 6e-05 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 7e-05 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 9e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.001 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.001 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 163 bits (415), Expect = 1e-47
Identities = 78/278 (28%), Positives = 111/278 (39%), Gaps = 36/278 (12%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL---GRRGGHKEWMTEVNFLGIVEHQNLV 148
+GEG FG VY K + VA+K + + + + E+ L ++H N+V
Sbjct: 6 KLGEGSFGKVYLARDKKT-----GKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 149 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLH 208
+L D+D+ LV EY G + L K L+ + L YLH
Sbjct: 61 RLYDVFEDEDKL----YLVMEYCEGGDLFDLL--KKRGRLSEDEARFYLRQILSALEYLH 114
Query: 209 EGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYV 268
I+ RD K NILLDE + KL+DFGLAR VGT Y APE +
Sbjct: 115 ---SKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTT---FVGTPEYMAPEVL 168
Query: 269 QTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPR 328
D+WS GV LYEL+TG+ P + + F++I P+
Sbjct: 169 LGKGYGKAVDIWSLGVILYELLTGKPPFPGD---------------DQLLELFKKIGKPK 213
Query: 329 LEGKYSLRLVSK-LSHVANLCLVKNARTRPKMSEVLEM 365
+S + LVK+ R E L+
Sbjct: 214 PPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQH 251
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 3e-47
Identities = 73/212 (34%), Positives = 110/212 (51%), Gaps = 21/212 (9%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGH-----KEWMTEVNFLGIVEHQN 146
+GEG FG VYKG +K ++VEVAVK L + +E++ E + ++H N
Sbjct: 6 KLGEGAFGEVYKGTLKGK-GDGKEVEVAVKTL--KEDASEQQIEEFLREARIMRKLDHPN 62
Query: 147 LVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAY 206
+VKL+G C +++ ++V EYMP G + YL L+ + L A ARG+ Y
Sbjct: 63 IVKLLGVCTEEE----PLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEY 118
Query: 207 LHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYA--A 264
L I RD + N L+ E K+SDFGL+R + + V G + A
Sbjct: 119 LESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKG---GKLPIRWMA 172
Query: 265 PEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 295
PE ++ G+ ++SDVWS+GV L+E+ T G P
Sbjct: 173 PESLKEGKFTSKSDVWSFGVLLWEIFTLGEEP 204
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 6e-47
Identities = 73/202 (36%), Positives = 100/202 (49%), Gaps = 20/202 (9%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL---GRRGGHKEWMTEVNFLGIVEHQNLVK 149
+GEGGFG VY K + +VA+K + +E + E+ L + H N+VK
Sbjct: 1 LGEGGFGTVYLARDKKT-----GKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVK 55
Query: 150 LVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHE 209
L G D++ + V EY GS+ L ++E L+ L+I GL YLH
Sbjct: 56 LYGVFEDENHLYL----VMEYCEGGSLKDLLK-ENEGKLSEDEILRILLQILEGLEYLHS 110
Query: 210 GMDFQIIVRDFKSSNILLDE-QWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPE-Y 267
II RD K NILLD KL+DFGL++L S+ +VGT Y APE
Sbjct: 111 ---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSL--LKTIVGTPAYMAPEVL 165
Query: 268 VQTGRLAARSDVWSYGVFLYEL 289
+ G + +SD+WS GV LYEL
Sbjct: 166 LGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 160 bits (408), Expect = 1e-46
Identities = 68/215 (31%), Positives = 105/215 (48%), Gaps = 20/215 (9%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL---GRRGGHKEWMTEVNFLGIVEHQNLV 148
+GEG FG VYKG +K + EVAVK L K+++ E + + H N+V
Sbjct: 2 KLGEGAFGEVYKGKLKGK--DGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVV 59
Query: 149 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYL-------SPKSETILTWAMRLKIAQDAA 201
+L+G C +++ LV EYM G + YL ++ L+ L A A
Sbjct: 60 RLLGVCTEEEPL----YLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIA 115
Query: 202 RGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMG 261
+G+ YL + + RD + N L+ E K+SDFGL+R + + T +
Sbjct: 116 KGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR 172
Query: 262 YAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 295
+ APE ++ G ++SDVWS+GV L+E+ T G P
Sbjct: 173 WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATP 207
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 3e-46
Identities = 71/213 (33%), Positives = 106/213 (49%), Gaps = 24/213 (11%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGH-----KEWMTEVNFLGIVEHQN 146
+GEG FG VYKG +K +KVEVAVK L + +E++ E + ++H N
Sbjct: 6 KLGEGAFGEVYKGKLKGK-GGKKKVEVAVKTL--KEDASEQQIEEFLREARIMRKLDHPN 62
Query: 147 LVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAY 206
+VKL+G C +++ +V EYM G + YL + + + L A ARG+ Y
Sbjct: 63 VVKLLGVCTEEEPL----YIVMEYMEGGDLLSYLRKNRPKL-SLSDLLSFALQIARGMEY 117
Query: 207 LHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMG---YA 263
L I RD + N L+ E K+SDFGL+R G +
Sbjct: 118 LESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD----DDYYRKRGGKLPIRWM 170
Query: 264 APEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 295
APE ++ G+ ++SDVWS+GV L+E+ T G +P
Sbjct: 171 APESLKEGKFTSKSDVWSFGVLLWEIFTLGEQP 203
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 157 bits (400), Expect = 2e-45
Identities = 68/211 (32%), Positives = 106/211 (50%), Gaps = 19/211 (9%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEW---MTEVNFLGIVEHQNLV 148
+GEG FG VYKG +K + + +VAVK L +E + E + + + H N+V
Sbjct: 6 KLGEGAFGEVYKGTLKGDGE-GTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIV 64
Query: 149 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLH 208
+L+G C + +V EYMP G + +L K LT L++A A+G+ YL
Sbjct: 65 RLLGVCTQGE----PLYIVTEYMPGGDLLDFL-RKHGEKLTLKDLLQMALQIAKGMEYLE 119
Query: 209 EGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMG---YAAP 265
+ RD + N L+ E K+SDFGL+R + + G + AP
Sbjct: 120 SK---NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRG---GGKLPIKWMAP 173
Query: 266 EYVQTGRLAARSDVWSYGVFLYELIT-GRRP 295
E ++ G+ ++SDVWS+GV L+E+ T G +P
Sbjct: 174 ESLKDGKFTSKSDVWSFGVLLWEIFTLGEQP 204
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 157 bits (398), Expect = 3e-45
Identities = 92/285 (32%), Positives = 121/285 (42%), Gaps = 36/285 (12%)
Query: 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIV 142
+ +G G FG VYK K + VAVK L +R + E+ L +
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGK-----IVAVKILKKRSEKSKKDQTARREIRILRRL 55
Query: 143 EHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAAR 202
H N+V+L+ D D LV EY G + YLS L+ KIA R
Sbjct: 56 SHPNIVRLIDAFEDKDHL----YLVMEYCEGGDLFDYLS--RGGPLSEDEAKKIALQILR 109
Query: 203 GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGY 262
GL YLH II RD K NILLDE K++DFGLA+ + T VGT Y
Sbjct: 110 GLEYLHS---NGIIHRDLKPENILLDENGVVKIADFGLAKKL--LKSSSSLTTFVGTPWY 164
Query: 263 AAPEYVQTGRLA-ARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 321
APE + G + DVWS GV LYEL+TG+ P + +L
Sbjct: 165 MAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQL-------------I 211
Query: 322 RQIVDPRLEG--KYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 364
R+I+ P LE + + CL K+ RP E+L+
Sbjct: 212 RRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 1e-34
Identities = 91/286 (31%), Positives = 129/286 (45%), Gaps = 48/286 (16%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG----HKEWMTEVNFLGIVEHQNL 147
+G G G V K L + P+ K+ +AVK + R K+ + E++ L +
Sbjct: 8 ELGAGNSGVVSKVLHR----PTGKI-MAVKTI-RLEINEAIQKQILRELDILHKCNSPYI 61
Query: 148 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLS----PKSETILTWAMRLKIAQDAARG 203
V G ++ + I EYM GS+D+ L E IL KIA +G
Sbjct: 62 VGFYGAFYNNGDISI----CMEYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKG 112
Query: 204 LAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYA 263
L YLHE +II RD K SNIL++ + KL DFG++ + ++ VGT Y
Sbjct: 113 LTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSG----QLVNSLAKTFVGTSSYM 166
Query: 264 APEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQ 323
APE +Q + +SD+WS G+ L EL TGR P P + +
Sbjct: 167 APERIQGNDYSVKSDIWSLGLSLIELATGRFPYP-----------PENDPPDGIFELLQY 215
Query: 324 IVD---PRL-EGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365
IV+ PRL GK+S NLCL+K+ R RP E+LE
Sbjct: 216 IVNEPPPRLPSGKFS----PDFQDFVNLCLIKDPRERPSYKELLEH 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 1e-34
Identities = 67/207 (32%), Positives = 107/207 (51%), Gaps = 11/207 (5%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHK---EWMTEVNFLGIVEHQNLVK 149
+GEG FG V D + +VAVK L G + ++ E+ L ++H+N+VK
Sbjct: 12 LGEGHFGKVELCRYDPLGD-NTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVK 70
Query: 150 LVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHE 209
G C R ++ L+ EY+P+GS+ YL + I L + +G+ YL
Sbjct: 71 YKGVCEKPGGRSLR--LIMEYLPSGSLRDYLQRHRDQINL-KRLLLFSSQICKGMDYLG- 126
Query: 210 GMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGP-SEGFTHVSTAVVGTMGYAAPEYV 268
+ I RD + NIL++ + K+SDFGLA++ P + + +V + + APE +
Sbjct: 127 --SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECL 184
Query: 269 QTGRLAARSDVWSYGVFLYELITGRRP 295
+T + ++ SDVWS+GV LYEL T P
Sbjct: 185 RTSKFSSASDVWSFGVTLYELFTYGDP 211
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 2e-34
Identities = 72/283 (25%), Positives = 121/283 (42%), Gaps = 31/283 (10%)
Query: 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQ--LGRRGGH--KEWMTEVNFLGI 141
++R ++G G FG VY L K++ + +AVK L + E+ L
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGE-----LMAVKSVELSGDSEEELEALEREIRILSS 55
Query: 142 VEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAA 201
++H N+V+ G D+++ + + EY+ GS+ L K L + K +
Sbjct: 56 LQHPNIVRYYGSERDEEKNTL--NIFLEYVSGGSLSSLL--KKFGKLPEPVIRKYTRQIL 111
Query: 202 RGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMG 261
GLAYLH I+ RD K +NIL+D KL+DFG A+ + +V GT
Sbjct: 112 EGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPY 168
Query: 262 YAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 321
+ APE ++ +D+WS G + E+ TG+ P SE + + +
Sbjct: 169 WMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPW------SELGNPMAALYKIGSSGEP 222
Query: 322 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 364
+I + L + CL ++ + RP E+L+
Sbjct: 223 PEIPE---------HLSEEAKDFLRKCLRRDPKKRPTADELLQ 256
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 2e-32
Identities = 67/208 (32%), Positives = 105/208 (50%), Gaps = 21/208 (10%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKE-WMTEVNFLGIVEHQNLVKLV 151
IG+G FG V G + QKV AVK L + ++ E + + + H NLV+L+
Sbjct: 14 IGKGEFGDVMLGDYRG-----QKV--AVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLL 66
Query: 152 GYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGM 211
G + + +V EYM GS+ YL + ++T A +L A D G+ YL E
Sbjct: 67 GVVLQGN--PL--YIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK- 121
Query: 212 DFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG 271
+ RD + N+L+ E AK+SDFGLA+ S + + + APE ++
Sbjct: 122 --NFVHRDLAARNVLVSEDLVAKVSDFGLAK---EASQGQDSGKL--PVKWTAPEALREK 174
Query: 272 RLAARSDVWSYGVFLYELIT-GRRPIDR 298
+ + +SDVWS+G+ L+E+ + GR P R
Sbjct: 175 KFSTKSDVWSFGILLWEIYSFGRVPYPR 202
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 2e-32
Identities = 74/218 (33%), Positives = 108/218 (49%), Gaps = 28/218 (12%)
Query: 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGI 141
N+ +IG G FG VYKGL + D VA+KQ+ K M E++ L
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGD-----FVAIKQISLEKIKEEALKSIMQEIDLLKN 55
Query: 142 VEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLS---PKSETILTWAMRLKIAQ 198
++H N+VK +G D I + EY NGS+ Q + P E+++ + + Q
Sbjct: 56 LKHPNIVKYIGSIETSDSLYI----ILEYAENGSLRQIIKKFGPFPESLVA----VYVYQ 107
Query: 199 DAARGLAYLHEGMDFQ-IIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVV 257
+GLAYLHE Q +I RD K++NIL + KL+DFG+A +VV
Sbjct: 108 -VLQGLAYLHE----QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS--KDDASVV 160
Query: 258 GTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRP 295
GT + APE ++ + SD+WS G + EL+TG P
Sbjct: 161 GTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 1e-31
Identities = 83/282 (29%), Positives = 118/282 (41%), Gaps = 37/282 (13%)
Query: 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHK--EWMTEVNFLGIVEH 144
F IG+GGFG VYK K + EVA+K + K + + E+ L +H
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRT-----GKEVAIKVIKLESKEKKEKIINEIQILKKCKH 56
Query: 145 QNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGL 204
N+VK G DE I V E+ GS+ L ++T LT + + ++ +GL
Sbjct: 57 PNIVKYYGSYLKKDELWI----VMEFCSGGSLKDLLKSTNQT-LTESQIAYVCKELLKGL 111
Query: 205 AYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAA 264
YLH II RD K++NILL KL DFGL+ + +VGT + A
Sbjct: 112 EYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNT---MVGTPYWMA 165
Query: 265 PEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQI 324
PE + ++D+WS G+ EL G+ P P K L +
Sbjct: 166 PEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP---MKALFKIA----------TN 212
Query: 325 VDPRLEG--KYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 364
P L K+S L CL KN RP ++L+
Sbjct: 213 GPPGLRNPEKWSDEFKDFLKK----CLQKNPEKRPTAEQLLK 250
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 1e-29
Identities = 67/215 (31%), Positives = 112/215 (52%), Gaps = 28/215 (13%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVE-VAVKQLGRRGGHKEW---MTEVNFLGIVEHQNL 147
VIG G FG V +G +K P +K VA+K L K+ +TE + +G +H N+
Sbjct: 11 VIGGGEFGEVCRGRLK---LPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNI 67
Query: 148 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYL 207
++L G + +++ EYM NGS+D++L +++ T + + + A G+ YL
Sbjct: 68 IRLEGVVT----KSRPVMIITEYMENGSLDKFLR-ENDGKFTVGQLVGMLRGIASGMKYL 122
Query: 208 HEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMG------ 261
E M++ + RD + NIL++ K+SDFGL+R S A T G
Sbjct: 123 SE-MNY--VHRDLAARNILVNSNLVCKVSDFGLSR------RLEDSEATYTTKGGKIPIR 173
Query: 262 YAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 295
+ APE + + + SDVWS+G+ ++E+++ G RP
Sbjct: 174 WTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 117 bits (293), Expect = 3e-29
Identities = 85/288 (29%), Positives = 115/288 (39%), Gaps = 35/288 (12%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEW-----MTEVNFLGIV-EHQ 145
+GEG FG VY + VA+K L ++ K + E+ L +
Sbjct: 7 KLGEGSFGEVYLAR--------DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 146 NLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYL-SPKSETILTWAMRLKIAQDAARGL 204
N+VKL + D+ LV EY+ GS++ L + L+ + L I L
Sbjct: 59 NIVKLYDFFQDEG----SLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSAL 114
Query: 205 AYLHEGMDFQIIVRDFKSSNILLDEQ-WNAKLSDFGLARLGPSEGFT----HVSTAVVGT 259
YLH II RD K NILLD KL DFGLA+L P G T + + VGT
Sbjct: 115 EYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGT 171
Query: 260 MGYAAPEYVQTGRLA---ARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS 316
GY APE + LA + SD+WS G+ LYEL+TG P + + S
Sbjct: 172 PGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQT-LKIILEL 230
Query: 317 DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 364
+ P S L L K+ + R S L
Sbjct: 231 PTPSLASPLSPSNPELISKAASDLLKK----LLAKDPKNRLSSSSDLS 274
|
Length = 384 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 112 bits (284), Expect = 1e-28
Identities = 77/289 (26%), Positives = 124/289 (42%), Gaps = 55/289 (19%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKV--EVAVKQLGRRGGHKEWMTEVNFLGIVEHQNLVK 149
IG+G FG VY L++ D V E+ + + + ++ + EV L + H N++K
Sbjct: 7 QIGKGSFGKVY--LVRRKSDGKLYVLKEIDLSNMSEKE-REDALNEVKILKKLNHPNIIK 63
Query: 150 LVGYCADDDERGIQRLL-VYEYMPNGSVDQYL--------SPKSETILTWAMRLKIAQDA 200
+ +L V EY G + Q + E IL W ++L +A
Sbjct: 64 YYESFEEKG-----KLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLA--- 115
Query: 201 ARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR-LGPSEGFTHVSTAVVGT 259
L YLH +I+ RD K NI L KL DFG+++ L + VVGT
Sbjct: 116 ---LKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA---KTVVGT 166
Query: 260 MGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 319
Y +PE Q +SD+WS G LYEL T + P + + +L
Sbjct: 167 PYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFE---GENLLEL------------ 211
Query: 320 QFRQIVD---PRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365
+I+ P + +YS S+L ++ + L K+ RP ++++L+
Sbjct: 212 -ALKILKGQYPPIPSQYS----SELRNLVSSLLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 1e-28
Identities = 67/216 (31%), Positives = 109/216 (50%), Gaps = 26/216 (12%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHK---EWMTEVNFLGIVEHQNLV 148
V+G G FG VYKG+ E K+ VA+K L K E + E + V+H ++V
Sbjct: 14 VLGSGAFGTVYKGVWI-PEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVV 72
Query: 149 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSP-----KSETILTWAMRLKIAQDAARG 203
+L+G C Q L+ + MP G + Y+ S+ +L W +++ A+G
Sbjct: 73 RLLGICL-----SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKG 121
Query: 204 LAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR-LGPSEGFTHVSTAVVGTMGY 262
++YL E +++ RD + N+L+ + K++DFGLA+ L E H V + +
Sbjct: 122 MSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKV-PIKW 177
Query: 263 AAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPID 297
A E + +SDVWSYGV ++EL+T G +P +
Sbjct: 178 MALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 3e-28
Identities = 79/283 (27%), Positives = 126/283 (44%), Gaps = 37/283 (13%)
Query: 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHK----EWMTEVNFLGI 141
+F IG+G FG V+K + K + K A+KQ+ ++ E + E L
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRK-----ADKRVYAMKQIDLSKMNRREREEAIDEARVLAK 55
Query: 142 VEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAA 201
++ +++ D + I V EY NG + + L + L +
Sbjct: 56 LDSSYIIRYYESFLDKGKLNI----VMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQIL 111
Query: 202 RGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR-LGPSEGFTHVSTAVVGTM 260
GLA+LH +I+ RD KS N+ LD N K+ D G+A+ L + F + +VGT
Sbjct: 112 LGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF---ANTIVGTP 165
Query: 261 GYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 320
Y +PE + +SDVW+ GV LYE TG+ P D N ++ L+ K
Sbjct: 166 YYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDAN---NQGALIL---------KI 213
Query: 321 FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVL 363
R + P + YS +L+ + + CL K+ R RP ++L
Sbjct: 214 IRGVFPP-VSQMYS----QQLAQLIDQCLTKDYRQRPDTFQLL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 5e-28
Identities = 77/225 (34%), Positives = 104/225 (46%), Gaps = 24/225 (10%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKV---EVAVKQLGRRGGHKEWM-TEVNFLGIVEHQNLV 148
+G+G FG V K++ K+ +V K+ + E TE N L + H +V
Sbjct: 1 LGKGSFGKVLLVRKKDTG----KLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIV 56
Query: 149 KLVGYCADDDERGIQRL-LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYL 207
KL + A E +L LV EY P G + +LS K R A+ L YL
Sbjct: 57 KL--HYAFQTEE---KLYLVLEYAPGGELFSHLS-KEGRFSEERARFYAAE-IVLALEYL 109
Query: 208 HE-GMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPE 266
H G II RD K NILLD + KL+DFGLA+ SEG + GT Y APE
Sbjct: 110 HSLG----IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPEYLAPE 163
Query: 267 YVQTGRLAARSDVWSYGVFLYELITGRRPI-DRNRPRSEQKLLQW 310
+ D WS GV LYE++TG+ P +R +K+L+
Sbjct: 164 VLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKD 208
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 7e-28
Identities = 67/220 (30%), Positives = 106/220 (48%), Gaps = 23/220 (10%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL---GRRGGHKEWMTEVNFLGIVEHQNLV 148
+GEG FG V+ G + E + K VAVK L K++ E L +H+N+V
Sbjct: 12 ELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIV 71
Query: 149 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYL-----------SPKSETI-LTWAMRLKI 196
K G C + D ++V+EYM +G ++++L SP S LT + L+I
Sbjct: 72 KFYGVCTEGD----PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQI 127
Query: 197 AQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAV 256
A A G+ YL F + RD + N L+ K+ DFG++R + + V
Sbjct: 128 AVQIASGMVYL-ASQHF--VHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHT 184
Query: 257 VGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 295
+ + + PE + + SDVWS+GV L+E+ T G++P
Sbjct: 185 MLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 8e-28
Identities = 81/283 (28%), Positives = 128/283 (45%), Gaps = 45/283 (15%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL---GRRGGHKEWMTEVNFLGIVEHQNLV 148
V+G+G G VYK K P+ K+ A+K++ G K+ + E+ L E +V
Sbjct: 8 VLGQGSSGVVYKVRHK----PTGKI-YALKKIHVDGDEEFRKQLLRELKTLRSCESPYVV 62
Query: 149 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPK---SETILTWAMRLKIAQDAARGLA 205
K Y A E I +V EYM GS+ L E +L IA+ +GL
Sbjct: 63 KC--YGAFYKEGEIS--IVLEYMDGGSLADLLKKVGKIPEPVLA-----YIARQILKGLD 113
Query: 206 YLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAP 265
YLH II RD K SN+L++ + K++DFG++++ + + VGT+ Y +P
Sbjct: 114 YLHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT--FVGTVTYMSP 169
Query: 266 EYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIV 325
E +Q + +D+WS G+ L E G+ P S +L+Q I
Sbjct: 170 ERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQ-------------AIC 216
Query: 326 D---PRL-EGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 364
D P L ++S + + CL K+ + RP +E+L+
Sbjct: 217 DGPPPSLPAEEFS----PEFRDFISACLQKDPKKRPSAAELLQ 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 6e-27
Identities = 83/254 (32%), Positives = 122/254 (48%), Gaps = 31/254 (12%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKE---WMTEVNFLGIVEHQNLV 148
V+GEG FG V + D + ++ VAVK L R G + W E+N L + H+N+V
Sbjct: 11 VLGEGHFGKVSLYCYDPANDGTGEM-VAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69
Query: 149 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLH 208
K G C++ +G+Q L+ EY+P GS+ YL PK + L A L AQ G+AYLH
Sbjct: 70 KYKGCCSEQGGKGLQ--LIMEYVPLGSLRDYL-PKHK--LNLAQLLLFAQQICEGMAYLH 124
Query: 209 EGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPS-EGFTHVSTAVVGTMGYAAPEY 267
I RD + N+LLD K+ DFGLA+ P + V + + A E
Sbjct: 125 SQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVEC 181
Query: 268 VQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDP 327
++ + + SDVWS+GV LYEL+T S K+F +++ P
Sbjct: 182 LKENKFSYASDVWSFGVTLYELLTH------------------CDSKQSPPKKFEEMIGP 223
Query: 328 RLEGKYSLRLVSKL 341
+ +RL+ L
Sbjct: 224 KQGQMTVVRLIELL 237
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-26
Identities = 72/212 (33%), Positives = 112/212 (52%), Gaps = 25/212 (11%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGR---RGGHKEWMTEVNFLGIVEHQNLVK 149
+G G FG V KG+ VEVAVK L + G KE++ E + + ++H +V+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKE--VEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 150 LVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSET----ILTWAMRLKIAQDAARGLA 205
L+G C +G +LV E P G + +YL + E + A ++ A G+A
Sbjct: 61 LIGVC-----KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQV------AMGMA 109
Query: 206 YLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR-LGPSEGFTHVSTAVVGTMGYAA 264
YL E F + RD + N+LL + AK+SDFG++R LG + +TA + + A
Sbjct: 110 YL-ESKHF--VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYA 166
Query: 265 PEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 295
PE + G+ +++SDVWSYGV L+E + G +P
Sbjct: 167 PECINYGKFSSKSDVWSYGVTLWEAFSYGAKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-26
Identities = 69/209 (33%), Positives = 103/209 (49%), Gaps = 24/209 (11%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHK--EWMTEVNFLGIVEHQNLVKL 150
+G G FG V+ G + +VAVK L + G ++ E + + H LV+L
Sbjct: 14 LGAGQFGEVWMGTWNGT------TKVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLVQL 66
Query: 151 VGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEG 210
C++++ I V EYM GS+ +L L + +A A G+AYL E
Sbjct: 67 YAVCSEEEPIYI----VTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYL-ES 121
Query: 211 MDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGT---MGYAAPEY 267
++ I RD + NIL+ E K++DFGLARL + +T A G + + APE
Sbjct: 122 RNY--IHRDLAARNILVGENLVCKIADFGLARLIEDDEYT----AREGAKFPIKWTAPEA 175
Query: 268 VQTGRLAARSDVWSYGVFLYELIT-GRRP 295
GR +SDVWS+G+ L E++T GR P
Sbjct: 176 ANYGRFTIKSDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 4e-26
Identities = 82/292 (28%), Positives = 121/292 (41%), Gaps = 35/292 (11%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG---HKEWMTEVNFLGIVEHQNLVK 149
+GEG G V K +KN+ + A+K + K+ + E+ + +VK
Sbjct: 9 LGEGAGGSVTKCRLKNT-----GMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVK 63
Query: 150 LVGYCADDDERGIQRLLVYEYMPNGSVDQ-YLSPKSETILTWAMRL-KIAQDAARGLAYL 207
G D+ I + EY GS+D Y K L KIA+ +GL+YL
Sbjct: 64 YYGAFLDESSSSIG--IAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYL 121
Query: 208 HEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEY 267
H +II RD K SNILL + KL DFG++ E ++ GT Y APE
Sbjct: 122 HSR---KIIHRDIKPSNILLTRKGQVKLCDFGVS----GELVNSLAGTFTGTSFYMAPER 174
Query: 268 VQTGRLAARSDVWSYGVFLYELITGRRPI--DRNRPRSEQKLLQWVKPYLSDAKQFRQIV 325
+Q + SDVWS G+ L E+ R P + P +LL Y+ +
Sbjct: 175 IQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLS----YIVNMPNPELKD 230
Query: 326 DPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE------MVNKIVD 371
+P K+S + CL K+ RP ++LE + K V+
Sbjct: 231 EPGNGIKWS----EEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKKVN 278
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 6e-26
Identities = 65/201 (32%), Positives = 98/201 (48%), Gaps = 17/201 (8%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGR--RGGHKEWMTEVNFLGIVEHQNLVKL 150
+G G FG V++GL KN V VA+K L +++ EV L + H++L+ L
Sbjct: 14 LGSGYFGEVWEGLWKNR------VRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 151 VGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEG 210
C+ + I + E M GS+ +L +L A + +A A G+AYL E
Sbjct: 68 FAVCSVGEPVYI----ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ 123
Query: 211 MDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT 270
I RD + NIL+ E K++DFGLARL + + + + APE
Sbjct: 124 ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASH 178
Query: 271 GRLAARSDVWSYGVFLYELIT 291
G + +SDVWS+G+ LYE+ T
Sbjct: 179 GTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 81/292 (27%), Positives = 121/292 (41%), Gaps = 51/292 (17%)
Query: 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWM-TEVNFLGIV 142
+ + IGEG G VYK + + EVA+K++ R +KE + E+ +
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRAT-----GKEVAIKKMRLRKQNKELIINEILIMKDC 72
Query: 143 EHQNLVKLVGYCADDDERGIQRL-LVYEYMPNGS----VDQYLSPKSETILTWAMRLKIA 197
+H N+V DE L +V EYM GS + Q +E + + +
Sbjct: 73 KHPNIVDYYDSYLVGDE-----LWVVMEYMDGGSLTDIITQNFVRMNEPQIAY-----VC 122
Query: 198 QDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVV 257
++ +GL YLH +I RD KS NILL + + KL+DFG A E S VV
Sbjct: 123 REVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VV 177
Query: 258 GTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 317
GT + APE ++ + D+WS G+ E+ G PYL +
Sbjct: 178 GTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG------------------EPPYLRE 219
Query: 318 --AKQFRQIVD---PRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 364
+ I P L K + + N CLVK+ RP E+L+
Sbjct: 220 PPLRALFLITTKGIPPL--KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-24
Identities = 64/220 (29%), Positives = 107/220 (48%), Gaps = 20/220 (9%)
Query: 88 SRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--GHKEWMTEVNFLGIVEHQ 145
+ IG G FG V+ G K +VA+K + R G ++++ E + + H
Sbjct: 7 TLVQEIGSGQFGLVWLGYWLE------KRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHP 59
Query: 146 NLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLA 205
LV+L G C + LV+E+M +G + YL + + L + D G+A
Sbjct: 60 KLVQLYGVCTERSPI----CLVFEFMEHGCLSDYLRAQRGKFSQETL-LGMCLDVCEGMA 114
Query: 206 YLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAP 265
YL +I RD + N L+ E K+SDFG+ R + +T ST + +++P
Sbjct: 115 YLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS-STGTKFPVKWSSP 170
Query: 266 EYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSE 304
E + +++SDVWS+GV ++E+ + G+ P + NR SE
Sbjct: 171 EVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYE-NRSNSE 209
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 5e-24
Identities = 67/210 (31%), Positives = 105/210 (50%), Gaps = 26/210 (12%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGH---KEWMTEVNFLGIVEHQNLVK 149
+G G FG V++GL N+ VAVK L + G K+++ E + + H L++
Sbjct: 14 LGAGQFGEVWEGLWNNT------TPVAVKTL--KPGTMDPKDFLAEAQIMKKLRHPKLIQ 65
Query: 150 LVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHE 209
L C ++ I V E M GS+ +YL + L + +A A G+AYL E
Sbjct: 66 LYAVCTLEEPIYI----VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYL-E 120
Query: 210 GMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGT---MGYAAPE 266
++ I RD + N+L+ E K++DFGLAR+ + + A G + + APE
Sbjct: 121 AQNY--IHRDLAARNVLVGENNICKVADFGLARVIKED----IYEAREGAKFPIKWTAPE 174
Query: 267 YVQTGRLAARSDVWSYGVFLYELIT-GRRP 295
R + +SDVWS+G+ L E++T GR P
Sbjct: 175 AALYNRFSIKSDVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 5e-24
Identities = 68/212 (32%), Positives = 102/212 (48%), Gaps = 25/212 (11%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKE--WMTEVNFLGIVEHQNLVKL 150
+G G FG V+ G + D VA+K + R G E ++ E + + H NLV+L
Sbjct: 12 LGSGQFGVVHLGKWRGKID------VAIKMI-REGAMSEDDFIEEAKVMMKLSHPNLVQL 64
Query: 151 VGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEG 210
G C +R I +V EYM NG + YL + L L + D + YL
Sbjct: 65 YGVCTK--QRPI--FIVTEYMANGCLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLESN 119
Query: 211 MDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGT---MGYAAPEY 267
I RD + N L+ E K+SDFGLAR + +T + GT + +A PE
Sbjct: 120 ---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT----SSQGTKFPVKWAPPEV 172
Query: 268 VQTGRLAARSDVWSYGVFLYELIT-GRRPIDR 298
R +++SDVWS+GV ++E+ + G+ P +R
Sbjct: 173 FDYSRFSSKSDVWSFGVLMWEVFSEGKMPYER 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 2e-23
Identities = 65/210 (30%), Positives = 116/210 (55%), Gaps = 17/210 (8%)
Query: 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL---GRRGGHKEWMTEVNFLGIVEHQNL 147
V +G G FGCV KG+ K ++++VA+K L + E M E + +++ +
Sbjct: 1 VELGSGNFGCVKKGVYKMR---KKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYI 57
Query: 148 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYL 207
V+++G C + +LV E G ++++LS K + I T + +++ + G+ YL
Sbjct: 58 VRMIGVCEAEA-----LMLVMEMASGGPLNKFLSGKKDEI-TVSNVVELMHQVSMGMKYL 111
Query: 208 HEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR-LGPSEGFTHVSTAVVGTMGYAAPE 266
EG +F + RD + N+LL Q AK+SDFGL++ LG + + +A + + APE
Sbjct: 112 -EGKNF--VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPE 168
Query: 267 YVQTGRLAARSDVWSYGVFLYELIT-GRRP 295
+ + ++RSDVWSYG+ ++E + G++P
Sbjct: 169 CINFRKFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 2e-23
Identities = 95/309 (30%), Positives = 123/309 (39%), Gaps = 89/309 (28%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTE----------------- 135
IG G FG V K L K S +AVK++ KE
Sbjct: 12 IGRGAFGTVNKMLHKPS-----GTIMAVKRIRSTVDEKE-QKRLLMDLDVVMRSSDCPYI 65
Query: 136 VNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQ-----YLSPKS---ETI 187
V F G + + G C + E M + S+D+ Y KS E I
Sbjct: 66 VKFYGALFRE------GDC----------WICMELM-DISLDKFYKYVYEVLKSVIPEEI 108
Query: 188 LTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA-RLGPS 246
L KIA + L YL E + +II RD K SNILLD N KL DFG++ +L S
Sbjct: 109 LG-----KIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161
Query: 247 EGFTHVSTAVVGTMGYAAPEYVQTGRLAA---RSDVWSYGVFLYELITGRRPIDRNRPRS 303
T G Y APE + RSDVWS G+ LYE+ TG+ P
Sbjct: 162 IAKTR----DAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYP------ 211
Query: 304 EQKLLQWVKPYLSDAKQFRQIVD---PRL----EGKYSLRLVSKLSHVANLCLVKNARTR 356
+W + Q Q+V P L E ++S V+ NLCL+K+ R
Sbjct: 212 -----KWNSVF----DQLTQVVKGDPPILSNSEEREFSPSFVN----FINLCLIKDESKR 258
Query: 357 PKMSEVLEM 365
PK E+LE
Sbjct: 259 PKYKELLEH 267
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 2e-23
Identities = 70/211 (33%), Positives = 102/211 (48%), Gaps = 33/211 (15%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVK-------QLGRRGGHKEWMTEVNFLGIVEHQ 145
IG+G FG VYKG++K EVAVK +R +++ E L +H
Sbjct: 3 IGKGNFGDVYKGVLKG------NTEVAVKTCRSTLPPDLKR----KFLQEAEILKQYDHP 52
Query: 146 NLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLA 205
N+VKL+G C +V E +P GS+ +L K + LT L+++ DAA G+
Sbjct: 53 NIVKLIGVCVQKQPI----YIVMELVPGGSLLTFLR-KKKNRLTVKKLLQMSLDAAAGME 107
Query: 206 YLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGT----MG 261
YL I RD + N L+ E K+SDFG++R E + T G +
Sbjct: 108 YLESK---NCIHRDLAARNCLVGENNVLKISDFGMSR----EEEGGIYTVSDGLKQIPIK 160
Query: 262 YAAPEYVQTGRLAARSDVWSYGVFLYELITG 292
+ APE + GR + SDVWSYG+ L+E +
Sbjct: 161 WTAPEALNYGRYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 3e-23
Identities = 63/216 (29%), Positives = 118/216 (54%), Gaps = 21/216 (9%)
Query: 88 SRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKE-----WMTEVNFLGIV 142
++ VIG G FG V++G++K ++V VA+K L + G+ E +++E + +G
Sbjct: 8 TKQKVIGAGEFGEVFRGILKMPG--RKEVAVAIKTL--KPGYTEKQRQDFLSEASIMGQF 63
Query: 143 EHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAAR 202
H N+++L G + +++ EYM NG++D+YL ++ + + + + A
Sbjct: 64 SHHNIIRLEGVVT----KFKPAMIITEYMENGALDKYLRDHDGEFSSYQL-VGMLRGIAA 118
Query: 203 GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL--GPSEGFTHVSTAVVGTM 260
G+ YL D + RD + NIL++ K+SDFGL+R+ EG T+ ++ +
Sbjct: 119 GMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEG-TYTTSGGKIPI 174
Query: 261 GYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 295
+ APE + + + SDVWS+G+ ++E+++ G RP
Sbjct: 175 RWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 4e-23
Identities = 80/234 (34%), Positives = 120/234 (51%), Gaps = 28/234 (11%)
Query: 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHK---EWMTEVNFLGIVE 143
R V+G G FG VYKG I E + K+ VA+K L G K E+M E + ++
Sbjct: 9 LKRVKVLGSGAFGTVYKG-IWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMD 67
Query: 144 HQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPK-----SETILTWAMRLKIAQ 198
H +LV+L+G C IQ LV + MP+G + Y+ S+ +L W +++
Sbjct: 68 HPHLVRLLGVCLSPT---IQ--LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI---- 118
Query: 199 DAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVG 258
A+G+ YL E +++ RD + N+L+ + K++DFGLARL EG A G
Sbjct: 119 --AKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARL--LEGDEKEYNADGG 171
Query: 259 TM--GYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQ 309
M + A E + + +SDVWSYGV ++EL+T G +P D R LL+
Sbjct: 172 KMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE 225
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 7e-23
Identities = 79/275 (28%), Positives = 123/275 (44%), Gaps = 34/275 (12%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQNLVKLV 151
+GEG +G VYK + K + VA+K + +E + E++ L + +VK
Sbjct: 10 KLGEGSYGSVYKAIHKET-----GQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYY 64
Query: 152 G-YCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEG 210
G Y + D +V EY GSV + ++T LT I +GL YLH
Sbjct: 65 GSYFKNTD-----LWIVMEYCGAGSVSDIMKITNKT-LTEEEIAAILYQTLKGLEYLH-- 116
Query: 211 MDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT 270
+ I RD K+ NILL+E+ AKL+DFG++ G V+GT + APE +Q
Sbjct: 117 -SNKKIHRDIKAGNILLNEEGQAKLADFGVS--GQLTDTMAKRNTVIGTPFWMAPEVIQE 173
Query: 271 GRLAARSDVWSYGVFLYELITGRRPIDRNRP-RSEQKLLQWVKPYLSDAKQFRQIVDPRL 329
++D+WS G+ E+ G+ P P R+ + P LSD +++ +
Sbjct: 174 IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFN--- 230
Query: 330 EGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 364
V K CLVK+ RP ++L+
Sbjct: 231 ------DFVKK-------CLVKDPEERPSAIQLLQ 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 1e-22
Identities = 75/266 (28%), Positives = 108/266 (40%), Gaps = 27/266 (10%)
Query: 92 VIGEGGFGCVYK-GLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQNLVKL 150
VIG+G FG V + + K K + +G + + E L + H LV L
Sbjct: 7 VIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCV-EKGSVRNVLNERRILQELNHPFLVNL 65
Query: 151 VGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKS----ETILTWAMRLKIAQDAARGLAY 206
Y D+E LV + + G + +LS K E + W + +A L Y
Sbjct: 66 W-YSFQDEE---NMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLA------LEY 115
Query: 207 LHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPE 266
LH II RD K NILLDEQ + ++DF +A + T T+ GT GY APE
Sbjct: 116 LHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TSTSGTPGYMAPE 169
Query: 267 YVQTGRLAARSDVWSYGVFLYELITGRRP--IDRNRPRSEQKLLQWVKPYLS---DAKQF 321
+ + D WS GV YE + G+RP R + + Q L + +
Sbjct: 170 VLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEA 229
Query: 322 RQIVDPRLEGKYSLRLVSKLSHVANL 347
++ LE RL L + N
Sbjct: 230 IDAINKLLERDPQKRLGDNLKDLKNH 255
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 1e-22
Identities = 59/215 (27%), Positives = 102/215 (47%), Gaps = 26/215 (12%)
Query: 93 IGEGGFGCVYKGLI--KNSEDPSQKVEVAVKQLGRRGGHK---EWMTEVNFLGIVEHQNL 147
+GEG FG VYKG + N + V A+K L K E+ E + ++H N+
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSV--AIKTLKENAEPKVQQEFRQEAELMSDLQHPNI 70
Query: 148 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYL---SPKSETILTWAMRLKIAQDAARGL 204
V L+G C + +++EY+ +G + ++L SP S+ + + + +
Sbjct: 71 VCLLGVCTKEQPT----CMLFEYLAHGDLHEFLVRNSPHSD--VGAESGDETVKSSLDCS 124
Query: 205 AYLH------EGMDF----QIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVST 254
+LH GM++ + RD + N L+ E K+SDFGL+R S + V +
Sbjct: 125 DFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQS 184
Query: 255 AVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYEL 289
+ + + PE + G+ SD+WS+GV L+E+
Sbjct: 185 KSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 2e-22
Identities = 64/205 (31%), Positives = 102/205 (49%), Gaps = 17/205 (8%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKE-WMTEVNFLGIVEHQNLVKLV 151
+G G FG V+ G +VA+K L + E ++ E N + ++H LV+L
Sbjct: 14 LGAGQFGEVWMGYYNGHT------KVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLY 67
Query: 152 GYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGM 211
+ ++ EYM NGS+ +L LT + +A A G+A++ E
Sbjct: 68 AVVTQE-----PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFI-ERK 121
Query: 212 DFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG 271
++ I RD +++NIL+ E K++DFGLARL +T A + + APE + G
Sbjct: 122 NY--IHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKF-PIKWTAPEAINYG 178
Query: 272 RLAARSDVWSYGVFLYELIT-GRRP 295
+SDVWS+G+ L E++T GR P
Sbjct: 179 TFTIKSDVWSFGILLTEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 2e-22
Identities = 76/236 (32%), Positives = 117/236 (49%), Gaps = 27/236 (11%)
Query: 93 IGEGGFGCVYKGLIKNSEDP-SQKVEVAVKQLGRRGG----HKEWMTEVNFLGIVEHQNL 147
+G G FG VY+G + P S + VAVK L R+G KE++ E + + H N+
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTL-RKGATDQEKKEFLKEAHLMSNFNHPNI 61
Query: 148 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYL-SPKSET----ILTWAMRLKIAQDAAR 202
VKL+G C ++ + ++ E M G + YL + E +LT L I D A+
Sbjct: 62 VKLLGVCLLNEPQ----YIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAK 117
Query: 203 GLAYLHEGMDFQIIVRDFKSSNILLDEQWNA-----KLSDFGLARLGPSEGFTHVSTAVV 257
G YL E M F I RD + N L+ E+ K+ DFGLAR + +
Sbjct: 118 GCVYL-EQMHF--IHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGL 174
Query: 258 GTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVK 312
+ + APE + G+ +SDVWS+GV ++E++T G++P + Q++LQ V
Sbjct: 175 LPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYP---ALNNQEVLQHVT 227
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 2e-22
Identities = 79/286 (27%), Positives = 121/286 (42%), Gaps = 42/286 (14%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL--GRRGGHKEWM--TEVNFLGIVEHQNL 147
IG+G FG V K ++ D K+ + K++ G ++ +EVN L ++H N+
Sbjct: 7 TIGKGSFGTVRK--VRRKSD--GKI-LVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNI 61
Query: 148 VKLVGYCADDDERGIQRL-LVYEYMPNGSVDQYLS--PKSETILTWAMRLKIAQDAARGL 204
V+ Y +R Q L +V EY G + Q + K + +I L
Sbjct: 62 VR---YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLAL 118
Query: 205 AYLHEGMDF--QIIVRDFKSSNILLDEQWNAKLSDFGLAR-LGPSEGFTHVSTAVVGTMG 261
H D ++ RD K +NI LD N KL DFGLA+ LG F VGT
Sbjct: 119 YECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAK---TYVGTPY 175
Query: 262 YAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK--PYLSDAK 319
Y +PE + +SD+WS G +YEL P R++ +L +K +
Sbjct: 176 YMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPF---TARNQLQLASKIKEGKF----- 227
Query: 320 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365
R+ +YS S+L+ V L + RP E+L++
Sbjct: 228 -------RRIPYRYS----SELNEVIKSMLNVDPDKRPSTEELLQL 262
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 2e-22
Identities = 67/205 (32%), Positives = 110/205 (53%), Gaps = 21/205 (10%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQNLVKLV 151
+IGEG FG V +G E QKV AVK + + ++ E + + H+NLV+L+
Sbjct: 13 IIGEGEFGAVLQG-----EYTGQKV--AVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLL 65
Query: 152 GYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGM 211
G G+ +V E M G++ +L + +++ L+ + D A G+ YL
Sbjct: 66 GVIL---HNGLY--IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK- 119
Query: 212 DFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG 271
+++ RD + NIL+ E AK+SDFGLAR+G V + + + + APE ++
Sbjct: 120 --KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG----VDNSKL-PVKWTAPEALKHK 172
Query: 272 RLAARSDVWSYGVFLYELIT-GRRP 295
+ +++SDVWSYGV L+E+ + GR P
Sbjct: 173 KFSSKSDVWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 3e-22
Identities = 66/207 (31%), Positives = 108/207 (52%), Gaps = 19/207 (9%)
Query: 93 IGEGGFG----CVYKGLIKNSEDPSQKVEVAVKQL--GRRGGH-KEWMTEVNFLGIVEHQ 145
+GEG FG C Y + E + +VAVK L G H + E+ L + H+
Sbjct: 12 LGEGHFGKVELCRY-----DPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHE 66
Query: 146 NLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLA 205
N+VK G C +D GI+ L+ E++P+GS+ +YL P+++ + +LK A +G+
Sbjct: 67 NIVKYKGICTEDGGNGIK--LIMEFLPSGSLKEYL-PRNKNKINLKQQLKYAVQICKGMD 123
Query: 206 YLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR-LGPSEGFTHVSTAVVGTMGYAA 264
YL Q + RD + N+L++ + K+ DFGL + + + + V + + + A
Sbjct: 124 YLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYA 180
Query: 265 PEYVQTGRLAARSDVWSYGVFLYELIT 291
PE + + SDVWS+GV LYEL+T
Sbjct: 181 PECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 4e-22
Identities = 71/214 (33%), Positives = 114/214 (53%), Gaps = 32/214 (14%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVN-FL--GIV----EH 144
VIG+G FGCVY G + +S+ QK+ AVK L R + EV FL GI+ H
Sbjct: 2 VIGKGHFGCVYHGTLIDSD--GQKIHCAVKSLNR----ITDLEEVEQFLKEGIIMKDFSH 55
Query: 145 QNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYL-----SPKSETILTWAMRLKIAQD 199
N++ L+G C + G L+V YM +G + ++ +P + ++ + ++
Sbjct: 56 PNVLSLLGICLPSE--GSP-LVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQ------ 106
Query: 200 AARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR-LGPSEGFT-HVSTAVV 257
A+G+ YL + + RD + N +LDE + K++DFGLAR + E ++ H T
Sbjct: 107 VAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAK 163
Query: 258 GTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT 291
+ + A E +QT + +SDVWS+GV L+EL+T
Sbjct: 164 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 5e-22
Identities = 63/208 (30%), Positives = 105/208 (50%), Gaps = 19/208 (9%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQNLVKLV 151
IG+G FG V G + +VAVK + + ++ E + + + H NLV+L+
Sbjct: 13 TIGKGEFGDVMLG-------DYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLL 65
Query: 152 GYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGM 211
G ++ +V EYM GS+ YL + ++L LK + D + YL E
Sbjct: 66 GVIVEEKG---GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL-EAN 121
Query: 212 DFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG 271
+F + RD + N+L+ E AK+SDFGL + E + T + + + APE ++
Sbjct: 122 NF--VHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKL-PVKWTAPEALREK 174
Query: 272 RLAARSDVWSYGVFLYELIT-GRRPIDR 298
+ + +SDVWS+G+ L+E+ + GR P R
Sbjct: 175 KFSTKSDVWSFGILLWEIYSFGRVPYPR 202
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 1e-21
Identities = 65/219 (29%), Positives = 104/219 (47%), Gaps = 25/219 (11%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL--GRRGGHKEWMTEVNFLGIVEHQNLVKL 150
+GEG FG V+ N K+ VAVK L K++ E L ++H+++VK
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 151 VGYCADDDERGIQRLLVYEYMPNGSVDQYL-------------SPKSETILTWAMRLKIA 197
G C + D ++V+EYM +G ++++L + +E LT + L IA
Sbjct: 73 YGVCVEGDPL----IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAE--LTQSQMLHIA 126
Query: 198 QDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVV 257
Q A G+ YL + RD + N L+ E K+ DFG++R S + V +
Sbjct: 127 QQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTM 183
Query: 258 GTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 295
+ + PE + + SDVWS GV L+E+ T G++P
Sbjct: 184 LPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 2e-21
Identities = 76/284 (26%), Positives = 130/284 (45%), Gaps = 35/284 (12%)
Query: 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKV--EVAVKQLGRRGGHKEWMTEVNFLGIVE 143
++ V+G+G FG L + +ED S V EV + +L + ++ + E+ L +++
Sbjct: 1 HYIPIRVLGKGAFGEAT--LYRRTEDDSLVVWKEVNLTRLSEKE-RRDALNEIVILSLLQ 57
Query: 144 HQNLVKLVGYCADDDERGIQRLLV-YEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAAR 202
H N++ + DD LL+ EY G++ + + + M L
Sbjct: 58 HPNIIAYYNHFMDD-----NTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVS 112
Query: 203 GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGY 262
++Y+H+ I+ RD K+ NI L + KL DFG++++ SE ++ T VVGT Y
Sbjct: 113 AVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE-YSMAET-VVGTPYY 167
Query: 263 AAPEYVQTGRLAARSDVWSYGVFLYELITGRRPID-RNRPRSEQKLLQWVKPYLSDAKQF 321
+PE Q + +SD+W+ G LYEL+T +R D N K++Q +
Sbjct: 168 MSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ---------GNY 218
Query: 322 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365
+V YS L+S + L ++ RP EVL+
Sbjct: 219 TPVVSV-----YSSELISLVHS----LLQQDPEKRPTADEVLDQ 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 2e-21
Identities = 55/216 (25%), Positives = 93/216 (43%), Gaps = 30/216 (13%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR---GGHKEWMTEVNFLGIVEHQNLVK 149
+G+G FG VY+GL K + VA+K + E++ E + + ++V+
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 150 LVGYCADDDERGIQRLLVYEYMPNGSVDQYL--------------SPKSETILTWAMRLK 195
L+G + G L+V E M G + YL P + + A +
Sbjct: 74 LLGVVS----TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEI- 128
Query: 196 IAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTA 255
A G+AYL + + RD + N ++ E K+ DFG+ R +
Sbjct: 129 -----ADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGK 180
Query: 256 VVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT 291
+ + + APE ++ G +SDVWS+GV L+E+ T
Sbjct: 181 GLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 3e-21
Identities = 87/289 (30%), Positives = 125/289 (43%), Gaps = 44/289 (15%)
Query: 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVN-------F 138
N+ R ++G+G FG VY D E+AVKQ+ E EVN
Sbjct: 3 NWRRGKLLGQGAFGRVYL-----CYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQL 57
Query: 139 LGIVEHQNLVKLVGYCADDDERGIQRLLVY-EYMPNGSVDQYLSPKSETILTWAMRLKIA 197
L ++H+ +V+ G C DDE L ++ EYMP GSV L K+ LT + K
Sbjct: 58 LKNLQHERIVQYYG-CLRDDET----LSIFMEYMPGGSVKDQL--KAYGALTETVTRKYT 110
Query: 198 QDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA-RLGPSEGFTHVSTAV 256
+ G+ YLH M I+ RD K +NIL D N KL DFG + RL +V
Sbjct: 111 RQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSV 167
Query: 257 VGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQW--VKPY 314
GT + +PE + ++DVWS G + E++T + P W +
Sbjct: 168 TGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP--------------WAEFEAM 213
Query: 315 LSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVL 363
+ K Q +P+L S + L V+NA+ RP E+L
Sbjct: 214 AAIFKIATQPTNPQLPSHVSPDARNFLR----RTFVENAKKRPSAEELL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 3e-21
Identities = 76/293 (25%), Positives = 130/293 (44%), Gaps = 48/293 (16%)
Query: 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQ--------LGRRGGHKEWMTEVNF 138
+++ V+G+G +G VY GL +Q +AVKQ L +++ EV+
Sbjct: 2 WTKGEVLGKGAYGTVYCGLT------NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDL 55
Query: 139 LGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLS---PKSETILTWAMRLK 195
L ++H N+V+ +G C DD+ I E++P GS+ L+ P E + K
Sbjct: 56 LKSLKHVNIVQYLGTCLDDNTISI----FMEFVPGGSISSILNRFGPLPEPVFC-----K 106
Query: 196 IAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR----LGPSEGFTH 251
+ G+AYLH ++ RD K +N++L KL DFG AR +G ++
Sbjct: 107 YTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSN 163
Query: 252 VSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWV 311
+ ++ GT + APE + +SD+WS G ++E+ TG+ P+ + R
Sbjct: 164 MLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLA-SMDRLAAMF---- 218
Query: 312 KPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 364
Y+ + PRL +S + CL ++ RP ++L
Sbjct: 219 --YIGAHRGLM----PRLPDSFSAAAID----FVTSCLTRDQHERPSALQLLR 261
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 3e-21
Identities = 66/214 (30%), Positives = 111/214 (51%), Gaps = 25/214 (11%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQK-VEVAVKQLGRRGGHKE-----WMTEVNFLGIVEHQ 145
VIG G FG V G +K P ++ + VA+K L + G+ E +++E + +G +H
Sbjct: 11 VIGAGEFGEVCSGRLKL---PGKREIPVAIKTL--KAGYTEKQRRDFLSEASIMGQFDHP 65
Query: 146 NLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLA 205
N++ L G + ++V EYM NGS+D +L K + T + + + A G+
Sbjct: 66 NIIHLEGVVT----KSKPVMIVTEYMENGSLDAFLR-KHDGQFTVIQLVGMLRGIASGMK 120
Query: 206 YLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL---GPSEGFTHVSTAVVGTMGY 262
YL D + RD + NIL++ K+SDFGL+R+ P +T + + +
Sbjct: 121 YLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRW 175
Query: 263 AAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 295
APE + + + SDVWSYG+ ++E+++ G RP
Sbjct: 176 TAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 4e-21
Identities = 63/219 (28%), Positives = 107/219 (48%), Gaps = 23/219 (10%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL--GRRGGHKEWMTEVNFLGIVEHQNLVKL 150
+GEG FG V+ N K+ VAVK L +++ E L +++HQ++V+
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 151 VGYCADDDERGIQRLLVYEYMPNGSVDQYL---SPKSETI----------LTWAMRLKIA 197
G C + G L+V+EYM +G ++++L P ++ + LT L IA
Sbjct: 73 YGVCTE----GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128
Query: 198 QDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVV 257
A G+ YL + F + RD + N L+ + K+ DFG++R S + V +
Sbjct: 129 SQIASGMVYL-ASLHF--VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 185
Query: 258 GTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 295
+ + PE + + SD+WS+GV L+E+ T G++P
Sbjct: 186 LPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 5e-21
Identities = 60/200 (30%), Positives = 103/200 (51%), Gaps = 14/200 (7%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGH-KEWMTEVNFLGIVEHQNLVKLV 151
+G G +G VY+G+ K + VAVK L +E++ E + ++H NLV+L+
Sbjct: 14 LGGGQYGEVYEGVWKK-----YSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 68
Query: 152 GYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGM 211
G C R ++ E+M G++ YL + + + L +A + + YL E
Sbjct: 69 GVCT----REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL-EKK 123
Query: 212 DFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG 271
+F I RD + N L+ E K++DFGL+RL + +T + A + + APE +
Sbjct: 124 NF--IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYN 180
Query: 272 RLAARSDVWSYGVFLYELIT 291
+ + +SDVW++GV L+E+ T
Sbjct: 181 KFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.8 bits (229), Expect = 6e-21
Identities = 81/307 (26%), Positives = 125/307 (40%), Gaps = 67/307 (21%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEW------MTEVNFLGIVEHQN 146
IGEG +G VYK K + + VA+K++ R +++ + E+ L + H N
Sbjct: 7 IGEGTYGQVYKARNKKTGEL-----VALKKI--RMENEKEGFPITAIREIKLLQKLRHPN 59
Query: 147 LVKLVGYCADDDERGIQRLLVYEYMP---NGSVDQYLSPKSETILTWAMRLK-IAQDAAR 202
+V+L + I +V+EYM G +D +E+ ++K +
Sbjct: 60 IVRLKEIVTSKGKGSI--YMVFEYMDHDLTGLLDSPEVKFTES------QIKCYMKQLLE 111
Query: 203 GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGY 262
GL YLH I+ RD K SNIL++ KL+DFGLAR + V+ T+ Y
Sbjct: 112 GLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWY 167
Query: 263 AAPEYVQTGRLAARS-----DVWSYGVFLYELITGRRPIDRNRPRSEQ-----KLL---- 308
PE + L A D+WS G L EL G +PI + EQ +L
Sbjct: 168 RPPELL----LGATRYGPEVDMWSVGCILAELFLG-KPIFQGSTELEQLEKIFELCGSPT 222
Query: 309 --QWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVAN----------LCLVKNARTR 356
W P +S F + + + Y RL H+ + L L + + R
Sbjct: 223 DENW--PGVSKLPWFENL---KPKKPYKRRLREFFKHLIDPSALDLLDKLLTL--DPKKR 275
Query: 357 PKMSEVL 363
+ L
Sbjct: 276 ISADQAL 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 7e-21
Identities = 64/227 (28%), Positives = 113/227 (49%), Gaps = 24/227 (10%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFL---GIVEHQNLV 148
++G G FG V+KG I E S K+ VA+K + R G + + + + G ++H +V
Sbjct: 14 LLGSGVFGTVHKG-IWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72
Query: 149 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETI-----LTWAMRLKIAQDAARG 203
+L+G C G LV + P GS+ ++ +++ L W +++ A+G
Sbjct: 73 RLLGICP-----GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQI------AKG 121
Query: 204 LAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYA 263
+ YL E +++ R+ + NILL +++DFG+A L + + + + +
Sbjct: 122 MYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWM 178
Query: 264 APEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQ 309
A E + GR +SDVWSYGV ++E+++ G P RP LL+
Sbjct: 179 ALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE 225
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 1e-20
Identities = 68/203 (33%), Positives = 103/203 (50%), Gaps = 24/203 (11%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHK---EWMTEVNFLGIVEHQNLV 148
++G+G FG V+KG +K+ K VAVK + ++++E L +H N+V
Sbjct: 2 LLGKGNFGEVFKGTLKD------KTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIV 55
Query: 149 KLVGYCADDDERGIQRLLVY---EYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLA 205
KL+G C QR +Y E +P G +L K + + T + +K A DAA G+A
Sbjct: 56 KLIGVCT-------QRQPIYIVMELVPGGDFLSFLRKKKDELKTKQL-VKFALDAAAGMA 107
Query: 206 YLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAP 265
YL I RD + N L+ E K+SDFG++R +G S + + AP
Sbjct: 108 YLESK---NCIHRDLAARNCLVGENNVLKISDFGMSR-QEDDGIYSSSGLKQIPIKWTAP 163
Query: 266 EYVQTGRLAARSDVWSYGVFLYE 288
E + GR ++ SDVWSYG+ L+E
Sbjct: 164 EALNYGRYSSESDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 1e-20
Identities = 69/221 (31%), Positives = 112/221 (50%), Gaps = 26/221 (11%)
Query: 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG---HKEWMTEVNFLGIVE 143
F + V+G G FG VYKGL E K+ VA+K+L +KE + E + V+
Sbjct: 9 FKKIKVLGSGAFGTVYKGLW-IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 67
Query: 144 HQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETI-----LTWAMRLKIAQ 198
+ ++ +L+G C +Q L+ + MP G + Y+ + I L W +++
Sbjct: 68 NPHVCRLLGICLTS---TVQ--LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI---- 118
Query: 199 DAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL-GPSEGFTHVSTAVV 257
A+G+ YL E +++ RD + N+L+ + K++DFGLA+L G E H V
Sbjct: 119 --AKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKV 173
Query: 258 GTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPID 297
+ + A E + +SDVWSYGV ++EL+T G +P D
Sbjct: 174 -PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 1e-20
Identities = 62/214 (28%), Positives = 117/214 (54%), Gaps = 23/214 (10%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQK-VEVAVKQLGRRGGH-----KEWMTEVNFLGIVEHQ 145
VIG G FG V +G +K P ++ + VA+K L + G+ +++++E + +G +H
Sbjct: 11 VIGAGEFGEVCRGRLKL---PGKREIFVAIKTL--KSGYTEKQRRDFLSEASIMGQFDHP 65
Query: 146 NLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLA 205
N++ L G + +++ E+M NG++D +L +++ T + + + A G+
Sbjct: 66 NIIHLEGVVT----KSRPVMIITEFMENGALDSFLR-QNDGQFTVIQLVGMLRGIAAGMK 120
Query: 206 YLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVG---TMGY 262
YL E M++ + RD + NIL++ K+SDFGL+R + T+ +G + +
Sbjct: 121 YLSE-MNY--VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRW 177
Query: 263 AAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 295
APE + + + SDVWSYG+ ++E+++ G RP
Sbjct: 178 TAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 1e-20
Identities = 78/303 (25%), Positives = 116/303 (38%), Gaps = 82/303 (27%)
Query: 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMT---EVNFLGIVE 143
F+ IG+G FG VYK + K + VA+K + E E+ FL
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRT-----NQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCR 57
Query: 144 HQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYL--SPKSETILTWAMRLKIAQDAA 201
+ K G + I + EY GS L ET + + +R +
Sbjct: 58 SPYITKYYGSFLKGSKLWI----IMEYCGGGSCLDLLKPGKLDETYIAFILR-----EVL 108
Query: 202 RGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAV----- 256
GL YLHE I RD K++NILL E+ + KL+DFG++ +++ +
Sbjct: 109 LGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVS--------GQLTSTMSKRNT 157
Query: 257 -VGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRP------------IDRNRPRS 303
VGT + APE ++ ++D+WS G+ EL G P I +N P
Sbjct: 158 FVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNP-- 215
Query: 304 EQKLLQWVKPYLSD---AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMS 360
P L +K F+ V LCL K+ + RP
Sbjct: 216 ---------PSLEGNKFSKPFKDFVS--------------------LCLNKDPKERPSAK 246
Query: 361 EVL 363
E+L
Sbjct: 247 ELL 249
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 2e-20
Identities = 68/216 (31%), Positives = 87/216 (40%), Gaps = 38/216 (17%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-----GGHKEWMTEVNFLGIVEHQNL 147
+G GGFG V L+K S+ A+K + +R G + +E L H +
Sbjct: 1 LGVGGFGRVE--LVKVK---SKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFI 55
Query: 148 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAAR----- 202
VKL Y D++ I L+ EY G + L R + AR
Sbjct: 56 VKL--YRTFKDKKYIYMLM--EYCLGGELWTILR----------DRGLFDEYTARFYIAC 101
Query: 203 ---GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGT 259
YLH II RD K N+LLD KL DFG A+ S T GT
Sbjct: 102 VVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW---TFCGT 155
Query: 260 MGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRP 295
Y APE + D WS G+ LYEL+TGR P
Sbjct: 156 PEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 2e-20
Identities = 64/206 (31%), Positives = 102/206 (49%), Gaps = 18/206 (8%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGH--KEWMTEVNFLGIVEHQNLVKL 150
+G G FG V+ G NS +VAVK L + G + ++ E N + ++H LV+L
Sbjct: 14 LGAGQFGEVWMGYYNNS------TKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRL 66
Query: 151 VGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEG 210
Y E I ++ EYM GS+ +L + + + A G+AY+
Sbjct: 67 --YAVVTKEEPI--YIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK 122
Query: 211 MDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT 270
I RD +++N+L+ E K++DFGLAR+ +T A + + APE +
Sbjct: 123 ---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINF 178
Query: 271 GRLAARSDVWSYGVFLYELIT-GRRP 295
G +SDVWS+G+ LYE++T G+ P
Sbjct: 179 GSFTIKSDVWSFGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 2e-20
Identities = 77/233 (33%), Positives = 108/233 (46%), Gaps = 45/233 (19%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQ----LGRRGGHKEWMTEVNFLGIVE---HQ 145
IGEG +G VYK D + VA+K+ L G + E+ L +E H
Sbjct: 7 IGEGAYGTVYKA-----RDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHP 61
Query: 146 NLVKLVGYCAD-DDERGIQRLLVYEYMPNGSVDQ----YLS--PKS----ETI--LTWAM 192
N+V+L+ C +R ++ LV+E+ VDQ YLS PK ETI L +
Sbjct: 62 NIVRLLDVCHGPRTDRELKLTLVFEH-----VDQDLATYLSKCPKPGLPPETIKDLMRQL 116
Query: 193 RLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHV 252
RG+ +LH +I+ RD K NIL+ K++DFGLAR+ F
Sbjct: 117 --------LRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARI---YSFEMA 162
Query: 253 STAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQ 305
T+VV T+ Y APE + A D+WS G EL RRP+ R ++Q
Sbjct: 163 LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFR-RRPLFRGTSEADQ 214
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 2e-20
Identities = 66/226 (29%), Positives = 104/226 (46%), Gaps = 38/226 (16%)
Query: 93 IGEGGFGCVYK----GLIKNSEDPSQKVEVAVKQLGRRGG---HKEWMTEVNFLGIVEHQ 145
IG+G FG V++ GL+ VAVK L ++ E + +H
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPF----TMVAVKMLKEEASADMQADFQREAALMAEFDHP 68
Query: 146 NLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYL---SPKSETI--------------- 187
N+VKL+G CA G L++EYM G ++++L SP+++
Sbjct: 69 NIVKLLGVCAV----GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124
Query: 188 --LTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGP 245
L+ +L IA+ A G+AYL E + + RD + N L+ E K++DFGL+R
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIY 181
Query: 246 SEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT 291
S + S + + PE + R SDVW+YGV L+E+ +
Sbjct: 182 SADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 89.6 bits (223), Expect = 3e-20
Identities = 69/234 (29%), Positives = 98/234 (41%), Gaps = 50/234 (21%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-----GGHKEWMTEVNFLGIVE-HQ 145
+IGEG F V K + ++ E A+K L +R K E L + H
Sbjct: 8 IIGEGSFSTVVLAKEK---ETNK--EYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 146 NLVKLVGYCADDDERGIQRL-LVYEYMPNGSVDQYL---SPKSETILTWAMRLKIAQ--D 199
++KL Y D+E L V EY PNG + QY+ E R A+
Sbjct: 63 GIIKLY-YTFQDEEN----LYFVLEYAPNGELLQYIRKYGSLDEKCT----RFYAAEILL 113
Query: 200 AARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL----GPSEGFTHVSTA 255
A L YLH II RD K NILLD+ + K++DFG A++ E +T
Sbjct: 114 A---LEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATN 167
Query: 256 --------------VVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRP 295
VGT Y +PE + SD+W+ G +Y+++TG+ P
Sbjct: 168 IDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 6e-20
Identities = 62/220 (28%), Positives = 102/220 (46%), Gaps = 24/220 (10%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLG--RRGGHKEWMTEVNFLGIVEHQNLVKL 150
+GEG FG V+ N K+ VAVK L K++ E L ++H+++VK
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 151 VGYCADDDERGIQRLLVYEYMPNGSVDQYLSP--------------KSETILTWAMRLKI 196
G C D D ++V+EYM +G ++++L +++ L + L I
Sbjct: 73 YGVCGDGDPL----IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128
Query: 197 AQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAV 256
A A G+ YL + RD + N L+ K+ DFG++R S + V
Sbjct: 129 ASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 185
Query: 257 VGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 295
+ + + PE + + SDVWS+GV L+E+ T G++P
Sbjct: 186 MLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 8e-20
Identities = 66/254 (25%), Positives = 117/254 (46%), Gaps = 35/254 (13%)
Query: 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKE----WMTEVNFLGI 141
+ + V+G G FG V+ K + V +KQ+ K+ E L +
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQK-----LVIIKQIPVEQMTKDERLAAQNECQVLKL 55
Query: 142 VEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPK------SETILTWAMRLK 195
+ H N+++ +D I V EY P G++ +Y+ + +TIL + +++
Sbjct: 56 LSHPNIIEYYENFLEDKALMI----VMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQIL 111
Query: 196 IAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNA-KLSDFGLARLGPSEGFTHVST 254
+A L ++H I+ RD K+ NILLD+ K+ DFG++++ S+ +
Sbjct: 112 LA------LHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS---KAY 159
Query: 255 AVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPID-RNRPRSEQKLLQWVKP 313
VVGT Y +PE + +SD+W+ G LYEL + +R + N P K++
Sbjct: 160 TVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFA 219
Query: 314 YLSD--AKQFRQIV 325
+SD + RQ++
Sbjct: 220 PISDRYSPDLRQLI 233
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 9e-20
Identities = 59/196 (30%), Positives = 88/196 (44%), Gaps = 27/196 (13%)
Query: 169 EYMPNGSVD---QYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNI 225
E+M GS+D + P IL KIA GL YL+ +I+ RD K SNI
Sbjct: 83 EFMDCGSLDRIYKKGGPIPVEILG-----KIAVAVVEGLTYLYN--VHRIMHRDIKPSNI 135
Query: 226 LLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVF 285
L++ + KL DFG++ E ++ VGT Y +PE +Q G+ +SDVWS G+
Sbjct: 136 LVNSRGQIKLCDFGVS----GELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGIS 191
Query: 286 LYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVD---PRL-EGKYSLRLVSKL 341
+ EL G+ P + + + + +QIV PRL + L
Sbjct: 192 IIELALGKFPFAFSNIDDDGQDDP-----MGILDLLQQIVQEPPPRLPSSDFPEDLRD-- 244
Query: 342 SHVANLCLVKNARTRP 357
+ CL+K+ RP
Sbjct: 245 --FVDACLLKDPTERP 258
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 9e-20
Identities = 64/217 (29%), Positives = 98/217 (45%), Gaps = 33/217 (15%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL----GRRGGHKEWMTEVNFLGIVEHQNLV 148
IG G FG VY + ++ + +AVK++ KE E+ L +++H NLV
Sbjct: 8 IGGGTFGKVYTAVNLDTGEL-----MAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLV 62
Query: 149 KLVGYCADDDERGIQRLLVY-EYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYL 207
K G ++ + ++ EY G++++ L + IL + GLAYL
Sbjct: 63 KYYGVEVHREK-----VYIFMEYCSGGTLEELL--EHGRILDEHVIRVYTLQLLEGLAYL 115
Query: 208 HEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA-RLGPS-----EGFTHVSTAVVGTMG 261
H I+ RD K +NI LD KL DFG A +L + E + GT
Sbjct: 116 HSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQS----LAGTPA 168
Query: 262 YAAPEYVQTGRLAAR---SDVWSYGVFLYELITGRRP 295
Y APE + G+ +D+WS G + E+ TG+RP
Sbjct: 169 YMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 1e-19
Identities = 62/225 (27%), Positives = 105/225 (46%), Gaps = 19/225 (8%)
Query: 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL---GRRGGHKEWMTEVNFL 139
+ + +G G FG VY+GL + + + +++VAVK L +++ E +
Sbjct: 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIM 63
Query: 140 GIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLS---PKSETILTWAMR--L 194
HQN+V+L+G + + R ++ E M G + +L P+ E + M+ L
Sbjct: 64 SKFNHQNIVRLIGVSFER----LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLL 119
Query: 195 KIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLD---EQWNAKLSDFGLARLGPSEGFTH 251
A+D A+G YL E I RD + N LL AK++DFG+AR +
Sbjct: 120 FCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYR 176
Query: 252 VSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 295
+ + + PE G +++DVWS+GV L+E+ + G P
Sbjct: 177 KGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP 221
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 1e-19
Identities = 65/212 (30%), Positives = 110/212 (51%), Gaps = 25/212 (11%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG--HKEWMTEVNFLGIVEHQNLVKL 150
+G G FG V G + D VA+K + + G E++ E + + H+ LV+L
Sbjct: 12 LGTGQFGVVKYGKWRGQYD------VAIKMI-KEGSMSEDEFIEEAKVMMKLSHEKLVQL 64
Query: 151 VGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEG 210
G C +R I +V EYM NG + YL + + L++ +D G+AYL
Sbjct: 65 YGVCTK--QRPI--YIVTEYMSNGCLLNYLREHGKR-FQPSQLLEMCKDVCEGMAYLESK 119
Query: 211 MDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGT---MGYAAPEY 267
Q I RD + N L+D+Q K+SDFGL+R + +T + VG+ + ++ PE
Sbjct: 120 ---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT----SSVGSKFPVRWSPPEV 172
Query: 268 VQTGRLAARSDVWSYGVFLYELIT-GRRPIDR 298
+ + +++SDVW++GV ++E+ + G+ P +R
Sbjct: 173 LLYSKFSSKSDVWAFGVLMWEVYSLGKMPYER 204
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 1e-19
Identities = 62/221 (28%), Positives = 106/221 (47%), Gaps = 34/221 (15%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQ--LGRR--GGHKEWM--------TEVNFL 139
+IG+G +G VY L + + +AVKQ L G H +E+ L
Sbjct: 8 LIGKGTYGRVYLALNVTTGE-----MMAVKQVELPATIAGRHDSRQKDMVKALRSEIETL 62
Query: 140 GIVEHQNLVKLVGYCADDDERGIQRLLVY-EYMPNGSVDQYLSP--KSETILTWAMRLKI 196
++H N+V+ +G+ E + L ++ EY+P GS+ L + E L ++
Sbjct: 63 KDLDHLNIVQYLGF-----ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQV 117
Query: 197 AQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAV 256
+ GLAYLH I+ RD K+ N+L+D K+SDFG+++ + ++
Sbjct: 118 LE----GLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSM 170
Query: 257 VGTMGYAAPEYVQTGR--LAARSDVWSYGVFLYELITGRRP 295
G++ + APE + + +A+ D+WS G + E+ GRRP
Sbjct: 171 QGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 2e-19
Identities = 91/302 (30%), Positives = 127/302 (42%), Gaps = 48/302 (15%)
Query: 80 LKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWM-TEVNF 138
L T F VIGEG +G VYK K + Q V A+K + +E + E N
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKT---GQLV--AIKIMDIIEDEEEEIKEEYNI 55
Query: 139 L-GIVEHQNLVKLVG--YCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLK 195
L H N+ G + Q LV E GSV + + + RLK
Sbjct: 56 LRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLV----KGLRKKGKRLK 111
Query: 196 ------IAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR-LGPSEG 248
I ++ RGLAYLHE ++I RD K NILL + KL DFG++ L + G
Sbjct: 112 EEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLG 168
Query: 249 FTHVSTAVVGTMGYAAPEYVQ-----TGRLAARSDVWSYGVFLYELITGRRPIDRNRP-R 302
+ +GT + APE + ARSDVWS G+ EL G+ P+ P R
Sbjct: 169 RRNTF---IGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR 225
Query: 303 SEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEV 362
+ K+ + P L + + + K + + CL+KN RP M E+
Sbjct: 226 ALFKIPRNPPPTLKSPENWSK----------------KFNDFISECLIKNYEQRPFMEEL 269
Query: 363 LE 364
LE
Sbjct: 270 LE 271
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 2e-19
Identities = 62/218 (28%), Positives = 97/218 (44%), Gaps = 12/218 (5%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQNLVKLV- 151
+G+GGFG V +K + ++ K+L +R G + + E L V + +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 152 GYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGM 211
+ DD LV M G + ++ E A + A GL +LH+
Sbjct: 61 AFETKDD-----LCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ-- 113
Query: 212 DFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG 271
+I+ RD K N+LLD+ N ++SD GLA GT GY APE +Q
Sbjct: 114 -RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIK---GRAGTPGYMAPEVLQGE 169
Query: 272 RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQ 309
D ++ G LYE+I GR P + + + E++ L+
Sbjct: 170 VYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELK 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 2e-19
Identities = 61/221 (27%), Positives = 107/221 (48%), Gaps = 29/221 (13%)
Query: 93 IGEGGFG----CVYKGLIKNSEDPS-----QKVEVAVKQL---GRRGGHKEWMTEVNFLG 140
+GEG FG C +GL + + + Q V VAVK L + +++ E+ +
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 141 IVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLS--------PKSETI--LTW 190
+++ N+++L+G C DD ++ EYM NG ++Q+LS + I ++
Sbjct: 73 RLKNPNIIRLLGVCVSDDPL----CMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128
Query: 191 AMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFT 250
A L +A A G+ YL + RD + N L+ + K++DFG++R S +
Sbjct: 129 ANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYY 185
Query: 251 HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT 291
+ V + + A E + G+ SDVW++GV L+E+ T
Sbjct: 186 RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 2e-19
Identities = 65/219 (29%), Positives = 99/219 (45%), Gaps = 46/219 (21%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL-GRR---GGHKEWMTEVNFLGIVEHQNLV 148
IGEG G V+K + + + VA+K++ RR G + + E+ L +H +V
Sbjct: 8 IGEGAHGIVFKAKDRETGET-----VALKKVALRRLEGGIPNQALREIKALQACQHPYVV 62
Query: 149 KLVGYCADDDERGIQRLLVYEYMPNG------SVDQYLSPKSETILTWAMRLKIAQDAAR 202
KL+ D G +LV EYMP+ ++ L P+++ M LK
Sbjct: 63 KLL----DVFPHGSGFVLVMEYMPSDLSEVLRDEERPL-PEAQVKSYMRMLLK------- 110
Query: 203 GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL---GPSEGFTHVSTAVVGT 259
G+AY+H I+ RD K +N+L+ K++DFGLARL ++H V T
Sbjct: 111 GVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSH----QVAT 163
Query: 260 MGYAAPEYVQTGRLAARS-----DVWSYGVFLYELITGR 293
Y APE + AR D+W+ G EL+ G
Sbjct: 164 RWYRAPELL----YGARKYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 2e-19
Identities = 71/294 (24%), Positives = 127/294 (43%), Gaps = 42/294 (14%)
Query: 87 FSRS-----VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHK---EWMTEVNF 138
F RS +G G FG V+ K E+ + V VK L + E+ E++
Sbjct: 2 FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDM 61
Query: 139 LGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYL---SPKSETI----LTWA 191
+ H+N+V+L+G C + + ++ EY G + Q+L K E + L+
Sbjct: 62 FRKLSHKNVVRLLGLCREAEPH----YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTK 117
Query: 192 MRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTH 251
++ + A G+ +L + + RD + N L+ Q K+S L++ + +
Sbjct: 118 QKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYK 174
Query: 252 VSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWV 311
+ A++ + + APE VQ + +SDVWS+GV ++E+ T Q
Sbjct: 175 LRNALI-PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT-----------------QGE 216
Query: 312 KPY--LSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVL 363
P+ LSD + ++ +LE S+L + C N + RP SE++
Sbjct: 217 LPFYGLSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELV 270
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 2e-19
Identities = 63/230 (27%), Positives = 97/230 (42%), Gaps = 27/230 (11%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGR---RGGHKEWMTEVNFLGIVEHQNLVK 149
+G+G FG V +G S + + VAVK L +++ E + ++H+NL++
Sbjct: 3 LGDGSFGVVRRGEWSTSG--GKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60
Query: 150 LVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHE 209
L G ++V E P GS+ L + + A A G+ YL
Sbjct: 61 LYGVVLTH-----PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES 115
Query: 210 GMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGT-MGYAAPEYV 268
+ I RD + NILL K+ DFGL R P +V + + APE +
Sbjct: 116 K---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESL 172
Query: 269 QTGRLAARSDVWSYGVFLYELIT-GRRP------------IDRNRPRSEQ 305
+T + SDVW +GV L+E+ T G P ID+ R E+
Sbjct: 173 RTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLER 222
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 2e-19
Identities = 66/230 (28%), Positives = 103/230 (44%), Gaps = 43/230 (18%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWM-----TEVNFLGIVEHQNL 147
I +G +G V+ K++ D A+K + + ++ TE + L + +
Sbjct: 1 ISKGAYGRVFLAKKKSTGDI-----YAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYV 55
Query: 148 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETIL--------TWAMRLKIAQD 199
VKL Y + ++ + LV EY+P G D ++L A R+ IA+
Sbjct: 56 VKL--YYSFQGKKNL--YLVMEYLPGG--DLA------SLLENVGSLDEDVA-RIYIAEI 102
Query: 200 AARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTA---- 255
L YLH II RD K NIL+D + KL+DFGL+++G +++
Sbjct: 103 VL-ALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKED 158
Query: 256 --VVGTMGYAAPEYVQTGRLAARS-DVWSYGVFLYELITGRRPIDRNRPR 302
+VGT Y APE V G+ +++ D WS G LYE + G P P
Sbjct: 159 KRIVGTPDYIAPE-VILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE 207
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 3e-19
Identities = 64/206 (31%), Positives = 101/206 (49%), Gaps = 18/206 (8%)
Query: 93 IGEGGFG----CVYKGLIKNSEDPSQKVEVAVKQLGRRGGH--KEWMTEVNFLGIVEHQN 146
+G+G FG C Y L N+ + VAVK+L +++ E+ L ++H N
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEV-----VAVKKLQHSTAEHLRDFEREIEILKSLQHDN 66
Query: 147 LVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAY 206
+VK G C R ++ LV EY+P GS+ YL E + + L A +G+ Y
Sbjct: 67 IVKYKGVCYSAGRRNLR--LVMEYLPYGSLRDYLQKHRERLDHRKL-LLYASQICKGMEY 123
Query: 207 LHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEG-FTHVSTAVVGTMGYAAP 265
L + + RD + NIL++ + K+ DFGL ++ P + + V + + AP
Sbjct: 124 LGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAP 180
Query: 266 EYVQTGRLAARSDVWSYGVFLYELIT 291
E + + + SDVWS+GV LYEL T
Sbjct: 181 ESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 3e-19
Identities = 64/213 (30%), Positives = 104/213 (48%), Gaps = 26/213 (12%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVK--QLGRRGGHKE-WMTEVNFLGIVEHQNLV 148
IGEG FG VY+G+ + E+ K+ VAVK + +E ++ E + +H ++V
Sbjct: 13 CIGEGQFGDVYQGVYMSPENE--KIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 149 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYL-----SPKSETILTWAMRLKIAQDAARG 203
KL+G ++ +V E P G + YL S +++ ++ +L A
Sbjct: 71 KLIGVITEN-----PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTA------ 119
Query: 204 LAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYA 263
LAYL E F + RD + N+L+ KL DFGL+R E + S + + +
Sbjct: 120 LAYL-ESKRF--VHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKL-PIKWM 175
Query: 264 APEYVQTGRLAARSDVWSYGVFLYE-LITGRRP 295
APE + R + SDVW +GV ++E L+ G +P
Sbjct: 176 APESINFRRFTSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 3e-19
Identities = 66/207 (31%), Positives = 103/207 (49%), Gaps = 17/207 (8%)
Query: 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKE-WMTEVNFLGIVEHQNLVK 149
V +G+G FG V+ G + VA+K L E ++ E + + H+ LV+
Sbjct: 12 VKLGQGCFGEVWMGTWNGT------TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 65
Query: 150 LVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHE 209
L +++ +V EYM GS+ +L + L + +A A G+AY+ E
Sbjct: 66 LYAVVSEE-----PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV-E 119
Query: 210 GMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQ 269
M++ + RD +++NIL+ E K++DFGLARL +T A + + APE
Sbjct: 120 RMNY--VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAAL 176
Query: 270 TGRLAARSDVWSYGVFLYELIT-GRRP 295
GR +SDVWS+G+ L EL T GR P
Sbjct: 177 YGRFTIKSDVWSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 3e-19
Identities = 72/277 (25%), Positives = 121/277 (43%), Gaps = 39/277 (14%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKV---EVAVKQLGRRGGHKEWMTEVNFLGIVEHQNLVK 149
+G+G +G VYK +K D +Q EV + + ++ + + E+ L V H N++
Sbjct: 8 LGKGSYGSVYK--VKRLSD-NQFYALKEVDLGSMSQKERE-DAVNEIRILASVNHPNII- 62
Query: 150 LVGYCADDDERGIQRL-LVYEYMPNGSVDQYLS--PKSETILTWAMRLKIAQDAARGLAY 206
+ +L +V EY P G + + +S K ++ +I RGL
Sbjct: 63 ----SYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQA 118
Query: 207 LHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPE 266
LHE +I+ RD KS+NILL K+ D G++++ +++ +GT Y APE
Sbjct: 119 LHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKK----NMAKTQIGTPHYMAPE 171
Query: 267 YVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVD 326
+ + +SD+WS G LYE+ T P + RS Q L V+ ++
Sbjct: 172 VWKGRPYSYKSDIWSLGCLLYEMATFAPPFE---ARSMQDLRYKVQ-----RGKY----- 218
Query: 327 PRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVL 363
P + YS L + L + RP ++L
Sbjct: 219 PPIPPIYS----QDLQNFIRSMLQVKPKLRPNCDKIL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 4e-19
Identities = 78/288 (27%), Positives = 125/288 (43%), Gaps = 57/288 (19%)
Query: 93 IGEGGFGCVYKGL---------IKNSE--DPSQKVEVAVKQLGRRGGHKEWMTEVNFLGI 141
+G G FG VY+GL +K D Q + AVKQL + E+ L
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQ---------EIALLSK 58
Query: 142 VEHQNLVKLVGYCADDDERGIQRLLVY-EYMPNGSVDQYLS---PKSETILTWAMRLKIA 197
++H N+V+ +G ++D L ++ E +P GS+ + L E ++ R +
Sbjct: 59 LQHPNIVQYLGTEREED-----NLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL 113
Query: 198 QDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVV 257
GL YLH D + RD K +NIL+D KL+DFG+A+ F +
Sbjct: 114 -----GLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFA---KSFK 162
Query: 258 GTMGYAAPEYV-QTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS 316
G+ + APE + Q G +D+WS G + E+ TG+ P S+ + + V +
Sbjct: 163 GSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPW------SQLEGVAAVF-KIG 215
Query: 317 DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 364
+K+ I D L + CL ++ RP +E+LE
Sbjct: 216 RSKELPPIPD---------HLSDEAKDFILKCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (215), Expect = 4e-19
Identities = 69/214 (32%), Positives = 104/214 (48%), Gaps = 37/214 (17%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKE------WMTEVNFLGIVEHQN 146
+GEG +G VYK K + VA+K++ R ++E + E++ L ++H N
Sbjct: 7 LGEGTYGVVYKARDKKT-----GEIVALKKI--RLDNEEEGIPSTALREISLLKELKHPN 59
Query: 147 LVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAY 206
+VKL+ + + LV+EY + +YL K L+ + I RGLAY
Sbjct: 60 IVKLLDVIHTER----KLYLVFEYCDM-DLKKYLD-KRPGPLSPNLIKSIMYQLLRGLAY 113
Query: 207 LHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL--GPSEGFTHVSTAVVGTMGYAA 264
H +I+ RD K NIL++ KL+DFGLAR P +TH VV T+ Y A
Sbjct: 114 CHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHE---VV-TLWYRA 166
Query: 265 PEYVQTGRLAARS-----DVWSYGVFLYELITGR 293
PE + L ++ D+WS G E+ITG+
Sbjct: 167 PEIL----LGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 6e-19
Identities = 58/181 (32%), Positives = 80/181 (44%), Gaps = 34/181 (18%)
Query: 195 KIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA-RLGPSEGFTHVS 253
KIA + L YLH + +I RD K SN+L++ KL DFG++ L S
Sbjct: 107 KIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS----VAK 160
Query: 254 TAVVGTMGYAAPEYVQTGRLAA----RSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQ 309
T G Y APE + +SDVWS G+ + EL TGR P D
Sbjct: 161 TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS----------- 209
Query: 310 WVKPYLSDAKQFRQIVD---PRL-EGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365
W P+ +Q +Q+V+ P+L K+S N CL KN + RP E+L+
Sbjct: 210 WKTPF----QQLKQVVEEPSPQLPAEKFSPEFQD----FVNKCLKKNYKERPNYPELLQH 261
Query: 366 V 366
Sbjct: 262 P 262
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 86.5 bits (215), Expect = 6e-19
Identities = 70/219 (31%), Positives = 100/219 (45%), Gaps = 39/219 (17%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQ--LGRRGGHKEW--MT---EVNFLGIVEHQ 145
+GEG + VYK K + VA+K+ LG R K+ T E+ L ++H
Sbjct: 8 LGEGTYAVVYKARDKET-----GRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHP 62
Query: 146 NLVKLVG-YCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGL 204
N++ L+ + + I LV+E+M +++ + KS +LT A RGL
Sbjct: 63 NIIGLLDVFGHKSN---IN--LVFEFME-TDLEKVIKDKS-IVLTPADIKSYMLMTLRGL 115
Query: 205 AYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL--GPSEGFTHVSTAVVGTMGY 262
YLH I+ RD K +N+L+ KL+DFGLAR P+ TH VV T Y
Sbjct: 116 EYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTH---QVV-TRWY 168
Query: 263 AAPEYVQTGRLAARS-----DVWSYGVFLYELITGRRPI 296
APE + AR D+WS G EL+ R P
Sbjct: 169 RAPELL----FGARHYGVGVDMWSVGCIFAELLL-RVPF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 8e-19
Identities = 69/223 (30%), Positives = 108/223 (48%), Gaps = 41/223 (18%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL---GRRGGHKEWMTEVNFL-GIVEHQNL 147
VIGEG FG V K IK +++ A+K++ + H+++ E+ L + H N+
Sbjct: 14 VIGEGNFGQVLKARIKKD---GLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 70
Query: 148 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYL--------------SPKSETILTWAMR 193
+ L+G C + RG L + EY P+G++ +L + + + L+
Sbjct: 71 INLLGAC---EHRGYLYLAI-EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 194 LKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVS 253
L A D ARG+ YL + Q I RD + NIL+ E + AK++DFGL+R
Sbjct: 127 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR--------GQE 175
Query: 254 TAVVGTMG-----YAAPEYVQTGRLAARSDVWSYGVFLYELIT 291
V TMG + A E + SDVWSYGV L+E+++
Sbjct: 176 VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 1e-18
Identities = 66/226 (29%), Positives = 100/226 (44%), Gaps = 34/226 (15%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWM---TEVNFLGIVEHQNLV 148
+GEG FG V K + + VAVK L E +E N L V H +++
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66
Query: 149 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYL--SPK--------------------SET 186
KL G C+ D LL+ EY GS+ +L S K E
Sbjct: 67 KLYGACSQDGPL----LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDER 122
Query: 187 ILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR-LGP 245
LT + A +RG+ YL E +++ RD + N+L+ E K+SDFGL+R +
Sbjct: 123 ALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYE 179
Query: 246 SEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT 291
+ + S + + + A E + +SDVWS+GV L+E++T
Sbjct: 180 EDSYVKRSKGRI-PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 1e-18
Identities = 90/295 (30%), Positives = 122/295 (41%), Gaps = 68/295 (23%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNF-LGIVEHQN----L 147
IG G G VYK K + +AVKQ+ RR G+KE + L +V + +
Sbjct: 23 IGSGTCGQVYKMRFKKT-----GHVMAVKQM-RRTGNKEENKRILMDLDVVLKSHDCPYI 76
Query: 148 VKLVGYCADDDERGI---------QRLL--VYEYMPNGSVDQYLSPKSETILTWAMRLKI 196
VK GY D + I +LL + +P E IL K+
Sbjct: 77 VKCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIP------------EDILG-----KM 119
Query: 197 AQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA-RLGPSEGFTHVSTA 255
+ L YL E +I RD K SNILLD N KL DFG++ RL S+ +A
Sbjct: 120 TVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA--KTRSA 175
Query: 256 VVGTMGYAAPEYV----QTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSE--QKLLQ 309
G Y APE + + R+DVWS G+ L EL TG+ P + E K+LQ
Sbjct: 176 --GCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQ 233
Query: 310 WVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 364
P L + F ++ LCL K+ R RPK E+L+
Sbjct: 234 EEPPSLPPNEGFSPDFCSFVD----------------LCLTKDHRKRPKYRELLQ 272
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 2e-18
Identities = 57/219 (26%), Positives = 106/219 (48%), Gaps = 24/219 (10%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGH-----KEWMTEVNFLGIVEHQN 146
++GEG FG V +G + + K VAVK + + H +E+++E + +H N
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLK--VAVKTM-KLDIHTYSEIEEFLSEAACMKDFDHPN 62
Query: 147 LVKLVGYC--ADDDERGIQRLLVYEYMPNGSVDQYL-SPKSETI---LTWAMRLKIAQDA 200
++KL+G C A ++ + +++ +M +G + +L + + L LK D
Sbjct: 63 VMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDI 122
Query: 201 ARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGF---THVSTAVV 257
A G+ YL + I RD + N +L E ++DFGL++ S + ++ V
Sbjct: 123 ALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 179
Query: 258 GTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 295
+ A E + ++SDVW++GV ++E+ T G+ P
Sbjct: 180 KWI---AIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 2e-18
Identities = 71/234 (30%), Positives = 111/234 (47%), Gaps = 37/234 (15%)
Query: 77 IAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEV 136
I +L+ ++F VIG G FG V L+++ S++V A+K L + K ++
Sbjct: 35 ITKLRMKAEDFDVIKVIGRGAFGEVQ--LVRHKS--SKQV-YAMKLLSKFEMIKR--SDS 87
Query: 137 NFL----GIVEHQN---LVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILT 189
F I+ H N +V+L + A D++ + +V EYMP G + +S +
Sbjct: 88 AFFWEERDIMAHANSEWIVQL--HYAFQDDKYL--YMVMEYMPGGDLVNLMS-NYDIPEK 142
Query: 190 WA----MRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGP 245
WA + +A DA + ++H RD K N+LLD+ + KL+DFG
Sbjct: 143 WARFYTAEVVLALDAIHSMGFIH---------RDVKPDNMLLDKSGHLKLADFGTCMKMD 193
Query: 246 SEGFTHVSTAVVGTMGYAAPEYVQT----GRLAARSDVWSYGVFLYELITGRRP 295
+ G TA VGT Y +PE +++ G D WS GVFLYE++ G P
Sbjct: 194 ANGMVRCDTA-VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 2e-18
Identities = 66/213 (30%), Positives = 96/213 (45%), Gaps = 29/213 (13%)
Query: 92 VIGEGGFGCVYK----GLIKNSEDPSQKVEVAVKQL---GRRGGHKEWMTEVNFLG-IVE 143
+G G FG V + GL K D KV AVK L + M+E+ + +
Sbjct: 42 TLGAGAFGKVVEATAYGLSK--SDAVMKV--AVKMLKPTAHSSEREALMSELKIMSHLGN 97
Query: 144 HQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARG 203
H+N+V L+G C G L++ EY G + +L K E+ LT L + A+G
Sbjct: 98 HENIVNLLGACT----IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKG 153
Query: 204 LAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVG----- 258
+A+L I RD + N+LL K+ DFGLAR + S VV
Sbjct: 154 MAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLAR-----DIMNDSNYVVKGNARL 205
Query: 259 TMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT 291
+ + APE + SDVWSYG+ L+E+ +
Sbjct: 206 PVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 2e-18
Identities = 66/224 (29%), Positives = 107/224 (47%), Gaps = 42/224 (18%)
Query: 89 RSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGH--KEWMTEVNFLGIVEHQN 146
VV+G+G +G VY D S +V +A+K++ R + E+ ++H+N
Sbjct: 12 ERVVLGKGTYGIVYAA-----RDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN 66
Query: 147 LVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPK-------SETILTWAMRLKIAQD 199
+V+ +G +++ I E +P GS+ L K +TI+ + ++
Sbjct: 67 IVQYLGSDSENGFFKI----FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQI----- 117
Query: 200 AARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNA-KLSDFG----LARLGP-SEGFTHVS 253
GL YLH+ QI+ RD K N+L++ K+SDFG LA + P +E FT
Sbjct: 118 -LEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFT--- 170
Query: 254 TAVVGTMGYAAPEYVQTGR--LAARSDVWSYGVFLYELITGRRP 295
GT+ Y APE + G A +D+WS G + E+ TG+ P
Sbjct: 171 ----GTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 2e-18
Identities = 64/220 (29%), Positives = 101/220 (45%), Gaps = 35/220 (15%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFL-GIVEHQNLVKL 150
VIGEG FG V + +IK +K+ H+++ E+ L + H N++ L
Sbjct: 9 VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINL 68
Query: 151 VGYCADDDERGIQRLLVYEYMPNGSVDQYLSPK--------------SETILTWAMRLKI 196
+G C + RG + + EY P G++ +L + + LT L+
Sbjct: 69 LGAC---ENRGYLYIAI-EYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQF 124
Query: 197 AQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAV 256
A D A G+ YL E Q I RD + N+L+ E +K++DFGL+R V
Sbjct: 125 ASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR--------GEEVYV 173
Query: 257 VGTMG-----YAAPEYVQTGRLAARSDVWSYGVFLYELIT 291
TMG + A E + +SDVWS+GV L+E+++
Sbjct: 174 KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 3e-18
Identities = 66/228 (28%), Positives = 111/228 (48%), Gaps = 31/228 (13%)
Query: 79 ELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPS-QKVEVAVKQLGRRGGHKE---WMT 134
EL + + R +G G FG + +G +K PS +++ VA+ L K+ ++
Sbjct: 1 ELDNKSIKIERI--LGTGRFGELCRGCLKL---PSKRELPVAIHTLRAGCSDKQRRGFLA 55
Query: 135 EVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRL 194
E LG +H N+V+L G RG ++V EYM NG++D +L K E L +
Sbjct: 56 EALTLGQFDHSNIVRLEGVIT----RGNTMMIVTEYMSNGALDSFLR-KHEGQLVAGQLM 110
Query: 195 KIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVST 254
+ A G+ YL E M + + + + +L++ K+S F + SE
Sbjct: 111 GMLPGLASGMKYLSE-MGY--VHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE------- 160
Query: 255 AVVGTMG------YAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 295
A+ TM +AAPE +Q ++ SDVWS+G+ ++E+++ G RP
Sbjct: 161 AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 4e-18
Identities = 71/280 (25%), Positives = 119/280 (42%), Gaps = 39/280 (13%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQNLVKLV- 151
+G+G FG VYK K + Q+ +++M E++ L +H N+V L
Sbjct: 13 LGDGAFGKVYKAQHKE---TGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYE 69
Query: 152 GYCADDDERGIQRLLVY-EYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEG 210
Y ++ L + E+ G++D + + E LT + + L +LH
Sbjct: 70 AYFYENK------LWILIEFCDGGALDS-IMLELERGLTEPQIRYVCRQMLEALNFLHSH 122
Query: 211 MDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYV-- 268
++I RD K+ NILL + KL+DFG++ S + +GT + APE V
Sbjct: 123 ---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVVAC 177
Query: 269 QTGRLAA---RSDVWSYGVFLYELITGRRP-IDRNRPRSEQKLLQWVKPYLSDAKQFRQI 324
+T + ++D+WS G+ L EL P + N R K+L+ P L ++
Sbjct: 178 ETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWS-- 235
Query: 325 VDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 364
S + CLVK+ RP +E+L+
Sbjct: 236 --------------SSFNDFLKSCLVKDPDDRPTAAELLK 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 7e-18
Identities = 64/211 (30%), Positives = 91/211 (43%), Gaps = 28/211 (13%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG----HKEWMTEVNFLGIVEHQNL 147
V+GEG +G V K K + + VA+K+ K + EV L + H+N+
Sbjct: 8 VVGEGAYGVVLKCRNKATGEI-----VAIKKFKESEDDEDVKKTALREVKVLRQLRHENI 62
Query: 148 VKLVGYCADDDERGIQRL-LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAY 206
V L RL LV+EY+ ++ + L + A+R I Q + +AY
Sbjct: 63 VNLKEAFRRKG-----RLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQ-LLQAIAY 115
Query: 207 LHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPE 266
H II RD K NIL+ E KL DFG AR + + + T V T Y APE
Sbjct: 116 CHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL-TDYVATRWYRAPE 171
Query: 267 ----YVQTGRLAARSDVWSYGVFLYELITGR 293
G+ DVW+ G + EL+ G
Sbjct: 172 LLVGDTNYGKPV---DVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 7e-18
Identities = 80/296 (27%), Positives = 119/296 (40%), Gaps = 53/296 (17%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMT---EVNFLGIVEHQNLVK 149
IG G FG V G K V VK+L E + EV + H N+++
Sbjct: 3 IGNGWFGKVLLGEAHRG---MSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQ 59
Query: 150 LVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWA---MRLKIAQDAARGLAY 206
+G C + I LLV E+ P G + YL + A + ++A + A GL +
Sbjct: 60 CLGQCIE----SIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLW 115
Query: 207 LHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPE 266
LH+ DF I D N L + K+ D+GLA E + + + APE
Sbjct: 116 LHQ-ADF--IHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPE 172
Query: 267 YVQ-------TGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDA 318
V+ +S++WS GV ++EL T +P P LSD
Sbjct: 173 LVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPY----------------PDLSDE 216
Query: 319 KQFRQIV--------DPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMV 366
+ +Q+V P+L+ KYS R V C + + TRP EV E++
Sbjct: 217 QVLKQVVREQDIKLPKPQLDLKYSDRWY----EVMQFCWL-DPETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 7e-18
Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 35/213 (16%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEW-----MTEVNFLGIVEHQNL 147
IGEG +G VYK ++ VA+K++ + E + E+ L + H N+
Sbjct: 7 IGEGTYGVVYKA--RDKLT---GEIVAIKKI-KLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 148 VKLVGYCADDDERGIQRL-LVYEYMPNG---SVDQYLSPKSETILTWAMRLKIAQDAARG 203
+KL+ D R L LV+E+M + E+++ + +G
Sbjct: 61 IKLL-----DVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYL-----YQLLQG 110
Query: 204 LAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL--GPSEGFTHVSTAVVGTMG 261
LA+ H I+ RD K N+L++ + KL+DFGLAR P +TH V T
Sbjct: 111 LAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTH----YVVTRW 163
Query: 262 YAAPEYVQTGRLAARS-DVWSYGVFLYELITGR 293
Y APE + + + D+WS G EL++ R
Sbjct: 164 YRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 8e-18
Identities = 73/217 (33%), Positives = 105/217 (48%), Gaps = 19/217 (8%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKE-WMTEVNFLGIVEHQNLVKLV 151
+G G FG V+ G + +VAVK L E ++ E + + H LV+L
Sbjct: 14 LGNGQFGEVWMGTWNGN------TKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLY 67
Query: 152 GYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGM 211
+ E I +V EYM GS+ +L L + +A A G+AY+ E M
Sbjct: 68 AVVS---EEPI--YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYI-ERM 121
Query: 212 DFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG 271
++ I RD +S+NIL+ + K++DFGLARL +T A + + APE G
Sbjct: 122 NY--IHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYG 178
Query: 272 RLAARSDVWSYGVFLYELIT-GRRPID--RNRPRSEQ 305
R +SDVWS+G+ L EL+T GR P NR EQ
Sbjct: 179 RFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQ 215
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-17
Identities = 52/133 (39%), Positives = 68/133 (51%), Gaps = 18/133 (13%)
Query: 169 EYMPNGSVDQYLSPKS---ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNI 225
E+M GS+DQ L E IL KI+ RGL YL E +I+ RD K SNI
Sbjct: 79 EHMDGGSLDQVLKKAGRIPENILG-----KISIAVLRGLTYLRE--KHKIMHRDVKPSNI 131
Query: 226 LLDEQWNAKLSDFGLARLGPSEGFTHVSTA--VVGTMGYAAPEYVQTGRLAARSDVWSYG 283
L++ + KL DFG++ G S A VGT Y +PE +Q +SD+WS G
Sbjct: 132 LVNSRGEIKLCDFGVS------GQLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLG 185
Query: 284 VFLYELITGRRPI 296
+ L E+ GR PI
Sbjct: 186 LSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 1e-17
Identities = 72/229 (31%), Positives = 114/229 (49%), Gaps = 28/229 (12%)
Query: 92 VIGEGGFGCVYKGL-IKNSEDPSQKVEVAVKQLGRR---GGHKEWMTEVNFLGIVEHQNL 147
V+G G FG VYKG+ I + E+ K+ VA+K L +KE + E + V +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGEN--VKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYV 71
Query: 148 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPK-----SETILTWAMRLKIAQDAAR 202
+L+G C + LV + MP G + Y+ S+ +L W +++ A+
Sbjct: 72 CRLLGICLTSTVQ-----LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AK 120
Query: 203 GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL-GPSEGFTHVSTAVVGTMG 261
G++YL E +++ RD + N+L+ + K++DFGLARL E H V +
Sbjct: 121 GMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKV-PIK 176
Query: 262 YAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQ 309
+ A E + R +SDVWSYGV ++EL+T G +P D R LL+
Sbjct: 177 WMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLE 225
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 2e-17
Identities = 61/212 (28%), Positives = 103/212 (48%), Gaps = 25/212 (11%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKE--WMTEVNFLGIVEHQNLVKL 150
+G G FG V+ G + +++VA+K + G E ++ E + + H LV+L
Sbjct: 12 LGSGQFGVVHLGKWRA------QIKVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQL 64
Query: 151 VGYCADDDERGIQRLLVY---EYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYL 207
G C Q+ +Y E+M NG + YL + + L+ M L + QD G+ YL
Sbjct: 65 YGVC-------TQQKPLYIVTEFMENGCLLNYLRQR-QGKLSKDMLLSMCQDVCEGMEYL 116
Query: 208 HEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEY 267
I RD + N L+ K+SDFG+ R + +T S A + ++ PE
Sbjct: 117 ERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKF-PVKWSPPEV 172
Query: 268 VQTGRLAARSDVWSYGVFLYELIT-GRRPIDR 298
+ +++SDVWS+GV ++E+ T G+ P ++
Sbjct: 173 FNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEK 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 2e-17
Identities = 79/290 (27%), Positives = 127/290 (43%), Gaps = 46/290 (15%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKV----EVAVKQLGRRGGHKE-------WMTEVNFLG- 140
+G G FGCVYK KN+ Q + E+ V +E ++EV +
Sbjct: 8 LGSGAFGCVYKVRKKNN---GQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKE 64
Query: 141 IVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETIL---TWAMRLKIA 197
+ H N+V+ ++D I L+ E P G L K + W + +++
Sbjct: 65 QLRHPNIVRYYKTFLENDRLYIVMDLI-EGAPLGEHFNSLKEKKQRFTEERIWNIFVQMV 123
Query: 198 QDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVV 257
L YLH+ + +I+ RD +NI+L E ++DFGLA+ E T+VV
Sbjct: 124 L----ALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKL---TSVV 174
Query: 258 GTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 317
GT+ Y+ PE V+ ++DVW++G LY++ T + P LS
Sbjct: 175 GTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN-------------MLSL 221
Query: 318 AKQFRQIV-DPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMV 366
A + + V +P EG YS ++ V CL +A RP + +V M+
Sbjct: 222 ATKIVEAVYEPLPEGMYS----EDVTDVITSCLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 3e-17
Identities = 79/289 (27%), Positives = 120/289 (41%), Gaps = 49/289 (16%)
Query: 92 VIGEGGFGCVYKGL-IKNSEDPSQKVEVAVKQLG---RRGGHKEWMTEVNFLGIVEHQNL 147
VIG G VY + + N+E +VA+K++ + E EV + H N+
Sbjct: 8 VIGVGATAVVYAAICLPNNE------KVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNV 61
Query: 148 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPK-SETILTWAMRLKIAQDAARGLAY 206
VK DE + V Y+ GS+ + L A+ + ++ +GL Y
Sbjct: 62 VKYYTSFVVGDELWL----VMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEY 117
Query: 207 LHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL-ARLGPSEGFTH-VSTAVVGTMGYAA 264
LH I RD K+ NILL E + K++DFG+ A L T V VGT + A
Sbjct: 118 LH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMA 174
Query: 265 PEYVQTGR-LAARSDVWSYGVFLYELITGRRPIDRNRP-RSEQKLLQWVKPYLSD----- 317
PE ++ ++D+WS+G+ EL TG P + P + LQ P L
Sbjct: 175 PEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYK 234
Query: 318 --AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 364
+K FR+++ LCL K+ RP E+L+
Sbjct: 235 KYSKSFRKMIS--------------------LCLQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 3e-17
Identities = 69/223 (30%), Positives = 107/223 (47%), Gaps = 41/223 (18%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL---GRRGGHKEWMTEVNFL-GIVEHQNL 147
VIGEG FG V K IK +++ A+K++ + H+++ E+ L + H N+
Sbjct: 2 VIGEGNFGQVLKARIKKD---GLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 58
Query: 148 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPK--------------SETILTWAMR 193
+ L+G C + RG L + EY P+G++ +L + + L+
Sbjct: 59 INLLGAC---EHRGYLYLAI-EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 114
Query: 194 LKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVS 253
L A D ARG+ YL + Q I RD + NIL+ E + AK++DFGL+R
Sbjct: 115 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR--------GQE 163
Query: 254 TAVVGTMG-----YAAPEYVQTGRLAARSDVWSYGVFLYELIT 291
V TMG + A E + SDVWSYGV L+E+++
Sbjct: 164 VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 3e-17
Identities = 64/223 (28%), Positives = 106/223 (47%), Gaps = 21/223 (9%)
Query: 76 TIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWM-- 133
TI + K ++R IG+G G VY + D + EVA+KQ+ + K+ +
Sbjct: 10 TIVSVGDPKKKYTRFEKIGQGASGTVYTAI-----DVATGQEVAIKQMNLQQQPKKELII 64
Query: 134 TEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMR 193
E+ + +H N+V + D G + +V EY+ GS+ ++ ET +
Sbjct: 65 NEILVMRENKHPNIVNYL----DSYLVGDELWVVMEYLAGGSLTDVVT---ETCMDEGQI 117
Query: 194 LKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL-ARLGPSEGFTHV 252
+ ++ + L +LH Q+I RD KS NILL + KL+DFG A++ P +
Sbjct: 118 AAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ---SK 171
Query: 253 STAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRP 295
+ +VGT + APE V + D+WS G+ E++ G P
Sbjct: 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 3e-17
Identities = 66/218 (30%), Positives = 101/218 (46%), Gaps = 20/218 (9%)
Query: 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVN-------F 138
N+ ++G+G FG VY D E+AVKQ+ E EVN
Sbjct: 3 NWRLGKLLGQGAFGRVYL-----CYDADTGRELAVKQVQFDPESPETSKEVNALECEIQL 57
Query: 139 LGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQ 198
L + H+ +V+ G D ER + + E+MP GS+ L KS LT + K +
Sbjct: 58 LKNLLHERIVQYYGCLRDPMERTLS--IFMEHMPGGSIKDQL--KSYGALTENVTRKYTR 113
Query: 199 DAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVS-TAVV 257
G++YLH M I+ RD K +NIL D N KL DFG ++ + + +V
Sbjct: 114 QILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVT 170
Query: 258 GTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRP 295
GT + +PE + ++D+WS G + E++T + P
Sbjct: 171 GTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 4e-17
Identities = 64/218 (29%), Positives = 101/218 (46%), Gaps = 20/218 (9%)
Query: 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVN-------F 138
N+ ++G G FG VY D E+AVKQ+ +E EVN
Sbjct: 3 NWRLGKLLGRGAFGEVYL-----CYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQL 57
Query: 139 LGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQ 198
L + H +V+ G D +E+ + + EYMP GS+ L K+ LT + + +
Sbjct: 58 LKNLRHDRIVQYYGCLRDPEEKKLS--IFVEYMPGGSIKDQL--KAYGALTENVTRRYTR 113
Query: 199 DAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVS-TAVV 257
+G++YLH M I+ RD K +NIL D N KL DFG ++ + + +V
Sbjct: 114 QILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVT 170
Query: 258 GTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRP 295
GT + +PE + ++DVWS + E++T + P
Sbjct: 171 GTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 4e-17
Identities = 77/263 (29%), Positives = 114/263 (43%), Gaps = 63/263 (23%)
Query: 60 PSYPSMSQRPSNLKEFTIAELKSATKNFS---RSVVIGEGGFGCVYKGLIKNSEDPSQKV 116
P P S S+ SA K+ S R IG G G VYK + + +
Sbjct: 46 PLPPPSSSSSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRL---- 101
Query: 117 EVAVKQLGRRGGHKEWMT-----EVNFLGIVEHQNLVKLVGYCADDDERG--IQRLLVYE 169
A+K + G H++ + E+ L V H N+VK C D + IQ LL E
Sbjct: 102 -YALKVI--YGNHEDTVRRQICREIEILRDVNHPNVVK----CHDMFDHNGEIQVLL--E 152
Query: 170 YMPNGSVD-------QYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKS 222
+M GS++ Q+L+ + IL+ G+AYLH I+ RD K
Sbjct: 153 FMDGGSLEGTHIADEQFLADVARQILS-------------GIAYLHRR---HIVHRDIKP 196
Query: 223 SNILLDEQWNAKLSDFGLAR-----LGPSEGFTHVSTAVVGTMGYAAPEYVQT----GRL 273
SN+L++ N K++DFG++R + P + VGT+ Y +PE + T G
Sbjct: 197 SNLLINSAKNVKIADFGVSRILAQTMDP-------CNSSVGTIAYMSPERINTDLNHGAY 249
Query: 274 AARS-DVWSYGVFLYELITGRRP 295
+ D+WS GV + E GR P
Sbjct: 250 DGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 5e-17
Identities = 65/207 (31%), Positives = 102/207 (49%), Gaps = 17/207 (8%)
Query: 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKE-WMTEVNFLGIVEHQNLVK 149
V +G+G FG V+ G + +VA+K L E ++ E + + H LV
Sbjct: 12 VKLGQGCFGEVWMGTWNGT------TKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVP 65
Query: 150 LVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHE 209
L +++ +V E+M GS+ +L L + +A A G+AY+ E
Sbjct: 66 LYAVVSEE-----PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYI-E 119
Query: 210 GMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQ 269
M++ I RD +++NIL+ + K++DFGLARL +T A + + APE
Sbjct: 120 RMNY--IHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKF-PIKWTAPEAAL 176
Query: 270 TGRLAARSDVWSYGVFLYELIT-GRRP 295
GR +SDVWS+G+ L EL+T GR P
Sbjct: 177 YGRFTIKSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 6e-17
Identities = 66/218 (30%), Positives = 103/218 (47%), Gaps = 20/218 (9%)
Query: 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVN-------F 138
N+ R ++G+G FG VY D E+A KQ+ E EV+
Sbjct: 3 NWRRGKLLGQGAFGRVYL-----CYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQL 57
Query: 139 LGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQ 198
L ++H+ +V+ G D E+ + + EYMP GSV L K+ LT ++ K +
Sbjct: 58 LKNLQHERIVQYYGCLRDRAEKTLT--IFMEYMPGGSVKDQL--KAYGALTESVTRKYTR 113
Query: 199 DAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVST-AVV 257
G++YLH M I+ RD K +NIL D N KL DFG ++ + + +V
Sbjct: 114 QILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVT 170
Query: 258 GTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRP 295
GT + +PE + ++DVWS G + E++T + P
Sbjct: 171 GTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 6e-17
Identities = 63/229 (27%), Positives = 109/229 (47%), Gaps = 21/229 (9%)
Query: 76 TIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWM-- 133
TI + K ++R IG+G G V+ + D + EVA+KQ+ + K+ +
Sbjct: 10 TIVSIGDPKKKYTRYEKIGQGASGTVF-----TAIDVATGQEVAIKQINLQKQPKKELII 64
Query: 134 TEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMR 193
E+ + +++ N+V + D G + +V EY+ GS+ ++ ET + A
Sbjct: 65 NEILVMKELKNPNIVNFL----DSFLVGDELFVVMEYLAGGSLTDVVT---ETCMDEAQI 117
Query: 194 LKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL-ARLGPSEGFTHV 252
+ ++ + L +LH Q+I RD KS N+LL + KL+DFG A++ P +
Sbjct: 118 AAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS---K 171
Query: 253 STAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRP 301
+ +VGT + APE V + D+WS G+ E++ G P P
Sbjct: 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 6e-17
Identities = 73/295 (24%), Positives = 131/295 (44%), Gaps = 32/295 (10%)
Query: 73 KEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEW 132
K TI ++ S+ K + VI G G YKG + ++ VK++
Sbjct: 681 KSITINDILSSLKEEN---VISRGKKGASYKGKSIKNG-----MQFVVKEINDVNSIPS- 731
Query: 133 MTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAM 192
+E+ +G ++H N+VKL+G C + L++EY+ ++ + L L+W
Sbjct: 732 -SEIADMGKLQHPNIVKLIGLCRSEKGA----YLIHEYIEGKNLSEVLRN-----LSWER 781
Query: 193 RLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHV 252
R KIA A+ L +LH ++V + I++D + L RL
Sbjct: 782 RRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL------RLSLPGLLCTD 835
Query: 253 STAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK 312
+ + + Y APE +T + +SD++ +G+ L EL+TG+ P D +++W +
Sbjct: 836 TKCFISS-AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGS-IVEWAR 893
Query: 313 PYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANL---CLVKNARTRPKMSEVLE 364
SD +DP + G S+ +++ V NL C + RP ++VL+
Sbjct: 894 YCYSDC-HLDMWIDPSIRGDVSVN-QNEIVEVMNLALHCTATDPTARPCANDVLK 946
|
Length = 968 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 6e-17
Identities = 79/281 (28%), Positives = 121/281 (43%), Gaps = 37/281 (13%)
Query: 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEW---MTEVNFLGIVE 143
F++ IG+G FG VYKG+ ++ +++V VA+K + E E+ L +
Sbjct: 6 FTKLERIGKGSFGEVYKGI----DNRTKEV-VAIKIIDLEEAEDEIEDIQQEITVLSQCD 60
Query: 144 HQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARG 203
+ + G +G + ++ EY+ GS L P L I ++ +G
Sbjct: 61 SPYITRYYGSYL----KGTKLWIIMEYLGGGSALDLLKPGP---LEETYIATILREILKG 113
Query: 204 LAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYA 263
L YLH + I RD K++N+LL EQ + KL+DFG+A G VGT +
Sbjct: 114 LDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWM 168
Query: 264 APEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQ 323
APE ++ ++D+WS G+ EL G P P L+ P
Sbjct: 169 APEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP---------- 218
Query: 324 IVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 364
P LEG+YS CL K+ R RP E+L+
Sbjct: 219 ---PTLEGQYS----KPFKEFVEACLNKDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 8e-17
Identities = 76/308 (24%), Positives = 141/308 (45%), Gaps = 60/308 (19%)
Query: 93 IGEGGFGCVYKGLIKNSED-PS----------QKVEVAVKQL---GRRGGHKEWMTEVNF 138
+GEG FG V+ + N +D P+ + + VAVK L + +++ EV
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 139 LGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLS---------------PK 183
L ++ N+++L+G C D+D ++ EYM NG ++Q+LS P
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDPL----CMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128
Query: 184 SETILT--WAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 241
+ + ++ L +A A G+ YL ++F + RD + N L+ E K++DFG++
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL-SSLNF--VHRDLATRNCLVGENLTIKIADFGMS 185
Query: 242 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRP 301
R + + + V + + A E + G+ SDVW++GV L+E++ + + +P
Sbjct: 186 RNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM----LCKEQP 241
Query: 302 RSE---QKLLQWVKPYLSDAKQ----FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNAR 354
E +++++ + D + FR P +G Y L L C ++ R
Sbjct: 242 YGELTDEQVIENAGEFFRDQGRQVYLFRPPPCP--QGLYELMLQ---------CWSRDCR 290
Query: 355 TRPKMSEV 362
RP S++
Sbjct: 291 ERPSFSDI 298
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 80.2 bits (197), Expect = 9e-17
Identities = 65/227 (28%), Positives = 107/227 (47%), Gaps = 17/227 (7%)
Query: 76 TIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTE 135
+I + K ++R IG+G G VY + D + EVA+KQ+ + K+ +
Sbjct: 10 SIVSVGDPKKKYTRFEKIGQGASGTVYTAI-----DIATGQEVAIKQMNLQQQPKKELII 64
Query: 136 VNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLK 195
L + E++N +V Y D G + +V EY+ GS+ ++ ET +
Sbjct: 65 NEILVMRENKN-PNIVNYL-DSYLVGDELWVVMEYLAGGSLTDVVT---ETCMDEGQIAA 119
Query: 196 IAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL-ARLGPSEGFTHVST 254
+ ++ + L +LH Q+I RD KS NILL + KL+DFG A++ P + +
Sbjct: 120 VCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS---KRS 173
Query: 255 AVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRP 301
+VGT + APE V + D+WS G+ E++ G P P
Sbjct: 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 1e-16
Identities = 73/300 (24%), Positives = 142/300 (47%), Gaps = 52/300 (17%)
Query: 93 IGEGGFG----CVYKGLIKNSED-------PSQKVEVAVKQL---GRRGGHKEWMTEVNF 138
+GEG FG C +G+ K + +Q V VAVK L + +++ E+
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 139 LGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLS---PKSE------TILT 189
+ ++ N+++L+ C D ++ EYM NG ++Q+LS P+ ++
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPL----CMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128
Query: 190 WAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGF 249
++ + +A A G+ YL ++F + RD + N L+ + + K++DFG++R S +
Sbjct: 129 YSTLIFMATQIASGMKYL-SSLNF--VHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDY 185
Query: 250 THVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSE---QK 306
+ V + + + E + G+ SDVW++GV L+E++T + + +P S+ ++
Sbjct: 186 YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT----LCKEQPYSQLSDEQ 241
Query: 307 LLQWVKPYLSDAKQFRQIVDPR----LEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEV 362
+++ + D Q RQ+ P+ + Y L L C +NA+ RP E+
Sbjct: 242 VIENTGEFFRD--QGRQVYLPKPALCPDSLYKLMLS---------CWRRNAKERPSFQEI 290
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 1e-16
Identities = 61/230 (26%), Positives = 108/230 (46%), Gaps = 37/230 (16%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVE--------------VAVKQL---GRRGGHKEWMTE 135
+GEG FG V+ + ++ E VAVK L ++++ E
Sbjct: 13 LGEGQFGEVH---LCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKE 69
Query: 136 VNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLS---PKSETI----- 187
V L + N+ +L+G C D + + EYM NG ++Q+L ++ +
Sbjct: 70 VKILSRLSDPNIARLLGVCTVDPPLCM----IMEYMENGDLNQFLQKHVAETSGLACNSK 125
Query: 188 -LTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPS 246
L+++ L +A A G+ YL E ++F + RD + N L+ + + K++DFG++R S
Sbjct: 126 SLSFSTLLYMATQIASGMRYL-ESLNF--VHRDLATRNCLVGKNYTIKIADFGMSRNLYS 182
Query: 247 EGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 295
+ V + + A E V G+ +SDVW++GV L+E++T R
Sbjct: 183 SDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQ 232
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 65/213 (30%), Positives = 105/213 (49%), Gaps = 29/213 (13%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEW-----MTEVNFLGIVEHQNL 147
IGEG +G VYK K + + VA+K++ R E + E++ L + H N+
Sbjct: 7 IGEGTYGVVYKARDKLTGE-----IVALKKI-RLETEDEGVPSTAIREISLLKELNHPNI 60
Query: 148 VKLVGYCADDDERGIQRL-LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAY 206
V+L+ + +L LV+E++ + + +Y+ T L + +G+AY
Sbjct: 61 VRLLDVVHSE-----NKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAY 114
Query: 207 LHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR-LG-PSEGFTHVSTAVVGTMGYAA 264
H +++ RD K N+L+D + KL+DFGLAR G P +TH VV T+ Y A
Sbjct: 115 CHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH---EVV-TLWYRA 167
Query: 265 PEYVQTGRLAARS-DVWSYGVFLYELITGRRPI 296
PE + R + D+WS G E++ RRP+
Sbjct: 168 PEILLGSRQYSTPVDIWSIGCIFAEMVN-RRPL 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 2e-16
Identities = 65/227 (28%), Positives = 107/227 (47%), Gaps = 17/227 (7%)
Query: 76 TIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTE 135
+I + K ++R IG+G G VY + D + EVA++Q+ + K+ +
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAM-----DVATGQEVAIRQMNLQQQPKKELII 65
Query: 136 VNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLK 195
L + E++N +V Y D G + +V EY+ GS+ ++ ET +
Sbjct: 66 NEILVMRENKN-PNIVNYL-DSYLVGDELWVVMEYLAGGSLTDVVT---ETCMDEGQIAA 120
Query: 196 IAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL-ARLGPSEGFTHVST 254
+ ++ + L +LH Q+I RD KS NILL + KL+DFG A++ P + +
Sbjct: 121 VCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS---KRS 174
Query: 255 AVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRP 301
+VGT + APE V + D+WS G+ E+I G P P
Sbjct: 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 2e-16
Identities = 82/283 (28%), Positives = 119/283 (42%), Gaps = 41/283 (14%)
Query: 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEW---MTEVNFLGIVE 143
F++ IG+G FG V+KG+ ++ +QKV VA+K + E E+ L +
Sbjct: 6 FTKLEKIGKGSFGEVFKGI----DNRTQKV-VAIKIIDLEEAEDEIEDIQQEITVLSQCD 60
Query: 144 HQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPK--SETILTWAMRLKIAQDAA 201
+ K G D + I + EY+ GS L P ET + +R +
Sbjct: 61 SPYVTKYYGSYLKDTKLWI----IMEYLGGGSALDLLEPGPLDETQIATILR-----EIL 111
Query: 202 RGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMG 261
+GL YLH + I RD K++N+LL E KL+DFG+A G VGT
Sbjct: 112 KGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPF 166
Query: 262 YAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 321
+ APE ++ +++D+WS G+ EL G P P L+ P
Sbjct: 167 WMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP-------- 218
Query: 322 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 364
P LEG YS L CL K RP E+L+
Sbjct: 219 -----PTLEGNYS----KPLKEFVEACLNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 57/165 (34%), Positives = 84/165 (50%), Gaps = 20/165 (12%)
Query: 169 EYMPNGSVDQYLSPKS---ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNI 225
E+M GS+DQ L E IL K++ RGLAYL E QI+ RD K SNI
Sbjct: 83 EHMDGGSLDQVLKEAKRIPEEILG-----KVSIAVLRGLAYLRE--KHQIMHRDVKPSNI 135
Query: 226 LLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVF 285
L++ + KL DFG++ + ++ + VGT Y +PE +Q + +SD+WS G+
Sbjct: 136 LVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLS 191
Query: 286 LYELITGRRPIDRNRPRSEQKLLQWV--KPYLSDAKQFRQIVDPR 328
L EL GR PI P + K L+ + +P + + + PR
Sbjct: 192 LVELAIGRYPI----PPPDAKELEAIFGRPVVDGEEGEPHSISPR 232
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 3e-16
Identities = 57/224 (25%), Positives = 97/224 (43%), Gaps = 31/224 (13%)
Query: 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHK--------EWMTEVN 137
+ + +G G F Y+ + D +AVKQ+ E+
Sbjct: 1 EWLKGQQLGTGAFSSCYQ-----ARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIR 55
Query: 138 FLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLS---PKSETILTWAMRL 194
+ + H ++++++G +D + E+M GSV LS E ++ +
Sbjct: 56 LMARLNHPHIIRMLGATCEDSHFNL----FVEWMAGGSVSHLLSKYGAFKEAVI-----I 106
Query: 195 KIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQ-WNAKLSDFGLA-RLGPS-EGFTH 251
+ RGL+YLHE QII RD K +N+L+D +++DFG A RL G
Sbjct: 107 NYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGE 163
Query: 252 VSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRP 295
++GT+ + APE ++ + DVWS G + E+ T + P
Sbjct: 164 FQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 4e-16
Identities = 70/219 (31%), Positives = 107/219 (48%), Gaps = 31/219 (14%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKV--EVAVKQLGRRGGHKEW-MTEVNFLGIVEHQNLV 148
IGEG FG +Y L K D V E+ + ++ + KE EV L ++H N+V
Sbjct: 7 KIGEGSFGKIY--LAKAKSDSEHCVIKEIDLTKMPVK--EKEASKKEVILLAKMKHPNIV 62
Query: 149 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPK------SETILTWAMRLKIAQDAAR 202
+ A E G + +V EY G + + ++ + + IL+W +++ +
Sbjct: 63 T---FFASFQENG-RLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL------ 112
Query: 203 GLAYLHEGMDFQIIVRDFKSSNILLDEQWN-AKLSDFGLAR-LGPSEGFTHVSTAVVGTM 260
GL ++H D +I+ RD KS NI L + AKL DFG+AR L S ++ VGT
Sbjct: 113 GLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS---MELAYTCVGTP 166
Query: 261 GYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRN 299
Y +PE Q ++D+WS G LYEL T + P + N
Sbjct: 167 YYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 4e-16
Identities = 74/289 (25%), Positives = 129/289 (44%), Gaps = 49/289 (16%)
Query: 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKV--EVAVKQLGRRGGHKEWMTEVNFLGIVEH 144
+ + IGEG FG L+K+ ED Q V E+ + ++ + +E EV L ++H
Sbjct: 2 YVKVKKIGEGSFGKAI--LVKSKEDGKQYVIKEINISKMSPKE-REESRKEVAVLSNMKH 58
Query: 145 QNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPK------SETILTWAMRLKIAQ 198
N+V+ Y +E G +V +Y G + + ++ + + IL W +++ +A
Sbjct: 59 PNIVQ---YQESFEENG-NLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLA- 113
Query: 199 DAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVG 258
L ++H D +I+ RD KS NI L + KL DFG+AR+ S ++ +G
Sbjct: 114 -----LKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST--VELARTCIG 163
Query: 259 TMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 318
T Y +PE + +SD+W+ G LYE+ T + +A
Sbjct: 164 TPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAF--------------------EA 203
Query: 319 KQFRQIVDPRLEGKY---SLRLVSKLSHVANLCLVKNARTRPKMSEVLE 364
+ +V + G Y S L ++ + +N R RP ++ +LE
Sbjct: 204 GNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 5e-16
Identities = 91/308 (29%), Positives = 130/308 (42%), Gaps = 39/308 (12%)
Query: 69 PSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGR-RG 127
P N + L T + IG+G +G VYK + N +D S AVK L
Sbjct: 6 PYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYK--VTNKKDGSL---AAVKILDPISD 60
Query: 128 GHKEWMTEVNFL-GIVEHQNLVKLVG-YCADDDERGIQRLLVYEYMPNGSVDQYLSP--K 183
+E E N L + H N+VK G + D G Q LV E GSV + +
Sbjct: 61 VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLI 120
Query: 184 SETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL-AR 242
L AM I A GL +LH +II RD K +NILL + KL DFG+ A+
Sbjct: 121 CGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQ 177
Query: 243 LGPSEGFTHVSTAVVGTMGYAAPEYVQTGR-----LAARSDVWSYGVFLYELITGRRPID 297
L + + S VGT + APE + + AR DVWS G+ EL G P+
Sbjct: 178 LTSTRLRRNTS---VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLF 234
Query: 298 RNRP-RSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTR 356
P ++ K+ + P L +++ +H + CL+K+ R
Sbjct: 235 DMHPVKTLFKIPRNPPPTLLHPEKW----------------CRSFNHFISQCLIKDFEAR 278
Query: 357 PKMSEVLE 364
P ++ +LE
Sbjct: 279 PSVTHLLE 286
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 77.6 bits (192), Expect = 5e-16
Identities = 65/225 (28%), Positives = 88/225 (39%), Gaps = 42/225 (18%)
Query: 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKE----------WMT 134
+F +G G FG V K S A+K L K +
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKY-----YALKIL-----SKAKIVKLKQVEHVLN 50
Query: 135 EVNFLGIVEHQNLVKLVGYCADDDERGIQRL-LVYEYMPNGSVDQYLSPKSETILTWAMR 193
E L + H LV L G DD L LV EY+P G + +L A R
Sbjct: 51 EKRILQSIRHPFLVNLYGSFQDDS-----NLYLVMEYVPGGELFSHLRKSGRFPEPVA-R 104
Query: 194 LKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVS 253
AQ L YLH I+ RD K N+LLD K++DFG A+ +T
Sbjct: 105 FYAAQVVL-ALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYT--- 157
Query: 254 TAVVGTMGYAAPEYVQT---GRLAARSDVWSYGVFLYELITGRRP 295
+ GT Y APE + + G+ D W+ G+ +YE++ G P
Sbjct: 158 --LCGTPEYLAPEIILSKGYGKAV---DWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 7e-16
Identities = 72/287 (25%), Positives = 127/287 (44%), Gaps = 30/287 (10%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLG--RRGGHKEWMTEVNFLGIVEHQNLVKL 150
+GEG FG V +G + N +D KV V ++ R +++++E + +H N+++L
Sbjct: 7 LGEGEFGSVMEGQL-NQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRL 65
Query: 151 VGYCADDDERG--IQRLLVYEYMPNGSVDQYL--SPKSET--ILTWAMRLKIAQDAARGL 204
+G C E +++ +M +G + +L S + L M +K D A G+
Sbjct: 66 IGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGM 125
Query: 205 AYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAA 264
YL I RD + N +L+E N ++DFGL++ + + + + A
Sbjct: 126 EYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIA 182
Query: 265 PEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQ 323
E + +SDVWS+GV ++E+ T G+ P P E + YL + +Q
Sbjct: 183 IESLADRVYTTKSDVWSFGVTMWEIATRGQTPY----PGVEN---SEIYDYLRQGNRLKQ 235
Query: 324 IVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIV 370
D L+G YSL + C + N + RP + + K +
Sbjct: 236 PPDC-LDGLYSL---------MSSCWLLNPKDRPSFETLRCELEKAL 272
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 9e-16
Identities = 68/265 (25%), Positives = 122/265 (46%), Gaps = 44/265 (16%)
Query: 89 RSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG-------HKEWMT----EVN 137
+ +IG G FG VY G+ + S +AVKQ+ + + E+
Sbjct: 4 KGALIGSGSFGSVYLGM-----NASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIA 58
Query: 138 FLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSV----DQYLSPKSETILTWAMR 193
L ++H+N+V+ +G D D I EY+P GSV + Y + + + + +
Sbjct: 59 LLKELQHENIVQYLGSSLDADHLNI----FLEYVPGGSVAALLNNYGAFEETLVRNFVRQ 114
Query: 194 LKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL----GPSEGF 249
+ +GL YLH + II RD K +NIL+D + K+SDFG+++ S
Sbjct: 115 I------LKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKT 165
Query: 250 THVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPI-DRNRPRSEQKLL 308
++ G++ + APE V+ ++D+WS G + E++TG+ P D + ++ K+
Sbjct: 166 NGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIG 225
Query: 309 QWVKPYL-----SDAKQF-RQIVDP 327
+ P + S+A F + +
Sbjct: 226 ENASPEIPSNISSEAIDFLEKTFEI 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 9e-16
Identities = 67/244 (27%), Positives = 103/244 (42%), Gaps = 43/244 (17%)
Query: 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVN------- 137
K+F +G+GG+G V+ K++ + VA+K++ + + EV
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEI-----VALKRMKKSLLF--KLNEVRHVLTERD 53
Query: 138 FLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSP----KSETILTWAMR 193
L + + LVKL+ Y DDE L EY+P G L+ + +
Sbjct: 54 ILTTTKSEWLVKLL-YAFQDDE---YLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAE 109
Query: 194 LKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVS 253
+ A DA L Y+H RD K N L+D + KL+DFGL S+G +
Sbjct: 110 MFEAVDALHELGYIH---------RDLKPENFLIDASGHIKLTDFGL-----SKGIVTYA 155
Query: 254 TAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRP-------RSEQK 306
+VVG+ Y APE ++ D WS G LYE + G P + P + ++
Sbjct: 156 NSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKE 215
Query: 307 LLQW 310
LQ
Sbjct: 216 TLQR 219
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-15
Identities = 101/334 (30%), Positives = 148/334 (44%), Gaps = 53/334 (15%)
Query: 63 PSMSQRPSNLKEFTIAEL---KSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVA 119
PS S R +LK+ IAEL + K F+ IG G FG VY + D VA
Sbjct: 1 PSTS-RAGSLKDPEIAELFFKEDPEKLFTDLREIGHGSFGAVY-----FARDVRTNEVVA 54
Query: 120 VKQLGRRG--GHKEW---MTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNG 174
+K++ G +++W + EV FL ++H N ++ G C R LV EY
Sbjct: 55 IKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG-CY---LREHTAWLVMEYCLGS 110
Query: 175 SVDQ---YLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW 231
+ D + P E + I A +GLAYLH +I RD K+ NILL E
Sbjct: 111 ASDLLEVHKKPLQEVEIA-----AITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPG 162
Query: 232 NAKLSDFGLARL-GPSEGFTHVSTAVVGTMGYAAPEYV---QTGRLAARSDVWSYGVFLY 287
KL+DFG A + P+ F VGT + APE + G+ + DVWS G+
Sbjct: 163 QVKLADFGSASIASPANSF-------VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI 215
Query: 288 ELITGRRPI-DRNRPRSEQKLLQWVKPYLSD---AKQFRQIVDPRLEGKYSLRLVSK--L 341
EL + P+ + N + + Q P L + FR VD L+ R S+ L
Sbjct: 216 ELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELL 275
Query: 342 SHVANLCLVKNARTRPKMSEVLEMVNKIVDASAE 375
H+ L R RP+ + +++++ + DA E
Sbjct: 276 KHMFVL------RERPE-TVLIDLIQRTKDAVRE 302
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 1e-15
Identities = 67/290 (23%), Positives = 132/290 (45%), Gaps = 44/290 (15%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKE---WMTEVNFLGIVEHQNLVK 149
+G+G FG VY+G ++ + VAVK + +E ++ E + + ++V+
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 150 LVGYCADDDERGIQRLLVYEYMPNGSVDQYLS---PKSET-----ILTWAMRLKIAQDAA 201
L+G + +G L+V E M +G + YL P++E T +++A + A
Sbjct: 74 LLGVVS----KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 129
Query: 202 RGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMG 261
G+AYL+ + + RD + N ++ + K+ DFG+ R + + +
Sbjct: 130 DGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186
Query: 262 YAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPY--LSDAK 319
+ APE ++ G SD+WS+GV L+E+ + +EQ PY LS+ +
Sbjct: 187 WMAPESLKDGVFTTSSDMWSFGVVLWEITS----------LAEQ-------PYQGLSNEQ 229
Query: 320 QFRQIVDPRLEGKYSLR---LVSKLSHVANLCLVKNARTRPKMSEVLEMV 366
+ ++D G Y + +++ + +C N + RP E++ ++
Sbjct: 230 VLKFVMD----GGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 1e-15
Identities = 59/200 (29%), Positives = 91/200 (45%), Gaps = 30/200 (15%)
Query: 169 EYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLD 228
E+M GS+D Y E +L +IA +GL YL +I+ RD K SN+L++
Sbjct: 79 EFMDGGSLDVYRK-IPEHVLG-----RIAVAVVKGLTYL---WSLKILHRDVKPSNMLVN 129
Query: 229 EQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYE 288
+ KL DFG++ + ++ VGT Y APE + + SDVWS G+ E
Sbjct: 130 TRGQVKLCDFGVST----QLVNSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFME 185
Query: 289 LITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVD---PRL-EGKYSLRLVSKLSHV 344
L GR P + +Q + L + + IVD P L G++S + V H
Sbjct: 186 LALGRFPYPQ---------IQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFV----HF 232
Query: 345 ANLCLVKNARTRPKMSEVLE 364
C+ K + RP +++
Sbjct: 233 ITQCMRKQPKERPAPENLMD 252
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 1e-15
Identities = 61/209 (29%), Positives = 104/209 (49%), Gaps = 19/209 (9%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHK----EWMTEVNFLGIVEHQNLV 148
+G G FG V KG+ K + S+K VAVK L E + E N + +++ +V
Sbjct: 3 LGSGNFGTVKKGMYKMKK--SEKT-VAVKILKNDNNDPALKDELLREANVMQQLDNPYIV 59
Query: 149 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLH 208
+++G C +LV E G ++++L +T ++ + G+ YL
Sbjct: 60 RMIGIC-----EAESWMLVMELAELGPLNKFLQKNKH--VTEKNITELVHQVSMGMKYLE 112
Query: 209 EGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR-LGPSEGFTHVSTAVVGTMGYAAPEY 267
E + RD + N+LL Q AK+SDFGL++ LG E + T + + APE
Sbjct: 113 ET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPEC 169
Query: 268 VQTGRLAARSDVWSYGVFLYELIT-GRRP 295
+ + +++SDVWS+GV ++E + G++P
Sbjct: 170 MNYYKFSSKSDVWSFGVLMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 1e-15
Identities = 70/251 (27%), Positives = 101/251 (40%), Gaps = 65/251 (25%)
Query: 82 SATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL----GRRGGHKEWMTEVN 137
S +++ +GEG FG VYK + VA+K++ + G + E+
Sbjct: 5 SKLRDYEILGKLGEGTFGEVYKARQIKT-----GRVVALKKILMHNEKDGFPITALREIK 59
Query: 138 FLGIVEHQNLVKLVGYCAD-DDERGIQRLLVYEYMP-----------NGSVDQYLSPKSE 185
L ++H N+V L+ + D+ +R VY P N SV
Sbjct: 60 ILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSV--------- 110
Query: 186 TILTWAMRLKIAQ------DAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 239
+L +Q G+ YLHE I+ RD K++NIL+D Q K++DFG
Sbjct: 111 -------KLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160
Query: 240 LARL---------GPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARS-----DVWSYGVF 285
LAR G G T T +V T Y PE + L R D+W G
Sbjct: 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELL----LGERRYTTAVDIWGIGCV 216
Query: 286 LYELITGRRPI 296
E+ T RRPI
Sbjct: 217 FAEMFT-RRPI 226
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 1e-15
Identities = 69/216 (31%), Positives = 97/216 (44%), Gaps = 29/216 (13%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVK----QLGRRGGHKEWMTEVNFLGIVE---HQ 145
IG G +G VYK + DP VA+K Q G + EV L +E H
Sbjct: 8 IGVGAYGTVYK-----ARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHP 62
Query: 146 NLVKLVGYCADD-DERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAAR-- 202
N+V+L+ CA +R + LV+E+ VDQ L + + + + +D R
Sbjct: 63 NIVRLMDVCATSRTDRETKVTLVFEH-----VDQDLRTYLDKVPPPGLPAETIKDLMRQF 117
Query: 203 --GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTM 260
GL +LH I+ RD K NIL+ KL+DFGLAR+ T VV T+
Sbjct: 118 LRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARI---YSCQMALTPVVVTL 171
Query: 261 GYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPI 296
Y APE + A D+WS G E+ R+P+
Sbjct: 172 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 1e-15
Identities = 63/223 (28%), Positives = 106/223 (47%), Gaps = 29/223 (13%)
Query: 93 IGEGGFGCVYKG-LIKNSEDPSQKVEVAVKQLGRRGGHKEW---MTEVNFLGIVEHQNLV 148
+GE FG +YKG L D +Q V A+K L ++W E + + + H N+V
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLV--AIKTLKDINNPQQWGEFQQEASLMAELHHPNIV 70
Query: 149 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYL---SPKSE------------TILTWAMR 193
L+G + +++EY+ G + ++L SP S+ + L
Sbjct: 71 CLLGVVTQEQPV----CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDF 126
Query: 194 LKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVS 253
L IA A G+ YL + +D + NIL+ EQ + K+SD GL+R S + V
Sbjct: 127 LHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQ 183
Query: 254 TAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 295
+ + + PE + G+ ++ SD+WS+GV L+E+ + G +P
Sbjct: 184 PKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 2e-15
Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 14/210 (6%)
Query: 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQ 145
+ R +G G FG V+ + SE +A+ ++ R + E L V H
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHP 61
Query: 146 NLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLA 205
+++L + + D+R + L+ EY+P G + YL ++ + + L A + L
Sbjct: 62 FIIRL--FWTEHDQRFLYMLM--EYVPGGELFSYL--RNSGRFSNSTGLFYASEIVCALE 115
Query: 206 YLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAP 265
YLH +I+ RD K NILLD++ + KL+DFG A+ +T + GT Y AP
Sbjct: 116 YLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWT-----LCGTPEYLAP 167
Query: 266 EYVQTGRLAARSDVWSYGVFLYELITGRRP 295
E +Q+ D W+ G+ +YE++ G P
Sbjct: 168 EVIQSKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 70/257 (27%), Positives = 101/257 (39%), Gaps = 57/257 (22%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKE-----WMTEVNFLGIVEHQN 146
VIG G FG V+ L+++ + +V A+K L + K E + L +
Sbjct: 8 VIGRGAFGEVW--LVRDKDT--GQV-YAMKVLRKSDMIKRNQIAHVRAERDILADADSPW 62
Query: 147 LVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQ-----DAA 201
+VKL Y + DE + LV EYMP G + L K A R IA+ D+
Sbjct: 63 IVKL--YYSFQDEEHL--YLVMEYMPGGDLMNLLIRKDVFPEETA-RFYIAELVLALDSV 117
Query: 202 RGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA-------------------- 241
L ++H RD K NIL+D + KL+DFGL
Sbjct: 118 HKLGFIH---------RDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLL 168
Query: 242 -------RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRR 294
R + + + VGT Y APE ++ D WS GV LYE++ G
Sbjct: 169 FRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFP 228
Query: 295 PI-DRNRPRSEQKLLQW 310
P + K++ W
Sbjct: 229 PFYSDTLQETYNKIINW 245
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 2e-15
Identities = 46/155 (29%), Positives = 66/155 (42%), Gaps = 22/155 (14%)
Query: 166 LVYEYMPNG---SVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKS 222
LV EY+ G S+ + L E WA + + G+ LH II RD K
Sbjct: 74 LVMEYLNGGDCASLIKTLGGLPED---WAK--QYIAEVVLGVEDLH---QRGIIHRDIKP 125
Query: 223 SNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSY 282
N+L+D+ + KL+DFGL+R G + VGT Y APE + SD WS
Sbjct: 126 ENLLIDQTGHLKLTDFGLSRNG------LENKKFVGTPDYLAPETILGVGDDKMSDWWSL 179
Query: 283 GVFLYELITGRRPIDRNRP-----RSEQKLLQWVK 312
G ++E + G P P + + W +
Sbjct: 180 GCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPE 214
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 3e-15
Identities = 58/214 (27%), Positives = 100/214 (46%), Gaps = 19/214 (8%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKE---WMTEVNFLGIV-EHQNLV 148
+GEG FG V K ++P++ VAVK L K+ ++E+ + ++ +H+N++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 149 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYL------SPKSETILTWAMRLKIAQDAAR 202
L+G C + +V EY +G++ +L + + Q
Sbjct: 80 NLLGVCTQEGPL----YVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLV 135
Query: 203 GLAY-LHEGMDF----QIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVV 257
AY + GM+F + I RD + N+L+ E K++DFGLAR + +T
Sbjct: 136 SFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGR 195
Query: 258 GTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT 291
+ + APE + +SDVWS+GV L+E+ T
Sbjct: 196 LPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 3e-15
Identities = 77/300 (25%), Positives = 118/300 (39%), Gaps = 68/300 (22%)
Query: 87 FSRSVVIGEGGFGCVYKGL-----------IKNSEDPSQKVEVAVKQLGRRGGHKEWMTE 135
+ R +IG G +G VY+G I N + P V + E
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVS-------------DIQRE 49
Query: 136 VNFLGIVEH---QNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYL--SPKSETILTW 190
V L + N+ K G I + EY GSV + P +E ++
Sbjct: 50 VALLSQLRQSQPPNITKYYGSYLKGPRLWI----IMEYAEGGSVRTLMKAGPIAEKYISV 105
Query: 191 AMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFT 250
+R + L Y+H+ +I RD K++NIL+ N KL DFG+A L
Sbjct: 106 IIR-----EVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAAL-----LN 152
Query: 251 HVS---TAVVGTMGYAAPEYVQTGRL-AARSDVWSYGVFLYELITGRRPIDRNRPRSEQK 306
S + VGT + APE + G+ ++D+WS G+ +YE+ TG N P S+
Sbjct: 153 QNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATG------NPPYSDVD 206
Query: 307 LLQWVKPYLSDAKQFRQIVDPRLEGK-YSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365
+ + + +K PRLE YS L CL + + R E+L+
Sbjct: 207 AFRAMM-LIPKSKP------PRLEDNGYS----KLLREFVAACLDEEPKERLSAEELLKS 255
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 69/232 (29%), Positives = 107/232 (46%), Gaps = 33/232 (14%)
Query: 77 IAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGR-----RGGHKE 131
I +L+ +++ VIG G FG V L+++ SQKV A+K L + R
Sbjct: 35 IRKLQMKAEDYDVVKVIGRGAFGEVQ--LVRHKS--SQKV-YAMKLLSKFEMIKRSDSAF 89
Query: 132 WMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWA 191
+ E + + +V+L +CA D++ + +V EYMP G + +S + WA
Sbjct: 90 FWEERDIMAFANSPWVVQL--FCAFQDDKYL--YMVMEYMPGGDLVNLMS-NYDVPEKWA 144
Query: 192 ----MRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSE 247
+ +A DA + +H RD K N+LLD+ + KL+DFG
Sbjct: 145 KFYTAEVVLALDAIHSMGLIH---------RDVKPDNMLLDKHGHLKLADFGTCMKMDET 195
Query: 248 GFTHVSTAVVGTMGYAAPEYVQT----GRLAARSDVWSYGVFLYELITGRRP 295
G TA VGT Y +PE +++ G D WS GVFL+E++ G P
Sbjct: 196 GMVRCDTA-VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 4e-15
Identities = 65/217 (29%), Positives = 99/217 (45%), Gaps = 12/217 (5%)
Query: 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQN 146
F + V+G+GGFG V ++ + ++ K++ +R G + E L V +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 147 LVKLV-GYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLA 205
+V L Y D LV M G + ++ E + A + GL
Sbjct: 62 VVSLAYAYETKD-----ALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLE 116
Query: 206 YLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAP 265
LH+ +I+ RD K NILLD+ + ++SD GLA P EG T VGT+GY AP
Sbjct: 117 DLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVP-EGQT--IKGRVGTVGYMAP 170
Query: 266 EYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPR 302
E V+ R D W+ G LYE+I G+ P + + +
Sbjct: 171 EVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 75.7 bits (187), Expect = 4e-15
Identities = 70/232 (30%), Positives = 102/232 (43%), Gaps = 67/232 (28%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVK------------QLGRRGGHKEWMTEVNFL- 139
+G+G +G V+K + + + ++V VA+K Q R E+ FL
Sbjct: 15 LGKGAYGIVWKAIDRRT----KEV-VALKKIFDAFRNATDAQRTFR--------EIMFLQ 61
Query: 140 GIVEHQNLVKLVG-YCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQ 198
+ +H N+VKL+ A++D + I LV+EYM ET L +R I +
Sbjct: 62 ELGDHPNIVKLLNVIKAEND-KDI--YLVFEYM-------------ETDLHAVIRANILE 105
Query: 199 DA---------ARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL---GPS 246
D + L Y+H G +I RD K SNILL+ KL+DFGLAR
Sbjct: 106 DVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEE 162
Query: 247 EGFTHVSTAVVGTMGYAAPEYVQTGRLAARS-----DVWSYGVFLYELITGR 293
V T V T Y APE + L + D+WS G L E++ G+
Sbjct: 163 NPENPVLTDYVATRWYRAPEIL----LGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 5e-15
Identities = 52/210 (24%), Positives = 100/210 (47%), Gaps = 18/210 (8%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQN---LVK 149
+G+G FG VY+G+ K + VA+K + +E + +N +++ N +V+
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 150 LVGYCADDDERGIQRLLVYEYMPNGSVDQYL--------SPKSETILTWAMRLKIAQDAA 201
L+G + +G L++ E M G + YL + + + +++A + A
Sbjct: 74 LLGVVS----QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIA 129
Query: 202 RGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMG 261
G+AYL+ + + RD + N ++ E + K+ DFG+ R + + +
Sbjct: 130 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186
Query: 262 YAAPEYVQTGRLAARSDVWSYGVFLYELIT 291
+ +PE ++ G SDVWS+GV L+E+ T
Sbjct: 187 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 5e-15
Identities = 63/218 (28%), Positives = 99/218 (45%), Gaps = 11/218 (5%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQNLVKLVG 152
+G+GGFG V +KN+ ++ K+L ++ G K + E L V +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL-- 58
Query: 153 YCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMD 212
A E LV M G + ++ E L + + G+ +LH
Sbjct: 59 --AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS--- 113
Query: 213 FQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGR 272
I+ RD K N+LLD+Q N +LSD GLA +G T T GT GY APE ++
Sbjct: 114 MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELK-DGKT--ITQRAGTNGYMAPEILKEEP 170
Query: 273 LAARSDVWSYGVFLYELITGRRPI-DRNRPRSEQKLLQ 309
+ D ++ G +YE++ GR P D ++++L +
Sbjct: 171 YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKR 208
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 6e-15
Identities = 82/286 (28%), Positives = 132/286 (46%), Gaps = 28/286 (9%)
Query: 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEW---MTEVNFLGIVE 143
F++ IG+G FG V+KG+ ++ +Q+V VA+K + E E+ L +
Sbjct: 6 FTKLERIGKGSFGEVFKGI----DNRTQQV-VAIKIIDLEEAEDEIEDIQQEITVLSQCD 60
Query: 144 HQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARG 203
+ K G +G + ++ EY+ GS L A LK + +G
Sbjct: 61 SPYVTKYYGSYL----KGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK---EILKG 113
Query: 204 LAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYA 263
L YLH + I RD K++N+LL EQ + KL+DFG+A G VGT +
Sbjct: 114 LDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWM 168
Query: 264 APEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRP-RSEQKLLQWVKPYLSD--AKQ 320
APE +Q +++D+WS G+ EL G P P R + + P L+ +K
Sbjct: 169 APEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKP 228
Query: 321 FRQIVDPRLEGKYSLRLVSK--LSHVANLCLVKNARTRPKMSEVLE 364
F++ +D L S R +K L H +VKNA+ ++E+++
Sbjct: 229 FKEFIDACLNKDPSFRPTAKELLKHKF---IVKNAKKTSYLTELID 271
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 6e-15
Identities = 65/219 (29%), Positives = 108/219 (49%), Gaps = 27/219 (12%)
Query: 93 IGEGGFGCVY--KGLIKNSEDPSQKVEVAVKQLGRRGGHKEW---MTEVNFLGIV-EHQN 146
+GEG FG V + + + + P++ V VAVK L K+ ++E+ + ++ +H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 147 LVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKS--------------ETILTWAM 192
++ L+G C D G +LV EY G++ +YL + E LT+
Sbjct: 80 IINLLGACTQD---GPLYVLV-EYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135
Query: 193 RLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHV 252
+ A ARG+ YL + I RD + N+L+ E K++DFGLAR + +
Sbjct: 136 LVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKK 192
Query: 253 STAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT 291
+T + + APE + +SDVWS+GV L+E+ T
Sbjct: 193 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 7e-15
Identities = 63/225 (28%), Positives = 99/225 (44%), Gaps = 38/225 (16%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMT--------EVNFLGIVEH 144
IG G +G VYK KN E A+K+ G KE T E+ L ++H
Sbjct: 8 IGRGTYGRVYKAKRKN---GKDGKEYAIKKFK---GDKEQYTGISQSACREIALLRELKH 61
Query: 145 QNLVKLVGYCADDDERGIQRLLVYEYMPN--GSVDQYLSPKSETILTWAMRLKIAQDAAR 202
+N+V LV + ++ + L+++Y + + ++ + +M +
Sbjct: 62 ENVVSLVEVFLEHADKSVY--LLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILN 119
Query: 203 GLAYLHEGMDFQIIVRDFKSSNILL----DEQWNAKLSDFGLARL--GPSEGFTHVSTAV 256
G+ YLH ++ RD K +NIL+ E+ K+ D GLARL P + + V
Sbjct: 120 GVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVV 176
Query: 257 VGTMGYAAPEYVQTGRLAARS-----DVWSYGVFLYELITGRRPI 296
V T+ Y APE + L AR D+W+ G EL+T PI
Sbjct: 177 V-TIWYRAPELL----LGARHYTKAIDIWAIGCIFAELLT-LEPI 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 8e-15
Identities = 77/274 (28%), Positives = 112/274 (40%), Gaps = 32/274 (11%)
Query: 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQN 146
F + V+G+GGFG V ++ + + K++ +R G + E L V Q
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 147 LVKLV-GYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLA 205
+V L Y D LV M G + ++ L A + GL
Sbjct: 62 VVNLAYAYETKD-----ALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLE 116
Query: 206 YLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAP 265
LH + RD K NILLD+ + ++SD GLA P EG VGT+GY AP
Sbjct: 117 DLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIP-EG--ESIRGRVGTVGYMAP 170
Query: 266 EYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIV 325
E + R D W G +YE+I G+ P R R E+ VK R+ V
Sbjct: 171 EVLNNQRYTLSPDYWGLGCLIYEMIEGQSPF---RGRKEK-----VK---------REEV 213
Query: 326 DPRL---EGKYSLRLVSKLSHVANLCLVKNARTR 356
D R+ E YS + + + + L K+ + R
Sbjct: 214 DRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQR 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 8e-15
Identities = 65/297 (21%), Positives = 123/297 (41%), Gaps = 43/297 (14%)
Query: 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVE 143
NF IG+G F VYK + +V + ++ ++ + E++ L ++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 144 HQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSE--------TILTWAMRLK 195
H N++K + +++E I V E G + + + + TI + ++L
Sbjct: 61 HPNVIKYLASFIENNELNI----VLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQL- 115
Query: 196 IAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTA 255
L ++H +I+ RD K +N+ + KL D GL R S+ T + +
Sbjct: 116 -----CSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK--TTAAHS 165
Query: 256 VVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPI---DRNRPRSEQKLLQWVK 312
+VGT Y +PE + +SD+WS G LYE+ + P N +K+ +
Sbjct: 166 LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDY 225
Query: 313 PYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 369
P L A + + +L + + C+ + RP +S VL++ ++
Sbjct: 226 PPLP-ADHYSE----------------ELRDLVSRCINPDPEKRPDISYVLQVAKEM 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 1e-14
Identities = 61/224 (27%), Positives = 104/224 (46%), Gaps = 37/224 (16%)
Query: 93 IGEGGFGCVYK--GLIKNSEDPSQKVEVAVKQLGRRGGHKEW---MTEVNFLGIV-EHQN 146
+GEG FG V + + P Q V VAVK L K+ ++E+ + ++ +H+N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 147 LVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPK--------------SETILTWAM 192
++ L+G C + G ++V EY G++ ++L + E L++
Sbjct: 80 IINLLGVCTQE---GPLYVIV-EYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135
Query: 193 RLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHV 252
+ A ARG+ YL + I RD + N+L+ E K++DFGLAR G +
Sbjct: 136 LVSCAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLAR-----GVHDI 187
Query: 253 STAVVGTMG-----YAAPEYVQTGRLAARSDVWSYGVFLYELIT 291
+ G + APE + +SDVWS+G+ ++E+ T
Sbjct: 188 DYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 1e-14
Identities = 66/230 (28%), Positives = 114/230 (49%), Gaps = 25/230 (10%)
Query: 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL---GRRGGHKEWMTEVNFLGIV 142
NF + +GEG + VYKG + + VA+K++ G + E++ + +
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTT-----GEIVALKEIHLDAEEGTPSTAIREISLMKEL 55
Query: 143 EHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLK-IAQDAA 201
+H+N+V+L ++ + +LV+EYM + + +Y+ +K
Sbjct: 56 KHENIVRLHDVIHTEN----KLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLL 110
Query: 202 RGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR-LG-PSEGFTHVSTAVVGT 259
+G+A+ HE +++ RD K N+L++++ KL+DFGLAR G P F S VV T
Sbjct: 111 KGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTF---SNEVV-T 163
Query: 260 MGYAAPEYVQTGRLAARS-DVWSYGVFLYELITGRRPIDRNRPRSEQKLL 308
+ Y AP+ + R + S D+WS G + E+ITG RP+ +Q L
Sbjct: 164 LWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITG-RPLFPGTNNEDQLLK 212
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 1e-14
Identities = 61/215 (28%), Positives = 108/215 (50%), Gaps = 24/215 (11%)
Query: 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL----GRRGGHKEWMTEVNFLGI 141
NF + IGEG +G VYK +N + +V VA+K++ G + E++ L
Sbjct: 1 NFQKVEKIGEGTYGVVYKA--RNKL--TGEV-VALKKIRLDTETEGVPSTAIREISLLKE 55
Query: 142 VEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAA 201
+ H N+VKL+ ++ + LV+E++ + + +++ + + +
Sbjct: 56 LNHPNIVKLLDVIHTEN----KLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLL 110
Query: 202 RGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR-LG-PSEGFTHVSTAVVGT 259
+GLA+ H +++ RD K N+L++ + KL+DFGLAR G P +TH VV T
Sbjct: 111 QGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH---EVV-T 163
Query: 260 MGYAAPEYVQTGRLAARS-DVWSYGVFLYELITGR 293
+ Y APE + + + + D+WS G E++T R
Sbjct: 164 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 1e-14
Identities = 74/241 (30%), Positives = 117/241 (48%), Gaps = 24/241 (9%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGR----RGGHKEWMT--EVNFLGIVEHQ 145
V+G+GG+G V++ + K + + K+ A+K L + R T E N L V+H
Sbjct: 3 VLGKGGYGKVFQ-VRKVTGADTGKI-FAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60
Query: 146 NLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLA 205
+V L+ Y + G + L+ EY+ G + +L + E I + + L
Sbjct: 61 FIVDLI-YAF---QTGGKLYLILEYLSGGELFMHL--EREGIFMEDTACFYLSEISLALE 114
Query: 206 YLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAP 265
+LH+ II RD K NILLD Q + KL+DFGL + EG V+ GT+ Y AP
Sbjct: 115 HLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG--TVTHTFCGTIEYMAP 169
Query: 266 EYVQTGRLAARSDVWSYGVFLYELITGRRPID-RNRPRSEQKLLQW---VKPYLS-DAKQ 320
E + D WS G +Y+++TG P NR ++ K+L+ + PYL+ +A+
Sbjct: 170 EILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARD 229
Query: 321 F 321
Sbjct: 230 L 230
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 1e-14
Identities = 64/207 (30%), Positives = 107/207 (51%), Gaps = 24/207 (11%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEW-----MTEVNFLGIVEHQNL 147
+GEG + VYKG K +++ VA+K++ R H+E + EV+ L ++H N+
Sbjct: 14 LGEGTYATVYKGRSKLTDN-----LVALKEI--RLEHEEGAPCTAIREVSLLKDLKHANI 66
Query: 148 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYL 207
V L + E+ + LV+EY+ + + QYL +I ++L + Q RGL Y
Sbjct: 67 VTL--HDIIHTEKSLT--LVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQ-LLRGLNYC 120
Query: 208 HEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPE- 266
H +++ RD K N+L++E+ KL+DFGLAR T+ + V T+ Y P+
Sbjct: 121 HRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDI 175
Query: 267 YVQTGRLAARSDVWSYGVFLYELITGR 293
+ + + + D+W G YE+ TGR
Sbjct: 176 LLGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 66/221 (29%), Positives = 101/221 (45%), Gaps = 20/221 (9%)
Query: 93 IGEGGFGCVYKGL-IKNSED--PSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQNLVK 149
IGEG +G V+K +KN ++V V + G + + L EH N+V+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 150 LVGYCA-DDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAA----RGL 204
L C +R + LV+E+ VDQ L+ + + + + +D RGL
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEH-----VDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 123
Query: 205 AYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAA 264
+LH +++ RD K NIL+ KL+DFGLAR+ F T+VV T+ Y A
Sbjct: 124 DFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVVTLWYRA 177
Query: 265 PEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQ 305
PE + A D+WS G E+ R+P+ R +Q
Sbjct: 178 PEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQ 217
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 59/219 (26%), Positives = 104/219 (47%), Gaps = 27/219 (12%)
Query: 93 IGEGGFGCVY--KGLIKNSEDPSQKVEVAVKQLGRRGGHKEW---MTEVNFLGIV-EHQN 146
+GEG FG V + L + + P + V VAVK L K+ ++E+ + ++ +H+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 147 LVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPK--------------SETILTWAM 192
++ L+G C D ++ EY G++ +YL + + +T+
Sbjct: 83 IINLLGACTQDGPL----YVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKD 138
Query: 193 RLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHV 252
+ ARG+ YL + I RD + N+L+ E K++DFGLAR + +
Sbjct: 139 LVSCTYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKK 195
Query: 253 STAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT 291
+T + + APE + +SDVWS+GV ++E+ T
Sbjct: 196 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 2e-14
Identities = 59/207 (28%), Positives = 88/207 (42%), Gaps = 35/207 (16%)
Query: 169 EYMPNGSVDQYLSPKSET-ILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL 227
EYM GS+D+ + T + + +I +GL +L E + II RD K +N+L+
Sbjct: 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLV 136
Query: 228 DEQWNAKLSDFGLA-RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAAR------SDVW 280
+ KL DFG++ L S ++ +G Y APE +++G SDVW
Sbjct: 137 NGNGQVKLCDFGVSGNLVAS-----LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVW 191
Query: 281 SYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVD---PRLEGKYSLRL 337
S G+ + E+ GR P P + Y + Q IVD P L YS
Sbjct: 192 SLGLSILEMALGRYPYP---PET----------YANIFAQLSAIVDGDPPTLPSGYS--- 235
Query: 338 VSKLSHVANLCLVKNARTRPKMSEVLE 364
CL K RP +++LE
Sbjct: 236 -DDAQDFVAKCLNKIPNRRPTYAQLLE 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 2e-14
Identities = 66/231 (28%), Positives = 99/231 (42%), Gaps = 53/231 (22%)
Query: 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMT-----EVNFL 139
F + IGEG +G VY+ D + VA+K++ R ++ + E+ L
Sbjct: 7 TEFEKLNRIGEGTYGIVYRA-----RDTTSGEIVALKKV-RMDNERDGIPISSLREITLL 60
Query: 140 GIVEHQNLVKL---------------VGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKS 184
+ H N+V+L + YC D + LL + MP P S
Sbjct: 61 LNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQD----LASLL--DNMPT--------PFS 106
Query: 185 ETILTWAMRLK-IAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL 243
E+ ++K + RGL YLHE II RD K SN+LL ++ K++DFGLAR
Sbjct: 107 ES------QVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLAR- 156
Query: 244 GPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARS-DVWSYGVFLYELITGR 293
T V T+ Y APE + + D+W+ G L EL+ +
Sbjct: 157 -TYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 2e-14
Identities = 37/101 (36%), Positives = 54/101 (53%), Gaps = 5/101 (4%)
Query: 197 AQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAV 256
A + GL +LHE II RD K N+LLD + + K++DFG+ + G G T ++
Sbjct: 102 AAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTF 156
Query: 257 VGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPID 297
GT Y APE + D W+ GV LYE++ G+ P +
Sbjct: 157 CGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFE 197
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 2e-14
Identities = 75/293 (25%), Positives = 119/293 (40%), Gaps = 58/293 (19%)
Query: 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLG-RRGGHKEWM-TEVNFLGIVE 143
V IGEG G V + D S +VAVK++ R+ +E + EV + +
Sbjct: 20 YLDNFVKIGEGSTGIV-----CIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQ 74
Query: 144 HQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAA-- 201
H N+V++ DE +V E++ G++ T + R+ Q A
Sbjct: 75 HPNIVEMYSSYLVGDEL----WVVMEFLEGGAL---------TDIVTHTRMNEEQIATVC 121
Query: 202 ----RGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAV- 256
+ L++LH +I RD KS +ILL KLSDFG VS V
Sbjct: 122 LAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFC--------AQVSKEVP 170
Query: 257 -----VGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWV 311
VGT + APE + D+WS G+ + E++ G P +
Sbjct: 171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPY-------------FN 217
Query: 312 KPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 364
+P L K+ R + P+L K ++ +L + LV++ R +E+L
Sbjct: 218 EPPLQAMKRIRDNLPPKL--KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-14
Identities = 54/167 (32%), Positives = 83/167 (49%), Gaps = 16/167 (9%)
Query: 169 EYMPNGSVDQYLSPKS---ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNI 225
E+M GS+DQ L E IL K++ +GL YL E +I+ RD K SNI
Sbjct: 83 EHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYLRE--KHKIMHRDVKPSNI 135
Query: 226 LLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVF 285
L++ + KL DFG++ + ++ + VGT Y +PE +Q + +SD+WS G+
Sbjct: 136 LVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLS 191
Query: 286 LYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGK 332
L E+ GR PI P +++ L + P D + PR G+
Sbjct: 192 LVEMAIGRYPIP--PPDAKELELMFGCPVEGDPAESETSPRPRPPGR 236
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 3e-14
Identities = 65/207 (31%), Positives = 108/207 (52%), Gaps = 24/207 (11%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEW-----MTEVNFLGIVEHQNL 147
+GEG + V+KG K +E+ VA+K++ R H+E + EV+ L ++H N+
Sbjct: 13 LGEGTYATVFKGRSKLTEN-----LVALKEI--RLEHEEGAPCTAIREVSLLKNLKHANI 65
Query: 148 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYL 207
V L + ER + LV+EY+ + + QYL + +++ + Q RGL+Y
Sbjct: 66 VTL--HDIIHTERCLT--LVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQ-LLRGLSYC 119
Query: 208 HEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPE- 266
H+ +I+ RD K N+L++E+ KL+DFGLAR T+ + V T+ Y P+
Sbjct: 120 HKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDV 174
Query: 267 YVQTGRLAARSDVWSYGVFLYELITGR 293
+ + + D+W G LYE+ TGR
Sbjct: 175 LLGSTEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 4e-14
Identities = 58/201 (28%), Positives = 94/201 (46%), Gaps = 20/201 (9%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR---GGHKEWMTEVNFLGIVEHQNLVK 149
IG G FG V+ G ++ P VAVK +++ E L H N+V+
Sbjct: 3 IGRGNFGEVFSGRLRADNTP-----VAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVR 57
Query: 150 LVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHE 209
L+G C I V E + G +L + + + +++ ++AA G+ YL
Sbjct: 58 LIGVCTQKQPIYI----VMELVQGGDFLTFLRTEGPRLKVKEL-IQMVENAAAGMEYLES 112
Query: 210 GMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTM--GYAAPEY 267
I RD + N L+ E+ K+SDFG++R E + ST + + + APE
Sbjct: 113 K---HCIHRDLAARNCLVTEKNVLKISDFGMSR--EEEDGVYASTGGMKQIPVKWTAPEA 167
Query: 268 VQTGRLAARSDVWSYGVFLYE 288
+ GR ++ SDVWS+G+ L+E
Sbjct: 168 LNYGRYSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 4e-14
Identities = 71/222 (31%), Positives = 103/222 (46%), Gaps = 34/222 (15%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGR-----RGGHKEWMTEVNFLGIVEHQN 146
V+G+G FG V+ L++ P A+K L + R + M E + L V H
Sbjct: 3 VLGQGSFGKVF--LVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKM-ERDILAEVNHPF 59
Query: 147 LVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAY 206
+VKL + A E + L+ +++ G + LS E + T +D LA
Sbjct: 60 IVKL--HYAFQTEGKL--YLILDFLRGGDLFTRLS--KEVMFT-------EEDVKFYLAE 106
Query: 207 LHEGMD----FQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTA--VVGTM 260
L +D II RD K NILLDE+ + KL+DFGL++ E H A GT+
Sbjct: 107 LALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK----ESIDHEKKAYSFCGTV 162
Query: 261 GYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPI---DRN 299
Y APE V +D WS+GV ++E++TG P DR
Sbjct: 163 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK 204
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 4e-14
Identities = 61/219 (27%), Positives = 105/219 (47%), Gaps = 27/219 (12%)
Query: 93 IGEGGFGCVY--KGLIKNSEDPSQKVEVAVKQLGRRGGHKEW---MTEVNFLGIV-EHQN 146
+GEG FG V + + + E P++ +VAVK L K+ ++E+ + ++ +H+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 147 LVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKS--------------ETILTWAM 192
++ L+G C D ++ EY G++ +YL + E L++
Sbjct: 86 IINLLGACTQDGPL----YVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKD 141
Query: 193 RLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHV 252
+ A ARG+ YL + I RD + N+L+ E K++DFGLAR +
Sbjct: 142 LVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 198
Query: 253 STAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT 291
+T + + APE + +SDVWS+GV L+E+ T
Sbjct: 199 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 4e-14
Identities = 65/209 (31%), Positives = 95/209 (45%), Gaps = 27/209 (12%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKE----WMTEVNFLGIVEHQNL 147
++GEG +G V K K+ E + ++ VA+K+ K M E+ L + H+NL
Sbjct: 8 LVGEGSYGMVMK--CKHKE--TGQI-VAIKKFLESEDDKMVKKIAMREIRMLKQLRHENL 62
Query: 148 VKLVGYCADDDERGIQRL-LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAY 206
V L+ R +RL LV+E++ + +D K L + K RG+ +
Sbjct: 63 VNLIEVF-----RRKKRLYLVFEFVDHTVLDDL--EKYPNGLDESRVRKYLFQILRGIEF 115
Query: 207 LHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL--GPSEGFTHVSTAVVGTMGYAA 264
H II RD K NIL+ + KL DFG AR P E V T V T Y A
Sbjct: 116 CHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE----VYTDYVATRWYRA 168
Query: 265 PEY-VQTGRLAARSDVWSYGVFLYELITG 292
PE V + D+W+ G + E++TG
Sbjct: 169 PELLVGDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 5e-14
Identities = 86/289 (29%), Positives = 122/289 (42%), Gaps = 64/289 (22%)
Query: 93 IGEGGFGCVYKGL-IKNSEDPSQKVEVAVKQLGRRG--GHKEW---MTEVNFLGIVEHQN 146
IG G FG VY ++ +E VA+K++ G +++W + EV FL + H N
Sbjct: 23 IGHGSFGAVYFARDVRTNE------VVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 147 LVKLVGYCADDDERGIQRLLVYEYMPNGS----VDQYLSPKSETILTWAMRLKIAQDAAR 202
++ G C + LV EY GS ++ + P E + I A +
Sbjct: 77 TIEYKG-CYLREHTA---WLVMEYCL-GSASDILEVHKKPLQEVEIA-----AICHGALQ 126
Query: 203 GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL-GPSEGFTHVSTAVVGTMG 261
GLAYLH + I RD K+ NILL E KL+DFG A L P+ F VGT
Sbjct: 127 GLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSF-------VGTPY 176
Query: 262 YAAPEYV---QTGRLAARSDVWSYGVFLYELITGRRPI-DRNRPRSEQKLLQWVKPYLSD 317
+ APE + G+ + DVWS G+ EL + P+ + N + + Q P LS
Sbjct: 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSS 236
Query: 318 ---AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVL 363
+ FR VD CL K + RP E+L
Sbjct: 237 NDWSDYFRNFVD--------------------SCLQKIPQDRPSSEELL 265
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 6e-14
Identities = 74/285 (25%), Positives = 113/285 (39%), Gaps = 51/285 (17%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQ--LGRRGGHKEWMTEVNFLGIVEHQNLVKL 150
IG G +G VYK + + VA+K L + E++ L H N+V
Sbjct: 11 IGSGTYGDVYKARDIATGE-----LVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAY 65
Query: 151 VGYCADDDERGIQRLLVYEYMPNGSVDQYLS----PKSETILTWAMRLKIAQDAARGLAY 206
G D+ I V EY GS+ P SE + + + ++ +GLAY
Sbjct: 66 FGSYLRRDKLWI----VMEYCGGGSLQDIYQVTRGPLSELQIAY-----VCRETLKGLAY 116
Query: 207 LHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVS---TAVVGTMGYA 263
LHE I RD K +NILL E + KL+DFG++ T + +GT +
Sbjct: 117 LHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQ-----LTATIAKRKSFIGTPYWM 168
Query: 264 APEYVQ---TGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 320
APE G + D+W+ G+ EL + P+ P + L K
Sbjct: 169 APEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPM--RALFLISK-------- 218
Query: 321 FRQIVDPRLE--GKYSLRLVSKLSHVANLCLVKNARTRPKMSEVL 363
P+L+ K+S CL K+ + RP +++L
Sbjct: 219 -SNFPPPKLKDKEKWSP----VFHDFIKKCLTKDPKKRPTATKLL 258
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 6e-14
Identities = 73/220 (33%), Positives = 103/220 (46%), Gaps = 31/220 (14%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEW-----MTEVNFLGIVEHQN 146
IGEG +G VYK K++ + VA+K++ R KE + E+ L + H+N
Sbjct: 14 QIGEGTYGQVYKARDKDTGE-----LVALKKV-RLDNEKEGFPITAIREIKILRQLNHRN 67
Query: 147 LVKLVGYCADD----DERGIQR--LLVYEYMPN---GSVDQYLSPKSETILTWAMRLKIA 197
+V L D D + + LV+EYM + G ++ L SE + M+
Sbjct: 68 IVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMK---- 123
Query: 198 QDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVV 257
GL Y H + RD K SNILL+ + KL+DFGLARL SE + V+
Sbjct: 124 -QLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI 179
Query: 258 GTMGYAAPE-YVQTGRLAARSDVWSYGVFLYELITGRRPI 296
T+ Y PE + R DVWS G L EL T ++PI
Sbjct: 180 -TLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 7e-14
Identities = 82/304 (26%), Positives = 123/304 (40%), Gaps = 37/304 (12%)
Query: 71 NLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGL-IKNSEDPSQKVEVAVKQLGRRGGH 129
+L + ++ L+ F V+G G +G VYKG +K + + KV +
Sbjct: 2 SLDDIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-----EE 56
Query: 130 KEWMTEVNFLG-IVEHQNLVKLVGYCADDDERGI--QRLLVYEYMPNGSVDQYLSPKSET 186
+E E+N L H+N+ G G Q LV E+ GSV +
Sbjct: 57 EEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGN 116
Query: 187 ILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL-ARLGP 245
L I ++ RGLA+LH ++I RD K N+LL E KL DFG+ A+L
Sbjct: 117 ALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 173
Query: 246 SEGFTHVSTAVVGTMGYAAPEYVQT-----GRLAARSDVWSYGVFLYELITGRRPIDRNR 300
+ G +GT + APE + RSD+WS G+ E+ G P+
Sbjct: 174 TVG---RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMH 230
Query: 301 PRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMS 360
P L+ P P+L+ K + K CLVKN +RP
Sbjct: 231 PMRALFLIPRNPP-------------PKLKSK---KWSKKFIDFIEGCLVKNYLSRPSTE 274
Query: 361 EVLE 364
++L+
Sbjct: 275 QLLK 278
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 8e-14
Identities = 64/215 (29%), Positives = 96/215 (44%), Gaps = 25/215 (11%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKE-WMTEVNFLGIVEHQNLVKL 150
V+GEG FG + L+ + QK + +L + E E L ++H N+V
Sbjct: 7 VVGEGSFG---RALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAF 63
Query: 151 VGYCADDDERGIQRLLVYEYMPNGSVDQYLSPK------SETILTWAMRLKIAQDAARGL 204
+ E +V EY G + Q + + +TIL W +++ + G+
Sbjct: 64 ----KESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GV 113
Query: 205 AYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAA 264
++HE +++ RD KS NI L + KL DFG ARL S G + VGT Y
Sbjct: 114 QHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG--AYACTYVGTPYYVP 168
Query: 265 PEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRN 299
PE + +SD+WS G LYEL T + P N
Sbjct: 169 PEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 8e-14
Identities = 64/227 (28%), Positives = 103/227 (45%), Gaps = 23/227 (10%)
Query: 77 IAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEV 136
I +L+ +++ VIG G FG V K++ ++ ++ +R + E
Sbjct: 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 94
Query: 137 NFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWA----M 192
+ + +V+L + A D+R + +V EYMP G + +S + WA
Sbjct: 95 DIMAFANSPWVVQL--FYAFQDDRYL--YMVMEYMPGGDLVNLMS-NYDVPEKWARFYTA 149
Query: 193 RLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHV 252
+ +A DA + ++H RD K N+LLD+ + KL+DFG EG
Sbjct: 150 EVVLALDAIHSMGFIH---------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRC 200
Query: 253 STAVVGTMGYAAPEYVQT----GRLAARSDVWSYGVFLYELITGRRP 295
TA VGT Y +PE +++ G D WS GVFLYE++ G P
Sbjct: 201 DTA-VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 9e-14
Identities = 88/302 (29%), Positives = 132/302 (43%), Gaps = 51/302 (16%)
Query: 93 IGEGGFGCVYKGL-IKNSEDPSQKVEVAVKQLGRRG--GHKEW---MTEVNFLGIVEHQN 146
IG G FG VY ++NSE VA+K++ G +++W + EV FL + H N
Sbjct: 23 IGHGSFGAVYFARDVRNSE------VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 147 LVKLVGYCADDDERGIQRLLVYEYMPNGSVDQ---YLSPKSETILTWAMRLKIAQDAARG 203
++ G C + LV EY + D + P E + + A +G
Sbjct: 77 TIQYRG-CYLREHTA---WLVMEYCLGSASDLLEVHKKPLQEVEIA-----AVTHGALQG 127
Query: 204 LAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL-GPSEGFTHVSTAVVGTMGY 262
LAYLH +I RD K+ NILL E KL DFG A + P+ F VGT +
Sbjct: 128 LAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF-------VGTPYW 177
Query: 263 AAPEYV---QTGRLAARSDVWSYGVFLYELITGRRPI-DRNRPRSEQKLLQWVKPYLSD- 317
APE + G+ + DVWS G+ EL + P+ + N + + Q P L
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSG 237
Query: 318 --AKQFRQIVDPRLEGKYSLRLVSK--LSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 373
++ FR VD L+ R S+ L H + R RP + +++++ + DA
Sbjct: 238 HWSEYFRNFVDSCLQKIPQDRPTSEVLLKH-RFVL-----RERP-PTVIMDLIQRTKDAV 290
Query: 374 AE 375
E
Sbjct: 291 RE 292
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (174), Expect = 1e-13
Identities = 63/218 (28%), Positives = 99/218 (45%), Gaps = 45/218 (20%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEW-----MTEVNFL-GIVEHQN 146
+G+G FG VY K + + V A+K++ ++ W + EV L + EH N
Sbjct: 7 LGDGTFGSVYLARNK---ETGELV--AIKKMKKK--FYSWEECMNLREVKSLRKLNEHPN 59
Query: 147 LVKLVGYCADDDERGIQRL-LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLA 205
+VKL ++DE L V+EYM G++ Q + + + ++ I +GLA
Sbjct: 60 IVKLKEVFRENDE-----LYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLA 113
Query: 206 YLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVS-----TAVVGTM 260
++H+ F RD K N+L+ K++DFGLAR + T V T
Sbjct: 114 HIHKHGFFH---RDLKPENLLVSGPEVVKIADFGLAR--------EIRSRPPYTDYVSTR 162
Query: 261 GYAAPEYVQTGRLAARS-----DVWSYGVFLYELITGR 293
Y APE + L + S D+W+ G + EL T R
Sbjct: 163 WYRAPEIL----LRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 64/220 (29%), Positives = 88/220 (40%), Gaps = 48/220 (21%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGR---RGGH-KEWMTEVNFLGIVEHQNLV 148
+G G +G V + +VA+K+L R H K E+ L ++H+N++
Sbjct: 23 VGSGAYGQVCSAFDTKT-----GRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVI 77
Query: 149 KLVG-YCADDDERGIQRLLVYEYMPNGSVD-------QYLSPKSETILTWAMRLKIAQDA 200
L+ + Q VY D Q LS L + +
Sbjct: 78 GLLDVFTPASSLEDFQD--VYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQI-------- 127
Query: 201 ARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTM 260
RGL Y+H II RD K SNI ++E K+ DFGLAR E T V T
Sbjct: 128 LRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE-----MTGYVATR 179
Query: 261 GYAAPE-------YVQTGRLAARSDVWSYGVFLYELITGR 293
Y APE Y QT D+WS G + EL+TG+
Sbjct: 180 WYRAPEIMLNWMHYNQT------VDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 86/287 (29%), Positives = 120/287 (41%), Gaps = 60/287 (20%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG--HKEW---MTEVNFLGIVEHQNL 147
IG G FG VY NS + +V VAVK++ G +++W + EV FL ++H N
Sbjct: 29 IGHGSFGAVY--FATNSH--TNEV-VAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNT 83
Query: 148 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQ---YLSPKSETILTWAMRLKIAQDAARGL 204
++ G C + LV EY + D + P E + I A +GL
Sbjct: 84 IEYKG-CYLKEHTA---WLVMEYCLGSASDLLEVHKKPLQEVEIA-----AITHGALQGL 134
Query: 205 AYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL-GPSEGFTHVSTAVVGTMGYA 263
AYLH +I RD K+ NILL E KL+DFG A P+ F VGT +
Sbjct: 135 AYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSF-------VGTPYWM 184
Query: 264 APEYV---QTGRLAARSDVWSYGVFLYELITGRRPI-DRNRPRSEQKLLQWVKPYLSD-- 317
APE + G+ + DVWS G+ EL + P+ + N + + Q P L
Sbjct: 185 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNE 244
Query: 318 -AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVL 363
FR VD CL K + RP +E+L
Sbjct: 245 WTDSFRGFVD--------------------YCLQKIPQERPASAELL 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 2e-13
Identities = 56/205 (27%), Positives = 96/205 (46%), Gaps = 17/205 (8%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKE-WMTEVNFLGIVEHQNLVKLV 151
+G G FG V+ ++ +VAVK + E ++ E N + ++H LVKL
Sbjct: 14 LGAGQFGEVWMATY------NKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLH 67
Query: 152 GYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGM 211
+ ++ E+M GS+ +L + + + A G+A++ +
Sbjct: 68 AVVTKE-----PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR- 121
Query: 212 DFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG 271
I RD +++NIL+ K++DFGLAR+ +T A + + APE + G
Sbjct: 122 --NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFG 178
Query: 272 RLAARSDVWSYGVFLYELIT-GRRP 295
+SDVWS+G+ L E++T GR P
Sbjct: 179 SFTIKSDVWSFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 2e-13
Identities = 55/221 (24%), Positives = 103/221 (46%), Gaps = 25/221 (11%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG---HKEWMTEVNFLGIVEHQNLVK 149
+GE FG VYKG + + Q VA+K L + +E+ E ++H N+V
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 150 LVGYCADDDERGIQRLLVYEYMPNGSVDQYL---SPKSE-----------TILTWAMRLK 195
L+G + +++ Y + + ++L SP S+ + L A +
Sbjct: 73 LLGVVTKEQPLS----MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVH 128
Query: 196 IAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTA 255
I A G+ +L ++ +D + N+L+ ++ N K+SD GL R + + +
Sbjct: 129 IVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGN 185
Query: 256 VVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 295
+ + + +PE + G+ + SD+WSYGV L+E+ + G +P
Sbjct: 186 SLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 41/104 (39%), Positives = 54/104 (51%), Gaps = 9/104 (8%)
Query: 206 YLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAP 265
YLH II RD K N+LLD + + K++DFG A+ P FT + GT Y AP
Sbjct: 133 YLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFT-----LCGTPEYLAP 184
Query: 266 EYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRP-RSEQKLL 308
E +Q+ D W+ GV LYE I G P + P R +K+L
Sbjct: 185 EVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKIL 228
|
Length = 329 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 2e-13
Identities = 66/212 (31%), Positives = 93/212 (43%), Gaps = 22/212 (10%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKE-----WMTEVNFLGIV-EHQ 145
V+G+G FG V +K S AVK L + ++ MTE L + H
Sbjct: 2 VLGKGSFGKVMLARLKESGRL-----YAVKVLKKDVILQDDDVECTMTEKRILSLARNHP 56
Query: 146 NLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLA 205
L +L C +R V E++ NG + KS R A + L
Sbjct: 57 FLTQLY-CCFQTPDR---LFFVMEFV-NGGDLMFHIQKSRRFDEARARF-YAAEITSALM 110
Query: 206 YLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAP 265
+LH D II RD K N+LLD + + KL+DFG+ + G G T ++ GT Y AP
Sbjct: 111 FLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--TSTFCGTPDYIAP 165
Query: 266 EYVQTGRLAARSDVWSYGVFLYELITGRRPID 297
E +Q D W+ GV LYE++ G P +
Sbjct: 166 EILQEMLYGPSVDWWAMGVLLYEMLCGHAPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 2e-13
Identities = 60/207 (28%), Positives = 104/207 (50%), Gaps = 24/207 (11%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEW-----MTEVNFLGIVEHQNL 147
+GEG + V+KG K +E+ VA+K++ R H+E + EV+ L ++H N+
Sbjct: 14 LGEGTYATVFKGRSKLTEN-----LVALKEI--RLEHEEGAPCTAIREVSLLKDLKHANI 66
Query: 148 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYL 207
V L D LV+EY+ + + QY+ + +++ + Q RGLAY
Sbjct: 67 VTLHDIVHTDK----SLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQ-ILRGLAYC 120
Query: 208 HEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPE- 266
H +++ RD K N+L++E+ KL+DFGLAR T+ + V T+ Y P+
Sbjct: 121 HRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDV 175
Query: 267 YVQTGRLAARSDVWSYGVFLYELITGR 293
+ + + + D+W G +E+ +GR
Sbjct: 176 LLGSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 3e-13
Identities = 64/287 (22%), Positives = 119/287 (41%), Gaps = 27/287 (9%)
Query: 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQ 145
NF IG G F VY+ P +V + ++ ++ + E++ L + H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 146 NLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLS--PKSETILTWAMRLKIAQDAARG 203
N++K + +D+E I V E G + Q + K + ++ K
Sbjct: 63 NVIKYLDSFIEDNELNI----VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSA 118
Query: 204 LAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYA 263
+ ++H +++ RD K +N+ + KL D GL R S+ T + ++VGT Y
Sbjct: 119 VEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK--TTAAHSLVGTPYYM 173
Query: 264 APEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQ 323
+PE + +SD+WS G LYE+ + P ++ S ++ Q
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-----------LFSLCQKIEQ 222
Query: 324 IVDPRLEGK-YSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 369
P L + YS KL + ++C+ + RP + V ++ ++
Sbjct: 223 CDYPPLPTEHYS----EKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 4e-13
Identities = 41/107 (38%), Positives = 53/107 (49%), Gaps = 6/107 (5%)
Query: 204 LAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYA 263
L LH+ F +I RD K NILLD Q + L DFGL +L + + GT Y
Sbjct: 106 LENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD--DDKTNTFCGTPEYL 160
Query: 264 APEYVQTGRLAARSDVWSYGVFLYELITGRRPI-DRNRPRSEQKLLQ 309
APE + D W+ GV LYE++TG P D N +K+LQ
Sbjct: 161 APELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQ 207
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 4e-13
Identities = 57/218 (26%), Positives = 102/218 (46%), Gaps = 34/218 (15%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKE---WMTEVNFLGIVEHQNLV 148
++ EG FG ++ G I E P ++ EV VK + + + E L + HQN++
Sbjct: 13 LLQEGTFGRIFYG-ILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNIL 71
Query: 149 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYL------SPKSETILTWAMRLKIAQDAAR 202
++ C +D E ++Y YM G++ +L + L+ + +A A
Sbjct: 72 PILHVCIEDGEP---PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIAC 128
Query: 203 GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR---------LGPSEGFTHVS 253
G++YLH+ +I +D + N ++DE+ K++D L+R LG +E
Sbjct: 129 GMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNEN----- 180
Query: 254 TAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT 291
+ + A E + ++ SDVWS+GV L+EL+T
Sbjct: 181 ----RPVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 4e-13
Identities = 65/214 (30%), Positives = 102/214 (47%), Gaps = 35/214 (16%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL----GRRGGHKEWMTEVNFLGIVEHQNLV 148
IGEG +G VYK D +A+K++ G + E++ L ++H N+V
Sbjct: 10 IGEGTYGVVYKA-----RDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIV 64
Query: 149 KLVGYCADDDERGIQRL-LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQ----DAARG 203
+L + +RL LV+EY+ D L ++ +A ++ + RG
Sbjct: 65 RLQDVVHSE-----KRLYLVFEYL-----DLDLKKHMDSSPDFAKNPRLIKTYLYQILRG 114
Query: 204 LAYLHEGMDFQIIVRDFKSSNILLDEQWNA-KLSDFGLAR-LG-PSEGFTHVSTAVVGTM 260
+AY H +++ RD K N+L+D + NA KL+DFGLAR G P FTH V T+
Sbjct: 115 IAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTH----EVVTL 167
Query: 261 GYAAPEYVQTGR-LAARSDVWSYGVFLYELITGR 293
Y APE + R + D+WS G E++ +
Sbjct: 168 WYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 4e-13
Identities = 85/289 (29%), Positives = 124/289 (42%), Gaps = 49/289 (16%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGR-RGGHKEWMTEVNFL-GIVEHQNLVKL 150
IG+G +G V+K + N ++ S+ AVK L +E E N L + +H N+VK
Sbjct: 26 IGKGTYGKVFK--VLNKKNGSK---AAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKF 80
Query: 151 VG-YCADDDERGIQRLLVYEYMPNGSVDQYL-------SPKSETILTWAMRLKIAQDAAR 202
G Y D + G Q LV E GSV + E I+ + I +A
Sbjct: 81 YGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAY-----ILHEALM 135
Query: 203 GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL-ARLGPSEGFTHVSTAVVGTMG 261
GL +LH + I RD K +NILL + KL DFG+ A+L + VGT
Sbjct: 136 GLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR---LRRNTSVGTPF 189
Query: 262 YAAPEYVQTGR-----LAARSDVWSYGVFLYELITGRRPIDRNRP-RSEQKLLQWVKPYL 315
+ APE + + AR DVWS G+ EL G P+ P R+ K+ + P L
Sbjct: 190 WMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTL 249
Query: 316 SDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 364
P L ++ + CL K+ RP +S++L+
Sbjct: 250 H---------QPELWS-------NEFNDFIRKCLTKDYEKRPTVSDLLQ 282
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.1 bits (170), Expect = 5e-13
Identities = 64/225 (28%), Positives = 95/225 (42%), Gaps = 45/225 (20%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGR------------RGGHKEWMTEVNFL 139
IG G +G V + D +VA+K++ R E+ L
Sbjct: 7 PIGSGAYGVVCSAV-----DKRTGRKVAIKKISNVFDDLIDAKRILR--------EIKLL 53
Query: 140 GIVEHQNLVKLVGYCADDDERGIQRL-LVYEYMPNGSVDQYLSPKSETILTWA-MRLKIA 197
+ H+N++ L+ + +V E M D + KS LT ++ +
Sbjct: 54 RHLRHENIIGLLDILRPPSPEDFNDVYIVTELME---TDLHKVIKSPQPLTDDHIQYFLY 110
Query: 198 QDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR-LGPSEGFTHVSTAV 256
Q RGL YLH +I RD K SNIL++ + K+ DFGLAR + P E T
Sbjct: 111 Q-ILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEY 166
Query: 257 VGTMGYAAPEYVQTGRLAARS-----DVWSYGVFLYELITGRRPI 296
V T Y APE + L++ D+WS G EL+T R+P+
Sbjct: 167 VVTRWYRAPELL----LSSSRYTKAIDIWSVGCIFAELLT-RKPL 206
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 5e-13
Identities = 76/284 (26%), Positives = 119/284 (41%), Gaps = 39/284 (13%)
Query: 92 VIGEGGFGCVYKGL-IKNSEDPSQKVEVAVKQLGRRGGHKEWMT-EVNFLG-IVEHQNLV 148
++G G +G VYKG +K + A+K + G +E + E+N L H+N+
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQ------LAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIA 66
Query: 149 KLVGYCADDDERGI--QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAY 206
G + G+ Q LV E+ GSV + L I ++ RGL++
Sbjct: 67 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSH 126
Query: 207 LHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL-ARLGPSEGFTHVSTAVVGTMGYAAP 265
LH+ ++I RD K N+LL E KL DFG+ A+L + G +GT + AP
Sbjct: 127 LHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG---RRNTFIGTPYWMAP 180
Query: 266 EYVQT-----GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 320
E + +SD+WS G+ E+ G P+ P L+
Sbjct: 181 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP----------- 229
Query: 321 FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 364
+ PRL+ K + K CLVKN RP ++++
Sbjct: 230 --RNPAPRLKSK---KWSKKFQSFIESCLVKNHSQRPTTEQLMK 268
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 6e-13
Identities = 36/101 (35%), Positives = 53/101 (52%), Gaps = 5/101 (4%)
Query: 197 AQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAV 256
A + A GL +LH II RD K N++LD + + K++DFG+ + G T +
Sbjct: 107 AAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT--TRTF 161
Query: 257 VGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPID 297
GT Y APE + D W++GV LYE++ G+ P D
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 6e-13
Identities = 46/145 (31%), Positives = 72/145 (49%), Gaps = 12/145 (8%)
Query: 166 LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNI 225
L+ +Y+ G + +L + E +R+ IA+ L +LH+ II RD K NI
Sbjct: 82 LILDYVNGGELFTHLY-QREHFTESEVRVYIAE-IVLALDHLHQ---LGIIYRDIKLENI 136
Query: 226 LLDEQWNAKLSDFGLAR--LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARS--DVWS 281
LLD + + L+DFGL++ L E + + GT+ Y APE ++ G D WS
Sbjct: 137 LLDSEGHVVLTDFGLSKEFLAEEEERAY---SFCGTIEYMAPEVIRGGSGGHDKAVDWWS 193
Query: 282 YGVFLYELITGRRPIDRNRPRSEQK 306
GV +EL+TG P + ++ Q
Sbjct: 194 LGVLTFELLTGASPFTVDGEQNSQS 218
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 7e-13
Identities = 56/220 (25%), Positives = 103/220 (46%), Gaps = 16/220 (7%)
Query: 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAV--KQLGRRGGHKEWMTEVNFLGIVEH 144
F+ ++G+G FG V + +K+ + QKV V + + +E++ E + +H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 145 QNLVKLVGYCADDDERGIQRL----LVYEYMPNGSVDQYL--SPKSETILTWAMR--LKI 196
N++KL+G R RL ++ +M +G + +L S E T ++ ++
Sbjct: 61 PNVIKLIGVSLR--SRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRF 118
Query: 197 AQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAV 256
D A G+ YL I RD + N +L+E ++DFGL++ S + A
Sbjct: 119 MIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCAS 175
Query: 257 VGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 295
+ + A E + SDVW++GV ++E++T G+ P
Sbjct: 176 KLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 7e-13
Identities = 36/101 (35%), Positives = 54/101 (53%), Gaps = 5/101 (4%)
Query: 197 AQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAV 256
A + + GL +LH II RD K N++LD + + K++DFG+ + +G T +
Sbjct: 107 AAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT--TRTF 161
Query: 257 VGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPID 297
GT Y APE + D W+YGV LYE++ G+ P D
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 7e-13
Identities = 70/224 (31%), Positives = 113/224 (50%), Gaps = 50/224 (22%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEW-----MTEVNFLGIVEHQNL 147
IGEG +G VYKG K + ++ VA+K++ R +E + E++ L ++H N+
Sbjct: 8 IGEGTYGVVYKGRNKKT----GQI-VAMKKI-RLESEEEGVPSTAIREISLLKELQHPNI 61
Query: 148 VKLVGYCADDDERGIQRL-LVYEYMPNGSVD--QYLS--PKSETILTWAMRLKIAQDAAR 202
V L + RL L++E++ S+D +YL PK + + DA
Sbjct: 62 VCLQDVLMQES-----RLYLIFEFL---SMDLKKYLDSLPKGQYM-----------DAEL 102
Query: 203 GLAYLH---EGMDF----QIIVRDFKSSNILLDEQWNAKLSDFGLAR-LG-PSEGFTHVS 253
+YL+ +G+ F +++ RD K N+L+D + KL+DFGLAR G P +TH
Sbjct: 103 VKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTH-- 160
Query: 254 TAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPI 296
VV T+ Y APE + R + D+WS G E+ T ++P+
Sbjct: 161 -EVV-TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT-KKPL 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 7e-13
Identities = 75/292 (25%), Positives = 134/292 (45%), Gaps = 40/292 (13%)
Query: 111 DPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEY 170
DP +KV L +E++ L +H +VK DD + + LL+ EY
Sbjct: 91 DPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHF----DDFKSDDKLLLIMEY 146
Query: 171 MPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAY------LHEGMDFQIIVRDFKSSN 224
G +++ + + + L + Q+ GL + L E +++ RD KS+N
Sbjct: 147 GSGGDLNKQIKQRLKEHLPF-------QEYEVGLLFYQIVLALDEVHSRKMMHRDLKSAN 199
Query: 225 ILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGV 284
I L KL DFG ++ V+++ GT Y APE + R + ++D+WS GV
Sbjct: 200 IFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGV 259
Query: 285 FLYELITGRRPIDRNRPRSEQKLLQWV-----KPY---LSDAKQFRQIVDPRLEGKYSLR 336
LYEL+T RP + S+++++Q V P+ +S + ++DP L +LR
Sbjct: 260 ILYELLTLHRPF---KGPSQREIMQQVLYGKYDPFPCPVSSGMK--ALLDPLLSKNPALR 314
Query: 337 LVSK-------LSHVANLC--LVKNARTRPKMSEVLEMVNKIVDASAEAGSP 379
++ L +VANL +V+++ T + E++ ++ ++ A P
Sbjct: 315 PTTQQLLHTEFLKYVANLFQDIVRHSETISP-HDREEILRQLQESGERAPPP 365
|
Length = 478 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 7e-13
Identities = 37/101 (36%), Positives = 53/101 (52%), Gaps = 5/101 (4%)
Query: 197 AQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAV 256
A + L +LH +I RD K NILLD + + KL+DFG+ + G G T +T
Sbjct: 102 AAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTTF 156
Query: 257 VGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPID 297
GT Y APE +Q D W+ GV +YE++ G+ P +
Sbjct: 157 CGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 8e-13
Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 10/216 (4%)
Query: 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQN 146
F V+G+GGFG V ++ + ++ K++ +R G + E L V +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 147 LVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAY 206
+V L Y + + LV M G + ++ + A + GL
Sbjct: 62 VVSL-AYAYETKD---ALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLED 117
Query: 207 LHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPE 266
L +I+ RD K NILLD++ + ++SD GLA P EG T VGT+GY APE
Sbjct: 118 LQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIP-EGET--VRGRVGTVGYMAPE 171
Query: 267 YVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPR 302
+ + D W G +YE+I G+ P + + R
Sbjct: 172 VINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKER 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 9e-13
Identities = 79/302 (26%), Positives = 126/302 (41%), Gaps = 49/302 (16%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHK--EWMTEVNFLGIVEHQNLVKL 150
+G+G FG VYK KN E A K + + + ++M E+ L H +VKL
Sbjct: 20 LGDGAFGKVYKA--KNKE---TGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKL 74
Query: 151 VGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEG 210
+G D + I + E+ P G+VD + + +++ I + L YLH
Sbjct: 75 LGAFYWDGKLWI----MIEFCPGGAVDAIMLELDRGLTEPQIQV-ICRQMLEALQYLHS- 128
Query: 211 MDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT 270
+II RD K+ N+LL + KL+DFG++ + + +GT + APE V
Sbjct: 129 --MKIIHRDLKAGNVLLTLDGDIKLADFGVS--AKNVKTLQRRDSFIGTPYWMAPEVVMC 184
Query: 271 GRLAA-----RSDVWSYGVFLYELITGRRPIDRNRP-RSEQKLLQWVKPYLSDAKQFRQI 324
+ ++D+WS G+ L E+ P P R K+ + P LS
Sbjct: 185 ETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPS----- 239
Query: 325 VDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE--MVNKIVDASAEAGSPRRP 382
K+S+ L L K+ TRP +++LE V+ + RP
Sbjct: 240 -------KWSMEFRDFL----KTALDKHPETRPSAAQLLEHPFVSSVTS--------NRP 280
Query: 383 LR 384
LR
Sbjct: 281 LR 282
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 1e-12
Identities = 70/212 (33%), Positives = 91/212 (42%), Gaps = 26/212 (12%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGR-----RGGHKEWMTEVN-FLGIVEHQ 145
VIG+G FG V L K+ D AVK L + + K M E N L V+H
Sbjct: 2 VIGKGSFGKVL--LAKHKAD---GKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHP 56
Query: 146 NLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLA 205
LV L Y ++ V +Y+ G + +L + + R A + A L
Sbjct: 57 FLVGL-HYSFQTADK---LYFVLDYVNGGELFFHLQ-RERSFPEPRARF-YAAEIASALG 110
Query: 206 YLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVV--GTMGYA 263
YLH II RD K NILLD Q + L+DFGL + EG H T GT Y
Sbjct: 111 YLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCK----EGIEHSKTTSTFCGTPEYL 163
Query: 264 APEYVQTGRLAARSDVWSYGVFLYELITGRRP 295
APE ++ D W G LYE++ G P
Sbjct: 164 APEVLRKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 36/97 (37%), Positives = 53/97 (54%), Gaps = 6/97 (6%)
Query: 202 RGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLG-PSEGFTHVSTAVVGTM 260
RGL Y+H ++ RD K SN+LL+ + K+ DFGLAR+ P T T V T
Sbjct: 117 RGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATR 173
Query: 261 GYAAPEYVQTGRLAARS-DVWSYGVFLYELITGRRPI 296
Y APE + + ++ D+WS G L E+++ RP+
Sbjct: 174 WYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN-RPL 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 2e-12
Identities = 76/274 (27%), Positives = 114/274 (41%), Gaps = 32/274 (11%)
Query: 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQN 146
F V+G+GGFG V ++ + ++ K++ +R G + E L V +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 147 LVKLV-GYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLA 205
+V L Y D LV M G + ++ + A + GL
Sbjct: 62 VVSLAYAYETKD-----ALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLE 116
Query: 206 YLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAP 265
LH +I+ RD K NILLD+ + ++SD GLA P EG T VGT+GY AP
Sbjct: 117 DLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIP-EGET--IRGRVGTVGYMAP 170
Query: 266 EYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIV 325
E V+ R D W G +YE+I G+ P R R E+ VK R+ V
Sbjct: 171 EVVKNERYTFSPDWWGLGCLIYEMIEGKSPF---RQRKEK-----VK---------REEV 213
Query: 326 DPRL---EGKYSLRLVSKLSHVANLCLVKNARTR 356
+ R+ + +YS + + L K+ R
Sbjct: 214 ERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFR 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 36/93 (38%), Positives = 53/93 (56%), Gaps = 5/93 (5%)
Query: 203 GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGY 262
GL +LH+ II RD K N+LLD+ + K++DFG+ + + G ST GT Y
Sbjct: 108 GLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMN-GEGKAST-FCGTPDY 162
Query: 263 AAPEYVQTGRLAARSDVWSYGVFLYELITGRRP 295
APE ++ + D WS+GV LYE++ G+ P
Sbjct: 163 IAPEILKGQKYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 3e-12
Identities = 64/286 (22%), Positives = 115/286 (40%), Gaps = 25/286 (8%)
Query: 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQ 145
NF IG G F VY+ P +V + L + + E++ L + H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 146 NLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLS--PKSETILTWAMRLKIAQDAARG 203
N++K +D+E I V E G + + + K + ++ K
Sbjct: 63 NVIKYYASFIEDNELNI----VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSA 118
Query: 204 LAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYA 263
L ++H +++ RD K +N+ + KL D GL R S+ T + ++VGT Y
Sbjct: 119 LEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK--TTAAHSLVGTPYYM 173
Query: 264 APEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQ 323
+PE + +SD+WS G LYE+ + P ++ S K+ Q
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-----------LYSLCKKIEQ 222
Query: 324 IVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 369
P L + +L + N+C+ + RP ++ V ++ ++
Sbjct: 223 CDYPPLPSDH---YSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 3e-12
Identities = 67/213 (31%), Positives = 105/213 (49%), Gaps = 34/213 (15%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEW-----MTEVNFLGIVEHQN 146
+GEG + VYKG K + VA+K++ R H+E + E + L ++H N
Sbjct: 12 KLGEGSYATVYKGRSKLTGQ-----LVALKEI--RLEHEEGAPFTAIREASLLKDLKHAN 64
Query: 147 LVKLVGYCADDDERGIQRLL--VYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGL 204
+V L D ++ L V+EY+ + + QY+ + +RL + Q RGL
Sbjct: 65 IVTL------HDIIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLFLFQ-LLRGL 116
Query: 205 AYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLG--PSEGFTHVSTAVVGTMGY 262
AY H +++ RD K N+L+ E+ KL+DFGLAR PS+ +++ VV T+ Y
Sbjct: 117 AYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSN---EVV-TLWY 169
Query: 263 AAPEYVQTGRLAARS--DVWSYGVFLYELITGR 293
P+ V G + D+W G YE+ TGR
Sbjct: 170 RPPD-VLLGSTEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 3e-12
Identities = 49/155 (31%), Positives = 71/155 (45%), Gaps = 18/155 (11%)
Query: 204 LAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYA 263
L +LHE II RD K N+LLD + + KL+D+G+ + G G T ++ GT Y
Sbjct: 109 LNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT--TSTFCGTPNYI 163
Query: 264 APEYVQTGRLAARSDVWSYGVFLYELITGRRPID--RNRPRSEQKLLQWVKPYLSDAKQF 321
APE ++ D W+ GV ++E++ GR P D +Q + YL
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQN----TEDYLFQVILE 219
Query: 322 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTR 356
+QI PR L K S V L K+ + R
Sbjct: 220 KQIRIPR-------SLSVKASSVLKGFLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 3e-12
Identities = 67/264 (25%), Positives = 112/264 (42%), Gaps = 26/264 (9%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVE-VAVKQLGRRGGHKEWMTEVNFLGIVEHQNLVKL 150
+IG GGFG VY G K ++ + K++ + G + E L +V + +
Sbjct: 1 IIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59
Query: 151 VGYCADDDERGIQRL-LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHE 209
V C +L + + M G + +LS + + A A + GL ++H
Sbjct: 60 V--CMSYAFHTPDKLSFILDLMNGGDLHYHLS--QHGVFSEAEMRFYAAEIILGLEHMHN 115
Query: 210 GMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQ 269
++ RD K +NILLDE + ++SD GLA S+ H S VGT GY APE +Q
Sbjct: 116 RF---VVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHAS---VGTHGYMAPEVLQ 168
Query: 270 TGRLAARSDVW-SYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPR 328
G S W S G L++L+ G P +++ + + ++ + +
Sbjct: 169 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-----------DRMTLTMAVE 217
Query: 329 LEGKYSLRLVSKLSHVANLCLVKN 352
L +S L S L + + +
Sbjct: 218 LPDSFSPELRSLLEGLLQRDVNRR 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 4e-12
Identities = 78/284 (27%), Positives = 123/284 (43%), Gaps = 37/284 (13%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWM---TEVNFLGIVEHQNLVK 149
IG G FG V G + + P+Q V VK+L +E M E ++H NL++
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQ---VVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQ 59
Query: 150 LVGYCADDDERGIQRLLVYEYMPNGSVDQYL-SPKSETILTWAMRL--KIAQDAARGLAY 206
+G C + LLV E+ P G + YL S + ++T ++A + A GL +
Sbjct: 60 CLGQCTEV----TPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLH 115
Query: 207 LHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPE 266
LH+ I D N LL K+ D+GL+ E + + + + APE
Sbjct: 116 LHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPE 172
Query: 267 YVQT--GRL-----AARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDA 318
V G L S+VWS GV ++EL G +P R S++++L +
Sbjct: 173 LVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPY---RHLSDEQVLTYTV-----R 224
Query: 319 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEV 362
+Q ++ PRL+ L L + V C ++ + RP EV
Sbjct: 225 EQQLKLPKPRLK----LPLSDRWYEVMQFCWLQPEQ-RPSAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 8e-12
Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 22/204 (10%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHK--EWMTEVNFLGIVEHQNLVKL 150
+G+G FG VYK +++ V A K + + + ++M E++ L +H N+VKL
Sbjct: 13 LGDGAFGKVYK-----AQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKL 67
Query: 151 VGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEG 210
+ ++ I + E+ G+VD + + E LT + + L YLHE
Sbjct: 68 LDAFYYENNLWI----LIEFCAGGAVDAVML-ELERPLTEPQIRVVCKQTLEALNYLHEN 122
Query: 211 MDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT 270
+II RD K+ NIL + KL+DFG++ + + +GT + APE V
Sbjct: 123 ---KIIHRDLKAGNILFTLDGDIKLADFGVS--AKNTRTIQRRDSFIGTPYWMAPEVVMC 177
Query: 271 GRLAAR-----SDVWSYGVFLYEL 289
R +DVWS G+ L E+
Sbjct: 178 ETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 9e-12
Identities = 69/208 (33%), Positives = 94/208 (45%), Gaps = 18/208 (8%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPS-QKVEVAVKQ--LGRRGGHKEWMTEVN-FLGIVEHQNL 147
VIG+G FG V L K D V+V K+ L R+ K M E N L V+H L
Sbjct: 2 VIGKGSFGKVL--LAKRKLDGKCYAVKVLQKKIVLNRKE-QKHIMAERNVLLKNVKHPFL 58
Query: 148 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYL 207
V L Y E+ V +++ G + +L + + R A+ A L YL
Sbjct: 59 VGL-HYSFQTTEK---LYFVLDFVNGGELFFHLQ-RERSFPEPRARFYAAE-IASALGYL 112
Query: 208 HEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEY 267
H I+ RD K NILLD Q + L+DFGL + G ++ T +T GT Y APE
Sbjct: 113 HS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT--TTTFCGTPEYLAPEV 167
Query: 268 VQTGRLAARSDVWSYGVFLYELITGRRP 295
++ D W G LYE++ G P
Sbjct: 168 IRKQPYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 1e-11
Identities = 36/95 (37%), Positives = 52/95 (54%), Gaps = 5/95 (5%)
Query: 203 GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGY 262
L YLHE II RD K N+LLD + + KL+D+G+ + G G T ++ GT Y
Sbjct: 108 ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNY 162
Query: 263 AAPEYVQTGRLAARSDVWSYGVFLYELITGRRPID 297
APE ++ D W+ GV ++E++ GR P D
Sbjct: 163 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 34/92 (36%), Positives = 49/92 (53%), Gaps = 5/92 (5%)
Query: 204 LAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYA 263
L YLH ++ RD K N++LD+ + K++DFGL + G S+G T GT Y
Sbjct: 108 LGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYL 162
Query: 264 APEYVQTGRLAARSDVWSYGVFLYELITGRRP 295
APE ++ D W GV +YE++ GR P
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 35/101 (34%), Positives = 54/101 (53%), Gaps = 5/101 (4%)
Query: 197 AQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAV 256
A + A GL +LH II RD K N++LD + + K++DFG+ + +G T +
Sbjct: 107 AAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT--TKTF 161
Query: 257 VGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPID 297
GT Y APE + D W++GV LYE++ G+ P +
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 72/274 (26%), Positives = 115/274 (41%), Gaps = 34/274 (12%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWM--TEVNFLGIVEHQNLVKL 150
IGEG G V K++ +VAVK++ R + + EV + H+N+V +
Sbjct: 30 IGEGSTGIVCIATEKHTGK-----QVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDM 84
Query: 151 VGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEG 210
DE + V E++ G++ ++ T + + R L+YLH
Sbjct: 85 YNSYLVGDELWV----VMEFLEGGALTDIVT---HTRMNEEQIATVCLSVLRALSYLHNQ 137
Query: 211 MDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT 270
+I RD KS +ILL KLSDFG E ++VGT + APE +
Sbjct: 138 ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE--VPKRKSLVGTPYWMAPEVISR 192
Query: 271 GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLE 330
D+WS G+ + E+I G P + +P L ++ R + PR+
Sbjct: 193 LPYGTEVDIWSLGIMVIEMIDGEPPY-------------FNEPPLQAMRRIRDNLPPRV- 238
Query: 331 GKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 364
K S ++ S L +L LV+ R E+L+
Sbjct: 239 -KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQ 271
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 35/95 (36%), Positives = 51/95 (53%), Gaps = 5/95 (5%)
Query: 203 GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGY 262
L +LHE II RD K N+LLD + KL+D+G+ + G G T ++ GT Y
Sbjct: 108 ALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT--TSTFCGTPNY 162
Query: 263 AAPEYVQTGRLAARSDVWSYGVFLYELITGRRPID 297
APE ++ D W+ GV ++E++ GR P D
Sbjct: 163 IAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 66/250 (26%), Positives = 108/250 (43%), Gaps = 52/250 (20%)
Query: 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEW-----MTEVNFL 139
+ + IG+G FG V+K K ++ VA+K++ KE + E+ L
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQ-----IVALKKV-LMENEKEGFPITALREIKIL 65
Query: 140 GIVEHQNLVKLVGYC-----ADDDERGIQRLLVYEY--------MPNGSVDQYLSPKSET 186
+++H+N+V L+ C + +G LV+E+ + N +V LS +
Sbjct: 66 QLLKHENVVNLIEICRTKATPYNRYKG-SFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKV 124
Query: 187 ILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR--LG 244
+ + GL Y+H +I+ RD K++NIL+ + KL+DFGLAR
Sbjct: 125 M----------KMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSL 171
Query: 245 PSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARS-----DVWSYGVFLYELITGRRPIDRN 299
+ T V T+ Y PE + L R D+W G + E+ T R PI +
Sbjct: 172 SKNSKPNRYTNRVVTLWYRPPELL----LGERDYGPPIDMWGAGCIMAEMWT-RSPIMQG 226
Query: 300 RPRSEQKLLQ 309
+EQ L
Sbjct: 227 --NTEQHQLT 234
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 3e-11
Identities = 38/106 (35%), Positives = 58/106 (54%), Gaps = 8/106 (7%)
Query: 203 GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGY 262
GL ++H ++ RD K +NILLDE + ++SD GLA S+ H S VGT GY
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHAS---VGTHGY 161
Query: 263 AAPEYVQTGRLAARSDVW-SYGVFLYELITGRRPIDRNRPRSEQKL 307
APE +Q G S W S G L++L+ G P +++ + + ++
Sbjct: 162 MAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 43/132 (32%), Positives = 64/132 (48%), Gaps = 11/132 (8%)
Query: 166 LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNI 225
V EY+ G + +LS E + + + L YLH G +I+ RD K N+
Sbjct: 72 FVMEYVNGGELFFHLS--RERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENL 126
Query: 226 LLDEQWNAKLSDFGLARLGPSEGFTHVST--AVVGTMGYAAPEYVQTGRLAARSDVWSYG 283
+LD+ + K++DFGL + EG T +T GT Y APE ++ D W G
Sbjct: 127 MLDKDGHIKITDFGLCK----EGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLG 182
Query: 284 VFLYELITGRRP 295
V +YE++ GR P
Sbjct: 183 VVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 3e-11
Identities = 58/234 (24%), Positives = 102/234 (43%), Gaps = 34/234 (14%)
Query: 93 IGEGGFGCVYKGLIKNSED-----PSQKVEVAVKQLGRRGGHKEWMTE-VNFLGIVEHQN 146
+G+G F +YKG+++ D P Q+V V +K LG E + + + H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 147 LVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAY 206
LVKL G C D + ++V EY+ G +D +L + + ++ +L +A+ A L Y
Sbjct: 63 LVKLYGVCVRD-----ENIMVEEYVKFGPLDVFLH-REKNNVSLHWKLDVAKQLASALHY 116
Query: 207 LHEGMDFQIIVRDFKSSNILLDE-------QWNAKLSDFGLAR-LGPSEGFTHVSTAVVG 258
L + +++ + NIL+ KLSD G+ + E V
Sbjct: 117 LEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSRE-------ERVE 166
Query: 259 TMGYAAPEYVQTGRLAARS--DVWSYGVFLYELITGRRPIDRN-RPRSEQKLLQ 309
+ + APE ++ G+ + D WS+G L E I + SE++
Sbjct: 167 RIPWIAPECIRNGQASLTIAADKWSFGTTLLE-ICSNGEEPLSTLSSSEKERFY 219
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 75/256 (29%), Positives = 108/256 (42%), Gaps = 22/256 (8%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVN-FLGIVEHQNLVKL 150
VIG+G FG V K E + K + ++ K M+E N L V+H LV L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 151 VGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEG 210
D + V +Y+ G + +L + L R A + A L YLH
Sbjct: 62 HFSFQTAD----KLYFVLDYINGGELFYHLQ-RERCFLEPRARF-YAAEIASALGYLHS- 114
Query: 211 MDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVST--AVVGTMGYAAPEYV 268
I+ RD K NILLD Q + L+DFGL + E H T GT Y APE +
Sbjct: 115 --LNIVYRDLKPENILLDSQGHIVLTDFGLCK----ENIEHNGTTSTFCGTPEYLAPEVL 168
Query: 269 QTGRLAARSDVWSYGVFLYELITGRRPI-DRNRPRSEQKLLQ---WVKPYLSDAKQFRQI 324
D W G LYE++ G P RN +L +KP ++++ R +
Sbjct: 169 HKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSA--RHL 226
Query: 325 VDPRLEGKYSLRLVSK 340
++ L+ + RL +K
Sbjct: 227 LEGLLQKDRTKRLGAK 242
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 4e-11
Identities = 65/207 (31%), Positives = 90/207 (43%), Gaps = 16/207 (7%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPS-QKVEVAVKQ-LGRRGGHKEWMTEVN-FLGIVEHQNLV 148
VIG+G FG V L K D S V+V K+ + ++ M E N L ++H LV
Sbjct: 2 VIGKGSFGKVL--LAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59
Query: 149 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLH 208
L Y E+ V +Y+ G + + + E A + A + YLH
Sbjct: 60 GL-HYSFQTAEK---LYFVLDYVNGGEL--FFHLQRERCFLEPRARFYAAEVASAIGYLH 113
Query: 209 EGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYV 268
II RD K NILLD Q + L+DFGL + G T ++ GT Y APE +
Sbjct: 114 S---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTFCGTPEYLAPEVL 168
Query: 269 QTGRLAARSDVWSYGVFLYELITGRRP 295
+ D W G LYE++ G P
Sbjct: 169 RKEPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 4e-11
Identities = 64/221 (28%), Positives = 101/221 (45%), Gaps = 45/221 (20%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL----GRRGGHKEWMTEVNFLGIVEHQNLV 148
IGEG +G V+K KN E VA+K++ G + E+ L ++H+N+V
Sbjct: 8 IGEGTYGTVFKA--KNRETHEI---VALKRVRLDDDDEGVPSSALREICLLKELKHKNIV 62
Query: 149 KLVGYCADDDERGIQRLLVYEYMP----------NGSVDQYLSPKSETILTWAMRLKIAQ 198
+L D + LV+EY NG +D E + ++ +L
Sbjct: 63 RLYDVLHSDKKL----TLVFEYCDQDLKKYFDSCNGDIDP------EIVKSFMFQL---- 108
Query: 199 DAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR-LG-PSEGFTHVSTAV 256
+GLA+ H ++ RD K N+L+++ KL+DFGLAR G P + +A
Sbjct: 109 --LKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCY----SAE 159
Query: 257 VGTMGYAAPEYVQTGRLAARS-DVWSYGVFLYELITGRRPI 296
V T+ Y P+ + +L + S D+WS G EL RP+
Sbjct: 160 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 5e-11
Identities = 62/219 (28%), Positives = 98/219 (44%), Gaps = 11/219 (5%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQNLVKLVG 152
+G+GGFG V ++ + ++ K+L +R G++ M E L V + +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLA- 59
Query: 153 YCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAA--RGLAYLHEG 210
A + + LV M G + ++ E + A GL +LH+
Sbjct: 60 -YAFQTKTDL--CLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR 116
Query: 211 MDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT 270
+II RD K N+LLD N ++SD GLA + +G + + GT G+ APE +Q
Sbjct: 117 ---RIIYRDLKPENVLLDNDGNVRISDLGLA-VELKDGQSK-TKGYAGTPGFMAPELLQG 171
Query: 271 GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQ 309
D ++ GV LYE+I R P + E K L+
Sbjct: 172 EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK 210
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 5e-11
Identities = 57/220 (25%), Positives = 97/220 (44%), Gaps = 17/220 (7%)
Query: 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQNLVKL 150
+ IGEG G V I + ++V V + L ++ + EV + +HQN+V++
Sbjct: 27 IKIGEGSTGIV---CIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEM 83
Query: 151 VGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEG 210
+E + + E++ G++ +S +T L + + + L YLH
Sbjct: 84 YKSYLVGEELWV----LMEFLQGGALTDIVS---QTRLNEEQIATVCESVLQALCYLHSQ 136
Query: 211 MDFQIIVRDFKSSNILLDEQWNAKLSDFGL-ARLGPSEGFTHVSTAVVGTMGYAAPEYVQ 269
+I RD KS +ILL KLSDFG A++ ++VGT + APE +
Sbjct: 137 ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD---VPKRKSLVGTPYWMAPEVIS 190
Query: 270 TGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQ 309
D+WS G+ + E++ G P + P K L+
Sbjct: 191 RTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR 230
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 62.6 bits (153), Expect = 6e-11
Identities = 63/222 (28%), Positives = 103/222 (46%), Gaps = 51/222 (22%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEW----MT---EVNFLGIVEHQ 145
I EG +G VY+ K + + VA+K+L KE +T E+N L ++H
Sbjct: 13 IEEGTYGVVYRARDKKTGEI-----VALKKLKM---EKEKEGFPITSLREINILLKLQHP 64
Query: 146 NLVKL----VGYCADDDERGIQRLLVYEYMPNG-------SVDQYLSPKSETILTWAMRL 194
N+V + VG ++ D + +V EY+ + +L + + ++
Sbjct: 65 NIVTVKEVVVG--SNLD----KIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLM------ 112
Query: 195 KIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL--GPSEGFTHV 252
G+A+LH D I+ RD K+SN+LL+ + K+ DFGLAR P + +T +
Sbjct: 113 ---LQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQL 166
Query: 253 STAVVGTMGYAAPE-YVQTGRLAARSDVWSYGVFLYELITGR 293
VV T+ Y APE + + D+WS G EL+T +
Sbjct: 167 ---VV-TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 6e-11
Identities = 60/233 (25%), Positives = 95/233 (40%), Gaps = 35/233 (15%)
Query: 79 ELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLG-----RRGGHKEWM 133
++K NF R+ +G G FG V KN + P VA+K+ ++
Sbjct: 26 KMKYEDFNFIRT--LGTGSFGRVILATYKNEDFPP----VAIKRFEKSKIIKQKQVDHVF 79
Query: 134 TEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMR 193
+E L + H V L G D+ LV E++ G +L
Sbjct: 80 SERKILNYINHPFCVNLYGSFKDES----YLYLVLEFVIGGEFFTFLRRNK--------- 126
Query: 194 LKIAQD-----AARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEG 248
+ D AA+ + I+ RD K N+LLD+ K++DFG A++ +
Sbjct: 127 -RFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRT 185
Query: 249 FTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRP 301
+T + GT Y APE + +D W+ G+F+YE++ G P N P
Sbjct: 186 YT-----LCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP 233
|
Length = 340 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 7e-11
Identities = 66/219 (30%), Positives = 98/219 (44%), Gaps = 49/219 (22%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG----HKEWMTEVNFLGIVEHQNLV 148
IGEG +G V+K +N E + ++ VA+K+ K + E+ L ++H NLV
Sbjct: 9 IGEGSYGVVFK--CRNRE--TGQI-VAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLV 63
Query: 149 KLVGYCADDDERGIQRL-LVYEYM-----------PNGSVDQYLSPKSETILTWAMRLKI 196
L+ + R ++L LV+EY P G V ++L K + W
Sbjct: 64 NLI-----EVFRRKRKLHLVFEYCDHTVLNELEKNPRG-VPEHLIKK----IIWQT---- 109
Query: 197 AQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL--GPSEGFTHVST 254
+ + + H+ I RD K NIL+ +Q KL DFG AR+ GP + +T
Sbjct: 110 ----LQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD--- 159
Query: 255 AVVGTMGYAAPEY-VQTGRLAARSDVWSYGVFLYELITG 292
V T Y APE V + DVW+ G EL+TG
Sbjct: 160 -YVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 7e-11
Identities = 34/93 (36%), Positives = 49/93 (52%), Gaps = 9/93 (9%)
Query: 202 RGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMG 261
RGL Y+H ++ RD K SNIL++E + K+ DFGLAR+ + T V T
Sbjct: 119 RGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQ-----MTGYVSTRY 170
Query: 262 YAAPEYVQT-GRLAARSDVWSYGVFLYELITGR 293
Y APE + T + D+WS G E++ G+
Sbjct: 171 YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 8e-11
Identities = 62/232 (26%), Positives = 100/232 (43%), Gaps = 22/232 (9%)
Query: 78 AELKSATKNFSRSVVIGEGGFGCV-YKGLIKNSEDPSQKV----EVAVKQLGRRGGHKEW 132
A K K + S V+G G G V + + E + KV ++ R
Sbjct: 25 ATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCC 84
Query: 133 MTEVNFLGIVE-HQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWA 191
+ +F IV+ H++ K + E + LV +Y G + Q + +++T T+
Sbjct: 85 LLNCDFFSIVKCHEDFAK---KDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFR 141
Query: 192 MRLKIAQDAARGLAYL------HEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGP 245
+ GL ++ H +I RD KS+NILL KL DFG +++
Sbjct: 142 -------EHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYA 194
Query: 246 SEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPID 297
+ V GT Y APE + + ++D++S GV LYEL+T +RP D
Sbjct: 195 ATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 34/96 (35%), Positives = 51/96 (53%), Gaps = 11/96 (11%)
Query: 203 GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR---LGPSEGFTHVSTAVVGT 259
GL +LH II RD K N++LD + K++DFG+ + G + ++ GT
Sbjct: 108 GLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR-----ASTFCGT 159
Query: 260 MGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRP 295
Y APE +Q + D WS+GV LYE++ G+ P
Sbjct: 160 PDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 64/215 (29%), Positives = 93/215 (43%), Gaps = 30/215 (13%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGR----RGGHKEWMTEVNFLGIVEHQNLV 148
IG G +G V KNSE +VA+K++ R K + E+ L ++H+N++
Sbjct: 13 IGRGAYGIVCSA--KNSE---TNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVI 67
Query: 149 KLVGYCADDDERGIQR------LLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAAR 202
+ D R +VYE M D + +S L+ R
Sbjct: 68 AI-----KDIMPPPHREAFNDVYIVYELM---DTDLHQIIRSSQTLSDDHCQYFLYQLLR 119
Query: 203 GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGY 262
GL Y+H ++ RD K SN+LL+ + K+ DFGLAR +G T V T Y
Sbjct: 120 GLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG--DFMTEYVVTRWY 174
Query: 263 AAPEYV-QTGRLAARSDVWSYGVFLYELITGRRPI 296
APE + DVWS G EL+ GR+P+
Sbjct: 175 RAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 38/94 (40%), Positives = 52/94 (55%), Gaps = 7/94 (7%)
Query: 203 GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGY 262
GL YLHE +I+ RD K N+LLD + K++DFGL + G GF ++ GT +
Sbjct: 113 GLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEG--MGFGDRTSTFCGTPEF 167
Query: 263 AAPEYVQTGRLAARS-DVWSYGVFLYELITGRRP 295
APE V T R+ D W GV +YE++ G P
Sbjct: 168 LAPE-VLTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 1e-10
Identities = 38/113 (33%), Positives = 58/113 (51%), Gaps = 14/113 (12%)
Query: 203 GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR---LGPSEGFTHVSTAVVGT 259
GL +LH I+ RD K NILLD + K++DFG+ + LG ++ + GT
Sbjct: 108 GLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK-----TCTFCGT 159
Query: 260 MGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK 312
Y APE + + D WS+GV LYE++ G+ P E++L Q ++
Sbjct: 160 PDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPF---HGHDEEELFQSIR 209
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 46/142 (32%), Positives = 60/142 (42%), Gaps = 23/142 (16%)
Query: 166 LVYEYMPNGSVDQYLSPKSETILTWAM------RLKIAQDAARGLAYLHEGMDFQIIVRD 219
LV EY P G + L+ + E M L +A + + Y+H RD
Sbjct: 78 LVMEYQPGGDLLSLLN-RYEDQFDEDMAQFYLAELVLAIHSVHQMGYVH---------RD 127
Query: 220 FKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT------GRL 273
K N+L+D + KL+DFG A + S VGT Y APE + T G
Sbjct: 128 IKPENVLIDRTGHIKLADFGSAARLTANK-MVNSKLPVGTPDYIAPEVLTTMNGDGKGTY 186
Query: 274 AARSDVWSYGVFLYELITGRRP 295
D WS GV YE+I GR P
Sbjct: 187 GVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 2e-10
Identities = 64/229 (27%), Positives = 92/229 (40%), Gaps = 54/229 (23%)
Query: 92 VIGEGGFGCV-----------YKGLIKNSEDPSQKVEVAVKQLGRR---GGHKEWMTEVN 137
VIG G FG V Y I N + ++ E A + R G + W+T ++
Sbjct: 8 VIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLH 67
Query: 138 FLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIA 197
+ A DE + LV +Y G + LS + + R +A
Sbjct: 68 Y----------------AFQDENNL--YLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLA 109
Query: 198 Q-----DAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG-LARLGPSEGFTH 251
+ D+ L Y+H RD K N+LLD+ + +L+DFG RL T
Sbjct: 110 EMVLAIDSVHQLGYVH---------RDIKPDNVLLDKNGHIRLADFGSCLRLLADG--TV 158
Query: 252 VSTAVVGTMGYAAPEYVQ-----TGRLAARSDVWSYGVFLYELITGRRP 295
S VGT Y +PE +Q GR D WS GV +YE++ G P
Sbjct: 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 71/267 (26%), Positives = 110/267 (41%), Gaps = 68/267 (25%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMT-----EVNFLGIVEHQN 146
VIG G FG V L++ + + + A+K+L + ++ E + L ++
Sbjct: 8 VIGRGAFGEVR--LVQKKD--TGHI-YAMKKLRKSEMLEKEQVAHVRAERDILAEADNPW 62
Query: 147 LVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQ-----DAA 201
+VKL Y + DE + L+ EY+P G + L K +T R IA+ D+
Sbjct: 63 VVKL--YYSFQDENYL--YLIMEYLPGGDMMTLLM-KKDTFTEEETRFYIAETILAIDSI 117
Query: 202 RGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA-------------RLGPSEG 248
L Y+H RD K N+LLD + + KLSDFGL L +
Sbjct: 118 HKLGYIH---------RDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALP 168
Query: 249 FTHVST-----------------------AVVGTMGYAAPE-YVQTGRLAARSDVWSYGV 284
+ + VGT Y APE ++QTG D WS GV
Sbjct: 169 SNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG-YNKECDWWSLGV 227
Query: 285 FLYELITGRRPIDRNRPRSE-QKLLQW 310
+YE++ G P + P+ +K++ W
Sbjct: 228 IMYEMLVGYPPFCSDNPQETYRKIINW 254
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 35/98 (35%), Positives = 49/98 (50%), Gaps = 7/98 (7%)
Query: 202 RGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTH--VSTAVVGT 259
RGL Y+H +I RD K SN+L++E ++ DFG+AR S H T V T
Sbjct: 118 RGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVAT 174
Query: 260 MGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPI 296
Y APE + + D+WS G E++ GRR +
Sbjct: 175 RWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 3e-10
Identities = 55/193 (28%), Positives = 79/193 (40%), Gaps = 27/193 (13%)
Query: 111 DPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEY 170
Q+ +V VK G E++ L + H+ ++ L+ R + V
Sbjct: 115 GDEQRKKVIVK-AVTGGKTPG--REIDILKTISHRAIINLI-----HAYR--WKSTVCMV 164
Query: 171 MPNGSVDQY-----LSPKS-ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSN 224
MP D + P E +T RL A LAYLH II RD K+ N
Sbjct: 165 MPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEA------LAYLHGR---GIIHRDVKTEN 215
Query: 225 ILLDEQWNAKLSDFGLA-RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYG 283
I LDE NA L DFG A +L T GT+ +PE + A++D+WS G
Sbjct: 216 IFLDEPENAVLGDFGAACKLDAHP-DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAG 274
Query: 284 VFLYELITGRRPI 296
+ L+E+ +
Sbjct: 275 LVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 4e-10
Identities = 33/93 (35%), Positives = 49/93 (52%), Gaps = 4/93 (4%)
Query: 203 GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGY 262
L YLH + ++ RD K N++LD+ + K++DFGL + G +G T GT Y
Sbjct: 107 ALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKTFCGTPEY 162
Query: 263 AAPEYVQTGRLAARSDVWSYGVFLYELITGRRP 295
APE ++ D W GV +YE++ GR P
Sbjct: 163 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 4e-10
Identities = 63/244 (25%), Positives = 105/244 (43%), Gaps = 24/244 (9%)
Query: 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWM--TEVNFLGIVEHQNLV 148
+ IGEG G V +K+S VAVK++ R + + EV + +H+N+V
Sbjct: 26 IKIGEGSTGIVCIATVKSSGK-----LVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVV 80
Query: 149 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLH 208
++ DE + V E++ G++ ++ T + + + L+ LH
Sbjct: 81 EMYNSYLVGDELWV----VMEFLEGGALTDIVT---HTRMNEEQIAAVCLAVLKALSVLH 133
Query: 209 EGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYV 268
+I RD KS +ILL KLSDFG E ++VGT + APE +
Sbjct: 134 AQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKSLVGTPYWMAPELI 188
Query: 269 QTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQ-WVKPYLSDAKQFRQIVDP 327
D+WS G+ + E++ G P P K+++ + P L + + V P
Sbjct: 189 SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHK----VSP 244
Query: 328 RLEG 331
L+G
Sbjct: 245 SLKG 248
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 4e-10
Identities = 42/130 (32%), Positives = 61/130 (46%), Gaps = 7/130 (5%)
Query: 166 LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNI 225
V EY G + +LS E + T + L YLH ++ RD K N+
Sbjct: 72 FVMEYANGGELFFHLS--RERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENL 126
Query: 226 LLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVF 285
+LD+ + K++DFGL + G S+G T GT Y APE ++ D W GV
Sbjct: 127 MLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVV 184
Query: 286 LYELITGRRP 295
+YE++ GR P
Sbjct: 185 MYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 61/224 (27%), Positives = 105/224 (46%), Gaps = 30/224 (13%)
Query: 81 KSATKNFSRSVVIGEGGFGCVYKGL-IKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFL 139
+S K++ +IG G FG VY+ + I SE +VA+K++ + +K E+ +
Sbjct: 62 RSPNKSYKLGNIIGNGSFGVVYEAICIDTSE------KVAIKKVLQDPQYKN--RELLIM 113
Query: 140 GIVEHQNLVKLVGY----CADDDERGIQRLLVYEYMPNGSVDQYL---SPKSETILTWAM 192
+ H N++ L Y C +E+ I +V E++P +V +Y+ + + + + +
Sbjct: 114 KNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLV 172
Query: 193 RLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNA-KLSDFGLAR--LGPSEGF 249
+L Q R LAY+H I RD K N+L+D + KL DFG A+ L
Sbjct: 173 KLYSYQ-LCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSV 228
Query: 250 THVSTAVVGTMGYAAPE-YVQTGRLAARSDVWSYGVFLYELITG 292
+++ + Y APE + D+WS G + E+I G
Sbjct: 229 SYICSRF-----YRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 6e-10
Identities = 63/222 (28%), Positives = 95/222 (42%), Gaps = 26/222 (11%)
Query: 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEH 144
++F VIG G FG V +KN++ + ++ +R + E + L +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVL-VNGD 59
Query: 145 QNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAM------RLKIAQ 198
+ + Y D+ LV +Y G + LS K E L M + IA
Sbjct: 60 NQWITTLHYAFQDEN---NLYLVMDYYVGGDLLTLLS-KFEDRLPEDMARFYLAEMVIAI 115
Query: 199 DAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVG 258
D+ L Y+H RD K NIL+D + +L+DFG + L E T S+ VG
Sbjct: 116 DSVHQLHYVH---------RDIKPDNILMDMNGHIRLADFG-SCLKLMEDGTVQSSVAVG 165
Query: 259 TMGYAAPEYVQT-----GRLAARSDVWSYGVFLYELITGRRP 295
T Y +PE +Q G+ D WS GV +YE++ G P
Sbjct: 166 TPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 6e-10
Identities = 59/216 (27%), Positives = 89/216 (41%), Gaps = 36/216 (16%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLG------IVEHQN 146
IG G FG V I D V VK+L KE + FL I++H N
Sbjct: 3 IGNGWFGKVLLSEIYT--DTG-VARVVVKELKANASSKE---QNEFLQQGDPYRILQHPN 56
Query: 147 LVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPK------SETILTWAMRLKIAQDA 200
+++ +G C + I LLV+EY G + YLS + S+ +L M +IA
Sbjct: 57 ILQCLGQCVE----AIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAA-- 110
Query: 201 ARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTM 260
G+ ++H+ + D N L K+ D+G+ E + +
Sbjct: 111 --GVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPL 165
Query: 261 GYAAPEYV---QTGRLAAR----SDVWSYGVFLYEL 289
+ APE V G + A S+VW+ GV L+EL
Sbjct: 166 RWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 6e-10
Identities = 84/298 (28%), Positives = 118/298 (39%), Gaps = 57/298 (19%)
Query: 76 TIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGH----KE 131
TI E+ +N S +G G +G V D + VAVK+L R K
Sbjct: 11 TIWEVPERYQNLSP---VGSGAYGSVCAAF-----DTKTGLRVAVKKLSRPFQSIIHAKR 62
Query: 132 WMTEVNFLGIVEHQNLVKL--VGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILT 189
E+ L ++H+N++ L V A E LV M D K + +
Sbjct: 63 TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM---GADLNNIVKCQKLTD 119
Query: 190 WAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGF 249
++ I Q RGL Y+H II RD K SN+ ++E K+ DFGLAR E
Sbjct: 120 DHVQFLIYQ-ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-- 173
Query: 250 THVSTAVVGTMGYAAPE-------YVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPR 302
T V T Y APE Y QT D+WS G + EL+TGR
Sbjct: 174 ---MTGYVATRWYRAPEIMLNWMHYNQT------VDIWSVGCIMAELLTGRT-------- 216
Query: 303 SEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMS 360
+ P Q + I+ RL G L+ K+S + +++ PKM+
Sbjct: 217 --------LFPGTDHIDQLKLIL--RLVGTPGAELLKKISSESARNYIQSLTQMPKMN 264
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 6e-10
Identities = 46/140 (32%), Positives = 63/140 (45%), Gaps = 18/140 (12%)
Query: 203 GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGY 262
L +LH+ II RD K NILLD + L+DFGL++ E + + GT+ Y
Sbjct: 117 ALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSK-EFHEDEVERAYSFCGTIEY 172
Query: 263 AAPEYVQTGRLAARS--DVWSYGVFLYELITGRRP------------IDRNRPRSEQKLL 308
AP+ V+ G D WS GV +YEL+TG P I R +SE
Sbjct: 173 MAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP 232
Query: 309 QWVKPYLSDAKQFRQIVDPR 328
Q + D Q + DP+
Sbjct: 233 QEMSALAKDIIQRLLMKDPK 252
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 7e-10
Identities = 65/230 (28%), Positives = 97/230 (42%), Gaps = 37/230 (16%)
Query: 76 TIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGH----KE 131
TI E+ ++ + +G G +G V L D +VA+K+L R K
Sbjct: 9 TIWEVPDRYRDLKQ---VGSGAYGTVCSAL-----DRRTGAKVAIKKLYRPFQSELFAKR 60
Query: 132 WMTEVNFLGIVEHQNLVKLVG-YCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTW 190
E+ L ++H+N++ L+ + D Y MP D K E +
Sbjct: 61 AYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDF--YLVMPFMGTDLGKLMKHEKLSED 118
Query: 191 AMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFT 250
++ + Q +GL Y+H II RD K N+ ++E K+ DFGLAR SE
Sbjct: 119 RIQFLVYQ-MLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE--- 171
Query: 251 HVSTAVVGTMGYAAPE-------YVQTGRLAARSDVWSYGVFLYELITGR 293
T V T Y APE Y QT D+WS G + E++TG+
Sbjct: 172 --MTGYVVTRWYRAPEVILNWMHYTQT------VDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 7e-10
Identities = 63/286 (22%), Positives = 120/286 (41%), Gaps = 49/286 (17%)
Query: 90 SVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGR-RGGHKEWM----TEVNFLGIVEH 144
SV+I E +YKG+ N E V ++ + GHK + E+ L ++
Sbjct: 25 SVLIKENDQNSIYKGIFNNKE-------VIIRTFKKFHKGHKVLIDITENEIKNLRRIDS 77
Query: 145 QNLVKLVGY---CADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAA 201
N++K+ G+ DD R L+ EY G + + L E L++ +L +A D
Sbjct: 78 NNILKIYGFIIDIVDDLPRLS---LILEYCTRGYLREVLD--KEKDLSFKTKLDMAIDCC 132
Query: 202 RGLAYLHE--GMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGT 259
+GL L++ ++ + S + L+ E + K+ GL ++ S F +V+
Sbjct: 133 KGLYNLYKYTNKPYKNL----TSVSFLVTENYKLKIICHGLEKILSSPPFKNVNF----- 183
Query: 260 MGYAAPEYVQT--GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 317
M Y + + + + D++S GV L+E+ TG+ P + L+
Sbjct: 184 MVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFEN----------------LTT 227
Query: 318 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVL 363
+ + I++ K L ++ + C ++ RP + E+L
Sbjct: 228 KEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEIL 273
|
Length = 283 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 9e-10
Identities = 45/160 (28%), Positives = 77/160 (48%), Gaps = 18/160 (11%)
Query: 144 HQNLVKLVGYCADDDERGIQRLL-VYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAAR 202
H N+V L+ D E L V+EY+P ++ + L+ ++ L ++
Sbjct: 37 HPNIVALL----DSGEAPPGLLFAVFEYVPGRTLREVLA--ADGALPAGETGRLMLQVLD 90
Query: 203 GLAYLHEGMDFQIIVRDFKSSNILL---DEQWNAKLSDFGLARLGPSEGFTHVSTA---- 255
LA H + I+ RD K NI++ + +AK+ DFG+ L P V+T
Sbjct: 91 ALACAH---NQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTT 147
Query: 256 -VVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRR 294
V+GT Y APE ++ + SD++++G+ E +TG+R
Sbjct: 148 EVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQR 187
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 37/99 (37%), Positives = 53/99 (53%), Gaps = 9/99 (9%)
Query: 202 RGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVS---TAVVG 258
GL Y+H ++ RD K N+L++ K+ DFGLAR G SE + T V
Sbjct: 116 CGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLAR-GFSENPGENAGFMTEYVA 171
Query: 259 TMGYAAPEYVQTGRLAARS-DVWSYGVFLYELITGRRPI 296
T Y APE + + + ++ DVWS G L EL+ GR+P+
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 2e-09
Identities = 60/229 (26%), Positives = 96/229 (41%), Gaps = 51/229 (22%)
Query: 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGH----KEWMTEVNFLG 140
+ ++ +G G +G V + K + + +VA+K+L R K E+ L
Sbjct: 15 ERYTSLKQVGSGAYGSVCSAIDKRTGE-----KVAIKKLSRPFQSEIFAKRAYRELTLLK 69
Query: 141 IVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYL-SPKSETILTWAMRLKIAQD 199
++H+N++ G+ + + D YL P +T L M +++D
Sbjct: 70 HMQHENVI------------GLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSED 117
Query: 200 AAR--------GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTH 251
+ GL Y+H II RD K N+ ++E K+ DFGLAR +E
Sbjct: 118 KVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADAE---- 170
Query: 252 VSTAVVGTMGYAAPE-------YVQTGRLAARSDVWSYGVFLYELITGR 293
T V T Y APE Y QT D+WS G + E++TG+
Sbjct: 171 -MTGYVVTRWYRAPEVILNWMHYNQT------VDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 3e-09
Identities = 38/104 (36%), Positives = 56/104 (53%), Gaps = 7/104 (6%)
Query: 204 LAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYA 263
L +LH+ I+ RD K NILLD + + L+DFGL++ SE + + GT+ Y
Sbjct: 118 LEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE-KERTYSFCGTIEYM 173
Query: 264 APEYV--QTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQ 305
APE + + G A D WS G+ ++EL+TG P R+ Q
Sbjct: 174 APEIIRGKGGHGKA-VDWWSLGILIFELLTGASPFTLEGERNTQ 216
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 3e-09
Identities = 61/205 (29%), Positives = 96/205 (46%), Gaps = 20/205 (9%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHK-EWMTEVNFLGIVEHQNLVKLV 151
+GEG + VYKG+ S Q V + V + G + E + L ++H N+V L
Sbjct: 13 LGEGSYATVYKGI---SRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLL- 68
Query: 152 GYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGM 211
D V+EYM + + QY+ + + +RL + Q RGLAY+H
Sbjct: 69 ---HDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQ-LLRGLAYIHGQ- 122
Query: 212 DFQIIVRDFKSSNILLDEQWNAKLSDFGLARLG--PSEGFTHVSTAVVGTMGYAAPEYVQ 269
I+ RD K N+L+ KL+DFGLAR PS+ + S+ VV T+ Y P+ +
Sbjct: 123 --HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTY---SSEVV-TLWYRPPDVLL 176
Query: 270 -TGRLAARSDVWSYGVFLYELITGR 293
++ D+W G E++ G+
Sbjct: 177 GATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 4e-09
Identities = 35/94 (37%), Positives = 48/94 (51%), Gaps = 7/94 (7%)
Query: 202 RGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMG 261
RGL YLH I+ RD K N+L++ K+ DFGLAR+ + H++ VV T
Sbjct: 114 RGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV-TQY 169
Query: 262 YAAPEYVQTG--RLAARSDVWSYGVFLYELITGR 293
Y APE + G + D+WS G EL+ R
Sbjct: 170 YRAPE-ILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 4e-09
Identities = 95/384 (24%), Positives = 154/384 (40%), Gaps = 73/384 (19%)
Query: 64 SMSQRPSNLKEFTIAELK-SATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQ 122
S S+R +N I + + K + IG G +G++ + D + VA+K+
Sbjct: 2 SRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGA-----QGIVCAAYDAILERNVAIKK 56
Query: 123 LGR----RGGHKEWMTEVNFLGIVEHQNLVKLVG-YCADDDERGIQRLLVYEYMPNGSVD 177
L R + K E+ + V H+N++ L+ + Q + + + + ++
Sbjct: 57 LSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLC 116
Query: 178 QY----LSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNA 233
Q L + + L + M G+ +LH II RD K SNI++
Sbjct: 117 QVIQMELDHERMSYLLYQMLC--------GIKHLHSA---GIIHRDLKPSNIVVKSDCTL 165
Query: 234 KLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-- 291
K+ DFGLAR + G + + T V T Y APE + D+WS G + E+I
Sbjct: 166 KILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
Query: 292 ----GRRPIDRNRPRSEQ----------KLLQWVKPYLSD---------AKQFRQIVDP- 327
G ID+ EQ KL V+ Y+ + K F ++ P
Sbjct: 223 VLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPA 282
Query: 328 -----RLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE--MVNKIVDAS-AEAGSP 379
+L+ + L+SK+ LV +A R + E L+ +N D S AEA P
Sbjct: 283 DSEHNKLKASQARDLLSKM-------LVIDASKRISVDEALQHPYINVWYDPSEAEAPPP 335
Query: 380 RRPLRSSTSRETPDHTKTKHKRRI 403
+ P + RE HT + K I
Sbjct: 336 KIPDKQLDERE---HTIEEWKELI 356
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 4e-09
Identities = 52/208 (25%), Positives = 101/208 (48%), Gaps = 17/208 (8%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQ--KVEVAVKQLGR--RGGHKEWMTEVNFLGIVEHQNLV 148
+G+G F ++KG+ + D + K EV +K L + R + + + + + H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 149 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETI-LTWAMRLKIAQDAARGLAYL 207
G C DE ++V EY+ GS+D YL I ++W +L++A+ A L +L
Sbjct: 63 LNYGVCVCGDES----IMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFL 116
Query: 208 HEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLG-PSEGFTHVSTAV-VGTMGYAAP 265
D + + + N+LL + + K + +L P T + + + + + P
Sbjct: 117 E---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPP 173
Query: 266 EYVQTGR-LAARSDVWSYGVFLYELITG 292
E ++ + L+ +D WS+G L+E+ +G
Sbjct: 174 ECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 5e-09
Identities = 61/223 (27%), Positives = 101/223 (45%), Gaps = 34/223 (15%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGR-----RGGHKEWMTEVNFLGIVEHQN 146
+I G +G VY L+++ E + A+K++ + R ++ E + L E+
Sbjct: 8 LISNGAYGAVY--LVRHKE---TRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPF 62
Query: 147 LVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAM-RLKIAQDAARGLA 205
+V + +C+ + +R + +V EY+ G L K+ L M R+ A+ L
Sbjct: 63 VVSM--FCSFETKRHL--CMVMEYVEGGDCATLL--KNIGALPVDMARMYFAE-TVLALE 115
Query: 206 YLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLG-------PSEGFTHVST---- 254
YLH ++ I+ RD K N+L+ + KL+DFGL+++G EG T
Sbjct: 116 YLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFL 172
Query: 255 --AVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRP 295
V GT Y APE + D W+ G+ LYE + G P
Sbjct: 173 DKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 6e-09
Identities = 55/212 (25%), Positives = 96/212 (45%), Gaps = 26/212 (12%)
Query: 99 GCVYKGLIKNSEDPSQKVEVAVKQLGRRGGH--KEWMTEVNFLGIVEHQNLVKL---VGY 153
GC GL+ ++ D VAVK++ K + E+ + ++H N+VK+ +G
Sbjct: 14 GCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGP 73
Query: 154 CADDDERGIQRL-------LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAY 206
D + L +V EYM D + + RL + Q RGL Y
Sbjct: 74 SGSDLTEDVGSLTELNSVYIVQEYM---ETDLANVLEQGPLSEEHARLFMYQ-LLRGLKY 129
Query: 207 LHEGMDFQIIVRDFKSSNILLD-EQWNAKLSDFGLARLGPSEGFTH---VSTAVVGTMGY 262
+H ++ RD K +N+ ++ E K+ DFGLAR+ ++H +S +V T Y
Sbjct: 130 IHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPH-YSHKGYLSEGLV-TKWY 184
Query: 263 AAPEYVQTGRLAARS-DVWSYGVFLYELITGR 293
+P + + ++ D+W+ G E++TG+
Sbjct: 185 RSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 8e-09
Identities = 51/201 (25%), Positives = 87/201 (43%), Gaps = 30/201 (14%)
Query: 112 PSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYM 171
P Q V +K +G++G + E L V H +++++ D G +V +
Sbjct: 88 PGQPDPVVLK-IGQKGTT---LIEAMLLQNVNHPSVIRM----KDTLVSGAITCMV---L 136
Query: 172 PNGSVDQYLSPKSETILTWAMR-------LKIAQDAARGLAYLHEGMDFQIIVRDFKSSN 224
P+ S D Y T LT R L I + GL YLH +II RD K+ N
Sbjct: 137 PHYSSDLY------TYLTKRSRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTEN 187
Query: 225 ILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGV 284
I +++ + D G A+ + GT+ APE + + +++D+WS G+
Sbjct: 188 IFINDVDQVCIGDLGAAQFPVVAP---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGI 244
Query: 285 FLYELITGRRPIDRNRPRSEQ 305
L+E++ I + P + +
Sbjct: 245 VLFEMLAYPSTIFEDPPSTPE 265
|
Length = 357 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 60/214 (28%), Positives = 89/214 (41%), Gaps = 24/214 (11%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQNLVKLV 151
VIG G FG V +K++E + ++ +R + E N L + Q + L
Sbjct: 8 VIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTL- 66
Query: 152 GYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQ-----DAARGLAY 206
Y D+ LV +Y G + LS + + R IA+ + L Y
Sbjct: 67 HYAFQDEN---YLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHY 123
Query: 207 LHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPE 266
+H RD K N+LLD + +L+DFG +G S A VGT Y +PE
Sbjct: 124 VH---------RDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVA-VGTPDYISPE 173
Query: 267 YVQT-----GRLAARSDVWSYGVFLYELITGRRP 295
+Q G+ D WS GV +YE++ G P
Sbjct: 174 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 1e-08
Identities = 58/210 (27%), Positives = 94/210 (44%), Gaps = 32/210 (15%)
Query: 93 IGEGGFGCVYKGLIKNS---EDPSQKV--EVAVKQLGRRGGHKEWMTEVNFLGIVEHQNL 147
+G+G FG VY L+K+ + KV E+ V +L + E L ++H +
Sbjct: 8 LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGEL-NPNETVQANQEAQLLSKLDHPAI 64
Query: 148 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSET--------ILTWAMRLKIAQD 199
VK + D I + EY +D L T + W ++L +
Sbjct: 65 VKFHASFLERDAFCI----ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL--- 117
Query: 200 AARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGT 259
G+ Y+H+ +I+ RD K+ NI L K+ DFG++RL G ++T GT
Sbjct: 118 ---GVHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRL--LMGSCDLATTFTGT 168
Query: 260 MGYAAPEYVQTGRLAARSDVWSYGVFLYEL 289
Y +PE ++ ++SD+WS G LYE+
Sbjct: 169 PYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 48/186 (25%), Positives = 76/186 (40%), Gaps = 24/186 (12%)
Query: 113 SQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYM- 171
++ E V + G+RGG TE + L + H ++++L G Y
Sbjct: 114 NKTCEHVVIKAGQRGGT---ATEAHILRAINHPSIIQLKG------------TFTYNKFT 158
Query: 172 ----PNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL 227
P D Y ++ + L I + R + YLHE +II RD K+ NI +
Sbjct: 159 CLILPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFI 215
Query: 228 DEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLY 287
+ + L DFG A P + + GT+ APE + D+WS G+ L+
Sbjct: 216 NHPGDVCLGDFGAACF-PVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLF 274
Query: 288 ELITGR 293
E+ T
Sbjct: 275 EMATCH 280
|
Length = 391 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 53/185 (28%), Positives = 79/185 (42%), Gaps = 51/185 (27%)
Query: 166 LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQ-----DAARGLAYLHEGMDFQIIVRDF 220
L+ E++P G + L K +T+ A + IA+ DA L ++H RD
Sbjct: 78 LIMEFLPGGDMMTLLM-KKDTLSEEATQFYIAETVLAIDAIHQLGFIH---------RDI 127
Query: 221 KSSNILLDEQWNAKLSDFGLA-------RLGPSEGFTH---------------------- 251
K N+LLD + + KLSDFGL R TH
Sbjct: 128 KPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKK 187
Query: 252 ----VSTAVVGTMGYAAPE-YVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPR-SEQ 305
++ + VGT Y APE ++QTG D WS GV +YE++ G P P+ + +
Sbjct: 188 NRRQLAYSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYR 246
Query: 306 KLLQW 310
K++ W
Sbjct: 247 KVMNW 251
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 60/231 (25%), Positives = 96/231 (41%), Gaps = 46/231 (19%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL----------------GRRGGHKEWMTEV 136
+GEG +G V K + D VA+K++ G G H + E+
Sbjct: 17 LGEGTYGKVEK-----AYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLREL 71
Query: 137 NFLGIVEHQNLVKLVG-YCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLK 195
+ ++H+N++ LV Y D I LV + M + + + K LT +
Sbjct: 72 KIMNEIKHENIMGLVDVYVEGD---FIN--LVMDIM-ASDLKKVVDRK--IRLTESQVKC 123
Query: 196 IAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR-LGPSEGFTHVS- 253
I GL LH+ + + RD +NI ++ + K++DFGLAR G +S
Sbjct: 124 ILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSK 180
Query: 254 ----------TAVVGTMGYAAPEYVQ-TGRLAARSDVWSYGVFLYELITGR 293
T+ V T+ Y APE + + D+WS G EL+TG+
Sbjct: 181 DETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 54/204 (26%), Positives = 89/204 (43%), Gaps = 17/204 (8%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG----HKEWMTEVNFLGIVEHQNL 147
V+G+G +G V L+++ D Q V +K+L R K E L ++H N+
Sbjct: 7 VVGKGSYGEV--SLVRHRTDGKQYV---IKKLNLRNASRRERKAAEQEAQLLSQLKHPNI 61
Query: 148 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYL 207
V +D +V + G + L + +L ++ A L YL
Sbjct: 62 VAYRESWEGEDG---LLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYL 118
Query: 208 HEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEY 267
HE I+ RD K+ N+ L K+ D G+AR+ E +++ ++GT Y +PE
Sbjct: 119 HEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARV--LENQCDMASTLIGTPYYMSPEL 173
Query: 268 VQTGRLAARSDVWSYGVFLYELIT 291
+SDVW+ G +YE+ T
Sbjct: 174 FSNKPYNYKSDVWALGCCVYEMAT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 2e-08
Identities = 57/202 (28%), Positives = 94/202 (46%), Gaps = 16/202 (7%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHK-EWMTEVNFLGIVEHQNLVKLV 151
+GEG + VYKG S+ + V + V +L G + E + L ++H N+V L
Sbjct: 13 LGEGSYATVYKG---KSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLL- 68
Query: 152 GYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGM 211
D LV+EY+ + + QY+ + ++L + Q RGL+Y+H+
Sbjct: 69 ---HDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQ-LLRGLSYIHQRY 123
Query: 212 DFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPE-YVQT 270
I+ RD K N+L+ + KL+DFGLAR T+ + V T+ Y P+ + +
Sbjct: 124 ---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV--TLWYRPPDVLLGS 178
Query: 271 GRLAARSDVWSYGVFLYELITG 292
+ D+W G E+I G
Sbjct: 179 TEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 3e-08
Identities = 71/278 (25%), Positives = 112/278 (40%), Gaps = 79/278 (28%)
Query: 85 KNFSRSVVIGEGGFG-----------CVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWM 133
++F VIG G FG VY I D +K +Q+G ++ +
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEK-----EQVGHIRAERDIL 55
Query: 134 TEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMR 193
E + L +V+ + Y D + L+ E++P G + L K +T+ +
Sbjct: 56 VEADSLWVVK-------MFYSFQDK---LNLYLIMEFLPGGDMMTLLM-KKDTLTEEETQ 104
Query: 194 LKIAQ-----DAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA------- 241
IA+ D+ L ++H RD K N+LLD + + KLSDFGL
Sbjct: 105 FYIAETVLAIDSIHQLGFIH---------RDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155
Query: 242 ---------RLGPSEGFT------------------HVSTAVVGTMGYAAPE-YVQTGRL 273
PS+ FT ++ + VGT Y APE ++QTG
Sbjct: 156 RTEFYRNLNHSLPSD-FTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTG-Y 213
Query: 274 AARSDVWSYGVFLYELITGRRPIDRNRPR-SEQKLLQW 310
D WS GV +YE++ G P P+ + +K++ W
Sbjct: 214 NKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNW 251
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 3e-08
Identities = 33/95 (34%), Positives = 46/95 (48%), Gaps = 6/95 (6%)
Query: 202 RGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVS-TAVVGTM 260
R L Y+H F RD K NIL + K+ DFGLAR+ ++ T + T V T
Sbjct: 114 RALKYIHTANVFH---RDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 261 GYAAPEYVQT--GRLAARSDVWSYGVFLYELITGR 293
Y APE + + D+WS G E++TG+
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 4e-08
Identities = 56/206 (27%), Positives = 90/206 (43%), Gaps = 19/206 (9%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKE----WMTEVNFLGIVEHQNL 147
V+GEG +G V K K +++ VA+K+ ++E + E+ L ++ +N+
Sbjct: 8 VVGEGAYGVVLKCRHKETKEI-----VAIKKFKDSEENEEVKETTLRELKMLRTLKQENI 62
Query: 148 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYL 207
V+L + R + LV+EY V++ + E + K+ + + +
Sbjct: 63 VEL----KEAFRRRGKLYLVFEY-----VEKNMLELLEEMPNGVPPEKVRSYIYQLIKAI 113
Query: 208 HEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEY 267
H I+ RD K N+L+ KL DFG AR SEG T V T Y +PE
Sbjct: 114 HWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFAR-NLSEGSNANYTEYVATRWYRSPEL 172
Query: 268 VQTGRLAARSDVWSYGVFLYELITGR 293
+ D+WS G L EL G+
Sbjct: 173 LLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 4e-08
Identities = 56/210 (26%), Positives = 91/210 (43%), Gaps = 18/210 (8%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQNLVKLVG 152
+G G +G VYK K+ +D E A+KQ+ G E+ L ++H N++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEK---EYALKQIEGTGISMSACREIALLRELKHPNVIALQK 65
Query: 153 YCADDDERGIQRLLVYEYMPNGSVDQY----LSPKSETILTWAMRLKIAQDAARGLAYLH 208
+R + L Y + ++ + K L +M + G+ YLH
Sbjct: 66 VFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125
Query: 209 EGMDFQIIVRDFKSSNILL----DEQWNAKLSDFGLARL--GPSEGFTHVSTAVVGTMGY 262
++ RD K +NIL+ E+ K++D G ARL P + + VV T Y
Sbjct: 126 ANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFWY 181
Query: 263 AAPEYVQTGRLAARS-DVWSYGVFLYELIT 291
APE + R ++ D+W+ G EL+T
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 4e-08
Identities = 46/153 (30%), Positives = 67/153 (43%), Gaps = 24/153 (15%)
Query: 146 NLVKLVGYCADDDERGIQRLLVYEYMPNGS----VDQYLSPKSETILTWAMRLKIAQDAA 201
N+V L Y +D LV ++ G + ++L+ E + WA + +A DA
Sbjct: 46 NMVCLHKYIVSED----SVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA- 100
Query: 202 RGLAYLH-EGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTM 260
LH EG I+ RD +NILLD++ + +L+ F SE V M
Sbjct: 101 -----LHREG----IVCRDLNPNNILLDDRGHIQLTYFSRW----SEVEDSCDGEAVENM 147
Query: 261 GYAAPEYVQTGRLAARSDVWSYGVFLYELITGR 293
Y APE D WS G L+EL+TG+
Sbjct: 148 -YCAPEVGGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 7e-08
Identities = 62/236 (26%), Positives = 100/236 (42%), Gaps = 23/236 (9%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQNLVKLVG 152
+G G +G VYK K+ +D + A+KQ+ G E+ L ++H N++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDR---DYALKQIEGTGISMSACREIALLRELKHPNVISLQK 65
Query: 153 YCADDDERGIQRLLVYEYMPNGSVDQY----LSPKSETILTWAMRLKIAQDAARGLAYLH 208
+R + L Y + ++ + K L M + G+ YLH
Sbjct: 66 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 125
Query: 209 EGMDFQIIVRDFKSSNILL----DEQWNAKLSDFGLARL--GPSEGFTHVSTAVVGTMGY 262
++ RD K +NIL+ E+ K++D G ARL P + + VV T Y
Sbjct: 126 ANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFWY 181
Query: 263 AAPEYVQTGRLAARS-DVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 317
APE + R ++ D+W+ G EL+T PI R Q+ ++ PY D
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFHCR----QEDIKTSNPYHHD 232
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 7e-08
Identities = 59/217 (27%), Positives = 90/217 (41%), Gaps = 28/217 (12%)
Query: 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGR----RGGHKEWMTEVNFLG 140
K + + IG G +G++ + D + VAVK+L R + K E+ L
Sbjct: 21 KRYQQLKPIGSGA-----QGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLK 75
Query: 141 IVEHQNLVKLVG-YCADDDERGIQRL-LVYEYMPNG---SVDQYLSPKSETILTWAMRLK 195
V H+N++ L+ + Q + LV E M + L + + L + M
Sbjct: 76 CVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLC- 134
Query: 196 IAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTA 255
G+ +LH II RD K SNI++ K+ DFGLAR + + T
Sbjct: 135 -------GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTACT---NFMMTP 181
Query: 256 VVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITG 292
V T Y APE + D+WS G + EL+ G
Sbjct: 182 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 7e-08
Identities = 55/217 (25%), Positives = 104/217 (47%), Gaps = 37/217 (17%)
Query: 93 IGEGGFGCVYKGLIKNSEDP-------SQKVEVAVKQLGRRGGHKE----WMTEVNFLGI 141
+G G +Y G++ +D ++++V +K L H++ + + +
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLD--PSHRDISLAFFETASMMRQ 60
Query: 142 VEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAA 201
V H+++V L G C R ++ ++V E++ G +D ++ KS+ +LT + K+A+ A
Sbjct: 61 VSHKHIVLLYGVCV----RDVENIMVEEFVEFGPLDLFMHRKSD-VLTTPWKFKVAKQLA 115
Query: 202 RGLAYLHEGMDFQIIVRDFKSSNILL-----DEQWNA--KLSDFGLARLGPSEGFTHVS- 253
L+YL D ++ + + NILL D + KLSD G+ T +S
Sbjct: 116 SALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP-------ITVLSR 165
Query: 254 TAVVGTMGYAAPEYVQTGR-LAARSDVWSYGVFLYEL 289
V + + APE V+ + L+ +D WS+G L+E+
Sbjct: 166 QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 8e-08
Identities = 69/283 (24%), Positives = 116/283 (40%), Gaps = 46/283 (16%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQNLVKLVG 152
IG G +G VYK N+ + + V +L E+ + +H N+V G
Sbjct: 17 IGSGTYGDVYKARNVNT---GELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFG 73
Query: 153 YCADDDERGIQRLLVYEYMPNGSV-DQY--LSPKSETILTWAMRLKIAQDAARGLAYLHE 209
D+ I E+ GS+ D Y P SE+ + + ++++ +GL YLH
Sbjct: 74 SYLRRDKLWIC----MEFCGGGSLQDIYHVTGPLSESQIAY-----VSRETLQGLYYLHS 124
Query: 210 GMDFQIIVRDFKSSNILLDEQWNAKLSDFGL-----ARLGPSEGFTHVSTAVVGTMGYAA 264
RD K +NILL + + KL+DFG+ A + + F +GT + A
Sbjct: 125 KGKMH---RDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSF-------IGTPYWMA 174
Query: 265 PEYVQTGRLAARS---DVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 321
PE R + D+W+ G+ EL + P+ P +L F
Sbjct: 175 PEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL--------FLMTKSNF 226
Query: 322 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 364
+ P+L+ K ++ + H + L KN + RP ++L+
Sbjct: 227 QP---PKLKDK--MKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 8e-08
Identities = 65/218 (29%), Positives = 93/218 (42%), Gaps = 44/218 (20%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGH----KEWMTEVNFLGIVEHQNLV 148
+G G +G V ++ D + +VAVK+L R + E+ L ++H+N++
Sbjct: 23 VGSGAYGSV-----CSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVI 77
Query: 149 KL--VGYCADDDERGIQRLLVYEYMP---NGSVD-QYLSPKSETILTWAMRLKIAQDAAR 202
L V A E + LV M N V Q LS + L + + R
Sbjct: 78 GLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQL--------LR 129
Query: 203 GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGY 262
GL Y+H II RD K SN+ ++E ++ DFGLAR E T V T Y
Sbjct: 130 GLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQADDE-----MTGYVATRWY 181
Query: 263 AAPE-------YVQTGRLAARSDVWSYGVFLYELITGR 293
APE Y QT D+WS G + EL+ G+
Sbjct: 182 RAPEIMLNWMHYNQT------VDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 1e-07
Identities = 32/93 (34%), Positives = 46/93 (49%), Gaps = 6/93 (6%)
Query: 204 LAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYA 263
L +LH+ + I+ RD K NILLD + L DFGL++ ++ T + GT Y
Sbjct: 109 LEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT--TNTFCGTTEYL 163
Query: 264 APE-YVQTGRLAARSDVWSYGVFLYELITGRRP 295
APE + D WS GV ++E+ G P
Sbjct: 164 APEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 36/121 (29%), Positives = 47/121 (38%), Gaps = 32/121 (26%)
Query: 203 GLAYLH-EGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHV--------- 252
L YLH G I+ RD K NILL E + LSDF L++ E
Sbjct: 115 ALEYLHLLG----IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRR 170
Query: 253 ------------------STAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRR 294
S + VGT Y APE + + D W+ G+ LYE++ G
Sbjct: 171 SSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTT 230
Query: 295 P 295
P
Sbjct: 231 P 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 2e-07
Identities = 52/221 (23%), Positives = 99/221 (44%), Gaps = 28/221 (12%)
Query: 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVK----QLGRRGGHKEWMTEVNFLGI 141
+ + IGEG +G VYK + D + VA+K ++ G + E++ L +
Sbjct: 2 AYEKLEKIGEGTYGKVYK-----ARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQM 56
Query: 142 VEHQN-LVKLVGYCADDDERG-IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQD 199
+ +V+L+ +++ G LV+EY+ + + +++ + K +
Sbjct: 57 LSESIYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGR-PLPAKTIKS 114
Query: 200 ----AARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNA-KLSDFGLARLG--PSEGFTHV 252
+G+A+ H+ ++ RD K N+L+D+Q K++D GL R P + +TH
Sbjct: 115 FMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH- 170
Query: 253 STAVVGTMGYAAPEYVQTGRLAARS-DVWSYGVFLYELITG 292
+V T+ Y APE + + D+WS G E+
Sbjct: 171 --EIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 50/195 (25%), Positives = 77/195 (39%), Gaps = 65/195 (33%)
Query: 167 VYEYMPNGSVDQYLSPKSETILTWAMRLKI-AQDAAR--------GLAYLHEGMDFQIIV 217
V +Y+P G +++ +RL I +D AR + +H+ M F I
Sbjct: 79 VMDYIPGGD-----------MMSLLIRLGIFEEDLARFYIAELTCAIESVHK-MGF--IH 124
Query: 218 RDFKSSNILLDEQWNAKLSDFGLA---------------------RLGPSEGFTHVSTA- 255
RD K NIL+D + KL+DFGL + PSE ++ +
Sbjct: 125 RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCR 184
Query: 256 -------------------VVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPI 296
+VGT Y APE + D WS GV LYE++ G+ P
Sbjct: 185 LKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPF 244
Query: 297 DRNRP-RSEQKLLQW 310
+ P ++ K++ W
Sbjct: 245 LADTPAETQLKVINW 259
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 38/126 (30%), Positives = 57/126 (45%), Gaps = 7/126 (5%)
Query: 168 YEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL 227
Y+ + V LS LT L ARG+ +L + RD + N+LL
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLL 270
Query: 228 DEQWNAKLSDFGLAR--LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVF 285
+ K+ DFGLAR + S + ST + + + APE + SDVWSYG+
Sbjct: 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFL--PVKWMAPESIFDNLYTTLSDVWSYGIL 328
Query: 286 LYELIT 291
L+E+ +
Sbjct: 329 LWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 33/91 (36%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 203 GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGY 262
G+ +LH II RD K SNI++ K+ DFGLAR + G + + T V T Y
Sbjct: 130 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYY 183
Query: 263 AAPEYVQTGRLAARSDVWSYGVFLYELITGR 293
APE + D+WS G + E+I G
Sbjct: 184 RAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 2e-07
Identities = 67/262 (25%), Positives = 107/262 (40%), Gaps = 44/262 (16%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGR----RGGHKEWMTEVNFLGIVEHQNLV 148
IG G +G++ + D VA+K+L R + K E+ + V H+N++
Sbjct: 25 IGSGA-----QGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 79
Query: 149 KLVGYCADDD--ERGIQRLLVYEYMPNG---SVDQYLSPKSETILTWAMRLKIAQDAARG 203
L+ E LV E M + L + + L + M G
Sbjct: 80 SLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC--------G 131
Query: 204 LAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYA 263
+ +LH II RD K SNI++ K+ DFGLAR + G + + T V T Y
Sbjct: 132 IKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 185
Query: 264 APEYVQTGRLAARSDVWSYGVFLYELI------TGRRPIDR-NR---------PRSEQKL 307
APE + D+WS G + E++ GR ID+ N+ P +KL
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245
Query: 308 LQWVKPYLSDAKQFRQIVDPRL 329
V+ Y+ + ++ + P+L
Sbjct: 246 QPTVRNYVENRPKYAGLTFPKL 267
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 7e-07
Identities = 34/97 (35%), Positives = 45/97 (46%), Gaps = 15/97 (15%)
Query: 209 EGMDF----QIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVG-----T 259
+GM F I RD + NILL K+ DFGLAR + S VV
Sbjct: 225 KGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLAR-----DIRNDSNYVVKGNARLP 279
Query: 260 MGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 295
+ + APE + SDVWSYG+ L+E+ + G P
Sbjct: 280 VKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP 316
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 8e-07
Identities = 70/279 (25%), Positives = 109/279 (39%), Gaps = 40/279 (14%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVE--HQNLVKL 150
+G G +G VYK + + AVK + G + + + E H N+V
Sbjct: 17 VGSGTYGDVYK-----ARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAY 71
Query: 151 VGYCADDDERGIQRLLVYEYMPNGSV-DQY--LSPKSETILTWAMRLKIAQDAARGLAYL 207
G ++ I EY GS+ D Y P SE + + R + +GLAYL
Sbjct: 72 FGSYLSREKLWI----CMEYCGGGSLQDIYHVTGPLSELQIAYVCR-----ETLQGLAYL 122
Query: 208 HEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEY 267
H RD K +NILL + + KL+DFG+A + +GT + APE
Sbjct: 123 HSKGKMH---RDIKGANILLTDNGDVKLADFGVA--AKITATIAKRKSFIGTPYWMAPEV 177
Query: 268 V---QTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQI 324
+ G D+W+ G+ EL + P+ P +L F+
Sbjct: 178 AAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL--------FLMSKSNFQP- 228
Query: 325 VDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVL 363
P+L+ K + S + + L KN + RP +L
Sbjct: 229 --PKLKDK--TKWSSTFHNFVKISLTKNPKKRPTAERLL 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 9e-07
Identities = 35/97 (36%), Positives = 50/97 (51%), Gaps = 15/97 (15%)
Query: 209 EGMDF----QIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVG-----T 259
+GMDF I RD + N+LL + AK+ DFGLAR + S VV
Sbjct: 223 QGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLAR-----DIMNDSNYVVKGNARLP 277
Query: 260 MGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 295
+ + APE + +SDVWSYG+ L+E+ + G+ P
Sbjct: 278 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 9e-07
Identities = 42/140 (30%), Positives = 64/140 (45%), Gaps = 13/140 (9%)
Query: 159 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQ------DAARGLAYLHEGMD 212
E G +L + P+ S +P ET W L + ARG+ +L
Sbjct: 138 EAGQASVLFSRFQPSTS--GSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFL---AS 192
Query: 213 FQIIVRDFKSSNILLDEQWNAKLSDFGLAR-LGPSEGFTHVSTAVVGTMGYAAPEYVQTG 271
+ I RD + NILL E K+ DFGLAR + + +A + + + APE +
Sbjct: 193 RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL-PLKWMAPESIFDK 251
Query: 272 RLAARSDVWSYGVFLYELIT 291
+SDVWS+GV L+E+ +
Sbjct: 252 VYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 9e-07
Identities = 35/116 (30%), Positives = 55/116 (47%), Gaps = 5/116 (4%)
Query: 177 DQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLS 236
D+ + LT + + ARG+ +L + I RD + NILL E K+
Sbjct: 159 DEEGDELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKIC 215
Query: 237 DFGLAR-LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT 291
DFGLAR + + A + + + APE + +SDVWS+GV L+E+ +
Sbjct: 216 DFGLARDIYKDPDYVRKGDARL-PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 48.4 bits (116), Expect = 3e-06
Identities = 53/215 (24%), Positives = 88/215 (40%), Gaps = 43/215 (20%)
Query: 93 IGEGGFGCVYKGL-IKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVE-------H 144
IGEG F V K K + A+K + + E +VN L ++ H
Sbjct: 7 IGEGTFSEVLKAQSRKTGK------YYAIKCMKKHFKSLE---QVNNLREIQALRRLSPH 57
Query: 145 QNLVKLVGYCADDDERG----IQRLL---VYEYMPNGSVDQYLSPKSETILTWAMRLKIA 197
N+++L+ D + G + L+ +YE + + L K + ++ +L
Sbjct: 58 PNILRLIE-VLFDRKTGRLALVFELMDMNLYELIKGRK--RPLPEK--RVKSYMYQL--- 109
Query: 198 QDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVV 257
+ L ++H F RD K NIL+ KL+DFG R S T +
Sbjct: 110 ---LKSLDHMHRNGIFH---RDIKPENILIK-DDILKLADFGSCRGIYS---KPPYTEYI 159
Query: 258 GTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELIT 291
T Y APE + T G + D+W+ G +E+++
Sbjct: 160 STRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (115), Expect = 4e-06
Identities = 42/139 (30%), Positives = 63/139 (45%), Gaps = 18/139 (12%)
Query: 165 LLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSN 224
+L+ +Y+ +G + L K E L+ A KI + L LH+ II D K N
Sbjct: 85 VLIMDYIKDGDLFDLL--KKEGKLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLEN 139
Query: 225 ILLDE-QWNAKLSDFGLARLGPSEGFTHVSTAVV--GTMGYAAPEYVQTGRLAARS-DVW 280
+L D + L D+GL + + T GT+ Y +PE + G S D W
Sbjct: 140 VLYDRAKDRIYLCDYGLCK--------IIGTPSCYDGTLDYFSPEKI-KGHNYDVSFDWW 190
Query: 281 SYGVFLYELITGRRPIDRN 299
+ GV YEL+TG+ P +
Sbjct: 191 AVGVLTYELLTGKHPFKED 209
|
Length = 267 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 5e-06
Identities = 41/146 (28%), Positives = 56/146 (38%), Gaps = 48/146 (32%)
Query: 211 MDFQIIVRDFKSSNILLDEQWNAKLSDFGLA----------------------------- 241
M F I RD K NIL+D + KL+DFGL
Sbjct: 120 MGF--IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEW 177
Query: 242 ----------RLGPSE---GFTH---VSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVF 285
RL P E H ++ ++VGT Y APE + D WS GV
Sbjct: 178 GDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237
Query: 286 LYELITGRRPIDRNRP-RSEQKLLQW 310
LYE++ G+ P P ++ K++ W
Sbjct: 238 LYEMLVGQPPFLAQTPLETQMKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.6 bits (115), Expect = 6e-06
Identities = 63/246 (25%), Positives = 105/246 (42%), Gaps = 61/246 (24%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHK-EWMTEVNFLGIVEHQNLVK-- 149
IG G FG V+ L+K+ A+ G + K + + EVN + ++H+N+V+
Sbjct: 21 IGNGRFGEVF--LVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYI 78
Query: 150 -------------LVGYC-ADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLK 195
L+ +C A D R IQ+ Y G ++++ +
Sbjct: 79 DRFLNKANQKLYILMEFCDAGDLSRNIQKC----YKMFGKIEEHAI------------VD 122
Query: 196 IAQDAARGLAYLHEGMDF----QIIVRDFKSSNILLDE----------QWN-------AK 234
I + LAY H D +++ RD K NI L Q N AK
Sbjct: 123 ITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAK 182
Query: 235 LSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYV--QTGRLAARSDVWSYGVFLYELITG 292
+ DFGL++ + G ++ + VGT Y +PE + +T +SD+W+ G +YEL +G
Sbjct: 183 IGDFGLSK---NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG 239
Query: 293 RRPIDR 298
+ P +
Sbjct: 240 KTPFHK 245
|
Length = 1021 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 9e-06
Identities = 45/176 (25%), Positives = 76/176 (43%), Gaps = 33/176 (18%)
Query: 209 EGMDF----QIIVRDFKSSNILLDEQWNAKLSDFGLAR-LGPSEGFTHVSTAVVGTMGYA 263
+GM+F + I RD + NILL E K+ DFGLAR + + A + + +
Sbjct: 190 KGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL-PLKWM 248
Query: 264 APEYVQTGRLAARSDVWSYGVFLYELIT-GRRP-----IDRNRPRSEQKLLQWVKPYLSD 317
APE + +SDVWS+GV L+E+ + G P ID R ++ + P +
Sbjct: 249 APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTT 308
Query: 318 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 373
+ ++ ++D C RP SE++E + ++ A+
Sbjct: 309 PEMYQTMLD---------------------CWHGEPSQRPTFSELVEHLGNLLQAN 343
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 9e-06
Identities = 32/96 (33%), Positives = 50/96 (52%), Gaps = 9/96 (9%)
Query: 203 GLAY-LHEGMDF----QIIVRDFKSSNILLDEQWNAKLSDFGLAR--LGPSEGFTHVSTA 255
G +Y + GM+F + RD + N+L+ E K+ DFGLAR + S + ST
Sbjct: 243 GFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTF 302
Query: 256 VVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT 291
+ + + APE + SDVWS+G+ L+E+ T
Sbjct: 303 L--PLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 6e-05
Identities = 40/163 (24%), Positives = 61/163 (37%), Gaps = 55/163 (33%)
Query: 194 LKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA------------ 241
L +A ++ + ++H RD K NIL+D + KL+DFGL
Sbjct: 110 LTLAIESVHKMGFIH---------RDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY 160
Query: 242 ---------RLGPSEGFTHVST------------------------AVVGTMGYAAPEYV 268
+ PS+ + VS ++VGT Y APE +
Sbjct: 161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVL 220
Query: 269 QTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQ-KLLQW 310
D WS GV L+E++ G+ P P Q K++ W
Sbjct: 221 LRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 7e-05
Identities = 49/231 (21%), Positives = 77/231 (33%), Gaps = 46/231 (19%)
Query: 166 LVYEYMPNGSVDQYL-----SPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDF 220
+V M GS + L E + + ++ D L Y+H F I R
Sbjct: 76 VVSPLMAYGSCEDLLKTHFPEGLPELAIAFILK-----DVLNALDYIHS-KGF--IHRSV 127
Query: 221 KSSNILLDEQWNAKLSDFGLARLGPSEGFTH-------VSTAVVGTMGYAAPEYVQTGRL 273
K+S+ILL LS + G S+ + + +PE +Q
Sbjct: 128 KASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKN--LPWLSPEVLQQNLQ 185
Query: 274 A--ARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK-------------PYLSDA 318
+SD++S G+ EL G P Q LL+ V+ Y
Sbjct: 186 GYNEKSDIYSVGITACELANGHVPFKDMPA--TQMLLEKVRGTVPCLLDKSTYPLYEDSM 243
Query: 319 KQFRQ------IVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVL 363
Q R D + Y+ LCL ++ +RP S++L
Sbjct: 244 SQSRSSNEHPNNRDSV-DHPYTRTFSEHFHQFVELCLQRDPESRPSASQLL 293
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 60/246 (24%), Positives = 91/246 (36%), Gaps = 54/246 (21%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL-----GRRGGHKEWMTEVNFLGIVEHQNL 147
IG+GG G VY DP VA+K++ K ++ E + H +
Sbjct: 10 IGKGGMGEVYLA-----YDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGI 64
Query: 148 VKLVGYCADDDERGIQRLLVYEYMP--NG--------SVDQYLSPKSE-----TILTWAM 192
V + C+D D VY MP G SV Q S E ++ +
Sbjct: 65 VPVYSICSDGD-------PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAF-- 115
Query: 193 RLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE-------QWNAKLS-----DFGL 240
L I + Y+H ++ RD K NILL W A + + L
Sbjct: 116 -LSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLL 171
Query: 241 ARLGPSEGFTHVSTA----VVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPI 296
+ S +VGT Y APE + + +D+++ GV LY+++T P
Sbjct: 172 DIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231
Query: 297 DRNRPR 302
R + R
Sbjct: 232 RRKKGR 237
|
Length = 932 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 2e-04
Identities = 32/156 (20%), Positives = 57/156 (36%), Gaps = 24/156 (15%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQNLVKLVG 152
+ G VY L+ ++ +K R + EV L ++ + L
Sbjct: 6 LKGGLTNRVY--LLGTKDED-----YVLKINPSREKGADREREVAILQLLARKGLPVPKV 58
Query: 153 YCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMD 212
+ + + L+ E++ + L SE + IA+ A LA LH+
Sbjct: 59 LASGESDGWS--YLLMEWIE----GETLDEVSE-----EEKEDIAEQLAELLAKLHQ--- 104
Query: 213 FQIIV---RDFKSSNILLDEQWNAKLSDFGLARLGP 245
++V D NIL+D+ + D+ A GP
Sbjct: 105 LPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGP 140
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 38/149 (25%), Positives = 64/149 (42%), Gaps = 15/149 (10%)
Query: 167 VYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNIL 226
+Y +M + + D P L R I + + Y+H D ++I RD K NI
Sbjct: 249 LYSFMYDEAFDWKDRP-----LLKQTR-AIMKQLLCAVEYIH---DKKLIHRDIKLENIF 299
Query: 227 LDEQWNAKLSDFGLARL--GPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGV 284
L+ L DFG A E F + VGT+ +PE + +D+WS G+
Sbjct: 300 LNCDGKIVLGDFGTAMPFEKEREAFDY---GWVGTVATNSPEILAGDGYCEITDIWSCGL 356
Query: 285 FLYELITGRR-PIDRNRPRSEQKLLQWVK 312
L ++++ PI + ++LL+ +
Sbjct: 357 ILLDMLSHDFCPIGDGGGKPGKQLLKIID 385
|
Length = 501 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 3e-04
Identities = 28/81 (34%), Positives = 40/81 (49%), Gaps = 11/81 (13%)
Query: 166 LVYEYMPNGSVDQYLSPKSETILTW---AMRLKIAQDAARGLAYLHEGMDFQIIVRDFKS 222
LV EY+ G V L I + M +K + A L YLH II RD K
Sbjct: 81 LVMEYLIGGDVKSLLH-----IYGYFDEEMAVKYISEVALALDYLHR---HGIIHRDLKP 132
Query: 223 SNILLDEQWNAKLSDFGLARL 243
N+L+ + + KL+DFGL+++
Sbjct: 133 DNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 9e-04
Identities = 50/202 (24%), Positives = 72/202 (35%), Gaps = 73/202 (36%)
Query: 166 LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQ-----DAARGLAYLHEGMDFQIIVRDF 220
L+ E++P G + L K +T R +A+ +A L ++H RD
Sbjct: 78 LIMEFLPGGDLMTMLI-KYDTFSEDVTRFYMAECVLAIEAVHKLGFIH---------RDI 127
Query: 221 KSSNILLDEQWNAKLSDFGLARLGPSEGF--THVST------------------------ 254
K NIL+D + KLSDFGL S GF H S
Sbjct: 128 KPDNILIDRGGHIKLSDFGL-----STGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVD 182
Query: 255 ------------------------AVVGTMGYAAPE-YVQTGRLAARSDVWSYGVFLYEL 289
+ VGT Y APE ++Q G D WS G ++E
Sbjct: 183 SINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQG-YGQECDWWSLGAIMFEC 241
Query: 290 ITGRRPI-DRNRPRSEQKLLQW 310
+ G P N + +K++ W
Sbjct: 242 LIGWPPFCSENSHETYRKIINW 263
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.001
Identities = 62/235 (26%), Positives = 93/235 (39%), Gaps = 49/235 (20%)
Query: 170 YMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE 229
+M GS + L ++ A+ I A RGL YLH+ I R+ K+S+IL+
Sbjct: 80 FMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISG 136
Query: 230 QWNAKLSD----FGLARLGPSE----GFTHVSTAVVGTMGYAAPEYVQTGRLA--ARSDV 279
LS + L R G F ST+V + + +PE ++ +SD+
Sbjct: 137 DGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSV---LPWLSPELLRQDLYGYNVKSDI 193
Query: 280 WSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK--PYL-----------SDAKQFRQIVD 326
+S G+ EL TGR P ++ R+ Q LLQ +K PY S K + VD
Sbjct: 194 YSVGITACELATGRVPF-QDMLRT-QMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVD 251
Query: 327 P------------------RLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVL 363
RL S ++ LCL ++ RP S +L
Sbjct: 252 SGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLL 306
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.001
Identities = 27/84 (32%), Positives = 40/84 (47%), Gaps = 5/84 (5%)
Query: 206 YLH-EGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAA 264
Y+H EG II RD K+ N+L++ + L DFG A T + GT+ A
Sbjct: 275 YIHGEG----IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNA 330
Query: 265 PEYVQTGRLAARSDVWSYGVFLYE 288
PE + D+WS G+ ++E
Sbjct: 331 PEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 426 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.94 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.94 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.93 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.9 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.89 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.88 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.88 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.88 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.87 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.87 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.85 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.85 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.85 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.85 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.84 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.83 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.82 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.8 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.79 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.79 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.78 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.75 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.72 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.71 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.69 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.6 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.52 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.48 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.48 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.44 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.42 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.37 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.37 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.31 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.31 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.31 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.27 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.15 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.14 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.12 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.04 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 99.0 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.99 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.94 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.92 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.62 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.62 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.62 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.61 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.58 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.57 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.54 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.53 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.41 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.38 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.28 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.26 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.25 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.23 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.19 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.01 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.92 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.91 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.91 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.83 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.75 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.75 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.67 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.64 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.46 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.41 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 97.11 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.09 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.96 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.94 | |
| PLN02236 | 344 | choline kinase | 96.93 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.79 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.78 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.66 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.65 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.41 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.38 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.3 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.28 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.24 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.23 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.97 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.82 | |
| PRK06149 | 972 | hypothetical protein; Provisional | 95.63 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 95.54 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.32 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-55 Score=424.16 Aligned_cols=289 Identities=55% Similarity=0.925 Sum_probs=253.0
Q ss_pred CCcccCHHHHHHHhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC--HHHHHHHHHHHhhcCCCCcc
Q 014363 71 NLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG--HKEWMTEVNFLGIVEHQNLV 148 (426)
Q Consensus 71 ~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~E~~~l~~l~HpnIv 148 (426)
....|++.++..+|++|+..+.||+|+||.||+|...++. .||||++..... ..+|.+|+.+|.+++|||+|
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~------~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv 134 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGT------VVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLV 134 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCC------EEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcc
Confidence 5678999999999999999999999999999999988752 799998876654 57799999999999999999
Q ss_pred ceEeEEEccCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeC
Q 014363 149 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLD 228 (426)
Q Consensus 149 ~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~ 228 (426)
+++|||.+.+. +.+||+|||++|+|.++|.......++|..+++|+.++|+||+|||..+.+.|||||||++|||||
T Consensus 135 ~LlGyC~e~~~---~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD 211 (361)
T KOG1187|consen 135 KLLGYCLEGGE---HRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLD 211 (361)
T ss_pred cEEEEEecCCc---eEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeEC
Confidence 99999998774 359999999999999999865433789999999999999999999998777899999999999999
Q ss_pred CCCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHH
Q 014363 229 EQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLL 308 (426)
Q Consensus 229 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~ 308 (426)
+++++||+|||+|+..+.. .........||.+|+|||++..+..+.|+|||||||+|+||+||+.|.+...+.....+.
T Consensus 212 ~~~~aKlsDFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~ 290 (361)
T KOG1187|consen 212 EDFNAKLSDFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLV 290 (361)
T ss_pred CCCCEEccCccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHH
Confidence 9999999999999766541 111111117999999999999999999999999999999999999999876666666789
Q ss_pred HhHhhhhhhhhhhhhhcCCcCC-CcccH-HHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhH
Q 014363 309 QWVKPYLSDAKQFRQIVDPRLE-GKYSL-RLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIV 370 (426)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~ 370 (426)
.|..+.+.+. .+.+++|+.+. ..+.. .....+..++.+|++.+|.+||+|.||++.|+.+.
T Consensus 291 ~w~~~~~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 291 EWAKPLLEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred HHHHHHHHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 9988877766 78899999987 66664 67788999999999999999999999999996554
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-53 Score=390.78 Aligned_cols=250 Identities=29% Similarity=0.438 Sum_probs=209.8
Q ss_pred CCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc---CCHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCce
Q 014363 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR---GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQ 163 (426)
Q Consensus 87 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~ 163 (426)
.+.+..||+|..|+||++.++.++. .+|+|.+.-. ...+++.+|++++...+||+||.+||.|..+.. +
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk~t~~-----i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~---~ 152 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHKPTGK-----IYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE---E 152 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEcCCCe-----EEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc---e
Confidence 4456689999999999999998765 8999998432 245678999999999999999999999998874 3
Q ss_pred EEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhcc-CCCCCeEeccCCCCceEeCCCCCeeEeeecccc
Q 014363 164 RLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHE-GMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 242 (426)
Q Consensus 164 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~-~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 242 (426)
.+|+||||++|+|++++... +.+++.....|+.+|++||.|||+ + +||||||||+|||++..|.|||||||.+.
T Consensus 153 isI~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~ 227 (364)
T KOG0581|consen 153 ISICMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSG 227 (364)
T ss_pred EEeehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccH
Confidence 59999999999999999754 449999999999999999999996 5 99999999999999999999999999998
Q ss_pred cCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhh
Q 014363 243 LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFR 322 (426)
Q Consensus 243 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (426)
..... ...+++||..|||||.+.+..|+.++||||||++++|+.+|+.||....+... ...+.+.
T Consensus 228 ~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~-----------~~~~Ll~ 292 (364)
T KOG0581|consen 228 ILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYL-----------DIFELLC 292 (364)
T ss_pred Hhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCC-----------CHHHHHH
Confidence 76543 45678999999999999999999999999999999999999999976421111 1112233
Q ss_pred hhcCCcCCCcccH-HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 323 QIVDPRLEGKYSL-RLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 323 ~~~~~~~~~~~~~-~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.+++.... ..+. .+++++++++..||+.||.+|||++|+++|
T Consensus 293 ~Iv~~ppP-~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 293 AIVDEPPP-RLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred HHhcCCCC-CCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 44442222 2333 488999999999999999999999999997
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-54 Score=394.01 Aligned_cols=251 Identities=25% Similarity=0.419 Sum_probs=206.9
Q ss_pred HhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---------CHHHHHHHHHHHhhcCCCCccceEeE
Q 014363 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---------GHKEWMTEVNFLGIVEHQNLVKLVGY 153 (426)
Q Consensus 83 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---------~~~~~~~E~~~l~~l~HpnIv~~~~~ 153 (426)
..+.|.+.+.||+|+||.|-+|..+.++. .||||+++.+. ......+|++||++|+|||||+++++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk-----~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~ 244 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGK-----QVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDF 244 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCc-----EEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeee
Confidence 35678889999999999999999887765 89999986543 12235699999999999999999999
Q ss_pred EEccCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCC---
Q 014363 154 CADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQ--- 230 (426)
Q Consensus 154 ~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~--- 230 (426)
|..++.. ||||||++||+|.+++..+. .+.+.....+++|++.||.|||++ ||+||||||+|||+..+
T Consensus 245 f~~~ds~----YmVlE~v~GGeLfd~vv~nk--~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~ 315 (475)
T KOG0615|consen 245 FEVPDSS----YMVLEYVEGGELFDKVVANK--YLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAED 315 (475)
T ss_pred eecCCce----EEEEEEecCccHHHHHHhcc--ccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcc
Confidence 9998865 99999999999999997554 488888899999999999999998 99999999999999766
Q ss_pred CCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCC---CCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHH
Q 014363 231 WNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRL---AARSDVWSYGVFLYELITGRRPIDRNRPRSEQKL 307 (426)
Q Consensus 231 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~ 307 (426)
..+||+|||+|+.... ...+.++||||.|.|||++.+..+ ..++|||||||+||-+++|.+||.......
T Consensus 316 ~llKItDFGlAK~~g~---~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~---- 388 (475)
T KOG0615|consen 316 CLLKITDFGLAKVSGE---GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP---- 388 (475)
T ss_pred eEEEecccchhhcccc---ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc----
Confidence 7799999999997653 345678999999999999987653 348899999999999999999997543321
Q ss_pred HHhHhhhhhhhhhhhhhcCCcCC--CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 308 LQWVKPYLSDAKQFRQIVDPRLE--GKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
....++...+.. ......++++..+||.+||..||++|||+.|+|+|
T Consensus 389 -----------sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 389 -----------SLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred -----------cHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 011122221111 12334678899999999999999999999999987
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-52 Score=404.54 Aligned_cols=252 Identities=27% Similarity=0.440 Sum_probs=211.9
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCceE
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQR 164 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~~ 164 (426)
..|...++||+|||+.||.+++..+++.++.+.|..|.+.+....+.+.+||+|.+.|+|||||+++++|+|....
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nV---- 93 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNV---- 93 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCce----
Confidence 5799999999999999999999777774333333333344556777899999999999999999999999998854
Q ss_pred EEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccC
Q 014363 165 LLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLG 244 (426)
Q Consensus 165 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 244 (426)
|||+|+|+.++|..++. .++.+++.+++.+++||+.||.|||++ +|+|||||..|+||+++.+|||+|||||...
T Consensus 94 YivLELC~~~sL~el~K--rrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~l 168 (592)
T KOG0575|consen 94 YIVLELCHRGSLMELLK--RRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQL 168 (592)
T ss_pred EEEEEecCCccHHHHHH--hcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeee
Confidence 99999999999999997 345699999999999999999999998 9999999999999999999999999999987
Q ss_pred CCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhh
Q 014363 245 PSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQI 324 (426)
Q Consensus 245 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (426)
..++ ....+.||||.|.|||++....++..+||||+||+||.||+|++||+...-.+ ....+
T Consensus 169 e~~~--Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vke----------------ty~~I 230 (592)
T KOG0575|consen 169 EYDG--ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKE----------------TYNKI 230 (592)
T ss_pred cCcc--cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHH----------------HHHHH
Confidence 7543 23456899999999999999999999999999999999999999997542211 11111
Q ss_pred cCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 325 VDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 325 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
... .-.++..++.+.++||.++|+.||.+|||+++|+.+
T Consensus 231 k~~--~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 231 KLN--EYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred Hhc--CcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 111 112334677889999999999999999999999987
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-51 Score=392.32 Aligned_cols=256 Identities=34% Similarity=0.547 Sum_probs=212.3
Q ss_pred cceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCceEE
Q 014363 90 SVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRL 165 (426)
Q Consensus 90 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~~~ 165 (426)
.+.||.|+||+||+|.+++.. .||+|.+.... ..+.|.+|+.+|.+++|||||+++|+|.+... ..+
T Consensus 46 ~~~iG~G~~g~V~~~~~~g~~------~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~---~~~ 116 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWRGTD------VVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG---SLC 116 (362)
T ss_pred hhhcccCCceeEEEEEeCCce------eEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC---ceE
Confidence 335999999999999998863 48999986542 14589999999999999999999999988762 248
Q ss_pred EEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCC-eEeccCCCCceEeCCCC-CeeEeeeccccc
Q 014363 166 LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQ-IIVRDFKSSNILLDEQW-NAKLSDFGLARL 243 (426)
Q Consensus 166 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~-iiHrDlkp~NILl~~~~-~~kl~DFGla~~ 243 (426)
|||||+++|+|.+++.......+++..++.|+.||+.|+.|||++ + ||||||||+|||++.++ ++||+|||+++.
T Consensus 117 iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~ 193 (362)
T KOG0192|consen 117 IVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSRE 193 (362)
T ss_pred EEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCcccee
Confidence 999999999999999875456699999999999999999999998 7 99999999999999998 999999999986
Q ss_pred CCCCCceeeeeeeecCcccCCchhhc--cCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhh
Q 014363 244 GPSEGFTHVSTAVVGTMGYAAPEYVQ--TGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 321 (426)
Q Consensus 244 ~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (426)
..... ...+...||+.|||||++. ...|+.|+||||||+++|||+||+.||....+.. ..
T Consensus 194 ~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~----------------~~ 255 (362)
T KOG0192|consen 194 KVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQ----------------VA 255 (362)
T ss_pred ecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHH----------------HH
Confidence 54321 2233468999999999999 5689999999999999999999999998754411 11
Q ss_pred hhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhhcc
Q 014363 322 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASAE 375 (426)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~~~ 375 (426)
..++........+..+++.+..++.+||..||+.||++.+|+..|+.+......
T Consensus 256 ~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 256 SAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred HHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 122222333334444778999999999999999999999999999988775543
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-51 Score=380.83 Aligned_cols=250 Identities=30% Similarity=0.496 Sum_probs=204.8
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
.++|...+.||.|+||+||+|+++.++. .||||.+.... ..+.+..|+.+|+.++|||||.+++++.+.+
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~-----~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~- 82 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGT-----EVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDD- 82 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCc-----eEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCC-
Confidence 4688889999999999999999998765 78999886553 3456789999999999999999999999887
Q ss_pred CCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCC------CCe
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQ------WNA 233 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~------~~~ 233 (426)
.+|||||||.||+|.+||+.++ .+++..+..++.|++.||++||++ +||||||||+||||+.. -.+
T Consensus 83 ---~i~lVMEyC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~L 154 (429)
T KOG0595|consen 83 ---FIYLVMEYCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVL 154 (429)
T ss_pred ---eEEEEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceE
Confidence 4599999999999999998765 499999999999999999999998 99999999999999765 458
Q ss_pred eEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhh
Q 014363 234 KLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKP 313 (426)
Q Consensus 234 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~ 313 (426)
||+|||+|+...... ...+.||++.|||||++....|+.|+|+||+|+|||+|++|+.||+.....+....++
T Consensus 155 KIADFGfAR~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~---- 227 (429)
T KOG0595|consen 155 KIADFGFARFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIK---- 227 (429)
T ss_pred EecccchhhhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHh----
Confidence 999999999877532 3456899999999999999999999999999999999999999998765543322111
Q ss_pred hhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 314 YLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
. +..+....+...+..+.+++...++.+|.+|-+..+-+.+
T Consensus 228 ---k--------~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~ 268 (429)
T KOG0595|consen 228 ---K--------GNEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDH 268 (429)
T ss_pred ---c--------cccccCchhhhccCchhhhhhHHHhcCccccCchHHhhhh
Confidence 1 1112222333444556677777788888888777665543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-52 Score=363.99 Aligned_cols=259 Identities=25% Similarity=0.377 Sum_probs=207.0
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc----CCHHHHHHHHHHHhhcCCCCccceEeE-EEccCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR----GGHKEWMTEVNFLGIVEHQNLVKLVGY-CADDDE 159 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~----~~~~~~~~E~~~l~~l~HpnIv~~~~~-~~~~~~ 159 (426)
.+|.++++||.|.||+||++....++. .+|.|.++-. ...+....|+.+|++|+|||||++|++ |.++.+
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~-----l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~e 93 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGK-----LVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNE 93 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcc-----hhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccch
Confidence 467888899999999999999877654 7888877522 234567899999999999999999983 444333
Q ss_pred CCceEEEEEeeCCCCChhhhccC--CCCCccCHHHHHHHHHHHHHHHHHhccCCC-CCeEeccCCCCceEeCCCCCeeEe
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSP--KSETILTWAMRLKIAQDAARGLAYLHEGMD-FQIIVRDFKSSNILLDEQWNAKLS 236 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~--~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~-~~iiHrDlkp~NILl~~~~~~kl~ 236 (426)
.++||||||.+|+|..+++. ...+.+++..+|+++.|++.||.++|.... .-|+||||||.||+|+.+|.+||+
T Consensus 94 ---vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLG 170 (375)
T KOG0591|consen 94 ---VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLG 170 (375)
T ss_pred ---hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeec
Confidence 25899999999999999863 334669999999999999999999998422 139999999999999999999999
Q ss_pred eecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhh
Q 014363 237 DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS 316 (426)
Q Consensus 237 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 316 (426)
||||++.+... .....+.+|||.||+||.+.+.+|+.++||||+||++|||+.-.+||.+..-. .+.
T Consensus 171 DfGL~r~l~s~--~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~---~L~-------- 237 (375)
T KOG0591|consen 171 DFGLGRFLSSK--TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLL---SLC-------- 237 (375)
T ss_pred cchhHhHhcch--hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHH---HHH--------
Confidence 99999987654 33345789999999999999999999999999999999999999999875221 111
Q ss_pred hhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHh
Q 014363 317 DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 369 (426)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~ 369 (426)
. .+-...........++..+..|+..|+..||+.||+.-.+++.+..-
T Consensus 238 --~---KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~~ 285 (375)
T KOG0591|consen 238 --K---KIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQSE 285 (375)
T ss_pred --H---HHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHHH
Confidence 1 11111122122256888999999999999999999976666665543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-51 Score=371.71 Aligned_cols=249 Identities=28% Similarity=0.400 Sum_probs=207.2
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-----CHHHHHHHHHHHhhcCCCCccceEeEEEccC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 158 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 158 (426)
.++|++.++||+|+||+||.++.++++. .+|+|++++.. ..+....|..||..++||+||+++..|++.+
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~k-----iYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~ 98 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGK-----IYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEE 98 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCc-----eeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCC
Confidence 4579999999999999999999887654 88999886553 4556889999999999999999999999877
Q ss_pred CCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeee
Q 014363 159 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 238 (426)
Q Consensus 159 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 238 (426)
. +|||+||+.||.|.-.|.+.+ .+++..+..++.+|+.||.|||++ |||||||||+|||||++|+++|+||
T Consensus 99 k----LylVld~~~GGeLf~hL~~eg--~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDF 169 (357)
T KOG0598|consen 99 K----LYLVLDYLNGGELFYHLQREG--RFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDF 169 (357)
T ss_pred e----EEEEEeccCCccHHHHHHhcC--CcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEecc
Confidence 4 599999999999999997654 499999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014363 239 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 318 (426)
Q Consensus 239 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 318 (426)
||++.....+ ..+.++|||+.|||||++.+.+|+.++|.||||+++|||++|.+||.........
T Consensus 170 gL~k~~~~~~--~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~------------- 234 (357)
T KOG0598|consen 170 GLCKEDLKDG--DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMY------------- 234 (357)
T ss_pred ccchhcccCC--CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHH-------------
Confidence 9998644332 2355689999999999999999999999999999999999999999865432211
Q ss_pred hhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCC----CHHHHHHH
Q 014363 319 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRP----KMSEVLEM 365 (426)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP----s~~eil~~ 365 (426)
..++... ....+...+.+.++++.++|..||++|. ++.+|-+|
T Consensus 235 ---~~I~~~k-~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~H 281 (357)
T KOG0598|consen 235 ---DKILKGK-LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRH 281 (357)
T ss_pred ---HHHhcCc-CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcC
Confidence 1222111 1123334667899999999999999995 56665543
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-49 Score=377.79 Aligned_cols=253 Identities=26% Similarity=0.402 Sum_probs=213.0
Q ss_pred HHHhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-----CHHHHHHHHHHHhhc-CCCCccceEeEE
Q 014363 81 KSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-----GHKEWMTEVNFLGIV-EHQNLVKLVGYC 154 (426)
Q Consensus 81 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-----~~~~~~~E~~~l~~l-~HpnIv~~~~~~ 154 (426)
....++|..++.||.|+|++|++|+.+.++ +.+|+|++.++. ..+-...|-.+|.+| .||.|++||..|
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~-----keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TF 143 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATG-----KEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTF 143 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCC-----ceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEe
Confidence 334678999999999999999999987755 489999886543 334567899999999 999999999999
Q ss_pred EccCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCee
Q 014363 155 ADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAK 234 (426)
Q Consensus 155 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~k 234 (426)
+|+.. +|+|+||+++|+|.++|.+.+ .|++.-++.++.+|+.||+|||++ |||||||||+|||||+||++|
T Consensus 144 QD~~s----LYFvLe~A~nGdll~~i~K~G--sfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhik 214 (604)
T KOG0592|consen 144 QDEES----LYFVLEYAPNGDLLDLIKKYG--SFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIK 214 (604)
T ss_pred ecccc----eEEEEEecCCCcHHHHHHHhC--cchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEE
Confidence 99875 499999999999999997664 499999999999999999999998 999999999999999999999
Q ss_pred EeeecccccCCCCCce---------ee--eeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchh
Q 014363 235 LSDFGLARLGPSEGFT---------HV--STAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRS 303 (426)
Q Consensus 235 l~DFGla~~~~~~~~~---------~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~ 303 (426)
|+|||.|+.+...... .. ...++||..|.+||++..+..+..+|||+||||||+|+.|.+||.+..+.
T Consensus 215 ITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney- 293 (604)
T KOG0592|consen 215 ITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY- 293 (604)
T ss_pred EeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH-
Confidence 9999999876543221 11 25699999999999999999999999999999999999999999765332
Q ss_pred hHHHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 304 EQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
..++.++. +.-.++..+++.+.+|+.+.|..||.+|++++||.+|
T Consensus 294 ---------------liFqkI~~--l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 294 ---------------LIFQKIQA--LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred ---------------HHHHHHHH--hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 12233332 2223555667889999999999999999999999887
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-49 Score=352.56 Aligned_cols=265 Identities=24% Similarity=0.339 Sum_probs=210.0
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC----HHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG----HKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
+.|+.+.++|+|+||.||+|+++++++ .||||++....+ .+-.++|+++|++|+|||+|.++++|....
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~Tgq-----IVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkr-- 74 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQ-----IVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKR-- 74 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCccc-----EEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcc--
Confidence 467888899999999999999999887 899999865443 345689999999999999999999998776
Q ss_pred CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecc
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 240 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 240 (426)
.++||+|||+..-|+ .+....+ .++...+.+++.|++.|+.|+|++ +||||||||+||||+.+|.+||||||+
T Consensus 75 --klhLVFE~~dhTvL~-eLe~~p~-G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGF 147 (396)
T KOG0593|consen 75 --KLHLVFEYCDHTVLH-ELERYPN-GVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGF 147 (396)
T ss_pred --eeEEEeeecchHHHH-HHHhccC-CCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchh
Confidence 459999999875554 4443433 389999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHh-------
Q 014363 241 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK------- 312 (426)
Q Consensus 241 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~------- 312 (426)
|+.....+ ..-+..+.|.+|.|||.+.+ ..|+..+||||+||++.||++|.+-|.+....+...++....
T Consensus 148 AR~L~~pg--d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prh 225 (396)
T KOG0593|consen 148 ARTLSAPG--DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRH 225 (396)
T ss_pred hHhhcCCc--chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHH
Confidence 99876432 23456789999999999887 679999999999999999999999998776655444433321
Q ss_pred -hhhhhhhhhhhhcCCcCCCcc-----cHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 313 -PYLSDAKQFRQIVDPRLEGKY-----SLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 313 -~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
..+....-+..+.-|...... -...+..+.+++..||..||.+|++.+|++.|
T Consensus 226 q~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 226 QSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred HHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 111222222222222222111 12355688899999999999999999999875
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-48 Score=372.37 Aligned_cols=255 Identities=30% Similarity=0.519 Sum_probs=214.3
Q ss_pred CCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCceEEE
Q 014363 88 SRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLL 166 (426)
Q Consensus 88 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~~~l 166 (426)
..++.||+|-||.||.|.++... .||+|.++... ..+.|.+|+++|++|+|+|||+++|+|..++. +||
T Consensus 209 ~l~~~LG~G~FG~V~~g~~~~~~------~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~p----iyI 278 (468)
T KOG0197|consen 209 KLIRELGSGQFGEVWLGKWNGST------KVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEP----IYI 278 (468)
T ss_pred HHHHHhcCCccceEEEEEEcCCC------cccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCc----eEE
Confidence 34557999999999999999875 58888887643 55789999999999999999999999998763 499
Q ss_pred EEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccCCC
Q 014363 167 VYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPS 246 (426)
Q Consensus 167 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 246 (426)
|||||+.|+|.+||....+..+...+.+.++.|||+|++||+++ ++|||||...||||++++.+||+|||||+...+
T Consensus 279 VtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d 355 (468)
T KOG0197|consen 279 VTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGD 355 (468)
T ss_pred EEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCC
Confidence 99999999999999986667799999999999999999999998 999999999999999999999999999996555
Q ss_pred CCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhc
Q 014363 247 EGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIV 325 (426)
Q Consensus 247 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (426)
+.+.. .....-...|.|||.+..+.++.|+|||||||+||||+| |+.||.+....+.. +.+
T Consensus 356 ~~Y~~-~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~-----------------~~l 417 (468)
T KOG0197|consen 356 DEYTA-SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVL-----------------ELL 417 (468)
T ss_pred Cceee-cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHH-----------------HHH
Confidence 44332 222234568999999999999999999999999999999 99999876433222 222
Q ss_pred CCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhh
Q 014363 326 DPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 373 (426)
Q Consensus 326 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~ 373 (426)
+...+-..+..++..+.+||..||..+|++|||++.+...|+++....
T Consensus 418 e~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 418 ERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST 465 (468)
T ss_pred hccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence 222333345568899999999999999999999999999998877543
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-48 Score=345.10 Aligned_cols=236 Identities=29% Similarity=0.459 Sum_probs=205.5
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-----CHHHHHHHHHHHhhcCCCCccceEeEEEccC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 158 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 158 (426)
.++|+.++.||.|+||.|.+++.+.++. .+|+|++.... ..+...+|..+|+.+.||+++++++.|.+..
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~-----yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~ 117 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGN-----YYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNS 117 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCc-----eeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCC
Confidence 3478889999999999999999888765 89999987654 3445778999999999999999999999877
Q ss_pred CCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeee
Q 014363 159 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 238 (426)
Q Consensus 159 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 238 (426)
. +||||||.+||.|..++++.++ +++..++.++.||+.||+|||+. +|++|||||+|||||.+|.+||+||
T Consensus 118 ~----lymvmeyv~GGElFS~Lrk~~r--F~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDF 188 (355)
T KOG0616|consen 118 N----LYMVMEYVPGGELFSYLRKSGR--FSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDF 188 (355)
T ss_pred e----EEEEEeccCCccHHHHHHhcCC--CCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEec
Confidence 4 5999999999999999976544 99999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014363 239 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 318 (426)
Q Consensus 239 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 318 (426)
|.|+..... +-+.||||.|+|||++...+|+.++|.|||||++|||+.|.+||....+.
T Consensus 189 GFAK~v~~r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~---------------- 247 (355)
T KOG0616|consen 189 GFAKRVSGR-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI---------------- 247 (355)
T ss_pred cceEEecCc-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH----------------
Confidence 999876542 55789999999999999999999999999999999999999999866541
Q ss_pred hhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCC
Q 014363 319 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTR 356 (426)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 356 (426)
.....++...+ .++..++.++.+|+..+|+.|-.+|
T Consensus 248 ~iY~KI~~~~v--~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 248 QIYEKILEGKV--KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred HHHHHHHhCcc--cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 12233443333 3667788899999999999999999
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-48 Score=361.97 Aligned_cols=258 Identities=28% Similarity=0.428 Sum_probs=205.7
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC--CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCc
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 162 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~ 162 (426)
.+|...+.||+|+||.||++....++. ..|+|.+.... ..+.+.+|+.+|.+|+|||||+++|....... .
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~-----~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~--~ 89 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGE-----LMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSREN--D 89 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCc-----ceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccC--e
Confidence 357778899999999999999887644 67888775442 14568999999999999999999997544433 2
Q ss_pred eEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCC-CCCeeEeeeccc
Q 014363 163 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE-QWNAKLSDFGLA 241 (426)
Q Consensus 163 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~-~~~~kl~DFGla 241 (426)
.++++|||+++|+|.+++...+. .+++..+..+++||++||+|||++ ||||+||||+|||++. ++.+||+|||++
T Consensus 90 ~~~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a 165 (313)
T KOG0198|consen 90 EYNIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLA 165 (313)
T ss_pred eeEeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccc
Confidence 46899999999999999987665 699999999999999999999998 9999999999999999 799999999999
Q ss_pred ccCCC-CCceeeeeeeecCcccCCchhhccCC-CCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014363 242 RLGPS-EGFTHVSTAVVGTMGYAAPEYVQTGR-LAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 319 (426)
Q Consensus 242 ~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 319 (426)
..... .........+.||+.|||||++..+. .+.++|||||||++.||+||+.||... ......+
T Consensus 166 ~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-~~~~~~~------------ 232 (313)
T KOG0198|consen 166 KKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-FEEAEAL------------ 232 (313)
T ss_pred cccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-cchHHHH------------
Confidence 86553 11122234578999999999998643 345999999999999999999999753 0001111
Q ss_pred hhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 014363 320 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNK 368 (426)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~ 368 (426)
..+........++..++.+..+++.+|++.||+.|||+.++|+|...
T Consensus 233 --~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 233 --LLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred --HHHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 11111111224556688899999999999999999999999998643
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-48 Score=369.57 Aligned_cols=250 Identities=28% Similarity=0.432 Sum_probs=211.4
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC--CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
...|....+||+|+.|.||.|....++. .||+|++.... ..+-+++|+.+|+.++|+|||++++.|...++
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~-----~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~de-- 344 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQ-----EVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDE-- 344 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCc-----eEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccce--
Confidence 3468888899999999999999777655 79999885443 34567899999999999999999998877654
Q ss_pred ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccc
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 241 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 241 (426)
+++||||++||+|.|.+... .+++.++..|++++++||+|||.+ ||+|||||.+|||++.+|.+||+|||++
T Consensus 345 --LWVVMEym~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFc 416 (550)
T KOG0578|consen 345 --LWVVMEYMEGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFC 416 (550)
T ss_pred --eEEEEeecCCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeee
Confidence 59999999999999998754 389999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhh
Q 014363 242 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 321 (426)
Q Consensus 242 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (426)
..+..... ...+.+|||.|||||++....|++++||||||++++||+-|.+||-...+.....++.
T Consensus 417 aqi~~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa------------ 482 (550)
T KOG0578|consen 417 AQISEEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA------------ 482 (550)
T ss_pred eccccccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHh------------
Confidence 87765432 3567899999999999999999999999999999999999999997544432222211
Q ss_pred hhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 322 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.+....-..+..++..+++++.+||+.|+++|+++.|+|+|
T Consensus 483 ---~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 483 ---TNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred ---hcCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 11222223445678899999999999999999999999997
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-47 Score=366.48 Aligned_cols=266 Identities=27% Similarity=0.417 Sum_probs=207.5
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC---HHHHHHHHHHHhhc-CCCCccceEeEEEccCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG---HKEWMTEVNFLGIV-EHQNLVKLVGYCADDDE 159 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~ 159 (426)
.++|.+.+.||+|+||.||+|.+...........||+|.+..... ...+.+|+.+|..+ +||||+++++++.....
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 457899999999999999999875443334455799999865432 34688999999999 89999999998876443
Q ss_pred CCceEEEEEeeCCCCChhhhccCCC-------------------------------------------------------
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPKS------------------------------------------------------- 184 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~~------------------------------------------------------- 184 (426)
..++||||+++|+|.+++....
T Consensus 86 ---~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (338)
T cd05102 86 ---PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE 162 (338)
T ss_pred ---ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence 3589999999999999886432
Q ss_pred -----CCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccCCCCCceeeeeeeecC
Q 014363 185 -----ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGT 259 (426)
Q Consensus 185 -----~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 259 (426)
...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...............++
T Consensus 163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~ 239 (338)
T cd05102 163 TDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239 (338)
T ss_pred ccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence 12477888899999999999999998 9999999999999999999999999999865332211112234567
Q ss_pred cccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHH
Q 014363 260 MGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLV 338 (426)
Q Consensus 260 ~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (426)
+.|+|||++.+..++.++|||||||++|||++ |..||........ .... + .+. .....+..++
T Consensus 240 ~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~--~~~~----~---------~~~-~~~~~~~~~~ 303 (338)
T cd05102 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE--FCQR----L---------KDG-TRMRAPENAT 303 (338)
T ss_pred ccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH--HHHH----H---------hcC-CCCCCCCCCC
Confidence 88999999998999999999999999999997 9999976432211 1110 0 000 0011122355
Q ss_pred HHHHHHHHhccccCCCCCCCHHHHHHHHHHhHh
Q 014363 339 SKLSHVANLCLVKNARTRPKMSEVLEMVNKIVD 371 (426)
Q Consensus 339 ~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~ 371 (426)
..+.+|+.+||+.||++|||+.||++.|+.++.
T Consensus 304 ~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 304 PEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 689999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-47 Score=366.76 Aligned_cols=249 Identities=31% Similarity=0.465 Sum_probs=206.8
Q ss_pred HhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-------CCHHHHHHHHHHHhhcC-CCCccceEeEE
Q 014363 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-------GGHKEWMTEVNFLGIVE-HQNLVKLVGYC 154 (426)
Q Consensus 83 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-------~~~~~~~~E~~~l~~l~-HpnIv~~~~~~ 154 (426)
..++|...+.||+|+||+|++|.+..++. .||+|.+.+. ...+.+.+|+.+++.++ ||||+++++++
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~-----~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~ 89 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGE-----KVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVF 89 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCC-----eEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEE
Confidence 46789999999999999999999887764 7899976553 22445668999999998 99999999999
Q ss_pred EccCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCC-CCe
Q 014363 155 ADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQ-WNA 233 (426)
Q Consensus 155 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~-~~~ 233 (426)
..... +|+||||+.||+|.+++... +.+.+..+..++.|++.||+|||++ ||+||||||+|||++.+ +++
T Consensus 90 ~t~~~----~~ivmEy~~gGdL~~~i~~~--g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~ 160 (370)
T KOG0583|consen 90 ATPTK----IYIVMEYCSGGDLFDYIVNK--GRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNL 160 (370)
T ss_pred ecCCe----EEEEEEecCCccHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCE
Confidence 88774 59999999999999999863 4488999999999999999999998 99999999999999999 999
Q ss_pred eEeeecccccCCCCCceeeeeeeecCcccCCchhhccCC-CC-CchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhH
Q 014363 234 KLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGR-LA-ARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWV 311 (426)
Q Consensus 234 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~ 311 (426)
||+|||++.... .......+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|..||+..... .+
T Consensus 161 Kl~DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~---~l---- 231 (370)
T KOG0583|consen 161 KLSDFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP---NL---- 231 (370)
T ss_pred EEeccccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH---HH----
Confidence 999999998764 1223456789999999999999977 86 6899999999999999999999863221 11
Q ss_pred hhhhhhhhhhhhhcCCcCCCcccHHH-HHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 312 KPYLSDAKQFRQIVDPRLEGKYSLRL-VSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
+..+..... .++..+ +.++..|+.+||+.||.+|+++.+|+.+
T Consensus 232 ---------~~ki~~~~~--~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h 275 (370)
T KOG0583|consen 232 ---------YRKIRKGEF--KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEH 275 (370)
T ss_pred ---------HHHHhcCCc--cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhC
Confidence 111111111 223334 7899999999999999999999999965
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=360.17 Aligned_cols=268 Identities=25% Similarity=0.324 Sum_probs=208.8
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
.+.|+.+++||+|+||.||+|++..++. .||+|++.-+. ......+||.||++|+||||+++.+...+...
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgk-----ivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~ 190 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGK-----IVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLS 190 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCc-----EEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCC
Confidence 4568888999999999999999877765 89999886443 34456899999999999999999999988743
Q ss_pred CCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeec
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 239 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 239 (426)
. .+|||+|||+. +|..++... .-.|++.++..+++|++.||+|||.+ ||+|||||.+|||||.+|.+||+|||
T Consensus 191 ~--siYlVFeYMdh-DL~GLl~~p-~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFG 263 (560)
T KOG0600|consen 191 G--SIYLVFEYMDH-DLSGLLSSP-GVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFG 263 (560)
T ss_pred c--eEEEEEecccc-hhhhhhcCC-CcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEecccc
Confidence 3 46999999976 888888643 34599999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHh-----h
Q 014363 240 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK-----P 313 (426)
Q Consensus 240 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~-----~ 313 (426)
||+++....... .+..+-|++|.|||++.+. .|+.++|+||.||||.||+.|++.|.+.........+-.+- .
T Consensus 264 LAr~y~~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~ 342 (560)
T KOG0600|consen 264 LARFYTPSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTED 342 (560)
T ss_pred ceeeccCCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChh
Confidence 999876654333 4557789999999988875 59999999999999999999999998876544433332110 0
Q ss_pred hhhhhhhhhhhcCCcCCCcc-------cHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 314 YLSDAKQFRQIVDPRLEGKY-------SLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.+. ...+.....-.....| ...++....+|+..+|..||.+|.|+.++|+.
T Consensus 343 ~W~-~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 343 YWP-VSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred ccc-cccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 111 0000000000001111 12345677899999999999999999999874
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-47 Score=353.21 Aligned_cols=262 Identities=27% Similarity=0.350 Sum_probs=213.3
Q ss_pred HHHHhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----------------CHHHHHHHHHHHhhcC
Q 014363 80 LKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----------------GHKEWMTEVNFLGIVE 143 (426)
Q Consensus 80 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----------------~~~~~~~E~~~l~~l~ 143 (426)
-....++|++++.||+|.||.|-+|+....+. .||+|++.+.. ..+...+||.||+++.
T Consensus 92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~-----l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~ 166 (576)
T KOG0585|consen 92 DRKQLNQYELIKEIGSGQYGKVKLARDEVDGK-----LYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLH 166 (576)
T ss_pred cceehhheehhhhhcCCccceEEEEeecCCCc-----EEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcC
Confidence 34457899999999999999999999766554 89999885432 2246789999999999
Q ss_pred CCCccceEeEEEccCCCCceEEEEEeeCCCCChhhhccCCCCCc-cCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCC
Q 014363 144 HQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETI-LTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKS 222 (426)
Q Consensus 144 HpnIv~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~-~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp 222 (426)
|||||+++++..+.... .+|||+|||..|.+...=. ... +.+.++++++.+++.||+|||.+ |||||||||
T Consensus 167 H~nVV~LiEvLDDP~s~--~~YlVley~s~G~v~w~p~---d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKP 238 (576)
T KOG0585|consen 167 HPNVVKLIEVLDDPESD--KLYLVLEYCSKGEVKWCPP---DKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKP 238 (576)
T ss_pred CcCeeEEEEeecCcccC--ceEEEEEeccCCccccCCC---CcccccHHHHHHHHHHHHHHHHHHHhc---Ceeccccch
Confidence 99999999999887655 6799999999988765432 233 89999999999999999999998 999999999
Q ss_pred CceEeCCCCCeeEeeecccccCCCC---CceeeeeeeecCcccCCchhhccCC---C-CCchhhHHHHHHHHHHHhCCCC
Q 014363 223 SNILLDEQWNAKLSDFGLARLGPSE---GFTHVSTAVVGTMGYAAPEYVQTGR---L-AARSDVWSYGVFLYELITGRRP 295 (426)
Q Consensus 223 ~NILl~~~~~~kl~DFGla~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~---~-~~~~DvwslGvil~elltg~~p 295 (426)
+|+||+++|++||+|||.+...... +........+|||.|+|||...++. + +.+.||||+||+||+|+.|+.|
T Consensus 239 sNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~P 318 (576)
T KOG0585|consen 239 SNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLP 318 (576)
T ss_pred hheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCC
Confidence 9999999999999999999865322 1122223468999999999887743 3 5689999999999999999999
Q ss_pred CCCCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhH
Q 014363 296 IDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIV 370 (426)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~ 370 (426)
|.+... .+.+..+++..+.-.....+.+.+.+||.++|++||+.|.++.+|..|..-..
T Consensus 319 F~~~~~----------------~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~ 377 (576)
T KOG0585|consen 319 FFDDFE----------------LELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTR 377 (576)
T ss_pred cccchH----------------HHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceecc
Confidence 976422 23345566666655555567889999999999999999999999998865433
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-48 Score=360.32 Aligned_cols=267 Identities=25% Similarity=0.340 Sum_probs=212.2
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-CHHHH--HHHHHHHhhcC-CCCccceEeEEEccCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-GHKEW--MTEVNFLGIVE-HQNLVKLVGYCADDDE 159 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~--~~E~~~l~~l~-HpnIv~~~~~~~~~~~ 159 (426)
.++|..++.||.|+||.||+|+.+.+++ .||||++++.- ..++. ++|+..|++|+ |||||++.+++.+.+.
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~-----~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~ 83 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGE-----LVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDR 83 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCc-----eeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCc
Confidence 4578899999999999999999887766 69999987653 33333 68999999998 9999999999988774
Q ss_pred CCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeec
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 239 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 239 (426)
.+|+||||| ..+|.+++..+ +..|++..+..|+.||++||+|+|.+ |+.|||+||+|||+.....+||+|||
T Consensus 84 ---~L~fVfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFG 155 (538)
T KOG0661|consen 84 ---ILYFVFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFG 155 (538)
T ss_pred ---eEeeeHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccc
Confidence 469999999 45999999877 67899999999999999999999999 99999999999999988899999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCchhhc-cCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhH-----hh
Q 014363 240 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQ-TGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWV-----KP 313 (426)
Q Consensus 240 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~-----~~ 313 (426)
+|+...... --+..+.|.+|.|||++. .+.|+.+.||||+|||++|+.+-++-|.+....+....+..+ +.
T Consensus 156 LARev~Skp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~ 232 (538)
T KOG0661|consen 156 LAREVRSKP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKD 232 (538)
T ss_pred cccccccCC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccc
Confidence 999765432 134578999999999765 567899999999999999999999989876544333222211 01
Q ss_pred hhhhhhhhhhhcCCcCCCc-------ccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014363 314 YLSDAKQFRQIVDPRLEGK-------YSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMV 366 (426)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L 366 (426)
.+..+..+...++-.+... .-...+.++.++|.+|+.+||.+|||++|++++-
T Consensus 233 ~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 233 SWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred cchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 1111222222232222211 1123678899999999999999999999999973
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=349.02 Aligned_cols=262 Identities=26% Similarity=0.400 Sum_probs=212.2
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
.+.|+...+||.|..++||+|+....++ .||||++.-+. ..+.+.+|+..|+.++||||++++..|..+..
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e-----~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~- 98 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNE-----VVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSE- 98 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCC-----EEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecce-
Confidence 3578899999999999999999887765 89999986543 34678999999999999999999999998774
Q ss_pred CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecc
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 240 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 240 (426)
+|+||.||.+|++.+++...-...+++..+..|++++++||.|||.+ |.||||||+.||||+.+|.|||+|||.
T Consensus 99 ---LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgv 172 (516)
T KOG0582|consen 99 ---LWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGV 172 (516)
T ss_pred ---eEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCcee
Confidence 59999999999999999876556699999999999999999999998 999999999999999999999999998
Q ss_pred cccCCCCCcee-ee-eeeecCcccCCchhhcc--CCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhh
Q 014363 241 ARLGPSEGFTH-VS-TAVVGTMGYAAPEYVQT--GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS 316 (426)
Q Consensus 241 a~~~~~~~~~~-~~-~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 316 (426)
+-.+...+... .. ..++||+.|||||++.. ..|+.|+||||||++..||.+|..||....+... +...+..
T Consensus 173 sa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv--Ll~tLqn--- 247 (516)
T KOG0582|consen 173 SASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV--LLLTLQN--- 247 (516)
T ss_pred eeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH--HHHHhcC---
Confidence 87554443222 22 57799999999999654 4699999999999999999999999987654321 1111110
Q ss_pred hhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 317 DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
. ........+.......+...+.+++..||+.||.+|||+++++++
T Consensus 248 -~--pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 248 -D--PPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred -C--CCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 0 000001112222233466789999999999999999999999986
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=366.89 Aligned_cols=248 Identities=27% Similarity=0.453 Sum_probs=210.4
Q ss_pred HhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-----CCHHHHHHHHHHHhhc-CCCCccceEeEEEc
Q 014363 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-----GGHKEWMTEVNFLGIV-EHQNLVKLVGYCAD 156 (426)
Q Consensus 83 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-----~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~ 156 (426)
..++|..+++||+|.||+|+++..+.+++ .+|||.++++ +..+..+.|.+|+... +||.+++++..|+.
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e-----~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT 440 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNE-----YYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQT 440 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCc-----EEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccccc
Confidence 35689999999999999999999998876 7899988765 3567889999999988 59999999999998
Q ss_pred cCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEe
Q 014363 157 DDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLS 236 (426)
Q Consensus 157 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~ 236 (426)
.+ ++|+||||+.||++..+++. ..+++..+..++..|+.||+|||++ +||+||||.+|||||.+|.+||+
T Consensus 441 ~~----~l~fvmey~~Ggdm~~~~~~---~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiA 510 (694)
T KOG0694|consen 441 KE----HLFFVMEYVAGGDLMHHIHT---DVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIA 510 (694)
T ss_pred CC----eEEEEEEecCCCcEEEEEec---ccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEec
Confidence 77 45999999999996555432 3499999999999999999999999 99999999999999999999999
Q ss_pred eecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhh
Q 014363 237 DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS 316 (426)
Q Consensus 237 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 316 (426)
|||+++.....+ ..+.++||||.|||||++.+..|+.++|.|||||+|||||.|..||.+.+.++
T Consensus 511 DFGlcKe~m~~g--~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee------------- 575 (694)
T KOG0694|consen 511 DFGLCKEGMGQG--DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE------------- 575 (694)
T ss_pred ccccccccCCCC--CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH-------------
Confidence 999999654333 35678999999999999999999999999999999999999999998764332
Q ss_pred hhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCH-----HHHHHH
Q 014363 317 DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKM-----SEVLEM 365 (426)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~-----~eil~~ 365 (426)
.+..++.. ...|+..++.+...||+++|..||++|.-+ .+|.+|
T Consensus 576 ---~FdsI~~d--~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~h 624 (694)
T KOG0694|consen 576 ---VFDSIVND--EVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKH 624 (694)
T ss_pred ---HHHHHhcC--CCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhC
Confidence 22333322 224677788999999999999999999754 555553
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-47 Score=328.07 Aligned_cols=249 Identities=27% Similarity=0.423 Sum_probs=213.1
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-----CCHHHHHHHHHHHhhcCCCCccceEeEEEccC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-----GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 158 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 158 (426)
.++|++++.||+|-||.||+|+.+.+.. .||+|++.+. ....++.+|++|.+.|+||||+++|+||.+..
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~-----IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~ 95 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLF-----IVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSK 95 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCc-----EEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccc
Confidence 4578999999999999999999887765 7899988544 34567889999999999999999999999987
Q ss_pred CCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeee
Q 014363 159 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 238 (426)
Q Consensus 159 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 238 (426)
. .||++||.++|.|...|.......+++.....++.|+|.||.|+|.+ +||||||||+|+|++.++.+||+||
T Consensus 96 r----iyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdf 168 (281)
T KOG0580|consen 96 R----IYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADF 168 (281)
T ss_pred e----eEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCC
Confidence 4 49999999999999999866666799999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014363 239 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 318 (426)
Q Consensus 239 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 318 (426)
|.+...+.. ...+.|||..|.+||...+..++..+|+|++|++.||++.|.+||......
T Consensus 169 GwsV~~p~~----kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~---------------- 228 (281)
T KOG0580|consen 169 GWSVHAPSN----KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS---------------- 228 (281)
T ss_pred CceeecCCC----CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH----------------
Confidence 999876532 245689999999999999999999999999999999999999999754311
Q ss_pred hhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014363 319 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMV 366 (426)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L 366 (426)
+....+... .-.++..++..+.++|.+||..+|.+|.+..|+++|-
T Consensus 229 etYkrI~k~--~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hp 274 (281)
T KOG0580|consen 229 ETYKRIRKV--DLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHP 274 (281)
T ss_pred HHHHHHHHc--cccCCcccChhHHHHHHHHhccCccccccHHHHhhhH
Confidence 112222211 1224456778999999999999999999999999874
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-47 Score=358.49 Aligned_cols=253 Identities=26% Similarity=0.383 Sum_probs=206.8
Q ss_pred HhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-----CCHHHHHHHHHHHhhcCCCCccceEeEEEcc
Q 014363 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-----GGHKEWMTEVNFLGIVEHQNLVKLVGYCADD 157 (426)
Q Consensus 83 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 157 (426)
..++|+.+++||+|+||.||+|+-++++. .+|+|++++. ...+....|-.+|...++|+||++|..|++.
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~-----iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~ 213 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGE-----IYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDK 213 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCc-----EEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCC
Confidence 35689999999999999999999888876 8999998654 3556778899999999999999999999998
Q ss_pred CCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEee
Q 014363 158 DERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 237 (426)
Q Consensus 158 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~D 237 (426)
+. +||||||++||++..+|... ..|++..+..++.+++.|++-||+. |+|||||||+|+|||..|++||+|
T Consensus 214 ~~----LYLiMEylPGGD~mTLL~~~--~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSD 284 (550)
T KOG0605|consen 214 EY----LYLIMEYLPGGDMMTLLMRK--DTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSD 284 (550)
T ss_pred Ce----eEEEEEecCCccHHHHHHhc--CcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeecc
Confidence 74 59999999999999999755 4599999999999999999999998 999999999999999999999999
Q ss_pred ecccccCCC----------------------CCce-----e------------------eeeeeecCcccCCchhhccCC
Q 014363 238 FGLARLGPS----------------------EGFT-----H------------------VSTAVVGTMGYAAPEYVQTGR 272 (426)
Q Consensus 238 FGla~~~~~----------------------~~~~-----~------------------~~~~~~gt~~y~aPE~~~~~~ 272 (426)
|||+.-... .... . .....+|||.|||||++.+..
T Consensus 285 FGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg 364 (550)
T KOG0605|consen 285 FGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG 364 (550)
T ss_pred ccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC
Confidence 999842211 0000 0 012357999999999999999
Q ss_pred CCCchhhHHHHHHHHHHHhCCCCCCCCCchhhH-HHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhcccc
Q 014363 273 LAARSDVWSYGVFLYELITGRRPIDRNRPRSEQ-KLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVK 351 (426)
Q Consensus 273 ~~~~~DvwslGvil~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 351 (426)
|+..+|+||||||+||||.|.+||....+..-- .++.|-.. +...-...++.+..+||.+||.
T Consensus 365 Y~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~---------------l~fP~~~~~s~eA~DLI~rll~- 428 (550)
T KOG0605|consen 365 YGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRET---------------LKFPEEVDLSDEAKDLITRLLC- 428 (550)
T ss_pred CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh---------------ccCCCcCcccHHHHHHHHHHhc-
Confidence 999999999999999999999999887664332 22222111 1111122345789999999999
Q ss_pred CCCCCC---CHHHHHHH
Q 014363 352 NARTRP---KMSEVLEM 365 (426)
Q Consensus 352 dp~~RP---s~~eil~~ 365 (426)
||++|. .++||.+|
T Consensus 429 d~~~RLG~~G~~EIK~H 445 (550)
T KOG0605|consen 429 DPENRLGSKGAEEIKKH 445 (550)
T ss_pred CHHHhcCcccHHHHhcC
Confidence 999996 57888765
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=339.09 Aligned_cols=253 Identities=27% Similarity=0.378 Sum_probs=213.4
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-----CHHHHHHHHHHHhhcCCCCccceEeEEEccCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
..|+.++.||+|.-|+||++..++++. .+|+|++.+.. ...+...|-+||+.++||.++.+|+.|..+..
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~-----~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~ 151 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNC-----LFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKY 151 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCc-----eEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccce
Confidence 356677889999999999999888763 89999986543 34567889999999999999999999988774
Q ss_pred CCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeec
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 239 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 239 (426)
.|++||||+||+|..++++...+.+++..+..++.+|+.||+|||.. |||+|||||+||||.++|++.|+||.
T Consensus 152 ----~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFD 224 (459)
T KOG0610|consen 152 ----SCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFD 224 (459)
T ss_pred ----eEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeecc
Confidence 49999999999999999988888999999999999999999999987 99999999999999999999999999
Q ss_pred ccccCCC---------------------------------C-C--------------------ceeeeeeeecCcccCCc
Q 014363 240 LARLGPS---------------------------------E-G--------------------FTHVSTAVVGTMGYAAP 265 (426)
Q Consensus 240 la~~~~~---------------------------------~-~--------------------~~~~~~~~~gt~~y~aP 265 (426)
|+..... . . ....+..++||-.|+||
T Consensus 225 LS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAP 304 (459)
T KOG0610|consen 225 LSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAP 304 (459)
T ss_pred ccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccc
Confidence 8743210 0 0 00123467899999999
Q ss_pred hhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHH
Q 014363 266 EYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVA 345 (426)
Q Consensus 266 E~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 345 (426)
|++.+..++.++|+|+|||+|||||.|..||.+... ...+..++-..+.-.....++..+++||
T Consensus 305 EvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~----------------~~Tl~NIv~~~l~Fp~~~~vs~~akDLI 368 (459)
T KOG0610|consen 305 EVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNN----------------KETLRNIVGQPLKFPEEPEVSSAAKDLI 368 (459)
T ss_pred eeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCc----------------hhhHHHHhcCCCcCCCCCcchhHHHHHH
Confidence 999999999999999999999999999999987543 2344555554444333346778999999
Q ss_pred HhccccCCCCCCC----HHHHHHH
Q 014363 346 NLCLVKNARTRPK----MSEVLEM 365 (426)
Q Consensus 346 ~~cl~~dp~~RPs----~~eil~~ 365 (426)
+++|.+||++|.. +.||-+|
T Consensus 369 r~LLvKdP~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 369 RKLLVKDPSKRLGSKRGAAEIKRH 392 (459)
T ss_pred HHHhccChhhhhccccchHHhhcC
Confidence 9999999999998 8888776
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-46 Score=356.48 Aligned_cols=246 Identities=32% Similarity=0.445 Sum_probs=207.7
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
++|.+.+.||+|+||.||+|+.+.+.. .||+|.+.+.+ ..+.+.+|++|++.|+|||||.++++|....+
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~-----~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~- 75 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQ-----VVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAH- 75 (808)
T ss_pred cchhHHHHhcCCccceeeeccccccee-----EEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccce-
Confidence 467888899999999999999777654 89999885543 34568899999999999999999999988764
Q ss_pred CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecc
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 240 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 240 (426)
+++|.|||.| +|..++...+ .++++.+..|+.+++.||.|||++ +|+|||+||.|||++.+|.+|+||||+
T Consensus 76 ---~~vVte~a~g-~L~~il~~d~--~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~ 146 (808)
T KOG0597|consen 76 ---LWVVTEYAVG-DLFTILEQDG--KLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGL 146 (808)
T ss_pred ---EEEEehhhhh-hHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhh
Confidence 5999999966 9999997654 499999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhh
Q 014363 241 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 320 (426)
Q Consensus 241 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (426)
|+.+... ..+.+...|||.|||||++.+.+|+..+|+||||||+|||++|++||....- ..++
T Consensus 147 Ar~m~~~--t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si---~~Lv------------ 209 (808)
T KOG0597|consen 147 ARAMSTN--TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSI---TQLV------------ 209 (808)
T ss_pred hhhcccC--ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHH---HHHH------------
Confidence 9976653 4556678899999999999999999999999999999999999999964211 1111
Q ss_pred hhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 321 FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
..++... ..++...+..+..++...|..||..|.+..+++.|
T Consensus 210 -~~I~~d~--v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 210 -KSILKDP--VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred -HHHhcCC--CCCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 1111111 12344678889999999999999999999999987
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=322.15 Aligned_cols=264 Identities=25% Similarity=0.352 Sum_probs=206.7
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
.+|..+++||+|.||.||+|++..+++ .||+|+++-.. -.....+|++.|+.++|+||+.++++|...+..
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~-----~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l 76 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGK-----RVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNL 76 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCc-----EEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCce
Confidence 367888899999999999999887765 79999886443 234678999999999999999999999887754
Q ss_pred CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecc
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 240 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 240 (426)
.||+||++ .+|+..|+.+ ...++...+..++.++++||+|||++ .|+||||||.|+||+.+|.+||+|||+
T Consensus 77 ----~lVfEfm~-tdLe~vIkd~-~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGL 147 (318)
T KOG0659|consen 77 ----SLVFEFMP-TDLEVVIKDK-NIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGL 147 (318)
T ss_pred ----EEEEEecc-ccHHHHhccc-ccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccc
Confidence 89999995 5999988755 35699999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHh--------H
Q 014363 241 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQW--------V 311 (426)
Q Consensus 241 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~--------~ 311 (426)
++.+....... ...+-|.+|.|||.+.|. .|+..+||||.|||+.||+-|.+-|.+....+....+-- .
T Consensus 148 Ar~f~~p~~~~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~ 225 (318)
T KOG0659|consen 148 ARFFGSPNRIQ--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQ 225 (318)
T ss_pred hhccCCCCccc--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCccc
Confidence 99887654322 223789999999988764 599999999999999999998777765543322221111 1
Q ss_pred hhhhhh---hhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 312 KPYLSD---AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 312 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
+|.+.. ...+...-.+.+.. .....++.+.+|+..||..||.+|++++|++++
T Consensus 226 WP~~~~lpdY~~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 226 WPEMTSLPDYVKIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred CccccccccHHHHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 111111 12222111222222 333456677999999999999999999999987
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=345.13 Aligned_cols=248 Identities=25% Similarity=0.412 Sum_probs=208.0
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-----CHHHHHHHHHHHhhcCCCCccceEeEEEccC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 158 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 158 (426)
..+|++.+.||+|+||.|-+|+....+. .||||.+.++. +.-.+.+|++||+.|+||||+.+|.+|...+
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR-----~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkd 126 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGR-----EVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKD 126 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCc-----EeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCc
Confidence 3478888899999999999998765554 89999886654 2335789999999999999999999998877
Q ss_pred CCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeee
Q 014363 159 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 238 (426)
Q Consensus 159 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 238 (426)
.+.|||||..+|.|+||+...+. +++.++..+++||+.|+.|+|.+ +++|||||.+|||+|.++++||+||
T Consensus 127 ----KIvivMEYaS~GeLYDYiSer~~--LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADF 197 (668)
T KOG0611|consen 127 ----KIVIVMEYASGGELYDYISERGS--LSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADF 197 (668)
T ss_pred ----eEEEEEEecCCccHHHHHHHhcc--ccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeecc
Confidence 45999999999999999976554 99999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCchhhccCCC-CCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh
Q 014363 239 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRL-AARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 317 (426)
Q Consensus 239 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 317 (426)
||+..+.... ..+++||++.|.+||++.+.+| ++.+|-|||||+||.|+.|..||++.+....
T Consensus 198 GLSNly~~~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~l------------- 261 (668)
T KOG0611|consen 198 GLSNLYADKK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRL------------- 261 (668)
T ss_pred chhhhhcccc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHH-------------
Confidence 9998876543 3567999999999999999988 5789999999999999999999998653221
Q ss_pred hhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014363 318 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVN 367 (426)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~ 367 (426)
.+++-..... .+..+....-||++||..||++|-|+.+|..|..
T Consensus 262 ---vrQIs~GaYr---EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 262 ---VRQISRGAYR---EPETPSDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred ---HHHhhccccc---CCCCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 1222221111 1123456778999999999999999999988753
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-46 Score=374.01 Aligned_cols=266 Identities=27% Similarity=0.452 Sum_probs=224.3
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC---HHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG---HKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
+.+....+.||+|+||+||+|...+-........||||.++.... .++|.+|+++|..|+|||||+++|+|.+.+..
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 345556678999999999999987766666778999999987654 46899999999999999999999999988765
Q ss_pred CceEEEEEeeCCCCChhhhccCCC------------CCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeC
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKS------------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLD 228 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~------------~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~ 228 (426)
|+|+|||..|+|.+||.... ..+++..+.+.|+.|||.|++||-++ .+|||||...|+||.
T Consensus 565 ----~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVg 637 (774)
T KOG1026|consen 565 ----CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVG 637 (774)
T ss_pred ----EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceec
Confidence 99999999999999996432 12388999999999999999999998 999999999999999
Q ss_pred CCCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHH
Q 014363 229 EQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKL 307 (426)
Q Consensus 229 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~ 307 (426)
++..|||+||||++..-..++......-.-..+|||||.+..++|+.++|||||||+|||+++ |..||.+...++....
T Consensus 638 e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~ 717 (774)
T KOG1026|consen 638 ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIEC 717 (774)
T ss_pred cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHH
Confidence 999999999999997665555554434445789999999999999999999999999999999 9999987654433322
Q ss_pred HHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhh
Q 014363 308 LQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 373 (426)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~ 373 (426)
+ ....+ -..+..++.++..||..||+.+|++||++.||-..|.......
T Consensus 718 i----------------~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 718 I----------------RAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred H----------------HcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 2 22233 3456678899999999999999999999999999998765443
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-47 Score=350.86 Aligned_cols=248 Identities=27% Similarity=0.412 Sum_probs=207.3
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
..|+....||+|.||.||+|.+..++. .||+|++.-+. ..+++.+|+.+|.+++++||.++|+.+......
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k-----~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~L- 86 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKK-----VVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKL- 86 (467)
T ss_pred cccccchhccccccceeeeeeeccccc-----eEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccH-
Confidence 357777899999999999999776654 89999986443 456788999999999999999999999887644
Q ss_pred ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccc
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 241 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 241 (426)
+++||||.||++.+.+.... .+.+..+.-|+++++.||.|||.+ +.+|||||+.|||+..+|.+||+|||++
T Consensus 87 ---wiiMey~~gGsv~~lL~~~~--~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa 158 (467)
T KOG0201|consen 87 ---WIIMEYCGGGSVLDLLKSGN--ILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVA 158 (467)
T ss_pred ---HHHHHHhcCcchhhhhccCC--CCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEeccee
Confidence 89999999999999996543 358888888999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhh
Q 014363 242 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 321 (426)
Q Consensus 242 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (426)
........ ...+++||+.|||||++.+..|+.|+||||||++.+||++|.+|+....+.....+ +
T Consensus 159 ~ql~~~~~--rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl-------------I 223 (467)
T KOG0201|consen 159 GQLTNTVK--RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL-------------I 223 (467)
T ss_pred eeeechhh--ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe-------------c
Confidence 87655432 23679999999999999988999999999999999999999999976554211111 1
Q ss_pred hhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 322 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
...-...+...+++.+++++..||+.||+.||++.++++|
T Consensus 224 ----pk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 224 ----PKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred ----cCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 1111222333677889999999999999999999999986
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=359.82 Aligned_cols=263 Identities=25% Similarity=0.413 Sum_probs=207.4
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC---HHHHHHHHHHHhhc-CCCCccceEeEEEccCCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG---HKEWMTEVNFLGIV-EHQNLVKLVGYCADDDER 160 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~~ 160 (426)
++|+..+.||+|+||.||+|.+...+.......||+|.+..... ...+.+|+.+++.+ +||||+++++++...+.
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~- 116 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP- 116 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC-
Confidence 47888999999999999999976655555566799999865432 34578999999999 89999999999987764
Q ss_pred CceEEEEEeeCCCCChhhhccCCC--------------------------------------------------------
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKS-------------------------------------------------------- 184 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~-------------------------------------------------------- 184 (426)
.++||||+++|+|.+++....
T Consensus 117 ---~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 117 ---VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred ---eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 499999999999999875321
Q ss_pred ------------CCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccCCCCCceee
Q 014363 185 ------------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHV 252 (426)
Q Consensus 185 ------------~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 252 (426)
...+++..++.|+.||+.||.|||++ +|+||||||+|||+++++.+||+|||+++..........
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~ 270 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV 270 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence 12478888999999999999999998 999999999999999999999999999976543322222
Q ss_pred eeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCC
Q 014363 253 STAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEG 331 (426)
Q Consensus 253 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (426)
.....++..|+|||++.+..++.++|||||||++|+|++ |..||........ .. .........
T Consensus 271 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~--~~--------------~~~~~~~~~ 334 (374)
T cd05106 271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK--FY--------------KMVKRGYQM 334 (374)
T ss_pred ccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH--HH--------------HHHHcccCc
Confidence 223345678999999998899999999999999999997 9999975432111 10 111111111
Q ss_pred cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhH
Q 014363 332 KYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIV 370 (426)
Q Consensus 332 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~ 370 (426)
..+...+.++.+++.+||+.||++|||+.+|++.|++++
T Consensus 335 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 335 SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 112224578999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-45 Score=358.58 Aligned_cols=263 Identities=26% Similarity=0.395 Sum_probs=204.7
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhc-CCCCccceEeEEEccCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDE 159 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~ 159 (426)
.++|+..+.||+|+||.||+|.+...........||+|.+.... ..+.+.+|+.+|..+ +||||+++++++.+.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 34688899999999999999986543333445679999986433 335688999999999 89999999999988764
Q ss_pred CCceEEEEEeeCCCCChhhhccCCC-------------------------------------------------------
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPKS------------------------------------------------------- 184 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~~------------------------------------------------------- 184 (426)
. ++|||||++|+|.+++....
T Consensus 114 ~----~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 189 (375)
T cd05104 114 T----LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV 189 (375)
T ss_pred c----eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence 4 99999999999999885422
Q ss_pred ------------------CCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccCCC
Q 014363 185 ------------------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPS 246 (426)
Q Consensus 185 ------------------~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 246 (426)
...+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 266 (375)
T cd05104 190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRN 266 (375)
T ss_pred ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccC
Confidence 12478888999999999999999998 999999999999999999999999999986543
Q ss_pred CCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhc
Q 014363 247 EGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIV 325 (426)
Q Consensus 247 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (426)
...........++..|+|||++.+..++.++|||||||++|||++ |..||....... .......
T Consensus 267 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~~~~------------- 331 (375)
T cd05104 267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYKMIK------------- 331 (375)
T ss_pred cccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHHHHH-------------
Confidence 322222223345678999999999999999999999999999998 888986543211 1111111
Q ss_pred CCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHh
Q 014363 326 DPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 369 (426)
Q Consensus 326 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~ 369 (426)
.......+...+.++.+|+.+||+.||++||++.||++.|++.
T Consensus 332 -~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 332 -EGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred -hCccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 0000111122356899999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-46 Score=359.31 Aligned_cols=248 Identities=28% Similarity=0.416 Sum_probs=209.2
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-----CHHHHHHHHHHHhhcCCCCccceEeEEEccC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 158 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 158 (426)
.+-|..++.||.|+-|.|-+|++..+++ ..|||.+.... ....+.+|+.||+.+.||||+++|+++.+..
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGq-----laaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~ 85 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQ-----LAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQ 85 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccc-----eeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCc
Confidence 4568899999999999999999988887 77888876542 3446789999999999999999999998876
Q ss_pred CCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeee
Q 014363 159 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 238 (426)
Q Consensus 159 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 238 (426)
++|+|+||++||.|.+++..++. +++.++.++++||+.|+.|||.. +|+||||||+|+|||..+++||+||
T Consensus 86 ----~lylvlEyv~gGELFdylv~kG~--l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADF 156 (786)
T KOG0588|consen 86 ----HLYLVLEYVPGGELFDYLVRKGP--LPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADF 156 (786)
T ss_pred ----eEEEEEEecCCchhHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeecc
Confidence 45999999999999999976654 99999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCchhhccCCCC-CchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh
Q 014363 239 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLA-ARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 317 (426)
Q Consensus 239 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 317 (426)
|+|.....+ ....+-||+|.|.+||++.+.+|+ .++||||.|||||.||||+.||++..- ..+...++.
T Consensus 157 GMAsLe~~g---klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi---r~LLlKV~~---- 226 (786)
T KOG0588|consen 157 GMASLEVPG---KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI---RVLLLKVQR---- 226 (786)
T ss_pred ceeecccCC---ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH---HHHHHHHHc----
Confidence 999865433 234567999999999999999995 599999999999999999999985322 222211111
Q ss_pred hhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014363 318 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMV 366 (426)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L 366 (426)
-.-..+..++.++.+||.+||..||+.|.|++||++|-
T Consensus 227 -----------G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 227 -----------GVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred -----------CcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence 00123345778999999999999999999999999984
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=356.23 Aligned_cols=265 Identities=29% Similarity=0.470 Sum_probs=213.7
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-----CCHHHHHHHHHHHhhcCCCCccceEeEEEccC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-----GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 158 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 158 (426)
.++-...++||+|+||.||+|..+..+..... .||+|..... ....+|++|+++|++++|||||++||++.+..
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~-~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~ 234 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVV-PVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE 234 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceee-eeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence 34555668999999999999998875432222 2899987642 24568999999999999999999999999887
Q ss_pred CCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeee
Q 014363 159 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 238 (426)
Q Consensus 159 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 238 (426)
.. +||||+|+||+|.++|..... .++..+.+.++.+.+.||+|||++ ++|||||-.+|+|++.++.+||+||
T Consensus 235 Pl----~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDF 306 (474)
T KOG0194|consen 235 PL----MLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDF 306 (474)
T ss_pred cc----EEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCcc
Confidence 55 999999999999999987654 589999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhh
Q 014363 239 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSD 317 (426)
Q Consensus 239 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 317 (426)
|+++.... +........-...|+|||.+..+.|+.++|||||||++||+++ |..||.+.......
T Consensus 307 GLs~~~~~--~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~------------ 372 (474)
T KOG0194|consen 307 GLSRAGSQ--YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVK------------ 372 (474)
T ss_pred ccccCCcc--eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHH------------
Confidence 99986541 1111112235679999999999999999999999999999999 88899875443211
Q ss_pred hhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhhcc
Q 014363 318 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASAE 375 (426)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~~~ 375 (426)
..++........+...+..+..++.+||..||++||+|.++.+.|+.+......
T Consensus 373 ----~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 373 ----AKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred ----HHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 112122222333445677899999999999999999999999999988766443
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=331.08 Aligned_cols=268 Identities=25% Similarity=0.317 Sum_probs=209.9
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHH----HHHHHHHHHhhcCCCCccceEeEEEccCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHK----EWMTEVNFLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~----~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
.+.|+.++.|++|+||.||+|+++.++. .||+|+++-+.... .-.+||.+|.+.+|||||.+-.+.....-
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~e-----IVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~ 149 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDE-----IVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNM 149 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcce-----eEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccc
Confidence 3467888899999999999999887765 89999987654332 35799999999999999999988876654
Q ss_pred CCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeec
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 239 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 239 (426)
. .+|||||||+. +|..+++... +.+...++..+..|++.||+|||.+ .|+|||||++|+|++..|.+||+|||
T Consensus 150 d--~iy~VMe~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFG 222 (419)
T KOG0663|consen 150 D--KIYIVMEYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFG 222 (419)
T ss_pred c--eeeeeHHHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccc
Confidence 4 46999999966 9999988655 5689999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhH-------
Q 014363 240 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWV------- 311 (426)
Q Consensus 240 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~------- 311 (426)
+|+.+.... ...+..+-|.+|.|||++.+. .|+.++|+||+|||+.||+++++-|.+.........+-..
T Consensus 223 LAR~ygsp~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~ 300 (419)
T KOG0663|consen 223 LAREYGSPL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEA 300 (419)
T ss_pred hhhhhcCCc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccc
Confidence 999887652 224557889999999988875 5999999999999999999999999876544333222111
Q ss_pred -hhhhhhhhh-----hhhhcCCcCCCcccHH-HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 312 -KPYLSDAKQ-----FRQIVDPRLEGKYSLR-LVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 312 -~~~~~~~~~-----~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
++.+..... +.+..-..+...+... +++.-.+|+..+|..||.+|.|+.|.|++
T Consensus 301 iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 301 IWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred cCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 111111110 0111111222223322 55778899999999999999999999987
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=339.02 Aligned_cols=248 Identities=22% Similarity=0.344 Sum_probs=198.4
Q ss_pred ceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC-----HHHHHHHHHHHhhcCCCCccceEeEEEccCCCCceEE
Q 014363 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG-----HKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRL 165 (426)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~-----~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~~~ 165 (426)
..||+|++|.||+|.+.+ ..||+|.+..... .+.+.+|+.+|.+++||||++++|++.+........+
T Consensus 26 ~~i~~g~~~~v~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~ 98 (283)
T PHA02988 26 VLIKENDQNSIYKGIFNN-------KEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLS 98 (283)
T ss_pred eEEeeCCceEEEEEEECC-------EEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceE
Confidence 579999999999998743 2799998865431 3567799999999999999999999977222222468
Q ss_pred EEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccCC
Q 014363 166 LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGP 245 (426)
Q Consensus 166 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 245 (426)
+||||+++|+|.+++... ..+++...+.++.|++.||.|||+. .+++||||||+|||+++++.+||+|||+++...
T Consensus 99 lv~Ey~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~ 174 (283)
T PHA02988 99 LILEYCTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILS 174 (283)
T ss_pred EEEEeCCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhc
Confidence 999999999999999754 3488999999999999999999973 278899999999999999999999999998654
Q ss_pred CCCceeeeeeeecCcccCCchhhcc--CCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhh
Q 014363 246 SEGFTHVSTAVVGTMGYAAPEYVQT--GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQ 323 (426)
Q Consensus 246 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (426)
... ....|+..|+|||++.+ ..++.++|||||||++|||++|..||.......... .
T Consensus 175 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~----------------~ 233 (283)
T PHA02988 175 SPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYD----------------L 233 (283)
T ss_pred ccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHH----------------H
Confidence 321 23468899999999876 679999999999999999999999998654321111 1
Q ss_pred hcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhH
Q 014363 324 IVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIV 370 (426)
Q Consensus 324 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~ 370 (426)
+.........+..++..+.+++.+||+.||++|||++||++.|+.+.
T Consensus 234 i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 234 IINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred HHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 11111111222346678999999999999999999999999998764
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=340.22 Aligned_cols=260 Identities=25% Similarity=0.455 Sum_probs=210.1
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC---HHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG---HKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
++|+..+.||+|+||.||+|.............+++|.+..... ...+.+|+.++..++||||+++++++.+...
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~-- 82 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQP-- 82 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCc--
Confidence 36888889999999999999987765555566899998865432 3468899999999999999999999887653
Q ss_pred ceEEEEEeeCCCCChhhhccCCCC--------------CccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEe
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSE--------------TILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL 227 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~--------------~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl 227 (426)
.+++|||+++++|.+++..... ..+++..++.++.|++.||.|||++ +++|+||||+|||+
T Consensus 83 --~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~ 157 (283)
T cd05048 83 --TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLV 157 (283)
T ss_pred --eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEE
Confidence 4899999999999999864321 4578899999999999999999998 99999999999999
Q ss_pred CCCCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHH
Q 014363 228 DEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQK 306 (426)
Q Consensus 228 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~ 306 (426)
++++.+||+|||++................+++.|+|||++.+..++.++|||||||++|||++ |..||.........
T Consensus 158 ~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~- 236 (283)
T cd05048 158 GEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVI- 236 (283)
T ss_pred cCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH-
Confidence 9999999999999976543322222334567889999999988899999999999999999998 99999765432211
Q ss_pred HHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 014363 307 LLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNK 368 (426)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~ 368 (426)
.. +........+..++.++.+|+.+||+.||++||+++||+++|++
T Consensus 237 --~~--------------i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 237 --EM--------------IRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred --HH--------------HHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 11 11111112334567899999999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=341.96 Aligned_cols=266 Identities=25% Similarity=0.451 Sum_probs=203.0
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCC-----------CCcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCCccce
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSED-----------PSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQNLVKL 150 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~-----------~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~ 150 (426)
++|.+.+.||+|+||.||+|.+..... ......||+|.+.... ....+.+|+.+|..++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 578889999999999999998754321 1233468999886543 23468899999999999999999
Q ss_pred EeEEEccCCCCceEEEEEeeCCCCChhhhccCCC-----------------CCccCHHHHHHHHHHHHHHHHHhccCCCC
Q 014363 151 VGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKS-----------------ETILTWAMRLKIAQDAARGLAYLHEGMDF 213 (426)
Q Consensus 151 ~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-----------------~~~~~~~~~~~i~~~i~~aL~~LH~~~~~ 213 (426)
++++.+.+. .++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+.
T Consensus 85 ~~~~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~--- 157 (304)
T cd05096 85 LGVCVDEDP----LCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL--- 157 (304)
T ss_pred EEEEecCCc----eEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---
Confidence 999987654 499999999999999885321 12467888999999999999999998
Q ss_pred CeEeccCCCCceEeCCCCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh--
Q 014363 214 QIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-- 291 (426)
Q Consensus 214 ~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-- 291 (426)
+|+||||||+|||++.++.+||+|||+++...............++..|+|||++.++.++.++||||||+++|||++
T Consensus 158 ~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~ 237 (304)
T cd05096 158 NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC 237 (304)
T ss_pred CccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHcc
Confidence 999999999999999999999999999986543332222334456889999999988899999999999999999987
Q ss_pred CCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014363 292 GRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVN 367 (426)
Q Consensus 292 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~ 367 (426)
+..||....... ............. .......+..++..+.+|+.+||+.||++|||+.+|.+.|+
T Consensus 238 ~~~p~~~~~~~~---~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 238 KEQPYGELTDEQ---VIENAGEFFRDQG-------RQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCCCCcCCHHH---HHHHHHHHhhhcc-------ccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 567776543221 1111111110000 00001111234568999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-45 Score=343.04 Aligned_cols=251 Identities=26% Similarity=0.424 Sum_probs=201.6
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-----CHHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
.|+..+.||+|+||.||+|.+..++. .||+|.+.... ....+.+|+.++..++|+||+++++++.+.+
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~-----~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~-- 73 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGK-----MYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKD-- 73 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCc-----eEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCC--
Confidence 37778899999999999999876654 78999875332 2345778999999999999999999988765
Q ss_pred CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecc
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 240 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 240 (426)
..++||||+++|+|.+++.......+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 74 --~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~ 148 (285)
T cd05631 74 --ALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGL 148 (285)
T ss_pred --eEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCC
Confidence 359999999999999888654444589999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhh
Q 014363 241 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 320 (426)
Q Consensus 241 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (426)
+....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.............
T Consensus 149 ~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~----------- 214 (285)
T cd05631 149 AVQIPEGE---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVD----------- 214 (285)
T ss_pred cEEcCCCC---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHH-----------
Confidence 98654321 1234579999999999999999999999999999999999999997654322111110
Q ss_pred hhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 014363 321 FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPK-----MSEVLEM 365 (426)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~eil~~ 365 (426)
..+. .....++..++..+.+|+.+||+.||++||+ +++++++
T Consensus 215 -~~~~--~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 215 -RRVK--EDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred -HHhh--cccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 0000 0111233345678999999999999999997 8888886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=346.49 Aligned_cols=264 Identities=28% Similarity=0.364 Sum_probs=204.8
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
.++|+..+.||+|+||.||++.+..++. .+|+|.+.... ....+.+|+++|+.++||||+++++++.+.+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 76 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGL-----IMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-- 76 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCc-----EEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC--
Confidence 3689999999999999999999876654 78888876442 2356889999999999999999999998765
Q ss_pred CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecc
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 240 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 240 (426)
..++||||+++++|.+++.... .+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||+
T Consensus 77 --~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 150 (331)
T cd06649 77 --EISICMEHMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGV 150 (331)
T ss_pred --EEEEEeecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCcc
Confidence 4599999999999999996543 488999999999999999999975 1699999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh---
Q 014363 241 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD--- 317 (426)
Q Consensus 241 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--- 317 (426)
+....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.............. +....
T Consensus 151 ~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~--~~~~~~~~ 224 (331)
T cd06649 151 SGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGR--PVVDGEEG 224 (331)
T ss_pred cccccccc----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcc--cccccccC
Confidence 87553321 2345799999999999998999999999999999999999999975443222111100 00000
Q ss_pred -----------------------------hhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014363 318 -----------------------------AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMV 366 (426)
Q Consensus 318 -----------------------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L 366 (426)
......+............++.++.+|+.+||+.||++|||+.+|+++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 225 EPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred CccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 0000001111111111123567899999999999999999999999974
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-45 Score=344.61 Aligned_cols=244 Identities=26% Similarity=0.375 Sum_probs=200.5
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-----CHHHHHHHHHHHhhcCCCCccceEeEEEccCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
++|+..+.||+|+||.||+|.+..++. .+|+|.+.... ..+.+.+|+.+++.++||||+++++++.+..
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~-----~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~- 74 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEH-----YYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQR- 74 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCC-----EEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCC-
Confidence 368889999999999999999876654 78999875432 3346788999999999999999999887755
Q ss_pred CCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeec
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 239 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 239 (426)
..|+||||+++|+|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 75 ---~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg 146 (291)
T cd05612 75 ---FLYMLMEYVPGGELFSYLRNSG--RFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFG 146 (291)
T ss_pred ---eEEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecC
Confidence 4599999999999999996543 488999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014363 240 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 319 (426)
Q Consensus 240 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 319 (426)
++...... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||..........
T Consensus 147 ~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~------------- 208 (291)
T cd05612 147 FAKKLRDR-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYE------------- 208 (291)
T ss_pred cchhccCC-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-------------
Confidence 99865432 224579999999999998889999999999999999999999997654321111
Q ss_pred hhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 014363 320 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPK-----MSEVLEM 365 (426)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~eil~~ 365 (426)
.+.... ..++...+..+.+++.+||+.||.+||+ ++++++|
T Consensus 209 ---~i~~~~--~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 209 ---KILAGK--LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred ---HHHhCC--cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 111111 1122334568899999999999999995 8999887
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-44 Score=347.18 Aligned_cols=247 Identities=26% Similarity=0.393 Sum_probs=192.5
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
.+|+.++.||+|+||.||+|.+..++. .|++|.+.... ....+.+|+++++.++|+||+++++++.+.+
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--- 145 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGR-----LYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNG--- 145 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCC-----EEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCC---
Confidence 356677889999999999999876554 79999885443 2356889999999999999999999997765
Q ss_pred ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccc
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 241 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 241 (426)
..++||||+++|+|.+.. ...+..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 146 -~~~lv~e~~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~ 215 (353)
T PLN00034 146 -EIQVLLEFMDGGSLEGTH------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVS 215 (353)
T ss_pred -eEEEEEecCCCCcccccc------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccc
Confidence 359999999999997643 256777889999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCchhhcc-----CCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhh
Q 014363 242 RLGPSEGFTHVSTAVVGTMGYAAPEYVQT-----GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS 316 (426)
Q Consensus 242 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 316 (426)
....... .......||..|+|||++.. ...+.++|||||||++|||++|+.||..........+....
T Consensus 216 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~----- 288 (353)
T PLN00034 216 RILAQTM--DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAI----- 288 (353)
T ss_pred eeccccc--ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHH-----
Confidence 8654321 11234579999999998743 22356899999999999999999999743322111111100
Q ss_pred hhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 317 DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
. ..........++..+.+||.+||+.||++||++.||+++
T Consensus 289 --------~-~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 289 --------C-MSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred --------h-ccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 000111223456789999999999999999999999997
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=348.20 Aligned_cols=265 Identities=27% Similarity=0.398 Sum_probs=208.4
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC---HHHHHHHHHHHhhc-CCCCccceEeEEEccCCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG---HKEWMTEVNFLGIV-EHQNLVKLVGYCADDDER 160 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~~ 160 (426)
++|++.++||+|+||.||+|...+.+.....+.||+|.+..... .+.+..|+.++.++ +||||+++++++...+.
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~- 85 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG- 85 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC-
Confidence 46889999999999999999876655555567899999865432 34577899999999 89999999998876543
Q ss_pred CceEEEEEeeCCCCChhhhccCCC--------------------------------------------------------
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKS-------------------------------------------------------- 184 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~-------------------------------------------------------- 184 (426)
..+++|||+++++|.+++....
T Consensus 86 --~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 86 --PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred --CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 3589999999999999885321
Q ss_pred ---CCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccCCCCCceeeeeeeecCcc
Q 014363 185 ---ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMG 261 (426)
Q Consensus 185 ---~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~ 261 (426)
...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++................++..
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 240 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence 12578999999999999999999998 999999999999999999999999999986543221122223456778
Q ss_pred cCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHH
Q 014363 262 YAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSK 340 (426)
Q Consensus 262 y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (426)
|+|||++.+..++.++|||||||++|||++ |..||........ +... +........+...+..
T Consensus 241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~--~~~~--------------~~~~~~~~~~~~~~~~ 304 (337)
T cd05054 241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--FCRR--------------LKEGTRMRAPEYATPE 304 (337)
T ss_pred ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH--HHHH--------------HhccCCCCCCccCCHH
Confidence 999999999999999999999999999998 9999975432211 1110 0000111112234568
Q ss_pred HHHHHHhccccCCCCCCCHHHHHHHHHHhHh
Q 014363 341 LSHVANLCLVKNARTRPKMSEVLEMVNKIVD 371 (426)
Q Consensus 341 l~~li~~cl~~dp~~RPs~~eil~~L~~~~~ 371 (426)
+.+++.+||+.+|++||++.||+++|+.++.
T Consensus 305 ~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 305 IYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=350.56 Aligned_cols=239 Identities=25% Similarity=0.434 Sum_probs=201.0
Q ss_pred cceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCceEEEEEe
Q 014363 90 SVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYE 169 (426)
Q Consensus 90 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~~~lv~E 169 (426)
++-||.|+.|.||+|+.++. .||||+++.- -..+|+-|++|+||||+.+.|+|.... .+|||||
T Consensus 129 LeWlGSGaQGAVF~Grl~ne-------tVAVKKV~el-----kETdIKHLRkLkH~NII~FkGVCtqsP----cyCIiME 192 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLHNE-------TVAVKKVREL-----KETDIKHLRKLKHPNIITFKGVCTQSP----CYCIIME 192 (904)
T ss_pred hhhhccCcccceeeeeccCc-------eehhHHHhhh-----hhhhHHHHHhccCcceeeEeeeecCCc----eeEEeee
Confidence 45699999999999998765 7999987532 246899999999999999999998766 4599999
Q ss_pred eCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccCCCCCc
Q 014363 170 YMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGF 249 (426)
Q Consensus 170 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 249 (426)
||..|-|...|+.. ..+.......+.++||.|++|||.+ .|||||||.-||||..+..|||+|||.++.....
T Consensus 193 fCa~GqL~~VLka~--~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-- 265 (904)
T KOG4721|consen 193 FCAQGQLYEVLKAG--RPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK-- 265 (904)
T ss_pred ccccccHHHHHhcc--CccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh--
Confidence 99999999999654 4488888999999999999999998 9999999999999999999999999999866543
Q ss_pred eeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCCcC
Q 014363 250 THVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRL 329 (426)
Q Consensus 250 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (426)
...-.++||..|||||++.+.+.++|+|||||||+|||||||..||...... ..+-.+=...+
T Consensus 266 -STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss----------------AIIwGVGsNsL 328 (904)
T KOG4721|consen 266 -STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS----------------AIIWGVGSNSL 328 (904)
T ss_pred -hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh----------------eeEEeccCCcc
Confidence 1234689999999999999999999999999999999999999999643211 00111112233
Q ss_pred CCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 014363 330 EGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNK 368 (426)
Q Consensus 330 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~ 368 (426)
.-..+..+++.++-|+++||+..|.+||++.+|+.||+.
T Consensus 329 ~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 329 HLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred cccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 444566788899999999999999999999999999974
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=348.93 Aligned_cols=245 Identities=25% Similarity=0.390 Sum_probs=201.5
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-----CCHHHHHHHHHHHhhcCCCCccceEeEEEccC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-----GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 158 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 158 (426)
.++|.+.+.||+|+||.||+|.++.++. .+|+|.+... ...+.+.+|+.+++.++||||+++++++.+.+
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 91 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGE-----YYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDEN 91 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCC-----EEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCC
Confidence 3578899999999999999999877654 7899987543 23356789999999999999999999998766
Q ss_pred CCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeee
Q 014363 159 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 238 (426)
Q Consensus 159 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 238 (426)
..|+||||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 92 ----~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Df 162 (329)
T PTZ00263 92 ----RVYFLLEFVVGGELFTHLRKAG--RFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDF 162 (329)
T ss_pred ----EEEEEEcCCCCChHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeec
Confidence 4599999999999999987543 488999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014363 239 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 318 (426)
Q Consensus 239 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 318 (426)
|++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.........
T Consensus 163 g~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~------------- 224 (329)
T PTZ00263 163 GFAKKVPDR-----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIY------------- 224 (329)
T ss_pred cCceEcCCC-----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHH-------------
Confidence 999865432 12357999999999999999999999999999999999999999754332111
Q ss_pred hhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 014363 319 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPK-----MSEVLEM 365 (426)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~eil~~ 365 (426)
..+....+ .++..++..+.+|+.+||+.||++||+ +++++.|
T Consensus 225 ---~~i~~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 225 ---EKILAGRL--KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred ---HHHhcCCc--CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 11111111 122234567899999999999999997 7888876
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-45 Score=330.59 Aligned_cols=270 Identities=24% Similarity=0.316 Sum_probs=211.0
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc----CCHHHHHHHHHHHhhcCCCCccceEeEEEc-cC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR----GGHKEWMTEVNFLGIVEHQNLVKLVGYCAD-DD 158 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~ 158 (426)
...|..++.||+|+||.|..|.++.++. .||+|++.+. ...++..+|+++|+.++|+||+.+++++.. ..
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~-----~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~ 95 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGE-----KVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSR 95 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCC-----EeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccc
Confidence 4567778899999999999999888764 8999988632 345678899999999999999999999876 22
Q ss_pred CCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeee
Q 014363 159 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 238 (426)
Q Consensus 159 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 238 (426)
......|+|+|+| +.+|...|+.. ..++...+..++.|++.||.|+|+. +|+||||||.|+|++.++.+||+||
T Consensus 96 ~~f~DvYiV~elM-etDL~~iik~~--~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DF 169 (359)
T KOG0660|consen 96 DKFNDVYLVFELM-ETDLHQIIKSQ--QDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDF 169 (359)
T ss_pred cccceeEEehhHH-hhHHHHHHHcC--ccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccc
Confidence 2234569999999 77999999654 3499999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCchhhc-cCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh
Q 014363 239 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQ-TGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 317 (426)
Q Consensus 239 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 317 (426)
|+|+...........+..+.|.+|.|||++. ...|+.+.||||+|||+.||++|++-|.+.+......++.....-. .
T Consensus 170 GLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP-~ 248 (359)
T KOG0660|consen 170 GLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTP-S 248 (359)
T ss_pred cceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCC-C
Confidence 9999875433333456788999999999765 4679999999999999999999999998876554444433221100 0
Q ss_pred hhh--------hhhhc---CCcCCCccc---HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 318 AKQ--------FRQIV---DPRLEGKYS---LRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 318 ~~~--------~~~~~---~~~~~~~~~---~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.+. ....+ .......+. ....+...+|+.+||..||.+|+|++|+|+|
T Consensus 249 ~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 249 EEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000 00111 111111111 1445788899999999999999999999997
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-44 Score=341.17 Aligned_cols=262 Identities=26% Similarity=0.437 Sum_probs=207.0
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
.+|+..+.||+|+||.||+|.+...+. .....|++|.+.... ..+.+.+|+.+++.++||||++++|++....
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~~--- 82 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGE-KVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST--- 82 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCC-ccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCCC---
Confidence 468999999999999999999766443 234568999886433 3457889999999999999999999997643
Q ss_pred ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccc
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 241 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 241 (426)
.++|+||+++|+|.+++.... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 83 --~~~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a 156 (316)
T cd05108 83 --VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLA 156 (316)
T ss_pred --ceeeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccc
Confidence 379999999999999997543 3488899999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhh
Q 014363 242 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 320 (426)
Q Consensus 242 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (426)
+...............++..|+|||++.+..++.++||||||+++|||++ |..||...........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~------------- 223 (316)
T cd05108 157 KLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI------------- 223 (316)
T ss_pred ccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-------------
Confidence 87654322222223345678999999999999999999999999999998 9999975432211111
Q ss_pred hhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhh
Q 014363 321 FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 373 (426)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~ 373 (426)
+........+..++..+.+++.+||+.||++||++.+++..|..+....
T Consensus 224 ----~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 224 ----LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred ----HhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 0000111111224457889999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=346.91 Aligned_cols=241 Identities=26% Similarity=0.369 Sum_probs=196.3
Q ss_pred ceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-----CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCceEE
Q 014363 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRL 165 (426)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~~~ 165 (426)
++||+|+||.||+|..+.++. .+|+|.+.... ....+.+|+.++..++||||+++++++...+ ..|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~-----~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~----~~~ 71 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGK-----YYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHD----RLC 71 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCC-----EEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCC----EEE
Confidence 369999999999999876654 79999886432 2345778999999999999999999998766 459
Q ss_pred EEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccCC
Q 014363 166 LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGP 245 (426)
Q Consensus 166 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 245 (426)
+||||+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 72 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~ 146 (323)
T cd05571 72 FVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 146 (323)
T ss_pred EEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccc
Confidence 999999999999998654 3489999999999999999999998 99999999999999999999999999987533
Q ss_pred CCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhc
Q 014363 246 SEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIV 325 (426)
Q Consensus 246 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (426)
... ......+||+.|+|||++.+..++.++|||||||++|||++|..||........... +.
T Consensus 147 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~----------------~~ 208 (323)
T cd05571 147 SDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL----------------IL 208 (323)
T ss_pred cCC--CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHH----------------HH
Confidence 221 123356799999999999999999999999999999999999999975432211110 11
Q ss_pred CCcCCCcccHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 014363 326 DPRLEGKYSLRLVSKLSHVANLCLVKNARTRP-----KMSEVLEM 365 (426)
Q Consensus 326 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~ 365 (426)
... ..++..++..+.+++.+||+.||++|| ++.++++|
T Consensus 209 ~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 209 MEE--IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred cCC--CCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 010 122334567899999999999999999 89999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=338.41 Aligned_cols=266 Identities=23% Similarity=0.291 Sum_probs=201.5
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
++|++.+.||+|+||.||+|.++.++. .+|+|.+.... ..+.+.+|+.+++.++||||+++++++...+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~-----~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 73 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKE-----IVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRG-- 73 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCc-----EEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCC--
Confidence 468999999999999999999876654 78888875432 3456789999999999999999999997765
Q ss_pred CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecc
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 240 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 240 (426)
..|+||||++++.+..+... ...+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 74 --~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~ 146 (287)
T cd07848 74 --KLYLVFEYVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGF 146 (287)
T ss_pred --EEEEEEecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccC
Confidence 45999999998877665532 23489999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHh-hhh----
Q 014363 241 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK-PYL---- 315 (426)
Q Consensus 241 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~-~~~---- 315 (426)
+........ .......|++.|+|||++.+..++.++|||||||++|+|++|+.||...........+.... +..
T Consensus 147 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 225 (287)
T cd07848 147 ARNLSEGSN-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQM 225 (287)
T ss_pred ccccccccc-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHH
Confidence 986543221 11234578999999999998899999999999999999999999997654332211111110 000
Q ss_pred ---hhhhhhhhhcCCcC------CCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 316 ---SDAKQFRQIVDPRL------EGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 316 ---~~~~~~~~~~~~~~------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
...........+.. ...+...++..+.+|+.+||+.||++|||++|+++|
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 226 KLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred HhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000000000000 011112356789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=347.44 Aligned_cols=252 Identities=25% Similarity=0.396 Sum_probs=203.7
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-----CCHHHHHHHHHHHhhcCCCCccceEeEEEccCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-----GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
++|++.+.||+|+||.||+|.+..++. .||+|.+... .....+..|+.++..++||||+++++++.+..
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~- 74 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGE-----IVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDE- 74 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCC-----EEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCC-
Confidence 468999999999999999999876654 7999988643 23356789999999999999999999998765
Q ss_pred CCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeec
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 239 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 239 (426)
..|+||||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 75 ---~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg 146 (333)
T cd05600 75 ---YLYLAMEYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFG 146 (333)
T ss_pred ---EEEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCc
Confidence 459999999999999999644 3488999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014363 240 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 319 (426)
Q Consensus 240 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 319 (426)
++..... ......||+.|+|||++.+..++.++|||||||++|||++|..||...........+..
T Consensus 147 ~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~--------- 212 (333)
T cd05600 147 LSKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKY--------- 212 (333)
T ss_pred CCccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHh---------
Confidence 9975433 23346799999999999999999999999999999999999999976543322111110
Q ss_pred hhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 320 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
................++.++.+++.+||..+|++||++.+++++
T Consensus 213 -~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 213 -WKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred -ccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 000111111111112356789999999999999999999999987
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-44 Score=351.32 Aligned_cols=264 Identities=23% Similarity=0.375 Sum_probs=208.0
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcC-CCCccceEeEEEccCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVE-HQNLVKLVGYCADDDE 159 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~-HpnIv~~~~~~~~~~~ 159 (426)
.++|.++++||+|+||.||+|.+...........||+|.+.... ..+.+.+|+.+|..+. ||||+++++++.+...
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 56788999999999999999997655444455679999986543 2356889999999995 9999999999987653
Q ss_pred CCceEEEEEeeCCCCChhhhccCCC-------------------------------------------------------
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPKS------------------------------------------------------- 184 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~~------------------------------------------------------- 184 (426)
.|||||||++|+|.+++....
T Consensus 116 ----~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (400)
T cd05105 116 ----IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM 191 (400)
T ss_pred ----eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence 599999999999998875321
Q ss_pred ---------------------------------------CCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCce
Q 014363 185 ---------------------------------------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNI 225 (426)
Q Consensus 185 ---------------------------------------~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NI 225 (426)
...+++..++.++.|++.||+|||+. +|+||||||+||
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Ni 268 (400)
T cd05105 192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNV 268 (400)
T ss_pred hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhE
Confidence 12377888899999999999999998 999999999999
Q ss_pred EeCCCCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhh
Q 014363 226 LLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSE 304 (426)
Q Consensus 226 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~ 304 (426)
|++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus 269 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~- 347 (400)
T cd05105 269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS- 347 (400)
T ss_pred EEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH-
Confidence 999999999999999986543222222233457788999999998899999999999999999997 999987532211
Q ss_pred HHHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhH
Q 014363 305 QKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIV 370 (426)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~ 370 (426)
.... .+........+..++..+.+++.+||+.||++||++.+|.+.|+.++
T Consensus 348 -~~~~--------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 348 -TFYN--------------KIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred -HHHH--------------HHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 1100 00001111122345678999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=344.77 Aligned_cols=259 Identities=27% Similarity=0.452 Sum_probs=206.4
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
.+.+.+...||+|.||+||+|.|.+ .||||.+.-.. ..+.|.+|+.++++-+|.||+-++|||..+..
T Consensus 391 ~~ev~l~~rIGsGsFGtV~Rg~whG--------dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 391 PEEVLLGERIGSGSFGTVYRGRWHG--------DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred HHHhhccceeccccccceeeccccc--------ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 3445667789999999999999987 59999986543 45679999999999999999999999988763
Q ss_pred CCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeec
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 239 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 239 (426)
.||..+|+|.+|+.+|+... ..|.....+.|++||++|+.|||.+ +|||||||..||++.+++.|||+|||
T Consensus 463 -----AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFG 533 (678)
T KOG0193|consen 463 -----AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFG 533 (678)
T ss_pred -----eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEeccc
Confidence 79999999999999998654 4589999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCchhhcc---CCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhh
Q 014363 240 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQT---GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS 316 (426)
Q Consensus 240 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 316 (426)
|+..-..-..........|...|||||+++. .+|+..+||||||+++|||++|..||..... ++.+..
T Consensus 534 Latvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~--dqIifm------- 604 (678)
T KOG0193|consen 534 LATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR--DQIIFM------- 604 (678)
T ss_pred ceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh--hheEEE-------
Confidence 9974322111122234568889999999874 4689999999999999999999999983221 111100
Q ss_pred hhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 014363 317 DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 372 (426)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~ 372 (426)
.+ +..+.+++ ......++.++++|+..||..++++||.+.+|+..|+.++..
T Consensus 605 VG---rG~l~pd~-s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 605 VG---RGYLMPDL-SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred ec---ccccCccc-hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 00 00000111 112235778999999999999999999999999999888754
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=362.36 Aligned_cols=263 Identities=24% Similarity=0.338 Sum_probs=211.6
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc--CCHHHHHHHHHHHhhcC-CCCccceEe-EEEcc-C
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR--GGHKEWMTEVNFLGIVE-HQNLVKLVG-YCADD-D 158 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~E~~~l~~l~-HpnIv~~~~-~~~~~-~ 158 (426)
..++++.++|.+|||+.||+|.+...+ +.+|+|++-.. .....+.+|+.+|++|. |+|||.+++ ..... .
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~-----~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~ 110 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGG-----KKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSS 110 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCC-----ceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccC
Confidence 346788899999999999999987764 47899987433 34567889999999995 999999999 33322 2
Q ss_pred CC-CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEee
Q 014363 159 ER-GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 237 (426)
Q Consensus 159 ~~-~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~D 237 (426)
.. ..+.+|+||||.||.|-|++..+-...|++.++++|+.|+++|+.+||.. ..+|||||||-+||||+.+|..||||
T Consensus 111 ~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCD 189 (738)
T KOG1989|consen 111 NNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCD 189 (738)
T ss_pred CCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCc
Confidence 22 35678999999999999999876666699999999999999999999986 56799999999999999999999999
Q ss_pred ecccccCCCCCcee-------eeeeeecCcccCCchhhc---cCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHH
Q 014363 238 FGLARLGPSEGFTH-------VSTAVVGTMGYAAPEYVQ---TGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKL 307 (426)
Q Consensus 238 FGla~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~ 307 (426)
||.+.......... ..-...-|+.|.|||++. +.+.++|+|||||||+||-||....||+....
T Consensus 190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~------ 263 (738)
T KOG1989|consen 190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK------ 263 (738)
T ss_pred ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc------
Confidence 99987432211000 011235689999999764 66789999999999999999999999986422
Q ss_pred HHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 014363 308 LQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 372 (426)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~ 372 (426)
..+++....-.....++..|.+||..||+.||++||++-+++..+.++...
T Consensus 264 --------------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 264 --------------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred --------------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 234444333333457889999999999999999999999999999887643
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-44 Score=334.28 Aligned_cols=259 Identities=26% Similarity=0.445 Sum_probs=207.5
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC---HHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG---HKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
++|.+.+.||+|+||.||+|.+...........+++|.+..... .+.+.+|+++|..++||||+++++++....
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--- 81 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGD--- 81 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCC---
Confidence 46788889999999999999886654444556899999865433 357899999999999999999999998765
Q ss_pred ceEEEEEeeCCCCChhhhccCCC------------CCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCC
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKS------------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE 229 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~------------~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~ 229 (426)
..++||||+++++|.+++...+ ...+++..+..++.|++.||.|||++ +++||||||+|||++.
T Consensus 82 -~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~ 157 (280)
T cd05049 82 -PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGY 157 (280)
T ss_pred -CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcC
Confidence 3599999999999999986432 23478899999999999999999998 9999999999999999
Q ss_pred CCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHH
Q 014363 230 QWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLL 308 (426)
Q Consensus 230 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~ 308 (426)
++.+||+|||++................+++.|+|||++.+..++.++||||||+++|||++ |..||...........+
T Consensus 158 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~ 237 (280)
T cd05049 158 DLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECI 237 (280)
T ss_pred CCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 99999999999975433222222233456789999999999999999999999999999998 99999754432211111
Q ss_pred HhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014363 309 QWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVN 367 (426)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~ 367 (426)
. . ......+...+..+.+++.+||+.||++||++.||++.|+
T Consensus 238 ~----------------~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 238 T----------------Q-GRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred H----------------c-CCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 0 0 0011112235678999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-45 Score=346.44 Aligned_cols=252 Identities=26% Similarity=0.399 Sum_probs=213.9
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
.++|..++++|+|+||.+++++++.... .+++|.+.-.. ......+|+.+++++.|||||.+++.|.+++.
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~-----~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~ 77 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDK-----LYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQ 77 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCc-----eEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCc
Confidence 3578899999999999999998877654 78888774332 23467899999999999999999999988774
Q ss_pred CCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeec
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 239 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 239 (426)
..+|||+||+||+|.+.|.......+++..+..++.|++.||+|||++ +|+|||||+.||+++.++.|||+|||
T Consensus 78 ---~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfG 151 (426)
T KOG0589|consen 78 ---LLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFG 151 (426)
T ss_pred ---eEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchh
Confidence 259999999999999999877777899999999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014363 240 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 319 (426)
Q Consensus 240 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 319 (426)
+|+...... ....+.+||+.||.||++.+.+|+.|+|||||||++|||++-+++|...+... ++.
T Consensus 152 laK~l~~~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~---Li~---------- 216 (426)
T KOG0589|consen 152 LAKILNPED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE---LIL---------- 216 (426)
T ss_pred hhhhcCCch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH---HHH----------
Confidence 999876543 23456899999999999999999999999999999999999999998654321 111
Q ss_pred hhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 320 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
+++ +......+..++.++..++..||+.+|+.||++.++|.+
T Consensus 217 ---ki~-~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 217 ---KIN-RGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ---HHh-hccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 111 112334556678899999999999999999999999986
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=345.88 Aligned_cols=246 Identities=25% Similarity=0.378 Sum_probs=201.2
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-----CCHHHHHHHHHHHhhcCCCCccceEeEEEccC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-----GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 158 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 158 (426)
.++|...+.||+|+||.||+|.++..+. ..||+|.+... ...+.+.+|+.++..++||||+++++++.+..
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~ 104 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDF----PPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES 104 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCC----eEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence 3478999999999999999998765431 26899987532 23456788999999999999999999998765
Q ss_pred CCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeee
Q 014363 159 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 238 (426)
Q Consensus 159 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 238 (426)
..|+||||+++|+|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+||
T Consensus 105 ----~~~lv~Ey~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DF 175 (340)
T PTZ00426 105 ----YLYLVLEFVIGGEFFTFLRRNK--RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDF 175 (340)
T ss_pred ----EEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecC
Confidence 4599999999999999996543 489999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014363 239 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 318 (426)
Q Consensus 239 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 318 (426)
|++...... .....||+.|+|||++.+..++.++|||||||++|||++|..||....+.....
T Consensus 176 G~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~------------ 238 (340)
T PTZ00426 176 GFAKVVDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQ------------ 238 (340)
T ss_pred CCCeecCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHH------------
Confidence 999865432 234679999999999998889999999999999999999999997654321111
Q ss_pred hhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 014363 319 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRP-----KMSEVLEM 365 (426)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~ 365 (426)
.+..... .++...+..+.+++.+||+.||++|+ ++++++++
T Consensus 239 ----~i~~~~~--~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 239 ----KILEGII--YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ----HHhcCCC--CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 1111111 12233456788999999999999995 89999886
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=334.42 Aligned_cols=266 Identities=26% Similarity=0.410 Sum_probs=200.7
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
.++|...+.||.|+||.||+|..+.++. .||+|.+.... ....+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-- 76 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTEN-----LVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTER-- 76 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCC-----EEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCC--
Confidence 3579999999999999999999876654 78999875332 3346789999999999999999999987765
Q ss_pred CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecc
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 240 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 240 (426)
..++||||+++ +|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 77 --~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~ 149 (288)
T cd07871 77 --CLTLVFEYLDS-DLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGL 149 (288)
T ss_pred --eEEEEEeCCCc-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcc
Confidence 45999999975 8988886443 3478899999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHh-------
Q 014363 241 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK------- 312 (426)
Q Consensus 241 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~------- 312 (426)
+....... .......|++.|+|||++.+ ..++.++|||||||++|+|++|..||...........+....
T Consensus 150 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 227 (288)
T cd07871 150 ARAKSVPT--KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEET 227 (288)
T ss_pred eeeccCCC--ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHH
Confidence 97543221 11234568999999998865 568999999999999999999999997655433322211100
Q ss_pred -hhhhhhhhhhhhcCCcCCCc----ccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 313 -PYLSDAKQFRQIVDPRLEGK----YSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 313 -~~~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
+.......+.....+..... .....+.++.+|+.+||+.||.+|||++|+++|
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 228 WPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00001111111111111000 011235678899999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=330.47 Aligned_cols=257 Identities=24% Similarity=0.421 Sum_probs=203.4
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC---HHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG---HKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
++|++.+.||+|+||.||+|.+.... .....+|+|.+..... ...+.+|+.++..++||||+++++++.....
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~--~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-- 80 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPS--KRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT-- 80 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCC--CceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC--
Confidence 46888999999999999999875432 2345789998876532 3468899999999999999999999987654
Q ss_pred ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccc
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 241 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 241 (426)
.++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +++||||||+|||++.++.+||+|||.+
T Consensus 81 --~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~ 154 (266)
T cd05064 81 --MMIVTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRL 154 (266)
T ss_pred --cEEEEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccc
Confidence 499999999999999987543 3589999999999999999999998 9999999999999999999999999987
Q ss_pred ccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhh
Q 014363 242 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 320 (426)
Q Consensus 242 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (426)
........ .......++..|+|||++.+..++.++|||||||++||+++ |..||...........+
T Consensus 155 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~------------ 221 (266)
T cd05064 155 QEDKSEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAV------------ 221 (266)
T ss_pred ccccccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH------------
Confidence 65322111 11112345678999999999999999999999999999875 99999765432211110
Q ss_pred hhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHh
Q 014363 321 FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 369 (426)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~ 369 (426)
.+ ......+..++..+.+++.+||+.+|++||++++|++.|+++
T Consensus 222 ----~~-~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 222 ----ED-GFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ----HC-CCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 00 011112234567899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-44 Score=368.91 Aligned_cols=266 Identities=27% Similarity=0.473 Sum_probs=218.2
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCc
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 162 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~ 162 (426)
+-...+.||+|+||.||.|...+.........||+|.+.+.. ...+|.+|..+|+.++|||||+++|++.+....
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~-- 770 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP-- 770 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc--
Confidence 445667899999999999998876554447789999987654 446799999999999999999999999996543
Q ss_pred eEEEEEeeCCCCChhhhccCCC-----CCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEee
Q 014363 163 QRLLVYEYMPNGSVDQYLSPKS-----ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 237 (426)
Q Consensus 163 ~~~lv~E~~~~g~L~~~l~~~~-----~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~D 237 (426)
+|++|||.||+|..||+..+ ...++....+.++.|||+|++||+++ ++|||||..+|+||++...|||+|
T Consensus 771 --~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 771 --LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred --EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcc
Confidence 99999999999999998652 34588999999999999999999998 999999999999999999999999
Q ss_pred ecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhh
Q 014363 238 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLS 316 (426)
Q Consensus 238 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 316 (426)
||+|+.+....+........-...|||||.+..+.++.|+|||||||+|||++| |..||......+...
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~---------- 915 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLL---------- 915 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHH----------
Confidence 999995544443333322233468999999999999999999999999999999 999998654432211
Q ss_pred hhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhhcc
Q 014363 317 DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASAE 375 (426)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~~~ 375 (426)
..+... +-..+..++..+.++|..||+.+|++||++..|++.+..+......
T Consensus 916 ------~~~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~ 967 (1025)
T KOG1095|consen 916 ------DVLEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALG 967 (1025)
T ss_pred ------HHHhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhcc
Confidence 111111 2234556889999999999999999999999999999888766544
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=333.89 Aligned_cols=263 Identities=25% Similarity=0.451 Sum_probs=210.7
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC--HHHHHHHHHHHhhcCCCCccceEeEEEccCCCCc
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG--HKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 162 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~ 162 (426)
.+|...+.||+|+||.||+|.+.........+.+++|.+..... .+.+.+|+.+++.++||||+++++++.....
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--- 81 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDP--- 81 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCc---
Confidence 35778889999999999999876655555666789998865542 3568899999999999999999999987653
Q ss_pred eEEEEEeeCCCCChhhhccCCC--------------CCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeC
Q 014363 163 QRLLVYEYMPNGSVDQYLSPKS--------------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLD 228 (426)
Q Consensus 163 ~~~lv~E~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~ 228 (426)
.++||||+++++|.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+|||++
T Consensus 82 -~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~ 157 (291)
T cd05094 82 -LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVG 157 (291)
T ss_pred -eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEc
Confidence 599999999999999986432 23488999999999999999999998 999999999999999
Q ss_pred CCCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHH
Q 014363 229 EQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKL 307 (426)
Q Consensus 229 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~ 307 (426)
.++.++|+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||.........
T Consensus 158 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~-- 235 (291)
T cd05094 158 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI-- 235 (291)
T ss_pred cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH--
Confidence 999999999999976544332222334557889999999998899999999999999999999 99998765432211
Q ss_pred HHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHh
Q 014363 308 LQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVD 371 (426)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~ 371 (426)
.. +..... ......++..+.+++.+||+.||++||++.+|++.|+++..
T Consensus 236 -~~-------------~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 236 -EC-------------ITQGRV-LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred -HH-------------HhCCCC-CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 11 001001 11122345689999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=328.57 Aligned_cols=255 Identities=25% Similarity=0.448 Sum_probs=205.3
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCce
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQ 163 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~ 163 (426)
.+|...+.||+|+||.||+|.++..+. .+++|.+.... ....+.+|+.+++.++||||+++++++.....
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~-----~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---- 76 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSL-----TVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP---- 76 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCc-----eEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCC----
Confidence 357778899999999999999876543 78899876543 34578899999999999999999999987664
Q ss_pred EEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccccc
Q 014363 164 RLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL 243 (426)
Q Consensus 164 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 243 (426)
.++||||+++++|.+++.......+++..++.++.|++.||+|||++ +++||||||+|||+++++.+||+|||++..
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~ 153 (263)
T cd05052 77 FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL 153 (263)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccc
Confidence 48999999999999999765555689999999999999999999998 999999999999999999999999999986
Q ss_pred CCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhhh
Q 014363 244 GPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQFR 322 (426)
Q Consensus 244 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (426)
....... ......++..|+|||.+.+..++.++||||||+++|||++ |..||........ ....
T Consensus 154 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~---~~~~----------- 218 (263)
T cd05052 154 MTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV---YELL----------- 218 (263)
T ss_pred cccceee-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHH-----------
Confidence 5432211 1112234668999999998899999999999999999998 9999875432211 1110
Q ss_pred hhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHh
Q 014363 323 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 369 (426)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~ 369 (426)
........+..++..+.+++.+||+.||++||++.++++.|+.+
T Consensus 219 ---~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 219 ---EKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred ---HCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 01111122234567899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=340.17 Aligned_cols=265 Identities=26% Similarity=0.339 Sum_probs=201.8
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
.++|+..+.||+|+||.||+|.+..++. .+++|.+.... ....+.+|+++++.++||||++++++|.+.+
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~-----~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 76 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGL-----IMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-- 76 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCc-----EEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECC--
Confidence 3689999999999999999999876654 67888775432 2356889999999999999999999998865
Q ss_pred CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecc
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 240 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 240 (426)
..++||||+++|+|.+++... ..+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||+
T Consensus 77 --~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~ 150 (333)
T cd06650 77 --EISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGV 150 (333)
T ss_pred --EEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCc
Confidence 459999999999999999653 3488999999999999999999974 2799999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhh-hh----
Q 014363 241 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKP-YL---- 315 (426)
Q Consensus 241 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~-~~---- 315 (426)
+...... ......|+..|+|||++.+..++.++|||||||++|+|++|..||................. ..
T Consensus 151 ~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (333)
T cd06650 151 SGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESE 226 (333)
T ss_pred chhhhhh----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccc
Confidence 8754322 12345799999999999988899999999999999999999999975443222111100000 00
Q ss_pred -----------------------hhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 316 -----------------------SDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 316 -----------------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
........+............++.++.+|+.+||+.||++|||+.|++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 227 TSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred cCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 00000000000000000011245678999999999999999999999886
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=344.59 Aligned_cols=262 Identities=22% Similarity=0.314 Sum_probs=197.5
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCce
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQ 163 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~ 163 (426)
.++|+..+.||+|+||.||+|.+..++. .||+|.... ..+.+|+.+|+.|+||||+++++++.... .
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~-----~vaiK~~~~----~~~~~E~~il~~l~HpnIv~~~~~~~~~~----~ 157 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCE-----HVVIKAGQR----GGTATEAHILRAINHPSIIQLKGTFTYNK----F 157 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCC-----EEEEechhh----hhhHHHHHHHHhCCCCCCCCEeEEEEECC----e
Confidence 4679999999999999999999876654 789997543 35789999999999999999999998765 3
Q ss_pred EEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccccc
Q 014363 164 RLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL 243 (426)
Q Consensus 164 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 243 (426)
.++|||++ +++|..++.... .+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 158 ~~lv~e~~-~~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~ 231 (391)
T PHA03212 158 TCLILPRY-KTDLYCYLAAKR--NIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACF 231 (391)
T ss_pred eEEEEecC-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccc
Confidence 49999999 468888886543 488999999999999999999998 999999999999999999999999999975
Q ss_pred CCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchh-----hHHHHHhHhhhh---
Q 014363 244 GPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRS-----EQKLLQWVKPYL--- 315 (426)
Q Consensus 244 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~-----~~~~~~~~~~~~--- 315 (426)
..... ........||+.|+|||++.+..++.++|||||||++|||++|..||....... ...+........
T Consensus 232 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p 310 (391)
T PHA03212 232 PVDIN-ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHP 310 (391)
T ss_pred ccccc-ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCCh
Confidence 32211 112234679999999999999999999999999999999999998875432110 111111000000
Q ss_pred -----hhhhhhhhhc---------CCcCCCc--ccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 316 -----SDAKQFRQIV---------DPRLEGK--YSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 316 -----~~~~~~~~~~---------~~~~~~~--~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.....+.... .+..... .....+.++.+|+.+||+.||++|||+.|++++
T Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 311 NEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred hhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0000000000 0000000 011356789999999999999999999999986
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=331.26 Aligned_cols=262 Identities=27% Similarity=0.431 Sum_probs=206.4
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC---HHHHHHHHHHHhhcCCCCccceEeEEEccCCCCc
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG---HKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 162 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~ 162 (426)
+|+..+.||+|+||.||+|.............+++|.+..... ...+.+|+.+++.++||||+++++.+...+.
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--- 77 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGP--- 77 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCC---
Confidence 4778889999999999999876544333445788998865443 3468899999999999999999999987664
Q ss_pred eEEEEEeeCCCCChhhhccCC----------------------CCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccC
Q 014363 163 QRLLVYEYMPNGSVDQYLSPK----------------------SETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDF 220 (426)
Q Consensus 163 ~~~lv~E~~~~g~L~~~l~~~----------------------~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDl 220 (426)
.+++|||+++++|.+++... ....+++..++.++.|++.||.|||+. +++||||
T Consensus 78 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~di 153 (290)
T cd05045 78 -LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDL 153 (290)
T ss_pred -cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhh
Confidence 39999999999999987532 123478899999999999999999998 9999999
Q ss_pred CCCceEeCCCCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCC
Q 014363 221 KSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRN 299 (426)
Q Consensus 221 kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~ 299 (426)
||+|||+++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|+|++ |..||...
T Consensus 154 kp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 233 (290)
T cd05045 154 AARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 233 (290)
T ss_pred hhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCC
Confidence 99999999999999999999976533221111223346778999999988889999999999999999998 99999764
Q ss_pred CchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHh
Q 014363 300 RPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVD 371 (426)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~ 371 (426)
.+.. +.... ........+..++..+.+++.+||+.+|++||++.|+++.|+++..
T Consensus 234 ~~~~---~~~~~--------------~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 234 APER---LFNLL--------------KTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred CHHH---HHHHH--------------hCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 4322 11111 1111111223345689999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=341.61 Aligned_cols=241 Identities=27% Similarity=0.387 Sum_probs=195.7
Q ss_pred ceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-----CCHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCceEE
Q 014363 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-----GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRL 165 (426)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~~~ 165 (426)
+.||+|+||.||+|....++. .+|+|.+... .....+.+|+.+++.++||||+++++++.+.+ ..|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~-----~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~----~~~ 71 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGK-----YYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKD----RLC 71 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCC-----EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC----EEE
Confidence 369999999999999876654 7899988643 23356788999999999999999999998766 459
Q ss_pred EEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccCC
Q 014363 166 LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGP 245 (426)
Q Consensus 166 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 245 (426)
+||||+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 72 lv~Ey~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~ 146 (328)
T cd05593 72 FVMEYVNGGELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGI 146 (328)
T ss_pred EEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCC
Confidence 999999999999888644 3489999999999999999999998 99999999999999999999999999987533
Q ss_pred CCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhc
Q 014363 246 SEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIV 325 (426)
Q Consensus 246 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (426)
... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||........... +.
T Consensus 147 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~----------------~~ 208 (328)
T cd05593 147 TDA--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL----------------IL 208 (328)
T ss_pred Ccc--cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHH----------------hc
Confidence 221 112346799999999999988999999999999999999999999975432211111 10
Q ss_pred CCcCCCcccHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 014363 326 DPRLEGKYSLRLVSKLSHVANLCLVKNARTRP-----KMSEVLEM 365 (426)
Q Consensus 326 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~ 365 (426)
.. ...++..++..+.+++.+||+.||++|| ++.|++++
T Consensus 209 ~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 209 ME--DIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred cC--CccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 00 0112234567889999999999999997 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=341.12 Aligned_cols=241 Identities=27% Similarity=0.364 Sum_probs=195.3
Q ss_pred ceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-----CCHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCceEE
Q 014363 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-----GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRL 165 (426)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~~~ 165 (426)
+.||+|+||.||+|....++. .||+|.+... .....+.+|+.+++.++||||+++++++...+ ..|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~----~~~ 71 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGR-----YYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD----RLC 71 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCC-----EEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCC----EEE
Confidence 369999999999999876654 7899988643 22345678999999999999999999998765 459
Q ss_pred EEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccCC
Q 014363 166 LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGP 245 (426)
Q Consensus 166 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 245 (426)
+||||+++|+|..++... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++....
T Consensus 72 lv~E~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~ 146 (323)
T cd05595 72 FVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 146 (323)
T ss_pred EEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhcccc
Confidence 999999999999888644 3489999999999999999999998 99999999999999999999999999987532
Q ss_pred CCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhc
Q 014363 246 SEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIV 325 (426)
Q Consensus 246 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (426)
... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.......... .+.
T Consensus 147 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~----------------~~~ 208 (323)
T cd05595 147 SDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE----------------LIL 208 (323)
T ss_pred CCC--CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHH----------------HHh
Confidence 221 11234679999999999999999999999999999999999999997543321111 111
Q ss_pred CCcCCCcccHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 014363 326 DPRLEGKYSLRLVSKLSHVANLCLVKNARTRP-----KMSEVLEM 365 (426)
Q Consensus 326 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~ 365 (426)
... ..++..+++.+.+++.+||+.||++|| ++.+++++
T Consensus 209 ~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 209 MEE--IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred cCC--CCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 111 112234567889999999999999998 89999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=341.36 Aligned_cols=269 Identities=22% Similarity=0.342 Sum_probs=199.1
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc----CCHHHHHHHHHHHhhcCCCCccceEeEEEccCC-C
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR----GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE-R 160 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~-~ 160 (426)
+|++.+.||+|+||.||+|.+..++. .||+|.+... .....+.+|+.+++.++||||+++++++..... .
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 75 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGE-----KVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 75 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCC-----EEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCC
Confidence 47888999999999999999876654 7899987532 233468899999999999999999998865432 1
Q ss_pred CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecc
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 240 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 240 (426)
....|+||||+ +++|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 76 ~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~ 149 (338)
T cd07859 76 FKDIYVVFELM-ESDLHQVIKAND--DLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGL 149 (338)
T ss_pred CceEEEEEecC-CCCHHHHHHhcc--cCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcc
Confidence 22469999999 468998886443 489999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCc-eeeeeeeecCcccCCchhhcc--CCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhh----
Q 014363 241 ARLGPSEGF-THVSTAVVGTMGYAAPEYVQT--GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKP---- 313 (426)
Q Consensus 241 a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~---- 313 (426)
++....... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.....
T Consensus 150 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 229 (338)
T cd07859 150 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSP 229 (338)
T ss_pred ccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 975432211 112234579999999999876 6789999999999999999999999976543221111110000
Q ss_pred ----hhhh--hhhhhhhcCCcCCCccc---HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 314 ----YLSD--AKQFRQIVDPRLEGKYS---LRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 314 ----~~~~--~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.+.. .......+.......+. ...+..+.+++.+||+.||++|||++|++++
T Consensus 230 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 230 ETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000 00000001111111111 1234678899999999999999999999986
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=339.28 Aligned_cols=239 Identities=24% Similarity=0.339 Sum_probs=193.2
Q ss_pred ecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-----CCHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCceEEEE
Q 014363 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-----GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLV 167 (426)
Q Consensus 93 lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~~~lv 167 (426)
||+|+||.||+|.+..++. .||+|.+... .....+..|+.++..++||||+++++++.+.+ ..|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~-----~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~lv 71 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQR-----IYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPE----KLYLV 71 (312)
T ss_pred CCcCCCeEEEEEEECCCCC-----EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCC----eEEEE
Confidence 7999999999999876554 7899987542 23356788999999999999999999988765 45999
Q ss_pred EeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccCCCC
Q 014363 168 YEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSE 247 (426)
Q Consensus 168 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 247 (426)
|||+++|+|.+++.... .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 72 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 146 (312)
T cd05585 72 LAFINGGELFHHLQREG--RFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD 146 (312)
T ss_pred EcCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccC
Confidence 99999999999986543 489999999999999999999998 9999999999999999999999999999754322
Q ss_pred CceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCC
Q 014363 248 GFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDP 327 (426)
Q Consensus 248 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (426)
. ......+||+.|+|||++.+..++.++|||||||++|+|++|..||....... .. ..+...
T Consensus 147 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~---~~-------------~~~~~~ 208 (312)
T cd05585 147 D--DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE---MY-------------RKILQE 208 (312)
T ss_pred C--CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH---HH-------------HHHHcC
Confidence 1 12345679999999999999999999999999999999999999997543211 10 111111
Q ss_pred cCCCcccHHHHHHHHHHHHhccccCCCCCCC---HHHHHHH
Q 014363 328 RLEGKYSLRLVSKLSHVANLCLVKNARTRPK---MSEVLEM 365 (426)
Q Consensus 328 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs---~~eil~~ 365 (426)
. ..++..++..+.+++.+||+.||++||+ +.|++.|
T Consensus 209 ~--~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 209 P--LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred C--CCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 1 1123345678899999999999999975 6777765
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=331.21 Aligned_cols=264 Identities=27% Similarity=0.458 Sum_probs=208.4
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC--CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCc
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 162 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~ 162 (426)
.+|.+.+.||+|+||.||++.............+++|.+.... ..+.+.+|+.++..++||||+++++++.....
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--- 81 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP--- 81 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc---
Confidence 4688889999999999999986554333445678999886543 34568899999999999999999999987653
Q ss_pred eEEEEEeeCCCCChhhhccCCC-----------CCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCC
Q 014363 163 QRLLVYEYMPNGSVDQYLSPKS-----------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW 231 (426)
Q Consensus 163 ~~~lv~E~~~~g~L~~~l~~~~-----------~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~ 231 (426)
.++||||+++++|.+++.... ...+++..++.++.|++.||+|||++ +++||||||+|||+++++
T Consensus 82 -~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~ 157 (288)
T cd05093 82 -LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENL 157 (288)
T ss_pred -cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCC
Confidence 499999999999999986332 13489999999999999999999998 999999999999999999
Q ss_pred CeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHh
Q 014363 232 NAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQW 310 (426)
Q Consensus 232 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~ 310 (426)
.+||+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||...........
T Consensus 158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~--- 234 (288)
T cd05093 158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC--- 234 (288)
T ss_pred cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---
Confidence 999999999976543322222223446788999999998889999999999999999998 8999875543211111
Q ss_pred HhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 014363 311 VKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 372 (426)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~ 372 (426)
+..... ...+..++..+.+|+.+||+.||.+|||+.++++.|+++...
T Consensus 235 -------------i~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 235 -------------ITQGRV-LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred -------------HHcCCc-CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 000000 001112456799999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=330.74 Aligned_cols=260 Identities=23% Similarity=0.447 Sum_probs=203.3
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
.++|+..+.||+|+||.||+|.++..........+++|.+.... ....+.+|+.+++.++||||+++++++.+...
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~- 83 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP- 83 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC-
Confidence 56799999999999999999987654333345679999885433 23467899999999999999999999876553
Q ss_pred CceEEEEEeeCCCCChhhhccCCC--------CCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCC
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKS--------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWN 232 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~--------~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~ 232 (426)
.++||||+++++|.+++.... ...+++..++.++.|++.||.|||+. +++||||||+|||+++++.
T Consensus 84 ---~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~ 157 (277)
T cd05062 84 ---TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFT 157 (277)
T ss_pred ---eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCC
Confidence 499999999999999986432 12357788999999999999999998 9999999999999999999
Q ss_pred eeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhH
Q 014363 233 AKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWV 311 (426)
Q Consensus 233 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~ 311 (426)
++|+|||++................+++.|+|||++.++.++.++|||||||++|||++ |..||............
T Consensus 158 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~--- 234 (277)
T cd05062 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV--- 234 (277)
T ss_pred EEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH---
Confidence 99999999875543222222223356788999999998899999999999999999999 78888754332111110
Q ss_pred hhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014363 312 KPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVN 367 (426)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~ 367 (426)
..... ...+...+..+.+++.+||+.||++|||+.|+++.|+
T Consensus 235 -------------~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 235 -------------MEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred -------------HcCCc-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 00000 0112234567999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=333.06 Aligned_cols=262 Identities=26% Similarity=0.413 Sum_probs=208.0
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC---HHHHHHHHHHHhhc-CCCCccceEeEEEccCCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG---HKEWMTEVNFLGIV-EHQNLVKLVGYCADDDER 160 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~~ 160 (426)
++|...+.||+|+||.||+|.............+|+|.+..... .+.+.+|+.+++++ +||||+++++++...+.
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~- 113 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP- 113 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc-
Confidence 46888999999999999999875444444566899998865432 34688999999999 89999999999987664
Q ss_pred CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecc
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 240 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 240 (426)
.++||||+++|+|.+++.......+++..++.++.|++.||+|||++ +|+|+||||+|||++.++.++|+|||+
T Consensus 114 ---~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 114 ---ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred ---eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcc
Confidence 49999999999999999755444589999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014363 241 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAK 319 (426)
Q Consensus 241 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 319 (426)
+................++..|+|||++.+..++.++|||||||++|+|++ |..||......... ..
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~--~~---------- 255 (302)
T cd05055 188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKF--YK---------- 255 (302)
T ss_pred cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHH--HH----------
Confidence 986543322122223456788999999998899999999999999999998 99998754322111 01
Q ss_pred hhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHh
Q 014363 320 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 369 (426)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~ 369 (426)
..........+...+..+.+++.+||..+|++||++.|+++.|+++
T Consensus 256 ----~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 256 ----LIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ----HHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 1111111111223456899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=333.54 Aligned_cols=263 Identities=26% Similarity=0.453 Sum_probs=208.5
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC---HHHHHHHHHHHhhc-CCCCccceEeEEEccCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG---HKEWMTEVNFLGIV-EHQNLVKLVGYCADDDE 159 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~ 159 (426)
.++|+..+.||+|+||.||+|.............+++|.+..... ...+.+|+.++..+ +||||+++++++.....
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP 90 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence 457888899999999999999987654344556889998865432 24578899999999 89999999999987653
Q ss_pred CCceEEEEEeeCCCCChhhhccCC--------------CCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCce
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPK--------------SETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNI 225 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~--------------~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NI 225 (426)
.++||||+++|+|.+++... ....+++..++.++.|++.||.|||+. +|+||||||+||
T Consensus 91 ----~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Ni 163 (293)
T cd05053 91 ----LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNV 163 (293)
T ss_pred ----eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeE
Confidence 49999999999999998542 234589999999999999999999998 999999999999
Q ss_pred EeCCCCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhh
Q 014363 226 LLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSE 304 (426)
Q Consensus 226 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~ 304 (426)
|++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||........
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 243 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 243 (293)
T ss_pred EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH
Confidence 999999999999999986554322222223345678999999988899999999999999999998 9999875432211
Q ss_pred HHHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhH
Q 014363 305 QKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIV 370 (426)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~ 370 (426)
... +........+..++..+.+|+.+||..||++|||+.|+++.|++++
T Consensus 244 ~~~-----------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 244 FKL-----------------LKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHH-----------------HHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 111 0111111122234568999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=330.13 Aligned_cols=253 Identities=33% Similarity=0.549 Sum_probs=197.2
Q ss_pred CcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC---HHHHHHHHHHHhhcCCCCccceEeEEEccCCCCceEE
Q 014363 89 RSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG---HKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRL 165 (426)
Q Consensus 89 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~~~ 165 (426)
..+.||.|.||.||+|.+.. ........|++|.++.... .+.+.+|++++++++||||++++|++..... .+
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~-~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~----~~ 77 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQ-KDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEP----LF 77 (259)
T ss_dssp EEEEEEEESSEEEEEEEEES-TTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSS----EE
T ss_pred EeeEEccCCCcEEEEEEEEc-ccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccc----cc
Confidence 35689999999999999984 2344567899999965433 4678999999999999999999999995543 59
Q ss_pred EEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccCC
Q 014363 166 LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGP 245 (426)
Q Consensus 166 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 245 (426)
+||||+++|+|.+++.......+++..++.|+.|++.||.|||++ +++|+||+++|||++.++.+||+|||++....
T Consensus 78 lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~ 154 (259)
T PF07714_consen 78 LVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPIS 154 (259)
T ss_dssp EEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc
Confidence 999999999999999877455699999999999999999999998 99999999999999999999999999998763
Q ss_pred CCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhh
Q 014363 246 SEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQI 324 (426)
Q Consensus 246 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (426)
............+...|+|||.+....++.++||||||+++|||++ |..||....... .... +
T Consensus 155 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~---~~~~-------------~ 218 (259)
T PF07714_consen 155 EKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE---IIEK-------------L 218 (259)
T ss_dssp TSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH---HHHH-------------H
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---cccc-------------c
Confidence 3332333344567889999999999899999999999999999999 789987553221 1111 1
Q ss_pred cCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014363 325 VDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMV 366 (426)
Q Consensus 325 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L 366 (426)
.+. .....+..++..+.+++..||..||++|||+.+|++.|
T Consensus 219 ~~~-~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 219 KQG-QRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HTT-EETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ccc-ccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 000 01112233567889999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=333.19 Aligned_cols=266 Identities=24% Similarity=0.335 Sum_probs=196.5
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
.++|.+.+.||+|+||.||+|....++. .+|+|.+.... ....+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-- 76 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGK-----LVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKE-- 76 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCC-----EEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCC--
Confidence 4679999999999999999999876543 78999876432 2345788999999999999999999998765
Q ss_pred CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecc
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 240 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 240 (426)
..++||||++ ++|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 77 --~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~ 149 (303)
T cd07869 77 --TLTLVFEYVH-TDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGL 149 (303)
T ss_pred --eEEEEEECCC-cCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCc
Confidence 4599999995 67877776432 3488899999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHH-HHHhHh--hh--
Q 014363 241 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQK-LLQWVK--PY-- 314 (426)
Q Consensus 241 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~-~~~~~~--~~-- 314 (426)
+....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.......... ...... +.
T Consensus 150 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 227 (303)
T cd07869 150 ARAKSVPS--HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNED 227 (303)
T ss_pred ceeccCCC--ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChh
Confidence 87543221 11234568999999998865 457889999999999999999999998654321110 000000 00
Q ss_pred -hhhhhhhhhhcCCcCC----CcccH-----HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 315 -LSDAKQFRQIVDPRLE----GKYSL-----RLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 315 -~~~~~~~~~~~~~~~~----~~~~~-----~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
+............... ..... ..+..+.+|+.+||+.||++|||+.|+++|
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 228 TWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred hccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 0000000000000000 00000 123568899999999999999999999985
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=330.39 Aligned_cols=258 Identities=22% Similarity=0.391 Sum_probs=204.9
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC---HHHHHHHHHHHhhcCCCCccceEeEEEccCCCCc
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG---HKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 162 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~ 162 (426)
+|.+.+.||+|+||.||+|.+..+........+|+|.+..... ...+.+|+.++..++||||+++++++.+...
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~--- 82 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQP--- 82 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCc---
Confidence 4666778999999999999987654444566899999875432 2457889999999999999999999987664
Q ss_pred eEEEEEeeCCCCChhhhccCC--------------CCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeC
Q 014363 163 QRLLVYEYMPNGSVDQYLSPK--------------SETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLD 228 (426)
Q Consensus 163 ~~~lv~E~~~~g~L~~~l~~~--------------~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~ 228 (426)
.++++||+++++|.+++... ....+++..++.++.|++.||.|||++ +|+||||||+|||++
T Consensus 83 -~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~ 158 (283)
T cd05091 83 -LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVF 158 (283)
T ss_pred -eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEec
Confidence 48999999999999998421 123478888999999999999999998 999999999999999
Q ss_pred CCCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHH
Q 014363 229 EQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKL 307 (426)
Q Consensus 229 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~ 307 (426)
+++.+||+|||+++...............+++.|+|||++.++.++.++||||||+++|||++ |..||....... .
T Consensus 159 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~ 235 (283)
T cd05091 159 DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD---V 235 (283)
T ss_pred CCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH---H
Confidence 999999999999886543332222334456789999999988889999999999999999998 888887543321 1
Q ss_pred HHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014363 308 LQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVN 367 (426)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~ 367 (426)
.. .+.+.. ...++..++..+.+++.+||+.+|++||++++|++.|+
T Consensus 236 ~~-------------~i~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~ 281 (283)
T cd05091 236 IE-------------MIRNRQ-VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281 (283)
T ss_pred HH-------------HHHcCC-cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence 11 111111 11223346678999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=342.81 Aligned_cols=253 Identities=25% Similarity=0.308 Sum_probs=195.3
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-----CHHHHHHHHHHHhhcCCCCccceEeEEEccCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
++|+..+.||+|+||+||+|....++. .+|+|.+.... ....+..|+.++..++||||+++++.+.+..
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~-----~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~- 74 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGH-----VYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKL- 74 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCC-----EEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCC-
Confidence 478899999999999999999876654 79999886432 2346778999999999999999999998765
Q ss_pred CCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeec
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 239 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 239 (426)
..|+||||+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 75 ---~~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFG 146 (363)
T cd05628 75 ---NLYLIMEFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFG 146 (363)
T ss_pred ---eEEEEEcCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeecc
Confidence 459999999999999999754 3489999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCc---------------------------------eeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHH
Q 014363 240 LARLGPSEGF---------------------------------THVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFL 286 (426)
Q Consensus 240 la~~~~~~~~---------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil 286 (426)
+++....... .......+||+.|+|||++.+..++.++|||||||++
T Consensus 147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil 226 (363)
T cd05628 147 LCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226 (363)
T ss_pred CcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHH
Confidence 9875432100 0011245799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccc--cCCCCCCCHHHHHH
Q 014363 287 YELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLV--KNARTRPKMSEVLE 364 (426)
Q Consensus 287 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~--~dp~~RPs~~eil~ 364 (426)
|||++|..||...........+. ... ... .... ...++.++.+++.+++. .++..||+++||++
T Consensus 227 ~ell~G~~Pf~~~~~~~~~~~i~------~~~---~~~---~~p~--~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~ 292 (363)
T cd05628 227 YEMLIGYPPFCSETPQETYKKVM------NWK---ETL---IFPP--EVPISEKAKDLILRFCCEWEHRIGAPGVEEIKT 292 (363)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHH------cCc---Ccc---cCCC--cCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhC
Confidence 99999999997654322111100 000 000 0010 11245677788877553 23345689999998
Q ss_pred H
Q 014363 365 M 365 (426)
Q Consensus 365 ~ 365 (426)
|
T Consensus 293 h 293 (363)
T cd05628 293 N 293 (363)
T ss_pred C
Confidence 7
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=348.42 Aligned_cols=267 Identities=20% Similarity=0.268 Sum_probs=195.8
Q ss_pred HHHHhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-CHHHHHHHHHHHhhcCC------CCccceEe
Q 014363 80 LKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-GHKEWMTEVNFLGIVEH------QNLVKLVG 152 (426)
Q Consensus 80 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~E~~~l~~l~H------pnIv~~~~ 152 (426)
+....++|.+.++||+|+||+||+|.+...+. .||+|++.... ....+..|+.++..++| ++|+++++
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~-----~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~ 198 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKE-----YCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQR 198 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCe-----EEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEE
Confidence 33456789999999999999999999876543 79999985432 23445677777777754 45888998
Q ss_pred EEEccCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhcc-CCCCCeEeccCCCCceEeCCCC
Q 014363 153 YCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHE-GMDFQIIVRDFKSSNILLDEQW 231 (426)
Q Consensus 153 ~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~-~~~~~iiHrDlkp~NILl~~~~ 231 (426)
++..... +.|+|||++ +++|.+++... ..+++..+..|+.||+.||+|||+ . +||||||||+|||++.++
T Consensus 199 ~~~~~~~---~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~ 269 (467)
T PTZ00284 199 YFQNETG---HMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSD 269 (467)
T ss_pred EEEcCCc---eEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCC
Confidence 8876432 468999998 77898888654 348999999999999999999996 5 999999999999998765
Q ss_pred ----------------CeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCC
Q 014363 232 ----------------NAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRP 295 (426)
Q Consensus 232 ----------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p 295 (426)
.+||+|||++..... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.|
T Consensus 270 ~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~p 344 (467)
T PTZ00284 270 TVVDPVTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLL 344 (467)
T ss_pred cccccccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 499999998764321 13356899999999999999999999999999999999999999
Q ss_pred CCCCCchhhHHHHHhHhhh----hhh---hhhhhhhcCC--cCCCcc---------------cHHHHHHHHHHHHhcccc
Q 014363 296 IDRNRPRSEQKLLQWVKPY----LSD---AKQFRQIVDP--RLEGKY---------------SLRLVSKLSHVANLCLVK 351 (426)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~----~~~---~~~~~~~~~~--~~~~~~---------------~~~~~~~l~~li~~cl~~ 351 (426)
|...........+...... +.. ......+.+. .+.... .......+.+||.+||+.
T Consensus 345 f~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~ 424 (467)
T PTZ00284 345 YDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHY 424 (467)
T ss_pred CCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCc
Confidence 9876543332222111000 000 0000000000 000000 001235678999999999
Q ss_pred CCCCCCCHHHHHHH
Q 014363 352 NARTRPKMSEVLEM 365 (426)
Q Consensus 352 dp~~RPs~~eil~~ 365 (426)
||++|||+.|+++|
T Consensus 425 dP~~R~ta~e~L~H 438 (467)
T PTZ00284 425 DRQKRLNARQMTTH 438 (467)
T ss_pred ChhhCCCHHHHhcC
Confidence 99999999999986
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=331.11 Aligned_cols=268 Identities=25% Similarity=0.349 Sum_probs=198.6
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhc---CCCCccceEeEEEcc
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIV---EHQNLVKLVGYCADD 157 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l---~HpnIv~~~~~~~~~ 157 (426)
++|++.+.||+|+||.||+|.+...+ ...+|+|.+.... ....+.+|+.+++.+ +||||+++++++...
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~ 76 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNG----GRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 76 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCC----CeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecc
Confidence 37889999999999999999875432 2368888875432 234566788777766 699999999998642
Q ss_pred C-CCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEe
Q 014363 158 D-ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLS 236 (426)
Q Consensus 158 ~-~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~ 236 (426)
. ......++||||++ ++|.+++.......+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+
T Consensus 77 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~ 152 (290)
T cd07862 77 RTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA 152 (290)
T ss_pred cCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEc
Confidence 2 12234699999996 6899998765555689999999999999999999998 99999999999999999999999
Q ss_pred eecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHH-HHhHhhhh
Q 014363 237 DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKL-LQWVKPYL 315 (426)
Q Consensus 237 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~-~~~~~~~~ 315 (426)
|||++...... .......||+.|+|||++.+..++.++|||||||++|||++|.+||........... ..... .
T Consensus 153 Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~--~ 227 (290)
T cd07862 153 DFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG--L 227 (290)
T ss_pred cccceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhC--C
Confidence 99999765432 123345789999999999988999999999999999999999999986543322111 11100 0
Q ss_pred hhhhhhhh-------hcCCcCCC---cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 316 SDAKQFRQ-------IVDPRLEG---KYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 316 ~~~~~~~~-------~~~~~~~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
........ ........ ......+..+.+++.+||+.||++|||+.|++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 228 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred CChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 00000000 00000000 0112345678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=338.48 Aligned_cols=266 Identities=25% Similarity=0.390 Sum_probs=206.1
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC---HHHHHHHHHHHhhc-CCCCccceEeEEEccCCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG---HKEWMTEVNFLGIV-EHQNLVKLVGYCADDDER 160 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~~ 160 (426)
++|.+.+.||+|+||.||+|.+.........+.||+|.+..... ...+.+|+.+|..+ +||||+++++++...+.
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~- 85 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG- 85 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC-
Confidence 47999999999999999999876655555677899999865432 34578999999999 78999999998876543
Q ss_pred CceEEEEEeeCCCCChhhhccCCC--------------------------------------------------------
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKS-------------------------------------------------------- 184 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~-------------------------------------------------------- 184 (426)
..++||||+++|+|.+++....
T Consensus 86 --~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 86 --PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred --ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 3589999999999999886421
Q ss_pred ---------CCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccCCCCCceeeeee
Q 014363 185 ---------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTA 255 (426)
Q Consensus 185 ---------~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 255 (426)
...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++..............
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 240 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 240 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence 12367888899999999999999998 999999999999999999999999999976432211111222
Q ss_pred eecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCccc
Q 014363 256 VVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYS 334 (426)
Q Consensus 256 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (426)
..++..|+|||++.+..++.++||||||+++|+|++ |..||........ ..... .. ......+
T Consensus 241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~~~~~----~~----------~~~~~~~ 304 (343)
T cd05103 241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FCRRL----KE----------GTRMRAP 304 (343)
T ss_pred CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH--HHHHH----hc----------cCCCCCC
Confidence 345678999999988899999999999999999997 9999865432111 11000 00 0000111
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 014363 335 LRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 372 (426)
Q Consensus 335 ~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~ 372 (426)
...++.+.+++.+||+.||++|||+.||+++|+.+++.
T Consensus 305 ~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 305 DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 12345789999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=324.92 Aligned_cols=258 Identities=27% Similarity=0.467 Sum_probs=204.9
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
++|+..+.||+|+||.||+|.+...+. ....+++|.+.... ....+..|+.++..++||||+++++++.....
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~--~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-- 79 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGK--KEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRP-- 79 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCC--CcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCc--
Confidence 568889999999999999999865421 23478999876443 23468899999999999999999999877653
Q ss_pred ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccc
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 241 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 241 (426)
.++||||+++++|.+++.... ..+++..++.++.|++.||.|||++ +|+|+||||+|||+++++.++|+|||++
T Consensus 80 --~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~ 153 (266)
T cd05033 80 --VMIITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLS 153 (266)
T ss_pred --eEEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchh
Confidence 499999999999999997543 3589999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhh
Q 014363 242 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 320 (426)
Q Consensus 242 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (426)
................++..|+|||.+.+..++.++||||||+++|+|++ |..||......... ...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~---~~~--------- 221 (266)
T cd05033 154 RRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVI---KAV--------- 221 (266)
T ss_pred hcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHH---HHH---------
Confidence 87642221222222345678999999998899999999999999999998 99999654322111 110
Q ss_pred hhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHh
Q 014363 321 FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 369 (426)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~ 369 (426)
... .....+..++..+.+++.+||+.+|++||++.||+++|+++
T Consensus 222 ----~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 222 ----EDG-YRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ----HcC-CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 000 00011223456889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=317.54 Aligned_cols=253 Identities=24% Similarity=0.350 Sum_probs=206.2
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCce
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQ 163 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~ 163 (426)
.++|++.++||+|.|+.||++.+..++.....+.+.+|++... +.+.+.+|++|.+.|+||||+++.+.+.....
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~---- 84 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESF---- 84 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccce----
Confidence 4578888899999999999999988887666666666666554 67789999999999999999999998877664
Q ss_pred EEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCC---CCCeeEeeecc
Q 014363 164 RLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE---QWNAKLSDFGL 240 (426)
Q Consensus 164 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~---~~~~kl~DFGl 240 (426)
.|||+|++.|++|..-|-.+ ..+++..+-..++||++||.|+|.+ +|||||+||+|+|+.. ..-+||+|||+
T Consensus 85 ~ylvFe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGv 159 (355)
T KOG0033|consen 85 HYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGL 159 (355)
T ss_pred eEEEEecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccce
Confidence 49999999999997655433 4588888999999999999999998 9999999999999953 33589999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhh
Q 014363 241 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 320 (426)
Q Consensus 241 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (426)
|..... ......++|||.|||||++...+|+..+|||+.||+||-|+.|.+||.+..... +
T Consensus 160 Ai~l~~---g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r---l------------- 220 (355)
T KOG0033|consen 160 AIEVND---GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR---L------------- 220 (355)
T ss_pred EEEeCC---ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH---H-------------
Confidence 987763 233456889999999999999999999999999999999999999997633211 1
Q ss_pred hhhhcCC--cCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 321 FRQIVDP--RLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 321 ~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
+.++... ...+.+-..++++.++|+++||..||.+|.|+.|.|.|
T Consensus 221 ye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 221 YEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred HHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 1111111 12222334567899999999999999999999999865
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=354.84 Aligned_cols=252 Identities=24% Similarity=0.341 Sum_probs=200.6
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC--CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCce
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQ 163 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~ 163 (426)
.|...+.||+|+||.||+|...... ...|++|.+.... ....+..|+.+|+.++|||||++++++...+ .
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~----~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~----~ 139 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDP----KEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDD----K 139 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCC----CeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECC----E
Confidence 4888999999999999999866542 1257777654332 2345678999999999999999999998765 4
Q ss_pred EEEEEeeCCCCChhhhccCC--CCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccc
Q 014363 164 RLLVYEYMPNGSVDQYLSPK--SETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 241 (426)
Q Consensus 164 ~~lv~E~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 241 (426)
.||||||+++|+|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 140 ~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla 216 (478)
T PTZ00267 140 LLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFS 216 (478)
T ss_pred EEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCc
Confidence 59999999999999887532 234588999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhh
Q 014363 242 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 321 (426)
Q Consensus 242 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (426)
...............+||+.|+|||++.+..++.++|||||||++|+|++|..||....... ...
T Consensus 217 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~---~~~------------ 281 (478)
T PTZ00267 217 KQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE---IMQ------------ 281 (478)
T ss_pred eecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH------------
Confidence 86654322223445679999999999999999999999999999999999999997543211 111
Q ss_pred hhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 322 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.+..... ...+..++..+.+++.+||+.||++||++.+++.+
T Consensus 282 -~~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 282 -QVLYGKY-DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred -HHHhCCC-CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 1111110 11223455789999999999999999999999764
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=327.28 Aligned_cols=260 Identities=26% Similarity=0.436 Sum_probs=203.1
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC---HHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG---HKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
++|...+.||+|+||.||+|.+...+. .....+++|.+..... ...+..|+.++..++||||+++++++...
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~---- 81 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGD-SIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGA---- 81 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCC-ceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECCC----
Confidence 467888899999999999999865543 2334578888754432 24567788899999999999999987533
Q ss_pred ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccc
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 241 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 241 (426)
..++++||+++|+|.+++.... ..+++..++.++.|++.||.|||++ +++||||||+|||+++++.+||+|||++
T Consensus 82 -~~~~i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~ 156 (279)
T cd05111 82 -SLQLVTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVA 156 (279)
T ss_pred -ccEEEEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccc
Confidence 2479999999999999997543 3489999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhh
Q 014363 242 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 320 (426)
Q Consensus 242 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (426)
+...............++..|+|||++.++.++.++||||||+++|||++ |..||.+..+.....+.. ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~-------~~~- 228 (279)
T cd05111 157 DLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE-------KGE- 228 (279)
T ss_pred eeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-------CCC-
Confidence 86543322222234557789999999998899999999999999999998 999997654332211111 000
Q ss_pred hhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHh
Q 014363 321 FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVD 371 (426)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~ 371 (426)
.. . .+..++..+..++.+||..||++|||+.|+++.|..+.+
T Consensus 229 --~~---~----~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 229 --RL---A----QPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred --cC---C----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 00 0 011134567889999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-43 Score=343.76 Aligned_cols=263 Identities=22% Similarity=0.402 Sum_probs=206.0
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC---HHHHHHHHHHHhhcC-CCCccceEeEEEccCCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG---HKEWMTEVNFLGIVE-HQNLVKLVGYCADDDER 160 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~E~~~l~~l~-HpnIv~~~~~~~~~~~~ 160 (426)
++|.+.+.||+|+||.||+|.+...........||+|.+..... .+.+.+|+.+|..+. ||||+++++++.....
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~- 115 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP- 115 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC-
Confidence 45778889999999999999987544444556899999975432 246889999999997 9999999999987664
Q ss_pred CceEEEEEeeCCCCChhhhccCCCC-------------------------------------------------------
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSE------------------------------------------------------- 185 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~------------------------------------------------------- 185 (426)
.++||||+++|+|.+++.....
T Consensus 116 ---~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (401)
T cd05107 116 ---IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM 192 (401)
T ss_pred ---cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence 4999999999999999864321
Q ss_pred -----------------------------------------CccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCc
Q 014363 186 -----------------------------------------TILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSN 224 (426)
Q Consensus 186 -----------------------------------------~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~N 224 (426)
..+++..++.++.|++.||+|||+. +|+||||||+|
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~N 269 (401)
T cd05107 193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARN 269 (401)
T ss_pred hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcce
Confidence 2367778889999999999999998 99999999999
Q ss_pred eEeCCCCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchh
Q 014363 225 ILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRS 303 (426)
Q Consensus 225 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~ 303 (426)
||+++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||.......
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~ 349 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE 349 (401)
T ss_pred EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence 9999999999999999976432221111223457889999999998889999999999999999998 889986543221
Q ss_pred hHHHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhH
Q 014363 304 EQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIV 370 (426)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~ 370 (426)
. .. ..+........+..++..+.+|+.+||..+|++||++++|++.|+.++
T Consensus 350 ~--~~--------------~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 350 Q--FY--------------NAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred H--HH--------------HHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 1 00 000111111122235678999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=345.83 Aligned_cols=252 Identities=26% Similarity=0.332 Sum_probs=199.2
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-----CCHHHHHHHHHHHhhcCCCCccceEeEEEccCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-----GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
++|+..+.||+|+||.||+|.+..++. .||+|.+... .....+.+|+.+|..++||||+++++++.+..
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~- 74 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGH-----IYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDEN- 74 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCC-----EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC-
Confidence 478999999999999999999877654 7999988643 22345778999999999999999999998766
Q ss_pred CCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeec
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 239 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 239 (426)
..|+||||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 75 ---~~~lv~E~~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg 146 (364)
T cd05599 75 ---YLYLIMEYLPGGDMMTLLMKKD--TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFG 146 (364)
T ss_pred ---eEEEEECCCCCcHHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecc
Confidence 4599999999999999986543 489999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCce------------------------------------eeeeeeecCcccCCchhhccCCCCCchhhHHHH
Q 014363 240 LARLGPSEGFT------------------------------------HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYG 283 (426)
Q Consensus 240 la~~~~~~~~~------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG 283 (426)
++......... ......+||+.|+|||++.+..++.++||||||
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 226 (364)
T cd05599 147 LCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLG 226 (364)
T ss_pred cceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecch
Confidence 98754321100 001134699999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCC---HH
Q 014363 284 VFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPK---MS 360 (426)
Q Consensus 284 vil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs---~~ 360 (426)
|++|||++|..||...........+. .. ...+.......+++.+.+++.+|+. +|.+|++ +.
T Consensus 227 ~il~el~~G~~Pf~~~~~~~~~~~i~------~~--------~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~ 291 (364)
T cd05599 227 VIMYEMLVGYPPFCSDNPQETYRKII------NW--------KETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVN 291 (364)
T ss_pred hHHHHhhcCCCCCCCCCHHHHHHHHH------cC--------CCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHH
Confidence 99999999999997654322111100 00 0000000111345688899999996 9999997 99
Q ss_pred HHHHH
Q 014363 361 EVLEM 365 (426)
Q Consensus 361 eil~~ 365 (426)
+++++
T Consensus 292 ~ll~h 296 (364)
T cd05599 292 EIKSH 296 (364)
T ss_pred HHhcC
Confidence 99886
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=337.03 Aligned_cols=244 Identities=27% Similarity=0.413 Sum_probs=194.4
Q ss_pred CCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-----CHHHHHHHHHHH---hhcCCCCccceEeEEEccC
Q 014363 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-----GHKEWMTEVNFL---GIVEHQNLVKLVGYCADDD 158 (426)
Q Consensus 87 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-----~~~~~~~E~~~l---~~l~HpnIv~~~~~~~~~~ 158 (426)
|.+.+.||+|+||.||+|.+..++. .||+|.+.... ..+.+..|++++ +.++||||+++++++.+..
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~-----~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~ 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGE-----LYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTED 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCC-----EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCC
Confidence 6678899999999999999876654 78999886432 234566676655 5668999999999998765
Q ss_pred CCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeee
Q 014363 159 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 238 (426)
Q Consensus 159 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 238 (426)
..|+||||+++++|..++.. ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 76 ----~~~lv~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Df 145 (324)
T cd05589 76 ----HVCFVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADF 145 (324)
T ss_pred ----EEEEEEcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcc
Confidence 45999999999999988854 2489999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014363 239 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 318 (426)
Q Consensus 239 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 318 (426)
|++....... ......+|++.|+|||++.+..++.++|||||||++|+|++|..||..........
T Consensus 146 g~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~------------ 211 (324)
T cd05589 146 GLCKEGMGFG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFD------------ 211 (324)
T ss_pred cCCccCCCCC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHH------------
Confidence 9987533221 12345679999999999999999999999999999999999999997654321111
Q ss_pred hhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 014363 319 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRP-----KMSEVLEM 365 (426)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~ 365 (426)
.+.... ..++..++..+.+++.+||+.||++|| ++.+++++
T Consensus 212 ----~i~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 212 ----SIVNDE--VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred ----HHHhCC--CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 111110 112233567889999999999999999 57777775
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=325.40 Aligned_cols=253 Identities=25% Similarity=0.464 Sum_probs=203.4
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCce
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQ 163 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~ 163 (426)
++|+..++||+|+||.||+|...+.. .+++|.+.... ..+.+.+|+.+++.++||||+++++++.+...
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~------~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---- 75 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNST------KVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEP---- 75 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCc------eEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC----
Confidence 46888999999999999999865542 68999876433 45678999999999999999999999877654
Q ss_pred EEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccccc
Q 014363 164 RLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL 243 (426)
Q Consensus 164 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 243 (426)
.+++|||+++++|.+++.......+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++..
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~ 152 (261)
T cd05072 76 IYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARV 152 (261)
T ss_pred cEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCcccee
Confidence 49999999999999999765455688999999999999999999998 999999999999999999999999999986
Q ss_pred CCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhhh
Q 014363 244 GPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQFR 322 (426)
Q Consensus 244 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (426)
....... ......++..|+|||++.++.++.++||||||+++|+|++ |..||......... ....
T Consensus 153 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~---~~~~---------- 218 (261)
T cd05072 153 IEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVM---SALQ---------- 218 (261)
T ss_pred cCCCcee-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHH---HHHH----------
Confidence 5433211 1223346778999999988889999999999999999998 99999754332111 1110
Q ss_pred hhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 014363 323 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNK 368 (426)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~ 368 (426)
.... ......++..+.+++.+||..+|++||+++++++.|++
T Consensus 219 ~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 219 RGYR----MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred cCCC----CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0000 01112345678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=327.21 Aligned_cols=271 Identities=24% Similarity=0.339 Sum_probs=206.8
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhcCCCCccceEeEEEccCCC-CceE
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER-GIQR 164 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~-~~~~ 164 (426)
.|...+++|.|+||.||+|....++. .||||+.-.+... -.+|+.+|+.++|||||++..+|....+. ....
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~-----~vAIKKv~~d~r~--knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEE-----EVAIKKVLQDKRY--KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCc-----eeEEEEecCCCCc--CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 57778899999999999999887744 8999987655432 24799999999999999999888765554 3455
Q ss_pred EEEEeeCCCCChhhhccCC--CCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCC-CCeeEeeeccc
Q 014363 165 LLVYEYMPNGSVDQYLSPK--SETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQ-WNAKLSDFGLA 241 (426)
Q Consensus 165 ~lv~E~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~-~~~kl~DFGla 241 (426)
.+||||+|. +|.++++.. .+..++.-.+.-+..||.+||.|||+. +|+||||||.|||+|.+ |.+||||||.|
T Consensus 98 nlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSA 173 (364)
T KOG0658|consen 98 NLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSA 173 (364)
T ss_pred HHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcc
Confidence 789999976 999888732 234477778888999999999999998 99999999999999976 89999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhh
Q 014363 242 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 320 (426)
Q Consensus 242 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (426)
+....... ..+...|..|.|||.+.+. .|+.+.||||.||++.||+-|++-|.+.........+-.+.- ....+.
T Consensus 174 K~L~~~ep---niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG-~Pt~e~ 249 (364)
T KOG0658|consen 174 KVLVKGEP---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLG-TPTRED 249 (364)
T ss_pred eeeccCCC---ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhC-CCCHHH
Confidence 97765432 3456789999999988764 599999999999999999999999988655433332221110 000111
Q ss_pred h------------hhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HHHhHh
Q 014363 321 F------------RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM--VNKIVD 371 (426)
Q Consensus 321 ~------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~--L~~~~~ 371 (426)
+ .++....+...+....+++..+|+.++|+.+|.+|.++.|++.+ ++++.+
T Consensus 250 I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~ 314 (364)
T KOG0658|consen 250 IKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD 314 (364)
T ss_pred HhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence 1 11111111112344567899999999999999999999999986 444443
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=345.07 Aligned_cols=250 Identities=26% Similarity=0.335 Sum_probs=202.4
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-----CCHHHHHHHHHHHhhcCCCCccceEeEEEccCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-----GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
++|.+.+.||+|+||.||+|.+..++. .||+|++... .....+..|+.++..++||||+++++++.+..
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~-----~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~- 74 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQ-----VYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEE- 74 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCC-----EEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCC-
Confidence 468899999999999999999876554 7999988643 23456789999999999999999999988765
Q ss_pred CCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeec
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 239 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 239 (426)
..|+||||+++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 75 ---~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg 146 (350)
T cd05573 75 ---HLYLVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFG 146 (350)
T ss_pred ---eEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCC
Confidence 459999999999999999755 4589999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCC---------------------------ceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhC
Q 014363 240 LARLGPSEG---------------------------FTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITG 292 (426)
Q Consensus 240 la~~~~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg 292 (426)
++....... .........||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g 226 (350)
T cd05573 147 LCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226 (350)
T ss_pred CCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccC
Confidence 997654322 00112345799999999999999999999999999999999999
Q ss_pred CCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcC--CcCCCcccHHHHHHHHHHHHhccccCCCCCCC-HHHHHHH
Q 014363 293 RRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVD--PRLEGKYSLRLVSKLSHVANLCLVKNARTRPK-MSEVLEM 365 (426)
Q Consensus 293 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-~~eil~~ 365 (426)
..||........... +.. ..+.......++..+.+++.+||. ||.+||+ +.+++++
T Consensus 227 ~~Pf~~~~~~~~~~~----------------i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 227 FPPFYSDTLQETYNK----------------IINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CCCCCCCCHHHHHHH----------------HhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 999976543211111 111 001101111156789999999997 9999999 9999987
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=354.75 Aligned_cols=261 Identities=25% Similarity=0.345 Sum_probs=207.1
Q ss_pred HHHHhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEE
Q 014363 80 LKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCA 155 (426)
Q Consensus 80 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 155 (426)
.....++|.+.+.||+|+||.||+|.+..++. .||+|.+.... ....+.+|+.++..++|+||+++++.+.
T Consensus 27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~-----~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~ 101 (496)
T PTZ00283 27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGE-----PFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFA 101 (496)
T ss_pred ccccCCCEEEEEEEecCCCEEEEEEEEcCCCC-----EEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeeccee
Confidence 34446799999999999999999999776554 79999885432 2345788999999999999999988776
Q ss_pred ccCCC----CceEEEEEeeCCCCChhhhccCC--CCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCC
Q 014363 156 DDDER----GIQRLLVYEYMPNGSVDQYLSPK--SETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE 229 (426)
Q Consensus 156 ~~~~~----~~~~~lv~E~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~ 229 (426)
..+.. ....++||||+++|+|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+|||++.
T Consensus 102 ~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~ 178 (496)
T PTZ00283 102 KKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCS 178 (496)
T ss_pred cccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeC
Confidence 43321 12358999999999999988643 234589999999999999999999998 9999999999999999
Q ss_pred CCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHH
Q 014363 230 QWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQ 309 (426)
Q Consensus 230 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~ 309 (426)
++.+||+|||+++..............+||+.|+|||++.+..++.++|||||||++|||++|..||....... ...
T Consensus 179 ~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~---~~~ 255 (496)
T PTZ00283 179 NGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE---VMH 255 (496)
T ss_pred CCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH---HHH
Confidence 99999999999986543322223345689999999999999999999999999999999999999997543211 111
Q ss_pred hHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 310 WVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
...... ....+..+++.+.+++.+||+.||++||++.+++++
T Consensus 256 -------------~~~~~~-~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 256 -------------KTLAGR-YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred -------------HHhcCC-CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 111100 111233456789999999999999999999999875
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=340.28 Aligned_cols=241 Identities=25% Similarity=0.360 Sum_probs=194.5
Q ss_pred ceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-----CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCceEE
Q 014363 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRL 165 (426)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~~~ 165 (426)
+.||+|+||.||+|.+..++. .+|+|.+.... ....+..|++++..++||||+++++++.+.+ ..|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~-----~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~----~~~ 71 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGR-----YYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD----RLC 71 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCC-----EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCC----EEE
Confidence 369999999999999876554 78999886431 2345678999999999999999999988765 459
Q ss_pred EEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhcc-CCCCCeEeccCCCCceEeCCCCCeeEeeecccccC
Q 014363 166 LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHE-GMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLG 244 (426)
Q Consensus 166 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~-~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 244 (426)
+||||+++|+|.+++... ..+++..+..++.||+.||+|||+ . +|+||||||+|||++.++.+||+|||++...
T Consensus 72 lv~E~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~ 146 (325)
T cd05594 72 FVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEG 146 (325)
T ss_pred EEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeec
Confidence 999999999999988644 348999999999999999999997 6 9999999999999999999999999998753
Q ss_pred CCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhh
Q 014363 245 PSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQI 324 (426)
Q Consensus 245 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (426)
.... .......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+
T Consensus 147 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i---------------- 208 (325)
T cd05594 147 IKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI---------------- 208 (325)
T ss_pred CCCC--cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHH----------------
Confidence 3221 1123457999999999999999999999999999999999999999754332111111
Q ss_pred cCCcCCCcccHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 014363 325 VDPRLEGKYSLRLVSKLSHVANLCLVKNARTRP-----KMSEVLEM 365 (426)
Q Consensus 325 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~ 365 (426)
.... ..++..++..+.+++.+||+.||++|+ ++.+++++
T Consensus 209 ~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 209 LMEE--IRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred hcCC--CCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 0000 112233557889999999999999996 89999886
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=328.08 Aligned_cols=259 Identities=25% Similarity=0.427 Sum_probs=202.8
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC---HHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG---HKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
.+|++.+.||+|+||.||+|.....+. .....+++|.+..... ...+.+|+.+++.++||||+++++++.....
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-- 81 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGM-DHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQP-- 81 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCC-CCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCc--
Confidence 467888899999999999998643321 2345789998865432 2467899999999999999999999887664
Q ss_pred ceEEEEEeeCCCCChhhhccCCC---------------CCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceE
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKS---------------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNIL 226 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~---------------~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NIL 226 (426)
.|+||||+++++|.+++.... ...+++..++.++.|++.||.|||++ +++||||||+|||
T Consensus 82 --~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nil 156 (283)
T cd05090 82 --VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNIL 156 (283)
T ss_pred --eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEE
Confidence 499999999999999985221 13478889999999999999999998 9999999999999
Q ss_pred eCCCCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhH
Q 014363 227 LDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQ 305 (426)
Q Consensus 227 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~ 305 (426)
++.++.+||+|||++................++..|+|||++.+..++.++||||||+++|||++ |..||.........
T Consensus 157 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~ 236 (283)
T cd05090 157 IGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVI 236 (283)
T ss_pred EcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 99999999999999986543332222334456778999999988889999999999999999998 99998754322111
Q ss_pred HHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 014363 306 KLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNK 368 (426)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~ 368 (426)
.. .. .......+..++..+.+++.+||+.||++||++.+|+++|..
T Consensus 237 ~~---~~--------------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 237 EM---VR--------------KRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HH---HH--------------cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11 10 000011222345688999999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=336.30 Aligned_cols=246 Identities=26% Similarity=0.413 Sum_probs=196.6
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-----CCHHHHHHHHHHHhhcCCC-CccceEeEEEccCC
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-----GGHKEWMTEVNFLGIVEHQ-NLVKLVGYCADDDE 159 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-----~~~~~~~~E~~~l~~l~Hp-nIv~~~~~~~~~~~ 159 (426)
+|++++.||+|+||.||+|....++. .||+|.+... ...+.+..|+.++..+.|+ +|+++++++.+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~-----~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~- 74 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDE-----LYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD- 74 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCC-----EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC-
Confidence 47888999999999999999877654 7899987642 2345678899999999765 5888888887765
Q ss_pred CCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeec
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 239 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 239 (426)
..|+||||+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 75 ---~~~lv~E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg 146 (324)
T cd05587 75 ---RLYFVMEYVNGGDLMYHIQQVG--KFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFG 146 (324)
T ss_pred ---EEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecC
Confidence 4599999999999999986543 488999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014363 240 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 319 (426)
Q Consensus 240 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 319 (426)
++....... ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ...
T Consensus 147 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~~~---------- 211 (324)
T cd05587 147 MCKENIFGG--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE---LFQ---------- 211 (324)
T ss_pred cceecCCCC--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---HHH----------
Confidence 987432221 12335679999999999999999999999999999999999999997654221 111
Q ss_pred hhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCH-----HHHHHH
Q 014363 320 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKM-----SEVLEM 365 (426)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~-----~eil~~ 365 (426)
.+... ...++..++..+.+++.+||..||++|++. ++++++
T Consensus 212 ---~i~~~--~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 212 ---SIMEH--NVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred ---HHHcC--CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 11111 112233456788999999999999999986 666654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=326.94 Aligned_cols=260 Identities=25% Similarity=0.438 Sum_probs=203.6
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
.++|.+.+.||+|+||.||+|.+...........+++|.+.... ....+..|+.+++.++|+||+++++++.+....
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 45788999999999999999998763333345578999876443 234688999999999999999999998876543
Q ss_pred CceEEEEEeeCCCCChhhhccCCCC-----CccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCC---C
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSE-----TILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW---N 232 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~-----~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~---~ 232 (426)
++||||+++++|.+++..... ..+++..++.++.||+.||+|||++ +++||||||+|||++.++ .
T Consensus 85 ----~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~ 157 (277)
T cd05036 85 ----FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRV 157 (277)
T ss_pred ----EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcc
Confidence 899999999999999865431 2489999999999999999999998 999999999999998765 5
Q ss_pred eeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhH
Q 014363 233 AKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWV 311 (426)
Q Consensus 233 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~ 311 (426)
+||+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||...........+
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~--- 234 (277)
T cd05036 158 AKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFV--- 234 (277)
T ss_pred eEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH---
Confidence 99999999986533222111122234568999999998999999999999999999997 99999764432211111
Q ss_pred hhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014363 312 KPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVN 367 (426)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~ 367 (426)
........+..++..+.+++.+||+.+|++||++.+|+++|+
T Consensus 235 --------------~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 235 --------------TGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred --------------HcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 001111223345678899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=326.49 Aligned_cols=274 Identities=27% Similarity=0.433 Sum_probs=206.0
Q ss_pred CC-CCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 86 NF-SRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 86 ~y-~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
+| ...+.||+|+||+||++..... .......+++|.+.... ....+.+|+++|+.++||||+++++++......
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~-~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~- 81 (283)
T cd05080 4 RYLKKIRVLGEGHFGKVSLYCYDPA-NDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGK- 81 (283)
T ss_pred hhceeceecccCCCcEEEEeeEccc-cCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCc-
Confidence 44 8889999999999998875432 12234478999886543 345788999999999999999999998765433
Q ss_pred ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccc
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 241 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 241 (426)
..++||||+++++|.+++... .+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 82 -~~~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~ 154 (283)
T cd05080 82 -GLQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLA 154 (283)
T ss_pred -eEEEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccc
Confidence 458999999999999998643 389999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCce-eeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhh
Q 014363 242 RLGPSEGFT-HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 320 (426)
Q Consensus 242 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (426)
......... .......++..|+|||++.+..++.++||||||+++|+|++|..||........ ......... .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~-~~~~~ 232 (283)
T cd05080 155 KAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQ-MTVVR 232 (283)
T ss_pred cccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhcccccc-cchhh
Confidence 865432211 111223456779999999888899999999999999999999999865432111 111100000 00011
Q ss_pred hhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhH
Q 014363 321 FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIV 370 (426)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~ 370 (426)
..+..+.......+..++..+.+++.+||+.+|++|||+++|++.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 233 LIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 11122222222223345678999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-43 Score=327.14 Aligned_cols=260 Identities=25% Similarity=0.438 Sum_probs=206.9
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC---HHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG---HKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
.++|.+.+.||+|+||.||+|.............+++|.+..... ...+.+|+.++..++||||+++++++.....
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~- 83 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP- 83 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC-
Confidence 357888999999999999999987655445566899999865432 3467899999999999999999999987654
Q ss_pred CceEEEEEeeCCCCChhhhccCCC--------CCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCC
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKS--------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWN 232 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~--------~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~ 232 (426)
.++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+. +++||||||+|||++.++.
T Consensus 84 ---~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~ 157 (277)
T cd05032 84 ---TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLT 157 (277)
T ss_pred ---cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCC
Confidence 499999999999999986432 12368889999999999999999998 9999999999999999999
Q ss_pred eeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhH
Q 014363 233 AKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWV 311 (426)
Q Consensus 233 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~ 311 (426)
+||+|||+++...............++..|+|||.+.++.++.++||||||+++|||++ |..||............
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~--- 234 (277)
T cd05032 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFV--- 234 (277)
T ss_pred EEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHH---
Confidence 99999999876543322222233457889999999988889999999999999999998 99999754432211111
Q ss_pred hhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014363 312 KPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVN 367 (426)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~ 367 (426)
. . ......+..++..+.+++.+||+.+|++|||+.++++.|+
T Consensus 235 ~-------------~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 235 I-------------D-GGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred h-------------c-CCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 0 0 0011112234678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=345.40 Aligned_cols=252 Identities=23% Similarity=0.320 Sum_probs=196.8
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-----CHHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
.|..++.||+|+||+||+|.+..++. .+|+|.+.... ....+.+|+.++..++||||+++++++.+.+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~-----~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~-- 74 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHA-----LYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKD-- 74 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCC-----EEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCC--
Confidence 58889999999999999999877654 78999886432 2346789999999999999999999998765
Q ss_pred CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecc
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 240 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 240 (426)
.+|+||||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+
T Consensus 75 --~~~lv~E~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl 147 (381)
T cd05626 75 --NLYFVMDYIPGGDMMSLLIRME--VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGL 147 (381)
T ss_pred --EEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcC
Confidence 4599999999999999986543 488999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCc---------------------------------------------eeeeeeeecCcccCCchhhccCCCCC
Q 014363 241 ARLGPSEGF---------------------------------------------THVSTAVVGTMGYAAPEYVQTGRLAA 275 (426)
Q Consensus 241 a~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ 275 (426)
+........ .......+||+.|+|||++.+..++.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ 227 (381)
T cd05626 148 CTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQ 227 (381)
T ss_pred CcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCC
Confidence 753211000 00012357999999999999889999
Q ss_pred chhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHh--ccccCC
Q 014363 276 RSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANL--CLVKNA 353 (426)
Q Consensus 276 ~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--cl~~dp 353 (426)
++|||||||++|||++|..||...........+. . ....+.......++.++.+++.+ |+..++
T Consensus 228 ~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~-------------~-~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~ 293 (381)
T cd05626 228 LCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVI-------------N-WENTLHIPPQVKLSPEAVDLITKLCCSAEER 293 (381)
T ss_pred ccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHH-------------c-cccccCCCCCCCCCHHHHHHHHHHccCcccc
Confidence 9999999999999999999997654322211100 0 00001111111345678888887 556666
Q ss_pred CCCCCHHHHHHH
Q 014363 354 RTRPKMSEVLEM 365 (426)
Q Consensus 354 ~~RPs~~eil~~ 365 (426)
..||++.+++.|
T Consensus 294 ~~R~~~~~~l~h 305 (381)
T cd05626 294 LGRNGADDIKAH 305 (381)
T ss_pred cCCCCHHHHhcC
Confidence 679999999987
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=335.54 Aligned_cols=241 Identities=28% Similarity=0.422 Sum_probs=193.4
Q ss_pred ceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-----CCHHHHHHHHHHHhhc-CCCCccceEeEEEccCCCCceE
Q 014363 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-----GGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDERGIQR 164 (426)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-----~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~~~~~~ 164 (426)
++||+|+||.||+|.++.++. .||+|.+... .....+..|..++..+ +||||+++++++.+.+ ..
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~-----~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~----~~ 71 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGR-----LYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPD----RL 71 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCC-----EEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCC----EE
Confidence 369999999999999876654 7899987543 2345677888888876 7999999999998765 45
Q ss_pred EEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccC
Q 014363 165 LLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLG 244 (426)
Q Consensus 165 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 244 (426)
|+||||+++|+|.+++.... .+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 72 ~iv~Ey~~~g~L~~~i~~~~--~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~ 146 (320)
T cd05590 72 FFVMEFVNGGDLMFHIQKSR--RFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 146 (320)
T ss_pred EEEEcCCCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeec
Confidence 99999999999999886543 489999999999999999999998 9999999999999999999999999998754
Q ss_pred CCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhh
Q 014363 245 PSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQI 324 (426)
Q Consensus 245 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (426)
.... .......||+.|+|||++.+..++.++|||||||++|+|++|..||......... . .+
T Consensus 147 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~---~-------------~i 208 (320)
T cd05590 147 IFNG--KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLF---E-------------AI 208 (320)
T ss_pred CcCC--CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHH---H-------------HH
Confidence 3221 1233467999999999999989999999999999999999999999765432111 1 11
Q ss_pred cCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCH------HHHHHH
Q 014363 325 VDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKM------SEVLEM 365 (426)
Q Consensus 325 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~------~eil~~ 365 (426)
..... .++..++..+.+++.+||+.||++||++ ++++.|
T Consensus 209 ~~~~~--~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 209 LNDEV--VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred hcCCC--CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 11110 1222355788999999999999999998 667665
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=322.47 Aligned_cols=254 Identities=26% Similarity=0.429 Sum_probs=203.7
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCc
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 162 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~ 162 (426)
.++|+..+.||+|+||.||+|.+..+ ..|++|.+.... ..+.+.+|+.+++.++||||+++++++.....
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~------~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--- 75 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNT------TPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEP--- 75 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCC------eEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCC---
Confidence 45688999999999999999986543 268999886543 45678999999999999999999999887654
Q ss_pred eEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccc
Q 014363 163 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 242 (426)
Q Consensus 163 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 242 (426)
.++||||+++++|.+++.......+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.
T Consensus 76 -~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~ 151 (261)
T cd05068 76 -IYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLAR 151 (261)
T ss_pred -eeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEE
Confidence 49999999999999999765545689999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhh
Q 014363 243 LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 321 (426)
Q Consensus 243 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (426)
........ ......++..|+|||++.+..++.++||||||+++|+|++ |..||...........+
T Consensus 152 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~------------- 217 (261)
T cd05068 152 VIKEDIYE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQV------------- 217 (261)
T ss_pred EccCCccc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH-------------
Confidence 66532211 1111223457999999988889999999999999999999 99999754322111110
Q ss_pred hhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 014363 322 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNK 368 (426)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~ 368 (426)
........+...+..+.+++.+||+.+|++||++.+|++.|++
T Consensus 218 ----~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 218 ----DQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred ----HcCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 0000111223355789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=321.58 Aligned_cols=249 Identities=28% Similarity=0.473 Sum_probs=202.3
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCceE
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQR 164 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~~ 164 (426)
.+|...+.||+|+||.||+|...+. .+++|.+......+.+.+|+.+++.++|+||+++++++...+. ..
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~-------~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~---~~ 75 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYRGN-------KVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG---GL 75 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEcCC-------cEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCC---ce
Confidence 4688889999999999999976532 6889988776667789999999999999999999998755432 35
Q ss_pred EEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccC
Q 014363 165 LLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLG 244 (426)
Q Consensus 165 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 244 (426)
++||||+++++|.+++.......+++..++.++.|++.||+|||++ +++||||||+||++++++.+||+|||++...
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~ 152 (256)
T cd05082 76 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 152 (256)
T ss_pred EEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceec
Confidence 9999999999999999765555689999999999999999999998 9999999999999999999999999998754
Q ss_pred CCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhhhh
Q 014363 245 PSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQ 323 (426)
Q Consensus 245 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (426)
... .....++..|+|||++.+..++.++||||||+++|+|++ |..||....... +....
T Consensus 153 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~---~~~~~------------ 212 (256)
T cd05082 153 SST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRV------------ 212 (256)
T ss_pred ccc-----CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH------------
Confidence 322 122345678999999998889999999999999999998 999986543211 11110
Q ss_pred hcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 014363 324 IVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNK 368 (426)
Q Consensus 324 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~ 368 (426)
...........++..+.+++.+||+.+|++|||+.++++.|+.
T Consensus 213 --~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 213 --EKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred --hcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 0011111223356789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=344.60 Aligned_cols=250 Identities=26% Similarity=0.362 Sum_probs=200.0
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-----CCHHHHHHHHHHHhhcCCCCccceEeEEEccC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-----GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 158 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 158 (426)
.++|+..+.||+|+||.||+|.+..++. .+|+|.+... .....+.+|+.+++.++||||+++++++.+..
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~-----~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~ 116 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQ-----VYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDK 116 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCC-----EEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 4679999999999999999999876654 7899988532 23345778999999999999999999988765
Q ss_pred CCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeee
Q 014363 159 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 238 (426)
Q Consensus 159 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 238 (426)
..|+||||+++|+|.+++... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 117 ----~~~lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~Df 186 (370)
T cd05596 117 ----YLYMVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF 186 (370)
T ss_pred ----EEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEec
Confidence 459999999999999998643 378888999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCchhhccC----CCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhh
Q 014363 239 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG----RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPY 314 (426)
Q Consensus 239 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 314 (426)
|++........ ......+||+.|+|||++.+. .++.++|||||||++|||++|..||........
T Consensus 187 G~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~---------- 255 (370)
T cd05596 187 GTCMKMDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT---------- 255 (370)
T ss_pred cceeeccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHH----------
Confidence 99976543221 112346799999999998653 378899999999999999999999976443211
Q ss_pred hhhhhhhhhhcCCc--CCCcccHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 014363 315 LSDAKQFRQIVDPR--LEGKYSLRLVSKLSHVANLCLVKNART--RPKMSEVLEM 365 (426)
Q Consensus 315 ~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~eil~~ 365 (426)
+..+.... +.......++..+.+++.+||+.+|.+ |+++.++++|
T Consensus 256 ------~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 256 ------YSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred ------HHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 11111111 111111135678999999999999987 9999999987
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-43 Score=333.95 Aligned_cols=241 Identities=24% Similarity=0.419 Sum_probs=191.1
Q ss_pred ceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-----CCHHHHHHHHHHHhhc-CCCCccceEeEEEccCCCCceE
Q 014363 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-----GGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDERGIQR 164 (426)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-----~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~~~~~~ 164 (426)
++||+|+||.||+|.+..++. .||+|.+... ...+.+..|..++..+ +||||+++++++.... ..
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~----~~ 71 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNE-----FFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKE----HL 71 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCC-----EEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCC----EE
Confidence 369999999999999877654 7899988643 2334556677777654 8999999999988765 45
Q ss_pred EEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccC
Q 014363 165 LLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLG 244 (426)
Q Consensus 165 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 244 (426)
|+||||+++|+|.+++.... .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 72 ~lv~e~~~gg~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~ 146 (316)
T cd05592 72 FFVMEYLNGGDLMFHIQSSG--RFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKEN 146 (316)
T ss_pred EEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeEC
Confidence 99999999999999886543 489999999999999999999998 9999999999999999999999999999754
Q ss_pred CCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhh
Q 014363 245 PSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQI 324 (426)
Q Consensus 245 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (426)
.... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||....... ... .+
T Consensus 147 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~---~~~-------------~i 208 (316)
T cd05592 147 MNGE--GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE---LFD-------------SI 208 (316)
T ss_pred CCCC--CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH---HHH-------------HH
Confidence 3221 22345679999999999999899999999999999999999999997643221 111 01
Q ss_pred cCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHH-HHHHH
Q 014363 325 VDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMS-EVLEM 365 (426)
Q Consensus 325 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~-eil~~ 365 (426)
... ...++..++..+.+++.+||+.||++||++. +++++
T Consensus 209 ~~~--~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05592 209 LND--RPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQH 248 (316)
T ss_pred HcC--CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 000 1122333566788999999999999999875 56553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=342.81 Aligned_cols=251 Identities=25% Similarity=0.364 Sum_probs=199.2
Q ss_pred HhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-----CCHHHHHHHHHHHhhcCCCCccceEeEEEcc
Q 014363 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-----GGHKEWMTEVNFLGIVEHQNLVKLVGYCADD 157 (426)
Q Consensus 83 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 157 (426)
..++|+..+.||+|+||.||+|.+..++. .+|+|.+... .....+.+|+.+++.++||||+++++++.+.
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~-----~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQK-----VYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD 115 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCC-----EEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence 35689999999999999999999877654 7899987532 2334577899999999999999999999876
Q ss_pred CCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEee
Q 014363 158 DERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 237 (426)
Q Consensus 158 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~D 237 (426)
. ..|+||||+++|+|.+++... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 116 ~----~~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~D 185 (370)
T cd05621 116 K----YLYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLAD 185 (370)
T ss_pred C----EEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEe
Confidence 5 459999999999999998643 378899999999999999999998 999999999999999999999999
Q ss_pred ecccccCCCCCceeeeeeeecCcccCCchhhccCC----CCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhh
Q 014363 238 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGR----LAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKP 313 (426)
Q Consensus 238 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~ 313 (426)
||++........ ......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||........
T Consensus 186 FG~a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~--------- 255 (370)
T cd05621 186 FGTCMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT--------- 255 (370)
T ss_pred cccceecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH---------
Confidence 999986543221 1223567999999999987543 78899999999999999999999976532211
Q ss_pred hhhhhhhhhhhcCCc--CCCcccHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 014363 314 YLSDAKQFRQIVDPR--LEGKYSLRLVSKLSHVANLCLVKNART--RPKMSEVLEM 365 (426)
Q Consensus 314 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~eil~~ 365 (426)
...+++.. +.......++..+.+++.+||..++.+ |+++.|+++|
T Consensus 256 -------~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 256 -------YSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred -------HHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 11111111 111111235678889999999855543 8999999997
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=324.56 Aligned_cols=261 Identities=26% Similarity=0.432 Sum_probs=205.2
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC---HHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG---HKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
..+|...+.||+|+||.||+|.+...+.. ..+.||+|.+..... ...+.+|+.++..++||||+++++++....
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~-~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-- 82 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGEN-VKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTST-- 82 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCc-cceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCCC--
Confidence 35688889999999999999997765432 244589998865432 356789999999999999999999987543
Q ss_pred CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecc
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 240 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 240 (426)
.+++|||+++|+|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+
T Consensus 83 ---~~l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~ 155 (279)
T cd05109 83 ---VQLVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGL 155 (279)
T ss_pred ---cEEEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCc
Confidence 379999999999999987543 3589999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014363 241 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAK 319 (426)
Q Consensus 241 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 319 (426)
++...............+++.|+|||.+.+..++.++||||||+++|||++ |..||........... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~---~~------- 225 (279)
T cd05109 156 ARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDL---LE------- 225 (279)
T ss_pred eeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH---HH-------
Confidence 986643322211222345678999999988899999999999999999998 8999875433211111 10
Q ss_pred hhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHh
Q 014363 320 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVD 371 (426)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~ 371 (426)
.......+..++..+.+++.+||+.||++||++.++++.|..+..
T Consensus 226 -------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 226 -------KGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred -------CCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 000111122345678999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=344.93 Aligned_cols=251 Identities=24% Similarity=0.312 Sum_probs=196.0
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-----CHHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
.|+.+++||+|+||.||+|....++. .+|+|.+.... ....+.+|+.+++.++||||+++++.+.+.+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~-----~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~-- 74 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKA-----LYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD-- 74 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCC-----EEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCC--
Confidence 58889999999999999999876654 78999886432 2346788999999999999999999998765
Q ss_pred CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecc
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 240 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 240 (426)
..|+||||+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 75 --~~~lv~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGl 147 (382)
T cd05625 75 --NLYFVMDYIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGL 147 (382)
T ss_pred --EEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCC
Confidence 459999999999999998654 3488999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCC---------------------------------------------ceeeeeeeecCcccCCchhhccCCCCC
Q 014363 241 ARLGPSEG---------------------------------------------FTHVSTAVVGTMGYAAPEYVQTGRLAA 275 (426)
Q Consensus 241 a~~~~~~~---------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~ 275 (426)
+....... ........+||+.|+|||++.+..++.
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ 227 (382)
T cd05625 148 CTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQ 227 (382)
T ss_pred CccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCC
Confidence 75321000 000112357999999999999999999
Q ss_pred chhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCC
Q 014363 276 RSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNART 355 (426)
Q Consensus 276 ~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~ 355 (426)
++|||||||++|||++|..||....+......+. . ....+.......+++++.+++.+|+ .+|++
T Consensus 228 ~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~-------------~-~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~ 292 (382)
T cd05625 228 LCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVI-------------N-WQTSLHIPPQAKLSPEASDLIIKLC-RGPED 292 (382)
T ss_pred eeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHH-------------c-cCCCcCCCCcccCCHHHHHHHHHHc-cCHhH
Confidence 9999999999999999999997654322111100 0 0001111111234567888888876 59999
Q ss_pred CCC---HHHHHHH
Q 014363 356 RPK---MSEVLEM 365 (426)
Q Consensus 356 RPs---~~eil~~ 365 (426)
|++ ++++++|
T Consensus 293 R~~~~~~~ei~~h 305 (382)
T cd05625 293 RLGKNGADEIKAH 305 (382)
T ss_pred cCCCCCHHHHhcC
Confidence 987 8888876
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=323.29 Aligned_cols=260 Identities=23% Similarity=0.427 Sum_probs=199.4
Q ss_pred CCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc----CCHHHHHHHHHHHhhcCCCCccceEeEEEccCC--C
Q 014363 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR----GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE--R 160 (426)
Q Consensus 87 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~--~ 160 (426)
|.+.+.||+|+||.||+|.+...+. ...+|+|.+... ...+.+..|+.+++.++||||+++++++..... .
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~---~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 77 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDS---ILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEG 77 (272)
T ss_pred CccccccCcccCceEEEeEEccCCC---eeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccC
Confidence 3566789999999999998766532 235888887543 234568889999999999999999998754321 1
Q ss_pred CceEEEEEeeCCCCChhhhccCC----CCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEe
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPK----SETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLS 236 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~----~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~ 236 (426)
....++||||+++|+|.+++... ....+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+
T Consensus 78 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~ 154 (272)
T cd05075 78 YPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVA 154 (272)
T ss_pred CCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEEC
Confidence 22458999999999999887421 224488999999999999999999998 99999999999999999999999
Q ss_pred eecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhh
Q 014363 237 DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYL 315 (426)
Q Consensus 237 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 315 (426)
|||++................+++.|++||++.+..++.++||||||+++|+|++ |..||....... .....
T Consensus 155 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~~~---- 227 (272)
T cd05075 155 DFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE---IYDYL---- 227 (272)
T ss_pred CCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHH----
Confidence 9999986644322222223346778999999998899999999999999999999 889987543221 11110
Q ss_pred hhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHh
Q 014363 316 SDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 369 (426)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~ 369 (426)
.... . ...+..++..+.+++.+||+.||++|||+.+|++.|+.+
T Consensus 228 ~~~~--------~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 228 RQGN--------R--LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred HcCC--------C--CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0000 0 011123456789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=340.21 Aligned_cols=265 Identities=23% Similarity=0.312 Sum_probs=200.4
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCce
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQ 163 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~ 163 (426)
..+|.+++.||+|+||.||+|...+.. ....|++|.+... ....+|+.+|+.++||||+++++++.... .
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~---~~~~v~vK~~~~~---~~~~~E~~il~~l~h~~iv~~~~~~~~~~----~ 160 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDE---QRKKVIVKAVTGG---KTPGREIDILKTISHRAIINLIHAYRWKS----T 160 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCc---cceeEEEEecccc---ccHHHHHHHHHhcCCCCccceeeeEeeCC----E
Confidence 457999999999999999999765432 3457888987654 34568999999999999999999988765 4
Q ss_pred EEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccccc
Q 014363 164 RLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL 243 (426)
Q Consensus 164 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 243 (426)
.|+|||++. ++|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 161 ~~lv~e~~~-~~l~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~ 234 (392)
T PHA03207 161 VCMVMPKYK-CDLFTYVDRS--GPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACK 234 (392)
T ss_pred EEEEehhcC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccc
Confidence 599999995 6888888433 4589999999999999999999998 999999999999999999999999999976
Q ss_pred CCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhH-HHHHhHhhhh------h
Q 014363 244 GPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQ-KLLQWVKPYL------S 316 (426)
Q Consensus 244 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~-~~~~~~~~~~------~ 316 (426)
..............||+.|+|||++.+..|+.++|||||||++|||++|..||.+....... .+.......- .
T Consensus 235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~ 314 (392)
T PHA03207 235 LDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFP 314 (392)
T ss_pred cCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccC
Confidence 54433222233567999999999999999999999999999999999999999765432211 1111110000 0
Q ss_pred h------hhhhhhhcCCcCCCccc-------HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 317 D------AKQFRQIVDPRLEGKYS-------LRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 317 ~------~~~~~~~~~~~~~~~~~-------~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
. ...+.+.. ......+. ...+.++.++|.+||..||++|||+.|++.+
T Consensus 315 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 315 QNGSTNLCKHFKQYA-IVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred CccchhHHHHHHhhc-ccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 00001110 00111010 1234578899999999999999999999997
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-43 Score=324.78 Aligned_cols=253 Identities=28% Similarity=0.484 Sum_probs=206.0
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC--CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
..+|+..+.||.|+||.||+|.+.... .+++|.+.... ....+..|+.+++.++||||+++++++.+...
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~------~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-- 76 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRV------RVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEP-- 76 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCC------cEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCC--
Confidence 456888999999999999999987732 68888886554 34678899999999999999999999987664
Q ss_pred ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccc
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 241 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 241 (426)
.++||||+++++|.+++.......+++..++.++.|++.||.|||++ +++|+||||+|||+++++.+||+|||++
T Consensus 77 --~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~ 151 (261)
T cd05148 77 --VYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLA 151 (261)
T ss_pred --eEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccch
Confidence 49999999999999999865556689999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhh
Q 014363 242 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 320 (426)
Q Consensus 242 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (426)
......... .....++..|+|||++.+..++.++||||||+++|+|++ |..||....... .....
T Consensus 152 ~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~---~~~~~--------- 217 (261)
T cd05148 152 RLIKEDVYL--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE---VYDQI--------- 217 (261)
T ss_pred hhcCCcccc--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH---HHHHH---------
Confidence 765433211 123346778999999988889999999999999999998 899997543211 11111
Q ss_pred hhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 014363 321 FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNK 368 (426)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~ 368 (426)
. .......+..++..+.+++.+||+.||++|||++++++.|+.
T Consensus 218 ----~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 218 ----T-AGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred ----H-hCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 0 011111223455788999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=344.28 Aligned_cols=252 Identities=23% Similarity=0.278 Sum_probs=195.9
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-----CHHHHHHHHHHHhhcCCCCccceEeEEEccCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
++|..++.||+|+||.||+|....++. .||+|.+.... ..+.+.+|++++..++||||+++++++.+..
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~-----~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~- 74 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGK-----IYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQ- 74 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCC-----EEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC-
Confidence 468899999999999999999876654 78999875432 2346788999999999999999999998766
Q ss_pred CCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeec
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 239 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 239 (426)
..|+||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 75 ---~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfG 146 (377)
T cd05629 75 ---YLYLIMEFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFG 146 (377)
T ss_pred ---eeEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecc
Confidence 359999999999999998654 3488999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCce---------------------------------------------eeeeeeecCcccCCchhhccCCCC
Q 014363 240 LARLGPSEGFT---------------------------------------------HVSTAVVGTMGYAAPEYVQTGRLA 274 (426)
Q Consensus 240 la~~~~~~~~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~ 274 (426)
+++........ ......+||+.|+|||++.+..++
T Consensus 147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 226 (377)
T cd05629 147 LSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYG 226 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCC
Confidence 98632210000 000124799999999999999999
Q ss_pred CchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCC
Q 014363 275 ARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNAR 354 (426)
Q Consensus 275 ~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~ 354 (426)
.++|||||||++|||++|..||...........+. .. ...+.-.....++..+.+++.+||. +|.
T Consensus 227 ~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~------~~--------~~~~~~p~~~~~s~~~~dli~~lL~-~~~ 291 (377)
T cd05629 227 QECDWWSLGAIMFECLIGWPPFCSENSHETYRKII------NW--------RETLYFPDDIHLSVEAEDLIRRLIT-NAE 291 (377)
T ss_pred CceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHH------cc--------CCccCCCCCCCCCHHHHHHHHHHhc-CHh
Confidence 99999999999999999999997654321111000 00 0000000011245678899999997 677
Q ss_pred CC---CCHHHHHHH
Q 014363 355 TR---PKMSEVLEM 365 (426)
Q Consensus 355 ~R---Ps~~eil~~ 365 (426)
+| +++.|++.+
T Consensus 292 ~r~~r~~~~~~l~h 305 (377)
T cd05629 292 NRLGRGGAHEIKSH 305 (377)
T ss_pred hcCCCCCHHHHhcC
Confidence 65 599999987
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=335.41 Aligned_cols=244 Identities=27% Similarity=0.408 Sum_probs=194.5
Q ss_pred ceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc------CCHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCceE
Q 014363 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR------GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQR 164 (426)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~------~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~~ 164 (426)
+.||+|+||.||++...... .....+|+|.+... .....+..|+.+|+.++||||+++++++.+.+ ..
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~----~~ 75 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGA--DTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGG----KL 75 (323)
T ss_pred ceeeecCCeEEEEEEEcccC--CCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCC----eE
Confidence 57999999999999864322 23447899987542 12345678999999999999999999998765 45
Q ss_pred EEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccC
Q 014363 165 LLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLG 244 (426)
Q Consensus 165 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 244 (426)
|+||||+++++|.+++... ..+.+..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 76 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 150 (323)
T cd05584 76 YLILEYLSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKES 150 (323)
T ss_pred EEEEeCCCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeec
Confidence 9999999999999998654 3478888999999999999999998 9999999999999999999999999998753
Q ss_pred CCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhh
Q 014363 245 PSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQI 324 (426)
Q Consensus 245 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (426)
.... .......||+.|+|||++.+..++.++|||||||++|||++|..||......... ..+
T Consensus 151 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~----------------~~~ 212 (323)
T cd05584 151 IHEG--TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTI----------------DKI 212 (323)
T ss_pred ccCC--CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHH----------------HHH
Confidence 3221 1223467999999999999888999999999999999999999999764432111 111
Q ss_pred cCCcCCCcccHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 014363 325 VDPRLEGKYSLRLVSKLSHVANLCLVKNARTRP-----KMSEVLEM 365 (426)
Q Consensus 325 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~ 365 (426)
..... ..+..++..+.+++.+||+.||++|| ++++++++
T Consensus 213 ~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 213 LKGKL--NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred HcCCC--CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 11111 12223456889999999999999999 89998885
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=347.40 Aligned_cols=268 Identities=24% Similarity=0.346 Sum_probs=196.4
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhcCCCCccceEeEEEccC----C
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQNLVKLVGYCADDD----E 159 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~----~ 159 (426)
.++|..++.||+|+||.||+|.+...+. .||+|.+.... ....+|+.+|+.++||||+++++++.... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~-----~vAiK~i~~~~--~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSE-----KVAIKKVLQDP--QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCC-----EEEEEEEecCc--chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 4679999999999999999999876554 78999875443 23457999999999999999999875432 2
Q ss_pred CCceEEEEEeeCCCCChhhhccC--CCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCC-CeeEe
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSP--KSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW-NAKLS 236 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~--~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~-~~kl~ 236 (426)
....+++||||+++ +|.+++.. .....+++..++.++.||+.||+|||++ +|+||||||+|||++.++ .+||+
T Consensus 138 ~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~ 213 (440)
T PTZ00036 138 KNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLC 213 (440)
T ss_pred CceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeee
Confidence 22346799999975 67666642 2234589999999999999999999998 999999999999998665 69999
Q ss_pred eecccccCCCCCceeeeeeeecCcccCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHH-HHhHh-h
Q 014363 237 DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKL-LQWVK-P 313 (426)
Q Consensus 237 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~-~~~~~-~ 313 (426)
|||+++...... ......||+.|+|||++.+. .|+.++|||||||++|||++|.+||.+......... .+... +
T Consensus 214 DFGla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p 290 (440)
T PTZ00036 214 DFGSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTP 290 (440)
T ss_pred ccccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 999998654321 12345789999999988764 689999999999999999999999976543322111 11100 0
Q ss_pred hhhhh----hhhhhhcCC-----cCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 314 YLSDA----KQFRQIVDP-----RLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 314 ~~~~~----~~~~~~~~~-----~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
..... ..+..+.-+ .+...++...+.++.+||.+||+.||.+|||+.|+++|
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 00000 000000000 11111222345689999999999999999999999987
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=345.56 Aligned_cols=252 Identities=25% Similarity=0.301 Sum_probs=197.7
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-----CCHHHHHHHHHHHhhcCCCCccceEeEEEccCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-----GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
++|++++.||+|+||.||+|....++. .+|+|.+... .....+.+|+.+|+.++||||+++++++.+.+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~-----~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~- 74 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNA-----LYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKD- 74 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCC-----EEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCC-
Confidence 368999999999999999999876654 7999988542 23456789999999999999999999998765
Q ss_pred CCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeec
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 239 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 239 (426)
.+|+||||+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 75 ---~~~lv~E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG 146 (376)
T cd05598 75 ---NLYFVMDYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFG 146 (376)
T ss_pred ---EEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCC
Confidence 459999999999999999654 3488899999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCC-----------------------------------------ceeeeeeeecCcccCCchhhccCCCCCchh
Q 014363 240 LARLGPSEG-----------------------------------------FTHVSTAVVGTMGYAAPEYVQTGRLAARSD 278 (426)
Q Consensus 240 la~~~~~~~-----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 278 (426)
++....... ........+||+.|+|||++.+..++.++|
T Consensus 147 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 226 (376)
T cd05598 147 LCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD 226 (376)
T ss_pred CCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCccee
Confidence 975321000 000012357999999999999999999999
Q ss_pred hHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCC-
Q 014363 279 VWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRP- 357 (426)
Q Consensus 279 vwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP- 357 (426)
||||||++|||++|..||....+......+... ...+.......++..+.+++.+|+ .+|.+|+
T Consensus 227 iwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~--------------~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~ 291 (376)
T cd05598 227 WWSVGVILYEMLVGQPPFLADTPAETQLKVINW--------------ETTLHIPSQAKLSREASDLILRLC-CGAEDRLG 291 (376)
T ss_pred eeeccceeeehhhCCCCCCCCCHHHHHHHHhcc--------------CccccCCCCCCCCHHHHHHHHHHh-cCHhhcCC
Confidence 999999999999999999865543221111000 000000111134567788888876 5999999
Q ss_pred --CHHHHHHH
Q 014363 358 --KMSEVLEM 365 (426)
Q Consensus 358 --s~~eil~~ 365 (426)
++.+++++
T Consensus 292 ~~t~~ell~h 301 (376)
T cd05598 292 KNGADEIKAH 301 (376)
T ss_pred CCCHHHHhCC
Confidence 99999987
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=318.29 Aligned_cols=270 Identities=23% Similarity=0.301 Sum_probs=204.0
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCC-ccceEeEEEccCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQN-LVKLVGYCADDDE 159 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~Hpn-Iv~~~~~~~~~~~ 159 (426)
..|..+++||+|+||+||+|+.+.++. .||+|++.-.. ......+|+.+|+.|+|+| ||.+++++.....
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~-----~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~ 85 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGK-----FVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNN 85 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCC-----EEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccc
Confidence 346666789999999999999888774 89999885432 3456789999999999999 9999999987652
Q ss_pred --CCceEEEEEeeCCCCChhhhccCCCC--CccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeE
Q 014363 160 --RGIQRLLVYEYMPNGSVDQYLSPKSE--TILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKL 235 (426)
Q Consensus 160 --~~~~~~lv~E~~~~g~L~~~l~~~~~--~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl 235 (426)
....+++|+||+ ..+|..++..... ..++...+..++.||+.||+|||++ +|+||||||.||||+++|.+||
T Consensus 86 ~~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKl 161 (323)
T KOG0594|consen 86 HRGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKL 161 (323)
T ss_pred ccccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEee
Confidence 223568999999 5599999987653 3577789999999999999999999 9999999999999999999999
Q ss_pred eeecccccCCCCCceeeeeeeecCcccCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhH---
Q 014363 236 SDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWV--- 311 (426)
Q Consensus 236 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~--- 311 (426)
+|||+|+...-... .-+..++|.+|.|||++.+. .|+..+||||+|||++||++++.-|.+.........+--.
T Consensus 162 aDFGlAra~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGt 239 (323)
T KOG0594|consen 162 ADFGLARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGT 239 (323)
T ss_pred eccchHHHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCC
Confidence 99999996553322 13456799999999999886 6999999999999999999999989876653322221111
Q ss_pred -----hhhhhhhhhhhhhcCCcC-CCcccH---HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 312 -----KPYLSDAKQFRQIVDPRL-EGKYSL---RLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 312 -----~~~~~~~~~~~~~~~~~~-~~~~~~---~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
+|...............- ...+.. .......+++.+||+.+|.+|.|++.++.|
T Consensus 240 P~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 240 PNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 111100000000000000 001111 111478899999999999999999999997
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-43 Score=336.86 Aligned_cols=254 Identities=26% Similarity=0.325 Sum_probs=197.2
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc------CCHHHHHHHHHHHhhc-CCCCccceEeEEEccC
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR------GGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDD 158 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~------~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~ 158 (426)
+|++.+.||+|+||.||++..... ......+|+|.+... ...+.+..|+.++..+ +||||+++++++...+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~--~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~ 78 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTG--HDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEA 78 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEccc--CCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCC
Confidence 478899999999999999986432 123457899987532 1234577899999999 5999999999887765
Q ss_pred CCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeee
Q 014363 159 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 238 (426)
Q Consensus 159 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 238 (426)
..++||||+++|+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+||
T Consensus 79 ----~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Df 149 (332)
T cd05614 79 ----KLHLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDF 149 (332)
T ss_pred ----EEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeC
Confidence 459999999999999998654 3489999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh
Q 014363 239 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 317 (426)
Q Consensus 239 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 317 (426)
|+++....... ......+||+.|+|||++.+. .++.++|||||||++|||++|..||.............
T Consensus 150 G~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~-------- 220 (332)
T cd05614 150 GLSKEFLSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVS-------- 220 (332)
T ss_pred cCCccccccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHH--------
Confidence 99976433221 122346799999999998865 47889999999999999999999996533221111100
Q ss_pred hhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 014363 318 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRP-----KMSEVLEM 365 (426)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~ 365 (426)
..+.. ....++..++..+.+++.+||+.||++|| ++++++++
T Consensus 221 ----~~~~~--~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 221 ----RRILK--CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred ----HHHhc--CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 00110 01122233567889999999999999999 78888876
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-43 Score=334.88 Aligned_cols=241 Identities=27% Similarity=0.438 Sum_probs=194.0
Q ss_pred ceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-----CCHHHHHHHHHHHhhc-CCCCccceEeEEEccCCCCceE
Q 014363 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-----GGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDERGIQR 164 (426)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-----~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~~~~~~ 164 (426)
++||+|+||.||+|.+..++. .||+|.+... .....+..|.+++..+ +||||+++++++.+.+ ..
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~-----~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~----~~ 71 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDE-----VYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKD----RL 71 (321)
T ss_pred CccccCCCeEEEEEEECCCCC-----EEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCC----eE
Confidence 369999999999999876654 7899987643 2334577899998876 8999999999998766 35
Q ss_pred EEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccC
Q 014363 165 LLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLG 244 (426)
Q Consensus 165 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 244 (426)
|+||||+++|+|..++.... .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 72 ~lv~E~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~ 146 (321)
T cd05591 72 FFVMEYVNGGDLMFQIQRSR--KFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEG 146 (321)
T ss_pred EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceec
Confidence 99999999999998886543 488999999999999999999998 9999999999999999999999999998754
Q ss_pred CCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhh
Q 014363 245 PSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQI 324 (426)
Q Consensus 245 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (426)
.... .......||+.|+|||++.+..++.++|||||||++|+|++|..||....... ... .+
T Consensus 147 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~---~~~-------------~i 208 (321)
T cd05591 147 ILNG--VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD---LFE-------------SI 208 (321)
T ss_pred ccCC--ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH---HHH-------------HH
Confidence 3222 12334679999999999999899999999999999999999999997654321 111 11
Q ss_pred cCCcCCCcccHHHHHHHHHHHHhccccCCCCCC-------CHHHHHHH
Q 014363 325 VDPRLEGKYSLRLVSKLSHVANLCLVKNARTRP-------KMSEVLEM 365 (426)
Q Consensus 325 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-------s~~eil~~ 365 (426)
..... .++..++..+.+++.+||+.||++|| ++++++++
T Consensus 209 ~~~~~--~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 209 LHDDV--LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred HcCCC--CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 11100 11223456889999999999999999 88888876
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=321.04 Aligned_cols=250 Identities=25% Similarity=0.472 Sum_probs=198.7
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCce
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQ 163 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~ 163 (426)
++|+..+.||+|+||.||+|.++... .+++|.+.... ....+.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~------~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---- 73 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQI------KVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKP---- 73 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCc------eEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCC----
Confidence 35778889999999999999876532 68899876433 45678999999999999999999999977653
Q ss_pred EEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccccc
Q 014363 164 RLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL 243 (426)
Q Consensus 164 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 243 (426)
.++||||+++|+|.+++.... ..+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||++..
T Consensus 74 ~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~ 149 (256)
T cd05114 74 LYIVTEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRY 149 (256)
T ss_pred EEEEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccc
Confidence 499999999999999987543 3488999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhhh
Q 014363 244 GPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQFR 322 (426)
Q Consensus 244 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (426)
....... ......++..|+|||++.+..++.++||||||+++|+|++ |+.||......... ..... . .
T Consensus 150 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~---~~i~~----~---~ 218 (256)
T cd05114 150 VLDDEYT-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVV---EMISR----G---F 218 (256)
T ss_pred cCCCcee-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH---HHHHC----C---C
Confidence 5432211 1122345678999999988889999999999999999999 89999754332111 11100 0 0
Q ss_pred hhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014363 323 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMV 366 (426)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L 366 (426)
.. ..+...+..+.+++.+||+.+|++||+++++++.|
T Consensus 219 ~~-------~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 219 RL-------YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CC-------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 00 01112346789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=333.40 Aligned_cols=241 Identities=24% Similarity=0.408 Sum_probs=191.8
Q ss_pred ceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-----CCHHHHHHHHHHHhhc-CCCCccceEeEEEccCCCCceE
Q 014363 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-----GGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDERGIQR 164 (426)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-----~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~~~~~~ 164 (426)
++||+|+||.||+|.++.++. .||+|.+... .....+..|..++..+ +||||+++++++.+.+ ..
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~-----~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~----~~ 71 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGE-----YFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKE----HL 71 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCC-----EEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCC----EE
Confidence 369999999999999887654 7899988643 2344567788888765 9999999999998765 45
Q ss_pred EEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccC
Q 014363 165 LLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLG 244 (426)
Q Consensus 165 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 244 (426)
|+||||+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 72 ~lv~E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~ 146 (316)
T cd05620 72 FFVMEFLNGGDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKEN 146 (316)
T ss_pred EEEECCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeec
Confidence 9999999999999988654 3488999999999999999999998 9999999999999999999999999998743
Q ss_pred CCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhh
Q 014363 245 PSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQI 324 (426)
Q Consensus 245 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (426)
.... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||....... +..... .
T Consensus 147 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~---~~~~~~-----------~ 210 (316)
T cd05620 147 VFGD--NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE---LFESIR-----------V 210 (316)
T ss_pred ccCC--CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---HHHHHH-----------h
Confidence 2211 12345679999999999999999999999999999999999999997543221 111100 0
Q ss_pred cCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCH-HHHHHH
Q 014363 325 VDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKM-SEVLEM 365 (426)
Q Consensus 325 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~-~eil~~ 365 (426)
..+ .++..++.++.+++.+||+.||++||++ +++++|
T Consensus 211 ~~~----~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h 248 (316)
T cd05620 211 DTP----HYPRWITKESKDILEKLFERDPTRRLGVVGNIRGH 248 (316)
T ss_pred CCC----CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 011 1222345678999999999999999998 466644
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=335.53 Aligned_cols=249 Identities=27% Similarity=0.350 Sum_probs=210.4
Q ss_pred HhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-----CHHHHHHHHHHHhhcC-CCCccceEeEEEc
Q 014363 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-----GHKEWMTEVNFLGIVE-HQNLVKLVGYCAD 156 (426)
Q Consensus 83 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-----~~~~~~~E~~~l~~l~-HpnIv~~~~~~~~ 156 (426)
....|+..+.||.|.||.||+|..+.++. .+|+|.+.+.. ....+.+|+.+|+++. |||||.++++|.+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~-----~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~ 107 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGK-----EVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFED 107 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCc-----eeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEc
Confidence 35678888999999999999999988765 77888775443 3357899999999998 9999999999999
Q ss_pred cCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCC----CC
Q 014363 157 DDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQ----WN 232 (426)
Q Consensus 157 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~----~~ 232 (426)
... .++|||+|.||.|.+.+... . +++..+..++.|++.|+.|||+. ||+||||||+|+|+... +.
T Consensus 108 ~~~----~~lvmEL~~GGeLfd~i~~~--~-~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ 177 (382)
T KOG0032|consen 108 PDS----VYLVMELCEGGELFDRIVKK--H-YSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGR 177 (382)
T ss_pred CCe----EEEEEEecCCchHHHHHHHc--c-CCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCc
Confidence 874 49999999999999999766 2 99999999999999999999998 99999999999999533 57
Q ss_pred eeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHh
Q 014363 233 AKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK 312 (426)
Q Consensus 233 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~ 312 (426)
+|++|||++..... .......+||+.|+|||++....|+..+||||+||++|.|++|.+||.+........
T Consensus 178 ik~~DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~------ 248 (382)
T KOG0032|consen 178 IKLIDFGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL------ 248 (382)
T ss_pred EEEeeCCCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH------
Confidence 99999999998765 233567899999999999999999999999999999999999999998754332221
Q ss_pred hhhhhhhhhhhhcCC--cCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 313 PYLSDAKQFRQIVDP--RLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 313 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.+... .....+-..++..+.+++..||..||.+|+|+.++|+|
T Consensus 249 ----------~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 249 ----------AILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred ----------HHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 11111 22333444678899999999999999999999999996
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=326.83 Aligned_cols=263 Identities=22% Similarity=0.428 Sum_probs=204.7
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC---HHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG---HKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
.++|++.+.||+|+||.||+|..++.........+|+|.+..... ...+.+|+.+++.++||||+++++++.+...
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~- 83 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP- 83 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC-
Confidence 467999999999999999999876533333455799998764432 2357789999999999999999999877653
Q ss_pred CceEEEEEeeCCCCChhhhccCCC--------CCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCC
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKS--------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWN 232 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~--------~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~ 232 (426)
.|+||||+++|+|.+++.... ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.
T Consensus 84 ---~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~ 157 (288)
T cd05061 84 ---TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFT 157 (288)
T ss_pred ---cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCc
Confidence 499999999999999996422 12356778889999999999999998 9999999999999999999
Q ss_pred eeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhH
Q 014363 233 AKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWV 311 (426)
Q Consensus 233 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~ 311 (426)
++|+|||+++...............++..|+|||.+.++.++.++|||||||++|||++ |..||......... ..
T Consensus 158 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~---~~- 233 (288)
T cd05061 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVL---KF- 233 (288)
T ss_pred EEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HH-
Confidence 99999999875543222222222345778999999998899999999999999999999 78898654332111 10
Q ss_pred hhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhH
Q 014363 312 KPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIV 370 (426)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~ 370 (426)
+.+... ...+...+..+.+++.+||+.||++|||+.++++.|.+.+
T Consensus 234 ------------~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 234 ------------VMDGGY-LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred ------------HHcCCC-CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 001000 0112234568999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=328.06 Aligned_cols=259 Identities=26% Similarity=0.442 Sum_probs=201.8
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc---CCHHHHHHHHHHHhhc-CCCCccceEeEEEccCCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR---GGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDER 160 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~---~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~~ 160 (426)
++|++.++||+|+||.||+|..+..+. ...+++|.+... ...+.+.+|+.++.++ +||||+++++++.+...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~---~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~- 77 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGL---KMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGY- 77 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCC---cceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCc-
Confidence 478889999999999999998876543 123567766532 2345688999999999 79999999999877653
Q ss_pred CceEEEEEeeCCCCChhhhccCCC--------------CCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceE
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKS--------------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNIL 226 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NIL 226 (426)
.++||||+++++|.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+|||
T Consensus 78 ---~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil 151 (297)
T cd05089 78 ---LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVL 151 (297)
T ss_pred ---ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEE
Confidence 499999999999999986432 12488899999999999999999998 9999999999999
Q ss_pred eCCCCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhH
Q 014363 227 LDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQ 305 (426)
Q Consensus 227 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~ 305 (426)
+++++.+||+|||++...... ........+..|+|||++.+..++.++|||||||++|||++ |..||.........
T Consensus 152 l~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~ 228 (297)
T cd05089 152 VGENLASKIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELY 228 (297)
T ss_pred ECCCCeEEECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 999999999999998642211 01111223557999999988889999999999999999997 99999754332111
Q ss_pred HHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhh
Q 014363 306 KLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 373 (426)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~ 373 (426)
. .+ ........+..++..+.+|+.+||+.+|.+||+++++++.|..+....
T Consensus 229 ---~-------------~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 229 ---E-------------KL-PQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred ---H-------------HH-hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 1 00 111111122235578899999999999999999999999999888654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=332.69 Aligned_cols=241 Identities=25% Similarity=0.425 Sum_probs=192.0
Q ss_pred ceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-----CCHHHHHHHHHHHhhc-CCCCccceEeEEEccCCCCceE
Q 014363 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-----GGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDERGIQR 164 (426)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-----~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~~~~~~ 164 (426)
+.||+|+||.||+|.+..++. .||+|.+... .....+..|..++..+ +||||+++++++.+.+ ..
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~----~~ 71 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQ-----FFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKE----NL 71 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCC-----EEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCC----EE
Confidence 369999999999999877654 7899988643 2334567788888764 9999999999998765 35
Q ss_pred EEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccC
Q 014363 165 LLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLG 244 (426)
Q Consensus 165 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 244 (426)
|+||||+++|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 72 ~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 146 (316)
T cd05619 72 FFVMEYLNGGDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKEN 146 (316)
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceEC
Confidence 9999999999999998653 3488999999999999999999998 9999999999999999999999999998753
Q ss_pred CCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhh
Q 014363 245 PSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQI 324 (426)
Q Consensus 245 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (426)
.... .......||+.|+|||++.+..++.++|||||||++|+|++|..||....... +...+. .
T Consensus 147 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~~~~i~-----------~ 210 (316)
T cd05619 147 MLGD--AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE---LFQSIR-----------M 210 (316)
T ss_pred CCCC--CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH---HHHHHH-----------h
Confidence 2211 11234679999999999999899999999999999999999999997644321 111100 0
Q ss_pred cCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHH-HHHHH
Q 014363 325 VDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMS-EVLEM 365 (426)
Q Consensus 325 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~-eil~~ 365 (426)
..+ .++..++..+.+++.+||+.||++||++. +++++
T Consensus 211 ~~~----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05619 211 DNP----CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQH 248 (316)
T ss_pred CCC----CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcC
Confidence 011 12223556789999999999999999997 67654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=319.71 Aligned_cols=246 Identities=25% Similarity=0.437 Sum_probs=194.1
Q ss_pred eecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCceEEEEE
Q 014363 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVY 168 (426)
Q Consensus 92 ~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~~~lv~ 168 (426)
.||+|+||.||+|.+..++. .+++|.+.... ....+.+|+++++.++||||+++++++.+... .++||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~-----~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~lv~ 72 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNT-----PVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQP----IYIVM 72 (252)
T ss_pred ccCcccCccEEEEEEecCCc-----eEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCC----eEEEE
Confidence 69999999999999876543 78999875433 23568899999999999999999999987653 49999
Q ss_pred eeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccCCCCC
Q 014363 169 EYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEG 248 (426)
Q Consensus 169 E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 248 (426)
||+++++|.+++.... ..+++..++.++.|++.||.|||++ +++||||||+|||++.++.+||+|||++.......
T Consensus 73 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 148 (252)
T cd05084 73 ELVQGGDFLTFLRTEG-PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGV 148 (252)
T ss_pred eeccCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCccccccc
Confidence 9999999999986433 3488999999999999999999998 99999999999999999999999999987543221
Q ss_pred ceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCC
Q 014363 249 FTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDP 327 (426)
Q Consensus 249 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (426)
.........++..|+|||.+.++.++.++||||||+++|+|++ |..||............ ..
T Consensus 149 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~-----------------~~ 211 (252)
T cd05084 149 YASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAI-----------------EQ 211 (252)
T ss_pred ccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHH-----------------Hc
Confidence 1111111123457999999998899999999999999999998 88888654322111111 01
Q ss_pred cCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014363 328 RLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVN 367 (426)
Q Consensus 328 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~ 367 (426)
......+..++..+.+++.+||+.+|++|||+.++++.|.
T Consensus 212 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 212 GVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 1111223345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=320.59 Aligned_cols=255 Identities=27% Similarity=0.446 Sum_probs=203.9
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCc
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 162 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~ 162 (426)
.++|.+.+.||+|+||.||+|.+.++. .+++|.+.... ..+.+.+|+.+++.++||||+++++++.+.
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~------~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~----- 73 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTT------RVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE----- 73 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCc------eEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEECCC-----
Confidence 356899999999999999999875542 58999887533 456789999999999999999999987442
Q ss_pred eEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccc
Q 014363 163 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 242 (426)
Q Consensus 163 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 242 (426)
..++||||+++|+|.+++.......+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~ 150 (262)
T cd05071 74 PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLAR 150 (262)
T ss_pred CcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCcee
Confidence 248999999999999999764444588999999999999999999998 99999999999999999999999999997
Q ss_pred cCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhh
Q 014363 243 LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 321 (426)
Q Consensus 243 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (426)
........ ......++..|+|||+..+..++.++||||||+++|+|++ |..||...........
T Consensus 151 ~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~-------------- 215 (262)
T cd05071 151 LIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ-------------- 215 (262)
T ss_pred eccccccc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHH--------------
Confidence 65433211 1123346778999999988899999999999999999999 8888875432211110
Q ss_pred hhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhH
Q 014363 322 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIV 370 (426)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~ 370 (426)
+.. .........++..+.+++.+||+.||++||++.++++.|+...
T Consensus 216 --~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 216 --VER-GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred --Hhc-CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 000 0011123346678899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=329.01 Aligned_cols=265 Identities=25% Similarity=0.435 Sum_probs=207.3
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCC--CCCCcceEEEEEEccccC---CHHHHHHHHHHHhhc-CCCCccceEeEEEcc
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNS--EDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIV-EHQNLVKLVGYCADD 157 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~--~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~ 157 (426)
..+|.+.+.||+|+||.||+|.+... ........+++|.+.... ....+.+|+.++..+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 45788889999999999999986432 122334578999886432 335688999999999 899999999999876
Q ss_pred CCCCceEEEEEeeCCCCChhhhccCCC--------------CCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCC
Q 014363 158 DERGIQRLLVYEYMPNGSVDQYLSPKS--------------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSS 223 (426)
Q Consensus 158 ~~~~~~~~lv~E~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~ 223 (426)
.. .++||||+++|+|.+++.... ...+++..++.++.|++.||.|||++ +|+||||||+
T Consensus 94 ~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~ 166 (304)
T cd05101 94 GP----LYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAAR 166 (304)
T ss_pred Cc----eEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeecccccc
Confidence 53 499999999999999986532 13478888999999999999999998 9999999999
Q ss_pred ceEeCCCCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCch
Q 014363 224 NILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPR 302 (426)
Q Consensus 224 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~ 302 (426)
|||++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 167 Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 246 (304)
T cd05101 167 NVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 246 (304)
T ss_pred eEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH
Confidence 99999999999999999986644322222233456778999999988889999999999999999998 78888654322
Q ss_pred hhHHHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 014363 303 SEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 372 (426)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~ 372 (426)
..... . ........+..++..+.+++.+||+.+|++||++.|+++.|++++.-
T Consensus 247 ~~~~~---~--------------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 247 ELFKL---L--------------KEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred HHHHH---H--------------HcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 11111 0 00001111224567899999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=324.86 Aligned_cols=259 Identities=25% Similarity=0.447 Sum_probs=203.1
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC--CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCc
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 162 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~ 162 (426)
.+|...++||+|+||.||+|.............+++|.+.... ....+.+|+++++.++||||+++++++.+...
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--- 81 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRP--- 81 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCc---
Confidence 3677788999999999999976543333445678888876433 34578899999999999999999999987653
Q ss_pred eEEEEEeeCCCCChhhhccCCCC-------------CccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCC
Q 014363 163 QRLLVYEYMPNGSVDQYLSPKSE-------------TILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE 229 (426)
Q Consensus 163 ~~~lv~E~~~~g~L~~~l~~~~~-------------~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~ 229 (426)
.+++|||+++++|.+++..... ..+++..++.++.|++.||+|||+. +++||||||+|||+++
T Consensus 82 -~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~ 157 (280)
T cd05092 82 -LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQ 157 (280)
T ss_pred -eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcC
Confidence 4999999999999999864321 2478999999999999999999998 9999999999999999
Q ss_pred CCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHH
Q 014363 230 QWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLL 308 (426)
Q Consensus 230 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~ 308 (426)
++.+||+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||...........
T Consensus 158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~- 236 (280)
T cd05092 158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIEC- 236 (280)
T ss_pred CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHH-
Confidence 99999999999975543222222223345788999999998899999999999999999998 8999865432211111
Q ss_pred HhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014363 309 QWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVN 367 (426)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~ 367 (426)
.... .....+..++..+.+++.+||+.||++||++++|++.|+
T Consensus 237 ---------------~~~~-~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 237 ---------------ITQG-RELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred ---------------HHcC-ccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 0000 001112234567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=342.27 Aligned_cols=263 Identities=21% Similarity=0.309 Sum_probs=195.7
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCceE
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQR 164 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~~ 164 (426)
.+|.+.+.||+|+||.||+|.+...+. .|++|... ...+.+|+++|++|+|||||++++++...+ ..
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~-----~vavK~~~----~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~----~~ 235 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQ-----RVVVKAGW----YASSVHEARLLRRLSHPAVLALLDVRVVGG----LT 235 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCC-----EEEEeccc----ccCHHHHHHHHHHCCCCCCCcEEEEEEECC----EE
Confidence 469999999999999999999876543 78888643 234678999999999999999999988765 34
Q ss_pred EEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccC
Q 014363 165 LLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLG 244 (426)
Q Consensus 165 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 244 (426)
++|||++ .++|.+++.... ..+++..++.|+.|++.||.|||++ +|+||||||+||||+.++.+||+|||+++..
T Consensus 236 ~lv~e~~-~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~ 310 (461)
T PHA03211 236 CLVLPKY-RSDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFA 310 (461)
T ss_pred EEEEEcc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceec
Confidence 9999999 568888876432 3589999999999999999999998 9999999999999999999999999999865
Q ss_pred CCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCch-----hhHHHHHhHhhhh---h
Q 014363 245 PSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPR-----SEQKLLQWVKPYL---S 316 (426)
Q Consensus 245 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~-----~~~~~~~~~~~~~---~ 316 (426)
.............||+.|+|||++.+..++.++|||||||+||||++|..|+...... ....+...+.... .
T Consensus 311 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~ 390 (461)
T PHA03211 311 RGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVD 390 (461)
T ss_pred ccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccc
Confidence 4322222233467999999999999999999999999999999999988765432211 1111111111100 0
Q ss_pred hh---------hhhhhh----cCCcCC-Cccc--HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 317 DA---------KQFRQI----VDPRLE-GKYS--LRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 317 ~~---------~~~~~~----~~~~~~-~~~~--~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.. ..+... ..+... ..+. ......+.+|+.+||+.||++|||+.|+|++
T Consensus 391 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 391 EFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred cCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00 000000 000000 0000 0234578899999999999999999999986
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-43 Score=328.85 Aligned_cols=251 Identities=27% Similarity=0.404 Sum_probs=201.4
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-----CHHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
+|+..++||+|+||.||++.+..++. .||+|.+.... ....+.+|+.+++.++||||+++++.+.+.+
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 73 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGK-----MYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKD-- 73 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCc-----eEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCC--
Confidence 47888999999999999999766543 78999875432 2245678999999999999999999987765
Q ss_pred CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecc
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 240 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 240 (426)
..++||||+++|+|.+++.......+++..+..++.|++.||.|||+. +++||||||+||++++++.++|+|||+
T Consensus 74 --~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~ 148 (285)
T cd05605 74 --ALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGL 148 (285)
T ss_pred --eEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCC
Confidence 459999999999999888654445589999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhh
Q 014363 241 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 320 (426)
Q Consensus 241 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (426)
+....... ......|++.|+|||++.+..++.++||||||+++|+|++|..||............
T Consensus 149 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~------------ 213 (285)
T cd05605 149 AVEIPEGE---TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEV------------ 213 (285)
T ss_pred ceecCCCC---ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHH------------
Confidence 97654321 122357899999999999888999999999999999999999999764332111100
Q ss_pred hhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 014363 321 FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRP-----KMSEVLEM 365 (426)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~ 365 (426)
...+. .....++..++..+.+|+.+||+.||++|| ++++++++
T Consensus 214 -~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 214 -ERRVK-EDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred -HHHhh-hcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 00010 011123344667899999999999999999 88898876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=334.43 Aligned_cols=246 Identities=25% Similarity=0.403 Sum_probs=196.5
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-----CHHHHHHHHHHHhhc-CCCCccceEeEEEccCC
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-----GHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDE 159 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-----~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~ 159 (426)
+|...+.||+|+||.||+|.+..++. .+|+|.+.... ....+..|..++..+ +|++|+++++++.+.+
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~-----~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~- 74 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDE-----LYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMD- 74 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCC-----EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCC-
Confidence 47888999999999999999876654 78999876432 234567788888877 6899999999987765
Q ss_pred CCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeec
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 239 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 239 (426)
..|+||||+++|+|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 75 ---~~~lv~E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG 146 (323)
T cd05616 75 ---RLYFVMEYVNGGDLMYQIQQVG--RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFG 146 (323)
T ss_pred ---EEEEEEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCC
Confidence 4599999999999999886543 488999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014363 240 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 319 (426)
Q Consensus 240 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 319 (426)
++....... ......+||+.|+|||++.+..++.++|||||||++|||++|..||....... +..
T Consensus 147 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~---~~~---------- 211 (323)
T cd05616 147 MCKENMWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---LFQ---------- 211 (323)
T ss_pred CceecCCCC--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH---HHH----------
Confidence 997543221 12334679999999999999999999999999999999999999997654321 111
Q ss_pred hhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCH-----HHHHHH
Q 014363 320 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKM-----SEVLEM 365 (426)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~-----~eil~~ 365 (426)
.+.... ..++...+..+.+++.+||+.||++|++. .+++++
T Consensus 212 ---~i~~~~--~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 212 ---SIMEHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred ---HHHhCC--CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 111111 12233456788999999999999999985 666554
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=329.43 Aligned_cols=264 Identities=26% Similarity=0.432 Sum_probs=206.0
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCC--CCcceEEEEEEccccC---CHHHHHHHHHHHhhc-CCCCccceEeEEEccC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSED--PSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIV-EHQNLVKLVGYCADDD 158 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~--~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~ 158 (426)
++|.+.+.||+|+||.||+|.+..... ......+++|.+.... ....+..|+.++..+ +||||+++++++...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 468999999999999999998754322 1233468999887543 234678899999999 8999999999998765
Q ss_pred CCCceEEEEEeeCCCCChhhhccCCC--------------CCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCc
Q 014363 159 ERGIQRLLVYEYMPNGSVDQYLSPKS--------------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSN 224 (426)
Q Consensus 159 ~~~~~~~lv~E~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~N 224 (426)
. .|+||||+++|+|.+++.... ...+++..++.++.|++.||+|||+. +++||||||+|
T Consensus 98 ~----~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~N 170 (307)
T cd05098 98 P----LYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARN 170 (307)
T ss_pred c----eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHh
Confidence 3 499999999999999996532 13488899999999999999999998 99999999999
Q ss_pred eEeCCCCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchh
Q 014363 225 ILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRS 303 (426)
Q Consensus 225 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~ 303 (426)
||++.++.+||+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus 171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~ 250 (307)
T cd05098 171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 250 (307)
T ss_pred eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH
Confidence 9999999999999999875543211111222234578999999998889999999999999999998 888886543211
Q ss_pred hHHHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 014363 304 EQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 372 (426)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~ 372 (426)
.... +........+...+.++.+++.+||..+|++||++.++++.|+.++..
T Consensus 251 ~~~~-----------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 251 LFKL-----------------LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred HHHH-----------------HHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 1111 000111112234567899999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=338.56 Aligned_cols=250 Identities=25% Similarity=0.318 Sum_probs=200.0
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-----CHHHHHHHHHHHhhcCCCCccceEeEEEccCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
++|...+.||+|+||.||+|.....+. .+|+|.+.... ..+.+.+|+.++..++||||+++++++.+..
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~-----~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~- 74 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGD-----IYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKD- 74 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCC-----EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCC-
Confidence 468899999999999999999876654 78999886432 3345788999999999999999999988765
Q ss_pred CCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeec
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 239 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 239 (426)
..|+||||+++|+|.+++.... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 75 ---~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg 147 (330)
T cd05601 75 ---NLYLVMEYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFG 147 (330)
T ss_pred ---eEEEEECCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCC
Confidence 4599999999999999997542 3589999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCchhhc------cCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhh
Q 014363 240 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQ------TGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKP 313 (426)
Q Consensus 240 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~ 313 (426)
++......... ......||+.|+|||++. ...++.++|||||||++|+|++|..||..........
T Consensus 148 ~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~------- 219 (330)
T cd05601 148 SAARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYN------- 219 (330)
T ss_pred CCeECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHH-------
Confidence 99865443221 233457999999999986 4567899999999999999999999997644321111
Q ss_pred hhhhhhhhhhhcCC--cCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 314 YLSDAKQFRQIVDP--RLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 314 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.++.. .+.-.....++..+.+|+..||. +|++||++.+++++
T Consensus 220 ---------~i~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 220 ---------NIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred ---------HHHcCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 11100 00001112356778999999998 99999999999876
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=331.82 Aligned_cols=241 Identities=28% Similarity=0.448 Sum_probs=194.5
Q ss_pred ceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-----CCHHHHHHHHHHHhhc-CCCCccceEeEEEccCCCCceE
Q 014363 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-----GGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDERGIQR 164 (426)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-----~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~~~~~~ 164 (426)
+.||+|+||.||+|.+..++. .+|+|.+... .....+..|..++..+ +||||+++++++.+.+ ..
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~-----~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~----~~ 71 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDE-----LYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKD----RL 71 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCC-----EEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCC----EE
Confidence 369999999999999876654 7899988643 2345567899999888 7999999999998765 45
Q ss_pred EEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccC
Q 014363 165 LLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLG 244 (426)
Q Consensus 165 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 244 (426)
|+||||+++|+|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 72 ~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 146 (318)
T cd05570 72 FFVMEYVNGGDLMFHIQRSG--RFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEG 146 (318)
T ss_pred EEEEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeec
Confidence 99999999999999886543 489999999999999999999998 9999999999999999999999999998753
Q ss_pred CCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhh
Q 014363 245 PSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQI 324 (426)
Q Consensus 245 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (426)
.... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||....... ... .+
T Consensus 147 ~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~---~~~-------------~i 208 (318)
T cd05570 147 ILGG--VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE---LFQ-------------SI 208 (318)
T ss_pred CcCC--CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH---HHH-------------HH
Confidence 2221 11234679999999999999999999999999999999999999997543211 111 11
Q ss_pred cCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCH-----HHHHHH
Q 014363 325 VDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKM-----SEVLEM 365 (426)
Q Consensus 325 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~-----~eil~~ 365 (426)
.... ..++..++..+.+++.+||+.||++||++ .+++++
T Consensus 209 ~~~~--~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 209 LEDE--VRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred HcCC--CCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 1111 11223356788999999999999999999 888775
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=325.83 Aligned_cols=267 Identities=24% Similarity=0.426 Sum_probs=206.8
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCC-----------CcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCCccc
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDP-----------SQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQNLVK 149 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~-----------~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~HpnIv~ 149 (426)
.++|.+.+.||+|+||.||+|.+...+.. .....+++|.+.... ..+.+.+|++++..++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 35789999999999999999987764322 234578999887553 3456889999999999999999
Q ss_pred eEeEEEccCCCCceEEEEEeeCCCCChhhhccCCC---------CCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccC
Q 014363 150 LVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKS---------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDF 220 (426)
Q Consensus 150 ~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~---------~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDl 220 (426)
+++++...+. .++||||+++++|.+++.... ...+++..++.++.|++.||.|||+. +++||||
T Consensus 84 ~~~~~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dl 156 (296)
T cd05051 84 LLGVCTVDPP----LCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDL 156 (296)
T ss_pred EEEEEecCCC----cEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Ccccccc
Confidence 9999987653 499999999999999986543 12589999999999999999999998 9999999
Q ss_pred CCCceEeCCCCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh--CCCCCCC
Q 014363 221 KSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT--GRRPIDR 298 (426)
Q Consensus 221 kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt--g~~p~~~ 298 (426)
||+||+++.++.++|+|||++................++..|+|||++.+..++.++||||||+++|||++ |..||..
T Consensus 157 kp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~ 236 (296)
T cd05051 157 ATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236 (296)
T ss_pred chhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence 99999999999999999999986544333333344567789999999988889999999999999999998 6778865
Q ss_pred CCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014363 299 NRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVN 367 (426)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~ 367 (426)
..... ............ ........+..++.++.+++.+||+.||++|||+.||++.|+
T Consensus 237 ~~~~~---~~~~~~~~~~~~-------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 237 LTDQQ---VIENAGHFFRDD-------GRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred cChHH---HHHHHHhccccc-------cccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 43221 111111100000 001111112234568999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=334.49 Aligned_cols=248 Identities=25% Similarity=0.375 Sum_probs=193.9
Q ss_pred ceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-----CHHHHHHHHHHHhhc-CCCCccceEeEEEccCCCCceE
Q 014363 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-----GHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDERGIQR 164 (426)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-----~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~~~~~~ 164 (426)
++||+|+||.||+|.+..++. .||+|.+.... ....+..|..++..+ +||||+++++++.+.. ..
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~-----~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~----~~ 71 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRR-----IYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTES----RL 71 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCC-----EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCC----EE
Confidence 369999999999999877654 78999886432 234577899999988 7999999999998765 45
Q ss_pred EEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccC
Q 014363 165 LLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLG 244 (426)
Q Consensus 165 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 244 (426)
|+||||+++|+|.+++... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 72 ~lv~e~~~~g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~ 146 (329)
T cd05588 72 FFVIEFVSGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 146 (329)
T ss_pred EEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCcccccc
Confidence 9999999999999888644 3489999999999999999999998 9999999999999999999999999998743
Q ss_pred CCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchh--hHHHHHhHhhhhhhhhhhh
Q 014363 245 PSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRS--EQKLLQWVKPYLSDAKQFR 322 (426)
Q Consensus 245 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 322 (426)
.... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||....... ......+.. .
T Consensus 147 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~---------~ 215 (329)
T cd05588 147 IRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLF---------Q 215 (329)
T ss_pred ccCC--CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHH---------H
Confidence 2211 12334689999999999999999999999999999999999999996432111 000001100 1
Q ss_pred hhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCC------HHHHHHH
Q 014363 323 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPK------MSEVLEM 365 (426)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs------~~eil~~ 365 (426)
.+..... ..+..++..+.+++.+||+.||++||+ ++++++|
T Consensus 216 ~~~~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 216 VILEKQI--RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred HHHcCCC--CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 1111111 122335567899999999999999997 6788765
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=319.61 Aligned_cols=251 Identities=27% Similarity=0.482 Sum_probs=199.4
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCce
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQ 163 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~ 163 (426)
++|...+.||+|+||.||+|.+.+.. .+++|.+.... ....+.+|+.++..++||||+++++++.+...
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~------~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---- 73 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQY------DVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRP---- 73 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCC------cEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCC----
Confidence 35778889999999999999876532 58999876543 45678999999999999999999999977654
Q ss_pred EEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccccc
Q 014363 164 RLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL 243 (426)
Q Consensus 164 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 243 (426)
.++||||+++|+|.+++..... .+++..++.++.|++.||.|||+. +++|+||||+|||++.++.+||+|||+++.
T Consensus 74 ~~lv~e~~~~~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~ 149 (256)
T cd05113 74 IYIVTEYMSNGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRY 149 (256)
T ss_pred cEEEEEcCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCcccee
Confidence 4999999999999999875433 589999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhhh
Q 014363 244 GPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQFR 322 (426)
Q Consensus 244 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (426)
....... ......++..|+|||++.+..++.++||||||+++|+|++ |..||...........
T Consensus 150 ~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~--------------- 213 (256)
T cd05113 150 VLDDEYT-SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEK--------------- 213 (256)
T ss_pred cCCCcee-ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHH---------------
Confidence 5433211 1122345678999999988889999999999999999999 9999975433211110
Q ss_pred hhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014363 323 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVN 367 (426)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~ 367 (426)
+... .....+...+..+.+++.+||+.||++||++.+|++.|+
T Consensus 214 -~~~~-~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 214 -VSQG-LRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred -HhcC-CCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 0000 000111123578899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=310.68 Aligned_cols=252 Identities=26% Similarity=0.400 Sum_probs=205.0
Q ss_pred HHHhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC------C----HHHHHHHHHHHhhc-CCCCccc
Q 014363 81 KSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG------G----HKEWMTEVNFLGIV-EHQNLVK 149 (426)
Q Consensus 81 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~------~----~~~~~~E~~~l~~l-~HpnIv~ 149 (426)
+..-+.|...+.||.|..+.|-++.++.++. .+|+|++.... . .+.-.+|+.||+++ .||+|++
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~-----e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~ 87 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGK-----EFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIID 87 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhccccc-----ceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEE
Confidence 4456688889999999999999999888765 67777763221 1 13456899999998 7999999
Q ss_pred eEeEEEccCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCC
Q 014363 150 LVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE 229 (426)
Q Consensus 150 ~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~ 229 (426)
+.+++..+... |+|+|.|+.|.|.|++... ..++++....|++|+.+|++|||.+ +||||||||+|||+++
T Consensus 88 l~D~yes~sF~----FlVFdl~prGELFDyLts~--VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILldd 158 (411)
T KOG0599|consen 88 LQDVYESDAFV----FLVFDLMPRGELFDYLTSK--VTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDD 158 (411)
T ss_pred eeeeccCcchh----hhhhhhcccchHHHHhhhh--eeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeecc
Confidence 99999887754 9999999999999999654 4599999999999999999999998 9999999999999999
Q ss_pred CCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhcc------CCCCCchhhHHHHHHHHHHHhCCCCCCCCCchh
Q 014363 230 QWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT------GRLAARSDVWSYGVFLYELITGRRPIDRNRPRS 303 (426)
Q Consensus 230 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslGvil~elltg~~p~~~~~~~~ 303 (426)
+.++||+|||.++.+.... .....||||+|+|||.+.. ..|+..+|+||+|||+|.|+.|.+||.....-.
T Consensus 159 n~~i~isDFGFa~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQml 235 (411)
T KOG0599|consen 159 NMNIKISDFGFACQLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQML 235 (411)
T ss_pred ccceEEeccceeeccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHH
Confidence 9999999999999876543 2346899999999998864 358889999999999999999999996432211
Q ss_pred hHHHHHhHhhhhhhhhhhhhhcCCcC--CCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 304 EQKLLQWVKPYLSDAKQFRQIVDPRL--EGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.. +.++.... ....-.+++...++||.+||+.||.+|.|++|+|+|
T Consensus 236 ML----------------R~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 236 ML----------------RMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred HH----------------HHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 11 11111111 111223577889999999999999999999999987
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=319.97 Aligned_cols=261 Identities=23% Similarity=0.428 Sum_probs=202.0
Q ss_pred CCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccCC--C
Q 014363 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE--R 160 (426)
Q Consensus 87 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~--~ 160 (426)
|.+.+.||+|+||.||+|...... .....+|+|.+.... ....+.+|+.+++.++||||+++++++..... .
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 78 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDD--GSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQK 78 (273)
T ss_pred CccccccCcCCCceEEEEEEecCC--CCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCcccc
Confidence 567789999999999999876532 123478999886442 23468899999999999999999998876443 1
Q ss_pred CceEEEEEeeCCCCChhhhccCC----CCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEe
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPK----SETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLS 236 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~----~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~ 236 (426)
....++||||+++|+|..++... ....+++..++.++.|++.||.|||+. +++||||||+||++++++.+||+
T Consensus 79 ~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~ 155 (273)
T cd05035 79 IPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVA 155 (273)
T ss_pred CcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEEC
Confidence 12358999999999999888432 223589999999999999999999998 99999999999999999999999
Q ss_pred eecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhh
Q 014363 237 DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYL 315 (426)
Q Consensus 237 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 315 (426)
|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||....... ......
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~---~~~~~~--- 229 (273)
T cd05035 156 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE---IYDYLR--- 229 (273)
T ss_pred CccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH---
Confidence 9999986543322211222345678999999988889999999999999999999 889986543211 111110
Q ss_pred hhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHh
Q 014363 316 SDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 369 (426)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~ 369 (426)
.. .....+..++..+.+++.+||+.||++||++.|+++.|+.+
T Consensus 230 ----------~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 230 ----------HG-NRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred ----------cC-CCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 01112234567899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=305.07 Aligned_cols=266 Identities=23% Similarity=0.312 Sum_probs=207.6
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc--CCHHHHHHHHHHHhhcCCCCccceEeEEEccCC-C
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR--GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE-R 160 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~-~ 160 (426)
.++|.+.+.||+|||+.||++..-.++ ..+|+|++.-. .+.+..++|++..++++||||++++++...... .
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~-----~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~ 94 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTG-----HLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDG 94 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcc-----cchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccC
Confidence 468999999999999999999855444 47888887433 356778999999999999999999988765432 2
Q ss_pred CceEEEEEeeCCCCChhhhccCC--CCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeee
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPK--SETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 238 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 238 (426)
....||+++|...|+|.+.+... .+..+++.+++.|+.+|++||++||+. ..+++||||||.|||+.+.+.++|.||
T Consensus 95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~ 173 (302)
T KOG2345|consen 95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDL 173 (302)
T ss_pred ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEec
Confidence 33469999999999999988643 234699999999999999999999998 335999999999999999999999999
Q ss_pred cccccCCCCCceee-------eeeeecCcccCCchhhccC---CCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHH
Q 014363 239 GLARLGPSEGFTHV-------STAVVGTMGYAAPEYVQTG---RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLL 308 (426)
Q Consensus 239 Gla~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~ 308 (426)
|.+....-...... ......|..|.|||.+.-. ..++++|||||||+||+|+.|..||+....
T Consensus 174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~------- 246 (302)
T KOG2345|consen 174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ------- 246 (302)
T ss_pred cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-------
Confidence 99976542111100 1123568999999988644 468899999999999999999999974211
Q ss_pred HhHhhhhhhhhh-hhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhH
Q 014363 309 QWVKPYLSDAKQ-FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIV 370 (426)
Q Consensus 309 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~ 370 (426)
.+.. ...+.++.+...-...+++.+.+++++||+.||.+||++.+++..++.+.
T Consensus 247 --------~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 247 --------QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred --------cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 1111 11223333333333348889999999999999999999999999988754
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=322.53 Aligned_cols=257 Identities=27% Similarity=0.393 Sum_probs=202.5
Q ss_pred HhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-CHHHHHHHHHHHhhc-CCCCccceEeEEEccCCC
Q 014363 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-GHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDER 160 (426)
Q Consensus 83 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~~ 160 (426)
+.+.|+..+.||+|+||.||+|.....+. .+++|.+.... ....+.+|+.++..+ +||||+++++++......
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~-----~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 78 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQ-----LAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 78 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCc-----EEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCC
Confidence 46678889999999999999998876654 78888875432 345788999999998 799999999998764322
Q ss_pred --CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeee
Q 014363 161 --GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 238 (426)
Q Consensus 161 --~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 238 (426)
....|+||||+++++|.+++.......+++..+..++.|++.||+|||+. +|+|+||||+||++++++.+||+||
T Consensus 79 ~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Df 155 (272)
T cd06637 79 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDF 155 (272)
T ss_pred CCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccC
Confidence 13569999999999999998765555689999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCchhhc-----cCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhh
Q 014363 239 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQ-----TGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKP 313 (426)
Q Consensus 239 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~ 313 (426)
|++....... .......|+..|+|||++. +..++.++|||||||++|+|++|..||............
T Consensus 156 g~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~----- 228 (272)
T cd06637 156 GVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI----- 228 (272)
T ss_pred CCceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH-----
Confidence 9997653221 1223467899999999886 345788999999999999999999999654322111100
Q ss_pred hhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 314 YLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
............++..+.+|+.+||..||.+|||+.+++++
T Consensus 229 -----------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 229 -----------PRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred -----------hcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 00000111112345678999999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=324.20 Aligned_cols=266 Identities=26% Similarity=0.350 Sum_probs=198.0
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhc---CCCCccceEeEEEccC
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIV---EHQNLVKLVGYCADDD 158 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l---~HpnIv~~~~~~~~~~ 158 (426)
+|+..+.||+|+||.||+|.++.++. .+|+|.+.... ....+.+|+.+++.+ +||||+++++++.+..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~-----~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~ 75 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGH-----FVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSR 75 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCc-----EEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeecccc
Confidence 47888999999999999999887654 78888875432 233566788777765 7999999999886532
Q ss_pred -CCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEee
Q 014363 159 -ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 237 (426)
Q Consensus 159 -~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~D 237 (426)
......++||||++ ++|.+++.......+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|
T Consensus 76 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~d 151 (288)
T cd07863 76 TDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLAD 151 (288)
T ss_pred CCCCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECc
Confidence 22335699999997 4888888765545589999999999999999999998 999999999999999999999999
Q ss_pred ecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHH-HHHhHhhhhh
Q 014363 238 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQK-LLQWVKPYLS 316 (426)
Q Consensus 238 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~-~~~~~~~~~~ 316 (426)
||++....... ......||..|+|||++.+..++.++|||||||++|+|++|.+||.......... ....... .
T Consensus 152 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~--~ 226 (288)
T cd07863 152 FGLARIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGL--P 226 (288)
T ss_pred cCccccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCC--C
Confidence 99997654321 1233568999999999998899999999999999999999999997654322111 1111000 0
Q ss_pred hhhhhhh-------hcCCcCC---CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 317 DAKQFRQ-------IVDPRLE---GKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 317 ~~~~~~~-------~~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
....... ...+... ......++..+.+++.+||+.||++|||+.|++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 227 PEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred ChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000000 0000000 01112345678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=324.45 Aligned_cols=245 Identities=26% Similarity=0.364 Sum_probs=192.7
Q ss_pred ecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-----CCHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCceEEEE
Q 014363 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-----GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLV 167 (426)
Q Consensus 93 lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~~~lv 167 (426)
||+|+||.||++..+.++. .+|+|.+... .....+..|+++++.++||||+++++++.+.. ..|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~-----~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~----~~~lv 71 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGK-----MYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKT----HLCLV 71 (277)
T ss_pred CCCCCceEEEEEEEccCCc-----EEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCC----eEEEE
Confidence 7999999999999877654 7888877532 12335567999999999999999999987755 45999
Q ss_pred EeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccCCCC
Q 014363 168 YEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSE 247 (426)
Q Consensus 168 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 247 (426)
|||++|++|.+++.......+++..+..++.|++.||+|||+. +|+||||||+|||++.++.++|+|||++......
T Consensus 72 ~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~ 148 (277)
T cd05607 72 MSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG 148 (277)
T ss_pred EecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCC
Confidence 9999999999888655555689999999999999999999998 9999999999999999999999999998765432
Q ss_pred CceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCC
Q 014363 248 GFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDP 327 (426)
Q Consensus 248 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (426)
. ......|+..|+|||++.+..++.++|||||||++|+|++|..||........... . .......
T Consensus 149 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~--~----------~~~~~~~ 213 (277)
T cd05607 149 K---TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEE--L----------KRRTLED 213 (277)
T ss_pred c---eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHH--H----------HHHhhcc
Confidence 1 12335689999999999988899999999999999999999999975432111100 0 0011111
Q ss_pred cCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 328 RLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 328 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.+.. ....++.++.+++.+||+.||++||++.|+++.
T Consensus 214 ~~~~-~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 214 EVKF-EHQNFTEESKDICRLFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred cccc-ccccCCHHHHHHHHHHhccCHhhCCCCccchhh
Confidence 1110 112356788999999999999999999776543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=328.20 Aligned_cols=260 Identities=28% Similarity=0.453 Sum_probs=201.6
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhc-CCCCccceEeEEEccCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDE 159 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~ 159 (426)
.++|++.+.||+|+||.||+|.++..+. ...+++|.+.... ....+.+|+.++.++ +||||+++++++.+.+.
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~---~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~ 82 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGL---RMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 82 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCc---eeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCC
Confidence 3578888999999999999999865432 2356777765432 334678899999999 89999999999977654
Q ss_pred CCceEEEEEeeCCCCChhhhccCCC--------------CCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCce
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPKS--------------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNI 225 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NI 225 (426)
.|+||||+++++|.+++.... ...+++..++.++.|++.||+|||++ +++||||||+||
T Consensus 83 ----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Ni 155 (303)
T cd05088 83 ----LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNI 155 (303)
T ss_pred ----ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheE
Confidence 499999999999999986432 12478999999999999999999998 999999999999
Q ss_pred EeCCCCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhh
Q 014363 226 LLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSE 304 (426)
Q Consensus 226 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~ 304 (426)
|++.++.+||+|||++....... ......++..|+|||++.+..++.++|||||||++|||++ |..||........
T Consensus 156 li~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~ 232 (303)
T cd05088 156 LVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL 232 (303)
T ss_pred EecCCCcEEeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHH
Confidence 99999999999999986322110 0111234667999999988889999999999999999998 9999965433211
Q ss_pred HHHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhh
Q 014363 305 QKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 373 (426)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~ 373 (426)
. ... ........+...+..+.+++.+||+.+|++||+++++++.|+.++...
T Consensus 233 ~---~~~--------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~ 284 (303)
T cd05088 233 Y---EKL--------------PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 284 (303)
T ss_pred H---HHH--------------hcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 1 100 000011112234567899999999999999999999999998876553
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=329.71 Aligned_cols=261 Identities=21% Similarity=0.341 Sum_probs=192.5
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCce
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQ 163 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~ 163 (426)
..+|.+++.||+|+||.||+|.....+. .|++|..... ....|+.+++.++||||+++++++.....
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~-----~valK~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---- 131 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPD-----PVVLKIGQKG----TTLIEAMLLQNVNHPSVIRMKDTLVSGAI---- 131 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCc-----eEEEEeCCcc----ccHHHHHHHHhCCCCCCcChhheEEeCCe----
Confidence 4579999999999999999999876644 7888875433 34579999999999999999999987653
Q ss_pred EEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccccc
Q 014363 164 RLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL 243 (426)
Q Consensus 164 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 243 (426)
.++||||+ .++|.+++.... ..+++..++.|+.||+.||.|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 132 ~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 206 (357)
T PHA03209 132 TCMVLPHY-SSDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQF 206 (357)
T ss_pred eEEEEEcc-CCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccc
Confidence 48999999 468888876433 4589999999999999999999998 999999999999999999999999999974
Q ss_pred CCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhH--------HHHHhHhhhh
Q 014363 244 GPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQ--------KLLQWVKPYL 315 (426)
Q Consensus 244 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~--------~~~~~~~~~~ 315 (426)
.... .......||+.|+|||++.+..++.++|||||||++|||+++..|+....+.... .+........
T Consensus 207 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~ 283 (357)
T PHA03209 207 PVVA---PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLK 283 (357)
T ss_pred cccC---cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhc
Confidence 3221 1123457999999999999999999999999999999999965554332221111 1111110000
Q ss_pred hhhhh---------hhhhcCC--cCCCcc-------cHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 316 SDAKQ---------FRQIVDP--RLEGKY-------SLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 316 ~~~~~---------~~~~~~~--~~~~~~-------~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
..... ...+++. .....+ ....+..+.++|.+||+.||++|||+.|+++|
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 284 VHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred cChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 00000 0000000 000000 01234566789999999999999999999986
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=324.22 Aligned_cols=266 Identities=24% Similarity=0.412 Sum_probs=201.6
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCC---------CCcceEEEEEEccccCC---HHHHHHHHHHHhhcCCCCccceEe
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSED---------PSQKVEVAVKQLGRRGG---HKEWMTEVNFLGIVEHQNLVKLVG 152 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~---------~~~~~~va~K~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~~ 152 (426)
++|++.+.||+|+||.||+|.....+. ......|++|.+..... ...+.+|+++++.++||||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 478899999999999999998754321 12334689998865432 346889999999999999999999
Q ss_pred EEEccCCCCceEEEEEeeCCCCChhhhccCCC----------CCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCC
Q 014363 153 YCADDDERGIQRLLVYEYMPNGSVDQYLSPKS----------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKS 222 (426)
Q Consensus 153 ~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~----------~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp 222 (426)
++..... .++||||+++++|.+++.... ...+++..++.++.|++.||+|||+. +++||||||
T Consensus 85 ~~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp 157 (295)
T cd05097 85 VCVSDDP----LCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLAT 157 (295)
T ss_pred EEcCCCc----cEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccCh
Confidence 9987654 499999999999999985432 12368889999999999999999998 999999999
Q ss_pred CceEeCCCCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh--CCCCCCCCC
Q 014363 223 SNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT--GRRPIDRNR 300 (426)
Q Consensus 223 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt--g~~p~~~~~ 300 (426)
+|||++.++.+||+|||++................++..|+|||++.++.++.++||||||+++|+|++ |..||....
T Consensus 158 ~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~ 237 (295)
T cd05097 158 RNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS 237 (295)
T ss_pred hhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC
Confidence 999999999999999999976543322222233456788999999998899999999999999999998 667776543
Q ss_pred chhhHHHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014363 301 PRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVN 367 (426)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~ 367 (426)
..... ......... .........+...+..+.+|+.+||+.||++|||+++|++.|.
T Consensus 238 ~~~~~---~~~~~~~~~-------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 238 DEQVI---ENTGEFFRN-------QGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred hHHHH---HHHHHhhhh-------ccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 32211 111000000 0000001111124568999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=317.93 Aligned_cols=252 Identities=28% Similarity=0.467 Sum_probs=201.1
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-CCHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCce
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQ 163 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~ 163 (426)
++|++.+.||+|+||.||+|...... .+++|.+... ...+.+.+|+.+++.++||||+++++++... .
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~------~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~-----~ 74 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNT------KVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSEE-----P 74 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCc------eeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEECCC-----C
Confidence 46888899999999999999876543 5888887643 3456789999999999999999999987532 2
Q ss_pred EEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccccc
Q 014363 164 RLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL 243 (426)
Q Consensus 164 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 243 (426)
.+++|||+++++|.+++.......+++..++.++.|++.||.|||+. +++||||||+||++++++.++|+|||++..
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~ 151 (260)
T cd05070 75 IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARL 151 (260)
T ss_pred cEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeee
Confidence 48999999999999999765445589999999999999999999998 999999999999999999999999999976
Q ss_pred CCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhhh
Q 014363 244 GPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQFR 322 (426)
Q Consensus 244 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (426)
....... ......++..|+|||++.+..++.++||||||+++|+|++ |..||....... .....
T Consensus 152 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~----------- 216 (260)
T cd05070 152 IEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE---VLEQV----------- 216 (260)
T ss_pred ccCcccc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHH-----------
Confidence 5432211 1122345678999999988889999999999999999999 889996543221 11110
Q ss_pred hhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 014363 323 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNK 368 (426)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~ 368 (426)
........+...+..+.+++.+||..+|++|||++++.+.|+.
T Consensus 217 ---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 217 ---ERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred ---HcCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0011112223456789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=317.77 Aligned_cols=249 Identities=29% Similarity=0.446 Sum_probs=203.0
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc----CCHHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR----GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
+|+..+.||+|+||.||+|....++. .+++|.+... .....+.+|+.+++.++||||+++++++.+..
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~-----~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--- 72 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKR-----VYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKG--- 72 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCc-----EEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCC---
Confidence 47778899999999999999876654 7888877532 23457889999999999999999999998765
Q ss_pred ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccc
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 241 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 241 (426)
..|+||||+++++|.+++.......+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++
T Consensus 73 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~ 148 (256)
T cd08529 73 -KLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVA 148 (256)
T ss_pred -EEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccc
Confidence 459999999999999999765445689999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhh
Q 014363 242 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 321 (426)
Q Consensus 242 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (426)
........ ......|++.|+|||++.+..++.++||||||+++|+|++|..||....... ...
T Consensus 149 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~------------ 211 (256)
T cd08529 149 KLLSDNTN--FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA---LIL------------ 211 (256)
T ss_pred eeccCccc--hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---HHH------------
Confidence 86543321 1234578999999999999899999999999999999999999997554211 111
Q ss_pred hhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 322 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.+... .....+..++..+.+++.+||+.+|++||++.+++++
T Consensus 212 -~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 212 -KIIRG-VFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred -HHHcC-CCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 11111 1112222456789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-43 Score=328.66 Aligned_cols=247 Identities=23% Similarity=0.392 Sum_probs=209.8
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
+-|...+.||+|.|+.|-+|++--++. .||||++.+.. ....+++|++.|+.++|||||++|++.....
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGe-----kVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQT-- 90 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGE-----KVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQT-- 90 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccc-----eeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccc--
Confidence 457778899999999999998776665 89999997654 3457899999999999999999999886654
Q ss_pred CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEe-CCCCCeeEeeec
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL-DEQWNAKLSDFG 239 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl-~~~~~~kl~DFG 239 (426)
.+|||+|.-++|+|.|||.++.. .+.+..+.+++.||+.|+.|+|.. +||||||||+||.+ ..-|-|||+|||
T Consensus 91 --KlyLiLELGD~GDl~DyImKHe~-Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFG 164 (864)
T KOG4717|consen 91 --KLYLILELGDGGDLFDYIMKHEE-GLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFG 164 (864)
T ss_pred --eEEEEEEecCCchHHHHHHhhhc-cccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeecc
Confidence 56999999999999999986654 489999999999999999999998 99999999999987 456789999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCchhhccCCCCC-chhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014363 240 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAA-RSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 318 (426)
Q Consensus 240 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 318 (426)
++..+.+.. ...+.||++.|-|||++.+..|+. ++||||||||||.|++|+.||..... .
T Consensus 165 FSNkf~PG~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAND----------------S 225 (864)
T KOG4717|consen 165 FSNKFQPGK---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAND----------------S 225 (864)
T ss_pred ccccCCCcc---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccc----------------h
Confidence 998766532 345689999999999999999975 89999999999999999999975432 2
Q ss_pred hhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 319 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
+.+-.++|... ..+..++.++++||..||+.||.+|.+.+||..+
T Consensus 226 ETLTmImDCKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 226 ETLTMIMDCKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred hhhhhhhcccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 33344455433 3566788999999999999999999999999764
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=335.19 Aligned_cols=267 Identities=24% Similarity=0.305 Sum_probs=198.7
Q ss_pred HhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccC
Q 014363 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 158 (426)
Q Consensus 83 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 158 (426)
..++|...+.||+|+||.||+|.+...+. .+|+|.+.... ....+.+|+.+++.++||||+++++++....
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 89 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDR-----NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK 89 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCc-----eEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccc
Confidence 45789999999999999999998765543 78999886432 2356778999999999999999999987543
Q ss_pred C--CCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEe
Q 014363 159 E--RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLS 236 (426)
Q Consensus 159 ~--~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~ 236 (426)
. .....|+||||+++ +|.+.+.. .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+
T Consensus 90 ~~~~~~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~ 161 (355)
T cd07874 90 SLEEFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKIL 161 (355)
T ss_pred cccccceeEEEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEe
Confidence 2 12246999999965 67666642 378889999999999999999998 99999999999999999999999
Q ss_pred eecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHH-HHHhHh-h-
Q 014363 237 DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQK-LLQWVK-P- 313 (426)
Q Consensus 237 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~-~~~~~~-~- 313 (426)
|||+++..... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+........ ...... +
T Consensus 162 Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (355)
T cd07874 162 DFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 238 (355)
T ss_pred eCcccccCCCc---cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 99999864332 12234578999999999999899999999999999999999999997654221111 000000 0
Q ss_pred --hhhh-hhhhhhhcCC---------------cC---CCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 314 --YLSD-AKQFRQIVDP---------------RL---EGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 314 --~~~~-~~~~~~~~~~---------------~~---~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.... .......+.. .+ ...........+.+|+.+||+.||++|||+.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 239 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000 0000000000 00 000111234678999999999999999999999997
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=324.95 Aligned_cols=201 Identities=26% Similarity=0.388 Sum_probs=163.4
Q ss_pred cceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCceEEEEEe
Q 014363 90 SVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYE 169 (426)
Q Consensus 90 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~~~lv~E 169 (426)
.++||+|+||.||+|..+... ..+.+|+|.+........+.+|+.+|+.++||||+++++++...... ..|+|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~---~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~--~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGK---DDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADR--KVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCC---CCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCc--EEEEEEe
Confidence 357999999999999876432 23478999987666566788999999999999999999998765433 5699999
Q ss_pred eCCCCChhhhccCC-------CCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEe----CCCCCeeEeee
Q 014363 170 YMPNGSVDQYLSPK-------SETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL----DEQWNAKLSDF 238 (426)
Q Consensus 170 ~~~~g~L~~~l~~~-------~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl----~~~~~~kl~DF 238 (426)
|+. ++|.+++... ....+++..+..++.||+.||.|||++ +|+||||||+|||+ +.++.+||+||
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07868 81 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred ccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence 995 5887776422 123488999999999999999999998 99999999999999 45678999999
Q ss_pred cccccCCCCCce-eeeeeeecCcccCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCC
Q 014363 239 GLARLGPSEGFT-HVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRN 299 (426)
Q Consensus 239 Gla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~ 299 (426)
|+++........ .......||+.|+|||++.+. .++.++|||||||++|+|++|.+||...
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred CceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 999865432211 112346789999999998764 5899999999999999999999999654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=317.69 Aligned_cols=253 Identities=26% Similarity=0.466 Sum_probs=203.2
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCc
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 162 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~ 162 (426)
.++|+++++||+|+||.||+|..+++ ..+++|.+.... ....+.+|+.+++.++||||+++++++.+.
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~------~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~----- 73 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGH------TKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQE----- 73 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCC------ceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEccC-----
Confidence 35788999999999999999986543 268999886543 456789999999999999999999987542
Q ss_pred eEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccc
Q 014363 163 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 242 (426)
Q Consensus 163 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 242 (426)
..+++|||+++++|.+++.......+++..++.++.|++.||+|||+. +++||||||+||+++.++.++|+|||++.
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 150 (260)
T cd05067 74 PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLAR 150 (260)
T ss_pred CcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCccee
Confidence 248999999999999998765555689999999999999999999998 99999999999999999999999999997
Q ss_pred cCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhh
Q 014363 243 LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 321 (426)
Q Consensus 243 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (426)
........ ......++..|+|||++....++.++||||||+++|+|++ |..||........... .
T Consensus 151 ~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~---~---------- 216 (260)
T cd05067 151 LIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQN---L---------- 216 (260)
T ss_pred ecCCCCcc-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHH---H----------
Confidence 65432211 1223346778999999988889999999999999999999 9999975443211111 0
Q ss_pred hhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 014363 322 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNK 368 (426)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~ 368 (426)
........+...+.++.+++.+||..+|++||++++++..|+.
T Consensus 217 ----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 217 ----ERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ----HcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 0001111122345689999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=320.11 Aligned_cols=264 Identities=24% Similarity=0.422 Sum_probs=207.9
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
.++|...++||+|+||.||+|.+.... ......+++|.+.... ....+.+|+.+++.++||||+++++++.....
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~-~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~- 82 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEK-PGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE- 82 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCC-CCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC-
Confidence 457888999999999999999987632 2234578888876443 23567899999999999999999998876432
Q ss_pred CceEEEEEeeCCCCChhhhccCCCC------CccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCee
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSE------TILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAK 234 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~------~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~k 234 (426)
..++++||+++++|.+++..... ..+++..++.++.|++.||+|||+. +++||||||+|||+++++.+|
T Consensus 83 --~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~k 157 (280)
T cd05043 83 --PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVK 157 (280)
T ss_pred --CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEE
Confidence 24899999999999999865321 4589999999999999999999998 999999999999999999999
Q ss_pred EeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhh
Q 014363 235 LSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKP 313 (426)
Q Consensus 235 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~ 313 (426)
|+|||+++.+.............++..|+|||++.+..++.++||||||+++||+++ |..||....+.. ...+..
T Consensus 158 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~- 233 (280)
T cd05043 158 ITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MAAYLK- 233 (280)
T ss_pred ECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---HHHHHH-
Confidence 999999986543332222233456778999999988889999999999999999999 999997654322 111111
Q ss_pred hhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHh
Q 014363 314 YLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVD 371 (426)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~ 371 (426)
. .........++..+.+++.+||..||++|||+.++++.|+.+..
T Consensus 234 ---~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 234 ---D----------GYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred ---c----------CCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 0 00001112345688999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=318.41 Aligned_cols=249 Identities=26% Similarity=0.444 Sum_probs=197.7
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCceE
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQR 164 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~~ 164 (426)
+|++.+.||+|+||.||+|.++... .+++|.+.... ....+.+|+.+++.++||||+++++++.+... .
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~------~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~----~ 74 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKI------DVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRP----I 74 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCc------cEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc----e
Confidence 5778889999999999999876432 68888876432 44578899999999999999999999876653 4
Q ss_pred EEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccC
Q 014363 165 LLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLG 244 (426)
Q Consensus 165 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 244 (426)
|+||||+++++|.+++.... ..+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++..
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~ 150 (256)
T cd05059 75 FIVTEYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYV 150 (256)
T ss_pred EEEEecCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceec
Confidence 99999999999999987543 2589999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhhhh
Q 014363 245 PSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQ 323 (426)
Q Consensus 245 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (426)
...... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||........... ...
T Consensus 151 ~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~-------------~~~ 216 (256)
T cd05059 151 LDDQYT-SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVES-------------VSA 216 (256)
T ss_pred cccccc-ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHH-------------HHc
Confidence 332111 1112234457999999998899999999999999999999 8999975433211111 000
Q ss_pred hcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014363 324 IVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMV 366 (426)
Q Consensus 324 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L 366 (426)
... ...+...+..+.+++.+||..+|++|||+.|+++.|
T Consensus 217 ~~~----~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 217 GYR----LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCc----CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 001 111123567899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=327.13 Aligned_cols=264 Identities=26% Similarity=0.453 Sum_probs=204.7
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCC--CCCcceEEEEEEccccCC---HHHHHHHHHHHhhc-CCCCccceEeEEEccC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSE--DPSQKVEVAVKQLGRRGG---HKEWMTEVNFLGIV-EHQNLVKLVGYCADDD 158 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~--~~~~~~~va~K~~~~~~~---~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~ 158 (426)
.+|.+.+.||+|+||.||+|...... .......+++|.+..... ...+..|+.+++.+ +||||+++++++.+..
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 47888999999999999999864322 123345788998865432 34678899999999 6999999999997765
Q ss_pred CCCceEEEEEeeCCCCChhhhccCCC--------------CCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCc
Q 014363 159 ERGIQRLLVYEYMPNGSVDQYLSPKS--------------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSN 224 (426)
Q Consensus 159 ~~~~~~~lv~E~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~N 224 (426)
. .++||||+++|+|.+++.... ...+++..+..++.|++.||.|||++ |++||||||+|
T Consensus 92 ~----~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~N 164 (314)
T cd05099 92 P----LYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARN 164 (314)
T ss_pred c----eEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeecccccee
Confidence 3 499999999999999986432 23488999999999999999999998 99999999999
Q ss_pred eEeCCCCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchh
Q 014363 225 ILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRS 303 (426)
Q Consensus 225 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~ 303 (426)
||++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|+|++ |..||.......
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~ 244 (314)
T cd05099 165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE 244 (314)
T ss_pred EEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999986543221111112234568999999998889999999999999999999 889986543322
Q ss_pred hHHHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 014363 304 EQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 372 (426)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~ 372 (426)
...... . ......+..++..+.+++.+||..||++||++.++++.|.++...
T Consensus 245 ~~~~~~----------------~-~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 296 (314)
T cd05099 245 LFKLLR----------------E-GHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296 (314)
T ss_pred HHHHHH----------------c-CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence 111110 0 000111223456888999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=332.99 Aligned_cols=248 Identities=25% Similarity=0.380 Sum_probs=192.6
Q ss_pred ceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-----CHHHHHHHHHHHhhc-CCCCccceEeEEEccCCCCceE
Q 014363 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-----GHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDERGIQR 164 (426)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-----~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~~~~~~ 164 (426)
+.||+|+||.||+|.+..++. .+|+|.+.... ....+..|+.++..+ +||||+++++++.+.. ..
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~-----~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~----~~ 71 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTER-----IYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES----RL 71 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCC-----EEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCC----EE
Confidence 369999999999999877654 78888876431 234567888888776 8999999999998765 45
Q ss_pred EEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccC
Q 014363 165 LLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLG 244 (426)
Q Consensus 165 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 244 (426)
|+||||+++|+|..++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 72 ~lv~E~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~ 146 (329)
T cd05618 72 FFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 146 (329)
T ss_pred EEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccc
Confidence 9999999999999888644 3489999999999999999999998 9999999999999999999999999998753
Q ss_pred CCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchh--hHHHHHhHhhhhhhhhhhh
Q 014363 245 PSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRS--EQKLLQWVKPYLSDAKQFR 322 (426)
Q Consensus 245 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 322 (426)
.... .......||+.|+|||++.+..++.++|||||||++|+|++|..||....... ......+.. .
T Consensus 147 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~---------~ 215 (329)
T cd05618 147 LRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF---------Q 215 (329)
T ss_pred cCCC--CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHH---------H
Confidence 2221 12234679999999999999999999999999999999999999996322111 000001100 0
Q ss_pred hhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCC------HHHHHHH
Q 014363 323 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPK------MSEVLEM 365 (426)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs------~~eil~~ 365 (426)
.+.... ..++...+..+.+++.+||+.||++||+ +.++++|
T Consensus 216 ~i~~~~--~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 216 VILEKQ--IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred HHhcCC--CCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 111111 1123345678899999999999999998 4677765
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=337.89 Aligned_cols=255 Identities=25% Similarity=0.347 Sum_probs=200.0
Q ss_pred HHHHhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-----CCHHHHHHHHHHHhhcCCCCccceEeEE
Q 014363 80 LKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-----GGHKEWMTEVNFLGIVEHQNLVKLVGYC 154 (426)
Q Consensus 80 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~~~~ 154 (426)
+....++|+..+.||+|+||.||+|.++.++. .+|+|.+... .....+.+|+.+++.++||||+++++++
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~-----~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~ 112 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRK-----VYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF 112 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCc-----EEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 33445789999999999999999999887654 7899987532 2234577899999999999999999999
Q ss_pred EccCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCee
Q 014363 155 ADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAK 234 (426)
Q Consensus 155 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~k 234 (426)
.+.. ..|+||||+++|+|.+++... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+|
T Consensus 113 ~~~~----~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ik 182 (371)
T cd05622 113 QDDR----YLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLK 182 (371)
T ss_pred EcCC----EEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEE
Confidence 8765 459999999999999998643 378889999999999999999998 999999999999999999999
Q ss_pred EeeecccccCCCCCceeeeeeeecCcccCCchhhccC----CCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHh
Q 014363 235 LSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG----RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQW 310 (426)
Q Consensus 235 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~ 310 (426)
|+|||++........ ......+||+.|+|||++.+. .++.++|||||||++|||++|..||........
T Consensus 183 L~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~------ 255 (371)
T cd05622 183 LADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT------ 255 (371)
T ss_pred EEeCCceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHH------
Confidence 999999986543321 122356799999999998754 378899999999999999999999976432211
Q ss_pred HhhhhhhhhhhhhhcCC--cCCCcccHHHHHHHHHHHHhccccCCCC--CCCHHHHHHHH
Q 014363 311 VKPYLSDAKQFRQIVDP--RLEGKYSLRLVSKLSHVANLCLVKNART--RPKMSEVLEMV 366 (426)
Q Consensus 311 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~eil~~L 366 (426)
+..++.. .+.......++..+.+++..||..++.+ |+++.+|+++.
T Consensus 256 ----------~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 256 ----------YSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred ----------HHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 1111110 1111112245678899999999844433 78999999874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=317.97 Aligned_cols=251 Identities=28% Similarity=0.420 Sum_probs=200.8
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-------CHHHHHHHHHHHhhcCCCCccceEeEEEcc
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-------GHKEWMTEVNFLGIVEHQNLVKLVGYCADD 157 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-------~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 157 (426)
++|...+.||+|+||.||+|....++. .+++|.+.... ....+.+|+.+++.++||||+++++++.+.
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~-----~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 76 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGR-----ELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDD 76 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCc-----EEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccC
Confidence 478899999999999999998766544 78888765322 124678899999999999999999999876
Q ss_pred CCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEee
Q 014363 158 DERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 237 (426)
Q Consensus 158 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~D 237 (426)
. ..++||||+++++|.+++.... .+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|
T Consensus 77 ~----~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~d 147 (263)
T cd06625 77 E----TLSIFMEYMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGD 147 (263)
T ss_pred C----eEEEEEEECCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEee
Confidence 5 4599999999999999986543 488899999999999999999998 999999999999999999999999
Q ss_pred ecccccCCCCCceee-eeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhh
Q 014363 238 FGLARLGPSEGFTHV-STAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS 316 (426)
Q Consensus 238 FGla~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 316 (426)
||++........... .....|+..|+|||++.+..++.++||||||+++|+|++|+.||.........
T Consensus 148 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~----------- 216 (263)
T cd06625 148 FGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI----------- 216 (263)
T ss_pred cccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH-----------
Confidence 999875432211110 12356888999999999888999999999999999999999999654322111
Q ss_pred hhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 317 DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
............+..++..+.+++.+||..+|++|||+.+++++
T Consensus 217 -----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 217 -----FKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -----HHHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 01111111122333456788999999999999999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=331.63 Aligned_cols=241 Identities=29% Similarity=0.388 Sum_probs=189.3
Q ss_pred ceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-----CHHHHHHHHH-HHhhcCCCCccceEeEEEccCCCCceE
Q 014363 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-----GHKEWMTEVN-FLGIVEHQNLVKLVGYCADDDERGIQR 164 (426)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-----~~~~~~~E~~-~l~~l~HpnIv~~~~~~~~~~~~~~~~ 164 (426)
++||+|+||+||+|.+..++. .||+|.+.... ....+..|.. +++.++||||+++++++.+.. ..
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~----~~ 71 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGK-----FYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTAD----KL 71 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCC-----EEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCC----EE
Confidence 369999999999999876654 79999885432 2234555554 567789999999999988765 45
Q ss_pred EEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccC
Q 014363 165 LLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLG 244 (426)
Q Consensus 165 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 244 (426)
|+||||+++|+|..++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 72 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~ 146 (323)
T cd05575 72 YFVLDYVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (323)
T ss_pred EEEEcCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCccc
Confidence 9999999999999988654 3488999999999999999999998 9999999999999999999999999998753
Q ss_pred CCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhh
Q 014363 245 PSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQI 324 (426)
Q Consensus 245 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (426)
.... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||......... ..+
T Consensus 147 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~----------------~~i 208 (323)
T cd05575 147 IEHS--KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMY----------------DNI 208 (323)
T ss_pred ccCC--CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHH----------------HHH
Confidence 2221 1233467999999999999999999999999999999999999999754321110 111
Q ss_pred cCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHH----HHHHH
Q 014363 325 VDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMS----EVLEM 365 (426)
Q Consensus 325 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~----eil~~ 365 (426)
..... ......+..+.+++.+||+.||++||++. +++++
T Consensus 209 ~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~ 251 (323)
T cd05575 209 LNKPL--RLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNH 251 (323)
T ss_pred HcCCC--CCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcC
Confidence 11111 11223467889999999999999999984 55543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=321.65 Aligned_cols=260 Identities=28% Similarity=0.462 Sum_probs=202.6
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC---HHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG---HKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
.++|+..+.||+|+||.||+|.+...........+++|.+..... ...+.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~- 82 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP- 82 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc-
Confidence 457889999999999999999876432223445789998865432 3568899999999999999999999887654
Q ss_pred CceEEEEEeeCCCCChhhhccCCC--------------------CCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccC
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKS--------------------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDF 220 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~--------------------~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDl 220 (426)
.++||||+++|+|.+++.... ...+++..++.++.|++.||.|||++ +++||||
T Consensus 83 ---~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl 156 (288)
T cd05050 83 ---MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDL 156 (288)
T ss_pred ---cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---Ceecccc
Confidence 499999999999999986321 12478888999999999999999998 9999999
Q ss_pred CCCceEeCCCCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCC
Q 014363 221 KSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRN 299 (426)
Q Consensus 221 kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~ 299 (426)
||+|||++.++.++|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||...
T Consensus 157 ~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~ 236 (288)
T cd05050 157 ATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM 236 (288)
T ss_pred cHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999875433221111222345678999999988899999999999999999998 88888654
Q ss_pred CchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014363 300 RPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVN 367 (426)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~ 367 (426)
.... .... +.+.... ..+..++..+.+++.+||+.+|++|||+.|+++.|+
T Consensus 237 ~~~~---~~~~-------------~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 237 AHEE---VIYY-------------VRDGNVL-SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred CHHH---HHHH-------------HhcCCCC-CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 3321 1111 1111110 112235578999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=329.51 Aligned_cols=240 Identities=26% Similarity=0.422 Sum_probs=192.2
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-----CCHHHHHHHHHHHhhcC-CCCccceEeEEEccCC
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-----GGHKEWMTEVNFLGIVE-HQNLVKLVGYCADDDE 159 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-----~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~~~~~ 159 (426)
+|+..+.||+|+||.||+|..+.++. .||+|.+... ...+.+..|+.++..+. |++|+++++++.+.+
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~- 74 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDE-----LYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVD- 74 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCC-----EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCC-
Confidence 47788899999999999999877654 7999988643 23345778999998885 577888988887765
Q ss_pred CCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeec
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 239 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 239 (426)
..|+||||+++|+|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 75 ---~~~lv~Ey~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg 146 (323)
T cd05615 75 ---RLYFVMEYVNGGDLMYHIQQVG--KFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFG 146 (323)
T ss_pred ---EEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccc
Confidence 4599999999999999986543 489999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014363 240 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 319 (426)
Q Consensus 240 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 319 (426)
++....... .......||+.|+|||++.+..++.++|||||||++|+|++|..||....... ...
T Consensus 147 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~~~---------- 211 (323)
T cd05615 147 MCKEHMVDG--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE---LFQ---------- 211 (323)
T ss_pred cccccCCCC--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH---HHH----------
Confidence 987543221 12334679999999999999899999999999999999999999997653321 111
Q ss_pred hhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCH
Q 014363 320 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKM 359 (426)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~ 359 (426)
.+.... ..++...+..+.+++.+||+.||.+|++.
T Consensus 212 ---~i~~~~--~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 212 ---SIMEHN--VSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ---HHHhCC--CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 111111 11233455688999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=333.42 Aligned_cols=265 Identities=25% Similarity=0.290 Sum_probs=198.3
Q ss_pred HhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc----CCHHHHHHHHHHHhhcCCCCccceEeEEEccC
Q 014363 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR----GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 158 (426)
Q Consensus 83 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 158 (426)
..++|+..+.||+|+||.||+|.+...+. .+|+|.+... .....+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 93 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGI-----NVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQK 93 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCc-----eeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCC
Confidence 35789999999999999999998776554 7899988543 23456789999999999999999999987554
Q ss_pred CC--CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEe
Q 014363 159 ER--GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLS 236 (426)
Q Consensus 159 ~~--~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~ 236 (426)
.. ....|+||||+++ +|.+.+.. .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+
T Consensus 94 ~~~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~ 165 (359)
T cd07876 94 SLEEFQDVYLVMELMDA-NLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKIL 165 (359)
T ss_pred CccccceeEEEEeCCCc-CHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEe
Confidence 21 1246999999965 56666532 278889999999999999999998 99999999999999999999999
Q ss_pred eecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhh
Q 014363 237 DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS 316 (426)
Q Consensus 237 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 316 (426)
|||+++..... .......||+.|+|||++.+..++.++|||||||++|+|++|..||......... .........
T Consensus 166 Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~--~~~~~~~~~ 240 (359)
T cd07876 166 DFGLARTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQW--NKVIEQLGT 240 (359)
T ss_pred cCCCccccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHhcCC
Confidence 99999754322 1123457899999999999999999999999999999999999999765432111 000000000
Q ss_pred h--------hhhhhhhcC--CcCC----------------CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 317 D--------AKQFRQIVD--PRLE----------------GKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 317 ~--------~~~~~~~~~--~~~~----------------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
. ......... +... .......+..+.+|+.+||+.||++|||+.|+++|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 241 PSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred CcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0 000000000 0000 00111234678999999999999999999999997
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=315.65 Aligned_cols=252 Identities=28% Similarity=0.475 Sum_probs=201.1
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCce
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQ 163 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~ 163 (426)
++|.+...||+|+||.||+|.+.... .+++|.+.... ..+.+.+|+.+++.++||||+++++++... .
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~------~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~ 74 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTT------KVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSEE-----P 74 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCc------eEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEcCC-----C
Confidence 45888889999999999999876543 58888876433 446788999999999999999999887532 2
Q ss_pred EEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccccc
Q 014363 164 RLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL 243 (426)
Q Consensus 164 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 243 (426)
.++||||+++++|.+++.......+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||++..
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~ 151 (260)
T cd05069 75 IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARL 151 (260)
T ss_pred cEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceE
Confidence 48999999999999999765445589999999999999999999998 999999999999999999999999999976
Q ss_pred CCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhhh
Q 014363 244 GPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQFR 322 (426)
Q Consensus 244 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (426)
....... ......++..|+|||++.+..++.++||||||+++|+|++ |..||....... .....
T Consensus 152 ~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~----------- 216 (260)
T cd05069 152 IEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE---VLEQV----------- 216 (260)
T ss_pred ccCCccc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH-----------
Confidence 5432211 1122346778999999988889999999999999999999 899997543221 11110
Q ss_pred hhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 014363 323 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNK 368 (426)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~ 368 (426)
.. ......+...+..+.+++.+||..||++||++++|++.|++
T Consensus 217 --~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 217 --ER-GYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred --Hc-CCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 00 01111223456789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=319.46 Aligned_cols=259 Identities=25% Similarity=0.440 Sum_probs=206.3
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC---HHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG---HKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
++|+....||.|+||.||+|..+..........+++|.+..... .+.+.+|++++++++||||+++++++.+...
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-- 82 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP-- 82 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc--
Confidence 47888999999999999999988766666667899998865443 3578999999999999999999999877654
Q ss_pred ceEEEEEeeCCCCChhhhccCCCC-------CccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCee
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSE-------TILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAK 234 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~-------~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~k 234 (426)
.++||||+++|+|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.++
T Consensus 83 --~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~ 157 (275)
T cd05046 83 --HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVK 157 (275)
T ss_pred --ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEE
Confidence 4999999999999999975441 1589999999999999999999998 999999999999999999999
Q ss_pred EeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhh
Q 014363 235 LSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKP 313 (426)
Q Consensus 235 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~ 313 (426)
|+|||++......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ....
T Consensus 158 l~~~~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---~~~~--- 230 (275)
T cd05046 158 VSLLSLSKDVYNSEYY-KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---VLNR--- 230 (275)
T ss_pred EcccccccccCccccc-ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---HHHH---
Confidence 9999998744322111 1223456778999999988888999999999999999999 888986433211 1111
Q ss_pred hhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014363 314 YLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVN 367 (426)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~ 367 (426)
.....+.......++..+.+++.+||+.+|++||++.|+++.|.
T Consensus 231 ----------~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 231 ----------LQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred ----------HHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 01111111112235568999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=337.64 Aligned_cols=252 Identities=24% Similarity=0.305 Sum_probs=196.6
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-----CCHHHHHHHHHHHhhcCCCCccceEeEEEccCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-----GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
++|+..+.||+|+||.||+|..+.++. .+|+|.+... .....+..|+.++..++||||+++++.+.+..
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~-----~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~- 74 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGH-----IYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKR- 74 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCC-----EEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC-
Confidence 368889999999999999999877654 7899988532 23456788999999999999999999998765
Q ss_pred CCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeec
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 239 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 239 (426)
..|+||||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 75 ---~~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG 146 (360)
T cd05627 75 ---NLYLIMEFLPGGDMMTLLMKKD--TLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFG 146 (360)
T ss_pred ---EEEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeecc
Confidence 4599999999999999986543 489999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCc---------------------------------eeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHH
Q 014363 240 LARLGPSEGF---------------------------------THVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFL 286 (426)
Q Consensus 240 la~~~~~~~~---------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil 286 (426)
++........ .......+||+.|+|||++.+..++.++|||||||++
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil 226 (360)
T cd05627 147 LCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226 (360)
T ss_pred CCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceecccccee
Confidence 9874422100 0001235799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCC---HHHHH
Q 014363 287 YELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPK---MSEVL 363 (426)
Q Consensus 287 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs---~~eil 363 (426)
|||++|..||....+......+. .. ...+.-.....++..+.+++.+|+. ||.+|++ +.+++
T Consensus 227 yel~tG~~Pf~~~~~~~~~~~i~------~~--------~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~ 291 (360)
T cd05627 227 YEMLIGYPPFCSETPQETYRKVM------NW--------KETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIK 291 (360)
T ss_pred eecccCCCCCCCCCHHHHHHHHH------cC--------CCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHh
Confidence 99999999997654432111110 00 0000000011245678888888764 9999984 78888
Q ss_pred HH
Q 014363 364 EM 365 (426)
Q Consensus 364 ~~ 365 (426)
+|
T Consensus 292 ~h 293 (360)
T cd05627 292 SH 293 (360)
T ss_pred cC
Confidence 76
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=324.87 Aligned_cols=265 Identities=25% Similarity=0.408 Sum_probs=199.3
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
++|...+.||+|+||.||+|..+.++. .+|+|.+.... ....+.+|+.+++.++||||+++++++...+
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--- 77 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTEN-----LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDK--- 77 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCC-----eEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCC---
Confidence 578999999999999999998776544 78899875332 3346788999999999999999999998765
Q ss_pred ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccc
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 241 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 241 (426)
..++||||+++ +|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 78 -~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 151 (309)
T cd07872 78 -SLTLVFEYLDK-DLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLA 151 (309)
T ss_pred -eEEEEEeCCCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccc
Confidence 35999999965 8888776443 3478899999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHh--------
Q 014363 242 RLGPSEGFTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK-------- 312 (426)
Q Consensus 242 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~-------- 312 (426)
....... .......+++.|+|||++.+ ..++.++||||||+++|+|++|..||...........+....
T Consensus 152 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 229 (309)
T cd07872 152 RAKSVPT--KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETW 229 (309)
T ss_pred eecCCCc--cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 7543221 11223468999999998865 458899999999999999999999997665433322221110
Q ss_pred hhhhhhhhhhhhcCCcCCC----cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 313 PYLSDAKQFRQIVDPRLEG----KYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
+.+.....+.....+.... .....++.++.+++.+||+.||.+|||+.|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 230 PGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 0000000000000000000 0111345678999999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=333.15 Aligned_cols=240 Identities=26% Similarity=0.350 Sum_probs=190.9
Q ss_pred ceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCceEEE
Q 014363 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLL 166 (426)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~~~l 166 (426)
+.||+|+||.||++...... .....+|+|++.... ....+..|+.+|++++||||+++++++.+.+ ..|+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~l 75 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGP--DAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEG----KLYL 75 (318)
T ss_pred ceeeeCCCEEEEEEEEeccC--CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCC----EEEE
Confidence 57999999999998764221 234478999886432 2345678999999999999999999998765 4599
Q ss_pred EEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccCCC
Q 014363 167 VYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPS 246 (426)
Q Consensus 167 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 246 (426)
||||+++|+|.+++... ..+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 76 v~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 150 (318)
T cd05582 76 ILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESID 150 (318)
T ss_pred EEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCC
Confidence 99999999999998643 3489999999999999999999998 999999999999999999999999999876433
Q ss_pred CCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcC
Q 014363 247 EGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVD 326 (426)
Q Consensus 247 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (426)
.. .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......... .+..
T Consensus 151 ~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~----------------~i~~ 212 (318)
T cd05582 151 HE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMT----------------MILK 212 (318)
T ss_pred CC--CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHH----------------HHHc
Confidence 21 12334679999999999998889999999999999999999999997543221110 1111
Q ss_pred CcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHH
Q 014363 327 PRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSE 361 (426)
Q Consensus 327 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~e 361 (426)
.. ..++..++..+.+++.+||+.||++||++.+
T Consensus 213 ~~--~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 213 AK--LGMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CC--CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 11 1122335678899999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=315.36 Aligned_cols=248 Identities=25% Similarity=0.439 Sum_probs=194.9
Q ss_pred eecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCceEEEE
Q 014363 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLV 167 (426)
Q Consensus 92 ~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~~~lv 167 (426)
.||+|+||.||+|.++... ....+++|.+.... ..+.+..|+.+++.++||||+++++++... ..++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~lv 73 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKK---SEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAE-----SWMLV 73 (257)
T ss_pred cCCCcCCcceEEeEEecCC---CceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-----CcEEE
Confidence 5899999999999765322 23479999886443 235688999999999999999999988543 24899
Q ss_pred EeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccCCCC
Q 014363 168 YEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSE 247 (426)
Q Consensus 168 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 247 (426)
|||+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 74 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~ 148 (257)
T cd05116 74 MELAELGPLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGAD 148 (257)
T ss_pred EecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCC
Confidence 9999999999999644 3489999999999999999999998 9999999999999999999999999999865433
Q ss_pred Ccee-eeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhc
Q 014363 248 GFTH-VSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIV 325 (426)
Q Consensus 248 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (426)
.... ......++..|+|||.+....++.++||||||+++|||++ |..||....... .....
T Consensus 149 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~i-------------- 211 (257)
T cd05116 149 ENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE---VTQMI-------------- 211 (257)
T ss_pred CCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH--------------
Confidence 2211 1112234678999999988889999999999999999998 999997543321 11111
Q ss_pred CCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHh
Q 014363 326 DPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 369 (426)
Q Consensus 326 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~ 369 (426)
........+..++..+.++|.+||+.||++||++++|.+.|+..
T Consensus 212 ~~~~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 212 ESGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred HCCCCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 11111122234567899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=319.31 Aligned_cols=249 Identities=26% Similarity=0.393 Sum_probs=211.4
Q ss_pred CCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCceEEE
Q 014363 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLL 166 (426)
Q Consensus 87 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~~~l 166 (426)
|.++.+||+|+||.||+|.++.++. .+|+|++.-+.+.+++..|+.||.+.+.|++|++||.+....+ +++
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~-----v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sD----LWI 105 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGH-----VLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSD----LWI 105 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCc-----EEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCc----eEe
Confidence 5566689999999999999998876 8999999999999999999999999999999999997766554 499
Q ss_pred EEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccCCC
Q 014363 167 VYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPS 246 (426)
Q Consensus 167 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 246 (426)
|||||..|++.+.++.+ ++.+.+.++..+++..++||+|||.. .-||||||..|||++.+|..||+|||++..+.+
T Consensus 106 VMEYCGAGSiSDI~R~R-~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD 181 (502)
T KOG0574|consen 106 VMEYCGAGSISDIMRAR-RKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD 181 (502)
T ss_pred ehhhcCCCcHHHHHHHh-cCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhh
Confidence 99999999999999754 45699999999999999999999987 889999999999999999999999999976554
Q ss_pred CCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcC
Q 014363 247 EGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVD 326 (426)
Q Consensus 247 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (426)
. .....+..|||.|||||++..-.|+.++||||||++..||..|++||....+-..... --.+
T Consensus 182 T--MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM---------------IPT~ 244 (502)
T KOG0574|consen 182 T--MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM---------------IPTK 244 (502)
T ss_pred h--HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEe---------------ccCC
Confidence 3 2234568899999999999999999999999999999999999999976543211000 0011
Q ss_pred CcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 327 PRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 327 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
+...-.-+...+.++.++++.||..+|++|-|+-++++|
T Consensus 245 PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 245 PPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 222223355678899999999999999999999999886
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=323.54 Aligned_cols=245 Identities=25% Similarity=0.333 Sum_probs=193.9
Q ss_pred ecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-----CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCceEEEE
Q 014363 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLV 167 (426)
Q Consensus 93 lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~~~lv 167 (426)
||+|+||+||+|.++.++. .+|+|.+.... ..+.+..|+.+++.++||||+++++++.... ..|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~-----~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~----~~~lv 71 (280)
T cd05608 1 LGKGGFGEVSACQMRATGK-----LYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKT----DLCLV 71 (280)
T ss_pred CCCCCceeEEEEEEccCCc-----EEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCC----eEEEE
Confidence 6999999999999876654 78999875432 2345678999999999999999999887765 35999
Q ss_pred EeeCCCCChhhhccCC--CCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccCC
Q 014363 168 YEYMPNGSVDQYLSPK--SETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGP 245 (426)
Q Consensus 168 ~E~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 245 (426)
|||+++|+|.+++... ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++....
T Consensus 72 ~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 148 (280)
T cd05608 72 MTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELK 148 (280)
T ss_pred EeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecC
Confidence 9999999998877432 234589999999999999999999998 99999999999999999999999999997654
Q ss_pred CCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhc
Q 014363 246 SEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIV 325 (426)
Q Consensus 246 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (426)
.... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||........... ......
T Consensus 149 ~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~------------~~~~~~ 214 (280)
T cd05608 149 DGQS--KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKE------------LKQRIL 214 (280)
T ss_pred CCCc--cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHH------------HHHhhc
Confidence 3221 12345799999999999999999999999999999999999999975432211100 001111
Q ss_pred CCcCCCcccHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 014363 326 DPRLEGKYSLRLVSKLSHVANLCLVKNARTRP-----KMSEVLEM 365 (426)
Q Consensus 326 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~ 365 (426)
... ..++..++..+.+++.+||+.||++|| ++++++++
T Consensus 215 ~~~--~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 215 NDS--VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred ccC--CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 111 122334667899999999999999999 77888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=321.94 Aligned_cols=267 Identities=24% Similarity=0.424 Sum_probs=202.0
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCC-----------CCCcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCCccc
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSE-----------DPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQNLVK 149 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~-----------~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~HpnIv~ 149 (426)
.++|++.+.||+|+||.||++.+.... .......+++|.+.... ....+.+|+.+++.++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 357899999999999999998654321 11223468999886543 2357889999999999999999
Q ss_pred eEeEEEccCCCCceEEEEEeeCCCCChhhhccCCCC---------CccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccC
Q 014363 150 LVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSE---------TILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDF 220 (426)
Q Consensus 150 ~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~---------~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDl 220 (426)
+++++.+.+. .++||||+++++|.+++..... ..+++..++.++.|++.||+|||+. +++|+||
T Consensus 84 ~~~~~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl 156 (296)
T cd05095 84 LLAVCITSDP----LCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDL 156 (296)
T ss_pred EEEEEecCCc----cEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccC
Confidence 9999987764 3999999999999999865321 2367888999999999999999998 9999999
Q ss_pred CCCceEeCCCCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh--CCCCCCC
Q 014363 221 KSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT--GRRPIDR 298 (426)
Q Consensus 221 kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt--g~~p~~~ 298 (426)
||+|||++.++.++|+|||++................++..|++||+..++.++.++|||||||++|||++ |..||..
T Consensus 157 kp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~ 236 (296)
T cd05095 157 ATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ 236 (296)
T ss_pred ChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence 99999999999999999999976543322222223345678999999888889999999999999999998 7788865
Q ss_pred CCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014363 299 NRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVN 367 (426)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~ 367 (426)
....... ....... ... ........+..++..+.+++.+||+.||++||++.+|++.|.
T Consensus 237 ~~~~~~~---~~~~~~~------~~~-~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 237 LSDEQVI---ENTGEFF------RDQ-GRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred cChHHHH---HHHHHHH------hhc-cccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 4332211 1110000 000 000000111234578999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=319.83 Aligned_cols=277 Identities=25% Similarity=0.360 Sum_probs=202.3
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC--CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCc
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 162 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~ 162 (426)
+.|++.+.||+|+||.||+|..... .......+++|.+.... ..+.+.+|+++++.++||||+++++++...+..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~-~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~-- 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPL-QDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR-- 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCC-cCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC--
Confidence 4688899999999999999986432 11233478999886543 235788999999999999999999988654432
Q ss_pred eEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccc
Q 014363 163 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 242 (426)
Q Consensus 163 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 242 (426)
..++||||+++++|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~ 156 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTK 156 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccc
Confidence 3589999999999999986433 3489999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCCCcee-eeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhh
Q 014363 243 LGPSEGFTH-VSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 321 (426)
Q Consensus 243 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (426)
......... ......++..|+|||++.+..++.++||||||+++|||++|..|+............. ..........+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 235 (284)
T cd05081 157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGN-DKQGQMIVYHL 235 (284)
T ss_pred cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhccc-ccccccchHHH
Confidence 654332111 1112234456999999998889999999999999999999887764322110000000 00000000001
Q ss_pred hhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHh
Q 014363 322 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 369 (426)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~ 369 (426)
.+.+...........++..+.+++.+||+.+|++|||+.||++.|+.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 236 IELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 111111111112234567899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=326.79 Aligned_cols=266 Identities=26% Similarity=0.442 Sum_probs=206.9
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCC--CCcceEEEEEEccccC---CHHHHHHHHHHHhhc-CCCCccceEeEEEccC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSED--PSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIV-EHQNLVKLVGYCADDD 158 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~--~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~ 158 (426)
.+|.+.+.||+|+||.||+|.+..... ......+++|.+.... ..+.+.+|+.++.++ +||||+++++++...+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 468899999999999999998754322 1233468999876433 235788999999999 8999999999998765
Q ss_pred CCCceEEEEEeeCCCCChhhhccCCC--------------CCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCc
Q 014363 159 ERGIQRLLVYEYMPNGSVDQYLSPKS--------------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSN 224 (426)
Q Consensus 159 ~~~~~~~lv~E~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~N 224 (426)
. .+++|||+++|+|.+++.... ...+++..++.++.|++.||.|||++ +++||||||+|
T Consensus 92 ~----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~N 164 (334)
T cd05100 92 P----LYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARN 164 (334)
T ss_pred c----eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccce
Confidence 3 499999999999999986432 23478889999999999999999998 99999999999
Q ss_pred eEeCCCCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchh
Q 014363 225 ILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRS 303 (426)
Q Consensus 225 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~ 303 (426)
||++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||.......
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 244 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 244 (334)
T ss_pred EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999999976543221111222334578999999999999999999999999999998 888886543221
Q ss_pred hHHHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhhc
Q 014363 304 EQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASA 374 (426)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~~ 374 (426)
.... . . .......+...+..+.+++.+||+.+|++||++.|+++.|..+.....
T Consensus 245 ~~~~---~-------------~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~ 298 (334)
T cd05100 245 LFKL---L-------------K-EGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS 298 (334)
T ss_pred HHHH---H-------------H-cCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence 1111 0 0 001111222345689999999999999999999999999999885543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=314.91 Aligned_cols=248 Identities=29% Similarity=0.485 Sum_probs=202.8
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC-HHHHHHHHHHHhhcCCCCccceEeEEEccCCCCce
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG-HKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQ 163 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~ 163 (426)
++|+..+.||.|+||.||+|...+ ..+++|.+..... .+.+.+|+.+++.++|+||+++++++.+.. .
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~~-------~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~ 74 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYRG-------QKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGN----P 74 (256)
T ss_pred hhccceeeeecCCCceEEEEEecC-------cEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCC----C
Confidence 478888999999999999998653 2689999876654 567899999999999999999999988754 3
Q ss_pred EEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccccc
Q 014363 164 RLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL 243 (426)
Q Consensus 164 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 243 (426)
.++||||+++++|.+++.......+++..++.++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++..
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~ 151 (256)
T cd05039 75 LYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKE 151 (256)
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccc
Confidence 59999999999999999766545689999999999999999999998 999999999999999999999999999986
Q ss_pred CCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhhh
Q 014363 244 GPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQFR 322 (426)
Q Consensus 244 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (426)
..... ....++..|+|||++..+.++.++||||||+++|+|++ |..||......... ....
T Consensus 152 ~~~~~-----~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~---~~~~---------- 213 (256)
T cd05039 152 ASQGQ-----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV---PHVE---------- 213 (256)
T ss_pred ccccc-----ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHH---HHHh----------
Confidence 53221 12335668999999988889999999999999999998 99999754322111 1100
Q ss_pred hhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 014363 323 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNK 368 (426)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~ 368 (426)
.......+..++..+.+++.+||..+|++||++.++++.|+.
T Consensus 214 ----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 214 ----KGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred ----cCCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 000111122346789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=323.00 Aligned_cols=262 Identities=29% Similarity=0.504 Sum_probs=205.1
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC---HHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG---HKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
.++|+..+.||+|+||.||+|.+...+.. ..+.+++|.+..... ...+.+|+.+++.++||||+++++++....
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~-- 82 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGET-VKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPT-- 82 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCc-ceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCCC--
Confidence 34678888999999999999998765442 345688998865433 236789999999999999999999987543
Q ss_pred CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecc
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 240 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 240 (426)
.++++||+++|+|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 83 ---~~~v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~ 155 (303)
T cd05110 83 ---IQLVTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGL 155 (303)
T ss_pred ---ceeeehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccc
Confidence 378999999999999987543 3478999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014363 241 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAK 319 (426)
Q Consensus 241 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 319 (426)
++...............++..|+|||++.+..++.++||||||+++|||++ |..||..........+.. ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~-------~~~ 228 (303)
T cd05110 156 ARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE-------KGE 228 (303)
T ss_pred cccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------CCC
Confidence 986543222212223445778999999998899999999999999999997 999997543222111111 000
Q ss_pred hhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 014363 320 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 372 (426)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~ 372 (426)
.. ..+..++..+.+++..||..+|++||++.++++.|+.+...
T Consensus 229 --------~~--~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 229 --------RL--PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred --------CC--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 00 01112345788999999999999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=317.42 Aligned_cols=257 Identities=23% Similarity=0.372 Sum_probs=203.9
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-----CCHHHHHHHHHHHhhcCCCCccceEeEEEccCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-----GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
++|++.+.||+|+||.||+|....++. .+++|.+... .....+.+|+.+++.++||||+++++++.+.+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~-----~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 75 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRK-----PVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDN- 75 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCC-----EEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECC-
Confidence 578999999999999999999876554 7888876432 12346789999999999999999999988765
Q ss_pred CCceEEEEEeeCCCCChhhhccCC--CCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEee
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPK--SETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 237 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~D 237 (426)
..++||||+++++|.+++... ....+++..++.++.|++.||.|||++ +++|+||||+|||++.++.++|+|
T Consensus 76 ---~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d 149 (267)
T cd08228 76 ---ELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGD 149 (267)
T ss_pred ---eEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECc
Confidence 359999999999999888532 234578899999999999999999998 999999999999999999999999
Q ss_pred ecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh
Q 014363 238 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 317 (426)
Q Consensus 238 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 317 (426)
||++........ ......|++.|+|||.+.+..++.++||||||+++|+|++|..||....... ......
T Consensus 150 ~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~-~~~~~~------- 219 (267)
T cd08228 150 LGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-FSLCQK------- 219 (267)
T ss_pred cccceeccchhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH-HHHHHH-------
Confidence 999876543221 1223568899999999988889999999999999999999999986533211 111110
Q ss_pred hhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHh
Q 014363 318 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 369 (426)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~ 369 (426)
+.............+..+.+++.+||+.+|++||++.+|++.|+.+
T Consensus 220 ------~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 220 ------IEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred ------HhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 0000111112234567899999999999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=323.54 Aligned_cols=265 Identities=26% Similarity=0.346 Sum_probs=201.5
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC---HHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG---HKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
++|++.+.||+|+||.||+|.+..++. .+++|.+..... ...+.+|++++..++||||+++++++.+.+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~-----~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--- 72 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGL-----IMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDG--- 72 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCe-----EEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC---
Confidence 368899999999999999998876653 688888764422 345789999999999999999999998766
Q ss_pred ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccc
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 241 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 241 (426)
..++||||+++++|.+++... ..+++..+..++.|++.||.|||+. .+++|+||||+|||++.++.+||+|||++
T Consensus 73 -~~~lv~ey~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 147 (308)
T cd06615 73 -EISICMEHMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVS 147 (308)
T ss_pred -EEEEEeeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCc
Confidence 459999999999999999654 3488999999999999999999973 28999999999999999999999999998
Q ss_pred ccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhh---
Q 014363 242 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA--- 318 (426)
Q Consensus 242 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--- 318 (426)
...... ......|+..|+|||++.+..++.++||||||+++|+|++|..||......................
T Consensus 148 ~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (308)
T cd06615 148 GQLIDS----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESH 223 (308)
T ss_pred cccccc----ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCc
Confidence 754322 1234578999999999988889999999999999999999999996543222211111000000000
Q ss_pred -----------------hhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014363 319 -----------------KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMV 366 (426)
Q Consensus 319 -----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L 366 (426)
..................++..+.+++.+||..||++||++.+|+++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 224 RPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred ccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 000000000000000112556799999999999999999999999873
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=333.47 Aligned_cols=268 Identities=23% Similarity=0.298 Sum_probs=199.0
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccCCC-
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER- 160 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~- 160 (426)
+|+.++.||+|+||.||+|.+..++. .||+|.+.... ..+.+.+|+.+++.++||||+++++++......
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 75 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGK-----RVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDP 75 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCC-----EEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccc
Confidence 47888999999999999999765543 78999875431 335688999999999999999999999875521
Q ss_pred CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecc
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 240 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 240 (426)
....|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 76 ~~~~~lv~e~~~-~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~ 149 (372)
T cd07853 76 FEEIYVVTELMQ-SDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGL 149 (372)
T ss_pred cceEEEEeeccc-cCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccc
Confidence 124699999995 5788877543 3489999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHh--hhhh-
Q 014363 241 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK--PYLS- 316 (426)
Q Consensus 241 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~--~~~~- 316 (426)
+........ .......+++.|+|||++.+. .++.++|||||||++|||++|+.||....+......+.... +...
T Consensus 150 a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~ 228 (372)
T cd07853 150 ARVEEPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEA 228 (372)
T ss_pred eeecccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence 986543221 112334689999999998774 47899999999999999999999998765433222211100 0000
Q ss_pred ---hhhhhhhhc-CCcCCC-------cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 317 ---DAKQFRQIV-DPRLEG-------KYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 317 ---~~~~~~~~~-~~~~~~-------~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
........+ ...... ......++++.+|+.+||+.||++|||+.|++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 229 MRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000000000 000000 0111235678999999999999999999999986
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=331.84 Aligned_cols=267 Identities=24% Similarity=0.306 Sum_probs=199.0
Q ss_pred HhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc----CCHHHHHHHHHHHhhcCCCCccceEeEEEccC
Q 014363 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR----GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 158 (426)
Q Consensus 83 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 158 (426)
..++|...+.||+|+||.||+|.+...+. .+|+|.+... .....+.+|+.+++.++||||+++++++....
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~ 96 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILER-----NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQK 96 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCc-----EEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccc
Confidence 35689999999999999999998776544 7899988643 23456789999999999999999999886543
Q ss_pred C--CCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEe
Q 014363 159 E--RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLS 236 (426)
Q Consensus 159 ~--~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~ 236 (426)
. .....|+||||+++ +|.+++.. .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+
T Consensus 97 ~~~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~ 168 (364)
T cd07875 97 SLEEFQDVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKIL 168 (364)
T ss_pred cccccCeEEEEEeCCCC-CHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEE
Confidence 2 12346999999965 77777642 278889999999999999999998 99999999999999999999999
Q ss_pred eecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHH-Hh-----
Q 014363 237 DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLL-QW----- 310 (426)
Q Consensus 237 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~-~~----- 310 (426)
|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+ ..
T Consensus 169 DfG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 245 (364)
T cd07875 169 DFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC 245 (364)
T ss_pred eCCCccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 999997653321 223457899999999999999999999999999999999999999765432221111 00
Q ss_pred ------Hhh----hhhhhhhh-----hhhcCCc---CCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 311 ------VKP----YLSDAKQF-----RQIVDPR---LEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 311 ------~~~----~~~~~~~~-----~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
..+ ...+...+ ....... ............+.+|+.+||+.||++|||+.|+++|
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 246 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000 00000000 0000000 0000111234578899999999999999999999997
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=314.96 Aligned_cols=249 Identities=27% Similarity=0.377 Sum_probs=201.4
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc---CCHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCc
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR---GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 162 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~ 162 (426)
+|++.+.||+|+||.||++.+..++. .+++|.+... ...+.+.+|+.+++.++||||+++++++.+..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~-----~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 71 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQ-----KYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADG---- 71 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCc-----eEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECC----
Confidence 47888999999999999999876554 7888877432 23456788999999999999999999998765
Q ss_pred eEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccc
Q 014363 163 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 242 (426)
Q Consensus 163 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 242 (426)
.+|+||||+++++|.+++.......+++..++.++.|++.||.|||++ +|+|+||||+|||+++++.++|+|||++.
T Consensus 72 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~ 148 (255)
T cd08219 72 HLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSAR 148 (255)
T ss_pred EEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcce
Confidence 459999999999999988755555689999999999999999999998 99999999999999999999999999997
Q ss_pred cCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhh
Q 014363 243 LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFR 322 (426)
Q Consensus 243 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (426)
....... ......|++.|+|||++.+..++.++||||||+++|+|++|..||..........
T Consensus 149 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~---------------- 210 (255)
T cd08219 149 LLTSPGA--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLIL---------------- 210 (255)
T ss_pred eeccccc--ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHH----------------
Confidence 6543221 1234578999999999998889999999999999999999999997543221110
Q ss_pred hhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 323 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.+... .....+..++..+.+++.+||+.||++||++.+|+..
T Consensus 211 ~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 211 KVCQG-SYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHhcC-CCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 00000 0111223455678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=330.03 Aligned_cols=238 Identities=29% Similarity=0.385 Sum_probs=186.9
Q ss_pred ceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-----CHHHHHHHHH-HHhhcCCCCccceEeEEEccCCCCceE
Q 014363 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-----GHKEWMTEVN-FLGIVEHQNLVKLVGYCADDDERGIQR 164 (426)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-----~~~~~~~E~~-~l~~l~HpnIv~~~~~~~~~~~~~~~~ 164 (426)
+.||+|+||.||+|.+..++. .+|+|.+.... ....+..|.. +++.++||||+++++++.+.+ ..
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~-----~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~----~~ 71 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEK-----FYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD----KL 71 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCC-----EEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCC----eE
Confidence 369999999999999876654 78999875432 2234444544 567789999999999998766 45
Q ss_pred EEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccC
Q 014363 165 LLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLG 244 (426)
Q Consensus 165 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 244 (426)
|+||||+++|+|.+++... ..+.+..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++...
T Consensus 72 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~ 146 (325)
T cd05602 72 YFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKEN 146 (325)
T ss_pred EEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCccc
Confidence 9999999999999998653 3478888899999999999999998 9999999999999999999999999998753
Q ss_pred CCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhh
Q 014363 245 PSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQI 324 (426)
Q Consensus 245 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (426)
.... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||........ .. .+
T Consensus 147 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~-------------~i 208 (325)
T cd05602 147 IEHN--GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM---YD-------------NI 208 (325)
T ss_pred ccCC--CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH---HH-------------HH
Confidence 2211 123356799999999999999999999999999999999999999975432211 11 11
Q ss_pred cCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHH
Q 014363 325 VDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEV 362 (426)
Q Consensus 325 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei 362 (426)
..... .....++..+.+++.+||+.||.+||++.+.
T Consensus 209 ~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~ 244 (325)
T cd05602 209 LNKPL--QLKPNITNSARHLLEGLLQKDRTKRLGAKDD 244 (325)
T ss_pred HhCCc--CCCCCCCHHHHHHHHHHcccCHHHCCCCCCC
Confidence 11111 1222355788999999999999999998743
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=323.32 Aligned_cols=251 Identities=28% Similarity=0.455 Sum_probs=199.8
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-----CHHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
.|+..++||+|+||.||+|.+..++. .+|+|.+.... ....+.+|+.+++.++|+||+++++.+.+.+
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~-----~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~-- 73 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGK-----MYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKD-- 73 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCc-----eEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCC--
Confidence 36778899999999999999887654 78888775432 2245678999999999999999999988765
Q ss_pred CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecc
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 240 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 240 (426)
..++||||+++++|.+++.......+++..++.++.|++.||.|||+. +|+||||||+||+++.++.++|+|||+
T Consensus 74 --~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~ 148 (285)
T cd05630 74 --ALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGL 148 (285)
T ss_pred --EEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccc
Confidence 459999999999999988655445589999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhh
Q 014363 241 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 320 (426)
Q Consensus 241 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (426)
+....... ......|+..|+|||++.+..++.++||||||+++|+|++|..||.............
T Consensus 149 ~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~----------- 214 (285)
T cd05630 149 AVHVPEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE----------- 214 (285)
T ss_pred eeecCCCc---cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHH-----------
Confidence 87543321 1123479999999999999899999999999999999999999997643221111100
Q ss_pred hhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 014363 321 FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPK-----MSEVLEM 365 (426)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~eil~~ 365 (426)
.... .....++..++..+.+|+.+||+.||++||| +.|++++
T Consensus 215 --~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 215 --RLVK-EVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred --hhhh-hhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 0000 0011122335567899999999999999999 8899885
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=329.95 Aligned_cols=248 Identities=26% Similarity=0.362 Sum_probs=193.2
Q ss_pred ceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-----CHHHHHHHHHHHhhc-CCCCccceEeEEEccCCCCceE
Q 014363 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-----GHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDERGIQR 164 (426)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-----~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~~~~~~ 164 (426)
++||+|+||.||+|....++. .+|+|.+.... ..+.+..|+.++.++ +||||+++++++.+.. ..
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~-----~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~----~~ 71 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQ-----IYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTS----RL 71 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCC-----EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCC----EE
Confidence 369999999999999877654 78999886432 234577899999888 7999999999987765 45
Q ss_pred EEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccC
Q 014363 165 LLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLG 244 (426)
Q Consensus 165 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 244 (426)
|+||||+++|+|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 72 ~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~ 146 (327)
T cd05617 72 FLVIEYVNGGDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEG 146 (327)
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceec
Confidence 9999999999999888643 3489999999999999999999998 9999999999999999999999999998753
Q ss_pred CCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhh
Q 014363 245 PSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQI 324 (426)
Q Consensus 245 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (426)
.... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.............+.. ..+
T Consensus 147 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~---------~~~ 215 (327)
T cd05617 147 LGPG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLF---------QVI 215 (327)
T ss_pred cCCC--CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHH---------HHH
Confidence 2211 12335679999999999999999999999999999999999999996432211111111100 011
Q ss_pred cCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCH------HHHHHH
Q 014363 325 VDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKM------SEVLEM 365 (426)
Q Consensus 325 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~------~eil~~ 365 (426)
.... ...+...+..+.+++.+||+.||++|+++ .++++|
T Consensus 216 ~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 216 LEKP--IRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred HhCC--CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 1111 11223355678999999999999999985 577665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=318.60 Aligned_cols=250 Identities=26% Similarity=0.386 Sum_probs=196.2
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
++|+..++||+|+||.||+|.+..++. .+++|.+.... ....+.+|+.++.+++||||+++++++....
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~-----~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--- 72 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRR-----ILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVEN--- 72 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCc-----EEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECC---
Confidence 367888999999999999998776544 78999875432 2346889999999999999999999998865
Q ss_pred ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccc
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 241 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 241 (426)
..++||||+++++|..+. .+++..+..++.|++.||.|||+. +|+|+||||+|||++.++.++|+|||++
T Consensus 73 -~~~lv~e~~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~ 142 (279)
T cd06619 73 -RISICTEFMDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVS 142 (279)
T ss_pred -EEEEEEecCCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcc
Confidence 358999999999997653 267888999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhh
Q 014363 242 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 321 (426)
Q Consensus 242 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (426)
...... ......|+..|+|||++.+..++.++||||||+++|+|++|..||............ ....
T Consensus 143 ~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~---------~~~~ 209 (279)
T cd06619 143 TQLVNS----IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMP---------LQLL 209 (279)
T ss_pred eecccc----cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccch---------HHHH
Confidence 755332 123457999999999999888999999999999999999999999653221111000 0000
Q ss_pred hhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 322 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
..+.+...........+.++.+++.+||+.||++||+++|++++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 210 QCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred HHHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 11111111111112245678999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=316.08 Aligned_cols=260 Identities=26% Similarity=0.435 Sum_probs=205.6
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC---HHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG---HKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
.+|...+.||+|+||.||+|.++..+. ...+.+++|.+..... ...+.+|+.++..++||||+++++++.. .
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~-~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~--- 81 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGE-KVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-S--- 81 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCC-CcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C---
Confidence 467888999999999999999876543 2345689998865543 3567899999999999999999999876 2
Q ss_pred ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccc
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 241 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 241 (426)
..++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +++||||||+|||++.++.+||+|||++
T Consensus 82 -~~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~ 156 (279)
T cd05057 82 -QVQLITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLA 156 (279)
T ss_pred -ceEEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCccc
Confidence 3589999999999999997543 3489999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhh
Q 014363 242 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 320 (426)
Q Consensus 242 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (426)
+...............++..|+|||.+....++.++||||||+++||+++ |..||......... +...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~---~~~~-------- 225 (279)
T cd05057 157 KLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIP---DLLE-------- 225 (279)
T ss_pred ccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHH---HHHh--------
Confidence 86543322111112234578999999988889999999999999999999 99999765432211 1110
Q ss_pred hhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHh
Q 014363 321 FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVD 371 (426)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~ 371 (426)
.......+..++..+.+++.+||..||++||++.++++.|..+..
T Consensus 226 ------~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 226 ------KGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred ------CCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 000111112244578899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=327.90 Aligned_cols=250 Identities=24% Similarity=0.391 Sum_probs=201.7
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc----CCHHHHHHHHHHHhhc-CCCCccceEeEEEccCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR----GGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDE 159 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~----~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~ 159 (426)
..|++++.||+||.+.||++...+.+ .+|+|++... .....|.+|+..|.+| .|.+||++|+|-..++
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~------iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~- 433 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQ------IYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDG- 433 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCc------chhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCc-
Confidence 46999999999999999999865543 5666655322 2345689999999999 6999999999988765
Q ss_pred CCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeec
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 239 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 239 (426)
.+||||||- ..+|..+|.++......| .+..+..||+.|+.++|.+ ||||-||||.|+|+-. |.+||+|||
T Consensus 434 ---~lYmvmE~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFG 504 (677)
T KOG0596|consen 434 ---YLYMVMECG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFG 504 (677)
T ss_pred ---eEEEEeecc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeec
Confidence 469999987 569999998776544445 7788999999999999999 9999999999999986 589999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCchhhccCC-----------CCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHH
Q 014363 240 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGR-----------LAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLL 308 (426)
Q Consensus 240 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~ 308 (426)
+|..+..+.........+||+.||+||.+.... .+.++||||||||||+|+.|++||....
T Consensus 505 IA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-------- 576 (677)
T KOG0596|consen 505 IANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-------- 576 (677)
T ss_pred hhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH--------
Confidence 999888777777777899999999999886432 4678999999999999999999997431
Q ss_pred HhHhhhhhhhhhhhhhcCCcCCCcccHHH-HHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 309 QWVKPYLSDAKQFRQIVDPRLEGKYSLRL-VSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.....+..+.++...-.|+.-- ..++.++|+.||+.||.+||++.|+|++
T Consensus 577 -------n~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 577 -------NQIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred -------HHHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 1223455566664433333211 1238999999999999999999999986
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=312.84 Aligned_cols=249 Identities=25% Similarity=0.486 Sum_probs=194.9
Q ss_pred eecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC---HHHHHHHHHHHhhcCCCCccceEeEEEccCCCCceEEEEE
Q 014363 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG---HKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVY 168 (426)
Q Consensus 92 ~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~~~lv~ 168 (426)
.||+|+||.||+|.+.... ....+++|.+..... .+.+.+|+.+++.++||||+++++++... ..++||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~---~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~-----~~~lv~ 73 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRK---KQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAE-----ALMLVM 73 (257)
T ss_pred ccCCCCcccEEEEEEecCC---CceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCC-----CeEEEE
Confidence 3899999999999875332 123688998865432 35688999999999999999999988543 248999
Q ss_pred eeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccCCCCC
Q 014363 169 EYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEG 248 (426)
Q Consensus 169 E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 248 (426)
||+++++|.+++.... ..+++..++.++.|++.||.|||++ +++||||||+|||++.++.+||+|||++.......
T Consensus 74 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 149 (257)
T cd05115 74 EMASGGPLNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADD 149 (257)
T ss_pred EeCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCc
Confidence 9999999999986432 3589999999999999999999998 99999999999999999999999999997544322
Q ss_pred cee-eeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcC
Q 014363 249 FTH-VSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVD 326 (426)
Q Consensus 249 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (426)
... ......++..|+|||++.+..++.++||||||+++|+|++ |..||...........+ .
T Consensus 150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~-----------------~ 212 (257)
T cd05115 150 SYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFI-----------------E 212 (257)
T ss_pred cceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH-----------------H
Confidence 111 1111233578999999988889999999999999999996 99999765332211111 1
Q ss_pred CcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHh
Q 014363 327 PRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 369 (426)
Q Consensus 327 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~ 369 (426)
.......+..++.++.+++.+||+.+|++||++.+|.+.|+.+
T Consensus 213 ~~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 213 QGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 1111122334567899999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=321.29 Aligned_cols=251 Identities=27% Similarity=0.432 Sum_probs=199.3
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-----CHHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
.|+..+.||+|+||+||+|.+..++. .+|+|.+.... ....+.+|+.+|+.++|+||+++++++.+.+
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~-----~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~-- 73 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGK-----MYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKD-- 73 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCc-----EEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCC--
Confidence 36677899999999999999876554 78888875432 2345678999999999999999999887765
Q ss_pred CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecc
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 240 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 240 (426)
..++||||+++++|.+++.......+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 74 --~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~ 148 (285)
T cd05632 74 --ALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGL 148 (285)
T ss_pred --EEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCc
Confidence 459999999999999888655445699999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhh
Q 014363 241 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 320 (426)
Q Consensus 241 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (426)
+....... ......|+..|+|||++.+..++.++||||||+++|+|++|..||.............
T Consensus 149 ~~~~~~~~---~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~----------- 214 (285)
T cd05632 149 AVKIPEGE---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVD----------- 214 (285)
T ss_pred ceecCCCC---cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-----------
Confidence 87543221 1223579999999999998899999999999999999999999997543321111110
Q ss_pred hhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 014363 321 FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPK-----MSEVLEM 365 (426)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~eil~~ 365 (426)
..... ....+...++..+.+|+..||+.||++||+ +.+++.+
T Consensus 215 -~~~~~--~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 215 -RRVLE--TEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred -Hhhhc--cccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 00000 011123345567899999999999999999 6777775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=328.61 Aligned_cols=236 Identities=28% Similarity=0.366 Sum_probs=185.5
Q ss_pred ceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-----CHHHHHHHHH-HHhhcCCCCccceEeEEEccCCCCceE
Q 014363 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-----GHKEWMTEVN-FLGIVEHQNLVKLVGYCADDDERGIQR 164 (426)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-----~~~~~~~E~~-~l~~l~HpnIv~~~~~~~~~~~~~~~~ 164 (426)
++||+|+||.||+|.+...+. .+|+|.+.... ....+..|.. +++.++||||+++++++.+.+ ..
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~-----~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~----~~ 71 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGS-----FYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAE----KL 71 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCC-----EEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCC----EE
Confidence 369999999999999876654 78999875432 2234555554 578899999999999988765 45
Q ss_pred EEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccC
Q 014363 165 LLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLG 244 (426)
Q Consensus 165 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 244 (426)
|+||||+++|+|..++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 72 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 146 (321)
T cd05603 72 YFVLDYVNGGELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (321)
T ss_pred EEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccC
Confidence 9999999999999888643 3488889999999999999999998 9999999999999999999999999998753
Q ss_pred CCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhh
Q 014363 245 PSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQI 324 (426)
Q Consensus 245 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (426)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|..||....... ... .+
T Consensus 147 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~-------------~i 208 (321)
T cd05603 147 VEPE--ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ---MYD-------------NI 208 (321)
T ss_pred CCCC--CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH---HHH-------------HH
Confidence 2211 12334679999999999998899999999999999999999999997643211 111 11
Q ss_pred cCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHH
Q 014363 325 VDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMS 360 (426)
Q Consensus 325 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ 360 (426)
....+ ..+...+..+.+++.+||+.||.+||++.
T Consensus 209 ~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 209 LHKPL--QLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred hcCCC--CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 11111 12223456789999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=312.68 Aligned_cols=251 Identities=30% Similarity=0.530 Sum_probs=202.3
Q ss_pred ceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC---HHHHHHHHHHHhhcCCCCccceEeEEEccCCCCceEEEE
Q 014363 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG---HKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLV 167 (426)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~~~lv 167 (426)
+.||+|+||.||+|...... .....+++|.+..... .+.+.+|+.++..++|+||+++++++.+.. ..++|
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~--~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~----~~~lv 74 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKD--GKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEE----PLYLV 74 (262)
T ss_pred CccccCCceEEEEEEEecCC--CCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCC----ceEEE
Confidence 36999999999999987541 2234789998876543 467889999999999999999999998744 35999
Q ss_pred EeeCCCCChhhhccCCC-------CCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecc
Q 014363 168 YEYMPNGSVDQYLSPKS-------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 240 (426)
Q Consensus 168 ~E~~~~g~L~~~l~~~~-------~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 240 (426)
|||+++++|.+++.... ...+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||.
T Consensus 75 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~ 151 (262)
T cd00192 75 LEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGL 151 (262)
T ss_pred EEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccc
Confidence 99999999999997642 24589999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014363 241 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAK 319 (426)
Q Consensus 241 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 319 (426)
+................++..|+|||.+....++.++||||||+++|+|++ |..||....... .....
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~-------- 220 (262)
T cd00192 152 SRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE---VLEYL-------- 220 (262)
T ss_pred ccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHH--------
Confidence 987654432222344567899999999988889999999999999999999 699997653221 11111
Q ss_pred hhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014363 320 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVN 367 (426)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~ 367 (426)
.. ......+..++.++.+++.+||..||++|||+.+++++|+
T Consensus 221 -----~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 221 -----RK-GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -----Hc-CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 00 1111223345678999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=312.99 Aligned_cols=250 Identities=28% Similarity=0.467 Sum_probs=196.9
Q ss_pred ceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC---HHHHHHHHHHHhhcCCCCccceEeEEEccCCCCceEEEE
Q 014363 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG---HKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLV 167 (426)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~~~lv 167 (426)
++||+|+||.||+|.+..... ....+++|.+..... .+.+.+|+.+++.++||||+++++++... ..++|
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~v 73 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSG--KEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGE-----PLMLV 73 (257)
T ss_pred CccCccCceeEEEeEeeccCC--CcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcCC-----ceEEE
Confidence 369999999999998765431 234789998875543 45788999999999999999999987643 24899
Q ss_pred EeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccCCCC
Q 014363 168 YEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSE 247 (426)
Q Consensus 168 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 247 (426)
|||+++++|.+++.... .+++..++.++.|++.||+|||.. +++|+||||+|||++.++.+||+|||+++.....
T Consensus 74 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~ 148 (257)
T cd05060 74 MELAPLGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAG 148 (257)
T ss_pred EEeCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecC
Confidence 99999999999997544 489999999999999999999998 9999999999999999999999999999865432
Q ss_pred Cceee-eeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhc
Q 014363 248 GFTHV-STAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIV 325 (426)
Q Consensus 248 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (426)
..... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||....... +...... .
T Consensus 149 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~---~~~~~~~----~------- 214 (257)
T cd05060 149 SDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE---VIAMLES----G------- 214 (257)
T ss_pred CcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH---HHHHHHc----C-------
Confidence 21111 111223568999999998899999999999999999998 999997643321 1111110 0
Q ss_pred CCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHh
Q 014363 326 DPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 369 (426)
Q Consensus 326 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~ 369 (426)
.....+..++..+.+++.+||..+|++||++.++++.|+.+
T Consensus 215 ---~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 215 ---ERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred ---CcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 00112223456889999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=315.07 Aligned_cols=258 Identities=25% Similarity=0.473 Sum_probs=201.9
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
++|...+.||+|+||.||+|.+...+. ....|++|.+.... ....|..|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~-- 79 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGK--REIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRP-- 79 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCC--CceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCc--
Confidence 357788899999999999999876542 23468999886543 34578899999999999999999999876653
Q ss_pred ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccc
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 241 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 241 (426)
.++||||+++++|.+++.... ..+++..++.++.|++.||.|||+. +++|+||||+|||++.++.+||+|||++
T Consensus 80 --~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~ 153 (269)
T cd05065 80 --VMIITEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLS 153 (269)
T ss_pred --eEEEEecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccc
Confidence 499999999999999987543 3489999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCceee-eeeee--cCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhh
Q 014363 242 RLGPSEGFTHV-STAVV--GTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSD 317 (426)
Q Consensus 242 ~~~~~~~~~~~-~~~~~--gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 317 (426)
........... ..... .+..|+|||++.+..++.++||||||+++|||++ |..||........ ..+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~---~~~i~----- 225 (269)
T cd05065 154 RFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV---INAIE----- 225 (269)
T ss_pred cccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHH---HHHHH-----
Confidence 75543221111 11111 2457999999998899999999999999999887 9999975443211 11110
Q ss_pred hhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHh
Q 014363 318 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 369 (426)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~ 369 (426)
. ......+..++..+.+++.+||+.+|++||++.+|+..|+.+
T Consensus 226 -----~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 226 -----Q----DYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred -----c----CCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 001111223456789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=314.13 Aligned_cols=258 Identities=24% Similarity=0.498 Sum_probs=202.6
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
++|+..+.||+|+||.||+|.....+. ....+++|.+.... ..+.+..|+.++..++||||+++++++.+.+.
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-- 80 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGR--KEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP-- 80 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCC--CceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC--
Confidence 467888899999999999999865432 23468888876442 23568899999999999999999999987664
Q ss_pred ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccc
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 241 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 241 (426)
.++||||+++++|.+++.... ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++
T Consensus 81 --~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~ 154 (268)
T cd05063 81 --AMIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLS 154 (268)
T ss_pred --cEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccc
Confidence 499999999999999986543 3589999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCceee-eeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014363 242 RLGPSEGFTHV-STAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAK 319 (426)
Q Consensus 242 ~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 319 (426)
........... ......+..|+|||++.+..++.++||||||+++|||++ |..||....... .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~---~~~~i-------- 223 (268)
T cd05063 155 RVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE---VMKAI-------- 223 (268)
T ss_pred eecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH---HHHHH--------
Confidence 76543221111 111223457999999988889999999999999999998 999996543221 11110
Q ss_pred hhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHh
Q 014363 320 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 369 (426)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~ 369 (426)
.. ..........+..+.+++.+||+.+|++||++.+|++.|+++
T Consensus 224 -----~~-~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 224 -----ND-GFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred -----hc-CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00 011111223557889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=313.46 Aligned_cols=254 Identities=28% Similarity=0.488 Sum_probs=203.4
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-CCHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCc
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 162 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~ 162 (426)
.++|.+.+.||+|+||.||+|...+. ..+++|.+... ...+.+.+|+.+++.++||||+++++++.....
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~------~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--- 75 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGT------TKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEP--- 75 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCC------ceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCc---
Confidence 45789999999999999999986643 26889988654 345689999999999999999999999876553
Q ss_pred eEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccc
Q 014363 163 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 242 (426)
Q Consensus 163 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 242 (426)
.++||||+++++|.+++.......+++..+..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++.
T Consensus 76 -~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~ 151 (261)
T cd05034 76 -IYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLAR 151 (261)
T ss_pred -eEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccce
Confidence 49999999999999999765545689999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhh
Q 014363 243 LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 321 (426)
Q Consensus 243 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (426)
........ ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||....... ......
T Consensus 152 ~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~~~~~--------- 218 (261)
T cd05034 152 LIEDDEYT-AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE---VLEQVE--------- 218 (261)
T ss_pred eccchhhh-hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH---------
Confidence 65432111 1112234678999999998889999999999999999999 999996543211 111100
Q ss_pred hhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 014363 322 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNK 368 (426)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~ 368 (426)
. ......+...+..+.+++.+||+.+|++||+++++++.|+.
T Consensus 219 -~----~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 219 -R----GYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred -c----CCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 0 00111112235689999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=314.10 Aligned_cols=247 Identities=27% Similarity=0.498 Sum_probs=200.1
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCceE
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQR 164 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~~ 164 (426)
++|++.+.||+|+||.||+|...+ ..+++|.+........+.+|+.++..++||||+++++++.... .
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~-------~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-----~ 73 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEYTG-------QKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHNG-----L 73 (254)
T ss_pred HHceeeeeeccCCCCceEecccCC-------CceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC-----c
Confidence 468889999999999999986432 2689998876666678899999999999999999999986543 3
Q ss_pred EEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccC
Q 014363 165 LLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLG 244 (426)
Q Consensus 165 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 244 (426)
++||||+++++|.+++.......+++..++.++.|++.||.|||+. +++||||||+|||++.++.+||+|||++...
T Consensus 74 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~ 150 (254)
T cd05083 74 YIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVG 150 (254)
T ss_pred EEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceec
Confidence 8999999999999999765555689999999999999999999998 9999999999999999999999999998754
Q ss_pred CCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhhhh
Q 014363 245 PSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQ 323 (426)
Q Consensus 245 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (426)
... ......+..|+|||.+.++.++.++||||||+++|+|++ |..||............
T Consensus 151 ~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~--------------- 210 (254)
T cd05083 151 SMG-----VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECV--------------- 210 (254)
T ss_pred ccc-----CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH---------------
Confidence 321 112234568999999988899999999999999999998 99999765432211110
Q ss_pred hcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 014363 324 IVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNK 368 (426)
Q Consensus 324 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~ 368 (426)
........+..++..+.+++.+||+.+|++||++++|++.|++
T Consensus 211 --~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 211 --EKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred --hCCCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 0011111122355788999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=316.35 Aligned_cols=258 Identities=22% Similarity=0.376 Sum_probs=204.5
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-----CHHHHHHHHHHHhhcCCCCccceEeEEEccCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
++|+..+.||+|+||.||+|....++. .+++|.+.... ....+.+|+.+++.++||||+++++++.+.+
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~-----~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~- 75 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGV-----PVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN- 75 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCc-----eEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCC-
Confidence 468888899999999999999766544 78888765321 2346889999999999999999999998765
Q ss_pred CCceEEEEEeeCCCCChhhhccCC--CCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEee
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPK--SETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 237 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~D 237 (426)
..+++|||+++++|.+++... ....+++..++.++.|++.||.|||++ +++|+||||+||+++.++.++|+|
T Consensus 76 ---~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~d 149 (267)
T cd08229 76 ---ELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGD 149 (267)
T ss_pred ---eEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECc
Confidence 359999999999999988632 234589999999999999999999998 999999999999999999999999
Q ss_pred ecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh
Q 014363 238 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 317 (426)
Q Consensus 238 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 317 (426)
||++........ ......|+..|+|||++.+..++.++||||||+++|+|++|..||....... .....
T Consensus 150 fg~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~-------- 218 (267)
T cd08229 150 LGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSLCK-------- 218 (267)
T ss_pred chhhhccccCCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH-HHHhh--------
Confidence 999876543221 1234568999999999988889999999999999999999999996533211 11100
Q ss_pred hhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhH
Q 014363 318 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIV 370 (426)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~ 370 (426)
.+............++..+.+++.+||+.||++|||+.+|++.+.++.
T Consensus 219 -----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 219 -----KIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred -----hhhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 011111111112246678999999999999999999999999988753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=332.47 Aligned_cols=262 Identities=33% Similarity=0.468 Sum_probs=210.0
Q ss_pred CCCCCcccCHHHHHHH---hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-----CHHHHHHHHHHH
Q 014363 68 RPSNLKEFTIAELKSA---TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-----GHKEWMTEVNFL 139 (426)
Q Consensus 68 ~~~~~~~~~~~~~~~~---~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-----~~~~~~~E~~~l 139 (426)
++..+++-+++++... .+-|+-++.||.|+||.||-|++..+.. .||||++.-.+ .+.++..|+.+|
T Consensus 6 r~GslKDPeiA~LF~k~DPEklf~dLrEIGHGSFGAVYfArd~~n~e-----vVAIKKMsySGKQs~EKWqDIlKEVrFL 80 (948)
T KOG0577|consen 6 RPGSLKDPEIADLFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSE-----VVAIKKMSYSGKQSNEKWQDILKEVRFL 80 (948)
T ss_pred CCCCCCCchHHHHHccCCHHHHHHHHHHhcCCccceeEEeeccCccc-----eeeeeeccccccccHHHHHHHHHHHHHH
Confidence 3444555455554322 3357788899999999999999877665 89999986443 345789999999
Q ss_pred hhcCCCCccceEeEEEccCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEecc
Q 014363 140 GIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRD 219 (426)
Q Consensus 140 ~~l~HpnIv~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrD 219 (426)
++|+|||+|.+-|.|..+... ||||||| -|+-.|++.-.. +++.+..+..|+.+.+.||.|||+. +.||||
T Consensus 81 ~~l~HPntieYkgCyLre~Ta----WLVMEYC-lGSAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLHS~---~~IHRD 151 (948)
T KOG0577|consen 81 RQLRHPNTIEYKGCYLREHTA----WLVMEYC-LGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSH---NRIHRD 151 (948)
T ss_pred HhccCCCcccccceeeccchH----HHHHHHH-hccHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHHHh---hHHhhh
Confidence 999999999999999887765 9999999 668888886443 4588999999999999999999998 999999
Q ss_pred CCCCceEeCCCCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhc---cCCCCCchhhHHHHHHHHHHHhCCCCC
Q 014363 220 FKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQ---TGRLAARSDVWSYGVFLYELITGRRPI 296 (426)
Q Consensus 220 lkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~elltg~~p~ 296 (426)
||..|||+++.|.|||+|||.|....+ ..+++|||.|||||++. .|.|+.++||||||++-.||.-.++|+
T Consensus 152 iKAGNILLse~g~VKLaDFGSAsi~~P------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPl 225 (948)
T KOG0577|consen 152 IKAGNILLSEPGLVKLADFGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 225 (948)
T ss_pred ccccceEecCCCeeeeccccchhhcCc------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCc
Confidence 999999999999999999999976544 35689999999999875 578999999999999999999999998
Q ss_pred CCCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 297 DRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.....-. .+. .+.+--.|.+. ....+..+..++..||+.-|.+|||..+++.|
T Consensus 226 FnMNAMS--ALY-----------HIAQNesPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 226 FNMNAMS--ALY-----------HIAQNESPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred cCchHHH--HHH-----------HHHhcCCCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 6432211 111 11111112222 34678899999999999999999999999875
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=319.26 Aligned_cols=265 Identities=28% Similarity=0.376 Sum_probs=206.0
Q ss_pred cCHHHHHHHhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-CHHHHHHHHHHHhhc-CCCCccceEe
Q 014363 75 FTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-GHKEWMTEVNFLGIV-EHQNLVKLVG 152 (426)
Q Consensus 75 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~E~~~l~~l-~HpnIv~~~~ 152 (426)
.+..++....+.|+..+.||.|+||.||+|.+...+. .+++|.+.... ....+..|+.++..+ +||||+++++
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~-----~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~ 80 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQ-----LAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYG 80 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCc-----EEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEee
Confidence 3455555667889999999999999999999876544 78888875442 345678899999998 7999999999
Q ss_pred EEEccCC--CCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCC
Q 014363 153 YCADDDE--RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQ 230 (426)
Q Consensus 153 ~~~~~~~--~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~ 230 (426)
++..... .....|++|||+++|+|.+++.......+++..++.++.|++.||.|||+. +++|+||||+||+++++
T Consensus 81 ~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~ 157 (282)
T cd06636 81 AFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTEN 157 (282)
T ss_pred ehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCC
Confidence 9864321 223569999999999999999765555688899999999999999999998 99999999999999999
Q ss_pred CCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhc-----cCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhH
Q 014363 231 WNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQ-----TGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQ 305 (426)
Q Consensus 231 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~ 305 (426)
+.++|+|||++....... .......|++.|+|||++. ...++.++|||||||++|+|++|..||....+....
T Consensus 158 ~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~ 235 (282)
T cd06636 158 AEVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL 235 (282)
T ss_pred CCEEEeeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh
Confidence 999999999987543211 1123457899999999876 345788999999999999999999999654321111
Q ss_pred HHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 306 KLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
. ..............++..+.+++.+||+.||.+||++.||+++
T Consensus 236 ~----------------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 236 F----------------LIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred h----------------hHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 1 0011111111122356789999999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=328.95 Aligned_cols=265 Identities=25% Similarity=0.325 Sum_probs=198.1
Q ss_pred HhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccC
Q 014363 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 158 (426)
Q Consensus 83 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 158 (426)
..++|...+.||+|+||.||+|.+..++. .||+|.+.... ..+.+.+|+.+|+.++||||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQ-----KVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPAT 87 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCC-----EEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccc
Confidence 45789999999999999999998776544 78999886432 2345778999999999999999999886432
Q ss_pred C--CCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEe
Q 014363 159 E--RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLS 236 (426)
Q Consensus 159 ~--~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~ 236 (426)
. .....|++||++ +++|.+++... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+
T Consensus 88 ~~~~~~~~~~~~~~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~ 160 (343)
T cd07878 88 SIENFNEVYLVTNLM-GADLNNIVKCQ---KLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRIL 160 (343)
T ss_pred cccccCcEEEEeecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEc
Confidence 1 123468999998 88998887532 389999999999999999999998 99999999999999999999999
Q ss_pred eecccccCCCCCceeeeeeeecCcccCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHH-hHhh-
Q 014363 237 DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQ-WVKP- 313 (426)
Q Consensus 237 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~-~~~~- 313 (426)
|||++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+. ....
T Consensus 161 Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 235 (343)
T cd07878 161 DFGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTP 235 (343)
T ss_pred CCccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 99999865432 234578999999999876 568899999999999999999999997644322111110 0000
Q ss_pred ---hhhh--hhhhhhhcCCcCCCcc-------cHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 314 ---YLSD--AKQFRQIVDPRLEGKY-------SLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 314 ---~~~~--~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.... ......... .+.... .....+.+.+|+.+||+.||++|||+.|+++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 236 SPEVLKKISSEHARKYIQ-SLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred CHHHHHhcchhhHHHHhh-ccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 000000000 000000 01123467899999999999999999999987
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-41 Score=311.13 Aligned_cols=255 Identities=28% Similarity=0.473 Sum_probs=194.5
Q ss_pred ceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCceEEEE
Q 014363 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLV 167 (426)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~~~lv 167 (426)
+.||+|+||.||+|.+.... .....+++|.+.... ..+.+.+|+.+++.++||||+++++++...+. ..++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---~~~lv 75 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSD--GQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEG---SPLVV 75 (262)
T ss_pred CcccccCCceEEEEEEecCC--CceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCC---CcEEE
Confidence 36899999999999876432 234578999875433 23577889999999999999999998765432 24899
Q ss_pred EeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccCCCC
Q 014363 168 YEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSE 247 (426)
Q Consensus 168 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 247 (426)
|||+++|+|.+++.... ..+++..++.++.|++.||.|||+. +++||||||+|||++.++.+||+|||+++.....
T Consensus 76 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~ 151 (262)
T cd05058 76 LPYMKHGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDK 151 (262)
T ss_pred EecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCC
Confidence 99999999999987543 2367778889999999999999998 9999999999999999999999999999754332
Q ss_pred Ccee--eeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhC-CCCCCCCCchhhHHHHHhHhhhhhhhhhhhhh
Q 014363 248 GFTH--VSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITG-RRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQI 324 (426)
Q Consensus 248 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (426)
.... ......++..|+|||.+.+..++.++||||||+++|||++| .+||...... .......
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~---~~~~~~~------------ 216 (262)
T cd05058 152 EYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF---DITVYLL------------ 216 (262)
T ss_pred cceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHh------------
Confidence 2111 11133467789999999888999999999999999999995 5566543221 1111110
Q ss_pred cCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHh
Q 014363 325 VDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVD 371 (426)
Q Consensus 325 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~ 371 (426)
. ......+...+..+.+++.+||+.+|++||++.+|++.|+.++.
T Consensus 217 -~-~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 217 -Q-GRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred -c-CCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 0 00011112345679999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=316.70 Aligned_cols=254 Identities=24% Similarity=0.358 Sum_probs=198.9
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC--CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
.++|++.+.||+|+||.||+|....++. .+++|.+.... ....+.+|+.+++.++||||+++++++....
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~-----~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~--- 79 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGE-----LAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSRE--- 79 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCe-----EEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC---
Confidence 3579999999999999999999866543 78888875432 3456788999999999999999999998765
Q ss_pred ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccc
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 241 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 241 (426)
..++||||+++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 80 -~~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~ 153 (267)
T cd06646 80 -KLWICMEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVA 153 (267)
T ss_pred -EEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccc
Confidence 459999999999999988643 3489999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCchhhc---cCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014363 242 RLGPSEGFTHVSTAVVGTMGYAAPEYVQ---TGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 318 (426)
Q Consensus 242 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 318 (426)
........ ......|+..|+|||.+. ...++.++||||||+++|+|++|..||....+....... . .
T Consensus 154 ~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~--~------~ 223 (267)
T cd06646 154 AKITATIA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM--S------K 223 (267)
T ss_pred eeeccccc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee--e------c
Confidence 76532211 123356889999999874 345788999999999999999999998644322111000 0 0
Q ss_pred hhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014363 319 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMV 366 (426)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L 366 (426)
.....+... ....++..+.+++.+||+.+|++||++++|+++|
T Consensus 224 ---~~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 224 ---SNFQPPKLK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred ---CCCCCCCCc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 000001111 1123457899999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=313.53 Aligned_cols=258 Identities=26% Similarity=0.463 Sum_probs=202.7
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
.+|.+.+.||+|+||.||+|.+...+. ....+++|.+.... ..+.+..|+.++..++||||+++++++...+.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-- 79 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGK--REIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKP-- 79 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCC--CceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc--
Confidence 468888999999999999998764432 23468888876433 23568899999999999999999999976653
Q ss_pred ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccc
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 241 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 241 (426)
.|+||||+++++|.+++.... ..+++..++.++.|++.||.|||+. +++||||||+|||++.++.++|+|||++
T Consensus 80 --~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~ 153 (267)
T cd05066 80 --VMIVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLS 153 (267)
T ss_pred --cEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcc
Confidence 499999999999999997543 3478999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCceee-eeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014363 242 RLGPSEGFTHV-STAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAK 319 (426)
Q Consensus 242 ~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 319 (426)
........... .....++..|+|||++.+..++.++||||||+++|++++ |..||.......... ...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~---~~~------- 223 (267)
T cd05066 154 RVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIK---AIE------- 223 (267)
T ss_pred cccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHH---HHh-------
Confidence 86543221111 112233568999999998889999999999999999887 999997654322111 110
Q ss_pred hhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHh
Q 014363 320 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 369 (426)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~ 369 (426)
+. .....+..++..+.+++.+||+.+|++||++.++++.|+++
T Consensus 224 ---~~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 224 ---EG----YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ---CC----CcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 00 00111223456889999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=322.97 Aligned_cols=263 Identities=25% Similarity=0.434 Sum_probs=213.3
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
.....+.++||+|-||.|.+|.... ...||+|.++... ...+|..|+++|.+|+|||||+++|+|..++..
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg------~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePi 610 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEG------PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPL 610 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecC------ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCch
Confidence 4456677899999999999998766 3489999997654 346799999999999999999999999988765
Q ss_pred CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecc
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 240 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 240 (426)
++|+||+++|+|.+|+..+....+.......|+.||+.|++||.+. ++|||||.+.|+|++.++++||+|||+
T Consensus 611 ----cmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgm 683 (807)
T KOG1094|consen 611 ----CMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGM 683 (807)
T ss_pred ----HHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCccc
Confidence 8999999999999999876433345566778999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh--CCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014363 241 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT--GRRPIDRNRPRSEQKLLQWVKPYLSDA 318 (426)
Q Consensus 241 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~ 318 (426)
++.+-...+.+.....+-...|||||.+..++++.++|||+||+++||+++ ...||.....+. .++....++...
T Consensus 684 sR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~---vven~~~~~~~~ 760 (807)
T KOG1094|consen 684 SRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ---VVENAGEFFRDQ 760 (807)
T ss_pred ccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH---HHHhhhhhcCCC
Confidence 997766666666667778899999999999999999999999999999876 788987544322 111111111111
Q ss_pred hhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHh
Q 014363 319 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 369 (426)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~ 369 (426)
. .......+.-++..+.++|.+||..|-++||+++++..+|.+.
T Consensus 761 ~-------~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 761 G-------RQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred C-------cceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 0 0111122345778899999999999999999999999998764
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=326.03 Aligned_cols=254 Identities=23% Similarity=0.304 Sum_probs=195.3
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-----CCHHHHHHHHHHHhhcCCCCccceEeEEEccCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-----GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
++|++.+.||+|+||.||++....++. .||+|.+... ...+.+.+|+.++..++||||+++++++.+.+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~-----~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~- 74 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQ-----VYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDEN- 74 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCC-----EEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCC-
Confidence 468899999999999999999877654 7999988532 23345788999999999999999999998765
Q ss_pred CCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeec
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 239 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 239 (426)
..|+||||+++|+|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 75 ---~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg 147 (331)
T cd05597 75 ---NLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFG 147 (331)
T ss_pred ---eEEEEEecCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECC
Confidence 4599999999999999996432 3488999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCchhhcc-----CCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhh
Q 014363 240 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQT-----GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPY 314 (426)
Q Consensus 240 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 314 (426)
++........ ......+||+.|+|||++.. ..++.++|||||||++|+|++|..||........... .
T Consensus 148 ~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~------i 220 (331)
T cd05597 148 SCLRLLADGT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK------I 220 (331)
T ss_pred ceeecCCCCC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHH------H
Confidence 9876543221 11223579999999999863 4578899999999999999999999975432211110 0
Q ss_pred hhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCC--CCCCHHHHHHH
Q 014363 315 LSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNAR--TRPKMSEVLEM 365 (426)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~--~RPs~~eil~~ 365 (426)
...... ..+. .....++..+.+++.+||..+++ .||++.+++++
T Consensus 221 ~~~~~~------~~~~-~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 221 MNHKEH------FQFP-PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred HcCCCc------ccCC-CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 000000 0000 01112566788999987765443 47899999987
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=312.15 Aligned_cols=250 Identities=23% Similarity=0.371 Sum_probs=201.2
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
+|++.+.||+|++|.||++..+.++. .+++|.+.... ..+.+.+|+.+++.++||||+++++.+...+.
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~-----~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-- 73 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGK-----QYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDG-- 73 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCc-----EEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCC--
Confidence 48889999999999999999876543 68888875432 33467889999999999999999988754332
Q ss_pred ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccc
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 241 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 241 (426)
..|+||||+++++|.+++.......+++.+++.++.|++.||.|||+. +++||||||+||+++.++.++|+|||++
T Consensus 74 -~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~ 149 (257)
T cd08223 74 -LLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIA 149 (257)
T ss_pred -EEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccce
Confidence 458999999999999999765455689999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhh
Q 014363 242 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 321 (426)
Q Consensus 242 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (426)
....... .......|++.|+|||++.+..++.++||||||+++++|++|..||..........
T Consensus 150 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~--------------- 212 (257)
T cd08223 150 RVLENQC--DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVY--------------- 212 (257)
T ss_pred EEecccC--CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHH---------------
Confidence 7654321 12234578999999999999899999999999999999999999997543211100
Q ss_pred hhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 322 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
......+ ...+...+..+.+++.+||+.||++||++.+++++
T Consensus 213 -~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 213 -RIIEGKL-PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred -HHHhcCC-CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000001 11233466789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=329.00 Aligned_cols=237 Identities=29% Similarity=0.353 Sum_probs=186.4
Q ss_pred ceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-----CHHHHHHHHH-HHhhcCCCCccceEeEEEccCCCCceE
Q 014363 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-----GHKEWMTEVN-FLGIVEHQNLVKLVGYCADDDERGIQR 164 (426)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-----~~~~~~~E~~-~l~~l~HpnIv~~~~~~~~~~~~~~~~ 164 (426)
++||+|+||.||+|....++. .+|+|.+.... ....+..|.. +++.++||||+++++++...+ ..
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~-----~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~----~~ 71 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGK-----CYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTE----KL 71 (325)
T ss_pred CceeeCCCeEEEEEEECCCCC-----EEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCC----EE
Confidence 369999999999999876654 78999875431 2234555654 467789999999999998765 45
Q ss_pred EEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccC
Q 014363 165 LLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLG 244 (426)
Q Consensus 165 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 244 (426)
|+||||+++|+|..++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 72 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~ 146 (325)
T cd05604 72 YFVLDFVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (325)
T ss_pred EEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccC
Confidence 9999999999999888643 3489999999999999999999998 9999999999999999999999999998753
Q ss_pred CCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhh
Q 014363 245 PSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQI 324 (426)
Q Consensus 245 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (426)
.... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||......... . .+
T Consensus 147 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~---~-------------~~ 208 (325)
T cd05604 147 IAQS--DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMY---D-------------NI 208 (325)
T ss_pred CCCC--CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHH---H-------------HH
Confidence 2211 1233567999999999999999999999999999999999999999764322111 1 11
Q ss_pred cCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHH
Q 014363 325 VDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSE 361 (426)
Q Consensus 325 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~e 361 (426)
....+ ......+..+.+++.+||+.||++||++.+
T Consensus 209 ~~~~~--~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 209 LHKPL--VLRPGASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred HcCCc--cCCCCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence 11111 111124567889999999999999998753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=323.54 Aligned_cols=251 Identities=23% Similarity=0.315 Sum_probs=195.8
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-----CCHHHHHHHHHHHhhcCCCCccceEeEEEccCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-----GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
++|...++||+|+||.||++.++..+. .+|+|.+... .....+..|+.++..++|+||+++++++.+..
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~-----~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~- 74 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADK-----VFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDEN- 74 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCC-----EEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC-
Confidence 468899999999999999999877654 7899987532 12335778999999999999999999998765
Q ss_pred CCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeec
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 239 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 239 (426)
..|+||||+++|+|.+++.... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 75 ---~~~lv~ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG 147 (332)
T cd05623 75 ---NLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFG 147 (332)
T ss_pred ---EEEEEEeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecc
Confidence 4599999999999999997532 3489999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCchhhc-----cCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhh
Q 014363 240 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQ-----TGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPY 314 (426)
Q Consensus 240 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 314 (426)
++........ ......+||+.|+|||++. ...++.++|||||||++|||++|+.||..........
T Consensus 148 ~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~-------- 218 (332)
T cd05623 148 SCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG-------- 218 (332)
T ss_pred hheecccCCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHH--------
Confidence 9875433221 1223457999999999986 3468899999999999999999999997543221111
Q ss_pred hhhhhhhhhhcCCcCC---CcccHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 014363 315 LSDAKQFRQIVDPRLE---GKYSLRLVSKLSHVANLCLVKNART--RPKMSEVLEM 365 (426)
Q Consensus 315 ~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~eil~~ 365 (426)
.+...... ......++..+.+++.+||..+++. |+++.|+++|
T Consensus 219 --------~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 219 --------KIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred --------HHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 11111000 0111235678899999988655444 6899999987
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=332.37 Aligned_cols=262 Identities=23% Similarity=0.303 Sum_probs=205.9
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-CHHHHHHHHHHHhhcC-CC-----CccceEeEEEccC
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-GHKEWMTEVNFLGIVE-HQ-----NLVKLVGYCADDD 158 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~E~~~l~~l~-Hp-----nIv~~~~~~~~~~ 158 (426)
+|.+.++||+|+||.|.+|.+..+++ .||||++++.. -..+...|+.+|..|+ |. |+|+++++|....
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e-----~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~ 261 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGE-----IVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN 261 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCc-----EEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc
Confidence 67888999999999999999888765 89999998765 3345678999999996 43 8999999999877
Q ss_pred CCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCC--CeeEe
Q 014363 159 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW--NAKLS 236 (426)
Q Consensus 159 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~--~~kl~ 236 (426)
+.|||+|.+ ..+|.++|+.+.-..++...++.|+.||+.||.+||+. +|||.||||+||||.+-+ .|||+
T Consensus 262 ----HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVI 333 (586)
T KOG0667|consen 262 ----HLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVI 333 (586)
T ss_pred ----ceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEE
Confidence 459999999 67999999988877899999999999999999999998 999999999999996544 59999
Q ss_pred eecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhh---
Q 014363 237 DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKP--- 313 (426)
Q Consensus 237 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~--- 313 (426)
|||.++....... ..+.+..|.|||++.+.+|+.+.||||||||++||++|.+-|.+....+....+..+.-
T Consensus 334 DFGSSc~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp 408 (586)
T KOG0667|consen 334 DFGSSCFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPP 408 (586)
T ss_pred ecccccccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCC
Confidence 9999987654322 56789999999999999999999999999999999999888877655444333322100
Q ss_pred --hhhhhhhhhhh--------------------------------cCC-cCC-------CcccHHHHHHHHHHHHhcccc
Q 014363 314 --YLSDAKQFRQI--------------------------------VDP-RLE-------GKYSLRLVSKLSHVANLCLVK 351 (426)
Q Consensus 314 --~~~~~~~~~~~--------------------------------~~~-~~~-------~~~~~~~~~~l~~li~~cl~~ 351 (426)
++........+ .+. ... .......-..+.+++.+||.+
T Consensus 409 ~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~ 488 (586)
T KOG0667|consen 409 PKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEW 488 (586)
T ss_pred HHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhcc
Confidence 00000000000 000 000 001112345788999999999
Q ss_pred CCCCCCCHHHHHHH
Q 014363 352 NARTRPKMSEVLEM 365 (426)
Q Consensus 352 dp~~RPs~~eil~~ 365 (426)
||.+|+|..|+++|
T Consensus 489 dP~~R~tp~qal~H 502 (586)
T KOG0667|consen 489 DPAERITPAQALNH 502 (586)
T ss_pred CchhcCCHHHHhcC
Confidence 99999999999997
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=350.13 Aligned_cols=261 Identities=23% Similarity=0.315 Sum_probs=202.4
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-----CHHHHHHHHHHHhhcCCCCccceEeEEEccCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
++|++.++||+|+||.||+|.+..++. .||+|++.... ..+.+.+|+.+++.++||||+++++++.+.+
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~-----~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~- 75 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSR-----RVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGD- 75 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCc-----EEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCC-
Confidence 579999999999999999999876554 79999886432 2356889999999999999999999998765
Q ss_pred CCceEEEEEeeCCCCChhhhccCCC---------CCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCC
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPKS---------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQ 230 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~~---------~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~ 230 (426)
..|+||||++||+|.+++.... ....++..++.++.||+.||+|||++ +|+||||||+|||++.+
T Consensus 76 ---~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~d 149 (932)
T PRK13184 76 ---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLF 149 (932)
T ss_pred ---EEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCC
Confidence 3599999999999999885311 12356677889999999999999998 99999999999999999
Q ss_pred CCeeEeeecccccCCCCCc----------------eeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCC
Q 014363 231 WNAKLSDFGLARLGPSEGF----------------THVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRR 294 (426)
Q Consensus 231 ~~~kl~DFGla~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~ 294 (426)
+.+||+|||++........ .......+||+.|+|||++.+..++.++|||||||++|||++|..
T Consensus 150 g~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~ 229 (932)
T PRK13184 150 GEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSF 229 (932)
T ss_pred CCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCC
Confidence 9999999999976521100 001123579999999999999999999999999999999999999
Q ss_pred CCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHHHHhHhh
Q 014363 295 PIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRP-KMSEVLEMVNKIVDA 372 (426)
Q Consensus 295 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-s~~eil~~L~~~~~~ 372 (426)
||........... .....+. .......++..+.+++.+||+.||++|| +++++++.|+.....
T Consensus 230 PF~~~~~~ki~~~--------------~~i~~P~-~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 230 PYRRKKGRKISYR--------------DVILSPI-EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred CCCCcchhhhhhh--------------hhccChh-hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 9975322111000 0000000 0001123556789999999999999995 677788888877654
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=315.40 Aligned_cols=249 Identities=29% Similarity=0.488 Sum_probs=193.5
Q ss_pred eecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhc-CCCCccceEeEEEccCCCCceEEEE
Q 014363 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDERGIQRLLV 167 (426)
Q Consensus 92 ~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~~~~~~~lv 167 (426)
+||+|+||.||+|.+..++. ...+++|.+.... ..+.+.+|+.++.++ +||||+++++++..... .++|
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~---~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~----~~lv 74 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGL---RMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY----LYLA 74 (270)
T ss_pred cCCCCCCceEEEEEEcCCCC---eeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCC----ceEE
Confidence 68999999999999876432 2356788776432 335688999999999 89999999999987664 4999
Q ss_pred EeeCCCCChhhhccCCC--------------CCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCe
Q 014363 168 YEYMPNGSVDQYLSPKS--------------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNA 233 (426)
Q Consensus 168 ~E~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~ 233 (426)
|||+++|+|.+++.... ...+++..++.++.|++.||+|||+. +++||||||+|||+++++.+
T Consensus 75 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~ 151 (270)
T cd05047 75 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 151 (270)
T ss_pred EEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeE
Confidence 99999999999986432 12478999999999999999999998 99999999999999999999
Q ss_pred eEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHh
Q 014363 234 KLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVK 312 (426)
Q Consensus 234 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~ 312 (426)
||+|||++....... .......+..|+|||++....++.++||||||+++|||++ |..||....... .....
T Consensus 152 kl~dfgl~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~~~~~- 224 (270)
T cd05047 152 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYEKL- 224 (270)
T ss_pred EECCCCCccccchhh---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH---HHHHH-
Confidence 999999986322110 0111234567999999988889999999999999999997 999996543211 11100
Q ss_pred hhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhH
Q 014363 313 PYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIV 370 (426)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~ 370 (426)
........+...+..+.+++.+||+.||.+|||+.++++.|+.++
T Consensus 225 -------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 225 -------------PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred -------------hCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 000011112234567899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=312.05 Aligned_cols=258 Identities=23% Similarity=0.381 Sum_probs=205.1
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-----CCHHHHHHHHHHHhhcCCCCccceEeEEEccCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-----GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
++|+..+.||+|+||.||+|....++. .+++|.+... ...+.+.+|+++++.++|+||+++++++.+.+
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~-----~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~- 75 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGR-----VVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENN- 75 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCC-----EEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCC-
Confidence 578999999999999999999875543 7888876432 23457889999999999999999999998765
Q ss_pred CCceEEEEEeeCCCCChhhhccCC--CCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEee
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPK--SETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 237 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~D 237 (426)
..++||||+++++|.+++... ....+++..++.++.|++.||.|||+. +++||||+|+||+++.++.++|+|
T Consensus 76 ---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d 149 (267)
T cd08224 76 ---ELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGD 149 (267)
T ss_pred ---eEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEec
Confidence 359999999999999988532 234589999999999999999999998 999999999999999999999999
Q ss_pred ecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh
Q 014363 238 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 317 (426)
Q Consensus 238 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 317 (426)
||++........ ......|+..|+|||.+.+..++.++||||||+++|+|++|..||...... ......
T Consensus 150 ~~~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~-------- 218 (267)
T cd08224 150 LGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCK-------- 218 (267)
T ss_pred cceeeeccCCCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc-HHHHHh--------
Confidence 999876543221 123356899999999998888999999999999999999999999643311 111110
Q ss_pred hhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhH
Q 014363 318 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIV 370 (426)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~ 370 (426)
.+............++..+.+++.+||..+|++||++.+|++.|..+.
T Consensus 219 -----~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 219 -----KIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred -----hhhcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 000001111111245678999999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=322.30 Aligned_cols=266 Identities=23% Similarity=0.309 Sum_probs=190.9
Q ss_pred ceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCceEEEEEee
Q 014363 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEY 170 (426)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~~~lv~E~ 170 (426)
.+||+|+||.||+|..++.. ....+|+|.+........+.+|+.+++.++||||+++++++...... ..++||||
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~---~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~--~~~lv~e~ 81 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGK---DEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDR--KVWLLFDY 81 (317)
T ss_pred eEeccCCCeeEEEEEecCCC---ccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCC--eEEEEEee
Confidence 57999999999999876532 23478999987666566788999999999999999999998765433 56999999
Q ss_pred CCCCChhhhccCC-------CCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEe----CCCCCeeEeeec
Q 014363 171 MPNGSVDQYLSPK-------SETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL----DEQWNAKLSDFG 239 (426)
Q Consensus 171 ~~~g~L~~~l~~~-------~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl----~~~~~~kl~DFG 239 (426)
++ ++|.+++... ....+++..++.++.|++.||.|||+. +|+||||||+|||+ +.++.+||+|||
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07867 82 AE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred eC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence 96 4777766421 123488999999999999999999998 99999999999999 566789999999
Q ss_pred ccccCCCCCce-eeeeeeecCcccCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCchhh-------HHHHHh
Q 014363 240 LARLGPSEGFT-HVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSE-------QKLLQW 310 (426)
Q Consensus 240 la~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~-------~~~~~~ 310 (426)
+++........ .......||+.|+|||++.+. .++.++|||||||++|||++|..||........ ..+...
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07867 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRI 237 (317)
T ss_pred ceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHH
Confidence 99865432211 112345789999999998764 578999999999999999999999965432110 011110
Q ss_pred Hhhhh----hhhhhh---------hhhc-CCc-----CC---CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 311 VKPYL----SDAKQF---------RQIV-DPR-----LE---GKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 311 ~~~~~----~~~~~~---------~~~~-~~~-----~~---~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
..... ...... .... ... +. ..........+.+|+.+||+.||.+|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h 314 (317)
T cd07867 238 FSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD 314 (317)
T ss_pred HHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence 00000 000000 0000 000 00 00001123468889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=317.32 Aligned_cols=276 Identities=23% Similarity=0.357 Sum_probs=203.4
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
..|+..+.||+|+||.||+|.+.... ......+++|.+.... ....+.+|+.+++.++||||+++++++.+.+..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~-~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~- 81 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEG-DNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN- 81 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCC-CCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC-
Confidence 35788899999999999999865321 2234579999886443 235688999999999999999999998875332
Q ss_pred ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccc
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 241 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 241 (426)
..++||||+++++|.+++.... ..+++..++.++.|++.||+|||++ +++||||||+|||++.++.+||+|||++
T Consensus 82 -~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~ 156 (284)
T cd05079 82 -GIKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLT 156 (284)
T ss_pred -ceEEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccc
Confidence 3589999999999999986443 3489999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCce-eeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhh
Q 014363 242 RLGPSEGFT-HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 320 (426)
Q Consensus 242 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (426)
......... .......|+..|+|||++.+..++.++||||||+++|+|+++..|+.............. ..... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~-~~~~~-~~~ 234 (284)
T cd05079 157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPT-HGQMT-VTR 234 (284)
T ss_pred cccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccc-ccccc-HHH
Confidence 865432211 122345677889999999888899999999999999999998776532211000000000 00000 000
Q ss_pred hhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHh
Q 014363 321 FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 369 (426)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~ 369 (426)
....+...........++..+.+|+.+||+.||++||++.++++.|+.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 235 LVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 0000111111111223567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=319.06 Aligned_cols=250 Identities=26% Similarity=0.410 Sum_probs=201.0
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC--CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
..+|+..+.||+|+||.||+|.....+. .+++|.+.... ..+.+.+|+.+++.+.||||+++++++.+..
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~-----~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~--- 90 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQ-----EVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD--- 90 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCc-----EEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCC---
Confidence 3578999999999999999998766544 78888775432 3457889999999999999999999988755
Q ss_pred ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccc
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 241 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 241 (426)
..|+||||+++++|.+++... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 91 -~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~ 163 (296)
T cd06654 91 -ELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC 163 (296)
T ss_pred -EEEEeecccCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccc
Confidence 469999999999999998642 378899999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhh
Q 014363 242 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 321 (426)
Q Consensus 242 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (426)
....... .......|++.|+|||.+.+..++.++|||||||++|+|++|..||....+... .....
T Consensus 164 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~--~~~~~---------- 229 (296)
T cd06654 164 AQITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--LYLIA---------- 229 (296)
T ss_pred hhccccc--cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh--HHHHh----------
Confidence 7543321 112235689999999999988899999999999999999999999975443211 11000
Q ss_pred hhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 322 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.........+..++..+.+++.+||..||++||++.+|+++
T Consensus 230 ---~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 230 ---TNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred ---cCCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 00000111223456778999999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=314.61 Aligned_cols=252 Identities=33% Similarity=0.513 Sum_probs=198.8
Q ss_pred CCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHH----HHHHHHHHHhhcCCCCccceEeEEEccCCCCc
Q 014363 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHK----EWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 162 (426)
Q Consensus 87 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~----~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~ 162 (426)
|+.++.||+|+||+||++.....+. .+++|.+....... ....|+.+++.++||||+++++++.+..
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~-----~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~---- 71 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQ-----KVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDN---- 71 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTE-----EEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESS----
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCe-----EEEEEEeccccccccccchhhhhhhccccccccccccccccccccc----
Confidence 5677899999999999999887664 79999987665322 2345999999999999999999998855
Q ss_pred eEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccc
Q 014363 163 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 242 (426)
Q Consensus 163 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 242 (426)
..++||||+++++|.+++.. ...+++..++.++.|+++||.+||+. +++|+||||+|||++.++.++|+|||.+.
T Consensus 72 ~~~~v~~~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~ 146 (260)
T PF00069_consen 72 YLYIVMEYCPGGSLQDYLQK--NKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSV 146 (260)
T ss_dssp EEEEEEEEETTEBHHHHHHH--HSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTE
T ss_pred cccccccccccccccccccc--cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccc
Confidence 45899999999999999972 34489999999999999999999998 99999999999999999999999999997
Q ss_pred cCCCCCceeeeeeeecCcccCCchhhc-cCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhh
Q 014363 243 LGPSEGFTHVSTAVVGTMGYAAPEYVQ-TGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 321 (426)
Q Consensus 243 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (426)
..... ........++..|+|||++. +..++.++||||||+++|+|++|..||.................. ..
T Consensus 147 ~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~-----~~ 219 (260)
T PF00069_consen 147 KLSEN--NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKR-----PL 219 (260)
T ss_dssp ESTST--TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHT-----HH
T ss_pred ccccc--ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccc-----cc
Confidence 54211 12234567899999999998 788999999999999999999999999865322222222111100 00
Q ss_pred hhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 322 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
..... ........+.+++.+||+.||++||++.+++++
T Consensus 220 ~~~~~------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 220 PSSSQ------QSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp HHHTT------SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred ccccc------ccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000 000012689999999999999999999999874
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=311.21 Aligned_cols=251 Identities=26% Similarity=0.390 Sum_probs=199.2
Q ss_pred ceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC---HHHHHHHHHHHhhcCCCCccceEeEEEccCCCCceEEEE
Q 014363 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG---HKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLV 167 (426)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~~~lv 167 (426)
++||+|+||.||+|.+...+ .....+++|.+..... .+.+.+|+.++++++||||+++++++.+ . ..++|
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~----~~~~v 73 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSG--GKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-H----PLMMV 73 (257)
T ss_pred CcCCccCcccEEeeeEecCC--CCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-C----eEEEE
Confidence 36899999999999986532 2334689999876543 4578899999999999999999999877 3 45999
Q ss_pred EeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccCCCC
Q 014363 168 YEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSE 247 (426)
Q Consensus 168 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 247 (426)
|||+++++|.+++.......+++..++.++.|++.||+|||++ +++|+||||+||+++.++.+||+|||++......
T Consensus 74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~ 150 (257)
T cd05040 74 TELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQN 150 (257)
T ss_pred EEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEecccccccccccc
Confidence 9999999999999765434589999999999999999999998 9999999999999999999999999999866432
Q ss_pred Cce-eeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhc
Q 014363 248 GFT-HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIV 325 (426)
Q Consensus 248 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (426)
... .......++..|+|||++.+..++.++||||||+++|+|++ |..||............. .
T Consensus 151 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-------------~-- 215 (257)
T cd05040 151 EDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKID-------------K-- 215 (257)
T ss_pred ccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------------h--
Confidence 211 11223457789999999998899999999999999999998 999997543322111100 0
Q ss_pred CCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014363 326 DPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVN 367 (426)
Q Consensus 326 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~ 367 (426)
.......+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus 216 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 216 -EGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -cCCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 00001112235578999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=312.50 Aligned_cols=252 Identities=27% Similarity=0.432 Sum_probs=187.3
Q ss_pred eecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC---HHHHHHHHHHHhhcCCCCccceEeEEEccCCCCceEEEEE
Q 014363 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG---HKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVY 168 (426)
Q Consensus 92 ~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~~~lv~ 168 (426)
.||+|+||.||+|..... .....+++|.+..... ...+.+|+.+++.++||||+++++++.+... .++||
T Consensus 2 ~lg~G~fg~v~~~~~~~~---~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~----~~lv~ 74 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRG---MSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIP----YLLVL 74 (269)
T ss_pred cCCccCCceEEEEEEecC---CCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCc----eEEEE
Confidence 589999999999975443 1234678887754432 3467899999999999999999999987653 49999
Q ss_pred eeCCCCChhhhccCCCC---CccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccCC
Q 014363 169 EYMPNGSVDQYLSPKSE---TILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGP 245 (426)
Q Consensus 169 E~~~~g~L~~~l~~~~~---~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 245 (426)
||+++|+|.+++..... ...++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 75 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 151 (269)
T cd05042 75 EFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQY 151 (269)
T ss_pred EeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccc
Confidence 99999999999865432 2356778889999999999999998 99999999999999999999999999987543
Q ss_pred CCCceeeeeeeecCcccCCchhhcc-------CCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhh
Q 014363 246 SEGFTHVSTAVVGTMGYAAPEYVQT-------GRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSD 317 (426)
Q Consensus 246 ~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 317 (426)
............++..|+|||++.. ..++.++|||||||++|||++ |..||........ +..... .
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~--~~~~~~----~ 225 (269)
T cd05042 152 PEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV--LKQVVR----E 225 (269)
T ss_pred cchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH--HHHHhh----c
Confidence 3222221223446778999998753 346789999999999999999 7888865432211 110000 0
Q ss_pred hhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014363 318 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMV 366 (426)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L 366 (426)
....... ...+..++..+.+++..|| .||++||++++|++.|
T Consensus 226 --~~~~~~~----~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 226 --QDIKLPK----PQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred --cCccCCC----CcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 0000111 1122345567788899998 5999999999999886
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=326.69 Aligned_cols=251 Identities=24% Similarity=0.312 Sum_probs=196.3
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-----CCHHHHHHHHHHHhhcCCCCccceEeEEEccCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-----GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
++|.+.+.||+|+||.||++.+..++. .+|+|.+... .....+.+|+.++..++|+||+++++++.+.+
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~-----~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~- 74 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTER-----IYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDEN- 74 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCC-----EEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC-
Confidence 478899999999999999999876654 7899987542 12345778999999999999999999998765
Q ss_pred CCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeec
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 239 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 239 (426)
..|+||||++||+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 75 ---~~~lv~Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG 147 (331)
T cd05624 75 ---YLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFG 147 (331)
T ss_pred ---EEEEEEeCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEecc
Confidence 4599999999999999997532 3488999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCchhhcc-----CCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhh
Q 014363 240 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQT-----GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPY 314 (426)
Q Consensus 240 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 314 (426)
++........ .......||+.|+|||++.+ +.++.++|||||||++|+|++|+.||..........
T Consensus 148 ~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~-------- 218 (331)
T cd05624 148 SCLKMNQDGT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG-------- 218 (331)
T ss_pred ceeeccCCCc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHH--------
Confidence 9976543321 12234579999999999875 567889999999999999999999997543321111
Q ss_pred hhhhhhhhhhcCCcCC---CcccHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 014363 315 LSDAKQFRQIVDPRLE---GKYSLRLVSKLSHVANLCLVKNART--RPKMSEVLEM 365 (426)
Q Consensus 315 ~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~eil~~ 365 (426)
.+...... ......++..+.+++.+||..++.+ |+++++++++
T Consensus 219 --------~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 219 --------KIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred --------HHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 11110000 0111234678999999999866544 4689999876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=314.93 Aligned_cols=252 Identities=29% Similarity=0.506 Sum_probs=196.7
Q ss_pred eecccCcEEEEEEEEcCCCC-CCcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCceEEEE
Q 014363 92 VIGEGGFGCVYKGLIKNSED-PSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLV 167 (426)
Q Consensus 92 ~lG~G~~g~Vy~~~~~~~~~-~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~~~lv 167 (426)
.||+|+||.||+|.+..... ......+++|.+.... ....+.+|+.+++.++||||+++++++.+... .++|
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~~v 77 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEP----QYII 77 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCC----eEEE
Confidence 68999999999998765431 1223468888775432 34578899999999999999999999977653 4999
Q ss_pred EeeCCCCChhhhccCC-----CCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCC-----CeeEee
Q 014363 168 YEYMPNGSVDQYLSPK-----SETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW-----NAKLSD 237 (426)
Q Consensus 168 ~E~~~~g~L~~~l~~~-----~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~-----~~kl~D 237 (426)
|||+++++|.+++... ....+++..++.++.|++.||.|||+. +++|+||||+|||++.++ .++|+|
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~d 154 (269)
T cd05044 78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGD 154 (269)
T ss_pred EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECC
Confidence 9999999999998643 223478899999999999999999998 999999999999999887 899999
Q ss_pred ecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhh
Q 014363 238 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLS 316 (426)
Q Consensus 238 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 316 (426)
||++................++..|+|||++.++.++.++||||||+++|+|++ |..||....... .....
T Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~---~~~~~----- 226 (269)
T cd05044 155 FGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE---VLQHV----- 226 (269)
T ss_pred cccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH---HHHHH-----
Confidence 999975543222222223456788999999999999999999999999999998 999996543221 11110
Q ss_pred hhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014363 317 DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVN 367 (426)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~ 367 (426)
........+...+..+.+++.+||+.+|++||++++|++.|+
T Consensus 227 ---------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 227 ---------TAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred ---------hcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 000011122345678899999999999999999999999885
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=311.30 Aligned_cols=253 Identities=23% Similarity=0.427 Sum_probs=201.7
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCc
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 162 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~ 162 (426)
.++|...+.||+|+||.||+|...... .+++|.+.... ..+.+.+|+.+++.++|+||+++++++.+ .
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~------~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~---- 73 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHT------KVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-E---- 73 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCc------cEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-C----
Confidence 457889999999999999999865433 58888876543 34578899999999999999999999876 2
Q ss_pred eEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccc
Q 014363 163 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 242 (426)
Q Consensus 163 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 242 (426)
..+++|||+++++|.+++.......+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++.
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~ 150 (260)
T cd05073 74 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLAR 150 (260)
T ss_pred CeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCccee
Confidence 348999999999999999765555688899999999999999999998 99999999999999999999999999997
Q ss_pred cCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhh
Q 014363 243 LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 321 (426)
Q Consensus 243 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (426)
........ ......++..|+|||++..+.++.++||||||+++|++++ |..||......... ....
T Consensus 151 ~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~---~~~~--------- 217 (260)
T cd05073 151 VIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI---RALE--------- 217 (260)
T ss_pred eccCCCcc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHH---HHHh---------
Confidence 65432211 1222345678999999988889999999999999999999 99999754322111 1100
Q ss_pred hhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 014363 322 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNK 368 (426)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~ 368 (426)
...........+..+.+++.+||+.+|++||++.++++.|+.
T Consensus 218 -----~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 218 -----RGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred -----CCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 000011112345689999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=353.17 Aligned_cols=256 Identities=25% Similarity=0.383 Sum_probs=198.3
Q ss_pred HhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccC
Q 014363 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 158 (426)
Q Consensus 83 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 158 (426)
..++|.+++.||+|+||.||+|.+...+. .+++|.+.... ....+..|+.+|..|+|||||+++++|.+..
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~-----~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~ 85 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQE-----FFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA 85 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCe-----EEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC
Confidence 45689999999999999999999876553 78888775332 3456889999999999999999999987654
Q ss_pred CCCceEEEEEeeCCCCChhhhccCCC--CCccCHHHHHHHHHHHHHHHHHhccCCC----CCeEeccCCCCceEeCC---
Q 014363 159 ERGIQRLLVYEYMPNGSVDQYLSPKS--ETILTWAMRLKIAQDAARGLAYLHEGMD----FQIIVRDFKSSNILLDE--- 229 (426)
Q Consensus 159 ~~~~~~~lv~E~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~~i~~aL~~LH~~~~----~~iiHrDlkp~NILl~~--- 229 (426)
.. .+||||||+++|+|.++|.... ...+++..++.|+.||+.||.|||+... .+||||||||+||||+.
T Consensus 86 ~~--~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~ 163 (1021)
T PTZ00266 86 NQ--KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIR 163 (1021)
T ss_pred CC--EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcc
Confidence 33 4699999999999999986421 2458999999999999999999998421 25999999999999964
Q ss_pred --------------CCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhcc--CCCCCchhhHHHHHHHHHHHhCC
Q 014363 230 --------------QWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT--GRLAARSDVWSYGVFLYELITGR 293 (426)
Q Consensus 230 --------------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~elltg~ 293 (426)
.+.+||+|||++....... ......||+.|+|||++.+ ..++.++||||||||||+|++|.
T Consensus 164 ~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk 240 (1021)
T PTZ00266 164 HIGKITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240 (1021)
T ss_pred ccccccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCC
Confidence 2348999999998654322 1234579999999999864 45889999999999999999999
Q ss_pred CCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 294 RPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 294 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.||....... .+...+. .. +.+. ....+..+.+||..||+.+|.+||++.|++.+
T Consensus 241 ~PF~~~~~~~--qli~~lk----------~~--p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 241 TPFHKANNFS--QLISELK----------RG--PDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred CCCCcCCcHH--HHHHHHh----------cC--CCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 9997543211 1111000 00 0110 01235678999999999999999999999964
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=310.50 Aligned_cols=251 Identities=28% Similarity=0.427 Sum_probs=204.5
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCceE
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQR 164 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~~ 164 (426)
++|+..+.||.|+||.||+|.+..++. .+++|.+......+.+.+|+++++.++||||+++++++.+.. ..
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~-----~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~----~~ 73 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQ-----VVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKNT----DL 73 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCc-----EEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCC----cE
Confidence 578889999999999999999876543 789998876655678999999999999999999999998765 45
Q ss_pred EEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccC
Q 014363 165 LLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLG 244 (426)
Q Consensus 165 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 244 (426)
|+++||+++++|.+++.... ..+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++...
T Consensus 74 ~l~~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~ 149 (256)
T cd06612 74 WIVMEYCGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQL 149 (256)
T ss_pred EEEEecCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhc
Confidence 99999999999999986433 3589999999999999999999998 9999999999999999999999999999865
Q ss_pred CCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhh
Q 014363 245 PSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQI 324 (426)
Q Consensus 245 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (426)
..... ......|+..|+|||++.+..++.++||||||+++|+|++|..||....+....... ..
T Consensus 150 ~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~-------------~~- 213 (256)
T cd06612 150 TDTMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI-------------PN- 213 (256)
T ss_pred ccCcc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh-------------cc-
Confidence 43321 123356889999999999889999999999999999999999999754332111000 00
Q ss_pred cCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 325 VDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 325 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
........+..++..+.+++.+||+.||++|||+.|++++
T Consensus 214 -~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 214 -KPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred -CCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 0000111223456789999999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=314.07 Aligned_cols=265 Identities=22% Similarity=0.348 Sum_probs=197.0
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
+|+..+.||+|+||.||+|....++. .|++|.+.... ..+.+.+|+.+++.++||||+++++++.+..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~-----~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--- 72 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQ-----IVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQES--- 72 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCc-----EEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCC---
Confidence 47888899999999999999876554 78898875332 2356789999999999999999999998765
Q ss_pred ceEEEEEeeCCCCChhhhccCCC-CCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecc
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKS-ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 240 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 240 (426)
..|+||||++ ++|.+++.... ...+++..++.++.|++.||+|||+. +++|+||||+|||++.++.+||+|||+
T Consensus 73 -~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~ 147 (285)
T cd07861 73 -RLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGL 147 (285)
T ss_pred -eEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccc
Confidence 4599999997 68888876433 25589999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHH-HHHhHh------
Q 014363 241 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQK-LLQWVK------ 312 (426)
Q Consensus 241 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~-~~~~~~------ 312 (426)
+....... .......+++.|+|||++.+. .++.++||||||+++|+|++|+.||.......... ......
T Consensus 148 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (285)
T cd07861 148 ARAFGIPV--RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDV 225 (285)
T ss_pred eeecCCCc--ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 87543321 112234678999999988654 47889999999999999999999997654322111 000000
Q ss_pred -hhhhhhhhhhhhcCCcCC---CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 313 -PYLSDAKQFRQIVDPRLE---GKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 313 -~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
+................. ......++.++.+++.+||+.||++|||+.+|+.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 226 WPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred hhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000000011111100000 00111256788899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=332.10 Aligned_cols=244 Identities=24% Similarity=0.435 Sum_probs=200.7
Q ss_pred eecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC--HHHHHHHHHHHhhcCCCCccceEeEEEccCCCCceEEEEEe
Q 014363 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG--HKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYE 169 (426)
Q Consensus 92 ~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~~~lv~E 169 (426)
+||+|+||+||-|++..+. +.+|||.+..+.+ .+.+..|+.+.+.|+|.|||+++|.+..++ .+-|.||
T Consensus 582 VLGKGTYG~VYA~RD~~tq-----vrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senG----f~kIFME 652 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQ-----VRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENG----FFKIFME 652 (1226)
T ss_pred EeecCceeEEEeeccccce-----eEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCC----eEEEEee
Confidence 7999999999999977765 4899999876553 356889999999999999999999987766 3478899
Q ss_pred eCCCCChhhhccCCCCCcc--CHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeC-CCCCeeEeeecccccCCC
Q 014363 170 YMPNGSVDQYLSPKSETIL--TWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLD-EQWNAKLSDFGLARLGPS 246 (426)
Q Consensus 170 ~~~~g~L~~~l~~~~~~~~--~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~-~~~~~kl~DFGla~~~~~ 246 (426)
-+|||+|.++++.+= +++ ++..+-.+.+||++||.|||++ .|||||||.+||||+ -.|.+||+|||.++....
T Consensus 653 qVPGGSLSsLLrskW-GPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg 728 (1226)
T KOG4279|consen 653 QVPGGSLSSLLRSKW-GPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG 728 (1226)
T ss_pred cCCCCcHHHHHHhcc-CCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhcc
Confidence 999999999997542 234 7888889999999999999998 999999999999995 578899999999986543
Q ss_pred CCceeeeeeeecCcccCCchhhccCC--CCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhh
Q 014363 247 EGFTHVSTAVVGTMGYAAPEYVQTGR--LAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQI 324 (426)
Q Consensus 247 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (426)
....+.++.||..|||||++..++ |+.++|||||||++.||.||++||-.........+ ++
T Consensus 729 --inP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMF---------------kV 791 (1226)
T KOG4279|consen 729 --INPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMF---------------KV 791 (1226)
T ss_pred --CCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhh---------------hh
Confidence 244567789999999999998764 89999999999999999999999965332111100 00
Q ss_pred cCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 325 VDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 325 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
=--......+...+.+.+.+|.+|+.+||.+||++.++|+.
T Consensus 792 GmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 792 GMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred cceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 00122345677889999999999999999999999999874
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=307.43 Aligned_cols=244 Identities=30% Similarity=0.488 Sum_probs=193.3
Q ss_pred eecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC---HHHHHHHHHHHhhcCCCCccceEeEEEccCCCCceEEEEE
Q 014363 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG---HKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVY 168 (426)
Q Consensus 92 ~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~~~lv~ 168 (426)
+||+|+||.||+|...+.. .+++|.+..... ...+.+|+.+++.++||||+++++++..... .++||
T Consensus 2 ~ig~g~~g~vy~~~~~~~~------~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~lv~ 71 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKT------PVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQP----IYIVM 71 (250)
T ss_pred ccCCCCCceEEEEEecCCc------EEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCc----cEEEE
Confidence 6999999999999865432 789998765432 2367899999999999999999999987664 49999
Q ss_pred eeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccCCCCC
Q 014363 169 EYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEG 248 (426)
Q Consensus 169 E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 248 (426)
||+++++|.+++.... ..+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||++.......
T Consensus 72 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 147 (250)
T cd05085 72 ELVPGGDFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI 147 (250)
T ss_pred ECCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccc
Confidence 9999999999986543 3478999999999999999999998 99999999999999999999999999987543221
Q ss_pred ceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCC
Q 014363 249 FTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDP 327 (426)
Q Consensus 249 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (426)
. .......++..|+|||++.++.++.++||||||+++|+|++ |..||............ . .
T Consensus 148 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~---~----------~---- 209 (250)
T cd05085 148 Y-SSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQV---E----------K---- 209 (250)
T ss_pred c-ccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH---H----------c----
Confidence 1 11112244678999999998889999999999999999998 99999754332111110 0 0
Q ss_pred cCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014363 328 RLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVN 367 (426)
Q Consensus 328 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~ 367 (426)
......+..++..+.+++.+||+.+|++||++.++++.|.
T Consensus 210 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 210 GYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 0011112235678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=314.99 Aligned_cols=276 Identities=25% Similarity=0.412 Sum_probs=207.1
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC---HHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG---HKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
..|+..+.||+|+||.||+|.+...+ ......+++|.+..... .+.+.+|+.+++.++||||+++++++...+..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~- 81 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLG-DNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR- 81 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCC-CCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC-
Confidence 35777889999999999999876442 22345799999876544 56789999999999999999999998774432
Q ss_pred ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccc
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 241 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 241 (426)
..++||||+++++|.+++.... ..+++..++.++.|++.||+|||+. +++|+||||+|||++.++.++|+|||++
T Consensus 82 -~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~ 156 (284)
T cd05038 82 -SLRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLA 156 (284)
T ss_pred -ceEEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccc
Confidence 4599999999999999997543 2489999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCce-eeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhh
Q 014363 242 RLGPSEGFT-HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 320 (426)
Q Consensus 242 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (426)
......... .......++..|++||.+.+..++.++||||||+++|||++|..|+.............. .. ......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~-~~-~~~~~~ 234 (284)
T cd05038 157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIA-QG-QMIVTR 234 (284)
T ss_pred cccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccc-cc-cccHHH
Confidence 876532211 112223456679999999888899999999999999999999999864322110000000 00 000001
Q ss_pred hhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHh
Q 014363 321 FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 369 (426)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~ 369 (426)
....+........+..++.++.+++.+||+.+|++||++.||++.|+.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 235 LLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1111111111122234457899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=311.67 Aligned_cols=243 Identities=24% Similarity=0.445 Sum_probs=187.8
Q ss_pred eecccCcEEEEEEEEcCCCC-------CCcceEEEEEEccccC--CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCc
Q 014363 92 VIGEGGFGCVYKGLIKNSED-------PSQKVEVAVKQLGRRG--GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 162 (426)
Q Consensus 92 ~lG~G~~g~Vy~~~~~~~~~-------~~~~~~va~K~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~ 162 (426)
.||+|+||.||+|....... ......+++|.+.... ....+.+|+.++..++||||+++++++.+....
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~-- 79 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN-- 79 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC--
Confidence 58999999999998654321 1234468888875432 334678899999999999999999999876644
Q ss_pred eEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCC-------eeE
Q 014363 163 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWN-------AKL 235 (426)
Q Consensus 163 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~-------~kl 235 (426)
++||||+++|+|..++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++. +++
T Consensus 80 --~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 80 --IMVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred --EEEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEe
Confidence 89999999999998886433 3489999999999999999999998 9999999999999987664 899
Q ss_pred eeecccccCCCCCceeeeeeeecCcccCCchhhc-cCCCCCchhhHHHHHHHHHHH-hCCCCCCCCCchhhHHHHHhHhh
Q 014363 236 SDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQ-TGRLAARSDVWSYGVFLYELI-TGRRPIDRNRPRSEQKLLQWVKP 313 (426)
Q Consensus 236 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGvil~ell-tg~~p~~~~~~~~~~~~~~~~~~ 313 (426)
+|||++...... ....|+..|+|||++. +..++.++|||||||++|||+ .|..||...........
T Consensus 154 ~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~------ 221 (262)
T cd05077 154 SDPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERF------ 221 (262)
T ss_pred CCCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHH------
Confidence 999998654321 2346788999999886 466899999999999999998 48888865332111110
Q ss_pred hhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014363 314 YLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVN 367 (426)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~ 367 (426)
...... ........+.+|+.+||+.||++||++.+|+++|+
T Consensus 222 -----------~~~~~~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 222 -----------YEGQCM--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred -----------HhcCcc--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 000000 01113457899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=313.45 Aligned_cols=253 Identities=26% Similarity=0.411 Sum_probs=189.7
Q ss_pred eecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC---HHHHHHHHHHHhhcCCCCccceEeEEEccCCCCceEEEEE
Q 014363 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG---HKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVY 168 (426)
Q Consensus 92 ~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~~~lv~ 168 (426)
.||+|+||.||+|...+.. ....+++|.+..... ...+.+|+.+++.++||||+++++++.+... .++||
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----~~lv~ 74 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGY---TPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTP----YLLVM 74 (269)
T ss_pred cccccCCceEEEEEEcCCC---CceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCC----cEEEE
Confidence 5899999999999875422 234688888765432 2467889999999999999999999887654 48999
Q ss_pred eeCCCCChhhhccCCC---CCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccCC
Q 014363 169 EYMPNGSVDQYLSPKS---ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGP 245 (426)
Q Consensus 169 E~~~~g~L~~~l~~~~---~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 245 (426)
||+++|+|.+++.... ....++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 75 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~ 151 (269)
T cd05087 75 EFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKY 151 (269)
T ss_pred ECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCcccccccc
Confidence 9999999999986432 22456778889999999999999998 99999999999999999999999999997544
Q ss_pred CCCceeeeeeeecCcccCCchhhccC-------CCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhh
Q 014363 246 SEGFTHVSTAVVGTMGYAAPEYVQTG-------RLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSD 317 (426)
Q Consensus 246 ~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 317 (426)
............|+..|+|||++.+. .++.++||||||+++|||++ |..||........... ..
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~---~~----- 223 (269)
T cd05087 152 KEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTY---TV----- 223 (269)
T ss_pred CcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHH---Hh-----
Confidence 33222222345678899999988642 35789999999999999997 9999975443221111 00
Q ss_pred hhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014363 318 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVN 367 (426)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~ 367 (426)
.........+.+ ....+..+.+++..|+ .+|++|||++||+..|.
T Consensus 224 ~~~~~~~~~~~~----~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 224 REQQLKLPKPRL----KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred hcccCCCCCCcc----CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 000001111111 1124457888999999 68999999999998763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=310.50 Aligned_cols=252 Identities=27% Similarity=0.419 Sum_probs=196.7
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-------CHHHHHHHHHHHhhcCCCCccceEeEEEcc
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-------GHKEWMTEVNFLGIVEHQNLVKLVGYCADD 157 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-------~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 157 (426)
.+|...+.||+|+||.||+|....++. .+++|.+.... ....+.+|+.+++.++||||+++++++.+.
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~-----~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 76 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGR-----ELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDR 76 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCc-----EEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcC
Confidence 468899999999999999998776544 78888765321 124578899999999999999999988764
Q ss_pred CCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEee
Q 014363 158 DERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 237 (426)
Q Consensus 158 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~D 237 (426)
... ..+++|||+++++|.+++.... .+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|
T Consensus 77 ~~~--~~~l~~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~d 149 (266)
T cd06651 77 AEK--TLTIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGD 149 (266)
T ss_pred CCC--EEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEcc
Confidence 322 4689999999999999986543 388899999999999999999988 999999999999999999999999
Q ss_pred ecccccCCCCCc-eeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhh
Q 014363 238 FGLARLGPSEGF-THVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS 316 (426)
Q Consensus 238 FGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 316 (426)
||++........ ........++..|+|||++.+..++.++||||||+++|+|++|..||.........
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~----------- 218 (266)
T cd06651 150 FGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAI----------- 218 (266)
T ss_pred CCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHH-----------
Confidence 999875432111 11112346889999999999888999999999999999999999999754321111
Q ss_pred hhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 317 DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
...........++......+.+++ +||..+|++||+++||+.|
T Consensus 219 -----~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 219 -----FKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred -----HHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 111111111223344566777887 6888899999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=310.90 Aligned_cols=249 Identities=27% Similarity=0.464 Sum_probs=198.0
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC-----------HHHHHHHHHHHhhcCCCCccceEeEE
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG-----------HKEWMTEVNFLGIVEHQNLVKLVGYC 154 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~-----------~~~~~~E~~~l~~l~HpnIv~~~~~~ 154 (426)
+|.+...||+|+||.||+|.....+. .+++|.+..... .+.+.+|+.+++.++||||+++++++
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~-----~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 75 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGE-----LMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSS 75 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCc-----EEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 46778899999999999998765443 788887753321 14578899999999999999999999
Q ss_pred EccCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCee
Q 014363 155 ADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAK 234 (426)
Q Consensus 155 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~k 234 (426)
.+... .++||||+++++|.+++... ..+++..+..++.|++.||+|||+. +++||||+|+||+++.++.+|
T Consensus 76 ~~~~~----~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~ 146 (267)
T cd06628 76 LDADH----LNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIK 146 (267)
T ss_pred EeCCc----cEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEE
Confidence 87664 48999999999999999654 3488899999999999999999998 999999999999999999999
Q ss_pred EeeecccccCCCCCce----eeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHh
Q 014363 235 LSDFGLARLGPSEGFT----HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQW 310 (426)
Q Consensus 235 l~DFGla~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~ 310 (426)
|+|||+++........ .......|+..|+|||.+.+..++.++||||||+++|+|++|..||....... ..
T Consensus 147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~--- 221 (267)
T cd06628 147 ISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ--AI--- 221 (267)
T ss_pred ecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH--HH---
Confidence 9999998865422111 11123468899999999998889999999999999999999999997542211 10
Q ss_pred HhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 311 VKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
..... ......+...+..+.+++.+||+.||++||++.||+++
T Consensus 222 -----------~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 222 -----------FKIGE-NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred -----------HHHhc-cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 00000 11112223456788999999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=311.13 Aligned_cols=258 Identities=25% Similarity=0.439 Sum_probs=203.3
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
++|...+.||+|+||.||+|.+.... .....+++|...... ..+.+.+|+.+++.++||||+++++++.+..
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~--~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--- 80 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPE--NEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITENP--- 80 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCC--CCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCCC---
Confidence 46888899999999999999876542 223468888876543 3457889999999999999999999987532
Q ss_pred ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccc
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 241 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 241 (426)
.++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +++|+||||+|||++.++.+||+|||++
T Consensus 81 --~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~ 154 (270)
T cd05056 81 --VWIVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLS 154 (270)
T ss_pred --cEEEEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCcee
Confidence 389999999999999997543 3489999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhh
Q 014363 242 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 320 (426)
Q Consensus 242 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (426)
......... ......++..|+|||.+....++.++||||||+++|+|++ |..||........... .. ..
T Consensus 155 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~---~~----~~-- 224 (270)
T cd05056 155 RYLEDESYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGR---IE----NG-- 224 (270)
T ss_pred eecccccce-ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH---HH----cC--
Confidence 765433211 1122334568999999988889999999999999999996 9999975543211110 00 00
Q ss_pred hhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHh
Q 014363 321 FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVD 371 (426)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~ 371 (426)
.....+..++..+.+++.+||..+|++|||+.++++.|+++..
T Consensus 225 --------~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 225 --------ERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred --------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 0001122356789999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=340.25 Aligned_cols=262 Identities=26% Similarity=0.490 Sum_probs=219.0
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCc
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 162 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~ 162 (426)
...+.++||.|.||.||+|..+..+. ..+.||||.++... ...+|+.|+.||.+++||||++|.|+.......
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgk--re~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~Pv-- 705 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGK--REITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPV-- 705 (996)
T ss_pred heEEEEEEecccccceecccccCCCC--cceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCcee--
Confidence 45577899999999999999887653 34589999997654 456799999999999999999999999877654
Q ss_pred eEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccc
Q 014363 163 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 242 (426)
Q Consensus 163 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 242 (426)
.||.|||++|+|+.||+.+.. .+++.+...++++|+.|++||-+. ++|||||...|||++.+..+|++||||++
T Consensus 706 --MIiTEyMENGsLDsFLR~~DG-qftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSR 779 (996)
T KOG0196|consen 706 --MIITEYMENGSLDSFLRQNDG-QFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSR 779 (996)
T ss_pred --EEEhhhhhCCcHHHHHhhcCC-ceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEecccccee
Confidence 899999999999999997764 499999999999999999999987 99999999999999999999999999999
Q ss_pred cCCCCCceeeeeeeec--CcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014363 243 LGPSEGFTHVSTAVVG--TMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAK 319 (426)
Q Consensus 243 ~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 319 (426)
...++. ....++.-| ...|.|||.+...+++.++|||||||++||.++ |..||......+.
T Consensus 780 vledd~-~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdV--------------- 843 (996)
T KOG0196|consen 780 VLEDDP-EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV--------------- 843 (996)
T ss_pred ecccCC-CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHH---------------
Confidence 875543 111222222 468999999999999999999999999999998 9999976543221
Q ss_pred hhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhhcc
Q 014363 320 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASAE 375 (426)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~~~ 375 (426)
+ ..++...+-..+.+++..|.+||..||++|..+||.+.+|+.+|++++.+...
T Consensus 844 -I-kaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~S 897 (996)
T KOG0196|consen 844 -I-KAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNS 897 (996)
T ss_pred -H-HHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchh
Confidence 1 11223334445668999999999999999999999999999999999876443
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=339.28 Aligned_cols=274 Identities=18% Similarity=0.278 Sum_probs=189.9
Q ss_pred HhCCCCCcceecccCcEEEEEEEEcCCCCCCcce--------------EEEEEEccc-cCCHHHHHHHHHHHhhcCCCCc
Q 014363 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKV--------------EVAVKQLGR-RGGHKEWMTEVNFLGIVEHQNL 147 (426)
Q Consensus 83 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~--------------~va~K~~~~-~~~~~~~~~E~~~l~~l~HpnI 147 (426)
..++|.+++.||+|+||+||+|..+......... .+..|.+.. ......+.+|+.+|..++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 4578999999999999999998765432211100 011111111 1123467899999999999999
Q ss_pred cceEeEEEccCCCCceEEEEEeeCCCCChhhhccCCC---CCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCc
Q 014363 148 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKS---ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSN 224 (426)
Q Consensus 148 v~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~---~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~N 224 (426)
+++++++.+.+. .|+|+|++ +++|.+++.... ........+..|+.||+.||.|||++ +|+||||||+|
T Consensus 226 v~l~~~~~~~~~----~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~N 297 (501)
T PHA03210 226 LKIEEILRSEAN----TYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLEN 297 (501)
T ss_pred CcEeEEEEECCe----eEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHH
Confidence 999999988764 49999999 457777764322 11234566778999999999999998 99999999999
Q ss_pred eEeCCCCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCC-CCCCCCchh
Q 014363 225 ILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRR-PIDRNRPRS 303 (426)
Q Consensus 225 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~-p~~~~~~~~ 303 (426)
||++.++.+||+|||++....... ........||+.|+|||++.+..++.++|||||||++|||++|.. |+.......
T Consensus 298 ILl~~~~~vkL~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~ 376 (501)
T PHA03210 298 IFLNCDGKIVLGDFGTAMPFEKER-EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKP 376 (501)
T ss_pred EEECCCCCEEEEeCCCceecCccc-ccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCH
Confidence 999999999999999998664322 112234679999999999999999999999999999999999875 444333222
Q ss_pred hHHHHHhHhhhhhh-------hhhhhhhcCCc----CCCccc-----HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 304 EQKLLQWVKPYLSD-------AKQFRQIVDPR----LEGKYS-----LRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 304 ~~~~~~~~~~~~~~-------~~~~~~~~~~~----~~~~~~-----~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
...+.......... ...+.+.++.. .....+ ...+..+.+++.+||+.||++|||+.|++++
T Consensus 377 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 377 GKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 22222221110000 00011111000 000000 0133567788999999999999999999986
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=322.68 Aligned_cols=263 Identities=21% Similarity=0.277 Sum_probs=194.5
Q ss_pred Ccceeccc--CcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCc
Q 014363 89 RSVVIGEG--GFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 162 (426)
Q Consensus 89 ~~~~lG~G--~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~ 162 (426)
++.+||+| +||+||++..+.++. .||+|.+.... ..+.+.+|+.+++.++||||+++++++..++
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~---- 72 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGE-----YVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN---- 72 (327)
T ss_pred hhhhccccccceEEEEEEeecccCc-----EEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECC----
Confidence 35679999 789999999887665 79999886542 2345678999999999999999999998876
Q ss_pred eEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccc
Q 014363 163 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 242 (426)
Q Consensus 163 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 242 (426)
..++||||+++|+|.+++.......+++..++.++.|++.||.|||++ +|+||||||+|||++.++.++++|||...
T Consensus 73 ~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~ 149 (327)
T cd08227 73 ELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNL 149 (327)
T ss_pred EEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhh
Confidence 359999999999999999755444589999999999999999999998 99999999999999999999999998754
Q ss_pred cCCCCCce-----eeeeeeecCcccCCchhhcc--CCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhh
Q 014363 243 LGPSEGFT-----HVSTAVVGTMGYAAPEYVQT--GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYL 315 (426)
Q Consensus 243 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 315 (426)
.....+.. .......++..|+|||++.+ ..++.++|||||||++|||++|..||........ .........
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~ 227 (327)
T cd08227 150 SMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKLNGTV 227 (327)
T ss_pred ccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH--HHHHhcCCc
Confidence 33211110 01122357788999999876 4589999999999999999999999975332111 100000000
Q ss_pred h---h-----hhhhh----------------------hhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 316 S---D-----AKQFR----------------------QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 316 ~---~-----~~~~~----------------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
. + ..... ..........+...+++.+.+++.+||+.||++|||++|++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 228 PCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred cccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 0 0 00000 0000000011223456789999999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=314.46 Aligned_cols=242 Identities=24% Similarity=0.428 Sum_probs=186.9
Q ss_pred eecccCcEEEEEEEEcCCC-------------------CCCcceEEEEEEccccC--CHHHHHHHHHHHhhcCCCCccce
Q 014363 92 VIGEGGFGCVYKGLIKNSE-------------------DPSQKVEVAVKQLGRRG--GHKEWMTEVNFLGIVEHQNLVKL 150 (426)
Q Consensus 92 ~lG~G~~g~Vy~~~~~~~~-------------------~~~~~~~va~K~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~ 150 (426)
.||+|+||.||+|.....+ .......|++|.+.... ....+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 5999999999999864321 12233568888885433 23467889999999999999999
Q ss_pred EeEEEccCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCC
Q 014363 151 VGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQ 230 (426)
Q Consensus 151 ~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~ 230 (426)
++++.+... .++||||+++|+|..++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++..
T Consensus 82 ~~~~~~~~~----~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~ 153 (274)
T cd05076 82 HGVCVRGSE----NIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARL 153 (274)
T ss_pred EEEEEeCCc----eEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEecc
Confidence 999987664 49999999999999998643 23588999999999999999999998 99999999999999765
Q ss_pred C-------CeeEeeecccccCCCCCceeeeeeeecCcccCCchhhcc-CCCCCchhhHHHHHHHHHHH-hCCCCCCCCCc
Q 014363 231 W-------NAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELI-TGRRPIDRNRP 301 (426)
Q Consensus 231 ~-------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~ell-tg~~p~~~~~~ 301 (426)
+ .+||+|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|..||....+
T Consensus 154 ~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~ 227 (274)
T cd05076 154 GLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP 227 (274)
T ss_pred CcccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh
Confidence 4 3899999988643221 12357888999998865 56899999999999999995 69999976543
Q ss_pred hhhHHHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014363 302 RSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMV 366 (426)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L 366 (426)
........ . ..... ......+.+++.+||+.+|++|||+.+|++.|
T Consensus 228 ~~~~~~~~-------------~--~~~~~----~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 228 SEKERFYE-------------K--KHRLP----EPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHHHHHHH-------------h--ccCCC----CCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 22211110 0 00111 11234688999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=315.32 Aligned_cols=265 Identities=29% Similarity=0.397 Sum_probs=202.8
Q ss_pred HHHHHHHhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-CHHHHHHHHHHHhhc-CCCCccceEeEE
Q 014363 77 IAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-GHKEWMTEVNFLGIV-EHQNLVKLVGYC 154 (426)
Q Consensus 77 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~E~~~l~~l-~HpnIv~~~~~~ 154 (426)
++.+....++|++.+.||+|+||.||+|.....+. .+++|.+.... ....+..|+.++..+ +||||+++++++
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~-----~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 84 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGS-----KAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMY 84 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCc-----eeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeee
Confidence 34445567899999999999999999999876543 78888875433 235678899999999 799999999988
Q ss_pred EccC-CCCceEEEEEeeCCCCChhhhccCC--CCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCC
Q 014363 155 ADDD-ERGIQRLLVYEYMPNGSVDQYLSPK--SETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW 231 (426)
Q Consensus 155 ~~~~-~~~~~~~lv~E~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~ 231 (426)
.... ..+...++||||+++++|.+++... ....+++..+..++.|++.||.|||+. +++||||||+||+++.++
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~ 161 (286)
T cd06638 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEG 161 (286)
T ss_pred eecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCC
Confidence 5432 2233579999999999999887521 234588999999999999999999998 999999999999999999
Q ss_pred CeeEeeecccccCCCCCceeeeeeeecCcccCCchhhcc-----CCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHH
Q 014363 232 NAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT-----GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQK 306 (426)
Q Consensus 232 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~ 306 (426)
.+||+|||++........ ......|++.|+|||++.. ..++.++|||||||++|+|++|..||.........
T Consensus 162 ~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~- 238 (286)
T cd06638 162 GVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL- 238 (286)
T ss_pred CEEEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHH-
Confidence 999999999876543221 1233468999999998753 45788999999999999999999999754321111
Q ss_pred HHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014363 307 LLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMV 366 (426)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L 366 (426)
... .....+.+ ..+..++..+.+++.+||+.||++|||+.||++++
T Consensus 239 -~~~-----------~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 239 -FKI-----------PRNPPPTL--HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred -hhc-----------cccCCCcc--cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 000 00000000 01112345789999999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=312.38 Aligned_cols=257 Identities=33% Similarity=0.424 Sum_probs=202.5
Q ss_pred HhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-CHHHHHHHHHHHhhc-CCCCccceEeEEEccCC-
Q 014363 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-GHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDE- 159 (426)
Q Consensus 83 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~- 159 (426)
.+++|+..+.||+|+||.||+|..+..+. .+++|.+.... ..+.+.+|+.+++.+ +||||+++++++.+...
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~-----~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 78 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQ-----LVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPP 78 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCc-----EEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCC
Confidence 46789999999999999999999876543 78888876543 346788999999999 79999999999987552
Q ss_pred -CCceEEEEEeeCCCCChhhhccCCC--CCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEe
Q 014363 160 -RGIQRLLVYEYMPNGSVDQYLSPKS--ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLS 236 (426)
Q Consensus 160 -~~~~~~lv~E~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~ 236 (426)
.+...++||||+++++|.+++.... ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.+||+
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~ 155 (275)
T cd06608 79 GNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLV 155 (275)
T ss_pred CcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEEC
Confidence 3445799999999999999886433 35689999999999999999999998 99999999999999999999999
Q ss_pred eecccccCCCCCceeeeeeeecCcccCCchhhcc-----CCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhH
Q 014363 237 DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT-----GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWV 311 (426)
Q Consensus 237 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~ 311 (426)
|||++....... .......|+..|+|||++.. ..++.++||||||+++|+|++|..||....... ...+
T Consensus 156 d~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~-- 229 (275)
T cd06608 156 DFGVSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR--ALFK-- 229 (275)
T ss_pred CCccceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH--HHHH--
Confidence 999987543321 11234568999999998754 346789999999999999999999996432211 1111
Q ss_pred hhhhhhhhhhhhhcCC-cCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 312 KPYLSDAKQFRQIVDP-RLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 312 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
+... ......+...+..+.+++.+||..||++|||+.+++++
T Consensus 230 ------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 230 ------------IPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred ------------hhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1100 00111122356789999999999999999999999874
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=317.19 Aligned_cols=266 Identities=24% Similarity=0.378 Sum_probs=198.2
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
.++|...+.||.|+||.||+|.++.++. .|++|.+.... ....+.+|+.+++.++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~-- 77 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDN-----LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEK-- 77 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCc-----EEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCC--
Confidence 3578999999999999999999876544 78889875332 3346788999999999999999999998765
Q ss_pred CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecc
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 240 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 240 (426)
..++||||++ ++|.+++.... ..+++..+..++.|++.||.|||+. +|+|+||||+|||++.++.+||+|||+
T Consensus 78 --~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~ 150 (301)
T cd07873 78 --SLTLVFEYLD-KDLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGL 150 (301)
T ss_pred --eEEEEEeccc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcc
Confidence 3599999996 58988886543 3488999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhh-----h
Q 014363 241 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKP-----Y 314 (426)
Q Consensus 241 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~-----~ 314 (426)
+....... .......+++.|+|||++.+. .++.++||||||+++|+|++|..||...........+..... .
T Consensus 151 ~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~ 228 (301)
T cd07873 151 ARAKSIPT--KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEET 228 (301)
T ss_pred hhccCCCC--CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhh
Confidence 97543221 112234578999999988654 478899999999999999999999976543322111110000 0
Q ss_pred hh---hhhhhhhhcCCcCCCc----ccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 315 LS---DAKQFRQIVDPRLEGK----YSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 315 ~~---~~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
+. ....+.....+..... ....++..+.+||.+||+.||.+|||++|++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 229 WPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred chhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00 0000000000000000 112345678999999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=309.00 Aligned_cols=251 Identities=26% Similarity=0.394 Sum_probs=202.1
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
+|+..+.||.|+||.||+|.+..++. .+++|.+.... ..+.+..|+.+++.++||||+++++++......
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~-----~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~- 74 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGK-----ILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQ- 74 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCC-----EEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCC-
Confidence 47888999999999999998776554 68888775432 234678899999999999999999988765433
Q ss_pred ceEEEEEeeCCCCChhhhccCC--CCCccCHHHHHHHHHHHHHHHHHhc-----cCCCCCeEeccCCCCceEeCCCCCee
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPK--SETILTWAMRLKIAQDAARGLAYLH-----EGMDFQIIVRDFKSSNILLDEQWNAK 234 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~~i~~aL~~LH-----~~~~~~iiHrDlkp~NILl~~~~~~k 234 (426)
..+++|||+++++|.+++... ....+++..++.++.|++.||.||| +. +++|+||||+||+++.++.+|
T Consensus 75 -~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~k 150 (265)
T cd08217 75 -TLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVK 150 (265)
T ss_pred -EEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEE
Confidence 468999999999999998643 2345899999999999999999999 66 999999999999999999999
Q ss_pred EeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhh
Q 014363 235 LSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPY 314 (426)
Q Consensus 235 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 314 (426)
|+|||++........ ......|++.|+|||++.+..++.++||||||+++|+|++|..||...... .+.+..
T Consensus 151 l~d~g~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~--- 222 (265)
T cd08217 151 LGDFGLAKILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL---QLASKI--- 222 (265)
T ss_pred EecccccccccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH---HHHHHH---
Confidence 999999987654321 123457899999999999888999999999999999999999999765421 111111
Q ss_pred hhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 315 LSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
........+...+..+.+++.+||+.+|++||++.+|+++
T Consensus 223 -----------~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 223 -----------KEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred -----------hcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 1111122334566789999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=327.62 Aligned_cols=258 Identities=24% Similarity=0.428 Sum_probs=217.8
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCce
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQ 163 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~ 163 (426)
.+.....+||-|.||.||.|.|+.-.- .||||.++.+. ..++|+.|+.+|+.++|||+|+++|+|..+...
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKkysl-----TvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF--- 338 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKKYSL-----TVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF--- 338 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeeccce-----eeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe---
Confidence 345566789999999999999987543 79999997665 567899999999999999999999999987754
Q ss_pred EEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccccc
Q 014363 164 RLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL 243 (426)
Q Consensus 164 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 243 (426)
|||.|||..|+|.+||+..++..++.-..+.++.||..|++||..+ ++|||||...|.|+.++..||++||||+++
T Consensus 339 -YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 339 -YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRL 414 (1157)
T ss_pred -EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhh
Confidence 9999999999999999988877788888899999999999999998 999999999999999999999999999998
Q ss_pred CCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhhh
Q 014363 244 GPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQFR 322 (426)
Q Consensus 244 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (426)
+..+.++.... ..-..-|.|||-+.-..++.|+|||+|||+|||+.| |-.||.+.+... ..
T Consensus 415 MtgDTYTAHAG-AKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSq-----------------VY 476 (1157)
T KOG4278|consen 415 MTGDTYTAHAG-AKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-----------------VY 476 (1157)
T ss_pred hcCCceecccC-ccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHH-----------------HH
Confidence 87654433221 123567999999999999999999999999999999 999998754322 22
Q ss_pred hhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 014363 323 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 372 (426)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~ 372 (426)
.++....+-+-+..|++.+.+||+.||+++|.+||++.|+-+.++.++..
T Consensus 477 ~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~ 526 (1157)
T KOG4278|consen 477 GLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS 526 (1157)
T ss_pred HHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence 22333333334456888999999999999999999999999999988754
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=308.27 Aligned_cols=250 Identities=26% Similarity=0.395 Sum_probs=202.2
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc----CCHHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR----GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
+|+..++||.|+||.||.+.....+. .+++|.+... .....+.+|+.++++++|+||+++++++.+..
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~-----~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--- 72 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDS-----LVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDN--- 72 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCc-----EEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCC---
Confidence 48889999999999999998776554 6788876432 23456889999999999999999999998765
Q ss_pred ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccc
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 241 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 241 (426)
..+++|||+++++|.+++.......+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++
T Consensus 73 -~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~ 148 (256)
T cd08221 73 -TLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGIS 148 (256)
T ss_pred -eEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcce
Confidence 459999999999999999765445689999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhh
Q 014363 242 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 321 (426)
Q Consensus 242 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (426)
........ ......|++.|+|||++.+..++.++||||||+++|+|++|..||..........
T Consensus 149 ~~~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~--------------- 211 (256)
T cd08221 149 KILGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVV--------------- 211 (256)
T ss_pred EEcccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHH---------------
Confidence 86543321 2234568999999999988888999999999999999999999997543221110
Q ss_pred hhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014363 322 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMV 366 (426)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L 366 (426)
.+..... ......++..+.+++.+||..+|++||++.++++++
T Consensus 212 -~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 212 -KIVQGNY-TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred -HHHcCCC-CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 1111111 111234567899999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=313.04 Aligned_cols=252 Identities=25% Similarity=0.391 Sum_probs=197.5
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC--CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCc
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 162 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~ 162 (426)
++|...+.||+|+||.||+|.+..++. .+++|.+.... ....+.+|+.+++.++||||+++++++.+.+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~-----~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~---- 79 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGE-----LAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRD---- 79 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCc-----EEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC----
Confidence 467888899999999999998776554 78888875443 2345788999999999999999999988765
Q ss_pred eEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccc
Q 014363 163 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 242 (426)
Q Consensus 163 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 242 (426)
..|+||||+++++|.+++...+ .+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++.
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~ 154 (267)
T cd06645 80 KLWICMEFCGGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSA 154 (267)
T ss_pred EEEEEEeccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeee
Confidence 4599999999999999986543 489999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCceeeeeeeecCcccCCchhhc---cCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014363 243 LGPSEGFTHVSTAVVGTMGYAAPEYVQ---TGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 319 (426)
Q Consensus 243 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 319 (426)
...... .......|+..|+|||++. ...++.++|||||||++|+|++|..||....+........ .
T Consensus 155 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~--~------- 223 (267)
T cd06645 155 QITATI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMT--K------- 223 (267)
T ss_pred EccCcc--cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhh--c-------
Confidence 553221 1123457999999999874 4568899999999999999999999986543321111100 0
Q ss_pred hhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 320 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.....+.... ...++..+.+++.+||+.+|++||++++|+++
T Consensus 224 --~~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 224 --SNFQPPKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred --cCCCCCcccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 0000011110 11244678899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=306.17 Aligned_cols=246 Identities=30% Similarity=0.498 Sum_probs=195.5
Q ss_pred ceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC---HHHHHHHHHHHhhcCCCCccceEeEEEccCCCCceEEEE
Q 014363 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG---HKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLV 167 (426)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~~~lv 167 (426)
++||+|+||.||+|.+.. +. .|++|.+..... ...+.+|+.++++++||||+++++++.+... .++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~-----~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~----~~~v 70 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NT-----EVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQP----IYIV 70 (251)
T ss_pred CccccCCCceEEEEEEeC-CC-----cEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCC----eEEE
Confidence 369999999999998765 33 789998765432 3578899999999999999999999987764 4999
Q ss_pred EeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccCCCC
Q 014363 168 YEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSE 247 (426)
Q Consensus 168 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 247 (426)
|||+++++|.+++.... ..+++..++.++.+++.||.|||++ +++||||||+|||++.++.+||+|||++......
T Consensus 71 ~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 146 (251)
T cd05041 71 MELVPGGSLLTFLRKKK-NRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGG 146 (251)
T ss_pred EEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCC
Confidence 99999999999986543 3478899999999999999999998 9999999999999999999999999999765432
Q ss_pred CceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcC
Q 014363 248 GFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVD 326 (426)
Q Consensus 248 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (426)
..........++..|+|||++.++.++.++||||||+++|+|++ |..||............ .
T Consensus 147 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~-----------------~ 209 (251)
T cd05041 147 IYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERI-----------------E 209 (251)
T ss_pred cceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHH-----------------h
Confidence 21111122334667999999988889999999999999999999 88888654432211111 0
Q ss_pred CcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014363 327 PRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVN 367 (426)
Q Consensus 327 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~ 367 (426)
.......+...+..+.+++.+||..+|++||++.|+++.|.
T Consensus 210 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 210 SGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred cCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 01111122345678999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=308.51 Aligned_cols=242 Identities=28% Similarity=0.521 Sum_probs=191.5
Q ss_pred ceecccCcEEEEEEEEcCCCC-----CCcceEEEEEEccccCC-HHHHHHHHHHHhhcCCCCccceEeEEEccCCCCceE
Q 014363 91 VVIGEGGFGCVYKGLIKNSED-----PSQKVEVAVKQLGRRGG-HKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQR 164 (426)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~~-----~~~~~~va~K~~~~~~~-~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~~ 164 (426)
+.||+|+||.||+|.+..... ......+++|.+..... ...+.+|+.+++.++||||+++++++.. .. .
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~----~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DE----N 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CC----c
Confidence 369999999999999886542 23344677887755433 5788999999999999999999999877 33 3
Q ss_pred EEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCC-------CeeEee
Q 014363 165 LLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW-------NAKLSD 237 (426)
Q Consensus 165 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~-------~~kl~D 237 (426)
++||||+++|+|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++ .+||+|
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCC
Confidence 899999999999999975442 588999999999999999999998 999999999999999887 799999
Q ss_pred ecccccCCCCCceeeeeeeecCcccCCchhhccC--CCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhh
Q 014363 238 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG--RLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPY 314 (426)
Q Consensus 238 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 314 (426)
||++..... .....++..|+|||++.+. .++.++||||||+++|+|++ |..||.............
T Consensus 152 fg~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~----- 220 (259)
T cd05037 152 PGIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ----- 220 (259)
T ss_pred CCccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-----
Confidence 999976433 2234577889999998876 78999999999999999999 577776543221111100
Q ss_pred hhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014363 315 LSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMV 366 (426)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L 366 (426)
. ..... ......+.+++.+||..+|++||++.+|++.|
T Consensus 221 --~--------~~~~~----~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 221 --D--------QHRLP----MPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred --c--------CCCCC----CCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 0 00000 01116889999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=308.82 Aligned_cols=252 Identities=26% Similarity=0.381 Sum_probs=198.4
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-------CHHHHHHHHHHHhhcCCCCccceEeEEEcc
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-------GHKEWMTEVNFLGIVEHQNLVKLVGYCADD 157 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-------~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 157 (426)
.+|...+.||+|+||.||+|.+..++. .|++|.+.... ..+.+.+|+.+++.++||||+++++++.+.
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~-----~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 76 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGR-----ELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDP 76 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCc-----EEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccC
Confidence 468889999999999999999776554 78888764221 124678899999999999999999988765
Q ss_pred CCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEee
Q 014363 158 DERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 237 (426)
Q Consensus 158 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~D 237 (426)
... .+++||||+++++|.+++.... .+++..++.++.|++.||.|||+. +++|+||||+|||++.++.++|+|
T Consensus 77 ~~~--~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~D 149 (265)
T cd06652 77 MER--TLSIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGD 149 (265)
T ss_pred CCc--eEEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECc
Confidence 432 4689999999999999986443 378888999999999999999998 999999999999999999999999
Q ss_pred ecccccCCCCCce-eeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhh
Q 014363 238 FGLARLGPSEGFT-HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS 316 (426)
Q Consensus 238 FGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 316 (426)
||++......... .......|+..|+|||++.+..++.++||||||+++|+|++|..||........
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~------------ 217 (265)
T cd06652 150 FGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA------------ 217 (265)
T ss_pred CccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH------------
Confidence 9998754321111 112234689999999999888899999999999999999999999975422111
Q ss_pred hhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 317 DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.............+......+.+++.+|+. +|++||++++|+++
T Consensus 218 ----~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 218 ----IFKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred ----HHHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 011111111223344566788899999995 99999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=313.01 Aligned_cols=243 Identities=23% Similarity=0.457 Sum_probs=189.1
Q ss_pred eecccCcEEEEEEEEcCCCC--CCcceEEEEEEccccC--CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCceEEEE
Q 014363 92 VIGEGGFGCVYKGLIKNSED--PSQKVEVAVKQLGRRG--GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLV 167 (426)
Q Consensus 92 ~lG~G~~g~Vy~~~~~~~~~--~~~~~~va~K~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~~~lv 167 (426)
.||.|+||.||+|..+..+. ......+++|.+.... ..+.+.+|+.+++.++||||+++++++...... ++|
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~----~lv 77 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDES----IMV 77 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCc----EEE
Confidence 69999999999998765432 2234467778765432 235678899999999999999999999876543 899
Q ss_pred EeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCC--------eeEeeec
Q 014363 168 YEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWN--------AKLSDFG 239 (426)
Q Consensus 168 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~--------~kl~DFG 239 (426)
|||+++|+|.+++..... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++. ++++|||
T Consensus 78 ~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKN-LINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred EecCCCCcHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccc
Confidence 999999999999975433 589999999999999999999998 9999999999999987765 6999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCchhhccC-CCCCchhhHHHHHHHHHHHhCC-CCCCCCCchhhHHHHHhHhhhhhh
Q 014363 240 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGR-RPIDRNRPRSEQKLLQWVKPYLSD 317 (426)
Q Consensus 240 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~ 317 (426)
++..... .....++..|+|||++.+. .++.++||||||+++|+|++|. .||............
T Consensus 154 ~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~--------- 218 (258)
T cd05078 154 ISITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY--------- 218 (258)
T ss_pred cccccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH---------
Confidence 8865432 1235688999999998864 5789999999999999999985 565443322111100
Q ss_pred hhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014363 318 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVN 367 (426)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~ 367 (426)
.. ...++.....++.+++.+||+.||++|||+++|++.|+
T Consensus 219 --------~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 219 --------ED--RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred --------Hc--cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 01112223467899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=326.76 Aligned_cols=240 Identities=26% Similarity=0.336 Sum_probs=186.0
Q ss_pred ecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-----CHHHHHHHHHHHhhc---CCCCccceEeEEEccCCCCceE
Q 014363 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-----GHKEWMTEVNFLGIV---EHQNLVKLVGYCADDDERGIQR 164 (426)
Q Consensus 93 lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-----~~~~~~~E~~~l~~l---~HpnIv~~~~~~~~~~~~~~~~ 164 (426)
||+|+||.||+|.+..++. .||+|.+.... ....+..|..++..+ .||||+++++++.+... .
T Consensus 1 lG~G~~g~Vy~~~~~~~~~-----~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~----~ 71 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRR-----IYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSD----L 71 (330)
T ss_pred CCCCCceEEEEEEECCCCC-----EEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCe----E
Confidence 7999999999999876654 79999885432 223345667777665 79999999999987663 5
Q ss_pred EEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccC
Q 014363 165 LLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLG 244 (426)
Q Consensus 165 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 244 (426)
|+||||+++|+|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 72 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~ 146 (330)
T cd05586 72 YLVTDYMSGGELFWHLQKE--GRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKAN 146 (330)
T ss_pred EEEEcCCCCChHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCC
Confidence 9999999999999988654 3489999999999999999999998 9999999999999999999999999998753
Q ss_pred CCCCceeeeeeeecCcccCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhh
Q 014363 245 PSEGFTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQ 323 (426)
Q Consensus 245 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (426)
.... ......+||+.|+|||++.+. .++.++|||||||++|+|++|..||...........+. ..
T Consensus 147 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~------~~------ 212 (330)
T cd05586 147 LTDN--KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIA------FG------ 212 (330)
T ss_pred CCCC--CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHH------cC------
Confidence 3221 123356799999999998764 47899999999999999999999997543221111000 00
Q ss_pred hcCCcCCCcccHHHHHHHHHHHHhccccCCCCCC----CHHHHHHH
Q 014363 324 IVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRP----KMSEVLEM 365 (426)
Q Consensus 324 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP----s~~eil~~ 365 (426)
...+. ...++..+.+++.+||+.||++|| ++.+++++
T Consensus 213 --~~~~~---~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 213 --KVRFP---KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred --CCCCC---CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 00111 112456788999999999999998 57777764
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=316.00 Aligned_cols=250 Identities=26% Similarity=0.404 Sum_probs=201.2
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC--CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
.++|+..+.||+|+||.||+|.....+. .|++|.+.... ..+.+.+|+.+++.++||||+++++++....
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--- 89 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQ-----EVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD--- 89 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCC-----EEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCC---
Confidence 4689999999999999999999766554 78898875432 3456789999999999999999999998765
Q ss_pred ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccc
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 241 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 241 (426)
..|+||||+++++|.+++... .+++..+..++.|++.||.|||+. +++||||||+|||++.++.++|+|||++
T Consensus 90 -~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~ 162 (297)
T cd06656 90 -ELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC 162 (297)
T ss_pred -EEEEeecccCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccc
Confidence 459999999999999998643 378899999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhh
Q 014363 242 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 321 (426)
Q Consensus 242 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (426)
........ ......|++.|+|||.+.+..++.++||||||+++|+|++|..||....+......
T Consensus 163 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~-------------- 226 (297)
T cd06656 163 AQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-------------- 226 (297)
T ss_pred eEccCCcc--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee--------------
Confidence 76543221 12335689999999999988899999999999999999999999965432111000
Q ss_pred hhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 322 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
...........+...+..+.+++.+||+.||++||++.+++++
T Consensus 227 -~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 227 -IATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred -eccCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000111223456678999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=313.87 Aligned_cols=266 Identities=32% Similarity=0.408 Sum_probs=205.5
Q ss_pred cCHHHHHHHhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-CHHHHHHHHHHHhhc-CCCCccceEe
Q 014363 75 FTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-GHKEWMTEVNFLGIV-EHQNLVKLVG 152 (426)
Q Consensus 75 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~E~~~l~~l-~HpnIv~~~~ 152 (426)
+++.++...+++|...+.||+|+||.||+|....++. .+++|.+.... ....+.+|+.++..+ +||||+++++
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~-----~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~ 86 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGS-----LAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYG 86 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCC-----EEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEE
Confidence 4455666678899999999999999999999876544 78888875433 345678899999999 8999999999
Q ss_pred EEEccCC-CCceEEEEEeeCCCCChhhhccCC--CCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCC
Q 014363 153 YCADDDE-RGIQRLLVYEYMPNGSVDQYLSPK--SETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE 229 (426)
Q Consensus 153 ~~~~~~~-~~~~~~lv~E~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~ 229 (426)
++...+. .+...|+||||+++++|.+++... ....+++..++.++.|++.||+|||+. +++||||||+||+++.
T Consensus 87 ~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~ 163 (291)
T cd06639 87 MFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTT 163 (291)
T ss_pred EEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcC
Confidence 9876432 223569999999999999987531 234589999999999999999999998 9999999999999999
Q ss_pred CCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccC-----CCCCchhhHHHHHHHHHHHhCCCCCCCCCchhh
Q 014363 230 QWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG-----RLAARSDVWSYGVFLYELITGRRPIDRNRPRSE 304 (426)
Q Consensus 230 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslGvil~elltg~~p~~~~~~~~~ 304 (426)
++.+||+|||++........ ......|+..|+|||++... .++.++|||||||++|+|++|+.||....+...
T Consensus 164 ~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~ 241 (291)
T cd06639 164 EGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT 241 (291)
T ss_pred CCCEEEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH
Confidence 99999999999876543221 12235688999999987643 367899999999999999999999975432111
Q ss_pred HHHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 305 QKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
+..... ...+.+ ..+......+.+++.+||+.+|++||++.|++++
T Consensus 242 --~~~~~~-----------~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 242 --LFKIPR-----------NPPPTL--LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred --HHHHhc-----------CCCCCC--CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 111000 000001 1112344679999999999999999999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=315.47 Aligned_cols=249 Identities=26% Similarity=0.420 Sum_probs=201.3
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc--CCHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCc
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR--GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 162 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~ 162 (426)
.+|+..+.||.|+||.||+|....++. .|++|.+... ...+.+.+|+.+++.++||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~-----~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---- 89 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQ-----EVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGD---- 89 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCc-----EEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCc----
Confidence 468999999999999999998766554 7888877533 24467889999999999999999999998765
Q ss_pred eEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccc
Q 014363 163 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 242 (426)
Q Consensus 163 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 242 (426)
..|+|+||+++++|.+++... .+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~ 163 (296)
T cd06655 90 ELFVVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCA 163 (296)
T ss_pred eEEEEEEecCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccch
Confidence 459999999999999988643 389999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhh
Q 014363 243 LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFR 322 (426)
Q Consensus 243 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (426)
....... ......|+..|+|||.+.+..++.++|||||||++|+|++|..||............. .
T Consensus 164 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~--~---------- 229 (296)
T cd06655 164 QITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA--T---------- 229 (296)
T ss_pred hcccccc--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--h----------
Confidence 5443221 1234568999999999988889999999999999999999999997654322211110 0
Q ss_pred hhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 323 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
........+..++..+.+++.+||..||++||++.+|+++
T Consensus 230 ---~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 230 ---NGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred ---cCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 0000011122355678999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=317.38 Aligned_cols=253 Identities=27% Similarity=0.388 Sum_probs=202.2
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-----CHHHHHHHHHHHhhcCCCCccceEeEEEccCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
++|+..+.||+|+||.||+|....++. .+++|.+.... ..+.+..|++++..++||||+++++++.+..
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~-----~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 74 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGK-----LFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTET- 74 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCc-----EEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCC-
Confidence 368888999999999999999876543 78999886543 3346789999999999999999999987755
Q ss_pred CCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeec
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 239 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 239 (426)
..|+||||+.+++|.+++.......+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||
T Consensus 75 ---~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg 148 (316)
T cd05574 75 ---YLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFD 148 (316)
T ss_pred ---EEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecc
Confidence 459999999999999999765556689999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCce---------------------------eeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhC
Q 014363 240 LARLGPSEGFT---------------------------HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITG 292 (426)
Q Consensus 240 la~~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg 292 (426)
++......... .......|+..|+|||++.+..++.++||||||+++|+|++|
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g 228 (316)
T cd05574 149 LSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG 228 (316)
T ss_pred hhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhC
Confidence 98754321100 011234689999999999988899999999999999999999
Q ss_pred CCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCC----HHHHHHH
Q 014363 293 RRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPK----MSEVLEM 365 (426)
Q Consensus 293 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs----~~eil~~ 365 (426)
..||........ +..+.............+..+.+++.+||+.||++||+ ++|++.+
T Consensus 229 ~~pf~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 229 TTPFKGSNRDET----------------FSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred CCCCCCCchHHH----------------HHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 999975433211 11111111111111125678999999999999999999 8888875
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=309.13 Aligned_cols=252 Identities=24% Similarity=0.401 Sum_probs=186.2
Q ss_pred eecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCceEEEEE
Q 014363 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVY 168 (426)
Q Consensus 92 ~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~~~lv~ 168 (426)
.||+|+||.||+|....... ...+++|.+.... ..+.+.+|+.+++.++||||+++++++.+... .|+||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~---~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~----~~lv~ 74 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTG---VARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIP----YLLVF 74 (268)
T ss_pred cCCCCcCceEEEEEEEcCCC---cceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCc----cEEEE
Confidence 59999999999997654322 2245566654332 34578999999999999999999999987653 49999
Q ss_pred eeCCCCChhhhccCCC--CCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccCCC
Q 014363 169 EYMPNGSVDQYLSPKS--ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPS 246 (426)
Q Consensus 169 E~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 246 (426)
||+++|+|.+++.... ....++..++.++.||+.||+|||+. +++||||||+|||++.++.+||+|||++.....
T Consensus 75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~ 151 (268)
T cd05086 75 EYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYK 151 (268)
T ss_pred ecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCc
Confidence 9999999999987532 23467777889999999999999998 999999999999999999999999999864322
Q ss_pred CCceeeeeeeecCcccCCchhhcc-------CCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014363 247 EGFTHVSTAVVGTMGYAAPEYVQT-------GRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDA 318 (426)
Q Consensus 247 ~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 318 (426)
...........|+..|+|||++.. ..++.++||||||+++|||++ |..||........... . +.
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~--~----~~-- 223 (268)
T cd05086 152 EDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNH--V----IK-- 223 (268)
T ss_pred chhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHH--H----Hh--
Confidence 211122234578899999998753 235779999999999999997 5678865432211110 0 00
Q ss_pred hhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014363 319 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMV 366 (426)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L 366 (426)
.......++.+.. .+...+.+++..|| .+|++||++++|++.|
T Consensus 224 ~~~~~~~~~~~~~----~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l 266 (268)
T cd05086 224 DQQVKLFKPQLEL----PYSERWYEVLQFCW-LSPEKRATAEEVHRLL 266 (268)
T ss_pred hcccccCCCccCC----CCcHHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence 0111122222222 24567888999999 6899999999999877
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=312.92 Aligned_cols=249 Identities=28% Similarity=0.408 Sum_probs=195.7
Q ss_pred CCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC--CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCceE
Q 014363 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQR 164 (426)
Q Consensus 87 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~~ 164 (426)
|++.+.||+|+||.||+|.....+. .+++|.+.... ..+.+.+|+.+++.++||||+++++++.... ..
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~-----~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~----~~ 77 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGV-----LAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN----NL 77 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCe-----EEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCC----EE
Confidence 5667789999999999998776543 67888875433 3456788999999999999999999998765 45
Q ss_pred EEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccC
Q 014363 165 LLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLG 244 (426)
Q Consensus 165 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 244 (426)
++||||+++++|..++... ...+++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||++...
T Consensus 78 ~~v~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~ 153 (282)
T cd06643 78 WILIEFCAGGAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKN 153 (282)
T ss_pred EEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccc
Confidence 9999999999999887542 23589999999999999999999998 9999999999999999999999999998754
Q ss_pred CCCCceeeeeeeecCcccCCchhhc-----cCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014363 245 PSEGFTHVSTAVVGTMGYAAPEYVQ-----TGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 319 (426)
Q Consensus 245 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 319 (426)
.... .......|++.|+|||++. +..++.++|||||||++|+|++|..||....... ......
T Consensus 154 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--~~~~~~-------- 221 (282)
T cd06643 154 TRTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR--VLLKIA-------- 221 (282)
T ss_pred cccc--cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH--HHHHHh--------
Confidence 3221 1123457899999999874 3457789999999999999999999997543211 111100
Q ss_pred hhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 320 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
....+. ...+..++..+.+++.+||+.||++||++.+++++
T Consensus 222 ---~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 222 ---KSEPPT--LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred ---hcCCCC--CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000001 11122356789999999999999999999999876
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=306.68 Aligned_cols=253 Identities=26% Similarity=0.373 Sum_probs=202.0
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC--CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCc
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 162 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~ 162 (426)
++|+..+.||.|+||.||+|....++. .+++|.+.... ..+.+.+|+.+++.++||||+++++++.+..
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~-----~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~---- 73 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGE-----LVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRD---- 73 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCC-----EEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCC----
Confidence 578899999999999999999876543 68888875432 4567899999999999999999999987765
Q ss_pred eEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccc
Q 014363 163 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 242 (426)
Q Consensus 163 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 242 (426)
..|++|||+++++|.+++.... ..+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++.
T Consensus 74 ~~~l~~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~ 149 (262)
T cd06613 74 KLWIVMEYCGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSA 149 (262)
T ss_pred EEEEEEeCCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccch
Confidence 4599999999999999886542 3489999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCceeeeeeeecCcccCCchhhccC---CCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014363 243 LGPSEGFTHVSTAVVGTMGYAAPEYVQTG---RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 319 (426)
Q Consensus 243 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 319 (426)
...... .......++..|+|||.+.+. .++.++||||||+++|+|++|..||............. .
T Consensus 150 ~~~~~~--~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~--~------- 218 (262)
T cd06613 150 QLTATI--AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLIS--K------- 218 (262)
T ss_pred hhhhhh--hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--h-------
Confidence 654321 112345788999999998776 78999999999999999999999997654322111100 0
Q ss_pred hhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 320 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
... . ..........+..+.+++.+||..+|.+|||+.+|+.+
T Consensus 219 --~~~-~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 219 --SNF-P-PPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred --ccC-C-CccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 0 00111233456789999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=312.65 Aligned_cols=246 Identities=27% Similarity=0.430 Sum_probs=197.4
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCc
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 162 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~ 162 (426)
.|+..+.||+|+||.||+|.+...+. .+++|.+.... ..+.+.+|+.+++.++||||+++++++....
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 75 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKE-----VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGT---- 75 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCe-----EEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCC----
Confidence 45666789999999999998765543 78999876433 2346789999999999999999999998765
Q ss_pred eEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccc
Q 014363 163 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 242 (426)
Q Consensus 163 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 242 (426)
..|+||||+++++|.+++.. ..+++..+..++.|++.||.|||++ +++|+||+|+||++++++.++|+|||++.
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~ 149 (277)
T cd06642 76 KLWIIMEYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAG 149 (277)
T ss_pred ceEEEEEccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccc
Confidence 35999999999999999864 3488999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhh
Q 014363 243 LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFR 322 (426)
Q Consensus 243 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (426)
...... .......|+..|+|||++.+..++.++||||||+++|||++|..||....+.....
T Consensus 150 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~---------------- 211 (277)
T cd06642 150 QLTDTQ--IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF---------------- 211 (277)
T ss_pred cccCcc--hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh----------------
Confidence 654321 11223568899999999998889999999999999999999999986433211100
Q ss_pred hhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 323 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
..............+..+.+++.+||+.+|++||++.+++++
T Consensus 212 -~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 212 -LIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred -hhhcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 000011111223456678999999999999999999999986
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=306.53 Aligned_cols=250 Identities=24% Similarity=0.496 Sum_probs=197.4
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCce
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQ 163 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~ 163 (426)
.+|+..+.||+|+||.||+|.+.... .+++|.+.... ....+.+|+++++.++||||+++++++.... .
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~------~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~ 73 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKR------KVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERS----P 73 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCC------eEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCC----c
Confidence 36777889999999999999876432 68899876443 4567899999999999999999999987765 3
Q ss_pred EEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccccc
Q 014363 164 RLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL 243 (426)
Q Consensus 164 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 243 (426)
.++||||+++++|.+++.... ..+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++..
T Consensus 74 ~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~ 149 (256)
T cd05112 74 ICLVFEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRF 149 (256)
T ss_pred eEEEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceee
Confidence 499999999999999986543 3478999999999999999999998 999999999999999999999999999875
Q ss_pred CCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhhh
Q 014363 244 GPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQFR 322 (426)
Q Consensus 244 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (426)
...... .......++..|+|||++.++.++.++||||||+++|+|++ |..||....... ...... .. .
T Consensus 150 ~~~~~~-~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~----~~---~ 218 (256)
T cd05112 150 VLDDQY-TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE---VVETIN----AG---F 218 (256)
T ss_pred cccCcc-cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH---HHHHHh----CC---C
Confidence 533211 11122335678999999998889999999999999999998 999997543221 111000 00 0
Q ss_pred hhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014363 323 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMV 366 (426)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L 366 (426)
.... +...+..+.+|+.+||+.+|++||++.++++.|
T Consensus 219 ~~~~-------~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 219 RLYK-------PRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCC-------CCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 0001 111346899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=310.71 Aligned_cols=248 Identities=30% Similarity=0.467 Sum_probs=201.1
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
++|+..+.||.|+||.||+|.+..++. .+++|.+.... ....+.+|+.+++.++||||+++++++.+..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~-----~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--- 72 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQ-----VVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGS--- 72 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCe-----EEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECC---
Confidence 368888899999999999999876554 78899876443 2346789999999999999999999988764
Q ss_pred ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccc
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 241 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 241 (426)
..|+|+||+++++|.+++... .+++..++.++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++
T Consensus 73 -~~~~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~ 145 (274)
T cd06609 73 -KLWIIMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVS 145 (274)
T ss_pred -eEEEEEEeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccc
Confidence 459999999999999998754 589999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhh
Q 014363 242 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 321 (426)
Q Consensus 242 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (426)
....... .......|++.|+|||++.+..++.++||||||+++|+|++|..||....+...... .
T Consensus 146 ~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~-------------~ 210 (274)
T cd06609 146 GQLTSTM--SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFL-------------I 210 (274)
T ss_pred eeecccc--cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHH-------------h
Confidence 8765432 122345788999999999988899999999999999999999999975442211100 0
Q ss_pred hhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 322 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.....+.+... .++..+.+++.+||..+|++||++++++++
T Consensus 211 ~~~~~~~~~~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 211 PKNNPPSLEGN---KFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred hhcCCCCCccc---ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 00011111111 155678999999999999999999999885
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=308.46 Aligned_cols=250 Identities=27% Similarity=0.457 Sum_probs=196.7
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC--------CHHHHHHHHHHHhhcCCCCccceEeEEEcc
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--------GHKEWMTEVNFLGIVEHQNLVKLVGYCADD 157 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~--------~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 157 (426)
+|...+.||+|+||.||+|..... ..+++|.+.... ....+.+|+.+++.++|+||+++++++.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~------~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 74 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQG------QLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD 74 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCC------CeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecC
Confidence 477888999999999999976432 268888775332 124578899999999999999999999876
Q ss_pred CCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEee
Q 014363 158 DERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 237 (426)
Q Consensus 158 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~D 237 (426)
. ..++||||+++++|.+++.... .+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|
T Consensus 75 ~----~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~d 145 (265)
T cd06631 75 N----TISIFMEFVPGGSISSILNRFG--PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLID 145 (265)
T ss_pred C----eEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEecc
Confidence 4 4599999999999999996543 478999999999999999999998 999999999999999999999999
Q ss_pred ecccccCCCCC----ceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhh
Q 014363 238 FGLARLGPSEG----FTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKP 313 (426)
Q Consensus 238 FGla~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~ 313 (426)
||++....... .........|+..|+|||++.+..++.++||||||+++|+|++|..||............
T Consensus 146 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~----- 220 (265)
T cd06631 146 FGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYI----- 220 (265)
T ss_pred chhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHh-----
Confidence 99987543211 111123456899999999999888999999999999999999999999754322111000
Q ss_pred hhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 314 YLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.. ........+..++..+.+++.+||+.+|++||++.+++++
T Consensus 221 --------~~--~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 221 --------GA--HRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred --------hh--ccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00 0000111222356788999999999999999999999874
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=305.62 Aligned_cols=254 Identities=30% Similarity=0.540 Sum_probs=200.8
Q ss_pred CCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCce
Q 014363 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQ 163 (426)
Q Consensus 87 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~ 163 (426)
|++.+.||.|+||.||+|.+..... .....+++|.+.... ..+.+..|+.++..++||||+++++++.+.. .
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~ 75 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSG-EKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEE----P 75 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCC-CCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC----e
Confidence 3567789999999999999876431 233579999986554 3457889999999999999999999998765 3
Q ss_pred EEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccccc
Q 014363 164 RLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL 243 (426)
Q Consensus 164 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 243 (426)
.+++|||+++++|.+++.......+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++..
T Consensus 76 ~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~ 152 (258)
T smart00219 76 LMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRD 152 (258)
T ss_pred eEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCcee
Confidence 59999999999999999754433389999999999999999999998 999999999999999999999999999986
Q ss_pred CCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhhh
Q 014363 244 GPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQFR 322 (426)
Q Consensus 244 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (426)
.......... ...+++.|+|||.+.+..++.++||||||+++++|++ |..||......... +...
T Consensus 153 ~~~~~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~---~~~~---------- 218 (258)
T smart00219 153 LYDDDYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVL---EYLK---------- 218 (258)
T ss_pred cccccccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHHh----------
Confidence 5543221111 2237789999999988889999999999999999998 78888653321111 1100
Q ss_pred hhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014363 323 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMV 366 (426)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L 366 (426)
.. .....+...+..+.+++.+||..||++|||+.++++.|
T Consensus 219 ---~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 219 ---KG-YRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ---cC-CCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 00 01111223567899999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=315.97 Aligned_cols=258 Identities=26% Similarity=0.352 Sum_probs=214.4
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCce
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQ 163 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~ 163 (426)
.+.|+.-++||+||||.||-++.+.++..++.+....|+++.+......++|-.||.+++.+.||.+--.|...+.
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~---- 259 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA---- 259 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc----
Confidence 3568889999999999999999999887666666666667777777788999999999999999999777777664
Q ss_pred EEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccccc
Q 014363 164 RLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL 243 (426)
Q Consensus 164 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 243 (426)
+||||..|.||+|.-+|...++..+++..++.++.+|+.||++||+. +||.|||||+|||+|+.|+++|+|.|||..
T Consensus 260 LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAve 336 (591)
T KOG0986|consen 260 LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVE 336 (591)
T ss_pred eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEe
Confidence 59999999999999999888877899999999999999999999998 999999999999999999999999999998
Q ss_pred CCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhh
Q 014363 244 GPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQ 323 (426)
Q Consensus 244 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (426)
+..... ....+||.+|||||++.++.|+...|.|||||+||||+.|+.||.......... .+.+
T Consensus 337 i~~g~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~e-------------Evdr 400 (591)
T KOG0986|consen 337 IPEGKP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKRE-------------EVDR 400 (591)
T ss_pred cCCCCc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHH-------------HHHH
Confidence 765432 234589999999999999999999999999999999999999997543322111 1111
Q ss_pred hcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 014363 324 IVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPK-----MSEVLEM 365 (426)
Q Consensus 324 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~eil~~ 365 (426)
.+ ......|+..+++++++|.+..|..||++|.. ++++.+|
T Consensus 401 r~-~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~H 446 (591)
T KOG0986|consen 401 RT-LEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEH 446 (591)
T ss_pred HH-hcchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhC
Confidence 11 01123466778899999999999999999974 4566554
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=308.47 Aligned_cols=247 Identities=26% Similarity=0.408 Sum_probs=201.6
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
..|+..+.||.|+||.||+|.+...+. .+++|.+.... ....+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--- 75 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQ-----VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGT--- 75 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCE-----EEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC---
Confidence 357778899999999999998776543 78888876433 2356788999999999999999999998765
Q ss_pred ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccc
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 241 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 241 (426)
..++||||+++++|.+++... .+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++
T Consensus 76 -~~~lv~e~~~~~~L~~~i~~~---~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~ 148 (277)
T cd06640 76 -KLWIIMEYLGGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVA 148 (277)
T ss_pred -EEEEEEecCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccc
Confidence 459999999999999998643 388899999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhh
Q 014363 242 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 321 (426)
Q Consensus 242 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (426)
....... .......++..|+|||++.+..++.++||||||+++|+|++|..||....+......
T Consensus 149 ~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~-------------- 212 (277)
T cd06640 149 GQLTDTQ--IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFL-------------- 212 (277)
T ss_pred eeccCCc--cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhh--------------
Confidence 7654322 112335688899999999888899999999999999999999999975443211111
Q ss_pred hhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 322 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
............++..+.+++.+||+.+|++||++.+++++
T Consensus 213 ---~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 213 ---IPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred ---hhcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 01111123344577889999999999999999999999887
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=304.35 Aligned_cols=248 Identities=26% Similarity=0.348 Sum_probs=206.3
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-----CHHHHHHHHHHHhhcCCCCccceEeEEEccC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 158 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 158 (426)
.++|..+++||+|.||+|-+++.+.++. .+|+|+++++. ....-..|-++|+..+||.+..+--.|+..+
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k-----~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~d 241 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGK-----LYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQD 241 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCc-----eeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCc
Confidence 4678899999999999999999776654 88999887653 2234568899999999999999877777766
Q ss_pred CCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeee
Q 014363 159 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 238 (426)
Q Consensus 159 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 238 (426)
.+|+||||+.||.|.-.|.. ...+++.....+...|+.||.|||++ +||.||||.+|+|+|.+|++||+||
T Consensus 242 ----rlCFVMeyanGGeLf~HLsr--er~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDF 312 (516)
T KOG0690|consen 242 ----RLCFVMEYANGGELFFHLSR--ERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDF 312 (516)
T ss_pred ----eEEEEEEEccCceEeeehhh--hhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeec
Confidence 45999999999999888864 34599999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014363 239 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 318 (426)
Q Consensus 239 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 318 (426)
|+++..... ...+.++||||.|+|||++....|+.++|.|.+||++|||++|+.||...+......++
T Consensus 313 GLCKE~I~~--g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLI---------- 380 (516)
T KOG0690|consen 313 GLCKEEIKY--GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELI---------- 380 (516)
T ss_pred ccchhcccc--cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHH----------
Confidence 999864433 34567899999999999999999999999999999999999999999755443322222
Q ss_pred hhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 014363 319 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRP-----KMSEVLEM 365 (426)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~ 365 (426)
+-.. -.++..++++.+.|+..+|..||.+|. .+.||.++
T Consensus 381 ------l~ed--~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 381 ------LMED--LKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred ------Hhhh--ccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 1111 135667788999999999999999995 46777664
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=312.10 Aligned_cols=255 Identities=26% Similarity=0.381 Sum_probs=200.7
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
++|+..+.||+|+||+||+|.+...+. .+++|.+.... ..+.+.+|+++++.++||||+++++++.+..
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~-----~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--- 76 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGT-----VMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNEN--- 76 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCc-----EEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCC---
Confidence 467888899999999999999876543 67888765332 3457889999999999999999999998875
Q ss_pred ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccc
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 241 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 241 (426)
.+++||||+++++|.+++... +.+++..+..++.+++.||.|||+. .+++||||||+||+++.++.++|+|||++
T Consensus 77 -~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~ 151 (284)
T cd06620 77 -NICMCMEFMDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVS 151 (284)
T ss_pred -EEEEEEecCCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcc
Confidence 459999999999999988653 3489999999999999999999963 28999999999999999999999999998
Q ss_pred ccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhh-----HHHHHhHhhhhh
Q 014363 242 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSE-----QKLLQWVKPYLS 316 (426)
Q Consensus 242 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~-----~~~~~~~~~~~~ 316 (426)
...... ......|+..|+|||++.+..++.++|||||||++|+|++|..||.......+ ......
T Consensus 152 ~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~------ 221 (284)
T cd06620 152 GELINS----IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDL------ 221 (284)
T ss_pred cchhhh----ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHH------
Confidence 654221 12245789999999999888899999999999999999999999975443211 111111
Q ss_pred hhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014363 317 DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMV 366 (426)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L 366 (426)
...+............++..+.+++.+||+.||++||++.|++++.
T Consensus 222 ----~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 222 ----LQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred ----HHHHhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 1111111111111123567899999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=310.88 Aligned_cols=251 Identities=25% Similarity=0.377 Sum_probs=198.1
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCc
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 162 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~ 162 (426)
+|+..+.||+|+||.||+|.+...+. .+++|.+.... ....+.+|+.++..++||||+++++++....
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~-----~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~---- 72 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGV-----TMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEG---- 72 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCc-----EEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCC----
Confidence 67888899999999999999875543 78888775432 2356889999999999999999999888765
Q ss_pred eEEEEEeeCCCCChhhhccCCC-CCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccc
Q 014363 163 QRLLVYEYMPNGSVDQYLSPKS-ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 241 (426)
Q Consensus 163 ~~~lv~E~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 241 (426)
..|+||||+++++|..++.... ...+++..+..++.|++.||.|||+. .+|+||||||+||+++.++.+||+|||++
T Consensus 73 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 150 (286)
T cd06622 73 AVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVS 150 (286)
T ss_pred eEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCc
Confidence 4599999999999999886531 23589999999999999999999963 28999999999999999999999999998
Q ss_pred ccCCCCCceeeeeeeecCcccCCchhhccCC------CCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhh
Q 014363 242 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGR------LAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYL 315 (426)
Q Consensus 242 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 315 (426)
....... .....|++.|+|||++.+.. ++.++|||||||++|+|++|..||..........
T Consensus 151 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~--------- 217 (286)
T cd06622 151 GNLVASL----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFA--------- 217 (286)
T ss_pred ccccCCc----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHH---------
Confidence 7543221 23346888999999886543 5789999999999999999999996543211111
Q ss_pred hhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 316 SDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.+..+... .....+..++..+.+++.+||+.+|++||++++++.+
T Consensus 218 ----~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 218 ----QLSAIVDG-DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred ----HHHHHhhc-CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 11111111 1112333467889999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=311.61 Aligned_cols=251 Identities=27% Similarity=0.392 Sum_probs=197.5
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC--CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCc
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 162 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~ 162 (426)
+.|++++.||.|+||.||+|.....+. .+++|.+.... ..+.+.+|+.+++.++||||+++++++....
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~-----~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 82 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGA-----LAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDG---- 82 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCc-----eEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCC----
Confidence 468899999999999999998876554 78888876543 2356788999999999999999999987765
Q ss_pred eEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccc
Q 014363 163 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 242 (426)
Q Consensus 163 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 242 (426)
..++||||+++++|..++.... ..+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.
T Consensus 83 ~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~ 158 (292)
T cd06644 83 KLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSA 158 (292)
T ss_pred eEEEEEecCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccce
Confidence 4599999999999988875433 3489999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCCCceeeeeeeecCcccCCchhhc-----cCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh
Q 014363 243 LGPSEGFTHVSTAVVGTMGYAAPEYVQ-----TGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 317 (426)
Q Consensus 243 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 317 (426)
...... .......+++.|+|||++. ...++.++|||||||++|+|++|..||....... ......
T Consensus 159 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--~~~~~~------ 228 (292)
T cd06644 159 KNVKTL--QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR--VLLKIA------ 228 (292)
T ss_pred eccccc--cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH--HHHHHh------
Confidence 533221 1123456889999999885 3446889999999999999999999997543211 111100
Q ss_pred hhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 318 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
....+. ...+..++..+.+++.+||..||++||++.+++++
T Consensus 229 -----~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 229 -----KSEPPT--LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred -----cCCCcc--CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000000 01122355678999999999999999999999875
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=307.44 Aligned_cols=253 Identities=26% Similarity=0.439 Sum_probs=200.5
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC--------CHHHHHHHHHHHhhcCCCCccceEeEEEcc
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--------GHKEWMTEVNFLGIVEHQNLVKLVGYCADD 157 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~--------~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 157 (426)
+|+..+.||+|+||.||+|....++. .+++|.+.... ..+.+.+|+.+++.++||||+++++++.+.
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~-----~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 75 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGT-----LMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCED 75 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCc-----EEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccC
Confidence 47888999999999999998765544 78888875432 235688999999999999999999999876
Q ss_pred CCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCC-CeeEe
Q 014363 158 DERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW-NAKLS 236 (426)
Q Consensus 158 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~-~~kl~ 236 (426)
+ ..++||||+++++|.+++... ..+++..++.++.|++.||.|||++ +++|+||||+||+++.++ .+||+
T Consensus 76 ~----~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~ 146 (268)
T cd06630 76 S----HFNLFVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIA 146 (268)
T ss_pred C----eEEEEEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEc
Confidence 5 359999999999999998643 3488999999999999999999998 999999999999998776 59999
Q ss_pred eecccccCCCCCc--eeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhh
Q 014363 237 DFGLARLGPSEGF--THVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPY 314 (426)
Q Consensus 237 DFGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 314 (426)
|||++........ ........|+..|+|||++.+..++.++||||||+++|+|++|..||............
T Consensus 147 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~------ 220 (268)
T cd06630 147 DFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI------ 220 (268)
T ss_pred ccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHH------
Confidence 9999876543211 11123456899999999998888999999999999999999999999644322111111
Q ss_pred hhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 315 LSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
............+...+..+.+++.+||+.+|++||++.+++++
T Consensus 221 -------~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 221 -------FKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred -------HHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 01111111223444567889999999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=308.11 Aligned_cols=253 Identities=23% Similarity=0.387 Sum_probs=196.9
Q ss_pred HhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC--CHHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 83 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
.++++.....||+|+||.||+|.+..++. .+++|.+.... ..+.+.+|+.+++.++|+||+++++++...+
T Consensus 6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~-----~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-- 78 (268)
T cd06624 6 EYDENGERVVLGKGTYGIVYAARDLSTQV-----RIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENG-- 78 (268)
T ss_pred ccccCCceEEEecCCceEEEEeEecCCCc-----EEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCC--
Confidence 45566666789999999999998766543 78999876543 3457889999999999999999999988765
Q ss_pred CceEEEEEeeCCCCChhhhccCCCCCcc--CHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCC-CCCeeEee
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSETIL--TWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE-QWNAKLSD 237 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~--~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~-~~~~kl~D 237 (426)
..++||||+++++|.+++.... ..+ ++..+..++.|++.||+|||+. +|+||||||+||+++. ++.++|+|
T Consensus 79 --~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~d 152 (268)
T cd06624 79 --FFKIFMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISD 152 (268)
T ss_pred --EEEEEEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEec
Confidence 4599999999999999987532 224 7888899999999999999998 9999999999999976 67899999
Q ss_pred ecccccCCCCCceeeeeeeecCcccCCchhhccCC--CCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhh
Q 014363 238 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGR--LAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYL 315 (426)
Q Consensus 238 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 315 (426)
||++....... .......|++.|+|||++.+.. ++.++||||||+++|+|++|..||............
T Consensus 153 fg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~------- 223 (268)
T cd06624 153 FGTSKRLAGIN--PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFK------- 223 (268)
T ss_pred chhheecccCC--CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhh-------
Confidence 99987543221 1122346899999999987644 788999999999999999999999653321111000
Q ss_pred hhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 316 SDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.........++..+...+.+++.+||+.+|++|||+.|++.+
T Consensus 224 --------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 224 --------VGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred --------hhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 000011112333456789999999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=306.89 Aligned_cols=256 Identities=28% Similarity=0.433 Sum_probs=203.2
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
++|+..+.||.|+||.||+|....++. .+++|.+.... ....+.+|+.+++.++|+||+++++.+....
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~-----~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--- 72 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNE-----KVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGD--- 72 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCc-----EEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCC---
Confidence 478899999999999999999776543 68889875432 3467889999999999999999999887755
Q ss_pred ceEEEEEeeCCCCChhhhccCCCC-CccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecc
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSE-TILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 240 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~-~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 240 (426)
..++||||+++++|.+++..... ..+++..+..++.|++.||.|||+. +++||||||+||++++++.++|+|||+
T Consensus 73 -~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~ 148 (267)
T cd06610 73 -ELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGV 148 (267)
T ss_pred -EEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccch
Confidence 45999999999999999975432 4589999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCce--eeeeeeecCcccCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh
Q 014363 241 ARLGPSEGFT--HVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 317 (426)
Q Consensus 241 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 317 (426)
+......... .......|+..|+|||++... .++.++||||||+++|+|++|..||........ .......
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~--~~~~~~~---- 222 (267)
T cd06610 149 SASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV--LMLTLQN---- 222 (267)
T ss_pred HHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh--HHHHhcC----
Confidence 9765543222 123445789999999998877 788999999999999999999999975433211 1111000
Q ss_pred hhhhhhhcCCcCCCcc-cHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 318 AKQFRQIVDPRLEGKY-SLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 318 ~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
..+.+.... ...++..+.+++.+||+.||++||++.+|+++
T Consensus 223 -------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 223 -------DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred -------CCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 001111111 12456788999999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=311.74 Aligned_cols=244 Identities=25% Similarity=0.387 Sum_probs=199.9
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-----CCHHHHHHHHHHHhhcCCCCccceEeEEEccCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-----GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
++|+..+.||+|+||.||+|.+...+. .+++|.+... ...+.+.+|+++++.++||||+++++++.+..
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~-----~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 74 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGK-----YYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDS- 74 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCC-----EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCC-
Confidence 368889999999999999999876543 7899987543 23456889999999999999999999998765
Q ss_pred CCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeec
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 239 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 239 (426)
..|+||||+++++|.+++... ..+++..+..++.|++.||.|||+. +++|+||+|+|||++.++.+||+|||
T Consensus 75 ---~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg 146 (290)
T cd05580 75 ---NLYLVMEYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFG 146 (290)
T ss_pred ---eEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCC
Confidence 359999999999999998654 3489999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014363 240 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 319 (426)
Q Consensus 240 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 319 (426)
++...... .....|++.|+|||.+.+..++.++||||||+++|+|++|..||..........
T Consensus 147 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------------- 208 (290)
T cd05580 147 FAKRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYE------------- 208 (290)
T ss_pred CccccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHH-------------
Confidence 99865433 234578999999999988888999999999999999999999997544211110
Q ss_pred hhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 014363 320 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRP-----KMSEVLEM 365 (426)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~ 365 (426)
.+.... ..++...+..+.+++.+||+.||.+|+ +++|++++
T Consensus 209 ---~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 209 ---KILEGK--VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred ---HHhcCC--ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 111111 112233467889999999999999999 78888765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=307.00 Aligned_cols=261 Identities=23% Similarity=0.420 Sum_probs=199.7
Q ss_pred CCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCC-
Q 014363 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG- 161 (426)
Q Consensus 87 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~- 161 (426)
|.+.++||+|+||.||+|.++... .....+++|.+.... ..+.+.+|+.+++.++||||+++++++......+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSED--GSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGR 78 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccC--CCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCc
Confidence 566778999999999999876432 234579999886532 3446789999999999999999999887643221
Q ss_pred -ceEEEEEeeCCCCChhhhccCC----CCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEe
Q 014363 162 -IQRLLVYEYMPNGSVDQYLSPK----SETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLS 236 (426)
Q Consensus 162 -~~~~lv~E~~~~g~L~~~l~~~----~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~ 236 (426)
...++++||+++|+|.+++... ....+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+
T Consensus 79 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~ 155 (273)
T cd05074 79 LPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVA 155 (273)
T ss_pred ccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEEC
Confidence 1347899999999998886421 122478899999999999999999998 99999999999999999999999
Q ss_pred eecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhh
Q 014363 237 DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYL 315 (426)
Q Consensus 237 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 315 (426)
|||+++...............+++.|++||.+.+..++.++||||||+++|+|++ |..||....... +..+..
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~---~~~~~~--- 229 (273)
T cd05074 156 DFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE---IYNYLI--- 229 (273)
T ss_pred cccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH---HHHHHH---
Confidence 9999986543221112223446678999999998889999999999999999999 888886543321 111110
Q ss_pred hhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHh
Q 014363 316 SDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 369 (426)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~ 369 (426)
... .+ ..+...+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 230 -~~~--------~~--~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 230 -KGN--------RL--KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred -cCC--------cC--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 000 00 01123456899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=307.17 Aligned_cols=254 Identities=26% Similarity=0.442 Sum_probs=197.3
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC------------CHHHHHHHHHHHhhcCCCCccceEeE
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG------------GHKEWMTEVNFLGIVEHQNLVKLVGY 153 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~------------~~~~~~~E~~~l~~l~HpnIv~~~~~ 153 (426)
+|...+.||.|+||.||+|.....+. .+++|.+.... ..+.+..|+.+++.++||||++++++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~-----~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 76 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGE-----MMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGF 76 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCc-----eeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEE
Confidence 46778899999999999998766544 68888764211 12357789999999999999999999
Q ss_pred EEccCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCe
Q 014363 154 CADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNA 233 (426)
Q Consensus 154 ~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~ 233 (426)
+..... .++||||+++++|.+++... ..+++..+..++.|++.||.|||+. +++||||+|+||+++.++.+
T Consensus 77 ~~~~~~----~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~ 147 (272)
T cd06629 77 ETTEEY----LSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGIC 147 (272)
T ss_pred eccCCc----eEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeE
Confidence 877653 49999999999999999754 3589999999999999999999998 99999999999999999999
Q ss_pred eEeeecccccCCCCCceeeeeeeecCcccCCchhhccCC--CCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhH
Q 014363 234 KLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGR--LAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWV 311 (426)
Q Consensus 234 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~ 311 (426)
+|+|||++................|+..|+|||++.... ++.++||||||+++|+|++|..||...... ......
T Consensus 148 ~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~~- 224 (272)
T cd06629 148 KISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI--AAMFKL- 224 (272)
T ss_pred EEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH--HHHHHh-
Confidence 999999997644321111223456889999999987655 789999999999999999999999643221 111100
Q ss_pred hhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 312 KPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
................++..+.+++.+||..+|++||++.+|+++
T Consensus 225 ---------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 225 ---------GNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred ---------hccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 000011111122223456789999999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=305.14 Aligned_cols=247 Identities=26% Similarity=0.426 Sum_probs=197.8
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-------CHHHHHHHHHHHhhcCCCCccceEeEEEccC
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-------GHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 158 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-------~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 158 (426)
+|+..+.||+|+||.||+|.....+. .+++|.+.... ..+.+.+|+.+++.++||||+++++++.+..
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~-----~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~ 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGD-----FFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREED 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCc-----EEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCC
Confidence 46778899999999999999875443 68888765432 3356889999999999999999999987765
Q ss_pred CCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeee
Q 014363 159 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 238 (426)
Q Consensus 159 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 238 (426)
..++||||+++++|.+++.... .+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.+||+||
T Consensus 76 ----~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~ 146 (258)
T cd06632 76 ----NLYIFLELVPGGSLAKLLKKYG--SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADF 146 (258)
T ss_pred ----eEEEEEEecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccC
Confidence 3599999999999999996543 488999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCchhhccCC-CCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh
Q 014363 239 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGR-LAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 317 (426)
Q Consensus 239 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 317 (426)
|++....... ......|+..|++||.+.... ++.++|+||||+++|+|++|..||....... ......
T Consensus 147 ~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~------ 215 (258)
T cd06632 147 GMAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA--AVFKIG------ 215 (258)
T ss_pred ccceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH--HHHHHH------
Confidence 9987654322 123456899999999987766 8999999999999999999999997543211 111000
Q ss_pred hhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 318 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
........+..+...+.+++.+||+.+|++||++.+++.+
T Consensus 216 --------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 216 --------RSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred --------hcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 0000111223355788999999999999999999999874
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=324.70 Aligned_cols=246 Identities=26% Similarity=0.415 Sum_probs=208.8
Q ss_pred HhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccC
Q 014363 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 158 (426)
Q Consensus 83 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 158 (426)
..+.|.+.+.||+|.|+.|.+|++..++. .||+|.+.+.. ....+.+|+++|..|+|||||+++.+.....
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~-----~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~ 128 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGT-----EVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEA 128 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCc-----eEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecc
Confidence 46789999999999999999999887754 89999886553 2234789999999999999999999998777
Q ss_pred CCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeee
Q 014363 159 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 238 (426)
Q Consensus 159 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 238 (426)
. +|+||||+.+|.+.+|+..++. ..+..+..++.|++.|++|||++ .|+|||||.+||||+.+.++||+||
T Consensus 129 ~----lylV~eya~~ge~~~yl~~~gr--~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDf 199 (596)
T KOG0586|consen 129 T----LYLVMEYASGGELFDYLVKHGR--MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADF 199 (596)
T ss_pred e----eEEEEEeccCchhHHHHHhccc--chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeecc
Confidence 5 4999999999999999987665 56688899999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCchhhccCCC-CCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh
Q 014363 239 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRL-AARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 317 (426)
Q Consensus 239 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 317 (426)
|++..+.. .....++||++.|.|||++.+..| ++.+|+||+|++||.|++|..||++..-.
T Consensus 200 gfS~~~~~---~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk--------------- 261 (596)
T KOG0586|consen 200 GFSTFFDY---GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK--------------- 261 (596)
T ss_pred ccceeecc---cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc---------------
Confidence 99998764 334567899999999999999887 56999999999999999999999864322
Q ss_pred hhhhhhhcCCcCCCcc--cHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 318 AKQFRQIVDPRLEGKY--SLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 318 ~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
......+.+.+ +...+.++.++|+++|.++|.+|++++++..+
T Consensus 262 -----~Lr~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 262 -----ELRPRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred -----cccchheeeeecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 11122222222 22356788999999999999999999999875
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=306.14 Aligned_cols=249 Identities=24% Similarity=0.370 Sum_probs=200.9
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc----CCHHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR----GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
+|+..+.||+|+||.||++.....+. .+++|.+... ...+.+.+|+.+++.++||||+++++++.+..
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~-----~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--- 72 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGK-----QYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENG--- 72 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCC-----EEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCC---
Confidence 47888999999999999999876544 7888887532 23457889999999999999999999987765
Q ss_pred ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccc
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 241 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 241 (426)
..++||||+++++|.+++.......+++..++.++.|++.||.|||+. +++|+||+|+|||++.++.++|+|||++
T Consensus 73 -~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~ 148 (256)
T cd08218 73 -NLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIA 148 (256)
T ss_pred -eEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccce
Confidence 459999999999999998755444588999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhh
Q 014363 242 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 321 (426)
Q Consensus 242 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (426)
........ ......|++.|+|||++.+..++.++||||||+++++|++|..||.........
T Consensus 149 ~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~---------------- 210 (256)
T cd08218 149 RVLNSTVE--LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLV---------------- 210 (256)
T ss_pred eecCcchh--hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHH----------------
Confidence 76543221 122346889999999998888999999999999999999999999754321110
Q ss_pred hhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 322 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
..++... ....+...+..+.+++.+||+.+|++||++.+|+++
T Consensus 211 ~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 211 LKIIRGS-YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred HHHhcCC-CCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 0111111 111223456789999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=311.06 Aligned_cols=266 Identities=27% Similarity=0.361 Sum_probs=200.6
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc----CCHHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR----GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
++|+..+.||+|+||.||+|.+..++. .|++|.+... ...+.+.+|+++++.++|+||+++++++.+.+
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~-----~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 73 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGE-----IVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKG-- 73 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCc-----EEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECC--
Confidence 368889999999999999999876554 7899987542 23457889999999999999999999998755
Q ss_pred CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecc
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 240 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 240 (426)
..++||||++++.+..++... ..+++..++.++.||+.||.|||+. +++|+||+|+||++++++.+||+|||+
T Consensus 74 --~~~iv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~ 146 (288)
T cd07833 74 --RLYLVFEYVERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGF 146 (288)
T ss_pred --EEEEEEecCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeec
Confidence 459999999987777666433 3489999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHh-hhhhh-
Q 014363 241 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK-PYLSD- 317 (426)
Q Consensus 241 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~-~~~~~- 317 (426)
+........ .......++..|+|||++.+. .++.++||||||+++|+|++|..||................ .....
T Consensus 147 ~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (288)
T cd07833 147 ARALRARPA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSH 225 (288)
T ss_pred ccccCCCcc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 986554321 122345788999999999887 78999999999999999999999997544322111111100 00000
Q ss_pred ------hhhhhh--hcCCc----CCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 318 ------AKQFRQ--IVDPR----LEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 318 ------~~~~~~--~~~~~----~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
...... ..... +...++..++..+.+++.+||..+|++||++++++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 226 QELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred hhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 000000 00000 0001222346789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=305.41 Aligned_cols=248 Identities=26% Similarity=0.421 Sum_probs=199.4
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
+|+..+.||+|+||.||+|....++. .+++|.+.... ....+.+|+.+++.++||||+++++++....
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~-----~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--- 72 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQK-----LVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDK--- 72 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCc-----EEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCC---
Confidence 57888999999999999999876543 78888875432 3456889999999999999999999887654
Q ss_pred ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCC-CeeEeeecc
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW-NAKLSDFGL 240 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~-~~kl~DFGl 240 (426)
..++||||+++++|.+++.......+++..++.++.|++.||+|||++ +++|+||||+||+++.++ .+||+|||+
T Consensus 73 -~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~ 148 (256)
T cd08220 73 -ALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGI 148 (256)
T ss_pred -EEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCC
Confidence 459999999999999999765555689999999999999999999998 999999999999998654 579999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhh
Q 014363 241 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 320 (426)
Q Consensus 241 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (426)
+....... ......|+..|+|||.+.+..++.++||||||+++|+|++|..||....... ....
T Consensus 149 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~---~~~~---------- 212 (256)
T cd08220 149 SKILSSKS---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA---LVLK---------- 212 (256)
T ss_pred ceecCCCc---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH---HHHH----------
Confidence 98654322 1223568999999999988888999999999999999999999997543221 1110
Q ss_pred hhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 321 FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.... .....+..++..+.+++.+||+.+|++|||+.|++++
T Consensus 213 ---~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 213 ---IMSG-TFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred ---HHhc-CCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 0000 0111222356689999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=309.93 Aligned_cols=265 Identities=26% Similarity=0.354 Sum_probs=199.3
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
++|+....||+|+||.||+|.++.++. .+++|.+.... ..+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~-----~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-- 73 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQ-----IVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKR-- 73 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCc-----EEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCC--
Confidence 468889999999999999999876554 78888775332 2356789999999999999999999998765
Q ss_pred CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecc
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 240 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 240 (426)
..++||||++++.|..++... ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+
T Consensus 74 --~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~ 146 (286)
T cd07847 74 --KLHLVFEYCDHTVLNELEKNP--RGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGF 146 (286)
T ss_pred --EEEEEEeccCccHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECcccc
Confidence 459999999999888877543 2489999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHH-hHhhhhhhh
Q 014363 241 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQ-WVKPYLSDA 318 (426)
Q Consensus 241 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~-~~~~~~~~~ 318 (426)
+........ ......++..|+|||++.+ ..++.++||||||+++|+|++|..||.+........... .........
T Consensus 147 ~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 224 (286)
T cd07847 147 ARILTGPGD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRH 224 (286)
T ss_pred ceecCCCcc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHH
Confidence 986543321 1223467889999998876 457889999999999999999999997654432221111 100000000
Q ss_pred hh-------hhhhcCCcCCCc-----ccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 319 KQ-------FRQIVDPRLEGK-----YSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 319 ~~-------~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.. ......+..... .....+..+.+++.+||+.+|++||++.|++.+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 225 QQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred hhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 00 000000100000 011345788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=318.88 Aligned_cols=257 Identities=25% Similarity=0.474 Sum_probs=215.0
Q ss_pred CCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCce
Q 014363 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQ 163 (426)
Q Consensus 87 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~ 163 (426)
....++||.|.||.||+|.+.+.. ...+..||||..+.+. +.+.|++|+.+|++++|||||+++|+|.+..
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~-kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P----- 464 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPE-KGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQP----- 464 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccc-cCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccc-----
Confidence 345568999999999999987753 4556679999887643 4678999999999999999999999998865
Q ss_pred EEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccccc
Q 014363 164 RLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL 243 (426)
Q Consensus 164 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 243 (426)
.+||||.++.|.|..|+..+.. .++......++.||..||.|||+. .+|||||...|||+....-|||+|||+++.
T Consensus 465 ~WivmEL~~~GELr~yLq~nk~-sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~ 540 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQNKD-SLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRY 540 (974)
T ss_pred eeEEEecccchhHHHHHHhccc-cchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhh
Confidence 3899999999999999986654 488888899999999999999998 999999999999999998999999999998
Q ss_pred CCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhhh
Q 014363 244 GPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQFR 322 (426)
Q Consensus 244 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (426)
..+..+...+ ...-..-|||||.+.-..++.++|||.|||.+||++. |..||.+-... +.+
T Consensus 541 ~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs----------------DVI- 602 (974)
T KOG4257|consen 541 LEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS----------------DVI- 602 (974)
T ss_pred ccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccccc----------------ceE-
Confidence 8876654433 2334568999999988899999999999999999998 99999764321 111
Q ss_pred hhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHh
Q 014363 323 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVD 371 (426)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~ 371 (426)
..++..-+...+..+++.+..|+.+||+.+|.+||.+.||...|.++..
T Consensus 603 ~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 603 GHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred EEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 1122233345667889999999999999999999999999999888765
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=311.41 Aligned_cols=262 Identities=24% Similarity=0.352 Sum_probs=194.2
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
+|+..+.||+|+||.||+|.+..++. .+++|.+.... ....+.+|+.+++.++||||+++++++.+..
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~-----~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~--- 72 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHE-----IVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDK--- 72 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCc-----EEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCC---
Confidence 47888999999999999999876654 68888775332 2346788999999999999999999998765
Q ss_pred ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccc
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 241 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 241 (426)
..++|+||++ ++|.+++.... ..+++..++.++.||++||.|||+. +++||||||+||+++.++.+||+|||++
T Consensus 73 -~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~ 146 (284)
T cd07839 73 -KLTLVFEYCD-QDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLA 146 (284)
T ss_pred -ceEEEEecCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchh
Confidence 3599999996 57877775432 3489999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCchhhccCC-CCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhh--hh
Q 014363 242 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGR-LAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS--DA 318 (426)
Q Consensus 242 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~ 318 (426)
....... .......+++.|+|||++.+.. ++.++|||||||++|+|++|..|+......... + ........ ..
T Consensus 147 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~-~-~~~~~~~~~~~~ 222 (284)
T cd07839 147 RAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ-L-KRIFRLLGTPTE 222 (284)
T ss_pred hccCCCC--CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHH-H-HHHHHHhCCCCh
Confidence 7543321 1122346789999999887654 789999999999999999999986543322111 1 10000000 00
Q ss_pred h---hhhhhcCC----cCC-----CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 319 K---QFRQIVDP----RLE-----GKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 319 ~---~~~~~~~~----~~~-----~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
. ......+. ... ......++..+.+++.+||+.||.+|||+.+++.+
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 223 ESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred HHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 0 00000000 000 01112356788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=292.86 Aligned_cols=246 Identities=28% Similarity=0.467 Sum_probs=193.4
Q ss_pred CCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHH---HHHHHHHHHhhc-CCCCccceEeEEEccCCCCc
Q 014363 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHK---EWMTEVNFLGIV-EHQNLVKLVGYCADDDERGI 162 (426)
Q Consensus 87 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~---~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~~~~ 162 (426)
...+..||.|+.|.|+++.++.++. .+|||.+.+.++.+ +++..+.++.+- ++|+||+.+|||..+...
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~-----iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV-- 166 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGH-----IIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDV-- 166 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccce-----EEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchH--
Confidence 3445679999999999999988664 89999998776554 455666666555 589999999999988765
Q ss_pred eEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccc
Q 014363 163 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 242 (426)
Q Consensus 163 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 242 (426)
++.||.| ..-++.++.. -.+++++..+-++...+++||.||.++ .+|+|||+||+|||+|+.|++||||||++-
T Consensus 167 --~IcMelM-s~C~ekLlkr-ik~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFGIsG 240 (391)
T KOG0983|consen 167 --FICMELM-STCAEKLLKR-IKGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFGISG 240 (391)
T ss_pred --HHHHHHH-HHHHHHHHHH-hcCCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeecccccc
Confidence 7889998 4455555543 335589999999999999999999986 599999999999999999999999999997
Q ss_pred cCCCCCceeeeeeeecCcccCCchhhcc---CCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014363 243 LGPSEGFTHVSTAVVGTMGYAAPEYVQT---GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 319 (426)
Q Consensus 243 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 319 (426)
.+-+.. ..+...|.+.|||||.+.. ..|+.++||||||++|+||.||..||.+...+- +.
T Consensus 241 rlvdSk---AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF--e~------------ 303 (391)
T KOG0983|consen 241 RLVDSK---AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF--EV------------ 303 (391)
T ss_pred eeeccc---ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH--HH------------
Confidence 654422 2334579999999998864 468999999999999999999999998643221 11
Q ss_pred hhhhhcC---CcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 320 QFRQIVD---PRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 320 ~~~~~~~---~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
+-.+++ +.+... ..+++.+.+++..||..|+.+||...++++|
T Consensus 304 -ltkvln~ePP~L~~~--~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 304 -LTKVLNEEPPLLPGH--MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred -HHHHHhcCCCCCCcc--cCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 111111 222222 2378899999999999999999999999986
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=327.91 Aligned_cols=244 Identities=25% Similarity=0.392 Sum_probs=193.4
Q ss_pred cceecccCcEEEEEEEEcCCCCCCcceEEEEEEc------cccCCHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCce
Q 014363 90 SVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL------GRRGGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQ 163 (426)
Q Consensus 90 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~------~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~ 163 (426)
..+||+|+|-+||+|.+...+. .||.-.+ +.....+.|..|+.+|+.|+|||||++|.++.+.... .
T Consensus 45 ~evLGrGafKtVYka~De~~gi-----EVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~--~ 117 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGI-----EVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNK--T 117 (632)
T ss_pred hhhcccccceeeeeccccccch-----hhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCc--e
Confidence 3479999999999999766654 4554332 2233457899999999999999999999999987764 4
Q ss_pred EEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCC-CCCeeEeeecccc
Q 014363 164 RLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE-QWNAKLSDFGLAR 242 (426)
Q Consensus 164 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~-~~~~kl~DFGla~ 242 (426)
+.+|+|.+..|+|..|+.+.+. ++...+..|++||++||.|||++ +++|||||||-+||+|+. .|.|||+|+|||.
T Consensus 118 in~iTEL~TSGtLr~Y~kk~~~--vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAt 194 (632)
T KOG0584|consen 118 INFITELFTSGTLREYRKKHRR--VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLAT 194 (632)
T ss_pred eeeeeecccCCcHHHHHHHhcc--CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHH
Confidence 5899999999999999987655 78889999999999999999998 779999999999999975 5889999999998
Q ss_pred cCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhh
Q 014363 243 LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFR 322 (426)
Q Consensus 243 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (426)
...... ....+|||.|||||+.. ..|++.+||||||++++||+|+..||..=.. ..++.
T Consensus 195 l~r~s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n----------------~AQIY 253 (632)
T KOG0584|consen 195 LLRKSH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN----------------PAQIY 253 (632)
T ss_pred Hhhccc----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC----------------HHHHH
Confidence 765322 23478999999999876 8899999999999999999999999963111 11111
Q ss_pred hhcCCcC-CCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 323 QIVDPRL-EGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 323 ~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
..+...+ +..+..--.+++++||.+||.. .++|||+.|+|++
T Consensus 254 KKV~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 254 KKVTSGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred HHHHcCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 1111111 1111111125899999999999 9999999999985
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=307.55 Aligned_cols=253 Identities=31% Similarity=0.446 Sum_probs=200.9
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
++|+..+.||.|+||.||+|.++..+. .+++|.+.... ....+.+|+++++.++||||+++++++....
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~-----~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--- 72 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGK-----IMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNG--- 72 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCc-----EEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCC---
Confidence 357778899999999999999876554 78999876543 3356889999999999999999999998764
Q ss_pred ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhcc-CCCCCeEeccCCCCceEeCCCCCeeEeeecc
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHE-GMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 240 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~-~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 240 (426)
..++++||+++++|.+++.... ..+++..+..++.|++.||+|||+ . +++|+||||+||+++.++.++|+|||.
T Consensus 73 -~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~ 147 (265)
T cd06605 73 -DISICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGV 147 (265)
T ss_pred -EEEEEEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeeccc
Confidence 4599999999999999997543 458899999999999999999999 7 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhh
Q 014363 241 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 320 (426)
Q Consensus 241 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (426)
+....... .....|+..|+|||.+.+..++.++||||||+++|+|++|..||......... ....
T Consensus 148 ~~~~~~~~----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-~~~~---------- 212 (265)
T cd06605 148 SGQLVNSL----AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG-IFEL---------- 212 (265)
T ss_pred chhhHHHH----hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccccc-HHHH----------
Confidence 87543221 11267899999999999889999999999999999999999999654211110 1111
Q ss_pred hhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 321 FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
................++..+.++|.+||..||++|||+.+++.+
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 213 LQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred HHHHhcCCCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 111111111111111266789999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=310.13 Aligned_cols=251 Identities=26% Similarity=0.387 Sum_probs=198.8
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC--CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCc
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 162 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~ 162 (426)
++|++.+.||.|+||.||+|.+..++. .+++|.+.... ..+.+..|+.+++.++||||+++++++....
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~-----~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 75 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGL-----FAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYEN---- 75 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCc-----EEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCC----
Confidence 468888899999999999999875443 78888875433 3456889999999999999999999998765
Q ss_pred eEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccc
Q 014363 163 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 242 (426)
Q Consensus 163 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 242 (426)
..|+||||+++++|.+++.... ..+++..++.++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||++.
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~ 151 (280)
T cd06611 76 KLWILIEFCDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSA 151 (280)
T ss_pred eEEEEeeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccch
Confidence 3599999999999999986533 3589999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCceeeeeeeecCcccCCchhhc-----cCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh
Q 014363 243 LGPSEGFTHVSTAVVGTMGYAAPEYVQ-----TGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 317 (426)
Q Consensus 243 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 317 (426)
...... .......|++.|+|||++. ...++.++||||||+++|+|++|..||......... ...
T Consensus 152 ~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~--~~~------- 220 (280)
T cd06611 152 KNKSTL--QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVL--LKI------- 220 (280)
T ss_pred hhcccc--cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHH--HHH-------
Confidence 543321 1223457899999999875 344678999999999999999999999764332111 110
Q ss_pred hhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 318 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.....+.+ ..+..++..+.+++.+||+.+|.+||++.+++++
T Consensus 221 ----~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 221 ----LKSEPPTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred ----hcCCCCCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 00000001 1122355688999999999999999999999886
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=306.93 Aligned_cols=257 Identities=28% Similarity=0.399 Sum_probs=201.0
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
++|...+.||.|++|.||+|.+...+ ..+++|.+.... ....+.+|+++++.++||||+++++++.+....
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~-----~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~- 74 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTG-----MIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSS- 74 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCC-----eEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCC-
Confidence 36788899999999999999987654 378999876443 245688999999999999999999998765533
Q ss_pred ceEEEEEeeCCCCChhhhccC--CCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeec
Q 014363 162 IQRLLVYEYMPNGSVDQYLSP--KSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 239 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~--~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 239 (426)
.+|+||||+++++|.+++.. .....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||
T Consensus 75 -~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg 150 (287)
T cd06621 75 -SIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFG 150 (287)
T ss_pred -eEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecc
Confidence 46999999999999988643 1234488899999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCc--hhhHHHHHhHhhhhhh
Q 014363 240 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRP--RSEQKLLQWVKPYLSD 317 (426)
Q Consensus 240 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~--~~~~~~~~~~~~~~~~ 317 (426)
++....... .....++..|+|||.+.+..++.++||||||+++|+|++|..||..... ........+...
T Consensus 151 ~~~~~~~~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---- 222 (287)
T cd06621 151 VSGELVNSL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN---- 222 (287)
T ss_pred ccccccccc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc----
Confidence 987543221 1234678899999999988999999999999999999999999976532 111122221111
Q ss_pred hhhhhhhcCCcCCCcc--cHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 318 AKQFRQIVDPRLEGKY--SLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 318 ~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
...+.+.... ....++.+.+++.+||..||++|||+.|++++
T Consensus 223 ------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 223 ------MPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred ------CCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 0000111111 12356789999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=328.79 Aligned_cols=250 Identities=27% Similarity=0.433 Sum_probs=197.9
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc--CCHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCce
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR--GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQ 163 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~ 163 (426)
-|.++..||.|+||.||+|..+.+.- ..|.|++... ...++++-||+||...+||+||++++.|..++.
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~-----lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enk---- 103 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKL-----LAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENK---- 103 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchh-----hhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCc----
Confidence 46667789999999999999876543 3345555333 345688999999999999999999998776664
Q ss_pred EEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccccc
Q 014363 164 RLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL 243 (426)
Q Consensus 164 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 243 (426)
++|+.|||.||-++..+-.-+ ..+++.++..+++|++.||.|||++ +|||||||..|||++-+|.++|+|||++-.
T Consensus 104 LwiliEFC~GGAVDaimlEL~-r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAK 179 (1187)
T KOG0579|consen 104 LWILIEFCGGGAVDAIMLELG-RVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAK 179 (1187)
T ss_pred eEEEEeecCCchHhHHHHHhc-cccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeeccccccc
Confidence 599999999999988876544 4599999999999999999999998 999999999999999999999999999864
Q ss_pred CCCCCceeeeeeeecCcccCCchhhcc-----CCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014363 244 GPSEGFTHVSTAVVGTMGYAAPEYVQT-----GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 318 (426)
Q Consensus 244 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 318 (426)
.... ......+.|||.|||||+... .+|+.++||||||++|.||..+.+|.....+- ..++...+. +
T Consensus 180 n~~t--~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM--RVllKiaKS---e- 251 (1187)
T KOG0579|consen 180 NKST--RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM--RVLLKIAKS---E- 251 (1187)
T ss_pred chhH--HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH--HHHHHHhhc---C-
Confidence 3321 223457899999999998753 57999999999999999999999998654331 111111110 0
Q ss_pred hhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 319 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.+.+ -.+...+..+.+++.+||..||..||++.++++|
T Consensus 252 -------PPTL--lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 252 -------PPTL--LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred -------CCcc--cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 0111 1234566789999999999999999999999875
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=310.86 Aligned_cols=265 Identities=26% Similarity=0.374 Sum_probs=198.4
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
++|+..+.||+|+||.||+|.++..+. .+++|.+.... ..+.+.+|+++++.++||||+++++++.+..
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~-----~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 73 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQ-----IVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKK-- 73 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCC-----EEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCC--
Confidence 468889999999999999999876543 78999875432 2356789999999999999999999997655
Q ss_pred CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecc
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 240 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 240 (426)
..|+||||+++++|..+.... ..+++..++.++.|++.||.|||+. +++|+||+|+||++++++.++|+|||+
T Consensus 74 --~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~ 146 (286)
T cd07846 74 --RLYLVFEFVDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGF 146 (286)
T ss_pred --eEEEEEecCCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeee
Confidence 459999999999998877543 2389999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHH-hHhhhhhhh
Q 014363 241 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQ-WVKPYLSDA 318 (426)
Q Consensus 241 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~-~~~~~~~~~ 318 (426)
+....... .......++..|+|||++.+ ..++.++||||||+++|+|++|..||............. .........
T Consensus 147 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (286)
T cd07846 147 ARTLAAPG--EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRH 224 (286)
T ss_pred eeeccCCc--cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhh
Confidence 87654322 11233568899999998875 447889999999999999999999997544322111111 000000000
Q ss_pred -------hhhhhhcCCcCCC-----cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 319 -------KQFRQIVDPRLEG-----KYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 319 -------~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
........+.... .....++..+.+++.+||+.+|++||++.+++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 225 QEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred HHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 0000000000000 0011346789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=308.16 Aligned_cols=266 Identities=24% Similarity=0.335 Sum_probs=194.4
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
.++|+..+.||+|+||.||+|..+..+. .|++|.+.... ....+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~-----~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 76 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQ-----LVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKK-- 76 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCc-----EEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCC--
Confidence 3578999999999999999999775543 78999875432 2345678999999999999999999998765
Q ss_pred CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecc
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 240 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 240 (426)
..++||||+++ +|.+++.... ..+++..++.++.|+++||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 77 --~~~lv~e~~~~-~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~ 149 (291)
T cd07844 77 --TLTLVFEYLDT-DLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGL 149 (291)
T ss_pred --eEEEEEecCCC-CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECcccc
Confidence 45999999974 9998886543 3588999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhH-HHHHh-Hhh----
Q 014363 241 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQ-KLLQW-VKP---- 313 (426)
Q Consensus 241 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~-~~~~~-~~~---- 313 (426)
++....... ......++..|+|||++.+ ..++.++||||||+++|+|++|..||........+ ..... ...
T Consensus 150 ~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (291)
T cd07844 150 ARAKSVPSK--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEE 227 (291)
T ss_pred ccccCCCCc--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChh
Confidence 875432111 1122356889999998865 45889999999999999999999999754421111 11000 000
Q ss_pred hhhhhhhhhhhcC--------CcCCCcc-cHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 314 YLSDAKQFRQIVD--------PRLEGKY-SLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 314 ~~~~~~~~~~~~~--------~~~~~~~-~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.+........... ..+.... .......+.+++.+||+.+|++|||+.|++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 228 TWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred hhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 0000000000000 0000000 00112677899999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=308.20 Aligned_cols=264 Identities=23% Similarity=0.351 Sum_probs=196.9
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
+|+..+.||.|+||.||+|.+..++. .+++|.+.... ....+.+|+++++.++||||+++++++.+...
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~-----~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-- 73 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGE-----VVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK-- 73 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCC-----EEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCc--
Confidence 47888999999999999999876554 78888875432 23468899999999999999999999876553
Q ss_pred ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccc
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 241 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 241 (426)
.++||||++ ++|..++.......+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++
T Consensus 74 --~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~ 147 (284)
T cd07860 74 --LYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA 147 (284)
T ss_pred --EEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccch
Confidence 599999995 6898888765555689999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCceeeeeeeecCcccCCchhhccCC-CCCchhhHHHHHHHHHHHhCCCCCCCCCchhhH-HHHHhHhh------
Q 014363 242 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGR-LAARSDVWSYGVFLYELITGRRPIDRNRPRSEQ-KLLQWVKP------ 313 (426)
Q Consensus 242 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~elltg~~p~~~~~~~~~~-~~~~~~~~------ 313 (426)
....... .......+++.|+|||++.+.. ++.++||||||+++|+|+||+.||......... ........
T Consensus 148 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (284)
T cd07860 148 RAFGVPV--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 225 (284)
T ss_pred hhcccCc--cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhh
Confidence 7543321 1122345788999999887644 588999999999999999999999764432111 11111000
Q ss_pred -hhhhhh----hhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 314 -YLSDAK----QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 314 -~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
...... .+.......+ ......++..+.+++.+||+.||++||++++++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 226 PGVTSLPDYKPSFPKWARQDF-SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred hhhhHHHHHHhhcccccccCH-HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 000000 0000000000 00111245678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=304.21 Aligned_cols=252 Identities=27% Similarity=0.445 Sum_probs=196.5
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc------------CCHHHHHHHHHHHhh-cCCCCccceEe
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR------------GGHKEWMTEVNFLGI-VEHQNLVKLVG 152 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~------------~~~~~~~~E~~~l~~-l~HpnIv~~~~ 152 (426)
+|+..+.||+|+||.||+|.+.... ...+++|.+... .....+.+|+.++.. ++||||+++++
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~----~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~ 76 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNG----QNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYK 76 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCC----CceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEe
Confidence 4778889999999999999987622 136888876421 122356788888875 79999999999
Q ss_pred EEEccCCCCceEEEEEeeCCCCChhhhccC--CCCCccCHHHHHHHHHHHHHHHHHhcc-CCCCCeEeccCCCCceEeCC
Q 014363 153 YCADDDERGIQRLLVYEYMPNGSVDQYLSP--KSETILTWAMRLKIAQDAARGLAYLHE-GMDFQIIVRDFKSSNILLDE 229 (426)
Q Consensus 153 ~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~--~~~~~~~~~~~~~i~~~i~~aL~~LH~-~~~~~iiHrDlkp~NILl~~ 229 (426)
++.+.+ ..++||||+++++|.+++.. .....+++..++.++.|++.||.|||+ . +++|+||+|+|||++.
T Consensus 77 ~~~~~~----~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~ 149 (269)
T cd08528 77 TFLEND----RLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGE 149 (269)
T ss_pred eEccCC----eEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECC
Confidence 998765 45999999999999988743 123458899999999999999999996 4 8999999999999999
Q ss_pred CCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHH
Q 014363 230 QWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQ 309 (426)
Q Consensus 230 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~ 309 (426)
++.+||+|||++....... ......|+..|++||.+.+..++.++||||||+++|+|++|..||...........
T Consensus 150 ~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~-- 224 (269)
T cd08528 150 DDKVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATK-- 224 (269)
T ss_pred CCcEEEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHH--
Confidence 9999999999998654432 23345789999999999988899999999999999999999999965432211110
Q ss_pred hHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014363 310 WVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVN 367 (426)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~ 367 (426)
+.+..........++..+.+++.+||+.||++||++.|+.+++.
T Consensus 225 --------------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 225 --------------IVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred --------------HhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 00111111111134568899999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=303.42 Aligned_cols=249 Identities=26% Similarity=0.415 Sum_probs=199.5
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc----CCHHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR----GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
+|...+.||+|+||.||+|..+..+. .+++|.+... ...+.+.+|+.+++.++||||+++++.+.+..
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~-----~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~--- 72 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSE-----HCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENG--- 72 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCc-----eEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCC---
Confidence 47788999999999999999877654 6788887543 24457789999999999999999999987765
Q ss_pred ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCC-eeEeeecc
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWN-AKLSDFGL 240 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~-~kl~DFGl 240 (426)
..++|+||+++++|.+++.......+++..++.++.|++.||.|||+. +++|+||||+||++++++. +||+|||.
T Consensus 73 -~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~ 148 (257)
T cd08225 73 -RLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGI 148 (257)
T ss_pred -eEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEeccccc
Confidence 459999999999999999765545589999999999999999999998 9999999999999998864 69999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhh
Q 014363 241 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 320 (426)
Q Consensus 241 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (426)
+....... .......|++.|+|||++.+..++.++||||||+++|+|++|..||........ .
T Consensus 149 ~~~~~~~~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~------------- 211 (257)
T cd08225 149 ARQLNDSM--ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQL--V------------- 211 (257)
T ss_pred chhccCCc--ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH--H-------------
Confidence 87654322 112234689999999999888899999999999999999999999975432111 0
Q ss_pred hhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 321 FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
........ .......+..+.+++.+||..+|++|||+.+++++
T Consensus 212 -~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 212 -LKICQGYF-APISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred -HHHhcccC-CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 01111111 11122345679999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=310.66 Aligned_cols=247 Identities=28% Similarity=0.420 Sum_probs=196.0
Q ss_pred CCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC--CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCceE
Q 014363 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQR 164 (426)
Q Consensus 87 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~~ 164 (426)
|.....||+|+||.||++.....+. .+++|.+.... ..+.+.+|+.+++.++||||+++++.+...+ ..
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~----~~ 94 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGK-----QVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGD----EL 94 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCC-----EEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCC----eE
Confidence 4444579999999999998766543 78898875432 3456889999999999999999999988765 35
Q ss_pred EEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccC
Q 014363 165 LLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLG 244 (426)
Q Consensus 165 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 244 (426)
|+||||+++++|.+++... .+++..++.++.|++.||.|||++ +|+||||||+||+++.++.++|+|||++...
T Consensus 95 ~lv~e~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (292)
T cd06658 95 WVVMEFLEGGALTDIVTHT---RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQV 168 (292)
T ss_pred EEEEeCCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhc
Confidence 9999999999999988532 388999999999999999999998 9999999999999999999999999998754
Q ss_pred CCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhh
Q 014363 245 PSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQI 324 (426)
Q Consensus 245 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (426)
.... .......|+..|+|||++.+..++.++||||||+++|||++|..||........... +...
T Consensus 169 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~-------------~~~~ 233 (292)
T cd06658 169 SKEV--PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR-------------IRDN 233 (292)
T ss_pred cccc--ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------------HHhc
Confidence 3221 112345789999999999888899999999999999999999999975433211110 1111
Q ss_pred cCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 325 VDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 325 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
....+.. ....+..+.+++.+||..||++|||+++++++
T Consensus 234 ~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 234 LPPRVKD--SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred CCCcccc--ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1111111 11345678899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=323.03 Aligned_cols=253 Identities=25% Similarity=0.407 Sum_probs=209.0
Q ss_pred CCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCce
Q 014363 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQ 163 (426)
Q Consensus 87 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~ 163 (426)
....++||+|.||.|++|.|+..+ ...+.||||.+.... ...+|++|+.+|.+|+|||++++||+..+..
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~ps--gk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~qp----- 184 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPS--GKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQP----- 184 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCC--CcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccch-----
Confidence 344567999999999999998743 466789999997654 4568999999999999999999999998743
Q ss_pred EEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccccc
Q 014363 164 RLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL 243 (426)
Q Consensus 164 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 243 (426)
..||||.+++|+|.+.|++.....|.......++.|||.|+.||..+ ++|||||...|||+.....|||+||||.+.
T Consensus 185 ~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRa 261 (1039)
T KOG0199|consen 185 AMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRA 261 (1039)
T ss_pred hhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceec
Confidence 37999999999999999875556788888899999999999999998 999999999999999988999999999997
Q ss_pred CCCCCce-eeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhh
Q 014363 244 GPSEGFT-HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 321 (426)
Q Consensus 244 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (426)
+...... .+.....-...|+|||.+....++.++|||+|||+||||++ |..||-+-.... +
T Consensus 262 Lg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q-----------------I 324 (1039)
T KOG0199|consen 262 LGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ-----------------I 324 (1039)
T ss_pred cCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH-----------------H
Confidence 6543322 22233345678999999999999999999999999999999 889997654322 2
Q ss_pred hhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014363 322 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMV 366 (426)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L 366 (426)
.+.+|..-.-.-+..+++++.+++..||..+|++|||+..|.+.+
T Consensus 325 L~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 325 LKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred HHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 222332223334556899999999999999999999999997543
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=305.51 Aligned_cols=265 Identities=17% Similarity=0.200 Sum_probs=188.1
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCH-------------HHHHHHHHHHhhcCCCCccce
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGH-------------KEWMTEVNFLGIVEHQNLVKL 150 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~-------------~~~~~E~~~l~~l~HpnIv~~ 150 (426)
.++|.+.++||+|+||.||+|.+..+.. ....+++|........ .....++..+..+.|+||+++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~--~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHC--INNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcc--cccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 3579999999999999999999776521 1224455543222110 112233445667799999999
Q ss_pred EeEEEccCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCC
Q 014363 151 VGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQ 230 (426)
Q Consensus 151 ~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~ 230 (426)
++.+..........++++|++ ..++.+.+... ...++..++.|+.|++.||+|||+. +|+||||||+|||++.+
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~ 162 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKL-VENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGN 162 (294)
T ss_pred EEeeeEecCCceEEEEEEehh-ccCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCC
Confidence 987765543333457888887 34666666432 2257788899999999999999998 99999999999999999
Q ss_pred CCeeEeeecccccCCCCCce-----eeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhH
Q 014363 231 WNAKLSDFGLARLGPSEGFT-----HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQ 305 (426)
Q Consensus 231 ~~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~ 305 (426)
+.++|+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|..||.........
T Consensus 163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~ 242 (294)
T PHA02882 163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL 242 (294)
T ss_pred CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH
Confidence 99999999999865322111 1122356999999999999999999999999999999999999999765322111
Q ss_pred HHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014363 306 KLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMV 366 (426)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L 366 (426)
.... . .+-...+....+. ....+..+.+++..|+..+|++||++++|++.|
T Consensus 243 ~~~~--~-----~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 243 IHAA--K-----CDFIKRLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHh--H-----HHHHHHhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 1000 0 0000111111110 112357899999999999999999999999876
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=309.82 Aligned_cols=247 Identities=26% Similarity=0.394 Sum_probs=196.0
Q ss_pred CCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc--CCHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCceE
Q 014363 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR--GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQR 164 (426)
Q Consensus 87 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~~ 164 (426)
|.....||+|+||.||+|.....+. .+++|.+... ...+.+.+|+.++..++||||+++++++...+ ..
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~-----~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~----~~ 93 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGR-----QVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGE----EL 93 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCC-----EEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCC----eE
Confidence 4445579999999999998765543 7888887432 24456889999999999999999999988765 45
Q ss_pred EEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccC
Q 014363 165 LLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLG 244 (426)
Q Consensus 165 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 244 (426)
|+||||+++++|..++.. ..+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++...
T Consensus 94 ~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~ 167 (297)
T cd06659 94 WVLMEFLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQI 167 (297)
T ss_pred EEEEecCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhc
Confidence 999999999999998754 2388999999999999999999998 9999999999999999999999999998754
Q ss_pred CCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhh
Q 014363 245 PSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQI 324 (426)
Q Consensus 245 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (426)
.... .......|+..|+|||++.+..++.++||||||+++|+|++|..||............ . ..
T Consensus 168 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~---~----------~~ 232 (297)
T cd06659 168 SKDV--PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL---R----------DS 232 (297)
T ss_pred cccc--ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---h----------cc
Confidence 4322 1123467899999999999888999999999999999999999999754332111110 0 00
Q ss_pred cCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 325 VDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 325 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
... ........+..+.+++.+||+.+|++||++.+++++
T Consensus 233 ~~~--~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 233 PPP--KLKNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CCC--CccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000 001112245678899999999999999999999996
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=324.55 Aligned_cols=274 Identities=28% Similarity=0.393 Sum_probs=205.3
Q ss_pred CCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc---CCHHHHHHHHHHHhhcCCCCccceEeEEEccC--CCC
Q 014363 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR---GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDD--ERG 161 (426)
Q Consensus 87 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~--~~~ 161 (426)
+...+.||+||||.||+|+++.+++ .||||.+... ...+.+.+|+++|++|+|||||+++++-.+.. -..
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~-----~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~ 89 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGR-----LVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVT 89 (732)
T ss_pred eeehhhhcCCccceeeeeccccccc-----chhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccc
Confidence 3445579999999999999888876 8999998764 45678899999999999999999988754433 012
Q ss_pred ceEEEEEeeCCCCChhhhccCC-CCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeC--CCCC--eeEe
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPK-SETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLD--EQWN--AKLS 236 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~-~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~--~~~~--~kl~ 236 (426)
....+|||||.||+|..++..- +...+++.+.+.++.+++.||.|||++ +|+||||||.||++- ++|+ .||+
T Consensus 90 ~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLt 166 (732)
T KOG4250|consen 90 RLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLT 166 (732)
T ss_pred ccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeee
Confidence 3458999999999999999753 234599999999999999999999998 999999999999983 3343 7999
Q ss_pred eecccccCCCCCceeeeeeeecCcccCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhh
Q 014363 237 DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYL 315 (426)
Q Consensus 237 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 315 (426)
|||.|+..++.. ...+++||..|++||++.. +.|+..+|.|||||++|+++||..||.......-..-+.|.. ..
T Consensus 167 DfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~-~t 242 (732)
T KOG4250|consen 167 DFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHI-IT 242 (732)
T ss_pred cccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhh-hc
Confidence 999999877654 4567899999999999984 889999999999999999999999997544332111111110 00
Q ss_pred hhhhhhhhhcCCcC------------CCcccHHHHHHHHHHHHhccccCCCCCC--CHHHHHHHHHHhHhh
Q 014363 316 SDAKQFRQIVDPRL------------EGKYSLRLVSKLSHVANLCLVKNARTRP--KMSEVLEMVNKIVDA 372 (426)
Q Consensus 316 ~~~~~~~~~~~~~~------------~~~~~~~~~~~l~~li~~cl~~dp~~RP--s~~eil~~L~~~~~~ 372 (426)
..+........+.. ...........+-.++..+|..+|++|- ...+....+..++..
T Consensus 243 kkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~ 313 (732)
T KOG4250|consen 243 KKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL 313 (732)
T ss_pred cCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence 00110000001111 1122334556677888889999999998 777777777766543
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=303.62 Aligned_cols=246 Identities=28% Similarity=0.429 Sum_probs=198.2
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCc
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 162 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~ 162 (426)
-|+..+.||.|+||.||+|.....+. .+|+|.+.... ....+.+|+.++..++||||+++++++.+..
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~-----~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---- 75 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQK-----VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT---- 75 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCc-----EEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCC----
Confidence 46778899999999999998765543 78999875432 2346788999999999999999999998765
Q ss_pred eEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccc
Q 014363 163 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 242 (426)
Q Consensus 163 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 242 (426)
..|+||||+++++|.+++... .+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.
T Consensus 76 ~~~lv~e~~~~~~l~~~i~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~ 149 (277)
T cd06641 76 KLWIIMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAG 149 (277)
T ss_pred eEEEEEEeCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccce
Confidence 359999999999999998643 388999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhh
Q 014363 243 LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFR 322 (426)
Q Consensus 243 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (426)
....... ......|+..|+|||.+.+..++.++|||||||++|+|++|..||...........+
T Consensus 150 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~-------------- 213 (277)
T cd06641 150 QLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLI-------------- 213 (277)
T ss_pred ecccchh--hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHH--------------
Confidence 6543211 123356889999999998888899999999999999999999999754322111100
Q ss_pred hhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 323 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
...........++..+.+++.+||+.+|++||++.+++++
T Consensus 214 ---~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 214 ---PKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred ---hcCCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0000111223355678999999999999999999999996
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=300.54 Aligned_cols=251 Identities=29% Similarity=0.430 Sum_probs=204.7
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
++|+..+.||+|++|.||+|.+...+. .+++|.+.... ....+..|+.++..++||||+++++++....
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~-----~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--- 72 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGK-----IYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEG--- 72 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCc-----EEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCC---
Confidence 368888999999999999999887544 78999886654 3567899999999999999999999998765
Q ss_pred ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhcc-CCCCCeEeccCCCCceEeCCCCCeeEeeecc
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHE-GMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 240 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~-~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 240 (426)
..++||||+++++|.+++... ..+++..++.++.|++.||+|||+ . +++|+||+|+||+++.++.++|+|||+
T Consensus 73 -~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~ 146 (264)
T cd06623 73 -EISIVLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGI 146 (264)
T ss_pred -eEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCcc
Confidence 459999999999999999754 448999999999999999999999 8 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhh
Q 014363 241 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 320 (426)
Q Consensus 241 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (426)
+......... .....++..|+|||.+.+..++.++||||||+++|+|++|..||..........+...
T Consensus 147 ~~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~---------- 214 (264)
T cd06623 147 SKVLENTLDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQA---------- 214 (264)
T ss_pred ceecccCCCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHH----------
Confidence 9865432211 2245689999999999988899999999999999999999999976542111111111
Q ss_pred hhhhcCCcCCCcccHH-HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 321 FRQIVDPRLEGKYSLR-LVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 321 ~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
+.... ....+.. ++..+.+++.+||..+|++||++.+++++
T Consensus 215 ---~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 215 ---ICDGP-PPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred ---HhcCC-CCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11111 1112223 56789999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=303.44 Aligned_cols=265 Identities=25% Similarity=0.343 Sum_probs=198.5
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
+|++.+.||.|+||.||+|.+..++. .+++|.+.... ....+.+|+.+++.++||||+++++++.+..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~-----~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--- 72 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGE-----TVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGS--- 72 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCc-----eEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCC---
Confidence 47888999999999999999876554 78888875432 3457889999999999999999999998755
Q ss_pred ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccc
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 241 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 241 (426)
..++||||+ +++|.+++.... ..+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++
T Consensus 73 -~~~~v~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~ 146 (286)
T cd07832 73 -GFVLVMEYM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLA 146 (286)
T ss_pred -eeEEEeccc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeec
Confidence 459999999 999999986443 4589999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHH-HhH-------h
Q 014363 242 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLL-QWV-------K 312 (426)
Q Consensus 242 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~-~~~-------~ 312 (426)
........ .......|+..|+|||++.+. .++.++||||||+++|+|++|.+||............ ... .
T Consensus 147 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (286)
T cd07832 147 RLFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETW 225 (286)
T ss_pred ccccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHH
Confidence 86544321 112235689999999988654 4688999999999999999998888654332211111 000 0
Q ss_pred hhhhhhhhhhhhcCCcCC----CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 313 PYLSDAKQFRQIVDPRLE----GKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
+..........+..+... .......+..+.+++.+||+.||++||++++++.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 226 PGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000000000000000 00011245789999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=306.81 Aligned_cols=264 Identities=24% Similarity=0.293 Sum_probs=197.3
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC-------HHHHHHHHHHHhhcCCCCccceEeEEEccC
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG-------HKEWMTEVNFLGIVEHQNLVKLVGYCADDD 158 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~-------~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 158 (426)
+|...+.||+|+||.||+|....++. .|++|.+..... ...+..|+.+++.++|+||+++++++.+..
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~-----~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~ 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGR-----IVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKS 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCc-----EEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCC
Confidence 47788899999999999999876544 789988754432 245678999999999999999999998854
Q ss_pred CCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeee
Q 014363 159 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 238 (426)
Q Consensus 159 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 238 (426)
..++||||+ +++|.+++.... ..+++..++.++.||++||.|||++ +++|+||||+|||++.++.++|+||
T Consensus 76 ----~~~lv~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~df 146 (298)
T cd07841 76 ----NINLVFEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADF 146 (298)
T ss_pred ----EEEEEEccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccc
Confidence 459999999 999999997543 3589999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHH-HhHhhh--
Q 014363 239 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLL-QWVKPY-- 314 (426)
Q Consensus 239 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~-~~~~~~-- 314 (426)
|++........ ......+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||............ ......
T Consensus 147 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (298)
T cd07841 147 GLARSFGSPNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTE 224 (298)
T ss_pred eeeeeccCCCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCch
Confidence 99986543321 1223356888999998865 45788999999999999999998887654432211111 000000
Q ss_pred --hhhhhhhhhhcCCcCCCc-----ccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 315 --LSDAKQFRQIVDPRLEGK-----YSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 315 --~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
+................. .....+..+.+++.+||+.||++|||+.|++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 225 ENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred hhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000000000000000000 112346788999999999999999999999995
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=309.30 Aligned_cols=254 Identities=24% Similarity=0.369 Sum_probs=196.7
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-----CHHHHHHHHHHHhhcCCCCccceEeEEEccCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
++|...+.||+|+||.||++.+...+. .|++|.+.... ....+.+|+.+++.++||||+++++.+....
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~-----~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~- 74 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQ-----RFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKR- 74 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCc-----EEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCC-
Confidence 368889999999999999999876644 78898875432 2346779999999999999999999987765
Q ss_pred CCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeec
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 239 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 239 (426)
..++||||++|++|.+++... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||
T Consensus 75 ---~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg 146 (305)
T cd05609 75 ---HLCMVMEYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFG 146 (305)
T ss_pred ---EEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCC
Confidence 459999999999999999654 3489999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCc-------------eeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHH
Q 014363 240 LARLGPSEGF-------------THVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQK 306 (426)
Q Consensus 240 la~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~ 306 (426)
+++....... ........|+..|+|||.+.+..++.++||||||+++|+|++|..||.+.....
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~--- 223 (305)
T cd05609 147 LSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE--- 223 (305)
T ss_pred CccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---
Confidence 9864211100 001123467889999999988889999999999999999999999997543221
Q ss_pred HHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014363 307 LLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVN 367 (426)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~ 367 (426)
+..... ......+. ....++..+.+++.+||+.||++||+..++++.|+
T Consensus 224 ~~~~~~--------~~~~~~~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 224 LFGQVI--------SDDIEWPE----GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ 272 (305)
T ss_pred HHHHHH--------hcccCCCC----ccccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence 111000 00000011 11135567899999999999999999655555544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=314.21 Aligned_cols=267 Identities=24% Similarity=0.312 Sum_probs=199.6
Q ss_pred HhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc----CCHHHHHHHHHHHhhcCCCCccceEeEEEccC
Q 014363 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR----GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 158 (426)
Q Consensus 83 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 158 (426)
..++|+..+.||+|+||.||+|....++. .+++|.+... .....+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 88 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQ-----NVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQK 88 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCC-----EEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCC
Confidence 35789999999999999999999876554 7899987542 23346778999999999999999999987543
Q ss_pred CC--CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEe
Q 014363 159 ER--GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLS 236 (426)
Q Consensus 159 ~~--~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~ 236 (426)
.. ....|+||||+. ++|.+.+... +++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+
T Consensus 89 ~~~~~~~~~lv~e~~~-~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~ 160 (353)
T cd07850 89 SLEEFQDVYLVMELMD-ANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKIL 160 (353)
T ss_pred CccccCcEEEEEeccC-CCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEc
Confidence 21 124599999995 5888877532 78899999999999999999998 99999999999999999999999
Q ss_pred eecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHH-HHHhH----
Q 014363 237 DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQK-LLQWV---- 311 (426)
Q Consensus 237 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~-~~~~~---- 311 (426)
|||++....... ......|+..|+|||++.+..++.++|||||||++|+|++|+.||.......... .....
T Consensus 161 Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 237 (353)
T cd07850 161 DFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPS 237 (353)
T ss_pred cCccceeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 999998654321 1233568899999999999999999999999999999999999997543221110 00000
Q ss_pred -----------hhhhhhh-----hhhhhhcCCcC----CCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 312 -----------KPYLSDA-----KQFRQIVDPRL----EGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 312 -----------~~~~~~~-----~~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
....... ..+.+.....+ ........+..+.+++.+||+.||++|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 238 DEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000 00000000000 000112346678999999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=306.38 Aligned_cols=266 Identities=23% Similarity=0.316 Sum_probs=194.6
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
+++|...+.||+|+||.||+|.....+. .+++|.+.... ....+.+|+.+++.++|+||+++++++.+..
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~-----~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-- 76 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQ-----LVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKE-- 76 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCc-----EEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCC--
Confidence 5689999999999999999999876554 78999875432 2236788999999999999999999998755
Q ss_pred CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecc
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 240 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 240 (426)
..|+||||+. ++|.+++.... ..+++..+..++.|++.||.|||+. +|+|+||||+|||++.++.+||+|||+
T Consensus 77 --~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~ 149 (291)
T cd07870 77 --TLTFVFEYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGL 149 (291)
T ss_pred --eEEEEEeccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEecccc
Confidence 4599999995 67776665332 3478888899999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014363 241 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 319 (426)
Q Consensus 241 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 319 (426)
+........ ......+++.|+|||++.+. .++.++||||||+++|+|++|..||.........-...+.........
T Consensus 150 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 227 (291)
T cd07870 150 ARAKSIPSQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTED 227 (291)
T ss_pred ccccCCCCC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChh
Confidence 875432211 12234578999999988754 578899999999999999999999976543222111111000000000
Q ss_pred ------hhh----hhcCCcCCCccc-----HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 320 ------QFR----QIVDPRLEGKYS-----LRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 320 ------~~~----~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
... ............ ......+.+++.+||+.||++|||+.|++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 228 TWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred hhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 000 000000000000 0124578899999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=309.91 Aligned_cols=271 Identities=23% Similarity=0.314 Sum_probs=196.7
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccc-----cCCHHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGR-----RGGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~-----~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
+|.+.+.||+|+||.||+|..... .....+|+|.+.. ......+.+|+.++..++||||+++++++.+....
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~---~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNG---KDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADK 77 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCC---CCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCc
Confidence 477888999999999999998762 1233899998876 33446778999999999999999999999876322
Q ss_pred CceEEEEEeeCCCCChhhhccCC---CCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCC----CCCe
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPK---SETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE----QWNA 233 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~---~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~----~~~~ 233 (426)
..++||||+++ +|.+++... ....+++..++.++.|++.||.|||+. +|+||||||+|||++. ++.+
T Consensus 78 --~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~ 151 (316)
T cd07842 78 --SVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVV 151 (316)
T ss_pred --eEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceE
Confidence 56999999965 676665422 123588999999999999999999998 9999999999999999 8999
Q ss_pred eEeeecccccCCCCCc-eeeeeeeecCcccCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCchh-------h
Q 014363 234 KLSDFGLARLGPSEGF-THVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRS-------E 304 (426)
Q Consensus 234 kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~-------~ 304 (426)
||+|||++........ ........++..|+|||++.+. .++.++||||||+++|+|++|..||....... .
T Consensus 152 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 231 (316)
T cd07842 152 KIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQR 231 (316)
T ss_pred EECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHH
Confidence 9999999986543322 1122345788999999988764 57899999999999999999999997654332 0
Q ss_pred HHHHHhHhhh----------hhhhhhhhhhcCCcCCCccc---------H--HHHHHHHHHHHhccccCCCCCCCHHHHH
Q 014363 305 QKLLQWVKPY----------LSDAKQFRQIVDPRLEGKYS---------L--RLVSKLSHVANLCLVKNARTRPKMSEVL 363 (426)
Q Consensus 305 ~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~---------~--~~~~~l~~li~~cl~~dp~~RPs~~eil 363 (426)
..+...+... ...........+......++ . ..+..+.+++.+||+.||++|||+.|++
T Consensus 232 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil 311 (316)
T cd07842 232 DQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEAL 311 (316)
T ss_pred HHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHh
Confidence 0111000000 00000000000000000011 1 2345788999999999999999999998
Q ss_pred HH
Q 014363 364 EM 365 (426)
Q Consensus 364 ~~ 365 (426)
++
T Consensus 312 ~~ 313 (316)
T cd07842 312 EH 313 (316)
T ss_pred cC
Confidence 75
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=349.82 Aligned_cols=266 Identities=25% Similarity=0.454 Sum_probs=207.9
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCce
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQ 163 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~ 163 (426)
...|...++||+|+||.||+|.....+. .||+|.+..... ....|++++++++|||||+++|+|.+....
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~-----~vavK~~~~~~~--~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~--- 758 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGM-----QFVVKEINDVNS--IPSSEIADMGKLQHPNIVKLIGLCRSEKGA--- 758 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCc-----EEEEEEccCCcc--ccHHHHHHHhhCCCCCcceEEEEEEcCCCC---
Confidence 4567888899999999999999765543 799998864432 224578999999999999999999887643
Q ss_pred EEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccccc
Q 014363 164 RLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL 243 (426)
Q Consensus 164 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 243 (426)
|+||||+++|+|.+++.. ++|..+..|+.|++.||+|||..+..+|+||||||+||+++.++.+++. ||....
T Consensus 759 -~lv~Ey~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~ 831 (968)
T PLN00113 759 -YLIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGL 831 (968)
T ss_pred -EEEEeCCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccc
Confidence 999999999999999952 8899999999999999999996555699999999999999999888876 665543
Q ss_pred CCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhh
Q 014363 244 GPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQ 323 (426)
Q Consensus 244 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (426)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||+..... ......|.+..... .....
T Consensus 832 ~~~------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~-~~~~~ 903 (968)
T PLN00113 832 LCT------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV-HGSIVEWARYCYSD-CHLDM 903 (968)
T ss_pred ccc------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC-CCcHHHHHHHhcCc-cchhh
Confidence 221 12236889999999999999999999999999999999999999643221 22344444332222 12334
Q ss_pred hcCCcCCC--cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhhc
Q 014363 324 IVDPRLEG--KYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASA 374 (426)
Q Consensus 324 ~~~~~~~~--~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~~ 374 (426)
.+++.+.. ........++.+++.+||+.||++||++.|+++.|+++.....
T Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~ 956 (968)
T PLN00113 904 WIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSS 956 (968)
T ss_pred eeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcccc
Confidence 44554433 2334566778899999999999999999999999998765443
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=299.85 Aligned_cols=252 Identities=25% Similarity=0.374 Sum_probs=199.1
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-------CCHHHHHHHHHHHhhcCCCCccceEeEEEcc
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-------GGHKEWMTEVNFLGIVEHQNLVKLVGYCADD 157 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-------~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 157 (426)
.+|.+.+.||+|+||.||+|.+..++. .+++|.+... .....+.+|+.+++.++||||+++++++.+.
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~-----~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 76 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGR-----ELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDP 76 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCC-----EEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcC
Confidence 478899999999999999999776544 7888876422 1224678899999999999999999998765
Q ss_pred CCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEee
Q 014363 158 DERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 237 (426)
Q Consensus 158 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~D 237 (426)
... .++++|||+++++|.+++.... .+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|
T Consensus 77 ~~~--~~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~d 149 (264)
T cd06653 77 EEK--KLSIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGD 149 (264)
T ss_pred CCC--EEEEEEEeCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECc
Confidence 432 4689999999999999986433 378899999999999999999998 999999999999999999999999
Q ss_pred ecccccCCCCCc-eeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhh
Q 014363 238 FGLARLGPSEGF-THVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS 316 (426)
Q Consensus 238 FGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 316 (426)
||+++....... ........|+..|+|||++.+..++.++||||||+++|+|++|..||.......
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------------- 216 (264)
T cd06653 150 FGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA------------- 216 (264)
T ss_pred cccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH-------------
Confidence 999975432110 011123568999999999988889999999999999999999999997542211
Q ss_pred hhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 317 DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.+.+..........+...+..+.+++.+||+ +|..||++.+++.|
T Consensus 217 ---~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 217 ---AIFKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred ---HHHHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 1111111122223445567889999999999 57999999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=293.74 Aligned_cols=257 Identities=23% Similarity=0.297 Sum_probs=208.3
Q ss_pred HhCCCCCc-ceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhc-CCCCccceEeEEEccCCC
Q 014363 83 ATKNFSRS-VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDER 160 (426)
Q Consensus 83 ~~~~y~~~-~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~~ 160 (426)
.+++|++. ++||-|-.|.|-.+.++.+++ .+|+|++... ....+|+++.-.. .|||||.++++|......
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~e-----kfALKvL~Ds---~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~ 130 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQE-----KFALKVLLDS---PKARREVELHWMASGHPHIVSIIDVYENSYQG 130 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchh-----hhHHHHHhcC---HHHHhHhhhhhhhcCCCceEEeehhhhhhccC
Confidence 45677654 589999999999999998877 7899988654 4567888876655 799999999999876655
Q ss_pred CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCC---CCCeeEee
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE---QWNAKLSD 237 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~---~~~~kl~D 237 (426)
-..+.+|||.|+||.|...+..++...+++.++..|++||..|+.|||+. +|.||||||+|+|... +..+||+|
T Consensus 131 rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtD 207 (400)
T KOG0604|consen 131 RKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTD 207 (400)
T ss_pred ceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecc
Confidence 55678999999999999999999999999999999999999999999998 9999999999999964 45699999
Q ss_pred ecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh
Q 014363 238 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 317 (426)
Q Consensus 238 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 317 (426)
||+|+...... ...+.|-||.|.|||++....|+...|+||+||++|-||+|.+||........-
T Consensus 208 fGFAK~t~~~~---~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ais------------ 272 (400)
T KOG0604|consen 208 FGFAKETQEPG---DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS------------ 272 (400)
T ss_pred cccccccCCCc---cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCC------------
Confidence 99998654322 234578899999999999999999999999999999999999999765432110
Q ss_pred hhhhhhhcCCcC--CCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 318 AKQFRQIVDPRL--EGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 318 ~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
...-..+..... ....-..+++..+++|+.+|..+|++|.|+.+++.+
T Consensus 273 pgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 273 PGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred hhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 011111111111 111223578899999999999999999999999986
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=306.71 Aligned_cols=249 Identities=27% Similarity=0.419 Sum_probs=200.1
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc--CCHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCc
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR--GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 162 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~ 162 (426)
++|...+.||+|+||.||+|....++. .+++|.+... ...+.+.+|+.+++.++||||+++++++.....
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~-----~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~--- 90 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQ-----EVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDE--- 90 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCC-----EEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCc---
Confidence 578899999999999999998765543 6888887533 244578899999999999999999999987653
Q ss_pred eEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccc
Q 014363 163 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 242 (426)
Q Consensus 163 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 242 (426)
.|+|+||+++++|.+++... .+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++.
T Consensus 91 -~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~ 163 (293)
T cd06647 91 -LWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA 163 (293)
T ss_pred -EEEEEecCCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCccee
Confidence 49999999999999998643 378899999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhh
Q 014363 243 LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFR 322 (426)
Q Consensus 243 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (426)
....... ......|++.|++||.+.+..++.++||||||+++|+|++|..||............
T Consensus 164 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~-------------- 227 (293)
T cd06647 164 QITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-------------- 227 (293)
T ss_pred ccccccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh--------------
Confidence 5543321 123356889999999998888999999999999999999999999754332110000
Q ss_pred hhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 323 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
..............+..+.+++.+||+.+|++||++.+++.+
T Consensus 228 -~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 228 -ATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred -hcCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000011111222355679999999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=304.79 Aligned_cols=251 Identities=27% Similarity=0.401 Sum_probs=191.7
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHH-HhhcCCCCccceEeEEEccCCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNF-LGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~-l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
++|++.+.||+|+||.||+|.+..++. .||+|.+.... ....+..|+.+ ++.++||||+++++++.....
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~- 74 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGT-----IMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGD- 74 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCc-----EEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCc-
Confidence 368889999999999999999876554 79999876442 23456667665 566799999999999987653
Q ss_pred CceEEEEEeeCCCCChhhhccCC--CCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeee
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPK--SETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 238 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 238 (426)
.|+||||++ |+|.+++... ....+++..++.++.|++.||+|||++ .+++||||||+|||++.++.+||+||
T Consensus 75 ---~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~df 148 (283)
T cd06617 75 ---VWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDF 148 (283)
T ss_pred ---EEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeec
Confidence 499999996 6887776532 224589999999999999999999974 38999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCchhhcc----CCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhh
Q 014363 239 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT----GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPY 314 (426)
Q Consensus 239 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 314 (426)
|++....... ......|+..|+|||++.+ ..++.++||||||+++|+|++|..||....... ..+
T Consensus 149 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~------- 217 (283)
T cd06617 149 GISGYLVDSV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF-QQL------- 217 (283)
T ss_pred cccccccccc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH-HHH-------
Confidence 9987653221 1223568899999998865 446889999999999999999999996432111 111
Q ss_pred hhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 315 LSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
...............++..+.+++.+||..+|++||++.+++++
T Consensus 218 -------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 218 -------KQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred -------HHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01111101111112356789999999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=349.68 Aligned_cols=255 Identities=28% Similarity=0.377 Sum_probs=204.9
Q ss_pred HHhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc----CCHHHHHHHHHHHhhcCCCCccceEeEEEcc
Q 014363 82 SATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR----GGHKEWMTEVNFLGIVEHQNLVKLVGYCADD 157 (426)
Q Consensus 82 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 157 (426)
..+-++.....||.|.||.||-|...++++ ..|+|-+.-. ...+.+.+|..+|..|+|||+|++||+-.+.
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGe-----llAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHR 1306 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGE-----LLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHR 1306 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccc-----hhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecH
Confidence 345578888999999999999999888776 5666655322 2345678999999999999999999998887
Q ss_pred CCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEee
Q 014363 158 DERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 237 (426)
Q Consensus 158 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~D 237 (426)
+.. +|.||||++|+|.+.+... +..++.....+..|++.||.|||++ |||||||||+||+|+.+|.+|++|
T Consensus 1307 ekv----~IFMEyC~~GsLa~ll~~g--ri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~D 1377 (1509)
T KOG4645|consen 1307 EKV----YIFMEYCEGGSLASLLEHG--RIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGD 1377 (1509)
T ss_pred HHH----HHHHHHhccCcHHHHHHhc--chhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeec
Confidence 755 8899999999999999643 3477777888999999999999999 999999999999999999999999
Q ss_pred ecccccCCCCC--ceeeeeeeecCcccCCchhhccC---CCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHh
Q 014363 238 FGLARLGPSEG--FTHVSTAVVGTMGYAAPEYVQTG---RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK 312 (426)
Q Consensus 238 FGla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~ 312 (426)
||.|....... .........||+.|||||++.+. ....++|||||||++.||+||+.||...+.+-...
T Consensus 1378 FGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIM------ 1451 (1509)
T KOG4645|consen 1378 FGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIM------ 1451 (1509)
T ss_pred ccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHH------
Confidence 99998765432 11112357899999999999864 46679999999999999999999997543321100
Q ss_pred hhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014363 313 PYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMV 366 (426)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L 366 (426)
.. +-..-...++..++.+-.++|.+||+.||++|.++.||+++-
T Consensus 1452 ---------y~-V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1452 ---------YH-VAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred ---------hH-HhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence 00 011122345556888999999999999999999999999873
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=306.82 Aligned_cols=267 Identities=24% Similarity=0.312 Sum_probs=198.4
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
++|+..+.||.|+||.||+|.+..++. .+++|.+.... ....+.+|+.+++.++||||+++++++......
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~-----~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 79 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGE-----IVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLD 79 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCc-----EEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCC
Confidence 468888999999999999999876543 68888875432 223567899999999999999999998776322
Q ss_pred CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecc
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 240 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 240 (426)
..|+||||++ ++|.+++.... ..+++..++.++.|++.||+|||+. +++|+||||+|||++.++.+||+|||+
T Consensus 80 --~~~lv~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~ 152 (293)
T cd07843 80 --KIYMVMEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGL 152 (293)
T ss_pred --cEEEEehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCc
Confidence 4699999996 59988886543 3589999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCchhhccCC-CCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHH-HhHh------
Q 014363 241 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGR-LAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLL-QWVK------ 312 (426)
Q Consensus 241 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~-~~~~------ 312 (426)
+........ ......+++.|+|||.+.+.. ++.++||||||+++|+|++|..||...........+ ....
T Consensus 153 ~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 230 (293)
T cd07843 153 AREYGSPLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKI 230 (293)
T ss_pred eeeccCCcc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHH
Confidence 986544321 122346789999999887544 688999999999999999999999765433221111 1000
Q ss_pred -hhhhhhh-----hhhhhcCCcCCCcccHH-HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 313 -PYLSDAK-----QFRQIVDPRLEGKYSLR-LVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 313 -~~~~~~~-----~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
+.+.... .........+...++.. .+..+.+++.+||+.||++|||+.|++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 231 WPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred HHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0000000 00000011111122222 46778999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=312.75 Aligned_cols=271 Identities=22% Similarity=0.290 Sum_probs=202.4
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
..+|+..+.||+|+||.||+|....++. .|++|.+.... ....+.+|+.+|+.++||||+++++++.....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~-----~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 78 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGK-----KVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGA 78 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCC-----EEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCC
Confidence 3689999999999999999999876654 78889876432 34567789999999999999999998876554
Q ss_pred CCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeec
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 239 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 239 (426)
.....|+||||+. ++|.+++.... .+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 79 ~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg 152 (334)
T cd07855 79 DFKDVYVVMDLME-SDLHHIIHSDQ--PLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFG 152 (334)
T ss_pred CCceEEEEEehhh-hhHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccc
Confidence 4456799999995 68999886443 389999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCce--eeeeeeecCcccCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhh---
Q 014363 240 LARLGPSEGFT--HVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKP--- 313 (426)
Q Consensus 240 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~--- 313 (426)
++......... .......|+..|+|||.+.+ ..++.++||||||+++|+|++|..||...........+.....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~ 232 (334)
T cd07855 153 MARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPS 232 (334)
T ss_pred cceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCCh
Confidence 99754332211 11234578999999998765 4588999999999999999999999976543222111110000
Q ss_pred --hhh--hhhhhhhh---cCCcCCC---cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 314 --YLS--DAKQFRQI---VDPRLEG---KYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 314 --~~~--~~~~~~~~---~~~~~~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.+. ........ ....... ......+..+.+++.+||+.+|++||++.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 233 EEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 000 00000000 0000000 0112346789999999999999999999999986
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=302.62 Aligned_cols=247 Identities=28% Similarity=0.434 Sum_probs=196.7
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc---CCHHHHHHHHHHHhhcC---CCCccceEeEEEccCC
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR---GGHKEWMTEVNFLGIVE---HQNLVKLVGYCADDDE 159 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~---~~~~~~~~E~~~l~~l~---HpnIv~~~~~~~~~~~ 159 (426)
.|+..+.||.|+||.||+|.+...+. .+++|.+... ...+.+.+|+.+++.+. ||||+++++++.+..
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~-----~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~- 75 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGR-----VVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGP- 75 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCc-----EEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCC-
Confidence 47788899999999999999866543 7899987543 23456888999999996 999999999987655
Q ss_pred CCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeec
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 239 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 239 (426)
..++||||+++++|.+++... .+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||
T Consensus 76 ---~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg 146 (277)
T cd06917 76 ---RLWIIMEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFG 146 (277)
T ss_pred ---EEEEEEecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCC
Confidence 459999999999999998643 489999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014363 240 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 318 (426)
Q Consensus 240 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 318 (426)
++....... .......|+..|+|||.+.++ .++.++||||||+++|+|++|..||............
T Consensus 147 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~---------- 214 (277)
T cd06917 147 VAALLNQNS--SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLI---------- 214 (277)
T ss_pred ceeecCCCc--cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcc----------
Confidence 998665432 112345689999999988754 4688999999999999999999999754322111000
Q ss_pred hhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 319 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.....+.+.. ...+..+.+++.+||+.||++||++.+++.+
T Consensus 215 ---~~~~~~~~~~---~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 215 ---PKSKPPRLED---NGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred ---ccCCCCCCCc---ccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 0000011111 1145689999999999999999999999885
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=302.53 Aligned_cols=247 Identities=26% Similarity=0.370 Sum_probs=200.5
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-----CCHHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-----GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
+|+..+.||.|+||.||+|.+..++. .+++|.+... ...+.+.+|++++++++||||+++++++.+..
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~-----~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 73 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKK-----MFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEE-- 73 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCc-----EEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCC--
Confidence 57888999999999999999876544 7899887543 23467889999999999999999999887655
Q ss_pred CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecc
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 240 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 240 (426)
..++|+||+++++|.+++... ..+++..+..++.|+++||.|||+. +++|+||+|+||++++++.++|+|||+
T Consensus 74 --~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~ 146 (258)
T cd05578 74 --NMYLVVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNI 146 (258)
T ss_pred --eEEEEEeCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeeccc
Confidence 459999999999999999754 3589999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhh
Q 014363 241 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 320 (426)
Q Consensus 241 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (426)
+....... ......|+..|+|||++.+..++.++||||||+++|+|++|..||.............
T Consensus 147 ~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~----------- 212 (258)
T cd05578 147 ATKVTPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRA----------- 212 (258)
T ss_pred ccccCCCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHH-----------
Confidence 87654332 1234568899999999988889999999999999999999999998654321111111
Q ss_pred hhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCH--HHHHH
Q 014363 321 FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKM--SEVLE 364 (426)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~--~eil~ 364 (426)
.... .....+...+..+.+++.+||+.||.+||++ +|+++
T Consensus 213 ---~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 213 ---KQET-ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred ---Hhcc-ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 0000 1122333456789999999999999999999 66654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=312.42 Aligned_cols=272 Identities=23% Similarity=0.303 Sum_probs=200.7
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCCccceEeEEEccCC-
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE- 159 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~- 159 (426)
.++|++.+.||+|+||.||+|.+..++. .|++|.+.... ....+.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 78 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGV-----KVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFE 78 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCC-----eEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeeccccc
Confidence 4689999999999999999999876554 78999875322 33467889999999999999999998876442
Q ss_pred CCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeec
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 239 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 239 (426)
.....|+||||++ ++|.+++... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 79 ~~~~~~lv~e~~~-~~l~~~~~~~---~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg 151 (336)
T cd07849 79 SFNDVYIVQELME-TDLYKLIKTQ---HLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFG 151 (336)
T ss_pred ccceEEEEehhcc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECccc
Confidence 2234699999995 5888877543 489999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCc-eeeeeeeecCcccCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh
Q 014363 240 LARLGPSEGF-THVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 317 (426)
Q Consensus 240 la~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 317 (426)
++........ ........|++.|+|||.+.+ ..++.++|||||||++|+|++|+.||...........+. ..+..
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~---~~~~~ 228 (336)
T cd07849 152 LARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLIL---GVLGT 228 (336)
T ss_pred ceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---HHcCC
Confidence 9976533211 111233578999999998754 468899999999999999999999997543221111110 00000
Q ss_pred --hhhhhhhcCC-----------cCCCc---ccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HHHhH
Q 014363 318 --AKQFRQIVDP-----------RLEGK---YSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM--VNKIV 370 (426)
Q Consensus 318 --~~~~~~~~~~-----------~~~~~---~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~--L~~~~ 370 (426)
.+....+... ..... .....+..+.+++.+||+.+|++|||+.|++++ ++...
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 229 PSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred CCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 0000000000 00000 011235678999999999999999999999998 55443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=296.07 Aligned_cols=253 Identities=27% Similarity=0.423 Sum_probs=204.6
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
+|...+.||+|++|.||+|....++. .+++|.+.... ..+.+.+|+.++++++||||+++++.+.+...
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~-----~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-- 73 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGE-----LMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEK-- 73 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCc-----EEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCC--
Confidence 47778899999999999999876543 78888876554 35678899999999999999999999987631
Q ss_pred ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccc
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 241 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 241 (426)
...++|+||+++++|.+++.... .+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||.+
T Consensus 74 ~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~ 148 (260)
T cd06606 74 NTLNIFLEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCA 148 (260)
T ss_pred CeEEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccE
Confidence 24599999999999999997554 589999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhh
Q 014363 242 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 321 (426)
Q Consensus 242 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (426)
................++..|+|||.+.+..++.++||||||+++++|++|..||......... .
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~---------------~ 213 (260)
T cd06606 149 KRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAA---------------L 213 (260)
T ss_pred EecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHH---------------H
Confidence 8765433211123457899999999998888999999999999999999999999765411100 0
Q ss_pred hhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 322 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
............+...+..+.+++.+||+.||++||++.+++++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 214 YKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred HhccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 01111111222334457889999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=302.99 Aligned_cols=272 Identities=24% Similarity=0.315 Sum_probs=197.3
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
.++|+..+.||+|+||.||+|....++. .|++|.+.... ....+.+|+.+++.++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~-----~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 85 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQ-----IVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAT 85 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCc-----EEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccc
Confidence 4579999999999999999999776544 78888775332 22356789999999999999999999876542
Q ss_pred C----CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeE
Q 014363 160 R----GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKL 235 (426)
Q Consensus 160 ~----~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl 235 (426)
. ....++||||+. ++|.+++.... ..+++..++.++.|++.||+|||++ +++|+||||+|||++.++.+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl 160 (310)
T cd07865 86 PYNRYKGSFYLVFEFCE-HDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKL 160 (310)
T ss_pred cccCCCceEEEEEcCCC-cCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEE
Confidence 1 235699999995 58888776433 3489999999999999999999998 9999999999999999999999
Q ss_pred eeecccccCCCCCce--eeeeeeecCcccCCchhhccCC-CCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHh
Q 014363 236 SDFGLARLGPSEGFT--HVSTAVVGTMGYAAPEYVQTGR-LAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK 312 (426)
Q Consensus 236 ~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~ 312 (426)
+|||++......... .......++..|+|||++.+.. ++.++||||||+++|+|++|..||...........+....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~ 240 (310)
T cd07865 161 ADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLC 240 (310)
T ss_pred CcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 999999765432211 1122346788999999886643 7889999999999999999999997655433222222111
Q ss_pred hh-----hhhhhhhhhhcCCcCCCcccH---------HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 313 PY-----LSDAKQFRQIVDPRLEGKYSL---------RLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 313 ~~-----~~~~~~~~~~~~~~~~~~~~~---------~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.. ..........-.......... .....+.+++.+||..||++|||++|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 241 GSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred CCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 00 000000000000000000000 123467799999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=338.63 Aligned_cols=255 Identities=27% Similarity=0.390 Sum_probs=211.2
Q ss_pred HHHHHhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccc-----cCCHHHHHHHHHHHhhcCCCCccceEeE
Q 014363 79 ELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGR-----RGGHKEWMTEVNFLGIVEHQNLVKLVGY 153 (426)
Q Consensus 79 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~-----~~~~~~~~~E~~~l~~l~HpnIv~~~~~ 153 (426)
+++-...+|.++++||+|+||.|.+++++.++. .||+|++++ ......|..|-.+|..-+.+=|+++.-.
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~-----VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyA 143 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEK-----VYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYA 143 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEeecccc-----chhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHH
Confidence 344446789999999999999999999988775 799998865 3455678899999999899999999988
Q ss_pred EEccCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCe
Q 014363 154 CADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNA 233 (426)
Q Consensus 154 ~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~ 233 (426)
|+|+.. +|+||||++||+|-.++.... .+++..+.+++..|+.||.-||+. |+|||||||+|||||..|++
T Consensus 144 FQD~~~----LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHi 214 (1317)
T KOG0612|consen 144 FQDERY----LYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHI 214 (1317)
T ss_pred hcCccc----eEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcE
Confidence 988774 599999999999999998665 599999999999999999999997 99999999999999999999
Q ss_pred eEeeecccccCCCCCceeeeeeeecCcccCCchhhcc-----CCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHH
Q 014363 234 KLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT-----GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLL 308 (426)
Q Consensus 234 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~ 308 (426)
||+|||.+-.+..++. ......+|||.|.+||++.. +.|+..+|.||+||++|||+.|..||.... ++
T Consensus 215 kLADFGsClkm~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads------lv 287 (1317)
T KOG0612|consen 215 KLADFGSCLKMDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS------LV 287 (1317)
T ss_pred eeccchhHHhcCCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH------HH
Confidence 9999999988776653 34566799999999999862 569999999999999999999999996432 11
Q ss_pred HhHhhhhhhhhhhhhhcCCcCCCccc--HHHHHHHHHHHHhccccCCCCCCC---HHHHHHH
Q 014363 309 QWVKPYLSDAKQFRQIVDPRLEGKYS--LRLVSKLSHVANLCLVKNARTRPK---MSEVLEM 365 (426)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dp~~RPs---~~eil~~ 365 (426)
+.+..+++-.-.-.+| ..++....+||...+. +|+.|.. ++++..|
T Consensus 288 ----------eTY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 288 ----------ETYGKIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH 338 (1317)
T ss_pred ----------HHHHHHhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence 2223333321111233 4578899999998876 7888887 9999887
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=305.45 Aligned_cols=268 Identities=26% Similarity=0.316 Sum_probs=197.8
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
.++|+..+.||+|+||.||+|.+..++. .||+|.+.... ....+.+|+.+++.++|+||+++++++.+...
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGE-----IVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHL 80 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCc-----EEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCC
Confidence 4579999999999999999999876654 78888875332 12346789999999999999999999876543
Q ss_pred CCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeec
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 239 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 239 (426)
. ..++||||+. ++|.+++.... ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||
T Consensus 81 ~--~~~lv~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg 153 (309)
T cd07845 81 D--SIFLVMEYCE-QDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFG 153 (309)
T ss_pred C--eEEEEEecCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccc
Confidence 2 3599999996 58888876432 4589999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhh-----
Q 014363 240 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKP----- 313 (426)
Q Consensus 240 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~----- 313 (426)
++........ ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||...........+.....
T Consensus 154 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 231 (309)
T cd07845 154 LARTYGLPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNES 231 (309)
T ss_pred eeeecCCccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChh
Confidence 9986543221 1222346788999998865 4578999999999999999999999976544332221111000
Q ss_pred hhhhhhhh---hhhcCC-cCCCcc---cHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 314 YLSDAKQF---RQIVDP-RLEGKY---SLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 314 ~~~~~~~~---~~~~~~-~~~~~~---~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.+...... ...... ...... ....+..+.++|.+||+.||++|||+.+++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 232 IWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred hchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000000 000000 000000 01236678899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=302.94 Aligned_cols=252 Identities=29% Similarity=0.440 Sum_probs=203.7
Q ss_pred HhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 83 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
..+.|+..+.||+|+||.||+|.+...+. .+++|.+.... ..+.+.+|+++++.++|+||+++++++....
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~-----~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--- 88 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGK-----EVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGD--- 88 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCc-----EEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECC---
Confidence 45678888999999999999999875443 78889886544 3567889999999999999999999998865
Q ss_pred ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccc
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 241 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 241 (426)
..|+|+||+++++|.+++.... ..+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++
T Consensus 89 -~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~ 163 (286)
T cd06614 89 -ELWVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFA 163 (286)
T ss_pred -EEEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchh
Confidence 4599999999999999997654 3589999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhh
Q 014363 242 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 321 (426)
Q Consensus 242 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (426)
........ ......++..|++||++.+..++.++||||||+++|+|++|..||....+......
T Consensus 164 ~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~-------------- 227 (286)
T cd06614 164 AQLTKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFL-------------- 227 (286)
T ss_pred hhhccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHH--------------
Confidence 75443211 12334688999999999888899999999999999999999999975433211110
Q ss_pred hhhcCCcCC-CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 322 RQIVDPRLE-GKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 322 ~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
+...... ......++..+.+++.+||+.+|.+||++.+++++
T Consensus 228 --~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 228 --ITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred --HHhcCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 0000000 11112256789999999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=304.27 Aligned_cols=244 Identities=28% Similarity=0.400 Sum_probs=192.7
Q ss_pred ecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-----CCHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCceEEEE
Q 014363 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-----GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLV 167 (426)
Q Consensus 93 lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~~~lv 167 (426)
||+|+||+||+|.....+. .+++|.+... .....+..|+.+++.++||||+++++++...+ ..|+|
T Consensus 1 lg~g~~g~vy~~~~~~~~~-----~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~lv 71 (277)
T cd05577 1 LGKGGFGEVCACQVKATGK-----MYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKD----DLCLV 71 (277)
T ss_pred CCCCCceeEEEEEEcCCCc-----EEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCC----eEEEE
Confidence 6999999999998776554 6888877432 23345678999999999999999999987765 45999
Q ss_pred EeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccCCCC
Q 014363 168 YEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSE 247 (426)
Q Consensus 168 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 247 (426)
|||+++++|.+++.......+++..++.++.|++.||.|||+. +++||||+|+||+++.++.+||+|||++......
T Consensus 72 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~ 148 (277)
T cd05577 72 MTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG 148 (277)
T ss_pred EecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccC
Confidence 9999999999998765545689999999999999999999998 9999999999999999999999999998765431
Q ss_pred CceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCC
Q 014363 248 GFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDP 327 (426)
Q Consensus 248 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (426)
. ......++..|+|||++.+..++.++||||||+++|+|++|+.||............. ....
T Consensus 149 ~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~------------~~~~-- 211 (277)
T cd05577 149 K---KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELK------------RRTL-- 211 (277)
T ss_pred C---ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHH------------hccc--
Confidence 1 1233468889999999988889999999999999999999999997654321111100 0000
Q ss_pred cCCCcccHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 014363 328 RLEGKYSLRLVSKLSHVANLCLVKNARTRP-----KMSEVLEM 365 (426)
Q Consensus 328 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~ 365 (426)
.....++..++..+.+++.+||+.||++|| ++.+++.+
T Consensus 212 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 212 EMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH 254 (277)
T ss_pred cccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence 011112233567889999999999999999 66667664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=303.63 Aligned_cols=241 Identities=25% Similarity=0.373 Sum_probs=186.4
Q ss_pred eecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-----CHHHHHHHHHHHhh---cCCCCccceEeEEEccCCCCce
Q 014363 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-----GHKEWMTEVNFLGI---VEHQNLVKLVGYCADDDERGIQ 163 (426)
Q Consensus 92 ~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-----~~~~~~~E~~~l~~---l~HpnIv~~~~~~~~~~~~~~~ 163 (426)
+||+|+||.||++....++. .+|+|.+.... ....+.+|..++.. .+||||+.+++++...+.
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~-----~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~---- 71 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGK-----MYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDK---- 71 (279)
T ss_pred CcccCCCeEEEEEEECCCCc-----EEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCe----
Confidence 48999999999999876544 78888775432 12234455544443 479999999999987653
Q ss_pred EEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccccc
Q 014363 164 RLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL 243 (426)
Q Consensus 164 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 243 (426)
.++||||+++++|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.++|+|||++..
T Consensus 72 ~~lv~e~~~~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~ 146 (279)
T cd05633 72 LCFILDLMNGGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 146 (279)
T ss_pred EEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCccee
Confidence 499999999999999886543 489999999999999999999998 999999999999999999999999999875
Q ss_pred CCCCCceeeeeeeecCcccCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhh
Q 014363 244 GPSEGFTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFR 322 (426)
Q Consensus 244 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (426)
..... .....|+..|+|||.+.+ ..++.++|||||||++|+|++|..||..........+...
T Consensus 147 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~------------ 210 (279)
T cd05633 147 FSKKK----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM------------ 210 (279)
T ss_pred ccccC----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH------------
Confidence 43221 223468999999998864 5589999999999999999999999975433221111110
Q ss_pred hhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 014363 323 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRP-----KMSEVLEM 365 (426)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~ 365 (426)
........+..++..+.+++.+||..||++|| +++|+++|
T Consensus 211 ---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 211 ---TLTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred ---hhcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 00111123334667899999999999999999 69999887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=307.04 Aligned_cols=253 Identities=31% Similarity=0.427 Sum_probs=191.9
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcC-CCCccceEeEEEccCCCC
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVE-HQNLVKLVGYCADDDERG 161 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~-HpnIv~~~~~~~~~~~~~ 161 (426)
+|...+.||+|+||.||++.+...+. .+++|.+.... ....+.+|+.++.++. ||||+++++++..+..
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~-----~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~-- 77 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGT-----IMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGD-- 77 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCC-----EEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCc--
Confidence 45556789999999999999876654 78999876432 3346789999999995 9999999999887653
Q ss_pred ceEEEEEeeCCCCChhhhc---cCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeee
Q 014363 162 IQRLLVYEYMPNGSVDQYL---SPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 238 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l---~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 238 (426)
.+++|||+. ++|.++. .......+++..+..++.|++.||+|||+. .+++||||||+|||++.++.+||+||
T Consensus 78 --~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~df 152 (288)
T cd06616 78 --CWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDF 152 (288)
T ss_pred --EEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeec
Confidence 489999985 4555433 222334589999999999999999999963 28999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCchhhccC---CCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhh
Q 014363 239 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG---RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYL 315 (426)
Q Consensus 239 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 315 (426)
|++....... ......|+..|+|||++.+. .++.++||||||+++|+|++|+.||...... ......
T Consensus 153 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~------ 222 (288)
T cd06616 153 GISGQLVDSI---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV-FDQLTQ------ 222 (288)
T ss_pred chhHHhccCC---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchH-HHHHhh------
Confidence 9997543321 11234689999999998876 6899999999999999999999999654310 000000
Q ss_pred hhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 316 SDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
......+.+.......++..+.+|+.+||+.||++|||+++|+.+
T Consensus 223 -----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 223 -----VVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred -----hcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000001122222223466789999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=305.57 Aligned_cols=247 Identities=31% Similarity=0.427 Sum_probs=194.9
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-----CHHHHHHHHHHHhhcCCCCccceEeEEEccC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 158 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 158 (426)
.+.|...+.||+|+||.||+|.....+. .|++|.+.... ..+.+.+|+.+++.++||||+++++++.+.+
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~-----~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~ 88 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNE-----VVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREH 88 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCc-----EEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCC
Confidence 3468888999999999999999876544 78888875332 2246789999999999999999999998766
Q ss_pred CCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeee
Q 014363 159 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 238 (426)
Q Consensus 159 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 238 (426)
. .|+||||++ |+|.+++.... ..+++..+..++.|++.||.|||+. +|+||||+|+||+++.++.+||+||
T Consensus 89 ~----~~lv~e~~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~df 159 (307)
T cd06607 89 T----AWLVMEYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADF 159 (307)
T ss_pred e----EEEEHHhhC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeec
Confidence 3 499999996 57777665332 3489999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCchhhc---cCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhh
Q 014363 239 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQ---TGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYL 315 (426)
Q Consensus 239 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 315 (426)
|++...... ....|+..|+|||++. ...++.++||||||+++|+|++|..||............
T Consensus 160 g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~------- 226 (307)
T cd06607 160 GSASLVSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI------- 226 (307)
T ss_pred CcceecCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHH-------
Confidence 998754332 2356888999999874 356888999999999999999999999754322111100
Q ss_pred hhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014363 316 SDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMV 366 (426)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L 366 (426)
............++..+.+++.+||+.||++||++.+|+.+.
T Consensus 227 ---------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 227 ---------AQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred ---------hcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 000001111223567899999999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=301.30 Aligned_cols=248 Identities=26% Similarity=0.400 Sum_probs=196.8
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC--CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCce
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQ 163 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~ 163 (426)
.|...+.||+|++|.||+|.....+. .+++|.+.... ..+.+.+|+.+++.++||||+++++++...+ .
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~-----~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~----~ 90 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGR-----QVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGD----E 90 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCC-----EEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCC----e
Confidence 45556789999999999998766543 78888775332 3456789999999999999999999988765 3
Q ss_pred EEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccccc
Q 014363 164 RLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL 243 (426)
Q Consensus 164 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 243 (426)
.++|+||+++++|.+++.. ..+++..+..++.|++.||+|||++ +++||||+|+||+++.++.++|+|||++..
T Consensus 91 ~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~ 164 (285)
T cd06648 91 LWVVMEFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQ 164 (285)
T ss_pred EEEEEeccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchh
Confidence 5999999999999999875 2388999999999999999999998 999999999999999999999999998875
Q ss_pred CCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhh
Q 014363 244 GPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQ 323 (426)
Q Consensus 244 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (426)
...... ......|++.|+|||.+.+..++.++||||||+++|+|++|..||....+....... ..
T Consensus 165 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~-------------~~ 229 (285)
T cd06648 165 VSKEVP--RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRI-------------RD 229 (285)
T ss_pred hccCCc--ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHH-------------Hh
Confidence 433211 123356899999999998888999999999999999999999999754332111110 00
Q ss_pred hcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 324 IVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 324 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
...+.+. ....++..+.+++.+||+.+|++||++.+++++
T Consensus 230 ~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 230 NLPPKLK--NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred cCCCCCc--ccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 0001111 111245689999999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=297.75 Aligned_cols=252 Identities=30% Similarity=0.449 Sum_probs=197.9
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
+|+..+.||+|+||.||+|....++. .+++|.+.... ..+.+..|+.+++.++|+||+++++++.+..
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~-----~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~--- 72 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGE-----LMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHRE--- 72 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCc-----EEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCC---
Confidence 57888999999999999998766543 78888875443 3457889999999999999999999987655
Q ss_pred ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccc
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 241 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 241 (426)
..++|+||+++++|.+++... ..+++..+..++.|++.||.|||+. +|+|+||+|+||++++++.+||+|||++
T Consensus 73 -~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~ 146 (264)
T cd06626 73 -KVYIFMEYCSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCA 146 (264)
T ss_pred -EEEEEEecCCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccc
Confidence 459999999999999999754 3478899999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCceee--eeeeecCcccCCchhhccCC---CCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhh
Q 014363 242 RLGPSEGFTHV--STAVVGTMGYAAPEYVQTGR---LAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS 316 (426)
Q Consensus 242 ~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 316 (426)
........... .....++..|+|||++.+.. ++.++||||||+++|+|++|..||............
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~-------- 218 (264)
T cd06626 147 VKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFH-------- 218 (264)
T ss_pred cccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHH--------
Confidence 86543322111 12356889999999988766 888999999999999999999999754321111000
Q ss_pred hhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 317 DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
......+.+. ....++..+.+++.+||+.+|++||++.+++.+
T Consensus 219 ----~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 219 ----VGAGHKPPIP--DSLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred ----HhcCCCCCCC--cccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000011111 111246678899999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=293.32 Aligned_cols=249 Identities=30% Similarity=0.461 Sum_probs=201.7
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC--CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCce
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQ 163 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~ 163 (426)
+|...+.||+|++|.||+|....++. .+++|.+.... ....+.+|+.+++.++||||+++++++.... .
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~-----~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~ 71 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGK-----EVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKD----E 71 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCc-----EEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC----e
Confidence 47778899999999999999876443 78899886654 5567899999999999999999999988765 3
Q ss_pred EEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccccc
Q 014363 164 RLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL 243 (426)
Q Consensus 164 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 243 (426)
.++++||+++++|.+++.... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||.+..
T Consensus 72 ~~l~~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~ 147 (253)
T cd05122 72 LWIVMEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQ 147 (253)
T ss_pred EEEEEecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccc
Confidence 599999999999999987543 3589999999999999999999998 999999999999999999999999999976
Q ss_pred CCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhh
Q 014363 244 GPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQ 323 (426)
Q Consensus 244 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (426)
...... .....|+..|+|||.+.+..++.++||||||+++|+|++|..||............. .
T Consensus 148 ~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-------------~ 211 (253)
T cd05122 148 LSDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIA-------------T 211 (253)
T ss_pred cccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH-------------h
Confidence 554321 334678999999999988888999999999999999999999997543221111100 0
Q ss_pred hcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 324 IVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 324 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
...+.+ .....++..+.+++.+||+.||++|||+.+++++
T Consensus 212 ~~~~~~--~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 212 NGPPGL--RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred cCCCCc--CcccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000001 1111235789999999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=303.06 Aligned_cols=268 Identities=20% Similarity=0.273 Sum_probs=196.1
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhc-CCCCccceEeEEEccCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDE 159 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~ 159 (426)
++|+..+.||+|+||.||+|.+..++. .|++|.+.... ....+.+|+.+++.+ +||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~-----~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~ 75 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGK-----LVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEK 75 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCc-----EEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCC
Confidence 368889999999999999999876554 78888765432 235678899999999 56999999998876554
Q ss_pred -CCceEEEEEeeCCCCChhhhccCCC---CCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCC-CCCee
Q 014363 160 -RGIQRLLVYEYMPNGSVDQYLSPKS---ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE-QWNAK 234 (426)
Q Consensus 160 -~~~~~~lv~E~~~~g~L~~~l~~~~---~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~-~~~~k 234 (426)
.....|+||||+++ +|.+++.... ...+++..++.++.||+.||.|||++ +|+||||||+||+++. ++.+|
T Consensus 76 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~k 151 (295)
T cd07837 76 NGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLK 151 (295)
T ss_pred CCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEE
Confidence 22346999999975 8888875432 23589999999999999999999998 9999999999999998 88999
Q ss_pred EeeecccccCCCCCceeeeeeeecCcccCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHH-HHHhHh
Q 014363 235 LSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQK-LLQWVK 312 (426)
Q Consensus 235 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~-~~~~~~ 312 (426)
|+|||++........ ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||.......... ......
T Consensus 152 l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~ 229 (295)
T cd07837 152 IADLGLGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLG 229 (295)
T ss_pred EeecccceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence 999999875432211 1122357889999998865 457899999999999999999999997644322111 111000
Q ss_pred hhhhhhhhhhhhcC-------CcC----CCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 313 PYLSDAKQFRQIVD-------PRL----EGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 313 ~~~~~~~~~~~~~~-------~~~----~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
. ........... +.. .......++..+.++|.+||+.||.+||++.|++.+
T Consensus 230 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 230 T--PTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred C--CChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0 00000000000 000 000112356788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=300.22 Aligned_cols=265 Identities=24% Similarity=0.374 Sum_probs=197.3
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCc
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 162 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~ 162 (426)
+|+..+.||.|++|.||+|.+..++. .+++|.+.... ....+.+|+.+++.++||||+++++++.+.+.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~-----~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~--- 72 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGE-----IVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENK--- 72 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCe-----EEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCc---
Confidence 57888999999999999999876543 78999875432 34567889999999999999999999988663
Q ss_pred eEEEEEeeCCCCChhhhccCCC-CCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccc
Q 014363 163 QRLLVYEYMPNGSVDQYLSPKS-ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 241 (426)
Q Consensus 163 ~~~lv~E~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 241 (426)
.++||||+++ +|.+++.... ...+++..+..++.|++.||.|||+. +++||||||+||++++++.++|+|||++
T Consensus 73 -~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~ 147 (284)
T cd07836 73 -LMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLA 147 (284)
T ss_pred -EEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchh
Confidence 4999999975 8888876443 24589999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHH-HHHhHh-hhhhhh
Q 014363 242 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQK-LLQWVK-PYLSDA 318 (426)
Q Consensus 242 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~-~~~~~~-~~~~~~ 318 (426)
........ ......++..|++||++.+. .++.++||||||+++|+|++|..||.......... ...... +.....
T Consensus 148 ~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (284)
T cd07836 148 RAFGIPVN--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTW 225 (284)
T ss_pred hhhcCCcc--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhH
Confidence 75433211 12234578899999988654 56889999999999999999999997654332211 111100 000000
Q ss_pred hhhhhh--cCCcCC-------CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 319 KQFRQI--VDPRLE-------GKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 319 ~~~~~~--~~~~~~-------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
...... ...... ..+....+..+.+++.+||+.||.+||++.+++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 226 PGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred HHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000000 000000 01112345788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=310.67 Aligned_cols=269 Identities=27% Similarity=0.378 Sum_probs=199.2
Q ss_pred HhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc----CCHHHHHHHHHHHhhc-CCCCccceEeEEEcc
Q 014363 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR----GGHKEWMTEVNFLGIV-EHQNLVKLVGYCADD 157 (426)
Q Consensus 83 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~----~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~ 157 (426)
..++|+..+.||+|+||.||+|.+..++. .+++|.+... .....+.+|+.++.++ +||||+++++++...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~-----~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~ 79 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKE-----VVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAE 79 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCe-----EEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccC
Confidence 35678889999999999999999775543 7888877432 2334577899999999 999999999998765
Q ss_pred CCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEee
Q 014363 158 DERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 237 (426)
Q Consensus 158 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~D 237 (426)
+.. ..|+||||++ ++|..++... .+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|
T Consensus 80 ~~~--~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d 150 (337)
T cd07852 80 NDK--DIYLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLAD 150 (337)
T ss_pred CCc--eEEEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEee
Confidence 432 4699999996 5999888643 488999999999999999999998 999999999999999999999999
Q ss_pred ecccccCCCCCce---eeeeeeecCcccCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhh
Q 014363 238 FGLARLGPSEGFT---HVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKP 313 (426)
Q Consensus 238 FGla~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~ 313 (426)
||++......... .......|+..|+|||++.+ ..++.++||||||+++|+|++|+.||.................
T Consensus 151 ~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~ 230 (337)
T cd07852 151 FGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIG 230 (337)
T ss_pred ccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 9999865433211 12234578999999998765 4578899999999999999999999976543322111111000
Q ss_pred hhhh-------hhhhhhhcCC---cCC---CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 314 YLSD-------AKQFRQIVDP---RLE---GKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 314 ~~~~-------~~~~~~~~~~---~~~---~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.... ......+++. .-. ......++..+.+++.+||+.||++|||+.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 231 PPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred CCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000 0000001100 000 00111246789999999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=298.77 Aligned_cols=242 Identities=26% Similarity=0.376 Sum_probs=195.0
Q ss_pred ecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-----CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCceEEEE
Q 014363 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLV 167 (426)
Q Consensus 93 lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~~~lv 167 (426)
||.|+||.||+|.....+. .+++|.+.... ..+.+.+|+.+++.++||||+++++++.+... .++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~-----~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~lv 71 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNR-----TFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKY----IYML 71 (262)
T ss_pred CCCCCceEEEEEEECCCCc-----EEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCc----cEEE
Confidence 6999999999999876443 78888875432 33568899999999999999999999887654 4999
Q ss_pred EeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccCCCC
Q 014363 168 YEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSE 247 (426)
Q Consensus 168 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 247 (426)
|||+++++|.+++.... .+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 72 ~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~ 146 (262)
T cd05572 72 MEYCLGGELWTILRDRG--LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG 146 (262)
T ss_pred EecCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCcc
Confidence 99999999999996543 388999999999999999999998 9999999999999999999999999999865433
Q ss_pred CceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCC
Q 014363 248 GFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDP 327 (426)
Q Consensus 248 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (426)
. ......|+..|++||.+.+..++.++|+||||+++|+|++|..||......... . ...+...
T Consensus 147 ~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~-------------~~~~~~~ 209 (262)
T cd05572 147 Q---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPME-I-------------YNDILKG 209 (262)
T ss_pred c---ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHH-H-------------HHHHhcc
Confidence 2 123457899999999998888999999999999999999999999765421111 1 1111111
Q ss_pred cCCCcccHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 014363 328 RLEGKYSLRLVSKLSHVANLCLVKNARTRPK-----MSEVLEM 365 (426)
Q Consensus 328 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~eil~~ 365 (426)
.....++...+..+.+++.+||+.||++||+ +.|++++
T Consensus 210 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~ 252 (262)
T cd05572 210 NGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKH 252 (262)
T ss_pred CCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcC
Confidence 1122233334678999999999999999999 8888774
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=302.02 Aligned_cols=264 Identities=23% Similarity=0.332 Sum_probs=196.4
Q ss_pred CCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCc
Q 014363 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 162 (426)
Q Consensus 87 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~ 162 (426)
|+..+.||.|++|.||+|.+..++. .|++|.+.... ....+.+|+.+++.++||||+++++++.+..
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~-----~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~---- 71 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGE-----IVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSEN---- 71 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCC-----EEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCC----
Confidence 6678899999999999999876544 78888875432 2356789999999999999999999998764
Q ss_pred eEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccc
Q 014363 163 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 242 (426)
Q Consensus 163 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 242 (426)
..|++|||++ ++|.+++.......+++..++.++.|+++||+|||++ +++||||+|+||+++.++.++|+|||++.
T Consensus 72 ~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~ 147 (283)
T cd07835 72 KLYLVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLAR 147 (283)
T ss_pred eEEEEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeeccccc
Confidence 4599999995 6899998765544589999999999999999999998 99999999999999999999999999997
Q ss_pred cCCCCCceeeeeeeecCcccCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHH-HHHhHhh-------
Q 014363 243 LGPSEGFTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQK-LLQWVKP------- 313 (426)
Q Consensus 243 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~-~~~~~~~------- 313 (426)
....... ......++..|+|||++.+. .++.++||||||+++|+|++|..||.......... ..+....
T Consensus 148 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (283)
T cd07835 148 AFGVPVR--TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWP 225 (283)
T ss_pred ccCCCcc--ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhh
Confidence 5432211 11223568899999987654 57889999999999999999999997654322211 1110000
Q ss_pred hhhhhhhhhhhcCC---cCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 314 YLSDAKQFRQIVDP---RLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 314 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.......+...... .........++..+.+++.+||+.||++||+++|++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 226 GVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000000000000 00001112344688999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=295.47 Aligned_cols=249 Identities=27% Similarity=0.400 Sum_probs=202.4
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc----CCHHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR----GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
+|...+.||.|+||.||++.+..++. .+++|.+... .....+.+|+++++.++|||++++++.+.+..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~-----~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~--- 72 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGK-----LYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKG--- 72 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCc-----EEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCC---
Confidence 47788899999999999999876443 7888887644 23456889999999999999999999988764
Q ss_pred ceEEEEEeeCCCCChhhhccCCC--CCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeec
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKS--ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 239 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 239 (426)
..++|+||+++++|.+++.... ...+++..+..++.+++.||.|||+. +++|+||+|+||+++.++.++|+|||
T Consensus 73 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~ 148 (258)
T cd08215 73 -KLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFG 148 (258)
T ss_pred -EEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCcc
Confidence 4599999999999999987542 35689999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014363 240 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 319 (426)
Q Consensus 240 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 319 (426)
++....... .......|++.|+|||.+.+..++.++||||||+++++|++|..||....... ...
T Consensus 149 ~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~---~~~---------- 213 (258)
T cd08215 149 ISKVLSSTV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE---LAL---------- 213 (258)
T ss_pred ceeecccCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH---HHH----------
Confidence 998654432 12334578999999999988889999999999999999999999997543211 110
Q ss_pred hhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 320 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
..... .....+..++..+.+++.+||..+|++||++.+++++
T Consensus 214 ---~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 214 ---KILKG-QYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred ---HHhcC-CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00110 1111222456789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=298.52 Aligned_cols=260 Identities=20% Similarity=0.243 Sum_probs=192.0
Q ss_pred CCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcC-CCCccceEeEEEccCCCCc
Q 014363 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVE-HQNLVKLVGYCADDDERGI 162 (426)
Q Consensus 87 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~-HpnIv~~~~~~~~~~~~~~ 162 (426)
|+..+.||+|+||.||+|.....+. .+++|.+.... .......|+.++.++. ||||+++++++.+....
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~-----~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~-- 73 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGK-----YYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTG-- 73 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCc-----EEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCC--
Confidence 5677889999999999999776544 78888876432 2234467899999884 99999999999876322
Q ss_pred eEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccc
Q 014363 163 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 242 (426)
Q Consensus 163 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 242 (426)
..++||||++ ++|.+++.... ..+++..++.++.|++.||+|||+. +++||||||+||+++. +.+||+|||++.
T Consensus 74 ~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~ 147 (282)
T cd07831 74 RLALVFELMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCR 147 (282)
T ss_pred cEEEEEecCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEeccccc
Confidence 4599999996 57877776432 3589999999999999999999998 9999999999999999 999999999997
Q ss_pred cCCCCCceeeeeeeecCcccCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh-hhh
Q 014363 243 LGPSEGFTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD-AKQ 320 (426)
Q Consensus 243 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~ 320 (426)
....... .....++..|+|||++.. +.++.++|||||||++|||++|..||........... ....... ...
T Consensus 148 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~---~~~~~~~~~~~ 221 (282)
T cd07831 148 GIYSKPP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAK---IHDVLGTPDAE 221 (282)
T ss_pred ccccCCC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHH---HHHHcCCCCHH
Confidence 6543211 123468899999997654 4578899999999999999999999976543222111 1100000 000
Q ss_pred hhhhcCC------cCCC-------cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 321 FRQIVDP------RLEG-------KYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 321 ~~~~~~~------~~~~-------~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
..+.... .... .....++..+.+++.+||+.+|++||++++++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 222 VLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred HHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 0000000 0000 0112456889999999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=333.24 Aligned_cols=257 Identities=23% Similarity=0.355 Sum_probs=194.1
Q ss_pred HHHhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCCccceEeEEEcc
Q 014363 81 KSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQNLVKLVGYCADD 157 (426)
Q Consensus 81 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 157 (426)
.....+|+.+.+||+||||.||+++.+-++. .||||++.-.. ....+.+|+..|++|+|||||++|..+.+.
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr-----~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs 549 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGR-----EYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVES 549 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccch-----hhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhcc
Confidence 4556789999999999999999999887765 79999986553 234578999999999999999887643211
Q ss_pred CCC-----------------------------------------------------------------------------
Q 014363 158 DER----------------------------------------------------------------------------- 160 (426)
Q Consensus 158 ~~~----------------------------------------------------------------------------- 160 (426)
...
T Consensus 550 ~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~ 629 (1351)
T KOG1035|consen 550 TAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRN 629 (1351)
T ss_pred CCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccc
Confidence 100
Q ss_pred ------------------------------C--------ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHH
Q 014363 161 ------------------------------G--------IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAAR 202 (426)
Q Consensus 161 ------------------------------~--------~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~ 202 (426)
. ..+||-||||+..+|.++++.+.... .....+.++++|++
T Consensus 630 ~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlE 708 (1351)
T KOG1035|consen 630 LSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILE 708 (1351)
T ss_pred cccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHH
Confidence 1 35688999999988888887554211 36678999999999
Q ss_pred HHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccCC----------------CCCceeeeeeeecCcccCCch
Q 014363 203 GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGP----------------SEGFTHVSTAVVGTMGYAAPE 266 (426)
Q Consensus 203 aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~----------------~~~~~~~~~~~~gt~~y~aPE 266 (426)
||.|+|++ |||||||||.||++++++.|||+|||+|.... ........+..+||..|+|||
T Consensus 709 GLaYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPE 785 (1351)
T KOG1035|consen 709 GLAYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPE 785 (1351)
T ss_pred HHHHHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHH
Confidence 99999998 99999999999999999999999999997611 001111345679999999999
Q ss_pred hhccCC---CCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCc--ccHHHHHHH
Q 014363 267 YVQTGR---LAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGK--YSLRLVSKL 341 (426)
Q Consensus 267 ~~~~~~---~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l 341 (426)
++.+.. |+.|+|+|||||+|+||+. ||..... ....+..+.+..++.. +.....+.-
T Consensus 786 ll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsME---------------Ra~iL~~LR~g~iP~~~~f~~~~~~~e 847 (1351)
T KOG1035|consen 786 LLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSME---------------RASILTNLRKGSIPEPADFFDPEHPEE 847 (1351)
T ss_pred HhcccccccccchhhhHHHHHHHHHHhc---cCCchHH---------------HHHHHHhcccCCCCCCcccccccchHH
Confidence 998654 9999999999999999985 4643211 1111222223333322 222333455
Q ss_pred HHHHHhccccCCCCCCCHHHHHH
Q 014363 342 SHVANLCLVKNARTRPKMSEVLE 364 (426)
Q Consensus 342 ~~li~~cl~~dp~~RPs~~eil~ 364 (426)
+.+|++|++.||++|||+.|+|.
T Consensus 848 ~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 848 ASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHHHHHhcCCCccCCCHHHHhh
Confidence 78999999999999999999986
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=291.93 Aligned_cols=276 Identities=25% Similarity=0.327 Sum_probs=203.1
Q ss_pred HhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc----CCHHHHHHHHHHHhhcCCCCccceEeEEEccC
Q 014363 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR----GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 158 (426)
Q Consensus 83 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 158 (426)
....|+.+..||+|+||.||+|..+++++.. .+.+|+|.++.. +......+|+.+++.|+||||+.+..+|...+
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr-~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKR-TKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD 100 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCccc-chhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence 3457999999999999999999877665432 457899999766 34456789999999999999999999888753
Q ss_pred CCCceEEEEEeeCCCCChhhhccCCC---CCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCC----C
Q 014363 159 ERGIQRLLVYEYMPNGSVDQYLSPKS---ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQ----W 231 (426)
Q Consensus 159 ~~~~~~~lv~E~~~~g~L~~~l~~~~---~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~----~ 231 (426)
. ..+|++||++. +|...|+-++ .+.++...+..|+.||+.|+.|||++ =|+||||||.|||+..+ |
T Consensus 101 ~---~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG 173 (438)
T KOG0666|consen 101 K---KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERG 173 (438)
T ss_pred c---eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccC
Confidence 2 46999999966 8888775332 24688999999999999999999998 89999999999999877 8
Q ss_pred CeeEeeecccccCCCCCcee-eeeeeecCcccCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCchhh-----
Q 014363 232 NAKLSDFGLARLGPSEGFTH-VSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSE----- 304 (426)
Q Consensus 232 ~~kl~DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~----- 304 (426)
.|||+|||+++.+...-... .....+-|.+|.|||.+.+. .|+.+.||||+|||+.||++-.+-|.+......
T Consensus 174 ~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pf 253 (438)
T KOG0666|consen 174 RVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPF 253 (438)
T ss_pred eeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCc
Confidence 99999999999876543222 23456789999999998875 489999999999999999998888865432211
Q ss_pred --HHHHHhH----------hhhhhhhhhhhhhc-CCc--CCCcccH-H-------HHHHHHHHHHhccccCCCCCCCHHH
Q 014363 305 --QKLLQWV----------KPYLSDAKQFRQIV-DPR--LEGKYSL-R-------LVSKLSHVANLCLVKNARTRPKMSE 361 (426)
Q Consensus 305 --~~~~~~~----------~~~~~~~~~~~~~~-~~~--~~~~~~~-~-------~~~~l~~li~~cl~~dp~~RPs~~e 361 (426)
..+.... ++.+.+.......+ +-+ ....... . -++...+|+.++|..||-+|.|+.+
T Consensus 254 q~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~q 333 (438)
T KOG0666|consen 254 QHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQ 333 (438)
T ss_pred hHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHH
Confidence 1111110 11111111110000 000 0000000 0 1133678999999999999999999
Q ss_pred HHHHH
Q 014363 362 VLEMV 366 (426)
Q Consensus 362 il~~L 366 (426)
.+++.
T Consensus 334 Aleh~ 338 (438)
T KOG0666|consen 334 ALEHP 338 (438)
T ss_pred Hhccc
Confidence 99873
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=308.94 Aligned_cols=272 Identities=22% Similarity=0.341 Sum_probs=201.7
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc----CCHHHHHHHHHHHhhcCCCCccceEeEEEccCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR----GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
.++|...+.||+|+||.||+|.+..++. .|++|.+... .....+.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~ 78 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNE-----KVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHR 78 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCC-----eEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccc
Confidence 4579999999999999999999776544 7899887532 234567789999999999999999998865432
Q ss_pred -CCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeee
Q 014363 160 -RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 238 (426)
Q Consensus 160 -~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 238 (426)
.....|+||||+. ++|.+++... ..+++..++.++.|++.||.|||++ +++||||||+|||++.++.+||+||
T Consensus 79 ~~~~~~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Df 152 (337)
T cd07858 79 EAFNDVYIVYELMD-TDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDF 152 (337)
T ss_pred cccCcEEEEEeCCC-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcC
Confidence 1124699999995 6898888654 3489999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHh-h---
Q 014363 239 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK-P--- 313 (426)
Q Consensus 239 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~-~--- 313 (426)
|++....... .......++..|+|||++.+ ..++.++||||||+++|+|++|..||................ .
T Consensus 153 g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 230 (337)
T cd07858 153 GLARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSE 230 (337)
T ss_pred ccccccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 9998654321 12234568899999998765 468899999999999999999999997654322111111000 0
Q ss_pred ----hhhhhhhhhhhc---CCcCCC---cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HHHh
Q 014363 314 ----YLSDAKQFRQIV---DPRLEG---KYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM--VNKI 369 (426)
Q Consensus 314 ----~~~~~~~~~~~~---~~~~~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~--L~~~ 369 (426)
.... ......+ ...... .....++..+.+++.+||+.+|++|||+++++++ +..+
T Consensus 231 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 231 EDLGFIRN-EKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred HHhhhcCc-hhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 0000 0000000 000000 0112356788999999999999999999999998 5544
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=306.42 Aligned_cols=260 Identities=23% Similarity=0.293 Sum_probs=191.9
Q ss_pred eeccc--CcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCceEE
Q 014363 92 VIGEG--GFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRL 165 (426)
Q Consensus 92 ~lG~G--~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~~~ 165 (426)
.||+| +||+||+|.+...+. .||+|.+.... ..+.+.+|+.+++.++||||++++++|...+. .+
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~----~~ 75 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGT-----LVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSW----LW 75 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCc-----EEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCc----eE
Confidence 46666 999999999866554 78999875432 23567889999999999999999999988663 49
Q ss_pred EEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccCC
Q 014363 166 LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGP 245 (426)
Q Consensus 166 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 245 (426)
+||||+++++|.+++.......+++..+..++.|++.||+|||+. +|+||||||+|||++.++.++++|||.+....
T Consensus 76 ~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~ 152 (328)
T cd08226 76 VISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLV 152 (328)
T ss_pred EEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhh
Confidence 999999999999998765445589999999999999999999998 99999999999999999999999998654322
Q ss_pred CCCcee-----eeeeeecCcccCCchhhccC--CCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhh-h---
Q 014363 246 SEGFTH-----VSTAVVGTMGYAAPEYVQTG--RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKP-Y--- 314 (426)
Q Consensus 246 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~-~--- 314 (426)
...... ......++..|+|||++.+. .++.++|||||||++|+|++|..||........ ....... .
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~ 230 (328)
T cd08226 153 RNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPPYSP 230 (328)
T ss_pred ccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH--HHHHhcCCCCCC
Confidence 111100 01112356779999998764 478999999999999999999999976532211 1110000 0
Q ss_pred -----hhhh-hh-------h--------------hhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 315 -----LSDA-KQ-------F--------------RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 315 -----~~~~-~~-------~--------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.... .. . .......+.......++..+.+|+.+||+.||++|||+.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 231 LDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred ccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0000 00 0 00111112222334567889999999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=302.28 Aligned_cols=266 Identities=22% Similarity=0.323 Sum_probs=195.5
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
++|+..+.||+|++|.||+|.+..++. .+++|.+.... ..+.+.+|+.+++.++||||+++++++.+..
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~-----~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 74 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNE-----TIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEK-- 74 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCc-----EEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCC--
Confidence 578899999999999999999876554 78999875432 2356789999999999999999999998765
Q ss_pred CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCC-CCCeeEeeec
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE-QWNAKLSDFG 239 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~-~~~~kl~DFG 239 (426)
..|+||||++ ++|.+++.......+++..+..++.||+.||+|||++ +++|+||+|+||+++. ++.+||+|||
T Consensus 75 --~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg 148 (294)
T PLN00009 75 --RLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFG 148 (294)
T ss_pred --eEEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccc
Confidence 4599999995 5888877655444468888999999999999999998 9999999999999985 5579999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHH-HhHh-h---
Q 014363 240 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLL-QWVK-P--- 313 (426)
Q Consensus 240 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~-~~~~-~--- 313 (426)
++....... .......+++.|+|||++.+. .++.++||||||+++|+|++|..||............ .... +
T Consensus 149 ~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 226 (294)
T PLN00009 149 LARAFGIPV--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEE 226 (294)
T ss_pred cccccCCCc--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 997543221 112234678999999988764 5788999999999999999999999765433221111 0000 0
Q ss_pred hhhhhhhhhhhc--CCcCCC----cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 314 YLSDAKQFRQIV--DPRLEG----KYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 314 ~~~~~~~~~~~~--~~~~~~----~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.+.......... .+.... ......+..+.+++.+||+.+|++||++.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 227 TWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000000000 000000 0112345678999999999999999999999985
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=304.00 Aligned_cols=248 Identities=30% Similarity=0.438 Sum_probs=195.1
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-----CHHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
.|...+.||+|+||.||+|....++. .+++|.+.... ....+..|+.+++.++|||++++++++.+...
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~-----~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~- 99 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNE-----VVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHT- 99 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCc-----EEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCe-
Confidence 47788899999999999999876554 78888875332 23467889999999999999999999987653
Q ss_pred CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecc
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 240 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 240 (426)
.++||||+++ +|.+++... ...+++..+..++.|++.||.|||+. +|+||||+|+||+++.++.+||+|||+
T Consensus 100 ---~~lv~e~~~g-~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~ 171 (317)
T cd06635 100 ---AWLVMEYCLG-SASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGS 171 (317)
T ss_pred ---EEEEEeCCCC-CHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCC
Confidence 4999999964 777776533 23489999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCchhhc---cCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh
Q 014363 241 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQ---TGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 317 (426)
Q Consensus 241 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 317 (426)
+..... .....|++.|+|||++. .+.++.++|||||||++|+|++|..||..........
T Consensus 172 ~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~----------- 234 (317)
T cd06635 172 ASIASP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY----------- 234 (317)
T ss_pred ccccCC------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHH-----------
Confidence 875432 22356889999999874 4568899999999999999999999986543211111
Q ss_pred hhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHh
Q 014363 318 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 369 (426)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~ 369 (426)
.+.............+..+.+++.+||+.+|.+||++.++++++...
T Consensus 235 -----~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~ 281 (317)
T cd06635 235 -----HIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVL 281 (317)
T ss_pred -----HHHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhh
Confidence 01111111111223556789999999999999999999999986543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=296.10 Aligned_cols=252 Identities=22% Similarity=0.309 Sum_probs=193.8
Q ss_pred HHHHHHHhCCCCCccee--cccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhc-CCCCccceEeE
Q 014363 77 IAELKSATKNFSRSVVI--GEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIV-EHQNLVKLVGY 153 (426)
Q Consensus 77 ~~~~~~~~~~y~~~~~l--G~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~ 153 (426)
..++....++|.+.+.+ |.|+||.||++..+.++. .+++|.+...... . .|+.....+ +||||++++++
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~-----~~~~k~~~~~~~~-~--~e~~~~~~~~~h~~iv~~~~~ 77 (267)
T PHA03390 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQK-----LFVQKIIKAKNFN-A--IEPMVHQLMKDNPNFIKLYYS 77 (267)
T ss_pred HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCc-----EEEEEEEehhhcc-h--hhHHHHHHhhcCCCEEEEEEE
Confidence 34445556777777776 999999999999877654 6788877543211 1 133333323 79999999999
Q ss_pred EEccCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCC-C
Q 014363 154 CADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW-N 232 (426)
Q Consensus 154 ~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~-~ 232 (426)
+...+ ..|+||||+++++|.+++.... .+++..++.++.|+++||.|||+. +++||||||+||+++.++ .
T Consensus 78 ~~~~~----~~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~ 148 (267)
T PHA03390 78 VTTLK----GHVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDR 148 (267)
T ss_pred EecCC----eeEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCe
Confidence 98866 4599999999999999996543 589999999999999999999998 999999999999999998 9
Q ss_pred eeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHh
Q 014363 233 AKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK 312 (426)
Q Consensus 233 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~ 312 (426)
++|+|||++...... ....|+..|+|||++.+..++.++||||||+++|+|++|..||....... .....+.
T Consensus 149 ~~l~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~- 220 (267)
T PHA03390 149 IYLCDYGLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLL- 220 (267)
T ss_pred EEEecCccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHH-
Confidence 999999998765432 23468999999999998899999999999999999999999997443221 1111110
Q ss_pred hhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCC-HHHHHHH
Q 014363 313 PYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPK-MSEVLEM 365 (426)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-~~eil~~ 365 (426)
...... .......+..+.+++.+||+.+|.+||+ +++++++
T Consensus 221 ----------~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 221 ----------KRQQKK--LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred ----------Hhhccc--CCcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 000100 1122246678999999999999999996 6999865
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=295.30 Aligned_cols=247 Identities=25% Similarity=0.380 Sum_probs=200.7
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc----CCHHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR----GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
+|++.+.||.|+||.||++....++. .+++|.+... .....+.+|+.+++.++||||+++++++.+..
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~-----~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--- 72 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQ-----FYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGN--- 72 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCC-----EEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCC---
Confidence 47788899999999999998776543 6888887542 23446788999999999999999999987764
Q ss_pred ceEEEEEeeCCCCChhhhccCC--CCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeec
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPK--SETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 239 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 239 (426)
..++||||+++++|.+++... ....+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||
T Consensus 73 -~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g 148 (256)
T cd08530 73 -KLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLG 148 (256)
T ss_pred -EEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeecc
Confidence 469999999999999988652 124589999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014363 240 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 319 (426)
Q Consensus 240 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 319 (426)
++...... ......|++.|++||.+.+..++.++|+||||+++|+|++|..||...........
T Consensus 149 ~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~------------ 212 (256)
T cd08530 149 ISKVLKKN----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYK------------ 212 (256)
T ss_pred chhhhccC----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH------------
Confidence 99866543 12235688999999999988899999999999999999999999976543211110
Q ss_pred hhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 320 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.........+...+.++.+++.+||..+|++||++.+++++
T Consensus 213 -----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 213 -----VQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred -----HhcCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 01111112233567789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=299.62 Aligned_cols=272 Identities=24% Similarity=0.286 Sum_probs=197.0
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
.++|++.+.||+|+||.||+|.+..++. .+++|.+.... ....+.+|+++++.++||||+++++++.+...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~-----~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGR-----VVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPD 81 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCc-----EEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccc
Confidence 4689999999999999999999876654 68888774322 23457889999999999999999998865442
Q ss_pred C----CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeE
Q 014363 160 R----GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKL 235 (426)
Q Consensus 160 ~----~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl 235 (426)
. ....++||||+.+ +|...+... ...+++..+..++.|+++||.|||+. +|+|+||||+|||+++++.+||
T Consensus 82 ~~~~~~~~~~lv~~~~~~-~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l 156 (311)
T cd07866 82 KSKRKRGSVYMVTPYMDH-DLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKI 156 (311)
T ss_pred cccccCceEEEEEecCCc-CHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEE
Confidence 2 3356999999964 677666543 23589999999999999999999998 9999999999999999999999
Q ss_pred eeecccccCCCCCce---------eeeeeeecCcccCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhH
Q 014363 236 SDFGLARLGPSEGFT---------HVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQ 305 (426)
Q Consensus 236 ~DFGla~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~ 305 (426)
+|||++......... .......|++.|+|||++.+. .++.++||||||+++|+|++|..||.........
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~ 236 (311)
T cd07866 157 ADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQL 236 (311)
T ss_pred CcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 999999754322111 111234678899999987654 5789999999999999999999999765443322
Q ss_pred HHHHhHhh-----hhhhhhhhhhhcCCcCCCccc-------HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 306 KLLQWVKP-----YLSDAKQFRQIVDPRLEGKYS-------LRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 306 ~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~-------~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
..+..... .+..........+.......+ ......+.+++.+||+.||++|||+.|++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 237 HLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 22111000 000000000000000000000 1233678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=304.10 Aligned_cols=273 Identities=24% Similarity=0.316 Sum_probs=201.7
Q ss_pred CHHHHHHHhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceE
Q 014363 76 TIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLV 151 (426)
Q Consensus 76 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~ 151 (426)
...++....++|.+.+.||+|+||.||+|....++. .||+|.+.... ..+.+.+|+.++..++||||++++
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~ 82 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGL-----RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 82 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCe-----EEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCccccee
Confidence 345566678999999999999999999998765543 78999886432 235677899999999999999999
Q ss_pred eEEEccCCC--CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCC
Q 014363 152 GYCADDDER--GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE 229 (426)
Q Consensus 152 ~~~~~~~~~--~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~ 229 (426)
+++...... ....|++++++ +++|.+++... .+++..++.++.|++.||+|||+. +|+||||||+||+++.
T Consensus 83 ~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~ 155 (345)
T cd07877 83 DVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 155 (345)
T ss_pred eeeeecccccccccEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcC
Confidence 988654321 12358888887 88998887643 389999999999999999999998 9999999999999999
Q ss_pred CCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHH
Q 014363 230 QWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLL 308 (426)
Q Consensus 230 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~ 308 (426)
++.+||+|||++...... .....|+..|+|||++.+ ..++.++|||||||++|+|++|..||...........+
T Consensus 156 ~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~ 230 (345)
T cd07877 156 DCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 230 (345)
T ss_pred CCCEEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999999999998754322 233568999999998866 56888999999999999999999999654432211111
Q ss_pred HhHh--------hhhhhh--hhhhhhcCCcCCCcc---cHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 309 QWVK--------PYLSDA--KQFRQIVDPRLEGKY---SLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 309 ~~~~--------~~~~~~--~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.... ..+... ......+.......+ ....+..+.+++.+||+.||.+||++.+++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 231 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0000 000000 000000000000000 01235678999999999999999999999987
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=303.55 Aligned_cols=271 Identities=22% Similarity=0.232 Sum_probs=193.9
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhc-CCCCccceEeEEEccCCC
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDER 160 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~~ 160 (426)
+|...+.||+|+||.||+|...... ....+|+|.+.... ..+.+.+|+.++..+ +||||+++++++......
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 77 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETS---EEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGN 77 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCC---cCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecccc
Confidence 4778889999999999999987641 12368999875421 245678899999999 699999999876543222
Q ss_pred CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecc
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 240 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 240 (426)
....|+++||+. ++|.+++... ..+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 78 ~~~~~~~~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~ 151 (332)
T cd07857 78 FNELYLYEELME-ADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGL 151 (332)
T ss_pred CCcEEEEEeccc-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCC
Confidence 234588999985 6898888543 3489999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCce--eeeeeeecCcccCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHH-HHhHh----
Q 014363 241 ARLGPSEGFT--HVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKL-LQWVK---- 312 (426)
Q Consensus 241 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~-~~~~~---- 312 (426)
+......... .......|+..|+|||++.+ ..++.++||||||+++|+|++|..||........... .....
T Consensus 152 a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 231 (332)
T cd07857 152 ARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDE 231 (332)
T ss_pred ceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCH
Confidence 9765432111 11223578999999998765 4689999999999999999999999976442211110 00000
Q ss_pred ---hhhhhhh--hhhhhcCCcCCCc---ccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 313 ---PYLSDAK--QFRQIVDPRLEGK---YSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 313 ---~~~~~~~--~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
..+.... ............. .....+..+.+++.+||+.||++|||+.+++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 232 ETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000 0000000000000 011135678999999999999999999999876
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=304.96 Aligned_cols=269 Identities=23% Similarity=0.329 Sum_probs=197.4
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
.++|...+.||+|+||.||+|.+..++. .+|+|.+.... ....+.+|+.+++.++||||+++++++.....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 88 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGE-----KVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVS 88 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCc-----EEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheeccccc
Confidence 4789999999999999999999766544 78999875432 23457899999999999999999999875432
Q ss_pred C--CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEee
Q 014363 160 R--GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 237 (426)
Q Consensus 160 ~--~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~D 237 (426)
. ....++|+||+. .+|..++. ..+++..+..++.|++.||+|||+. +++||||||+|||++.++.+||+|
T Consensus 89 ~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~d 160 (342)
T cd07879 89 GDEFQDFYLVMPYMQ-TDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILD 160 (342)
T ss_pred CCCCceEEEEecccc-cCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEee
Confidence 1 124589999995 47777653 2388999999999999999999998 999999999999999999999999
Q ss_pred ecccccCCCCCceeeeeeeecCcccCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhh---
Q 014363 238 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKP--- 313 (426)
Q Consensus 238 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~--- 313 (426)
||++...... .....++..|+|||++.+ ..++.++|||||||++|||++|+.||...........+.....
T Consensus 161 fg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 235 (342)
T cd07879 161 FGLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG 235 (342)
T ss_pred CCCCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 9998754322 223567889999998876 4588999999999999999999999976543221111110000
Q ss_pred -----hhhhh--hhhhhhcCCcCCCcc---cHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HHHhH
Q 014363 314 -----YLSDA--KQFRQIVDPRLEGKY---SLRLVSKLSHVANLCLVKNARTRPKMSEVLEM--VNKIV 370 (426)
Q Consensus 314 -----~~~~~--~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~--L~~~~ 370 (426)
.+... ............... ....+..+.+++.+||+.||++||++++++.+ ++...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 236 PEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred HHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 00000 000000000000000 01234678899999999999999999999976 65543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=301.42 Aligned_cols=265 Identities=23% Similarity=0.328 Sum_probs=198.3
Q ss_pred HHHhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc----CCHHHHHHHHHHHhhcCCCCccceEeEEEc
Q 014363 81 KSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR----GGHKEWMTEVNFLGIVEHQNLVKLVGYCAD 156 (426)
Q Consensus 81 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 156 (426)
...+++|+..+.||.|+||.||+|....++. .+++|.+... ...+.+..|+.+++.++||||+++++++..
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 80 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQ-----NVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFIS 80 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCC-----EEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEec
Confidence 3457889999999999999999999776554 7888876432 234577899999999999999999999876
Q ss_pred cCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEe
Q 014363 157 DDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLS 236 (426)
Q Consensus 157 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~ 236 (426)
... ..|+||||+ +++|.+++... .+++..+..++.|+++||.|||+. +|+||||+|+|||++.++.+||+
T Consensus 81 ~~~---~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~ 150 (328)
T cd07856 81 PLE---DIYFVTELL-GTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKIC 150 (328)
T ss_pred CCC---cEEEEeehh-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeC
Confidence 443 358999999 66898888632 378888899999999999999998 99999999999999999999999
Q ss_pred eecccccCCCCCceeeeeeeecCcccCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHH-hHhhh
Q 014363 237 DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQ-WVKPY 314 (426)
Q Consensus 237 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~-~~~~~ 314 (426)
|||++...... .....++..|+|||++.+ ..++.++||||||+++|+|++|..||............. .....
T Consensus 151 dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~ 225 (328)
T cd07856 151 DFGLARIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTP 225 (328)
T ss_pred ccccccccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 99998754321 123467889999998766 568999999999999999999999997654422211111 00000
Q ss_pred -------hhhhhhhhhhcCCcCCCccc-----HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 315 -------LSDAKQFRQIVDPRLEGKYS-----LRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 315 -------~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
........-..........+ ..++..+.+++.+||+.+|++||++.+++.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 226 PDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred CHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000000000011111 1245789999999999999999999999876
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=298.12 Aligned_cols=244 Identities=26% Similarity=0.401 Sum_probs=193.9
Q ss_pred cceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC--CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCceEEEE
Q 014363 90 SVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLV 167 (426)
Q Consensus 90 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~~~lv 167 (426)
..+||+|+||.||++....++. .+++|.+.... ....+.+|+.+++.++||||+++++++...+ ..++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~-----~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~lv 95 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGK-----LVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD----ELWVV 95 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCe-----EEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCC----EEEEE
Confidence 3579999999999998876554 78888875332 3456889999999999999999999998765 45999
Q ss_pred EeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccCCCC
Q 014363 168 YEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSE 247 (426)
Q Consensus 168 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 247 (426)
|||+++++|.+++... .+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 96 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~ 169 (292)
T cd06657 96 MEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 169 (292)
T ss_pred EecCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccc
Confidence 9999999999987532 378999999999999999999998 9999999999999999999999999998755432
Q ss_pred CceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCC
Q 014363 248 GFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDP 327 (426)
Q Consensus 248 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (426)
. .......|++.|+|||++.+..++.++||||||+++|+|++|..||............. .....
T Consensus 170 ~--~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~-------------~~~~~ 234 (292)
T cd06657 170 V--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR-------------DNLPP 234 (292)
T ss_pred c--ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-------------hhCCc
Confidence 1 11233568999999999988889999999999999999999999997543321111110 01111
Q ss_pred cCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 328 RLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 328 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.+. ....++..+.+++.+||+.||.+||++.+++++
T Consensus 235 ~~~--~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 235 KLK--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred ccC--CcccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 111 011245678899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=293.98 Aligned_cols=276 Identities=26% Similarity=0.406 Sum_probs=201.2
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhh--cCCCCccceEeEEEccCCCCce
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGI--VEHQNLVKLVGYCADDDERGIQ 163 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~--l~HpnIv~~~~~~~~~~~~~~~ 163 (426)
..+..++||+|.||.||+|...+. .||||++... ..+.|.+|-+|.+. ++|+||++++++-........+
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~~~-------~VAVKifp~~-~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~e 282 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLDNR-------LVAVKIFPEQ-EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRME 282 (534)
T ss_pred chhhHHHhhcCccceeehhhccCc-------eeEEEecCHH-HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccc
Confidence 344556799999999999998763 7999998654 35678888888776 4899999999887765544557
Q ss_pred EEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCC------CCCeEeccCCCCceEeCCCCCeeEee
Q 014363 164 RLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGM------DFQIIVRDFKSSNILLDEQWNAKLSD 237 (426)
Q Consensus 164 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~------~~~iiHrDlkp~NILl~~~~~~kl~D 237 (426)
++||+||.+.|+|.+||..+- ++|....+|+..+++||+|||+.. .++|+|||||..||||..|+...|+|
T Consensus 283 ywLVt~fh~kGsL~dyL~~nt---isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD 359 (534)
T KOG3653|consen 283 YWLVTEFHPKGSLCDYLKANT---ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD 359 (534)
T ss_pred eeEEeeeccCCcHHHHHHhcc---ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence 799999999999999997543 999999999999999999999642 46899999999999999999999999
Q ss_pred ecccccCCCCCceeeeeeeecCcccCCchhhccCCC-C-----CchhhHHHHHHHHHHHhCCCCCCCCCchhhH-HHHHh
Q 014363 238 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRL-A-----ARSDVWSYGVFLYELITGRRPIDRNRPRSEQ-KLLQW 310 (426)
Q Consensus 238 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~-----~~~DvwslGvil~elltg~~p~~~~~~~~~~-~~~~~ 310 (426)
||+|..+............+||.+|||||++.+... . .+.||||+|.+||||++...-++.....+.+ .+...
T Consensus 360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~e 439 (534)
T KOG3653|consen 360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAE 439 (534)
T ss_pred cceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHH
Confidence 999987764433333345799999999999986432 2 3689999999999999976544311100000 00000
Q ss_pred Hhhhhhhhhhhhhh-----cCCcCCCcccH-HHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhh
Q 014363 311 VKPYLSDAKQFRQI-----VDPRLEGKYSL-RLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 373 (426)
Q Consensus 311 ~~~~~~~~~~~~~~-----~~~~~~~~~~~-~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~ 373 (426)
+... ...+.++.. ..|.+...... .-...+++.+..||+.|++.|.|+.=+.+.+.++....
T Consensus 440 vG~h-Pt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 440 VGNH-PTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred hcCC-CCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 0000 000111111 11222111111 23467889999999999999999999988887775443
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=298.41 Aligned_cols=249 Identities=28% Similarity=0.439 Sum_probs=200.7
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-----CCHHHHHHHHHHHhhcC-CCCccceEeEEEccC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-----GGHKEWMTEVNFLGIVE-HQNLVKLVGYCADDD 158 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-----~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~~~~ 158 (426)
++|...+.||+|+||.||+|....++. .+++|.+... .....+..|+.++..+. ||||+++++++.+..
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~-----~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~ 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNK-----EYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEE 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCC-----EEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCc
Confidence 468889999999999999999876544 7888887542 22356788999999998 999999999887665
Q ss_pred CCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeee
Q 014363 159 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 238 (426)
Q Consensus 159 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 238 (426)
..++||||+++++|.+++.... .+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+||
T Consensus 76 ----~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df 146 (280)
T cd05581 76 ----NLYFVLEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDF 146 (280)
T ss_pred ----eEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCC
Confidence 3599999999999999997543 499999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCce------------------eeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCC
Q 014363 239 GLARLGPSEGFT------------------HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNR 300 (426)
Q Consensus 239 Gla~~~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~ 300 (426)
|++......... .......|+..|+|||++.+..++.++||||||++++++++|..||....
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 226 (280)
T cd05581 147 GTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN 226 (280)
T ss_pred ccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 998765432211 12234568899999999988889999999999999999999999997654
Q ss_pred chhhHHHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCH----HHHHHH
Q 014363 301 PRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKM----SEVLEM 365 (426)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~----~eil~~ 365 (426)
.... . .... .....++..++..+.+++.+||+.+|++||++ .+++++
T Consensus 227 ~~~~---~-------------~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 227 EYLT---F-------------QKIL--KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred HHHH---H-------------HHHH--hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 2110 0 1111 11112333446789999999999999999999 887764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=294.98 Aligned_cols=265 Identities=26% Similarity=0.346 Sum_probs=196.6
Q ss_pred CCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhc---CCCCccceEeEEEccCC
Q 014363 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIV---EHQNLVKLVGYCADDDE 159 (426)
Q Consensus 87 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l---~HpnIv~~~~~~~~~~~ 159 (426)
|++.+.||+|+||.||+|.++.++. .+++|.+.... ....+.+|+.++..+ +||||+++++++.+.+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~-----~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 75 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGR-----FVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRT 75 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCC-----EEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccC
Confidence 5678899999999999999876443 78999886332 223566788877666 69999999999987654
Q ss_pred -CCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeee
Q 014363 160 -RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 238 (426)
Q Consensus 160 -~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 238 (426)
.....+++|||++ ++|.+++.......+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.+||+||
T Consensus 76 ~~~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~df 151 (287)
T cd07838 76 DRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADF 151 (287)
T ss_pred CCCceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEecc
Confidence 2223699999996 4898888654444589999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh-
Q 014363 239 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD- 317 (426)
Q Consensus 239 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~- 317 (426)
|++........ .....++..|+|||++.+..++.++||||||+++|+|++|..||.......... .........
T Consensus 152 g~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 226 (287)
T cd07838 152 GLARIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLD--KIFDVIGLPS 226 (287)
T ss_pred CcceeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHH--HHHHHcCCCC
Confidence 99976543221 123457889999999998899999999999999999999999997644322111 111100000
Q ss_pred hhhh-------hhhcCCcCC---CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 318 AKQF-------RQIVDPRLE---GKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 318 ~~~~-------~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.... ......... .......+..+.+++.+||+.||++||++.+++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 227 EEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred hHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 0000 000000000 11122456788899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=295.31 Aligned_cols=263 Identities=24% Similarity=0.292 Sum_probs=197.6
Q ss_pred CCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCc
Q 014363 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 162 (426)
Q Consensus 87 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~ 162 (426)
|...+.||.|++|.||+|....++. .+++|.+.... ....+.+|+.+++.++||||+++++++.+..
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~-----~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---- 71 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGE-----IVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKG---- 71 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCc-----EEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCC----
Confidence 5677889999999999999765543 68888875432 2456789999999999999999999988765
Q ss_pred eEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccc
Q 014363 163 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 242 (426)
Q Consensus 163 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 242 (426)
..++||||+++ +|.+++.... ..+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||.+.
T Consensus 72 ~~~~v~e~~~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~ 146 (283)
T cd05118 72 DLYLVFEFMDT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLAR 146 (283)
T ss_pred CEEEEEeccCC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeE
Confidence 35999999965 8888876543 4589999999999999999999998 99999999999999999999999999997
Q ss_pred cCCCCCceeeeeeeecCcccCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhH-h-hhhhhhh
Q 014363 243 LGPSEGFTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWV-K-PYLSDAK 319 (426)
Q Consensus 243 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~-~-~~~~~~~ 319 (426)
...... .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||............... . +......
T Consensus 147 ~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (283)
T cd05118 147 SFGSPV--RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWP 224 (283)
T ss_pred ecCCCc--ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcc
Confidence 665432 112234688899999998876 6889999999999999999999999765432221111000 0 0000000
Q ss_pred hhhh--------hcCC--cCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 320 QFRQ--------IVDP--RLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 320 ~~~~--------~~~~--~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.+.+ .... .........++..+.+++.+||+.||.+||++.+++.+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 225 KFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred cchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0000 0000 00011123467889999999999999999999999875
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=289.73 Aligned_cols=247 Identities=32% Similarity=0.474 Sum_probs=200.1
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
+|+..+.||+|++|.||+|.....+. .+++|.+.... ....+.+|+++++.++|||++++++++.+..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~-----~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--- 72 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGD-----FVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSD--- 72 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCc-----EEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCC---
Confidence 47788999999999999998776554 68888876543 3456889999999999999999999987754
Q ss_pred ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccc
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 241 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 241 (426)
..+++|||+++++|.+++... ..+++..++.++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++
T Consensus 73 -~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~ 146 (254)
T cd06627 73 -SLYIILEYAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVA 146 (254)
T ss_pred -EEEEEEecCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccc
Confidence 459999999999999998654 3589999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhh
Q 014363 242 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 321 (426)
Q Consensus 242 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (426)
......... .....|+..|+|||.+.+..++.++||||||+++|+|++|..||........ ....
T Consensus 147 ~~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~--~~~~----------- 211 (254)
T cd06627 147 TKLNDVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA--LFRI----------- 211 (254)
T ss_pred eecCCCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH--HHHH-----------
Confidence 866543211 2345689999999998888889999999999999999999999975432111 1000
Q ss_pred hhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 322 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.. ......+...+..+.+++.+||..+|++||++.+++.+
T Consensus 212 ~~----~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 212 VQ----DDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred hc----cCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 00 01112223456788999999999999999999999864
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=296.71 Aligned_cols=241 Identities=26% Similarity=0.380 Sum_probs=185.9
Q ss_pred eecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-----CHHHHHHHHH---HHhhcCCCCccceEeEEEccCCCCce
Q 014363 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-----GHKEWMTEVN---FLGIVEHQNLVKLVGYCADDDERGIQ 163 (426)
Q Consensus 92 ~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-----~~~~~~~E~~---~l~~l~HpnIv~~~~~~~~~~~~~~~ 163 (426)
+||+|+||.||+|....++. .||+|.+.... ....+..|.. .++...||||+++++++.+.+ .
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~----~ 71 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGK-----MYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD----K 71 (278)
T ss_pred CcccCCCeEEEEEEEecCCC-----EEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCC----E
Confidence 48999999999998766544 78999875432 1122344443 344458999999999988766 3
Q ss_pred EEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccccc
Q 014363 164 RLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL 243 (426)
Q Consensus 164 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 243 (426)
.++||||++|++|.+++... ..+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++..
T Consensus 72 ~~~v~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~ 146 (278)
T cd05606 72 LSFILDLMNGGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 146 (278)
T ss_pred EEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccc
Confidence 59999999999999988643 3589999999999999999999998 999999999999999999999999999875
Q ss_pred CCCCCceeeeeeeecCcccCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhh
Q 014363 244 GPSEGFTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFR 322 (426)
Q Consensus 244 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (426)
..... .....|+..|+|||++.++ .++.++||||||+++|+|++|..||............. ..
T Consensus 147 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~-----------~~ 211 (278)
T cd05606 147 FSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR-----------MT 211 (278)
T ss_pred cCccC----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHH-----------Hh
Confidence 43221 2235799999999998754 58999999999999999999999997653322111100 00
Q ss_pred hhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 014363 323 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRP-----KMSEVLEM 365 (426)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~ 365 (426)
..... ..+...+..+.+++.+||..+|++|| ++.+++++
T Consensus 212 ~~~~~----~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 212 LTMAV----ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred hccCC----CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 00111 12223467899999999999999999 99999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=297.63 Aligned_cols=270 Identities=27% Similarity=0.338 Sum_probs=198.3
Q ss_pred HhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccC
Q 014363 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 158 (426)
Q Consensus 83 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 158 (426)
..++|++.+.||+|+||.||+|.+...+. .|++|.+.... ....+.+|+.+++.++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~-----~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~ 79 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGE-----LVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQ 79 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCc-----EEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcc
Confidence 45689999999999999999999876554 68888875432 3346778999999999999999999987654
Q ss_pred C------CCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCC
Q 014363 159 E------RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWN 232 (426)
Q Consensus 159 ~------~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~ 232 (426)
. .....++|+||+++ +|.+++... ...+++..++.++.|++.||+|||+. +|+|+||||+||++++++.
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~ 154 (302)
T cd07864 80 DALDFKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQ 154 (302)
T ss_pred hhhhccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCc
Confidence 1 11256999999976 777776543 23589999999999999999999998 9999999999999999999
Q ss_pred eeEeeecccccCCCCCceeeeeeeecCcccCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhH
Q 014363 233 AKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWV 311 (426)
Q Consensus 233 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~ 311 (426)
+||+|||++........ .......++..|+|||++.+. .++.++|||||||++|+|++|+.||...........+...
T Consensus 155 ~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~ 233 (302)
T cd07864 155 IKLADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRL 233 (302)
T ss_pred EEeCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 99999999986543321 111223567889999987653 5788999999999999999999999765433222221111
Q ss_pred hhhhhhhhhhhhhcC--------------CcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 312 KPYLSDAKQFRQIVD--------------PRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 312 ~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
... ........+.. ..+.. ....++..+.+++.+||+.||++||++.+++.+
T Consensus 234 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 234 CGS-PCPAVWPDVIKLPYFNTMKPKKQYRRRLRE-EFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred hCC-CChhhcccccccccccccccccccccchhh-hcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000 00000000000 00000 011246789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=303.25 Aligned_cols=267 Identities=24% Similarity=0.325 Sum_probs=198.3
Q ss_pred HHhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEcc
Q 014363 82 SATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADD 157 (426)
Q Consensus 82 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 157 (426)
...++|+..+.||+|+||.||+|....++. .||+|.+.... ....+.+|+.+|+.++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 86 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGA-----KVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPD 86 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCc-----EEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCC
Confidence 346789999999999999999998776543 78999875432 234678999999999999999999998765
Q ss_pred CCCC--ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeE
Q 014363 158 DERG--IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKL 235 (426)
Q Consensus 158 ~~~~--~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl 235 (426)
.... ...++||||+ +++|.+++.. ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||
T Consensus 87 ~~~~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl 159 (343)
T cd07880 87 LSLDRFHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKI 159 (343)
T ss_pred ccccccceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEE
Confidence 4321 2458999999 7899888863 2489999999999999999999998 9999999999999999999999
Q ss_pred eeecccccCCCCCceeeeeeeecCcccCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHH-HHHhHh-
Q 014363 236 SDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQK-LLQWVK- 312 (426)
Q Consensus 236 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~-~~~~~~- 312 (426)
+|||++...... .....+++.|+|||++.+ ..++.++||||||+++|+|++|..||.......... ......
T Consensus 160 ~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 234 (343)
T cd07880 160 LDFGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGT 234 (343)
T ss_pred eecccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 999999764332 223467899999998876 457889999999999999999999997544321111 000000
Q ss_pred ------hhhhh--hhhhhhhcCCcCCC---cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 313 ------PYLSD--AKQFRQIVDPRLEG---KYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 313 ------~~~~~--~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
..+.. .......+...... .....++..+.+++.+||+.||++|||+.+++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 235 PSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred CCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000 00000000000000 0111345678899999999999999999999975
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=293.73 Aligned_cols=265 Identities=25% Similarity=0.347 Sum_probs=196.4
Q ss_pred CCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCc
Q 014363 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 162 (426)
Q Consensus 87 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~ 162 (426)
|++.+.||.|+||.||+|.....+. .+++|.+.... ....+.+|+.+++.++||||+++++++.+... .
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~-----~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~--~ 73 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGE-----LVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGK--G 73 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCe-----EEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCC--C
Confidence 5677899999999999999876543 78899886542 33567899999999999999999999987621 1
Q ss_pred eEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccc
Q 014363 163 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 242 (426)
Q Consensus 163 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 242 (426)
..++||||+++ +|.+++.... ..+++..++.++.|++.||+|||+. +++|+||||+|||+++++.+||+|||++.
T Consensus 74 ~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~ 148 (287)
T cd07840 74 SIYMVFEYMDH-DLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLAR 148 (287)
T ss_pred cEEEEeccccc-cHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEcccccee
Confidence 45999999974 8888886542 3589999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCCCceeeeeeeecCcccCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhh
Q 014363 243 LGPSEGFTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 321 (426)
Q Consensus 243 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (426)
....... .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||................... .....
T Consensus 149 ~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~-~~~~~ 226 (287)
T cd07840 149 PYTKRNS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSP-TDENW 226 (287)
T ss_pred eccCCCc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC-chhhc
Confidence 6644321 11223457889999997765 457899999999999999999999997654322211111000000 00000
Q ss_pred hhh--------cCC------cCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 322 RQI--------VDP------RLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 322 ~~~--------~~~------~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
... ... .+...+...++..+.+++.+||..+|++||++.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 227 PGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred cccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 000 000 00000111126788999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=292.03 Aligned_cols=240 Identities=25% Similarity=0.316 Sum_probs=184.3
Q ss_pred ceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-----CHHHHHHHHHHH-hhcCCCCccceEeEEEccCCCCceE
Q 014363 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-----GHKEWMTEVNFL-GIVEHQNLVKLVGYCADDDERGIQR 164 (426)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-----~~~~~~~E~~~l-~~l~HpnIv~~~~~~~~~~~~~~~~ 164 (426)
+.||.|+||.||+|.....+. .+++|.+.... ....+..|..++ ...+||||+++++++...+ ..
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~----~~ 72 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGD-----YFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKD----YL 72 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCC-----eEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCC----eE
Confidence 469999999999998876554 78999875432 112344555444 4458999999999998755 45
Q ss_pred EEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccC
Q 014363 165 LLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLG 244 (426)
Q Consensus 165 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 244 (426)
|+||||+++++|.+++.... .+++..+..++.|++.||.|||+. +++||||+|+||+++.++.+||+|||++...
T Consensus 73 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 147 (260)
T cd05611 73 YLVMEYLNGGDCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNG 147 (260)
T ss_pred EEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceec
Confidence 99999999999999996543 488999999999999999999998 9999999999999999999999999998754
Q ss_pred CCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhh
Q 014363 245 PSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQI 324 (426)
Q Consensus 245 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (426)
.. .....|+..|+|||.+.+..++.++||||||+++|+|++|..||............. . .
T Consensus 148 ~~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~------~------~- 208 (260)
T cd05611 148 LE------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNIL------S------R- 208 (260)
T ss_pred cc------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH------h------c-
Confidence 32 223568899999999988888999999999999999999999997543321111000 0 0
Q ss_pred cCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014363 325 VDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 364 (426)
Q Consensus 325 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~ 364 (426)
...........++..+.+++.+||+.||++||++.++.+
T Consensus 209 -~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~ 247 (260)
T cd05611 209 -RINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQE 247 (260)
T ss_pred -ccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHH
Confidence 000111111235678999999999999999997654433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=300.82 Aligned_cols=257 Identities=27% Similarity=0.399 Sum_probs=200.7
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---------CHHHHHHHHHHHhhcCCCCccceEeEEE
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---------GHKEWMTEVNFLGIVEHQNLVKLVGYCA 155 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---------~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 155 (426)
++|-.+.+||+|||+.||+|.+..... .||+|+..-.. ..+...+|.+|.+.|+||.||++|+||.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqR-----YvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfs 537 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQR-----YVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFS 537 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhh-----eeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeee
Confidence 356667799999999999998665543 78888764322 3345789999999999999999999997
Q ss_pred ccCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeC---CCCC
Q 014363 156 DDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLD---EQWN 232 (426)
Q Consensus 156 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~---~~~~ 232 (426)
-+... +|-|+|||+|.+|+-||..+ +.+++.++..|+.||+.||.||.+. ..+|||-||||.|||+. .-|.
T Consensus 538 lDtds---FCTVLEYceGNDLDFYLKQh--klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGe 611 (775)
T KOG1151|consen 538 LDTDS---FCTVLEYCEGNDLDFYLKQH--KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGE 611 (775)
T ss_pred ecccc---ceeeeeecCCCchhHHHHhh--hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccce
Confidence 65543 58999999999999999765 4589999999999999999999987 67999999999999994 3478
Q ss_pred eeEeeecccccCCCCCcee-----eeeeeecCcccCCchhhccC----CCCCchhhHHHHHHHHHHHhCCCCCCCCCchh
Q 014363 233 AKLSDFGLARLGPSEGFTH-----VSTAVVGTMGYAAPEYVQTG----RLAARSDVWSYGVFLYELITGRRPIDRNRPRS 303 (426)
Q Consensus 233 ~kl~DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslGvil~elltg~~p~~~~~~~~ 303 (426)
+||+||||++.+.++.+.. .+....||.+|++||.+.-+ ..+.|+||||+|||+|+++.|+.||+.+..
T Consensus 612 IKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs-- 689 (775)
T KOG1151|consen 612 IKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS-- 689 (775)
T ss_pred eEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh--
Confidence 9999999999887655442 34567899999999977533 468899999999999999999999986532
Q ss_pred hHHHHHhHhhhhhhhhhhhhhcCC-cCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 304 EQKLLQWVKPYLSDAKQFRQIVDP-RLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.+++.+.. .++.. .+.-..-+.++.+...+|++||+..-++|....++..+
T Consensus 690 QQdILqeN-----------TIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~d 741 (775)
T KOG1151|consen 690 QQDILQEN-----------TILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACD 741 (775)
T ss_pred HHHHHhhh-----------chhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence 22222210 11111 01111112466789999999999999999999888664
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=293.75 Aligned_cols=244 Identities=27% Similarity=0.410 Sum_probs=191.6
Q ss_pred ecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-----CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCceEEEE
Q 014363 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLV 167 (426)
Q Consensus 93 lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~~~lv 167 (426)
||.|+||.||+|.+..++. .+++|.+.... ..+.+.+|++++..++||||+++++.+.... ..|+|
T Consensus 1 lg~g~~~~vy~~~~~~~~~-----~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~----~~~lv 71 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGD-----IYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKK----NLYLV 71 (265)
T ss_pred CCCCCceEEEEEEECCCCC-----EEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCc----EEEEE
Confidence 6899999999999876554 78999875442 3456889999999999999999998887654 45999
Q ss_pred EeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccCCCC
Q 014363 168 YEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSE 247 (426)
Q Consensus 168 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 247 (426)
|||+++++|.+++.... .+++..++.++.||+.||.|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 72 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~ 146 (265)
T cd05579 72 MEYLPGGDLASLLENVG--SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVR 146 (265)
T ss_pred EecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccC
Confidence 99999999999997543 489999999999999999999998 9999999999999999999999999998754332
Q ss_pred Cc------eeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhh
Q 014363 248 GF------THVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 321 (426)
Q Consensus 248 ~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (426)
.. ........++..|++||.+.+..++.++||||||+++|+|++|..||..........
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~--------------- 211 (265)
T cd05579 147 RQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQ--------------- 211 (265)
T ss_pred cccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH---------------
Confidence 11 112234568899999999988889999999999999999999999997554321111
Q ss_pred hhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014363 322 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMV 366 (426)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L 366 (426)
...............+..+.+++.+||+.+|++|||+.++.+.|
T Consensus 212 -~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 212 -NILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred -HHhcCCcCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 11110111111111367889999999999999999995544443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=298.20 Aligned_cols=258 Identities=23% Similarity=0.280 Sum_probs=188.3
Q ss_pred eecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc----CCHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCceEEEE
Q 014363 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR----GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLV 167 (426)
Q Consensus 92 ~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~~~lv 167 (426)
.+|.|++ ||++....++ ..+|+|.+... ...+.+.+|+.+++.++||||+++++++.+... .+++
T Consensus 9 ~~~~~~~--v~~~~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~----~~~~ 77 (314)
T cd08216 9 CFEDLMI--VHLAKHKPTN-----TLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSE----LYVV 77 (314)
T ss_pred hhcCCce--EEEEEecCCC-----CEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCe----EEEE
Confidence 3444444 4554444433 37899987543 234578899999999999999999999987653 5999
Q ss_pred EeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccCCCC
Q 014363 168 YEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSE 247 (426)
Q Consensus 168 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 247 (426)
|||+++|+|.+++.......+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.+......
T Consensus 78 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~ 154 (314)
T cd08216 78 SPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKH 154 (314)
T ss_pred EeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccc
Confidence 9999999999999765445588999999999999999999998 9999999999999999999999999988654322
Q ss_pred Cc-----eeeeeeeecCcccCCchhhcc--CCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhh---hhh
Q 014363 248 GF-----THVSTAVVGTMGYAAPEYVQT--GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPY---LSD 317 (426)
Q Consensus 248 ~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~---~~~ 317 (426)
.. ........++..|+|||++.. ..++.++|||||||++|||++|..||........ ........ +..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~ 232 (314)
T cd08216 155 GKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LLEKVRGTVPCLLD 232 (314)
T ss_pred cccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccCccccc
Confidence 11 111233467889999999876 3588999999999999999999999975432211 11111000 000
Q ss_pred hhh-------hhh----hc----CCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 318 AKQ-------FRQ----IV----DPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 318 ~~~-------~~~----~~----~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
... ... .. ...........+..++.+++.+||+.||++|||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 233 KSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred cCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 000 000 00 0011122334566789999999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=303.66 Aligned_cols=269 Identities=24% Similarity=0.312 Sum_probs=201.6
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc----CCHHHHHHHHHHHhhcCCCCccceEeEEEccC-CC
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR----GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDD-ER 160 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~-~~ 160 (426)
+|.+.+.||.|+||.||+|.....+. .+++|.+... ...+.+.+|+.+++.++||||+++++++.+.. ..
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~-----~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGR-----KVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPED 75 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCc-----EEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCccc
Confidence 47888999999999999999776543 7899887643 23467889999999999999999999988764 12
Q ss_pred CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecc
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 240 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 240 (426)
....|+||||++ ++|.+++.... .+++..++.++.|++.||.|||+. +|+||||||+|||++.++.++|+|||+
T Consensus 76 ~~~~~lv~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~ 149 (330)
T cd07834 76 FNDVYIVTELME-TDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGL 149 (330)
T ss_pred ccceEEEecchh-hhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCc
Confidence 224699999996 58988886543 589999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCc-eeeeeeeecCcccCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHh-Hhhhhh-
Q 014363 241 ARLGPSEGF-THVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQW-VKPYLS- 316 (426)
Q Consensus 241 a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~-~~~~~~- 316 (426)
+........ ........++..|+|||++.+. .++.++||||||+++|+|++|..||...........+.. ......
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 229 (330)
T cd07834 150 ARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEE 229 (330)
T ss_pred eEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChh
Confidence 986544321 0112345688999999999887 789999999999999999999999976553322111110 000000
Q ss_pred -----hhhhhhhhcC---CcCC---CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 317 -----DAKQFRQIVD---PRLE---GKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 317 -----~~~~~~~~~~---~~~~---~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
........+. .... .......+..+.+++.+||+.+|++||++.+++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 230 DLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred HhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0000000000 0000 00111246788999999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=296.12 Aligned_cols=241 Identities=27% Similarity=0.434 Sum_probs=202.2
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-----CCHHHHHHHHHHHhhc-CCCCccceEeEEEcc
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-----GGHKEWMTEVNFLGIV-EHQNLVKLVGYCADD 157 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-----~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~ 157 (426)
..+|..+.+||+|+||.|-+|..+++.+ .+|||+++++ ++.+.-+.|-++|... +-|.++++...|+.-
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdE-----LyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTm 422 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDE-----LYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTM 422 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcch-----hhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhh
Confidence 3579999999999999999999888766 6777776543 4555667899999887 678899999888877
Q ss_pred CCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEee
Q 014363 158 DERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 237 (426)
Q Consensus 158 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~D 237 (426)
+. +|+||||+.||+|--.|++-+. +.+..+..++.+|+-||-|||++ |||.||||.+|||+|.+|++||+|
T Consensus 423 DR----LyFVMEyvnGGDLMyhiQQ~Gk--FKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~D 493 (683)
T KOG0696|consen 423 DR----LYFVMEYVNGGDLMYHIQQVGK--FKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIAD 493 (683)
T ss_pred hh----eeeEEEEecCchhhhHHHHhcc--cCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeee
Confidence 64 4999999999999888876654 88888999999999999999998 999999999999999999999999
Q ss_pred ecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh
Q 014363 238 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 317 (426)
Q Consensus 238 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 317 (426)
||+++..-..+ ..+.++||||.|+|||++...+|+..+|.||+||+||||+.|++||++.+.. .+
T Consensus 494 FGmcKEni~~~--~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~---el---------- 558 (683)
T KOG0696|consen 494 FGMCKENIFDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED---EL---------- 558 (683)
T ss_pred cccccccccCC--cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH---HH----------
Confidence 99998644333 3466899999999999999999999999999999999999999999875432 22
Q ss_pred hhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCC
Q 014363 318 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPK 358 (426)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs 358 (426)
++.+++.. -.|+..++.+...+....|...|.+|..
T Consensus 559 ---F~aI~ehn--vsyPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 559 ---FQAIMEHN--VSYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred ---HHHHHHcc--CcCcccccHHHHHHHHHHhhcCCccccC
Confidence 22333322 2467778889999999999999999953
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=305.36 Aligned_cols=270 Identities=20% Similarity=0.285 Sum_probs=195.5
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC--CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
..+|...+.||.|+||.||+|....++. .|++|.+.... ..+.+.+|+.+++.++||||+++++++.......
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~-----~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDK-----RVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDL 78 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCc-----EEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccc
Confidence 3689999999999999999999876554 78888775433 4456889999999999999999998776543211
Q ss_pred ----------ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeC-CC
Q 014363 162 ----------IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLD-EQ 230 (426)
Q Consensus 162 ----------~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~-~~ 230 (426)
...|+||||++ ++|.+++... .+++..++.++.|++.||.|||+. +|+||||||+||+++ .+
T Consensus 79 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~ 151 (342)
T cd07854 79 TEDVGSLTELNSVYIVQEYME-TDLANVLEQG---PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTED 151 (342)
T ss_pred ccccccccccceEEEEeeccc-ccHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCC
Confidence 14689999996 5898887532 388999999999999999999998 999999999999997 45
Q ss_pred CCeeEeeecccccCCCCCce-eeeeeeecCcccCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHH
Q 014363 231 WNAKLSDFGLARLGPSEGFT-HVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLL 308 (426)
Q Consensus 231 ~~~kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~ 308 (426)
+.+||+|||++......... .......|+..|+|||++.. ..++.++|||||||++|+|++|..||....+.......
T Consensus 152 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~ 231 (342)
T cd07854 152 LVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLI 231 (342)
T ss_pred ceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 57899999999754322111 11123467889999997654 45788999999999999999999999765443222211
Q ss_pred HhHhhhhh--hhhh----hhhhcC---CcCCC---cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 309 QWVKPYLS--DAKQ----FRQIVD---PRLEG---KYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 309 ~~~~~~~~--~~~~----~~~~~~---~~~~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
....+... .... ...... ..... ......+.++.+++.+||+.||++|||+.+++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 232 LESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred HHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 11000000 0000 000000 00000 0011245678899999999999999999999976
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=297.16 Aligned_cols=243 Identities=31% Similarity=0.451 Sum_probs=190.6
Q ss_pred CCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-----CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 87 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
|...+.||+|+||.||+|....++. .+++|.+.... ....+.+|+.+++.++|||++++++++.+..
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~-----~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--- 94 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNE-----VVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEH--- 94 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCc-----EEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCC---
Confidence 6667789999999999998766544 78888875322 2246788999999999999999999998765
Q ss_pred ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccc
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 241 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 241 (426)
..|+||||+. |+|.+++.... ..+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++
T Consensus 95 -~~~lv~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~ 168 (313)
T cd06633 95 -TAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSA 168 (313)
T ss_pred -EEEEEEecCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCC
Confidence 3599999995 57777775432 3489999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCceeeeeeeecCcccCCchhhc---cCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014363 242 RLGPSEGFTHVSTAVVGTMGYAAPEYVQ---TGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 318 (426)
Q Consensus 242 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 318 (426)
..... .....|+..|+|||++. .+.++.++||||||+++|+|++|..||.............
T Consensus 169 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~--------- 233 (313)
T cd06633 169 SKSSP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA--------- 233 (313)
T ss_pred cccCC------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH---------
Confidence 64322 22456899999999874 4568889999999999999999999987543221111100
Q ss_pred hhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 319 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
...........++..+.+++.+||+.+|.+||++.+++.+
T Consensus 234 -------~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 234 -------QNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -------hcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000111112344578999999999999999999999976
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=293.07 Aligned_cols=263 Identities=24% Similarity=0.318 Sum_probs=195.4
Q ss_pred CCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcC-CCCccceEeEEEccCCCCc
Q 014363 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVE-HQNLVKLVGYCADDDERGI 162 (426)
Q Consensus 87 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~-HpnIv~~~~~~~~~~~~~~ 162 (426)
|.+.+.||+|+||.||+|.....+. .+++|.+.... ......+|+..+..++ ||||+++++++.+.+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~-----~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~---- 71 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGE-----LVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFREND---- 71 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCc-----EEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCC----
Confidence 5677899999999999999876543 78999875442 2234567999999998 999999999998755
Q ss_pred eEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccc
Q 014363 163 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 242 (426)
Q Consensus 163 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 242 (426)
..++||||+ +|+|.+++.......+++..++.++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++.
T Consensus 72 ~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~ 147 (283)
T cd07830 72 ELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAR 147 (283)
T ss_pred cEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccce
Confidence 359999999 88999888765444689999999999999999999998 99999999999999999999999999997
Q ss_pred cCCCCCceeeeeeeecCcccCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHH-HHhHhhh----hh
Q 014363 243 LGPSEGFTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKL-LQWVKPY----LS 316 (426)
Q Consensus 243 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~-~~~~~~~----~~ 316 (426)
....... .....|+..|+|||++.. ..++.++||||||+++++|++|..||........... ....... +.
T Consensus 148 ~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (283)
T cd07830 148 EIRSRPP---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWP 224 (283)
T ss_pred eccCCCC---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhh
Confidence 6543211 223568899999998754 4578999999999999999999999976543322111 1110000 00
Q ss_pred hhhhhhhhcCCcCCC-------cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 317 DAKQFRQIVDPRLEG-------KYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 317 ~~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.........+..+.. ......+..+.+++.+||+.||++||++.|++.+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 225 EGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred hHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 000000000000000 0011124679999999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=291.65 Aligned_cols=251 Identities=24% Similarity=0.344 Sum_probs=191.8
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccc----cCCHHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGR----RGGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~----~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
+|.+.+.||+|+||.||++.+...... ....++|.+.. ......+..|+.+++.++||||+++++++.+...
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-- 76 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAE--ERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDA-- 76 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCc--ceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCc--
Confidence 477888999999999999987654321 11122332221 1223456789999999999999999999877653
Q ss_pred ceEEEEEeeCCCCChhhhccC--CCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeec
Q 014363 162 IQRLLVYEYMPNGSVDQYLSP--KSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 239 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~--~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 239 (426)
.++||||+++++|.+++.. .....+++..++.++.|++.||.|||+. +++|+||||+||+++. +.+||+|||
T Consensus 77 --~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g 150 (260)
T cd08222 77 --FCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFG 150 (260)
T ss_pred --eEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccC
Confidence 4999999999999988853 2234589999999999999999999998 9999999999999975 569999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014363 240 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 319 (426)
Q Consensus 240 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 319 (426)
++....... .......|++.|+|||.+.+..++.++||||||+++|+|++|..||....... ..
T Consensus 151 ~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~---~~----------- 214 (260)
T cd08222 151 VSRLLMGSC--DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS---VV----------- 214 (260)
T ss_pred ceeecCCCc--ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH---HH-----------
Confidence 987654322 12234568899999999988889999999999999999999999996432211 10
Q ss_pred hhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 320 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
..... ......+..++..+.+++.+||..||++||++.+++++
T Consensus 215 --~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 215 --LRIVE-GPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred --HHHHc-CCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 01111 11112234566789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=301.82 Aligned_cols=266 Identities=23% Similarity=0.281 Sum_probs=193.0
Q ss_pred CCCCC-cceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCH----------------HHHHHHHHHHhhcCCCCc
Q 014363 85 KNFSR-SVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGH----------------KEWMTEVNFLGIVEHQNL 147 (426)
Q Consensus 85 ~~y~~-~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~----------------~~~~~E~~~l~~l~HpnI 147 (426)
++|.. .+.||.|+||.||+|.+...+. .|++|.+...... ..+.+|+.+++.++||||
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 82 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGK-----IVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENI 82 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCC-----eEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcce
Confidence 45653 4679999999999999776544 7888877543211 247799999999999999
Q ss_pred cceEeEEEccCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEe
Q 014363 148 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL 227 (426)
Q Consensus 148 v~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl 227 (426)
+++++++...+ ..++||||++ |+|.+++... ..+++..+..++.|++.||+|||+. +++|+||+|+||++
T Consensus 83 v~~~~~~~~~~----~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill 152 (335)
T PTZ00024 83 MGLVDVYVEGD----FINLVMDIMA-SDLKKVVDRK--IRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFI 152 (335)
T ss_pred eeeeEEEecCC----cEEEEEeccc-cCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEE
Confidence 99999998765 3599999996 6899888643 3488999999999999999999998 99999999999999
Q ss_pred CCCCCeeEeeecccccCCCCCc------------eeeeeeeecCcccCCchhhccC-CCCCchhhHHHHHHHHHHHhCCC
Q 014363 228 DEQWNAKLSDFGLARLGPSEGF------------THVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRR 294 (426)
Q Consensus 228 ~~~~~~kl~DFGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~ 294 (426)
+.++.+||+|||++........ ........+++.|+|||.+.+. .++.++||||||+++|+|++|..
T Consensus 153 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~ 232 (335)
T PTZ00024 153 NSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKP 232 (335)
T ss_pred CCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 9999999999999976541110 1111234578899999988764 46889999999999999999999
Q ss_pred CCCCCCchhhHHHH-HhHhhh----hhhhhhhhhh--cCCcCCC---cccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014363 295 PIDRNRPRSEQKLL-QWVKPY----LSDAKQFRQI--VDPRLEG---KYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 364 (426)
Q Consensus 295 p~~~~~~~~~~~~~-~~~~~~----~~~~~~~~~~--~~~~~~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~ 364 (426)
||...........+ ...... +......... ....... ......+..+.+++.+||+.+|++||+++|++.
T Consensus 233 p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 233 LFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred CCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 99765433211111 100000 0000000000 0000000 001123567889999999999999999999998
Q ss_pred H
Q 014363 365 M 365 (426)
Q Consensus 365 ~ 365 (426)
+
T Consensus 313 ~ 313 (335)
T PTZ00024 313 H 313 (335)
T ss_pred C
Confidence 6
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=297.92 Aligned_cols=247 Identities=30% Similarity=0.409 Sum_probs=192.9
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-----CCHHHHHHHHHHHhhcCCCCccceEeEEEccCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-----GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
..|+..+.||+|+||.||+|....++. .+++|.+... .....+.+|+.+++.++|||++++++++.+...
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~-----~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 89 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSE-----VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHT 89 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCc-----EEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCe
Confidence 347777889999999999999876554 6888877532 123467789999999999999999999987653
Q ss_pred CCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeec
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 239 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 239 (426)
.++||||+. |+|.+++.... ..+++..+..++.|++.||.|||+. +++||||||+|||++.++.++|+|||
T Consensus 90 ----~~lv~e~~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg 160 (308)
T cd06634 90 ----AWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFG 160 (308)
T ss_pred ----eEEEEEccC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcc
Confidence 499999996 57877765332 3488999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCchhhc---cCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhh
Q 014363 240 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQ---TGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS 316 (426)
Q Consensus 240 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 316 (426)
++..... .....|++.|+|||++. ...++.++|||||||++|+|++|..||.......... .
T Consensus 161 ~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~--~------- 225 (308)
T cd06634 161 SASIMAP------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY--H------- 225 (308)
T ss_pred cceeecC------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHH--H-------
Confidence 9875432 12356889999999875 3567889999999999999999999986543211110 0
Q ss_pred hhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014363 317 DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVN 367 (426)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~ 367 (426)
.............++..+.+++.+||+.+|++||++.+++.+..
T Consensus 226 -------~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 226 -------IAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred -------HhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 00001111112245677899999999999999999999998743
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=312.45 Aligned_cols=264 Identities=30% Similarity=0.413 Sum_probs=215.1
Q ss_pred HHHHHHHhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-CHHHHHHHHHHHhhc-CCCCccceEeEE
Q 014363 77 IAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-GHKEWMTEVNFLGIV-EHQNLVKLVGYC 154 (426)
Q Consensus 77 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~E~~~l~~l-~HpnIv~~~~~~ 154 (426)
++.+...+..|+++++||.|.+|.||+++.+..+. ..|+|+..... ..+++..|.+||+.+ .|||++.+||+|
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~-----~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~ 85 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQ-----LAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAF 85 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCc-----eeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEE
Confidence 33444456789999999999999999999877654 56777665443 345778899999998 899999999988
Q ss_pred EccC-CCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCe
Q 014363 155 ADDD-ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNA 233 (426)
Q Consensus 155 ~~~~-~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~ 233 (426)
.-.+ ..+.+++||||||.||+..|++..-....+.|..+..|++.++.||.+||.+ .++|||||-.|||++.++.|
T Consensus 86 ~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~V 162 (953)
T KOG0587|consen 86 IKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEV 162 (953)
T ss_pred EEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcE
Confidence 6432 4456899999999999999999866567799999999999999999999998 99999999999999999999
Q ss_pred eEeeecccccCCCCCceeeeeeeecCcccCCchhhccC-----CCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHH
Q 014363 234 KLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG-----RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLL 308 (426)
Q Consensus 234 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~ 308 (426)
||+|||++...... .....+.+|||.|||||++... .|+..+|+||||++..||.-|.+|+....+...
T Consensus 163 KLvDFGvSaQldsT--~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra---- 236 (953)
T KOG0587|consen 163 KLVDFGVSAQLDST--VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA---- 236 (953)
T ss_pred EEeeeeeeeeeecc--cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh----
Confidence 99999999876543 2335678999999999998754 378899999999999999999999976544211
Q ss_pred HhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 309 QWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.|.-..+|...-.-+...+.++.++|..||..|.++||++.++++|
T Consensus 237 -----------LF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 237 -----------LFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred -----------hccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 1111123333444456788999999999999999999999999875
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=295.75 Aligned_cols=252 Identities=30% Similarity=0.448 Sum_probs=191.0
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhc-CCCCccceEeEEEccCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDE 159 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~ 159 (426)
.++|...+.||+|+||.||+|.+..++. .+++|.+.... ....+..|+.++..+ .||||+++++++.+...
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~-----~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 88 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGH-----VMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSD 88 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCe-----EEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCe
Confidence 3578889999999999999999876543 78999886432 234566788777666 59999999999987653
Q ss_pred CCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeec
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 239 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 239 (426)
.|+||||++ ++|.+++.... ..+++..+..++.|++.||+|||+. .+|+||||+|+||++++++.+||+|||
T Consensus 89 ----~~~v~e~~~-~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg 160 (296)
T cd06618 89 ----VFICMELMS-TCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFG 160 (296)
T ss_pred ----EEEEeeccC-cCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccc
Confidence 599999984 57777665432 3589999999999999999999962 289999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCchhhccCC----CCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhh
Q 014363 240 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGR----LAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYL 315 (426)
Q Consensus 240 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 315 (426)
++........ .....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||...... ...+.....
T Consensus 161 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~--- 233 (296)
T cd06618 161 ISGRLVDSKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-FEVLTKILQ--- 233 (296)
T ss_pred cchhccCCCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-HHHHHHHhc---
Confidence 9875533211 12335788999999987553 788999999999999999999999643221 111111000
Q ss_pred hhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 316 SDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
. ..+... ....++..+.+++.+||..||++||++.+++++
T Consensus 234 -~-------~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 234 -E-------EPPSLP--PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred -C-------CCCCCC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 000010 111245678999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=314.47 Aligned_cols=257 Identities=26% Similarity=0.428 Sum_probs=214.0
Q ss_pred CCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCce
Q 014363 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQ 163 (426)
Q Consensus 87 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~ 163 (426)
....++||+|+||+||+|.+--. ....+..||+|++.... ...+++.|+-+|.+|+|||+++++|+|....
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pe-ge~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~----- 771 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPE-GENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST----- 771 (1177)
T ss_pred hhhhceeccccceeEEeeeEecC-CceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-----
Confidence 34466899999999999999876 44566789999986554 3568999999999999999999999998766
Q ss_pred EEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccccc
Q 014363 164 RLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL 243 (426)
Q Consensus 164 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 243 (426)
..||++|+++|.|.+|++.++ ..+.....+.|..||++|+.|||++ .++||||-..|||+..-..+||+|||+++.
T Consensus 772 ~qlvtq~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~l 847 (1177)
T KOG1025|consen 772 LQLVTQLMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKL 847 (1177)
T ss_pred HHHHHHhcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhc
Confidence 268999999999999998754 4478888899999999999999998 999999999999999999999999999998
Q ss_pred CCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhhh
Q 014363 244 GPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQFR 322 (426)
Q Consensus 244 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (426)
....+.........-.+.|||-|.+....|+.++|||||||++||++| |..||++....+..++
T Consensus 848 l~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dl--------------- 912 (1177)
T KOG1025|consen 848 LAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDL--------------- 912 (1177)
T ss_pred cCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHH---------------
Confidence 776654443333444678999999999999999999999999999999 9999987654433322
Q ss_pred hhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhH
Q 014363 323 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIV 370 (426)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~ 370 (426)
+....+-..++.++.++..++.+||..|+..||+++++...+.++.
T Consensus 913 --le~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a 958 (1177)
T KOG1025|consen 913 --LEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA 958 (1177)
T ss_pred --HhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence 2222222344557788999999999999999999999998887654
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=293.17 Aligned_cols=256 Identities=25% Similarity=0.325 Sum_probs=196.1
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc------CCHHHHHHHHHHHhhc-CCCCccceEeEEEccC
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR------GGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDD 158 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~------~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~ 158 (426)
+|+..+.||+|+||.||++...... .....+++|.+... ...+.+..|+.++..+ +||||+++++.+....
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~--~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~ 78 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGH--DAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDT 78 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccc--cCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCC
Confidence 4778889999999999999865322 22347888887532 1234678899999999 6999999999887655
Q ss_pred CCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeee
Q 014363 159 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 238 (426)
Q Consensus 159 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 238 (426)
..++||||+++|+|.+++... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+||
T Consensus 79 ----~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df 149 (288)
T cd05583 79 ----KLHLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDF 149 (288)
T ss_pred ----EEEEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEEC
Confidence 358999999999999998643 3488999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCchhhccCC--CCCchhhHHHHHHHHHHHhCCCCCCCCCchhh-HHHHHhHhhhh
Q 014363 239 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGR--LAARSDVWSYGVFLYELITGRRPIDRNRPRSE-QKLLQWVKPYL 315 (426)
Q Consensus 239 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslGvil~elltg~~p~~~~~~~~~-~~~~~~~~~~~ 315 (426)
|++........ .......|+..|+|||.+.+.. ++.++||||||+++|+|++|..||........ .....
T Consensus 150 g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~------ 222 (288)
T cd05583 150 GLSKEFLAEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISR------ 222 (288)
T ss_pred ccccccccccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHH------
Confidence 99876543221 1123356899999999987655 78899999999999999999999964322111 11100
Q ss_pred hhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 014363 316 SDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNK 368 (426)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~ 368 (426)
.+... ....+..++..+.+++.+||+.||++|||+.++.+.|+.
T Consensus 223 -------~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 223 -------RILKS--KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred -------HHHcc--CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 01100 111223355678999999999999999998877766653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=292.04 Aligned_cols=253 Identities=26% Similarity=0.361 Sum_probs=194.0
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC------CHHHHHHHHHHHhhc-CCCCccceEeEEEccC
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG------GHKEWMTEVNFLGIV-EHQNLVKLVGYCADDD 158 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~------~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~ 158 (426)
+|+..+.||+|+||.||+|...... .....|++|.+.... ..+.+..|+.++..+ +|+||+++++.+....
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~--~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~ 78 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGH--DSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDT 78 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCC--CCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCC
Confidence 4778889999999999999865321 123478999875422 235678899999999 6999999998887755
Q ss_pred CCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeee
Q 014363 159 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 238 (426)
Q Consensus 159 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 238 (426)
..|+||||+++++|.+++.... .+++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+||
T Consensus 79 ----~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~df 149 (290)
T cd05613 79 ----KLHLILDYINGGELFTHLSQRE--RFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDF 149 (290)
T ss_pred ----eEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeC
Confidence 3589999999999999986543 488899999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCchhhccC--CCCCchhhHHHHHHHHHHHhCCCCCCCCCchhh-HHHHHhHhhhh
Q 014363 239 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG--RLAARSDVWSYGVFLYELITGRRPIDRNRPRSE-QKLLQWVKPYL 315 (426)
Q Consensus 239 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvil~elltg~~p~~~~~~~~~-~~~~~~~~~~~ 315 (426)
|++........ .......|+..|+|||.+.+. .++.++||||||+++|+|++|..||........ .....
T Consensus 150 g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~------ 222 (290)
T cd05613 150 GLSKEFHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISR------ 222 (290)
T ss_pred ccceecccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHH------
Confidence 99976543221 112245689999999988753 467899999999999999999999964322111 11110
Q ss_pred hhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 014363 316 SDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRP-----KMSEVLEM 365 (426)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~ 365 (426)
.+... ...++..++..+.+++.+||+.||++|| ++.+++.+
T Consensus 223 -------~~~~~--~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 223 -------RILKS--EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred -------Hhhcc--CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 01000 1112333567889999999999999997 77887775
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=281.81 Aligned_cols=271 Identities=23% Similarity=0.365 Sum_probs=202.2
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcc----ccCCHHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLG----RRGGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~----~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
+.|....+||+|.||.||+|+.++++. .||+|++- +.+-.....+|+++|..|+|+|++.+++.|......
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~k-----kvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp 91 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGK-----KVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATP 91 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccc-----hhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCC
Confidence 457777789999999999999887764 56776542 223345678999999999999999999888654333
Q ss_pred Cc----eEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEe
Q 014363 161 GI----QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLS 236 (426)
Q Consensus 161 ~~----~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~ 236 (426)
.. .+|+||.+|+. +|..++... ...++...+.+++.++..||.|+|.. .|+|||+|++|+||+.+|.+||+
T Consensus 92 ~~r~r~t~ylVf~~ceh-DLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklA 166 (376)
T KOG0669|consen 92 TNRDRATFYLVFDFCEH-DLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLA 166 (376)
T ss_pred cccccceeeeeHHHhhh-hHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEee
Confidence 22 37999999965 888888643 24588999999999999999999998 99999999999999999999999
Q ss_pred eecccccCCCCC--ceeeeeeeecCcccCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhH--
Q 014363 237 DFGLARLGPSEG--FTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWV-- 311 (426)
Q Consensus 237 DFGla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~-- 311 (426)
|||+++.+.... ....-+..+-|.+|.+||.+.+. .|+++.|||+-|||+.||.+|.+-+.++.......++...
T Consensus 167 DFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcG 246 (376)
T KOG0669|consen 167 DFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCG 246 (376)
T ss_pred ccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhc
Confidence 999997654221 11123455679999999988765 5899999999999999999999999887665544444321
Q ss_pred ------hhhhhhhhhhhhhcCCcCCCcccHHH---------HHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 312 ------KPYLSDAKQFRQIVDPRLEGKYSLRL---------VSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 312 ------~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
+|...+......+--+.+....-..+ .++..+|+.++|..||.+|+++++++.|
T Consensus 247 s~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 247 SITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred cCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 22222222222221111111111111 2367799999999999999999999876
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=288.15 Aligned_cols=265 Identities=26% Similarity=0.435 Sum_probs=206.0
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhh--cCCCCccceEeEEEccCCCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGI--VEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~--l~HpnIv~~~~~~~~~~~~~ 161 (426)
..+....+.||+|.||+||+|.+++. .||||++...+ ...+.+|.+|.+- |+|+||+.+++.-..+....
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wrGe-------~VAVKiF~srd-E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~ 281 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWRGE-------DVAVKIFSSRD-ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSW 281 (513)
T ss_pred hheeEEEEEecCccccceeeccccCC-------ceEEEEecccc-hhhhhhHHHHHHHHHhccchhhhhhhccccCCCce
Confidence 35677888999999999999999986 69999997654 4678888777665 59999999998877766667
Q ss_pred ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhcc-----CCCCCeEeccCCCCceEeCCCCCeeEe
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHE-----GMDFQIIVRDFKSSNILLDEQWNAKLS 236 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~-----~~~~~iiHrDlkp~NILl~~~~~~kl~ 236 (426)
.|++||.+|.+.|+|.|||... .++....++++..+|.||+|||. ++.+.|.|||||..|||+..+|..-|+
T Consensus 282 TQLwLvTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IA 358 (513)
T KOG2052|consen 282 TQLWLVTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 358 (513)
T ss_pred EEEEEeeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEe
Confidence 8999999999999999999753 48899999999999999999994 345789999999999999999999999
Q ss_pred eecccccCCCC--CceeeeeeeecCcccCCchhhccCC----C--CCchhhHHHHHHHHHHHhC----------CCCCCC
Q 014363 237 DFGLARLGPSE--GFTHVSTAVVGTMGYAAPEYVQTGR----L--AARSDVWSYGVFLYELITG----------RRPIDR 298 (426)
Q Consensus 237 DFGla~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~----~--~~~~DvwslGvil~elltg----------~~p~~~ 298 (426)
|+|||...... ......+..+||.+|||||++...- + -..+||||||+++||++.. +.||..
T Consensus 359 DLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd 438 (513)
T KOG2052|consen 359 DLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYD 438 (513)
T ss_pred eceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCccc
Confidence 99999765432 1222345679999999999987532 2 2369999999999999864 356654
Q ss_pred CCchhhHHHHHhHhhhhhhhhhhhhhc-----CCcCCCcc-cHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHh
Q 014363 299 NRPRSEQKLLQWVKPYLSDAKQFRQIV-----DPRLEGKY-SLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVD 371 (426)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~-~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~ 371 (426)
..+.+.. .+++++++ .|.+.... +-.....+.++|+.||..||..|-|+--|-+.|.++..
T Consensus 439 ~Vp~DPs------------~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 439 VVPSDPS------------FEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCCCCCC------------HHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 3221110 11122221 12222111 22566789999999999999999999999999988764
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=299.88 Aligned_cols=266 Identities=25% Similarity=0.339 Sum_probs=198.5
Q ss_pred HhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccC
Q 014363 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 158 (426)
Q Consensus 83 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 158 (426)
..++|+....||+|+||.||+|.+..++. .+++|.+.... ....+.+|+.+++.++||||+++++++....
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~-----~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGR-----KVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPAS 87 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCc-----EEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccc
Confidence 35689999999999999999999876554 78999875421 2345778999999999999999998776544
Q ss_pred C--CCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEe
Q 014363 159 E--RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLS 236 (426)
Q Consensus 159 ~--~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~ 236 (426)
. .....++|+||+ +++|.+++.. ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 88 ~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~ 160 (343)
T cd07851 88 SLEDFQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKIL 160 (343)
T ss_pred cccccccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEc
Confidence 2 122469999999 6799998864 3489999999999999999999998 99999999999999999999999
Q ss_pred eecccccCCCCCceeeeeeeecCcccCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHH-HhHhh-
Q 014363 237 DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLL-QWVKP- 313 (426)
Q Consensus 237 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~-~~~~~- 313 (426)
|||++...... .....++..|+|||.+.+ ..++.++||||||+++|+|++|..||...........+ .....
T Consensus 161 dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~ 235 (343)
T cd07851 161 DFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTP 235 (343)
T ss_pred ccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Confidence 99999765432 233468899999998865 36788999999999999999999999765432211111 10000
Q ss_pred ---h---hh--hhhhhhhhcCCcCCCccc---HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 314 ---Y---LS--DAKQFRQIVDPRLEGKYS---LRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 314 ---~---~~--~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
. +. ....+...+.......+. ...+..+.+++.+||+.||++|||+.+|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 236 DEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred CHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 0 00 000000000000000111 1236789999999999999999999999886
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=283.41 Aligned_cols=273 Identities=23% Similarity=0.360 Sum_probs=224.4
Q ss_pred HHHHHHHhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCCccceEeE
Q 014363 77 IAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQNLVKLVGY 153 (426)
Q Consensus 77 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~ 153 (426)
..++.-...+++..-++-+|.||.||.|.++........+.+.+|.+++.. ....+.+|...+..+.|||+..+.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 345555566788888999999999999998876655555566667665443 33467889999999999999999999
Q ss_pred EEccCCCCceEEEEEeeCCCCChhhhccC------CCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEe
Q 014363 154 CADDDERGIQRLLVYEYMPNGSVDQYLSP------KSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL 227 (426)
Q Consensus 154 ~~~~~~~~~~~~lv~E~~~~g~L~~~l~~------~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl 227 (426)
+.++... +++++.++.-|+|..|+.. ...+.++..+...++.|++.|++|||++ +|||.||...|.+|
T Consensus 356 ~ie~~~~---P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvI 429 (563)
T KOG1024|consen 356 SIEDYAT---PFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVI 429 (563)
T ss_pred EeeccCc---ceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhccee
Confidence 9876543 5889999999999999972 2234577788889999999999999998 99999999999999
Q ss_pred CCCCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHH
Q 014363 228 DEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQK 306 (426)
Q Consensus 228 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~ 306 (426)
|+..++||+|=.+++..-+.++............||+||.+.+..|+.++|||||||+||||+| |+.||...++.+...
T Consensus 430 dd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ 509 (563)
T KOG1024|consen 430 DDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEH 509 (563)
T ss_pred hhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHH
Confidence 9999999999999998776666665556667889999999999999999999999999999999 999998877755443
Q ss_pred HHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 014363 307 LLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 372 (426)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~ 372 (426)
. +.++..+. .+.++++++..+|..||+.+|++||+++|+..-|.+...+
T Consensus 510 y-------lkdGyRla----------QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 510 Y-------LKDGYRLA----------QPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred H-------Hhccceec----------CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 2 23333322 2335889999999999999999999999999998876543
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=319.07 Aligned_cols=145 Identities=30% Similarity=0.411 Sum_probs=126.9
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-----CHHHHHHHHHHHhhcCCCCccceEeEEEccC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 158 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 158 (426)
.++|.+++.||+|+||.||+|.+...+. .||+|++.... ....+..|+.++..++||||+++++++....
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~-----~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~ 77 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSK-----LYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSAN 77 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCc-----EEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECC
Confidence 3578999999999999999999876544 79999886432 1356788999999999999999998887655
Q ss_pred CCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeee
Q 014363 159 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 238 (426)
Q Consensus 159 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 238 (426)
..||||||+++++|.+++.... .+++..++.|+.||+.||.|||.+ +|+||||||+||||+.++.+||+||
T Consensus 78 ----~~~lVmEy~~g~~L~~li~~~~--~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DF 148 (669)
T cd05610 78 ----NVYLVMEYLIGGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDF 148 (669)
T ss_pred ----EEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeC
Confidence 4599999999999999986543 488899999999999999999998 9999999999999999999999999
Q ss_pred cccc
Q 014363 239 GLAR 242 (426)
Q Consensus 239 Gla~ 242 (426)
|+++
T Consensus 149 Gls~ 152 (669)
T cd05610 149 GLSK 152 (669)
T ss_pred CCCc
Confidence 9985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=288.45 Aligned_cols=263 Identities=27% Similarity=0.363 Sum_probs=196.3
Q ss_pred CCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc----CCHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCc
Q 014363 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR----GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 162 (426)
Q Consensus 87 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~ 162 (426)
|+..+.||+|+||.||+|.....+. .+++|.+... ...+.+..|+.+++.++||||+++++++.+..
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~-----~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~---- 71 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGE-----IVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTER---- 71 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCc-----EEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCC----
Confidence 5567789999999999999876554 7888887643 23456788999999999999999999988764
Q ss_pred eEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccc
Q 014363 163 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 242 (426)
Q Consensus 163 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 242 (426)
..++||||++ ++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||+|+||++++++.++|+|||++.
T Consensus 72 ~~~~v~e~~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~ 146 (282)
T cd07829 72 KLYLVFEYCD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLAR 146 (282)
T ss_pred ceEEEecCcC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCccc
Confidence 3599999997 58999997543 3489999999999999999999998 99999999999999999999999999997
Q ss_pred cCCCCCceeeeeeeecCcccCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHH-HHHhHhh----hhh
Q 014363 243 LGPSEGFTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQK-LLQWVKP----YLS 316 (426)
Q Consensus 243 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~-~~~~~~~----~~~ 316 (426)
....... ......++..|+|||.+.+. .++.++||||||+++|||++|..||.......... ....... .+.
T Consensus 147 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (282)
T cd07829 147 AFGIPLR--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWP 224 (282)
T ss_pred ccCCCcc--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHH
Confidence 6543221 12234567889999998776 78999999999999999999999997654322111 1110000 000
Q ss_pred hhhhh---hhhcCCcCCC---cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 317 DAKQF---RQIVDPRLEG---KYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 317 ~~~~~---~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
..... .......... ......+..+.+++.+||+.||++||++.+++.+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 225 GVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred hhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 00000 0000000000 0011235689999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=302.97 Aligned_cols=242 Identities=26% Similarity=0.336 Sum_probs=197.6
Q ss_pred HhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhc-CCCCccceEeEEEccCCCC
Q 014363 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 83 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~~~ 161 (426)
.+..|.....+|.|+|+.|-.+.+..+.. ..++|++.+. ..+..+|+.++... +||||+++.+.+.+...
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~-----~~~vkii~~~--~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~-- 390 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQ-----EPAVKIISKR--ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKE-- 390 (612)
T ss_pred cchhhccccccCCCCccceeeeecccccc-----chhheecccc--ccccccccchhhhhcCCCcceeecceecCCce--
Confidence 35678888889999999999998777654 7888888665 23345778777666 89999999999988664
Q ss_pred ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEe-CCCCCeeEeeecc
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL-DEQWNAKLSDFGL 240 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl-~~~~~~kl~DFGl 240 (426)
.|+|||.+.|+-|.+.+..... ....+..|+.+|+.|+.|||++ |||||||||+|||+ +..++++|+|||.
T Consensus 391 --~~~v~e~l~g~ell~ri~~~~~---~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~ 462 (612)
T KOG0603|consen 391 --IYLVMELLDGGELLRRIRSKPE---FCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGF 462 (612)
T ss_pred --eeeeehhccccHHHHHHHhcch---hHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEech
Confidence 5999999999998887765432 2267778999999999999998 99999999999999 6999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhh
Q 014363 241 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 320 (426)
Q Consensus 241 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (426)
++..... ..+.+-|..|.|||++....|++++||||||++||+||+|+.||...... .
T Consensus 463 a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~--------------- 520 (612)
T KOG0603|consen 463 WSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--I--------------- 520 (612)
T ss_pred hhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--H---------------
Confidence 9876554 23356789999999999999999999999999999999999999754332 1
Q ss_pred hhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 321 FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
++......+.+...++...++|+.+||+.||.+||++.++..+
T Consensus 521 --ei~~~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 521 --EIHTRIQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred --HHHHhhcCCccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 1111112233446688899999999999999999999999987
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=297.94 Aligned_cols=244 Identities=26% Similarity=0.398 Sum_probs=199.4
Q ss_pred cceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc----CCHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCceEE
Q 014363 90 SVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR----GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRL 165 (426)
Q Consensus 90 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~~~ 165 (426)
.++||.|.||+||-|.++.++. .||||++.+. +....+.+|+.||.++.||.||.+...|...+. .|
T Consensus 569 devLGSGQFG~VYgg~hRktGr-----dVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~er----vF 639 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGR-----DVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPER----VF 639 (888)
T ss_pred HhhccCCcceeeecceecccCc-----eeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCce----EE
Confidence 4689999999999999998876 7899988543 355678999999999999999999988887774 59
Q ss_pred EEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCC---CCeeEeeecccc
Q 014363 166 LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQ---WNAKLSDFGLAR 242 (426)
Q Consensus 166 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~---~~~kl~DFGla~ 242 (426)
+|||-+ .|++.++|-....+.+++.....++.||+.||.|||.+ +|+|.||||+|||+... -++||||||.|+
T Consensus 640 VVMEKl-~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfAR 715 (888)
T KOG4236|consen 640 VVMEKL-HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFAR 715 (888)
T ss_pred EEehhh-cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeecccccee
Confidence 999999 45666666544456699999999999999999999998 99999999999999654 359999999999
Q ss_pred cCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhh
Q 014363 243 LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFR 322 (426)
Q Consensus 243 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (426)
.+..... ....+|||.|+|||++.+..|+..-|+||.|||+|--++|..||.......++ ++ ..
T Consensus 716 iIgEksF---RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQ--IQ-----------NA 779 (888)
T KOG4236|consen 716 IIGEKSF---RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQ--IQ-----------NA 779 (888)
T ss_pred ecchhhh---hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHH--hh-----------cc
Confidence 8876543 45689999999999999999999999999999999999999999765432222 11 11
Q ss_pred hhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 323 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.++-+. ..-..++....+||...|+..-++|-|.+..+.+
T Consensus 780 aFMyPp---~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 780 AFMYPP---NPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred ccccCC---CchhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 222111 1123566788899999999999999999988765
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=312.62 Aligned_cols=263 Identities=29% Similarity=0.493 Sum_probs=208.2
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCC--CcceEEEEEEccccC---CHHHHHHHHHHHhhc-CCCCccceEeEEEccC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDP--SQKVEVAVKQLGRRG---GHKEWMTEVNFLGIV-EHQNLVKLVGYCADDD 158 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~--~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~ 158 (426)
++..+.+.||+|.||.|++|........ .....||+|.++... ..+.+..|+++|..+ .||||+.++|.|....
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~ 375 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG 375 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence 3445556899999999999986644322 236789999986554 356889999999999 7999999999998844
Q ss_pred CCCceEEEEEeeCCCCChhhhccCCC------------C--CccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCc
Q 014363 159 ERGIQRLLVYEYMPNGSVDQYLSPKS------------E--TILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSN 224 (426)
Q Consensus 159 ~~~~~~~lv~E~~~~g~L~~~l~~~~------------~--~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~N 224 (426)
. .++|+||+..|+|.++++.++ . ..++....+.++.||+.|++||++. ++|||||...|
T Consensus 376 ~----~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRN 448 (609)
T KOG0200|consen 376 P----LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARN 448 (609)
T ss_pred c----eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhhhh
Confidence 3 499999999999999998665 0 1388899999999999999999998 99999999999
Q ss_pred eEeCCCCCeeEeeecccccCCCCCceeeeeeeec--CcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCc
Q 014363 225 ILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVG--TMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRP 301 (426)
Q Consensus 225 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~ 301 (426)
||+.++..+||+|||+++........... .-.| ...|||||.+....|+.++|||||||+|||+++ |..||.+...
T Consensus 449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~-~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~ 527 (609)
T KOG0200|consen 449 VLITKNKVIKIADFGLARDHYNKDYYRTK-SSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP 527 (609)
T ss_pred EEecCCCEEEEccccceeccCCCCceEec-CCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc
Confidence 99999999999999999965544333211 1122 345999999999999999999999999999999 9999976321
Q ss_pred hhhHHHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHh
Q 014363 302 RSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVD 371 (426)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~ 371 (426)
. ..+.++ +.....-..+..+..++.++|+.||+.+|++||++.++.+.|+..+.
T Consensus 528 ~--~~l~~~--------------l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 528 T--EELLEF--------------LKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred H--HHHHHH--------------HhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 1 111111 12222223344567899999999999999999999999999998653
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=281.27 Aligned_cols=238 Identities=31% Similarity=0.417 Sum_probs=190.9
Q ss_pred ecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-----CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCceEEEE
Q 014363 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLV 167 (426)
Q Consensus 93 lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~~~lv 167 (426)
||.|+||.||++.....+. .+++|.+.... ....+..|+.+++.++||||+++++.+.... ..++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~-----~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~~v 71 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGK-----LYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEE----KLYLV 71 (250)
T ss_pred CCCCCceEEEEEEECCCCc-----EEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCC----eeEEE
Confidence 6999999999999876443 78888875432 3447889999999999999999999887655 35999
Q ss_pred EeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccCCCC
Q 014363 168 YEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSE 247 (426)
Q Consensus 168 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 247 (426)
|||+++++|.+++.... .+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 72 ~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~ 146 (250)
T cd05123 72 LEYAPGGELFSHLSKEG--RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSE 146 (250)
T ss_pred EecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccC
Confidence 99999999999997543 489999999999999999999998 9999999999999999999999999999765432
Q ss_pred CceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCC
Q 014363 248 GFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDP 327 (426)
Q Consensus 248 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (426)
. .......++..|++||.+.+...+.++|+||||+++|+|++|..||...... .... .+..
T Consensus 147 ~--~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~~~~-------------~~~~- 207 (250)
T cd05123 147 G--SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK---EIYE-------------KILK- 207 (250)
T ss_pred C--CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHHH-------------HHhc-
Confidence 1 1233456889999999998888899999999999999999999999754321 1111 1111
Q ss_pred cCCCcccHHHHHHHHHHHHhccccCCCCCCCH---HHHHH
Q 014363 328 RLEGKYSLRLVSKLSHVANLCLVKNARTRPKM---SEVLE 364 (426)
Q Consensus 328 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~---~eil~ 364 (426)
....++...+..+.+++.+||..||++||++ .++++
T Consensus 208 -~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~ 246 (250)
T cd05123 208 -DPLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKA 246 (250)
T ss_pred -CCCCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHh
Confidence 0112223346788999999999999999999 55554
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=281.11 Aligned_cols=257 Identities=31% Similarity=0.402 Sum_probs=195.9
Q ss_pred CcccCHHHHHHHhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC---HHHHHHHHHHHhh-cCCCCc
Q 014363 72 LKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG---HKEWMTEVNFLGI-VEHQNL 147 (426)
Q Consensus 72 ~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~E~~~l~~-l~HpnI 147 (426)
...|+-+.++. +..||.|+||+|++..++.++. .+|||++..... .+++..|.+...+ -+.|||
T Consensus 58 ~~~F~~~~Lqd-------lg~iG~G~fG~V~KM~hk~sg~-----~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~I 125 (361)
T KOG1006|consen 58 LHTFTSDNLQD-------LGEIGNGAFGTVNKMLHKPSGK-----LMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNI 125 (361)
T ss_pred ccccccchHHH-------HHHhcCCcchhhhhhhcCccCc-----EEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHH
Confidence 44555444443 3459999999999999888765 899999975543 4567778876554 489999
Q ss_pred cceEeEEEccCCCCceEEEEEeeCCCCChhhhcc---CCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCc
Q 014363 148 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLS---PKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSN 224 (426)
Q Consensus 148 v~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~---~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~N 224 (426)
|++||.+..++.. ++.||.| ..+|+.+.. ......+++...-.|....+.||.||... ..||||||||+|
T Consensus 126 VkfyGa~F~EGdc----WiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSN 198 (361)
T KOG1006|consen 126 VKFYGALFSEGDC----WICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSN 198 (361)
T ss_pred HHHhhhhhcCCce----eeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhh
Confidence 9999998887754 9999999 457765432 22234488988889999999999999975 589999999999
Q ss_pred eEeCCCCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhcc--CCCCCchhhHHHHHHHHHHHhCCCCCCCCCch
Q 014363 225 ILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT--GRLAARSDVWSYGVFLYELITGRRPIDRNRPR 302 (426)
Q Consensus 225 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~elltg~~p~~~~~~~ 302 (426)
||++..|.+||||||++..+...- ..+...|...|||||.+.. ..|+-++||||||++|||+.||..||......
T Consensus 199 ILldr~G~vKLCDFGIcGqLv~Si---AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv 275 (361)
T KOG1006|consen 199 ILLDRHGDVKLCDFGICGQLVDSI---AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV 275 (361)
T ss_pred eEEecCCCEeeecccchHhHHHHH---HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH
Confidence 999999999999999997654321 1233578999999998864 35899999999999999999999999764332
Q ss_pred hhHHHHHhHhhhhhhhhhhhhhcCC---cCCC-cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 303 SEQKLLQWVKPYLSDAKQFRQIVDP---RLEG-KYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~-~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
- +++.+++.. .+.. .-...++..+..++..||..|.++||.+.+++++
T Consensus 276 f---------------eql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 276 F---------------EQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred H---------------HHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 1 222233221 1111 1123467789999999999999999999999876
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=279.12 Aligned_cols=266 Identities=25% Similarity=0.377 Sum_probs=199.9
Q ss_pred HHHHHHHhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC--CHHHHHHHHHHHhhc-CCCCccceEeE
Q 014363 77 IAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--GHKEWMTEVNFLGIV-EHQNLVKLVGY 153 (426)
Q Consensus 77 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~E~~~l~~l-~HpnIv~~~~~ 153 (426)
+.++...++ +.||+|+|+.|--+....++ +.+|||++.+.. ...+..+|++++... .|+||+++++|
T Consensus 75 F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~-----~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLief 144 (463)
T KOG0607|consen 75 FEDMYKLTS-----ELLGEGAYASVQTCVSIQTG-----KEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEF 144 (463)
T ss_pred HHHHHHhHH-----HHhcCccceeeeeeeeeccc-----hhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHH
Confidence 455555443 47999999999998866554 389999986554 456789999999998 79999999999
Q ss_pred EEccCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCC-
Q 014363 154 CADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWN- 232 (426)
Q Consensus 154 ~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~- 232 (426)
|.++.. +|||||-|.||.|...|.++. .+++.++..+.++|+.||.|||.+ ||.||||||+|||-.....
T Consensus 145 FEdd~~----FYLVfEKm~GGplLshI~~~~--~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~v 215 (463)
T KOG0607|consen 145 FEDDTR----FYLVFEKMRGGPLLSHIQKRK--HFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKV 215 (463)
T ss_pred hcccce----EEEEEecccCchHHHHHHHhh--hccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCc
Confidence 998874 599999999999999997654 499999999999999999999998 9999999999999966544
Q ss_pred --eeEeeecccccCCCCC-----ceeeeeeeecCcccCCchhhc-----cCCCCCchhhHHHHHHHHHHHhCCCCCCCCC
Q 014363 233 --AKLSDFGLARLGPSEG-----FTHVSTAVVGTMGYAAPEYVQ-----TGRLAARSDVWSYGVFLYELITGRRPIDRNR 300 (426)
Q Consensus 233 --~kl~DFGla~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltg~~p~~~~~ 300 (426)
+|||||.|..-..... .+....+.+|+..|||||+.. ...|+.+.|.||||||||-||+|.+||.+.=
T Consensus 216 sPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~C 295 (463)
T KOG0607|consen 216 SPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHC 295 (463)
T ss_pred CceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCcc
Confidence 8999999875432111 111223578999999999764 2358999999999999999999999996532
Q ss_pred chhhHHHHHhHh---hhhhhhhhhhhhcCCcCC--CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 301 PRSEQKLLQWVK---PYLSDAKQFRQIVDPRLE--GKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 301 ~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
..+- -|-+ ........+..+.+.... ..--..++.+.++++..+|..|+.+|.++.+++.+
T Consensus 296 g~dC----GWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnh 361 (463)
T KOG0607|consen 296 GADC----GWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH 361 (463)
T ss_pred CCcC----CccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence 1100 0000 000011222233322221 11123678899999999999999999999999884
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=254.08 Aligned_cols=264 Identities=23% Similarity=0.329 Sum_probs=197.1
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
+|...++||+|+||+||+|+.+++.+ .||+|.+.-+. ......+|+-+|+.|+|.|||+++++...+.
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~e-----ivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdk--- 74 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHE-----IVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK--- 74 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccc-----eEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCc---
Confidence 46667789999999999999887765 78999875443 3457899999999999999999999887765
Q ss_pred ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccc
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 241 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 241 (426)
.+-+|+|||+ .+|..|...-+ +.++.+.+..++.|+++||.|+|++ ++.||||||.|+||+.+|.+||+|||++
T Consensus 75 -kltlvfe~cd-qdlkkyfdsln-g~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfgla 148 (292)
T KOG0662|consen 75 -KLTLVFEFCD-QDLKKYFDSLN-GDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLA 148 (292)
T ss_pred -eeEEeHHHhh-HHHHHHHHhcC-CcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchh
Confidence 4589999994 58888877543 3488899999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCchhhccCC-CCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhh--h
Q 014363 242 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGR-LAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLS--D 317 (426)
Q Consensus 242 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~--~ 317 (426)
+.+.-.. ..-...+-|.+|.+|.++.+.+ |+...|+||-|||+.|+.. |++-|.+.+-.+....+-+..-... .
T Consensus 149 rafgipv--rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~ 226 (292)
T KOG0662|consen 149 RAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQ 226 (292)
T ss_pred hhcCCce--EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCcccc
Confidence 9765432 2234557899999999988765 8999999999999999998 5554555433222222222110000 0
Q ss_pred hhhhhhhcCCcCCCccc---------HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 318 AKQFRQIVDPRLEGKYS---------LRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 318 ~~~~~~~~~~~~~~~~~---------~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
...+.++-|-.....|+ +.....-++++++.|.-+|..|.++++.+++
T Consensus 227 wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 227 WPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 01111111111111111 1233455688999999999999999999886
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=282.14 Aligned_cols=264 Identities=20% Similarity=0.267 Sum_probs=203.9
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-CHHHHHHHHHHHhhcC--CCC----ccceEeEEEc
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-GHKEWMTEVNFLGIVE--HQN----LVKLVGYCAD 156 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~E~~~l~~l~--Hpn----Iv~~~~~~~~ 156 (426)
+++|.+...+|+|+||.|-.+.+.... ..||+|+++.-. ..+..+-|+++|.++. -|+ +|++.++|..
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~-----~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy 162 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETK-----EHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY 162 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCC-----ceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc
Confidence 789999999999999999999877653 389999986543 3456688999999993 233 6777788876
Q ss_pred cCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCC-------
Q 014363 157 DDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE------- 229 (426)
Q Consensus 157 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~------- 229 (426)
.+ +.|||+|.+ |.++.++|..++..+++...+..|+.|++++++|||+. +++|-||||+|||+..
T Consensus 163 rg----hiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~ 234 (415)
T KOG0671|consen 163 RG----HICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTY 234 (415)
T ss_pred cC----ceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEe
Confidence 66 459999999 78999999988888899999999999999999999998 9999999999999842
Q ss_pred -------------CCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCC
Q 014363 230 -------------QWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPI 296 (426)
Q Consensus 230 -------------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~ 296 (426)
+..++|+|||.|+..... ....+.|..|.|||++.+-+++...||||+||||+||.+|..-|
T Consensus 235 ~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LF 309 (415)
T KOG0671|consen 235 NPKKKVCFIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLF 309 (415)
T ss_pred ccCCccceeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceec
Confidence 235899999999864432 25678999999999999999999999999999999999999999
Q ss_pred CCCCchhhHHHHHhHhhhhhh----hh--------------------hhhhhcCCcCC-C---cccHHHHHHHHHHHHhc
Q 014363 297 DRNRPRSEQKLLQWVKPYLSD----AK--------------------QFRQIVDPRLE-G---KYSLRLVSKLSHVANLC 348 (426)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~----~~--------------------~~~~~~~~~~~-~---~~~~~~~~~l~~li~~c 348 (426)
......+...+++.+...+.. .. ......++... . ........+|.+|+++|
T Consensus 310 qtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~m 389 (415)
T KOG0671|consen 310 QTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRM 389 (415)
T ss_pred ccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHH
Confidence 877655444333322110000 00 00000000000 0 00112446799999999
Q ss_pred cccCCCCCCCHHHHHHH
Q 014363 349 LVKNARTRPKMSEVLEM 365 (426)
Q Consensus 349 l~~dp~~RPs~~eil~~ 365 (426)
|..||.+|+|+.|++.|
T Consensus 390 L~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 390 LEFDPARRITLREALSH 406 (415)
T ss_pred HccCccccccHHHHhcC
Confidence 99999999999999986
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=280.00 Aligned_cols=220 Identities=20% Similarity=0.203 Sum_probs=175.9
Q ss_pred cCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCceEEEEEeeCCCCC
Q 014363 96 GGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGS 175 (426)
Q Consensus 96 G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~~~lv~E~~~~g~ 175 (426)
|.||.||++.+..++. .+++|.+.... .+..|...+....||||+++++++.+.. ..++||||+++|+
T Consensus 4 g~~~~v~~~~~~~~~~-----~~~~K~i~~~~---~~~~~~~~~~~~~~~~i~~~~~~~~~~~----~~~lv~e~~~~~~ 71 (237)
T cd05576 4 GVIDKVLLVMDTRTQQ-----TFILKGLRKSS---EYSRERLTIIPHCVPNMVCLHKYIVSED----SVFLVLQHAEGGK 71 (237)
T ss_pred cccceEEEEEEccCCc-----EEEEEeecchh---hhhhHHHHHHhcCCCceeehhhheecCC----eEEEEEecCCCCC
Confidence 8999999999877654 79999886543 3345556666668999999999988765 4599999999999
Q ss_pred hhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccCCCCCceeeeee
Q 014363 176 VDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTA 255 (426)
Q Consensus 176 L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 255 (426)
|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||.+...... ...
T Consensus 72 L~~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~ 141 (237)
T cd05576 72 LWSHISKFL--NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDG 141 (237)
T ss_pred HHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc-----ccc
Confidence 999986543 389999999999999999999998 9999999999999999999999999987654332 123
Q ss_pred eecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCcccH
Q 014363 256 VVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSL 335 (426)
Q Consensus 256 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (426)
..++..|+|||.+.+..++.++||||+|+++|||++|..|+...... .... .....+.
T Consensus 142 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~------------------~~~~----~~~~~~~ 199 (237)
T cd05576 142 EAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG------------------INTH----TTLNIPE 199 (237)
T ss_pred CCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh------------------cccc----cccCCcc
Confidence 45677899999998888999999999999999999999887532110 0000 0001222
Q ss_pred HHHHHHHHHHHhccccCCCCCCCH
Q 014363 336 RLVSKLSHVANLCLVKNARTRPKM 359 (426)
Q Consensus 336 ~~~~~l~~li~~cl~~dp~~RPs~ 359 (426)
.++..+.+++.+||+.||++||++
T Consensus 200 ~~~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 200 WVSEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred cCCHHHHHHHHHHccCCHHHhcCC
Confidence 355688999999999999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=296.14 Aligned_cols=249 Identities=23% Similarity=0.330 Sum_probs=206.2
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-----CCHHHHHHHHHHHhhcCCCCccceEeEEEccC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-----GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 158 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 158 (426)
..+++.+..||-||||.|-++....... .+|+|.+++. ...+.+..|-.||...+.|.||++|-.|.+..
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~-----~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~k 493 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKA-----TFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSK 493 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccch-----HHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccch
Confidence 3466677789999999999988766432 4666666543 35567889999999999999999999998877
Q ss_pred CCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeee
Q 014363 159 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 238 (426)
Q Consensus 159 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 238 (426)
.. |++||-|-||.|...|+.++. ++...+..++..+++|++|||++ +||+|||||+|+|++.+|-+||.||
T Consensus 494 yv----YmLmEaClGGElWTiLrdRg~--Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDF 564 (732)
T KOG0614|consen 494 YV----YMLMEACLGGELWTILRDRGS--FDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDF 564 (732)
T ss_pred hh----hhhHHhhcCchhhhhhhhcCC--cccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeeh
Confidence 54 999999999999999976554 89999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014363 239 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 318 (426)
Q Consensus 239 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 318 (426)
|+|+...... .+.++||||.|.|||++.+..++.++|.||||+++|||++|.+||.+.++-..-.+
T Consensus 565 GFAKki~~g~---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~----------- 630 (732)
T KOG0614|consen 565 GFAKKIGSGR---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNL----------- 630 (732)
T ss_pred hhHHHhccCC---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHH-----------
Confidence 9999876643 35679999999999999999999999999999999999999999987665322211
Q ss_pred hhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 014363 319 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPK-----MSEVLEM 365 (426)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~eil~~ 365 (426)
++..--.-.++..+.....+|++++...+|.+|.. +.+|-+|
T Consensus 631 -----ILkGid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 631 -----ILKGIDKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred -----HHhhhhhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 11111112355567778889999999999999975 6777665
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=306.18 Aligned_cols=272 Identities=21% Similarity=0.225 Sum_probs=173.7
Q ss_pred HhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhcCCCCccceEeEEEc-c-CCC
Q 014363 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQNLVKLVGYCAD-D-DER 160 (426)
Q Consensus 83 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~-~~~ 160 (426)
..++|...+.||+|+||.||+|.+..+.. .....||+|++......+.+..| .+....+.+++.++..+.. . ...
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~-~~~~~vAvK~~~~~~~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~ 206 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQS-KKEGKYVLKKATEYGAVEIWMNE--RVRRACPNSCADFVYGFLEPVSSKK 206 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCcc-ccCcEEEEEEecccchhHHHHHH--HHHhhchhhHHHHHHhhhccccccc
Confidence 46789999999999999999999877621 22347999987654433332222 1222233333333222211 0 012
Q ss_pred CceEEEEEeeCCCCChhhhccCCCCC------------------ccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCC
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSET------------------ILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKS 222 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~~------------------~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp 222 (426)
....++||||+++++|.+++...... ......+..++.|++.||+|||++ +|+||||||
T Consensus 207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP 283 (566)
T PLN03225 207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKP 283 (566)
T ss_pred CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCH
Confidence 23569999999999999988643210 112334667999999999999998 999999999
Q ss_pred CceEeCC-CCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccC----------------------CCCCchhh
Q 014363 223 SNILLDE-QWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG----------------------RLAARSDV 279 (426)
Q Consensus 223 ~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~Dv 279 (426)
+|||++. ++.+||+|||+++...... ........|++.|+|||.+... .++.++||
T Consensus 284 ~NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 284 QNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 9999986 5789999999997553321 2223457899999999966432 23456799
Q ss_pred HHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCccc------HHHHHHHHHHHHhccccCC
Q 014363 280 WSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYS------LRLVSKLSHVANLCLVKNA 353 (426)
Q Consensus 280 wslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~l~~li~~cl~~dp 353 (426)
|||||+||||+++..|++.. ...+...+...-.+...+...+.+....... ........+|+.+||+.||
T Consensus 363 wSlGviL~el~~~~~~~~~~----~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP 438 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSN----LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG 438 (566)
T ss_pred HHHHHHHHHHHhCcCCCchH----HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence 99999999999977665421 1111111100000001111111111100000 0012245589999999999
Q ss_pred CCCCCHHHHHHH
Q 014363 354 RTRPKMSEVLEM 365 (426)
Q Consensus 354 ~~RPs~~eil~~ 365 (426)
++|||+.|+++|
T Consensus 439 ~kR~ta~e~L~H 450 (566)
T PLN03225 439 RQRISAKAALAH 450 (566)
T ss_pred ccCCCHHHHhCC
Confidence 999999999987
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=268.89 Aligned_cols=248 Identities=25% Similarity=0.389 Sum_probs=193.9
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-----CCHHHHHHHHHHHhhc-CCCCccceEeEEEcc
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-----GGHKEWMTEVNFLGIV-EHQNLVKLVGYCADD 157 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-----~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~ 157 (426)
.++|..+++||+|+|++|.++.++.+.+ .+|+|+++++ .+..=...|-.+..+- +||.+|-+...|+.+
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~q-----iyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqte 323 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQ-----IYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTE 323 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccce-----eeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhccc
Confidence 5689999999999999999999887755 7888877543 2223345676666665 899999999888877
Q ss_pred CCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEee
Q 014363 158 DERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 237 (426)
Q Consensus 158 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~D 237 (426)
.. +|+|.||++||+|--.+++.. .++++.+..+..+|+.||.|||++ |||.||||.+|||+|.+|++||+|
T Consensus 324 sr----lffvieyv~ggdlmfhmqrqr--klpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltd 394 (593)
T KOG0695|consen 324 SR----LFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTD 394 (593)
T ss_pred ce----EEEEEEEecCcceeeehhhhh--cCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecc
Confidence 64 599999999999987776543 399999999999999999999999 999999999999999999999999
Q ss_pred ecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCch-hhHHHHHhHhhhhh
Q 014363 238 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPR-SEQKLLQWVKPYLS 316 (426)
Q Consensus 238 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~-~~~~~~~~~~~~~~ 316 (426)
+|+++..-..+ ..+.++||||.|.|||++.+..|+..+|.|+|||+++||+.|+.||+.-... .++..-++
T Consensus 395 ygmcke~l~~g--d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedy------ 466 (593)
T KOG0695|consen 395 YGMCKEGLGPG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDY------ 466 (593)
T ss_pred cchhhcCCCCC--cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHH------
Confidence 99998654443 3467899999999999999999999999999999999999999999742211 11111111
Q ss_pred hhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCC
Q 014363 317 DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPK 358 (426)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs 358 (426)
.++-++...+. .+...+-....+++.-|..||.+|..
T Consensus 467 ---lfqvilekqir--iprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 467 ---LFQVILEKQIR--IPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred ---HHHHHhhhccc--ccceeehhhHHHHHHhhcCCcHHhcC
Confidence 11222222222 23334445667888889999999853
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=288.39 Aligned_cols=206 Identities=28% Similarity=0.392 Sum_probs=172.1
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-----CHHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
-|..++.||-|+||+|.++.-.++. ..+|+|.+.+.+ .......|-.||..-+.+-||+||-.|.|.+..
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~-----~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnL 704 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTR-----ALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNL 704 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchh-----hHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCce
Confidence 4667789999999999999865543 367888776543 334567899999999999999999999998854
Q ss_pred CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecc
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 240 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 240 (426)
|+||+|++||++-.+|.+. +.|++..+..++.++..|+++.|.. |+|||||||+|||||.+|++||+||||
T Consensus 705 ----YFVMdYIPGGDmMSLLIrm--gIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGL 775 (1034)
T KOG0608|consen 705 ----YFVMDYIPGGDMMSLLIRM--GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGL 775 (1034)
T ss_pred ----EEEEeccCCccHHHHHHHh--ccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccc
Confidence 9999999999999998754 4699999999999999999999987 999999999999999999999999999
Q ss_pred cccCCC--------CCce--------------------------------eeeeeeecCcccCCchhhccCCCCCchhhH
Q 014363 241 ARLGPS--------EGFT--------------------------------HVSTAVVGTMGYAAPEYVQTGRLAARSDVW 280 (426)
Q Consensus 241 a~~~~~--------~~~~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvw 280 (426)
+.-+.- .+.. ......+||+.|+|||++....|+...|.|
T Consensus 776 CTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdww 855 (1034)
T KOG0608|consen 776 CTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWW 855 (1034)
T ss_pred cccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhh
Confidence 853210 0000 001246899999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCchhhH
Q 014363 281 SYGVFLYELITGRRPIDRNRPRSEQ 305 (426)
Q Consensus 281 slGvil~elltg~~p~~~~~~~~~~ 305 (426)
|.|||||||+.|+.||-...+..-+
T Consensus 856 s~gvil~em~~g~~pf~~~tp~~tq 880 (1034)
T KOG0608|consen 856 SVGVILYEMLVGQPPFLADTPGETQ 880 (1034)
T ss_pred HhhHHHHHHhhCCCCccCCCCCcce
Confidence 9999999999999999877665444
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=262.33 Aligned_cols=237 Identities=32% Similarity=0.468 Sum_probs=190.0
Q ss_pred CcEEEEEEEEcCCCCCCcceEEEEEEccccCC---HHHHHHHHHHHhhcCCCCccceEeEEEccCCCCceEEEEEeeCCC
Q 014363 97 GFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG---HKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPN 173 (426)
Q Consensus 97 ~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~~~lv~E~~~~ 173 (426)
+||.||+|.+..++. .+++|.+..... .+.+.+|++.++.++|+||+++++++.... ..++++||+++
T Consensus 1 ~~g~v~~~~~~~~~~-----~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~----~~~l~~e~~~~ 71 (244)
T smart00220 1 SFGKVYLARDKKTGK-----LVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDED----KLYLVMEYCDG 71 (244)
T ss_pred CceEEEEEEECCCCc-----EEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCC----EEEEEEeCCCC
Confidence 589999999876543 789998865543 578899999999999999999999988754 45999999999
Q ss_pred CChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccCCCCCceeee
Q 014363 174 GSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVS 253 (426)
Q Consensus 174 g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 253 (426)
++|.+++..... +++..++.++.+++.+|.|||+. +++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus 72 ~~L~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~ 143 (244)
T smart00220 72 GDLFDLLKKRGR--LSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LL 143 (244)
T ss_pred CCHHHHHHhccC--CCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc---cc
Confidence 999999865433 88999999999999999999998 99999999999999999999999999998655432 23
Q ss_pred eeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCcc
Q 014363 254 TAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKY 333 (426)
Q Consensus 254 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (426)
....++..|++||.+.+..++.++||||||+++++|++|..||...... ....+... ........
T Consensus 144 ~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~--~~~~~~~~-------------~~~~~~~~ 208 (244)
T smart00220 144 TTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL--LELFKKIG-------------KPKPPFPP 208 (244)
T ss_pred ccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHh-------------ccCCCCcc
Confidence 3456889999999998888999999999999999999999999753211 11111110 00000000
Q ss_pred cH-HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 334 SL-RLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 334 ~~-~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.. .++..+.+++.+||..+|++||++.+++++
T Consensus 209 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~ 241 (244)
T smart00220 209 PEWKISPEAKDLIRKLLVKDPEKRLTAEEALQH 241 (244)
T ss_pred ccccCCHHHHHHHHHHccCCchhccCHHHHhhC
Confidence 00 145689999999999999999999999873
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=284.51 Aligned_cols=273 Identities=20% Similarity=0.252 Sum_probs=183.3
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCC-----------CCcceEEEEEEccccCC----------------HHHHHHHH
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSED-----------PSQKVEVAVKQLGRRGG----------------HKEWMTEV 136 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~-----------~~~~~~va~K~~~~~~~----------------~~~~~~E~ 136 (426)
.++|.+.++||+|+||.||+|.....+. ....+.||+|++..... .+....|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 5689999999999999999997533221 12335799999754321 12234577
Q ss_pred HHHhhcCCCCc-----cceEeEEEccCC----CCceEEEEEeeCCCCChhhhccCCCC----------------------
Q 014363 137 NFLGIVEHQNL-----VKLVGYCADDDE----RGIQRLLVYEYMPNGSVDQYLSPKSE---------------------- 185 (426)
Q Consensus 137 ~~l~~l~HpnI-----v~~~~~~~~~~~----~~~~~~lv~E~~~~g~L~~~l~~~~~---------------------- 185 (426)
.++.+++|.++ ++++++|..... .....+|||||+++++|.++++....
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77788866654 677888764211 11245999999999999998864211
Q ss_pred CccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccCCCCCceeeeeeeecCcccCCc
Q 014363 186 TILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAP 265 (426)
Q Consensus 186 ~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aP 265 (426)
..+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++........ .......+|+.|+||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSPP 379 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeCh
Confidence 1246778889999999999999998 999999999999999999999999999975432211 111122357899999
Q ss_pred hhhccCC--------------------CC--CchhhHHHHHHHHHHHhCCC-CCCCCCchhhHHHHHhHhhhhhhhhhhh
Q 014363 266 EYVQTGR--------------------LA--ARSDVWSYGVFLYELITGRR-PIDRNRPRSEQKLLQWVKPYLSDAKQFR 322 (426)
Q Consensus 266 E~~~~~~--------------------~~--~~~DvwslGvil~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (426)
|.+.... |+ .+.||||+||++|+|++|.. ||......... +.. .-.+....+
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~-~~~----~~~~~~~~r 454 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTE-LRQ----YDNDLNRWR 454 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhH-Hhh----ccchHHHHH
Confidence 9875432 11 24799999999999999875 66532111100 000 000001111
Q ss_pred hhcCCcCCCcccHHHHHHHHHHHHhccccCC---CCCCCHHHHHHH
Q 014363 323 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNA---RTRPKMSEVLEM 365 (426)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp---~~RPs~~eil~~ 365 (426)
........-......+....+|+.+||..+| .+|+|++|+|+|
T Consensus 455 ~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 455 MYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred hhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 1111111111122356788999999999766 689999999987
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=264.96 Aligned_cols=268 Identities=21% Similarity=0.274 Sum_probs=203.0
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-CHHHHHHHHHHHhhcC-----CC---CccceEeEEE
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-GHKEWMTEVNFLGIVE-----HQ---NLVKLVGYCA 155 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~E~~~l~~l~-----Hp---nIv~~~~~~~ 155 (426)
++|-..++||-|-|++||+|.+.... +.||+|+.+... ..+..+.||++|++++ |+ +||+|+++|.
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~-----r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fk 152 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNK-----RYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFK 152 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCC-----eEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccce
Confidence 68999999999999999999977654 489999987554 4456789999999982 33 6999999999
Q ss_pred ccCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCC-----
Q 014363 156 DDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQ----- 230 (426)
Q Consensus 156 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~----- 230 (426)
..+..+.+.|||+|++ |-+|..+|.....+.++...+.+|++||+.||.|||..| ||||-||||+|||+..+
T Consensus 153 hsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~e~~~~ 229 (590)
T KOG1290|consen 153 HSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCSTEIDPA 229 (590)
T ss_pred ecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeeccccchh
Confidence 9999999999999999 889999998877778999999999999999999999985 99999999999998311
Q ss_pred --------------------------------------------------------------------------------
Q 014363 231 -------------------------------------------------------------------------------- 230 (426)
Q Consensus 231 -------------------------------------------------------------------------------- 230 (426)
T Consensus 230 ~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~ 309 (590)
T KOG1290|consen 230 KDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRI 309 (590)
T ss_pred hhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCC
Confidence
Q ss_pred --------------------------------------------------------------------------------
Q 014363 231 -------------------------------------------------------------------------------- 230 (426)
Q Consensus 231 -------------------------------------------------------------------------------- 230 (426)
T Consensus 310 n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~ 389 (590)
T KOG1290|consen 310 NGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPEC 389 (590)
T ss_pred CccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCcc
Confidence
Q ss_pred -CCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCc----hhhH
Q 014363 231 -WNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRP----RSEQ 305 (426)
Q Consensus 231 -~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~----~~~~ 305 (426)
.++||+|||-|..... ..+.-..|..|.|||++.+..|+..+||||++|++|||+||..-|+.... .+++
T Consensus 390 di~vKIaDlGNACW~~k-----hFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDED 464 (590)
T KOG1290|consen 390 DIRVKIADLGNACWVHK-----HFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDED 464 (590)
T ss_pred ceeEEEeeccchhhhhh-----hhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHH
Confidence 0123333333332110 11223467889999999999999999999999999999999998864332 2233
Q ss_pred HHHHhHh-------hhhhhhhhhhhhcCCc----------CC---------CcccHHHHHHHHHHHHhccccCCCCCCCH
Q 014363 306 KLLQWVK-------PYLSDAKQFRQIVDPR----------LE---------GKYSLRLVSKLSHVANLCLVKNARTRPKM 359 (426)
Q Consensus 306 ~~~~~~~-------~~~~~~~~~~~~~~~~----------~~---------~~~~~~~~~~l~~li~~cl~~dp~~RPs~ 359 (426)
.+...+. .+...+..-+++++.+ .+ -.++.....++.+++.=||+.+|++|||+
T Consensus 465 HiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA 544 (590)
T KOG1290|consen 465 HIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTA 544 (590)
T ss_pred HHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccH
Confidence 3322221 1111122222222211 11 12455677899999999999999999999
Q ss_pred HHHHHH
Q 014363 360 SEVLEM 365 (426)
Q Consensus 360 ~eil~~ 365 (426)
.++++|
T Consensus 545 ~~cl~h 550 (590)
T KOG1290|consen 545 AQCLKH 550 (590)
T ss_pred HHHhcC
Confidence 999987
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=246.65 Aligned_cols=198 Identities=25% Similarity=0.360 Sum_probs=160.3
Q ss_pred CCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC---HHHHHHHHHHHhhc-CCCCccceEeEEEccCCCCc
Q 014363 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG---HKEWMTEVNFLGIV-EHQNLVKLVGYCADDDERGI 162 (426)
Q Consensus 87 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~~~~ 162 (426)
...+..||+|+||.|-+.++..++. .+|+|.+...-. .+..+.|+.+...- .+|.+|++||...++...
T Consensus 48 L~~i~elGrGayG~vekmrh~~sg~-----imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv-- 120 (282)
T KOG0984|consen 48 LVGIEELGRGAYGVVEKMRHIQSGT-----IMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV-- 120 (282)
T ss_pred hhhhhhhcCCccchhhheeeccCCe-----EEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE--
Confidence 3345569999999998888877664 889999865532 34567788876665 899999999988777654
Q ss_pred eEEEEEeeCCCCChhhhccC--CCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecc
Q 014363 163 QRLLVYEYMPNGSVDQYLSP--KSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 240 (426)
Q Consensus 163 ~~~lv~E~~~~g~L~~~l~~--~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 240 (426)
++.||.| ..+|+.+-.+ ..+..+++..+-+|+..++.||.|||++ ..|||||+||+||||+.+|++||||||+
T Consensus 121 --wIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGI 195 (282)
T KOG0984|consen 121 --WICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGI 195 (282)
T ss_pred --EEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEccccc
Confidence 8999999 4588766532 2235589999999999999999999997 5899999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCchhhcc----CCCCCchhhHHHHHHHHHHHhCCCCCCCC
Q 014363 241 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQT----GRLAARSDVWSYGVFLYELITGRRPIDRN 299 (426)
Q Consensus 241 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslGvil~elltg~~p~~~~ 299 (426)
+-.+.+.. ..+...|...|||||.+.. ..|+-++||||||++++||.+++.||+..
T Consensus 196 sG~L~dSi---Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 196 SGYLVDSI---AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred ceeehhhh---HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 97654321 1122468899999998764 36899999999999999999999999754
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=244.22 Aligned_cols=262 Identities=21% Similarity=0.328 Sum_probs=199.2
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhcC-CCCccceEeEEEccCCCCc
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVE-HQNLVKLVGYCADDDERGI 162 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~~~~~~~~ 162 (426)
.++|++.+++|+|.|+.||.|....+.+ .+.+|.++.- ..+.+.+|+.||..|. ||||++++++..+....
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~e-----K~ViKiLKPV-kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sk-- 108 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNE-----KCVIKILKPV-KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESK-- 108 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCc-----eEEEeeechH-HHHHHHHHHHHHHhccCCCCeeehhhhhcCcccc--
Confidence 4689999999999999999998665544 6778877543 3467899999999996 99999999999887655
Q ss_pred eEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCC-CeeEeeeccc
Q 014363 163 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW-NAKLSDFGLA 241 (426)
Q Consensus 163 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~-~~kl~DFGla 241 (426)
.+.||+||+++.+...+.. .++...+..++.+++.||.|||+. ||+|||+||.|++||... .++|+|+|+|
T Consensus 109 tpaLiFE~v~n~Dfk~ly~-----tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLA 180 (338)
T KOG0668|consen 109 TPSLIFEYVNNTDFKQLYP-----TLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLA 180 (338)
T ss_pred CchhHhhhhccccHHHHhh-----hhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchH
Confidence 3489999998877766543 277788899999999999999998 999999999999998654 5999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHh--------
Q 014363 242 RLGPSEGFTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK-------- 312 (426)
Q Consensus 242 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~-------- 312 (426)
.++-.... -.-.+.+..|--||.+.. ..|+..-|+|||||+|..|+..+.||.......++ ++..++
T Consensus 181 EFYHp~~e---YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQ-LVkIakVLGt~el~ 256 (338)
T KOG0668|consen 181 EFYHPGKE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ-LVKIAKVLGTDELY 256 (338)
T ss_pred hhcCCCce---eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHH-HHHHHHHhChHHHH
Confidence 98755322 223467888999998765 45899999999999999999999999876554433 222211
Q ss_pred ----hh-hhhhhhhhhhcCCcCCCccc-------H-HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 313 ----PY-LSDAKQFRQIVDPRLEGKYS-------L-RLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 313 ----~~-~~~~~~~~~~~~~~~~~~~~-------~-~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.+ +.-...+..++.......+. . -.+++..+++.+.|..|..+|+|++|.+.|
T Consensus 257 ~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 257 AYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 00 01112222222221111111 0 134788899999999999999999999987
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=254.26 Aligned_cols=268 Identities=23% Similarity=0.323 Sum_probs=198.1
Q ss_pred CCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc----CCHHHHHHHHHHHhhcCCCCccceEeEEEccCCC-C
Q 014363 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR----GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER-G 161 (426)
Q Consensus 87 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~-~ 161 (426)
.+..+.||.|+||.||.+.+..+ .+.+++|++..- ...+.+.+|+++|..++|.|++..+++..-.... .
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRd-----grrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfF 129 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRS-----GKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFF 129 (449)
T ss_pred CCCCCcccccceeEEEeccCCCC-----ccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHH
Confidence 44566899999999999875544 447888887433 2457889999999999999999998877643321 1
Q ss_pred ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccc
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 241 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 241 (426)
.++|+|.|.| ..+|...|-. ...++...+.-++.||++||+|||+. +|.||||||.|+|++.+..+||||||++
T Consensus 130 qEiYV~TELm-QSDLHKIIVS--PQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLA 203 (449)
T KOG0664|consen 130 QELYVLTELM-QSDLHKIIVS--PQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLA 203 (449)
T ss_pred HHHHHHHHHH-Hhhhhheecc--CCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccc
Confidence 2347889998 5688888743 45588889999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHh--h-----
Q 014363 242 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK--P----- 313 (426)
Q Consensus 242 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~--~----- 313 (426)
+.-......+ .+..+-|-.|.|||++.+. .|+.++||||.|||+.||+..+.-|..-.+....+++.-.. +
T Consensus 204 Rvee~d~~~h-MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaM 282 (449)
T KOG0664|consen 204 RTWDQRDRLN-MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAM 282 (449)
T ss_pred cccchhhhhh-hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHH
Confidence 9766544333 3345678899999999875 48999999999999999999999998766655544433211 0
Q ss_pred -hhhhhhhhhhhcCCcCCC-c----c----cHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014363 314 -YLSDAKQFRQIVDPRLEG-K----Y----SLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVN 367 (426)
Q Consensus 314 -~~~~~~~~~~~~~~~~~~-~----~----~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~ 367 (426)
...++.. ..++...... . | +..-..+...++..++..||++|.+..+.+.++.
T Consensus 283 r~ACEGAk-~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 283 KYACEGAK-NHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred HHHhhhhH-HHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 0001111 1111111111 1 1 0122345667888899999999999999988754
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=270.50 Aligned_cols=195 Identities=27% Similarity=0.430 Sum_probs=169.0
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCH----------HHHHHHHHHHhhcC---CCCccceE
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGH----------KEWMTEVNFLGIVE---HQNLVKLV 151 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~----------~~~~~E~~~l~~l~---HpnIv~~~ 151 (426)
..|+.++.||.|+||.|++|.++... ..|.+|.+.++... -..-.|+.||..|+ |+||++++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~-----~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlL 635 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENN-----YEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLL 635 (772)
T ss_pred ccceeeeeccccccceEEEeeecccc-----eEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhh
Confidence 46899999999999999999988764 37889988655311 12346999999997 99999999
Q ss_pred eEEEccCCCCceEEEEEeeC-CCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCC
Q 014363 152 GYCADDDERGIQRLLVYEYM-PNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQ 230 (426)
Q Consensus 152 ~~~~~~~~~~~~~~lv~E~~-~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~ 230 (426)
++|++++. +||+||-. +|.+|.++|..+.+ +++.++..|++||+.|+++||+. ||||||||-+||.++.+
T Consensus 636 dfFEddd~----yyl~te~hg~gIDLFd~IE~kp~--m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~ 706 (772)
T KOG1152|consen 636 DFFEDDDY----YYLETEVHGEGIDLFDFIEFKPR--MDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSN 706 (772)
T ss_pred heeecCCe----eEEEecCCCCCcchhhhhhccCc--cchHHHHHHHHHHHhcccccccc---CceecccccccEEEecC
Confidence 99999885 49999985 67899999987655 89999999999999999999998 99999999999999999
Q ss_pred CCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCC-CCchhhHHHHHHHHHHHhCCCCCC
Q 014363 231 WNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRL-AARSDVWSYGVFLYELITGRRPID 297 (426)
Q Consensus 231 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~elltg~~p~~ 297 (426)
|-+||+|||.+....... ...++||..|.|||++.+.+| +..-|||+||++||.++....||.
T Consensus 707 g~~klidfgsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 707 GFVKLIDFGSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred CeEEEeeccchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999999999997665433 345889999999999999988 567899999999999999999984
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=284.32 Aligned_cols=247 Identities=26% Similarity=0.365 Sum_probs=184.3
Q ss_pred CCCCcceecccCcEE-EEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhc-CCCCccceEeEEEccCCCCce
Q 014363 86 NFSRSVVIGEGGFGC-VYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDERGIQ 163 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~-Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~~~~~ 163 (426)
-|...+++|.|+-|+ ||+|...+. .||||++-.+. .....+|+..|+.- +|||||++|+.-.+.. .
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~ye~R-------~VAVKrll~e~-~~~A~rEi~lL~eSD~H~NviRyyc~E~d~q----F 577 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVYEGR-------EVAVKRLLEEF-FDFAQREIQLLQESDEHPNVIRYYCSEQDRQ----F 577 (903)
T ss_pred eeccHHHcccCCCCcEEEEEeeCCc-------eehHHHHhhHh-HHHHHHHHHHHHhccCCCceEEEEeeccCCc----e
Confidence 355566899999986 899987764 79999886442 33567999999988 7999999987655554 4
Q ss_pred EEEEEeeCCCCChhhhccCCCCC--ccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCC---C--CCeeEe
Q 014363 164 RLLVYEYMPNGSVDQYLSPKSET--ILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE---Q--WNAKLS 236 (426)
Q Consensus 164 ~~lv~E~~~~g~L~~~l~~~~~~--~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~---~--~~~kl~ 236 (426)
.||..|.| ..+|.+++...... .......+.++.|++.||++||+. +||||||||.||||+. + .+++|+
T Consensus 578 ~YIalELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iS 653 (903)
T KOG1027|consen 578 LYIALELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKIS 653 (903)
T ss_pred EEEEehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEec
Confidence 59999999 56999999864111 111133467899999999999997 9999999999999965 3 468999
Q ss_pred eecccccCCCCCce-eeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhC-CCCCCCCCchhhHHHHHhHhhh
Q 014363 237 DFGLARLGPSEGFT-HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITG-RRPIDRNRPRSEQKLLQWVKPY 314 (426)
Q Consensus 237 DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~ 314 (426)
|||+++........ .......||-+|+|||++....-..++|||||||++|+.++| .+||+..-......
T Consensus 654 DfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NI-------- 725 (903)
T KOG1027|consen 654 DFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANI-------- 725 (903)
T ss_pred ccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhh--------
Confidence 99999987643321 124467899999999999998888899999999999999995 99997543221111
Q ss_pred hhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 315 LSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
+.....+.. +.. ..+. +..+||.+|+..+|..||++.+|+.|
T Consensus 726 l~~~~~L~~-----L~~--~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 726 LTGNYTLVH-----LEP--LPDC--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred hcCccceee-----ecc--CchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 111111100 000 0011 78899999999999999999999764
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-32 Score=247.43 Aligned_cols=265 Identities=26% Similarity=0.297 Sum_probs=193.1
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc----CCHHHHHHHHHHHhhcCCCCccceEeEEEccCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR----GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
..+|..++.+|.|+- .|..|.+.-.+ ..|++|+.... ...++..+|+..+..++|+||++++.+|.-...
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~-----~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~ 89 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLG-----RPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKT 89 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhcc-----CceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCcccc
Confidence 347778888999988 56666544333 36788776433 244677899999999999999999999864332
Q ss_pred C--CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEee
Q 014363 160 R--GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 237 (426)
Q Consensus 160 ~--~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~D 237 (426)
. ....|+||||| ..+|...+.- .++-..+..|+.|++.|++|||+. +|+||||||+||++..++.+||.|
T Consensus 90 l~~~~e~y~v~e~m-~~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~d 161 (369)
T KOG0665|consen 90 LEEFQEVYLVMELM-DANLCQVILM----ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILD 161 (369)
T ss_pred HHHHHhHHHHHHhh-hhHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeecc
Confidence 1 12348999999 5689888762 277788999999999999999998 999999999999999999999999
Q ss_pred ecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhH------------
Q 014363 238 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQ------------ 305 (426)
Q Consensus 238 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~------------ 305 (426)
||+++.... ....+..+.|..|.|||++.+..|.+.+||||+||++.||++|..-|.+....+.-
T Consensus 162 fg~ar~e~~---~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~ 238 (369)
T KOG0665|consen 162 FGLARTEDT---DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDP 238 (369)
T ss_pred chhhcccCc---ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCH
Confidence 999985433 23456678999999999999988999999999999999999999988754321110
Q ss_pred ----HHHHhHhhhhhhhhh-----hhhhc-CCcCCCc--ccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 306 ----KLLQWVKPYLSDAKQ-----FRQIV-DPRLEGK--YSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 306 ----~~~~~~~~~~~~~~~-----~~~~~-~~~~~~~--~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.+...+..+.....+ +.+.+ |...... .+..-...+.+++.+||..||++|.|++++|.|
T Consensus 239 ~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 239 SFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 111111111111111 01111 0000000 011234567899999999999999999999997
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=235.04 Aligned_cols=210 Identities=38% Similarity=0.611 Sum_probs=180.3
Q ss_pred ecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC---HHHHHHHHHHHhhcCCCCccceEeEEEccCCCCceEEEEEe
Q 014363 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG---HKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYE 169 (426)
Q Consensus 93 lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~~~lv~E 169 (426)
||+|++|.||++....++. .+++|.+..... .+.+.+|+..++.+.|++|+++++++.... ..+++||
T Consensus 1 l~~g~~~~v~~~~~~~~~~-----~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~----~~~~~~e 71 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGK-----KVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDEN----HLYLVME 71 (215)
T ss_pred CCcCCceEEEEEEecCCCc-----EEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC----eEEEEEe
Confidence 6899999999999875433 789999876654 377999999999999999999999998764 4599999
Q ss_pred eCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCC-CCCeeEeeecccccCCCCC
Q 014363 170 YMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE-QWNAKLSDFGLARLGPSEG 248 (426)
Q Consensus 170 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~-~~~~kl~DFGla~~~~~~~ 248 (426)
|+++++|.+++.... ..+++..++.++.+++.+|++||+. +++|+||+|.||+++. ++.++|+|||.+.......
T Consensus 72 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~ 147 (215)
T cd00180 72 YCEGGSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDK 147 (215)
T ss_pred cCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCc
Confidence 999999999987542 3488999999999999999999998 9999999999999999 8999999999998654432
Q ss_pred ceeeeeeeecCcccCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCC
Q 014363 249 FTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDP 327 (426)
Q Consensus 249 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (426)
. ......+...|++||.+... .++.++|+|+||+++++|
T Consensus 148 ~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------- 187 (215)
T cd00180 148 S--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------- 187 (215)
T ss_pred c--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------
Confidence 1 12335678899999998877 788999999999999999
Q ss_pred cCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014363 328 RLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMV 366 (426)
Q Consensus 328 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L 366 (426)
..+.+++..|++.||++||++.++++++
T Consensus 188 -----------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 -----------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred -----------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 2577899999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-32 Score=238.07 Aligned_cols=254 Identities=20% Similarity=0.391 Sum_probs=188.6
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-CHHHHHHHHHHHhhc-CCCCccceEeEEEccCCCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-GHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~~~ 161 (426)
.+.|.+.+.||+|.||.+-+|.++.+.. .+++|.+.... ..++|.+|...--.| .|.||+..|++......
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t-----~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d-- 95 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKT-----RIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSD-- 95 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCce-----EEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCc--
Confidence 3478899999999999999999988765 78999887654 567899998876666 68999998876444332
Q ss_pred ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEe-C-CCCCeeEeeec
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL-D-EQWNAKLSDFG 239 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl-~-~~~~~kl~DFG 239 (426)
.+++++||+|.|+|..-+...+ +.+.....++.|++.||.|||++ ++||||||.+|||| + +..++||||||
T Consensus 96 -~YvF~qE~aP~gdL~snv~~~G---igE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG 168 (378)
T KOG1345|consen 96 -AYVFVQEFAPRGDLRSNVEAAG---IGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFG 168 (378)
T ss_pred -eEEEeeccCccchhhhhcCccc---ccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecc
Confidence 3488999999999999887644 88899999999999999999998 99999999999999 2 34479999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCchhhccC---C--CCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhh
Q 014363 240 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG---R--LAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPY 314 (426)
Q Consensus 240 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~--~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 314 (426)
+.+..+.. .....-+..|.+||..... . ..+.+|||.||+++|.++||+.||... ...+.....|..-
T Consensus 169 ~t~k~g~t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka-~~~d~~Y~~~~~w- 241 (378)
T KOG1345|consen 169 LTRKVGTT-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKA-SIMDKPYWEWEQW- 241 (378)
T ss_pred cccccCce-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhh-hccCchHHHHHHH-
Confidence 98754321 1223456789999976532 2 467899999999999999999999732 2222222222211
Q ss_pred hhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014363 315 LSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMV 366 (426)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L 366 (426)
.+-..+.++..+ ..+++.+..+.++-|..++++|--+.++.+..
T Consensus 242 -------~~rk~~~~P~~F-~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 242 -------LKRKNPALPKKF-NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred -------hcccCccCchhh-cccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 111122222222 23567788899999999999995555554443
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-32 Score=267.36 Aligned_cols=253 Identities=26% Similarity=0.378 Sum_probs=200.8
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcc--ccCCHHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLG--RRGGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~--~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
..+|..+..+|.|+||.||+++++.+++ ..|+|.++ ...+.+-+.+|+-+++..+|||||.++|.+...+..
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~e-----laavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dkl- 87 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGE-----LAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKL- 87 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCc-----hhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCc-
Confidence 4578889999999999999999888776 45666554 334556678999999999999999999999887754
Q ss_pred ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccc
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 241 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 241 (426)
++.||||.||+|.+.-+ ...++++.++..++++.++||+|||+. +-+|||||-.|||+++.|.+|++|||.+
T Consensus 88 ---wicMEycgggslQdiy~--~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvs 159 (829)
T KOG0576|consen 88 ---WICMEYCGGGSLQDIYH--VTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVS 159 (829)
T ss_pred ---EEEEEecCCCcccceee--ecccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCch
Confidence 99999999999998764 345699999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCceeeeeeeecCcccCCchhhc---cCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014363 242 RLGPSEGFTHVSTAVVGTMGYAAPEYVQ---TGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 318 (426)
Q Consensus 242 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 318 (426)
-.+... -.....+.||+.|||||+.. .+.|...+|||++|++..|+---++|.....+.....+.. +
T Consensus 160 aqitat--i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmT--k------ 229 (829)
T KOG0576|consen 160 AQITAT--IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMT--K------ 229 (829)
T ss_pred hhhhhh--hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhh--c------
Confidence 765432 22345789999999999763 5779999999999999999988888865444322222211 1
Q ss_pred hhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 319 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
..+. .+.+. -.....+.+.++++.||-.+|.+||++..+|+|
T Consensus 230 S~~q---pp~lk--Dk~kws~~fh~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 230 SGFQ---PPTLK--DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred cCCC---CCccc--CCccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence 0110 11111 112355678899999999999999999988763
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-32 Score=257.88 Aligned_cols=266 Identities=21% Similarity=0.255 Sum_probs=202.7
Q ss_pred HhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-CHHHHHHHHHHHhhcCC------CCccceEeEEE
Q 014363 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-GHKEWMTEVNFLGIVEH------QNLVKLVGYCA 155 (426)
Q Consensus 83 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~E~~~l~~l~H------pnIv~~~~~~~ 155 (426)
..++|.+....|+|-|++|.+|.+...+. .||||++.+.. -.+.=+.|++||.+|+. -|+++++-.|.
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~-----~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~ 504 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQ-----EVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFK 504 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCC-----eeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhh
Confidence 45678888899999999999998776654 89999997653 23444689999999953 37899988887
Q ss_pred ccCCCCceEEEEEeeCCCCChhhhccCCCC-CccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCC-Ce
Q 014363 156 DDDERGIQRLLVYEYMPNGSVDQYLSPKSE-TILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW-NA 233 (426)
Q Consensus 156 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~-~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~-~~ 233 (426)
... ++|||+|-+ ..+|.+.|...+. ..|....+..++.|+.-||..|... +|+|.||||+|||+++.- .+
T Consensus 505 hkn----HLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iL 576 (752)
T KOG0670|consen 505 HKN----HLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNIL 576 (752)
T ss_pred hcc----eeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCccee
Confidence 765 569999998 6799999976543 3478888999999999999999987 999999999999998764 57
Q ss_pred eEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhh
Q 014363 234 KLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKP 313 (426)
Q Consensus 234 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~ 313 (426)
||||||.|........ +.+.-+..|.|||++.+-+|+...|+||+||+||||.||+..|.+........+.--++-
T Consensus 577 KLCDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KG 652 (752)
T KOG0670|consen 577 KLCDFGSASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKG 652 (752)
T ss_pred eeccCccccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcC
Confidence 9999999987654332 224456789999999999999999999999999999999999988776555443322110
Q ss_pred hhhh-----------------------------------------hhhhhhhcCCc-CCCcccHHHHHHHHHHHHhcccc
Q 014363 314 YLSD-----------------------------------------AKQFRQIVDPR-LEGKYSLRLVSKLSHVANLCLVK 351 (426)
Q Consensus 314 ~~~~-----------------------------------------~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~ 351 (426)
.+.+ ...+...+... -...-.......+.+|+.+||.+
T Consensus 653 k~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~L 732 (752)
T KOG0670|consen 653 KFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLIL 732 (752)
T ss_pred CCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhcc
Confidence 0000 01111111100 00111224567899999999999
Q ss_pred CCCCCCCHHHHHHH
Q 014363 352 NARTRPKMSEVLEM 365 (426)
Q Consensus 352 dp~~RPs~~eil~~ 365 (426)
||++|.|..+.|+|
T Consensus 733 dP~KRit~nqAL~H 746 (752)
T KOG0670|consen 733 DPEKRITVNQALKH 746 (752)
T ss_pred ChhhcCCHHHHhcC
Confidence 99999999999987
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-31 Score=242.96 Aligned_cols=270 Identities=25% Similarity=0.370 Sum_probs=198.7
Q ss_pred HHhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhc-CCCCccceEeEEEccCCC
Q 014363 82 SATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDER 160 (426)
Q Consensus 82 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~~ 160 (426)
...+.|..+.+||+|+|++||++.+... ......||+|.+........+..|+++|..+ -+.||+++.+.+...+.
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~--~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~- 109 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQ--DTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ- 109 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhh--ccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCCe-
Confidence 3456789999999999999999987662 2344589999998888888999999999999 68999999999887774
Q ss_pred CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCC-CCCeeEeeec
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE-QWNAKLSDFG 239 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~-~~~~kl~DFG 239 (426)
..+||||++...-.++... ++...+..+++.++.||.++|.+ |||||||||.|+|.+. .+.-.|.|||
T Consensus 110 ---v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFg 178 (418)
T KOG1167|consen 110 ---VAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFG 178 (418)
T ss_pred ---eEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEech
Confidence 4999999999888888753 67888999999999999999998 9999999999999974 4568999999
Q ss_pred ccccCC-----------------C-----------------CCce--------eeeeeeecCcccCCchhhcc-CCCCCc
Q 014363 240 LARLGP-----------------S-----------------EGFT--------HVSTAVVGTMGYAAPEYVQT-GRLAAR 276 (426)
Q Consensus 240 la~~~~-----------------~-----------------~~~~--------~~~~~~~gt~~y~aPE~~~~-~~~~~~ 276 (426)
+|.... . .+.. ...-...||++|.|||++.. +..+++
T Consensus 179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta 258 (418)
T KOG1167|consen 179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA 258 (418)
T ss_pred hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence 996210 0 0000 01123569999999998765 456889
Q ss_pred hhhHHHHHHHHHHHhCCCCCCCCCchhhH--HHHHh---------Hh-h----hhh--h----h---hhhhhhcCCcC--
Q 014363 277 SDVWSYGVFLYELITGRRPIDRNRPRSEQ--KLLQW---------VK-P----YLS--D----A---KQFRQIVDPRL-- 329 (426)
Q Consensus 277 ~DvwslGvil~elltg~~p~~~~~~~~~~--~~~~~---------~~-~----~~~--~----~---~~~~~~~~~~~-- 329 (426)
+||||.|||++.++++..||.......+. ++... +. + .+. + . ..+..+.-..+
T Consensus 259 iDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~ 338 (418)
T KOG1167|consen 259 IDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYK 338 (418)
T ss_pred cceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccc
Confidence 99999999999999999999754332111 11100 00 0 000 0 0 00001100000
Q ss_pred ------C-CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 330 ------E-GKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 330 ------~-~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
. .......+..+.+++.+||..||.+|.|+++.|+|
T Consensus 339 ~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 339 SRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred ccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 0 00111234578899999999999999999999986
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-29 Score=228.52 Aligned_cols=198 Identities=35% Similarity=0.508 Sum_probs=167.9
Q ss_pred CCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCce
Q 014363 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQ 163 (426)
Q Consensus 87 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~ 163 (426)
|...+.||.|++|.||+|.....+. .+++|.+.... ..+.+.+|+..+..++|+|++++++++.....
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~-----~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~---- 71 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGE-----LVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEP---- 71 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCc-----EEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCc----
Confidence 5667889999999999999876443 78999886543 35678899999999999999999999877653
Q ss_pred EEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccccc
Q 014363 164 RLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL 243 (426)
Q Consensus 164 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 243 (426)
.++++||+++++|.+++...... +++..+..++.+++.+|.+||+. +++|+||+|.||+++.++.++|+|||++..
T Consensus 72 ~~~v~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~ 147 (225)
T smart00221 72 LYLVMEYCEGGDLFDYLRKKGGK-LSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARF 147 (225)
T ss_pred eEEEEeccCCCCHHHHHHhcccC-CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeE
Confidence 49999999999999998754321 78899999999999999999998 999999999999999999999999999987
Q ss_pred CCCCCceeeeeeeecCcccCCchhh-ccCCCCCchhhHHHHHHHHHHHhCCCCCCC
Q 014363 244 GPSEGFTHVSTAVVGTMGYAAPEYV-QTGRLAARSDVWSYGVFLYELITGRRPIDR 298 (426)
Q Consensus 244 ~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslGvil~elltg~~p~~~ 298 (426)
..... ........++..|++||.+ ....++.++|||+||+++++|++|+.||..
T Consensus 148 ~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 148 IHRDL-AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ecCcc-cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 65432 0122345788899999988 666778899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-30 Score=273.39 Aligned_cols=201 Identities=17% Similarity=0.215 Sum_probs=140.0
Q ss_pred hcCC-CCccceEeEEEccC---CCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeE
Q 014363 141 IVEH-QNLVKLVGYCADDD---ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQII 216 (426)
Q Consensus 141 ~l~H-pnIv~~~~~~~~~~---~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~ii 216 (426)
.++| +||++++++|.... .....++++|||+ +++|.++|... ...+++..++.++.||++||.|||++ +|+
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---gIv 102 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQ---GIV 102 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence 4456 58888888873222 1112347788988 66999999743 34589999999999999999999998 999
Q ss_pred eccCCCCceEeCCCC-------------------CeeEeeecccccCCCCCc--------------eeeeeeeecCcccC
Q 014363 217 VRDFKSSNILLDEQW-------------------NAKLSDFGLARLGPSEGF--------------THVSTAVVGTMGYA 263 (426)
Q Consensus 217 HrDlkp~NILl~~~~-------------------~~kl~DFGla~~~~~~~~--------------~~~~~~~~gt~~y~ 263 (426)
||||||+||||+..+ .+||+|||+++....... .......+||+.||
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 999999999996544 455666666543211000 00011246899999
Q ss_pred CchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHH
Q 014363 264 APEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSH 343 (426)
Q Consensus 264 aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 343 (426)
|||++.+..|+.++|||||||+||||++|..|+..... ...... .....+.. .........
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~-----~~~~~~---------~~~~~~~~-----~~~~~~~~~ 243 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR-----TMSSLR---------HRVLPPQI-----LLNWPKEAS 243 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH-----HHHHHH---------HhhcChhh-----hhcCHHHHH
Confidence 99999999999999999999999999999888642110 000000 00111100 011234568
Q ss_pred HHHhccccCCCCCCCHHHHHHH
Q 014363 344 VANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 344 li~~cl~~dp~~RPs~~eil~~ 365 (426)
++.+||+.||.+||++.||+++
T Consensus 244 ~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 244 FCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHhCCCChhhCcChHHHhhc
Confidence 8899999999999999999875
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=214.00 Aligned_cols=169 Identities=21% Similarity=0.242 Sum_probs=127.9
Q ss_pred CChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccCCCCCceeee
Q 014363 174 GSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVS 253 (426)
Q Consensus 174 g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 253 (426)
|+|.+++...+ ..+++..++.|+.|++.||.|||++ + ||+|||++.++.+|+ ||++......
T Consensus 1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~------ 62 (176)
T smart00750 1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPE------ 62 (176)
T ss_pred CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeeccc------
Confidence 68999997532 4599999999999999999999987 5 999999999999999 9998765432
Q ss_pred eeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCcc
Q 014363 254 TAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKY 333 (426)
Q Consensus 254 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (426)
...||+.|||||++.+..++.++|||||||++|||++|..||....... ..+...... .... .+ .....
T Consensus 63 -~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~-~~~~~~~~~-------~~~~-~~-~~~~~ 131 (176)
T smart00750 63 -QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS-AILEILLNG-------MPAD-DP-RDRSN 131 (176)
T ss_pred -cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc-HHHHHHHHH-------hccC-Cc-ccccc
Confidence 1268999999999999999999999999999999999999996532211 111110000 0000 00 00011
Q ss_pred cHHHHH--HHHHHHHhccccCCCCCCCHHHHHHHHHHhHh
Q 014363 334 SLRLVS--KLSHVANLCLVKNARTRPKMSEVLEMVNKIVD 371 (426)
Q Consensus 334 ~~~~~~--~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~ 371 (426)
...... .+.+++.+||..||++||++.|+++++..+..
T Consensus 132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 132 LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 223333 69999999999999999999999999877654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-26 Score=221.29 Aligned_cols=262 Identities=22% Similarity=0.270 Sum_probs=198.1
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC--HHHHHHHHHHHhhcCC----CCccceEeEEE-ccC
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG--HKEWMTEVNFLGIVEH----QNLVKLVGYCA-DDD 158 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~E~~~l~~l~H----pnIv~~~~~~~-~~~ 158 (426)
+|.+.+.||+|+||.||+|...... ...+|+|....... ...+..|+.++..+.. +++..+++... ...
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~----~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~ 94 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEK----NKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTED 94 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCC----CeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCc
Confidence 7999999999999999999976654 44678887655432 2268889999999973 58888888874 333
Q ss_pred CCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCC-----CCe
Q 014363 159 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQ-----WNA 233 (426)
Q Consensus 159 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~-----~~~ 233 (426)
..|+||+.+ |.+|.++......+.++...++.|+.|++.+|++||+. |++||||||+|+++... ..+
T Consensus 95 ----~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~ 166 (322)
T KOG1164|consen 95 ----FNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTL 166 (322)
T ss_pred ----eeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceE
Confidence 349999999 89999988655556799999999999999999999998 99999999999999765 359
Q ss_pred eEeeecccc--cCCCCCce----e-e-eeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhH
Q 014363 234 KLSDFGLAR--LGPSEGFT----H-V-STAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQ 305 (426)
Q Consensus 234 kl~DFGla~--~~~~~~~~----~-~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~ 305 (426)
.|.|||+++ ........ . . ...+.||..|+++....+...+.+.|+||++.++.+++.|..||.........
T Consensus 167 ~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~ 246 (322)
T KOG1164|consen 167 YLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLK 246 (322)
T ss_pred EEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchH
Confidence 999999998 33222111 1 1 22456999999999999999999999999999999999999999654432221
Q ss_pred -HHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhh
Q 014363 306 -KLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 373 (426)
Q Consensus 306 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~ 373 (426)
.+.+... ...... .....+..+.+++..+-..+..++|....+...|.......
T Consensus 247 ~~~~~~~~----------~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 247 SKFEKDPR----------KLLTDR----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred HHHHHHhh----------hhcccc----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 1111100 000000 11223456677777777799999999999999988776553
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.6e-27 Score=210.06 Aligned_cols=265 Identities=15% Similarity=0.224 Sum_probs=208.8
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhc-CCCCccceEeEEEccCCCCce
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDERGIQ 163 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~~~~~ 163 (426)
-.|.++++||+|.||..+.|...-.++ .||||.-.......++..|.+..+.| ..++|..+|-|.......
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne-----~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~N--- 99 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNE-----PVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYN--- 99 (449)
T ss_pred ccceeccccccCcceeeecccccccCc-----eEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchh---
Confidence 378999999999999999998665544 89999988777777899999999998 578999998665554433
Q ss_pred EEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCC-----CeeEeee
Q 014363 164 RLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW-----NAKLSDF 238 (426)
Q Consensus 164 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~-----~~kl~DF 238 (426)
.||||.+ |.+|+|+.+-.++ .|+.+.++.|+.|++.-++|+|++ .+|.|||||+|+||...+ .+.|+||
T Consensus 100 -iLVidLL-GPSLEDLFD~CgR-~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDF 173 (449)
T KOG1165|consen 100 -ILVIDLL-GPSLEDLFDLCGR-RFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDF 173 (449)
T ss_pred -hhhhhhh-CcCHHHHHHHhcC-cccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEec
Confidence 7999999 9999999886554 499999999999999999999998 999999999999996443 4899999
Q ss_pred cccccCCCCCcee-----eeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhh
Q 014363 239 GLARLGPSEGFTH-----VSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKP 313 (426)
Q Consensus 239 Gla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~ 313 (426)
|+|+.+.+..... ......||..||+--...+.+.+.+.|+-|||-++++.|-|..||.+..........+.
T Consensus 174 GmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeK--- 250 (449)
T KOG1165|consen 174 GMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEK--- 250 (449)
T ss_pred cchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHH---
Confidence 9999876543211 23467899999999998999999999999999999999999999988655433222211
Q ss_pred hhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhh
Q 014363 314 YLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 373 (426)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~ 373 (426)
+.+.-...........++.++..-+...-.++-.+-|+.+-+...+.++++..
T Consensus 251 -------IGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~ 303 (449)
T KOG1165|consen 251 -------IGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRL 303 (449)
T ss_pred -------hccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhc
Confidence 11111111111223346778888888888889999999999988888887653
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.7e-27 Score=201.39 Aligned_cols=265 Identities=20% Similarity=0.252 Sum_probs=208.1
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhcCC-CCccceEeEEEccCCCCc
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEH-QNLVKLVGYCADDDERGI 162 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l~H-pnIv~~~~~~~~~~~~~~ 162 (426)
.++|..++.||.|+||.+|.|....++. .||+|.-.......++..|.++...|++ ..|..+..|..+....
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge-----~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~yn-- 86 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGE-----EVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYN-- 86 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCc-----eEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccccccc--
Confidence 5789999999999999999999887776 8999999888888889999999999965 5778887777776654
Q ss_pred eEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCC---CCeeEeeec
Q 014363 163 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQ---WNAKLSDFG 239 (426)
Q Consensus 163 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~---~~~kl~DFG 239 (426)
.+||+.+ |.+|+++..-.. ..++..+++-++-|++.-++|+|.+ ++|||||||+|+|..-+ ..+.|+|||
T Consensus 87 --vlVMdLL-GPsLEdLfnfC~-R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFG 159 (341)
T KOG1163|consen 87 --VLVMDLL-GPSLEDLFNFCS-RRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFG 159 (341)
T ss_pred --eeeeecc-CccHHHHHHHHh-hhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEecc
Confidence 8999999 999999886443 3489999999999999999999998 99999999999999643 358999999
Q ss_pred ccccCCCCCce-----eeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhh
Q 014363 240 LARLGPSEGFT-----HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPY 314 (426)
Q Consensus 240 la~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 314 (426)
+|+.+.+.... .......||..|.+--...+...+.+.|+-|+|.+|.++.-|..||.+..+.........+
T Consensus 160 LaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI--- 236 (341)
T KOG1163|consen 160 LAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKI--- 236 (341)
T ss_pred chhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHH---
Confidence 99876543211 1234678999999988877778889999999999999999999999987654433222211
Q ss_pred hhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 014363 315 LSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 372 (426)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~ 372 (426)
.+..-..........++.++.-.+..|-..--++-|+..-+-+.+..++..
T Consensus 237 -------~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ 287 (341)
T KOG1163|consen 237 -------SEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRT 287 (341)
T ss_pred -------HHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhh
Confidence 111111111112234567788888999999999999998888877666544
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=220.86 Aligned_cols=176 Identities=19% Similarity=0.191 Sum_probs=131.0
Q ss_pred HHhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-------CCHHHHHHHHHHHhhcCCCCccceEeEE
Q 014363 82 SATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-------GGHKEWMTEVNFLGIVEHQNLVKLVGYC 154 (426)
Q Consensus 82 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-------~~~~~~~~E~~~l~~l~HpnIv~~~~~~ 154 (426)
...++|...+.||+|+||+||+|.++.... ..+|+|.+... .....+.+|+++|+.++|+||+..+..+
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~----~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~ 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPG----TARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCC----eEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc
Confidence 345689999999999999999998765221 25788876422 1234688999999999999999643221
Q ss_pred EccCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccC-CCCceEeCCCCCe
Q 014363 155 ADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDF-KSSNILLDEQWNA 233 (426)
Q Consensus 155 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDl-kp~NILl~~~~~~ 233 (426)
+ ..||||||++|++|... ... . ...++.|+++||.|||++ ||+|||| ||+|||++.++.+
T Consensus 91 ---~----~~~LVmE~~~G~~L~~~-~~~-----~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~i 151 (365)
T PRK09188 91 ---G----KDGLVRGWTEGVPLHLA-RPH-----G---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEA 151 (365)
T ss_pred ---C----CcEEEEEccCCCCHHHh-Ccc-----c---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCE
Confidence 2 23999999999999732 111 1 146788999999999998 9999999 9999999999999
Q ss_pred eEeeecccccCCCCCceee------eeeeecCcccCCchhhccCC------CCCchhhH
Q 014363 234 KLSDFGLARLGPSEGFTHV------STAVVGTMGYAAPEYVQTGR------LAARSDVW 280 (426)
Q Consensus 234 kl~DFGla~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~------~~~~~Dvw 280 (426)
||+|||+++.....+.... -....+++.|+|||.+.... .+..+|-|
T Consensus 152 kLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 152 AVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred EEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 9999999987654331111 13567889999999886432 23446665
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.7e-28 Score=245.56 Aligned_cols=258 Identities=21% Similarity=0.234 Sum_probs=191.7
Q ss_pred CCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCH----HHHHHHHHHHhhcCCCCccceEeEEEccCCCCce
Q 014363 88 SRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGH----KEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQ 163 (426)
Q Consensus 88 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~----~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~ 163 (426)
....++|.|++|.|+.+...........+.+.++ ....... ..+..|+.+-..|.|||++..+..+.+....
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~-~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~--- 396 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVR-VKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGI--- 396 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcc-cCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccc---
Confidence 4567899999998888876655544444444443 2122111 1256688888889999998887776665543
Q ss_pred EEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccccc
Q 014363 164 RLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL 243 (426)
Q Consensus 164 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 243 (426)
+-+||||++ +|..++... ..+....+-.+++|++.||+|||+. ||.|||||++|++++.+|.+||+|||.+..
T Consensus 397 -~~~mE~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~v 469 (601)
T KOG0590|consen 397 -LQSMEYCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASV 469 (601)
T ss_pred -hhhhhcccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCccee
Confidence 344999999 999998654 2478888899999999999999998 999999999999999999999999999986
Q ss_pred CCCCCce--eeeeeeecCcccCCchhhccCCCCC-chhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhh
Q 014363 244 GPSEGFT--HVSTAVVGTMGYAAPEYVQTGRLAA-RSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 320 (426)
Q Consensus 244 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (426)
+.-.... ......+|+..|+|||++.+..|++ .+||||.|++++.|++|+.||........+. .+ ...
T Consensus 470 f~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-~~--------~~~ 540 (601)
T KOG0590|consen 470 FRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-KT--------NNY 540 (601)
T ss_pred eccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-hh--------hcc
Confidence 5433322 5566789999999999999999987 6999999999999999999997544332221 00 000
Q ss_pred hhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 321 FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
..+.....-.......++...+.+|.+||++||.+|.|+++|++.
T Consensus 541 ~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 541 SDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred ccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 000001111112233567788999999999999999999999874
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-26 Score=204.19 Aligned_cols=245 Identities=22% Similarity=0.403 Sum_probs=192.6
Q ss_pred CcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCceE
Q 014363 89 RSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQR 164 (426)
Q Consensus 89 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~~ 164 (426)
.+.+|.+...|+.|+|++.+.. +..|++.-+. ...+|..|.-.|+.+.||||+.++|.|..... +
T Consensus 194 l~tkl~e~hsgelwrgrwqgnd-------ivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppn----l 262 (448)
T KOG0195|consen 194 LITKLAESHSGELWRGRWQGND-------IVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPN----L 262 (448)
T ss_pred hhhhhccCCCcccccccccCcc-------hhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCC----c
Confidence 3446889999999999998763 3445443222 33578999999999999999999999988764 4
Q ss_pred EEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEe--eecccc
Q 014363 165 LLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLS--DFGLAR 242 (426)
Q Consensus 165 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~--DFGla~ 242 (426)
.+|..||+.|+|...++......++..++.+++.+++.|++|||+. ++-|.---|....|+||++...+|+ |--++
T Consensus 263 v~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfs- 340 (448)
T KOG0195|consen 263 VIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFS- 340 (448)
T ss_pred eEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceee-
Confidence 8999999999999999988777788899999999999999999986 3234445789999999999887765 22111
Q ss_pred cCCCCCceeeeeeeecCcccCCchhhccCCCC---CchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014363 243 LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLA---ARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 319 (426)
Q Consensus 243 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 319 (426)
.......-.|.||+||.++..+-+ .++|+|||.++||||.|...||....+-+
T Consensus 341 --------fqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspme---------------- 396 (448)
T KOG0195|consen 341 --------FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPME---------------- 396 (448)
T ss_pred --------eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchh----------------
Confidence 112233457899999999876543 47999999999999999999998654421
Q ss_pred hhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhH
Q 014363 320 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIV 370 (426)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~ 370 (426)
---++.-..+....++..+..+..|+.-|+..||.+||.++.|+-.|+++.
T Consensus 397 cgmkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 397 CGMKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred hhhhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 112233344555667778889999999999999999999999999998864
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.3e-24 Score=204.17 Aligned_cols=258 Identities=32% Similarity=0.468 Sum_probs=193.3
Q ss_pred CCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-----CHHHHHHHHHHHhhcCCC-CccceEeEEEccCCC
Q 014363 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-----GHKEWMTEVNFLGIVEHQ-NLVKLVGYCADDDER 160 (426)
Q Consensus 87 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-----~~~~~~~E~~~l~~l~Hp-nIv~~~~~~~~~~~~ 160 (426)
|.....||.|+||.||++.+. ..+++|.+.... ....+.+|+.++..+.|+ +|+++++++.....
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~- 72 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--------KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGS- 72 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--------cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCE-
Confidence 667788999999999999876 367888775443 245688999999999988 79999999955442
Q ss_pred CceEEEEEeeCCCCChhhhccCCCC-CccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCC-CeeEeee
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSE-TILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW-NAKLSDF 238 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~-~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~-~~kl~DF 238 (426)
.+++++|+.++++.+++..... ..+.......++.|++.++.|+|.. +++||||||+|||++..+ .++++||
T Consensus 73 ---~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~df 146 (384)
T COG0515 73 ---LYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDF 146 (384)
T ss_pred ---EEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEecc
Confidence 4899999999999977754321 2588899999999999999999998 999999999999999998 6999999
Q ss_pred cccccCCCCCcee----eeeeeecCcccCCchhhcc---CCCCCchhhHHHHHHHHHHHhCCCCCCCCCch-hhHHHHHh
Q 014363 239 GLARLGPSEGFTH----VSTAVVGTMGYAAPEYVQT---GRLAARSDVWSYGVFLYELITGRRPIDRNRPR-SEQKLLQW 310 (426)
Q Consensus 239 Gla~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslGvil~elltg~~p~~~~~~~-~~~~~~~~ 310 (426)
|++.......... ......|+..|++||.+.+ ..+....|+||+|++++++++|..||...... ........
T Consensus 147 g~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 226 (384)
T COG0515 147 GLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKI 226 (384)
T ss_pred CcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHH
Confidence 9998554332221 2456789999999999987 57888999999999999999999997655431 01111111
Q ss_pred HhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 311 VKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
...... . .................+.+++..|+..+|..|.+..+....
T Consensus 227 ~~~~~~---~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 227 ILELPT---P---SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred HHhcCC---c---ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 110000 0 000001100002233578899999999999999999887775
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.5e-24 Score=190.11 Aligned_cols=174 Identities=10% Similarity=0.101 Sum_probs=132.9
Q ss_pred HhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC--HH---H------HHHHHHHHhhcCCCCccceE
Q 014363 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG--HK---E------WMTEVNFLGIVEHQNLVKLV 151 (426)
Q Consensus 83 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~--~~---~------~~~E~~~l~~l~HpnIv~~~ 151 (426)
..++|..+++||.|+||.||++.. +. ..+++|.+..... .. . +.+|+..+.++.||+|..+.
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~------~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~ 101 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DY------GKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLN 101 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CC------CcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcce
Confidence 367899999999999999999654 22 1589999864431 11 1 57899999999999999999
Q ss_pred eEEEccCCC----CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEe
Q 014363 152 GYCADDDER----GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL 227 (426)
Q Consensus 152 ~~~~~~~~~----~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl 227 (426)
+++.+.... ....+|||||++|.+|.++.. +++ ....+++.+|..||.. |++||||||+||++
T Consensus 102 d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili 168 (232)
T PRK10359 102 DFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIV 168 (232)
T ss_pred EeeeecccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEE
Confidence 987654321 124589999999999988742 333 2456999999999998 99999999999999
Q ss_pred CCCCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh
Q 014363 228 DEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT 291 (426)
Q Consensus 228 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt 291 (426)
+.+| ++|+|||.......... ...++....|+.++|||+||+++..+..
T Consensus 169 ~~~g-i~liDfg~~~~~~e~~a--------------~d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 169 SKNG-LRIIDLSGKRCTAQRKA--------------KDRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred eCCC-EEEEECCCcccccchhh--------------HHHHHHHhHhcccccccceeEeehHHHH
Confidence 9988 99999998865432110 0114445567789999999999886653
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.8e-23 Score=180.40 Aligned_cols=137 Identities=13% Similarity=0.068 Sum_probs=104.6
Q ss_pred cceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC-----------HHH-----------------HHHHHHHHhh
Q 014363 90 SVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG-----------HKE-----------------WMTEVNFLGI 141 (426)
Q Consensus 90 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~-----------~~~-----------------~~~E~~~l~~ 141 (426)
...||+|+||.||+|... ++. .||+|.+..... ... ...|+++|..
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~-----~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 75 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGE-----ERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKR 75 (190)
T ss_pred CCccccccceEEEEEECC-CCC-----EEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHH
Confidence 357999999999999875 333 799998854311 011 2349999999
Q ss_pred cCCCCccceEeEEEccCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHh-ccCCCCCeEeccC
Q 014363 142 VEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYL-HEGMDFQIIVRDF 220 (426)
Q Consensus 142 l~HpnIv~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~L-H~~~~~~iiHrDl 220 (426)
+.++++.....+.... .+|||||++|+++...+.. ...++...+..++.|++.+|.|| |+. ||+||||
T Consensus 76 l~~~~v~~p~~~~~~~------~~iVmE~i~g~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDl 144 (190)
T cd05147 76 LVTAGIPCPEPILLKS------HVLVMEFIGDDGWAAPRLK--DAPLSESKARELYLQVIQIMRILYQDC---RLVHADL 144 (190)
T ss_pred HHHCCCCCCcEEEecC------CEEEEEEeCCCCCcchhhh--cCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCC
Confidence 9888875444332221 1899999998877654322 23488899999999999999999 687 9999999
Q ss_pred CCCceEeCCCCCeeEeeecccccC
Q 014363 221 KSSNILLDEQWNAKLSDFGLARLG 244 (426)
Q Consensus 221 kp~NILl~~~~~~kl~DFGla~~~ 244 (426)
||+|||++ ++.++|+|||++...
T Consensus 145 kP~NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 145 SEYNLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred CHHHEEEE-CCcEEEEEccccccC
Confidence 99999998 478999999999743
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.8e-22 Score=175.88 Aligned_cols=137 Identities=16% Similarity=0.068 Sum_probs=106.7
Q ss_pred cceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC----------------------------HHHHHHHHHHHhh
Q 014363 90 SVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG----------------------------HKEWMTEVNFLGI 141 (426)
Q Consensus 90 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~----------------------------~~~~~~E~~~l~~ 141 (426)
...||+|+||.||+|.+. ++ ..||+|.+..... ...+..|+..+.+
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g-----~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 75 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DG-----EELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKR 75 (190)
T ss_pred CceeecCCCcEEEEEEcC-CC-----CEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHH
Confidence 457999999999999876 33 3799998764321 1123578999999
Q ss_pred cCCCCccceEeEEEccCCCCceEEEEEeeCCCCChhhh-ccCCCCCccCHHHHHHHHHHHHHHHHHhcc-CCCCCeEecc
Q 014363 142 VEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQY-LSPKSETILTWAMRLKIAQDAARGLAYLHE-GMDFQIIVRD 219 (426)
Q Consensus 142 l~HpnIv~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~-l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~-~~~~~iiHrD 219 (426)
+.|++|.....+.... .||||||++|+++... +.. ..++...+..++.|++.+|.+||. . ||+|||
T Consensus 76 l~~~~i~~p~~~~~~~------~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrD 143 (190)
T cd05145 76 LYEAGVPVPEPILLKK------NVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGD 143 (190)
T ss_pred HHhCCCCCceEEEecC------CEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCC
Confidence 9999886554443332 2899999988865433 322 337788889999999999999999 7 999999
Q ss_pred CCCCceEeCCCCCeeEeeecccccCC
Q 014363 220 FKSSNILLDEQWNAKLSDFGLARLGP 245 (426)
Q Consensus 220 lkp~NILl~~~~~~kl~DFGla~~~~ 245 (426)
|||+|||++ ++.++|+|||++....
T Consensus 144 lkP~NIll~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 144 LSEYNILYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred CChhhEEEE-CCCEEEEEcccceecC
Confidence 999999999 7899999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.6e-24 Score=206.37 Aligned_cols=227 Identities=26% Similarity=0.350 Sum_probs=176.6
Q ss_pred eecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcC-CCCccceEeEEEccCCCCceEEE
Q 014363 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVE-HQNLVKLVGYCADDDERGIQRLL 166 (426)
Q Consensus 92 ~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~-HpnIv~~~~~~~~~~~~~~~~~l 166 (426)
++|+|.||.|+++.-... ......+++|...... .......|-.++...+ ||.+|++.-.++.+... ++
T Consensus 1 vlg~g~~gkvfLvrk~~g--~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl----~l 74 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGG--ADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKL----YL 74 (612)
T ss_pred CCCcCCCcchHHHHHhcc--ccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccch----hH
Confidence 379999999998653322 2233456666654321 1124557788888886 99999998777776644 89
Q ss_pred EEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccCCC
Q 014363 167 VYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPS 246 (426)
Q Consensus 167 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 246 (426)
+++|..||.|...+.... .+.+.....+...++-|++++|+. +|+|||+|++||+++.+|++++.|||+++..-.
T Consensus 75 ~ld~~rgg~lft~l~~~~--~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~ 149 (612)
T KOG0603|consen 75 ILDFLRGGDLFTRLSKEV--MFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVK 149 (612)
T ss_pred hhhhcccchhhhccccCC--chHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHh
Confidence 999999999988876543 377788888889999999999998 999999999999999999999999999986543
Q ss_pred CCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcC
Q 014363 247 EGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVD 326 (426)
Q Consensus 247 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (426)
.. ..|||..|||||++. .+..++|.||||++++||++|..||... ....++.
T Consensus 150 ~~------~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~--------------------~~~~Il~ 201 (612)
T KOG0603|consen 150 EK------IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGD--------------------TMKRILK 201 (612)
T ss_pred hh------hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchH--------------------HHHHHhh
Confidence 32 128999999999987 6788999999999999999999999750 1111111
Q ss_pred CcCCCcccHHHHHHHHHHHHhccccCCCCCCCH
Q 014363 327 PRLEGKYSLRLVSKLSHVANLCLVKNARTRPKM 359 (426)
Q Consensus 327 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~ 359 (426)
....++...+..+.+++..++..+|.+|.-.
T Consensus 202 --~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 202 --AELEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred --hccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 1234566778888999999999999999654
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.6e-22 Score=173.10 Aligned_cols=183 Identities=18% Similarity=0.099 Sum_probs=135.0
Q ss_pred CcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC------HHHHHHHHHHHhhcC-CCCccceEeEEEccCCCC
Q 014363 89 RSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG------HKEWMTEVNFLGIVE-HQNLVKLVGYCADDDERG 161 (426)
Q Consensus 89 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~------~~~~~~E~~~l~~l~-HpnIv~~~~~~~~~~~~~ 161 (426)
....|++|+||+||.+...+ ..++.+.+..... ...+.+|+++|.+|. |++|++++++.
T Consensus 6 ~~~~l~~~~f~~v~~~~~~~-------~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~------- 71 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRGGE-------RKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD------- 71 (218)
T ss_pred cceeecCCCcceEEEeecCC-------ceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc-------
Confidence 45679999999999765422 2566666654432 124789999999995 58899998861
Q ss_pred ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccC-CCCceEeCCCCCeeEeeecc
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDF-KSSNILLDEQWNAKLSDFGL 240 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDl-kp~NILl~~~~~~kl~DFGl 240 (426)
..+++|||+.|.+|.+.+.. ....++.|++.+|.++|++ ||+|||| ||+|||++.++.++|+|||+
T Consensus 72 -~~~lvmeyI~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~ 138 (218)
T PRK12274 72 -GRHLDRSYLAGAAMYQRPPR---------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQL 138 (218)
T ss_pred -CEEEEEeeecCccHHhhhhh---------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCC
Confidence 13899999999998754321 1135788999999999998 9999999 79999999999999999999
Q ss_pred cccCCCCCce-------ee----eeeeecCcccCCchhhccC-CCC-CchhhHHHHHHHHHHHhCCCCCCC
Q 014363 241 ARLGPSEGFT-------HV----STAVVGTMGYAAPEYVQTG-RLA-ARSDVWSYGVFLYELITGRRPIDR 298 (426)
Q Consensus 241 a~~~~~~~~~-------~~----~~~~~gt~~y~aPE~~~~~-~~~-~~~DvwslGvil~elltg~~p~~~ 298 (426)
+......+.. .. ......++.|++|+...-- ..+ ...+.++.|.-+|.++|+..++..
T Consensus 139 A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 139 AVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred ceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 9865443310 00 0112367888999854322 233 567889999999999999988754
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.4e-22 Score=181.29 Aligned_cols=235 Identities=20% Similarity=0.293 Sum_probs=148.0
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-----CHHHHHHHHHHHhhcCC----------CCccce
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-----GHKEWMTEVNFLGIVEH----------QNLVKL 150 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-----~~~~~~~E~~~l~~l~H----------pnIv~~ 150 (426)
.+.....||.|+++.||.+.+..+++ .+++|++.... ..+.+.+|.-....+.+ -.++..
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~-----~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P 87 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGE-----EFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVP 87 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTE-----EEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---
T ss_pred EEEEccccccCCceEEEEEEEccCCc-----eEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEee
Confidence 34556789999999999999887765 88998874322 33455666544444322 122222
Q ss_pred EeEEEc---------cC-CCCc---eEEEEEeeCCCCChhhhccC-----CCCCccCHHHHHHHHHHHHHHHHHhccCCC
Q 014363 151 VGYCAD---------DD-ERGI---QRLLVYEYMPNGSVDQYLSP-----KSETILTWAMRLKIAQDAARGLAYLHEGMD 212 (426)
Q Consensus 151 ~~~~~~---------~~-~~~~---~~~lv~E~~~~g~L~~~l~~-----~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~ 212 (426)
++.... .. .... ..+++|+-+ .++|.+++.. .....+....++.+..|+++.+++||..
T Consensus 88 ~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~-- 164 (288)
T PF14531_consen 88 LDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY-- 164 (288)
T ss_dssp SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT--
T ss_pred eEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc--
Confidence 222211 11 0000 236788888 5688887641 1122345556677889999999999998
Q ss_pred CCeEeccCCCCceEeCCCCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccC--------CCCCchhhHHHHH
Q 014363 213 FQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG--------RLAARSDVWSYGV 284 (426)
Q Consensus 213 ~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~DvwslGv 284 (426)
|++|+||||+|++++.+|.++|+||+........ . .. ...+..|.+||..... .++.+.|.|+||+
T Consensus 165 -GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~---~-~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~ 238 (288)
T PF14531_consen 165 -GLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTR---Y-RC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGI 238 (288)
T ss_dssp -TEEEST-SGGGEEE-TTS-EEE--GGGEEETTEE---E-EG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHH
T ss_pred -ceEecccceeeEEEcCCCCEEEcChHHHeecCce---e-ec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHH
Confidence 9999999999999999999999999887654321 1 11 3355789999976542 4788999999999
Q ss_pred HHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCC
Q 014363 285 FLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTR 356 (426)
Q Consensus 285 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 356 (426)
++|.|.||..||+...+..... ..-..+. +.++.++.||..+|+.||++|
T Consensus 239 ~ly~lWC~~lPf~~~~~~~~~~---------------------~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 239 TLYSLWCGRLPFGLSSPEADPE---------------------WDFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHHSS-STCCCGGGSTSG---------------------GGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHHccCCCCCCCcccccc---------------------ccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999999999998643221110 0112334 788999999999999999988
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.8e-21 Score=173.33 Aligned_cols=139 Identities=17% Similarity=0.262 Sum_probs=105.3
Q ss_pred CCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc--CCHHHHHHHHHHHhhc-----CCCCccceEeEEEccCC
Q 014363 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR--GGHKEWMTEVNFLGIV-----EHQNLVKLVGYCADDDE 159 (426)
Q Consensus 87 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~E~~~l~~l-----~HpnIv~~~~~~~~~~~ 159 (426)
.....+||+|+||.||. +.... ..++|++... ...+.+.+|+.+++.+ +||||++++|++.++..
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~------~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g 75 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDA------QRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCG 75 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCc------CeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCC
Confidence 34456899999999995 44322 1257766432 2456789999999999 67999999999988754
Q ss_pred CCceEEEEEee--CCCCChhhhccCCCCCccCHHHHHHHHHHHHHHH-HHhccCCCCCeEeccCCCCceEeCC----CCC
Q 014363 160 RGIQRLLVYEY--MPNGSVDQYLSPKSETILTWAMRLKIAQDAARGL-AYLHEGMDFQIIVRDFKSSNILLDE----QWN 232 (426)
Q Consensus 160 ~~~~~~lv~E~--~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL-~~LH~~~~~~iiHrDlkp~NILl~~----~~~ 232 (426)
.+..+.+|||| +++|+|.+++... .+++. ..++.|++.++ +|||++ +|+||||||+|||++. ++.
T Consensus 76 ~g~v~~~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~ 147 (210)
T PRK10345 76 TGYVYDVIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVI 147 (210)
T ss_pred CeEEEEEEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCc
Confidence 44334589999 5579999999653 25555 35677888777 999998 9999999999999974 347
Q ss_pred eeEeeeccc
Q 014363 233 AKLSDFGLA 241 (426)
Q Consensus 233 ~kl~DFGla 241 (426)
++|+||+.+
T Consensus 148 ~~LiDg~G~ 156 (210)
T PRK10345 148 PVVCDNIGE 156 (210)
T ss_pred EEEEECCCC
Confidence 999995443
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.4e-22 Score=204.62 Aligned_cols=245 Identities=20% Similarity=0.251 Sum_probs=172.2
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHH---HHHHHhhcCCCCccceEeEEEccCC
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMT---EVNFLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~---E~~~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
+|...+.||.+.|=+|.+|+++.+ .|.+|++-+.+ ....+.+ |++ ...++|||++++--+......
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG-------~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kA 95 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREG-------LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKA 95 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCc-------eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHH
Confidence 566777899999999999987765 57888875554 3334444 444 455699999998655443332
Q ss_pred CCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeec
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 239 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 239 (426)
. |||-+|. .-+|+|.+..+. .+...+.+.|+.|++.||.-+|.. ||+|||||.+||||+.=.-+.|+||.
T Consensus 96 A----ylvRqyv-khnLyDRlSTRP--FL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFA 165 (1431)
T KOG1240|consen 96 A----YLVRQYV-KHNLYDRLSTRP--FLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFA 165 (1431)
T ss_pred H----HHHHHHH-hhhhhhhhccch--HHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhccc
Confidence 2 7888898 459999987554 367777788999999999999998 99999999999999998889999997
Q ss_pred ccccC--CCC---CceeeeeeeecCcccCCchhhccC----------C-CCCchhhHHHHHHHHHHHh-CCCCCCCCCch
Q 014363 240 LARLG--PSE---GFTHVSTAVVGTMGYAAPEYVQTG----------R-LAARSDVWSYGVFLYELIT-GRRPIDRNRPR 302 (426)
Q Consensus 240 la~~~--~~~---~~~~~~~~~~gt~~y~aPE~~~~~----------~-~~~~~DvwslGvil~ellt-g~~p~~~~~~~ 302 (426)
.-+.. +.+ ++.....+-..-..|+|||.+-.. . .+++-||||+||+++||++ |++||...
T Consensus 166 sFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS--- 242 (1431)
T KOG1240|consen 166 SFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS--- 242 (1431)
T ss_pred ccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH---
Confidence 66532 111 111111222233579999977541 1 5678999999999999999 78888521
Q ss_pred hhHHHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 303 SEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.+..+-. ......+.+-..++. ..++.++..|++.||++|.++++.|+.
T Consensus 243 ---QL~aYr~----~~~~~~e~~Le~Ied-------~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 243 ---QLLAYRS----GNADDPEQLLEKIED-------VSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred ---HHHhHhc----cCccCHHHHHHhCcC-------ccHHHHHHHHHccCchhccCHHHHHHh
Confidence 1111111 001111111111211 257899999999999999999999985
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.7e-21 Score=188.90 Aligned_cols=217 Identities=27% Similarity=0.465 Sum_probs=161.2
Q ss_pred HhhcCCCCccceEeEEEccCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCe-Ee
Q 014363 139 LGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQI-IV 217 (426)
Q Consensus 139 l~~l~HpnIv~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~i-iH 217 (426)
|+.+.|.|+.+++|.+.+.. ..++|.+||..|+|.|.+... ...+++.-...++++++.||+|||.- .| .|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~----~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~h 72 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGP----EMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHNS---PIGYH 72 (484)
T ss_pred CcccchhhhhhheeeEecCC----ceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhcC---cceee
Confidence 46789999999999999885 348999999999999999753 34588888999999999999999986 44 99
Q ss_pred ccCCCCceEeCCCCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCC-------CCCchhhHHHHHHHHHHH
Q 014363 218 RDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGR-------LAARSDVWSYGVFLYELI 290 (426)
Q Consensus 218 rDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DvwslGvil~ell 290 (426)
+.++..|.++|..+.+||+|||+.................-...|.|||.+.... .+.+.||||||++++|++
T Consensus 73 g~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~ 152 (484)
T KOG1023|consen 73 GALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEIL 152 (484)
T ss_pred eeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHH
Confidence 9999999999999999999999987654211011111122346799999988642 356799999999999999
Q ss_pred hCCCCCCCCCchhh-HHHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHh
Q 014363 291 TGRRPIDRNRPRSE-QKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 369 (426)
Q Consensus 291 tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~ 369 (426)
+...||........ ..++..+.. .......+.+.... ...+.+..++..||..+|++||++++|-..++.+
T Consensus 153 ~r~~~~~~~~~~~~~~eii~~~~~------~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~ 224 (484)
T KOG1023|consen 153 FRSGPFDLRNLVEDPDEIILRVKK------GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI 224 (484)
T ss_pred hccCccccccccCChHHHHHHHHh------cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence 99999976433222 233322221 01111222222111 3445789999999999999999999998877665
Q ss_pred Hh
Q 014363 370 VD 371 (426)
Q Consensus 370 ~~ 371 (426)
..
T Consensus 225 ~~ 226 (484)
T KOG1023|consen 225 NK 226 (484)
T ss_pred cc
Confidence 43
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.2e-22 Score=201.60 Aligned_cols=210 Identities=26% Similarity=0.395 Sum_probs=145.3
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCce
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQ 163 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~ 163 (426)
..+|..+++|-.|+||.||.++++.+.. .+|+|. ++... |++ ||..+ .+..
T Consensus 82 e~df~~IklisngAygavylvrh~~trq-----rfa~ki-Nkq~l---------ilR-----nilt~----a~np----- 132 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQ-----RFAMKI-NKQNL---------ILR-----NILTF----AGNP----- 132 (1205)
T ss_pred ccccceeEeeccCCCCceeeeecccccc-----chhhcc-cccch---------hhh-----ccccc----cCCc-----
Confidence 4689999999999999999998876654 677743 32210 111 12222 1111
Q ss_pred EEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccccc
Q 014363 164 RLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL 243 (426)
Q Consensus 164 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 243 (426)
+.| |+-...+...+ .++.. ++.+++|||+. ||+|||+||+|+||+.-|++|++|||+++.
T Consensus 133 -fvv------gDc~tllk~~g--~lPvd--------mvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~ 192 (1205)
T KOG0606|consen 133 -FVV------GDCATLLKNIG--PLPVD--------MVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKK 192 (1205)
T ss_pred -cee------chhhhhcccCC--CCcch--------hhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhh
Confidence 233 33333443222 23332 27799999987 999999999999999999999999999875
Q ss_pred CCCCC-------------ceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHh
Q 014363 244 GPSEG-------------FTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQW 310 (426)
Q Consensus 244 ~~~~~-------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~ 310 (426)
..... ........+||+.|.|||++....|+..+|+|++|+|+||.+.|..||++..+++....+-
T Consensus 193 GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vi- 271 (1205)
T KOG0606|consen 193 GLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI- 271 (1205)
T ss_pred hhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhh-
Confidence 32110 0111345699999999999999999999999999999999999999999887654332111
Q ss_pred HhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCC
Q 014363 311 VKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRP 357 (426)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP 357 (426)
.+...+. .-....+.++++++.++|+.+|..|-
T Consensus 272 -----sd~i~wp---------E~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 272 -----SDDIEWP---------EEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred -----hhhcccc---------ccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 0100000 01223456899999999999999994
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.6e-21 Score=197.24 Aligned_cols=250 Identities=18% Similarity=0.187 Sum_probs=175.0
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhcC---CCCccceEeEEEccCCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVE---HQNLVKLVGYCADDDER 160 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l~---HpnIv~~~~~~~~~~~~ 160 (426)
...|.+.+.||+|+||+||+|...+ .+.||+|+-+.....+ |.-=.+++.+|+ -+-|.++.......+..
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~------~~~~alK~e~P~~~WE-fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSN------GKLVALKVEKPPNPWE-FYICLQVMERLKPQMLPSIMHISSAHVFQNAS 769 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCC------CcEEEEEeecCCCcee-eeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence 4568888899999999999998766 2389999876665432 322334455555 23344444333333332
Q ss_pred CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCC-------CCCe
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE-------QWNA 233 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~-------~~~~ 233 (426)
+||+||.+.|+|.+++. ..+.++|..+..+..|++..|++||.. +|||+||||+|.||.. .-.+
T Consensus 770 ----~lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l 840 (974)
T KOG1166|consen 770 ----VLVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGL 840 (974)
T ss_pred ----eeeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccce
Confidence 89999999999999997 455699999999999999999999998 9999999999999942 2348
Q ss_pred eEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhh
Q 014363 234 KLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKP 313 (426)
Q Consensus 234 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~ 313 (426)
+|+|||.+..+..-.........++|-.+-.+|+..|..++..+|.|.|+.+++.||.|+..=.
T Consensus 841 ~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q~---------------- 904 (974)
T KOG1166|consen 841 YLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYMEV---------------- 904 (974)
T ss_pred EEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHHh----------------
Confidence 9999999875432221233556789999999999999999999999999999999999864210
Q ss_pred hhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 014363 314 YLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 372 (426)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~ 372 (426)
.+.....++..+..-+..+. ..+++..+|..|-..=|...+|...|++.+..
T Consensus 905 ----~~g~~~~~~~~~~Ry~~~~~---W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~ 956 (974)
T KOG1166|consen 905 ----KNGSSWMVKTNFPRYWKRDM---WNKFFDLLLNPDCDTLPNLQELRTELEEVLAE 956 (974)
T ss_pred ----cCCcceeccccchhhhhHHH---HHHHHHHHhCcCcccchhHHHHHHHHHHHHHH
Confidence 00000001111111111122 23444555655555558888888888877654
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=9.1e-21 Score=175.30 Aligned_cols=202 Identities=20% Similarity=0.283 Sum_probs=142.8
Q ss_pred CCCCccceEeEEEccCCC-----------------------CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHH
Q 014363 143 EHQNLVKLVGYCADDDER-----------------------GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQD 199 (426)
Q Consensus 143 ~HpnIv~~~~~~~~~~~~-----------------------~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~ 199 (426)
+|||||++.++|.++-.. +..+|+||...+. +|.+|+..+. .+.....-|+.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~---~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH---RSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC---CchHHHHHHHHH
Confidence 599999999988653211 3456899998854 8999986544 455666778999
Q ss_pred HHHHHHHhccCCCCCeEeccCCCCceEe--CCCCC--eeEeeecccccCCCCCc----eeeeeeeecCcccCCchhhccC
Q 014363 200 AARGLAYLHEGMDFQIIVRDFKSSNILL--DEQWN--AKLSDFGLARLGPSEGF----THVSTAVVGTMGYAAPEYVQTG 271 (426)
Q Consensus 200 i~~aL~~LH~~~~~~iiHrDlkp~NILl--~~~~~--~kl~DFGla~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~ 271 (426)
+++|+.|||.+ ||.|||+|.+|||| |+|+. +.|+|||++--....+. ..-.-...|...-||||+....
T Consensus 350 lLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~ 426 (598)
T KOG4158|consen 350 LLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV 426 (598)
T ss_pred HHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence 99999999999 99999999999998 44443 78999998853322111 1111234577888999987643
Q ss_pred C------CCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHH
Q 014363 272 R------LAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVA 345 (426)
Q Consensus 272 ~------~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 345 (426)
+ .-.|+|.|+.|.+.||++....||...... . -+....++..-+. .+..+++.+.+++
T Consensus 427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem-~-----------L~~r~Yqe~qLPa----lp~~vpp~~rqlV 490 (598)
T KOG4158|consen 427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM-L-----------LDTRTYQESQLPA----LPSRVPPVARQLV 490 (598)
T ss_pred CCCceeeccchhhhhhhhhhHHHHhccCCcccccchh-e-----------echhhhhhhhCCC----CcccCChHHHHHH
Confidence 2 235899999999999999999999652110 0 0111122222222 3345667889999
Q ss_pred HhccccCCCCCCCHHHHHHHHH
Q 014363 346 NLCLVKNARTRPKMSEVLEMVN 367 (426)
Q Consensus 346 ~~cl~~dp~~RPs~~eil~~L~ 367 (426)
...|+.||++|++..-....|+
T Consensus 491 ~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 491 FDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHhcCCccccCCccHHHhHHH
Confidence 9999999999999766555443
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.83 E-value=9.1e-22 Score=188.80 Aligned_cols=173 Identities=21% Similarity=0.338 Sum_probs=131.3
Q ss_pred eEEEEEeeCCCCChhhhccCC-CCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccc
Q 014363 163 QRLLVYEYMPNGSVDQYLSPK-SETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 241 (426)
Q Consensus 163 ~~~lv~E~~~~g~L~~~l~~~-~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 241 (426)
.+||.|++|...+|.++|..+ .....++...+.++.|++.|+.| + +.+|+|+||.||++..+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence 468999999999999999643 23447788889999999999999 5 9999999999999999999999999999
Q ss_pred ccCCCCC----ceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhh
Q 014363 242 RLGPSEG----FTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLS 316 (426)
Q Consensus 242 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 316 (426)
....... .....+...||..||+||.+.+..|+.++||||||+||+||++ -..+++.
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er------------------ 465 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER------------------ 465 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH------------------
Confidence 7655433 1122445789999999999999999999999999999999998 3333321
Q ss_pred hhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHH
Q 014363 317 DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSE 361 (426)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~e 361 (426)
...+..+-+..+...+-.+.+ .-..|+.+++.+.|.+||++.+
T Consensus 466 -~~t~~d~r~g~ip~~~~~d~p-~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 466 -IATLTDIRDGIIPPEFLQDYP-EEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred -HHhhhhhhcCCCChHHhhcCc-HHHHHHHHhcCCCcccCchHHH
Confidence 112222223333222222222 3458999999999999994443
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.6e-19 Score=164.66 Aligned_cols=140 Identities=16% Similarity=0.088 Sum_probs=107.1
Q ss_pred CCCCcceecccCcEEEEEEE-EcCCCCCCcceEEEEEEccccCC--------------------------HHHHHHHHHH
Q 014363 86 NFSRSVVIGEGGFGCVYKGL-IKNSEDPSQKVEVAVKQLGRRGG--------------------------HKEWMTEVNF 138 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~-~~~~~~~~~~~~va~K~~~~~~~--------------------------~~~~~~E~~~ 138 (426)
-|.+.+.||+|+||.||+|. +..++ ..||+|.+..... ...+..|+.+
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g-----~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 103 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSG-----KERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRN 103 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCC-----cEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHH
Confidence 48899999999999999998 43333 3789998753310 0124689999
Q ss_pred HhhcCCC--CccceEeEEEccCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCC-e
Q 014363 139 LGIVEHQ--NLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQ-I 215 (426)
Q Consensus 139 l~~l~Hp--nIv~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~-i 215 (426)
+.++.+. .+.+++++ . . .++||||++|++|..+.... ..+....+..++.|++.+|.+||.. + |
T Consensus 104 L~~L~~~~i~~p~~~~~---~-~----~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---g~i 170 (237)
T smart00090 104 LQRLYEAGVPVPKPIAW---R-R----NVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLYKE---GEL 170 (237)
T ss_pred HHHHHhcCCCCCeeeEe---c-C----ceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHHhc---CCE
Confidence 9999753 34455443 1 1 28999999998887665322 2355666788999999999999998 8 9
Q ss_pred EeccCCCCceEeCCCCCeeEeeecccccC
Q 014363 216 IVRDFKSSNILLDEQWNAKLSDFGLARLG 244 (426)
Q Consensus 216 iHrDlkp~NILl~~~~~~kl~DFGla~~~ 244 (426)
+||||||+|||++ ++.++|+|||.+...
T Consensus 171 iH~Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 171 VHGDLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred EeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence 9999999999999 889999999998743
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=6.9e-19 Score=158.43 Aligned_cols=132 Identities=20% Similarity=0.308 Sum_probs=106.9
Q ss_pred ceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----------CHHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----------GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----------~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
+.||+|++|.||+|.+.+. .+++|...... ....+.+|+.++..+.|++|+....++.+....
T Consensus 2 ~~l~~G~~~~vy~~~~~~~-------~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 74 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGI-------KAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENF 74 (211)
T ss_pred cccccCceEEEEEEeeCCC-------ceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCC
Confidence 4799999999999987332 46777654321 113577899999999999988777666655433
Q ss_pred CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecc
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 240 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 240 (426)
++||||++|++|.+++.... . .+..++.+++.+|.+||+. +++|+|++|.|||++ ++.++|+|||+
T Consensus 75 ----~lv~e~~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~ 140 (211)
T PRK14879 75 ----IIVMEYIEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGL 140 (211)
T ss_pred ----EEEEEEeCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCc
Confidence 89999999999999985421 2 7788999999999999998 999999999999999 78999999998
Q ss_pred ccc
Q 014363 241 ARL 243 (426)
Q Consensus 241 a~~ 243 (426)
+..
T Consensus 141 a~~ 143 (211)
T PRK14879 141 AEF 143 (211)
T ss_pred ccC
Confidence 864
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.79 E-value=8.3e-19 Score=156.42 Aligned_cols=128 Identities=21% Similarity=0.337 Sum_probs=100.4
Q ss_pred eecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----------CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----------GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 92 ~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----------~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
.||+|+||.||+|.+.+. .+++|...... ....+.+|++++..+.|+++.....++.+....
T Consensus 1 ~ig~G~~~~vy~~~~~~~-------~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~- 72 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGL-------KAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNK- 72 (199)
T ss_pred CCCCCceEEEEEeecCCc-------cEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCC-
Confidence 489999999999985432 57777643321 124567899999999988765554444444433
Q ss_pred ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccc
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 241 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 241 (426)
++||||++|++|.+++.... . .++.+++.+|.+||+. +++|+|++|.|||++ ++.++++|||++
T Consensus 73 ---~lv~e~~~g~~l~~~~~~~~---~------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a 136 (199)
T TIGR03724 73 ---TIVMEYIEGKPLKDVIEEGN---D------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLG 136 (199)
T ss_pred ---EEEEEEECCccHHHHHhhcH---H------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCC
Confidence 89999999999998875321 1 7899999999999998 999999999999999 789999999998
Q ss_pred cc
Q 014363 242 RL 243 (426)
Q Consensus 242 ~~ 243 (426)
..
T Consensus 137 ~~ 138 (199)
T TIGR03724 137 KY 138 (199)
T ss_pred cC
Confidence 75
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.79 E-value=1e-18 Score=178.64 Aligned_cols=141 Identities=21% Similarity=0.252 Sum_probs=108.5
Q ss_pred HhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-----CCHHHHHHHHHHHhhcCCCCccceEeEEEcc
Q 014363 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-----GGHKEWMTEVNFLGIVEHQNLVKLVGYCADD 157 (426)
Q Consensus 83 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 157 (426)
....|...+.||+|+||.||+|.+..... ..++ ...|..... ...+.+.+|++++..++|++|+..+.++.+.
T Consensus 331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~-v~k~-~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~ 408 (535)
T PRK09605 331 VKRRKIPDHLIGKGAEADIKKGEYLGRDA-VIKE-RVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP 408 (535)
T ss_pred cccccCccceeccCCcEEEEEEeecCccc-eeEE-EecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC
Confidence 34556778899999999999998765421 1111 111111111 1124578999999999999999887777665
Q ss_pred CCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEee
Q 014363 158 DERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 237 (426)
Q Consensus 158 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~D 237 (426)
... ++||||++|++|.+++. ....++.+++.+|.|||+. +++||||||+|||+ .++.++|+|
T Consensus 409 ~~~----~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liD 470 (535)
T PRK09605 409 EEK----TIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLID 470 (535)
T ss_pred CCC----EEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEe
Confidence 433 89999999999998874 3467899999999999998 99999999999999 677999999
Q ss_pred eccccc
Q 014363 238 FGLARL 243 (426)
Q Consensus 238 FGla~~ 243 (426)
||+++.
T Consensus 471 FGla~~ 476 (535)
T PRK09605 471 FGLGKY 476 (535)
T ss_pred Cccccc
Confidence 999975
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.5e-18 Score=154.75 Aligned_cols=137 Identities=18% Similarity=0.099 Sum_probs=105.6
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC------------------------CHHHHHHHHHHH
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG------------------------GHKEWMTEVNFL 139 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~------------------------~~~~~~~E~~~l 139 (426)
...|...+.||+|+||.||+|...+ + ..+++|.+.... ....+..|+.++
T Consensus 14 ~~~~~~~~~i~~G~~g~Vy~~~~~~-g-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 14 GVVESLGNQIGVGKESDVYLALDPD-G-----NPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred CchhhcCCccccCcceEEEEEEcCC-C-----CEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence 3348888999999999999998653 2 278999764321 011356789999
Q ss_pred hhcCCC--CccceEeEEEccCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEe
Q 014363 140 GIVEHQ--NLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIV 217 (426)
Q Consensus 140 ~~l~Hp--nIv~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiH 217 (426)
..+.|+ .+++.++. .. .++||||++|++|...... .....++.+++.++.++|.. +|+|
T Consensus 88 ~~l~~~~i~v~~~~~~----~~----~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~---gi~H 148 (198)
T cd05144 88 KALYEEGFPVPKPIDW----NR----HAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKH---GIIH 148 (198)
T ss_pred HHHHHcCCCCCceeec----CC----ceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHC---CCCc
Confidence 999887 45555432 11 2899999999999776431 23457889999999999998 9999
Q ss_pred ccCCCCceEeCCCCCeeEeeecccccCC
Q 014363 218 RDFKSSNILLDEQWNAKLSDFGLARLGP 245 (426)
Q Consensus 218 rDlkp~NILl~~~~~~kl~DFGla~~~~ 245 (426)
|||||+||++++++.++|+|||++....
T Consensus 149 ~Dl~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 149 GDLSEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred CCCCcccEEEcCCCcEEEEECCccccCC
Confidence 9999999999999999999999996443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.75 E-value=8.4e-20 Score=186.40 Aligned_cols=255 Identities=25% Similarity=0.324 Sum_probs=190.1
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcC-CCCccceEeEEEccCCC
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVE-HQNLVKLVGYCADDDER 160 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~-HpnIv~~~~~~~~~~~~ 160 (426)
.|...+.||+|+|+.|-........ ...+++|.+.... ..+....|..+-..+. |+|++++++...+....
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~----~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~ 96 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDP----ESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSY 96 (601)
T ss_pred cccccccccccccchhhhhhhcCCC----cceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccc
Confidence 5666667999999999887653332 2356666664442 2234456888888886 99999999988777654
Q ss_pred CceEEEEEeeCCCCChhhhc-cCCCCCccCHHHHHHHHHHHHHHHHHhc-cCCCCCeEeccCCCCceEeCCCC-CeeEee
Q 014363 161 GIQRLLVYEYMPNGSVDQYL-SPKSETILTWAMRLKIAQDAARGLAYLH-EGMDFQIIVRDFKSSNILLDEQW-NAKLSD 237 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l-~~~~~~~~~~~~~~~i~~~i~~aL~~LH-~~~~~~iiHrDlkp~NILl~~~~-~~kl~D 237 (426)
+++++|..|+++.+.+ .... ...+......++.|+..+|.|+| .. ++.|+||||+|.+++..+ .++++|
T Consensus 97 ----~~~~~~s~g~~~f~~i~~~~~-~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~d 168 (601)
T KOG0590|consen 97 ----LLSLSYSDGGSLFSKISHPDS-TGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIAD 168 (601)
T ss_pred ----ccccCcccccccccccccCCc-cCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCC
Confidence 8999999999999988 4322 13556667789999999999999 76 999999999999999999 999999
Q ss_pred ecccccCCC-CCceeeeeeeec-CcccCCchhhccCC-CCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhh
Q 014363 238 FGLARLGPS-EGFTHVSTAVVG-TMGYAAPEYVQTGR-LAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPY 314 (426)
Q Consensus 238 FGla~~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~~-~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 314 (426)
||+|..+.. .+........+| ++.|+|||...+.. ..+..|+||.|+++.-+++|..|++........ ...|..
T Consensus 169 f~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-~~~~~~-- 245 (601)
T KOG0590|consen 169 FGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-YSSWKS-- 245 (601)
T ss_pred chhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-ceeecc--
Confidence 999987766 555555667789 99999999888754 467899999999999999999999765433211 111110
Q ss_pred hhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 315 LSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.. ................+++.+++..+|+.|.+.+++...
T Consensus 246 --~~--------~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d 286 (601)
T KOG0590|consen 246 --NK--------GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLD 286 (601)
T ss_pred --cc--------cccccCccccCChhhhhcccccccCCchhcccccccccc
Confidence 00 000111222345567788899999999999999988654
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.72 E-value=9e-17 Score=135.92 Aligned_cols=135 Identities=21% Similarity=0.196 Sum_probs=110.5
Q ss_pred CcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhcCC--CCccceEeEEEccCCCCceEEE
Q 014363 89 RSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEH--QNLVKLVGYCADDDERGIQRLL 166 (426)
Q Consensus 89 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l~H--pnIv~~~~~~~~~~~~~~~~~l 166 (426)
..+.||.|.++.||++...+ ..+++|..........+..|+.++..+.| .+++++++++...+ ..++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-------~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~----~~~~ 70 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-------EDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDG----WSYL 70 (155)
T ss_pred cceecccccccceEEEEecC-------CeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCC----ccEE
Confidence 35679999999999998754 26888988655444578899999999976 58999988876553 3499
Q ss_pred EEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccccc
Q 014363 167 VYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL 243 (426)
Q Consensus 167 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 243 (426)
+|||++++.+..+ +......++.+++++|.+||.....+++|+||+|+|||+++.+.++++|||.+..
T Consensus 71 v~e~~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 71 LMEWIEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred EEEecCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 9999998877654 4456677899999999999985444799999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.1e-16 Score=146.33 Aligned_cols=136 Identities=18% Similarity=0.182 Sum_probs=102.8
Q ss_pred ceec-ccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---------------CHHHHHHHHHHHhhcCCCCc--cceEe
Q 014363 91 VVIG-EGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---------------GHKEWMTEVNFLGIVEHQNL--VKLVG 152 (426)
Q Consensus 91 ~~lG-~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---------------~~~~~~~E~~~l~~l~HpnI--v~~~~ 152 (426)
..|| .||.|+||.+...+. .+++|.+.... ....+.+|+.++..|.|++| +..++
T Consensus 37 ~~lg~~~g~gtv~~v~~~~~-------~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~ 109 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTPGV-------NWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIA 109 (239)
T ss_pred ceeecCCCCccEEEEEeCCc-------eEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEe
Confidence 4687 888999998876432 57777664321 12457789999999998875 77777
Q ss_pred EEEccCCCCceEEEEEeeCCC-CChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCC
Q 014363 153 YCADDDERGIQRLLVYEYMPN-GSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW 231 (426)
Q Consensus 153 ~~~~~~~~~~~~~lv~E~~~~-g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~ 231 (426)
+...........++||||++| .+|.+++... .++.. .+.+++.+|.+||+. ||+||||||+|||++.++
T Consensus 110 ~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~ 179 (239)
T PRK01723 110 ARVVRHGLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDG 179 (239)
T ss_pred eeeeecCcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCC
Confidence 755433322233699999997 6898887542 24443 357899999999998 999999999999999999
Q ss_pred CeeEeeeccccc
Q 014363 232 NAKLSDFGLARL 243 (426)
Q Consensus 232 ~~kl~DFGla~~ 243 (426)
.++|+|||.+..
T Consensus 180 ~v~LIDfg~~~~ 191 (239)
T PRK01723 180 KFWLIDFDRGEL 191 (239)
T ss_pred CEEEEECCCccc
Confidence 999999998864
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.9e-16 Score=139.65 Aligned_cols=134 Identities=20% Similarity=0.136 Sum_probs=94.3
Q ss_pred cceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC----HHH----------------------HHHHHHHHhhcC
Q 014363 90 SVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG----HKE----------------------WMTEVNFLGIVE 143 (426)
Q Consensus 90 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~----~~~----------------------~~~E~~~l~~l~ 143 (426)
.+.||+|+||.||+|...+ + ..|++|++..... ... ...|...+..+.
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~-~-----~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 75 (187)
T cd05119 2 GGPIGTGKEADVYLALDGD-G-----EPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLY 75 (187)
T ss_pred CcccccccceeEEEEECCC-C-----CEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHH
Confidence 4579999999999998662 2 2789998754321 011 134666666664
Q ss_pred CC--CccceEeEEEccCCCCceEEEEEeeCCCCChhhh-ccCCCCCccCHHHHHHHHHHHHHHHHHhcc-CCCCCeEecc
Q 014363 144 HQ--NLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQY-LSPKSETILTWAMRLKIAQDAARGLAYLHE-GMDFQIIVRD 219 (426)
Q Consensus 144 Hp--nIv~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~-l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~-~~~~~iiHrD 219 (426)
+. .+.+.+++. ..++||||++++.+... +.... .. ..+..++.+++.++.++|. . +|+|+|
T Consensus 76 ~~~~~~~~~~~~~--------~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~D 140 (187)
T cd05119 76 EAGVPVPKPIDLN--------RHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREA---GLVHGD 140 (187)
T ss_pred HcCCCCCceEecC--------CCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCC
Confidence 43 345555431 12899999998554321 11110 11 5677899999999999998 7 999999
Q ss_pred CCCCceEeCCCCCeeEeeecccccCC
Q 014363 220 FKSSNILLDEQWNAKLSDFGLARLGP 245 (426)
Q Consensus 220 lkp~NILl~~~~~~kl~DFGla~~~~ 245 (426)
|||+||+++ ++.++|+|||.+....
T Consensus 141 l~p~Nili~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 141 LSEYNILVD-DGKVYIIDVPQAVEID 165 (187)
T ss_pred CChhhEEEE-CCcEEEEECccccccc
Confidence 999999999 8899999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.60 E-value=7e-15 Score=144.22 Aligned_cols=251 Identities=24% Similarity=0.280 Sum_probs=180.0
Q ss_pred CCCCCcceecc--cCcEEEEEEEEcCCCCCCcceEEEEEEccc--c--CCHHHHHHHHHHHhhc-CCCCccceEeEEEcc
Q 014363 85 KNFSRSVVIGE--GGFGCVYKGLIKNSEDPSQKVEVAVKQLGR--R--GGHKEWMTEVNFLGIV-EHQNLVKLVGYCADD 157 (426)
Q Consensus 85 ~~y~~~~~lG~--G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~--~--~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~ 157 (426)
..|.....+|. |.+|.||.+.... ......+++|.-.. . .....-.+|+.....+ .|+|.++.+..+...
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~---~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~ 190 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTN---SESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGS 190 (524)
T ss_pred hhcccccccccCCCCCceeecccCCc---ccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccC
Confidence 35667778999 9999999987622 12233677776321 1 2223345677777777 699999988777776
Q ss_pred CCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHH----HHHHhccCCCCCeEeccCCCCceEeCCC-CC
Q 014363 158 DERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAAR----GLAYLHEGMDFQIIVRDFKSSNILLDEQ-WN 232 (426)
Q Consensus 158 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~----aL~~LH~~~~~~iiHrDlkp~NILl~~~-~~ 232 (426)
+.. |+-+|+| +.+|..+..... ..++....+.++.+... ||.++|.. +++|-|+||+||++..+ ..
T Consensus 191 ~~l----fiqtE~~-~~sl~~~~~~~~-~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s 261 (524)
T KOG0601|consen 191 GIL----FIQTELC-GESLQSYCHTPC-NFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTS 261 (524)
T ss_pred Ccc----eeeeccc-cchhHHhhhccc-ccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccce
Confidence 644 8889999 578888876443 33777888888889888 99999998 99999999999999999 88
Q ss_pred eeEeeecccccCCCCCcee---eeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHH
Q 014363 233 AKLSDFGLARLGPSEGFTH---VSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQ 309 (426)
Q Consensus 233 ~kl~DFGla~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~ 309 (426)
.+++|||+...+....... ......|...|++||.. ++-++...|||+||.++.+..+|..++-..... .
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~------~ 334 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNS------S 334 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCC------C
Confidence 9999999998776544221 12233688899999965 467899999999999999999987665332100 0
Q ss_pred hHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 310 WVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
| ..+++ ..+...+......++...+..+++.+|-.|++.+.+..+
T Consensus 335 W--------~~~r~---~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 335 W--------SQLRQ---GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred c--------ccccc---ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 0 01111 112222333344556668899999999999999888664
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.52 E-value=6.5e-14 Score=139.00 Aligned_cols=139 Identities=19% Similarity=0.182 Sum_probs=94.0
Q ss_pred cceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHH---------------------------------------
Q 014363 90 SVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHK--------------------------------------- 130 (426)
Q Consensus 90 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~--------------------------------------- 130 (426)
.+.||.|++|.||+|+.+++. .||||+..... .+
T Consensus 122 ~~plasaSigQVh~A~l~~G~------~VaVKv~rp~i-~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l 194 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGK------EVAVKVLRPGI-EKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTL 194 (437)
T ss_pred CcceeeeehhheEEEEecCCC------EEEEEeeCCCc-HHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHH
Confidence 367999999999999987543 79999874321 11
Q ss_pred ----HHHHHHHHHhhc----CCCCccceEeEEEccCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHH
Q 014363 131 ----EWMTEVNFLGIV----EHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAAR 202 (426)
Q Consensus 131 ----~~~~E~~~l~~l----~HpnIv~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~ 202 (426)
++.+|+..+.++ .|.+-+.+-.++.+... ..+|||||++|++|.++....... .. ...++..++.
T Consensus 195 ~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~---~~vLvmE~i~G~~L~~~~~~~~~~-~~---~~~ia~~~~~ 267 (437)
T TIGR01982 195 RRELDLRREAANASELGENFKNDPGVYVPEVYWDRTS---ERVLTMEWIDGIPLSDIAALDEAG-LD---RKALAENLAR 267 (437)
T ss_pred HHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcC---CceEEEEeECCcccccHHHHHhcC-CC---HHHHHHHHHH
Confidence 234455555554 23222333222222111 238999999999998876422111 22 2346666665
Q ss_pred -HHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccCC
Q 014363 203 -GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGP 245 (426)
Q Consensus 203 -aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 245 (426)
.+..+|.. |++|+|++|.||+++.++.++|+|||++....
T Consensus 268 ~~l~ql~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 268 SFLNQVLRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHHHHHhC---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 46788887 99999999999999999999999999997654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.3e-13 Score=117.85 Aligned_cols=129 Identities=18% Similarity=0.127 Sum_probs=94.4
Q ss_pred cceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-CHHHHHHHHHHHhhcCCCCcc-ceEeEEEccCCCCceEEEE
Q 014363 90 SVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-GHKEWMTEVNFLGIVEHQNLV-KLVGYCADDDERGIQRLLV 167 (426)
Q Consensus 90 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~E~~~l~~l~HpnIv-~~~~~~~~~~~~~~~~~lv 167 (426)
++.|+.|.++.||++...+ ..+++|...... ....+..|+.++..+.+.+++ +++.+... . .++|
T Consensus 3 ~~~l~~G~~~~vy~~~~~~-------~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~--~----~~lv 69 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVAN-------KKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDPE--T----GVLI 69 (170)
T ss_pred eeecCCcccCceEEEEECC-------eEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeCC--C----CeEE
Confidence 3568999999999988642 268999875543 234567899999999665544 55544322 2 2799
Q ss_pred EeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCC--CCCeEeccCCCCceEeCCCCCeeEeeecccc
Q 014363 168 YEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGM--DFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 242 (426)
Q Consensus 168 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~--~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 242 (426)
|||++|.++.+.. . ....++.+++++|..||... ..+++|+|++|.||+++ ++.++++|||.+.
T Consensus 70 ~e~i~G~~l~~~~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 70 TEFIEGSELLTED-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred EEecCCCcccccc-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 9999998886531 1 11245678999999999872 12369999999999999 6689999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.6e-14 Score=129.99 Aligned_cols=208 Identities=21% Similarity=0.285 Sum_probs=141.2
Q ss_pred HHHHhhcCCCCccceEeEEEccCC-CCceEEEEEeeCCCCChhhhccCC--CCCccCHHHHHHHHHHHHHHHHHhccCCC
Q 014363 136 VNFLGIVEHQNLVKLVGYCADDDE-RGIQRLLVYEYMPNGSVDQYLSPK--SETILTWAMRLKIAQDAARGLAYLHEGMD 212 (426)
Q Consensus 136 ~~~l~~l~HpnIv~~~~~~~~~~~-~~~~~~lv~E~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~~i~~aL~~LH~~~~ 212 (426)
+.-|-++.|.|||++..|+.+... ......++.|||..|+|..+|++. ....+....-.+++-||+.||.|||+. +
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-D 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-C
Confidence 345566689999999999877554 233457899999999999999743 234566677778999999999999985 8
Q ss_pred CCeEeccCCCCceEeCCCCCeeEeeecccccCCC--CCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHH
Q 014363 213 FQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPS--EGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELI 290 (426)
Q Consensus 213 ~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~--~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell 290 (426)
+.|+|+++..+.|++..+|-+||.--.-...-.. ...........|-++|.+||.=.....+.++|||+||+..++|.
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 8999999999999999998888753211110000 00001111234678999999766666778999999999999999
Q ss_pred hCCCCCCCCCch-hhHHHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 291 TGRRPIDRNRPR-SEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 291 tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.+..--...... ..+.-+. ... -.+.. ..-+.++..|++..|..||+|.+++-|
T Consensus 277 ilEiq~tnseS~~~~ee~ia-------------~~i-~~len-------~lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 277 ILEIQSTNSESKVEVEENIA-------------NVI-IGLEN-------GLQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred HheeccCCCcceeehhhhhh-------------hhe-eeccC-------ccccCcCcccccCCCCCCcchhhhhcC
Confidence 876543221111 0010000 000 00000 112367788999999999999998764
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.4e-13 Score=138.30 Aligned_cols=143 Identities=16% Similarity=0.097 Sum_probs=93.8
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----------------------------C--------
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----------------------------G-------- 128 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----------------------------~-------- 128 (426)
..|+. +.||+|++|+||+|+.++++. .||||+....- .
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~-----~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~ 193 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGR-----EVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEF 193 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCC-----EEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHH
Confidence 35666 789999999999999887443 79999885431 0
Q ss_pred H------HHHHHHHHHHhhc----CCCCccceEeEEEccCCCCceEEEEEeeCCCCChhhhc--cCCC--CCccCHHHHH
Q 014363 129 H------KEWMTEVNFLGIV----EHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYL--SPKS--ETILTWAMRL 194 (426)
Q Consensus 129 ~------~~~~~E~~~l~~l----~HpnIv~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l--~~~~--~~~~~~~~~~ 194 (426)
. -++.+|+..+.++ .+.+.+.+-.++.+-. ...+|||||++|+.|.++- ...+ ...+....+.
T Consensus 194 ~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~s---t~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~ 270 (537)
T PRK04750 194 EKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYC---SETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVE 270 (537)
T ss_pred HHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccC---CCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHH
Confidence 0 0234455555444 2443343333333211 1238999999999998742 2221 1124444444
Q ss_pred HHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCC----CeeEeeecccccCCC
Q 014363 195 KIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW----NAKLSDFGLARLGPS 246 (426)
Q Consensus 195 ~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~----~~kl~DFGla~~~~~ 246 (426)
.++.|+. .. |++|+|+||.||+++.+| +++++|||++.....
T Consensus 271 ~~~~Qif-------~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 271 VFFTQVF-------RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHHHH-------hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 5555554 34 999999999999999988 999999999976643
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.42 E-value=8e-14 Score=136.84 Aligned_cols=250 Identities=20% Similarity=0.181 Sum_probs=170.6
Q ss_pred HHHhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhc-CCCCccceEeEEE
Q 014363 81 KSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIV-EHQNLVKLVGYCA 155 (426)
Q Consensus 81 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l-~HpnIv~~~~~~~ 155 (426)
...+.+|..+..||.|.|+.|+.+..+..++ ..+++|...+.. +...-..|+-+...+ .|.+++..+..+.
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~----~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~ 336 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGD----CIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWS 336 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCC----ceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcc
Confidence 3446789999999999999999987553332 256777654332 111224566666665 6888888766665
Q ss_pred ccCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCC-CCee
Q 014363 156 DDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQ-WNAK 234 (426)
Q Consensus 156 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~-~~~k 234 (426)
.... .|+-.|||+++++...+.. ...+.+...+.+..|++.++.++|+. .++|+|+||+||++..+ +.-+
T Consensus 337 ~~r~----~~ip~e~~~~~s~~l~~~~--~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~ 407 (524)
T KOG0601|consen 337 QLRQ----GYIPLEFCEGGSSSLRSVT--SQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSK 407 (524)
T ss_pred cccc----ccCchhhhcCcchhhhhHH--HHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhh
Confidence 5443 3788999999998876632 23377778899999999999999987 99999999999999886 7789
Q ss_pred EeeecccccCCCCCceeeeeeeecCcccC--CchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHh
Q 014363 235 LSDFGLARLGPSEGFTHVSTAVVGTMGYA--APEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK 312 (426)
Q Consensus 235 l~DFGla~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~ 312 (426)
+.|||+...+... .....+.-+++ +++......+..++|++|||..+.+.++|..--....
T Consensus 408 ~~~~~~~t~~~~~-----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~------------ 470 (524)
T KOG0601|consen 408 LGDFGCWTRLAFS-----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV------------ 470 (524)
T ss_pred cccccccccccee-----cccccccccccccchhhccccccccccccccccccccccccCcccCcccc------------
Confidence 9999988642211 11122333444 5555556678889999999999999999864322110
Q ss_pred hhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHh
Q 014363 313 PYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 369 (426)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~ 369 (426)
....+...... .. ......+..+...+...++..||.+.++..+..-.
T Consensus 471 -------~~~~i~~~~~p-~~-~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 471 -------QSLTIRSGDTP-NL-PGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred -------cceeeeccccc-CC-CchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 01111111111 01 11225677788889999999999999887765433
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.37 E-value=1.1e-11 Score=108.64 Aligned_cols=140 Identities=16% Similarity=0.090 Sum_probs=96.3
Q ss_pred ceecccCcEEEEEEEEcCCC-CCCcceEEEEEEcccc-----------------------CC-HHHH----HHHHHHHhh
Q 014363 91 VVIGEGGFGCVYKGLIKNSE-DPSQKVEVAVKQLGRR-----------------------GG-HKEW----MTEVNFLGI 141 (426)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~-~~~~~~~va~K~~~~~-----------------------~~-~~~~----~~E~~~l~~ 141 (426)
..||.|--+.||.|...+.. .......+|+|..... .+ .+.+ .+|++.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 46899999999999754310 0112347888865311 00 1122 379999999
Q ss_pred cC--CCCccceEeEEEccCCCCceEEEEEeeCCCCChhh-hccCCCCCccCHHHHHHHHHHHHHHHHHh-ccCCCCCeEe
Q 014363 142 VE--HQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQ-YLSPKSETILTWAMRLKIAQDAARGLAYL-HEGMDFQIIV 217 (426)
Q Consensus 142 l~--HpnIv~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~-~l~~~~~~~~~~~~~~~i~~~i~~aL~~L-H~~~~~~iiH 217 (426)
+. .-++.+++++ ... +|||||+.+..+.. .+.. ..++......+..+++.+|..| |.. +|+|
T Consensus 83 l~~~Gv~vP~pi~~--~~~------~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~---glVH 148 (197)
T cd05146 83 MQKAGIPCPEVVVL--KKH------VLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVH 148 (197)
T ss_pred HHHcCCCCCeEEEe--cCC------EEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhC---Ceec
Confidence 84 3567777765 222 89999997643321 2221 1245556677889999999999 887 9999
Q ss_pred ccCCCCceEeCCCCCeeEeeecccccCC
Q 014363 218 RDFKSSNILLDEQWNAKLSDFGLARLGP 245 (426)
Q Consensus 218 rDlkp~NILl~~~~~~kl~DFGla~~~~ 245 (426)
+||++.|||++ ++.+.|+|||.+....
T Consensus 149 GDLs~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 149 ADLSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence 99999999997 4689999999886543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.37 E-value=1.7e-13 Score=141.35 Aligned_cols=245 Identities=21% Similarity=0.219 Sum_probs=164.0
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-----CCHHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-----GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
.|.+.+-+-.|.+|.++.+.-...+. ..+.|..... ...+....+-.++-...||-++...--+....
T Consensus 805 ~~~i~~p~qS~sp~ss~p~~pa~sgh-----~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rs-- 877 (1205)
T KOG0606|consen 805 GFEITKPSQSGSPSSSFPASPAGSGH-----TRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRS-- 877 (1205)
T ss_pred cceecccccCCCCcccccCCcccccc-----ccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCC--
Confidence 45556677889999988876554443 1222222111 11222233333333334555554433322222
Q ss_pred CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecc
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 240 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 240 (426)
..+|+++|+.+++|...++.-+ ..+.......+..+..+++|||.. .+.|+|++|.|+|+..+|..+++|||+
T Consensus 878 --P~~L~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t 950 (1205)
T KOG0606|consen 878 --PLPLVGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGT 950 (1205)
T ss_pred --CcchhhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccc
Confidence 2489999999999999887543 355555666777888999999986 699999999999999999999999984
Q ss_pred cccCCC------C---------------C--------ceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh
Q 014363 241 ARLGPS------E---------------G--------FTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT 291 (426)
Q Consensus 241 a~~~~~------~---------------~--------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt 291 (426)
...... . . .........||+.|.+||.+.+......+|+|++|++++|.++
T Consensus 951 ~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~ 1030 (1205)
T KOG0606|consen 951 LSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLT 1030 (1205)
T ss_pred ccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhc
Confidence 322110 0 0 0011234679999999999999999999999999999999999
Q ss_pred CCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCc-ccHHHHHHHHHHHHhccccCCCCCCCHH
Q 014363 292 GRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGK-YSLRLVSKLSHVANLCLVKNARTRPKMS 360 (426)
Q Consensus 292 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dp~~RPs~~ 360 (426)
|.+||....+.. .++.+....+.+. -+...+....+++...+..+|.+|-.+.
T Consensus 1031 g~pp~na~tpq~----------------~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1031 GIPPFNAETPQQ----------------IFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCCCCCcchhh----------------hhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 999998655432 2233333222222 2234556788999999999999997765
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.31 E-value=2.3e-11 Score=102.66 Aligned_cols=141 Identities=21% Similarity=0.251 Sum_probs=100.2
Q ss_pred CcceecccCcEEEEEEEEcCCCCCCcceEEEEEE-ccccC---------CHHHHHHHHHHHhhcCCCCccceEeEEEccC
Q 014363 89 RSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQ-LGRRG---------GHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 158 (426)
Q Consensus 89 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~-~~~~~---------~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 158 (426)
...+|-+|+-+.|+++.+.+. ...||. +.+.. ..++..+|+++|.++.--.|.--.=++.|..
T Consensus 11 ~l~likQGAEArv~~~~~~Ge-------~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~ 83 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGE-------AAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTY 83 (229)
T ss_pred cceeeeccceeeEeeeccCCc-------eeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecC
Confidence 566899999999999987653 333442 32221 2346778999999885444433333455544
Q ss_pred CCCceEEEEEeeCCC-CChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCC---ee
Q 014363 159 ERGIQRLLVYEYMPN-GSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWN---AK 234 (426)
Q Consensus 159 ~~~~~~~lv~E~~~~-g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~---~k 234 (426)
.. .|+|||++| .++.+++...............++..+-+.|.-||.+ +|+|+||..+||++..++. +.
T Consensus 84 ~~----~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~ 156 (229)
T KOG3087|consen 84 GG----QIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPI 156 (229)
T ss_pred CC----eEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceE
Confidence 43 799999977 4778887654443334444467889999999999998 9999999999999966553 58
Q ss_pred Eeeeccccc
Q 014363 235 LSDFGLARL 243 (426)
Q Consensus 235 l~DFGla~~ 243 (426)
|+|||++..
T Consensus 157 lIdfgls~~ 165 (229)
T KOG3087|consen 157 LIDFGLSSV 165 (229)
T ss_pred EEeecchhc
Confidence 999999863
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.31 E-value=1.8e-11 Score=121.72 Aligned_cols=159 Identities=17% Similarity=0.232 Sum_probs=115.5
Q ss_pred EEEEEEccccCC--HHHHHHHHHHHhhcCCCCccceEeEEEccCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHH
Q 014363 117 EVAVKQLGRRGG--HKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRL 194 (426)
Q Consensus 117 ~va~K~~~~~~~--~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~ 194 (426)
.+.+........ .....+-++.|+.|+||||+++++.+..++ ..|||+|.+. .|..++.. +....+.
T Consensus 39 ~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~----~~ylvTErV~--Pl~~~lk~-----l~~~~v~ 107 (690)
T KOG1243|consen 39 PVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEG----TLYLVTERVR--PLETVLKE-----LGKEEVC 107 (690)
T ss_pred ceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccC----ceEEEeeccc--cHHHHHHH-----hHHHHHH
Confidence 455555544433 345677889999999999999999888776 3599999984 66777754 3355566
Q ss_pred HHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCC
Q 014363 195 KIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLA 274 (426)
Q Consensus 195 ~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 274 (426)
..+.||+.||.|||+. .+++|++|.-+.|+++..|..||++|.++........ ......---.|..|+.+... +
T Consensus 108 ~Gl~qIl~AL~FL~~d--~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s--~ 181 (690)
T KOG1243|consen 108 LGLFQILAALSFLNDD--CNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPS--E 181 (690)
T ss_pred HHHHHHHHHHHHHhcc--CCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCcc--c
Confidence 6789999999999865 3999999999999999999999999998864332211 01111112235566543222 2
Q ss_pred CchhhHHHHHHHHHHHhC
Q 014363 275 ARSDVWSYGVFLYELITG 292 (426)
Q Consensus 275 ~~~DvwslGvil~elltg 292 (426)
-..|.|-||+++++++.|
T Consensus 182 ~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cchhhhhHHHHHHHHhCc
Confidence 457999999999999998
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.31 E-value=2.8e-11 Score=102.69 Aligned_cols=128 Identities=23% Similarity=0.341 Sum_probs=92.8
Q ss_pred eecccCcEEEEEEEEcCCCCCCcceEEEEEE-ccccC---------CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQ-LGRRG---------GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 92 ~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~-~~~~~---------~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
.+++|+-+.+|.+.+.+. .+.+|. +.+.. ......+|++++.++.--.|.--+=|+.+.+..
T Consensus 3 ~i~~GAEa~i~~~~~~g~-------~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~- 74 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGL-------PAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNG- 74 (204)
T ss_pred hhhCCcceeEEeeeccCc-------ceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCC-
Confidence 588999999999876543 233332 22221 123467899999998544443333344455443
Q ss_pred ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccc
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 241 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 241 (426)
.|+|||++|-.|.+++... ...++..|-.-+.-||.. ||+|+||.++||++..+. +.++||||+
T Consensus 75 ---~I~me~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg 138 (204)
T COG3642 75 ---LIVMEYIEGELLKDALEEA---------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLG 138 (204)
T ss_pred ---EEEEEEeCChhHHHHHHhc---------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcc
Confidence 7999999999999888643 245677777788889998 999999999999998874 999999998
Q ss_pred cc
Q 014363 242 RL 243 (426)
Q Consensus 242 ~~ 243 (426)
..
T Consensus 139 ~~ 140 (204)
T COG3642 139 EF 140 (204)
T ss_pred cc
Confidence 74
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.27 E-value=9.1e-11 Score=106.07 Aligned_cols=143 Identities=17% Similarity=0.169 Sum_probs=107.4
Q ss_pred ceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcCC--CCccceEeEEEccCCCCceEE
Q 014363 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEH--QNLVKLVGYCADDDERGIQRL 165 (426)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~H--pnIv~~~~~~~~~~~~~~~~~ 165 (426)
+.||.|.++.||++...++ ..+++|...... ....+..|+.++..+.+ .++.+++.+....... ...+
T Consensus 4 ~~l~~G~~n~~~~v~~~~g------~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~-~~~~ 76 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGG------RRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVL-GTPF 76 (223)
T ss_pred eecCCCccceEEEEEecCC------cceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCcc-CCce
Confidence 4689999999999986541 267888875433 34578899999999965 4567787776543211 1238
Q ss_pred EEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCC----------------------------------
Q 014363 166 LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGM---------------------------------- 211 (426)
Q Consensus 166 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~---------------------------------- 211 (426)
+||||++|.++.+.+.. ..++......++.+++++|..||+..
T Consensus 77 ~v~e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (223)
T cd05154 77 YVMERVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDE 153 (223)
T ss_pred EEEEEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccc
Confidence 99999999998876642 23677777788889999999888520
Q ss_pred -------------------CCCeEeccCCCCceEeCC--CCCeeEeeeccccc
Q 014363 212 -------------------DFQIIVRDFKSSNILLDE--QWNAKLSDFGLARL 243 (426)
Q Consensus 212 -------------------~~~iiHrDlkp~NILl~~--~~~~kl~DFGla~~ 243 (426)
...++|+|+.|.|||++. ++.+.|+||+.+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 154 PPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred cHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 246799999999999998 66689999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.15 E-value=2e-09 Score=104.22 Aligned_cols=218 Identities=16% Similarity=0.227 Sum_probs=150.0
Q ss_pred cEEEEEEEEcCCCCCCcceEEEEEEccccCC--HHHHHHHHHHHhhcCCCCccceEeEEEccCCCCceEEEEEeeCCC-C
Q 014363 98 FGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG--HKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPN-G 174 (426)
Q Consensus 98 ~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~~~lv~E~~~~-g 174 (426)
-.+.|++....++. .|.+|+++.... ......-+++++++.|+|||++.++|........-+++|++|.|+ +
T Consensus 289 ~~Ttyk~~s~~DG~-----~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~ 363 (655)
T KOG3741|consen 289 SITTYKATSNVDGN-----AYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSP 363 (655)
T ss_pred cceeEeeeeccCCc-----eeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCc
Confidence 34678888766554 788888833221 112234578899999999999999988655555677999999875 5
Q ss_pred ChhhhccCC-------------CCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccc
Q 014363 175 SVDQYLSPK-------------SETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 241 (426)
Q Consensus 175 ~L~~~l~~~-------------~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 241 (426)
+|.++--.. .+...++..+|.++.|++.||.++|+. |+.-+-|.|.+||++.+.+++|+..|..
T Consensus 364 TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~ 440 (655)
T KOG3741|consen 364 TLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIM 440 (655)
T ss_pred hHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccce
Confidence 665543211 123478899999999999999999998 9999999999999999999999999887
Q ss_pred ccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhh
Q 014363 242 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 321 (426)
Q Consensus 242 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (426)
.....+. .+| +.+ -.+-|.=.||.+++.|.||..--..... .+.. ..
T Consensus 441 Dvl~~d~--------------~~~--le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~--~~~s------------~~ 487 (655)
T KOG3741|consen 441 DVLQEDP--------------TEP--LES---QQQNDLRDLGLLLLALATGTENSNRTDS--TQSS------------HL 487 (655)
T ss_pred eeecCCC--------------Ccc--hhH---HhhhhHHHHHHHHHHHhhcccccccccc--hHHH------------HH
Confidence 6554332 011 111 2356889999999999999653211110 0000 00
Q ss_pred hhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014363 322 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMV 366 (426)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L 366 (426)
......++.++.+++......++++ -++.+++.++
T Consensus 488 ---------~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~ 522 (655)
T KOG3741|consen 488 ---------TRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI 522 (655)
T ss_pred ---------HHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence 0111235566777777777777776 6777777653
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.14 E-value=1.2e-09 Score=101.19 Aligned_cols=141 Identities=13% Similarity=0.038 Sum_probs=97.1
Q ss_pred eecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC-------------HHHHHHHHHHHhhcCC--CCccceEeEEEc
Q 014363 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG-------------HKEWMTEVNFLGIVEH--QNLVKLVGYCAD 156 (426)
Q Consensus 92 ~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~-------------~~~~~~E~~~l~~l~H--pnIv~~~~~~~~ 156 (426)
.+-......|+++...+ ..+.+|....... ...+.+|...+..|.. -..+.++++...
T Consensus 29 ~v~~~~~rrvvr~~~~g-------~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~ 101 (268)
T PRK15123 29 VFRELEGRRTLRFELAG-------KSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGER 101 (268)
T ss_pred EEecCCCceEEEEEECC-------EEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEe
Confidence 34444444466655432 2677886533321 1147789999888843 334555666643
Q ss_pred cCCC-CceEEEEEeeCCCC-ChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCC-----
Q 014363 157 DDER-GIQRLLVYEYMPNG-SVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE----- 229 (426)
Q Consensus 157 ~~~~-~~~~~lv~E~~~~g-~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~----- 229 (426)
.... ....+||||++++. +|.+++........+......++.+++..+.-||.. ||+|+|+++.|||++.
T Consensus 102 ~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~ 178 (268)
T PRK15123 102 GSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGR 178 (268)
T ss_pred cCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCC
Confidence 2211 22458999999876 798887533223355667778999999999999998 9999999999999975
Q ss_pred --CCCeeEeeecccc
Q 014363 230 --QWNAKLSDFGLAR 242 (426)
Q Consensus 230 --~~~~kl~DFGla~ 242 (426)
++.+.|+||+.+.
T Consensus 179 ~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 179 EEDLKLSVIDLHRAQ 193 (268)
T ss_pred CCCceEEEEECCccc
Confidence 4679999999875
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.12 E-value=7.7e-09 Score=97.88 Aligned_cols=277 Identities=18% Similarity=0.214 Sum_probs=164.1
Q ss_pred CCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhc-CCCCccceEeEEE---ccCCCCce
Q 014363 88 SRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIV-EHQNLVKLVGYCA---DDDERGIQ 163 (426)
Q Consensus 88 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~---~~~~~~~~ 163 (426)
...+.||+|+-+.+|-.-.-. + .|| |+....... ...+.+..|... .||-+-.-+.+=. .....+..
T Consensus 14 ~~gr~LgqGgea~ly~l~e~~--d-----~VA-KIYh~Pppa-~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~ 84 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEVR--D-----QVA-KIYHAPPPA-AQAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKV 84 (637)
T ss_pred CCCccccCCccceeeecchhh--c-----hhh-eeecCCCch-HHHHHHHHhccCCCCcchhhhhcccHHHhhCCCccce
Confidence 445679999999999642211 1 233 333322211 112334444444 6664433111110 01111122
Q ss_pred EEEEEeeCCCCC-hhhhccC----CCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeee
Q 014363 164 RLLVYEYMPNGS-VDQYLSP----KSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 238 (426)
Q Consensus 164 ~~lv~E~~~~g~-L~~~l~~----~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 238 (426)
.-++|..++|.. +..++.. ..-....|...+.+++.++.+.+-||.. |.+-+|+.++|+|+++++.+.|.|-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVds 161 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDS 161 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcc
Confidence 457788776642 2233321 1123478999999999999999999998 9889999999999999999999985
Q ss_pred cccccCCCCCceeeeeeeecCcccCCchhhc-----cCCCCCchhhHHHHHHHHHHHhC-CCCCCCCCchh-----hHHH
Q 014363 239 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQ-----TGRLAARSDVWSYGVFLYELITG-RRPIDRNRPRS-----EQKL 307 (426)
Q Consensus 239 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltg-~~p~~~~~~~~-----~~~~ 307 (426)
..-... ..+ ......+|...|.+||.-. +..-+...|.|.|||++++++.| ++||.+..... ...-
T Consensus 162 Dsfqi~-~ng--~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~ 238 (637)
T COG4248 162 DSFQIN-ANG--TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETD 238 (637)
T ss_pred cceeec-cCC--ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhh
Confidence 433322 222 1223457999999999654 23346779999999999999996 99997643211 1101
Q ss_pred HHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccC--CCCCCCHHHHHHHHHHhHhhhccCCCCCC
Q 014363 308 LQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKN--ARTRPKMSEVLEMVNKIVDASAEAGSPRR 381 (426)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d--p~~RPs~~eil~~L~~~~~~~~~~~~~~~ 381 (426)
+.. -.+....+.+.-..+......-.-+++.+..+..+|+... +.-|||++..+..|..+.+...++.....
T Consensus 239 Ia~--g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C~v~a~ 312 (637)
T COG4248 239 IAH--GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKCTVSAM 312 (637)
T ss_pred hhc--ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhhhhccc
Confidence 000 0001111111111111111112245678888889998643 56899999999999888777666544333
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.9e-09 Score=94.23 Aligned_cols=98 Identities=20% Similarity=0.237 Sum_probs=65.6
Q ss_pred HHHHHHHHHhhcCCC--CccceEeEEEccCCCCceEEEEEeeCC--CCChhhhccCCCCCccCHHHHHHHHHHHHHHHHH
Q 014363 131 EWMTEVNFLGIVEHQ--NLVKLVGYCADDDERGIQRLLVYEYMP--NGSVDQYLSPKSETILTWAMRLKIAQDAARGLAY 206 (426)
Q Consensus 131 ~~~~E~~~l~~l~Hp--nIv~~~~~~~~~~~~~~~~~lv~E~~~--~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~ 206 (426)
...+|++.|.++..- ++.+++++. .. +|||||++ |..+..+.... ++......++.+++..+..
T Consensus 54 ~~~~E~~~L~~l~~~Gv~vP~p~~~~--~~------~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~ 121 (188)
T PF01163_consen 54 WAKKEFRNLKRLYEAGVPVPKPYDYN--RN------VIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIK 121 (188)
T ss_dssp HHHHHHHHHHHCCCTT-SS--EEEEE--TT------EEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHCCccCCcEEEEe--CC------EEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHH
Confidence 356899999999655 577777553 22 89999998 65555443221 2233455677888886555
Q ss_pred -hccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccC
Q 014363 207 -LHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLG 244 (426)
Q Consensus 207 -LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 244 (426)
+|.. ||+|+||.+.|||++++ .+.|+|||.+...
T Consensus 122 ~~~~~---givHGDLs~~NIlv~~~-~~~iIDf~qav~~ 156 (188)
T PF01163_consen 122 MLHKA---GIVHGDLSEYNILVDDG-KVYIIDFGQAVDS 156 (188)
T ss_dssp HHHCT---TEEESS-STTSEEEETT-CEEE--GTTEEET
T ss_pred HHHhc---CceecCCChhhEEeecc-eEEEEecCcceec
Confidence 5677 99999999999999988 9999999988643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.00 E-value=7.7e-09 Score=92.51 Aligned_cols=110 Identities=24% Similarity=0.249 Sum_probs=87.6
Q ss_pred HHHHHHHHHHHhhcC--CCCccceEeEEEccCCCCceEEEEEeeCCCC-ChhhhccCCCCCccCHHHHHHHHHHHHHHHH
Q 014363 129 HKEWMTEVNFLGIVE--HQNLVKLVGYCADDDERGIQRLLVYEYMPNG-SVDQYLSPKSETILTWAMRLKIAQDAARGLA 205 (426)
Q Consensus 129 ~~~~~~E~~~l~~l~--HpnIv~~~~~~~~~~~~~~~~~lv~E~~~~g-~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~ 205 (426)
.....+|...+..|. .-.+++.+++...........+||+|++++. +|.+++..... .+......++.+++..+.
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIA 132 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHH
Confidence 346788998888884 3346777777766544444568999999884 79998865332 556667889999999999
Q ss_pred HhccCCCCCeEeccCCCCceEeCCCC---CeeEeeeccccc
Q 014363 206 YLHEGMDFQIIVRDFKSSNILLDEQW---NAKLSDFGLARL 243 (426)
Q Consensus 206 ~LH~~~~~~iiHrDlkp~NILl~~~~---~~kl~DFGla~~ 243 (426)
-||.. ||+|+|+++.|||++.++ .+.|+||+-++.
T Consensus 133 ~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 133 KLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99998 999999999999999887 799999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.99 E-value=1.4e-08 Score=89.33 Aligned_cols=141 Identities=18% Similarity=0.098 Sum_probs=103.8
Q ss_pred ecccCcEEEEEEEEcCCCCCCcceEEEEEEccc--------cCCHHHHHHHHHHHhhcCC--CCccceEeEEEccCCCCc
Q 014363 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGR--------RGGHKEWMTEVNFLGIVEH--QNLVKLVGYCADDDERGI 162 (426)
Q Consensus 93 lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~--------~~~~~~~~~E~~~l~~l~H--pnIv~~~~~~~~~~~~~~ 162 (426)
-|+||.+.|++....+. .+-+|+-.. ......|.+|+..|..|.. -.+.+++.+.........
T Consensus 26 ~~rgG~SgV~r~~~~g~-------~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~ 98 (216)
T PRK09902 26 YRRNGMSGVQCVERNGK-------KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEW 98 (216)
T ss_pred cCCCCcceEEEEEeCCc-------EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCce
Confidence 46789999998765443 466675431 2355689999999999843 335555533223333344
Q ss_pred eEEEEEeeCCC-CChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCC--eeEeeec
Q 014363 163 QRLLVYEYMPN-GSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWN--AKLSDFG 239 (426)
Q Consensus 163 ~~~lv~E~~~~-g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~--~kl~DFG 239 (426)
+-+||+|-++| -+|.+++....-...+......++.+++..|.-||.. |+.|+|+.+.|||++.++. ++++||.
T Consensus 99 rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlE 175 (216)
T PRK09902 99 RALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLE 175 (216)
T ss_pred EEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhh
Confidence 56899998753 6888888655444467777889999999999999998 9999999999999986677 9999998
Q ss_pred cccc
Q 014363 240 LARL 243 (426)
Q Consensus 240 la~~ 243 (426)
-++.
T Consensus 176 k~r~ 179 (216)
T PRK09902 176 KSRR 179 (216)
T ss_pred ccch
Confidence 7653
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.94 E-value=2.4e-10 Score=114.19 Aligned_cols=150 Identities=23% Similarity=0.346 Sum_probs=107.3
Q ss_pred HHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccCCCCC-c------eeeeeeeecCcccCCchhhccC
Q 014363 199 DAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEG-F------THVSTAVVGTMGYAAPEYVQTG 271 (426)
Q Consensus 199 ~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-~------~~~~~~~~gt~~y~aPE~~~~~ 271 (426)
+++.||.|+|.. .++||+.|.|++|.++.++..||+.|+.+....... + ........-...|.|||++.+.
T Consensus 107 ~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred cccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 455899999985 689999999999999999999999999886443211 0 0111122346789999999988
Q ss_pred CCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccc
Q 014363 272 RLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLV 350 (426)
Q Consensus 272 ~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 350 (426)
..+.++|+||||+++|.+.. |+.-+......... .+....+..-...++..+++++.+-+.+++.
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~--------------~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~ 250 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY--------------SFSRNLLNAGAFGYSNNLPSELRESLKKLLN 250 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcchh--------------hhhhcccccccccccccCcHHHHHHHHHHhc
Confidence 88899999999999999995 44444433221111 1111122222234556788899999999999
Q ss_pred cCCCCCCCHHHHHH
Q 014363 351 KNARTRPKMSEVLE 364 (426)
Q Consensus 351 ~dp~~RPs~~eil~ 364 (426)
.++.-||++.++..
T Consensus 251 ~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 251 GDSAVRPTLDLLLS 264 (700)
T ss_pred CCcccCcchhhhhc
Confidence 99999998887754
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.92 E-value=8.1e-09 Score=93.01 Aligned_cols=133 Identities=18% Similarity=0.106 Sum_probs=93.6
Q ss_pred CCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC------------------------CHHHHHHHHHHHhhc
Q 014363 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG------------------------GHKEWMTEVNFLGIV 142 (426)
Q Consensus 87 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~------------------------~~~~~~~E~~~l~~l 142 (426)
..++..||-|--+.||.|...... .+++|...-.. ......+|.++|..|
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~------~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L 166 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGR------KVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRL 166 (304)
T ss_pred HhhccccccCccceEEEEECCCCC------EEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHh
Confidence 556789999999999999876443 78888542110 112457899999999
Q ss_pred CCC--CccceEeEEEccCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccC
Q 014363 143 EHQ--NLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDF 220 (426)
Q Consensus 143 ~Hp--nIv~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDl 220 (426)
.-. .+.+.+++-.. .+||||++|-.|...-- +....-.|+..|++-+.-+-.. ||||+|+
T Consensus 167 ~~~G~~VP~P~~~nRH--------aVvMe~ieG~eL~~~r~-------~~en~~~il~~il~~~~~~~~~---GiVHGDl 228 (304)
T COG0478 167 YPEGVKVPKPIAWNRH--------AVVMEYIEGVELYRLRL-------DVENPDEILDKILEEVRKAYRR---GIVHGDL 228 (304)
T ss_pred hhcCCCCCCccccccc--------eeeeehcccceeecccC-------cccCHHHHHHHHHHHHHHHHHc---CccccCC
Confidence 654 67777654321 79999999877765431 1222334444555554444444 9999999
Q ss_pred CCCceEeCCCCCeeEeeeccccc
Q 014363 221 KSSNILLDEQWNAKLSDFGLARL 243 (426)
Q Consensus 221 kp~NILl~~~~~~kl~DFGla~~ 243 (426)
.+-|||++++|.++++||--+..
T Consensus 229 SefNIlV~~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 229 SEFNILVTEDGDIVVIDWPQAVP 251 (304)
T ss_pred chheEEEecCCCEEEEeCccccc
Confidence 99999999999999999976653
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.62 E-value=5.4e-09 Score=103.65 Aligned_cols=189 Identities=21% Similarity=0.142 Sum_probs=132.7
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhcCCCC-ccceEeEEEccCCCCc
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQN-LVKLVGYCADDDERGI 162 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l~Hpn-Iv~~~~~~~~~~~~~~ 162 (426)
+..+....-+++|+++++||.+.... +.+..+.+... ....-++++|.+++||| .+..++-+..++
T Consensus 241 ~kws~~fh~fvK~altknpKkRptae------klL~h~fvs~~---l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~---- 307 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTAE------KLLQHPFVSQT---LSRRLAIELLDKVNNPNPVVRYLEDYDGED---- 307 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCChh------hheeceeeccc---hhhHHHHHHHHHccCCCCcccccccCCccc----
Confidence 34444555689999999998753322 13334444333 44556889999999999 444433333222
Q ss_pred eEEEEEeeCCCC-ChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccc
Q 014363 163 QRLLVYEYMPNG-SVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 241 (426)
Q Consensus 163 ~~~lv~E~~~~g-~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 241 (426)
..+++|+++.++ +-...+. ...-.+...+...+.+.-+++|++||+. .-+|+| |||..+ +..+..||+..
T Consensus 308 ~~~i~~~i~s~~rs~~~~~~-~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~ 378 (829)
T KOG0576|consen 308 YLWIPMRICSTGRSSALEMT-VSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVP 378 (829)
T ss_pred ccchhhhhhcCCccccccCC-hhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCC
Confidence 458899999877 3322221 1122345555667778888999999975 458888 888776 57999999998
Q ss_pred ccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCC
Q 014363 242 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPID 297 (426)
Q Consensus 242 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~ 297 (426)
..+.... ......+|+.++|||+...+.+..+.|+|++|+-..+|.-|.+|-.
T Consensus 379 ~~L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 379 PQLTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred cccCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 7665432 3456789999999999999999999999999998888877777654
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.62 E-value=7.4e-07 Score=79.73 Aligned_cols=153 Identities=16% Similarity=0.152 Sum_probs=100.4
Q ss_pred cccCHHHHHHHhCCCCCcceec---ccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---------------------C
Q 014363 73 KEFTIAELKSATKNFSRSVVIG---EGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---------------------G 128 (426)
Q Consensus 73 ~~~~~~~~~~~~~~y~~~~~lG---~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---------------------~ 128 (426)
...+...+.....+..+....| .|--+.||+|...+. ..+|+|+..... +
T Consensus 33 D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~------~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~ 106 (268)
T COG1718 33 DKRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDG------RYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSN 106 (268)
T ss_pred hhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCC------ceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCC
Confidence 3445666666666666666555 455567999875333 378999774221 1
Q ss_pred HHH-----HHHHHHHHhhc--CCCCccceEeEEEccCCCCceEEEEEeeCCCCCh-hhhccCCCCCccCHHHHHHHHHHH
Q 014363 129 HKE-----WMTEVNFLGIV--EHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSV-DQYLSPKSETILTWAMRLKIAQDA 200 (426)
Q Consensus 129 ~~~-----~~~E~~~l~~l--~HpnIv~~~~~~~~~~~~~~~~~lv~E~~~~g~L-~~~l~~~~~~~~~~~~~~~i~~~i 200 (426)
... ...|+..|.++ .+-.+.+-+++... .|||||+....+ .-.|. ...+.......+..++
T Consensus 107 rr~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~~~n--------VLvMEfIg~~g~pAP~Lk---Dv~~e~~e~~~~~~~~ 175 (268)
T COG1718 107 RRKLVFAWARKEFRNLKRAYEAGVRVPEPIAFRNN--------VLVMEFIGDDGLPAPRLK---DVPLELEEAEGLYEDV 175 (268)
T ss_pred HHHHHHHHHHHHHHHHHHHHHcCCCCCCceeecCC--------eEEEEeccCCCCCCCCcc---cCCcCchhHHHHHHHH
Confidence 111 24688888888 35566777766532 799999854311 11111 1123333566778888
Q ss_pred HHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccCC
Q 014363 201 ARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGP 245 (426)
Q Consensus 201 ~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 245 (426)
++.+.-|-.. .++||+||..-|||+. ++.+.|+|||-|....
T Consensus 176 v~~~~~l~~~--a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 176 VEYMRRLYKE--AGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred HHHHHHHHHh--cCcccccchhhheEEE-CCeEEEEECccccccC
Confidence 8888877762 2999999999999999 7799999999886543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.62 E-value=7.1e-07 Score=80.93 Aligned_cols=133 Identities=18% Similarity=0.117 Sum_probs=83.1
Q ss_pred ceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhcCCCC--ccceEeEEEccCCCCceEEEEE
Q 014363 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQN--LVKLVGYCADDDERGIQRLLVY 168 (426)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l~Hpn--Iv~~~~~~~~~~~~~~~~~lv~ 168 (426)
..||+|..+.||+.. +. .+.+|............+|.+++..+..-. +.+++++..+.+. ..+||
T Consensus 7 ~~i~~G~t~~~y~~~----~~-----~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~----~glv~ 73 (226)
T TIGR02172 7 TQTGEGGNGESYTHK----TG-----KWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGR----LGLIY 73 (226)
T ss_pred eeecCCCCcceeEec----CC-----CEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCe----eeeee
Confidence 468999999999841 11 466787766555667899999999985433 4677777765543 36899
Q ss_pred eeCCCCC-hhhhccCCCCCccCHHHHHHHHHHHHHH---------------------------------------HHHhc
Q 014363 169 EYMPNGS-VDQYLSPKSETILTWAMRLKIAQDAARG---------------------------------------LAYLH 208 (426)
Q Consensus 169 E~~~~g~-L~~~l~~~~~~~~~~~~~~~i~~~i~~a---------------------------------------L~~LH 208 (426)
|+++|.+ +...+.. +......++.++++. ..+|.
T Consensus 74 e~i~G~~~~~~~~~~------~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~ 147 (226)
T TIGR02172 74 ELIVGKRSFSRIISD------NPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIK 147 (226)
T ss_pred eecCCccchhhhhcC------CHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHH
Confidence 9998863 2211110 000000111111111 11111
Q ss_pred cC-CCCCeEeccCCCCceEeCCCCCeeEeeeccccc
Q 014363 209 EG-MDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL 243 (426)
Q Consensus 209 ~~-~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 243 (426)
.. ....++|+|+.|.||++++++ +.|+||+.+..
T Consensus 148 ~~~~~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 148 EVPDTSTCLHGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred hCCCCCceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 11 123578999999999999988 99999998753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.61 E-value=2.5e-07 Score=78.23 Aligned_cols=129 Identities=17% Similarity=0.177 Sum_probs=92.3
Q ss_pred CCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhcCCCCccc-eEeEEEccCCCCceEEE
Q 014363 88 SRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQNLVK-LVGYCADDDERGIQRLL 166 (426)
Q Consensus 88 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l~HpnIv~-~~~~~~~~~~~~~~~~l 166 (426)
...+.||+|++|.||+|.+.+. .+++|+-..+.....+..|+++|..+.--++.. +|.|-.+ ++
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~~~-------~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~--------~i 89 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWRGG-------EVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYGED--------FI 89 (201)
T ss_pred hhhhhhhcccccEEEEeeccCc-------eEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEechh--------hh
Confidence 3456799999999999998875 689998888888889999999999998776654 4444322 57
Q ss_pred EEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCC-CCceEeCCCCCeeEeeeccccc
Q 014363 167 VYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFK-SSNILLDEQWNAKLSDFGLARL 243 (426)
Q Consensus 167 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlk-p~NILl~~~~~~kl~DFGla~~ 243 (426)
.|||+.|-.|.+.-... +... +..+++.---|-.. ||-|+.|. |...+|..++.+.|+||.-|+.
T Consensus 90 ~me~i~G~~L~~~~~~~-----~rk~----l~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 90 RMEYIDGRPLGKLEIGG-----DRKH----LLRVLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhcCcchhhhhhcc-----cHHH----HHHHHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 79999998887765421 2222 23444553334443 99999997 4444444444999999998863
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.58 E-value=1.5e-06 Score=76.19 Aligned_cols=101 Identities=26% Similarity=0.285 Sum_probs=80.4
Q ss_pred HHHHHHHhhcCC-CCccceEeEEEccCCCCceEEEEEeeCCCCChhhh---ccCCCCCccCHHHHHHHHHHHHHHHHHhc
Q 014363 133 MTEVNFLGIVEH-QNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQY---LSPKSETILTWAMRLKIAQDAARGLAYLH 208 (426)
Q Consensus 133 ~~E~~~l~~l~H-pnIv~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~---l~~~~~~~~~~~~~~~i~~~i~~aL~~LH 208 (426)
..|.-+|+.+++ +++++++|+|-+ ++|.||.+.+++... +... ...+|..+.+|+.++++.+.+|+
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~--------~~v~E~~~~~~~~~~~~~l~~~--~~~~w~~R~~iA~~lL~~l~~l~ 76 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR--------FYVVEYVGAGSLYGIYRPLSQF--LQSPWEQRAKIALQLLELLEELD 76 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC--------EEEEEeecCccccccccccccc--cccCHHHHHHHHHHHHHHHHHHh
Confidence 468888999976 699999999943 789999987655321 1111 12689999999999999999999
Q ss_pred cCCCCCeEeccCCCCceEeCCCCCeeEeeeccccc
Q 014363 209 EGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL 243 (426)
Q Consensus 209 ~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 243 (426)
......+.-.|++++|+-++++|++|++|...+..
T Consensus 77 ~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 77 HGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred cCCCCcEEEeecchHHeEEeCCCcEEEEechhcch
Confidence 85333566799999999999999999999987654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.57 E-value=1.1e-06 Score=77.81 Aligned_cols=138 Identities=13% Similarity=0.108 Sum_probs=88.8
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCH--H---------HHHHHHHHHhhcCC---CCccc
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGH--K---------EWMTEVNFLGIVEH---QNLVK 149 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~--~---------~~~~E~~~l~~l~H---pnIv~ 149 (426)
.++|...+++-......|.+....+. .+.+|........ + ...+++..+..+.. -.++.
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei~~~-------kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~ 102 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEIDGK-------KYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPAD 102 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEECCc-------EEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccc
Confidence 56788888888877777776654442 6788876554311 1 12234444444422 23333
Q ss_pred eEeEEEccC-CCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeC
Q 014363 150 LVGYCADDD-ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLD 228 (426)
Q Consensus 150 ~~~~~~~~~-~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~ 228 (426)
++.+..-.. ......+|||||++|..|.++.. +++ .++..+++++.-||.. |+.|+|+.|.|++++
T Consensus 103 ~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~ 169 (229)
T PF06176_consen 103 PYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVS 169 (229)
T ss_pred ceeeeeeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEE
Confidence 332222211 11123368999999998877643 332 2456677889999998 999999999999999
Q ss_pred CCCCeeEeeecccc
Q 014363 229 EQWNAKLSDFGLAR 242 (426)
Q Consensus 229 ~~~~~kl~DFGla~ 242 (426)
+++ ++++||+..+
T Consensus 170 ~~~-i~iID~~~k~ 182 (229)
T PF06176_consen 170 NNG-IRIIDTQGKR 182 (229)
T ss_pred CCc-EEEEECcccc
Confidence 664 9999998665
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.54 E-value=3.5e-07 Score=91.84 Aligned_cols=138 Identities=18% Similarity=0.133 Sum_probs=86.6
Q ss_pred ceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC----------------------------H-------------
Q 014363 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG----------------------------H------------- 129 (426)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~----------------------------~------------- 129 (426)
+.|+.++-|+||+|+.+++. .||||+....-. .
T Consensus 131 ~PiAsASIaQVH~A~L~sG~------~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ 204 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGE------EVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLRE 204 (517)
T ss_pred CchhhhhHhhheeEEecCCC------EEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHH
Confidence 57999999999999998743 899998743310 0
Q ss_pred -HHHHHHHHHHhhc-----CCCC--ccceEeEEEccCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHH
Q 014363 130 -KEWMTEVNFLGIV-----EHQN--LVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAA 201 (426)
Q Consensus 130 -~~~~~E~~~l~~l-----~Hpn--Iv~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~ 201 (426)
-++.+|+..+.++ +.|+ |.++|--+ .. ...|+|||++|..+.+...... ..++...+.....++.
T Consensus 205 ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~--t~----~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f 277 (517)
T COG0661 205 ELDYRREAANAERFRENFKDDPDVYVPKVYWEY--TT----RRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF 277 (517)
T ss_pred HhCHHHHHHHHHHHHHHcCCCCCeEeceeehhc--cC----CcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH
Confidence 0234555555555 2233 23332111 11 2289999999999988843222 1244332222221111
Q ss_pred HHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccCCC
Q 014363 202 RGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPS 246 (426)
Q Consensus 202 ~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 246 (426)
----+-| |++|.|..|.||+++.+|++.+.|||+....+.
T Consensus 278 ~~q~~~d-----gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 278 LRQLLRD-----GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHHHHhc-----CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 1111223 999999999999999999999999999876553
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.53 E-value=9.7e-07 Score=80.19 Aligned_cols=145 Identities=17% Similarity=0.170 Sum_probs=84.6
Q ss_pred cceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhcCCC--CccceEeEEEccCCCCceEEEE
Q 014363 90 SVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQ--NLVKLVGYCADDDERGIQRLLV 167 (426)
Q Consensus 90 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l~Hp--nIv~~~~~~~~~~~~~~~~~lv 167 (426)
++.|+.|..+.||++...+ + .+++|..........+..|+.++..|... .+.+++.+.......+ ..+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~------~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~-~~~~~ 73 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-G------RYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNG-FPYLL 73 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-S------EEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETS-EEEEE
T ss_pred CccCCCCCeeeEEEEEECC-c------EEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccc-cceEE
Confidence 4579999999999998666 2 68889876554456778999999888433 3567776554433222 36899
Q ss_pred EeeCCCCChhhh----------------c---cCC--CCCccCHHH---------HHHH------------HHHHHH-HH
Q 014363 168 YEYMPNGSVDQY----------------L---SPK--SETILTWAM---------RLKI------------AQDAAR-GL 204 (426)
Q Consensus 168 ~E~~~~g~L~~~----------------l---~~~--~~~~~~~~~---------~~~i------------~~~i~~-aL 204 (426)
|++++|..+... + +.. ....+.... .... ...+.. .+
T Consensus 74 ~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (239)
T PF01636_consen 74 MEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLL 153 (239)
T ss_dssp EEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHH
T ss_pred EEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHH
Confidence 999999888771 0 000 000001000 0000 111122 22
Q ss_pred HHhcc----CCCCCeEeccCCCCceEeC-CCCCeeEeeecccc
Q 014363 205 AYLHE----GMDFQIIVRDFKSSNILLD-EQWNAKLSDFGLAR 242 (426)
Q Consensus 205 ~~LH~----~~~~~iiHrDlkp~NILl~-~~~~~kl~DFGla~ 242 (426)
..++. .....++|+|+.|.|||++ +++.+-|+||+.+.
T Consensus 154 ~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 154 QELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 33331 1235799999999999999 66666899998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.41 E-value=1.1e-06 Score=87.90 Aligned_cols=138 Identities=18% Similarity=0.121 Sum_probs=88.9
Q ss_pred ceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC---------------------------------------HHH
Q 014363 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG---------------------------------------HKE 131 (426)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~---------------------------------------~~~ 131 (426)
+.||.-+.|.||+|+.+++. .||||+-+..-. .-+
T Consensus 167 ~piaaASlaQVhrA~L~~G~------~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELD 240 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGE------DVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELD 240 (538)
T ss_pred chhhhcchhheEEEEecCCC------EEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcc
Confidence 57999999999999998843 799997543210 002
Q ss_pred HHHHHHHHhh----cCCCC------ccceEeEEEccCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHH
Q 014363 132 WMTEVNFLGI----VEHQN------LVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAA 201 (426)
Q Consensus 132 ~~~E~~~l~~----l~Hpn------Iv~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~ 201 (426)
|.+|++...+ +.|-+ |.++|-.+.. ...|+||||+|..+.|.-.-.. ..++...+..-+.+..
T Consensus 241 F~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st------~RVLtME~~~G~~i~Dl~~i~~-~gi~~~~i~~~l~~~~ 313 (538)
T KOG1235|consen 241 FTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLST------KRVLTMEYVDGIKINDLDAIDK-RGISPHDILNKLVEAY 313 (538)
T ss_pred hHHHHHhHHHHHHHHHhcccccceeCCeehhhcCc------ceEEEEEecCCccCCCHHHHHH-cCCCHHHHHHHHHHHH
Confidence 4445543333 34544 5555433322 2489999999988876532222 1255554444443333
Q ss_pred HHHHHhccCCCCCeEeccCCCCceEeCC----CCCeeEeeecccccCCC
Q 014363 202 RGLAYLHEGMDFQIIVRDFKSSNILLDE----QWNAKLSDFGLARLGPS 246 (426)
Q Consensus 202 ~aL~~LH~~~~~~iiHrDlkp~NILl~~----~~~~kl~DFGla~~~~~ 246 (426)
.-.-+.| |++|.|-.|.||+++. ++.+.+.|||+......
T Consensus 314 ~~qIf~~-----GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 314 LEQIFKT-----GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HHHHHhc-----CCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 3333333 9999999999999983 67899999999876543
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.38 E-value=5.9e-06 Score=75.93 Aligned_cols=138 Identities=19% Similarity=0.158 Sum_probs=81.4
Q ss_pred ecccCc-EEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhc-CCCCccceEeEEEccCCCCceEEEEEee
Q 014363 93 IGEGGF-GCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDERGIQRLLVYEY 170 (426)
Q Consensus 93 lG~G~~-g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~~~~~~~lv~E~ 170 (426)
|..|.+ ..||+....+ . .+.+|...... ...+.+|++++..+ .+--+.+++++....+. .++|||+
T Consensus 6 ~~~g~~~~~v~~~~~~~-~------~~~vk~~~~~~-~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~----~~lv~e~ 73 (244)
T cd05150 6 VTEGQSGATVYRLDGKN-P------GLYLKIAPSGP-TYELEREAERLRWLAGKLPVPEVIDYGSDDGR----AWLLTSA 73 (244)
T ss_pred cCCCCCcCeEEEEcCCC-C------cEEEEecCCCc-ccchHHHHHHHHHHHhcCCCCeEEEEEecCCc----cEEEEEe
Confidence 445555 6799886432 1 57777765443 34577899999888 34456677877765432 3899999
Q ss_pred CCCCChhhhcc-------------------CCC--CCccCHH--HHHHH-----------------------HHHHHHHH
Q 014363 171 MPNGSVDQYLS-------------------PKS--ETILTWA--MRLKI-----------------------AQDAARGL 204 (426)
Q Consensus 171 ~~~g~L~~~l~-------------------~~~--~~~~~~~--~~~~i-----------------------~~~i~~aL 204 (426)
++|.+|..... ... ...+... ..... +.++...|
T Consensus 74 i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 153 (244)
T cd05150 74 VPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAEL 153 (244)
T ss_pred eCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHH
Confidence 99988764421 000 0001000 00000 11111111
Q ss_pred HHhc-cCCCCCeEeccCCCCceEeCCCCCeeEeeecccc
Q 014363 205 AYLH-EGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 242 (426)
Q Consensus 205 ~~LH-~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 242 (426)
.... ......++|+|+.|.|||+++++.+.|+||+.+.
T Consensus 154 ~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 154 EATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred HhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 1111 0112468999999999999998778899998775
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.28 E-value=1.8e-05 Score=85.37 Aligned_cols=83 Identities=14% Similarity=0.197 Sum_probs=56.5
Q ss_pred cceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcC-CCCc--cceEeEEEccCCCCce
Q 014363 90 SVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVE-HQNL--VKLVGYCADDDERGIQ 163 (426)
Q Consensus 90 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~-HpnI--v~~~~~~~~~~~~~~~ 163 (426)
++.|+.|.+..+|+......+. ...+++|+..... ....+.+|+++|+.+. |++| .+++.++.+....+ .
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~---~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G-~ 118 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGS---VKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIG-T 118 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCc---ceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCC-C
Confidence 5678999999999987654321 1245566543321 3346889999999995 6665 88888887653322 3
Q ss_pred EEEEEeeCCCCCh
Q 014363 164 RLLVYEYMPNGSV 176 (426)
Q Consensus 164 ~~lv~E~~~~g~L 176 (426)
.|+||||++|..+
T Consensus 119 ~flVME~v~G~~~ 131 (822)
T PLN02876 119 AFYIMEYLEGRIF 131 (822)
T ss_pred ceEEEEecCCccc
Confidence 4899999988654
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.26 E-value=2.4e-05 Score=74.03 Aligned_cols=82 Identities=15% Similarity=0.123 Sum_probs=56.7
Q ss_pred CCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhcCC---CCccceEeEEEccCCCCce
Q 014363 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEH---QNLVKLVGYCADDDERGIQ 163 (426)
Q Consensus 87 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l~H---pnIv~~~~~~~~~~~~~~~ 163 (426)
-...+.||.|..+.||+....+. .+.+|..+.......+..|+..|+.|.- -.+.++++++.+....+ .
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~~~-------~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g-~ 87 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDSQG-------NPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPG-P 87 (297)
T ss_pred hheeeecCCccceeEEEEEcCCC-------CEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCC-C
Confidence 34455799999999998753332 3555654332244688999999999843 46889998886543222 2
Q ss_pred EEEEEeeCCCCCh
Q 014363 164 RLLVYEYMPNGSV 176 (426)
Q Consensus 164 ~~lv~E~~~~g~L 176 (426)
.+||||+++|+++
T Consensus 88 ~~LVmE~i~G~~~ 100 (297)
T PRK10593 88 DVLLLERLRGVSV 100 (297)
T ss_pred eEEEEeccCCEec
Confidence 4999999998765
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.25 E-value=1.3e-06 Score=92.69 Aligned_cols=200 Identities=20% Similarity=0.201 Sum_probs=140.5
Q ss_pred HHHHHHHhhcCCCCccceEeEEEccCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCC
Q 014363 133 MTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMD 212 (426)
Q Consensus 133 ~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~ 212 (426)
.-|+..+.++.|+|++.+++|-......+....+..|+|..-++...+.... .++....+.+..++.+||.|+|+.
T Consensus 230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~--~i~~~~~r~~~~~~~~GL~~~h~~-- 305 (1351)
T KOG1035|consen 230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG--SIPLETLRILHQKLLEGLAYLHSL-- 305 (1351)
T ss_pred HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc--ccCHHHHHHHHHHHhhhHHHHHHh--
Confidence 4566777888999999999988776655444456678888888887776443 478888888999999999999987
Q ss_pred CCeEeccCCCC---ceEeCCCCCeeEe--eecccccCCCCCceeeeeeeecCcccCCchhhccCCCCC--chhhHHHHHH
Q 014363 213 FQIIVRDFKSS---NILLDEQWNAKLS--DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAA--RSDVWSYGVF 285 (426)
Q Consensus 213 ~~iiHrDlkp~---NILl~~~~~~kl~--DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~DvwslGvi 285 (426)
...|.-|..+ +...+.++.+.++ ||+.+......... ....-+..+.++|......+.. ..|+|.+|..
T Consensus 306 -~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll 381 (1351)
T KOG1035|consen 306 -SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLL 381 (1351)
T ss_pred -ccceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHHHHHHH
Confidence 5555544444 4445666777777 99888766544322 2234566788888777666555 4799999999
Q ss_pred HHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 286 LYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 286 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
+..+..|..+-.... ....+++. .....+.+...+|+..++++|+++.+++.+
T Consensus 382 ~~~~~~~~~i~~~~~-------------------~~~~~l~~--------~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~ 434 (1351)
T KOG1035|consen 382 LLQLSQGEDISEKSA-------------------VPVSLLDV--------LSTSELLDALPKCLDEDSEERLSALELLTH 434 (1351)
T ss_pred HhhhhhcCccccccc-------------------chhhhhcc--------ccchhhhhhhhhhcchhhhhccchhhhhhc
Confidence 999999876543210 00111111 011146678889999999999999999987
Q ss_pred HH
Q 014363 366 VN 367 (426)
Q Consensus 366 L~ 367 (426)
.-
T Consensus 435 ~f 436 (1351)
T KOG1035|consen 435 PF 436 (1351)
T ss_pred hh
Confidence 53
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.23 E-value=1.7e-05 Score=72.53 Aligned_cols=78 Identities=12% Similarity=0.135 Sum_probs=48.7
Q ss_pred ceecccCcEE-EEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhcCCC---CccceEeEEEccCCCCceEEE
Q 014363 91 VVIGEGGFGC-VYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQ---NLVKLVGYCADDDERGIQRLL 166 (426)
Q Consensus 91 ~~lG~G~~g~-Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l~Hp---nIv~~~~~~~~~~~~~~~~~l 166 (426)
+.|+.|+... ||+.. . .+.+|..........+..|+++|..|... .+.++++.....+. ....++
T Consensus 3 ~~~~~gG~~n~vy~~~----~------~~VlR~~~~~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~-~~~~~~ 71 (235)
T cd05155 3 EPVDSGGTDNATFRLG----D------DMSVRLPSAAGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEG-YPWPWS 71 (235)
T ss_pred eeccCCCcccceEEcC----C------ceEEEcCCccchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccC-CCcceE
Confidence 4678777774 89751 1 35667655544456788999999988532 34555544332221 112378
Q ss_pred EEeeCCCCChhhh
Q 014363 167 VYEYMPNGSVDQY 179 (426)
Q Consensus 167 v~E~~~~g~L~~~ 179 (426)
+|++++|.++.+.
T Consensus 72 l~~~i~G~~l~~~ 84 (235)
T cd05155 72 VYRWLEGETATAA 84 (235)
T ss_pred EEEeecCCCCCcc
Confidence 9999999877543
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.19 E-value=4.8e-05 Score=66.70 Aligned_cols=127 Identities=25% Similarity=0.306 Sum_probs=90.1
Q ss_pred CCCCCcceecccCc-EEEEEEEEcCCCCCCcceEEEEEEccc---c--------------------CCHHHHHHHHHHHh
Q 014363 85 KNFSRSVVIGEGGF-GCVYKGLIKNSEDPSQKVEVAVKQLGR---R--------------------GGHKEWMTEVNFLG 140 (426)
Q Consensus 85 ~~y~~~~~lG~G~~-g~Vy~~~~~~~~~~~~~~~va~K~~~~---~--------------------~~~~~~~~E~~~l~ 140 (426)
.+++.++.||.|.- |.||++.+.+. .+|+|.+.. . .....|..|.+...
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~-------~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfg 109 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGR-------IYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFG 109 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCe-------EEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhH
Confidence 68889999999999 99999988764 799998311 0 01135778888877
Q ss_pred hc---CCCCc--cceEeEEEccC--------------CCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHH
Q 014363 141 IV---EHQNL--VKLVGYCADDD--------------ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAA 201 (426)
Q Consensus 141 ~l---~HpnI--v~~~~~~~~~~--------------~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~ 201 (426)
+| .+.++ |+++||..-.. .......||.||++... .+.... +.+|.
T Consensus 110 RLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~~~----~~~~~ 174 (207)
T PF13095_consen 110 RLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQIRD----IPQML 174 (207)
T ss_pred HHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccchhH----HHHHH
Confidence 77 45566 99999985331 11233467888776533 123333 45667
Q ss_pred HHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccc
Q 014363 202 RGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 241 (426)
Q Consensus 202 ~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 241 (426)
+-|..+|.. ||+-+|+++.|.. .-||+|||.+
T Consensus 175 ~dl~~~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 175 RDLKILHKL---GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHHHHC---CeeeccCcccccc-----CCEEEecccC
Confidence 778889988 9999999999986 3489999864
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.01 E-value=0.00013 Score=64.40 Aligned_cols=129 Identities=19% Similarity=0.291 Sum_probs=84.0
Q ss_pred cceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC------------------CHHHHHHHHHHHhhcC------CC
Q 014363 90 SVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG------------------GHKEWMTEVNFLGIVE------HQ 145 (426)
Q Consensus 90 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~------------------~~~~~~~E~~~l~~l~------Hp 145 (426)
...||+|+.=.||. +.... ...||+..... ..++..+|+.....+. +.
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp------~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~ 77 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDP------NLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWS 77 (199)
T ss_pred CcccccCCCceEEE--CCCCC------CeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccc
Confidence 45799999999995 33322 24455543332 3456677777666655 78
Q ss_pred CccceEeEEEccCCCCceEEEEEeeCC------CCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEecc
Q 014363 146 NLVKLVGYCADDDERGIQRLLVYEYMP------NGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRD 219 (426)
Q Consensus 146 nIv~~~~~~~~~~~~~~~~~lv~E~~~------~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrD 219 (426)
+|.+++|+...+... -+|+|.+. ..+|.+++.... ++. ..... +-+-..||-+. +|+.+|
T Consensus 78 ~i~r~~G~veT~~G~----Glv~e~I~d~dG~~s~TL~~~l~~~~---~~~-~~~~~---L~~f~~~l~~~---~Iv~~d 143 (199)
T PF10707_consen 78 HIPRFYGFVETNLGL----GLVVELIRDADGNISPTLEDYLKEGG---LTE-ELRQA---LDEFKRYLLDH---HIVIRD 143 (199)
T ss_pred ccccEeEEEecCCce----EEEEEEEECCCCCcCccHHHHHHcCC---ccH-HHHHH---HHHHHHHHHHc---CCeecC
Confidence 999999999887654 56777652 346778874332 554 33333 33445566666 899999
Q ss_pred CCCCceEeCCCC----CeeEee-ecc
Q 014363 220 FKSSNILLDEQW----NAKLSD-FGL 240 (426)
Q Consensus 220 lkp~NILl~~~~----~~kl~D-FGl 240 (426)
|+|.||++.... .+.|+| ||-
T Consensus 144 l~~~NIv~~~~~~~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 144 LNPHNIVVQRRDSGEFRLVLIDGLGE 169 (199)
T ss_pred CCcccEEEEecCCCceEEEEEeCCCC
Confidence 999999995332 477777 443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.92 E-value=0.0002 Score=65.32 Aligned_cols=76 Identities=17% Similarity=0.195 Sum_probs=46.4
Q ss_pred cceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCH-HHHHHHHHHHhhcCCC-CccceEeEEEccCCCCceEEEE
Q 014363 90 SVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGH-KEWMTEVNFLGIVEHQ-NLVKLVGYCADDDERGIQRLLV 167 (426)
Q Consensus 90 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~-~~~~~E~~~l~~l~Hp-nIv~~~~~~~~~~~~~~~~~lv 167 (426)
++.|..|-...+|++...+. ....+.+|........ -...+|+.++..+... -.+++++.+. + .+|
T Consensus 3 i~~l~gG~tN~~~~v~~~~~----~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~------~~l 70 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKED----NQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ--N------GLI 70 (235)
T ss_pred EEEcCCcccceEEEEEcCCC----CCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC--C------cEE
Confidence 34677888889999864420 0125777766433211 2234799999988443 3455554332 1 479
Q ss_pred EeeCCCCChh
Q 014363 168 YEYMPNGSVD 177 (426)
Q Consensus 168 ~E~~~~g~L~ 177 (426)
|||++|.++.
T Consensus 71 ~e~i~G~~l~ 80 (235)
T cd05157 71 YEFIPGRTLE 80 (235)
T ss_pred EEeeCCCcCC
Confidence 9999987763
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.00013 Score=69.02 Aligned_cols=145 Identities=14% Similarity=0.088 Sum_probs=83.3
Q ss_pred cceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhcCCC--CccceEeEEEccC--CCCceEE
Q 014363 90 SVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQ--NLVKLVGYCADDD--ERGIQRL 165 (426)
Q Consensus 90 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l~Hp--nIv~~~~~~~~~~--~~~~~~~ 165 (426)
++.|..|....+|+....+. .+.+|.... .....+..|+.++..|.+- .+.+++....... ......+
T Consensus 19 i~~i~~G~~n~~y~v~~~~~-------~~vLr~~~~-~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~ 90 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSG-------RYVLTLFEK-VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA 90 (296)
T ss_pred eecccCccccceEEEEeCCC-------cEEEEEcCC-CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence 55677888889998764332 477787765 4456677899988888433 2445443210000 0011348
Q ss_pred EEEeeCCCCChhhh----c----------c----CCCC-----CccCHHHHH----------HHHHHHHHHHHHhcc---
Q 014363 166 LVYEYMPNGSVDQY----L----------S----PKSE-----TILTWAMRL----------KIAQDAARGLAYLHE--- 209 (426)
Q Consensus 166 lv~E~~~~g~L~~~----l----------~----~~~~-----~~~~~~~~~----------~i~~~i~~aL~~LH~--- 209 (426)
+|++|++|..+... . + .... ....|.... .....+..++.++..
T Consensus 91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~ 170 (296)
T cd05153 91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP 170 (296)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence 99999998776431 0 0 0000 001111110 011112233444432
Q ss_pred -CCCCCeEeccCCCCceEeCCCCCeeEeeecccc
Q 014363 210 -GMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 242 (426)
Q Consensus 210 -~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 242 (426)
....+++|+|+.|.|||+++++.+.|+||+.+.
T Consensus 171 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 171 SDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred hcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 123479999999999999998777899998775
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.00015 Score=67.20 Aligned_cols=135 Identities=13% Similarity=0.067 Sum_probs=75.5
Q ss_pred ecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCH--HHHHHHHHHHhhcCCCCc-cceEeEEEccCCCCceEEEEEe
Q 014363 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGH--KEWMTEVNFLGIVEHQNL-VKLVGYCADDDERGIQRLLVYE 169 (426)
Q Consensus 93 lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~--~~~~~E~~~l~~l~HpnI-v~~~~~~~~~~~~~~~~~lv~E 169 (426)
+..|-...+|+....+ ..+.+|........ -...+|..+++.+..-.+ .+++++. .+ ++|||
T Consensus 4 ~~~G~tn~~y~~~~~~-------~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~~------~~v~e 68 (256)
T TIGR02721 4 LSGGLTNRSWRIEHPG-------ISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--EH------WLLVE 68 (256)
T ss_pred CCCcCcCCeEEEEeCC-------ccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--CC------EEEEE
Confidence 5667788899876221 15667765433211 235789999999854433 4455443 22 68999
Q ss_pred eCCCCChhhh-----------------ccCCC--CCccCHH-HHHHHHHHH---------HHHHHHhcc-----CCCCCe
Q 014363 170 YMPNGSVDQY-----------------LSPKS--ETILTWA-MRLKIAQDA---------ARGLAYLHE-----GMDFQI 215 (426)
Q Consensus 170 ~~~~g~L~~~-----------------l~~~~--~~~~~~~-~~~~i~~~i---------~~aL~~LH~-----~~~~~i 215 (426)
|++|..+... ++... ...++.. .+..+..++ ...+..+-. .....+
T Consensus 69 ~i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 148 (256)
T TIGR02721 69 WLEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAP 148 (256)
T ss_pred eccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCee
Confidence 9998776532 01110 1111111 111111111 111111111 112368
Q ss_pred EeccCCCCceEeCCCCCeeEeeeccccc
Q 014363 216 IVRDFKSSNILLDEQWNAKLSDFGLARL 243 (426)
Q Consensus 216 iHrDlkp~NILl~~~~~~kl~DFGla~~ 243 (426)
+|+|+.|.|||+++++ +.|+||..+..
T Consensus 149 ~H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 149 LHMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred ecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 9999999999999877 78999998754
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.00043 Score=65.93 Aligned_cols=159 Identities=16% Similarity=0.140 Sum_probs=88.4
Q ss_pred HHHHHHHhCCCCC-----cceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhcCCC--Cccc
Q 014363 77 IAELKSATKNFSR-----SVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQ--NLVK 149 (426)
Q Consensus 77 ~~~~~~~~~~y~~-----~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l~Hp--nIv~ 149 (426)
.+++......|.. ++.++.|....+|+....+. .+.+|..........+..|++++..|... .+.+
T Consensus 9 ~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~-------~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~ 81 (307)
T TIGR00938 9 DEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVG-------RYILTLYEKRVKAEELPFFLALTTHLAARGLPVPK 81 (307)
T ss_pred HHHHHHHHHhcCCCCceeccccCCccccceEEEEeCCC-------cEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCc
Confidence 3455555445543 45677777788998764322 46677765543455667788888887432 2444
Q ss_pred eEeEEEcc--CCCCceEEEEEeeCCCCChhhh--------------ccCCCC----------CccCHHHHH---------
Q 014363 150 LVGYCADD--DERGIQRLLVYEYMPNGSVDQY--------------LSPKSE----------TILTWAMRL--------- 194 (426)
Q Consensus 150 ~~~~~~~~--~~~~~~~~lv~E~~~~g~L~~~--------------l~~~~~----------~~~~~~~~~--------- 194 (426)
++...... .....+.++++||++|..+... ++.... ..-.|....
T Consensus 82 ~i~t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~ 161 (307)
T TIGR00938 82 PVKSRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQ 161 (307)
T ss_pred cccCCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccc
Confidence 44321100 0011245899999988654311 010000 001111100
Q ss_pred ---HHHHHHHHHHHHhcc----CCCCCeEeccCCCCceEeCCCCCeeEeeecccc
Q 014363 195 ---KIAQDAARGLAYLHE----GMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 242 (426)
Q Consensus 195 ---~i~~~i~~aL~~LH~----~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 242 (426)
.....+...++++.. ....+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 162 l~~~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 162 LEAHMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCHHHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 011122334544432 224589999999999999988777899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00047 Score=67.48 Aligned_cols=74 Identities=20% Similarity=0.137 Sum_probs=51.0
Q ss_pred ceecccCcEEEEEEEEcCCCCCCcceEEEEEEccc---------cCCHHHHHHHHHHHhhcC---CCCccceEeEEEccC
Q 014363 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGR---------RGGHKEWMTEVNFLGIVE---HQNLVKLVGYCADDD 158 (426)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~---------~~~~~~~~~E~~~l~~l~---HpnIv~~~~~~~~~~ 158 (426)
+.||.|.+..||++...++. +.+.||+... .-..+....|.+.|..+. -.++++++.+.. +
T Consensus 32 ~elggGn~N~VyrV~~~~g~-----~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~ 104 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGG-----KSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--E 104 (401)
T ss_pred eEcCCCceEEEEEEEeCCCC-----eEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--C
Confidence 47999999999999875432 2578887431 123456778888888862 346788887633 2
Q ss_pred CCCceEEEEEeeCCCCC
Q 014363 159 ERGIQRLLVYEYMPNGS 175 (426)
Q Consensus 159 ~~~~~~~lv~E~~~~g~ 175 (426)
. .++||||+++..
T Consensus 105 ~----~~lVME~L~~~~ 117 (401)
T PRK09550 105 L----AVTVMEDLSDHK 117 (401)
T ss_pred C----CEEEEecCCCcc
Confidence 2 289999998644
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00036 Score=66.86 Aligned_cols=159 Identities=14% Similarity=0.093 Sum_probs=83.1
Q ss_pred CHHHHHHHhCCCCC-----cceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhcCCC--Ccc
Q 014363 76 TIAELKSATKNFSR-----SVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQ--NLV 148 (426)
Q Consensus 76 ~~~~~~~~~~~y~~-----~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l~Hp--nIv 148 (426)
+..++......|.. .+.|+.|....+|+....+. .+.+|+.. ....+.+..|+.++..|... .+.
T Consensus 8 s~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-------~~vLK~~~-~~~~~~l~~~~~~l~~L~~~glpvP 79 (319)
T PRK05231 8 SDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-------EYVLTLFE-RLTAEDLPFFLGLMQHLAARGVPVP 79 (319)
T ss_pred CHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-------cEEEEEec-cCChHHhHHHHHHHHHHHHCCCCCC
Confidence 44455554455544 34566777778998764332 46778765 33445555677777776322 233
Q ss_pred ceEeEEEcc--CCCCceEEEEEeeCCCCChhh-----h------c---cCCC---------CCcc-CHHHHHH-------
Q 014363 149 KLVGYCADD--DERGIQRLLVYEYMPNGSVDQ-----Y------L---SPKS---------ETIL-TWAMRLK------- 195 (426)
Q Consensus 149 ~~~~~~~~~--~~~~~~~~lv~E~~~~g~L~~-----~------l---~~~~---------~~~~-~~~~~~~------- 195 (426)
+++...... .......++++||++|..+.. . + +... ...+ .|.....
T Consensus 80 ~~i~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (319)
T PRK05231 80 APVARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLA 159 (319)
T ss_pred cceeCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccC
Confidence 443211000 001124589999998875421 1 0 0000 0001 1111110
Q ss_pred -----HHHH-HHHHHHHhcc----CCCCCeEeccCCCCceEeCCCCCeeEeeecccc
Q 014363 196 -----IAQD-AARGLAYLHE----GMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 242 (426)
Q Consensus 196 -----i~~~-i~~aL~~LH~----~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 242 (426)
.+.+ +...++.+.. ....+++|+|+.|.|||++.+...-|+||+.+.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 160 DEQAALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred hhHHHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 1111 1112222221 124589999999999999976556899999875
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00056 Score=64.96 Aligned_cols=144 Identities=22% Similarity=0.270 Sum_probs=81.2
Q ss_pred ceecccCcEEEEEEEEcCCC-CCCcceEEEEEEccccC-CHHHHHHHHHHHhhcCCCC-ccceEeEEEccCCCCceEEEE
Q 014363 91 VVIGEGGFGCVYKGLIKNSE-DPSQKVEVAVKQLGRRG-GHKEWMTEVNFLGIVEHQN-LVKLVGYCADDDERGIQRLLV 167 (426)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~-~~~~~~~va~K~~~~~~-~~~~~~~E~~~l~~l~Hpn-Iv~~~~~~~~~~~~~~~~~lv 167 (426)
+.|..|-...||+....... .......+.+|...... ......+|+.++..+.... ..++++++. + .+|
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~--~------~~v 75 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFP--N------GRI 75 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeC--C------Cch
Confidence 35666777789988654310 00112357777765432 2235678999998884333 345565543 1 358
Q ss_pred EeeCCCCChhhh-c----------------cCCCCC-------ccC--HHHHHH--------------------------
Q 014363 168 YEYMPNGSVDQY-L----------------SPKSET-------ILT--WAMRLK-------------------------- 195 (426)
Q Consensus 168 ~E~~~~g~L~~~-l----------------~~~~~~-------~~~--~~~~~~-------------------------- 195 (426)
+||++|..+... + +..... ..+ +.....
T Consensus 76 ~e~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (302)
T cd05156 76 EEFIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSL 155 (302)
T ss_pred hheeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHH
Confidence 999998776532 1 100000 000 101000
Q ss_pred HHHHHHHHHHHhcc------CCCCCeEeccCCCCceEeCCC----CCeeEeeecccc
Q 014363 196 IAQDAARGLAYLHE------GMDFQIIVRDFKSSNILLDEQ----WNAKLSDFGLAR 242 (426)
Q Consensus 196 i~~~i~~aL~~LH~------~~~~~iiHrDlkp~NILl~~~----~~~kl~DFGla~ 242 (426)
+...+...+..|-. .....++|+|+.+.|||++++ +.+.|+||..+.
T Consensus 156 ~~~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 156 FLEDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 11122222333431 134579999999999999985 789999998875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.64 E-value=5e-06 Score=90.25 Aligned_cols=161 Identities=12% Similarity=0.030 Sum_probs=115.1
Q ss_pred HHHHHHHHhhcCCCCccceEeEEEccCCCCceEEEEEeeCCCCChhhhccCCCCC--ccCHHHHHHHHHHHHHHHHHhcc
Q 014363 132 WMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSET--ILTWAMRLKIAQDAARGLAYLHE 209 (426)
Q Consensus 132 ~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~--~~~~~~~~~i~~~i~~aL~~LH~ 209 (426)
...|..-++...|+++...+.-....... ..+..++|+.+|.+.+.|.+.... .+...-+...-.+.+.+..-+|+
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~--ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls 1353 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSEST--EEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILS 1353 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCCh--HHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhh
Confidence 34555556667899988776544333222 338899999999999988754322 23333333333343666666665
Q ss_pred CCC--CCeEeccCCCCceEeCCCCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHH
Q 014363 210 GMD--FQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLY 287 (426)
Q Consensus 210 ~~~--~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ 287 (426)
..+ .-.+|+++|+.|.+|..+..+|+.++|+.+..... ........+++.|+.|++...-.++.++|+|..|+.+|
T Consensus 1354 ~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~--~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly 1431 (2724)
T KOG1826|consen 1354 LTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV--LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLY 1431 (2724)
T ss_pred cccCCccchhhhhhhhccceecCCcccccccccccccCch--HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHH
Confidence 432 24789999999999999999999999999832221 22234567889999999988888999999999999999
Q ss_pred HHHhCCCCC
Q 014363 288 ELITGRRPI 296 (426)
Q Consensus 288 elltg~~p~ 296 (426)
+..-|..+|
T Consensus 1432 ~rs~~n~~f 1440 (2724)
T KOG1826|consen 1432 LRSDGNAYF 1440 (2724)
T ss_pred HHhcccHHH
Confidence 999888776
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.00024 Score=66.17 Aligned_cols=133 Identities=17% Similarity=0.117 Sum_probs=90.3
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcc-----------cc--------CC-----HHHHHHHHHHHhh
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLG-----------RR--------GG-----HKEWMTEVNFLGI 141 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~-----------~~--------~~-----~~~~~~E~~~l~~ 141 (426)
-++.++.||-|--+.||.+-+..+. ..++|... ++ .. .-...+|+..|+.
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~------~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmka 166 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGN------PLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKA 166 (465)
T ss_pred hhhhccccccccccceEEEecCCCC------chhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHH
Confidence 4678889999999999999877554 45555321 00 01 1134679999999
Q ss_pred cC-CC-CccceEeEEEccCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEecc
Q 014363 142 VE-HQ-NLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRD 219 (426)
Q Consensus 142 l~-Hp-nIv~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrD 219 (426)
|. |- -+.+.+++.. -++|||++.|..|...-+- .+... +...+..-+.-|-.+ |+||+|
T Consensus 167 L~e~gfpVPkpiD~~R--------H~Vvmelv~g~Pl~~v~~v-----~d~~~---ly~~lm~~Iv~la~~---GlIHgD 227 (465)
T KOG2268|consen 167 LYERGFPVPKPIDHNR--------HCVVMELVDGYPLRQVRHV-----EDPPT---LYDDLMGLIVRLANH---GLIHGD 227 (465)
T ss_pred HHHcCCCCCCcccccc--------eeeHHHhhcccceeeeeec-----CChHH---HHHHHHHHHHHHHHc---Cceecc
Confidence 83 33 3555555432 2899999999888765432 22232 333444444555566 999999
Q ss_pred CCCCceEeCCCCCeeEeeeccccc
Q 014363 220 FKSSNILLDEQWNAKLSDFGLARL 243 (426)
Q Consensus 220 lkp~NILl~~~~~~kl~DFGla~~ 243 (426)
..-=||++++++.++++||--+..
T Consensus 228 FNEFNimv~dd~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 228 FNEFNIMVKDDDKIVVIDFPQMVS 251 (465)
T ss_pred cchheeEEecCCCEEEeechHhhc
Confidence 999999999999999999976543
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.0023 Score=59.82 Aligned_cols=30 Identities=27% Similarity=0.450 Sum_probs=25.5
Q ss_pred CeEeccCCCCceEeCCCCC-eeEeeeccccc
Q 014363 214 QIIVRDFKSSNILLDEQWN-AKLSDFGLARL 243 (426)
Q Consensus 214 ~iiHrDlkp~NILl~~~~~-~kl~DFGla~~ 243 (426)
.++|+|+.|.|||+++++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 5899999999999997555 46999998864
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.0031 Score=59.89 Aligned_cols=103 Identities=19% Similarity=0.225 Sum_probs=71.1
Q ss_pred ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccc
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 241 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 241 (426)
...|++|++- |++|...- ...++++..++++.+..+.-+..+ ...-|||+.-.||||+ +|+|-|+||-++
T Consensus 299 ~y~yl~~kdh-gt~is~ik------~~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId-~GnvtLIDfkls 368 (488)
T COG5072 299 LYLYLHFKDH-GTPISIIK------ADRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID-EGNVTLIDFKLS 368 (488)
T ss_pred eEEEEEEecC-Cceeeeee------cccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee-cCceEEEEeeee
Confidence 3557788876 66664322 256788999999988888777764 6899999999999999 899999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHH
Q 014363 242 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSY 282 (426)
Q Consensus 242 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl 282 (426)
+.....+. .-....--|-.+.| .-+..-|||-+
T Consensus 369 Rl~~~q~~-------isy~rldhp~lF~G-~dd~QFeIYrl 401 (488)
T COG5072 369 RLSYSQGI-------ISYNRLDHPDLFNG-VDDYQFEIYRL 401 (488)
T ss_pred ecccCCce-------eeccccCchhhhcC-ccceeeeHHHH
Confidence 85433221 11222334544543 33556677654
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.013 Score=57.34 Aligned_cols=78 Identities=14% Similarity=0.097 Sum_probs=51.3
Q ss_pred cceecccCcEEEEEEEEcCCCCCCcceEEEEEEcc-----cc----CCHHHHHHHHHHHhhcC---CCCccceEeEEEcc
Q 014363 90 SVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLG-----RR----GGHKEWMTEVNFLGIVE---HQNLVKLVGYCADD 157 (426)
Q Consensus 90 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~-----~~----~~~~~~~~E~~~l~~l~---HpnIv~~~~~~~~~ 157 (426)
.+.||.|..-.||+..... + .+.||+-. .. ....+-..|+..|..+. ..++.++|.++.+.
T Consensus 37 ~~eiggGn~N~VyrV~~~~-~------svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~ 109 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSSS-G------SFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTM 109 (418)
T ss_pred EEEcCCCceeeEEEEEcCC-c------cEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCC
Confidence 4578999999999977532 1 47777654 11 13344456677776663 34788899888754
Q ss_pred CCCCceEEEEEeeCCC--CChhhhc
Q 014363 158 DERGIQRLLVYEYMPN--GSVDQYL 180 (426)
Q Consensus 158 ~~~~~~~~lv~E~~~~--g~L~~~l 180 (426)
. +++|||+++ ..+.+.+
T Consensus 110 ~------vlvME~L~~~~~ilr~~L 128 (418)
T PLN02756 110 A------LIGMRYLEPPHIILRKGL 128 (418)
T ss_pred C------EEEEeecCCcceehhhhh
Confidence 3 899999976 3454444
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.96 E-value=0.012 Score=56.65 Aligned_cols=71 Identities=14% Similarity=0.088 Sum_probs=44.9
Q ss_pred eecccCcEEEEEEEEcCCCCCCcceEEEEEEccc---------cCCHHHHHHHHHHHhhcC--CC-CccceEeEEEccCC
Q 014363 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGR---------RGGHKEWMTEVNFLGIVE--HQ-NLVKLVGYCADDDE 159 (426)
Q Consensus 92 ~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~---------~~~~~~~~~E~~~l~~l~--Hp-nIv~~~~~~~~~~~ 159 (426)
.||.|....||++...++. +.+.||+-.. .-...+...|...|+... -| .++++|.|-.+.
T Consensus 2 EigdGnlN~VfrV~~~~g~-----~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D~e~-- 74 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGD-----RAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFDTEM-- 74 (370)
T ss_pred cCCCCceEEEEEEEcCCCC-----eeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEcccc--
Confidence 4799999999999854321 2578886421 123345567888887662 34 466666543322
Q ss_pred CCceEEEEEeeCCC
Q 014363 160 RGIQRLLVYEYMPN 173 (426)
Q Consensus 160 ~~~~~~lv~E~~~~ 173 (426)
..+|||+++.
T Consensus 75 ----~~~vMEdL~~ 84 (370)
T TIGR01767 75 ----AVTVMEDLSH 84 (370)
T ss_pred ----ceehHhhCcc
Confidence 2689999854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.0021 Score=63.56 Aligned_cols=167 Identities=20% Similarity=0.272 Sum_probs=93.3
Q ss_pred CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHh
Q 014363 128 GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYL 207 (426)
Q Consensus 128 ~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~L 207 (426)
....+.-.+.+++.+.|+|+...+++.....+. ..+|||++ +.+|++++..+.. -.. ++ + -
T Consensus 25 ~s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r---~IVV~e~~-~~Sled~~~~~~l---~~~-------s~---~--~ 85 (725)
T KOG1093|consen 25 NSIQILGRFQYLKSLQHDNLCQYLDFSRGKHER---VIVVMEHY-TMSLEDILKTGNL---KDE-------SL---L--A 85 (725)
T ss_pred cHHHHhhhhHHHHhhcCccceeeEeeecCccce---EEEEehhh-ccchHHHHHhccc---chh-------hh---c--c
Confidence 445677788899999999999999887665543 47899999 7799998865431 111 11 0 1
Q ss_pred ccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHH
Q 014363 208 HEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLY 287 (426)
Q Consensus 208 H~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ 287 (426)
| ++.|-. .++++| -++... |- ...+|+|||++|.++.
T Consensus 86 ~-----~~~~~~------------~~~~td-~~~t~~--------------------~~-----~~~pKsdVwsl~~i~~ 122 (725)
T KOG1093|consen 86 H-----GVLHLN------------IIYITD-HFLTKY--------------------PS-----PIGPKSDVWSLGFIIL 122 (725)
T ss_pred c-----ccceeh------------hhhccc-cccccC--------------------CC-----CCCcchhhhhHHHHHH
Confidence 2 443322 234444 111100 00 1114999999999999
Q ss_pred HHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHH
Q 014363 288 ELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEV 362 (426)
Q Consensus 288 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei 362 (426)
++.-|..-+...........+.. +............ ...+...+...+.++...|+-..|..||...++
T Consensus 123 el~L~~~l~~~~~~s~~l~~i~k---~~~~d~~~~~~a~---e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~ 191 (725)
T KOG1093|consen 123 ELYLGISLEAELTESEYLEILLK---YYTDDQELLSTAM---EHLIQLLADKKRLPLLKKCLWLEPIIRPLPMEL 191 (725)
T ss_pred HHHHhhHHHHHHHHHHHHHHHHH---hccCchhHHHHHH---HHHHHHhhhHhHHHHhccCCccccccccchhHH
Confidence 99998765532221111111110 0000000000000 001223455677788889999999888865554
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.016 Score=56.15 Aligned_cols=142 Identities=15% Similarity=0.205 Sum_probs=78.5
Q ss_pred eecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC-HHHHHHHHHHHhhcCCCCc-cceEeEEEccCCCCceEEEEEe
Q 014363 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG-HKEWMTEVNFLGIVEHQNL-VKLVGYCADDDERGIQRLLVYE 169 (426)
Q Consensus 92 ~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~E~~~l~~l~HpnI-v~~~~~~~~~~~~~~~~~lv~E 169 (426)
.|-.|-.-.+|++....... .....+.+|....... .-.-.+|+.++..+..-++ .++++++.. ..|+|
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~-~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~--------g~v~e 113 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEG-NLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPN--------GRVEE 113 (344)
T ss_pred EcCCcccceeEEEEeCCCCC-CCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECC--------ceEEE
Confidence 45456777899986543211 1223677787654321 1123679999998854444 456665522 25899
Q ss_pred eCCCCChhhh-c----------------cCCC----CCccCHHHHHHHHHHH-----------------HHHHHH----h
Q 014363 170 YMPNGSVDQY-L----------------SPKS----ETILTWAMRLKIAQDA-----------------ARGLAY----L 207 (426)
Q Consensus 170 ~~~~g~L~~~-l----------------~~~~----~~~~~~~~~~~i~~~i-----------------~~aL~~----L 207 (426)
|+++.+|... + +... .....+..+..++.++ ...+.. +
T Consensus 114 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~ 193 (344)
T PLN02236 114 FIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKEL 193 (344)
T ss_pred eeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHh
Confidence 9987776421 0 1100 0011222222222111 111111 2
Q ss_pred cc-CCCCCeEeccCCCCceEeCC-CCCeeEeeecccc
Q 014363 208 HE-GMDFQIIVRDFKSSNILLDE-QWNAKLSDFGLAR 242 (426)
Q Consensus 208 H~-~~~~~iiHrDlkp~NILl~~-~~~~kl~DFGla~ 242 (426)
.. .....++|+|+++.|||+++ ++.+.|+||..+.
T Consensus 194 ~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 194 SGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred cccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 21 22347899999999999986 4679999998875
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.02 Score=54.31 Aligned_cols=108 Identities=23% Similarity=0.330 Sum_probs=68.0
Q ss_pred HHHHHHHHHHhhcCC--CCccceEeEEEccCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHH-HHHHHHHHH
Q 014363 130 KEWMTEVNFLGIVEH--QNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIA-QDAARGLAY 206 (426)
Q Consensus 130 ~~~~~E~~~l~~l~H--pnIv~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~-~~i~~aL~~ 206 (426)
....+|+.+|+.+.- .-+...+++|.+.. .+ ..|.||+|++|..+.+.+.... .. ..++ ..++..|.-
T Consensus 66 ~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~-~g-~pf~v~~~veGe~~~~~~~~~~---~~----~~~~~~~l~~~La~ 136 (321)
T COG3173 66 HDEKREYRVIAALLDVDVPVPRAFGLCGEGY-LG-TPFYVMEWVEGEVVWSALPPES---LG----RQFALDALADFLAE 136 (321)
T ss_pred hHHHhHHHHHHHhcCCCCCCcccccccccCC-CC-CceEEEEEecceeccCcCCccc---ch----HHHHHHHHHHHHHH
Confidence 455678888888732 33455677777665 22 3489999998854443332111 00 0111 233444444
Q ss_pred hc--------------------------------------------------cC-----CCCCeEeccCCCCceEeCCCC
Q 014363 207 LH--------------------------------------------------EG-----MDFQIIVRDFKSSNILLDEQW 231 (426)
Q Consensus 207 LH--------------------------------------------------~~-----~~~~iiHrDlkp~NILl~~~~ 231 (426)
|| .+ ....++|+|+.+.||+++.++
T Consensus 137 LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~ 216 (321)
T COG3173 137 LHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGR 216 (321)
T ss_pred HhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCC
Confidence 44 21 134699999999999999998
Q ss_pred CeeEeeecccccCCC
Q 014363 232 NAKLSDFGLARLGPS 246 (426)
Q Consensus 232 ~~kl~DFGla~~~~~ 246 (426)
-+-+.||+++...+.
T Consensus 217 ~~gVlDwe~~~lGDP 231 (321)
T COG3173 217 PTGVLDWELATLGDP 231 (321)
T ss_pred eeEEEeccccccCCc
Confidence 899999999976543
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.78 E-value=0.0084 Score=56.26 Aligned_cols=76 Identities=17% Similarity=0.235 Sum_probs=46.1
Q ss_pred CCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhcC---CCCccceEeEEEccCCCCce
Q 014363 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVE---HQNLVKLVGYCADDDERGIQ 163 (426)
Q Consensus 87 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l~---HpnIv~~~~~~~~~~~~~~~ 163 (426)
.+..+.++.|....+|+.. ..+ ..+.+|... ......|..|+.-|+.|. --.+.+++++....+..
T Consensus 19 i~~~~~v~GG~i~~a~~~~--~~~-----~~~FvK~~~-~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~--- 87 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD--TDG-----GSYFVKVNS-ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDA--- 87 (288)
T ss_dssp --EEEEE--SSSSEEEEEE--TTS------EEEEEEEE-GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCC---
T ss_pred eeeeEecCCCChhheEEEE--CCC-----ccEEEEecC-hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCc---
Confidence 3445678989999999876 222 267888766 444567889999888883 34577888888765544
Q ss_pred EEEEEeeCCCC
Q 014363 164 RLLVYEYMPNG 174 (426)
Q Consensus 164 ~~lv~E~~~~g 174 (426)
||||||++.+
T Consensus 88 -fLlle~l~~~ 97 (288)
T PF03881_consen 88 -FLLLEFLEMG 97 (288)
T ss_dssp -EEEEE-----
T ss_pred -eEEEEeecCC
Confidence 8999999776
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.66 E-value=0.042 Score=52.56 Aligned_cols=142 Identities=17% Similarity=0.218 Sum_probs=80.1
Q ss_pred ecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhcC-C--CC---ccceEeEEEccCCCCceEEE
Q 014363 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVE-H--QN---LVKLVGYCADDDERGIQRLL 166 (426)
Q Consensus 93 lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l~-H--pn---Iv~~~~~~~~~~~~~~~~~l 166 (426)
|.+ .-..||+....++ .+.+|.........++..|+..|..|. + += |..+=|-....-..+...+-
T Consensus 34 l~s-~eN~~f~~~~~~g-------~~iLki~~~~~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~ 105 (331)
T COG2334 34 LNS-EENSNFRVQTEDG-------RYILKIYRPGWTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAA 105 (331)
T ss_pred ccc-ccCceEEEEecCC-------CeEEEEecCCCCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEE
Confidence 444 4456888776554 347787766556677888888888883 2 11 22221111111011124588
Q ss_pred EEeeCCCCChhh-hc------------------cC----C--CCCccCHHH-------------HHHHHHHHHHHHHHhc
Q 014363 167 VYEYMPNGSVDQ-YL------------------SP----K--SETILTWAM-------------RLKIAQDAARGLAYLH 208 (426)
Q Consensus 167 v~E~~~~g~L~~-~l------------------~~----~--~~~~~~~~~-------------~~~i~~~i~~aL~~LH 208 (426)
|++|++|..+.. .- .. + ......|.. ......++...+..+.
T Consensus 106 lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~ 185 (331)
T COG2334 106 LFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLL 185 (331)
T ss_pred EEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHH
Confidence 999999988873 11 00 0 001223320 0112233333344333
Q ss_pred cC----CCC-C--eEeccCCCCceEeCCCCC-eeEeeecccc
Q 014363 209 EG----MDF-Q--IIVRDFKSSNILLDEQWN-AKLSDFGLAR 242 (426)
Q Consensus 209 ~~----~~~-~--iiHrDlkp~NILl~~~~~-~kl~DFGla~ 242 (426)
+. ... + +||+|+.|.|||++.+.. +.++|||-+.
T Consensus 186 ~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 186 ARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 22 122 3 999999999999999875 8999999775
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.65 E-value=0.0041 Score=55.66 Aligned_cols=30 Identities=30% Similarity=0.452 Sum_probs=21.5
Q ss_pred CCeEeccCCCCceEe-CCCCCeeEeeecccc
Q 014363 213 FQIIVRDFKSSNILL-DEQWNAKLSDFGLAR 242 (426)
Q Consensus 213 ~~iiHrDlkp~NILl-~~~~~~kl~DFGla~ 242 (426)
..++|+||.+.|||+ +.++.++|+||..|.
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 368999999999999 888999999998875
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.41 E-value=0.036 Score=52.94 Aligned_cols=135 Identities=16% Similarity=0.157 Sum_probs=87.5
Q ss_pred eecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc------------------------CCHHH----HHHHHHHHhhcC
Q 014363 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR------------------------GGHKE----WMTEVNFLGIVE 143 (426)
Q Consensus 92 ~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~------------------------~~~~~----~~~E~~~l~~l~ 143 (426)
.|..|--+.||.|...++. .+|||+.+.. ...+. ...|++-|.+|+
T Consensus 151 CiSTGKEANVYHat~~dG~------~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~ 224 (520)
T KOG2270|consen 151 CISTGKEANVYHATEEDGS------EFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLN 224 (520)
T ss_pred ccccCccceeEeeecCCCc------eEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHH
Confidence 5677888899998866654 5788865311 01111 246888888886
Q ss_pred CCCccceEeEEEccCCCCceEEEEEeeCCCCCh-hhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCC
Q 014363 144 HQNLVKLVGYCADDDERGIQRLLVYEYMPNGSV-DQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKS 222 (426)
Q Consensus 144 HpnIv~~~~~~~~~~~~~~~~~lv~E~~~~g~L-~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp 222 (426)
...|.----+..... +|||+|+....- .-.|. .-.++...+..+-.|++.-+.-|-..| ++||.||.-
T Consensus 225 ~aGIP~PePIlLk~h------VLVM~FlGrdgw~aPkLK---d~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSE 293 (520)
T KOG2270|consen 225 NAGIPCPEPILLKNH------VLVMEFLGRDGWAAPKLK---DASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSE 293 (520)
T ss_pred hcCCCCCCceeeecc------eEeeeeccCCCCcCcccc---cccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhh
Confidence 554432211122221 799999942111 11121 223666777788888888888887664 899999999
Q ss_pred CceEeCCCCCeeEeeecccccC
Q 014363 223 SNILLDEQWNAKLSDFGLARLG 244 (426)
Q Consensus 223 ~NILl~~~~~~kl~DFGla~~~ 244 (426)
-|+|+-+ |.+.|+|.+-+...
T Consensus 294 fN~Lyhd-G~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 294 FNLLYHD-GKLYIIDVSQSVEH 314 (520)
T ss_pred hhheEEC-CEEEEEEccccccC
Confidence 9999875 58999999877643
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.38 E-value=0.033 Score=52.97 Aligned_cols=30 Identities=23% Similarity=0.281 Sum_probs=26.1
Q ss_pred CCCeEeccCCCCceEeCCCCCeeEeeecccc
Q 014363 212 DFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 242 (426)
Q Consensus 212 ~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 242 (426)
..+++|+|+.+.|||++. +.+.|+||+.+.
T Consensus 186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 358999999999999988 678999998764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.30 E-value=0.027 Score=53.67 Aligned_cols=32 Identities=19% Similarity=0.252 Sum_probs=28.6
Q ss_pred CCCeEeccCCCCceEeCCCCCeeEeeeccccc
Q 014363 212 DFQIIVRDFKSSNILLDEQWNAKLSDFGLARL 243 (426)
Q Consensus 212 ~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 243 (426)
..+++|+|+.++|||+++++.+.|+||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 45899999999999999999999999988764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.28 E-value=0.037 Score=54.26 Aligned_cols=80 Identities=15% Similarity=0.222 Sum_probs=45.9
Q ss_pred cceecccCcEEEEEEEEcCCC-CCCcceEEEEEEccccC-CHHHHHHHHHHHhhcCCCCc-cceEeEEEccCCCCceEEE
Q 014363 90 SVVIGEGGFGCVYKGLIKNSE-DPSQKVEVAVKQLGRRG-GHKEWMTEVNFLGIVEHQNL-VKLVGYCADDDERGIQRLL 166 (426)
Q Consensus 90 ~~~lG~G~~g~Vy~~~~~~~~-~~~~~~~va~K~~~~~~-~~~~~~~E~~~l~~l~HpnI-v~~~~~~~~~~~~~~~~~l 166 (426)
++.|..|-...+|++...... .....+.|.+....... -.-.-.+|+.++..+...++ .++++.+.. ++
T Consensus 55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~--------g~ 126 (383)
T PTZ00384 55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD--------FT 126 (383)
T ss_pred EEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC--------EE
Confidence 345656888889998754332 11111224444322211 01122578999999965544 555655532 68
Q ss_pred EEeeCCCCChh
Q 014363 167 VYEYMPNGSVD 177 (426)
Q Consensus 167 v~E~~~~g~L~ 177 (426)
|.||++|..|.
T Consensus 127 l~efIeGr~l~ 137 (383)
T PTZ00384 127 IQEWVEGNTMG 137 (383)
T ss_pred EEEEeccccCC
Confidence 99999987764
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.24 E-value=0.064 Score=59.39 Aligned_cols=145 Identities=17% Similarity=0.218 Sum_probs=78.1
Q ss_pred ceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhc--CCCC--ccceEe------EEE-ccCC
Q 014363 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIV--EHQN--LVKLVG------YCA-DDDE 159 (426)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l--~Hpn--Iv~~~~------~~~-~~~~ 159 (426)
+.|+ |..-.+|+....+.. .+.+|+.+..........|...|..| +++. +.+++- +.. ....
T Consensus 31 ~~L~-s~~d~nf~v~~~~g~------~yVLKi~~~~~~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~ 103 (1013)
T PRK06148 31 TPLD-GERDLNFRLTTDDGA------DYILKIVNPSEPRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPD 103 (1013)
T ss_pred eecC-CcCCceEEEEeCCCC------eEEEEEcCCccchhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCC
Confidence 4554 345678887644322 68889887655445555666677655 2222 223221 111 1111
Q ss_pred CCceEEEEEeeCCCCChhhhcc-------------------------CCCCCccCHHH-----------------HHHHH
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLS-------------------------PKSETILTWAM-----------------RLKIA 197 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~-------------------------~~~~~~~~~~~-----------------~~~i~ 197 (426)
.....+-+++|++|..|.+... ......+.|.. ...++
T Consensus 104 G~~~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l 183 (1013)
T PRK06148 104 GEPRLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALV 183 (1013)
T ss_pred CceEEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHH
Confidence 1224567899999987765211 00001122211 11222
Q ss_pred HHHHHHHH-----HhccCCCCCeEeccCCCCceEeCCCC--Cee-Eeeeccccc
Q 014363 198 QDAARGLA-----YLHEGMDFQIIVRDFKSSNILLDEQW--NAK-LSDFGLARL 243 (426)
Q Consensus 198 ~~i~~aL~-----~LH~~~~~~iiHrDlkp~NILl~~~~--~~k-l~DFGla~~ 243 (426)
.++++... .+. ....++||+|+.+.|||++.++ ++. |+|||.+..
T Consensus 184 ~~~~~~~~~~v~p~l~-~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 184 ERFLARFERNVAPRLA-ALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred HHHHHHHHHHHHHHHh-cCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 23333222 122 2245899999999999999875 555 999998753
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.23 E-value=0.035 Score=54.18 Aligned_cols=73 Identities=21% Similarity=0.250 Sum_probs=47.4
Q ss_pred cceecccCcEEEEEEEEcCCCCCCcceEEEEEEccc--------cCCHHHHHHHHHHHhhcC--CC-CccceEeEEEccC
Q 014363 90 SVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGR--------RGGHKEWMTEVNFLGIVE--HQ-NLVKLVGYCADDD 158 (426)
Q Consensus 90 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~--------~~~~~~~~~E~~~l~~l~--Hp-nIv~~~~~~~~~~ 158 (426)
.+.||-|.-.-||++...... ..|.||+-.. .-..++..-|.++|+.+. -| .++++|.|-.+..
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~-----~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D~e~~ 108 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKN-----ISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFDSVMN 108 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCC-----ceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEECcHHh
Confidence 457899999999999864211 2578886421 123456677888888762 34 5666765533322
Q ss_pred CCCceEEEEEeeCCC
Q 014363 159 ERGIQRLLVYEYMPN 173 (426)
Q Consensus 159 ~~~~~~~lv~E~~~~ 173 (426)
.+|||+++.
T Consensus 109 ------~~vMEdL~~ 117 (409)
T PRK12396 109 ------CCVMEDLSD 117 (409)
T ss_pred ------hHHHHhCcc
Confidence 689999854
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.97 E-value=0.09 Score=50.58 Aligned_cols=142 Identities=16% Similarity=0.223 Sum_probs=76.2
Q ss_pred eecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC-HHHHHHHHHHHhhcCCCCc-cceEeEEEccCCCCceEEEEEe
Q 014363 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG-HKEWMTEVNFLGIVEHQNL-VKLVGYCADDDERGIQRLLVYE 169 (426)
Q Consensus 92 ~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~E~~~l~~l~HpnI-v~~~~~~~~~~~~~~~~~lv~E 169 (426)
.|..|=.-.+|+....+... ....+.++....... .-.-.+|..+++.+..-++ .++++++. . -+|.+
T Consensus 21 ~l~gGlTN~~~~v~~~~~~~--~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~-------G~i~~ 90 (330)
T PLN02421 21 RISGGITNLLLKVSVKEENG--NEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVFG-N-------GMIQS 90 (330)
T ss_pred EeCCcccceEEEEEecCCCC--CCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEeC-C-------cEeeh
Confidence 45456666788876543211 112567776654321 1123579999999865554 45665552 1 25899
Q ss_pred eCCCCChhh--h-----c----------cCCC----CCccCHHHHHHHHHHH-------------------------HHH
Q 014363 170 YMPNGSVDQ--Y-----L----------SPKS----ETILTWAMRLKIAQDA-------------------------ARG 203 (426)
Q Consensus 170 ~~~~g~L~~--~-----l----------~~~~----~~~~~~~~~~~i~~~i-------------------------~~a 203 (426)
|++|..|.. + + +... ...-.+..+..+..++ +..
T Consensus 91 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (330)
T PLN02421 91 FINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVE 170 (330)
T ss_pred hhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHH
Confidence 998766532 1 1 1100 0011122222222221 111
Q ss_pred HHHhc-c-CCCCCeEeccCCCCceEeCC-CCCeeEeeeccccc
Q 014363 204 LAYLH-E-GMDFQIIVRDFKSSNILLDE-QWNAKLSDFGLARL 243 (426)
Q Consensus 204 L~~LH-~-~~~~~iiHrDlkp~NILl~~-~~~~kl~DFGla~~ 243 (426)
+..+. . ..+.-++|+|+.+.|||+++ ++.++++||..|..
T Consensus 171 l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 171 LKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 11111 1 11234799999999999975 57899999988753
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.82 E-value=0.063 Score=48.01 Aligned_cols=56 Identities=27% Similarity=0.377 Sum_probs=38.5
Q ss_pred EEEEEEccccCCHHHHHHHHHHHhhcC---CCCccceEeEEEccCCCCceEEEEEeeCCCCChh
Q 014363 117 EVAVKQLGRRGGHKEWMTEVNFLGIVE---HQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVD 177 (426)
Q Consensus 117 ~va~K~~~~~~~~~~~~~E~~~l~~l~---HpnIv~~~~~~~~~~~~~~~~~lv~E~~~~g~L~ 177 (426)
.+-+|.-.. .....|..|+.-|..|. --++.+++.+-.+.+. .|+||||++-+.+.
T Consensus 41 ~~FvK~n~~-~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~----sylVle~L~~~~~d 99 (286)
T COG3001 41 PFFVKCNQR-EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDH----SYLVLEYLPTGPLD 99 (286)
T ss_pred ceEEEecch-hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCe----eEEEEeeccCCCCC
Confidence 577776433 23456788888887774 3457777766655553 49999999887775
|
|
| >PRK06149 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.63 E-value=0.41 Score=53.01 Aligned_cols=162 Identities=15% Similarity=0.185 Sum_probs=85.8
Q ss_pred ccCHHHHHHHh-CCCCCc---ceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhcCC----C
Q 014363 74 EFTIAELKSAT-KNFSRS---VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEH----Q 145 (426)
Q Consensus 74 ~~~~~~~~~~~-~~y~~~---~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l~H----p 145 (426)
.++..++.... ..|.+. ..|+.+. -.+|+....+ + .+.+|+.........+..|..+|..|.. -
T Consensus 16 ~ls~~~~~~ll~~~ygl~~~~~~L~s~~-d~nf~v~t~~-~------~yVLKi~~~~~~~~~l~~e~~~l~hL~~~~~gl 87 (972)
T PRK06149 16 DVSEAQAERILAEHYGLSGTLTELGSQQ-DRNFRVDSDG-G------RFVLKICHAAYAAVELEAQHAALRHLAEREPAL 87 (972)
T ss_pred CCCHHHHHHHHHHhcCCceEEEecCCcC-cceEEEEecC-C------cEEEEeCCccCChHHHHHHHHHHHHHHhhCCCC
Confidence 35666666655 466652 4555333 3678765432 1 5788888755555667778888877731 1
Q ss_pred CccceEe------EEEccCCCCceEEEEEeeCCCCChhhh--cc-----------------------CCCCCccCHHH--
Q 014363 146 NLVKLVG------YCADDDERGIQRLLVYEYMPNGSVDQY--LS-----------------------PKSETILTWAM-- 192 (426)
Q Consensus 146 nIv~~~~------~~~~~~~~~~~~~lv~E~~~~g~L~~~--l~-----------------------~~~~~~~~~~~-- 192 (426)
.+.+++- +...........+-+++|++|..+.+. +. ......+.|..
T Consensus 88 pvp~pi~t~~G~~~~~~~~~g~~~~vrL~~~l~G~~~~~~~~~~~~~~~~lG~~lArlh~al~~f~hp~~~r~~~Wdl~~ 167 (972)
T PRK06149 88 RVPVVIPALDGEELLTLDVRGQGLRVRLLDYLPGQPLTRLGHLAPASVAGLGALCARVARALADFDHPGLDRTLQWDLRH 167 (972)
T ss_pred CCceeeECCCCCeEEEEecCCceEEEEEEEecCCccccccCCCCHHHHHHHHHHHHHHHHHHcCCCCCCCCCccccchhh
Confidence 2223321 111111112245779999998666431 10 00001132321
Q ss_pred ----------------HHHHHHHHH----HHHHHhccCCCCCeEeccCCCCceEeCCCC--C---eeEeeeccccc
Q 014363 193 ----------------RLKIAQDAA----RGLAYLHEGMDFQIIVRDFKSSNILLDEQW--N---AKLSDFGLARL 243 (426)
Q Consensus 193 ----------------~~~i~~~i~----~aL~~LH~~~~~~iiHrDlkp~NILl~~~~--~---~kl~DFGla~~ 243 (426)
...++.+++ ..+.-+-.....++||+|+.+.|||++.+. . .-|+|||.+..
T Consensus 168 ~~~~~~~ll~~i~d~~~r~~l~~~~~~~~~~l~~~~~~L~~g~IH~Dl~~~Nilv~~~~~~~~~v~giIDFgD~~~ 243 (972)
T PRK06149 168 AGPVVAHLLSHITDPAQRARIAEATRDAARRLQPLAPALPLQAVHLDITDDNVVGSRDADGRWQPDGVIDFGDLVR 243 (972)
T ss_pred hHHHHHHHHhhcCCHHHHHHHHHHHHHHHHHhhhhhhhCcccccCCCCCcccEEEcCCCCCCcceeEEEEcccchh
Confidence 011111211 112111112256899999999999998653 3 37999998753
|
|
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=95.54 E-value=0.18 Score=47.49 Aligned_cols=29 Identities=38% Similarity=0.471 Sum_probs=24.3
Q ss_pred CeEeccCCCCceEeCCC--C---CeeEeeecccc
Q 014363 214 QIIVRDFKSSNILLDEQ--W---NAKLSDFGLAR 242 (426)
Q Consensus 214 ~iiHrDlkp~NILl~~~--~---~~kl~DFGla~ 242 (426)
-++|||++..|||+..+ | .+++.||-+++
T Consensus 216 vl~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~ 249 (294)
T PF02958_consen 216 VLCHGDFWTNNILFKYDDDGKPIDVVLIDFQLAR 249 (294)
T ss_pred EEEcCccCHHhEeEccccccccccceeecccccc
Confidence 58999999999999654 3 58999998775
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.32 E-value=0.045 Score=53.00 Aligned_cols=59 Identities=24% Similarity=0.202 Sum_probs=44.1
Q ss_pred EEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeC
Q 014363 165 LLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLD 228 (426)
Q Consensus 165 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~ 228 (426)
.|+-+|.+|.++..++...+ .+++.+.+++.-.+.||.-+--- -+.+|.|+.|.||++.
T Consensus 321 vl~E~~~~Gl~v~~~v~~~~---~pe~l~kkva~lg~~AllkMl~v--DNFvHaDlHPGNVlir 379 (565)
T KOG1236|consen 321 VLVETYERGLSVLRFVKWKS---QPEALVKKVAKLGVNALLKMLIV--DNFVHADLHPGNVLIR 379 (565)
T ss_pred eeeeeccccccHHhhhhccc---ChHHHHHHHHHHHHHHHHHHHHh--hcceecccCCCcEEEE
Confidence 67788999999999997654 45566667777666676543321 1899999999999994
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 426 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-58 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-57 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 9e-46 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 5e-45 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-43 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-43 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-42 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-39 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 6e-22 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 8e-22 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-21 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-21 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-21 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 9e-21 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-20 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-20 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-20 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-20 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-20 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-20 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-20 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-20 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-20 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-20 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-20 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-20 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-20 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-20 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-20 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-20 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-20 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-20 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-20 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-20 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-20 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-20 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-20 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 6e-20 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 8e-20 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 9e-20 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 9e-20 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-19 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-19 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-19 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-19 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-19 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-19 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-19 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-19 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-19 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-19 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-19 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-19 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-19 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-19 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-19 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-19 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-19 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-19 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-19 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-19 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-19 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-19 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-19 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-19 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-19 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-19 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-19 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 5e-19 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-18 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-18 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-18 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-18 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-18 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-18 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-18 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-18 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-18 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-18 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-18 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-18 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-18 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-18 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-18 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-18 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-18 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-18 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-18 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 6e-18 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 6e-18 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 6e-18 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 6e-18 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 7e-18 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 7e-18 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 7e-18 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 8e-18 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 8e-18 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 8e-18 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 8e-18 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-18 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-18 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 9e-18 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-18 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 9e-18 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-17 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-17 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-17 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-17 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-17 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-17 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-17 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-17 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-17 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-17 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-17 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-17 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-17 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-17 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-17 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-17 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-17 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-17 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-17 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-17 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-17 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-17 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-17 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-17 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-17 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-17 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-17 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-17 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-17 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-17 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-17 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-17 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-17 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-17 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-17 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-17 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-17 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-17 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-17 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-17 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 5e-17 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-17 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-17 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 5e-17 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-17 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 5e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 6e-17 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 6e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-17 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 6e-17 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 6e-17 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 6e-17 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 6e-17 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 7e-17 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 7e-17 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 7e-17 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-17 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 7e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 8e-17 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 8e-17 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 8e-17 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 8e-17 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 8e-17 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 9e-17 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 9e-17 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 9e-17 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 9e-17 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-16 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-16 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-16 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-16 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-16 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-16 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-16 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-16 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-16 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-16 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-16 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-16 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-16 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-16 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-16 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-16 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-16 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-16 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-16 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-16 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-16 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-16 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-16 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-16 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-16 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-16 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-16 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-16 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-16 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-16 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-16 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-16 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-16 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-16 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-16 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-16 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-16 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-16 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-16 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-16 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-16 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-16 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-16 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-16 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-16 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-16 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-16 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-16 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-16 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-16 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-16 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-16 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-16 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-16 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-16 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-16 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-16 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-16 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-16 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-16 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-16 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-16 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-16 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-16 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 6e-16 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 6e-16 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 6e-16 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-16 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 8e-16 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 8e-16 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 9e-16 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 9e-16 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-15 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-15 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-15 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-15 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-15 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-15 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-15 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-15 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-15 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-15 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-15 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-15 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-15 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-15 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-15 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-15 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-15 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-15 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-15 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-15 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-15 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-15 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-15 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-15 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-15 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-15 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-15 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-15 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-15 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-15 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-15 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-15 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-15 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-15 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-15 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-15 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-15 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-15 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-15 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-15 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-15 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 5e-15 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 5e-15 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 5e-15 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-15 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 5e-15 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 6e-15 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 6e-15 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 7e-15 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-15 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 8e-15 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 8e-15 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 8e-15 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 8e-15 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-15 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 9e-15 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 9e-15 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 9e-15 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-14 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-14 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-14 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-14 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-14 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-14 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-14 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-14 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-14 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-14 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-14 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-14 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-14 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-14 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-14 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-14 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-14 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-14 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-14 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-14 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-14 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 5e-14 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-14 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-14 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 6e-14 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 6e-14 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-14 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 6e-14 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 6e-14 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 6e-14 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 6e-14 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-14 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 6e-14 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 7e-14 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 7e-14 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 8e-14 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 8e-14 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 8e-14 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 8e-14 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 9e-14 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 9e-14 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 9e-14 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 9e-14 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-13 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-13 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-13 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-13 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-13 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-13 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-13 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-13 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-13 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-13 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-13 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-13 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-13 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-13 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-13 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-13 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-13 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-13 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-13 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-13 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-13 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-13 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-13 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-13 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-13 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-13 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-13 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-13 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-13 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-13 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-13 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-13 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-13 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-13 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-13 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-13 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-13 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-13 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-13 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-13 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-13 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-13 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-13 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-13 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-13 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-13 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-13 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-13 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-13 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-13 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-13 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-13 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-13 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-13 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 5e-13 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 5e-13 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 5e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-13 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 6e-13 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 6e-13 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 7e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 7e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 7e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 7e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-13 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 9e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 9e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 9e-13 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 9e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 9e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-13 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 9e-13 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-13 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-12 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-12 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-12 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-12 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-12 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-12 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-12 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-12 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-12 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-12 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-12 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-12 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-12 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-12 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-12 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-12 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-12 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-12 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-12 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-12 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-12 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-12 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-12 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-12 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-12 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-12 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-12 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-12 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-12 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-12 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-12 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-12 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-12 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-12 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-12 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-12 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-12 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-12 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-12 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-12 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-12 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-12 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-12 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-12 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-12 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-12 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-12 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-12 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-12 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-12 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-12 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-12 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-12 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-12 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-12 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-12 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-12 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-12 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-12 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-12 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-12 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-12 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-12 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 5e-12 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 5e-12 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 5e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-12 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 5e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-12 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 6e-12 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-12 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 6e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 6e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 7e-12 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-12 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-12 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 8e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 8e-12 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 8e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-12 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 8e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 9e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 9e-12 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 9e-12 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-12 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-12 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 9e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 9e-12 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 9e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 9e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 9e-12 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 9e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 9e-12 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 9e-12 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-11 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-11 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-11 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-11 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-11 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-11 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-11 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-11 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-11 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-11 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-11 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-11 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-11 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-11 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-11 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-11 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-11 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-11 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-11 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-11 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-11 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-11 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-11 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-11 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-11 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-11 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-11 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 4e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-11 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-11 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 6e-11 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 6e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 7e-11 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 7e-11 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 7e-11 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 7e-11 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 8e-11 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 8e-11 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 8e-11 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 8e-11 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 8e-11 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 9e-11 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-10 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-10 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-10 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-10 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-10 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-10 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-10 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-10 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-10 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-10 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-10 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-10 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-10 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-10 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-10 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-10 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-10 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-10 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-10 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-10 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-10 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-10 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-10 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-10 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-10 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-10 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-10 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-10 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-10 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-10 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-10 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-10 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-10 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-10 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-10 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-10 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-10 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-10 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-10 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-10 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-10 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-10 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-10 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-10 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 5e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-10 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-10 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-10 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-10 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 5e-10 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-10 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-10 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-10 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 6e-10 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 6e-10 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 6e-10 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 6e-10 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 6e-10 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 6e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 6e-10 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 6e-10 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 6e-10 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 6e-10 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 6e-10 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 6e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 7e-10 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 7e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 7e-10 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-10 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 7e-10 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 7e-10 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 7e-10 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 7e-10 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 7e-10 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 7e-10 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 7e-10 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 7e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 7e-10 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 7e-10 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 7e-10 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 7e-10 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 7e-10 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 7e-10 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 8e-10 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 8e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 8e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-10 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 8e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-10 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 8e-10 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 8e-10 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 8e-10 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 8e-10 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-10 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 8e-10 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 8e-10 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 8e-10 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 8e-10 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 8e-10 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 8e-10 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 8e-10 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 9e-10 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 9e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 9e-10 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 9e-10 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-10 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-09 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-09 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-09 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-09 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-09 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-09 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-09 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-09 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-09 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-09 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-09 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-09 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-09 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-09 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-09 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-09 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-09 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-09 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-09 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-09 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-09 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-09 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-09 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 4e-09 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-09 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-09 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-09 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-09 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-09 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-09 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-09 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 5e-09 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 5e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-09 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 5e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 6e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 6e-09 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 6e-09 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 6e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 6e-09 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 7e-09 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 7e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 7e-09 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 7e-09 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 7e-09 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 8e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 8e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 8e-09 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 8e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 9e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-08 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-08 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-08 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-08 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-08 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-08 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-08 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-08 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-08 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-08 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-08 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-08 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-08 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-08 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-08 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-08 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 4e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-08 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 4e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-08 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-08 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-08 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 5e-08 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 5e-08 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 5e-08 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 5e-08 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-08 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 5e-08 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 5e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-08 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 5e-08 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 5e-08 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-08 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-08 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 6e-08 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-08 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 6e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 6e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 6e-08 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 7e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 7e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 7e-08 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 8e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 8e-08 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 9e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-07 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-07 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-07 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-07 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-07 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-07 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-07 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-07 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-07 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-07 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-07 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-07 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-07 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-07 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-07 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-07 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-07 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-07 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-07 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-07 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 5e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-07 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 7e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 8e-07 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 9e-07 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-06 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-06 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-06 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-06 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-06 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-06 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-06 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-06 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-06 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-06 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-06 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-06 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-06 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-06 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-06 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 3e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-06 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-06 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-06 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 5e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 5e-06 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 5e-06 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-06 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 6e-06 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 6e-06 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 6e-06 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 7e-06 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 7e-06 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 8e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 8e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 8e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 9e-06 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 461 bits (1189), Expect = e-164
Identities = 111/322 (34%), Positives = 166/322 (51%), Gaps = 31/322 (9%)
Query: 64 SMSQRPSNLKEFTIAELKSATKNFSRSV------VIGEGGFGCVYKGLIKNSEDPSQKVE 117
S+ + F+ ELK+ T NF +GEGGFG VYKG + N+
Sbjct: 4 SLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTT------- 56
Query: 118 VAVKQLGRRG------GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYM 171
VAVK+L +++ E+ + +H+NLV+L+G+ +D D LVY YM
Sbjct: 57 VAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGD----DLCLVYVYM 112
Query: 172 PNGSVDQYL-SPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQ 230
PNGS+ L L+W MR KIAQ AA G+ +LHE I RD KS+NILLDE
Sbjct: 113 PNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEA 169
Query: 231 WNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELI 290
+ AK+SDFGLAR T +++ +VGT Y APE + G + +SD++S+GV L E+I
Sbjct: 170 FTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEII 228
Query: 291 TGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLV 350
TG +D +R Q LL + + K +D ++ V + VA+ CL
Sbjct: 229 TGLPAVDEHRE--PQLLLDIKEEIEDEEKTIEDYIDKKMND-ADSTSVEAMYSVASQCLH 285
Query: 351 KNARTRPKMSEVLEMVNKIVDA 372
+ RP + +V +++ ++ +
Sbjct: 286 EKKNKRPDIKKVQQLLQEMTAS 307
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 431 bits (1110), Expect = e-151
Identities = 113/311 (36%), Positives = 166/311 (53%), Gaps = 18/311 (5%)
Query: 59 RPSYPSMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEV 118
+ S P + +L+ AT NF +IG G FG VYKG++++ +V
Sbjct: 13 NDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGA------KV 66
Query: 119 AVKQLGRRG--GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSV 176
A+K+ G +E+ TE+ L H +LV L+G+C + + + +L+Y+YM NG++
Sbjct: 67 ALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN----EMILIYKYMENGNL 122
Query: 177 DQYL--SPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAK 234
++L S ++W RL+I AARGL YLH II RD KS NILLDE + K
Sbjct: 123 KRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPK 179
Query: 235 LSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRR 294
++DFG+++ G TH+ST V GT+GY PEY GRL +SDV+S+GV L+E++ R
Sbjct: 180 ITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARS 239
Query: 295 PIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNAR 354
I ++ PR L +W + Q QIVDP L K + K A CL ++
Sbjct: 240 AIVQSLPREMVNLAEWAVESH-NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSE 298
Query: 355 TRPKMSEVLEM 365
RP M +VL
Sbjct: 299 DRPSMGDVLWK 309
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 412 bits (1061), Expect = e-144
Identities = 135/302 (44%), Positives = 185/302 (61%), Gaps = 19/302 (6%)
Query: 71 NLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL---GRRG 127
LK F++ EL+ A+ NFS ++G GGFG VYKG + + VAVK+L +G
Sbjct: 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGT------LVAVKRLKEERTQG 69
Query: 128 GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYL--SPKSE 185
G ++ TEV + + H+NL++L G+C +RLLVY YM NGSV L P+S+
Sbjct: 70 GELQFQTEVEMISMAVHRNLLRLRGFCMTPT----ERLLVYPYMANGSVASCLRERPESQ 125
Query: 186 TILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGP 245
L W R +IA +ARGLAYLH+ D +II RD K++NILLDE++ A + DFGLA+L
Sbjct: 126 PPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 185
Query: 246 SEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQ 305
THV+TAV GT+G+ APEY+ TG+ + ++DV+ YGV L ELITG+R D R ++
Sbjct: 186 -YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD 244
Query: 306 K--LLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVL 363
LL WVK L + K+ +VD L+G Y V +L VA LC + RPKMSEV+
Sbjct: 245 DVMLLDWVKGLLKE-KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVV 303
Query: 364 EM 365
M
Sbjct: 304 RM 305
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 256 bits (655), Expect = 9e-83
Identities = 75/326 (23%), Positives = 124/326 (38%), Gaps = 32/326 (9%)
Query: 64 SMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL 123
S+ + L + V G FGCV+K + N VAVK
Sbjct: 3 HHHHHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEY-------VAVKIF 55
Query: 124 GRRGGHKEWM--TEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLS 181
+ W EV L ++H+N+++ +G + L+ + GS+ +L
Sbjct: 56 -PIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK 114
Query: 182 PKSETILTWAMRLKIAQDAARGLAYLHEGMDFQ-------IIVRDFKSSNILLDEQWNAK 234
+++W IA+ ARGLAYLHE + I RD KS N+LL A
Sbjct: 115 ---ANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTAC 171
Query: 235 LSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAA-----RSDVWSYGVFLYEL 289
++DFGLA + + VGT Y APE ++ R D+++ G+ L+EL
Sbjct: 172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWEL 231
Query: 290 ITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIV-----DPRLEGKY-SLRLVSKLSH 343
+ D + + + S +++V P L + ++ L
Sbjct: 232 ASRCTAADGPVDEYMLPFEEEIGQHPSLE-DMQEVVVHKKKRPVLRDYWQKHAGMAMLCE 290
Query: 344 VANLCLVKNARTRPKMSEVLEMVNKI 369
C +A R V E + ++
Sbjct: 291 TIEECWDHDAEARLSAGCVGERITQM 316
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 2e-63
Identities = 75/336 (22%), Positives = 127/336 (37%), Gaps = 41/336 (12%)
Query: 74 EFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWM 133
E +E N +IG G +G VYKG + VAVK + ++
Sbjct: 2 EAAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERP-------VAVKVF-SFANRQNFI 53
Query: 134 TEVN--FLGIVEHQNLVKLVGYCADDDERG-IQRLLVYEYMPNGSVDQYLSPKSETILTW 190
E N + ++EH N+ + + G ++ LLV EY PNGS+ +YLS + W
Sbjct: 54 NEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT---SDW 110
Query: 191 AMRLKIAQDAARGLAYLHEGMDF------QIIVRDFKSSNILLDEQWNAKLSDFGLAR-- 242
++A RGLAYLH + I RD S N+L+ +SDFGL+
Sbjct: 111 VSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRL 170
Query: 243 ----LGPSEGFTHVSTAVVGTMGYAAPEYVQ-------TGRLAARSDVWSYGVFLYELIT 291
L + + + VGT+ Y APE ++ + D+++ G+ +E+
Sbjct: 171 TGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM 230
Query: 292 GRRPIDRNRPRSEQKL-LQWVKPYLSDAKQFRQIVD-----PRLEGKYSL--RLVSKLSH 343
+ E ++ Q + + +V P+ + V L
Sbjct: 231 RCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKE 290
Query: 344 VANLCLVKNARTRPKMSEVLEMVNKIVDASAEAGSP 379
C ++A R E + +++ S
Sbjct: 291 TIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSV 326
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 7e-58
Identities = 75/291 (25%), Positives = 129/291 (44%), Gaps = 43/291 (14%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWM----TEVNFLGIVEHQNL 147
IG G FG V++ S+ VAVK L + H E + EV + + H N+
Sbjct: 44 KIGAGSFGTVHRAEWHGSD-------VAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 148 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYL-SPKSETILTWAMRLKIAQDAARGLAY 206
V +G I V EY+ GS+ + L + L RL +A D A+G+ Y
Sbjct: 97 VLFMGAVTQPPNLSI----VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNY 152
Query: 207 LHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPE 266
LH + I+ R+ KS N+L+D+++ K+ DFGL+RL S + S + GT + APE
Sbjct: 153 LH-NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS--SKSAAGTPEWMAPE 209
Query: 267 YVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVD 326
++ +SDV+S+GV L+EL T + +P+ Q+V
Sbjct: 210 VLRDEPSNEKSDVYSFGVILWELATLQ------------------QPW--GNLNPAQVVA 249
Query: 327 PRLEGKYSLRLVS----KLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 373
L + +++ + C RP + +++++ ++ ++
Sbjct: 250 AVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 2e-57
Identities = 76/312 (24%), Positives = 119/312 (38%), Gaps = 47/312 (15%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQNLVKLV 151
V+G G FG V K + + VA+KQ+ K ++ E+ L V H N+VKL
Sbjct: 15 VVGRGAFGVVCKAKWRAKD-------VAIKQIESESERKAFIVELRQLSRVNHPNIVKLY 67
Query: 152 GYCADDDERGIQRLLVYEYMPNGSVDQYL-SPKSETILTWAMRLKIAQDAARGLAYLHEG 210
G C + LV EY GS+ L + T A + ++G+AYLH
Sbjct: 68 GACLNP------VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121
Query: 211 MDFQIIVRDFKSSNILLDEQWN-AKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQ 269
+I RD K N+LL K+ DFG A T G+ + APE +
Sbjct: 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD-----IQTHMTNNKGSAAWMAPEVFE 176
Query: 270 TGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRL 329
+ + DV+S+G+ L+E+IT R+P D A + V
Sbjct: 177 GSNYSEKCDVFSWGIILWEVITRRKPFDE---------------IGGPAFRIMWAV---- 217
Query: 330 EGKYSLRLV------SKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASAEAGSPRRPL 383
R + + C K+ RP M E+++++ ++ A P +
Sbjct: 218 --HNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYP 275
Query: 384 RSSTSRETPDHT 395
+ D
Sbjct: 276 CQHSLPPGEDGR 287
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 4e-56
Identities = 63/291 (21%), Positives = 121/291 (41%), Gaps = 52/291 (17%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGH----KEWMTEVNFLGIVEHQNL 147
+ E G ++KG + ++ + VK L R +++ E L I H N+
Sbjct: 17 KLNENHSGELWKGRWQGND-------IVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNV 69
Query: 148 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYL 207
+ ++G C L+ +MP GS+ L + ++ + +K A D ARG+A+L
Sbjct: 70 LPVLGACQSPPAPHP--TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFL 127
Query: 208 HEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEY 267
H ++ I S ++++DE A++S + + S + + APE
Sbjct: 128 H-TLEPLIPRHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMYAPAWVAPEA 179
Query: 268 VQTGRLAA---RSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQI 324
+Q +D+WS+ V L+EL+T P + LS+ + ++
Sbjct: 180 LQKKPEDTNRRSADMWSFAVLLWELVTREVP--------------F--ADLSNMEIGMKV 223
Query: 325 VDPRLEGKYSLRLV------SKLSHVANLCLVKNARTRPKMSEVLEMVNKI 369
LEG LR +S + +C+ ++ RPK ++ ++ K+
Sbjct: 224 A---LEG---LRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 2e-55
Identities = 70/301 (23%), Positives = 127/301 (42%), Gaps = 62/301 (20%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGH---------KEWMTEVNFLGIV 142
IG+GGFG V+KG + K VA+K L +E+ EV + +
Sbjct: 26 QIGKGGFGLVHKGRLV-----KDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL 80
Query: 143 EHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAAR 202
H N+VKL G + +V E++P G + L + W+++L++ D A
Sbjct: 81 NHPNIVKLYGLMHN------PPRMVMEFVPCGDLYHRLL-DKAHPIKWSVKLRLMLDIAL 133
Query: 203 GLAYLHEGMDFQIIVRDFKSSNILLDEQW-----NAKLSDFGLARLGPSEGFTHVSTAVV 257
G+ Y+ + I+ RD +S NI L AK++DFGL++ H + ++
Sbjct: 134 GIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-----SVHSVSGLL 187
Query: 258 GTMGYAAPEYVQTGRLAA---RSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPY 314
G + APE + ++D +S+ + LY ++TG P +
Sbjct: 188 GNFQWMAPE-TIGAEEESYTEKADTYSFAMILYTILTGEGP------------------F 228
Query: 315 LSDAKQFRQIVDPRLEGKYSLRLV------SKLSHVANLCLVKNARTRPKMSEVLEMVNK 368
D + +I + + LR +L +V LC + + RP S +++ +++
Sbjct: 229 --DEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286
Query: 369 I 369
+
Sbjct: 287 L 287
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 7e-55
Identities = 69/316 (21%), Positives = 114/316 (36%), Gaps = 51/316 (16%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGH--KEWMTEVNFLGIVEHQNLVK 149
V+G+G FG K + + + +K+L R + ++ EV + +EH N++K
Sbjct: 17 VLGKGCFGQAIKVTHRETG-----EVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLK 71
Query: 150 LVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHE 209
+G D + + EY+ G++ + ++ W+ R+ A+D A G+AYLH
Sbjct: 72 FIGVLYKDK----RLNFITEYIKGGTLRGIIK-SMDSQYPWSQRVSFAKDIASGMAYLHS 126
Query: 210 GMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFT------------HVSTAVV 257
II RD S N L+ E N ++DFGLARL E VV
Sbjct: 127 ---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVV 183
Query: 258 GTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 317
G + APE + + DV+S+G+ L E+I PR+
Sbjct: 184 GNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRT-------------- 229
Query: 318 AKQFRQIVDPRLEGKYSLRLVS----KLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 373
+ G + C + RP ++ + +
Sbjct: 230 -----MDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETL-RMH 283
Query: 374 AEAGSPRRPLRSSTSR 389
P P R
Sbjct: 284 LAGHLPLGPQLEQLDR 299
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 1e-54
Identities = 71/299 (23%), Positives = 112/299 (37%), Gaps = 34/299 (11%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWM--TEVNFLGIVEHQNLVK 149
+G+G +G V++G + VAVK R K W TE+ ++ H+N++
Sbjct: 15 CVGKGRYGEVWRGSWQGEN-------VAVKIFSSRD-EKSWFRETELYNTVMLRHENILG 66
Query: 150 LVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHE 209
+ Q L+ Y GS+ YL + L L+I A GLA+LH
Sbjct: 67 FIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT---LDTVSCLRIVLSIASGLAHLHI 123
Query: 210 GMDFQ-----IIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHV--STAVVGTMGY 262
+ I RD KS NIL+ + ++D GLA + + VGT Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 263 AAPE------YVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS 316
APE V R D+W++G+ L+E+ + V P
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDY--KPPFYDVVPNDP 241
Query: 317 DAKQFRQIV---DPRLEGKYSLRLVSKLSHVANL---CLVKNARTRPKMSEVLEMVNKI 369
+ R++V R L+ +A L C +N R + + + KI
Sbjct: 242 SFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 183 bits (465), Expect = 2e-54
Identities = 65/301 (21%), Positives = 111/301 (36%), Gaps = 32/301 (10%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWM--TEVNFLGIVEHQNLVK 149
IG+G +G V+ G + + VAVK W TE+ ++ H+N++
Sbjct: 44 QIGKGRYGEVWMGKWRGEK-------VAVKVF-FTTEEASWFRETEIYQTVLMRHENILG 95
Query: 150 LVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHE 209
+ Q L+ +Y NGS+ YL + L LK+A + GL +LH
Sbjct: 96 FIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT---LDAKSMLKLAYSSVSGLCHLHT 152
Query: 210 GMDFQ-----IIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTH--VSTAVVGTMGY 262
+ I RD KS NIL+ + ++D GLA S+ VGT Y
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212
Query: 263 AAPE------YVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS 316
PE + +D++S+G+ L+E+ R + V S
Sbjct: 213 MPPEVLDESLNRNHFQSYIMADMYSFGLILWEVAR-RCVSGGIVEEYQLPYHDLVPSDPS 271
Query: 317 DAKQFRQIVD----PRLEGKYSLRLV-SKLSHVANLCLVKNARTRPKMSEVLEMVNKIVD 371
+ P ++S ++ + C N +R V + + K+ +
Sbjct: 272 YEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331
Query: 372 A 372
+
Sbjct: 332 S 332
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 9e-54
Identities = 75/296 (25%), Positives = 117/296 (39%), Gaps = 56/296 (18%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGH------KEWMTEVNFLGIVEHQ 145
+IG GGFG VY+ E VAVK + E +++H
Sbjct: 14 IIGIGGFGKVYRAFWIGDE-------VAVKAARHDPDEDISQTIENVRQEAKLFAMLKHP 66
Query: 146 NLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLA 205
N++ L G C + + V E+ G +++ LS K + + + A ARG+
Sbjct: 67 NIIALRGVCLKEPNLCL----VMEFARGGPLNRVLSGKR---IPPDILVNWAVQIARGMN 119
Query: 206 YLHEGMDFQIIVRDFKSSNILLDE--------QWNAKLSDFGLARLGPSEGFTHVSTAVV 257
YLH+ II RD KSSNIL+ + K++DFGLAR +
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT----KMSAA 175
Query: 258 GTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 317
G + APE ++ + SDVWSYGV L+EL+TG P+
Sbjct: 176 GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE------------------VPF--R 215
Query: 318 AKQFRQIVDPRLEGKYSLRLVS----KLSHVANLCLVKNARTRPKMSEVLEMVNKI 369
+ K +L + S + + C + +RP + +L+ + I
Sbjct: 216 GIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 6e-53
Identities = 70/300 (23%), Positives = 120/300 (40%), Gaps = 36/300 (12%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTE--VNFLGIVEHQNLVK 149
IG+G FG V++G + E VAVK + W E + ++ H+N++
Sbjct: 49 SIGKGRFGEVWRGKWRGEE-------VAVKIF-SSREERSWFREAEIYQTVMLRHENILG 100
Query: 150 LVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHE 209
+ D+ Q LV +Y +GS+ YL+ + +T +K+A A GLA+LH
Sbjct: 101 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHM 157
Query: 210 GMDFQ-----IIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTH--VSTAVVGTMGY 262
+ I RD KS NIL+ + ++D GLA S T VGT Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217
Query: 263 AAPEYVQTGRLAA-------RSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYL 315
APE V + R+D+++ G+ +E+ + Q + P
Sbjct: 218 MAPE-VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED--YQLPYYDLVPSD 274
Query: 316 SDAKQFRQIV---DPRLEGKYSLRLVSKLSHVANL---CLVKNARTRPKMSEVLEMVNKI 369
++ R++V R + L +A + C N R + + ++++
Sbjct: 275 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 7e-53
Identities = 80/285 (28%), Positives = 121/285 (42%), Gaps = 38/285 (13%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWM----TEVNFLGIVEHQNLV 148
IG G FG VYKG +VAVK L + + EV L H N++
Sbjct: 32 IGSGSFGTVYKGKWHG--------DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 83
Query: 149 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLH 208
+GY Q +V ++ S+ +L SET + IA+ ARG+ YLH
Sbjct: 84 LFMGYSTAP-----QLAIVTQWCEGSSLYHHLH-ASETKFEMKKLIDIARQTARGMDYLH 137
Query: 209 EGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPE-- 266
II RD KS+NI L E K+ DFGLA +H + G++ + APE
Sbjct: 138 AK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194
Query: 267 -YVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS-DAKQFRQI 324
+ + +SDV+++G+ LYEL+TG+ P R +Q + + LS D + R
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-DQIIEMVGRGSLSPDLSKVRSN 253
Query: 325 VDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 369
++ + CL K RP +L + ++
Sbjct: 254 CPK------------RMKRLMAECLKKKRDERPSFPRILAEIEEL 286
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 8e-53
Identities = 70/360 (19%), Positives = 130/360 (36%), Gaps = 62/360 (17%)
Query: 45 TSQNVSAISVESEARPSYPSMSQRPSNLKEFTI--AELKSATKNFSRSVVIGEGGFGCVY 102
N+S +S S R + SQ L+E+ I +L+ IG+G FG VY
Sbjct: 2 PEMNLSLLSARSFPRKA----SQTSIFLQEWDIPFEQLEIGEL-------IGKGRFGQVY 50
Query: 103 KGLIKNSEDPSQKVEVAVKQLGRRGGHKEWM----TEVNFLGIVEHQNLVKLVGYCADDD 158
G EVA++ + +++ + EV H+N+V +G C
Sbjct: 51 HGRWHG--------EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102
Query: 159 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVR 218
I + ++ + ++ +L +IAQ+ +G+ YLH I+ +
Sbjct: 103 HLAI----ITSLCKGRTLYSVVR-DAKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHK 154
Query: 219 DFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVS---TAVVGTMGYAAPEYVQTGRLAA 275
D KS N+ D ++DFGL + G + + APE ++
Sbjct: 155 DLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDT 213
Query: 276 ---------RSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVD 326
SDV++ G YEL P E + Q + + +
Sbjct: 214 EEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA--EAIIWQ-M------GTGMKPNLS 264
Query: 327 PRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASAEAGSPRRPLRSS 386
+ + ++S + C RP +++++M+ K+ + P +S+
Sbjct: 265 Q-------IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHFWKSA 317
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 1e-41
Identities = 63/332 (18%), Positives = 111/332 (33%), Gaps = 47/332 (14%)
Query: 56 SEARPSYPSMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQK 115
+ + S R + + + + + K++ +GEGGF V E
Sbjct: 2 GSSHHHHHHSSGRENLYFQGHMVIIDN--KHYLFIQKLGEGGFSYVDLV-----EGLHDG 54
Query: 116 VEVAVKQLGRRGGH--KEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPN 173
A+K++ +E E + + H N+++LV YC + + L+ +
Sbjct: 55 HFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKR 114
Query: 174 GSVDQYLS--PKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW 231
G++ + LT L + RGL +H RD K +NILL ++
Sbjct: 115 GTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEG 171
Query: 232 NAKLSDFGLARLGPSEGFTHVS-------TAVVGTMGYAAPEYVQTGRLAA---RSDVWS 281
L D G A T+ Y APE R+DVWS
Sbjct: 172 QPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWS 231
Query: 282 YGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKL 341
G LY ++ G P D + + L ++ + S+ +
Sbjct: 232 LGCVLYAMMFGEGPYDMVFQKGDSVAL-------------------AVQNQLSIPQSPRH 272
Query: 342 SHVA-NL---CLVKNARTRPKMSEVLEMVNKI 369
S L + + RP + +L + +
Sbjct: 273 SSALWQLLNSMMTVDPHQRPHIPLLLSQLEAL 304
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 9e-41
Identities = 64/232 (27%), Positives = 104/232 (44%), Gaps = 24/232 (10%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG---HKEWMTEVNFLGIVEHQNLV 148
+GEG FG V D + +VAVK L G + E+ L + H+N+V
Sbjct: 28 DLGEGHFGKVELCRYDPEGD-NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 149 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLH 208
K G C +D GI+ L+ E++P+GS+ +YL PK++ + +LK A +G+ YL
Sbjct: 87 KYKGICTEDGGNGIK--LIMEFLPSGSLKEYL-PKNKNKINLKQQLKYAVQICKGMDYLG 143
Query: 209 EGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMG-----YA 263
+ + RD + N+L++ + K+ DFGL + ++ V +
Sbjct: 144 S-RQY--VHRDLAARNVLVESEHQVKIGDFGLTKAIETDK----EYYTVKDDRDSPVFWY 196
Query: 264 APEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPY 314
APE + + SDVWS+GV L+EL+T L +
Sbjct: 197 APECLMQSKFYIASDVWSFGVTLHELLTYCDSD----SSPMALFLKMIGPTH 244
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 2e-40
Identities = 76/321 (23%), Positives = 130/321 (40%), Gaps = 40/321 (12%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG---HKEWMTEVNFLGIVEHQNLV 148
+G+G FG V D + VAVKQL + G +++ E+ L + +V
Sbjct: 30 QLGKGNFGSVELCRYDPLGD-NTGALVAVKQL-QHSGPDQQRDFQREIQILKALHSDFIV 87
Query: 149 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLH 208
K G + ++ LV EY+P+G + +L + L + L + +G+ YL
Sbjct: 88 KYRGVSYGPGRQSLR--LVMEYLPSGCLRDFL-QRHRARLDASRLLLYSSQICKGMEYLG 144
Query: 209 EGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMG-----YA 263
+ RD + NIL++ + + K++DFGLA+L P + VV G +
Sbjct: 145 S-RRC--VHRDLAARNILVESEAHVKIADFGLAKLLPLDK----DYYVVREPGQSPIFWY 197
Query: 264 APEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQFR 322
APE + + +SDVWS+GV LYEL T + + + P LS +
Sbjct: 198 APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL- 256
Query: 323 QIVDPRLEGKYSLRLV------SKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASAEA 376
LE RL +++ + LC + + RP S + ++ + S
Sbjct: 257 ------LEEGQ--RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS--- 305
Query: 377 GSPRRPLRSSTSRETPDHTKT 397
+ E H+ +
Sbjct: 306 -RGCETHAFTAHPEGKHHSLS 325
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-40
Identities = 65/214 (30%), Positives = 101/214 (47%), Gaps = 26/214 (12%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGH-----KEWMTEVNFLGIVEHQN 146
V+G G FG VYKGL E K+ VA+K+L R KE + E + V++ +
Sbjct: 22 VLGSGAFGTVYKGLWIP-EGEKVKIPVAIKEL--REATSPKANKEILDEAYVMASVDNPH 78
Query: 147 LVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAY 206
+ +L+G C L+ + MP G + Y+ + + + L A+G+ Y
Sbjct: 79 VCRLLGICLTS-----TVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 207 LHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR-LGPSEGFTHVSTAVVGTM---GY 262
L E + RD + N+L+ + K++DFGLA+ LG E H G +
Sbjct: 133 L-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE----GGKVPIKW 185
Query: 263 AAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 295
A E + +SDVWSYGV ++EL+T G +P
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 4e-40
Identities = 64/230 (27%), Positives = 102/230 (44%), Gaps = 20/230 (8%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL--GRRGGHKEWMTEVNFLGIVEHQNLVK 149
+G+G FG V +D + VAVK+L +++ E+ L ++H N+VK
Sbjct: 17 QLGKGNFGSVEMCRYDPLQD-NTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 150 LVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHE 209
G C R ++ L+ EY+P GS+ YL K + + L+ +G+ YL
Sbjct: 76 YKGVCYSAGRRNLK--LIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 210 GMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMG-----YAA 264
+ I RD + NIL++ + K+ DFGL ++ P + V G + A
Sbjct: 133 -KRY--IHRDLATRNILVENENRVKIGDFGLTKVLPQDK----EFFKVKEPGESPIFWYA 185
Query: 265 PEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPY 314
PE + + + SDVWS+GV LYEL T P +E +
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELFTYIEK--SKSPPAEFMRMIGNDKQ 233
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 5e-40
Identities = 67/323 (20%), Positives = 122/323 (37%), Gaps = 42/323 (13%)
Query: 77 IAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKE---WM 133
+ ++ + S ++G+G V++G K + A+K + M
Sbjct: 1 MGSQSTSNHLWLLSDILGQGATANVFRGRHKKT-----GDLFAIKVFNNISFLRPVDVQM 55
Query: 134 TEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYL-SPKSETILTWAM 192
E L + H+N+VKL + +++ ++L+ E+ P GS+ L P + L +
Sbjct: 56 REFEVLKKLNHKNIVKL--FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESE 113
Query: 193 RLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL----DEQWNAKLSDFGLAR-LGPSE 247
L + +D G+ +L E I+ R+ K NI+ D Q KL+DFG AR L E
Sbjct: 114 FLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE 170
Query: 248 GFTHVSTAVVGTMGYAAPEYVQTGRLA--------ARSDVWSYGVFLYELITGRRP-IDR 298
F ++ GT Y P+ + L A D+WS GV Y TG P
Sbjct: 171 QFV----SLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF 226
Query: 299 NRPRSEQKLLQWVK--PYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVA--------NLC 348
PR ++++ + ++ + ++ + + LS
Sbjct: 227 EGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANI 286
Query: 349 LVKNARTRPKMSEVLEMVNKIVD 371
L + + + I+
Sbjct: 287 LEADQEKCWGFDQFFAETSDILH 309
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 1e-39
Identities = 64/230 (27%), Positives = 102/230 (44%), Gaps = 20/230 (8%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL--GRRGGHKEWMTEVNFLGIVEHQNLVK 149
+G+G FG V +D + VAVK+L +++ E+ L ++H N+VK
Sbjct: 48 QLGKGNFGSVEMCRYDPLQD-NTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 150 LVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHE 209
G C R ++ L+ EY+P GS+ YL K + + L+ +G+ YL
Sbjct: 107 YKGVCYSAGRRNLK--LIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGT 163
Query: 210 GMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMG-----YAA 264
+ I RD + NIL++ + K+ DFGL ++ P + V G + A
Sbjct: 164 -KRY--IHRDLATRNILVENENRVKIGDFGLTKVLPQDK----EYYKVKEPGESPIFWYA 216
Query: 265 PEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPY 314
PE + + + SDVWS+GV LYEL T P +E +
Sbjct: 217 PESLTESKFSVASDVWSFGVVLYELFTYIEK--SKSPPAEFMRMIGNDKQ 264
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-39
Identities = 73/232 (31%), Positives = 100/232 (43%), Gaps = 26/232 (11%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG---HKEWMTEVNFLGIVEHQNLV 148
+GEG FG V + D VAVK L G W E++ L + H++++
Sbjct: 38 DLGEGHFGKVSLYCYDPTND-GTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 149 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLH 208
K G C D +Q LV EY+P GS+ YL S + A L AQ G+AYLH
Sbjct: 97 KYKGCCEDAGAASLQ--LVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYLH 151
Query: 209 EGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMG-----YA 263
+ I RD + N+LLD K+ DFGLA+ P V G +
Sbjct: 152 A-QHY--IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH----EYYRVREDGDSPVFWY 204
Query: 264 APEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPY 314
APE ++ + SDVWS+GV LYEL+T + + L
Sbjct: 205 APECLKEYKFYYASDVWSFGVTLYELLTHCDSS----QSPPTKFLELIGIAQ 252
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 3e-39
Identities = 62/208 (29%), Positives = 104/208 (50%), Gaps = 25/208 (12%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQNLVKLV 151
IG+G FG V G + ++ VAVK + + ++ E + + + H NLV+L+
Sbjct: 200 TIGKGEFGDVMLGDYRGNK-------VAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLL 252
Query: 152 GYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGM 211
G ++ +V EYM GS+ YL + ++L LK + D + YL EG
Sbjct: 253 GVIVEEKG---GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL-EGN 308
Query: 212 DFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGT---MGYAAPEYV 268
+F + RD + N+L+ E AK+SDFGL + S+ + + APE +
Sbjct: 309 NF--VHRDLAARNVLVSEDNVAKVSDFGLTK--------EASSTQDTGKLPVKWTAPEAL 358
Query: 269 QTGRLAARSDVWSYGVFLYELIT-GRRP 295
+ + + +SDVWS+G+ L+E+ + GR P
Sbjct: 359 REKKFSTKSDVWSFGILLWEIYSFGRVP 386
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 4e-39
Identities = 66/323 (20%), Positives = 121/323 (37%), Gaps = 42/323 (13%)
Query: 77 IAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKE---WM 133
+ ++ + S ++G+G V++G K + A+K + M
Sbjct: 1 MGSQSTSNHLWLLSDILGQGATANVFRGRHKKT-----GDLFAIKVFNNISFLRPVDVQM 55
Query: 134 TEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYL-SPKSETILTWAM 192
E L + H+N+VKL + +++ ++L+ E+ P GS+ L P + L +
Sbjct: 56 REFEVLKKLNHKNIVKL--FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESE 113
Query: 193 RLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL----DEQWNAKLSDFGLAR-LGPSE 247
L + +D G+ +L E I+ R+ K NI+ D Q KL+DFG AR L E
Sbjct: 114 FLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE 170
Query: 248 GFTHVSTAVVGTMGYAAPEYVQTGRLAARS--------DVWSYGVFLYELITGRRP-IDR 298
F ++ GT Y P+ + L D+WS GV Y TG P
Sbjct: 171 QFV----SLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF 226
Query: 299 NRPRSEQKLLQWVK--PYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVA--------NLC 348
PR ++++ + ++ + ++ + + LS
Sbjct: 227 EGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANI 286
Query: 349 LVKNARTRPKMSEVLEMVNKIVD 371
L + + + I+
Sbjct: 287 LEADQEKCWGFDQFFAETSDILH 309
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 5e-39
Identities = 57/213 (26%), Positives = 112/213 (52%), Gaps = 23/213 (10%)
Query: 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQN 146
+ +G G FG V +G+ + ++++VA+K L ++G +E M E + +++
Sbjct: 16 IELGCGNFGSVRQGVYRM---RKKQIDVAIKVL-KQGTEKADTEEMMREAQIMHQLDNPY 71
Query: 147 LVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAY 206
+V+L+G C + +LV E G + ++L K E + + ++ + G+ Y
Sbjct: 72 IVRLIGVCQAE-----ALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKY 125
Query: 207 LHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTM---GYA 263
L E +F + RD + N+LL + AK+SDFGL++ ++ + + + +
Sbjct: 126 L-EEKNF--VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS--AGKWPLKWY 180
Query: 264 APEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 295
APE + + ++RSDVWSYGV ++E ++ G++P
Sbjct: 181 APECINFRKFSSRSDVWSYGVTMWEALSYGQKP 213
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 7e-39
Identities = 71/354 (20%), Positives = 130/354 (36%), Gaps = 57/354 (16%)
Query: 54 VESEARPSYPSMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPS 113
++ +++ + K + NF IG G F VY+ D
Sbjct: 1 MDEQSQGMQGPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRA--ACLLD-- 56
Query: 114 QKVEVAVKQ--LGRRGGHKE---WMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVY 168
V VA+K+ + K + E++ L + H N++K +D+E I V
Sbjct: 57 -GVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI----VL 111
Query: 169 EYMPNGSVDQYLSPKS--------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDF 220
E G + + + T+ + ++L L ++H +++ RD
Sbjct: 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQL------CSALEHMH---SRRVMHRDI 162
Query: 221 KSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVW 280
K +N+ + KL D GL R S+ T + ++VGT Y +PE + +SD+W
Sbjct: 163 KPANVFITATGVVKLGDLGLGRFFSSK--TTAAHSLVGTPYYMSPERIHENGYNFKSDIW 220
Query: 281 SYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSK 340
S G LYE+ + P + + L + K + P YS +
Sbjct: 221 SLGCLLYEMAALQSPFYGD-KMNLYSLCK---------KIEQCDYPPLPSDHYS----EE 266
Query: 341 LSHVANLCLVKNARTRPKMSEVLEMVNKIVDASAEAGSPRRPLRSSTSRETPDH 394
L + N+C+ + RP ++ V ++ ++ SS H
Sbjct: 267 LRQLVNMCINPDPEKRPDVTYVYDVAKRM----------HACTASSLEHHHHHH 310
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-38
Identities = 58/208 (27%), Positives = 90/208 (43%), Gaps = 17/208 (8%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGR---RGGHKEWMTEVNFLGIVEHQNLV 148
IG G FG V+ G ++ VAVK +++ E L H N+V
Sbjct: 121 QIGRGNFGEVFSGRLRA-----DNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIV 175
Query: 149 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLH 208
+L+G C +V E + G +L + L L++ DAA G+ YL
Sbjct: 176 RLIGVCTQKQPI----YIVMELVQGGDFLTFLRTEGAR-LRVKTLLQMVGDAAAGMEYLE 230
Query: 209 EGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYV 268
I RD + N L+ E+ K+SDFG++R + + + APE +
Sbjct: 231 SK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEAL 287
Query: 269 QTGRLAARSDVWSYGVFLYELIT-GRRP 295
GR ++ SDVWS+G+ L+E + G P
Sbjct: 288 NYGRYSSESDVWSFGILLWETFSLGASP 315
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-38
Identities = 70/242 (28%), Positives = 109/242 (45%), Gaps = 26/242 (10%)
Query: 68 RPSNLKEFTIAELKSATKNFSRSVV-----IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQ 122
S L + ++ S +V IG G FGCVY G + +++ +K+ AVK
Sbjct: 3 DLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDND--GKKIHCAVKS 60
Query: 123 LGRRGGHKEW---MTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQY 179
L R E +TE + H N++ L+G C + L+V YM +G + +
Sbjct: 61 LNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG---SPLVVLPYMKHGDLRNF 117
Query: 180 LSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 239
+ T + A+G+ YL F + RD + N +LDE++ K++DFG
Sbjct: 118 IR-NETHNPTVKDLIGFGLQVAKGMKYL-ASKKF--VHRDLAARNCMLDEKFTVKVADFG 173
Query: 240 LARLGPSEGFTHVSTAVVGT-----MGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GR 293
LAR + + V M A E +QT + +SDVWS+GV L+EL+T G
Sbjct: 174 LARDMYDKEYYSVHNKTGAKLPVKWM---ALESLQTQKFTTKSDVWSFGVLLWELMTRGA 230
Query: 294 RP 295
P
Sbjct: 231 PP 232
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-38
Identities = 57/214 (26%), Positives = 101/214 (47%), Gaps = 27/214 (12%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL----GRRGGHKEWMTEVNFLGIVEHQNL 147
+G G FG V KG + VAVK L E + E N + +++ +
Sbjct: 24 ELGSGNFGTVKKGYYQM---KKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 148 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYL 207
V+++G C + +LV E G +++YL + +++ + G+ YL
Sbjct: 81 VRMIGICEAE-----SWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYL 133
Query: 208 HEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMG-----Y 262
E +F + RD + N+LL Q AK+SDFGL++ ++ + T G +
Sbjct: 134 -EESNF--VHRDLAARNVLLVTQHYAKISDFGLSKALRADE----NYYKAQTHGKWPVKW 186
Query: 263 AAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 295
APE + + +++SDVWS+GV ++E + G++P
Sbjct: 187 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-38
Identities = 73/268 (27%), Positives = 119/268 (44%), Gaps = 26/268 (9%)
Query: 42 SELTSQNVSAISVESEARPSYPSMSQRPSNLKEFTIAELKSATKNFSRSVV-----IGEG 96
EL++ E+ ++ S L + ++ S +V IG G
Sbjct: 41 EELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRG 100
Query: 97 GFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEW---MTEVNFLGIVEHQNLVKLVGY 153
FGCVY G + +++ +K+ AVK L R E +TE + H N++ L+G
Sbjct: 101 HFGCVYHGTLLDND--GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGI 158
Query: 154 CADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDF 213
C + L+V YM +G + ++ ++ T + A+G+ +L F
Sbjct: 159 CLRSEG---SPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQVAKGMKFL-ASKKF 213
Query: 214 QIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGT-----MGYAAPEYV 268
+ RD + N +LDE++ K++DFGLAR + F V M A E +
Sbjct: 214 --VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM---ALESL 268
Query: 269 QTGRLAARSDVWSYGVFLYELIT-GRRP 295
QT + +SDVWS+GV L+EL+T G P
Sbjct: 269 QTQKFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-38
Identities = 62/211 (29%), Positives = 102/211 (48%), Gaps = 31/211 (14%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQNLVKLV 151
IG+G FG V G + ++ VAVK + + ++ E + + + H NLV+L+
Sbjct: 28 TIGKGEFGDVMLGDYRGNK-------VAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLL 80
Query: 152 GYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGM 211
G ++ +V EYM GS+ YL + ++L LK + D + YL EG
Sbjct: 81 GVIVEEKG---GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL-EGN 136
Query: 212 DFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGT------MGYAAP 265
+F + RD + N+L+ E AK+SDFGL + S+ AP
Sbjct: 137 NF--VHRDLAARNVLVSEDNVAKVSDFGLTK--------EASSTQDTGKLPVKWT---AP 183
Query: 266 EYVQTGRLAARSDVWSYGVFLYELIT-GRRP 295
E ++ + + +SDVWS+G+ L+E+ + GR P
Sbjct: 184 EALREKKFSTKSDVWSFGILLWEIYSFGRVP 214
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-38
Identities = 64/211 (30%), Positives = 100/211 (47%), Gaps = 27/211 (12%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG---HKEWMTEVNFLGIVEHQNLV 148
IG G FG V+ G N K +VA+K + R G ++++ E + + H LV
Sbjct: 15 EIGSGQFGLVHLGYWLN------KDKVAIKTI--REGAMSEEDFIEEAEVMMKLSHPKLV 66
Query: 149 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLH 208
+L G C + LV E+M +G + YL + L + D G+AYL
Sbjct: 67 QLYGVCLEQAPI----CLVTEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGMAYL- 120
Query: 209 EGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTM---GYAAP 265
E I RD + N L+ E K+SDFG+ R + +T + GT +A+P
Sbjct: 121 EEACV--IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT----SSTGTKFPVKWASP 174
Query: 266 EYVQTGRLAARSDVWSYGVFLYELIT-GRRP 295
E R +++SDVWS+GV ++E+ + G+ P
Sbjct: 175 EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP 205
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-38
Identities = 65/207 (31%), Positives = 104/207 (50%), Gaps = 19/207 (9%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--GHKEWMTEVNFLGIVEHQNLVK 149
+G+G FG V+ G VA+K L + G + ++ E + + H+ LV+
Sbjct: 191 KLGQGCFGEVWMGTWNG------TTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQ 243
Query: 150 LVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHE 209
L +++ +V EYM GS+ +L ++ L + +A A G+AY+ E
Sbjct: 244 LYAVVSEE-----PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV-E 297
Query: 210 GMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQ 269
M++ + RD +++NIL+ E K++DFGLARL +T A + + APE
Sbjct: 298 RMNY--VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAAL 354
Query: 270 TGRLAARSDVWSYGVFLYELIT-GRRP 295
GR +SDVWS+G+ L EL T GR P
Sbjct: 355 YGRFTIKSDVWSFGILLTELTTKGRVP 381
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 4e-38
Identities = 68/282 (24%), Positives = 106/282 (37%), Gaps = 41/282 (14%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKE----WMTEVNFLGIVEHQNL 147
IG G F VYKGL D VEVA +L R K + E L ++H N+
Sbjct: 33 EIGRGSFKTVYKGL-----DTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 87
Query: 148 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYL 207
V+ + +LV E M +G++ YL K ++ + + +GL +L
Sbjct: 88 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL--KRFKVMKIKVLRSWCRQILKGLQFL 145
Query: 208 HEGMDFQIIVRDFKSSNILLD-EQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPE 266
H II RD K NI + + K+ D GLA L + + AV+GT + APE
Sbjct: 146 HT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA----SFAKAVIGTPEFMAPE 200
Query: 267 YVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVD 326
+ DV+++G+ + E+ T P S+ + QI
Sbjct: 201 MYEEK-YDESVDVYAFGMCMLEMATSEYP-------------------YSECQNAAQIYR 240
Query: 327 PRLEGKYSLRLVSKLSHVA----NLCLVKNARTRPKMSEVLE 364
G C+ +N R + ++L
Sbjct: 241 RVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 5e-38
Identities = 59/211 (27%), Positives = 103/211 (48%), Gaps = 20/211 (9%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEW---MTEVNFLGIVEHQNLV 148
V+G G FG V+KG+ E S K+ V +K + + G + + + +G ++H ++V
Sbjct: 20 VLGSGVFGTVHKGVWIP-EGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 149 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLH 208
+L+G C LV +Y+P GS+ ++ + L + L A+G+ YL
Sbjct: 79 RLLGLCPGS-----SLQLVTQYLPLGSLLDHVR-QHRGALGPQLLLNWGVQIAKGMYYL- 131
Query: 209 EGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTM---GYAAP 265
E + R+ + N+LL +++DFG+A L P + + + + A
Sbjct: 132 EEHGM--VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYS---EAKTPIKWMAL 186
Query: 266 EYVQTGRLAARSDVWSYGVFLYELIT-GRRP 295
E + G+ +SDVWSYGV ++EL+T G P
Sbjct: 187 ESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 7e-38
Identities = 61/213 (28%), Positives = 95/213 (44%), Gaps = 21/213 (9%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEW---MTEVNFLGIVEHQNLV 148
VIG+G FG VY G + + A+K L R ++ + E + + H N++
Sbjct: 28 VIGKGHFGVVYHGEYIDQAQNRIQC--AIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 149 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLH 208
L+G + ++ YM +G + Q++ + T + ARG+ YL
Sbjct: 86 ALIGIMLPPEGL---PHVLLPYMCHGDLLQFIR-SPQRNPTVKDLISFGLQVARGMEYL- 140
Query: 209 EGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGT-----MGYA 263
F + RD + N +LDE + K++DFGLAR + V
Sbjct: 141 AEQKF--VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT--- 195
Query: 264 APEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 295
A E +QT R +SDVWS+GV L+EL+T G P
Sbjct: 196 ALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 7e-38
Identities = 65/211 (30%), Positives = 102/211 (48%), Gaps = 20/211 (9%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGH-----KEWMTEVNFLGIVEHQN 146
V+G G FG VYKGL E K+ VA+K+L R KE + E + V++ +
Sbjct: 22 VLGSGAFGTVYKGLWI-PEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMASVDNPH 78
Query: 147 LVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAY 206
+ +L+G C L+ + MP G + Y+ + + + L A+G+ Y
Sbjct: 79 VCRLLGICLTS-----TVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 207 LHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR-LGPSEGFTHVSTAVVGTMGYAAP 265
L E + RD + N+L+ + K++DFGLA+ LG E H V + + A
Sbjct: 133 L-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKWMAL 188
Query: 266 EYVQTGRLAARSDVWSYGVFLYELIT-GRRP 295
E + +SDVWSYGV ++EL+T G +P
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-37
Identities = 58/210 (27%), Positives = 98/210 (46%), Gaps = 25/210 (11%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--GHKEWMTEVNFLGIVEHQNLVK 149
+G G FG V+ +VAVK + + G + ++ E N + ++H LVK
Sbjct: 195 KLGAGQFGEVWMATYNK------HTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVK 247
Query: 150 LVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHE 209
L + ++ E+M GS+ +L + + + A G+A++ E
Sbjct: 248 LHAVVTKE-----PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI-E 301
Query: 210 GMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMG---YAAPE 266
++ I RD +++NIL+ K++DFGLAR+ +T A G + APE
Sbjct: 302 QRNY--IHRDLRAANILVSASLVCKIADFGLARVIEDNEYT----AREGAKFPIKWTAPE 355
Query: 267 YVQTGRLAARSDVWSYGVFLYELIT-GRRP 295
+ G +SDVWS+G+ L E++T GR P
Sbjct: 356 AINFGSFTIKSDVWSFGILLMEIVTYGRIP 385
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-37
Identities = 60/208 (28%), Positives = 107/208 (51%), Gaps = 19/208 (9%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGH---KEWMTEVNFLGIVEHQNLV 148
+G G +G VY+G+ K + VAVK L + +E++ E + ++H NLV
Sbjct: 227 KLGGGQYGEVYEGVWKKYS-----LTVAVKTL--KEDTMEVEEFLKEAAVMKEIKHPNLV 279
Query: 149 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLH 208
+L+G C + ++ E+M G++ YL + ++ + L +A + + YL
Sbjct: 280 QLLGVCTREP----PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL- 334
Query: 209 EGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYV 268
E +F I R+ + N L+ E K++DFGL+RL + +T + A + + APE +
Sbjct: 335 EKKNF--IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESL 391
Query: 269 QTGRLAARSDVWSYGVFLYELIT-GRRP 295
+ + +SDVW++GV L+E+ T G P
Sbjct: 392 AYNKFSIKSDVWAFGVLLWEIATYGMSP 419
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-37
Identities = 58/218 (26%), Positives = 101/218 (46%), Gaps = 23/218 (10%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGH-----KEWMTEVNFLGIVEHQN 146
++GEG FG V +G +K + S K VAVK + + +E+++E + H N
Sbjct: 41 ILGEGEFGSVMEGNLKQEDGTSLK--VAVKTM-KLDNSSQREIEEFLSEAACMKDFSHPN 97
Query: 147 LVKLVGYCADDDERGIQRLLV-YEYMPNGSVDQYL----SPKSETILTWAMRLKIAQDAA 201
+++L+G C + +GI + +V +M G + YL + LK D A
Sbjct: 98 VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157
Query: 202 RGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAV---VG 258
G+ YL +F + RD + N +L + ++DFGL++ S + V
Sbjct: 158 LGMEYL-SNRNF--LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 214
Query: 259 TMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 295
+ A E + ++SDVW++GV ++E+ T G P
Sbjct: 215 WI---AIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 2e-37
Identities = 57/212 (26%), Positives = 105/212 (49%), Gaps = 24/212 (11%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNL 147
++GEG FG VY+G+ N + +K+ VAVK ++ +++M+E + ++H ++
Sbjct: 19 ILGEGFFGEVYEGVYTNHK--GEKINVAVKTC-KKDCTLDNKEKFMSEAVIMKNLDHPHI 75
Query: 148 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYL 207
VKL+G ++ ++ E P G + YL +++ L + + + +AYL
Sbjct: 76 VKLIGIIEEE-----PTWIIMELYPYGELGHYLE-RNKNSLKVLTLVLYSLQICKAMAYL 129
Query: 208 HEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTM---GYAA 264
E ++ + RD NIL+ KL DFGL+R E + S T + +
Sbjct: 130 -ESINC--VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKAS----VTRLPIKWMS 182
Query: 265 PEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 295
PE + R SDVW + V ++E+++ G++P
Sbjct: 183 PESINFRRFTTASDVWMFAVCMWEILSFGKQP 214
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-37
Identities = 63/293 (21%), Positives = 112/293 (38%), Gaps = 47/293 (16%)
Query: 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEH 144
+F +IG GGFG V+K K+ D +K++ + +++ EV L ++H
Sbjct: 11 MDFKEIELIGSGGFGQVFKA--KHRID---GKTYVIKRV--KYNNEKAEREVKALAKLDH 63
Query: 145 QNLVKLVGYCADDDERGIQRL------------LVYEYMPNGSVDQYLSPKSETILTWAM 192
N+V G D + E+ G+++Q++ + L +
Sbjct: 64 VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 123
Query: 193 RLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHV 252
L++ + +G+ Y+H ++I RD K SNI L + K+ DFGL ++G
Sbjct: 124 ALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR-- 178
Query: 253 STAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK 312
T GT+ Y +PE + + D+++ G+ L EL+ K
Sbjct: 179 -TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT-----AFETSKFFT--- 229
Query: 313 PYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365
+ D + + K + L K RP SE+L
Sbjct: 230 ----------DLRDGIISDIFD----KKEKTLLQKLLSKKPEDRPNTSEILRT 268
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-37
Identities = 56/211 (26%), Positives = 103/211 (48%), Gaps = 27/211 (12%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG---HKEWMTEVNFLGIVEHQNLV 148
+G G FG V G + + +VA+K + + G E++ E + + H+ LV
Sbjct: 31 ELGTGQFGVVKYGKWRG------QYDVAIKMI--KEGSMSEDEFIEEAKVMMNLSHEKLV 82
Query: 149 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLH 208
+L G C ++ EYM NG + YL + L++ +D + YL
Sbjct: 83 QLYGVCTKQRPI----FIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYL- 136
Query: 209 EGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTM---GYAAP 265
E F + RD + N L+++Q K+SDFGL+R + +T + VG+ ++ P
Sbjct: 137 ESKQF--LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT----SSVGSKFPVRWSPP 190
Query: 266 EYVQTGRLAARSDVWSYGVFLYELIT-GRRP 295
E + + +++SD+W++GV ++E+ + G+ P
Sbjct: 191 EVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 221
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-37
Identities = 62/211 (29%), Positives = 107/211 (50%), Gaps = 25/211 (11%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGH---KEWMTEVNFLGIVEHQNLV 148
+G G +G VY+G+ K + VAVK L + +E++ E + ++H NLV
Sbjct: 20 KLGGGQYGEVYEGVWKK-----YSLTVAVKTL--KEDTMEVEEFLKEAAVMKEIKHPNLV 72
Query: 149 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLH 208
+L+G C + ++ E+M G++ YL + ++ + L +A + + YL
Sbjct: 73 QLLGVCTREP----PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL- 127
Query: 209 EGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGT---MGYAAP 265
E +F I RD + N L+ E K++DFGL+RL + + TA G + + AP
Sbjct: 128 EKKNF--IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY----TAHAGAKFPIKWTAP 181
Query: 266 EYVQTGRLAARSDVWSYGVFLYELIT-GRRP 295
E + + + +SDVW++GV L+E+ T G P
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-37
Identities = 73/304 (24%), Positives = 116/304 (38%), Gaps = 54/304 (17%)
Query: 80 LKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTE 135
+ S +++ IG G +G K K+ + K+L + ++E
Sbjct: 1 MPSRAEDYEVLYTIGTGSYGRCQKIRRKSD-----GKILVWKELDYGSMTEAEKQMLVSE 55
Query: 136 VNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKS--------ETI 187
VN L ++H N+V+ Y D +V EY G + ++ + E +
Sbjct: 56 VNLLRELKHPNIVRY--YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV 113
Query: 188 LTWAMRLKIAQDAARGLAYLHE--GMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR-LG 244
L +L L H ++ RD K +N+ LD + N KL DFGLAR L
Sbjct: 114 LRVMTQL------TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN 167
Query: 245 PSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSE 304
F VGT Y +PE + +SD+WS G LYEL P S+
Sbjct: 168 HDTSFAK---TFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT---AFSQ 221
Query: 305 QKLLQWVKPYLSDAKQFRQIVD---PRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSE 361
++L +I + R+ +YS +L+ + L RP + E
Sbjct: 222 KEL-------------AGKIREGKFRRIPYRYS----DELNEIITRMLNLKDYHRPSVEE 264
Query: 362 VLEM 365
+LE
Sbjct: 265 ILEN 268
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 3e-37
Identities = 60/213 (28%), Positives = 105/213 (49%), Gaps = 23/213 (10%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG----HKEWMTEVNFLGIVEHQNL 147
+IG G G V G ++ + V VA+K L + G +++++E + +G +H N+
Sbjct: 56 IIGSGDSGEVCYGRLRV--PGQRDVPVAIKAL-KAGYTERQRRDFLSEASIMGQFDHPNI 112
Query: 148 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYL 207
++L G ++V EYM NGS+D +L + T + + + G+ YL
Sbjct: 113 IRLEGVVTRGR----LAMIVTEYMENGSLDTFLR-THDGQFTIMQLVGMLRGVGAGMRYL 167
Query: 208 HEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR-LGPSEGFTHVSTAVVGTM---GYA 263
+ + + RD + N+L+D K+SDFGL+R L + +T G +
Sbjct: 168 -SDLGY--VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTT---GGKIPIRWT 221
Query: 264 APEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 295
APE + ++ SDVWS+GV ++E++ G RP
Sbjct: 222 APEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 5e-37
Identities = 67/211 (31%), Positives = 104/211 (49%), Gaps = 27/211 (12%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGH---KEWMTEVNFLGIVEHQNLV 148
+G G FG V+ G +VAVK L + G ++ E N + ++HQ LV
Sbjct: 20 RLGAGQFGEVWMGYYNG------HTKVAVKSL--KQGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 149 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLH 208
+L + ++ EYM NGS+ +L S LT L +A A G+A++
Sbjct: 72 RLYAVVTQE-----PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI- 125
Query: 209 EGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTM---GYAAP 265
E ++ I RD +++NIL+ + + K++DFGLARL +T G + AP
Sbjct: 126 EERNY--IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE----GAKFPIKWTAP 179
Query: 266 EYVQTGRLAARSDVWSYGVFLYELIT-GRRP 295
E + G +SDVWS+G+ L E++T GR P
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRIP 210
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 6e-37
Identities = 65/207 (31%), Positives = 104/207 (50%), Gaps = 19/207 (9%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--GHKEWMTEVNFLGIVEHQNLVK 149
+G+G FG V+ G VA+K L + G + ++ E + + H+ LV+
Sbjct: 274 KLGQGCFGEVWMGTWNG------TTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQ 326
Query: 150 LVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHE 209
L +++ +V EYM GS+ +L ++ L + +A A G+AY+ E
Sbjct: 327 LYAVVSEE-----PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV-E 380
Query: 210 GMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQ 269
M++ + RD +++NIL+ E K++DFGLARL +T A + + APE
Sbjct: 381 RMNY--VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAAL 437
Query: 270 TGRLAARSDVWSYGVFLYELIT-GRRP 295
GR +SDVWS+G+ L EL T GR P
Sbjct: 438 YGRFTIKSDVWSFGILLTELTTKGRVP 464
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 7e-37
Identities = 61/211 (28%), Positives = 101/211 (47%), Gaps = 27/211 (12%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG---HKEWMTEVNFLGIVEHQNLV 148
+G G FG V G K + +VAVK + + G E+ E + + H LV
Sbjct: 15 ELGSGQFGVVKLGKWKG------QYDVAVKMI--KEGSMSEDEFFQEAQTMMKLSHPKLV 66
Query: 149 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLH 208
K G C+ + +V EY+ NG + YL + L + L++ D G+A+L
Sbjct: 67 KFYGVCSKEY----PIYIVTEYISNGCLLNYLRSHGKG-LEPSQLLEMCYDVCEGMAFL- 120
Query: 209 EGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTM---GYAAP 265
E F I RD + N L+D K+SDFG+ R + + + VGT ++AP
Sbjct: 121 ESHQF--IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV----SSVGTKFPVKWSAP 174
Query: 266 EYVQTGRLAARSDVWSYGVFLYELIT-GRRP 295
E + +++SDVW++G+ ++E+ + G+ P
Sbjct: 175 EVFHYFKYSSKSDVWAFGILMWEVFSLGKMP 205
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 7e-37
Identities = 62/323 (19%), Positives = 122/323 (37%), Gaps = 54/323 (16%)
Query: 59 RPSYPSMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEV 118
S + + ++ + +S IG GG V++ L + +
Sbjct: 7 HSSGVDLGTENLYFQSMSVK-----GRIYSILKQIGSGGSSKVFQVLNEKKQ------IY 55
Query: 119 AVKQLGRRGGHKEWM----TEVNFLGIVEHQNL--VKLVGYCADDDERGIQRLLVYEYMP 172
A+K + + + E+ +L ++ + ++L Y D I +V E
Sbjct: 56 AIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY--I--YMVMECG- 110
Query: 173 NGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWN 232
N ++ +L K + + R ++ + +H I+ D K +N L+ +
Sbjct: 111 NIDLNSWL--KKKKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVDG-M 164
Query: 233 AKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQ-----------TGRLAARSDVWS 281
KL DFG+A + + V + VGT+ Y PE ++ +++ +SDVWS
Sbjct: 165 LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWS 224
Query: 282 YGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKL 341
G LY + G+ P + ++ + I+DP E ++ L
Sbjct: 225 LGCILYYMTYGKTPFQQ---------------IINQISKLHAIIDPNHEIEFPDIPEKDL 269
Query: 342 SHVANLCLVKNARTRPKMSEVLE 364
V CL ++ + R + E+L
Sbjct: 270 QDVLKCCLKRDPKQRISIPELLA 292
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 8e-37
Identities = 72/373 (19%), Positives = 134/373 (35%), Gaps = 66/373 (17%)
Query: 66 SQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGR 125
S + T + + + R IGEG FG + +K++
Sbjct: 5 HHHSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTED-----GRQYVIKEINI 59
Query: 126 RG-GHKEW---MTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLS 181
KE EV L ++H N+V+ ++ I V +Y G + + ++
Sbjct: 60 SRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYI----VMDYCEGGDLFKRIN 115
Query: 182 PKS------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKL 235
+ + IL W +++ L ++H+ +I+ RD KS NI L + +L
Sbjct: 116 AQKGVLFQEDQILDWFVQI------CLALKHVHDR---KILHRDIKSQNIFLTKDGTVQL 166
Query: 236 SDFGLAR-LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRR 294
DFG+AR L + A +GT Y +PE + +SD+W+ G LYEL T +
Sbjct: 167 GDFGIARVLNSTVELAR---ACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKH 223
Query: 295 PIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVD---PRLEGKYSLRLVSKLSHVANLCLVK 351
+ S + L +I+ P + YS L + + +
Sbjct: 224 AFE---AGSMKNL-------------VLKIISGSFPPVSLHYS----YDLRSLVSQLFKR 263
Query: 352 NARTRPKMSEVLE-----------MVNKIVDASAEAGSPRRPLRSSTSRETPDHTKTKHK 400
N R RP ++ +LE + +++ + + + P +
Sbjct: 264 NPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFCLKTFSKFGSQPIPAKRPASGQNSIS 323
Query: 401 RRIIESKTRESGT 413
+ T+ +
Sbjct: 324 VMPAQKITKPAAK 336
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 9e-37
Identities = 58/210 (27%), Positives = 112/210 (53%), Gaps = 17/210 (8%)
Query: 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL---GRRGGHKEWMTEVNFLGIVEHQNL 147
+ +G G FG V +G+ + ++++VA+K L + +E M E + +++ +
Sbjct: 342 IELGCGNFGSVRQGVYRM---RKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 398
Query: 148 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYL 207
V+L+G C + +LV E G + ++L K E + + ++ + G+ YL
Sbjct: 399 VRLIGVCQAE-----ALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYL 452
Query: 208 HEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR-LGPSEGFTHVSTAVVGTMGYAAPE 266
E +F + R+ + N+LL + AK+SDFGL++ LG + + +A + + APE
Sbjct: 453 -EEKNF--VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE 509
Query: 267 YVQTGRLAARSDVWSYGVFLYELIT-GRRP 295
+ + ++RSDVWSYGV ++E ++ G++P
Sbjct: 510 CINFRKFSSRSDVWSYGVTMWEALSYGQKP 539
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 1e-36
Identities = 65/215 (30%), Positives = 113/215 (52%), Gaps = 26/215 (12%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG----HKEWMTEVNFLGIVEHQNL 147
VIG G FG VYKG++K S ++V VA+K L + G +++ E +G H N+
Sbjct: 51 VIGAGEFGEVYKGMLKTS-SGKKEVPVAIKTL-KAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 148 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYL 207
++L G + +++ EYM NG++D++L + + + + + + A G+ YL
Sbjct: 109 IRLEGVISKYKPM----MIITEYMENGALDKFLR-EKDGEFSVLQLVGMLRGIAAGMKYL 163
Query: 208 HEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMG------ 261
M++ + RD + NIL++ K+SDFGL+R+ + A T G
Sbjct: 164 -ANMNY--VHRDLAARNILVNSNLVCKVSDFGLSRVLEDD-----PEATYTTSGGKIPIR 215
Query: 262 YAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 295
+ APE + + + SDVWS+G+ ++E++T G RP
Sbjct: 216 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-36
Identities = 56/218 (25%), Positives = 99/218 (45%), Gaps = 22/218 (10%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL----GRRGGHKEWMTEVNFLGIVEHQNL 147
++G+G FG V + +K + V+VAVK L +E++ E + +H ++
Sbjct: 30 MLGKGEFGSVREAQLKQEDGS--FVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 148 VKLVGYCADDDERGIQR--LLVYEYMPNGSVDQYL----SPKSETILTWAMRLKIAQDAA 201
KLVG +G +++ +M +G + +L ++ L ++ D A
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147
Query: 202 RGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAV---VG 258
G+ YL +F I RD + N +L E ++DFGL+R S + A V
Sbjct: 148 CGMEYL-SSRNF--IHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK 204
Query: 259 TMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 295
+ A E + SDVW++GV ++E++T G+ P
Sbjct: 205 WL---ALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-36
Identities = 62/213 (29%), Positives = 97/213 (45%), Gaps = 22/213 (10%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL-----GRRGGHKEWMTEVNFLGIVEHQN 146
+G+G FG V +G + V VAVK L + +++ EVN + ++H+N
Sbjct: 25 KLGDGSFGVVRRGEWDAPS--GKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 147 LVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAY 206
L++L G +V E P GS+ L L + + A A G+ Y
Sbjct: 83 LIRLYGVVLTP-----PMKMVTELAPLGSLLDRLRKHQGHFLLGTL-SRYAVQVAEGMGY 136
Query: 207 LHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR-LGPSEGFTHVSTAVVGTMGYA-- 263
L E F I RD + N+LL + K+ DFGL R L ++ + + +A
Sbjct: 137 L-ESKRF--IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEH--RKVPFAWC 191
Query: 264 APEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 295
APE ++T + SD W +GV L+E+ T G+ P
Sbjct: 192 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-36
Identities = 63/341 (18%), Positives = 127/341 (37%), Gaps = 51/341 (14%)
Query: 41 GSELTSQNVSAISVESEARPSYPSMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGC 100
GS + + + P + ++ +K + +S IG GG
Sbjct: 14 GSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKG--RIYSILKQIGSGGSSK 71
Query: 101 VYKGLIKNSEDPSQKVEVAVKQLGRRGGHKE----WMTEVNFLGIVEHQNL--VKLVGYC 154
V++ L + + A+K + + + E+ +L ++ + ++L Y
Sbjct: 72 VFQVLNEKKQ------IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 125
Query: 155 ADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQ 214
D +V E N ++ +L K + + R ++ + +H+
Sbjct: 126 ITDQYI----YMVMEC-GNIDLNSWL--KKKKSIDPWERKSYWKNMLEAVHTIHQ---HG 175
Query: 215 IIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQ----- 269
I+ D K +N L+ + KL DFG+A + + V + VG + Y PE ++
Sbjct: 176 IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSS 234
Query: 270 ------TGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQ 323
+++ +SDVWS G LY + G+ P + ++ +
Sbjct: 235 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ---------------IINQISKLHA 279
Query: 324 IVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 364
I+DP E ++ L V CL ++ + R + E+L
Sbjct: 280 IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-36
Identities = 62/223 (27%), Positives = 102/223 (45%), Gaps = 29/223 (13%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL--GRRGGHKEWMTEVNFLGIVEHQNLVK 149
+GEG FG V+ N K+ VAVK L +++ E L +++HQ++V+
Sbjct: 48 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 150 LVGYCADDDERGIQRLLVYEYMPNGSVDQYL-------------SPKSETILTWAMRLKI 196
G C + L+V+EYM +G ++++L + L L +
Sbjct: 108 FFGVCTEGR----PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 197 AQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAV 256
A A G+ YL G+ F + RD + N L+ + K+ DFG++R S + V
Sbjct: 164 ASQVAAGMVYL-AGLHF--VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 220
Query: 257 ---VGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 295
+ M PE + + SDVWS+GV L+E+ T G++P
Sbjct: 221 MLPIRWM---PPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-36
Identities = 54/224 (24%), Positives = 98/224 (43%), Gaps = 40/224 (17%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQ--KVEVAVKQL--GRRGGHKEWMTEVNFLGIVEHQNL 147
+G+G F ++KG+ + D Q + EV +K L R + + + + + H++L
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74
Query: 148 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYL 207
V G C DE +LV E++ GS+D YL K++ + +L++A+ A + +L
Sbjct: 75 VLNYGVCVCGDEN----ILVQEFVKFGSLDTYLK-KNKNCINILWKLEVAKQLAAAMHFL 129
Query: 208 HEGMDFQIIVRDFKSSNILLDEQWN--------AKLSDFGLARLGPSEGFTHVSTAVVGT 259
E I + + NILL + + KLSD G++ V+
Sbjct: 130 -EENTL--IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT------------VLPK 174
Query: 260 MGY------AAPEYVQTGRL-AARSDVWSYGVFLYELIT-GRRP 295
PE ++ + +D WS+G L+E+ + G +P
Sbjct: 175 DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-36
Identities = 56/212 (26%), Positives = 97/212 (45%), Gaps = 24/212 (11%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNL 147
IGEG FG V++G+ + E+P + VA+K + ++++ E + +H ++
Sbjct: 22 CIGEGQFGDVHQGIYMSPENP--ALAVAIKTC-KNCTSDSVREKFLQEALTMRQFDHPHI 78
Query: 148 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYL 207
VKL+G ++ ++ E G + +L + L A + A + LAYL
Sbjct: 79 VKLIGVITEN-----PVWIIMELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTALAYL 132
Query: 208 HEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTM---GYAA 264
E F + RD + N+L+ KL DFGL+R + S + A
Sbjct: 133 -ESKRF--VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS----KGKLPIKWMA 185
Query: 265 PEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 295
PE + R + SDVW +GV ++E++ G +P
Sbjct: 186 PESINFRRFTSASDVWMFGVCMWEILMHGVKP 217
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-36
Identities = 65/226 (28%), Positives = 102/226 (45%), Gaps = 36/226 (15%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL--GRRGGHKEWMTEVNFLGIVEHQNLVKL 150
+GEG FG V+ N K+ VAVK L K++ E L ++H+++VK
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 151 VGYCADDDERGIQRLLVYEYMPNGSVDQYL--------------SPKSETILTWAMRLKI 196
G C D D ++V+EYM +G ++++L +++ L + L I
Sbjct: 83 YGVCGDGD----PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 197 AQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAV 256
A A G+ YL F + RD + N L+ K+ DFG++R S + V
Sbjct: 139 ASQIASGMVYL-ASQHF--VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGG-- 193
Query: 257 VGT------MGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 295
T M PE + + SDVWS+GV L+E+ T G++P
Sbjct: 194 -HTMLPIRWM---PPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-36
Identities = 61/297 (20%), Positives = 117/297 (39%), Gaps = 49/297 (16%)
Query: 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMT----EVNFLG 140
+ +S IG GG V++ L + + A+K + + + E+ +L
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNEKKQ------IYAIKYVNLEEADNQTLDSYRNEIAYLN 62
Query: 141 IVEHQNL--VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQ 198
++ + ++L Y D I +V E N ++ +L K + + R +
Sbjct: 63 KLQQHSDKIIRLYDYEITDQY--I--YMVMEC-GNIDLNSWL--KKKKSIDPWERKSYWK 115
Query: 199 DAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVG 258
+ + +H I+ D K +N L+ + KL DFG+A + + V + VG
Sbjct: 116 NMLEAVHTIH---QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVG 171
Query: 259 TMGYAAPEYVQ-----------TGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKL 307
T+ Y PE ++ +++ +SDVWS G LY + G+ P +
Sbjct: 172 TVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ--------- 222
Query: 308 LQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 364
++ + I+DP E ++ L V CL ++ + R + E+L
Sbjct: 223 ------IINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 273
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 4e-36
Identities = 64/214 (29%), Positives = 104/214 (48%), Gaps = 25/214 (11%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEW---MTEVNFLGIVEHQNLV 148
V+G G FG V G +K ++ VA+K L K+ + E + +G +H N++
Sbjct: 52 VVGAGEFGEVCSGRLKLPSKK--EISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 149 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLH 208
+L G ++V EYM NGS+D +L K + T + + + A G+ YL
Sbjct: 110 RLEGVVTKSKPV----MIVTEYMENGSLDSFLR-KHDAQFTVIQLVGMLRGIASGMKYL- 163
Query: 209 EGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMG------Y 262
M + + RD + NIL++ K+SDFGL R+ + A T G +
Sbjct: 164 SDMGY--VHRDLAARNILINSNLVCKVSDFGLGRVLEDD-----PEAAYTTRGGKIPIRW 216
Query: 263 AAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 295
+PE + + + SDVWSYG+ L+E+++ G RP
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 6e-36
Identities = 54/221 (24%), Positives = 96/221 (43%), Gaps = 29/221 (13%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEW---MTEVNFLGIVEHQNLV 148
+G+G FG VY+G+ K + VA+K + +E + E + + ++V
Sbjct: 32 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91
Query: 149 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYL--------SPKSETILTWAMRLKIAQDA 200
+L+G + L++ E M G + YL + + + +++A +
Sbjct: 92 RLLGVVSQGQ----PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 147
Query: 201 ARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTM 260
A G+AYL F + RD + N ++ E + K+ DFG+ R + G
Sbjct: 148 ADGMAYL-NANKF--VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY-----RKGGK 199
Query: 261 GY-----AAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 295
G +PE ++ G SDVWS+GV L+E+ T +P
Sbjct: 200 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 1e-35
Identities = 54/229 (23%), Positives = 95/229 (41%), Gaps = 39/229 (17%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGH-----KEWMTEVNFLGIVEHQN 146
+GE FG VYKG + Q VA+K L + +E+ E ++H N
Sbjct: 16 ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL--KDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 147 LVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYL--------------SPKSETILTWAM 192
+V L+G D +++ Y +G + ++L ++ L
Sbjct: 74 VVCLLGVVTKDQ----PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPD 129
Query: 193 RLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHV 252
+ + A G+ YL + +D + N+L+ ++ N K+SD GL R +
Sbjct: 130 FVHLVAQIAAGMEYL-SSHHV--VHKDLATRNVLVYDKLNVKISDLGLFREVYAA----- 181
Query: 253 STAVVGTMG-----YAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 295
+ + APE + G+ + SD+WSYGV L+E+ + G +P
Sbjct: 182 DYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-35
Identities = 60/217 (27%), Positives = 92/217 (42%), Gaps = 24/217 (11%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKE---WMTEVNFLGIVEHQNLV 148
+G GGFG V + + +++ +VA+KQ + K W E+ + + H N+V
Sbjct: 21 RLGTGGFGYVLRWIHQDT-----GEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 149 KLVGYCADDDERGIQR----LLVYEYMPNGSVDQYL-SPKSETILTWAMRLKIAQDAARG 203
D + + LL EY G + +YL ++ L + D +
Sbjct: 76 SA--REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 204 LAYLHEGMDFQIIVRDFKSSNILLD---EQWNAKLSDFGLARLGPSEGFTHVSTAVVGTM 260
L YLHE II RD K NI+L ++ K+ D G A+ VGT+
Sbjct: 134 LRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEF---VGTL 187
Query: 261 GYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPID 297
Y APE ++ + D WS+G +E ITG RP
Sbjct: 188 QYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFL 224
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-35
Identities = 63/285 (22%), Positives = 115/285 (40%), Gaps = 20/285 (7%)
Query: 17 TTPKSLFSIRSSCATFNDNEVGRIGSELTSQNVSAISVESEARPSYPSMSQRPSNLKEFT 76
F IR + Q V + +V Y + +
Sbjct: 322 NGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPS 381
Query: 77 IAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGH-----KE 131
+ + + IGEG FG V++G+ + E+P + VA+K + ++
Sbjct: 382 TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENP--AMAVAIKTC--KNCTSDSVREK 437
Query: 132 WMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWA 191
++ E + +H ++VKL+G ++ ++ E G + +L + + L A
Sbjct: 438 FLQEALTMRQFDHPHIVKLIGVITEN-----PVWIIMELCTLGELRSFLQVRKFS-LDLA 491
Query: 192 MRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTH 251
+ A + LAYL E F + RD + N+L+ KL DFGL+R +
Sbjct: 492 SLILYAYQLSTALAYL-ESKRF--VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK 548
Query: 252 VSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 295
S + + + APE + R + SDVW +GV ++E++ G +P
Sbjct: 549 ASKGKL-PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 592
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 5e-35
Identities = 60/221 (27%), Positives = 91/221 (41%), Gaps = 29/221 (13%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEW---MTEVNFLGIVEHQNLV 148
+G G FG VY+G + + ++VAVK L ++ + E + HQN+V
Sbjct: 37 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 96
Query: 149 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYL-----SPKSETILTWAMRLKIAQDAARG 203
+ +G R ++ E M G + +L P + L L +A+D A G
Sbjct: 97 RCIGVSLQSL----PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152
Query: 204 LAYLHEGMDFQIIVRDFKSSNILLDEQWN---AKLSDFGLARLGPSEGFTHVSTAVVGTM 260
YL E F I RD + N LL AK+ DFG+AR + G
Sbjct: 153 CQYL-EENHF--IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY-----RKGGC 204
Query: 261 GY-----AAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 295
PE G +++D WS+GV L+E+ + G P
Sbjct: 205 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 9e-35
Identities = 70/234 (29%), Positives = 105/234 (44%), Gaps = 54/234 (23%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTE---VNFLG-------I 141
VIGEG FG V K IK +++ A+K++ KE+ ++ +F G +
Sbjct: 32 VIGEGNFGQVLKARIKK---DGLRMDAAIKRM------KEYASKDDHRDFAGELEVLCKL 82
Query: 142 VEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYL--------------SPKSETI 187
H N++ L+G C L EY P+G++ +L + + +
Sbjct: 83 GHHPNIINLLGACEHRG----YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 138
Query: 188 LTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSE 247
L+ L A D ARG+ YL Q I RD + NIL+ E + AK++DFGL+R
Sbjct: 139 LSSQQLLHFAADVARGMDYL-SQK--QFIHRDLAARNILVGENYVAKIADFGLSR----- 190
Query: 248 GFTHVSTAVVGTMG-----YAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 295
V TMG + A E + SDVWSYGV L+E+++ G P
Sbjct: 191 ---GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-34
Identities = 62/223 (27%), Positives = 94/223 (42%), Gaps = 33/223 (14%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGH-----KEWMTEVNFLGIVEHQN 146
+G G FG VY+G + + ++VAVK L +++ E + HQN
Sbjct: 78 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--PEVCSEQDELDFLMEALIISKFNHQN 135
Query: 147 LVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYL---SPKSETILTWAMR--LKIAQDAA 201
+V+ +G R ++ E M G + +L P+ + AM L +A+D A
Sbjct: 136 IVRCIGVSLQSL----PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 191
Query: 202 RGLAYLHEGMDFQIIVRDFKSSNILLDEQWN---AKLSDFGLARLGPSEGFTHVSTAVVG 258
G YL E F I RD + N LL AK+ DFG+AR G+ G
Sbjct: 192 CGCQYL-EENHF--IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYY-----RKG 243
Query: 259 TMGY-----AAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 295
PE G +++D WS+GV L+E+ + G P
Sbjct: 244 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 4e-34
Identities = 72/329 (21%), Positives = 120/329 (36%), Gaps = 48/329 (14%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWM--TEVNFL-GIVEHQNLV 148
V+ EGGF VY+ +D E A+K+L K EV F+ + H N+V
Sbjct: 35 VLAEGGFAFVYEA-----QDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIV 89
Query: 149 KLVGYCADDDERGIQR----LLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGL 204
+ + E LL+ E V+ +S L+ LKI R +
Sbjct: 90 QFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAV 149
Query: 205 AYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA---RLGPSEGFTHVSTAVV---- 257
++H II RD K N+LL Q KL DFG A P ++ A+V
Sbjct: 150 QHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEI 208
Query: 258 ---GTMGYAAPEYVQTGR---LAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWV 311
T Y PE + + + D+W+ G LY L + P + ++ +++
Sbjct: 209 TRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG---AKLRIVN-- 263
Query: 312 KPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVD 371
++ S + L N R ++EV+ + +I
Sbjct: 264 -------GKYSIPPHDT----QYTVFHSLIRA----MLQVNPEERLSIAEVVHQLQEI-- 306
Query: 372 ASAEAGSPRRPLRSSTSRETPDHTKTKHK 400
A+A +P+ P+ + + T +
Sbjct: 307 AAARNVNPKSPITELLEQNGGYGSATLSR 335
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-33
Identities = 59/232 (25%), Positives = 89/232 (38%), Gaps = 43/232 (18%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTE---VNFLG-------I 141
+G G FG V + + + VAVK L KE T + I
Sbjct: 34 PLGRGAFGQVIEADAFGIDKTATCRTVAVKML------KEGATHSEHRALMSELKILIHI 87
Query: 142 VEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYL--------------SPKSETI 187
H N+V L+G C +++ E+ G++ YL +
Sbjct: 88 GHHLNVVNLLGACTKPGG---PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 144
Query: 188 LTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSE 247
LT + + A+G+ +L I RD + NILL E+ K+ DFGLAR +
Sbjct: 145 LTLEHLICYSFQVAKGMEFL-ASRKC--IHRDLAARNILLSEKNVVKICDFGLARDIYKD 201
Query: 248 GFTHVSTAV---VGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 295
+ M APE + +SDVWS+GV L+E+ + G P
Sbjct: 202 PDYVRKGDARLPLKWM---APETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-33
Identities = 63/237 (26%), Positives = 86/237 (36%), Gaps = 52/237 (21%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEW---MTEVNFL-GIVEHQNL 147
+G G FG V + + VAVK L E M+E+ L + H N+
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 148 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYL----------------SPKSETILTWA 191
V L+G C L++ EY G + +L E L
Sbjct: 90 VNLLGACTIGGP----TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145
Query: 192 MRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTH 251
L + A+G+A+L I RD + NILL K+ DFGLAR
Sbjct: 146 DLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARD-------- 194
Query: 252 VSTAVVGTMGYA------------APEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 295
+ Y APE + SDVWSYG+FL+EL + G P
Sbjct: 195 ----IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-33
Identities = 73/322 (22%), Positives = 114/322 (35%), Gaps = 51/322 (15%)
Query: 50 SAISVESEARPSYPSMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNS 109
+S EA + S PS + F ++F R +G G +G V+K ++
Sbjct: 29 RRVSFRGEASETLQSPGYDPSRPESFFQ-------QSFQRLSRLGHGSYGEVFKV--RSK 79
Query: 110 EDPSQKVEVAVKQLGRRG-GHKE---WMTEVNFL-GIVEHQNLVKLVGYCADDDERGIQR 164
ED AVK+ G K+ + EV + +H V+L +
Sbjct: 80 ED---GRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGG-----I 131
Query: 165 L-LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSS 223
L L E S+ Q+ L A +D LA+LH ++ D K +
Sbjct: 132 LYLQTELC-GPSLQQHCE-AWGASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPA 186
Query: 224 NILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYG 283
NI L + KL DFGL + G V G Y APE +Q A +DV+S G
Sbjct: 187 NIFLGPRGRCKLGDFGLLVELGTAGAGEV---QEGDPRYMAPELLQGSYGTA-ADVFSLG 242
Query: 284 VFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSH 343
+ + E+ Q+L + + P S S+L
Sbjct: 243 LTILEVACNMELPHGGEGW--QQL-------------RQGYLPPEFTAGLS----SELRS 283
Query: 344 VANLCLVKNARTRPKMSEVLEM 365
V + L + + R +L +
Sbjct: 284 VLVMMLEPDPKLRATAEALLAL 305
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 6e-33
Identities = 58/302 (19%), Positives = 104/302 (34%), Gaps = 49/302 (16%)
Query: 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKE---WMTEVNFLGI 141
+F +G GGFG V++ KN D A+K++ M EV L
Sbjct: 5 TDFEPIQCLGRGGFGVVFE--AKNKVD---DCNYAIKRIRLPNRELAREKVMREVKALAK 59
Query: 142 VEHQNLVKLVGYCADDDERGIQ-----RLLVY---EYMPNGSVDQYLSP-KSETILTWAM 192
+EH +V+ + + ++ +Y + ++ +++ + ++
Sbjct: 60 LEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSV 119
Query: 193 RLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL--------- 243
L I A + +LH ++ RD K SNI K+ DFGL
Sbjct: 120 CLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQT 176
Query: 244 -GPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPR 302
T VGT Y +PE + + + D++S G+ L+EL+ P
Sbjct: 177 VLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ--- 230
Query: 303 SEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEV 362
E+ R + P L + + L + RP+ +
Sbjct: 231 MERVRT---------LTDVRNLKFPPLFTQKY----PCEYVMVQDMLSPSPMERPEAINI 277
Query: 363 LE 364
+E
Sbjct: 278 IE 279
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 9e-33
Identities = 43/358 (12%), Positives = 84/358 (23%), Gaps = 59/358 (16%)
Query: 42 SELTSQNVSAISVESEARPSYPSMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCV 101
EL E A + + P N + + L + + G V
Sbjct: 19 EELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVV 78
Query: 102 YKGLIKNSEDPSQKVEVAVK-----QLGRRGGHKEWMTEVNFLGIVEHQNLVKLVGYC-- 154
+ D + + A+K R + + ++ +
Sbjct: 79 FLV-----RDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRL 133
Query: 155 --------------------ADDDERGIQRLLVYEYMPNGSVDQYLS-----PKSETILT 189
DD LL+ + ++ S
Sbjct: 134 LLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAA-SVDLELLFSTLDFVYVFRGDEG 192
Query: 190 WAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGF 249
+ R A L ++ F N+ + L D +
Sbjct: 193 ILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT--- 246
Query: 250 THVSTAVVGTMGYAAPEYVQTGRLA--ARSDVWSYGVFLYELITGRRPIDRNRPRSEQK- 306
A + YA E++ + W G+ +Y + P P +
Sbjct: 247 --RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSW 304
Query: 307 LLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 364
++ +D+ F K L+ + L + R R E +E
Sbjct: 305 KRPSLRVPGTDSLAFGSCTPLPDFVK---TLIGRF-------LNFDRRRRLLPLEAME 352
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-32
Identities = 57/356 (16%), Positives = 114/356 (32%), Gaps = 72/356 (20%)
Query: 45 TSQNVSAISVESEARPSYPSMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVY-- 102
+S S + ++ + ++ I + +G F +
Sbjct: 3 LGSMKDILSNYSNLIYLNKYVKEKDKYINDYRIIR------------TLNQGKFNKIILC 50
Query: 103 -------------KGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQNLVK 149
K L++ D ++ + + K E+ + ++++ +
Sbjct: 51 EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFK---NELQIITDIKNEYCLT 107
Query: 150 LVGYCADDDERGIQRL-LVYEYMPNGSVDQYLSPKSETILTWAMRL------KIAQDAAR 202
G + D + ++YEYM N S+ ++ + + I +
Sbjct: 108 CEGIITNYD-----EVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLN 162
Query: 203 GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGY 262
+Y+H + I RD K SNIL+D+ KLSDFG + + + + GT +
Sbjct: 163 SFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK---KIKGS-RGTYEF 216
Query: 263 AAPEYVQTGRLA---ARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK------P 313
PE+ + A+ D+WS G+ LY + P S +L ++ P
Sbjct: 217 MPPEFFS-NESSYNGAKVDIWSLGICLYVMFYNVVPFSLK--ISLVELFNNIRTKNIEYP 273
Query: 314 YLSDAKQFRQIVDPRLEGKYSL-----RLVSKLSHVANLCLVKNARTRPKMSEVLE 364
+ + L + L KN R + L+
Sbjct: 274 LDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLF-------LRKNPAERITSEDALK 322
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-32
Identities = 74/285 (25%), Positives = 119/285 (41%), Gaps = 55/285 (19%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMT-----EVNFLGIVEHQN 146
+G+G FG VY K S K +A+K L + K + EV + H N
Sbjct: 16 PLGKGKFGNVYLAREKQS-----KFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70
Query: 147 LVKLVGYCADDDERGIQRL-LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLA 205
+++L GY D R+ L+ EY P G+V + L + + + A L+
Sbjct: 71 ILRLYGYFHDAT-----RVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALS 123
Query: 206 YLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAP 265
Y H ++I RD K N+LL K++DFG + PS T + GT+ Y P
Sbjct: 124 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTDLCGTLDYLPP 176
Query: 266 EYVQTGRLAARSDVWSYGVFLYELITGRRPI-DRNRPRSEQKLLQWVK----PYLS-DAK 319
E ++ + D+WS GV YE + G+ P + +++ + V+ +++ A+
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR-VEFTFPDFVTEGAR 235
Query: 320 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 364
L+S+L L N RP + EVLE
Sbjct: 236 ----------------DLISRL-------LKHNPSQRPMLREVLE 257
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-32
Identities = 90/377 (23%), Positives = 139/377 (36%), Gaps = 79/377 (20%)
Query: 64 SMSQ--RPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVK 121
SM+ +L E ++ L+ F ++G G +G VYKG + A+K
Sbjct: 1 SMASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKT-----GQLAAIK 55
Query: 122 QLGRRGGHKEW-MTEVNFLG-IVEHQNLVKLVG-YCADDDERGIQRL-LVYEYMPNGSVD 177
+ G +E E+N L H+N+ G + + +L LV E+ GSV
Sbjct: 56 VMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVT 115
Query: 178 QYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 237
+ L I ++ RGL++LH+ ++I RD K N+LL E KL D
Sbjct: 116 DLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVD 172
Query: 238 FGL-ARLGPSEGFTHVSTAVVGT---MGYAAPEYVQTGRLA-----ARSDVWSYGVFLYE 288
FG+ A+L +T +GT M APE + +SD+WS G+ E
Sbjct: 173 FGVSAQL--DRTVGRRNT-FIGTPYWM---APEVIACDENPDATYDFKSDLWSLGITAIE 226
Query: 289 LITGRRP------------IDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEG-KYSL 335
+ G P I RN PRL+ K+S
Sbjct: 227 MAEGAPPLCDMHPMRALFLIPRNPA-------------------------PRLKSKKWS- 260
Query: 336 RLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASAEAGSPRRPLRSSTSRETPDHT 395
K CLVKN RP ++++ + + R L+ R
Sbjct: 261 ---KKFQSFIESCLVKNHSQRPATEQLMK--HPFIRDQPNERQVRIQLKDHIDR------ 309
Query: 396 KTKHKRRIIESKTRESG 412
K + E++ SG
Sbjct: 310 TKKKRGEKDETEYEYSG 326
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-32
Identities = 84/320 (26%), Positives = 124/320 (38%), Gaps = 70/320 (21%)
Query: 65 MSQRPSNLKEFTIAELKS-ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL 123
M+ P + LK+ + F++ IG+G FG V+KG+ + + VA+K +
Sbjct: 1 MAHSPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRT-----QKVVAIKII 55
Query: 124 GRRGGHKEW---MTEVNFLGIVEHQNLVKLVG-YCADDDERGIQRL-LVYEYMPNGSVDQ 178
E E+ L + + K G Y D L ++ EY+ GS
Sbjct: 56 DLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTK------LWIIMEYLGGGSALD 109
Query: 179 YLSPK--SETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLS 236
L P ET + I ++ +GL YLH + I RD K++N+LL E KL+
Sbjct: 110 LLEPGPLDETQIAT-----ILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLA 161
Query: 237 DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRP- 295
DFG+A G VGT + APE ++ +++D+WS G+ EL G P
Sbjct: 162 DFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPH 219
Query: 296 -----------IDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHV 344
I +N P P LEG YS L
Sbjct: 220 SELHPMKVLFLIPKNNP-------------------------PTLEGNYS----KPLKEF 250
Query: 345 ANLCLVKNARTRPKMSEVLE 364
CL K RP E+L+
Sbjct: 251 VEACLNKEPSFRPTAKELLK 270
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 7e-32
Identities = 64/237 (27%), Positives = 96/237 (40%), Gaps = 47/237 (19%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGH-----KEWMTEVNFLGIVEHQN 146
IGEG FG V++ VAVK L + ++ E + ++ N
Sbjct: 54 DIGEGAFGRVFQARAPGLLPYEPFTMVAVKML--KEEASADMQADFQREAALMAEFDNPN 111
Query: 147 LVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYL----------------------SPKS 184
+VKL+G CA L++EYM G ++++L S
Sbjct: 112 IVKLLGVCAVGK----PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 167
Query: 185 ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLG 244
L+ A +L IA+ A G+AYL F + RD + N L+ E K++DFGL+R
Sbjct: 168 PPPLSCAEQLCIARQVAAGMAYL-SERKF--VHRDLATRNCLVGENMVVKIADFGLSRNI 224
Query: 245 PSEGFTHVSTAVVGTMGY-----AAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 295
S PE + R SDVW+YGV L+E+ + G +P
Sbjct: 225 YSA-----DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 7e-32
Identities = 58/234 (24%), Positives = 95/234 (40%), Gaps = 50/234 (21%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGH----KEWMTEVNFL-GIVEHQN 146
+G G FG V + ++VAVK L + H + M+E+ + + +H+N
Sbjct: 53 TLGAGAFGKVVEATAFGLGKEDAVLKVAVKML-KSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 147 LVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYL------------SPKSETILTWAMRL 194
+V L+G C L++ EY G + +L + + + L
Sbjct: 112 IVNLLGACTHGGP----VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLL 167
Query: 195 KIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVST 254
+ A+G+A+L + I RD + N+LL AK+ DFGLAR
Sbjct: 168 HFSSQVAQGMAFL-ASKNC--IHRDVAARNVLLTNGHVAKIGDFGLARD----------- 213
Query: 255 AVVGTMGYA------------APEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 295
++ Y APE + +SDVWSYG+ L+E+ + G P
Sbjct: 214 -IMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 8e-32
Identities = 59/244 (24%), Positives = 93/244 (38%), Gaps = 61/244 (25%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGH-----KEWMTEVNFL-GIVEHQ 145
V+G G FG V ++VAVK L + + M+E+ + + H+
Sbjct: 52 VLGSGAFGKVMNATAYGISKTGVSIQVAVKML--KEKADSSEREALMSELKMMTQLGSHE 109
Query: 146 NLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYL---------------------SPKS 184
N+V L+G C L++EY G + YL +
Sbjct: 110 NIVNLLGACTLSGP----IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165
Query: 185 ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLG 244
+LT+ L A A+G+ +L + RD + N+L+ K+ DFGLAR
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARD- 221
Query: 245 PSEGFTHVSTAVVGTMGYA------------APEYVQTGRLAARSDVWSYGVFLYELIT- 291
++ Y APE + G +SDVWSYG+ L+E+ +
Sbjct: 222 -----------IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL 270
Query: 292 GRRP 295
G P
Sbjct: 271 GVNP 274
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 8e-32
Identities = 76/286 (26%), Positives = 117/286 (40%), Gaps = 56/286 (19%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMT-----EVNFLGIVEHQNL 147
+G+G F VY ++ +EVA+K + ++ +K M EV ++H ++
Sbjct: 19 LGKGSFAGVY--RAESIHT---GLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSI 73
Query: 148 VKLVGYCADDDERGIQRL-LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAY 206
++L Y D + + LV E NG +++YL + + R + Q G+ Y
Sbjct: 74 LELYNYFEDSN-----YVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQ-IITGMLY 127
Query: 207 LHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPE 266
LH I+ RD SN+LL N K++DFGLA H + GT Y +PE
Sbjct: 128 LHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC--GTPNYISPE 182
Query: 267 YVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK-------PYLS-DA 318
SDVWS G Y L+ GR P D + + L V +LS +A
Sbjct: 183 IATRSAHGLESDVWSLGCMFYTLLIGRPPFDT---DTVKNTLNKVVLADYEMPSFLSIEA 239
Query: 319 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 364
K L+ +L L +N R +S VL+
Sbjct: 240 K----------------DLIHQL-------LRRNPADRLSLSSVLD 262
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-31
Identities = 69/293 (23%), Positives = 117/293 (39%), Gaps = 60/293 (20%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG---HKEWMTEVNF-LGIVEHQNL 147
+G G +G V K PS ++ +AVK++ K + +++ + V+
Sbjct: 14 ELGRGAYGVVEKMRHV----PSGQI-MAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFT 68
Query: 148 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYL-------SPKSETILTWAMRLKIAQDA 200
V G + + I E M + S+D++ E IL KIA
Sbjct: 69 VTFYGALFREGDVWI----CMELM-DTSLDKFYKQVIDKGQTIPEDILG-----KIAVSI 118
Query: 201 ARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL-ARLGPSEGFTHVSTAVVGT 259
+ L +LH +I RD K SN+L++ K+ DFG+ L G
Sbjct: 119 VKALEHLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDI----DAGC 172
Query: 260 MGYAAPEYVQTGRLAA----RSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYL 315
Y APE + +SD+WS G+ + EL R P D +
Sbjct: 173 KPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYD---------------SWG 217
Query: 316 SDAKQFRQIVD---PRL-EGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 364
+ +Q +Q+V+ P+L K+S ++ + CL KN++ RP E+++
Sbjct: 218 TPFQQLKQVVEEPSPQLPADKFS----AEFVDFTSQCLKKNSKERPTYPELMQ 266
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 1e-31
Identities = 67/235 (28%), Positives = 99/235 (42%), Gaps = 43/235 (18%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGH-----KEWMTEVNFLGIVEHQN 146
+GEG FG V K + + + VAVK L + ++ ++E N L V H +
Sbjct: 30 TLGEGEFGKVVKATAFHLKGRAGYTTVAVKML--KENASPSELRDLLSEFNVLKQVNHPH 87
Query: 147 LVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYL----------------------SPKS 184
++KL G C+ D LL+ EY GS+ +L
Sbjct: 88 VIKLYGACSQDGP----LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143
Query: 185 ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLG 244
E LT + A ++G+ YL M + RD + NIL+ E K+SDFGL+R
Sbjct: 144 ERALTMGDLISFAWQISQGMQYL-AEMKL--VHRDLAARNILVAEGRKMKISDFGLSRDV 200
Query: 245 PSEGFTHVSTAV---VGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 295
E + V M A E + +SDVWS+GV L+E++T G P
Sbjct: 201 YEEDSYVKRSQGRIPVKWM---AIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-31
Identities = 68/288 (23%), Positives = 114/288 (39%), Gaps = 61/288 (21%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVK-----QLGRRGGHKEWMTEVNFLGIVEHQN 146
+G+G FG VY K + K +A+K QL + G + E+ + H N
Sbjct: 21 PLGKGKFGNVYLAREKQN-----KFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPN 75
Query: 147 LVKLVGYCADDDERGIQRL-LVYEYMPNGSVDQYLSPK---SETILTWAMRLKIAQDAAR 202
++++ Y D R+ L+ E+ P G + + L E + + A
Sbjct: 76 ILRMYNYFHDRK-----RIYLMLEFAPRGELYKELQKHGRFDE----QRSATFMEE-LAD 125
Query: 203 GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGY 262
L Y HE ++I RD K N+L+ + K++DFG + PS GT+ Y
Sbjct: 126 ALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-RRRTM---CGTLDY 178
Query: 263 AAPEYVQTGRLAARSDVWSYGVFLYELITGRRPI-DRNRPRSEQKLLQWVK----PYLS- 316
PE ++ + D+W GV YE + G P + + ++++ V P+LS
Sbjct: 179 LPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVN-VDLKFPPFLSD 237
Query: 317 DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 364
+K L+SKL L + R + V+E
Sbjct: 238 GSK----------------DLISKL-------LRYHPPQRLPLKGVME 262
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-31
Identities = 69/331 (20%), Positives = 114/331 (34%), Gaps = 93/331 (28%)
Query: 60 PSYPSMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVA 119
P + P + + + +G+GGF ++ D K A
Sbjct: 2 KEIPEVLVDPRSRRRYVRGRF------------LGKGGFAKCFEI-----SDADTKEVFA 44
Query: 120 VKQLGRRGGHKEWM-----TEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVY---EYM 171
K + + K E++ + HQ++V G+ D+D V+ E
Sbjct: 45 GKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDF-------VFVVLELC 97
Query: 172 PNGSVDQYLSPKSETILTWAMRLKIAQDAAR--------GLAYLHEGMDFQIIVRDFKSS 223
S+ + + L + AR G YLH +I RD K
Sbjct: 98 RRRSLLELHKRRK--------ALT--EPEARYYLRQIVLGCQYLHRNR---VIHRDLKLG 144
Query: 224 NILLDEQWNAKLSDFGLA-RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSY 282
N+ L+E K+ DFGLA ++ V GT Y APE + + DVWS
Sbjct: 145 NLFLNEDLEVKIGDFGLATKVEYDGERKKVL---CGTPNYIAPEVLSKKGHSFEVDVWSI 201
Query: 283 GVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSL------- 335
G +Y L+ G+ P + S K + +I + +YS+
Sbjct: 202 GCIMYTLLVGKPPFE----TSCLKET------------YLRIK----KNEYSIPKHINPV 241
Query: 336 --RLVSKLSHVANLCLVKNARTRPKMSEVLE 364
L+ K+ L + RP ++E+L
Sbjct: 242 AASLIQKM-------LQTDPTARPTINELLN 265
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-31
Identities = 62/307 (20%), Positives = 106/307 (34%), Gaps = 54/307 (17%)
Query: 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEW-MTEVNFLGIV 142
+F V+G+G FG V K +N+ D A+K++ ++EV L +
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKA--RNALD---SRYYAIKKIRHTEEKLSTILSEVMLLASL 59
Query: 143 EHQNLVKLVGYCADDDERGIQRL---------LVYEYMPNGSVDQYLSPK---SETILTW 190
HQ +V+ + + EY NG++ + + + W
Sbjct: 60 NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW 119
Query: 191 AMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFT 250
++ + L+Y+H II RD K NI +DE N K+ DFGLA+
Sbjct: 120 ----RLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDI 172
Query: 251 HVS------------TAVVGTMGYAAPEYVQ-TGRLAARSDVWSYGVFLYELITGRRPID 297
T+ +GT Y A E + TG + D++S G+ +E+I
Sbjct: 173 LKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFST-G 231
Query: 298 RNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRP 357
R +KL + P + + + + RP
Sbjct: 232 MERVNILKKLRSVSIEF-----------PPDFDDNKMKVEKKIIRL----LIDHDPNKRP 276
Query: 358 KMSEVLE 364
+L
Sbjct: 277 GARTLLN 283
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-31
Identities = 55/225 (24%), Positives = 82/225 (36%), Gaps = 27/225 (12%)
Query: 78 AELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVN 137
E + + +G G FG V++ D + AVK++ E E+
Sbjct: 51 YEYREEVHWMTHQPRVGRGSFGEVHRMK-----DKQTGFQCAVKKVRLEVFRVE---ELV 102
Query: 138 FLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPK---SETILTWAMRL 194
+ +V L G + I E + GS+ Q + E L
Sbjct: 103 ACAGLSSPRIVPLYGAVREGPWVNI----FMELLEGGSLGQLIKQMGCLPEDRA-----L 153
Query: 195 KIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQ-WNAKLSDFGLA-RLGPSEGFTHV 252
A GL YLH +I+ D K+ N+LL A L DFG A L P +
Sbjct: 154 YYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSL 210
Query: 253 STA--VVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRP 295
T + GT + APE V A+ D+WS + ++ G P
Sbjct: 211 LTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-31
Identities = 76/291 (26%), Positives = 115/291 (39%), Gaps = 57/291 (19%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEW---MTEVNFL-GIVEHQNL 147
+G G G V+K + + +AVKQ+ R G +E + +++ + + +
Sbjct: 32 EMGSGTCGQVWKMRFRKT-----GHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYI 86
Query: 148 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLS---PKSETILTWAMRLKIAQDAARGL 204
V+ G + + I E M + P E IL K+ + L
Sbjct: 87 VQCFGTFITNTDVFI----AMELMGTCAEKLKKRMQGPIPERILG-----KMTVAIVKAL 137
Query: 205 AYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL-ARLGPSEGFTHVSTAVVGTMGYA 263
YL E +I RD K SNILLDE+ KL DFG+ RL + G Y
Sbjct: 138 YYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA----KDRSAGCAAYM 191
Query: 264 APEYVQTGRLA-----ARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 318
APE + R+DVWS G+ L EL TG+ P +D
Sbjct: 192 APERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYK---------------NCKTDF 236
Query: 319 KQFRQIVD---PRLEG--KYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 364
+ +++ P L G +S S + CL K+ R RPK +++LE
Sbjct: 237 EVLTKVLQEEPPLLPGHMGFSGDFQSFV----KDCLTKDHRKRPKYNKLLE 283
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-31
Identities = 85/297 (28%), Positives = 123/297 (41%), Gaps = 64/297 (21%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG---HKEWMTEVNF-LGIVEHQNL 147
IG G +G V K + K S +AVK++ K+ + +++ + + +
Sbjct: 29 EIGRGAYGSVNKMVHKPS-----GQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYI 83
Query: 148 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLS--------PKSETILTWAMRLKIAQD 199
V+ G + + I E M + S D++ E IL KI
Sbjct: 84 VQFYGALFREGDCWI----CMELM-STSFDKFYKYVYSVLDDVIPEEILG-----KITLA 133
Query: 200 AARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL-ARLGPSEGFTHVSTAVVG 258
+ L +L E + +II RD K SNILLD N KL DFG+ +L S T G
Sbjct: 134 TVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTR----DAG 187
Query: 259 TMGYAAPEYVQTGRLAA----RSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPY 314
Y APE + RSDVWS G+ LYEL TGR P +
Sbjct: 188 CRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYP---------------KW 232
Query: 315 LSDAKQFRQIVD---PRL----EGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 364
S Q Q+V P+L E ++S ++ + NLCL K+ RPK E+L+
Sbjct: 233 NSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFV----NLCLTKDESKRPKYKELLK 285
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 4e-31
Identities = 63/231 (27%), Positives = 100/231 (43%), Gaps = 40/231 (17%)
Query: 92 VIGEGGFGCVYKGLIKN--SEDPSQKVEVAVKQLGRRGGHKEW---MTEVNFL-GIVEHQ 145
+GEG FG V + P + V VAVK L K+ ++E+ + I +H+
Sbjct: 42 PLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 146 NLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYL--------------SPKSETILTWA 191
N++ L+G C D ++ EY G++ +YL + E +T+
Sbjct: 102 NIINLLGACTQDGPL----YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 192 MRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTH 251
+ ARG+ YL I RD + N+L+ E K++DFGLAR + +
Sbjct: 158 DLVSCTYQLARGMEYL-ASQKC--IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214
Query: 252 VSTAVVGT------MGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 295
+T M APE + +SDVWS+GV ++E+ T G P
Sbjct: 215 KTT---NGRLPVKWM---APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 7e-31
Identities = 75/339 (22%), Positives = 123/339 (36%), Gaps = 69/339 (20%)
Query: 45 TSQNVSAISVESEARPSYPSMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKG 104
+ V A P P+ + + E + + + + R +G+GGF ++
Sbjct: 3 APADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVD--PRSRRRYVRGRFLGKGGFAKCFEI 60
Query: 105 LIKNSEDPSQKVEVAVKQLGRRGGHKEWM-----TEVNFLGIVEHQNLVKLVGYCADDDE 159
D K A K + + K E++ + HQ++V G+ D+D
Sbjct: 61 -----SDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDF 115
Query: 160 RGIQRLLVY---EYMPNGSVDQYLSPKSETILT-WAMRLKIAQDAARGLAYLHEGMDFQI 215
V+ E S+ + K LT R + Q G YLH +
Sbjct: 116 -------VFVVLELCRRRSLLELH--KRRKALTEPEARYYLRQ-IVLGCQYLHRNR---V 162
Query: 216 IVRDFKSSNILLDEQWNAKLSDFGLA-RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLA 274
I RD K N+ L+E K+ DFGLA ++ V GT Y APE + +
Sbjct: 163 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL---CGTPNYIAPEVLSKKGHS 219
Query: 275 ARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYS 334
DVWS G +Y L+ G+ P + S K + +I + +YS
Sbjct: 220 FEVDVWSIGCIMYTLLVGKPPFE----TSCLKET------------YLRI----KKNEYS 259
Query: 335 L---------RLVSKLSHVANLCLVKNARTRPKMSEVLE 364
+ L+ K+ L + RP ++E+L
Sbjct: 260 IPKHINPVAASLIQKM-------LQTDPTARPTINELLN 291
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 8e-31
Identities = 65/297 (21%), Positives = 106/297 (35%), Gaps = 56/297 (18%)
Query: 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFL-GIVEH 144
+F V+G G G + + ++ +VAVK++ EV L EH
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNR------DVAVKRILPEC-FSFADREVQLLRESDEH 77
Query: 145 QNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGL 204
N+++ +C + D + + E ++ +Y+ K L + Q GL
Sbjct: 78 PNVIRY--FCTEKDRQFQ--YIAIELCA-ATLQEYVEQKDFAHLGLEPI-TLLQQTTSGL 131
Query: 205 AYLHEGMDFQIIV-RDFKSSNILLDEQWN-----AKLSDFGLAR-LGPSEGFTHVSTAVV 257
A+LH IV RD K NIL+ A +SDFGL + L + V
Sbjct: 132 AHLHS----LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVP 187
Query: 258 GTMGYAAPEYVQ---TGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPY 314
GT G+ APE + D++S G Y +I+ P+
Sbjct: 188 GTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH-----------------PF 230
Query: 315 LSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANL-------CLVKNARTRPKMSEVLE 364
++ I L G SL + H + + + + RP VL+
Sbjct: 231 GKSLQRQANI----LLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 66/237 (27%), Positives = 98/237 (41%), Gaps = 52/237 (21%)
Query: 92 VIGEGGFGCVYKGLIKN--SEDPSQKVEVAVKQLGRRGGHKEWMTE---VNFL------- 139
+GEG FG V + P++ +VAVK L K TE + +
Sbjct: 76 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML------KSDATEKDLSDLISEMEMMK 129
Query: 140 GIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYL--------------SPKSE 185
I +H+N++ L+G C D ++ EY G++ +YL S E
Sbjct: 130 MIGKHKNIINLLGACTQDGPL----YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 185
Query: 186 TILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGP 245
L+ + A ARG+ YL I RD + N+L+ E K++DFGLAR
Sbjct: 186 EQLSSKDLVSCAYQVARGMEYL-ASKKC--IHRDLAARNVLVTEDNVMKIADFGLARDIH 242
Query: 246 SEGFTHVSTAVVGT------MGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 295
+ +T M APE + +SDVWS+GV L+E+ T G P
Sbjct: 243 HIDYYKKTT---NGRLPVKWM---APEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-30
Identities = 61/244 (25%), Positives = 103/244 (42%), Gaps = 32/244 (13%)
Query: 64 SMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQ- 122
SM E + E VV+G+G +G VY G ++ +V +A+K+
Sbjct: 1 SMRSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSN-----QVRIAIKEI 55
Query: 123 -LGRRGGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLS 181
+ E+ ++H+N+V+ +G +++ I E +P GS+ L
Sbjct: 56 PERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKI----FMEQVPGGSLSALLR 111
Query: 182 ------PKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLD-EQWNAK 234
+E + + GL YLH+ QI+ RD K N+L++ K
Sbjct: 112 SKWGPLKDNEQTIG-----FYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLK 163
Query: 235 LSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQ---TGRLAARSDVWSYGVFLYELIT 291
+SDFG ++ G + GT+ Y APE + G A +D+WS G + E+ T
Sbjct: 164 ISDFGTSKR--LAGINPCTETFTGTLQYMAPEIIDKGPRGYGKA-ADIWSLGCTIIEMAT 220
Query: 292 GRRP 295
G+ P
Sbjct: 221 GKPP 224
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-30
Identities = 82/310 (26%), Positives = 126/310 (40%), Gaps = 62/310 (20%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL---GRRGGHKEWMTEVNFLGIVEHQNLV 148
+G G G V+K K S + +A K + + + + E+ L +V
Sbjct: 40 ELGAGNGGVVFKVSHKPS-----GLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94
Query: 149 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYL---SPKSETILTWAMRLKIAQDAARGLA 205
G D E I E+M GS+DQ L E IL K++ +GL
Sbjct: 95 GFYGAFYSDGEISI----CMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLT 145
Query: 206 YLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA-RLGPSEGFTHVSTAVVGTMGYAA 264
YL E +I+ RD K SNIL++ + KL DFG++ +L S + V GT Y +
Sbjct: 146 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-----GTRSYMS 198
Query: 265 PEYVQTGRLAARSDVWSYGVFLYELITGRRPI--------------------------DR 298
PE +Q + +SD+WS G+ L E+ GR PI R
Sbjct: 199 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 258
Query: 299 NRPRSEQKLLQWVKPYLSDAKQFRQIVD---PRL-EGKYSLRLVSKLSHVANLCLVKNAR 354
R K +P ++ + IV+ P+L G +SL + N CL+KN
Sbjct: 259 TPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFV----NKCLIKNPA 314
Query: 355 TRPKMSEVLE 364
R + +++
Sbjct: 315 ERADLKQLMV 324
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 120 bits (301), Expect = 3e-30
Identities = 49/406 (12%), Positives = 104/406 (25%), Gaps = 82/406 (20%)
Query: 32 FNDNEVGR--IGSELTSQNVSAISVESEARPSYPSMSQRPSNLKEFTIAELKSATKNFSR 89
F + G I + + SE S S ++S R
Sbjct: 19 FRGTDPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPR 78
Query: 90 SV----VIGEGGFGCVYKGLIKNSEDPSQKVEVAVK------------------------ 121
++ V+G+ + D V
Sbjct: 79 TLVRGTVLGQEDPYAYLEA-----TDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLR 133
Query: 122 QLGRRGGHKEWMTEVNFLG---IVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQ 178
L K+ + F+ +V+ K++ D+ + + ++
Sbjct: 134 LLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQT 193
Query: 179 YLSPKSETI-----LTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNA 233
+ L RL++ R LA LH + ++ + +I+LD++
Sbjct: 194 FGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGV 250
Query: 234 KLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYV-----QTGRLAARSDVWSYGVFLYE 288
L+ F + + A + + D W+ G+ +Y
Sbjct: 251 FLTGFEHLVRDGASAVS-PIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW 309
Query: 289 LITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVD-PRLEGKYSLRLVSKLSHVANL 347
+ P + + +W+ FR + P+ L+
Sbjct: 310 IWCADLPNTDD---AALGGSEWI---------FRSCKNIPQ----PVRALLEGF------ 347
Query: 348 CLVKNARTRPKMSEVLE------MVNKIVDASAEAGSPRRPLRSST 387
L R + +E + ++ A + P R
Sbjct: 348 -LRYPKEDRLLPLQAMETPEYEQLRTELSAALPLYQTDGEPTREGG 392
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-30
Identities = 63/231 (27%), Positives = 100/231 (43%), Gaps = 40/231 (17%)
Query: 92 VIGEGGFGCVYKGLIKN--SEDPSQKVEVAVKQLGRRGGHKEW---MTEVNFL-GIVEHQ 145
+GEG FG V + P + V VAVK L K+ ++E+ + I +H+
Sbjct: 88 PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 147
Query: 146 NLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYL--------------SPKSETILTWA 191
N++ L+G C D ++ EY G++ +YL + E +T+
Sbjct: 148 NIINLLGACTQDGPL----YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 203
Query: 192 MRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTH 251
+ ARG+ YL I RD + N+L+ E K++DFGLAR + +
Sbjct: 204 DLVSCTYQLARGMEYL-ASQKC--IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 260
Query: 252 VSTAVVGT------MGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 295
+T M APE + +SDVWS+GV ++E+ T G P
Sbjct: 261 KTT---NGRLPVKWM---APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 5e-30
Identities = 43/349 (12%), Positives = 92/349 (26%), Gaps = 71/349 (20%)
Query: 55 ESEARPSYPSMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVY------------ 102
A S S S + +EL + R V+G+
Sbjct: 43 MQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFE 102
Query: 103 -KGLIKNSEDPSQKVE------VAVKQLGRRGGHKEWMTEVNFLG---IVEHQNLVKLVG 152
PS ++ + ++ L K+ + F+ +V+ K++
Sbjct: 103 VHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIR 162
Query: 153 YCADDDERGIQRLLVYEYMPNGSVDQYLS-----PKSETILTWAMRLKIAQDAARGLAYL 207
D+ + + ++ + + L RL++ R LA L
Sbjct: 163 VRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASL 222
Query: 208 HEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEY 267
H + ++ + +I+LD++ L+ F + G+ PE
Sbjct: 223 H---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD------GARVVSSVSRGFEPPEL 273
Query: 268 VQTGRLAA-----------RSDVWSYGVFLYELITGRRP-IDRNRPRSEQKLLQWVKPYL 315
+ D W+ G+ +Y + P + + + K
Sbjct: 274 EARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRSCKNIP 333
Query: 316 SDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 364
+ L+ L R + +E
Sbjct: 334 QPVRA----------------LLEGF-------LRYPKEDRLLPLQAME 359
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 6e-30
Identities = 42/254 (16%), Positives = 82/254 (32%), Gaps = 26/254 (10%)
Query: 60 PSYPSMSQRPSNLKEFTI-AELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEV 118
SYP+ + L E + +K ++GEG F VY+ + D K +
Sbjct: 39 SSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKF 98
Query: 119 AVKQLGRRGGHKEWMT--EVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSV 176
+K + ++ + L +K + +LV E G++
Sbjct: 99 VLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNG----SVLVGELYSYGTL 154
Query: 177 DQYL---SPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL------ 227
+ E ++ + + A + +H+ +II D K N +L
Sbjct: 155 LNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLE 211
Query: 228 -----DEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRL-AARSDVWS 281
D L D G + + TA T G+ E + + + + D +
Sbjct: 212 QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVE-MLSNKPWNYQIDYFG 270
Query: 282 YGVFLYELITGRRP 295
+Y ++ G
Sbjct: 271 VAATVYCMLFGTYM 284
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 6e-30
Identities = 50/214 (23%), Positives = 82/214 (38%), Gaps = 30/214 (14%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFL----------GI 141
++G GG G VY+ ED ++ VA+K + + ++ F G
Sbjct: 41 LVGRGGMGDVYEA-----EDTVRERIVALKLM-----SETLSSDPVFRTRMQREARTAGR 90
Query: 142 VEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAA 201
++ ++V + + D Q + + + L + + L + I +
Sbjct: 91 LQEPHVVPIHDFGEIDG----QLYVDMRLINGVDLAAML--RRQGPLAPPRAVAIVRQIG 144
Query: 202 RGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMG 261
L H RD K NIL+ A L DFG+A E T + VGT+
Sbjct: 145 SALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-TVGTLY 200
Query: 262 YAAPEYVQTGRLAARSDVWSYGVFLYELITGRRP 295
Y APE R+D+++ LYE +TG P
Sbjct: 201 YMAPERFSESHATYRADIYALTCVLYECLTGSPP 234
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-29
Identities = 58/214 (27%), Positives = 94/214 (43%), Gaps = 26/214 (12%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFL----------GIV 142
+G GG V+ D +VAVK L + + +F +
Sbjct: 20 LGFGGMSEVHLA-----RDLRDHRDVAVKVL-----RADLARDPSFYLRFRREAQNAAAL 69
Query: 143 EHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAAR 202
H +V + + G +V EY+ ++ + +E +T +++ DA +
Sbjct: 70 NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV--HTEGPMTPKRAIEVIADACQ 127
Query: 203 GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVST-AVVGTMG 261
L + H+ II RD K +NI++ K+ DFG+AR G + T AV+GT
Sbjct: 128 ALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 262 YAAPEYVQTGRLAARSDVWSYGVFLYELITGRRP 295
Y +PE + + ARSDV+S G LYE++TG P
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-29
Identities = 80/331 (24%), Positives = 133/331 (40%), Gaps = 56/331 (16%)
Query: 46 SQNVSAISVESEARPSYPSMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGL 105
S V + + + Q + L+ + + V IGEG G V
Sbjct: 8 SSGVDLGTENLYFQSGVVTHEQFKAALRM--VVDQGDPRLLLDSYVKIGEGSTGIVCLAR 65
Query: 106 IKNSEDPSQKVEVAVKQLGRRGGHKE--WMTEVNFLGIVEHQNLVKLVG-YCADDDERGI 162
K+S +VAVK + R + EV + +H N+V++ Y ++
Sbjct: 66 EKHS-----GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEE---- 116
Query: 163 QRL-LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFK 221
L ++ E++ G++ +S L + + + LAYLH +I RD K
Sbjct: 117 --LWVLMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIK 168
Query: 222 SSNILLDEQWNAKLSDFGL-ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVW 280
S +ILL KLSDFG A++ S+ + +VGT + APE + A D+W
Sbjct: 169 SDSILLTLDGRVKLSDFGFCAQI--SKDVPKRKS-LVGTPYWMAPEVISRSLYATEVDIW 225
Query: 281 SYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD--AKQFRQIVD---PRLEG--KY 333
S G+ + E++ G P PY SD + +++ D P+L+ K
Sbjct: 226 SLGIMVIEMVDG-EP-----------------PYFSDSPVQAMKRLRDSPPPKLKNSHKV 267
Query: 334 SLRLVSKLSHVANLCLVKNARTRPKMSEVLE 364
S L L LV++ + R E+L+
Sbjct: 268 SPVLRDFLE----RMLVRDPQERATAQELLD 294
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-29
Identities = 55/213 (25%), Positives = 92/213 (43%), Gaps = 30/213 (14%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFL----------GIV 142
+G GG VY ED ++VA+K + + L +
Sbjct: 19 LGGGGMSTVYLA-----EDTILNIKVAIKAI-----FIPPREKEETLKRFEREVHNSSQL 68
Query: 143 EHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAAR 202
HQN+V + D DE LV EY+ ++ +Y+ +S L+ +
Sbjct: 69 SHQNIVSM--I--DVDEEDDCYYLVMEYIEGPTLSEYI--ESHGPLSVDTAINFTNQILD 122
Query: 203 GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGY 262
G+ + H+ +I+ RD K NIL+D K+ DFG+A+ T + V+GT+ Y
Sbjct: 123 GIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ-TNHVLGTVQY 178
Query: 263 AAPEYVQTGRLAARSDVWSYGVFLYELITGRRP 295
+PE + +D++S G+ LYE++ G P
Sbjct: 179 FSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-29
Identities = 56/312 (17%), Positives = 100/312 (32%), Gaps = 73/312 (23%)
Query: 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQ--LGRRGGH--KEWMTEVNFL 139
T F IG G FG V+K D A+K+ G + + EV
Sbjct: 10 TTEFHELEKIGSGEFGSVFKC--VKRLD---GCIYAIKRSKKPLAGSVDEQNALREVYAH 64
Query: 140 -GIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLS--PKSETILTWAMRLKI 196
+ +H ++V+ A+DD IQ EY GS+ +S + + A +
Sbjct: 65 AVLGQHSHVVRYFSAWAEDDHMLIQ----NEYCNGGSLADAISENYRIMSYFKEAELKDL 120
Query: 197 AQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE-------------------QWNAKLSD 237
RGL Y+H ++ D K SNI + + K+ D
Sbjct: 121 LLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGD 177
Query: 238 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQ--TGRLAARSDVWSYGVFLYELITGRRP 295
G S G + A E +Q L +D+++ + +
Sbjct: 178 LGHVTRISS------PQVEEGDSRFLANEVLQENYTHLPK-ADIFALALTVVCAAGA--- 227
Query: 296 IDRNRPRSEQKLLQWVKPYLSDAKQFRQIVD---PRLEGKYSLRLVSKLSHVANLCLVKN 352
+P + Q+ +I PR+ S + + + + + +
Sbjct: 228 ----------------EPLPRNGDQWHEIRQGRLPRIPQVLS----QEFTELLKVMIHPD 267
Query: 353 ARTRPKMSEVLE 364
RP +++
Sbjct: 268 PERRPSAMALVK 279
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-29
Identities = 73/288 (25%), Positives = 121/288 (42%), Gaps = 44/288 (15%)
Query: 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKE--WMTEVNFLGI 141
K ++R IG+G G VY + + EVA++Q+ + K+ + E+ +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVAT-----GQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 142 VEHQNLVKLVG-YCADDDERGIQRL-LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQD 199
++ N+V + Y D+ L +V EY+ GS+ ++ T + + ++
Sbjct: 74 NKNPNIVNYLDSYLVGDE------LWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRE 124
Query: 200 AARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL-ARLGPSEGFTHVSTAVVG 258
+ L +LH Q+I RD KS NILL + KL+DFG A++ + + ST +VG
Sbjct: 125 CLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI--TPEQSKRST-MVG 178
Query: 259 TMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 318
T + APE V + D+WS G+ E+I G P P L+
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT----- 233
Query: 319 KQFRQIVDPRLEG--KYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 364
P L+ K S L+ CL + R E+L+
Sbjct: 234 --------PELQNPEKLSAIFRDFLN----RCLEMDVEKRGSAKELLQ 269
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-28
Identities = 80/321 (24%), Positives = 121/321 (37%), Gaps = 57/321 (17%)
Query: 63 PSMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQ 122
S N ++ + E VIG G V P ++ VA+K+
Sbjct: 5 SSALPWSINRDDYELQE------------VIGSGATAVVQAAYCA----PKKEK-VAIKR 47
Query: 123 LGRRGGHKEW---MTEVNFLGIVEHQNLVKLVG-YCADDDERGIQRL-LVYEYMPNGSVD 177
+ + E+ + H N+V + D+ L LV + + GSV
Sbjct: 48 INLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE------LWLVMKLLSGGSVL 101
Query: 178 QYLSPKSETILTWAMRLK------IAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW 231
+ + L I ++ GL YLH+ I RD K+ NILL E
Sbjct: 102 DIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDG 158
Query: 232 NAKLSDFGL-ARLGPSEGFTHVS--TAVVGT---MGYAAPEYVQTGRL-AARSDVWSYGV 284
+ +++DFG+ A L T VGT M APE ++ R ++D+WS+G+
Sbjct: 159 SVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWM---APEVMEQVRGYDFKADIWSFGI 215
Query: 285 FLYELITGRRPIDRNRP-RSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSH 343
EL TG P + P + LQ P L Q D + KY +S
Sbjct: 216 TAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQ-----DKEMLKKYGKSFRKMIS- 269
Query: 344 VANLCLVKNARTRPKMSEVLE 364
LCL K+ RP +E+L
Sbjct: 270 ---LCLQKDPEKRPTAAELLR 287
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-28
Identities = 77/298 (25%), Positives = 123/298 (41%), Gaps = 64/298 (21%)
Query: 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVE 143
+ F +GEG +G VYK + K + VA+KQ+ +E + E++ + +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKET-----GQIVAIKQVPVESDLQEIIKEISIMQQCD 82
Query: 144 HQNLVKLVG-YCADDDERGIQRL-LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAA 201
++VK G Y + D L +V EY GSV + + LT I Q
Sbjct: 83 SPHVVKYYGSYFKNTD------LWIVMEYCGAGSVSDIIRLR-NKTLTEDEIATILQSTL 135
Query: 202 RGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL-ARLGPSEGFTHVSTAVVGTM 260
+GL YLH + I RD K+ NILL+ + +AKL+DFG+ +L ++ +T V+GT
Sbjct: 136 KGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQL--TDTMAKRNT-VIGTP 189
Query: 261 GYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRP------------IDRNRPRSEQKLL 308
+ APE +Q +D+WS G+ E+ G+ P I N P
Sbjct: 190 FWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPP------- 242
Query: 309 QWVKPYLSDAKQFRQIVDPRLEG--KYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 364
P +S + CLVK+ R +++L+
Sbjct: 243 ------------------PTFRKPELWSDNFTDFVK----QCLVKSPEQRATATQLLQ 278
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-27
Identities = 84/356 (23%), Positives = 126/356 (35%), Gaps = 85/356 (23%)
Query: 42 SELTSQNVSAISVESEARPSYPSM------SQRPSNLKEFTIAELKSA---TKNFSRSVV 92
S + + + + R +LK+ +AEL K FS
Sbjct: 2 SYYHHHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLRE 61
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQ--LGRRGGHKEW---MTEVNFLGIVEHQNL 147
IG G FG VY + + VA+K+ + +++W + EV FL + H N
Sbjct: 62 IGHGSFGAVYFARDVRNSE-----VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNT 116
Query: 148 VKLVG-YCADDDERGIQRL-LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLA 205
++ G Y + LV EY + D + L + A +GLA
Sbjct: 117 IQYRGCYLREHT------AWLVMEYCLGSASDLLEV--HKKPLQEVEIAAVTHGALQGLA 168
Query: 206 YLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL-ARLGPSEGFTHVSTAVVGTMGYAA 264
YLH +I RD K+ NILL E KL DFG + + P+ F VGT + A
Sbjct: 169 YLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSF-------VGTPYWMA 218
Query: 265 PEYVQTGRLA---ARSDVWSYGVFLYELITGRRP------------IDRNRPRSEQKLLQ 309
PE + + DVWS G+ EL + P I +N
Sbjct: 219 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-------- 270
Query: 310 WVKPYLSDAKQFRQIVDPRLE-GKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 364
P L+ G +S + + CL K + RP +L+
Sbjct: 271 -----------------PALQSGHWSEYFRNFVD----SCLQKIPQDRPTSEVLLK 305
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 66/319 (20%), Positives = 102/319 (31%), Gaps = 59/319 (18%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPS-QKVEVAVKQLGRRGGHKEWMT----EVNFLGIVEHQN 146
I GG G +Y D + V +K L G E E FL V H +
Sbjct: 87 CIAHGGLGWIYLA-----LDRNVNGRPVVLKGL-VHSGDAEAQAMAMAERQFLAEVVHPS 140
Query: 147 LVKLVGYCADDDERGIQRL-LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLA 205
+V++ + D G +V EY+ S+ + K L A + + L+
Sbjct: 141 IVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK----LPVAEAIAYLLEILPALS 196
Query: 206 YLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAP 265
YLH ++ D K NI+L E+ KL D G + GT G+ AP
Sbjct: 197 YLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVS-----RINSFG-YLYGTPGFQAP 246
Query: 266 EYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIV 325
E V +D+++ G L L
Sbjct: 247 EIV-RTGPTVATDIYTVGRTLAALTLDLP------------------TRNGRYVDGLPED 287
Query: 326 DPRLEGKYSL-RLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASAEAGSPR---- 380
DP L+ S RL+ + + + R R +E EM ++ E +
Sbjct: 288 DPVLKTYDSYGRLLRR-------AIDPDPRQRFTTAE--EMSAQLTGVLREVVAQDTGVP 338
Query: 381 RPLRSSTSRETPDHTKTKH 399
RP S+ +
Sbjct: 339 RPGLSTIFSPSRSTFGVDL 357
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-27
Identities = 71/308 (23%), Positives = 121/308 (39%), Gaps = 77/308 (25%)
Query: 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHK--EWMTEVNFLGI 141
+ + +G+G FG VYK K + A K + + + +++ E+ L
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKET-----GALAAAKVIETKSEEELEDYIVEIEILAT 72
Query: 142 VEHQNLVKLVG-YCADDDERGIQRL-LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQD 199
+H +VKL+G Y D L ++ E+ P G+VD + LT + +
Sbjct: 73 CDHPYIVKLLGAYYHDGK------LWIMIEFCPGGAVDAIMLELDRG-LTEPQIQVVCRQ 125
Query: 200 AARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL-ARLGPSEGFTHVSTAVVG 258
L +LH +II RD K+ N+L+ + + +L+DFG+ A+ + + +G
Sbjct: 126 MLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKN--LKTLQKRDS-FIG 179
Query: 259 T---MGYAAPEYVQTGRLA-----ARSDVWSYGVFLYELITGRRP------------IDR 298
T M APE V + ++D+WS G+ L E+ P I +
Sbjct: 180 TPYWM---APEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK 236
Query: 299 NRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLE--GKYSLRLVSKLSHVANLCLVKNARTR 356
+ P P L K+S+ L + L KN TR
Sbjct: 237 SDP-------------------------PTLLTPSKWSVEFRDFLK----IALDKNPETR 267
Query: 357 PKMSEVLE 364
P +++LE
Sbjct: 268 PSAAQLLE 275
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 8e-27
Identities = 65/378 (17%), Positives = 110/378 (29%), Gaps = 63/378 (16%)
Query: 66 SQRPSNLKEFTIAELKSATKNFSRSVVIGEG--GFGCVYKGLIKNSEDPSQKVEVAVKQL 123
NL ++ + VIG+G V K P+ + V V+++
Sbjct: 6 HHHMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYK----PTGEY-VTVRRI 60
Query: 124 ----GRRGGHKEWMTEVNFLGIVEHQNLVKLVG-YCADDDERGIQRL-LVYEYMPNGSVD 177
E++ + H N+V + AD++ L +V +M GS
Sbjct: 61 NLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE------LWVVTSFMAYGSAK 114
Query: 178 QYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 237
+ + I Q + L Y+H + R K+S+IL+ LS
Sbjct: 115 DLICTHFMDGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSG 171
Query: 238 FGLARLGPSEG-----FTHVSTAVVGTMGYAAPEYVQTGRLA--ARSDVWSYGVFLYELI 290
S G V + + +PE +Q A+SD++S G+ EL
Sbjct: 172 LRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELA 231
Query: 291 TGRRP------------IDRNRP----------------RSEQKLLQWVKPYLSDAKQFR 322
G P + + R
Sbjct: 232 NGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPR 291
Query: 323 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE------MVNKIVDASAEA 376
Y H CL +N RP S +L + + +A E
Sbjct: 292 PSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRASEALPEL 351
Query: 377 GSPRRPLRSSTSRETPDH 394
P P+ + ++ DH
Sbjct: 352 LRPVTPITNFEGSQSQDH 369
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 9e-27
Identities = 73/288 (25%), Positives = 115/288 (39%), Gaps = 62/288 (21%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWM----TEVNFLGIVEHQNLV 148
IG+G F V + EVA+K + + + + EV + I+ H N+V
Sbjct: 23 IGKGNFAKVKLARHILT-----GREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIV 77
Query: 149 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAAR------ 202
KL + + E+ + L+ EY G V YL R+K + AR
Sbjct: 78 KL--FEVIETEKTL--YLIMEYASGGEVFDYLVAHG--------RMK--EKEARSKFRQI 123
Query: 203 --GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTM 260
+ Y H+ I+ RD K+ N+LLD N K++DFG + G G
Sbjct: 124 VSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF---CGAP 177
Query: 261 GYAAPEYVQTGRL--AARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 318
YAAPE Q G+ DVWS GV LY L++G P D +
Sbjct: 178 PYAAPELFQ-GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ----------------NLK 220
Query: 319 KQFRQIVDPRLEGKYSL--RLVSKLSHVANLCLVKNARTRPKMSEVLE 364
+ ++ L GKY + + + ++ LV N R + ++++
Sbjct: 221 ELRERV----LRGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 79/369 (21%), Positives = 130/369 (35%), Gaps = 81/369 (21%)
Query: 27 SSCATF-NDNEVGRIGS-ELTSQNVSAISVESEARPSYPSMSQRPSNLKEFTIAELKSAT 84
S TF N VG+ L + + A+S+ + ++ ++ K+
Sbjct: 81 SGNGTFVNTELVGKGKRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYP------KALR 134
Query: 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR----GGHKEW------MT 134
+ S +G G G V + + +VA++ + +R G +E T
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKT-----CKKVAIRIISKRKFAIGSAREADPALNVET 189
Query: 135 EVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRL 194
E+ L + H ++K+ + +D +V E M G + + L A
Sbjct: 190 EIEILKKLNHPCIIKIKNFFDAED-----YYIVLELMEGGELFDKVVGNKR--LKEATCK 242
Query: 195 KIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL---DEQWNAKLSDFGLARLGPSEGFTH 251
+ YLHE II RD K N+LL +E K++DFG +++
Sbjct: 243 LYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM- 298
Query: 252 VSTAVVGTMGYAAPEYVQTGRLAARS---DVWSYGVFLYELITGRRPIDRNRPRSEQKLL 308
+ GT Y APE + + A + D WS GV L+ ++G P +R
Sbjct: 299 --RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR-------- 348
Query: 309 QWVKPYLSDAKQFRQIVDPRLEGKYSLR-------------LVSKLSHVANLCLVKNART 355
+ QI GKY+ LV KL LV + +
Sbjct: 349 -------TQVSLKDQI----TSGKYNFIPEVWAEVSEKALDLVKKL-------LVVDPKA 390
Query: 356 RPKMSEVLE 364
R E L
Sbjct: 391 RFTTEEALR 399
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 59/303 (19%), Positives = 107/303 (35%), Gaps = 59/303 (19%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLG-IVEHQNLVKL 150
++G G G V VAVK++ + E+ L +H N+++
Sbjct: 22 ILGYGSSGTVVFQGSFQGR------PVAVKRM-LIDFCDIALMEIKLLTESDDHPNVIRY 74
Query: 151 VGYCADDDERGIQRLLVYEYMPNGSVDQYL-----SPKSETILTWAMRLKIAQDAARGLA 205
YC++ +R + + E N ++ + S ++ + + + + A G+A
Sbjct: 75 --YCSETTDRFL--YIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129
Query: 206 YLHEGMDFQIIV-RDFKSSNILLD-------------EQWNAKLSDFGLAR-LGPSE-GF 249
+LH I+ RD K NIL+ E +SDFGL + L + F
Sbjct: 130 HLHS----LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSF 185
Query: 250 THVSTAVVGTMGYAAPEYVQTGRLAARS-------DVWSYGVFLYELIT-GRRPIDRNRP 301
GT G+ APE ++ D++S G Y +++ G+ P
Sbjct: 186 RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245
Query: 302 RSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSE 361
R + R ++ E L+S+ + + RP +
Sbjct: 246 RESNIIRGIFSLDEMKCLHDRSLIA---EAT---DLISQ-------MIDHDPLKRPTAMK 292
Query: 362 VLE 364
VL
Sbjct: 293 VLR 295
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-26
Identities = 64/266 (24%), Positives = 105/266 (39%), Gaps = 29/266 (10%)
Query: 51 AISVESEARPSYPSMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSE 110
+ E +Q P ++ ++F ++GEG F V +
Sbjct: 3 GTAAEPRPGAGSLQHAQPPPQPRKKRP-------EDFKFGKILGEGSFSTVVLARELATS 55
Query: 111 DPSQKVEVAVKQLG-----RRGGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRL 165
E A+K L + E + + ++H VKL DD+ +L
Sbjct: 56 R-----EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE-----KL 105
Query: 166 -LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSN 224
Y NG + +Y+ K + R A+ L YLH II RD K N
Sbjct: 106 YFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAE-IVSALEYLHG---KGIIHRDLKPEN 160
Query: 225 ILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGV 284
ILL+E + +++DFG A++ E + + VGT Y +PE + SD+W+ G
Sbjct: 161 ILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGC 220
Query: 285 FLYELITGRRP-IDRNRPRSEQKLLQ 309
+Y+L+ G P N QK+++
Sbjct: 221 IIYQLVAGLPPFRAGNEYLIFQKIIK 246
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 5e-26
Identities = 57/324 (17%), Positives = 104/324 (32%), Gaps = 60/324 (18%)
Query: 63 PSMSQRPSNLKEFTIAELKSATKNFSR-----SVVIGEGGFGCVYKGLIKNSEDPSQKVE 117
S+ E + + V+G G G V + + + +
Sbjct: 2 AHHHHHHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRT-----GQK 56
Query: 118 VAVKQLGRRGGHKEWMTEVNFLG-IVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSV 176
A+K L + EV+ ++V ++ + L++ E M G +
Sbjct: 57 CALKLLYDS---PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGEL 113
Query: 177 DQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL---DEQWNA 233
+ + + T +I +D + +LH I RD K N+L ++
Sbjct: 114 FSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVL 170
Query: 234 KLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGR 293
KL+DFG A+ T Y APE + + D+WS GV +Y L+ G
Sbjct: 171 KLTDFGFAKETTQNALQ----TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGF 226
Query: 294 RPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLR-------------LVSK 340
P N ++ + R+I G+Y L+
Sbjct: 227 PPFYSNTGQAISPGM------------KRRI----RLGQYGFPNPEWSEVSEDAKQLIRL 270
Query: 341 LSHVANLCLVKNARTRPKMSEVLE 364
L L + R +++ +
Sbjct: 271 L-------LKTDPTERLTITQFMN 287
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-26
Identities = 70/323 (21%), Positives = 123/323 (38%), Gaps = 51/323 (15%)
Query: 55 ESEARPSYPSMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQ 114
S R + + F ++ ++ + R +G G +G V K +
Sbjct: 7 HSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVT----- 61
Query: 115 KVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEY 170
VE A+K + + + + + EV L +++H N++KL + D LV E
Sbjct: 62 HVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKR----NYYLVMEC 117
Query: 171 MPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL--- 227
G + + I + G+ YLH+ I+ RD K N+LL
Sbjct: 118 YKGGELFDEI--IHRMKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESK 172
Query: 228 DEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLY 287
++ K+ DFGL+ + +GT Y APE V + + DVWS GV L+
Sbjct: 173 EKDALIKIVDFGLSAV---FENQKKMKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILF 228
Query: 288 ELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLV--SKLSHVA 345
L+ G P +++Q++ R++ +GKY+ +S A
Sbjct: 229 ILLAGYPPFGG---QTDQEI-------------LRKV----EKGKYTFDSPEWKNVSEGA 268
Query: 346 ----NLCLVKNARTRPKMSEVLE 364
L +++ R + LE
Sbjct: 269 KDLIKQMLQFDSQRRISAQQALE 291
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-25
Identities = 72/290 (24%), Positives = 115/290 (39%), Gaps = 61/290 (21%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMT-----EVNFLGIVEHQNL 147
+GEG +G V + + VAVK + + E+ ++ H+N+
Sbjct: 15 LGEGAYGEVQLA-----VNRVTEEAVAVKIVDMK--RAVDCPENIKKEICINKMLNHENV 67
Query: 148 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAAR----- 202
VK G+ + + L EY G + + P + + A+
Sbjct: 68 VKFYGHRREGNI--Q--YLFLEYCSGGELFDRIEPDI--------GMP--EPDAQRFFHQ 113
Query: 203 ---GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA---RLGPSEGFTHVSTAV 256
G+ YLH I RD K N+LLDE+ N K+SDFGLA R E +
Sbjct: 114 LMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM--- 167
Query: 257 VGTMGYAAPEYVQTGRL--AARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPY 314
GT+ Y APE + R A DVWS G+ L ++ G P D+ S Q+ W +
Sbjct: 168 CGTLPYVAPE-LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS-DSCQEYSDWKE-- 223
Query: 315 LSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 364
K+ +++ L L+ K+ LV+N R + ++ +
Sbjct: 224 ----KKTYLNPWKKID-SAPLALLHKI-------LVENPSARITIPDIKK 261
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-25
Identities = 52/224 (23%), Positives = 86/224 (38%), Gaps = 39/224 (17%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMT------EVNFLGIVEHQ 145
++GEG +G V + D AVK L ++ + E+ L + H+
Sbjct: 12 LLGEGSYGKVKEV-----LDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHK 66
Query: 146 NLVKLVGYCADDDERGIQRLLVYEYMPNGSVD--QYLSPKSETILTWAMRLKIAQDAAR- 202
N+++LV +++++ + +V EY G + + K R + Q A
Sbjct: 67 NVIQLVDVLYNEEKQKM--YMVMEYCVCGMQEMLDSVPEK---------RFPVCQ--AHG 113
Query: 203 -------GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTA 255
GL YLH I+ +D K N+LL K+S G+A
Sbjct: 114 YFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT 170
Query: 256 VVGTMGYAAPEYVQTGRL--AARSDVWSYGVFLYELITGRRPID 297
G+ + PE + D+WS GV LY + TG P +
Sbjct: 171 SQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-25
Identities = 65/220 (29%), Positives = 93/220 (42%), Gaps = 41/220 (18%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMT-----EVNFLGIVEHQNL 147
+G G FG V G E +VAVK L R+ + E+ L + H ++
Sbjct: 19 LGVGTFGKVKIG-----EHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHI 73
Query: 148 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAAR----- 202
+KL Y +V EY+ G + Y+ R++ + AR
Sbjct: 74 IKL--YQVISTPTDF--FMVMEYVSGGELFDYICKHG--------RVE--EMEARRLFQQ 119
Query: 203 ---GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGT 259
+ Y H ++ RD K N+LLD NAK++DFGL+ + F S G+
Sbjct: 120 ILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS---CGS 173
Query: 260 MGYAAPEYVQTGRL--AARSDVWSYGVFLYELITGRRPID 297
YAAPE + GRL D+WS GV LY L+ G P D
Sbjct: 174 PNYAAPEVIS-GRLYAGPEVDIWSCGVILYALLCGTLPFD 212
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 71/283 (25%), Positives = 119/283 (42%), Gaps = 44/283 (15%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVK-----QLGRRGGHKEWMTEVNFLGIVEHQN 146
V+G+G FG V K + E AVK Q+ ++ + + EV L ++H N
Sbjct: 33 VLGKGSFGEVILCKDKIT-----GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 147 LVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAY 206
++KL + D LV E G + + S + +I + G+ Y
Sbjct: 88 IMKLYEFFEDKG----YFYLVGEVYTGGELFDEI--ISRKRFSEVDAARIIRQVLSGITY 141
Query: 207 LHEGMDFQIIVRDFKSSNILL---DEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYA 263
+H+ +I+ RD K N+LL + N ++ DFGL+ + +GT Y
Sbjct: 142 MHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH---FEASKKMKDKIGTAYYI 195
Query: 264 APEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK--PYLSDAKQF 321
APE V G + DVWS GV LY L++G P + +E +L+ V+ Y + Q+
Sbjct: 196 APE-VLHGTYDEKCDVWSTGVILYILLSGCPPFNG---ANEYDILKKVEKGKYTFELPQW 251
Query: 322 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 364
+++ + K L+ K+ L R + L+
Sbjct: 252 KKVSE---SAK---DLIRKM-------LTYVPSMRISARDALD 281
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 67/351 (19%), Positives = 111/351 (31%), Gaps = 91/351 (25%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMT----------EVNFLGIV 142
+G G FG V+ D + EV VK + + ++ E+ L V
Sbjct: 32 LGSGAFGFVWTA-----VDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV 86
Query: 143 EHQNLVKLVGYCADDDERGIQRLLVYEYMPNGS-VDQYLSPKSETILTWAMRLKIAQDAA 201
EH N++K+ +++ Q LV E +G + ++ RL + A
Sbjct: 87 EHANIIKV--LDIFENQGFFQ--LVMEKHGSGLDLFAFIDRHP--------RLD--EPLA 132
Query: 202 R--------GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVS 253
+ YL II RD K NI++ E + KL DFG A +
Sbjct: 133 SYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTF 189
Query: 254 TAVVGTMGYAAPEYVQTGRL--AARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWV 311
GT+ Y APE + G ++WS GV LY L+ P
Sbjct: 190 ---CGTIEYCAPEVLM-GNPYRGPELEMWSLGVTLYTLVFEENPFC-------------- 231
Query: 312 KPYLSDAKQFRQIVDPRLEGKYSL---------RLVSKLSHVANLCLVKNARTRPKMSEV 362
+ + +E LVS L L R + ++
Sbjct: 232 --------ELEET----VEAAIHPPYLVSKELMSLVSGL-------LQPVPERRTTLEKL 272
Query: 363 LEM--VNKIVDASAEAGSPRRPLRSSTSRETPDHTKTKHKRRIIESKTRES 411
+ V + V+ + + S + R + + +
Sbjct: 273 VTDPWVTQPVNLADYTWEEVFRVNKPESGVLSAASLEMGNRSLSDVAQAQE 323
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 4e-25
Identities = 72/290 (24%), Positives = 115/290 (39%), Gaps = 61/290 (21%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMT-----EVNFLGIVEHQNL 147
+GEG +G V + + VAVK + + E+ ++ H+N+
Sbjct: 15 LGEGAYGEVQLA-----VNRVTEEAVAVKIVDMK--RAVDCPENIKKEICINKMLNHENV 67
Query: 148 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAAR----- 202
VK G+ + + L EY G + + P + + A+
Sbjct: 68 VKFYGHRREGNI--Q--YLFLEYCSGGELFDRIEPDI--------GMP--EPDAQRFFHQ 113
Query: 203 ---GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA---RLGPSEGFTHVSTAV 256
G+ YLH I RD K N+LLDE+ N K+SDFGLA R E +
Sbjct: 114 LMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM--- 167
Query: 257 VGTMGYAAPEYVQTGRL--AARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPY 314
GT+ Y APE + R A DVWS G+ L ++ G P D+ S Q+ W +
Sbjct: 168 CGTLPYVAPE-LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS-DSCQEYSDWKE-- 223
Query: 315 LSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 364
K+ +++ L L+ K+ LV+N R + ++ +
Sbjct: 224 ----KKTYLNPWKKID-SAPLALLHKI-------LVENPSARITIPDIKK 261
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 7e-25
Identities = 73/405 (18%), Positives = 129/405 (31%), Gaps = 111/405 (27%)
Query: 10 DKKDEPPTTPKSLFSIRSSCATFNDNEVGRIGSELTSQNVSAISVESEARPSYPSMSQRP 69
+K+ + R ++ ++ ++A+P + +
Sbjct: 16 NKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPK-GTENLYF 74
Query: 70 SNLKEFTIAELKSATKNFSR----SVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGR 125
++ +A K F + VIG G V + + + + E AVK +
Sbjct: 75 QSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRAT-----GHEFAVKIMEV 129
Query: 126 R----------GGHKEWMTEVNFL-GIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNG 174
+ E + L + H +++ L+ + + LV++ M G
Sbjct: 130 TAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY--ESSSFM--FLVFDLMRKG 185
Query: 175 -------SVDQYLSPKSETILTWAMRLKIAQDAAR-------GLAYLHEGMDFQIIV-RD 219
SE ++ +++LH IV RD
Sbjct: 186 ELFDYLTEKVAL----SE------------KETRSIMRSLLEAVSFLHA----NNIVHRD 225
Query: 220 FKSSNILLDEQWNAKLSDFGLAR-LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARS- 277
K NILLD+ +LSDFG + L P E + GT GY APE ++
Sbjct: 226 LKPENILLDDNMQIRLSDFGFSCHLEPGEKL----RELCGTPGYLAPEILKCSMDETHPG 281
Query: 278 -----DVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGK 332
D+W+ GV L+ L+ G P R + + R I +EG+
Sbjct: 282 YGKEVDLWACGVILFTLLAGSPPFWH---RRQILM-------------LRMI----MEGQ 321
Query: 333 YSLR-------------LVSKLSHVANLCLVKNARTRPKMSEVLE 364
Y L+S+L L + R + L+
Sbjct: 322 YQFSSPEWDDRSSTVKDLISRL-------LQVDPEARLTAEQALQ 359
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 74/297 (24%), Positives = 105/297 (35%), Gaps = 75/297 (25%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMT-EVNFLGIVEHQNLVKLV 151
IG G FG D K VAVK + R E + E+ + H N+V+
Sbjct: 28 IGSGNFGVARLM-----RDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFK 82
Query: 152 GYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAAR--------G 203
I + EY G + + + R +D AR G
Sbjct: 83 EVILTPTHLAI----IMEYASGGELYERICNAG--------RFS--EDEARFFFQQLLSG 128
Query: 204 LAYLHEGMDFQIIVRDFKSSNILLDEQW--NAKLSDFGLARLGPSEGFTHVSTAVVGTMG 261
++Y H QI RD K N LLD K+ DFG ++ + VGT
Sbjct: 129 VSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGTPA 182
Query: 262 YAAPEYVQTGRL--AARSDVWSYGVFLYELITGRRPI-DRNRPRSEQKLLQWVKPYLSDA 318
Y APE V + +DVWS GV LY ++ G P D PR +K +Q +
Sbjct: 183 YIAPE-VLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRI------- 234
Query: 319 KQFRQIVDPRLEGKYSL-----------RLVSKLSHVANLCLVKNARTRPKMSEVLE 364
L KYS+ L+S++ V + TR + E+
Sbjct: 235 ----------LSVKYSIPDDIRISPECCHLISRI-------FVADPATRISIPEIKT 274
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 77/313 (24%), Positives = 122/313 (38%), Gaps = 77/313 (24%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMT--EVNFLG-IVEHQNLV 148
V+GEG V + + E AVK + ++ GH EV L H+N++
Sbjct: 20 VLGEGAHARVQTCINLIT-----SQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVL 74
Query: 149 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPK---SETILTWAMRLKIAQDAAR--- 202
+L+ + ++D LV+E M GS+ ++ + +E +A+
Sbjct: 75 ELIEFFEEEDR----FYLVFEKMRGGSILSHIHKRRHFNE------------LEASVVVQ 118
Query: 203 ----GLAYLHEGMDFQIIV-RDFKSSNILL---DEQWNAKLSDFGLAR-LGPSEGFTHVS 253
L +LH + I RD K NIL ++ K+ DF L + + + +S
Sbjct: 119 DVASALDFLHN----KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIS 174
Query: 254 TA----VVGTMGYAAPEYVQTGRLAARS-----DVWSYGVFLYELITGRRPIDRNRPRSE 304
T G+ Y APE V+ A D+WS GV LY L++G P R S+
Sbjct: 175 TPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFV-GRCGSD 233
Query: 305 QKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLR-------------LVSKLSHVANLCLVK 351
+ F I EGKY L+SKL LV+
Sbjct: 234 CGWDRGEACPACQNMLFESI----QEGKYEFPDKDWAHISCAAKDLISKL-------LVR 282
Query: 352 NARTRPKMSEVLE 364
+A+ R ++VL+
Sbjct: 283 DAKQRLSAAQVLQ 295
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 69/319 (21%), Positives = 104/319 (32%), Gaps = 105/319 (32%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-----------GGHKEWMTEVNFL- 139
++G G V + + K + E AVK + + + EV+ L
Sbjct: 24 ILGRGVSSVVRRCIHKPT-----CKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78
Query: 140 GIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNG-------SVDQYLSPKSETILTWAM 192
+ H N+++L + LV++ M G SE
Sbjct: 79 KVSGHPNIIQLKDTY--ETNTFF--FLVFDLMKKGELFDYLTEKVTL----SE------- 123
Query: 193 RLKIAQDAAR-------GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR-LG 244
++ + + LH+ I+ RD K NILLD+ N KL+DFG + L
Sbjct: 124 -----KETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLD 175
Query: 245 PSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARS------DVWSYGVFLYELITGRRPIDR 298
P E V GT Y APE ++ D+WS GV +Y L+ G P
Sbjct: 176 PGEKL----REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH 231
Query: 299 NRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLR-------------LVSKLSHVA 345
R + + R I + G Y LVS+
Sbjct: 232 ---RKQMLM-------------LRMI----MSGNYQFGSPEWDDYSDTVKDLVSRF---- 267
Query: 346 NLCLVKNARTRPKMSEVLE 364
LV + R E L
Sbjct: 268 ---LVVQPQKRYTAEEALA 283
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 72/342 (21%), Positives = 129/342 (37%), Gaps = 86/342 (25%)
Query: 50 SAISVESEARPSYPSMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNS 109
S ++ + P+ P P K+ E + ++G+GGFG V+ G
Sbjct: 1 SMLTKPLQGPPAPPGTPTPPPGGKDREAFE-----AEYRLGPLLGKGGFGTVFAG--HRL 53
Query: 110 EDPSQKVEVAVKQLGRRGGHKEWMT--------EVNFLGIV----EHQNLVKLVGYCADD 157
D +++VA+K + R EV L V H +++L+ +
Sbjct: 54 TD---RLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQ 110
Query: 158 DERGIQRLLVYEY-MPNGSVDQYLSPKSETILTWAMRLKIAQDAAR--------GLAYLH 208
+ +LV E +P + Y++ K + + +R + + H
Sbjct: 111 EG--F--MLVLERPLPAQDLFDYITEKG----------PLGEGPSRCFFGQVVAAIQHCH 156
Query: 209 EGMDFQIIVRDFKSSNILLD-EQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEY 267
++ RD K NIL+D + AKL DFG L E + GT Y+ PE+
Sbjct: 157 SRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY-TDF---DGTRVYSPPEW 209
Query: 268 VQTGR-LAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQ---WVKPYLS-DAKQFR 322
+ + A + VWS G+ LY+++ G P + +Q++L+ ++S D
Sbjct: 210 ISRHQYHALPATVWSLGILLYDMVCGDIPFE-----RDQEILEAELHFPAHVSPDCCA-- 262
Query: 323 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 364
L+ + CL +RP + E+L
Sbjct: 263 --------------LIRR-------CLAPKPSSRPSLEEILL 283
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 78/297 (26%), Positives = 121/297 (40%), Gaps = 73/297 (24%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKE----WMTEVNFLGIVEHQNL 147
++G+G FG V K + + + E AVK + + + + EV L ++H N+
Sbjct: 29 MLGKGSFGEVLKCKDRIT-----QQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 148 VKLVGYCADDDERGIQRLLVYEYMPNG-------SVDQYLSPKSETILTWAMRLKIAQDA 200
+KL D +V E G ++ SE DA
Sbjct: 84 MKLFEILEDSS----SFYIVGELYTGGELFDEIIKRKRF----SE------------HDA 123
Query: 201 AR-------GLAYLHEGMDFQIIVRDFKSSNILL---DEQWNAKLSDFGLARL-GPSEGF 249
AR G+ Y+H+ I+ RD K NILL ++ + K+ DFGL+ +
Sbjct: 124 ARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM 180
Query: 250 THVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQ 309
+GT Y APE V G + DVWS GV LY L++G P ++E +L+
Sbjct: 181 K----DRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPPFYG---KNEYDILK 232
Query: 310 WVK--PYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 364
V+ Y D Q+R I D + K L+ K+ L + R ++ LE
Sbjct: 233 RVETGKYAFDLPQWRTISD---DAK---DLIRKM-------LTFHPSLRITATQCLE 276
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 64/341 (18%), Positives = 115/341 (33%), Gaps = 71/341 (20%)
Query: 45 TSQNVSAISVESEARPSYPSMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKG 104
+S + S R S+ + K E + + ++G GGFG VY G
Sbjct: 3 SSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSG 62
Query: 105 LIKNSEDPSQKVEVAVKQLGRRGGHKEWMT--------EVNFLGIVEHQ--NLVKLVGYC 154
D + VA+K + + EV L V +++L+ +
Sbjct: 63 --IRVSD---NLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117
Query: 155 ADDDERGIQRLLVYEYMPNGSVD--QYLSPKSETILTWAMRL------KIAQDAARGLAY 206
D +L+ E P D +++ + L + +
Sbjct: 118 ERPDSF----VLILER-PEPVQDLFDFITERG--------ALQEELARSFFWQVLEAVRH 164
Query: 207 LHEGMDFQIIVRDFKSSNILLD-EQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAP 265
H + ++ RD K NIL+D + KL DFG L + GT Y+ P
Sbjct: 165 CH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGAL-LKDTVYTDF---DGTRVYSPP 217
Query: 266 EYVQTGR-LAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS-DAKQFRQ 323
E+++ R + VWS G+ LY+++ G P + + ++ + + +S + +
Sbjct: 218 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQV--FFRQRVSSECQH--- 272
Query: 324 IVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 364
L+ CL RP E+
Sbjct: 273 -------------LIRW-------CLALRPSDRPTFEEIQN 293
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-24
Identities = 71/315 (22%), Positives = 115/315 (36%), Gaps = 86/315 (27%)
Query: 93 IGEGGFGCVYKG------------------LIKNSEDPSQKVEVAVKQLGRRGGHKEWMT 134
IG+G +G V LI+ + P + +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 135 -----EVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILT 189
E+ L ++H N+VKLV D +E + +V+E + G V + + K
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHL--YMVFELVNQGPVMEVPTLK------ 132
Query: 190 WAMRL------KIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL 243
L QD +G+ YLH +II RD K SN+L+ E + K++DFG++
Sbjct: 133 ---PLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSNE 186
Query: 244 -GPSEGFTHVSTAVVGTMGYAAPEYVQTGRLA---ARSDVWSYGVFLYELITGRRPIDRN 299
S+ + VGT + APE + R DVW+ GV LY + G+ P
Sbjct: 187 FKGSDALLSNT---VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243
Query: 300 RPRSEQKLLQWVK---------PYLS-DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCL 349
L +K P ++ D K L++++ L
Sbjct: 244 ---RIMCLHSKIKSQALEFPDQPDIAEDLK----------------DLITRM-------L 277
Query: 350 VKNARTRPKMSEVLE 364
KN +R + E+
Sbjct: 278 DKNPESRIVVPEIKL 292
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 67/220 (30%), Positives = 95/220 (43%), Gaps = 41/220 (18%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMT-----EVNFLGIVEHQNL 147
+G G FG V G + +VAVK L R+ + E+ L + H ++
Sbjct: 24 LGVGTFGKVKVG-----KHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHI 78
Query: 148 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAAR----- 202
+KL Y I +V EY+ G + Y+ RL + +R
Sbjct: 79 IKL--YQVISTPSDI--FMVMEYVSGGELFDYICKNG--------RLD--EKESRRLFQQ 124
Query: 203 ---GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGT 259
G+ Y H M ++ RD K N+LLD NAK++DFGL+ + F S G+
Sbjct: 125 ILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS---CGS 178
Query: 260 MGYAAPEYVQTGRL--AARSDVWSYGVFLYELITGRRPID 297
YAAPE + GRL D+WS GV LY L+ G P D
Sbjct: 179 PNYAAPEVIS-GRLYAGPEVDIWSSGVILYALLCGTLPFD 217
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-24
Identities = 63/306 (20%), Positives = 102/306 (33%), Gaps = 89/306 (29%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR---GGHKEWMTEVNFLGIVEHQNLV 148
+G G FG V+ ++S +E +K + + ++ E+ L ++H N++
Sbjct: 29 KLGSGAFGDVHLVEERSS-----GLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNII 83
Query: 149 KLVGYCADDDERGIQRLLVYEYMPNG-------SVDQYLSPKSETILTWAMRLKIAQDAA 201
K+ D +V E G S SE A
Sbjct: 84 KIFEVFEDYHNM----YIVMETCEGGELLERIVSAQARGKALSE------------GYVA 127
Query: 202 R-------GLAYLHEGMDFQIIVRDFKSSNILL---DEQWNAKLSDFGLAR-LGPSEGFT 250
LAY H ++ +D K NIL K+ DFGLA E T
Sbjct: 128 ELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHST 184
Query: 251 HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQW 310
GT Y APE V + + D+WS GV +Y L+TG P S +++
Sbjct: 185 ----NAAGTALYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTGCLPFTG---TSLEEV--- 233
Query: 311 VKPYLSDAKQFRQIVDPRLEGKYSLR------------LVSKLSHVANLCLVKNARTRPK 358
++ + + L+ ++ L K+ RP
Sbjct: 234 ----------QQKA----TYKEPNYAVECRPLTPQAVDLLKQM-------LTKDPERRPS 272
Query: 359 MSEVLE 364
++VL
Sbjct: 273 AAQVLH 278
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 76/346 (21%), Positives = 121/346 (34%), Gaps = 89/346 (25%)
Query: 60 PSYPSMSQRPSNLKEFTIAE---LKSATKNFSR----SVVIGEGGFGCVYKGLIKNSEDP 112
+ S + + I ++ +G G +G V KN
Sbjct: 4 HHHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNG--- 60
Query: 113 SQKVEVAVKQLGRR---------------GGHKEWMTEVNFLGIVEHQNLVKLVGYCADD 157
E A+K + + H+E E++ L ++H N++KL D
Sbjct: 61 --HSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDK 118
Query: 158 DERGIQRLLVYEYMPNG-------SVDQYLSPKSETILTWAMRLKIAQDAAR-------G 203
LV E+ G + ++ E DAA G
Sbjct: 119 K----YFYLVTEFYEGGELFEQIINRHKF----DE------------CDAANIMKQILSG 158
Query: 204 LAYLHEGMDFQIIVRDFKSSNILL---DEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTM 260
+ YLH+ I+ RD K NILL + N K+ DFGL+ + +GT
Sbjct: 159 ICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSF---FSKDYKLRDRLGTA 212
Query: 261 GYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK--PYLSDA 318
Y APE V + + DVWS GV +Y L+ G P +++Q +++ V+ Y D
Sbjct: 213 YYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPPFGG---QNDQDIIKKVEKGKYYFDF 268
Query: 319 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 364
++ I D E K L+ + L + R E L
Sbjct: 269 NDWKNISD---EAK---ELIKLM-------LTYDYNKRCTAEEALN 301
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 8e-24
Identities = 60/326 (18%), Positives = 102/326 (31%), Gaps = 81/326 (24%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-------GGHKEWMTEVNFLGIVEH 144
IG+G +G V + + + A+K + + + TEV + + H
Sbjct: 33 AIGQGSYGVVRVAIENQT-----RAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHH 87
Query: 145 QNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQ------ 198
N+ +L D+ LV E G + L+ + +
Sbjct: 88 PNIARLYEVYEDEQYI----CLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCP 143
Query: 199 -------------------------DAAR-------GLAYLHEGMDFQIIVRDFKSSNIL 226
+ L YLH I RD K N L
Sbjct: 144 ECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFL 200
Query: 227 L--DEQWNAKLSDFGLARL--GPSEGFTHVSTAVVGTMGYAAPEYVQTGRLA--ARSDVW 280
++ + KL DFGL++ + G + T GT + APE + T + + D W
Sbjct: 201 FSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAW 260
Query: 281 SYGVFLYELITGRRPIDRNRPRSEQKLLQWVK--PYLSDAKQFRQIVDPRLEGKYSLRLV 338
S GV L+ L+ G P ++ + V + + + + L+
Sbjct: 261 SAGVLLHLLLMGAVPFPG---VNDADTISQVLNKKLCFENPNYNVLSP---LAR---DLL 311
Query: 339 SKLSHVANLCLVKNARTRPKMSEVLE 364
S L L +N R L+
Sbjct: 312 SNL-------LNRNVDERFDAMRALQ 330
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 1e-23
Identities = 65/302 (21%), Positives = 106/302 (35%), Gaps = 85/302 (28%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR--GGHKEWMTEVNFLGIVEHQNLVK 149
IG G +G V + K + ++ A K++ + + E+ + ++H N+++
Sbjct: 16 TIGRGSWGEVKIAVQKGT-----RIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 70
Query: 150 LVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPK---SETILTWAMRLKIAQDAAR---- 202
L D+ + LV E G + + + K E DAAR
Sbjct: 71 LYETFEDNTDI----YLVMELCTGGELFERVVHKRVFRE------------SDAARIMKD 114
Query: 203 ---GLAYLHEGMDFQIIVRDFKSSNILL---DEQWNAKLSDFGLAR-LGPSEGFTHVSTA 255
+AY H+ + RD K N L KL DFGLA P +
Sbjct: 115 VLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMR----T 167
Query: 256 VVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYL 315
VGT Y +P+ V G D WS GV +Y L+ G P ++ ++
Sbjct: 168 KVGTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCGYPPFSA---PTDSEV-------- 215
Query: 316 SDAKQFRQIVDPRLEGKYSLR-------------LVSKLSHVANLCLVKNARTRPKMSEV 362
+I EG ++ L+ +L L K+ + R +
Sbjct: 216 -----MLKI----REGTFTFPEKDWLNVSPQAESLIRRL-------LTKSPKQRITSLQA 259
Query: 363 LE 364
LE
Sbjct: 260 LE 261
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-23
Identities = 65/220 (29%), Positives = 100/220 (45%), Gaps = 42/220 (19%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMT-----EVNFLGIVEHQNL 147
+GEG FG V + +VA+K + R+ K M E+++L ++ H ++
Sbjct: 17 LGEGSFGKVKLA-----THYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHI 71
Query: 148 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAAR----- 202
+KL Y I ++V EY G + Y+ K R+ +D R
Sbjct: 72 IKL--YDVITTPTDI--VMVIEYA-GGELFDYIVEKK--------RMT--EDEGRRFFQQ 116
Query: 203 ---GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGT 259
+ Y H +I+ RD K N+LLD+ N K++DFGL+ + F S G+
Sbjct: 117 IICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS---CGS 170
Query: 260 MGYAAPEYVQTGRL--AARSDVWSYGVFLYELITGRRPID 297
YAAPE + G+L DVWS G+ LY ++ GR P D
Sbjct: 171 PNYAAPEVIN-GKLYAGPEVDVWSCGIVLYVMLVGRLPFD 209
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 3e-23
Identities = 63/305 (20%), Positives = 101/305 (33%), Gaps = 91/305 (29%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWM--TEVNFLGIVEHQNLVK 149
V+G G F V+ + A+K + + ++ E+ L ++H+N+V
Sbjct: 16 VLGSGAFSEVFLV-----KQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVT 70
Query: 150 LVGYCADDDERGIQRLLVYEYMPNG-------SVDQYLSPKSETILTWAMRLKIAQDAAR 202
L LV + + G Y +E +DA+
Sbjct: 71 LEDIYESTTHY----YLVMQLVSGGELFDRILERGVY----TE------------KDASL 110
Query: 203 -------GLAYLHEGMDFQIIVRDFKSSNILL---DEQWNAKLSDFGLARLGPSEGFTHV 252
+ YLH + I+ RD K N+L +E ++DFGL+++ + +
Sbjct: 111 VIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMS-- 165
Query: 253 STAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK 312
GT GY APE + + D WS GV Y L+ G P +E KL
Sbjct: 166 --TACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYE---ETESKL----- 215
Query: 313 PYLSDAKQFRQIVDPRLEGKYSLR-------------LVSKLSHVANLCLVKNARTRPKM 359
F +I EG Y + L L K+ R
Sbjct: 216 --------FEKI----KEGYYEFESPFWDDISESAKDFICHL-------LEKDPNERYTC 256
Query: 360 SEVLE 364
+ L
Sbjct: 257 EKALS 261
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 3e-23
Identities = 72/308 (23%), Positives = 114/308 (37%), Gaps = 95/308 (30%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKE----WMTEVNFLGIVEHQNL 147
++G+G FG V K + + + E AVK + + + + EV L ++H N+
Sbjct: 29 MLGKGSFGEVLKCKDRIT-----QQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 148 VKLVGYCADDDERGIQRLLVYEYMPNG-------SVDQYLSPKSETILTWAMRLKIAQDA 200
+KL D +V E G ++ SE DA
Sbjct: 84 MKLFEILEDSSSF----YIVGELYTGGELFDEIIKRKRF----SE------------HDA 123
Query: 201 AR-------GLAYLHEGMDFQIIVRDFKSSNILL---DEQWNAKLSDFGLAR-LGPSEGF 249
AR G+ Y+H I+ RD K NILL ++ + K+ DFGL+ +
Sbjct: 124 ARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM 180
Query: 250 THVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQ 309
+GT Y APE V G + DVWS GV LY L++G P ++E +
Sbjct: 181 K----DRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPPFYG---KNEYDI-- 230
Query: 310 WVKPYLSDAKQFRQIVDPRLEGKYSLR-------------LVSKLSHVANLCLVKNARTR 356
+++ GKY+ L+ K+ L + R
Sbjct: 231 -----------LKRV----ETGKYAFDLPQWRTISDDAKDLIRKM-------LTFHPSLR 268
Query: 357 PKMSEVLE 364
++ LE
Sbjct: 269 ITATQCLE 276
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 8e-23
Identities = 58/304 (19%), Positives = 95/304 (31%), Gaps = 82/304 (26%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLG-IVEHQNLVKL 150
V+G G G V + K + + + A+K L + EV + ++V++
Sbjct: 69 VLGLGINGKVLQIFNKRT-----QEKFALKMLQDC---PKARREVELHWRASQCPHIVRI 120
Query: 151 VGYCADDDERGIQRLLVYEYMPNGS-----VDQYLSPKSETILTWAMRLKIAQDAAR--- 202
V + L+V E + G D+ +E ++A+
Sbjct: 121 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTE------------REASEIMK 168
Query: 203 ----GLAYLHEGMDFQIIVRDFKSSNILL---DEQWNAKLSDFGLAR-LGPSEGFTHVST 254
+ YLH I RD K N+L KL+DFG A+ T
Sbjct: 169 SIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT---- 221
Query: 255 AVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRP-IDRNRPRSEQKLLQWVKP 313
T Y APE + + D+WS GV +Y L+ G P + +
Sbjct: 222 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM------ 275
Query: 314 YLSDAKQFRQIVDPRLEGKYSLR-------------LVSKLSHVANLCLVKNARTRPKMS 360
+I G+Y L+ L L R ++
Sbjct: 276 -------KTRI----RMGQYEFPNPEWSEVSEEVKMLIRNL-------LKTEPTQRMTIT 317
Query: 361 EVLE 364
E +
Sbjct: 318 EFMN 321
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 9e-23
Identities = 58/221 (26%), Positives = 90/221 (40%), Gaps = 31/221 (14%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQNLVKLVG 152
+G G +G VYK K D + A+KQ+ G E+ L ++H N++ L
Sbjct: 29 VGRGTYGHVYKAKRK---DGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQK 85
Query: 153 YCADDDERGIQRLLVYEYMPN------GSVDQYLSPKSETILTWAMRLKIAQDAARGLAY 206
+R + L+++Y + + K L M + G+ Y
Sbjct: 86 VFLSHADRKV--WLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 143
Query: 207 LHEGMDFQIIVRDFKSSNILLDEQWNA----KLSDFGLARL--GPSEGFTHVSTAVVGTM 260
LH ++ RD K +NIL+ + K++D G ARL P + + VV T
Sbjct: 144 LHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TF 199
Query: 261 GYAAPEYVQTGRLAARS-----DVWSYGVFLYELITGRRPI 296
Y APE + L AR D+W+ G EL+T PI
Sbjct: 200 WYRAPELL----LGARHYTKAIDIWAIGCIFAELLT-SEPI 235
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 9e-23
Identities = 70/302 (23%), Positives = 114/302 (37%), Gaps = 82/302 (27%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLG-IVEHQNLVKL 150
IG G + + + K + +E AVK + + ++ E+ L +H N++ L
Sbjct: 29 DIGVGSYSVCKRCIHKAT-----NMEFAVKIIDKS--KRDPTEEIEILLRYGQHPNIITL 81
Query: 151 VGYCADDDERGIQRLLVYEYMPNGSVDQYLSPK---SETILTWAMRLKIAQDAAR----- 202
DD + + +V E M G + + + SE ++A+
Sbjct: 82 KDVY--DDGKYV--YVVTELMKGGELLDKILRQKFFSE------------REASAVLFTI 125
Query: 203 --GLAYLHEGMDFQIIV-RDFKSSNILL-DEQWNA---KLSDFGLARLGPSEGFTHVSTA 255
+ YLH Q +V RD K SNIL DE N ++ DFG A+ +E +
Sbjct: 126 TKTVEYLHA----QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN--GLLMT 179
Query: 256 VVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYL 315
T + APE ++ A D+WS GV LY ++TG P + +++
Sbjct: 180 PCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEI-------- 231
Query: 316 SDAKQFRQIVDPRLEGKYSLR-------------LVSKLSHVANLCLVKNARTRPKMSEV 362
+I GK+SL LVSK+ L + R + V
Sbjct: 232 -----LARI----GSGKFSLSGGYWNSVSDTAKDLVSKM-------LHVDPHQRLTAALV 275
Query: 363 LE 364
L
Sbjct: 276 LR 277
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 1e-22
Identities = 66/231 (28%), Positives = 93/231 (40%), Gaps = 32/231 (13%)
Query: 81 KSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNF-- 138
AT + IG G +G VYK +S VA+K + R +
Sbjct: 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGH-----FVALKSV-RVPNGGGGGGGLPIST 58
Query: 139 ---------LGIVEHQNLVKLVGYCADDDERGIQRL-LVYEYMPNGSVD--QYLSPKSET 186
L EH N+V+L+ CA ++ LV+E++ D YL
Sbjct: 59 VREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ---DLRTYLDKAPPP 115
Query: 187 ILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL-GP 245
L + + RGL +LH I+ RD K NIL+ KL+DFGLAR+
Sbjct: 116 GLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSY 172
Query: 246 SEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPI 296
T V VV T+ Y APE + A D+WS G E+ R+P+
Sbjct: 173 QMALTPV---VV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 218
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 1e-22
Identities = 68/300 (22%), Positives = 107/300 (35%), Gaps = 74/300 (24%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLG-IVEHQNLVKL 150
+GEG F K + K S AVK + +R E+ L H N+VKL
Sbjct: 18 PLGEGSFSICRKCVHKKS-----NQAFAVKIISKRMEANTQ-KEITALKLCEGHPNIVKL 71
Query: 151 VGYCADDDERGIQRLLVYEYMPNGSVDQYLSPK---SETILTWAMRLKIAQDAAR----- 202
D LV E + G + + + K SE +A+
Sbjct: 72 HEVFHDQLH----TFLVMELLNGGELFERIKKKKHFSE------------TEASYIMRKL 115
Query: 203 --GLAYLHEGMDFQIIVRDFKSSNILL---DEQWNAKLSDFGLARLGPSEGFTHVSTAVV 257
++++H D ++ RD K N+L ++ K+ DFG ARL P +
Sbjct: 116 VSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--QPLKTPC 170
Query: 258 GTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 317
T+ YAAPE + D+WS GV LY +++G+ P + S
Sbjct: 171 FTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCT---------SA 221
Query: 318 AKQFRQIVDPRLEGKYSLR-------------LVSKLSHVANLCLVKNARTRPKMSEVLE 364
+ ++I +G +S L+ L L + R KMS +
Sbjct: 222 VEIMKKI----KKGDFSFEGEAWKNVSQEAKDLIQGL-------LTVDPNKRLKMSGLRY 270
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 99.2 bits (247), Expect = 2e-22
Identities = 74/353 (20%), Positives = 132/353 (37%), Gaps = 58/353 (16%)
Query: 8 NWDKKDEPPTTPKSLFSIRSSCAT---------FNDNEVGRIGSELTSQNVSAISVESEA 58
++K + I + F+ + + + L + V +
Sbjct: 91 KYEKLETEEERLVCSREIFDTYIMKELLACSHPFSKSAIEHVQGHLVKKQVPPDLFQPYI 150
Query: 59 RPSYPSMSQRP-----SNLKEFTIAELKSATKN-------FSRSVVIGEGGFGCVYKGLI 106
++ + K + K+ N FS +IG GGFG VY
Sbjct: 151 EEICQNLRGDVFQKFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRK 210
Query: 107 KNSEDPSQKVEVAVKQLG-----RRGGHKEWMTEVNFLGIVEHQN---LVKLVGYCADDD 158
++ K+ A+K L + G + E L +V + +V + Y
Sbjct: 211 ADT----GKM-YAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMS-YAFHTP 264
Query: 159 ERGIQRL-LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIV 217
++ L + + M G + +LS + MR A+ GL ++H ++
Sbjct: 265 DK----LSFILDLMNGGDLHYHLS-QHGVFSEADMRFYAAE-IILGLEHMHN---RFVVY 315
Query: 218 RDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARS 277
RD K +NILLDE + ++SD GLA + H A VGT GY APE +Q G S
Sbjct: 316 RDLKPANILLDEHGHVRISDLGLACDFS-KKKPH---ASVGTHGYMAPEVLQKGVAYDSS 371
Query: 278 -DVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK-------PYLS-DAKQF 321
D +S G L++L+ G P +++ + + ++ + S + +
Sbjct: 372 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSL 424
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 3e-22
Identities = 65/227 (28%), Positives = 100/227 (44%), Gaps = 27/227 (11%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLG-----RRGGHKEWMTEVNFLGIVEHQN 146
IG+G FG V ++ K A+K + R + E+ + +EH
Sbjct: 22 AIGKGSFGKVCIVQKNDT-----KKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPF 76
Query: 147 LVKLVGYCADDDERGIQRL-LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLA 205
LV L Y D+E + +V + + G + +L ++ ++L I + L
Sbjct: 77 LVNLW-YSFQDEED----MFMVVDLLLGGDLRYHLQ-QNVHFKEETVKLFICE-LVMALD 129
Query: 206 YLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAP 265
YL +II RD K NILLDE + ++DF +A + P E T + GT Y AP
Sbjct: 130 YLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI---TTMAGTKPYMAP 183
Query: 266 EYVQTGRLAARS---DVWSYGVFLYELITGRRPIDRNRPRSEQKLLQ 309
E + + A S D WS GV YEL+ GRRP S ++++
Sbjct: 184 EMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVH 230
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 3e-22
Identities = 61/293 (20%), Positives = 116/293 (39%), Gaps = 67/293 (22%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWM-TEVNFLGIVEHQNLVKL 150
+G G FG V++ + +S K K + +G + + E++ L I H+N++ L
Sbjct: 12 DLGRGEFGIVHRCVETSS-----KKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHL 66
Query: 151 VGYCADDDERGIQRLLVYEYMPNG-------SVDQYLSPKSETILTWAMRLKIAQDAAR- 202
+E ++++E++ + L+ + +
Sbjct: 67 HESFESMEEL----VMIFEFISGLDIFERINTSAFELNER---------------EIVSY 107
Query: 203 ------GLAYLHEGMDFQIIVRDFKSSNILLDEQWNA--KLSDFGLAR-LGPSEGFTHVS 253
L +LH I D + NI+ + ++ K+ +FG AR L P + F
Sbjct: 108 VHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR--- 161
Query: 254 TAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK- 312
+ Y APE Q ++ +D+WS G +Y L++G P + Q++++ +
Sbjct: 162 -LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA---ETNQQIIENIMN 217
Query: 313 -PYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 364
Y D + F++I E V +L LVK ++R SE L+
Sbjct: 218 AEYTFDEEAFKEISI---EAM---DFVDRL-------LVKERKSRMTASEALQ 257
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 95.3 bits (237), Expect = 5e-22
Identities = 54/343 (15%), Positives = 99/343 (28%), Gaps = 84/343 (24%)
Query: 85 KNFSRSVVIGEGGFGCVYKGL--------------IKNSEDPSQKVEVAVKQLGRRG--- 127
+F +G GGFG V++ + N E +KV VK L +
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 128 ---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRL------------------- 165
W+ E +
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 166 ------------LVYEYMPNGSVDQYLSP-KSETILTWAMRLKIAQDAARGLAYLHEGMD 212
+ + ++ +++ S + L I A + +LH
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH---S 182
Query: 213 FQIIVRDFKSSNILLDEQWNAKLSDFGLAR----------LGPSEGFTHVSTAVVGTMGY 262
++ RD K SNI K+ DFGL + T VGT Y
Sbjct: 183 KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242
Query: 263 AAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFR 322
+PE + + + D++S G+ L+EL+ + E+ + R
Sbjct: 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSF------STQMERVRI---------ITDVR 287
Query: 323 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365
+ P L + + + L + RP+ ++++E
Sbjct: 288 NLKFPLLFTQKY----PQEHMMVQDMLSPSPTERPEATDIIEN 326
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 5e-22
Identities = 64/308 (20%), Positives = 107/308 (34%), Gaps = 94/308 (30%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKE----WMTEVNFLGIVEHQNL 147
+G+G F V + + K + +E A K + + E ++H N+
Sbjct: 13 ELGKGAFSVVRRCVHKTT-----GLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 67
Query: 148 VKLVGYCADDDERGIQRLLVYEYMPNG-------SVDQYLSPKSETILTWAMRLKIAQDA 200
V+L ++ LV++ + G + + Y SE DA
Sbjct: 68 VRLHDSIQEESFH----YLVFDLVTGGELFEDIVAREFY----SE------------ADA 107
Query: 201 AR-------GLAYLHEGMDFQIIVRDFKSSNILL---DEQWNAKLSDFGLAR-LGPSEGF 249
+ +AY H I+ R+ K N+LL + KL+DFGLA + SE +
Sbjct: 108 SHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW 164
Query: 250 THVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQ 309
GT GY +PE ++ + D+W+ GV LY L+ G P + +L
Sbjct: 165 H----GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD---EDQHRL-- 215
Query: 310 WVKPYLSDAKQFRQIVDPRLEGKYSLR-------------LVSKLSHVANLCLVKNARTR 356
+ QI G Y L+ + L N + R
Sbjct: 216 -----------YAQI----KAGAYDYPSPEWDTVTPEAKSLIDSM-------LTVNPKKR 253
Query: 357 PKMSEVLE 364
+ L+
Sbjct: 254 ITADQALK 261
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 6e-22
Identities = 58/221 (26%), Positives = 94/221 (42%), Gaps = 37/221 (16%)
Query: 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEW--MT---EVNFLG 140
+ + IGEG +G V+K +++ VA+K+ E+ L
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQ-----IVAIKKF-LESEDDPVIKKIALREIRMLK 57
Query: 141 IVEHQNLVKLVGYCADDDERGIQRL-LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQD 199
++H NLV L+ + R +RL LV+EY + +V L + + + + I
Sbjct: 58 QLKHPNLVNLL-----EVFRRKRRLHLVFEYCDH-TVLHELD-RYQRGVPEHLVKSITWQ 110
Query: 200 AARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL--GPSEGFTHVSTAVV 257
+ + + H+ I RD K NIL+ + KL DFG ARL GPS+ + V
Sbjct: 111 TLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDD----EV 163
Query: 258 GTMGYAAPEYVQTGRLAARS-----DVWSYGVFLYELITGR 293
T Y +PE + + DVW+ G EL++G
Sbjct: 164 ATRWYRSPELL----VGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 6e-22
Identities = 65/228 (28%), Positives = 111/228 (48%), Gaps = 39/228 (17%)
Query: 82 SATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEW--MT---EV 136
S++ F + +G G + VYKGL K + VA+K++ + +E T E+
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVY-----VALKEV--KLDSEEGTPSTAIREI 54
Query: 137 NFLGIVEHQNLVKLVGYCADDDERGIQRL-LVYEYMPN---GSVDQYLSPKSETILTWAM 192
+ + ++H+N+V+L ++ +L LV+E+M N +D + L +
Sbjct: 55 SLMKELKHENIVRLYDVIHTEN-----KLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNL 109
Query: 193 RLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL--GPSEGFT 250
+GLA+ HE +I+ RD K N+L++++ KL DFGLAR P F+
Sbjct: 110 VKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFS 166
Query: 251 HVSTAVVGTMGYAAPEYVQTGRLAARS-----DVWSYGVFLYELITGR 293
VV T+ Y AP+ + + +R+ D+WS G L E+ITG+
Sbjct: 167 SE---VV-TLWYRAPDVL----MGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 7e-22
Identities = 70/245 (28%), Positives = 108/245 (44%), Gaps = 26/245 (10%)
Query: 74 EFTIAELKSATKN-FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLG-----RRG 127
++ E + TKN F + V+G+GGFG V ++ + K+ A K+L +R
Sbjct: 172 QWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRAT----GKM-YACKKLEKKRIKKRK 226
Query: 128 GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRL-LVYEYMPNGSVDQYLSPKSET 186
G + E L V + +V L Y + + L LV M G + ++ +
Sbjct: 227 GEAMALNEKQILEKVNSRFVVSLA-YAYETKDA----LCLVLTLMNGGDLKFHIYHMGQA 281
Query: 187 ILTWA-MRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGP 245
A A+ GL LH +I+ RD K NILLD+ + ++SD GLA P
Sbjct: 282 GFPEARAVFYAAE-ICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVP 337
Query: 246 SEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRP-IDRNRPRSE 304
VGT+GY APE V+ R D W+ G LYE+I G+ P R +
Sbjct: 338 EGQTIK---GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR 394
Query: 305 QKLLQ 309
+++ +
Sbjct: 395 EEVER 399
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 9e-22
Identities = 76/367 (20%), Positives = 147/367 (40%), Gaps = 49/367 (13%)
Query: 13 DEPPTTPKSLFSIRSSCATFNDNEVGRIGSELTSQNVSAIS-VESEARPSYPSMSQRPSN 71
++L+ + D+ G ++ N + +++ + P+
Sbjct: 10 SGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAP 69
Query: 72 LKEFTIAELKSATKNFS------RSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGR 125
F + + + ++ ++G G FG V+K + +++A K +
Sbjct: 70 PAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETAT-----GLKLAAKIIKT 124
Query: 126 RG--GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPK 183
RG +E E++ + ++H NL++L ++ +LV EY+ G + + +
Sbjct: 125 RGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDI----VLVMEYVDGGELFDRIIDE 180
Query: 184 SETILTWAMRLKIAQDAARGLAYLHEGMDFQIIV-RDFKSSNILLDEQWNA--KLSDFGL 240
S LT + + G+ ++H+ I+ D K NIL + K+ DFGL
Sbjct: 181 SYN-LTELDTILFMKQICEGIRHMHQ----MYILHLDLKPENILCVNRDAKQIKIIDFGL 235
Query: 241 AR-LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRN 299
AR P E GT + APE V ++ +D+WS GV Y L++G P +
Sbjct: 236 ARRYKPREKLK----VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGD 291
Query: 300 RPRSEQKLLQWVK--PYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRP 357
++ + L + + + ++F+ I + E K +SKL L+K R
Sbjct: 292 ---NDAETLNNILACRWDLEDEEFQDISE---EAK---EFISKL-------LIKEKSWRI 335
Query: 358 KMSEVLE 364
SE L+
Sbjct: 336 SASEALK 342
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 9e-22
Identities = 69/269 (25%), Positives = 112/269 (41%), Gaps = 38/269 (14%)
Query: 64 SMSQRPSNLKEF---------TIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQ 114
S +R N+ E+ + +++ ++F VIG G FG V ++K +
Sbjct: 44 SPLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVA--VVK--LKNAD 99
Query: 115 KVEVAVKQLG-----RRGGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRL-LVY 168
KV A+K L +R + E + L + + + L + A D+ L LV
Sbjct: 100 KV-FAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL--HYAFQDDN---NLYLVM 153
Query: 169 EYMPNGSVDQYLSPKSETILTWAM-RLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL 227
+Y G + LS K E L M R +A+ + +H+ + RD K NIL+
Sbjct: 154 DYYVGGDLLTLLS-KFEDRLPEEMARFYLAE-MVIAIDSVHQ---LHYVHRDIKPDNILM 208
Query: 228 DEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARS-----DVWSY 282
D + +L+DFG +G S A VGT Y +PE +Q D WS
Sbjct: 209 DMNGHIRLADFGSCLKLMEDGTVQSSVA-VGTPDYISPEILQAMEGGKGRYGPECDWWSL 267
Query: 283 GVFLYELITGRRP-IDRNRPRSEQKLLQW 310
GV +YE++ G P + + K++
Sbjct: 268 GVCMYEMLYGETPFYAESLVETYGKIMNH 296
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 93.7 bits (234), Expect = 1e-21
Identities = 56/227 (24%), Positives = 101/227 (44%), Gaps = 41/227 (18%)
Query: 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEW--MT---EVNFL 139
+ + + IGEG +G V+K + + + VA+K++ R E + E+ L
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEI-----VALKRV-RLDDDDEGVPSSALREICLL 55
Query: 140 GIVEHQNLVKLVGYCADDDERGIQRL-LVYEYMPNGSVD--QYLSPKSETILTWAMRLKI 196
++H+N+V+L D ++L LV+E+ D +Y + + ++ +
Sbjct: 56 KELKHKNIVRLH-----DVLHSDKKLTLVFEFCDQ---DLKKYFDSCNGDLDPEIVKSFL 107
Query: 197 AQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL--GPSEGFTHVST 254
Q +GL + H ++ RD K N+L++ KL++FGLAR P ++
Sbjct: 108 FQ-LLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE-- 161
Query: 255 AVVGTMGYAAPEYVQTGRLAARS-----DVWSYGVFLYELITGRRPI 296
VV T+ Y P+ + A+ D+WS G EL RP+
Sbjct: 162 -VV-TLWYRPPDVL----FGAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 1e-21
Identities = 66/240 (27%), Positives = 97/240 (40%), Gaps = 36/240 (15%)
Query: 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLG-----RRGGHKEWMTEVNFL 139
F V+G GGFG V+ +K + K+ A K+L +R G++ M E L
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKAT----GKL-YACKKLNKKRLKKRKGYQGAMVEKKIL 239
Query: 140 GIVEHQNLVKLVGYCADDDERGIQRL-LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQ 198
V + +V L Y + L LV M G + ++ E +
Sbjct: 240 AKVHSRFIVSLA-YAFETKTD----LCLVMTIMNGGDIRYHIYNVDE------DNPGFQE 288
Query: 199 DAAR--------GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFT 250
A GL +LH+ II RD K N+LLD+ N ++SD GLA +
Sbjct: 289 PRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK 345
Query: 251 HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRP-IDRNRPRSEQKLLQ 309
+ GT G+ APE + D ++ GV LYE+I R P R ++L Q
Sbjct: 346 --TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ 403
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 1e-21
Identities = 69/326 (21%), Positives = 121/326 (37%), Gaps = 46/326 (14%)
Query: 46 SQNVSAISVESEARPSYPSMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGL 105
+ + +P +K+ S + +G G FG V++ +
Sbjct: 18 YDGPKINDYDKFYEDIWKKYVPQPVEVKQ------GSVYDYYDILEELGSGAFGVVHRCV 71
Query: 106 IKNSEDPSQKVEVAVKQL-GRRGGHKEWM-TEVNFLGIVEHQNLVKLVGYCADDDERGIQ 163
K + K + K + E++ + + H L+ L D E
Sbjct: 72 EKAT-----GRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEM--- 123
Query: 164 RLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSS 223
+L+ E++ G + ++ + ++ A + + A GL ++HE I+ D K
Sbjct: 124 -VLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPE 178
Query: 224 NILLDEQWNA--KLSDFGLAR-LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVW 280
NI+ + + + K+ DFGLA L P E T +AAPE V + +D+W
Sbjct: 179 NIMCETKKASSVKIIDFGLATKLNPDEIVK----VTTATAEFAAPEIVDREPVGFYTDMW 234
Query: 281 SYGVFLYELITGRRPIDRNRPRSEQKLLQWVK--PYLSDAKQFRQIVDPRLEGKYSLRLV 338
+ GV Y L++G P + + LQ VK + D F + E K +
Sbjct: 235 AIGVLGYVLLSGLSPFAGE---DDLETLQNVKRCDWEFDEDAFSSVSP---EAK---DFI 285
Query: 339 SKLSHVANLCLVKNARTRPKMSEVLE 364
L L K R R + + LE
Sbjct: 286 KNL-------LQKEPRKRLTVHDALE 304
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 1e-21
Identities = 70/342 (20%), Positives = 122/342 (35%), Gaps = 99/342 (28%)
Query: 63 PSMSQRPSNLKEFTIAE-LKSATKNFSRS----VVIGEGGFGCVYKGLIKNSEDPSQKVE 117
P M+ + +E + +A+ FS + +G+G F V + + K + +E
Sbjct: 2 PHMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTT-----GLE 56
Query: 118 VAVKQLGRR----GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPN 173
A K + + ++ E ++H N+V+L ++ LV++ +
Sbjct: 57 FAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFH----YLVFDLVTG 112
Query: 174 G-------SVDQYLSPKSETILTWAMRLKIAQDAAR-------GLAYLHEGMDFQIIVRD 219
G + + Y SE DA+ +AY H I+ R+
Sbjct: 113 GELFEDIVAREFY----SE------------ADASHCIQQILESIAYCHSNG---IVHRN 153
Query: 220 FKSSNILL---DEQWNAKLSDFGLAR-LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAA 275
K N+LL + KL+DFGLA + SE + GT GY +PE ++ +
Sbjct: 154 LKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH----GFAGTPGYLSPEVLKKDPYSK 209
Query: 276 RSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSL 335
D+W+ GV LY L+ G P + +L + QI G Y
Sbjct: 210 PVDIWACGVILYILLVGYPPFWD---EDQHRL-------------YAQI----KAGAYDY 249
Query: 336 R-------------LVSKLSHVANLCLVKNARTRPKMSEVLE 364
L+ + L N + R + L+
Sbjct: 250 PSPEWDTVTPEAKSLIDSM-------LTVNPKKRITADQALK 284
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 2e-21
Identities = 70/307 (22%), Positives = 117/307 (38%), Gaps = 85/307 (27%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQ------LGRRGGHKEWM-TEVNFLGIVEH 144
VIG+G F V + + + + + AVK G E + E + +++H
Sbjct: 31 VIGKGPFSVVRRCINRET-----GQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 145 QNLVKLVGYCADDDERGIQRLLVYEYMPNG-----------SVDQYLSPKSETILTWAMR 193
++V+L+ + D +V+E+M + Y SE + + MR
Sbjct: 86 PHIVELLETYSSDGML----YMVFEFMDGADLCFEIVKRADAGFVY----SEAVASHYMR 137
Query: 194 LKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL---DEQWNAKLSDFGLARLGPSEGFT 250
+I + L Y H+ + II RD K +LL + KL FG+A G
Sbjct: 138 -QILE----ALRYCHD-NN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL- 188
Query: 251 HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQW 310
V+ VGT + APE V+ DVW GV L+ L++G P ++++L
Sbjct: 189 -VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFY----GTKERL--- 240
Query: 311 VKPYLSDAKQFRQIVDPRLEGKYSLR-------------LVSKLSHVANLCLVKNARTRP 357
F I ++GKY + LV ++ L+ + R
Sbjct: 241 ----------FEGI----IKGKYKMNPRQWSHISESAKDLVRRM-------LMLDPAERI 279
Query: 358 KMSEVLE 364
+ E L
Sbjct: 280 TVYEALN 286
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 2e-21
Identities = 73/341 (21%), Positives = 114/341 (33%), Gaps = 108/341 (31%)
Query: 65 MSQRPSNLKE-FTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL 123
MS P L++ + +++ +G G G V + + +VA+K +
Sbjct: 1 MSVYPKALRDEYIMSK------------TLGSGACGEVKLAFERKT-----CKKVAIKII 43
Query: 124 GRR----GGHKEW------MTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPN 173
+R G +E TE+ L + H ++K+ + +D +V E M
Sbjct: 44 SKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-----YYIVLELMEG 98
Query: 174 GSVDQYLSPK---SETILTWAMRLKIAQDAAR-------GLAYLHEGMDFQIIVRDFKSS 223
G + + E + YLHE II RD K
Sbjct: 99 GELFDKVVGNKRLKE------------ATCKLYFYQMLLAVQYLHENG---IIHRDLKPE 143
Query: 224 NILL---DEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAAR---- 276
N+LL +E K++DFG +++ + GT Y APE V A
Sbjct: 144 NVLLSSQEEDCLIKITDFGHSKILGETSLM---RTLCGTPTYLAPE-VLVSVGTAGYNRA 199
Query: 277 SDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLR 336
D WS GV L+ ++G P +R + QI GKY+
Sbjct: 200 VDCWSLGVILFICLSGYPPFSEHR---------------TQVSLKDQI----TSGKYNFI 240
Query: 337 -------------LVSKLSHVANLCLVKNARTRPKMSEVLE 364
LV KL LV + + R E L
Sbjct: 241 PEVWAEVSEKALDLVKKL-------LVVDPKARFTTEEALR 274
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 61/307 (19%), Positives = 109/307 (35%), Gaps = 91/307 (29%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR----GGHKEWMTEVNFLGIVEHQNL 147
+G+G F V + + + E A + + H++ E +++H N+
Sbjct: 18 ELGKGAFSVVRRCVKVLA-----GQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNI 72
Query: 148 VKLVGYCADDDERGIQRLLVYEYMPNG-------SVDQYLSPKSETILTWAMRLKIAQDA 200
V+L +++ L+++ + G + + Y SE DA
Sbjct: 73 VRLHDSISEEGHH----YLIFDLVTGGELFEDIVAREYY----SE------------ADA 112
Query: 201 AR-------GLAYLHEGMDFQIIVRDFKSSNILL---DEQWNAKLSDFGLARLGPSEGFT 250
+ + + H+ M ++ R+ K N+LL + KL+DFGLA E
Sbjct: 113 SHCIQQILEAVLHCHQ-MG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ-- 167
Query: 251 HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQW 310
GT GY +PE ++ D+W+ GV LY L+ G P + +L
Sbjct: 168 QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWD---EDQHRL--- 221
Query: 311 VKPYLSDAKQFRQIVDPRLEGKYSLR-------------LVSKLSHVANLCLVKNARTRP 357
++QI G Y L++K+ L N R
Sbjct: 222 ----------YQQI----KAGAYDFPSPEWDTVTPEAKDLINKM-------LTINPSKRI 260
Query: 358 KMSEVLE 364
+E L+
Sbjct: 261 TAAEALK 267
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 2e-21
Identities = 72/300 (24%), Positives = 108/300 (36%), Gaps = 81/300 (27%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQNLVKLV 151
+G G VY+ + + A+K L + K TE+ L + H N++KL
Sbjct: 60 ELGRGATSIVYRC-----KQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLK 114
Query: 152 GYCADDDERGIQRLLVYEYMPNGSVDQYLSPK---SETILTWAMRLKIAQDAAR------ 202
E LV E + G + + K SE +DAA
Sbjct: 115 EIFETPTEI----SLVLELVTGGELFDRIVEKGYYSE------------RDAADAVKQIL 158
Query: 203 -GLAYLHEGMDFQIIVRDFKSSNILL---DEQWNAKLSDFGLAR-LGPSEGFTHVSTAVV 257
+AYLHE I+ RD K N+L K++DFGL++ + V
Sbjct: 159 EAVAYLHE-NG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMK----TVC 211
Query: 258 GTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 317
GT GY APE ++ D+WS G+ Y L+ G P R +Q +
Sbjct: 212 GTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFY--DERGDQFM---------- 259
Query: 318 AKQFRQIVDPRLEGKYSLR-------------LVSKLSHVANLCLVKNARTRPKMSEVLE 364
FR+I L +Y LV KL +V + + R + L+
Sbjct: 260 ---FRRI----LNCEYYFISPWWDEVSLNAKDLVRKL-------IVLDPKKRLTTFQALQ 305
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 2e-21
Identities = 69/257 (26%), Positives = 108/257 (42%), Gaps = 44/257 (17%)
Query: 77 IAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLG-----RRGGHKE 131
I +L+ +++ VIG G FG V L+++ ++KV A+K L +R
Sbjct: 61 IRDLRMKAEDYEVVKVIGRGAFGEVQ--LVRHKS--TRKV-YAMKLLSKFEMIKRSDSAF 115
Query: 132 WMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRL-LVYEYMPNGSVDQYLSPKSETILTW 190
+ E + + +V+L + A D+R L +V EYMP G + +S
Sbjct: 116 FWEERDIMAFANSPWVVQL--FYAFQDDR---YLYMVMEYMPGGDLVNLMS--------- 161
Query: 191 AMRLKIAQDAAR--------GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 242
+ + AR L +H I RD K N+LLD+ + KL+DFG
Sbjct: 162 --NYDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCM 216
Query: 243 LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAAR----SDVWSYGVFLYELITGRRP-ID 297
EG TA VGT Y +PE +++ D WS GVFLYE++ G P
Sbjct: 217 KMNKEGMVRCDTA-VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 275
Query: 298 RNRPRSEQKLLQWVKPY 314
+ + K++
Sbjct: 276 DSLVGTYSKIMNHKNSL 292
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 95.3 bits (237), Expect = 2e-21
Identities = 73/360 (20%), Positives = 139/360 (38%), Gaps = 50/360 (13%)
Query: 14 EPPTTPKSLFSIRSSCATFNDNEVGRIGSELTSQNVSAISVESEARPSYPSMSQRPSNLK 73
+P + +V G + + + + ++ + +P +K
Sbjct: 92 KPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIK 151
Query: 74 EFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLG-RRGGHKEW 132
+ ++ +G G FG V++ + + A K + KE
Sbjct: 152 HDHV------LDHYDIHEELGTGAFGVVHRVTERAT-----GNNFAAKFVMTPHESDKET 200
Query: 133 M-TEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGS-VDQYLSPKSETILTW 190
+ E+ + ++ H LV L DD+E +++YE+M G ++ ++ ++
Sbjct: 201 VRKEIQTMSVLRHPTLVNLHDAFEDDNEM----VMIYEFMSGGELFEKVADEHNK--MSE 254
Query: 191 AMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNA--KLSDFGLAR-LGPSE 247
++ + +GL ++HE + D K NI+ + + KL DFGL L P +
Sbjct: 255 DEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311
Query: 248 GFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRP-IDRNRPRSEQK 306
GT +AAPE + + +D+WS GV Y L++G P N + +
Sbjct: 312 SVKVT----TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN----DDE 363
Query: 307 LLQWVK--PYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 364
L+ VK + D F I + +GK + KL L+ + TR + + LE
Sbjct: 364 TLRNVKSCDWNMDDSAFSGISE---DGK---DFIRKL-------LLADPNTRMTIHQALE 410
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 3e-21
Identities = 67/228 (29%), Positives = 102/228 (44%), Gaps = 28/228 (12%)
Query: 81 KSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWM--T---E 135
A + + IGEG +G V+K ++ ++ + V A+K++ R +E M + E
Sbjct: 7 CRADQQYECVAEIGEGAYGKVFKA--RDLKNGGRFV--ALKRV-RVQTGEEGMPLSTIRE 61
Query: 136 VNFL---GIVEHQNLVKLVGYCADDDERGIQRL-LVYEYMPNGSVD--QYLSPKSETILT 189
V L EH N+V+L C +L LV+E++ D YL E +
Sbjct: 62 VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ---DLTTYLDKVPEPGVP 118
Query: 190 WAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL-GPSEG 248
+ RGL +LH +++ RD K NIL+ KL+DFGLAR+
Sbjct: 119 TETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA 175
Query: 249 FTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPI 296
T V VV T+ Y APE + A D+WS G E+ R+P+
Sbjct: 176 LTSV---VV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 218
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 4e-21
Identities = 55/221 (24%), Positives = 91/221 (41%), Gaps = 37/221 (16%)
Query: 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEW-----MTEVNFLG 140
+ ++GEG +G V K K++ VA+K+ + M E+ L
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKDTGR-----IVAIKKF-LESDDDKMVKKIAMREIKLLK 79
Query: 141 IVEHQNLVKLVGYCADDDERGIQRL-LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQD 199
+ H+NLV L+ + + +R LV+E++ + ++ L + ++ + Q
Sbjct: 80 QLRHENLVNLL-----EVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQ- 132
Query: 200 AARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL--GPSEGFTHVSTAVV 257
G+ + H II RD K NIL+ + KL DFG AR P E + V
Sbjct: 133 IINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDD----EV 185
Query: 258 GTMGYAAPEYVQTGRLAARS-----DVWSYGVFLYELITGR 293
T Y APE + + DVW+ G + E+ G
Sbjct: 186 ATRWYRAPELL----VGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 4e-21
Identities = 67/254 (26%), Positives = 102/254 (40%), Gaps = 42/254 (16%)
Query: 56 SEARPSYPSMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQK 115
A P + + +F I LK VIG G F V ++K + +
Sbjct: 44 QWAEPIVVRLKEVRLQRDDFEI--LK----------VIGRGAFSEVA--VVK--MKQTGQ 87
Query: 116 VEVAVKQLG-----RRGGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRL-LVYE 169
V A+K + +RG + E + L + + + +L + A DE L LV E
Sbjct: 88 V-YAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL--HFAFQDEN---YLYLVME 141
Query: 170 YMPNGSVDQYLSPKSETILTWAM-RLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLD 228
Y G + LS K + M R +A+ + +H + RD K NILLD
Sbjct: 142 YYVGGDLLTLLS-KFGERIPAEMARFYLAEIVM-AIDSVHR---LGYVHRDIKPDNILLD 196
Query: 229 EQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARS-------DVWS 281
+ +L+DFG ++G A VGT Y +PE +Q + D W+
Sbjct: 197 RCGHIRLADFGSCLKLRADGTVRSLVA-VGTPDYLSPEILQAVGGGPGTGSYGPECDWWA 255
Query: 282 YGVFLYELITGRRP 295
GVF YE+ G+ P
Sbjct: 256 LGVFAYEMFYGQTP 269
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 5e-21
Identities = 61/302 (20%), Positives = 109/302 (36%), Gaps = 79/302 (26%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEW----MTEVNFLGIVEHQ-N 146
+G G F V + + K++ E A K L +R ++ + E+ L + +
Sbjct: 36 ELGRGKFAVVRQCISKST-----GQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPR 90
Query: 147 LVKLVGYCADDDERGIQRLLVYEYMPNGS-----VDQYLSPKSETILTWAMRLKIAQDAA 201
++ L + E +L+ EY G + + SE + ++ +I +
Sbjct: 91 VINLHEVYENTSEI----ILILEYAAGGEIFSLCLPELAEMVSENDVIRLIK-QILE--- 142
Query: 202 RGLAYLHEGMDFQIIV-RDFKSSNILL---DEQWNAKLSDFGLAR-LGPSEGFTHVSTAV 256
G+ YLH+ IV D K NILL + K+ DFG++R +G + +
Sbjct: 143 -GVYYLHQ----NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELR----EI 193
Query: 257 VGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRP-IDRNRPRSEQKLLQWVKPYL 315
+GT Y APE + + +D+W+ G+ Y L+T P + +
Sbjct: 194 MGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED---------------- 237
Query: 316 SDAKQFRQIVDPRLEGKYSLR-------------LVSKLSHVANLCLVKNARTRPKMSEV 362
+ + + I + + L LVKN RP
Sbjct: 238 -NQETYLNI----SQVNVDYSEETFSSVSQLATDFIQSL-------LVKNPEKRPTAEIC 285
Query: 363 LE 364
L
Sbjct: 286 LS 287
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 6e-21
Identities = 73/295 (24%), Positives = 111/295 (37%), Gaps = 63/295 (21%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEW--------MTEVNFLGIVE 143
+G G F V K K++ +E A K + +R EV+ L V
Sbjct: 19 ELGSGQFAIVKKCREKST-----GLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 144 HQNLVKLVGYCADDDERGIQRLLVYEYMPNG-------SVDQYLSPKSETILTWAMRLKI 196
H N++ L + + +L+ E + G + SE T ++ +I
Sbjct: 74 HHNVITLHDVYENRTDV----VLILELVSGGELFDFLAQKESL----SEEEATSFIK-QI 124
Query: 197 AQDAARGLAYLHEGMDFQIIVRDFKSSNILL----DEQWNAKLSDFGLAR-LGPSEGFTH 251
G+ YLH +I D K NI+L + KL DFGLA + F
Sbjct: 125 LD----GVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK- 176
Query: 252 VSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWV 311
+ GT + APE V L +D+WS GV Y L++G P + ++Q+ L +
Sbjct: 177 ---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANI 230
Query: 312 K--PYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 364
Y D + F + K + KL LVK R R + E L
Sbjct: 231 TSVSYDFDEEFFSHTSE---LAK---DFIRKL-------LVKETRKRLTIQEALR 272
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 6e-21
Identities = 65/217 (29%), Positives = 95/217 (43%), Gaps = 39/217 (17%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVK---QLGRRGGHKEWMTEVNFLGIVEHQNLV 148
VIG G FG V++ + S+ EVA+K Q R E+ + IV+H N+V
Sbjct: 47 VIGNGSFGVVFQAKLVESD------EVAIKKVLQDKRFKN-----RELQIMRIVKHPNVV 95
Query: 149 KL--VGYCADDDERGIQRLLVYEYMPNGSVDQYL--SPKSETILTWAM-RLKIAQDAARG 203
L Y D + + LV EY+P +V + K + + + +L + Q R
Sbjct: 96 DLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQ-LLRS 153
Query: 204 LAYLHEGMDFQIIVRDFKSSNILLDEQWNA-KLSDFGLAR-LGPSEGFTHVSTAVVGTMG 261
LAY+H I RD K N+LLD KL DFG A+ L E + +
Sbjct: 154 LAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVS----YICSRY 206
Query: 262 YAAPEYVQTGRLAARS-----DVWSYGVFLYELITGR 293
Y APE + A + D+WS G + EL+ G+
Sbjct: 207 YRAPELI----FGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 8e-21
Identities = 63/228 (27%), Positives = 105/228 (46%), Gaps = 42/228 (18%)
Query: 81 KSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEW--MT---E 135
+ + + + +GEG +G VYK VA+K++ R E T E
Sbjct: 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGR------IVALKRI-RLDAEDEGIPSTAIRE 69
Query: 136 VNFLGIVEHQNLVKLVGYCADDDERGIQRL-LVYEYMPNGSVD--QYLSPKSETILTWAM 192
++ L + H N+V L+ D + L LV+E+M D + L + +
Sbjct: 70 ISLLKELHHPNIVSLI-----DVIHSERCLTLVFEFMEK---DLKKVLDENKTGLQDSQI 121
Query: 193 RLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL--GPSEGFT 250
++ + Q RG+A+ H+ +I+ RD K N+L++ KL+DFGLAR P +T
Sbjct: 122 KIYLYQ-LLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYT 177
Query: 251 HVSTAVVGTMGYAAPEYVQTGRLAARS-----DVWSYGVFLYELITGR 293
H VV T+ Y AP+ + + ++ D+WS G E+ITG+
Sbjct: 178 HE---VV-TLWYRAPDVL----MGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 1e-20
Identities = 65/307 (21%), Positives = 102/307 (33%), Gaps = 87/307 (28%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEW--------MTEVNFLGIVE 143
+G G F V K K + E A K + +R EVN L +
Sbjct: 12 ELGSGQFAIVRKCRQKGT-----GKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66
Query: 144 HQNLVKLVGYCADDDERGIQRLLVYEYMPNG-------SVDQYLSPKSETILTWAMRLKI 196
H N++ L + + +L+ E + G + +E T ++ +I
Sbjct: 67 HPNIITLHDIFENKTDV----VLILELVSGGELFDFLAEKESL----TEDEATQFLK-QI 117
Query: 197 AQDAARGLAYLHEGMDFQIIVRDFKSSNILL----DEQWNAKLSDFGLAR-LGPSEGFTH 251
G+ YLH +I D K NI+L KL DFG+A + F
Sbjct: 118 LD----GVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFK- 169
Query: 252 VSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRP-IDRNRPRSEQKLLQW 310
+ GT + APE V L +D+WS GV Y L++G P +
Sbjct: 170 ---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET----------- 215
Query: 311 VKPYLSDAKQFRQIVDPRLEGKYSLR-------------LVSKLSHVANLCLVKNARTRP 357
+ I Y + +L LVK+ + R
Sbjct: 216 ------KQETLTNI----SAVNYDFDEEYFSNTSELAKDFIRRL-------LVKDPKRRM 258
Query: 358 KMSEVLE 364
+++ LE
Sbjct: 259 TIAQSLE 265
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 2e-20
Identities = 70/224 (31%), Positives = 110/224 (49%), Gaps = 42/224 (18%)
Query: 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEW--MT---EVNFL 139
+ + + +GEG + VYKG K +++ VA+K++ R H+E T EV+ L
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNL-----VALKEI--RLEHEEGAPCTAIREVSLL 54
Query: 140 GIVEHQNLVKLVGYCADDDERGIQRL-LVYEYMPNGSVD--QYLSPKSETILTWAMRLKI 196
++H N+V L D + L LV+EY+ D QYL I ++L +
Sbjct: 55 KDLKHANIVTLH-----DIIHTEKSLTLVFEYLDK---DLKQYLDDCGNIINMHNVKLFL 106
Query: 197 AQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL--GPSEGFTHVST 254
Q RGLAY H +++ RD K N+L++E+ KL+DFGLAR P++ + +
Sbjct: 107 FQ-LLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNE-- 160
Query: 255 AVVGTMGYAAPEYVQTGRLAARS-----DVWSYGVFLYELITGR 293
VV T+ Y P+ + L + D+W G YE+ TGR
Sbjct: 161 -VV-TLWYRPPDIL----LGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 89.5 bits (223), Expect = 3e-20
Identities = 59/224 (26%), Positives = 100/224 (44%), Gaps = 42/224 (18%)
Query: 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEW--MT---EVNFL 139
+ + IGEG +G VYK E A+K++ R E T E++ L
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGE------TFALKKI-RLEKEDEGIPSTTIREISIL 54
Query: 140 GIVEHQNLVKLVGYCADDDERGIQRL-LVYEYMPNGSVD--QYLSPKSETILTWAMRLKI 196
++H N+VKL RL LV+E++ D + L + + + +
Sbjct: 55 KELKHSNIVKLYDVIHTKK-----RLVLVFEHLDQ---DLKKLLDVCEGGLESVTAKSFL 106
Query: 197 AQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL--GPSEGFTHVST 254
Q G+AY H+ +++ RD K N+L++ + K++DFGLAR P +TH
Sbjct: 107 LQ-LLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE-- 160
Query: 255 AVVGTMGYAAPEYVQTGRLAARS-----DVWSYGVFLYELITGR 293
+V T+ Y AP+ + + ++ D+WS G E++ G
Sbjct: 161 -IV-TLWYRAPDVL----MGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 4e-20
Identities = 74/295 (25%), Positives = 112/295 (37%), Gaps = 63/295 (21%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEW--------MTEVNFLGIVE 143
+G G F V K K++ +E A K + +R EV+ L V
Sbjct: 19 ELGSGQFAIVKKCREKST-----GLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73
Query: 144 HQNLVKLVGYCADDDERGIQRLLVYEYMPNG-------SVDQYLSPKSETILTWAMRLKI 196
H N++ L + + +L+ E + G + SE T ++ +I
Sbjct: 74 HPNIITLHDVYENRTDV----VLILELVSGGELFDFLAQKESL----SEEEATSFIK-QI 124
Query: 197 AQDAARGLAYLHEGMDFQIIVRDFKSSNILL----DEQWNAKLSDFGLAR-LGPSEGFTH 251
G+ YLH +I D K NI+L + KL DFGLA + F
Sbjct: 125 LD----GVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK- 176
Query: 252 VSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWV 311
+ GT + APE V L +D+WS GV Y L++G P + ++Q+ L +
Sbjct: 177 ---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANI 230
Query: 312 K--PYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 364
Y D + F Q + K + KL LVK R R + E L
Sbjct: 231 TAVSYDFDEEFFSQTSE---LAK---DFIRKL-------LVKETRKRLTIQEALR 272
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 5e-20
Identities = 66/302 (21%), Positives = 113/302 (37%), Gaps = 77/302 (25%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR--------GGHKEWMTEVNFLGIVE 143
+G G F V K K++ ++ A K + +R ++ EV+ L ++
Sbjct: 18 ELGSGQFAVVKKCREKST-----GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 144 HQNLVKLVGYCADDDERGIQRLLVYEYMPNG-------SVDQYLSPKSETILTWAMRLKI 196
H N++ L + + +L+ E + G + +E
Sbjct: 73 HPNVITLHEVYENKTDV----ILILELVAGGELFDFLAEKESL----TE----------- 113
Query: 197 AQDAAR-------GLAYLHEGMDFQIIVRDFKSSNILL----DEQWNAKLSDFGLAR-LG 244
++A G+ YLH QI D K NI+L + K+ DFGLA +
Sbjct: 114 -EEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 169
Query: 245 PSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSE 304
F + GT + APE V L +D+WS GV Y L++G P + ++
Sbjct: 170 FGNEFK----NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD---TK 222
Query: 305 QKLLQWVK--PYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEV 362
Q+ L V Y + + F K + +L LVK+ + R + +
Sbjct: 223 QETLANVSAVNYEFEDEYFSNTSA---LAK---DFIRRL-------LVKDPKKRMTIQDS 269
Query: 363 LE 364
L+
Sbjct: 270 LQ 271
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 5e-20
Identities = 59/263 (22%), Positives = 106/263 (40%), Gaps = 49/263 (18%)
Query: 52 ISVESEARPSYPSMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSED 111
++ + + A ++ + R +GEG +G VYK + + +
Sbjct: 1 MAHHHHHHMGTLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNE 60
Query: 112 PSQKVEVAVKQLGRRGGHKEWM--T---EVNFLGIVEHQNLVKLVGYCADDDERGIQRL- 165
VA+K++ R +E + T EV+ L ++H+N+++L + RL
Sbjct: 61 T-----VAIKRI-RLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNH-----RLH 109
Query: 166 LVYEYMPN---GSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKS 222
L++EY N +D+ I ++ +L G+ + H + + RD K
Sbjct: 110 LIFEYAENDLKKYMDKNPDVSMRVIKSFLYQL------INGVNFCHSR---RCLHRDLKP 160
Query: 223 SNILLDEQWNA-----KLSDFGLARL--GPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAA 275
N+LL + K+ DFGLAR P FTH ++ T+ Y PE + L +
Sbjct: 161 QNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHE---II-TLWYRPPEIL----LGS 212
Query: 276 RS-----DVWSYGVFLYELITGR 293
R D+WS E++
Sbjct: 213 RHYSTSVDIWSIACIWAEMLMKT 235
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 7e-20
Identities = 62/242 (25%), Positives = 92/242 (38%), Gaps = 32/242 (13%)
Query: 65 MSQRPSNLKEFTIAELKSAT----KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAV 120
M R F E+ +T K + IG G G V D + VA+
Sbjct: 1 MGSRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAY-----DAILERNVAI 55
Query: 121 KQLGRRGGH----KEWMTEVNFLGIVEHQNLVKLVG-YCADDDERGIQRL-LVYEYMP-- 172
K+L R + K E+ + V H+N++ L+ + Q + +V E M
Sbjct: 56 KKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN 115
Query: 173 -NGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW 231
+ L + + L + M G+ +LH II RD K SNI++
Sbjct: 116 LCQVIQMELDHERMSYLLYQM--------LCGIKHLHSA---GIIHRDLKPSNIVVKSDC 164
Query: 232 NAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT 291
K+ DFGLAR + T V T Y APE + D+WS G + E+I
Sbjct: 165 TLKILDFGLARTAGTSFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIK 221
Query: 292 GR 293
G
Sbjct: 222 GG 223
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 7e-20
Identities = 71/236 (30%), Positives = 106/236 (44%), Gaps = 45/236 (19%)
Query: 79 ELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEW-----M 133
++KS K + + +GEG F VYK KN+ VA+K++ + G E
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQI-----VAIKKI-KLGHRSEAKDGINR 57
Query: 134 T---EVNFLGIVEHQNLVKLVGYCADDDERGIQRL-LVYEYMPNGSVD--QYLSPKSETI 187
T E+ L + H N++ L+ + LV+++M D + S +
Sbjct: 58 TALREIKLLQELSHPNIIGLLDAFGHKS-----NISLVFDFMET---DLEVIIKDNS-LV 108
Query: 188 LTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL--GP 245
LT + +GL YLH+ I+ RD K +N+LLDE KL+DFGLA+ P
Sbjct: 109 LTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 165
Query: 246 SEGFTHVSTAVVGTMGYAAPEYVQTGRLAARS-----DVWSYGVFLYELITGRRPI 296
+ +TH VV T Y APE + AR D+W+ G L EL+ R P
Sbjct: 166 NRAYTHQ---VV-TRWYRAPELL----FGARMYGVGVDMWAVGCILAELLL-RVPF 212
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 8e-20
Identities = 67/277 (24%), Positives = 113/277 (40%), Gaps = 41/277 (14%)
Query: 40 IGSELTSQNVSAISVESEARPSYPSMSQRPSNLKEFTIAELKSATKNFSRSV-------- 91
+ + + + + ++ SM + + + R
Sbjct: 1 MSGRPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTK 60
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQNLVKL- 150
VIG G FG VY+ + +S + VA+K++ + E+ + ++H N+V+L
Sbjct: 61 VIGNGSFGVVYQAKLCDSGE-----LVAIKKV--LQDKRFKNRELQIMRKLDHCNIVRLR 113
Query: 151 -VGYCADDDERGIQRLLVYEYMPNGSVDQYL--SPKSETILTWA-MRLKIAQDAARGLAY 206
Y + + + + LV +Y+P +V + +++ L ++L + Q R LAY
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSLAY 171
Query: 207 LHEGMDFQIIVRDFKSSNILLDEQWNA-KLSDFGLAR-LGPSEGFTHVSTAVVGTMGYAA 264
+H F I RD K N+LLD KL DFG A+ L E + + Y A
Sbjct: 172 IHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS----YICSRYYRA 224
Query: 265 PEYVQTGRLAARS-----DVWSYGVFLYELITGRRPI 296
PE + A DVWS G L EL+ G +PI
Sbjct: 225 PELI----FGATDYTSSIDVWSAGCVLAELLLG-QPI 256
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 1e-19
Identities = 70/307 (22%), Positives = 119/307 (38%), Gaps = 60/307 (19%)
Query: 42 SELTSQNVSAISVESEARPSYPSMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCV 101
++ ++V+ E R + + ++ F + LK V+G G +G V
Sbjct: 23 ADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFEL--LK----------VLGTGAYGKV 70
Query: 102 YKGLIKNSEDPSQKVEVAVKQLG-----RRGGHKEW-MTEVNFLGIVEHQN-LVKLVGYC 154
+ L++ A+K L ++ E TE L + LV L Y
Sbjct: 71 F--LVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLH-YA 127
Query: 155 ADDDERGIQRL-LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAAR--------GLA 205
+ + L L+ +Y+ G + +LS R + + + L
Sbjct: 128 FQTETK----LHLILDYINGGELFTHLS----------QRERFTEHEVQIYVGEIVLALE 173
Query: 206 YLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAP 265
+LH+ II RD K NILLD + L+DFGL++ ++ GT+ Y AP
Sbjct: 174 HLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD-FCGTIEYMAP 229
Query: 266 EYVQTGRLAARSDV--WSYGVFLYELITGRRP-----IDRNRPRSEQKLLQ---WVKPYL 315
+ V+ G V WS GV +YEL+TG P ++ +++L+ +
Sbjct: 230 DIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM 289
Query: 316 S-DAKQF 321
S AK
Sbjct: 290 SALAKDL 296
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 58/231 (25%), Positives = 99/231 (42%), Gaps = 33/231 (14%)
Query: 81 KSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQ--LGRRGGHKEWMTEVNF 138
+ F + G+G FG V G K++ VA+K+ R ++E + +
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMS-----VAIKKVIQDPRFRNRE-LQIMQD 72
Query: 139 LGIVEHQNLVKLVGY---CADDDERGIQRLLVYEYMPNGSVDQYL--SPKSETILTWA-M 192
L ++ H N+V+L Y + D R I +V EY+P+ ++ + + + +
Sbjct: 73 LAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILI 131
Query: 193 RLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQ-WNAKLSDFGLAR-LGPSEGFT 250
++ + Q R + LH + RD K N+L++E KL DFG A+ L PSE
Sbjct: 132 KVFLFQ-LIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNV 189
Query: 251 HVSTAVVGTMGYAAPEYVQTGRLAARS-----DVWSYGVFLYELITGRRPI 296
+ + Y APE + + D+WS G E++ G PI
Sbjct: 190 A----YICSRYYRAPELI----FGNQHYTTAVDIWSVGCIFAEMMLG-EPI 231
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 2e-19
Identities = 70/253 (27%), Positives = 109/253 (43%), Gaps = 48/253 (18%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLG-----RRGGHKEW-MTEVNFLGIVEHQ 145
V+G+GG+G V+ ++ + A+K L R E N L V+H
Sbjct: 24 VLGKGGYGKVF--QVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHP 81
Query: 146 NLVKLVGYCADDDERGIQRL-LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAAR-- 202
+V L+ Y + L L+ EY+ G + L E I +D A
Sbjct: 82 FIVDLI-YAFQTGGK----LYLILEYLSGGELFMQLE--REGIFM--------EDTACFY 126
Query: 203 ------GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAV 256
L +LH+ II RD K NI+L+ Q + KL+DFGL + +G +
Sbjct: 127 LAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV--THTF 181
Query: 257 VGTMGYAAPEYVQT---GRLAARSDVWSYGVFLYELITGRRP-IDRNRPRSEQKLLQ--- 309
GT+ Y APE + R D WS G +Y+++TG P NR ++ K+L+
Sbjct: 182 CGTIEYMAPEILMRSGHNRAV---DWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL 238
Query: 310 WVKPYLS-DAKQF 321
+ PYL+ +A+
Sbjct: 239 NLPPYLTQEARDL 251
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 3e-19
Identities = 61/235 (25%), Positives = 100/235 (42%), Gaps = 48/235 (20%)
Query: 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWM--T---EVNFLG 140
+ + IG+G FG V+K + + VA+K++ KE T E+ L
Sbjct: 18 KYEKLAKIGQGTFGEVFKARHRKTGQK-----VALKKV-LMENEKEGFPITALREIKILQ 71
Query: 141 IVEHQNLVKLVGYCADDDERGIQRL----LVYEYMPNGSVDQ----YLSPKSETILTWAM 192
+++H+N+V L+ C + LV+++ + LS T +
Sbjct: 72 LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFC-----EHDLAGLLSNVLVK-FTLSE 125
Query: 193 RLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL------GPS 246
++ Q GL Y+H +I+ RD K++N+L+ KL+DFGLAR
Sbjct: 126 IKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 182
Query: 247 EGFTHVSTAVVGTMGYAAPEYVQTGRLAARS-----DVWSYGVFLYELITGRRPI 296
+T+ VV T+ Y PE + L R D+W G + E+ T R PI
Sbjct: 183 NRYTNR---VV-TLWYRPPELL----LGERDYGPPIDLWGAGCIMAEMWT-RSPI 228
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 3e-19
Identities = 68/281 (24%), Positives = 105/281 (37%), Gaps = 49/281 (17%)
Query: 41 GSELTSQNVSAISVESEARPSYPSMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGC 100
GSE S + + + + SQ + L +F +K +G G FG
Sbjct: 9 GSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDR--IK----------TLGTGSFGR 56
Query: 101 VYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEW----------MTEVNFLGIVEHQNLVKL 150
V L+K S A+K L K+ + E L V LVKL
Sbjct: 57 VM--LVK--HKESGNH-YAMKIL-----DKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 151 VGYCADDDERGIQRL-LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHE 209
D+ L +V EY+ G + +L + R AQ YLH
Sbjct: 107 EFSFKDNS-----NLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAAQ-IVLTFEYLHS 159
Query: 210 GMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQ 269
+I RD K N+L+D+Q +++DFG A+ +T + GT APE +
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEIIL 211
Query: 270 TGRLAARSDVWSYGVFLYELITGRRP-IDRNRPRSEQKLLQ 309
+ D W+ GV +YE+ G P + +K++
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS 252
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 87.6 bits (217), Expect = 7e-19
Identities = 60/253 (23%), Positives = 97/253 (38%), Gaps = 31/253 (12%)
Query: 53 SVESEARPSYPSMSQRPSNLKEFTIAELKSA---TKNFSRSVVIGEGGFGCVYKGLIKNS 109
V+ + +MS+ + + +++ S K + IG G G V
Sbjct: 27 QVDVSYIAKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAY---- 82
Query: 110 EDPSQKVEVAVKQLGRRGGH----KEWMTEVNFLGIVEHQNLVKLVG-YCADDDERGIQR 164
D VA+K+L R + K E+ + V H+N++ L+ + Q
Sbjct: 83 -DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 141
Query: 165 L-LVYEYMP---NGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDF 220
+ LV E M + L + + L + M G+ +LH II RD
Sbjct: 142 VYLVMELMDANLCQVIQMELDHERMSYLLYQM--------LCGIKHLHSA---GIIHRDL 190
Query: 221 KSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVW 280
K SNI++ K+ DFGLAR + T V T Y APE + D+W
Sbjct: 191 KPSNIVVKSDCTLKILDFGLARTAGTSFMM---TPYVVTRYYRAPEVILGMGYKENVDIW 247
Query: 281 SYGVFLYELITGR 293
S G + E++ +
Sbjct: 248 SVGCIMGEMVRHK 260
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 9e-19
Identities = 67/247 (27%), Positives = 105/247 (42%), Gaps = 59/247 (23%)
Query: 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEW----------MTE 135
+F +G G FG V+ LI+ + + A+K L KE E
Sbjct: 7 DFQILRTLGTGSFGRVH--LIR--SRHNGRY-YAMKVL-----KKEIVVRLKQVEHTNDE 56
Query: 136 VNFLGIVEHQNLVKLVGYCADDDERGIQRL-LVYEYMPNGSVDQYLSPKSETILTWAMRL 194
L IV H ++++ G D ++ ++ +Y+ G + L KS+
Sbjct: 57 RLMLSIVTHPFIIRMWGTFQDAQ-----QIFMIMDYIEGGELFSLLR-KSQ--------- 101
Query: 195 KIAQDAAR--------GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPS 246
+ A+ L YLH II RD K NILLD+ + K++DFG A+ P
Sbjct: 102 RFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158
Query: 247 EGFTHVSTAVVGTMGYAAPEYVQT---GRLAARSDVWSYGVFLYELITGRRP-IDRNRPR 302
+T + GT Y APE V T + D WS+G+ +YE++ G P D N +
Sbjct: 159 VTYT-----LCGTPDYIAPEVVSTKPYNKSI---DWWSFGILIYEMLAGYTPFYDSNTMK 210
Query: 303 SEQKLLQ 309
+ +K+L
Sbjct: 211 TYEKILN 217
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 1e-18
Identities = 70/295 (23%), Positives = 122/295 (41%), Gaps = 63/295 (21%)
Query: 48 NVSAISVESEARPSYPSMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIK 107
++ I++ + + +F + LK V+G+G FG V+ L+K
Sbjct: 4 SIKEIAITHHVKEGHEKAD-----PSQFEL--LK----------VLGQGSFGKVF--LVK 44
Query: 108 NSEDPSQKVEVAVKQLGR----RGGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQ 163
+ A+K L + E + L V H +VKL Y + +
Sbjct: 45 KISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLH-YAFQTEGK--- 100
Query: 164 RL-LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAAR--------GLAYLHEGMDFQ 214
L L+ +++ G + LS + ++ + L +LH
Sbjct: 101 -LYLILDFLRGGDLFTRLS----------KEVMFTEEDVKFYLAELALALDHLHS---LG 146
Query: 215 IIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT---G 271
II RD K NILLDE+ + KL+DFGL++ + + GT+ Y APE V
Sbjct: 147 IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSFCGTVEYMAPEVVNRRGHT 204
Query: 272 RLAARSDVWSYGVFLYELITGRRP-IDRNRPRSEQKLLQ---WVKPYLS-DAKQF 321
+ A D WS+GV ++E++TG P ++R + +L+ + +LS +A+
Sbjct: 205 QSA---DWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSL 256
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 7e-17
Identities = 36/307 (11%), Positives = 87/307 (28%), Gaps = 65/307 (21%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGH-----KEWMTEVNFLGIVEHQN 146
G ++ D + +VA+ + +G +E ++ L ++
Sbjct: 38 FHGGVPPLQFWQA-----LDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92
Query: 147 LVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAY 206
+ + V G L+V E++ GS+ + +T + ++ Q A
Sbjct: 93 VAR-VLDVVHTRAGG---LVVAEWIRGGSLQEVA----DTSPSPVGAIRAMQSLAAAADA 144
Query: 207 LHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPE 266
H + + S + + + L+
Sbjct: 145 AHR---AGVALSIDHPSRVRVSIDGDVVLAYPA----------------------TMPDA 179
Query: 267 YVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSE-QKLLQWVKPYLSDAKQFRQIV 325
+ D+ G LY L+ R P+ RS + + + +
Sbjct: 180 -------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDI 232
Query: 326 DPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASAEAGSPRRPLRS 385
++ + ++ + + R S +L ++ + A A+ P+
Sbjct: 233 PFQIS-----AVAAR-------SVQGDGGIRSA-STLLNLMQQ-ATAVADRTEVLGPIDE 278
Query: 386 STSRETP 392
+ P
Sbjct: 279 APVSAAP 285
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 1e-16
Identities = 49/223 (21%), Positives = 78/223 (34%), Gaps = 41/223 (18%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMT-------------EVNF 138
I G +G V G+ VA+K++ + E+
Sbjct: 29 FISSGSYGAVCAGVDSEGI------PVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 139 LGIVEHQNLVKLVGYCADDDERGIQRL-LVYEYMPN------GSVDQYLSPKSETILTWA 191
L H N++ L +E + +L LV E M +SP+ +
Sbjct: 83 LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYH 142
Query: 192 MRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTH 251
+ GL LHE ++ RD NILL + + + DF LAR ++
Sbjct: 143 I--------LLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTADAN-- 189
Query: 252 VSTAVVGTMGYAAPEYVQTGRLAARS-DVWSYGVFLYELITGR 293
T V Y APE V + + D+WS G + E+ +
Sbjct: 190 -KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 56/225 (24%), Positives = 93/225 (41%), Gaps = 41/225 (18%)
Query: 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGH----KEWMTEVNFL 139
K + +G G +G V + D +VA+K+L R K E+ L
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAI-----DKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLL 77
Query: 140 GIVEHQNLVKLVG-YCADDDERGIQRL-LVYEYMPNGSVDQYLSPKSETILTWAMRLKIA 197
++H+N++ L+ + R LV +M +T L M LK +
Sbjct: 78 KHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-------------QTDLQKIMGLKFS 124
Query: 198 QD--------AARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGF 249
++ +GL Y+H ++ RD K N+ ++E K+ DFGLAR
Sbjct: 125 EEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLAR-----HA 176
Query: 250 THVSTAVVGTMGYAAPEYVQTGRLAARS-DVWSYGVFLYELITGR 293
T V T Y APE + + ++ D+WS G + E++TG+
Sbjct: 177 DAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 4e-16
Identities = 53/304 (17%), Positives = 88/304 (28%), Gaps = 103/304 (33%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLG-IVEHQNLVKL 150
V+G G G V + K + + + A+K L + EV + ++V++
Sbjct: 25 VLGLGINGKVLQIFNKRT-----QEKFALKMLQDC---PKARREVELHWRASQCPHIVRI 76
Query: 151 VGYCADDDERGIQRLLVYEYMPNGS-----VDQYLSPKSETILTWAMRLKIAQDAAR--- 202
V + L+V E + G D+ +E ++A+
Sbjct: 77 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTE------------REASEIMK 124
Query: 203 ----GLAYLHEGMDFQIIV-RDFKSSNILL---DEQWNAKLSDFGLARLGPSEGFTHVST 254
+ YLH I RD K N+L KL+DFG A
Sbjct: 125 SIGEAIQYLHS----INIAHRDVKPENLLYTSKRPNAILKLTDFGFA------------- 167
Query: 255 AVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRP-IDRNRPRSEQKLLQWVKP 313
E + D+WS GV +Y L+ G P + +
Sbjct: 168 ----------KE-TTGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM------ 210
Query: 314 YLSDAKQFRQIVDPRLEGKYSLR-------------LVSKLSHVANLCLVKNARTRPKMS 360
+I G+Y L+ L L R ++
Sbjct: 211 -------KTRI----RMGQYEFPNPEWSEVSEEVKMLIRNL-------LKTEPTQRMTIT 252
Query: 361 EVLE 364
E +
Sbjct: 253 EFMN 256
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 4e-16
Identities = 48/216 (22%), Positives = 84/216 (38%), Gaps = 40/216 (18%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFL-GIVEHQNLVKLV 151
+G G + V++ + + + +V VK L + K+ E+ L + N++ L
Sbjct: 44 LGRGKYSEVFEAI-----NITNNEKVVVKIL-KPVKKKKIKREIKILENLRGGPNIITLA 97
Query: 152 GYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSET--------ILTWAMRLKIAQDAARG 203
D R LV+E++ N Q ++ IL +
Sbjct: 98 DIVKDPVSR--TPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEIL-------------KA 142
Query: 204 LAYLHEGMDFQIIVRDFKSSNILLD-EQWNAKLSDFGLARLG-PSEGFTHVSTAVVGTMG 261
L Y H I+ RD K N+++D E +L D+GLA P + + V +
Sbjct: 143 LDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR----VASRY 195
Query: 262 YAAPEYVQTGRLAARS-DVWSYGVFLYELITGRRPI 296
+ PE + ++ S D+WS G L +I + P
Sbjct: 196 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 6e-16
Identities = 63/217 (29%), Positives = 89/217 (41%), Gaps = 36/217 (16%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEV-AVKQLGRRGGHKEW----------MTEVNFLG 140
++G+G FG V K + A+K L KE +TE L
Sbjct: 155 LLGKGTFGKVILVKEKATG------RYYAMKIL-----KKEVIVAKDEVAHTLTENRVLQ 203
Query: 141 IVEHQNLVKLVGYCADDDERGIQRL-LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQD 199
H L L Y +R L V EY G + +LS + R A+
Sbjct: 204 NSRHPFLTALK-YSFQTHDR----LCFVMEYANGGELFFHLS-RERVFSEDRARFYGAE- 256
Query: 200 AARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGT 259
L YLH + ++ RD K N++LD+ + K++DFGL + G +G T GT
Sbjct: 257 IVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKTFCGT 312
Query: 260 MGYAAPEYVQTGRLAARS-DVWSYGVFLYELITGRRP 295
Y APE V R+ D W GV +YE++ GR P
Sbjct: 313 PEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 76.9 bits (189), Expect = 1e-15
Identities = 60/273 (21%), Positives = 92/273 (33%), Gaps = 75/273 (27%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVA---VKQLGRRGGHKEWMTE------------- 135
+G G FG V + + + VA +K+ H+ M+E
Sbjct: 29 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 88
Query: 136 VNFLG-----------IVE---HQNLVKLV---------------------GYCADDDER 160
VN LG IVE NL + Y
Sbjct: 89 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVD 148
Query: 161 GIQRLLVYEYMPNGSVDQYLSPKS--------------ETILTWAMRLKIAQDAARGLAY 206
+RL + + ++ KS + LT + + A+G+ +
Sbjct: 149 LKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEF 208
Query: 207 LHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAV---VGTMGYA 263
L + I RD + NILL E+ K+ DFGLAR + + M
Sbjct: 209 LASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM--- 262
Query: 264 APEYVQTGRLAARSDVWSYGVFLYELIT-GRRP 295
APE + +SDVWS+GV L+E+ + G P
Sbjct: 263 APETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 77.8 bits (191), Expect = 2e-15
Identities = 69/307 (22%), Positives = 113/307 (36%), Gaps = 37/307 (12%)
Query: 2 KCFPFTNWDKKDEPPTTPKSLFSIRSSCATFNDNEVGRIGSELTSQNVSAISVESEARPS 61
+ +K K L G G+E Q + +
Sbjct: 259 SLSFGISELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAP 318
Query: 62 YPSMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVK 121
+ S + + +F+ +V+G+G FG V K +++ AVK
Sbjct: 319 EEKTANTISKFDNNGNRD-RMKLTDFNFLMVLGKGSFGKVMLSERKGTDE-----LYAVK 372
Query: 122 QLGRRGGHKEW----------MTEVNFLGIV-EHQNLVKLVGYCADDDERGIQRL-LVYE 169
L K+ M E L + + L +L C +R L V E
Sbjct: 373 IL-----KKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH-SCFQTMDR----LYFVME 422
Query: 170 YMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE 229
Y+ G D + + A + A GL +L II RD K N++LD
Sbjct: 423 YVNGG--DLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDS 477
Query: 230 QWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARS-DVWSYGVFLYE 288
+ + K++DFG+ + +G T + GT Y APE + + +S D W++GV LYE
Sbjct: 478 EGHIKIADFGMCKENIWDGVT--TKTFCGTPDYIAPE-IIAYQPYGKSVDWWAFGVLLYE 534
Query: 289 LITGRRP 295
++ G+ P
Sbjct: 535 MLAGQAP 541
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 36/94 (38%), Positives = 50/94 (53%), Gaps = 7/94 (7%)
Query: 203 GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGY 262
L +LH+ II RD K N+LLD + + KL+DFG+ + G G T + GT Y
Sbjct: 136 ALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT--TATFCGTPDY 190
Query: 263 AAPEYVQTGRLAARS-DVWSYGVFLYELITGRRP 295
APE + L + D W+ GV LYE++ G P
Sbjct: 191 IAPE-ILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 2e-15
Identities = 37/94 (39%), Positives = 52/94 (55%), Gaps = 7/94 (7%)
Query: 203 GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGY 262
L YLHE II RD K N+LLD + + KL+D+G+ + G G T ++ GT Y
Sbjct: 122 ALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNY 176
Query: 263 AAPEYVQTGRLAARS-DVWSYGVFLYELITGRRP 295
APE + G S D W+ GV ++E++ GR P
Sbjct: 177 IAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 2e-15
Identities = 33/94 (35%), Positives = 52/94 (55%), Gaps = 7/94 (7%)
Query: 203 GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGY 262
GL +L II RD K N++LD + + K++DFG+ + +G T + GT Y
Sbjct: 133 GLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT--TKTFCGTPDY 187
Query: 263 AAPEYVQTGRLAARS-DVWSYGVFLYELITGRRP 295
APE + + +S D W++GV LYE++ G+ P
Sbjct: 188 IAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 2e-15
Identities = 64/217 (29%), Positives = 89/217 (41%), Gaps = 37/217 (17%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEV-AVKQLGRRGGHKEW----------MTEVNFLG 140
++G+G FG V K + A+K L KE +TE L
Sbjct: 12 LLGKGTFGKVILVREKATG------RYYAMKIL-----RKEVIIAKDEVAHTVTESRVLQ 60
Query: 141 IVEHQNLVKLVGYCADDDERGIQRL-LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQD 199
H L L Y +R L V EY G + +LS + R A+
Sbjct: 61 NTRHPFLTALK-YAFQTHDR----LCFVMEYANGGELFFHLS-RERVFTEERARFYGAE- 113
Query: 200 AARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGT 259
L YLH ++ RD K N++LD+ + K++DFGL + G S+G T GT
Sbjct: 114 IVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGT 168
Query: 260 MGYAAPEYVQTGRLAARS-DVWSYGVFLYELITGRRP 295
Y APE V R+ D W GV +YE++ GR P
Sbjct: 169 PEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 3e-15
Identities = 35/94 (37%), Positives = 50/94 (53%), Gaps = 7/94 (7%)
Query: 203 GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGY 262
GL +LH I+ RD K NILLD+ + K++DFG+ + + GT Y
Sbjct: 130 GLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNTFCGTPDY 184
Query: 263 AAPEYVQTGRLAARS-DVWSYGVFLYELITGRRP 295
APE + G+ S D WS+GV LYE++ G+ P
Sbjct: 185 IAPE-ILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 3e-15
Identities = 36/94 (38%), Positives = 46/94 (48%), Gaps = 7/94 (7%)
Query: 203 GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGY 262
L YLH I+ RD K NILLD Q + L+DFGL + T ++ GT Y
Sbjct: 151 ALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST--TSTFCGTPEY 205
Query: 263 AAPEYVQTGRLAARS-DVWSYGVFLYELITGRRP 295
APE V + R+ D W G LYE++ G P
Sbjct: 206 LAPE-VLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 3e-15
Identities = 60/217 (27%), Positives = 90/217 (41%), Gaps = 24/217 (11%)
Query: 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGH----KEWMTEVNFL 139
+ + +G G +G V D + VAVK+L R K E+ L
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAF-----DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 82
Query: 140 GIVEHQNLVKLVG-YCADDDERGIQRL-LVYEYMPNGSVDQYLSPKSETILTWAMRLKIA 197
++H+N++ L+ + + LV M D K + + ++ I
Sbjct: 83 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG---ADLNNIVKCQKLTDDHVQFLIY 139
Query: 198 QDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVV 257
Q RGL Y+H II RD K SN+ ++E K+ DFGLAR T V
Sbjct: 140 Q-ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTADEMTGYV 190
Query: 258 GTMGYAAPEYVQTGRLAARS-DVWSYGVFLYELITGR 293
T Y APE + ++ D+WS G + EL+TGR
Sbjct: 191 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 4e-15
Identities = 61/249 (24%), Positives = 94/249 (37%), Gaps = 46/249 (18%)
Query: 65 MSQRPSNLKEFTIAELKSA----TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAV 120
MS P F E+ + +G G +G V + D +VA+
Sbjct: 1 MSSPPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAV-----DGRTGAKVAI 55
Query: 121 KQLGRRGGH----KEWMTEVNFLGIVEHQNLVKLVG-YCADDDERGIQRL-LVYEYMPNG 174
K+L R K E+ L + H+N++ L+ + D+ LV +M
Sbjct: 56 KKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--- 112
Query: 175 SVDQYLSPKSETILTWAMRLKIAQDA---------ARGLAYLHEGMDFQIIVRDFKSSNI 225
T L M+ + + +GL Y+H II RD K N+
Sbjct: 113 ----------GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNL 159
Query: 226 LLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARS-DVWSYGV 284
++E K+ DFGLAR T V T Y APE + ++ D+WS G
Sbjct: 160 AVNEDCELKILDFGLAR-----QADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGC 214
Query: 285 FLYELITGR 293
+ E+ITG+
Sbjct: 215 IMAEMITGK 223
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 5e-15
Identities = 37/94 (39%), Positives = 52/94 (55%), Gaps = 7/94 (7%)
Query: 203 GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGY 262
L YLHE II RD K N+LLD + + KL+D+G+ + G G T ++ GT Y
Sbjct: 165 ALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNY 219
Query: 263 AAPEYVQTGRLAARS-DVWSYGVFLYELITGRRP 295
APE + G S D W+ GV ++E++ GR P
Sbjct: 220 IAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 6e-15
Identities = 58/260 (22%), Positives = 100/260 (38%), Gaps = 76/260 (29%)
Query: 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGR------RGGHKEWMTEVN 137
+K +S +G G FG V + S A+K++ + R E++
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKR-----FALKKVLQDPRYKNR--------ELD 52
Query: 138 FLGIVEHQNLVKL--VGYCADDDERGIQRL------------------------------ 165
+ +++H N++KL Y D+E +
Sbjct: 53 IMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKY 112
Query: 166 --LVYEYMPNGSVDQYL--SPKSETILTWA-MRLKIAQDAARGLAYLHEGMDFQIIVRDF 220
++ EY+P+ ++ + L +S + + + I Q R + ++H I RD
Sbjct: 113 LNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQ-LFRAVGFIHS---LGICHRDI 167
Query: 221 KSSNILLD-EQWNAKLSDFGLAR-LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARS- 277
K N+L++ + KL DFG A+ L PSE + + Y APE + L A
Sbjct: 168 KPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAY----ICSRFYRAPELM----LGATEY 219
Query: 278 ----DVWSYGVFLYELITGR 293
D+WS G ELI G+
Sbjct: 220 TPSIDLWSIGCVFGELILGK 239
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 3e-14
Identities = 58/237 (24%), Positives = 92/237 (38%), Gaps = 60/237 (25%)
Query: 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGR-----------RGGHKEW 132
++ IGEG +G V D KV VA+K++ R
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAY-----DNLNKVRVAIKKISPFEHQTYCQRTLR------ 74
Query: 133 MTEVNFLGIVEHQNLVKLVGYCADDDERGIQRL-LVYEYMPNGSVDQYLSPKSETILTWA 191
E+ L H+N++ + ++ + +V + M ET L
Sbjct: 75 --EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-------------ETDLYKL 119
Query: 192 MRLKIAQDA---------ARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 242
++ + + RGL Y+H ++ RD K SN+LL+ + K+ DFGLAR
Sbjct: 120 LKTQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLAR 176
Query: 243 -LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARS-----DVWSYGVFLYELITGR 293
P T T V T Y APE + L ++ D+WS G L E+++ R
Sbjct: 177 VADPDHDHTGFLTEYVATRWYRAPEIM----LNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 8e-14
Identities = 58/301 (19%), Positives = 100/301 (33%), Gaps = 60/301 (19%)
Query: 38 GRIGSELTSQNVSAISVESEARPSYPSMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGG 97
G++ T + + S + P ++ I + +IG G
Sbjct: 12 HNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQI------PDRYEIRHLIGTGS 65
Query: 98 FGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGH----KEWMTEVNFLGIVEHQNLVKLVGY 153
+G V + D +K VA+K++ R K + E+ L + H ++VK++
Sbjct: 66 YGHVCEAY-----DKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDI 120
Query: 154 CADDDERGIQRL-LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMD 212
D L +V E D ++ LT + + G+ Y+H
Sbjct: 121 VIPKDVEKFDELYVVLEIAD---SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSA-- 175
Query: 213 FQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAP------- 265
I+ RD K +N L+++ + K+ DFGLAR + +
Sbjct: 176 -GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTK 234
Query: 266 -------EYVQTGR--------LAARS-----DVWSYGVFLYELIT----------GRRP 295
+V T R L + DVWS G EL+ R P
Sbjct: 235 NLKRQLTGHVVT-RWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGP 293
Query: 296 I 296
+
Sbjct: 294 L 294
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 55/239 (23%), Positives = 90/239 (37%), Gaps = 41/239 (17%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGH----KEWMTEVNFLGIVEHQNL 147
+IG G +G VY D + + VA+K++ R K + E+ L ++ +
Sbjct: 33 LIGRGSYGYVYLAY-----DKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYI 87
Query: 148 VKLVGYCADDDERGIQRL-LVYEYMPNGSVDQYLSPKSETILTWA-MRLKIAQDAARGLA 205
++L DD L +V E D K+ LT ++ + G
Sbjct: 88 IRLYDLIIPDDLLKFDELYIVLEIAD---SDLKKLFKTPIFLTEEHIKTILYN-LLLGEN 143
Query: 206 YLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAP 265
++HE II RD K +N LL++ + K+ DFGLAR SE T++ +
Sbjct: 144 FIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPH 200
Query: 266 ---------EYVQTGR--------LAARS-----DVWSYGVFLYELITGRRPIDRNRPR 302
+V T R L + D+WS G EL+ + +
Sbjct: 201 NKNLKKQLTSHVVT-RWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN 258
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 2e-13
Identities = 55/228 (24%), Positives = 93/228 (40%), Gaps = 49/228 (21%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL-------GRRGGHKEWMT--EVNFLGIV 142
+G GG G V+ + D VA+K++ + E+ + +
Sbjct: 18 PLGCGGNGLVFSAV-----DNDCDKRVAIKKIVLTDPQSVKH-------ALREIKIIRRL 65
Query: 143 EHQNLVKLV------GYCADDDERGIQRL----LVYEYMPNGSVDQYLSPKSETILTWAM 192
+H N+VK+ G DD + L +V EYM D + +L
Sbjct: 66 DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME---TDLANVLEQGPLLEEHA 122
Query: 193 RLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLD-EQWNAKLSDFGLAR-LGPSEGFT 250
RL + Q RGL Y+H ++ RD K +N+ ++ E K+ DFGLAR + P
Sbjct: 123 RLFMYQ-LLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHK 178
Query: 251 HVSTAVVGTMGYAAPEYVQTGRLAARS-----DVWSYGVFLYELITGR 293
+ + T Y +P + L+ + D+W+ G E++TG+
Sbjct: 179 GHLSEGLVTKWYRSPRLL----LSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 5e-13
Identities = 53/235 (22%), Positives = 83/235 (35%), Gaps = 65/235 (27%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL--------GRRGGHKEWMT--EVNFLGI 141
++GEG +G V VA+K++ R T E+ L
Sbjct: 18 LLGEGAYGVVCSAT-----HKPTGEIVAIKKIEPFDKPLFALR-------TLREIKILKH 65
Query: 142 VEHQNLVKLVGYCADDDERGIQRL-LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDA 200
+H+N++ + D + ++ E M +T L + ++ D
Sbjct: 66 FKHENIITIFNIQRPDSFENFNEVYIIQELM-------------QTDLHRVISTQMLSDD 112
Query: 201 ---------ARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTH 251
R + LH +I RD K SN+L++ + K+ DFGLAR+ +
Sbjct: 113 HIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADN 169
Query: 252 VS--------TAVVGTMGYAAPEYVQTGRLAARS-----DVWSYGVFLYELITGR 293
V T Y APE + L + DVWS G L EL R
Sbjct: 170 SEPTGQQSGMVEFVATRWYRAPEVM----LTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 6e-13
Identities = 57/237 (24%), Positives = 96/237 (40%), Gaps = 59/237 (24%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMT----EVNFLG-IVEHQN 146
+G+G +G V+K + D VAVK++ + E+ L + H+N
Sbjct: 16 KLGKGAYGIVWKSI-----DRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHEN 70
Query: 147 LVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDA------ 200
+V L+ D++R + LV++YM ET L +R I +
Sbjct: 71 IVNLLNVLRADNDRDV--YLVFDYM-------------ETDLHAVIRANILEPVHKQYVV 115
Query: 201 ---ARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVV 257
+ + YLH G ++ RD K SNILL+ + + K++DFGL+R + + +
Sbjct: 116 YQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLS 172
Query: 258 GTMGYAAP--------EYVQTGR--------LAARS-----DVWSYGVFLYELITGR 293
+YV T R L + D+WS G L E++ G+
Sbjct: 173 INENTENFDDDQPILTDYVAT-RWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 8e-11
Identities = 46/227 (20%), Positives = 76/227 (33%), Gaps = 33/227 (14%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQNLVKLVG 152
IG+GGFGC+Y + +SE VK + TE+ F ++
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSD--NGPLFTELKFYQRAAKPEQIQKWI 100
Query: 153 YCADDDERGIQRLLVYEYMPNGSVD------QYLSPKSETILTWAMR-------LKIAQD 199
G+ + + I + L+++
Sbjct: 101 RTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLR 160
Query: 200 AARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAK--LSDFGLA-RLGPSEGFTHVS--- 253
L Y+HE + + D K+SN+LL+ + + L D+GLA R P +
Sbjct: 161 ILDILEYIHE---HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADP 217
Query: 254 -TAVVGTMGYA---APEYVQTGRLAARSDVWSYG-VFLYELITGRRP 295
GT+ + A V R R D+ G + +TG P
Sbjct: 218 KRCHDGTIEFTSIDAHNGVAPSR---RGDLEILGYCMIQ-WLTGHLP 260
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 59.5 bits (143), Expect = 1e-09
Identities = 71/472 (15%), Positives = 134/472 (28%), Gaps = 181/472 (38%)
Query: 4 FPFTNWDKKDEPPTTPKSLF-SIRSSCATFNDNEVGRIGSELTSQNVSAISVESEARPSY 62
F + + P+ ++ R +NDN+V NVS R
Sbjct: 93 FLMSPIKTEQRQPSMMTRMYIEQRDR--LYNDNQV------FAKYNVS--------RL-- 134
Query: 63 PSMSQRPSNLKEFTIAELKSATKNFSRSVVI-GEGGFGCVYKGLIKNSEDPSQK----VE 117
Q L++ + EL+ A V+I G G G K ++
Sbjct: 135 ----QPYLKLRQ-ALLELRPAKN-----VLIDGVLGSG---------------KTWVALD 169
Query: 118 VA--VKQLGRRGGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRL--LVYEYMPN 173
V K + W+ + C + ++ L L+Y+ PN
Sbjct: 170 VCLSYKVQCKMDFKIFWLN----------------LKNCNSPETV-LEMLQKLLYQIDPN 212
Query: 174 GS--VDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW 231
+ D + K +R+ Q R L + + +++ ++L
Sbjct: 213 WTSRSDHSSNIK--------LRIHSIQAELRRL----------LKSKPYENCLLVLLNVQ 254
Query: 232 NAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT 291
NAK + F ++ T R +D FL T
Sbjct: 255 NAKAWN----------AFNLSCKILLTT------------RFKQVTD------FLSAATT 286
Query: 292 GRRPIDRNR-----PRSEQKLLQWVKPYLSD----------------AKQFRQIVDPRLE 330
+D + + LL+++ D A+ R + +
Sbjct: 287 THISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLA-TWD 345
Query: 331 GKYSLRLVSKLSHVANLCL--VKNARTR---------PK----MSEVLE----------- 364
+ KL+ + L ++ A R P + +L
Sbjct: 346 N-WKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDV 404
Query: 365 --MVNKIVDASAEAGSPRRPLRSSTS--------RETPDHTKTKHKRRIIES 406
+VNK+ S ++P S+ S + ++ H R I++
Sbjct: 405 MVVVNKLHKYSLVE---KQPKESTISIPSIYLELKVKLENEYALH-RSIVDH 452
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.1 bits (98), Expect = 4e-04
Identities = 39/252 (15%), Positives = 83/252 (32%), Gaps = 66/252 (26%)
Query: 208 HEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTH--VSTAVVGTMGYAAP 265
H MDF+ ++ +IL + +A + +F + + +S + + +
Sbjct: 4 HHHMDFETGEHQYQYKDILSVFE-DAFVDNFDCKDV---QDMPKSILSKEEIDHIIMSKD 59
Query: 266 EYVQTGRLAARSDVWS--------YGVFL-------YELITGR-RPIDRNRPRSEQKLLQ 309
T RL W+ F+ Y+ + + R + ++
Sbjct: 60 AVSGTLRL-----FWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIE 114
Query: 310 WVKPYLSDAKQFRQIVDPRLEGKYSLR-LVSKLSHVANL-----------CLV----KNA 353
+D + F + RL+ LR + +L N+ + +
Sbjct: 115 QRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSY 174
Query: 354 RTRPKMS---------------EVLEMVNKI---VDASAEAGSPRRPLRSSTSRETPDHT 395
+ + KM VLEM+ K+ +D + + R SS +
Sbjct: 175 KVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTS----RSDHSSNIKLRIHSI 230
Query: 396 KTKHKRRIIESK 407
+ + RR+++SK
Sbjct: 231 QAE-LRRLLKSK 241
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 3e-08
Identities = 51/222 (22%), Positives = 78/222 (35%), Gaps = 43/222 (19%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEH-QNLVKLV 151
IG G FG +Y G D + EVA+K + H + E +++ + +
Sbjct: 17 IGSGSFGDIYLG-----TDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIR 71
Query: 152 GYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMR-------LKIAQDAARGL 204
A+ D Y M V + L P E + + R L +A +
Sbjct: 72 WCGAEGD---------YNVM----VMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRI 118
Query: 205 AYLHEGMDFQIIVRDFKSSNILLDEQWNAK---LSDFGLARL-GPSEGFTHV----STAV 256
Y+H I RD K N L+ + DFGLA+ + H+ + +
Sbjct: 119 EYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNL 175
Query: 257 VGTMGYA---APEYVQTGRLAARSDVWSYGVFLYELITGRRP 295
GT YA ++ R R D+ S G L G P
Sbjct: 176 TGTARYASINTHLGIEQSR---RDDLESLGYVLMYFNLGSLP 214
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 54.1 bits (129), Expect = 3e-08
Identities = 28/198 (14%), Positives = 55/198 (27%), Gaps = 43/198 (21%)
Query: 83 ATKNFSRSVVIGEGGFGCVYKGL------------IKNSEDPSQKVEVAVKQLGRRGGHK 130
T+ R IGEG FG V++ + I+ + + + +++
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 131 EWMTEVNFLGIVEHQNLVKLVG--------------------------YCADDDERGIQR 164
+ ++ ++ + + L D + Q
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137
Query: 165 LLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSN 224
+V E+ G L + + A I LA + RD N
Sbjct: 138 FIVLEFEFGGID---LEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGN 192
Query: 225 ILLDEQWNAKLSDFGLAR 242
+LL + KL +
Sbjct: 193 VLLKKTSLKKLHYTLNGK 210
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 7e-08
Identities = 40/224 (17%), Positives = 71/224 (31%), Gaps = 45/224 (20%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEH-QNLVKLV 151
IGEG FG +++G + +VA+K RR + E ++ + +
Sbjct: 18 IGEGSFGVIFEG-----TNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVY 72
Query: 152 GYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMR-------LKIAQDAARGL 204
+ + + + V L P E +L R A+ +
Sbjct: 73 YFGQEGL---------HNVL----VIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARV 119
Query: 205 AYLHEGMDFQIIVRDFKSSNILLDEQWNAK-----LSDFGLARL-GPSEGFTHV----ST 254
+HE + RD K N L+ + + DFG+ + H+
Sbjct: 120 QSIHE-KSL--VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKK 176
Query: 255 AVVGTMGYA---APEYVQTGRLAARSDVWSYGVFLYELITGRRP 295
+ GT Y + R R D+ + G + G P
Sbjct: 177 NLSGTARYMSINTHLGREQSR---RDDLEALGHVFMYFLRGSLP 217
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 45/224 (20%), Positives = 71/224 (31%), Gaps = 45/224 (20%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEH-QNLVKLV 151
IG G FG + G ++ VA+K + + E F + + ++
Sbjct: 17 IGCGNFGELRLG-----KNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVY 71
Query: 152 GYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMR-------LKIAQDAARGL 204
+ Y M V + L P E + R L IA +
Sbjct: 72 YFGPCGK---------YNAM----VLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRM 118
Query: 205 AYLHEGMDFQIIVRDFKSSNILLDEQWNAK-----LSDFGLARL-GPSEGFTHV----ST 254
Y+H +I RD K N L+ N + DF LA+ E H+
Sbjct: 119 EYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHK 175
Query: 255 AVVGTMGYA---APEYVQTGRLAARSDVWSYGVFLYELITGRRP 295
++ GT Y + R R D+ + G + G P
Sbjct: 176 SLTGTARYMSINTHLGKEQSR---RDDLEALGHMFMYFLRGSLP 216
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 51.2 bits (122), Expect = 3e-07
Identities = 48/221 (21%), Positives = 79/221 (35%), Gaps = 41/221 (18%)
Query: 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQNLVKLVG 152
IG G FG +Y G + EVA+K + H + + E I++ + V
Sbjct: 15 IGSGSFGEIYLG-----TNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVR 69
Query: 153 YCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMR-------LKIAQDAARGLA 205
+ + + Y + V L P E + + R L +A +
Sbjct: 70 WFGVEGD--------YNVL----VMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
Query: 206 YLHEGMDFQIIVRDFKSSNILLDEQWNAK---LSDFGLARL-GPSEGFTHV----STAVV 257
++H + RD K N L+ A + DFGLA+ + H+ + +
Sbjct: 118 FVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLT 174
Query: 258 GTMGYA---APEYVQTGRLAARSDVWSYGVFLYELITGRRP 295
GT YA ++ R R D+ S G L + G P
Sbjct: 175 GTARYASVNTHLGIEQSR---RDDLESLGYVLMYFLRGSLP 212
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 3e-07
Identities = 58/225 (25%), Positives = 86/225 (38%), Gaps = 55/225 (24%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL-GRRGGHKEWMTEVNFLGIVEHQNLVKL 150
VIG+G FG V K D VA+K + + H++ E+ L ++L K
Sbjct: 104 VIGKGSFGQVVKAY-----DHKVHQHVALKMVRNEKRFHRQAAEEIRIL-----EHLRK- 152
Query: 151 VGYCAD-DDERGIQRLL-------------------VYEYMPNGSVDQYLSPKSETILTW 190
D D+ + +L +YE + Q S
Sbjct: 153 ----QDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNK-FQGFSLP------- 200
Query: 191 AMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNA--KLSDFGLARLGPSEG 248
+R K A + L LH +II D K NILL +Q + K+ DFG +
Sbjct: 201 LVR-KFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRV 256
Query: 249 FTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGR 293
+T++ + Y APE + R D+WS G L EL+TG
Sbjct: 257 YTYIQSRF-----YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 4e-07
Identities = 43/220 (19%), Positives = 83/220 (37%), Gaps = 31/220 (14%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL-GRRGGHKEWMTEVNFL----------- 139
+G G F V+ ++D VA+K + G + + E+ L
Sbjct: 26 KLGWGHFSTVWL-----AKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 80
Query: 140 GIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQD 199
+ +++KL+ + G+ ++V+E + ++ + + +I++
Sbjct: 81 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQ 139
Query: 200 AARGLAYLHEGMDFQIIVRDFKSSNILLDE------QWNAKLSDFGLARLGPSEGFTHVS 253
GL Y+H II D K N+L++ K++D G A +
Sbjct: 140 LLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 197
Query: 254 TAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGR 293
T Y +PE + +D+WS ++ELITG
Sbjct: 198 TRE-----YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 5e-07
Identities = 37/239 (15%), Positives = 73/239 (30%), Gaps = 57/239 (23%)
Query: 93 IGEGGFGCVYKG---LIKNSEDPSQKVEVAVK-------------QLGRRGGHKEWMTEV 136
G +Y+ + QK + ++K R +
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 137 NFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMR--- 193
+ +G+ D+ Y ++ V L ++ L + +
Sbjct: 110 KLYST-PLLAIPTCMGFGVHQDK--------YRFL----VLPSLGRSLQSALDVSPKHVL 156
Query: 194 -----LKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAK--LSDFGLARLGPS 246
L++A L +LHE + + + + NI +D + ++ L+ +G A
Sbjct: 157 SERSVLQVACRLLDALEFLHE---NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCP 213
Query: 247 EGFTHV------STAVVGTMGYA---APEYVQTGRLAARSDVWSYG-VFLYELITGRRP 295
G HV + G + + + R RSD+ S G L + G P
Sbjct: 214 SG-KHVAYVEGSRSPHEGDLEFISMDLHKGCGPSR---RSDLQSLGYCMLK-WLYGFLP 267
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 49/216 (22%), Positives = 84/216 (38%), Gaps = 35/216 (16%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL-GRRGGHKEWMTEVNFLGIVEHQNLVKL 150
+IG+G FG V K D ++ VA+K + ++ + EV L +L
Sbjct: 61 LIGKGSFGQVVKAY-----DRVEQEWVAIKIIKNKKAFLNQAQIEVRLL---------EL 106
Query: 151 VGYCADDDERGIQRL-----------LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQD 199
+ + + I L LV+E + + ++ L + ++ + K AQ
Sbjct: 107 MNKHDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQ 165
Query: 200 AARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNA--KLSDFGLARLGPSEGFTHVSTAVV 257
L +L + II D K NILL + K+ DFG + + ++ +
Sbjct: 166 MCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF- 223
Query: 258 GTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGR 293
Y +PE + D+WS G L E+ TG
Sbjct: 224 ----YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 4e-06
Identities = 49/237 (20%), Positives = 87/237 (36%), Gaps = 56/237 (23%)
Query: 93 IGEGGFGCVYKGL--------------IKNSEDPSQKVEVAV-KQLGRRGGHKEWMTE-- 135
IG GGFG +Y ++ E+ E+ +++ ++ K+W+
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 136 VNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMR-- 193
+++LGI G + + R +V E L + I
Sbjct: 105 LDYLGI------PLFYGSGLTEFKGRSYRFMVME---------RLGIDLQKISGQNGTFK 149
Query: 194 ----LKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAK--LSDFGLA-RLGPS 246
L++ L Y+HE + + D K++N+LL + + L+D+GL+ R P+
Sbjct: 150 KSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPN 206
Query: 247 EGFTHVS----TAVVGTMGYA---APEYVQTGRLAARSDVWSYG-VFLYELITGRRP 295
GT+ + A + V R RSDV G L + G+ P
Sbjct: 207 GNHKQYQENPRKGHNGTIEFTSLDAHKGVALSR---RSDVEILGYCMLR-WLCGKLP 259
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 46.1 bits (109), Expect = 1e-05
Identities = 32/152 (21%), Positives = 44/152 (28%), Gaps = 56/152 (36%)
Query: 195 KIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL--------------------------- 227
KI Q +GL YLH +II D K NILL
Sbjct: 150 KIIQQVLQGLDYLHT--KCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSG 207
Query: 228 ----------------------DEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAP 265
E+ K++D G A T + T Y +
Sbjct: 208 SAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVH-----KHFTEDIQTRQYRSL 262
Query: 266 EYVQTGRLAARSDVWSYGVFLYELITGRRPID 297
E + +D+WS +EL TG +
Sbjct: 263 EVLIGSGYNTPADIWSTACMAFELATGDYLFE 294
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 426 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.93 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.85 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.73 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.44 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.29 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.25 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.15 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.9 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.61 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.53 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.52 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.51 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.48 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.33 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.18 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.98 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.85 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.76 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.71 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.65 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.64 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.61 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.45 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.3 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.26 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.23 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.13 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.74 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.7 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.89 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.92 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 89.75 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 87.36 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 84.61 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-61 Score=452.35 Aligned_cols=264 Identities=26% Similarity=0.454 Sum_probs=215.3
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC--CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCc
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 162 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~ 162 (426)
++|.+.+.||+|+||+||+|.+...........||||.+.... ..+.|.+|+++|++|+|||||+++|+|.+.+.
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~--- 89 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP--- 89 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS---
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE---
Confidence 4688889999999999999998765444556789999997543 34679999999999999999999999988664
Q ss_pred eEEEEEeeCCCCChhhhccCCC-----------CCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCC
Q 014363 163 QRLLVYEYMPNGSVDQYLSPKS-----------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW 231 (426)
Q Consensus 163 ~~~lv~E~~~~g~L~~~l~~~~-----------~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~ 231 (426)
+|||||||++|+|.++|...+ ...++|..++.|+.||+.||+|||++ +||||||||+||||++++
T Consensus 90 -~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~ 165 (299)
T 4asz_A 90 -LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENL 165 (299)
T ss_dssp -EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGG
T ss_pred -EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCC
Confidence 599999999999999996432 34599999999999999999999998 999999999999999999
Q ss_pred CeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHh
Q 014363 232 NAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQW 310 (426)
Q Consensus 232 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~ 310 (426)
.+||+|||+|+...............||+.|||||++.++.|+.++|||||||+||||+| |+.||....... +...
T Consensus 166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~---~~~~ 242 (299)
T 4asz_A 166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VIEC 242 (299)
T ss_dssp CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HHHH
T ss_pred cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH
Confidence 999999999987654443444445689999999999999999999999999999999999 899998654322 1111
Q ss_pred HhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 014363 311 VKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 372 (426)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~ 372 (426)
+. .. .....+..+++++.+|+.+||+.||++|||++||++.|+.+...
T Consensus 243 i~-------------~~-~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 243 IT-------------QG-RVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp HH-------------HT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HH-------------cC-CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 11 00 01122334667899999999999999999999999999988654
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-60 Score=452.09 Aligned_cols=264 Identities=25% Similarity=0.451 Sum_probs=207.5
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC--CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCc
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 162 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~ 162 (426)
++|.+.++||+|+||+||+|.++..........||||.+.... ..+.|.+|+++|++|+|||||+++|+|.+...
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~--- 117 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRP--- 117 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS---
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE---
Confidence 4567778999999999999998765444556789999997543 34579999999999999999999999987663
Q ss_pred eEEEEEeeCCCCChhhhccCCC-------------CCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCC
Q 014363 163 QRLLVYEYMPNGSVDQYLSPKS-------------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE 229 (426)
Q Consensus 163 ~~~lv~E~~~~g~L~~~l~~~~-------------~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~ 229 (426)
+|||||||++|+|.+++.... ...++|..++.|+.||+.||+|||++ +||||||||+||||++
T Consensus 118 -~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~ 193 (329)
T 4aoj_A 118 -LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQ 193 (329)
T ss_dssp -EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEET
T ss_pred -EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECC
Confidence 599999999999999986532 24589999999999999999999998 9999999999999999
Q ss_pred CCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHH
Q 014363 230 QWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLL 308 (426)
Q Consensus 230 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~ 308 (426)
++.+||+|||+++..............+||+.|||||++.+..|+.++|||||||+||||+| |+.||........ .
T Consensus 194 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~---~ 270 (329)
T 4aoj_A 194 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA---I 270 (329)
T ss_dssp TTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHH---H
T ss_pred CCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHH---H
Confidence 99999999999987654443444456789999999999999999999999999999999999 9999986543221 1
Q ss_pred HhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 014363 309 QWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 372 (426)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~ 372 (426)
..+. . ......+..+++++.+|+.+||+.||++|||++||+++|+.+...
T Consensus 271 ~~i~----------~----g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 271 DCIT----------Q----GRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HHHH----------H----TCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHH----------c----CCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 1110 0 001122334667899999999999999999999999999988654
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-60 Score=449.01 Aligned_cols=260 Identities=22% Similarity=0.392 Sum_probs=210.4
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCc
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 162 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~ 162 (426)
++++.+.||+|+||+||+|.+.........+.||||.+.... ..+.|.+|+.+|++|+|||||+++|+|.+....
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~-- 104 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPL-- 104 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC--
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEE--
Confidence 456678999999999999998765444556789999986543 356899999999999999999999999887644
Q ss_pred eEEEEEeeCCCCChhhhccCCC--------------CCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeC
Q 014363 163 QRLLVYEYMPNGSVDQYLSPKS--------------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLD 228 (426)
Q Consensus 163 ~~~lv~E~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~ 228 (426)
+||||||++|+|.++|.... ...+++..++.|+.||+.||+|||++ +||||||||+||||+
T Consensus 105 --~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~ 179 (308)
T 4gt4_A 105 --SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVY 179 (308)
T ss_dssp --EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred --EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEEC
Confidence 99999999999999996432 23589999999999999999999998 999999999999999
Q ss_pred CCCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHH
Q 014363 229 EQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKL 307 (426)
Q Consensus 229 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~ 307 (426)
+++.+||+|||+++..............+||+.|||||++.++.|+.++|||||||+||||+| |..||.+..... +
T Consensus 180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~---~ 256 (308)
T 4gt4_A 180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD---V 256 (308)
T ss_dssp GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH---H
T ss_pred CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH---H
Confidence 999999999999986544333333455789999999999999999999999999999999998 899998654322 2
Q ss_pred HHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHh
Q 014363 308 LQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 369 (426)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~ 369 (426)
...+. .. .....+..++..+.+|+.+||+.||++|||+.||+++|+..
T Consensus 257 ~~~i~-------------~~-~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 257 VEMIR-------------NR-QVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHHH-------------TT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHH-------------cC-CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11111 11 11123345677899999999999999999999999999753
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-59 Score=442.41 Aligned_cols=260 Identities=30% Similarity=0.470 Sum_probs=203.6
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
.++|.+.+.||+|+||+||+|.++. .||||.++... ..+.|.+|+.+|++++|||||+++|++.++ .
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--------~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~-~ 105 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG--------DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKD-N 105 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS--------EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-S
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC--------cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECC-e
Confidence 3567888999999999999998653 58999886432 235789999999999999999999998643 2
Q ss_pred CCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeec
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 239 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 239 (426)
+|||||||+||+|.++|.... ..+++..++.|+.||+.||+|||++ +||||||||+||||++++.+||+|||
T Consensus 106 ----~~iVmEy~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFG 177 (307)
T 3omv_A 106 ----LAIVTQWCEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFG 177 (307)
T ss_dssp ----CEEEEECCSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCS
T ss_pred ----EEEEEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeecc
Confidence 489999999999999996543 3599999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCchhhcc---CCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhh
Q 014363 240 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQT---GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS 316 (426)
Q Consensus 240 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 316 (426)
+|+..............+||+.|||||++.+ +.|+.++|||||||+||||+||+.||........... .+.
T Consensus 178 la~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~--~~~---- 251 (307)
T 3omv_A 178 LATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIF--MVG---- 251 (307)
T ss_dssp SCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHH--HHH----
T ss_pred CceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHH--HHh----
Confidence 9987654333334456789999999999864 4589999999999999999999999976543221111 000
Q ss_pred hhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 014363 317 DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 372 (426)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~ 372 (426)
.....+.+ ...+..++..+.+|+.+||+.||++|||+.||+++|+.+...
T Consensus 252 -----~~~~~p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~ 301 (307)
T 3omv_A 252 -----RGYASPDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS 301 (307)
T ss_dssp -----TTCCCCCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred -----cCCCCCCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence 01111111 123345667899999999999999999999999999887644
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-60 Score=453.39 Aligned_cols=251 Identities=24% Similarity=0.388 Sum_probs=204.3
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
.++|++++.||+|+||+||+|.++.++. .||+|++.... ..+.+.+|+.+|+.|+|||||++++++.+.+
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~-----~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~- 96 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGR-----QYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENG- 96 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCC-----EEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCC-----EEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECC-
Confidence 3589999999999999999999887654 89999986443 2456889999999999999999999998866
Q ss_pred CCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeec
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 239 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 239 (426)
.+|||||||+||+|.++|.......+++..++.|+.||+.||+|||++ +||||||||+||||+.+|.+||+|||
T Consensus 97 ---~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFG 170 (350)
T 4b9d_A 97 ---SLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFG 170 (350)
T ss_dssp ---EEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTT
T ss_pred ---EEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccc
Confidence 469999999999999999766556689999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014363 240 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 319 (426)
Q Consensus 240 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 319 (426)
+|+..... .......+||+.|||||++.+..|+.++|||||||+||||++|+.||.+....... .
T Consensus 171 la~~~~~~--~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~---~---------- 235 (350)
T 4b9d_A 171 IARVLNST--VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLV---L---------- 235 (350)
T ss_dssp EESCCCHH--HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---H----------
T ss_pred cceeecCC--cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH---H----------
Confidence 99865432 12234578999999999999999999999999999999999999999865432111 1
Q ss_pred hhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 320 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.++.... ...+..++.++.+||.+||+.||++|||++|+++|
T Consensus 236 ---~i~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 236 ---KIISGSF-PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp ---HHHHTCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ---HHHcCCC-CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111111 11223456789999999999999999999999986
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-59 Score=443.72 Aligned_cols=265 Identities=23% Similarity=0.247 Sum_probs=213.5
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCce
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQ 163 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~ 163 (426)
.+.|...++||+|+||.||+|.++.++. .||+|++..+. ...+|+.+|+.|+|||||++++++.+.+ .
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~-----~vAiK~i~~~~---~~~~E~~il~~l~HpnIV~l~~~~~~~~----~ 124 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGF-----QCAVKKVRLEV---FRVEELVACAGLSSPRIVPLYGAVREGP----W 124 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCC-----EEEEEEEETTT---CCTHHHHTTTTCCCTTBCCEEEEEEETT----E
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCC-----EEEEEEECHHH---hHHHHHHHHHhCCCCCCCcEEEEEEECC----E
Confidence 3467888899999999999999887664 89999997543 2357999999999999999999998866 4
Q ss_pred EEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCC-CeeEeeecccc
Q 014363 164 RLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW-NAKLSDFGLAR 242 (426)
Q Consensus 164 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~-~~kl~DFGla~ 242 (426)
+|||||||+||+|.++|... +.+++..++.|+.||+.||+|||++ +||||||||+||||+.+| ++||+|||+|+
T Consensus 125 ~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~ 199 (336)
T 4g3f_A 125 VNIFMELLEGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHAL 199 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCE
T ss_pred EEEEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCe
Confidence 59999999999999999754 3499999999999999999999998 999999999999999987 69999999998
Q ss_pred cCCCCCce---eeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014363 243 LGPSEGFT---HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 319 (426)
Q Consensus 243 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 319 (426)
........ ......+||+.|||||++.+..|+.++|||||||++|||++|..||...........+. ..
T Consensus 200 ~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~------~~-- 271 (336)
T 4g3f_A 200 CLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIA------SE-- 271 (336)
T ss_dssp EC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHH------HS--
T ss_pred EccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHH------cC--
Confidence 76543221 12334689999999999999999999999999999999999999997654332211110 00
Q ss_pred hhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhhccCCCCC
Q 014363 320 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASAEAGSPR 380 (426)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~~~~~~~~ 380 (426)
+.....++..+++.+.+||.+||+.||++|||+.||+++|...+........|.
T Consensus 272 -------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw 325 (336)
T 4g3f_A 272 -------PPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPW 325 (336)
T ss_dssp -------CCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCS
T ss_pred -------CCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCC
Confidence 000012233466789999999999999999999999999998887655544443
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-60 Score=443.76 Aligned_cols=249 Identities=25% Similarity=0.395 Sum_probs=210.7
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-----CCHHHHHHHHHHHhhcCCCCccceEeEEEccCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-----GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
++|+++++||+|+||+||+|.++.++. .||+|.+... ...+.+.+|+++|+.|+|||||+++++|.+.+
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~-----~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~- 105 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSR-----EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE- 105 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCC-----EEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-
T ss_pred cccEEEEEEecccCeEEEEEEECCCCC-----EEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC-
Confidence 469999999999999999999887765 8999998532 34567899999999999999999999998876
Q ss_pred CCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeec
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 239 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 239 (426)
.+|||||||+||+|.+++... +.+++..+..++.||+.||+|||++ +|+||||||+||||+.+|.+||+|||
T Consensus 106 ---~~yivmEy~~gG~L~~~i~~~--~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFG 177 (311)
T 4aw0_A 106 ---KLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFG 177 (311)
T ss_dssp ---EEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred ---EEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcC
Confidence 469999999999999999754 3499999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014363 240 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 319 (426)
Q Consensus 240 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 319 (426)
+|+............+.+||+.|||||++.+..|+.++|||||||++|||++|..||....... +..
T Consensus 178 la~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~~~---------- 244 (311)
T 4aw0_A 178 TAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL---IFA---------- 244 (311)
T ss_dssp TCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH----------
T ss_pred CceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHH----------
Confidence 9998765444444567899999999999999999999999999999999999999997654321 111
Q ss_pred hhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 320 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.++.... .++..+++++.+||.+||+.||++|||++|++.+
T Consensus 245 ---~i~~~~~--~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~ 285 (311)
T 4aw0_A 245 ---KIIKLEY--DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 285 (311)
T ss_dssp ---HHHHTCC--CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred ---HHHcCCC--CCCcccCHHHHHHHHHHccCCHhHCcChHHHcCC
Confidence 1111111 1233456789999999999999999999998655
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-59 Score=451.27 Aligned_cols=270 Identities=25% Similarity=0.383 Sum_probs=223.4
Q ss_pred HhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC---HHHHHHHHHHHhhcCC-CCccceEeEEEccC
Q 014363 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG---HKEWMTEVNFLGIVEH-QNLVKLVGYCADDD 158 (426)
Q Consensus 83 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~E~~~l~~l~H-pnIv~~~~~~~~~~ 158 (426)
..++|++++.||+|+||+||+|.+...+...+.+.||+|.+..... .+.|.+|+.+|.++.| ||||+++|+|.+.+
T Consensus 62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~ 141 (353)
T 4ase_A 62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 141 (353)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC
Confidence 4578999999999999999999999887778888999999976543 3568999999999965 89999999997654
Q ss_pred CCCceEEEEEeeCCCCChhhhccCCC--------------CCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCc
Q 014363 159 ERGIQRLLVYEYMPNGSVDQYLSPKS--------------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSN 224 (426)
Q Consensus 159 ~~~~~~~lv~E~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~N 224 (426)
. .+|||||||++|+|.++|.... ...+++..++.|+.||+.||+|||++ +||||||||+|
T Consensus 142 ~---~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~N 215 (353)
T 4ase_A 142 G---PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARN 215 (353)
T ss_dssp S---CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred C---EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCccc
Confidence 2 2489999999999999996432 23489999999999999999999998 99999999999
Q ss_pred eEeCCCCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchh
Q 014363 225 ILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRS 303 (426)
Q Consensus 225 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~ 303 (426)
||+++++.+||+|||+|+..............+||+.|||||++.+..|+.++|||||||+||||+| |..||.+.....
T Consensus 216 ILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~ 295 (353)
T 4ase_A 216 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 295 (353)
T ss_dssp EEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred eeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999987655444444556789999999999999999999999999999999998 999997654321
Q ss_pred hHHHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhhc
Q 014363 304 EQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASA 374 (426)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~~ 374 (426)
. +...+ ........+..+++++.++|.+||+.||++|||+.||+++|+.++++..
T Consensus 296 ~--~~~~i--------------~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~~ 350 (353)
T 4ase_A 296 E--FCRRL--------------KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 350 (353)
T ss_dssp H--HHHHH--------------HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred H--HHHHH--------------HcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHhh
Confidence 1 11111 0011112233456789999999999999999999999999999887643
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-59 Score=445.90 Aligned_cols=249 Identities=26% Similarity=0.402 Sum_probs=209.0
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc--CCHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCc
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR--GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 162 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~ 162 (426)
..|+..+.||+|+||+||+|.++.++. .||+|++... ...+.+.+|+.+|+.++|||||+++++|.+.+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~-----~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~---- 144 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGK-----LVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD---- 144 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCC-----EEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETT----
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCC-----EEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC----
Confidence 469999999999999999999887765 8999998533 34567899999999999999999999999876
Q ss_pred eEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccc
Q 014363 163 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 242 (426)
Q Consensus 163 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 242 (426)
.+|||||||+||+|.+++... .+++..+..|+.||+.||+|||++ +||||||||+||||+.+|.+||+|||+|+
T Consensus 145 ~~~ivmEy~~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~ 218 (346)
T 4fih_A 145 ELWVVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCA 218 (346)
T ss_dssp EEEEEECCCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCce
Confidence 469999999999999999643 399999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhh
Q 014363 243 LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFR 322 (426)
Q Consensus 243 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (426)
...... ......+||+.|||||++.+..|+.++|||||||++|||++|..||...........+ .
T Consensus 219 ~~~~~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i-------------~ 283 (346)
T 4fih_A 219 QVSKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI-------------R 283 (346)
T ss_dssp ECCSSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-------------H
T ss_pred ecCCCC--CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH-------------H
Confidence 765432 2245679999999999999999999999999999999999999999765432211111 1
Q ss_pred hhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 323 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
....+.+ .....+++++.+||.+||+.||++|||++|+++|
T Consensus 284 ~~~~~~~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 284 DNLPPRL--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp HSSCCCC--SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cCCCCCC--CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1111111 1223466789999999999999999999999986
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-59 Score=435.20 Aligned_cols=248 Identities=24% Similarity=0.418 Sum_probs=200.3
Q ss_pred CCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCce
Q 014363 88 SRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQ 163 (426)
Q Consensus 88 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~ 163 (426)
...++||+|+||+||+|.++.++. .||+|.+.... ..+.|.+|+.+|++|+|||||+++++|.+.......
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~-----~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 103 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTV-----EVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCC-----EEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCe-----EEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcE
Confidence 556789999999999999887654 89999986443 235689999999999999999999999765433345
Q ss_pred EEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCC--eEeccCCCCceEeCC-CCCeeEeeecc
Q 014363 164 RLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQ--IIVRDFKSSNILLDE-QWNAKLSDFGL 240 (426)
Q Consensus 164 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~--iiHrDlkp~NILl~~-~~~~kl~DFGl 240 (426)
+|||||||+||+|.+++... ..+++..++.|+.||+.||+|||++ + ||||||||+||||+. +|.+||+|||+
T Consensus 104 ~~lvmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGl 178 (290)
T 3fpq_A 104 IVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGL 178 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTG
T ss_pred EEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcC
Confidence 79999999999999999754 3589999999999999999999997 6 999999999999974 79999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhh
Q 014363 241 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 320 (426)
Q Consensus 241 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (426)
|+..... .....+||+.|||||++.+ .|+.++|||||||+||||+||+.||....... .+...
T Consensus 179 a~~~~~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~--~~~~~---------- 241 (290)
T 3fpq_A 179 ATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA--QIYRR---------- 241 (290)
T ss_dssp GGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH--HHHHH----------
T ss_pred CEeCCCC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH--HHHHH----------
Confidence 9865432 2345789999999998864 69999999999999999999999997543321 11111
Q ss_pred hhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 321 FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
+........++...++++.+||.+||+.||++|||++|+++|
T Consensus 242 ---i~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 242 ---VTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp ---HTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ---HHcCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111111112223345679999999999999999999999986
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-58 Score=448.31 Aligned_cols=249 Identities=26% Similarity=0.402 Sum_probs=209.0
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc--CCHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCc
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR--GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 162 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~ 162 (426)
+.|+.++.||+|+||.||+|.++.++. .||+|++... ...+.+.+|+.+|+.++|||||+++++|.+.+
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~-----~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~---- 221 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGK-----LVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD---- 221 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCC-----EEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETT----
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCC-----EEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECC----
Confidence 569999999999999999999987765 8999998543 34567899999999999999999999999876
Q ss_pred eEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccc
Q 014363 163 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 242 (426)
Q Consensus 163 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 242 (426)
.+|||||||+||+|.+++... .+++..+..|+.||+.||+|||++ +||||||||+||||+.+|.+||+|||+|+
T Consensus 222 ~~~iVmEy~~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~ 295 (423)
T 4fie_A 222 ELWVVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCA 295 (423)
T ss_dssp EEEEEEECCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCE
T ss_pred EEEEEEeCCCCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccce
Confidence 469999999999999999643 399999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhh
Q 014363 243 LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFR 322 (426)
Q Consensus 243 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (426)
...... ......+||+.|||||++.+..|+.++|||||||++|||++|..||.+.........+ .
T Consensus 296 ~~~~~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i-------------~ 360 (423)
T 4fie_A 296 QVSKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI-------------R 360 (423)
T ss_dssp ECCSSC--CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-------------H
T ss_pred ECCCCC--ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH-------------H
Confidence 765432 2245679999999999999999999999999999999999999999765432211111 1
Q ss_pred hhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 323 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
....+.+ .....+++++.+||.+||+.||++|||+.|+++|
T Consensus 361 ~~~~~~~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 361 DNLPPRL--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp HSCCCCC--SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cCCCCCC--cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1111111 1122356789999999999999999999999986
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-57 Score=423.35 Aligned_cols=246 Identities=25% Similarity=0.419 Sum_probs=191.7
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-----CCHHHHHHHHHHHhhcCCCCccceEeEEEccC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-----GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 158 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 158 (426)
.++|++++.||+|+||+||+|.++.++. .||+|.+... ...+.+.+|+.+|+.++|||||++++++.+.+
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~-----~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~ 86 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQ-----KVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKD 86 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCC-----EEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCC-----EEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence 3689999999999999999999876654 8999988543 23457899999999999999999999998866
Q ss_pred CCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeee
Q 014363 159 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 238 (426)
Q Consensus 159 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 238 (426)
..||||||| +|+|.+++..++ .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 87 ----~~~ivmEy~-~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DF 156 (275)
T 3hyh_A 87 ----EIIMVIEYA-GNELFDYIVQRD--KMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADF 156 (275)
T ss_dssp ----EEEEEEECC-CEEHHHHHHHSC--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCS
T ss_pred ----EEEEEEeCC-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeec
Confidence 469999999 689999987543 499999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCchhhccCCC-CCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh
Q 014363 239 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRL-AARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 317 (426)
Q Consensus 239 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 317 (426)
|+|+...... .....+||+.|||||++.+..| +.++|||||||++|+|++|+.||...... .+...+
T Consensus 157 Gla~~~~~~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~---~~~~~i------ 224 (275)
T 3hyh_A 157 GLSNIMTDGN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP---VLFKNI------ 224 (275)
T ss_dssp SCC------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH------
T ss_pred CCCeecCCCC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH---HHHHHH------
Confidence 9998654322 2345789999999999998876 57999999999999999999999764322 111111
Q ss_pred hhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 318 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.... ..++..+++++.+|+.+||+.||++|||++|+++|
T Consensus 225 -------~~~~--~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 225 -------SNGV--YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp -------HHTC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred -------HcCC--CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1110 11223456789999999999999999999999986
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-58 Score=430.77 Aligned_cols=250 Identities=26% Similarity=0.353 Sum_probs=198.2
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
++|++++.||+|+||+||+|++..+. ...+.||+|.+.... ....+.+|+.+|+.++|||||++++++.+++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~-- 99 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGS--DARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEG-- 99 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSST--TTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETT--
T ss_pred cccEEEEEEecCCCeEEEEEEEccCC--CCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC--
Confidence 46999999999999999999875432 234579999886432 2346889999999999999999999998876
Q ss_pred CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecc
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 240 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 240 (426)
.+|||||||+||+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.+|.+||+|||+
T Consensus 100 --~~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGl 172 (304)
T 3ubd_A 100 --KLYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGL 172 (304)
T ss_dssp --EEEEEECCCTTCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEE
T ss_pred --EEEEEEEcCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEeccccc
Confidence 469999999999999999754 3499999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhh
Q 014363 241 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 320 (426)
Q Consensus 241 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (426)
|+...... ......+||+.|||||++.+..|+.++|||||||++|||++|..||.+........
T Consensus 173 a~~~~~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~-------------- 236 (304)
T 3ubd_A 173 SKESIDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMT-------------- 236 (304)
T ss_dssp EEC-------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--------------
T ss_pred ceeccCCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHH--------------
Confidence 98654322 22345789999999999999999999999999999999999999998654322111
Q ss_pred hhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCH-----HHHHHH
Q 014363 321 FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKM-----SEVLEM 365 (426)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~-----~eil~~ 365 (426)
.+.... ..++..+++++.+||.+||+.||++|||+ +|+++|
T Consensus 237 --~i~~~~--~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 237 --MILKAK--LGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp --HHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred --HHHcCC--CCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 111111 12233466789999999999999999984 677765
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-56 Score=424.20 Aligned_cols=274 Identities=24% Similarity=0.364 Sum_probs=202.6
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHH--HHHHHHhhcCCCCccceEeEEEccCCCCce
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWM--TEVNFLGIVEHQNLVKLVGYCADDDERGIQ 163 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~--~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~ 163 (426)
+|.+.+.||+|+||+||+|.+++ ..||||++..... +.+. .|+..+.+++|||||+++|++.+.+....+
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~~g-------~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~ 75 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKWRG-------EEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEETT-------EEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred EEEEEEEEeeCCCeEEEEEEECC-------EEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceE
Confidence 57778899999999999998753 3799999975543 3333 456666788999999999999887655556
Q ss_pred EEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCC-----CCCeEeccCCCCceEeCCCCCeeEeee
Q 014363 164 RLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGM-----DFQIIVRDFKSSNILLDEQWNAKLSDF 238 (426)
Q Consensus 164 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~-----~~~iiHrDlkp~NILl~~~~~~kl~DF 238 (426)
+|||||||++|+|.+++... .+++..++.|+.|++.||+|||++. .++||||||||+||||+.++.+||+||
T Consensus 76 ~~lV~Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DF 152 (303)
T 3hmm_A 76 LWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEEEecCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeC
Confidence 79999999999999999754 3899999999999999999999752 348999999999999999999999999
Q ss_pred cccccCCCCCcee--eeeeeecCcccCCchhhccC------CCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHh
Q 014363 239 GLARLGPSEGFTH--VSTAVVGTMGYAAPEYVQTG------RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQW 310 (426)
Q Consensus 239 Gla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~ 310 (426)
|+++......... .....+||+.|||||++.+. .|+.++|||||||+||||+||..||.......... ...
T Consensus 153 Gla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~-~~~ 231 (303)
T 3hmm_A 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY-YDL 231 (303)
T ss_dssp TTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT-TTT
T ss_pred CCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccc-hhc
Confidence 9998654432221 23356899999999998764 36779999999999999999988775322110000 000
Q ss_pred Hhhhhhhhhhh-hhh----cCCcCCCcc-cHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 014363 311 VKPYLSDAKQF-RQI----VDPRLEGKY-SLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 372 (426)
Q Consensus 311 ~~~~~~~~~~~-~~~----~~~~~~~~~-~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~ 372 (426)
.+........ ..+ +++.+.... ....+..+.+|+.+||+.||++|||+.||++.|+.+.+.
T Consensus 232 -~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 232 -VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp -SCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -ccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 0000000001 111 122222221 235677899999999999999999999999999988653
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-55 Score=416.63 Aligned_cols=255 Identities=20% Similarity=0.331 Sum_probs=191.3
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
.++|++++.||+|+||+||+|.++.++. .||+|.+.... ..+.+.+|+.+|+.|+|||||++++++.+.+..
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~-----~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~ 78 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDC-----NYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTT 78 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCC-----EEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCC-----EEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcc
Confidence 3468999999999999999999887654 89999986443 235688999999999999999999999765531
Q ss_pred --------CceEEEEEeeCCCCChhhhccCCCC-CccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCC
Q 014363 161 --------GIQRLLVYEYMPNGSVDQYLSPKSE-TILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW 231 (426)
Q Consensus 161 --------~~~~~lv~E~~~~g~L~~~l~~~~~-~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~ 231 (426)
...+|||||||++|+|.+++..... ...++..++.|+.||+.||+|||++ +|+||||||+||||+.++
T Consensus 79 ~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~ 155 (299)
T 4g31_A 79 EKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDD 155 (299)
T ss_dssp --------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTC
T ss_pred ccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCC
Confidence 2246999999999999999976543 2356677889999999999999998 999999999999999999
Q ss_pred CeeEeeecccccCCCCCce----------eeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCc
Q 014363 232 NAKLSDFGLARLGPSEGFT----------HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRP 301 (426)
Q Consensus 232 ~~kl~DFGla~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~ 301 (426)
.+||+|||+|+........ ......+||+.|||||++.+..|+.++|||||||++|||++ ||....
T Consensus 156 ~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~- 231 (299)
T 4g31_A 156 VVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM- 231 (299)
T ss_dssp CEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH-
T ss_pred cEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc-
Confidence 9999999999876432211 11235689999999999999999999999999999999996 775311
Q ss_pred hhhHHHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 302 RSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
..... +..+.+.... ......++.+.+|+.+||+.||++|||+.|++++
T Consensus 232 -~~~~~-------------~~~~~~~~~p-~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 232 -ERVRT-------------LTDVRNLKFP-PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp -HHHHH-------------HHHHHTTCCC-HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -HHHHH-------------HHHHhcCCCC-CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 00000 1111111111 1122345667899999999999999999999885
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-54 Score=418.74 Aligned_cols=270 Identities=23% Similarity=0.275 Sum_probs=204.7
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccCC-
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE- 159 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~- 159 (426)
++|++++.||+|+||+||+|.++.++. .||+|++.... ..+.+.+|+.+|+.|+|||||++++++.....
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~-----~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 128 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQ-----QVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPY 128 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCC-----EEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCT
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCC-----EEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeeccccc
Confidence 579999999999999999999887665 89999986543 23467899999999999999999999875422
Q ss_pred -CCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeee
Q 014363 160 -RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 238 (426)
Q Consensus 160 -~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 238 (426)
....+|||||||+ |+|.+++... +.+++..+..|+.||+.||+|||++ +||||||||+|||++.+|.+||+||
T Consensus 129 ~~~~~~~ivmE~~~-g~L~~~i~~~--~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DF 202 (398)
T 4b99_A 129 GEFKSVYVVLDLME-SDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDF 202 (398)
T ss_dssp TTCCCEEEEEECCS-EEHHHHHTSS--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCC
T ss_pred ccCCEEEEEEeCCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeec
Confidence 1235799999995 6899999654 4599999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCC--ceeeeeeeecCcccCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhh
Q 014363 239 GLARLGPSEG--FTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYL 315 (426)
Q Consensus 239 Gla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 315 (426)
|+|+...... ........+||+.|||||++.+. .|+.++|||||||++|||++|++||.+.........+.......
T Consensus 203 Gla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p 282 (398)
T 4b99_A 203 GMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTP 282 (398)
T ss_dssp TTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred ceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 9998654321 12234467999999999998875 56999999999999999999999998765433222221110000
Q ss_pred h--h-----hhhhhh---hcCCcCCCc---ccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 316 S--D-----AKQFRQ---IVDPRLEGK---YSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 316 ~--~-----~~~~~~---~~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
. . ...... .+....... .....++++.+||.+||+.||++|||++|+|+|
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 283 SPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp CGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0 0 000000 000000000 011235688999999999999999999999987
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-53 Score=408.93 Aligned_cols=268 Identities=22% Similarity=0.292 Sum_probs=203.1
Q ss_pred HhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhc-CCCCccceEeEEEccCCCC
Q 014363 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 83 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~~~ 161 (426)
..+.|++++.||+|+||+||+|.++.. ....+.||+|.+........+.+|+++|..+ +|||||+++++|.+.+
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~--~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~--- 93 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQ--VGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKND--- 93 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBT--TSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETT---
T ss_pred ccCcEEEEEEEecccCcEEEEEEEccc--CCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECC---
Confidence 457899999999999999999987532 2245689999998777777889999999998 7999999999998866
Q ss_pred ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCC-CCeeEeeecc
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQ-WNAKLSDFGL 240 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~-~~~kl~DFGl 240 (426)
+.|||||||+||+|.+++. .+++..+..++.||+.||+|||++ ||+||||||+|||++.+ +.+||+|||+
T Consensus 94 -~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGl 164 (361)
T 4f9c_A 94 -HVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGL 164 (361)
T ss_dssp -EEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred -EEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCC
Confidence 4699999999999999984 289999999999999999999998 99999999999999876 7999999999
Q ss_pred cccCCCCCc--------------------------eeeeeeeecCcccCCchhhccC-CCCCchhhHHHHHHHHHHHhCC
Q 014363 241 ARLGPSEGF--------------------------THVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGR 293 (426)
Q Consensus 241 a~~~~~~~~--------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~ 293 (426)
|+....... .......+||+.|||||++.+. .|+.++||||+||++|||++|+
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~ 244 (361)
T 4f9c_A 165 AQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGR 244 (361)
T ss_dssp CEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTC
T ss_pred CcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCC
Confidence 975433211 1112346899999999999875 5899999999999999999999
Q ss_pred CCCCCCCchhhHHHHHhHhhh-----hhhh------------------hhhhhhc------CCcC---------CCcccH
Q 014363 294 RPIDRNRPRSEQKLLQWVKPY-----LSDA------------------KQFRQIV------DPRL---------EGKYSL 335 (426)
Q Consensus 294 ~p~~~~~~~~~~~~~~~~~~~-----~~~~------------------~~~~~~~------~~~~---------~~~~~~ 335 (426)
.||........+ +.....-. .... ....+.+ .+.. ......
T Consensus 245 ~Pf~~~~~~~~~-l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 323 (361)
T 4f9c_A 245 YPFYKASDDLTA-LAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWN 323 (361)
T ss_dssp SSSSCCSSHHHH-HHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CT
T ss_pred CCCCCCCCHHHH-HHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccc
Confidence 999755433221 11110000 0000 0000000 0000 000111
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 336 RLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 336 ~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.+++++.+|+.+||+.||++|||++|+++|
T Consensus 324 ~is~~a~DLl~~lL~~dP~~R~ta~eaL~H 353 (361)
T 4f9c_A 324 EVPDEAYDLLDKLLDLNPASRITAEEALLH 353 (361)
T ss_dssp TCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred cCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 245678999999999999999999999986
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-52 Score=425.07 Aligned_cols=249 Identities=25% Similarity=0.366 Sum_probs=202.7
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-----CCHHHHHHH---HHHHhhcCCCCccceEeEEE
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-----GGHKEWMTE---VNFLGIVEHQNLVKLVGYCA 155 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-----~~~~~~~~E---~~~l~~l~HpnIv~~~~~~~ 155 (426)
.++|+++++||+|+||+||+|.++.++. .||+|++... .....+.+| +.+++.++|||||+++++|.
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~-----~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~ 262 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGK-----MYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH 262 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCC-----EEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCC-----EEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEE
Confidence 4679999999999999999999987765 8999998532 233334444 56677789999999999999
Q ss_pred ccCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeE
Q 014363 156 DDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKL 235 (426)
Q Consensus 156 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl 235 (426)
+.+ .+|||||||+||+|.++|... +.+++..+..++.||+.||+|||++ +||||||||+||||+.+|++||
T Consensus 263 ~~~----~lylVmEy~~GGdL~~~l~~~--~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL 333 (689)
T 3v5w_A 263 TPD----KLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRI 333 (689)
T ss_dssp CSS----EEEEEECCCCSCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEE
T ss_pred ECC----EEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEe
Confidence 876 469999999999999999754 3499999999999999999999998 9999999999999999999999
Q ss_pred eeecccccCCCCCceeeeeeeecCcccCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhh
Q 014363 236 SDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPY 314 (426)
Q Consensus 236 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 314 (426)
+|||+|+...... ..+.+||+.|||||++.. ..|+.++|||||||+||||++|.+||.+........+...
T Consensus 334 ~DFGlA~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~---- 405 (689)
T 3v5w_A 334 SDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM---- 405 (689)
T ss_dssp CCCTTCEECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHH----
T ss_pred cccceeeecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh----
Confidence 9999998765432 345799999999999975 5799999999999999999999999975433222221111
Q ss_pred hhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 014363 315 LSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPK-----MSEVLEM 365 (426)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~eil~~ 365 (426)
+.... ..++..+++++.+||.+||+.||++|++ ++||++|
T Consensus 406 ---------i~~~~--~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 406 ---------TLTMA--VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp ---------HHHCC--CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred ---------hcCCC--CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 11111 1233446678999999999999999998 7888876
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=422.63 Aligned_cols=252 Identities=21% Similarity=0.351 Sum_probs=209.0
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC--CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
.++|++++.||+|+||.||+|.++.++. .||+|.+.... ..+.+.+|+.+|+.|+|||||+++++|.+..
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~-----~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--- 227 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGN-----NFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN--- 227 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCC-----EEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSS---
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCC-----EEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECC---
Confidence 4689999999999999999999887765 89999886543 3456889999999999999999999998866
Q ss_pred ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCC--CCeeEeeec
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQ--WNAKLSDFG 239 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~--~~~kl~DFG 239 (426)
.+|||||||+||+|.++|.... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||
T Consensus 228 -~~~iv~E~~~gg~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG 302 (573)
T 3uto_A 228 -EMVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFG 302 (573)
T ss_dssp -EEEEEEECCCCCBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCS
T ss_pred -EEEEEEeecCCCcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeecc
Confidence 4699999999999999986443 3599999999999999999999998 99999999999999854 899999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014363 240 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 319 (426)
Q Consensus 240 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 319 (426)
+|+...... .....+||+.|||||++.+..|+.++|||||||++|||++|..||.+.........+..
T Consensus 303 ~a~~~~~~~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~--------- 370 (573)
T 3uto_A 303 LTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKS--------- 370 (573)
T ss_dssp SCEECCTTS---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHT---------
T ss_pred ceeEccCCC---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHh---------
Confidence 999875543 23457899999999999999999999999999999999999999986543221111100
Q ss_pred hhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 320 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.+..........++..+.+||.+||+.||++|||+.|+++|
T Consensus 371 -----~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 371 -----CDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp -----TCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -----CCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01111122223456789999999999999999999999986
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=386.10 Aligned_cols=284 Identities=39% Similarity=0.689 Sum_probs=232.7
Q ss_pred cCHHHHHHHhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC--CHHHHHHHHHHHhhcCCCCccceEe
Q 014363 75 FTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--GHKEWMTEVNFLGIVEHQNLVKLVG 152 (426)
Q Consensus 75 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~ 152 (426)
+.+.++...+++|...+.||+|+||.||+|.+.++ ..||+|.+.... ..+.+.+|+.+++.++||||+++++
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 102 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDG------AKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIG 102 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTC------CEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEE
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCC------CEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 33444455688999999999999999999986532 379999886543 3467899999999999999999999
Q ss_pred EEEccCCCCceEEEEEeeCCCCChhhhccCCCC--CccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCC
Q 014363 153 YCADDDERGIQRLLVYEYMPNGSVDQYLSPKSE--TILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQ 230 (426)
Q Consensus 153 ~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~--~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~ 230 (426)
++.+.+.. ++||||+++|+|.+++..... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.+
T Consensus 103 ~~~~~~~~----~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~ 175 (321)
T 2qkw_B 103 FCDERNEM----ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDEN 175 (321)
T ss_dssp ECCCTTCC----EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTT
T ss_pred EEcCCCeE----EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCC
Confidence 99876644 999999999999999975432 3589999999999999999999998 99999999999999999
Q ss_pred CCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHh
Q 014363 231 WNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQW 310 (426)
Q Consensus 231 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~ 310 (426)
+.+||+|||++................||+.|+|||++.+..++.++||||||+++|+|++|+.||....+........|
T Consensus 176 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~ 255 (321)
T 2qkw_B 176 FVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEW 255 (321)
T ss_dssp CCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHH
T ss_pred CCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHH
Confidence 99999999999865433323333456799999999999999999999999999999999999999987655544444444
Q ss_pred HhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 014363 311 VKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 372 (426)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~ 372 (426)
.... .....+...+++.+........+..+.+++.+||+.||++|||+.|++++|+.++..
T Consensus 256 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 256 AVES-HNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp THHH-HTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred hhhc-cccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 3221 112234455566666677888999999999999999999999999999999988753
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-49 Score=384.20 Aligned_cols=266 Identities=26% Similarity=0.436 Sum_probs=215.4
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCC--CCCcceEEEEEEccccCC---HHHHHHHHHHHhhc-CCCCccceEeEEEcc
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSE--DPSQKVEVAVKQLGRRGG---HKEWMTEVNFLGIV-EHQNLVKLVGYCADD 157 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~--~~~~~~~va~K~~~~~~~---~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~ 157 (426)
.++|.+.+.||+|+||.||+|.+.... .......||+|.+..... .+.+.+|+.+|+.+ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 457899999999999999999976432 234566899999976543 34688999999999 899999999999876
Q ss_pred CCCCceEEEEEeeCCCCChhhhccCCC--------------CCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCC
Q 014363 158 DERGIQRLLVYEYMPNGSVDQYLSPKS--------------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSS 223 (426)
Q Consensus 158 ~~~~~~~~lv~E~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~ 223 (426)
+.. |+||||+++|+|.+++.... ...+++..++.++.||+.||+|||++ +|+||||||+
T Consensus 160 ~~~----~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~ 232 (370)
T 2psq_A 160 GPL----YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 232 (370)
T ss_dssp SSC----EEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGG
T ss_pred CCE----EEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ceeccccchh
Confidence 644 99999999999999997543 23488999999999999999999998 9999999999
Q ss_pred ceEeCCCCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCch
Q 014363 224 NILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPR 302 (426)
Q Consensus 224 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~ 302 (426)
|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 233 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~ 312 (370)
T 2psq_A 233 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 312 (370)
T ss_dssp GEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred hEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 99999999999999999986554332222334567889999999999999999999999999999999 99999765432
Q ss_pred hhHHHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhh
Q 014363 303 SEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 373 (426)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~ 373 (426)
.....+ ........+..++..+.+++.+||+.||++||++.|++++|+.++...
T Consensus 313 ~~~~~~-----------------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 313 ELFKLL-----------------KEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp GHHHHH-----------------HTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHH-----------------hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 211111 001111223345678999999999999999999999999999988654
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=379.17 Aligned_cols=287 Identities=46% Similarity=0.767 Sum_probs=234.1
Q ss_pred CCCcccCHHHHHHHhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCC
Q 014363 70 SNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQN 146 (426)
Q Consensus 70 ~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~Hpn 146 (426)
.....|+..++....++|+..+.||+|+||.||+|.+.+. ..||+|.+.... ....+.+|+.+++.++|||
T Consensus 15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~ 88 (326)
T 3uim_A 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADG------TLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 88 (326)
T ss_dssp CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSS------CCEEEEECCC-----CCCHHHHHHHGGGTCCCTT
T ss_pred CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCC------CEEEEEEeccccCchHHHHHHHHHHHHHhccCCC
Confidence 3456789999999999999999999999999999975432 379999986543 2336899999999999999
Q ss_pred ccceEeEEEccCCCCceEEEEEeeCCCCChhhhccCCCC--CccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCc
Q 014363 147 LVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSE--TILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSN 224 (426)
Q Consensus 147 Iv~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~--~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~N 224 (426)
|+++++++.+.... ++||||+++|+|.+++..... ..+++..++.|+.|++.||.|||+++..+|+||||||+|
T Consensus 89 iv~~~~~~~~~~~~----~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~N 164 (326)
T 3uim_A 89 LLRLRGFCMTPTER----LLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAAN 164 (326)
T ss_dssp BCCCCEEECCSSCC----EEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGG
T ss_pred ccceEEEEecCCce----EEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhh
Confidence 99999999876654 899999999999999976432 348999999999999999999998755699999999999
Q ss_pred eEeCCCCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCC--ch
Q 014363 225 ILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNR--PR 302 (426)
Q Consensus 225 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~--~~ 302 (426)
||++.++.+||+|||++........ .......||+.|+|||++.+..++.++||||||+++|+|++|..||.... ..
T Consensus 165 il~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 243 (326)
T 3uim_A 165 ILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND 243 (326)
T ss_dssp EEECTTCCEEECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTT
T ss_pred EEECCCCCEEeccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccc
Confidence 9999999999999999987654332 22345679999999999998899999999999999999999999996211 01
Q ss_pred hhHHHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 014363 303 SEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNK 368 (426)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~ 368 (426)
.......|..... .........+..+...+....+..+.+++.+||+.||++|||+.||+++|+.
T Consensus 244 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 244 DDVMLLDWVKGLL-KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp SCSBHHHHHTTTT-SSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred cchhHHHHHHHHh-hchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 1112223332222 2233445556666777888899999999999999999999999999999975
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-49 Score=382.33 Aligned_cols=276 Identities=25% Similarity=0.372 Sum_probs=222.6
Q ss_pred CHHHHHHHhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC---HHHHHHHHHHHhhc-CCCCccceE
Q 014363 76 TIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG---HKEWMTEVNFLGIV-EHQNLVKLV 151 (426)
Q Consensus 76 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~E~~~l~~l-~HpnIv~~~ 151 (426)
.........++|.+.+.||+|+||.||+|.+.........+.||+|.+..... .+.+.+|+.++..+ +||||++++
T Consensus 13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~ 92 (359)
T 3vhe_A 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 92 (359)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence 34444455788999999999999999999987665666778999999976543 34688999999999 899999999
Q ss_pred eEEEccCCCCceEEEEEeeCCCCChhhhccCCCC----------------------------------------------
Q 014363 152 GYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSE---------------------------------------------- 185 (426)
Q Consensus 152 ~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~---------------------------------------------- 185 (426)
+++.+.+. ..++||||+++|+|.+++.....
T Consensus 93 ~~~~~~~~---~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (359)
T 3vhe_A 93 GACTKPGG---PLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVE 169 (359)
T ss_dssp EEECSTTS---CCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------
T ss_pred eeeecCCC---ceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccc
Confidence 99987553 24899999999999999975432
Q ss_pred ------------------CccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccCCCC
Q 014363 186 ------------------TILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSE 247 (426)
Q Consensus 186 ------------------~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 247 (426)
..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 246 (359)
T 3vhe_A 170 EKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246 (359)
T ss_dssp --------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC
T ss_pred ccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeeccc
Confidence 1289999999999999999999998 9999999999999999999999999999866544
Q ss_pred CceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcC
Q 014363 248 GFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVD 326 (426)
Q Consensus 248 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (426)
..........||+.|+|||++.+..++.++||||||+++|+|++ |..||......... ..... .
T Consensus 247 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~--~~~~~----------~--- 311 (359)
T 3vhe_A 247 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--CRRLK----------E--- 311 (359)
T ss_dssp TTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH--HHHHH----------H---
T ss_pred ccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHH--HHHHH----------c---
Confidence 33344456778999999999999999999999999999999998 99999765432211 11000 0
Q ss_pred CcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhh
Q 014363 327 PRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 373 (426)
Q Consensus 327 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~ 373 (426)
......+..+++.+.+++.+||+.||++|||+.||+++|+.++.+.
T Consensus 312 -~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 312 -GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp -TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -CCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 0111122234568999999999999999999999999999988654
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-49 Score=375.80 Aligned_cols=278 Identities=26% Similarity=0.353 Sum_probs=211.8
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCc
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 162 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~ 162 (426)
.++|++.++||+|+||.||+|.+.+ ..||+|.+.... ....+..|+.+|..++||||+++++++.+......
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLLN-------EYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDV 95 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEETT-------EEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred hhhchhhheecccCceEEEEEEECC-------CEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCc
Confidence 4689999999999999999998763 379999986543 23345678999999999999999999998765555
Q ss_pred eEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCC-------CCCeEeccCCCCceEeCCCCCeeE
Q 014363 163 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGM-------DFQIIVRDFKSSNILLDEQWNAKL 235 (426)
Q Consensus 163 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~-------~~~iiHrDlkp~NILl~~~~~~kl 235 (426)
..++||||+++|+|.+++... .+++..++.++.|++.||+|||+.. ..+|+||||||+|||++.++.+||
T Consensus 96 ~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL 172 (322)
T 3soc_A 96 DLWLITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACI 172 (322)
T ss_dssp EEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEE
T ss_pred eEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEE
Confidence 679999999999999999653 3899999999999999999999741 228999999999999999999999
Q ss_pred eeecccccCCCCCceeeeeeeecCcccCCchhhccC-----CCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHh
Q 014363 236 SDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG-----RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQW 310 (426)
Q Consensus 236 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~ 310 (426)
+|||+++...............||+.|+|||++.+. .++.++|||||||++|||++|..||..............
T Consensus 173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~ 252 (322)
T 3soc_A 173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE 252 (322)
T ss_dssp CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence 999999866543333233446799999999998863 456688999999999999999999976433211111110
Q ss_pred Hhhhhhhhhhhh-hhcC----CcCCCcc-cHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 014363 311 VKPYLSDAKQFR-QIVD----PRLEGKY-SLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 372 (426)
Q Consensus 311 ~~~~~~~~~~~~-~~~~----~~~~~~~-~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~ 372 (426)
.... ....... .... +.+...+ ....+..+.+|+.+||+.||++|||+.||++.|+.+.+.
T Consensus 253 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 253 IGQH-PSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp HCSS-CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hccC-CchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 0000 0000111 1111 1111111 124567799999999999999999999999999988754
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=367.80 Aligned_cols=250 Identities=26% Similarity=0.403 Sum_probs=207.0
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc--CCHHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR--GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
.++|+..+.||+|+||.||+|.+..++. .||+|.+... ...+.+.+|+.+++.++||||+++++++.+.+
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--- 90 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQ-----EVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD--- 90 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCC-----EEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT---
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCc-----EEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECC---
Confidence 4689999999999999999999766554 7999987533 35567899999999999999999999998766
Q ss_pred ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccc
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 241 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 241 (426)
..|+||||+++|+|.+++... .+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 91 -~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~ 163 (297)
T 3fxz_A 91 -ELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC 163 (297)
T ss_dssp -EEEEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred -EEEEEEECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCc
Confidence 459999999999999999754 389999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhh
Q 014363 242 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 321 (426)
Q Consensus 242 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (426)
........ ......||+.|+|||++.+..++.++||||||+++|+|++|..||.............
T Consensus 164 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~------------ 229 (297)
T 3fxz_A 164 AQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA------------ 229 (297)
T ss_dssp EECCSTTC--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH------------
T ss_pred eecCCccc--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------------
Confidence 86654322 2345689999999999999999999999999999999999999997654322111110
Q ss_pred hhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 322 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.. .......+..++..+.+++.+||+.||++|||+.|++++
T Consensus 230 -~~--~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 230 -TN--GTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp -HH--CSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -hC--CCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 00 001111233456789999999999999999999999986
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=370.74 Aligned_cols=258 Identities=28% Similarity=0.449 Sum_probs=201.5
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
.++|++.+.||+|+||.||+|.+.+ ..||+|.+.... ..+.+.+|+.++++++||||+++++++.+...
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 108 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEWHG-------SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN 108 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-------EEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC
T ss_pred hhHceeeeEeecCCCeEEEEEEECC-------CcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc
Confidence 5678999999999999999998643 269999986543 23468899999999999999999999987765
Q ss_pred CCceEEEEEeeCCCCChhhhccCCCC-CccCHHHHHHHHHHHHHHHHHhccCCCCC--eEeccCCCCceEeCCCCCeeEe
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPKSE-TILTWAMRLKIAQDAARGLAYLHEGMDFQ--IIVRDFKSSNILLDEQWNAKLS 236 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~~~-~~~~~~~~~~i~~~i~~aL~~LH~~~~~~--iiHrDlkp~NILl~~~~~~kl~ 236 (426)
. ++||||+++|+|.+++..... ..+++..++.++.|++.||+|||++ + |+||||||+|||++.++.+||+
T Consensus 109 ~----~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~ 181 (309)
T 3p86_A 109 L----SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVC 181 (309)
T ss_dssp C----EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEEC
T ss_pred e----EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEEC
Confidence 4 999999999999999975432 3489999999999999999999998 8 9999999999999999999999
Q ss_pred eecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhh
Q 014363 237 DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS 316 (426)
Q Consensus 237 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 316 (426)
|||+++...... .......||+.|+|||++.+..++.++||||||+++|+|++|..||.............
T Consensus 182 Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~------- 252 (309)
T 3p86_A 182 DFGLSRLKASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVG------- 252 (309)
T ss_dssp CCC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHH-------
T ss_pred CCCCCccccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-------
Confidence 999997543321 12345679999999999999999999999999999999999999997654322111110
Q ss_pred hhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhh
Q 014363 317 DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 373 (426)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~ 373 (426)
........+..++..+.+|+.+||+.||++|||+.+|++.|+.++...
T Consensus 253 ---------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 253 ---------FKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp ---------HSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred ---------hcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 001111223345678999999999999999999999999999988654
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-47 Score=359.81 Aligned_cols=282 Identities=38% Similarity=0.631 Sum_probs=225.8
Q ss_pred CCcccCHHHHHHHhCCCCCc------ceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC------CHHHHHHHHHH
Q 014363 71 NLKEFTIAELKSATKNFSRS------VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG------GHKEWMTEVNF 138 (426)
Q Consensus 71 ~~~~~~~~~~~~~~~~y~~~------~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~------~~~~~~~E~~~ 138 (426)
....|+..++..++++|... +.||+|+||.||+|.+.+ ..+|+|.+.... ..+.+.+|+.+
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~E~~~ 83 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-------TTVAVKKLAAMVDITTEELKQQFDQEIKV 83 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESSS-------CEEEEEEECCCTTSCTTTHHHHHHHHHHH
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEECC-------ceEEEEEEecccCcchHHHHHHHHHHHHH
Confidence 35678999999999999887 899999999999998632 278999875432 24578899999
Q ss_pred HhhcCCCCccceEeEEEccCCCCceEEEEEeeCCCCChhhhccCCC-CCccCHHHHHHHHHHHHHHHHHhccCCCCCeEe
Q 014363 139 LGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKS-ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIV 217 (426)
Q Consensus 139 l~~l~HpnIv~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiH 217 (426)
++.++||||+++++++.+.... ++||||+++++|.+++.... ...+++..++.++.|++.||.|||++ +|+|
T Consensus 84 l~~l~h~~i~~~~~~~~~~~~~----~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H 156 (307)
T 2nru_A 84 MAKCQHENLVELLGFSSDGDDL----CLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIH 156 (307)
T ss_dssp HHHCCCTTBCCEEEEECSSSSC----EEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred HHhcCCCCeEEEEEEEecCCce----EEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---Ceec
Confidence 9999999999999999876644 99999999999999986432 24589999999999999999999998 9999
Q ss_pred ccCCCCceEeCCCCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCC
Q 014363 218 RDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPID 297 (426)
Q Consensus 218 rDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~ 297 (426)
|||||+|||++.++.+||+|||++................||+.|+|||++.+ .++.++||||||+++|+|++|..||.
T Consensus 157 ~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~ 235 (307)
T 2nru_A 157 RDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVD 235 (307)
T ss_dssp SCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBC
T ss_pred CCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcc
Confidence 99999999999999999999999987654333333445679999999998764 58999999999999999999999997
Q ss_pred CCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhH
Q 014363 298 RNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIV 370 (426)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~ 370 (426)
......... .+..........+...++..+ ...+...+..+.+++.+||+.||++|||+.+|+++|+.+.
T Consensus 236 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 236 EHREPQLLL--DIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp TTBSSSBTT--HHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred cCcchHHHH--HHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 644322111 111111111222333444433 3355678889999999999999999999999999999874
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-48 Score=369.01 Aligned_cols=263 Identities=24% Similarity=0.439 Sum_probs=211.2
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
.++|.+.+.||+|+||.||+|.+..++. ....||+|.+.... ..+.+.+|+.+++.++||||+++++++.+....
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 125 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQ--RDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA 125 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTS--CCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCC
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCC--CCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCcc
Confidence 3578899999999999999999875543 34469999987543 335688999999999999999999999876644
Q ss_pred CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecc
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 240 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 240 (426)
|+||||+++|+|.+++.... ..+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 126 ----~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 197 (325)
T 3kul_A 126 ----MIVTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGL 197 (325)
T ss_dssp ----EEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSS
T ss_pred ----EEEeeCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCc
Confidence 99999999999999996543 3489999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCc-eeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014363 241 ARLGPSEGF-THVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDA 318 (426)
Q Consensus 241 a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 318 (426)
+........ ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||...........+
T Consensus 198 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~---------- 267 (325)
T 3kul_A 198 SRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV---------- 267 (325)
T ss_dssp CEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHH----------
T ss_pred ccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH----------
Confidence 987654321 122233456889999999999999999999999999999999 99999765432211111
Q ss_pred hhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhh
Q 014363 319 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 373 (426)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~ 373 (426)
........+..++..+.+|+.+||+.||++|||+.+|++.|+.++...
T Consensus 268 -------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 268 -------EEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp -------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred -------HcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence 011111223345678999999999999999999999999999988653
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-48 Score=372.00 Aligned_cols=267 Identities=25% Similarity=0.429 Sum_probs=215.1
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhc-CCCCccceEeEEEccCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDE 159 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~ 159 (426)
.++|...+.||+|+||.||+|.+...........||+|.+.... ..+.+.+|+.++..+ +||||+++++++.+.+.
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 123 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 123 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence 46899999999999999999998665455566789999986442 345789999999999 99999999999987664
Q ss_pred CCceEEEEEeeCCCCChhhhccCCCC---------------------CccCHHHHHHHHHHHHHHHHHhccCCCCCeEec
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPKSE---------------------TILTWAMRLKIAQDAARGLAYLHEGMDFQIIVR 218 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~~~---------------------~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHr 218 (426)
. ++||||+++|+|.+++..... ..+++..++.++.||+.||+|||++ +|+||
T Consensus 124 ~----~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~ 196 (344)
T 1rjb_A 124 I----YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHR 196 (344)
T ss_dssp C----EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEET
T ss_pred c----EEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccC
Confidence 4 999999999999999976432 2378999999999999999999998 99999
Q ss_pred cCCCCceEeCCCCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCC
Q 014363 219 DFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPID 297 (426)
Q Consensus 219 Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~ 297 (426)
||||+|||++.++.+||+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |..||.
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 276 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence 9999999999999999999999986644433334455678999999999999999999999999999999998 999997
Q ss_pred CCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhh
Q 014363 298 RNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 373 (426)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~ 373 (426)
........ . ..+........+..++..+.+|+.+||+.||++|||+.+|+++|+.+....
T Consensus 277 ~~~~~~~~--~--------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 336 (344)
T 1rjb_A 277 GIPVDANF--Y--------------KLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA 336 (344)
T ss_dssp TCCCSHHH--H--------------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred cCCcHHHH--H--------------HHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence 65432111 1 111111111222335678999999999999999999999999999887654
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-48 Score=371.51 Aligned_cols=262 Identities=26% Similarity=0.437 Sum_probs=208.2
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc---CCHHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR---GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
.++|+..+.||+|+||.||+|.+..++.. ....|++|.+... ...+.+.+|+.+++.++||||+++++++.+..
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 90 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEK-VKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-- 90 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC-----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS--
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCce-EEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC--
Confidence 35799999999999999999998766543 3445788987543 34567899999999999999999999998753
Q ss_pred CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecc
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 240 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 240 (426)
.++|+||+++|+|.+++.... ..+++..++.|+.||+.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 91 ---~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~ 163 (327)
T 3poz_A 91 ---VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGL 163 (327)
T ss_dssp ---EEEEEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTH
T ss_pred ---eEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcc
Confidence 489999999999999997543 3489999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014363 241 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAK 319 (426)
Q Consensus 241 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 319 (426)
++...............||+.|+|||++.+..++.++||||||+++|||++ |..||...........+.
T Consensus 164 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~---------- 233 (327)
T 3poz_A 164 AKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE---------- 233 (327)
T ss_dssp HHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH----------
T ss_pred eeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHH----------
Confidence 987654443333444567889999999999999999999999999999999 999998654432222111
Q ss_pred hhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 014363 320 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 372 (426)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~ 372 (426)
.......+..++..+.+++.+||+.||++||++.|++++|+.+...
T Consensus 234 -------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 234 -------KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp -------TTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred -------cCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 1111122233556899999999999999999999999999988754
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-49 Score=381.58 Aligned_cols=268 Identities=24% Similarity=0.408 Sum_probs=211.2
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
.++|.+++.||+|+||.||+|.+...........||+|.+.... ....+.+|+.+++.++||||+++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 35789999999999999999997765455566789999986543 334688999999999999999999999876644
Q ss_pred CceEEEEEeeCCCCChhhhccCCC-----CCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCC---C
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKS-----ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW---N 232 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~-----~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~---~ 232 (426)
++||||+++|+|.+++.... ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++ .
T Consensus 150 ----~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~ 222 (367)
T 3l9p_A 150 ----FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRV 222 (367)
T ss_dssp ----EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCC
T ss_pred ----EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCce
Confidence 99999999999999996432 13489999999999999999999998 999999999999999555 5
Q ss_pred eeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhH
Q 014363 233 AKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWV 311 (426)
Q Consensus 233 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~ 311 (426)
+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||...........+
T Consensus 223 ~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i--- 299 (367)
T 3l9p_A 223 AKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV--- 299 (367)
T ss_dssp EEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH---
T ss_pred EEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH---
Confidence 99999999975422211122334568999999999999999999999999999999998 99999765432211111
Q ss_pred hhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhhcc
Q 014363 312 KPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASAE 375 (426)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~~~ 375 (426)
. .......+..++..+.+|+.+||+.||++|||+.+|+++|+.+......
T Consensus 300 ~--------------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~~ 349 (367)
T 3l9p_A 300 T--------------SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 349 (367)
T ss_dssp H--------------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHH
T ss_pred H--------------cCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChhh
Confidence 0 0011112233556799999999999999999999999999988765443
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=369.18 Aligned_cols=264 Identities=26% Similarity=0.402 Sum_probs=210.6
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC--CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
.++|...++||+|+||.||+|.+..++. .||+|.+.... ..+.+.+|+.+++.++||||+++++++.+..
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~-----~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--- 80 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGE-----VMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDK--- 80 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCC-----EEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT---
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCc-----EEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCC---
Confidence 3578899999999999999999877654 78999875433 3457889999999999999999999998765
Q ss_pred ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccc
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 241 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 241 (426)
..++||||+++|+|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 81 -~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 155 (310)
T 3s95_A 81 -RLNFITEYIKGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLA 155 (310)
T ss_dssp -EEEEEEECCTTCBHHHHHHHCC-TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTC
T ss_pred -eeEEEEEecCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccc
Confidence 4599999999999999997543 3489999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCcee------------eeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHH
Q 014363 242 RLGPSEGFTH------------VSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQ 309 (426)
Q Consensus 242 ~~~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~ 309 (426)
.......... ......||+.|+|||++.+..++.++||||||+++|+|++|..||...........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~-- 233 (310)
T 3s95_A 156 RLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG-- 233 (310)
T ss_dssp EECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSS--
T ss_pred eecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHh--
Confidence 8654322111 11146799999999999999999999999999999999999999875433211100
Q ss_pred hHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhhcc
Q 014363 310 WVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASAE 375 (426)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~~~ 375 (426)
.......+.. .+..++..+.+++.+||+.||++|||+.++++.|+.+......
T Consensus 234 ---------~~~~~~~~~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~ 286 (310)
T 3s95_A 234 ---------LNVRGFLDRY----CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAG 286 (310)
T ss_dssp ---------BCHHHHHHHT----CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred ---------hhhhcccccc----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccC
Confidence 0000111111 1122345788999999999999999999999999998766543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-48 Score=371.70 Aligned_cols=247 Identities=26% Similarity=0.422 Sum_probs=204.9
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
.++|.+.+.||+|+||.||+|.+..++. .||+|.+.... ..+.+.+|+.+|+.++||||+++++++.+..
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~- 87 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGR-----EVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEK- 87 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCC-----EEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCC-----EEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC-
Confidence 5689999999999999999999876654 89999986442 2346789999999999999999999998765
Q ss_pred CCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeec
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 239 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 239 (426)
..|+||||+++|+|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 88 ---~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG 159 (328)
T 3fe3_A 88 ---TLYLIMEYASGGEVFDYLVAHG--RMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFG 159 (328)
T ss_dssp ---EEEEEECCCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTT
T ss_pred ---EEEEEEECCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeecc
Confidence 4599999999999999986543 489999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCchhhccCCCC-CchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014363 240 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLA-ARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 318 (426)
Q Consensus 240 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 318 (426)
++....... .....+||+.|+|||++.+..+. .++|||||||++|+|++|..||...........+
T Consensus 160 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i---------- 226 (328)
T 3fe3_A 160 FSNEFTVGG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV---------- 226 (328)
T ss_dssp CCGGGSSSC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH----------
T ss_pred CceecCCCC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHH----------
Confidence 998654432 23456899999999999988875 7999999999999999999999865432211111
Q ss_pred hhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 319 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
..... ..+...+..+.+|+.+||+.||++|||++|++++
T Consensus 227 ------~~~~~--~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 227 ------LRGKY--RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp ------HHCCC--CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred ------HhCCC--CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 10100 1222355788999999999999999999999986
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-48 Score=367.20 Aligned_cols=265 Identities=28% Similarity=0.407 Sum_probs=216.8
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC---HHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG---HKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
.++|.+.+.||+|+||.||+|.+...........||+|.+..... .+.+.+|+.+++.++||||+++++++.+....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 467899999999999999999986544344556899999875543 35678999999999999999999999876644
Q ss_pred CceEEEEEeeCCCCChhhhccCCCC----------------------CccCHHHHHHHHHHHHHHHHHhccCCCCCeEec
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSE----------------------TILTWAMRLKIAQDAARGLAYLHEGMDFQIIVR 218 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~----------------------~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHr 218 (426)
++||||+++++|.+++..... ..+++..++.++.||+.||.|||++ +|+||
T Consensus 102 ----~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~ 174 (314)
T 2ivs_A 102 ----LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHR 174 (314)
T ss_dssp ----EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECC
T ss_pred ----EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCccc
Confidence 999999999999999975432 3489999999999999999999998 99999
Q ss_pred cCCCCceEeCCCCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCC
Q 014363 219 DFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPID 297 (426)
Q Consensus 219 Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~ 297 (426)
||||+|||++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||.
T Consensus 175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 254 (314)
T 2ivs_A 175 DLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 254 (314)
T ss_dssp CCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999987654433333344567899999999999899999999999999999999 999997
Q ss_pred CCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 014363 298 RNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 372 (426)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~ 372 (426)
..........+. .......+..++..+.+++.+||+.||++|||+.+|+++|+++...
T Consensus 255 ~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 255 GIPPERLFNLLK-----------------TGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp TCCGGGHHHHHH-----------------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCHHHHHHHhh-----------------cCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 654432221111 0111122234567899999999999999999999999999998754
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-48 Score=368.96 Aligned_cols=253 Identities=25% Similarity=0.396 Sum_probs=204.6
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
.++|++.+.||+|+||.||+|.+..++. .||+|.+.... ..+.+.+|+.+++.++||||+++++++.+..
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-- 78 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEE-----AVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN-- 78 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCC-----EEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSS--
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCc-----EEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCC--
Confidence 4689999999999999999999886654 79999885433 2356889999999999999999999998765
Q ss_pred CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecc
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 240 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 240 (426)
..|+||||+++|+|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 79 --~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~ 151 (323)
T 3tki_A 79 --IQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGL 151 (323)
T ss_dssp --EEEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred --eEEEEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeec
Confidence 459999999999999999754 3489999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCchhhccCCC-CCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014363 241 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRL-AARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 319 (426)
Q Consensus 241 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 319 (426)
+...............+||+.|+|||++.+..+ +.++|||||||++|+|++|..||......... ...+.
T Consensus 152 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~~~-------- 222 (323)
T 3tki_A 152 ATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWK-------- 222 (323)
T ss_dssp CEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH-HHHHH--------
T ss_pred cceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH-HHHHh--------
Confidence 986543333333445789999999999988776 67899999999999999999999765432111 11110
Q ss_pred hhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 320 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
...........++..+.+|+.+||+.||++|||+.|++++
T Consensus 223 ------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 223 ------EKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp ------TTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ------cccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 0011111112355678899999999999999999999986
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=369.10 Aligned_cols=248 Identities=27% Similarity=0.370 Sum_probs=206.2
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-----CCHHHHHHHHHHHhhcCCCCccceEeEEEccC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-----GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 158 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 158 (426)
.++|+.++.||+|+||.||+|..+.++. .||+|.+... .....+.+|+.+|..++||||+++++++.+.+
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~ 78 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGR-----YYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCC-----EEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCC-----EEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCC
Confidence 3578999999999999999999876654 7999998543 34567889999999999999999999998766
Q ss_pred CCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeee
Q 014363 159 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 238 (426)
Q Consensus 159 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 238 (426)
..|+||||++||+|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.+|.+||+||
T Consensus 79 ----~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DF 149 (337)
T 1o6l_A 79 ----RLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDF 149 (337)
T ss_dssp ----EEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCC
T ss_pred ----EEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeec
Confidence 459999999999999998643 3489999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014363 239 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 318 (426)
Q Consensus 239 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 318 (426)
|+++...... ......+||+.|+|||++.+..++.++|||||||++|||++|..||...........
T Consensus 150 G~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~----------- 216 (337)
T 1o6l_A 150 GLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL----------- 216 (337)
T ss_dssp TTCBCSCCTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-----------
T ss_pred cchhhcccCC--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHH-----------
Confidence 9998643322 123457899999999999999999999999999999999999999976432211111
Q ss_pred hhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 014363 319 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRP-----KMSEVLEM 365 (426)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~ 365 (426)
+.... ..++..++..+.+||.+||+.||++|| +++||++|
T Consensus 217 -----i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 217 -----ILMEE--IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp -----HHHCC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -----HHcCC--CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 11111 112334567899999999999999999 89999886
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=371.72 Aligned_cols=249 Identities=26% Similarity=0.348 Sum_probs=205.2
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC--------CHHHHHHHHHHHhhcCCCCccceEeEEE
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--------GHKEWMTEVNFLGIVEHQNLVKLVGYCA 155 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~--------~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 155 (426)
.++|.+.+.||+|+||.||+|.++.++. .||+|.+.... ..+.+.+|+.+|..++||||+++++++.
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~-----~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~ 85 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGL-----EYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYE 85 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCC-----EEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCC-----EEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEE
Confidence 4679999999999999999999887654 79999886543 2467899999999999999999999998
Q ss_pred ccCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCC----
Q 014363 156 DDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW---- 231 (426)
Q Consensus 156 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~---- 231 (426)
+.. ..|+||||++||+|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++
T Consensus 86 ~~~----~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~ 156 (361)
T 2yab_A 86 NRT----DVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIP 156 (361)
T ss_dssp CSS----EEEEEEECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSC
T ss_pred eCC----EEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCcc
Confidence 765 459999999999999999654 3599999999999999999999998 999999999999998877
Q ss_pred CeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhH
Q 014363 232 NAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWV 311 (426)
Q Consensus 232 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~ 311 (426)
.+||+|||++....... .....+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.........
T Consensus 157 ~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~---- 229 (361)
T 2yab_A 157 HIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN---- 229 (361)
T ss_dssp CEEECCCSSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH----
T ss_pred CEEEEecCCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----
Confidence 79999999998765432 13356799999999999999999999999999999999999999976543221111
Q ss_pred hhhhhhhhhhhhhcCCcC--CCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 312 KPYLSDAKQFRQIVDPRL--EGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
+..... ...+...++..+.+||.+||..||++|||+.|+++|
T Consensus 230 ------------i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 230 ------------ITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp ------------HHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ------------HHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 111100 001112345689999999999999999999999875
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-48 Score=378.72 Aligned_cols=259 Identities=24% Similarity=0.416 Sum_probs=210.0
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC---HHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG---HKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
.++|...+.||+|+||.||+|.+..++. .||+|.+..... .+.+.+|+.+|+.++||||+++++++.+....
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 187 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNT-----LVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPI 187 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCC-----EEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCe-----EEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCc
Confidence 4578889999999999999999876543 899999875432 24678999999999999999999999876643
Q ss_pred CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecc
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 240 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 240 (426)
|+||||+++|+|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 188 ----~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~ 259 (377)
T 3cbl_A 188 ----YIVMELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGM 259 (377)
T ss_dssp ----EEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGG
T ss_pred ----EEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCC
Confidence 99999999999999997432 3489999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014363 241 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAK 319 (426)
Q Consensus 241 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 319 (426)
++...............+++.|+|||++.++.++.++|||||||++|||++ |..||...........+
T Consensus 260 s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~----------- 328 (377)
T 3cbl_A 260 SREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFV----------- 328 (377)
T ss_dssp CEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHH-----------
T ss_pred ceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-----------
Confidence 986543322211223346788999999999999999999999999999998 99999765432211111
Q ss_pred hhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 014363 320 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 372 (426)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~ 372 (426)
........+..++..+.+||.+||+.||++|||+.+|++.|+.+...
T Consensus 329 ------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 329 ------EKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp ------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------HcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 01111122233567899999999999999999999999999988653
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=374.90 Aligned_cols=268 Identities=26% Similarity=0.431 Sum_probs=217.2
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCC--CCCcceEEEEEEccccCCH---HHHHHHHHHHhhc-CCCCccceEeEEEcc
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSE--DPSQKVEVAVKQLGRRGGH---KEWMTEVNFLGIV-EHQNLVKLVGYCADD 157 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~--~~~~~~~va~K~~~~~~~~---~~~~~E~~~l~~l-~HpnIv~~~~~~~~~ 157 (426)
.++|.+.+.||+|+||.||+|.+.... .......||+|.+...... ..+.+|+.+++.+ +||||+++++++.+.
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 457899999999999999999976533 2244567999998765433 5688999999999 999999999999876
Q ss_pred CCCCceEEEEEeeCCCCChhhhccCCC--------------CCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCC
Q 014363 158 DERGIQRLLVYEYMPNGSVDQYLSPKS--------------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSS 223 (426)
Q Consensus 158 ~~~~~~~~lv~E~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~ 223 (426)
+.. ++||||+++|+|.+++.... ...+++..++.|+.||+.||.|||+. +|+||||||+
T Consensus 148 ~~~----~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~ 220 (382)
T 3tt0_A 148 GPL----YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAAR 220 (382)
T ss_dssp SSC----EEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGG
T ss_pred Cce----EEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcc
Confidence 654 99999999999999997543 23589999999999999999999998 9999999999
Q ss_pred ceEeCCCCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCch
Q 014363 224 NILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPR 302 (426)
Q Consensus 224 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~ 302 (426)
|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 221 NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~ 300 (382)
T 3tt0_A 221 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 300 (382)
T ss_dssp GEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred eEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999986654332233344568899999999999999999999999999999999 99999765432
Q ss_pred hhHHHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhhcc
Q 014363 303 SEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASAE 375 (426)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~~~ 375 (426)
..... +. .......+..++..+.+|+.+||+.||++|||+.||+++|+.+......
T Consensus 301 ~~~~~---~~--------------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 356 (382)
T 3tt0_A 301 ELFKL---LK--------------EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSN 356 (382)
T ss_dssp HHHHH---HH--------------TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCS
T ss_pred HHHHH---HH--------------cCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 21111 10 1111112233557899999999999999999999999999999866543
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-48 Score=371.13 Aligned_cols=267 Identities=27% Similarity=0.438 Sum_probs=214.9
Q ss_pred HhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC---HHHHHHHHHHHhhcCCCCccceEeEEEccCC
Q 014363 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG---HKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 83 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
..++|...+.||+|+||.||+|.+...........||+|.+..... .+.+.+|+.+++.++||||+++++++.+...
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 124 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 124 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence 4678999999999999999999988654445567899999876543 3568899999999999999999999987664
Q ss_pred CCceEEEEEeeCCCCChhhhccCCC----------------------CCccCHHHHHHHHHHHHHHHHHhccCCCCCeEe
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPKS----------------------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIV 217 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~~----------------------~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiH 217 (426)
. |+||||+++|+|.+++.... ...+++..++.++.||+.||.|||++ +|+|
T Consensus 125 ~----~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH 197 (343)
T 1luf_A 125 M----CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVH 197 (343)
T ss_dssp C----EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred e----EEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---Ceec
Confidence 3 99999999999999987532 14589999999999999999999998 9999
Q ss_pred ccCCCCceEeCCCCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCC
Q 014363 218 RDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPI 296 (426)
Q Consensus 218 rDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~ 296 (426)
|||||+|||++.++.+||+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |..||
T Consensus 198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 277 (343)
T 1luf_A 198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 277 (343)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence 99999999999999999999999976543322222344578999999999999999999999999999999999 99999
Q ss_pred CCCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhh
Q 014363 297 DRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 373 (426)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~ 373 (426)
........... +.+... ...+..++..+.+++.+||+.||++|||+.+|+++|+.+.+..
T Consensus 278 ~~~~~~~~~~~----------------~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 278 YGMAHEEVIYY----------------VRDGNI-LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp TTSCHHHHHHH----------------HHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred CCCChHHHHHH----------------HhCCCc-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 76543211111 111111 1122345578999999999999999999999999999887543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-48 Score=368.44 Aligned_cols=263 Identities=24% Similarity=0.414 Sum_probs=210.3
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
.++|...+.||+|+||.||+|.+..++.. ....|++|.+.... ....+.+|+.++..++||||+++++++.+.
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~-~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--- 87 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGES-IKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGS--- 87 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCS-CCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECBS---
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCce-EEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC---
Confidence 35789999999999999999998776543 34458888875432 334678999999999999999999998643
Q ss_pred CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecc
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 240 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 240 (426)
..++||||+++|+|.+++... ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 88 --~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~ 161 (325)
T 3kex_A 88 --SLQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGV 161 (325)
T ss_dssp --SEEEEEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSG
T ss_pred --ccEEEEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCc
Confidence 258999999999999999754 34589999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014363 241 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAK 319 (426)
Q Consensus 241 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 319 (426)
++...............||+.|+|||++.+..++.++||||||+++|+|++ |..||...........+..
T Consensus 162 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~--------- 232 (325)
T 3kex_A 162 ADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEK--------- 232 (325)
T ss_dssp GGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHT---------
T ss_pred ccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHc---------
Confidence 987765443334455678899999999999999999999999999999999 9999987554332222111
Q ss_pred hhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhh
Q 014363 320 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 373 (426)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~ 373 (426)
......+..++..+.+++.+||+.||++|||+.+++++|+.+....
T Consensus 233 --------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~ 278 (325)
T 3kex_A 233 --------GERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP 278 (325)
T ss_dssp --------TCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred --------CCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 0011111223456889999999999999999999999999886543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=364.03 Aligned_cols=267 Identities=26% Similarity=0.411 Sum_probs=218.1
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC---HHHHHHHHHHHhhc-CCCCccceEeEEEccCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG---HKEWMTEVNFLGIV-EHQNLVKLVGYCADDDE 159 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~ 159 (426)
.++|...+.||+|+||.||+|.+...........||+|.+..... .+.+.+|+.++..+ +||||+++++++.+.+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 467999999999999999999976544455667899999875543 35688999999999 99999999999987664
Q ss_pred CCceEEEEEeeCCCCChhhhccCCCC----------------CccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCC
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPKSE----------------TILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSS 223 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~~~----------------~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~ 223 (426)
. ++||||+++|+|.+++..... ..+++..++.++.|++.||.|||++ +|+||||||+
T Consensus 102 ~----~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~ 174 (313)
T 1t46_A 102 T----LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAAR 174 (313)
T ss_dssp C----EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGG
T ss_pred c----EEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccc
Confidence 4 999999999999999975432 2489999999999999999999998 9999999999
Q ss_pred ceEeCCCCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCch
Q 014363 224 NILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPR 302 (426)
Q Consensus 224 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~ 302 (426)
|||++.++.+||+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 175 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 254 (313)
T 1t46_A 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (313)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred eEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch
Confidence 99999999999999999987655443333445678899999999999999999999999999999999 99999765432
Q ss_pred hhHHHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhh
Q 014363 303 SEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 373 (426)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~ 373 (426)
... .... .. ......+..++..+.+++.+||+.||++|||+.|++++|++++...
T Consensus 255 ~~~--~~~~----------~~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 255 SKF--YKMI----------KE----GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp HHH--HHHH----------HH----TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred hHH--HHHh----------cc----CCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 111 1100 01 1111112234578999999999999999999999999999988653
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=371.14 Aligned_cols=280 Identities=18% Similarity=0.252 Sum_probs=213.9
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC-------------HHHHHHHHHHHhhcCCCCccce
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG-------------HKEWMTEVNFLGIVEHQNLVKL 150 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~-------------~~~~~~E~~~l~~l~HpnIv~~ 150 (426)
.++|.+.+.||+|+||.||+|.+..+......+.||+|.+..... ...+..|+..+..++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 568999999999999999999998776555567899999865431 1223456667777889999999
Q ss_pred EeEEEccCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeC--
Q 014363 151 VGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLD-- 228 (426)
Q Consensus 151 ~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~-- 228 (426)
++++..........||||||+ +++|.+++... ...+++..++.|+.||+.||+|||++ +|+||||||+|||++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYK 188 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEESS
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEecC
Confidence 999987654444679999999 99999999754 24599999999999999999999998 999999999999998
Q ss_pred CCCCeeEeeecccccCCCCCce-----eeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchh
Q 014363 229 EQWNAKLSDFGLARLGPSEGFT-----HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRS 303 (426)
Q Consensus 229 ~~~~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~ 303 (426)
.++.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|..||.......
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~ 268 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence 8899999999999765432111 11134569999999999999999999999999999999999999997533221
Q ss_pred hHHHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhhcc
Q 014363 304 EQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASAE 375 (426)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~~~ 375 (426)
.. ........ ...+..+++..+. ...++..+.+++..||+.||++||++.+|++.|+.++.....
T Consensus 269 ~~--~~~~~~~~--~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~ 333 (364)
T 3op5_A 269 KY--VRDSKIRY--RENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGS 333 (364)
T ss_dssp HH--HHHHHHHH--HHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred HH--HHHHHHHh--hhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence 11 11111000 1112222221111 012356899999999999999999999999999998876443
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=363.42 Aligned_cols=276 Identities=25% Similarity=0.372 Sum_probs=221.9
Q ss_pred HHHHHHHhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC---HHHHHHHHHHHhhc-CCCCccceEe
Q 014363 77 IAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG---HKEWMTEVNFLGIV-EHQNLVKLVG 152 (426)
Q Consensus 77 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~E~~~l~~l-~HpnIv~~~~ 152 (426)
........++|.+.+.||+|+||.||+|.+...........||+|.+..... .+.+.+|+.++..+ +||||+++++
T Consensus 19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 98 (316)
T 2xir_A 19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 98 (316)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence 3344444678999999999999999999987655556677999999876543 34688999999999 7999999999
Q ss_pred EEEccCCCCceEEEEEeeCCCCChhhhccCCCCC--------------ccCHHHHHHHHHHHHHHHHHhccCCCCCeEec
Q 014363 153 YCADDDERGIQRLLVYEYMPNGSVDQYLSPKSET--------------ILTWAMRLKIAQDAARGLAYLHEGMDFQIIVR 218 (426)
Q Consensus 153 ~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~--------------~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHr 218 (426)
++...+. ..++||||+++|+|.+++...... .+++..++.++.|++.||.|||++ +|+||
T Consensus 99 ~~~~~~~---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~ 172 (316)
T 2xir_A 99 ACTKPGG---PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHR 172 (316)
T ss_dssp EECCTTS---CCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred EEecCCC---ceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Ccccc
Confidence 9876543 248999999999999999765432 288999999999999999999998 99999
Q ss_pred cCCCCceEeCCCCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCC
Q 014363 219 DFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPID 297 (426)
Q Consensus 219 Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~ 297 (426)
||||+|||++.++.+||+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |..||.
T Consensus 173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~ 252 (316)
T 2xir_A 173 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 252 (316)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence 9999999999999999999999987654433334455678999999999999999999999999999999998 999997
Q ss_pred CCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhhc
Q 014363 298 RNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASA 374 (426)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~~ 374 (426)
........ .... .... ....+..++..+.+++.+||+.||++|||+.||+++|+.++....
T Consensus 253 ~~~~~~~~--~~~~----------~~~~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 313 (316)
T 2xir_A 253 GVKIDEEF--CRRL----------KEGT----RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313 (316)
T ss_dssp TCCCSHHH--HHHH----------HHTC----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred ccchhHHH--HHHh----------ccCc----cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 65432211 1100 0000 111122345689999999999999999999999999999987654
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=360.69 Aligned_cols=260 Identities=28% Similarity=0.392 Sum_probs=211.5
Q ss_pred ccCHHHHHHHhCC----------CCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc--CCHHHHHHHHHHHhh
Q 014363 74 EFTIAELKSATKN----------FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR--GGHKEWMTEVNFLGI 141 (426)
Q Consensus 74 ~~~~~~~~~~~~~----------y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~E~~~l~~ 141 (426)
.|+.+++..+++. |...+.||+|+||.||+|.+..++. .||+|.+... ...+.+.+|+.+++.
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~-----~vavK~~~~~~~~~~~~~~~E~~~l~~ 98 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGR-----QVAVKMMDLRKQQRRELLFNEVVIMRD 98 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCC-----EEEEEEEETTTCCSHHHHHHHHHHHTT
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCc-----EEEEEEEeccchhHHHHHHHHHHHHHh
Confidence 4677777777654 6677899999999999999876554 8999988543 345678999999999
Q ss_pred cCCCCccceEeEEEccCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCC
Q 014363 142 VEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFK 221 (426)
Q Consensus 142 l~HpnIv~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlk 221 (426)
++||||+++++++.... ..++||||+++++|.+++... .+++..++.++.|++.||.|||+. +|+|||||
T Consensus 99 l~h~niv~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~---~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlk 168 (321)
T 2c30_A 99 YQHFNVVEMYKSYLVGE----ELWVLMEFLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIK 168 (321)
T ss_dssp CCCTTBCCEEEEEEETT----EEEEEECCCCSCBHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCS
T ss_pred CCCCCcceEEEEEEECC----EEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCC
Confidence 99999999999998765 459999999999999998643 389999999999999999999998 99999999
Q ss_pred CCceEeCCCCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCc
Q 014363 222 SSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRP 301 (426)
Q Consensus 222 p~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~ 301 (426)
|+|||++.++.+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus 169 p~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~ 246 (321)
T 2c30_A 169 SDSILLTLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP 246 (321)
T ss_dssp GGGEEECTTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred HHHEEECCCCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999999999999999999986544321 13456799999999999999999999999999999999999999976543
Q ss_pred hhhHHHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 302 RSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
...... +.....+.+ .....++..+.+++.+||+.||++|||+.|++++
T Consensus 247 ~~~~~~-------------~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 247 VQAMKR-------------LRDSPPPKL--KNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HHHHHH-------------HHHSSCCCC--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHH-------------HhcCCCCCc--CccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 221111 011111111 1122345689999999999999999999999986
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=359.46 Aligned_cols=273 Identities=24% Similarity=0.309 Sum_probs=213.3
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc---CCHHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR---GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
.++|.+.++||+|+||.||+|.+..++. .||+|.+... ...+.+.+|+.+|+.++||||+++++++.+....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 82 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGD-----LFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTR 82 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCC-----EEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTC
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCc-----EEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCc
Confidence 3578999999999999999999887654 8999998643 2456788999999999999999999999876543
Q ss_pred CceEEEEEeeCCCCChhhhccCCCC-CccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEe----CCCCCeeE
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSE-TILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL----DEQWNAKL 235 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~-~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl----~~~~~~kl 235 (426)
..++||||+++++|.+++..... ..+++..++.++.|++.||+|||++ +|+||||||+|||+ +.++.+||
T Consensus 83 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL 157 (319)
T 4euu_A 83 --HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKL 157 (319)
T ss_dssp --CEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEE
T ss_pred --eEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEE
Confidence 45999999999999999975432 2389999999999999999999998 99999999999999 78888999
Q ss_pred eeecccccCCCCCceeeeeeeecCcccCCchhhc--------cCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhh-HH
Q 014363 236 SDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQ--------TGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSE-QK 306 (426)
Q Consensus 236 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~-~~ 306 (426)
+|||+++....... .....||+.|+|||++. +..++.++|||||||++|||++|..||........ ..
T Consensus 158 ~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~ 234 (319)
T 4euu_A 158 TDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE 234 (319)
T ss_dssp CCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHH
T ss_pred ccCCCceecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHH
Confidence 99999987654321 23467999999999886 57789999999999999999999999975433221 11
Q ss_pred HHHhHhhhhh-h-hhhhhhhc--------CCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHh
Q 014363 307 LLQWVKPYLS-D-AKQFRQIV--------DPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 369 (426)
Q Consensus 307 ~~~~~~~~~~-~-~~~~~~~~--------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~ 369 (426)
....+..... . ........ .......+...++..+.+++.+||+.||++|||++|++++..+.
T Consensus 235 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 235 VMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp HHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred HHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 1111110000 0 00000000 11122245678889999999999999999999999999998764
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=357.36 Aligned_cols=256 Identities=26% Similarity=0.485 Sum_probs=209.4
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCce
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQ 163 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~ 163 (426)
++|+..+.||+|+||.||+|.+.... .||+|.+.... ..+.+.+|+.++++++||||+++++++.+...
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~------~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~---- 79 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKD------KVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP---- 79 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTE------EEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS----
T ss_pred hhceeeheecCCCccEEEEEEecCCC------eEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCc----
Confidence 57888999999999999999976532 68999987554 56789999999999999999999999987653
Q ss_pred EEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccccc
Q 014363 164 RLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL 243 (426)
Q Consensus 164 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 243 (426)
.++||||+++++|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 155 (269)
T 4hcu_A 80 ICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRF 155 (269)
T ss_dssp EEEEEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGG
T ss_pred eEEEEEeCCCCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccc
Confidence 499999999999999996543 3589999999999999999999998 999999999999999999999999999986
Q ss_pred CCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhhh
Q 014363 244 GPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQFR 322 (426)
Q Consensus 244 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (426)
...... .......||+.|+|||++.+..++.++||||||+++|+|++ |..||...........+ .
T Consensus 156 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~-------------~ 221 (269)
T 4hcu_A 156 VLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI-------------S 221 (269)
T ss_dssp BCCHHH-HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH-------------H
T ss_pred cccccc-ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH-------------h
Confidence 543211 11223456788999999999999999999999999999999 99999765432211110 0
Q ss_pred hhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 014363 323 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 372 (426)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~ 372 (426)
. ......+...+..+.+++.+||+.||++|||+.+++++|+++.+.
T Consensus 222 ~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 222 T----GFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp T----TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred c----CccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 0 011112223456899999999999999999999999999998754
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-47 Score=358.91 Aligned_cols=263 Identities=25% Similarity=0.417 Sum_probs=204.4
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhh--cCCCCccceEeEEEccCCCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGI--VEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~--l~HpnIv~~~~~~~~~~~~~ 161 (426)
.++|++.+.||+|+||.||+|.+.+ ..||+|.+... ....+..|.+++.. ++||||+++++++.+.....
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~vavK~~~~~-~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~ 78 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSWQG-------ENVAVKIFSSR-DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSS 78 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEETT-------EEEEEEEECGG-GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTE
T ss_pred cCcEEEEEeeccCCCcEEEEEEECC-------EEEEEEEeccc-cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCC
Confidence 4689999999999999999998742 37999998654 34556677777766 79999999999987765545
Q ss_pred ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhc--------cCCCCCeEeccCCCCceEeCCCCCe
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLH--------EGMDFQIIVRDFKSSNILLDEQWNA 233 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH--------~~~~~~iiHrDlkp~NILl~~~~~~ 233 (426)
...++||||+++|+|.+++... .+++..++.++.|++.||+||| +. +|+||||||+|||++.++.+
T Consensus 79 ~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~ 152 (301)
T 3q4u_A 79 TQLWLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQC 152 (301)
T ss_dssp EEEEEEECCCTTCBHHHHHTTC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCE
T ss_pred ceeEEehhhccCCCHHHHHhhc---ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCE
Confidence 5679999999999999999643 4899999999999999999999 77 99999999999999999999
Q ss_pred eEeeecccccCCCCCcee--eeeeeecCcccCCchhhccC------CCCCchhhHHHHHHHHHHHhC----------CCC
Q 014363 234 KLSDFGLARLGPSEGFTH--VSTAVVGTMGYAAPEYVQTG------RLAARSDVWSYGVFLYELITG----------RRP 295 (426)
Q Consensus 234 kl~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslGvil~elltg----------~~p 295 (426)
||+|||++.......... ......||+.|+|||++.+. .++.++||||||+++|||++| ..|
T Consensus 153 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~p 232 (301)
T 3q4u_A 153 CIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP 232 (301)
T ss_dssp EECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccc
Confidence 999999997654332221 12345799999999999876 445789999999999999999 888
Q ss_pred CCCCCchhhH--HHHHhHhhhhhhhhhhhhhcCCcCC-CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHh
Q 014363 296 IDRNRPRSEQ--KLLQWVKPYLSDAKQFRQIVDPRLE-GKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 369 (426)
Q Consensus 296 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~ 369 (426)
|......... ...... ......+.+. ..+....+..+.+|+.+||+.||++|||+.||++.|+++
T Consensus 233 f~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 233 FYDVVPNDPSFEDMRKVV---------CVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTTTSCSSCCHHHHHHHH---------TTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccCCCCcchhhhhHHH---------hccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 8653322111 110000 0000111111 112345788999999999999999999999999999875
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=363.92 Aligned_cols=251 Identities=20% Similarity=0.295 Sum_probs=206.0
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCc
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 162 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~ 162 (426)
.++|.+.+.||+|+||.||+|.+..++. .+|+|.+.... ....+.+|+.+|+.++||||+++++++.+..
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~-----~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~---- 74 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKK-----TYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESME---- 74 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTE-----EEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETT----
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCc-----EEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCC----
Confidence 4689999999999999999999876553 78999886543 3456789999999999999999999998765
Q ss_pred eEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCC--CCCeeEeeecc
Q 014363 163 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE--QWNAKLSDFGL 240 (426)
Q Consensus 163 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~--~~~~kl~DFGl 240 (426)
..++||||+++|+|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+|||++. ++.+||+|||+
T Consensus 75 ~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~ 150 (321)
T 1tki_A 75 ELVMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQ 150 (321)
T ss_dssp EEEEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTT
T ss_pred EEEEEEEeCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCC
Confidence 4599999999999999997543 3589999999999999999999998 9999999999999987 78999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhh
Q 014363 241 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 320 (426)
Q Consensus 241 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (426)
+....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||...........
T Consensus 151 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~------------- 214 (321)
T 1tki_A 151 ARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIEN------------- 214 (321)
T ss_dssp CEECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH-------------
T ss_pred CeECCCCC---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHH-------------
Confidence 98765432 23456799999999999988899999999999999999999999976543211111
Q ss_pred hhhhcCCcCC--CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014363 321 FRQIVDPRLE--GKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMV 366 (426)
Q Consensus 321 ~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L 366 (426)
+...... ......++..+.+++.+||+.||++|||+.|++++-
T Consensus 215 ---i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp 259 (321)
T 1tki_A 215 ---IMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHP 259 (321)
T ss_dssp ---HHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred ---HHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcCh
Confidence 1100000 000113457899999999999999999999999973
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=366.29 Aligned_cols=263 Identities=26% Similarity=0.440 Sum_probs=207.4
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc---CCHHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR---GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
.++|+.++.||+|+||.||+|.+..++.. ....|++|.+... ...+.+.+|+.++..++||||+++++++.+..
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~-~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-- 90 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEK-VKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-- 90 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCS-CCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS--
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCce-EEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC--
Confidence 45799999999999999999998776543 3445788887543 35578899999999999999999999998754
Q ss_pred CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecc
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 240 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 240 (426)
.++|+||+++|+|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 91 ---~~~v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~ 163 (327)
T 3lzb_A 91 ---VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGL 163 (327)
T ss_dssp ---EEEEECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC
T ss_pred ---ceEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcc
Confidence 489999999999999997543 3489999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014363 241 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAK 319 (426)
Q Consensus 241 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 319 (426)
+................||+.|+|||++.+..++.++||||||+++|+|++ |..||...........+
T Consensus 164 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~----------- 232 (327)
T 3lzb_A 164 AKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL----------- 232 (327)
T ss_dssp ----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH-----------
T ss_pred eeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH-----------
Confidence 987654333333344567889999999999999999999999999999999 99999865443322111
Q ss_pred hhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhh
Q 014363 320 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 373 (426)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~ 373 (426)
........+..++..+.+++.+||+.||++|||+.|+++.|+.+....
T Consensus 233 ------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 280 (327)
T 3lzb_A 233 ------EKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp ------HTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred ------HcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence 111111222335568999999999999999999999999999987553
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-48 Score=372.18 Aligned_cols=248 Identities=28% Similarity=0.413 Sum_probs=201.3
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-----CCHHHHHHHHHHHhhc-CCCCccceEeEEEcc
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-----GGHKEWMTEVNFLGIV-EHQNLVKLVGYCADD 157 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-----~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~ 157 (426)
.++|+++++||+|+||.||+|.++.++. .||+|.+... ...+.+..|..+|..+ +||||+++++++.+.
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~-----~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~ 96 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGD-----LYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTP 96 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCC-----EEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCC-----EEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeC
Confidence 4689999999999999999999887654 8999998643 3456688999999988 799999999999876
Q ss_pred CCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEee
Q 014363 158 DERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 237 (426)
Q Consensus 158 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~D 237 (426)
. ..|+||||++||+|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.+|.+||+|
T Consensus 97 ~----~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~D 167 (353)
T 3txo_A 97 D----RLFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLAD 167 (353)
T ss_dssp S----EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECC
T ss_pred C----EEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEcc
Confidence 6 459999999999999999654 3489999999999999999999998 999999999999999999999999
Q ss_pred ecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh
Q 014363 238 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 317 (426)
Q Consensus 238 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 317 (426)
||+++...... ......+||+.|+|||++.+..|+.++|||||||++|||++|..||..........
T Consensus 168 FG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~----------- 234 (353)
T 3txo_A 168 FGMCKEGICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFE----------- 234 (353)
T ss_dssp CTTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-----------
T ss_pred ccceeecccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHH-----------
Confidence 99998543322 22445789999999999999899999999999999999999999997654322111
Q ss_pred hhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCH------HHHHHH
Q 014363 318 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKM------SEVLEM 365 (426)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~------~eil~~ 365 (426)
.+.... ..++..++..+.+|+.+||+.||++||++ +||++|
T Consensus 235 -----~i~~~~--~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 235 -----AILNDE--VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp -----HHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred -----HHHcCC--CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 111111 11233356788999999999999999998 788875
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=360.05 Aligned_cols=251 Identities=28% Similarity=0.382 Sum_probs=198.5
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----------------------------CHHHHHHH
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----------------------------GHKEWMTE 135 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----------------------------~~~~~~~E 135 (426)
.++|.+.+.||+|+||.||+|.+..++ ..||+|.+.... ..+.+.+|
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 86 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDN-----TYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQE 86 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTT-----EEEEEEEEECC-------------------------------CHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCC-----cEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHH
Confidence 468999999999999999999987654 379999885432 12568899
Q ss_pred HHHHhhcCCCCccceEeEEEccCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCe
Q 014363 136 VNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQI 215 (426)
Q Consensus 136 ~~~l~~l~HpnIv~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~i 215 (426)
+.+|+.++||||+++++++.+.... ..|+||||+++++|.+++.. ..+++..++.++.|++.||+|||++ +|
T Consensus 87 ~~~l~~l~h~~iv~~~~~~~~~~~~--~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i 158 (298)
T 2zv2_A 87 IAILKKLDHPNVVKLVEVLDDPNED--HLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQ---KI 158 (298)
T ss_dssp HHHHHTCCCTTBCCEEEEEECSSSS--EEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred HHHHHhCCCCCCCeEEEEEEcCCCC--EEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHC---Ce
Confidence 9999999999999999999874432 56999999999999987653 3489999999999999999999998 99
Q ss_pred EeccCCCCceEeCCCCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCC---CCCchhhHHHHHHHHHHHhC
Q 014363 216 IVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGR---LAARSDVWSYGVFLYELITG 292 (426)
Q Consensus 216 iHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslGvil~elltg 292 (426)
+||||||+|||++.++.+||+|||++....... .......||+.|+|||++.+.. ++.++||||||+++|+|++|
T Consensus 159 vH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g 236 (298)
T 2zv2_A 159 IHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFG 236 (298)
T ss_dssp ECCCCCGGGEEECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHS
T ss_pred eccCCCHHHEEECCCCCEEEecCCCcccccccc--ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHC
Confidence 999999999999999999999999998765432 1234567999999999987665 37789999999999999999
Q ss_pred CCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 293 RRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 293 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
..||....... +..... ...........++..+.+++.+||+.||++|||+.|+++|
T Consensus 237 ~~pf~~~~~~~---~~~~~~-------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 237 QCPFMDERIMC---LHSKIK-------------SQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp SCSSCCSSHHH---HHHHHH-------------HCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred CCCCCCccHHH---HHHHHh-------------cccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 99997643211 111000 0001111112345689999999999999999999999875
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=361.92 Aligned_cols=265 Identities=17% Similarity=0.205 Sum_probs=212.9
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhc-CCCCccceEeEEEccCCCCc
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDERGI 162 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~~~~ 162 (426)
.++|.+.+.||+|+||.||+|.+..++ ..||+|.+......+.+.+|+.+++.+ +||||+++++++.+..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~---- 78 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTN-----EYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGK---- 78 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTT-----EEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETT----
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCC-----cEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCC----
Confidence 357999999999999999999976654 489999987666667799999999999 9999999999998865
Q ss_pred eEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCC-----eeEee
Q 014363 163 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWN-----AKLSD 237 (426)
Q Consensus 163 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~-----~kl~D 237 (426)
..++||||+ +++|.+++... ...+++..++.|+.|++.||+|||++ +|+||||||+|||++.++. +||+|
T Consensus 79 ~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~D 153 (330)
T 2izr_A 79 YNAMVLELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIID 153 (330)
T ss_dssp EEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECC
T ss_pred ccEEEEEeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEE
Confidence 459999999 99999999754 24599999999999999999999998 9999999999999998887 99999
Q ss_pred ecccccCCCCCcee-----eeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHh
Q 014363 238 FGLARLGPSEGFTH-----VSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK 312 (426)
Q Consensus 238 FGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~ 312 (426)
||++.......... ......||+.|+|||++.+..++.++||||||+++|||++|..||..............+.
T Consensus 154 Fg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~ 233 (330)
T 2izr_A 154 FALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIG 233 (330)
T ss_dssp CTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHH
T ss_pred cccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHH
Confidence 99998654322111 1245689999999999999999999999999999999999999998765443333222211
Q ss_pred hhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhh
Q 014363 313 PYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 373 (426)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~ 373 (426)
..... .. ... + ...++ .+.+++..||+.||.+||++++|++.|+++....
T Consensus 234 ~~~~~-~~-~~~----~----~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 234 DTKRA-TP-IEV----L----CENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp HHHHH-SC-HHH----H----TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred hhhcc-CC-HHH----H----hccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 10000 00 000 0 00123 8999999999999999999999999999887654
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=366.73 Aligned_cols=283 Identities=22% Similarity=0.368 Sum_probs=197.5
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
.++|+..+.||+|+||.||+|.+...+. ....||+|.+.... ..+.+.+|+.+++.++||||+++++++.+...
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDG--SFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC---------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCC--cceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 4689999999999999999998765432 22368999886432 34678999999999999999999999987653
Q ss_pred CC--ceEEEEEeeCCCCChhhhccCCC----CCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCe
Q 014363 160 RG--IQRLLVYEYMPNGSVDQYLSPKS----ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNA 233 (426)
Q Consensus 160 ~~--~~~~lv~E~~~~g~L~~~l~~~~----~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~ 233 (426)
.+ ...++||||+++|+|.+++.... ...+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCE
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCE
Confidence 21 12389999999999999985321 12489999999999999999999998 99999999999999999999
Q ss_pred eEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHh
Q 014363 234 KLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVK 312 (426)
Q Consensus 234 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~ 312 (426)
||+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||............
T Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~---- 252 (323)
T 3qup_A 177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL---- 252 (323)
T ss_dssp EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH----
T ss_pred EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHH----
Confidence 9999999986654333333344567889999999999999999999999999999999 99999765433221111
Q ss_pred hhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhhccCCCCCCCCCCCCC
Q 014363 313 PYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASAEAGSPRRPLRSSTS 388 (426)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~~~~~~~~~~~~~~~~ 388 (426)
.. ......+..++..+.+++.+||+.||++|||+.++++.|++++...........|......
T Consensus 253 ------------~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~pl~~~~~ 315 (323)
T 3qup_A 253 ------------IG-GNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDPLYINIE 315 (323)
T ss_dssp ------------HT-TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC----------------
T ss_pred ------------hc-CCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCCCCCCCCC
Confidence 10 0011122345578999999999999999999999999999998776555444444444333
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-47 Score=380.05 Aligned_cols=254 Identities=27% Similarity=0.447 Sum_probs=211.4
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCce
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQ 163 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~ 163 (426)
.++|...+.||+|+||.||+|.+.+ ..||+|.+......+.+.+|+.+|++++||||+++++++.+... .
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~~-------~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~ 261 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYRG-------NKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG---G 261 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-------EEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTS---C
T ss_pred hHHeEEEeeecCcCCeeEEEEEecC-------CeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCC---c
Confidence 4578889999999999999998753 27999999877777889999999999999999999999877542 3
Q ss_pred EEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccccc
Q 014363 164 RLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL 243 (426)
Q Consensus 164 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 243 (426)
.|+||||+++|+|.+++.......+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 262 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 338 (450)
T 1k9a_A 262 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKE 338 (450)
T ss_dssp EEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccc
Confidence 59999999999999999866555579999999999999999999998 999999999999999999999999999985
Q ss_pred CCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhhh
Q 014363 244 GPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQFR 322 (426)
Q Consensus 244 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (426)
.... .....+++.|+|||++.+..++.++||||||+++|||++ |..||...........+
T Consensus 339 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i-------------- 399 (450)
T 1k9a_A 339 ASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-------------- 399 (450)
T ss_dssp CC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHH--------------
T ss_pred cccc-----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH--------------
Confidence 4322 122367899999999999999999999999999999998 99999765432211111
Q ss_pred hhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 014363 323 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 372 (426)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~ 372 (426)
........+..++..+.+||.+||+.||++|||+.+|++.|+.+...
T Consensus 400 ---~~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 400 ---EKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp ---HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ---HcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 00111122334667899999999999999999999999999988755
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=369.05 Aligned_cols=267 Identities=24% Similarity=0.382 Sum_probs=217.0
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhc-CCCCccceEeEEEccCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDE 159 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~ 159 (426)
.++|...+.||+|+||.||+|.+...+.....+.||+|.+.... ..+.+.+|+.++..+ +||||+++++++.+.+.
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 124 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence 56899999999999999999999887766677789999987654 335688999999999 89999999999987664
Q ss_pred CCceEEEEEeeCCCCChhhhccCCC------------CCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEe
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPKS------------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL 227 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~~------------~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl 227 (426)
. ++||||+++|+|.+++.... ...+++..++.++.|++.||.|||++ +|+||||||+|||+
T Consensus 125 ~----~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 125 V----LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLL 197 (333)
T ss_dssp C----EEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEE
T ss_pred e----EEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEE
Confidence 4 99999999999999986421 23478999999999999999999998 99999999999999
Q ss_pred CCCCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHH
Q 014363 228 DEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQK 306 (426)
Q Consensus 228 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~ 306 (426)
+.++.+||+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |..||..........
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~ 277 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY 277 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHH
T ss_pred CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHH
Confidence 9999999999999986543333333445678899999999999999999999999999999999 999997654322111
Q ss_pred HHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhh
Q 014363 307 LLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 373 (426)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~ 373 (426)
... ........+...+..+.+++.+||+.||++|||+.||+++|+.+....
T Consensus 278 --~~~--------------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 328 (333)
T 2i1m_A 278 --KLV--------------KDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED 328 (333)
T ss_dssp --HHH--------------HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred --HHH--------------hcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence 100 001111112234568899999999999999999999999999887543
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-47 Score=359.74 Aligned_cols=260 Identities=28% Similarity=0.429 Sum_probs=203.9
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCceE
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQR 164 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~~ 164 (426)
++|++.+.||+|+||.||+|.+.+ ..||+|.+......+.+.+|+.+++.++||||+++++++.+. .
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~~-------~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~------~ 74 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWRA-------KDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLNP------V 74 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETT-------EEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCTTT------T
T ss_pred hHeeeeeEeecCCCceEEEEEECC-------eeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC------c
Confidence 468889999999999999998753 379999998777777899999999999999999999987643 2
Q ss_pred EEEEeeCCCCChhhhccCCCC-CccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCC-eeEeeecccc
Q 014363 165 LLVYEYMPNGSVDQYLSPKSE-TILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWN-AKLSDFGLAR 242 (426)
Q Consensus 165 ~lv~E~~~~g~L~~~l~~~~~-~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~-~kl~DFGla~ 242 (426)
++||||+++|+|.+++..... ..+++..++.++.|++.||+|||+....+|+||||||+|||++.++. +||+|||++.
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~ 154 (307)
T 2eva_A 75 CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC 154 (307)
T ss_dssp EEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--
T ss_pred EEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccc
Confidence 899999999999999975443 24788999999999999999999932239999999999999998887 7999999997
Q ss_pred cCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhh
Q 014363 243 LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFR 322 (426)
Q Consensus 243 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (426)
..... .....||+.|+|||++.+..++.++||||||+++|+|++|..||............. ..
T Consensus 155 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~-----------~~ 218 (307)
T 2eva_A 155 DIQTH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWA-----------VH 218 (307)
T ss_dssp ---------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHH-----------HH
T ss_pred ccccc-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHH-----------Hh
Confidence 54322 223569999999999999999999999999999999999999997543322111100 00
Q ss_pred hhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhhccCC
Q 014363 323 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASAEAG 377 (426)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~~~~~ 377 (426)
.. ........++..+.+++.+||+.||++|||+.++++.|+.+........
T Consensus 219 ~~----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~ 269 (307)
T 2eva_A 219 NG----TRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGAD 269 (307)
T ss_dssp TT----CCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTT
T ss_pred cC----CCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCC
Confidence 00 1111223355689999999999999999999999999999876655433
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=360.67 Aligned_cols=260 Identities=23% Similarity=0.375 Sum_probs=203.6
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-----CHHHHHHHHHHHhhcCCCCccceEeEEEccC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 158 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 158 (426)
.++|++.+.||+|+||.||+|.+...+. .||+|.+.... ..+.+.+|+.++..++||||+++++++.+.+
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~ 84 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNI-----KVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDD 84 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCS-----EEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSS
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCC-----eEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCC
Confidence 4679999999999999999999876554 79999874332 2356889999999999999999999998765
Q ss_pred CCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeee
Q 014363 159 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 238 (426)
Q Consensus 159 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 238 (426)
..|+||||+++++|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 85 ----~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Df 155 (294)
T 4eqm_A 85 ----CYYLVMEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDF 155 (294)
T ss_dssp ----EEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC
T ss_pred ----eEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeC
Confidence 4599999999999999996543 489999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014363 239 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 318 (426)
Q Consensus 239 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 318 (426)
|++........ .......||+.|+|||++.+..++.++||||||+++|+|++|..||......... .....
T Consensus 156 g~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~--~~~~~------ 226 (294)
T 4eqm_A 156 GIAKALSETSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA--IKHIQ------ 226 (294)
T ss_dssp SSSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH--HHHHS------
T ss_pred CCccccccccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH--HHHhh------
Confidence 99986543321 2233467999999999999999999999999999999999999999765432111 00000
Q ss_pred hhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHHHHhHh
Q 014363 319 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRP-KMSEVLEMVNKIVD 371 (426)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-s~~eil~~L~~~~~ 371 (426)
. ..+.........++..+.+++.+||+.||++|| +++++.+.|..+..
T Consensus 227 ----~-~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 227 ----D-SVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp ----S-CCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred ----c-cCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 0 000000112223557899999999999999998 89999998887653
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=354.24 Aligned_cols=257 Identities=25% Similarity=0.413 Sum_probs=209.6
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCc
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 162 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~ 162 (426)
.++|++.+.||+|+||.||+|.+.+. ..||+|.+.... ..+.+.+|+.++..++||||+++++++.+...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~------~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~--- 77 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQ------YDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYP--- 77 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTT------EEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS---
T ss_pred hhheeeeeeeccCCCceEEEEEecCc------eeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCc---
Confidence 46789999999999999999987653 268999987554 56778999999999999999999999976653
Q ss_pred eEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccc
Q 014363 163 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 242 (426)
Q Consensus 163 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 242 (426)
.++||||+++++|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.
T Consensus 78 -~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~ 152 (268)
T 3sxs_A 78 -IYIVTEYISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTR 152 (268)
T ss_dssp -EEEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEE
T ss_pred -eEEEEEccCCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccce
Confidence 49999999999999999653 23489999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhh
Q 014363 243 LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 321 (426)
Q Consensus 243 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (426)
....... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.............
T Consensus 153 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~------------ 219 (268)
T 3sxs_A 153 YVLDDQY-VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS------------ 219 (268)
T ss_dssp ECCTTCE-EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH------------
T ss_pred ecchhhh-hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHH------------
Confidence 7654432 22334557788999999999899999999999999999999 999997654322111110
Q ss_pred hhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 014363 322 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 372 (426)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~ 372 (426)
.. .....+...+..+.+++.+||+.||++|||+.+++++|+.+.+.
T Consensus 220 -~~----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 220 -QG----HRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp -TT----CCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred -cC----CCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 00 01111122456799999999999999999999999999887543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-47 Score=363.08 Aligned_cols=251 Identities=25% Similarity=0.357 Sum_probs=204.6
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC--------CHHHHHHHHHHHhhcCCCCccceEeEEE
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--------GHKEWMTEVNFLGIVEHQNLVKLVGYCA 155 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~--------~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 155 (426)
.++|...+.||+|+||.||+|.+..++. .||+|.+.... ..+.+.+|+.+|+.++||||+++++++.
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~-----~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 84 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGL-----QYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE 84 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCC-----EEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCc-----EEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 3568999999999999999999877654 79999885432 3567899999999999999999999998
Q ss_pred ccCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCC----
Q 014363 156 DDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW---- 231 (426)
Q Consensus 156 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~---- 231 (426)
+.. ..++||||+++++|.+++... ..+++..++.++.||+.||.|||+. +|+||||||+|||++.++
T Consensus 85 ~~~----~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~ 155 (326)
T 2y0a_A 85 NKT----DVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKP 155 (326)
T ss_dssp CSS----EEEEEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSC
T ss_pred eCC----EEEEEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCC
Confidence 765 459999999999999999654 3589999999999999999999998 999999999999999887
Q ss_pred CeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhH
Q 014363 232 NAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWV 311 (426)
Q Consensus 232 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~ 311 (426)
.+||+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+..
T Consensus 156 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~- 231 (326)
T 2y0a_A 156 RIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA- 231 (326)
T ss_dssp CEEECCCTTCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHH-
T ss_pred CEEEEECCCCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHh-
Confidence 79999999998764322 12346799999999999999999999999999999999999999976543221111100
Q ss_pred hhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 312 KPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.............+..+.+|+.+||+.||++|||+.|++++
T Consensus 232 -------------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 232 -------------VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp -------------TCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred -------------cCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00011111112345678999999999999999999999986
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-47 Score=361.24 Aligned_cols=245 Identities=25% Similarity=0.411 Sum_probs=205.1
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-----CCHHHHHHHHHHHhhcCCCCccceEeEEEccC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-----GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 158 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 158 (426)
.++|++.+.||+|+||.||+|..+.++. .||+|.+... ...+.+.+|+.+++.++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~-----~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~ 79 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGR-----YYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ 79 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCC-----EEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCC-----EEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCC
Confidence 3578999999999999999999876654 8999988643 34567889999999999999999999998765
Q ss_pred CCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeee
Q 014363 159 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 238 (426)
Q Consensus 159 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 238 (426)
..|+||||++||+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.+|.+||+||
T Consensus 80 ----~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Df 150 (318)
T 1fot_A 80 ----QIFMIMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDF 150 (318)
T ss_dssp ----EEEEEECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred ----EEEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeec
Confidence 4599999999999999997543 489999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014363 239 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 318 (426)
Q Consensus 239 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 318 (426)
|+++..... ....+||+.|+|||++.+..++.++|||||||++|||++|..||.........
T Consensus 151 g~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~------------- 212 (318)
T 1fot_A 151 GFAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY------------- 212 (318)
T ss_dssp SSCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-------------
T ss_pred CcceecCCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH-------------
Confidence 999865432 23568999999999999999999999999999999999999999764322111
Q ss_pred hhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 014363 319 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRP-----KMSEVLEM 365 (426)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~ 365 (426)
..++...+ .++..++..+.+++.+||+.||++|| ++++|++|
T Consensus 213 ---~~i~~~~~--~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 213 ---EKILNAEL--RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp ---HHHHHCCC--CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ---HHHHhCCC--CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 11111111 12234567899999999999999999 89999876
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=353.45 Aligned_cols=266 Identities=15% Similarity=0.220 Sum_probs=214.3
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhc-CCCCccceEeEEEccCCCCc
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDERGI 162 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~~~~ 162 (426)
.++|.+.+.||+|+||.||+|.+..++ ..||+|.+......+.+.+|+.++..+ +|+||+++++++.+..
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~---- 79 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNN-----QQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGL---- 79 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTT-----EEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETT----
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCC-----cEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCc----
Confidence 457999999999999999999976554 489999987776667899999999999 8999999999987765
Q ss_pred eEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCC-----eeEee
Q 014363 163 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWN-----AKLSD 237 (426)
Q Consensus 163 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~-----~kl~D 237 (426)
..++||||+ +++|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++. +||+|
T Consensus 80 ~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~D 154 (298)
T 1csn_A 80 HNVLVIDLL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVD 154 (298)
T ss_dssp EEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECC
T ss_pred eeEEEEEec-CCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEE
Confidence 459999999 999999997543 3489999999999999999999998 9999999999999987776 99999
Q ss_pred ecccccCCCCCce-----eeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHh
Q 014363 238 FGLARLGPSEGFT-----HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK 312 (426)
Q Consensus 238 FGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~ 312 (426)
||++......... .......||+.|+|||++.+..++.++||||||+++|+|++|..||................
T Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 234 (298)
T 1csn_A 155 FGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG 234 (298)
T ss_dssp CTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHH
T ss_pred CccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHH
Confidence 9999866543221 11345679999999999999999999999999999999999999998755433332222111
Q ss_pred hhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhh
Q 014363 313 PYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 373 (426)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~ 373 (426)
..... ..... ....++..+.+++.+||+.||++||++++|++.|+.+....
T Consensus 235 ~~~~~-~~~~~---------~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~ 285 (298)
T 1csn_A 235 EKKQS-TPLRE---------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 285 (298)
T ss_dssp HHHHH-SCHHH---------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred hhccC-ccHHH---------HHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhc
Confidence 10000 00000 01124568999999999999999999999999999988654
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=368.76 Aligned_cols=251 Identities=24% Similarity=0.349 Sum_probs=190.6
Q ss_pred HhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCc
Q 014363 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 162 (426)
Q Consensus 83 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~ 162 (426)
..++|.+.+.||+|+||.||+|.+..++. .||+|.+......+.+.+|+.+|..++||||+++++++.+..
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~-----~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---- 121 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQK-----PYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPT---- 121 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCC-----EEEEEEEEC----------CHHHHHCCCTTBCCEEEEEECSS----
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCc-----EEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEecCC----
Confidence 35689999999999999999999876654 799999987666677889999999999999999999998765
Q ss_pred eEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCC---CCCeeEeeec
Q 014363 163 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE---QWNAKLSDFG 239 (426)
Q Consensus 163 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~---~~~~kl~DFG 239 (426)
..++||||+++|+|.+++... ..+++..++.++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||
T Consensus 122 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg 196 (349)
T 2w4o_A 122 EISLVLELVTGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFG 196 (349)
T ss_dssp EEEEEECCCCSCBHHHHHTTC--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC
T ss_pred eEEEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCc
Confidence 459999999999999999754 3489999999999999999999998 9999999999999975 8899999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014363 240 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 319 (426)
Q Consensus 240 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 319 (426)
++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||........ ...
T Consensus 197 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~---------- 261 (349)
T 2w4o_A 197 LSKIVEHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF--MFR---------- 261 (349)
T ss_dssp -------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH--HHH----------
T ss_pred cccccCccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH--HHH----------
Confidence 998654321 23456799999999999999999999999999999999999999975443211 111
Q ss_pred hhhhhcCCc--CCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 320 QFRQIVDPR--LEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 320 ~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.+.... ........++..+.+|+.+||+.||++|||+.|++++
T Consensus 262 ---~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 262 ---RILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp ---HHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ---HHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111110 1111122356789999999999999999999999985
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=377.50 Aligned_cols=254 Identities=24% Similarity=0.331 Sum_probs=206.1
Q ss_pred HHhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-----CCHHHHHHHHHHHhhcCCCCccceEeEEEc
Q 014363 82 SATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-----GGHKEWMTEVNFLGIVEHQNLVKLVGYCAD 156 (426)
Q Consensus 82 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 156 (426)
...++|..+++||+|+||.||+|.++.++. .||+|.+... .....+.+|+.++..++||||+++++++.+
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~-----~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRK-----VYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCC-----EEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred cCccccEEEEEEEcCCCEEEEEEEECCCCc-----EEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 346789999999999999999999887654 7999988542 234468899999999999999999999987
Q ss_pred cCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEe
Q 014363 157 DDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLS 236 (426)
Q Consensus 157 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~ 236 (426)
.. ..||||||++||+|.+++... .+++..++.++.||+.||+|||++ +|+||||||+|||++.+|.+||+
T Consensus 141 ~~----~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~ 210 (410)
T 3v8s_A 141 DR----YLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLA 210 (410)
T ss_dssp SS----EEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEEC
T ss_pred CC----EEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEe
Confidence 65 459999999999999998643 389999999999999999999998 99999999999999999999999
Q ss_pred eecccccCCCCCceeeeeeeecCcccCCchhhccCC----CCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHh
Q 014363 237 DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGR----LAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK 312 (426)
Q Consensus 237 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~ 312 (426)
|||+++....... ......+||+.|+|||++.+.. |+.++|||||||++|||++|..||...........+.
T Consensus 211 DFG~a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~--- 286 (410)
T 3v8s_A 211 DFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM--- 286 (410)
T ss_dssp CCTTCEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH---
T ss_pred ccceeEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHH---
Confidence 9999987654432 2234678999999999998765 7899999999999999999999997654322111110
Q ss_pred hhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 014363 313 PYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNART--RPKMSEVLEM 365 (426)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~eil~~ 365 (426)
... ....-+ ....++..+.+||.+||+.+|.+ ||+++||++|
T Consensus 287 ---~~~---~~~~~p-----~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 287 ---NHK---NSLTFP-----DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp ---THH---HHCCCC-----TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred ---hcc---ccccCC-----CcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 000 000000 01124578999999999999988 9999999987
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=353.76 Aligned_cols=252 Identities=27% Similarity=0.500 Sum_probs=204.3
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC---------HHHHHHHHHHHhhcCCCCccceEeEE
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG---------HKEWMTEVNFLGIVEHQNLVKLVGYC 154 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~---------~~~~~~E~~~l~~l~HpnIv~~~~~~ 154 (426)
.++|...+.||+|+||.||+|.+..++. .||+|.+..... .+.+.+|+.+++.++||||+++++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 92 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKS-----VVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM 92 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCC-----EEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred hccceehhccccCCceeEEEEEEcCCce-----EEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheee
Confidence 3579999999999999999999876654 799999854321 15788999999999999999999998
Q ss_pred EccCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCC--eEeccCCCCceEeCCCCC
Q 014363 155 ADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQ--IIVRDFKSSNILLDEQWN 232 (426)
Q Consensus 155 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~--iiHrDlkp~NILl~~~~~ 232 (426)
.+.. ++||||+++|+|.+++.... ..+++..++.++.|++.||+|||++ + |+||||||+|||++.++.
T Consensus 93 ~~~~------~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~ 162 (287)
T 4f0f_A 93 HNPP------RMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDE 162 (287)
T ss_dssp TTTT------EEEEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCT
T ss_pred cCCC------eEEEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCC
Confidence 6644 79999999999998886543 4589999999999999999999998 8 999999999999988776
Q ss_pred -----eeEeeecccccCCCCCceeeeeeeecCcccCCchhhc--cCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhH
Q 014363 233 -----AKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQ--TGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQ 305 (426)
Q Consensus 233 -----~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~ 305 (426)
+||+|||++...... .....||+.|+|||++. ...++.++||||||+++|+|++|..||.........
T Consensus 163 ~~~~~~kl~Dfg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 237 (287)
T 4f0f_A 163 NAPVCAKVADFGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK 237 (287)
T ss_dssp TCSCCEEECCCTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH
T ss_pred CCceeEEeCCCCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHH
Confidence 999999999754331 34467999999999984 455788999999999999999999999765443221
Q ss_pred HHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHh
Q 014363 306 KLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 369 (426)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~ 369 (426)
... ...........+..+++.+.+++.+||+.||++|||+.|+++.|+++
T Consensus 238 ~~~--------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 238 FIN--------------MIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HHH--------------HHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred HHH--------------HHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 111 11111222223344567899999999999999999999999999753
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=360.60 Aligned_cols=279 Identities=24% Similarity=0.381 Sum_probs=208.9
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC--CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
.++|++++.||+|+||.||+|.+... .......||+|.+.... ..+.+.+|+.++..++||||+++++++...+..
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~- 86 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPL-QDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR- 86 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTT-CSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT-
T ss_pred HHHhhhhheeeccCCEEEEEEEEecc-cCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC-
Confidence 45789999999999999999986432 22344689999986543 235788999999999999999999998764322
Q ss_pred ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccc
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 241 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 241 (426)
..++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 87 -~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~ 161 (295)
T 3ugc_A 87 -NLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLT 161 (295)
T ss_dssp -SCEEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred -ceEEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCccc
Confidence 2489999999999999997543 3489999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCc-eeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhh---h
Q 014363 242 RLGPSEGF-THVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS---D 317 (426)
Q Consensus 242 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~ 317 (426)
........ ........|+..|+|||++.+..++.++||||||+++|+|++|..|+...... .......... .
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~----~~~~~~~~~~~~~~ 237 (295)
T 3ugc_A 162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE----FMRMIGNDKQGQMI 237 (295)
T ss_dssp C-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH----HHHHHCTTCCTHHH
T ss_pred ccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH----HHhhhcCccccchh
Confidence 86543221 11223345778899999999999999999999999999999999998643211 1110000000 0
Q ss_pred hhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhh
Q 014363 318 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 373 (426)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~ 373 (426)
.......+........+..++..+.+++.+||+.||++|||+.||++.|+.+.+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 238 VFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 00111111111122233456678999999999999999999999999999987653
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-47 Score=370.93 Aligned_cols=263 Identities=26% Similarity=0.473 Sum_probs=199.4
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
.++|.+.+.||+|+||.||+|.+.... .....||+|.+.... ..+.+.+|+.+|.+++||||+++++++.+....
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 121 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPS--KKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV 121 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTT--SCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCC--CCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCce
Confidence 357999999999999999999876322 123469999986543 335688999999999999999999999876643
Q ss_pred CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecc
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 240 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 240 (426)
++||||+++|+|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 122 ----~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 193 (373)
T 2qol_A 122 ----MIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGL 193 (373)
T ss_dssp ----EEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC--
T ss_pred ----EEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCcc
Confidence 99999999999999997543 3589999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCcee-eeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014363 241 ARLGPSEGFTH-VSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDA 318 (426)
Q Consensus 241 a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 318 (426)
++......... ......+++.|+|||++.+..++.++||||||+++|||++ |..||......... ..+
T Consensus 194 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~---~~i------- 263 (373)
T 2qol_A 194 GRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI---KAV------- 263 (373)
T ss_dssp --------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHH---HHH-------
T ss_pred ccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHH-------
Confidence 98654332111 1222346788999999999999999999999999999998 99999765432211 111
Q ss_pred hhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhh
Q 014363 319 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 373 (426)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~ 373 (426)
........+..++..+.+++.+||+.||++||++.+|++.|+.+....
T Consensus 264 -------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 264 -------DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp -------HTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred -------HcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 001111122245578999999999999999999999999999987653
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-47 Score=369.46 Aligned_cols=250 Identities=26% Similarity=0.374 Sum_probs=205.5
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-----CCHHHHHHHHHHHhhcCCCCccceEeEEEccC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-----GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 158 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 158 (426)
.++|.+++.||+|+||.||+|.+..++. .||+|.+... .....+.+|+.+|..++|||||++++++.+..
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~-----~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 88 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKK-----MYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE 88 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCC-----EEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCC-----EEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 3579999999999999999999887654 7999988533 34567889999999999999999999998766
Q ss_pred CCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeee
Q 014363 159 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 238 (426)
Q Consensus 159 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 238 (426)
..|+||||++||+|.+++... ..+++..++.++.||+.||.|||++ ||+||||||+|||++.+|.+||+||
T Consensus 89 ----~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DF 159 (384)
T 4fr4_A 89 ----DMFMVVDLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDF 159 (384)
T ss_dssp ----EEEEEECCCTTEEHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred ----EEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEecc
Confidence 459999999999999999754 3499999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCchhhcc---CCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhh
Q 014363 239 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT---GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYL 315 (426)
Q Consensus 239 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 315 (426)
|++....... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.................
T Consensus 160 G~a~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~-- 234 (384)
T 4fr4_A 160 NIAAMLPRET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET-- 234 (384)
T ss_dssp TTCEECCTTC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH--
T ss_pred ceeeeccCCC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh--
Confidence 9998764332 2345789999999999864 4589999999999999999999999976544333322221110
Q ss_pred hhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCC-HHHHHHH
Q 014363 316 SDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPK-MSEVLEM 365 (426)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-~~eil~~ 365 (426)
....++..++..+.+||.+||+.||++||+ +++|+++
T Consensus 235 -------------~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~h 272 (384)
T 4fr4_A 235 -------------TVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNF 272 (384)
T ss_dssp -------------CCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred -------------cccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcC
Confidence 011223345678999999999999999998 7777764
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=385.25 Aligned_cols=257 Identities=25% Similarity=0.450 Sum_probs=213.6
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCc
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 162 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~ 162 (426)
..+|...+.||+|+||.||+|.++..+ ..||+|.+.... ..+.+.+|+.+|+.++||||+++++++.+....
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~-----~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~-- 291 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYS-----LTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF-- 291 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGT-----EEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC--
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCC-----eEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcE--
Confidence 456888999999999999999987643 489999987553 567899999999999999999999999876644
Q ss_pred eEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccc
Q 014363 163 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 242 (426)
Q Consensus 163 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 242 (426)
||||||+++|+|.+++.......+++..++.|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 292 --~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 366 (495)
T 1opk_A 292 --YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSR 366 (495)
T ss_dssp --EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEE
T ss_pred --EEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccce
Confidence 9999999999999999765556689999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhh
Q 014363 243 LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 321 (426)
Q Consensus 243 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (426)
....... .......+++.|+|||++.+..++.++|||||||++|||++ |..||...........
T Consensus 367 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~-------------- 431 (495)
T 1opk_A 367 LMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL-------------- 431 (495)
T ss_dssp CCTTCCE-ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH--------------
T ss_pred eccCCce-eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH--------------
Confidence 7654322 22233456789999999999999999999999999999999 9999976543321111
Q ss_pred hhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhH
Q 014363 322 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIV 370 (426)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~ 370 (426)
+........+..++..+.+||.+||+.||++|||+.+|++.|+.+.
T Consensus 432 ---~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 432 ---LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp ---HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred ---HHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 1111111223345678999999999999999999999999998765
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=356.17 Aligned_cols=257 Identities=25% Similarity=0.451 Sum_probs=206.8
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCc
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 162 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~ 162 (426)
.++|...+.||+|+||.||+|.+... ..||+|.+.... ..+.+.+|+.++..++||||+++++++.+...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~------~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~--- 93 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQ------YDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRP--- 93 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTT------EEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS---
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCC------CeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCC---
Confidence 45789999999999999999987653 269999987554 56789999999999999999999999977653
Q ss_pred eEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccc
Q 014363 163 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 242 (426)
Q Consensus 163 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 242 (426)
.++||||+++++|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++.
T Consensus 94 -~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 168 (283)
T 3gen_A 94 -IFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSR 168 (283)
T ss_dssp -EEEEECCCTTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGG
T ss_pred -eEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccc
Confidence 499999999999999997532 3489999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhh
Q 014363 243 LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 321 (426)
Q Consensus 243 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (426)
....... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...........+
T Consensus 169 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~------------- 234 (283)
T 3gen_A 169 YVLDDEY-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI------------- 234 (283)
T ss_dssp GBCCHHH-HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH-------------
T ss_pred ccccccc-ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHH-------------
Confidence 6543211 11223456788999999999999999999999999999998 99999765432211111
Q ss_pred hhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 014363 322 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 372 (426)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~ 372 (426)
... .....+...+..+.+++.+||+.||++|||+.+++++|.++.+.
T Consensus 235 ~~~----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 235 AQG----LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp HTT----CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hcc----cCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 111 11111223456899999999999999999999999999998764
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=368.32 Aligned_cols=249 Identities=23% Similarity=0.374 Sum_probs=204.8
Q ss_pred HhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-----CCHHHHHHHHHHHhhc-CCCCccceEeEEEc
Q 014363 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-----GGHKEWMTEVNFLGIV-EHQNLVKLVGYCAD 156 (426)
Q Consensus 83 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-----~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~ 156 (426)
..++|...+.||+|+||.||+|.++.++. .||+|.+... .....+..|..++..+ +||||+++++++.+
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~ 89 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQ-----FFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT 89 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTE-----EEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCC-----EEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe
Confidence 45789999999999999999999876553 8999998643 3456788999999887 99999999999987
Q ss_pred cCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEe
Q 014363 157 DDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLS 236 (426)
Q Consensus 157 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~ 236 (426)
.. ..|+||||++||+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.+|.+||+
T Consensus 90 ~~----~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~ 160 (345)
T 1xjd_A 90 KE----NLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIA 160 (345)
T ss_dssp SS----EEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEEC
T ss_pred CC----EEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEe
Confidence 65 4599999999999999996533 489999999999999999999998 99999999999999999999999
Q ss_pred eecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhh
Q 014363 237 DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS 316 (426)
Q Consensus 237 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 316 (426)
|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++|..||...........+
T Consensus 161 DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i-------- 230 (345)
T 1xjd_A 161 DFGMCKENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI-------- 230 (345)
T ss_dssp CCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------
T ss_pred EChhhhhcccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH--------
Confidence 999998543222 1234578999999999999999999999999999999999999999765432111111
Q ss_pred hhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHH-HHHHH
Q 014363 317 DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMS-EVLEM 365 (426)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~-eil~~ 365 (426)
... ...++..++..+.+|+.+||+.||++||++. +|++|
T Consensus 231 --------~~~--~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~h 270 (345)
T 1xjd_A 231 --------RMD--NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 270 (345)
T ss_dssp --------HHC--CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred --------HhC--CCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence 000 0112233567899999999999999999998 77764
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-47 Score=376.27 Aligned_cols=253 Identities=21% Similarity=0.312 Sum_probs=203.6
Q ss_pred HhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccC
Q 014363 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 158 (426)
Q Consensus 83 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 158 (426)
..++|++.+.||+|+||.||+|.+..++. .+|+|.+.... ..+.+.+|+.+|+.++||||+++++++.+..
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~-----~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 83 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQ-----EYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEG 83 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTE-----EEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSS
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCc-----EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECC
Confidence 45689999999999999999999876653 78999886543 2356889999999999999999999998765
Q ss_pred CCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeC---CCCCeeE
Q 014363 159 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLD---EQWNAKL 235 (426)
Q Consensus 159 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~---~~~~~kl 235 (426)
..|+||||++||+|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||
T Consensus 84 ----~~~lv~E~~~gg~L~~~i~~~~--~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL 154 (444)
T 3soa_A 84 ----HHYLIFDLVTGGELFEDIVARE--YYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKL 154 (444)
T ss_dssp ----EEEEEECCCBCCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEE
T ss_pred ----EEEEEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEE
Confidence 4599999999999999887543 489999999999999999999998 999999999999998 4678999
Q ss_pred eeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhh
Q 014363 236 SDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYL 315 (426)
Q Consensus 236 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 315 (426)
+|||++....... ......+||+.|+|||++.+..|+.++|||||||++|+|++|..||........... +..
T Consensus 155 ~DFG~a~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~---i~~-- 227 (444)
T 3soa_A 155 ADFGLAIEVEGEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQ---IKA-- 227 (444)
T ss_dssp CCCSSCBCCCTTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHH--
T ss_pred ccCceeEEecCCC--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHH---HHh--
Confidence 9999998665432 223356899999999999999999999999999999999999999976443211111 100
Q ss_pred hhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 316 SDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.. ..........+++.+.+|+.+||+.||++|||+.|++++
T Consensus 228 -------~~--~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 228 -------GA--YDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp -------TC--CCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -------CC--CCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 00 001111112345789999999999999999999999986
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=379.25 Aligned_cols=261 Identities=23% Similarity=0.305 Sum_probs=208.1
Q ss_pred HHHHHHhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-----CCHHHHHHHHHHHhhcCCCCccceEe
Q 014363 78 AELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-----GGHKEWMTEVNFLGIVEHQNLVKLVG 152 (426)
Q Consensus 78 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~~ 152 (426)
.++....++|+.+++||+|+||+||+|.++.++ ..||+|++... .....+.+|+.++..++||||+++++
T Consensus 67 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~-----~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~ 141 (437)
T 4aw2_A 67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNAD-----KVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHY 141 (437)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTT-----EEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEE
T ss_pred hcccCChhheEEEEEEEeCCCEEEEEEEEcCCC-----cEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 334445678999999999999999999988754 37999998542 23345889999999999999999999
Q ss_pred EEEccCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCC
Q 014363 153 YCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWN 232 (426)
Q Consensus 153 ~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~ 232 (426)
+|.+.. ..||||||++||+|.+++.... ..+++..++.++.||+.||.|||+. +|+||||||+||||+.++.
T Consensus 142 ~~~~~~----~~~lV~Ey~~gg~L~~~l~~~~-~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~ 213 (437)
T 4aw2_A 142 AFQDDN----NLYLVMDYYVGGDLLTLLSKFE-DRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGH 213 (437)
T ss_dssp EEECSS----EEEEEECCCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSC
T ss_pred EEeeCC----EEEEEEecCCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCC
Confidence 998866 4599999999999999997532 3499999999999999999999998 9999999999999999999
Q ss_pred eeEeeecccccCCCCCceeeeeeeecCcccCCchhhc-----cCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHH
Q 014363 233 AKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQ-----TGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKL 307 (426)
Q Consensus 233 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~ 307 (426)
+||+|||+++....... ......+||+.|+|||++. .+.|+.++|||||||++|||++|..||...........
T Consensus 214 vkL~DFGla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~ 292 (437)
T 4aw2_A 214 IRLADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK 292 (437)
T ss_dssp EEECCCTTCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH
T ss_pred EEEcchhhhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHh
Confidence 99999999986654332 2234568999999999987 46689999999999999999999999986543222111
Q ss_pred HHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 014363 308 LQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNART--RPKMSEVLEM 365 (426)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~eil~~ 365 (426)
+. ... .....+.. ...++..+.+||.+||..+|++ ||+++|+++|
T Consensus 293 i~------~~~---~~~~~p~~----~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 293 IM------NHK---ERFQFPTQ----VTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp HH------THH---HHCCCCSS----CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred hh------hcc---ccccCCcc----cccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 10 000 00101111 1124578999999999888888 9999999986
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-47 Score=372.18 Aligned_cols=255 Identities=24% Similarity=0.384 Sum_probs=202.7
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-----CHHHHHHHHHHHhhc-CCCCccceEeEEEcc
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-----GHKEWMTEVNFLGIV-EHQNLVKLVGYCADD 157 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-----~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~ 157 (426)
.++|+++++||+|+||.||+|.++.++. .||+|++.... ....+..|..+|.++ +||||+++++++.+.
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~-----~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~ 125 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDR-----IYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE 125 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTE-----EEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCC-----EEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEEC
Confidence 4579999999999999999999887653 79999986432 234578999999887 899999999999876
Q ss_pred CCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEee
Q 014363 158 DERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 237 (426)
Q Consensus 158 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~D 237 (426)
. ..|+||||++||+|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+||||+.+|.+||+|
T Consensus 126 ~----~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~D 196 (396)
T 4dc2_A 126 S----RLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTD 196 (396)
T ss_dssp S----EEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECC
T ss_pred C----EEEEEEEcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEee
Confidence 5 459999999999999998654 3499999999999999999999998 999999999999999999999999
Q ss_pred ecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHH--HHHhHhhhh
Q 014363 238 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQK--LLQWVKPYL 315 (426)
Q Consensus 238 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~--~~~~~~~~~ 315 (426)
||+++...... ......+||+.|+|||++.+..|+.++|||||||++|||++|..||.......... ....
T Consensus 197 FGla~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~----- 269 (396)
T 4dc2_A 197 YGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDY----- 269 (396)
T ss_dssp CTTCBCCCCTT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHH-----
T ss_pred cceeeecccCC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHH-----
Confidence 99998533222 22456789999999999999999999999999999999999999996432211100 0000
Q ss_pred hhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCH------HHHHHH
Q 014363 316 SDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKM------SEVLEM 365 (426)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~------~eil~~ 365 (426)
....+....+ .++..++..+.+||.+||+.||++||++ .||++|
T Consensus 270 ----~~~~i~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 270 ----LFQVILEKQI--RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp ----HHHHHHHCCC--CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred ----HHHHHhcccc--CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 0111111111 2333456789999999999999999995 677765
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-47 Score=356.30 Aligned_cols=260 Identities=25% Similarity=0.455 Sum_probs=216.7
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCc
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 162 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~ 162 (426)
.++|+..+.||+|+||.||+|.+...+ ..||+|.+.... ..+.+.+|+.+++.++||||+++++++.+...
T Consensus 12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~--- 83 (288)
T 3kfa_A 12 RTDITMKHKLGGGQYGEVYEGVWKKYS-----LTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP--- 83 (288)
T ss_dssp GGGEEEEEESGGGTTCSEEEEEEGGGT-----EEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS---
T ss_pred ccceeEEeecCCCCceeEEEeEecCCC-----EEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC---
Confidence 467899999999999999999987654 379999987554 34678999999999999999999999977653
Q ss_pred eEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccc
Q 014363 163 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 242 (426)
Q Consensus 163 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 242 (426)
.++||||+++++|.+++.......+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++.
T Consensus 84 -~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~ 159 (288)
T 3kfa_A 84 -FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSR 159 (288)
T ss_dssp -EEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGG
T ss_pred -EEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccce
Confidence 49999999999999999876666799999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhh
Q 014363 243 LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 321 (426)
Q Consensus 243 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (426)
....... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||............
T Consensus 160 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~------------- 225 (288)
T 3kfa_A 160 LMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL------------- 225 (288)
T ss_dssp TSCSSSS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH-------------
T ss_pred eccCCcc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------------
Confidence 7654332 22344567899999999999999999999999999999999 99999765433222111
Q ss_pred hhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhh
Q 014363 322 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 373 (426)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~ 373 (426)
........+..++..+.+++.+||+.||++|||+.++++.|+.+....
T Consensus 226 ----~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 226 ----EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp ----HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ----hccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 111111223345678999999999999999999999999999887653
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=366.51 Aligned_cols=252 Identities=22% Similarity=0.348 Sum_probs=204.1
Q ss_pred HhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccC
Q 014363 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 158 (426)
Q Consensus 83 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 158 (426)
..++|.+.+.||+|+||.||+|.++.++. .||+|.+.... ..+.+.+|+.+++.++||||+++++++.+..
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~-----~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~ 101 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGL-----EFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEES 101 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCC-----EEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCC-----EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC
Confidence 35689999999999999999999877654 89999986543 2356789999999999999999999998765
Q ss_pred CCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCC---CeeE
Q 014363 159 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW---NAKL 235 (426)
Q Consensus 159 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~---~~kl 235 (426)
..|+||||+++|+|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++ .+||
T Consensus 102 ----~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl 172 (362)
T 2bdw_A 102 ----FHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKL 172 (362)
T ss_dssp ----EEEEEECCCCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEE
T ss_pred ----EEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEE
Confidence 459999999999999998654 3489999999999999999999998 999999999999998654 5999
Q ss_pred eeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhh
Q 014363 236 SDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYL 315 (426)
Q Consensus 236 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 315 (426)
+|||++....... .....+||+.|+|||++.+..|+.++|||||||++|+|++|..||....... +...+..
T Consensus 173 ~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~---~~~~i~~-- 244 (362)
T 2bdw_A 173 ADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR---LYAQIKA-- 244 (362)
T ss_dssp CCCTTCBCCTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHH--
T ss_pred eecCcceEecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHHh--
Confidence 9999998665332 1234689999999999999999999999999999999999999997643321 1111100
Q ss_pred hhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 316 SDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
. ...........++..+.+|+.+||+.||++|||+.|++++
T Consensus 245 -~--------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 245 -G--------AYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp -T--------CCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -C--------CCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 0000111112356789999999999999999999999876
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=352.63 Aligned_cols=260 Identities=27% Similarity=0.469 Sum_probs=210.6
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCc
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 162 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~ 162 (426)
.++|.+.+.||+|+||.||+|.+.+. ..|++|.+.... ..+.+.+|+.+++.++||||+++++++.+..
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~------~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---- 81 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGH------TKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEP---- 81 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTT------EEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS----
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCC------cEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcCCC----
Confidence 45788999999999999999987643 368999886543 5678899999999999999999999986432
Q ss_pred eEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccc
Q 014363 163 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 242 (426)
Q Consensus 163 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 242 (426)
.++||||+++++|.+++.......+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.
T Consensus 82 -~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 157 (279)
T 1qpc_A 82 -IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLAR 157 (279)
T ss_dssp -CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred -cEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccc
Confidence 38999999999999999754333589999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhh
Q 014363 243 LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 321 (426)
Q Consensus 243 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (426)
....... .......+++.|+|||++.+..++.++||||||+++|+|++ |..||......... ....
T Consensus 158 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~---~~~~--------- 224 (279)
T 1qpc_A 158 LIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI---QNLE--------- 224 (279)
T ss_dssp ECSSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH---HHHH---------
T ss_pred cccCccc-ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHH---HHHh---------
Confidence 7654322 22234457889999999998899999999999999999999 99999765432111 1100
Q ss_pred hhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhhcc
Q 014363 322 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASAE 375 (426)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~~~ 375 (426)
. ......+..++..+.+++.+||+.||++|||+.++++.|+.+......
T Consensus 225 -~----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 273 (279)
T 1qpc_A 225 -R----GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEG 273 (279)
T ss_dssp -T----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred -c----ccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccC
Confidence 0 011112234557899999999999999999999999999998876443
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=364.39 Aligned_cols=245 Identities=25% Similarity=0.353 Sum_probs=205.2
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-----CCHHHHHHHHHHHhhcCCCCccceEeEEEccC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-----GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 158 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 158 (426)
.++|..++.||+|+||.||+|.++.++. .||+|.+... ...+.+.+|+.+|..++||||+++++++.+..
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~-----~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 114 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGN-----HYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 114 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCC-----EEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCC-----EEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 3578999999999999999999876654 8999988543 34567889999999999999999999998765
Q ss_pred CCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeee
Q 014363 159 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 238 (426)
Q Consensus 159 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 238 (426)
..|+||||++||+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.+|.+||+||
T Consensus 115 ----~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DF 185 (350)
T 1rdq_E 115 ----NLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDF 185 (350)
T ss_dssp ----EEEEEEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred ----EEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEccc
Confidence 4599999999999999997543 489999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014363 239 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 318 (426)
Q Consensus 239 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 318 (426)
|+++..... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||..........
T Consensus 186 g~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~------------ 248 (350)
T 1rdq_E 186 GFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE------------ 248 (350)
T ss_dssp TTCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------------
T ss_pred ccceeccCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHH------------
Confidence 999865432 235689999999999999999999999999999999999999997654321111
Q ss_pred hhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 014363 319 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPK-----MSEVLEM 365 (426)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~eil~~ 365 (426)
.+....+ .++..++..+.++|.+||+.||++||+ +++|++|
T Consensus 249 ----~i~~~~~--~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 249 ----KIVSGKV--RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp ----HHHHCCC--CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred ----HHHcCCC--CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 1111111 122345678999999999999999998 8999876
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=357.26 Aligned_cols=278 Identities=27% Similarity=0.420 Sum_probs=215.1
Q ss_pred CCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC---HHHHHHHHHHHhhcCCCCccceEeEEEccCCCCce
Q 014363 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG---HKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQ 163 (426)
Q Consensus 87 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~ 163 (426)
|+.++.||+|+||.||+|.+... .......||+|.+..... .+.+.+|+.+++.++||||+++++++.+.+.. .
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~--~ 109 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPT-NDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAA--S 109 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSC-C--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTT--E
T ss_pred HhhhheecCCCCeEEEEEEEccC-CCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCc--e
Confidence 48899999999999999977543 233456899999976543 34688999999999999999999999876533 5
Q ss_pred EEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccccc
Q 014363 164 RLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL 243 (426)
Q Consensus 164 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 243 (426)
.++||||+++|+|.+++.... +++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++..
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 183 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKA 183 (318)
T ss_dssp EEEEECCCTTCBHHHHGGGSC---CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEEEecccCCcHHHHHhhCC---CCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcccccc
Confidence 699999999999999997543 89999999999999999999998 999999999999999999999999999987
Q ss_pred CCCCCce-eeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhh
Q 014363 244 GPSEGFT-HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFR 322 (426)
Q Consensus 244 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (426)
....... .......||+.|+|||++.+..++.++||||||+++|+|++|..||....... .....+.... .......
T Consensus 184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-~~~~~~~~~~-~~~~~~~ 261 (318)
T 3lxp_A 184 VPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-LELIGIAQGQ-MTVLRLT 261 (318)
T ss_dssp CCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-HHHHCSCCHH-HHHHHHH
T ss_pred ccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh-hhhhcccccc-hhHHHHH
Confidence 6543322 22344568899999999999899999999999999999999999986432110 0000000000 0011122
Q ss_pred hhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhhcc
Q 014363 323 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASAE 375 (426)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~~~ 375 (426)
..+........+..++..+.+|+.+||+.||++|||+.|+++.|+.+.+....
T Consensus 262 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~ 314 (318)
T 3lxp_A 262 ELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQG 314 (318)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC
T ss_pred HHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhcc
Confidence 22222223333445667899999999999999999999999999999877654
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-47 Score=371.90 Aligned_cols=258 Identities=21% Similarity=0.267 Sum_probs=196.0
Q ss_pred hCCCCCc-ceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhh-cCCCCccceEeEEEccCCCC
Q 014363 84 TKNFSRS-VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGI-VEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 84 ~~~y~~~-~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~-l~HpnIv~~~~~~~~~~~~~ 161 (426)
.++|... ++||+|+||.||+|.++.++. .||+|.+... ..+.+|+.++.+ .+||||+++++++.......
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~-----~vAiK~~~~~---~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~ 131 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQE-----KFALKMLQDC---PKARREVELHWRASQCPHIVRIVDVYENLYAGR 131 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCC-----EEEEEEEECS---HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCC-----EEEEEEeCcc---hhHHHHHHHHHHhcCCCCcceEeEEEeecccCC
Confidence 4467666 689999999999999877654 8999998643 567889998754 58999999999987633223
Q ss_pred ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCC---CCCeeEeee
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE---QWNAKLSDF 238 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~---~~~~kl~DF 238 (426)
...||||||++||+|.+++.......+++..++.|+.||+.||.|||++ +|+||||||+|||++. ++.+||+||
T Consensus 132 ~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DF 208 (400)
T 1nxk_A 132 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDF 208 (400)
T ss_dssp EEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred cEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEec
Confidence 3579999999999999999876556699999999999999999999998 9999999999999997 788999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhH-HHHHhHhhhhhh
Q 014363 239 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQ-KLLQWVKPYLSD 317 (426)
Q Consensus 239 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~ 317 (426)
|+++...... .....+||+.|+|||++.+..|+.++|||||||++|+|++|..||......... .....+..
T Consensus 209 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~---- 281 (400)
T 1nxk_A 209 GFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM---- 281 (400)
T ss_dssp TTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHH----
T ss_pred ccccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHc----
Confidence 9998654321 234568999999999999999999999999999999999999999765432110 00000000
Q ss_pred hhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014363 318 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMV 366 (426)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L 366 (426)
.. ..........++..+.+||.+||+.||++|||+.|+++|-
T Consensus 282 ----~~---~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 323 (400)
T 1nxk_A 282 ----GQ---YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 323 (400)
T ss_dssp ----TC---CCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred ----Cc---ccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 00 0001111123567899999999999999999999999974
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-47 Score=353.92 Aligned_cols=261 Identities=22% Similarity=0.391 Sum_probs=199.4
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC---HHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG---HKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
.++|++.+.||+|+||.||+|.+...+. ....|++|.+..... .+.+.+|+.+++.++||||+++++++.+.
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--- 88 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPEN--PALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN--- 88 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC----CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS---
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCC--CceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEccC---
Confidence 4578999999999999999999865432 345789999865432 35688999999999999999999998543
Q ss_pred CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecc
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 240 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 240 (426)
..|+||||+++++|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 89 --~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 162 (281)
T 1mp8_A 89 --PVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGL 162 (281)
T ss_dssp --SCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC---
T ss_pred --ccEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECcccc
Confidence 2389999999999999997543 3489999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014363 241 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAK 319 (426)
Q Consensus 241 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 319 (426)
+........ .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...........+
T Consensus 163 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i----------- 230 (281)
T 1mp8_A 163 SRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI----------- 230 (281)
T ss_dssp -----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH-----------
T ss_pred ccccCcccc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHH-----------
Confidence 986543321 11233457889999999999999999999999999999997 99999765433211111
Q ss_pred hhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhh
Q 014363 320 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 373 (426)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~ 373 (426)
... .....+..++..+.+++.+||+.||++|||+.|+++.|+.+....
T Consensus 231 -----~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 231 -----ENG-ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp -----HTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -----HcC-CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 000 011123345678999999999999999999999999999987653
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-47 Score=367.01 Aligned_cols=251 Identities=23% Similarity=0.362 Sum_probs=202.4
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-------CCHHHHHHHHHHHhhcCCCCccceEeEEEc
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-------GGHKEWMTEVNFLGIVEHQNLVKLVGYCAD 156 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-------~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 156 (426)
.++|++.+.||+|+||.||+|.++.++. .||+|.+... ...+.+.+|+.+++.++||||+++++++.+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 97 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQ-----QFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS 97 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCC-----EEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCC-----EEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 3579999999999999999999877654 8999987432 145678999999999999999999999987
Q ss_pred cCCCCceEEEEEeeCCCCChhhhccCC--CCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCC--
Q 014363 157 DDERGIQRLLVYEYMPNGSVDQYLSPK--SETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWN-- 232 (426)
Q Consensus 157 ~~~~~~~~~lv~E~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~-- 232 (426)
.. ..|+||||+++++|.+++... ....+++..++.++.||+.||+|||++ +|+||||||+|||++.++.
T Consensus 98 ~~----~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~ 170 (351)
T 3c0i_A 98 DG----MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSA 170 (351)
T ss_dssp TT----EEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTC
T ss_pred CC----EEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCC
Confidence 65 459999999999998877532 123489999999999999999999998 9999999999999987655
Q ss_pred -eeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhH
Q 014363 233 -AKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWV 311 (426)
Q Consensus 233 -~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~ 311 (426)
+||+|||++....... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||..... .+....
T Consensus 171 ~vkl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~i 244 (351)
T 3c0i_A 171 PVKLGGFGVAIQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE----RLFEGI 244 (351)
T ss_dssp CEEECCCTTCEECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH----HHHHHH
T ss_pred cEEEecCcceeEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH----HHHHHH
Confidence 9999999998765432 123456799999999999999999999999999999999999999976321 111110
Q ss_pred hhhhhhhhhhhhhcCCcCC--CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 312 KPYLSDAKQFRQIVDPRLE--GKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
...... ......++..+.+|+.+||+.||++|||+.|+++|
T Consensus 245 -------------~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 245 -------------IKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp -------------HHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -------------HcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 000000 00001245689999999999999999999999985
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=360.64 Aligned_cols=268 Identities=25% Similarity=0.431 Sum_probs=214.3
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCC--CCCcceEEEEEEccccCC---HHHHHHHHHHHhhc-CCCCccceEeEEEcc
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSE--DPSQKVEVAVKQLGRRGG---HKEWMTEVNFLGIV-EHQNLVKLVGYCADD 157 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~--~~~~~~~va~K~~~~~~~---~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~ 157 (426)
.++|.+.+.||+|+||.||+|.+.... .......||+|.+..... .+.+.+|+.+++.+ +||||+++++++.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 457899999999999999999986432 123455899999976543 34688999999999 999999999999876
Q ss_pred CCCCceEEEEEeeCCCCChhhhccCCCC--------------CccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCC
Q 014363 158 DERGIQRLLVYEYMPNGSVDQYLSPKSE--------------TILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSS 223 (426)
Q Consensus 158 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~--------------~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~ 223 (426)
... |+||||+++|+|.+++..... ..+++..++.++.||+.||.|||++ +|+||||||+
T Consensus 114 ~~~----~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~ 186 (334)
T 2pvf_A 114 GPL----YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 186 (334)
T ss_dssp SCC----EEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGG
T ss_pred Cce----EEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccc
Confidence 644 999999999999999975431 2489999999999999999999998 9999999999
Q ss_pred ceEeCCCCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCch
Q 014363 224 NILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPR 302 (426)
Q Consensus 224 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~ 302 (426)
|||++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 187 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 266 (334)
T 2pvf_A 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 266 (334)
T ss_dssp GEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred eEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH
Confidence 99999999999999999987655433333444567899999999998899999999999999999999 99999765432
Q ss_pred hhHHHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhhcc
Q 014363 303 SEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASAE 375 (426)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~~~ 375 (426)
..... +. .. .....+..++..+.+++.+||+.||++|||+.|++++|+.++.....
T Consensus 267 ~~~~~---~~----------~~----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~ 322 (334)
T 2pvf_A 267 ELFKL---LK----------EG----HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322 (334)
T ss_dssp HHHHH---HH----------HT----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred HHHHH---Hh----------cC----CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence 21111 10 00 01112233557899999999999999999999999999999876443
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=349.74 Aligned_cols=252 Identities=29% Similarity=0.473 Sum_probs=195.2
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC------CHHHHHHHHHHHhhcCCCCccceEeEEEcc
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG------GHKEWMTEVNFLGIVEHQNLVKLVGYCADD 157 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~------~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 157 (426)
.++|+..+.||+|+||.||+|.+.+ ..+|+|.+.... ..+.+.+|+.+++.++||||+++++++.+.
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 78 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWIG-------DEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKE 78 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEETT-------EEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC
T ss_pred hhheeeeeeeccCCCeEEEEEEEcC-------CeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 3578999999999999999998753 278999875432 245788999999999999999999999876
Q ss_pred CCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCC--------
Q 014363 158 DERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE-------- 229 (426)
Q Consensus 158 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~-------- 229 (426)
... ++||||+++++|.+++... .+++..++.++.|++.||.|||++...+|+||||||+|||++.
T Consensus 79 ~~~----~lv~e~~~~~~L~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~ 151 (271)
T 3dtc_A 79 PNL----CLVMEFARGGPLNRVLSGK---RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLS 151 (271)
T ss_dssp --C----EEEEECCTTEEHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCS
T ss_pred Cce----EEEEEcCCCCCHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEeccccccccc
Confidence 643 9999999999999998643 4899999999999999999999981112999999999999986
Q ss_pred CCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHH
Q 014363 230 QWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQ 309 (426)
Q Consensus 230 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~ 309 (426)
++.+||+|||++....... .....||+.|+|||++.+..++.++||||||+++|+|++|..||.........
T Consensus 152 ~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~---- 223 (271)
T 3dtc_A 152 NKILKITDFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVA---- 223 (271)
T ss_dssp SCCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHH----
T ss_pred CcceEEccCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH----
Confidence 7789999999997654322 22457999999999999999999999999999999999999999765422111
Q ss_pred hHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHh
Q 014363 310 WVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 369 (426)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~ 369 (426)
............+..++..+.+++.+||+.||++|||+.|++++|+.+
T Consensus 224 ------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 224 ------------YGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp ------------HHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred ------------HhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 111111222223344567899999999999999999999999999753
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=380.63 Aligned_cols=257 Identities=23% Similarity=0.431 Sum_probs=209.2
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCc
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 162 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~ 162 (426)
.++|...+.||+|+||.||+|.+... ..||+|.+.... ..+.+.+|+.+|+.++||||+++++++...
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~~~------~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~----- 255 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYNKH------TKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKE----- 255 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTT------EEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEECSS-----
T ss_pred hHHeEEEEEcccCCceEEEEEEECCc------cEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEeCC-----
Confidence 56788999999999999999998643 379999987543 567899999999999999999999998632
Q ss_pred eEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccc
Q 014363 163 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 242 (426)
Q Consensus 163 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 242 (426)
..|+||||+++|+|.+++.......+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 256 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 332 (454)
T 1qcf_A 256 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLAR 332 (454)
T ss_dssp SCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGG
T ss_pred ccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCce
Confidence 248999999999999999755434588999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhh
Q 014363 243 LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 321 (426)
Q Consensus 243 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (426)
........ ......+|+.|+|||++..+.++.++|||||||++|||++ |..||........... +.
T Consensus 333 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~---i~--------- 399 (454)
T 1qcf_A 333 VIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA---LE--------- 399 (454)
T ss_dssp GBCCHHHH-TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH---HH---------
T ss_pred EcCCCcee-ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH---HH---------
Confidence 75432111 1123456789999999999999999999999999999999 9999976543221111 10
Q ss_pred hhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 014363 322 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 372 (426)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~ 372 (426)
. ......+..++..+.+||.+||+.||++|||+.+|++.|+.+...
T Consensus 400 -~----~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 400 -R----GYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp -H----TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred -c----CCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 0 011112234567899999999999999999999999999987644
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=358.22 Aligned_cols=255 Identities=20% Similarity=0.315 Sum_probs=199.6
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
.++|+..+.||+|+||.||+|.++.++. .||+|++.... ..+.+.+|+.+|+.++||||+++++++.+....
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~-----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 79 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDC-----NYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPE 79 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCC-----EEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSC
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCc-----EEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccc
Confidence 4679999999999999999999876554 89999986432 346789999999999999999999998765421
Q ss_pred -----------------------------------------------------CceEEEEEeeCCCCChhhhccCCCC-C
Q 014363 161 -----------------------------------------------------GIQRLLVYEYMPNGSVDQYLSPKSE-T 186 (426)
Q Consensus 161 -----------------------------------------------------~~~~~lv~E~~~~g~L~~~l~~~~~-~ 186 (426)
....++||||+++++|.+++..... .
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~ 159 (332)
T 3qd2_B 80 KWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLE 159 (332)
T ss_dssp HHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGG
T ss_pred hhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCcc
Confidence 1236999999999999999976543 3
Q ss_pred ccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccCCCCCce----------eeeeee
Q 014363 187 ILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFT----------HVSTAV 256 (426)
Q Consensus 187 ~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~----------~~~~~~ 256 (426)
..++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++......... ......
T Consensus 160 ~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (332)
T 3qd2_B 160 DREHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQ 236 (332)
T ss_dssp GSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSC
T ss_pred chhhHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhcccccccccccccccc
Confidence 456677899999999999999998 9999999999999999999999999999876543211 112345
Q ss_pred ecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCcccHH
Q 014363 257 VGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLR 336 (426)
Q Consensus 257 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (426)
.||+.|+|||++.+..++.++||||||+++|+|++|..|+.. ..... ...... ........
T Consensus 237 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-----~~~~~-------------~~~~~~-~~~~~~~~ 297 (332)
T 3qd2_B 237 VGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-----RVRII-------------TDVRNL-KFPLLFTQ 297 (332)
T ss_dssp C-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHHH-------------HHHHTT-CCCHHHHH
T ss_pred CCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-----HHHHH-------------HHhhcc-CCCccccc
Confidence 799999999999999999999999999999999998766421 01110 111111 11112234
Q ss_pred HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 337 LVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 337 ~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.++.+.+++.+||+.||++|||+.|++++
T Consensus 298 ~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 298 KYPQEHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HCHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred CChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence 55678999999999999999999999985
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-47 Score=378.33 Aligned_cols=258 Identities=26% Similarity=0.450 Sum_probs=205.5
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCc
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 162 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~ 162 (426)
.++|...+.||+|+||.||+|.+..+ ..||+|.+.... ..+.+.+|+.+|+.++||||+++++++.+ ..
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~------~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~--- 252 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGT------TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP--- 252 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT------EEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS---
T ss_pred hhHceeeeeecCCCCeEEEEEEECCC------ceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cc---
Confidence 45788899999999999999998753 269999987543 55789999999999999999999999865 22
Q ss_pred eEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccc
Q 014363 163 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 242 (426)
Q Consensus 163 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 242 (426)
.++||||+++|+|.+++.......+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 253 -~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~ 328 (452)
T 1fmk_A 253 -IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLAR 328 (452)
T ss_dssp -CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC
T ss_pred -eEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccce
Confidence 38999999999999999754334589999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhh
Q 014363 243 LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 321 (426)
Q Consensus 243 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (426)
....... .......++..|+|||++.++.++.++||||||+++|||++ |..||........... +
T Consensus 329 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~---i---------- 394 (452)
T 1fmk_A 329 LIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ---V---------- 394 (452)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH---H----------
T ss_pred ecCCCce-ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH---H----------
Confidence 6543221 11233457889999999999999999999999999999999 9999976543221111 0
Q ss_pred hhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhh
Q 014363 322 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 373 (426)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~ 373 (426)
........+..++..+.+||.+||+.||++|||+++|++.|+.+....
T Consensus 395 ----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 395 ----ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442 (452)
T ss_dssp ----HTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred ----HcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence 001111223345678999999999999999999999999999876543
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=349.67 Aligned_cols=253 Identities=23% Similarity=0.382 Sum_probs=206.2
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
.++|...+.||+|+||.||+|.+.+ ..+|+|.+.... ..+.+.+|+.+++.++||||+++++++.+...
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 81 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQG-------NDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPA 81 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEETT-------EEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTS
T ss_pred HHHhHHHHHhcCCCcceEEEEEECC-------eeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCC
Confidence 3578999999999999999999753 378999986543 23568899999999999999999999987632
Q ss_pred CCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCC--eEeccCCCCceEeCCCCCeeEee
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQ--IIVRDFKSSNILLDEQWNAKLSD 237 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~--iiHrDlkp~NILl~~~~~~kl~D 237 (426)
. ..++||||+++|+|.+++.......+++..++.++.|++.||.|||++ + |+||||||+|||++.++.++|+|
T Consensus 82 ~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~ 156 (271)
T 3kmu_A 82 P--HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISM 156 (271)
T ss_dssp S--SCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEG
T ss_pred C--CeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEe
Confidence 2 349999999999999999876655699999999999999999999997 7 99999999999999999999999
Q ss_pred ecccccCCCCCceeeeeeeecCcccCCchhhccCCCCC---chhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhh
Q 014363 238 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAA---RSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPY 314 (426)
Q Consensus 238 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 314 (426)
||++..... ....||+.|+|||++.+..++. ++||||||+++|+|++|..||..........
T Consensus 157 ~~~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-------- 221 (271)
T 3kmu_A 157 ADVKFSFQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGM-------- 221 (271)
T ss_dssp GGSCCTTSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHH--------
T ss_pred ccceeeecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHH--------
Confidence 988764322 2346899999999998766555 7999999999999999999997654322111
Q ss_pred hhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHh
Q 014363 315 LSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVD 371 (426)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~ 371 (426)
...........+..++..+.+++.+||+.||++|||+.++++.|+.+.+
T Consensus 222 --------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 222 --------KVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp --------HHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred --------HHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 1111111222333456789999999999999999999999999998753
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=352.90 Aligned_cols=264 Identities=22% Similarity=0.327 Sum_probs=199.5
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
++|+..+.||+|+||+||+|.+..++. .||+|.+.... ....+.+|+.+++.++||||+++++++.+..
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 74 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHE-----IVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK-- 74 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCC-----EEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT--
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCc-----eEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCC--
Confidence 578999999999999999999877654 79999886433 2356789999999999999999999998765
Q ss_pred CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecc
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 240 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 240 (426)
..++||||+++ +|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 75 --~~~lv~e~~~~-~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~ 147 (292)
T 3o0g_A 75 --KLTLVFEFCDQ-DLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGL 147 (292)
T ss_dssp --EEEEEEECCSE-EHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred --EEEEEEecCCC-CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeccc
Confidence 45999999976 555555432 23489999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCchhhccCC-CCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhh-hh
Q 014363 241 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGR-LAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS-DA 318 (426)
Q Consensus 241 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~ 318 (426)
+....... .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||......... +......... ..
T Consensus 148 ~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~-~~~i~~~~~~~~~ 224 (292)
T 3o0g_A 148 ARAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ-LKRIFRLLGTPTE 224 (292)
T ss_dssp CEECCSCC--SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH-HHHHHHHHCCCCT
T ss_pred ceecCCcc--ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHH-HHHHHHHhCCCCh
Confidence 98654322 1233467899999999988766 799999999999999999988886544332211 1111110000 00
Q ss_pred ---hhhhhhcC---------CcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 319 ---KQFRQIVD---------PRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 319 ---~~~~~~~~---------~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.......+ ..........++..+.+|+.+||+.||++|||++|+++|
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 225 EQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00000000 000011122456788999999999999999999999986
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=365.00 Aligned_cols=252 Identities=22% Similarity=0.325 Sum_probs=205.2
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC--CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
.++|.+.+.||+|+||.||+|.+..++. .+|+|.+.... ....+.+|+.+|+.++||||+++++++.+..
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~-----~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~--- 121 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGR-----VFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY--- 121 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCC-----EEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS---
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCC-----EEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCC---
Confidence 4689999999999999999999877654 78999886543 3346889999999999999999999998765
Q ss_pred ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCC--CCCeeEeeec
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE--QWNAKLSDFG 239 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~--~~~~kl~DFG 239 (426)
..++||||+++|+|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+|||++. ++.+||+|||
T Consensus 122 -~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG 196 (387)
T 1kob_A 122 -EMVLILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFG 196 (387)
T ss_dssp -EEEEEEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCT
T ss_pred -EEEEEEEcCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecc
Confidence 4599999999999999997543 3589999999999999999999998 9999999999999974 5779999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014363 240 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 319 (426)
Q Consensus 240 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 319 (426)
++........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||......... ..+..
T Consensus 197 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~---~~i~~------ 264 (387)
T 1kob_A 197 LATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL---QNVKR------ 264 (387)
T ss_dssp TCEECCTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH---HHHHH------
T ss_pred cceecCCCcc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHH---HHHHh------
Confidence 9987654322 23457999999999999999999999999999999999999999765332111 11100
Q ss_pred hhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 320 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
............++..+.+||.+||+.||++|||+.|++++
T Consensus 265 -----~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 265 -----CDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp -----CCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred -----CCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 00011111122356789999999999999999999999986
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-47 Score=361.61 Aligned_cols=285 Identities=22% Similarity=0.344 Sum_probs=214.3
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC--CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
.++|++.+.||+|+||.||+|.+... .......||+|.+.... ..+.+.+|+.+++.++||||+++++++...+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~- 99 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPL-GDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQ- 99 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTT-SSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSC-
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccC-CCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCc-
Confidence 35789999999999999999986432 22345689999986554 334689999999999999999999998865433
Q ss_pred ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccc
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 241 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 241 (426)
..++||||+++++|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 100 -~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 174 (327)
T 3lxl_A 100 -SLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLA 174 (327)
T ss_dssp -EEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGC
T ss_pred -eEEEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccc
Confidence 5699999999999999997432 3489999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCce-eeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhh
Q 014363 242 RLGPSEGFT-HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 320 (426)
Q Consensus 242 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (426)
......... .......||+.|+|||++.+..++.++||||||+++|+|++|..||........... ...........
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~--~~~~~~~~~~~ 252 (327)
T 3lxl_A 175 KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMM--GCERDVPALSR 252 (327)
T ss_dssp EECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHC--C----CCHHHH
T ss_pred eecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhc--ccccccccHHH
Confidence 876543322 223345688899999999999999999999999999999999999864321100000 00000001111
Q ss_pred hhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhhccCC
Q 014363 321 FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASAEAG 377 (426)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~~~~~ 377 (426)
....+........+..++..+.+|+.+||+.||++|||+.|++++|+.+........
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 309 (327)
T 3lxl_A 253 LLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCE 309 (327)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--------
T ss_pred HHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCcc
Confidence 222222222333344567889999999999999999999999999999887654443
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=352.02 Aligned_cols=258 Identities=29% Similarity=0.486 Sum_probs=194.3
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
.++|++.+.||+|+||.||+|.+.. .+|+|.+.... ..+.+.+|+.+++.++||||+++++++....
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~--------~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 93 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG--------DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQ- 93 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS--------EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS-
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC--------ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccCCc-
Confidence 4689999999999999999997543 48999886443 2356889999999999999999999764432
Q ss_pred CCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeec
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 239 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 239 (426)
.++||||+++++|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 94 ----~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg 165 (289)
T 3og7_A 94 ----LAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFG 165 (289)
T ss_dssp ----CEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC
T ss_pred ----cEEEEEecCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccce
Confidence 389999999999999996543 4589999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCchhhc---cCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhh
Q 014363 240 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQ---TGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS 316 (426)
Q Consensus 240 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 316 (426)
++................||+.|+|||++. +..++.++||||||+++|+|++|..||........ +......
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~~~--- 240 (289)
T 3og7_A 166 LATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--IIEMVGR--- 240 (289)
T ss_dssp ------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH--HHHHHHH---
T ss_pred eccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH--HHHHhcc---
Confidence 997654322223334567999999999986 56788899999999999999999999976543221 1111100
Q ss_pred hhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhH
Q 014363 317 DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIV 370 (426)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~ 370 (426)
....+. .......++..+.+|+.+||+.||++|||+.++++.|+++.
T Consensus 241 ------~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 241 ------GSLSPD-LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp ------TSCCCC-TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ------cccCcc-hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 001111 11122345678999999999999999999999999998875
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=364.12 Aligned_cols=267 Identities=22% Similarity=0.438 Sum_probs=213.3
Q ss_pred HHhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC---HHHHHHHHHHHhhcCCCCccceEeEEEccC
Q 014363 82 SATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG---HKEWMTEVNFLGIVEHQNLVKLVGYCADDD 158 (426)
Q Consensus 82 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 158 (426)
...++|.+.+.||+|+||.||+|.+...........||+|.+..... ...+.+|+.+++.++||||+++++++.+..
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 101 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 101 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCC
Confidence 34578999999999999999999877433334456899999875543 335789999999999999999999998766
Q ss_pred CCCceEEEEEeeCCCCChhhhccCCC--------CCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCC
Q 014363 159 ERGIQRLLVYEYMPNGSVDQYLSPKS--------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQ 230 (426)
Q Consensus 159 ~~~~~~~lv~E~~~~g~L~~~l~~~~--------~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~ 230 (426)
.. ++||||+++|+|.+++.... ...+++..++.++.|++.||.|||++ +|+||||||+|||++.+
T Consensus 102 ~~----~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~ 174 (322)
T 1p4o_A 102 PT----LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 174 (322)
T ss_dssp SC----EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTT
T ss_pred cc----EEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCC
Confidence 44 99999999999999986421 13468999999999999999999998 99999999999999999
Q ss_pred CCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHH
Q 014363 231 WNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQ 309 (426)
Q Consensus 231 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~ 309 (426)
+.+||+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |..||...........
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~-- 252 (322)
T 1p4o_A 175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF-- 252 (322)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHH--
T ss_pred CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHH--
Confidence 9999999999976543322222334567899999999999999999999999999999999 8999976533211111
Q ss_pred hHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 014363 310 WVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 372 (426)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~ 372 (426)
+..... ...+..++..+.+++.+||+.||++|||+.|++++|+.+...
T Consensus 253 --------------~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~ 300 (322)
T 1p4o_A 253 --------------VMEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300 (322)
T ss_dssp --------------HHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred --------------HHcCCc-CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence 111110 112234567899999999999999999999999999887543
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-47 Score=359.58 Aligned_cols=262 Identities=26% Similarity=0.371 Sum_probs=199.8
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-----CHHHHHHHHHHHhhcCCCCccceEeEEEccC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 158 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 158 (426)
.++|++.+.||+|+||.||+|.+..++ ..||+|.+.... ....+.+|+.++..++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 85 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDH-----RDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET 85 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTT-----EEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCC-----ceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC
Confidence 468999999999999999999986654 389999986542 1246789999999999999999999998776
Q ss_pred CCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeee
Q 014363 159 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 238 (426)
Q Consensus 159 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 238 (426)
..+...|+||||+++++|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Df 160 (311)
T 3ork_A 86 PAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDF 160 (311)
T ss_dssp TTEEEEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCC
T ss_pred CCCcccEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeec
Confidence 65556699999999999999996543 489999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCce-eeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh
Q 014363 239 GLARLGPSEGFT-HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 317 (426)
Q Consensus 239 Gla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 317 (426)
|++......... .......||+.|+|||++.+..++.++||||||+++|+|++|..||.......... .... .
T Consensus 161 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~--~~~~----~ 234 (311)
T 3ork_A 161 GIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY--QHVR----E 234 (311)
T ss_dssp SCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH--HHHH----C
T ss_pred cCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH--HHhc----C
Confidence 999865433211 22334679999999999999999999999999999999999999997654322111 1000 0
Q ss_pred hhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH-HHHh
Q 014363 318 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM-VNKI 369 (426)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~-L~~~ 369 (426)
...........++..+.+++.+||+.||++||++.+++.+ |...
T Consensus 235 --------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 235 --------DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp --------CCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred --------CCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 0000000011245689999999999999999987776654 4443
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=363.65 Aligned_cols=248 Identities=25% Similarity=0.394 Sum_probs=204.5
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-----CCHHHHHHHHHHHhhc-CCCCccceEeEEEcc
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-----GGHKEWMTEVNFLGIV-EHQNLVKLVGYCADD 157 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-----~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~ 157 (426)
.++|..+++||+|+||.||+|.++.++ ..||+|.+... ...+.+..|..+|..+ +||||+++++++.+.
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~-----~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~ 93 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTD-----ELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM 93 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEE-----EEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECS
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCC-----CEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcC
Confidence 568999999999999999999987643 48999998643 3456788999999988 899999999999876
Q ss_pred CCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEee
Q 014363 158 DERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 237 (426)
Q Consensus 158 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~D 237 (426)
+ ..|+||||++||+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.+|.+||+|
T Consensus 94 ~----~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~D 164 (353)
T 2i0e_A 94 D----RLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIAD 164 (353)
T ss_dssp S----EEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECC
T ss_pred C----EEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEe
Confidence 5 4699999999999999997533 489999999999999999999998 999999999999999999999999
Q ss_pred ecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh
Q 014363 238 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 317 (426)
Q Consensus 238 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 317 (426)
||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++|..||....... +..
T Consensus 165 FG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~---~~~-------- 231 (353)
T 2i0e_A 165 FGMCKENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---LFQ-------- 231 (353)
T ss_dssp CTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH--------
T ss_pred CCcccccccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH---HHH--------
Confidence 99998643222 12345789999999999999999999999999999999999999997643321 111
Q ss_pred hhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 014363 318 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPK-----MSEVLEM 365 (426)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~eil~~ 365 (426)
.++...+ .++..++..+.+|+.+||+.||++||+ +++|++|
T Consensus 232 -----~i~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 232 -----SIMEHNV--AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp -----HHHHCCC--CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred -----HHHhCCC--CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1111111 123345678999999999999999995 5788775
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=356.51 Aligned_cols=265 Identities=22% Similarity=0.285 Sum_probs=199.5
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
.++|++++.||+|+||.||+|.+..+ ..||+|.+.... ....+.+|+.+++.++||||+++++++.+..
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~- 92 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQG------RIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSER- 92 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTS------CEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSS-
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCC------CEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCC-
Confidence 57899999999999999999997542 279999886433 2356889999999999999999999998765
Q ss_pred CCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeec
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 239 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 239 (426)
..++||||+++ +|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 93 ---~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg 164 (311)
T 3niz_A 93 ---CLTLVFEFMEK-DLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFG 164 (311)
T ss_dssp ---CEEEEEECCSE-EHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred ---EEEEEEcCCCC-CHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCc
Confidence 35999999975 7888776543 4489999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHh-Hhh----
Q 014363 240 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQW-VKP---- 313 (426)
Q Consensus 240 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~-~~~---- 313 (426)
++........ ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+.. ...
T Consensus 165 ~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 242 (311)
T 3niz_A 165 LARAFGIPVR--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPR 242 (311)
T ss_dssp TCEETTSCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTT
T ss_pred CceecCCCcc--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChH
Confidence 9987643321 1234578999999999876 5689999999999999999999999976554332221111 000
Q ss_pred hhhhhhhhhhhcC---CcCCC----cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 314 YLSDAKQFRQIVD---PRLEG----KYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 314 ~~~~~~~~~~~~~---~~~~~----~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.+........... ..... .....++.++.+|+.+||+.||++|||++|+++|
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 243 EWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp TSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0000000000000 00000 0111244688999999999999999999999985
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=365.57 Aligned_cols=252 Identities=24% Similarity=0.343 Sum_probs=193.9
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCc
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 162 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~ 162 (426)
.++|.+.+.||+|+||.||+|.+..++. .||+|.+.... ..+.+.+|+.+++.++||||+++++++.+..
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~---- 89 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKE-----LVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPT---- 89 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCC-----EEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSS----
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCc-----EEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCC----
Confidence 4589999999999999999999886654 89999986543 3467889999999999999999999998765
Q ss_pred eEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCC--eeEeeecc
Q 014363 163 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWN--AKLSDFGL 240 (426)
Q Consensus 163 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~--~kl~DFGl 240 (426)
..|+||||+++|+|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++. +||+|||+
T Consensus 90 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~ 164 (361)
T 3uc3_A 90 HLAIIMEYASGGELYERICNAG--RFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGY 164 (361)
T ss_dssp EEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCC
T ss_pred EEEEEEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCc
Confidence 4599999999999999986433 489999999999999999999998 9999999999999987765 99999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCchhhccCCCCCc-hhhHHHHHHHHHHHhCCCCCCCCCchhh-HHHHHhHhhhhhhh
Q 014363 241 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAAR-SDVWSYGVFLYELITGRRPIDRNRPRSE-QKLLQWVKPYLSDA 318 (426)
Q Consensus 241 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslGvil~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~ 318 (426)
++..... ......+||+.|+|||++.+..++.+ +|||||||++|+|++|..||........ ....
T Consensus 165 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~---------- 231 (361)
T 3uc3_A 165 SKSSVLH---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTI---------- 231 (361)
T ss_dssp C------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHH----------
T ss_pred ccccccc---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHH----------
Confidence 9743322 12344679999999999988888765 8999999999999999999975432211 1111
Q ss_pred hhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 319 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
..+............++..+.+||.+||+.||++|||+.|+++|
T Consensus 232 ---~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 232 ---QRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp ---HHHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred ---HHHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 11111111111111245788999999999999999999999997
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-46 Score=354.31 Aligned_cols=268 Identities=22% Similarity=0.398 Sum_probs=202.6
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
.++|.+.+.||+|+||.||+|.+.... .....||+|.+.... ..+.+.+|+.+++.++||||+++++++.+...
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQED--GTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECTT--SCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred HHHeeeccceeecCCeEEEEEEEeccC--CceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 567899999999999999999876532 235579999986443 23568899999999999999999999987553
Q ss_pred CC-ceEEEEEeeCCCCChhhhccC----CCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCee
Q 014363 160 RG-IQRLLVYEYMPNGSVDQYLSP----KSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAK 234 (426)
Q Consensus 160 ~~-~~~~lv~E~~~~g~L~~~l~~----~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~k 234 (426)
.+ ...++||||+++|+|.+++.. .....+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~k 187 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVC 187 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEE
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEE
Confidence 21 245899999999999999842 2234589999999999999999999998 999999999999999999999
Q ss_pred EeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhh
Q 014363 235 LSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKP 313 (426)
Q Consensus 235 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~ 313 (426)
|+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||...........
T Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~------ 261 (313)
T 3brb_A 188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDY------ 261 (313)
T ss_dssp ECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH------
T ss_pred EeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHH------
Confidence 999999986544332223344567889999999999999999999999999999999 8899976543221111
Q ss_pred hhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhh
Q 014363 314 YLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 373 (426)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~ 373 (426)
+.. ......+..++..+.+++.+||+.||++|||+.+++++|+.++...
T Consensus 262 ----------~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 262 ----------LLH-GHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp ----------HHT-TCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ----------HHc-CCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 101 0111223345678999999999999999999999999999988654
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=352.08 Aligned_cols=254 Identities=27% Similarity=0.445 Sum_probs=202.7
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCce
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQ 163 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~ 163 (426)
.++|...+.||+|+||.||+|.+.+ ..|++|.+......+.+.+|+.+++.++||||+++++++.+... .
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---~ 89 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYRG-------NKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG---G 89 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-------EEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC-----C
T ss_pred hhhceEEeEEecCCCceEEEEEEcC-------CEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCC---c
Confidence 4578999999999999999998753 37999999877777889999999999999999999999765432 2
Q ss_pred EEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccccc
Q 014363 164 RLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL 243 (426)
Q Consensus 164 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 243 (426)
.++||||+++++|.+++.......+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~ 166 (278)
T 1byg_A 90 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKE 166 (278)
T ss_dssp CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC---
T ss_pred eEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccc
Confidence 48999999999999999754434478999999999999999999998 999999999999999999999999999875
Q ss_pred CCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhhh
Q 014363 244 GPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQFR 322 (426)
Q Consensus 244 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (426)
.... .....+++.|+|||++.+..++.++||||||+++|+|++ |..||..........
T Consensus 167 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~---------------- 225 (278)
T 1byg_A 167 ASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP---------------- 225 (278)
T ss_dssp --------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHH----------------
T ss_pred cccc-----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHH----------------
Confidence 4332 223467899999999999999999999999999999998 999997654321111
Q ss_pred hhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 014363 323 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 372 (426)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~ 372 (426)
.+........+..++..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 226 -~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 226 -RVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp -HHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -HHhcCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 0111111122334567899999999999999999999999999988754
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=349.79 Aligned_cols=263 Identities=21% Similarity=0.312 Sum_probs=196.7
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
++|...+.||+|+||.||+|.+..+ ..+|+|.+.... ....+.+|+.+++.++||||+++++++.+.+.
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~- 74 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYG------ETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR- 74 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTS------CEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC-
T ss_pred ccchhhhhcccCCCEEEEEEEcCCC------CEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCe-
Confidence 5789999999999999999987432 279999885433 23578899999999999999999999987653
Q ss_pred CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecc
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 240 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 240 (426)
.++||||+++ +|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 75 ---~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 146 (288)
T 1ob3_A 75 ---LVLVFEHLDQ-DLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGL 146 (288)
T ss_dssp ---EEEEEECCSE-EHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTH
T ss_pred ---EEEEEEecCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECcc
Confidence 5999999975 8988887543 3489999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHH-HhHhh----h
Q 014363 241 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLL-QWVKP----Y 314 (426)
Q Consensus 241 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~-~~~~~----~ 314 (426)
+....... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||...........+ ..... .
T Consensus 147 ~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 224 (288)
T 1ob3_A 147 ARAFGIPV--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKN 224 (288)
T ss_dssp HHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred ccccCccc--cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhh
Confidence 98654321 112345789999999998764 5899999999999999999999999765432221111 10000 0
Q ss_pred hhhhhhhhhhcCCcC-------CCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 315 LSDAKQFRQIVDPRL-------EGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 315 ~~~~~~~~~~~~~~~-------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
+........ .++.. ...+...++..+.+|+.+||+.||++|||++|++++
T Consensus 225 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 225 WPNVTELPK-YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp STTGGGSTT-CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred chhhhcccc-cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000000000 00000 001112356788999999999999999999999985
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=366.33 Aligned_cols=270 Identities=21% Similarity=0.267 Sum_probs=203.8
Q ss_pred hCCCCCcceeccc--CcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEcc
Q 014363 84 TKNFSRSVVIGEG--GFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADD 157 (426)
Q Consensus 84 ~~~y~~~~~lG~G--~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 157 (426)
.++|++++.||+| +||.||+|.+..++. .||+|.+.... ..+.+.+|+.+++.++|||||++++++.+.
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 98 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGE-----YVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD 98 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCC-----EEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCC-----EEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEEC
Confidence 4579999999999 999999999886654 89999986543 234677899999999999999999999876
Q ss_pred CCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEee
Q 014363 158 DERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 237 (426)
Q Consensus 158 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~D 237 (426)
. ..|+||||+++|+|.+++.......+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 99 ~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~d 171 (389)
T 3gni_B 99 N----ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSG 171 (389)
T ss_dssp T----EEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECC
T ss_pred C----EEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcc
Confidence 6 459999999999999999766555699999999999999999999998 999999999999999999999999
Q ss_pred ecccccCCCCCce-----eeeeeeecCcccCCchhhcc--CCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHH-HH
Q 014363 238 FGLARLGPSEGFT-----HVSTAVVGTMGYAAPEYVQT--GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKL-LQ 309 (426)
Q Consensus 238 FGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~-~~ 309 (426)
||++......+.. ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||........... ..
T Consensus 172 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 251 (389)
T 3gni_B 172 LRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN 251 (389)
T ss_dssp GGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--
T ss_pred cccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc
Confidence 9998654322111 11223478999999999987 5799999999999999999999999976543322110 00
Q ss_pred hHhhhhhhh-----hh-------------hhhhc---------CCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHH
Q 014363 310 WVKPYLSDA-----KQ-------------FRQIV---------DPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEV 362 (426)
Q Consensus 310 ~~~~~~~~~-----~~-------------~~~~~---------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei 362 (426)
...+.+... .. ..... .......+...++..+.+||.+||+.||++|||+.|+
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~el 331 (389)
T 3gni_B 252 GTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTL 331 (389)
T ss_dssp ------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHH
T ss_pred CCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 000000000 00 00000 0000111233456789999999999999999999999
Q ss_pred HHH
Q 014363 363 LEM 365 (426)
Q Consensus 363 l~~ 365 (426)
+++
T Consensus 332 l~h 334 (389)
T 3gni_B 332 LNH 334 (389)
T ss_dssp TTS
T ss_pred hcC
Confidence 986
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=353.22 Aligned_cols=275 Identities=23% Similarity=0.363 Sum_probs=210.1
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
..|+..+.||+|+||.||+|.+... .......||+|.+.... ..+.+.+|+.++..++||||+++++++.+.+..
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~- 98 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPE-GDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN- 98 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTT-SSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---C-
T ss_pred hhhhhhhccCCCCceEEEEEEEccc-cCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCc-
Confidence 4688899999999999999986432 23345689999986443 446789999999999999999999999876433
Q ss_pred ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccc
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 241 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 241 (426)
..++||||+++|+|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 99 -~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 99 -GIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLT 173 (302)
T ss_dssp -CEEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred -eEEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECccccc
Confidence 4589999999999999995432 3489999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCce-eeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhh--hhh
Q 014363 242 RLGPSEGFT-HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYL--SDA 318 (426)
Q Consensus 242 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~--~~~ 318 (426)
......... .......||..|+|||++.+..++.++||||||+++|+|++|..|+..... .......+.. ...
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~ 249 (302)
T 4e5w_A 174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMA----LFLKMIGPTHGQMTV 249 (302)
T ss_dssp EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH----HHHHHHCSCCGGGHH
T ss_pred ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhh----HHhhccCCcccccCH
Confidence 876543322 223455688899999999999999999999999999999999998643211 0000000000 001
Q ss_pred hhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhH
Q 014363 319 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIV 370 (426)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~ 370 (426)
......+........+..++..+.+|+.+||+.||++|||+.++++.|+.++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 250 TRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 1111111122222334456678999999999999999999999999999875
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-47 Score=372.93 Aligned_cols=260 Identities=23% Similarity=0.287 Sum_probs=206.2
Q ss_pred HHHHHHhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-----CCHHHHHHHHHHHhhcCCCCccceEe
Q 014363 78 AELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-----GGHKEWMTEVNFLGIVEHQNLVKLVG 152 (426)
Q Consensus 78 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~~ 152 (426)
.+.....++|+.+++||+|+||.||+|.++.++. .||+|.+... ...+.+.+|..++..++||||+++++
T Consensus 54 ~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~-----~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~ 128 (412)
T 2vd5_A 54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQ-----VYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHF 128 (412)
T ss_dssp HHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCC-----EEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEE
T ss_pred hhccCChhhEEEEEEEeeCCCeEEEEEEECCCCC-----EEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEE
Confidence 3344456789999999999999999999876654 8999998642 23345789999999999999999999
Q ss_pred EEEccCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCC
Q 014363 153 YCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWN 232 (426)
Q Consensus 153 ~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~ 232 (426)
++.+.. ..||||||++||+|.+++...+ ..+++..++.++.||+.||+|||++ +|+||||||+|||++.+|.
T Consensus 129 ~~~~~~----~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~ 200 (412)
T 2vd5_A 129 AFQDEN----YLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGH 200 (412)
T ss_dssp EEECSS----EEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSC
T ss_pred EEeeCC----EEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCC
Confidence 998865 4599999999999999997532 3489999999999999999999998 9999999999999999999
Q ss_pred eeEeeecccccCCCCCceeeeeeeecCcccCCchhhc-------cCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhH
Q 014363 233 AKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQ-------TGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQ 305 (426)
Q Consensus 233 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~ 305 (426)
+||+|||+++....... ......+||+.|+|||++. ...|+.++|||||||++|||++|..||.........
T Consensus 201 vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~ 279 (412)
T 2vd5_A 201 IRLADFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETY 279 (412)
T ss_dssp EEECCCTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH
T ss_pred EEEeechhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHH
Confidence 99999999987654332 2233568999999999987 356899999999999999999999999765432211
Q ss_pred HHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCC---CCHHHHHHH
Q 014363 306 KLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTR---PKMSEVLEM 365 (426)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R---Ps~~eil~~ 365 (426)
..+.. .. .....+ .....++.++.+||.+||. +|++| |+++||++|
T Consensus 280 ~~i~~------~~---~~~~~p----~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 280 GKIVH------YK---EHLSLP----LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp HHHHT------HH---HHCCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred HHHHh------cc---cCcCCC----ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 11100 00 000001 1122356789999999999 99998 699999886
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=365.35 Aligned_cols=275 Identities=21% Similarity=0.258 Sum_probs=210.5
Q ss_pred cccCHHHHHHHhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-CHHHHHHHHHHHhhcC-----CCC
Q 014363 73 KEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-GHKEWMTEVNFLGIVE-----HQN 146 (426)
Q Consensus 73 ~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~E~~~l~~l~-----Hpn 146 (426)
..|++.+.....++|.+.+.||+|+||.||+|.+..++. .||+|.+.... ....+..|+.++..+. |||
T Consensus 23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~ 97 (360)
T 3llt_A 23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKK-----YYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNN 97 (360)
T ss_dssp GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCC-----EEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGG
T ss_pred eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCe-----EEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCC
Confidence 344444444557899999999999999999999876654 89999986532 3456778999999986 999
Q ss_pred ccceEeEEEccCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceE
Q 014363 147 LVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNIL 226 (426)
Q Consensus 147 Iv~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NIL 226 (426)
|+++++++...+ ..++||||+ +++|.+++.......+++..++.++.||+.||+|||++ +|+||||||+|||
T Consensus 98 iv~~~~~~~~~~----~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIl 169 (360)
T 3llt_A 98 IVKYHGKFMYYD----HMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENIL 169 (360)
T ss_dssp BCCEEEEEEETT----EEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred eecccceeeECC----eeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEE
Confidence 999999998865 459999999 99999999876655699999999999999999999998 9999999999999
Q ss_pred eCC-------------------------CCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHH
Q 014363 227 LDE-------------------------QWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWS 281 (426)
Q Consensus 227 l~~-------------------------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws 281 (426)
++. ++.+||+|||++...... .....||+.|+|||++.+..++.++||||
T Consensus 170 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Diws 244 (360)
T 3llt_A 170 LDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWS 244 (360)
T ss_dssp ESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHH
T ss_pred EccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHH
Confidence 975 788999999999865432 23467999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhh-------hhhhhcC-CcC----C----------------Ccc
Q 014363 282 YGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK-------QFRQIVD-PRL----E----------------GKY 333 (426)
Q Consensus 282 lGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~-~~~----~----------------~~~ 333 (426)
|||++|+|++|..||...........+........... .....++ ... . ..+
T Consensus 245 lG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 324 (360)
T 3llt_A 245 FGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLY 324 (360)
T ss_dssp HHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHH
T ss_pred HHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhccccc
Confidence 99999999999999986554332222221110000000 0000000 000 0 000
Q ss_pred cHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 334 SLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 334 ~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.....+.+.+|+.+||+.||++|||+.|++++
T Consensus 325 ~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 356 (360)
T 3llt_A 325 KIIKHELFCDFLYSILQIDPTLRPSPAELLKH 356 (360)
T ss_dssp HHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred ccchHHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 01112678899999999999999999999875
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=362.47 Aligned_cols=246 Identities=25% Similarity=0.408 Sum_probs=202.5
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-----CCHHHHHHHHHHHhhcCCCCccceEeEEEccC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-----GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 158 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 158 (426)
.++|.+.+.||+|+||.||+|.+..++. .||+|.+... .....+.+|+.+++.++||||+++++++.+..
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 82 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQ-----KVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPT 82 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCC-----EEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCC-----EEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC
Confidence 4689999999999999999999876654 8999987532 23457889999999999999999999998765
Q ss_pred CCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeee
Q 014363 159 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 238 (426)
Q Consensus 159 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 238 (426)
..++||||+ +|+|.+++.... .+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+||
T Consensus 83 ----~~~lv~E~~-~g~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DF 152 (336)
T 3h4j_B 83 ----DIVMVIEYA-GGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADF 152 (336)
T ss_dssp ----EEEEEECCC-CEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCS
T ss_pred ----EEEEEEECC-CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEe
Confidence 459999999 789988886543 489999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCchhhccCCC-CCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh
Q 014363 239 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRL-AARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 317 (426)
Q Consensus 239 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 317 (426)
|++....... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.......
T Consensus 153 G~s~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~-------------- 215 (336)
T 3h4j_B 153 GLSNIMTDGN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN-------------- 215 (336)
T ss_dssp SCTBTTTTSB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT--------------
T ss_pred ccceeccCCc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH--------------
Confidence 9998654332 2334679999999999988776 679999999999999999999997542211
Q ss_pred hhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 318 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
....+.. .....+..++..+.+|+.+||+.||.+|||++|++++
T Consensus 216 --~~~~i~~--~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 216 --LFKKVNS--CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp --CBCCCCS--SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred --HHHHHHc--CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 0001100 0112233456789999999999999999999999987
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-46 Score=353.52 Aligned_cols=245 Identities=24% Similarity=0.275 Sum_probs=192.5
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhc-CCCCccceEeEEEccC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIV-EHQNLVKLVGYCADDD 158 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~ 158 (426)
.++|+..++||+|+||+||+|.+..++. .||+|++.... ....+..|+..+..+ +||||+++++++.+..
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~ 130 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGR-----LYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGG 130 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSC-----EEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCe-----EEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCC
Confidence 3579999999999999999999876554 89999875432 223445666666555 9999999999998765
Q ss_pred CCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeee
Q 014363 159 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 238 (426)
Q Consensus 159 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 238 (426)
..|+||||+ +++|.+++.... ..+++..++.|+.|++.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 131 ----~~~lv~e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DF 201 (311)
T 3p1a_A 131 ----ILYLQTELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDF 201 (311)
T ss_dssp ----EEEEEEECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCC
T ss_pred ----EEEEEEecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccc
Confidence 459999999 779988886543 3599999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014363 239 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 318 (426)
Q Consensus 239 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 318 (426)
|++....... ......||+.|+|||++.+ .++.++|||||||++|||++|..|+.....
T Consensus 202 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~----------------- 260 (311)
T 3p1a_A 202 GLLVELGTAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG----------------- 260 (311)
T ss_dssp TTCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH-----------------
T ss_pred eeeeecccCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH-----------------
Confidence 9998654322 2334579999999998875 799999999999999999999776643210
Q ss_pred hhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 319 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
...+........+...++..+.+++.+||+.||++|||+.|++++
T Consensus 261 --~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 261 --WQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp --HHHHTTTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred --HHHHhccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 011111111111222345789999999999999999999999985
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=374.65 Aligned_cols=271 Identities=24% Similarity=0.300 Sum_probs=187.4
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccC-
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDD- 158 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~- 158 (426)
.++|.++++||+|+||.||+|.++.++. .||+|++.... ..+.+.+|+.+|+.++|||||++++++....
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~-----~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 126 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKR-----VVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDV 126 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--C-----EEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCT
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCc-----EEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCc
Confidence 3689999999999999999999876654 89999885432 3456889999999999999999999986543
Q ss_pred CCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeee
Q 014363 159 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 238 (426)
Q Consensus 159 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 238 (426)
......|+||||+ +++|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+||||+.++.+||+||
T Consensus 127 ~~~~~~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DF 200 (458)
T 3rp9_A 127 EKFDELYVVLEIA-DSDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDF 200 (458)
T ss_dssp TTCCCEEEEECCC-SEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCC
T ss_pred ccCceEEEEEecc-ccchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeeccc
Confidence 2223569999998 57999998654 3499999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCc-------------------------eeeeeeeecCcccCCchhh-ccCCCCCchhhHHHHHHHHHHHh-
Q 014363 239 GLARLGPSEGF-------------------------THVSTAVVGTMGYAAPEYV-QTGRLAARSDVWSYGVFLYELIT- 291 (426)
Q Consensus 239 Gla~~~~~~~~-------------------------~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslGvil~ellt- 291 (426)
|+++....... .......+||+.|+|||++ .+..|+.++|||||||+||||++
T Consensus 201 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 201 GLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred ccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 99986542211 0123456899999999976 45679999999999999999999
Q ss_pred ----------CCCCCCCCCchh-----------------hHHHHHhHhhhhhh-------------hhhhhhhcCCcCCC
Q 014363 292 ----------GRRPIDRNRPRS-----------------EQKLLQWVKPYLSD-------------AKQFRQIVDPRLEG 331 (426)
Q Consensus 292 ----------g~~p~~~~~~~~-----------------~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~ 331 (426)
|.++|.+..... .......+...+.. .......+......
T Consensus 281 ~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (458)
T 3rp9_A 281 IKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGT 360 (458)
T ss_dssp STTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCC
T ss_pred ccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCC
Confidence 566665432110 00000000000000 00000000000000
Q ss_pred ---cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 332 ---KYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 332 ---~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
......+..+.+||.+||+.||++|||++|+++|
T Consensus 361 ~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H 397 (458)
T 3rp9_A 361 DLAERFPASSADAIHLLKRMLVFNPNKRITINECLAH 397 (458)
T ss_dssp CGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0112246788999999999999999999999997
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=360.98 Aligned_cols=255 Identities=25% Similarity=0.383 Sum_probs=202.3
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-----CHHHHHHHHHHHhhc-CCCCccceEeEEEcc
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-----GHKEWMTEVNFLGIV-EHQNLVKLVGYCADD 157 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-----~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~ 157 (426)
.++|..++.||+|+||.||+|.++.++ ..||+|.+.... ..+.+.+|+.++..+ +||||+++++++.+.
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~ 82 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTD-----RIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE 82 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTT-----EEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCC-----CEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeC
Confidence 357899999999999999999987654 389999986542 234578899999988 899999999999876
Q ss_pred CCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEee
Q 014363 158 DERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 237 (426)
Q Consensus 158 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~D 237 (426)
. ..|+||||+++|+|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.+|.+||+|
T Consensus 83 ~----~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~D 153 (345)
T 3a8x_A 83 S----RLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTD 153 (345)
T ss_dssp S----EEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECC
T ss_pred C----EEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEe
Confidence 5 469999999999999998653 3489999999999999999999998 999999999999999999999999
Q ss_pred ecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhH--HHHHhHhhhh
Q 014363 238 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQ--KLLQWVKPYL 315 (426)
Q Consensus 238 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~--~~~~~~~~~~ 315 (426)
||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++|..||......... .....
T Consensus 154 FG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~----- 226 (345)
T 3a8x_A 154 YGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDY----- 226 (345)
T ss_dssp GGGCBCSCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHH-----
T ss_pred ccccccccCCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHH-----
Confidence 99998643222 1234578999999999999999999999999999999999999999653221100 00000
Q ss_pred hhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCH------HHHHHH
Q 014363 316 SDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKM------SEVLEM 365 (426)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~------~eil~~ 365 (426)
....+..... .++..++..+.+|+.+||+.||++||++ .|+++|
T Consensus 227 ----~~~~i~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 227 ----LFQVILEKQI--RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp ----HHHHHHHCCC--CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred ----HHHHHHcCCC--CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 0011111111 1233456789999999999999999995 677765
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=367.01 Aligned_cols=269 Identities=23% Similarity=0.359 Sum_probs=194.7
Q ss_pred HHhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc----CCHHHHHHHHHHHhhcC-CCCccceEeEEEc
Q 014363 82 SATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR----GGHKEWMTEVNFLGIVE-HQNLVKLVGYCAD 156 (426)
Q Consensus 82 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~----~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~~ 156 (426)
...++|++++.||+|+||.||+|.+..++. .||+|++... .....+.+|+.+|..+. ||||+++++++..
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~-----~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~ 80 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGE-----VVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRA 80 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCC-----EEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCC-----EEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEec
Confidence 346789999999999999999999877654 8999988543 23456789999999997 9999999999986
Q ss_pred cCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEe
Q 014363 157 DDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLS 236 (426)
Q Consensus 157 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~ 236 (426)
.+.. ..|+||||++ ++|.+++... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+
T Consensus 81 ~~~~--~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~ 151 (388)
T 3oz6_A 81 DNDR--DVYLVFDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVA 151 (388)
T ss_dssp TTSS--CEEEEEECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEEC
T ss_pred CCCC--EEEEEecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEec
Confidence 5533 4699999996 6899988643 489999999999999999999998 99999999999999999999999
Q ss_pred eecccccCCCCC-------------------ceeeeeeeecCcccCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCC
Q 014363 237 DFGLARLGPSEG-------------------FTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPI 296 (426)
Q Consensus 237 DFGla~~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~ 296 (426)
|||+++...... ........+||+.|+|||++.+ ..|+.++|||||||++|||++|..||
T Consensus 152 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf 231 (388)
T 3oz6_A 152 DFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIF 231 (388)
T ss_dssp CCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred CCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCC
Confidence 999998653210 1112345689999999999876 67899999999999999999999999
Q ss_pred CCCCchhhHHHHHhHhhhhhhhhhhh---------------hhc---CCcCCCccc------------HHHHHHHHHHHH
Q 014363 297 DRNRPRSEQKLLQWVKPYLSDAKQFR---------------QIV---DPRLEGKYS------------LRLVSKLSHVAN 346 (426)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~---~~~~~~~~~------------~~~~~~l~~li~ 346 (426)
.+.........+..... ........ ... .......++ ..+++.+.+|+.
T Consensus 232 ~~~~~~~~~~~i~~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~ 310 (388)
T 3oz6_A 232 PGSSTMNQLERIIGVID-FPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLD 310 (388)
T ss_dssp CCSSHHHHHHHHHHHHC-CCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHH
T ss_pred CCCCHHHHHHHHHHhcC-CCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHH
Confidence 87554332221111000 00000000 000 000000000 023567899999
Q ss_pred hccccCCCCCCCHHHHHHH
Q 014363 347 LCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 347 ~cl~~dp~~RPs~~eil~~ 365 (426)
+||+.||++|||+.|+++|
T Consensus 311 ~~L~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 311 KLLQFNPNKRISANDALKH 329 (388)
T ss_dssp HHCCSSGGGSCCHHHHTTS
T ss_pred HhhccCcccCCCHHHHhCC
Confidence 9999999999999999987
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=355.91 Aligned_cols=267 Identities=24% Similarity=0.373 Sum_probs=188.9
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
.++|+.++.||+|+||.||+|.++.++. .||+|.+.... ..+.+.+|+.+++.++||||+++++++.+.+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-- 76 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGV-----YVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTEN-- 76 (317)
T ss_dssp ---------------CEEEEEECSSSCC-----EEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTT--
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCc-----EEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECC--
Confidence 4679999999999999999998776544 89999886432 3467889999999999999999999998765
Q ss_pred CceEEEEEeeCCCCChhhhccCC----CCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEe
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPK----SETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLS 236 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~----~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~ 236 (426)
..++||||++ |+|.+++... ....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+
T Consensus 77 --~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~ 150 (317)
T 2pmi_A 77 --KLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLG 150 (317)
T ss_dssp --EEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEEC
T ss_pred --eEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEEC
Confidence 4699999997 5998888532 123489999999999999999999998 99999999999999999999999
Q ss_pred eecccccCCCCCceeeeeeeecCcccCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhH-hh-
Q 014363 237 DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWV-KP- 313 (426)
Q Consensus 237 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~-~~- 313 (426)
|||++....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+... ..
T Consensus 151 Dfg~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 228 (317)
T 2pmi_A 151 DFGLARAFGIPV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTP 228 (317)
T ss_dssp CCSSCEETTSCC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC
T ss_pred cCccceecCCCc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 999998654322 11234579999999999876 46899999999999999999999999865543222211110 00
Q ss_pred ---hhhhhhhhhh---hcCCcCCC--------cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 314 ---YLSDAKQFRQ---IVDPRLEG--------KYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 314 ---~~~~~~~~~~---~~~~~~~~--------~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.+........ ........ .....++..+.+|+.+||+.||++|||+.|++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 229 NESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp CTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 0000000000 00000000 0011245689999999999999999999999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=359.02 Aligned_cols=267 Identities=24% Similarity=0.411 Sum_probs=205.1
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
.++|.+.+.||+|+||.||+|.+...........||+|.+.... ....+.+|+.+++.++||||+++++++.+....
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 45799999999999999999986544333445689999986443 335688999999999999999999999876644
Q ss_pred CceEEEEEeeCCCCChhhhccCCCC-----CccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCC---CCC
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSE-----TILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE---QWN 232 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~-----~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~---~~~ 232 (426)
|+||||+++++|.+++..... ..+++..++.++.|++.||.|||++ +|+||||||+|||++. +..
T Consensus 109 ----~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~ 181 (327)
T 2yfx_A 109 ----FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRV 181 (327)
T ss_dssp ----EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCC
T ss_pred ----EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcce
Confidence 999999999999999975432 3488999999999999999999998 9999999999999984 446
Q ss_pred eeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhH
Q 014363 233 AKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWV 311 (426)
Q Consensus 233 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~ 311 (426)
+||+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |..||......... ..+
T Consensus 182 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~---~~~ 258 (327)
T 2yfx_A 182 AKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL---EFV 258 (327)
T ss_dssp EEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH---HHH
T ss_pred EEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHH---HHH
Confidence 99999999975433322222334568999999999999999999999999999999998 99999765432111 111
Q ss_pred hhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhhc
Q 014363 312 KPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASA 374 (426)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~~ 374 (426)
. . ......+..++..+.+++.+||+.||++||++.+|+++|+.+.....
T Consensus 259 ~-------------~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~ 307 (327)
T 2yfx_A 259 T-------------S-GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 307 (327)
T ss_dssp H-------------T-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred h-------------c-CCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHH
Confidence 0 0 00111223355689999999999999999999999999998876543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=354.11 Aligned_cols=269 Identities=26% Similarity=0.324 Sum_probs=204.0
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-------CHHHHHHHHHHHhhcC---CCCccceEeE
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-------GHKEWMTEVNFLGIVE---HQNLVKLVGY 153 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-------~~~~~~~E~~~l~~l~---HpnIv~~~~~ 153 (426)
.++|++.+.||+|+||.||+|.+..++. .||+|.+.... ....+.+|+.+++.++ ||||++++++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~ 82 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGH-----FVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDV 82 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCC-----EEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCc-----EEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeee
Confidence 5789999999999999999999766554 79999875322 2346778888887774 9999999999
Q ss_pred EEccCC-CCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCC
Q 014363 154 CADDDE-RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWN 232 (426)
Q Consensus 154 ~~~~~~-~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~ 232 (426)
+..... .....++||||+. ++|.+++.......+++..++.++.||+.||+|||++ +|+||||||+|||++.++.
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~ 158 (308)
T 3g33_A 83 CATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGT 158 (308)
T ss_dssp EEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSC
T ss_pred eeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCC
Confidence 987543 2235699999996 6999999876666699999999999999999999998 9999999999999999999
Q ss_pred eeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHh
Q 014363 233 AKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK 312 (426)
Q Consensus 233 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~ 312 (426)
+||+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+....
T Consensus 159 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~ 235 (308)
T 3g33_A 159 VKLADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLI 235 (308)
T ss_dssp EEECSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHH
T ss_pred EEEeeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 9999999998654322 2345679999999999999999999999999999999999999997654332221111000
Q ss_pred hhhhhhhhhh-------hhcCCcCCC---cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 313 PYLSDAKQFR-------QIVDPRLEG---KYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 313 ~~~~~~~~~~-------~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
... ...... ......... .....++..+.+|+.+||+.||++|||+.|+++|
T Consensus 236 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 236 GLP-PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp CCC-CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCC-ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 000 000000 000000000 0111345788999999999999999999999986
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=379.10 Aligned_cols=252 Identities=29% Similarity=0.445 Sum_probs=208.8
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-----CCHHHHHHHHHHHhhcCCCCccceEeEEEccC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-----GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 158 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 158 (426)
.++|...++||+|+||.||+|.++.++. .||+|.+... .....+.+|+.+|..++||||+++++++.+..
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~-----~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~ 257 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGK-----MYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKD 257 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCC-----EEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCC-----EEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCC
Confidence 4579999999999999999999877654 8999988532 34566889999999999999999999998765
Q ss_pred CCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeee
Q 014363 159 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 238 (426)
Q Consensus 159 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 238 (426)
..|+||||++||+|.+++.......+++..++.++.||+.||+|||++ +|+||||||+||||+.+|.+||+||
T Consensus 258 ----~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DF 330 (576)
T 2acx_A 258 ----ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDL 330 (576)
T ss_dssp ----EEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred ----EEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEec
Confidence 469999999999999999766555699999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhh-HHHHHhHhhhhhh
Q 014363 239 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSE-QKLLQWVKPYLSD 317 (426)
Q Consensus 239 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~ 317 (426)
|++....... .....+||+.|+|||++.+..|+.++|||||||++|||++|..||........ ..+.....
T Consensus 331 Gla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~----- 402 (576)
T 2acx_A 331 GLAVHVPEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK----- 402 (576)
T ss_dssp TTCEECCTTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHH-----
T ss_pred ccceecccCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhh-----
Confidence 9998765432 12346899999999999998999999999999999999999999976543211 11111100
Q ss_pred hhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 014363 318 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRP-----KMSEVLEM 365 (426)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~ 365 (426)
. ....++..++..+.+||.+||+.||++|| +++||++|
T Consensus 403 --------~--~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 403 --------E--VPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp --------H--CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred --------c--ccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 0 01122334567899999999999999999 78999886
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=374.81 Aligned_cols=248 Identities=25% Similarity=0.357 Sum_probs=196.6
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-----CCHHHHHHHHHHHhhcCCCCccceEeEEEccC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-----GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 158 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 158 (426)
.++|+..+.||+|+||.||+|.+..++. .||+|.+... .....+.+|+.+|+.++||||+++++++.+.+
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~ 221 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGR-----YYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD 221 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCC-----EEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETT
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCC-----EEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCC
Confidence 4679999999999999999999877654 8999988543 23356788999999999999999999998866
Q ss_pred CCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhcc-CCCCCeEeccCCCCceEeCCCCCeeEee
Q 014363 159 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHE-GMDFQIIVRDFKSSNILLDEQWNAKLSD 237 (426)
Q Consensus 159 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~-~~~~~iiHrDlkp~NILl~~~~~~kl~D 237 (426)
..|+||||+++|+|.+++... ..+++..++.++.||+.||+|||+ + +|+||||||+||||+.++.+||+|
T Consensus 222 ----~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~D 292 (446)
T 4ejn_A 222 ----RLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITD 292 (446)
T ss_dssp ----EEEEEECCCSSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECC
T ss_pred ----EEEEEEeeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEcc
Confidence 459999999999999998643 348999999999999999999997 7 999999999999999999999999
Q ss_pred ecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh
Q 014363 238 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 317 (426)
Q Consensus 238 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 317 (426)
||+++...... ......+||+.|+|||++.+..|+.++|||||||++|||++|..||...........+
T Consensus 293 FG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i--------- 361 (446)
T 4ejn_A 293 FGLCKEGIKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI--------- 361 (446)
T ss_dssp CCCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---------
T ss_pred CCCceeccCCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHH---------
Confidence 99998643322 2234578999999999999999999999999999999999999999765432211111
Q ss_pred hhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 014363 318 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRP-----KMSEVLEM 365 (426)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~ 365 (426)
.... ..++..+++.+.+||.+||+.||++|| +++|+++|
T Consensus 362 -------~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 362 -------LMEE--IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp -------HHCC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -------HhCC--CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 0000 112233567899999999999999999 99999986
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=346.59 Aligned_cols=256 Identities=26% Similarity=0.465 Sum_probs=208.3
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCce
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQ 163 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~ 163 (426)
++|...+.||+|+||.||+|.+... ..|++|.+.... ..+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~------~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~--- 78 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNK------DKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI--- 78 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTT------EEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC---
T ss_pred hheeeeeEecCCCceeEEEEEecCC------CeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCe---
Confidence 5788899999999999999998643 278999987554 456889999999999999999999999876643
Q ss_pred EEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccccc
Q 014363 164 RLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL 243 (426)
Q Consensus 164 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 243 (426)
++||||+++++|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 79 -~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 153 (267)
T 3t9t_A 79 -CLVTEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRF 153 (267)
T ss_dssp -EEEECCCTTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGG
T ss_pred -EEEEeCCCCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccc
Confidence 99999999999999997543 3589999999999999999999998 999999999999999999999999999986
Q ss_pred CCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhhh
Q 014363 244 GPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQFR 322 (426)
Q Consensus 244 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (426)
...... .......|++.|+|||++.+..++.++||||||+++|+|++ |..||........... ..
T Consensus 154 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~---i~---------- 219 (267)
T 3t9t_A 154 VLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED---IS---------- 219 (267)
T ss_dssp BCCHHH-HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH---HH----------
T ss_pred cccccc-cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHH---Hh----------
Confidence 543211 11223457789999999998999999999999999999999 8999976543211110 00
Q ss_pred hhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 014363 323 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 372 (426)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~ 372 (426)
.. .....+...+..+.+++.+||+.||++|||+.+++++|+++.+.
T Consensus 220 ~~----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 220 TG----FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp TT----CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cC----CcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 00 01111223456889999999999999999999999999988753
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=355.37 Aligned_cols=265 Identities=27% Similarity=0.486 Sum_probs=204.3
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC---HHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG---HKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
++|...+.||+|+||.||+|.+...+. .....||+|.+..... ...+.+|+.++..++||||+++++++.+...
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-- 120 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSG-KKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP-- 120 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC----CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS--
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCC-CccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCC--
Confidence 467788999999999999999876432 2345699999875432 3468899999999999999999999977553
Q ss_pred ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccc
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 241 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 241 (426)
.++||||+++|+|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 121 --~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 194 (333)
T 1mqb_A 121 --MMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLS 194 (333)
T ss_dssp --EEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred --cEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcc
Confidence 599999999999999997542 3589999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCce-eeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014363 242 RLGPSEGFT-HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAK 319 (426)
Q Consensus 242 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 319 (426)
......... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||......... ..
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~---~~--------- 262 (333)
T 1mqb_A 195 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM---KA--------- 262 (333)
T ss_dssp ----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH---HH---------
T ss_pred hhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHH---HH---------
Confidence 865432211 11223456889999999999999999999999999999999 99999754332111 11
Q ss_pred hhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhhcc
Q 014363 320 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASAE 375 (426)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~~~ 375 (426)
+.+ ......+..++..+.+++.+||+.||++||++.++++.|+.+......
T Consensus 263 ----~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~ 313 (333)
T 1mqb_A 263 ----IND-GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS 313 (333)
T ss_dssp ----HHT-TCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGG
T ss_pred ----HHC-CCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchh
Confidence 000 011112234567899999999999999999999999999998865443
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=349.32 Aligned_cols=261 Identities=23% Similarity=0.411 Sum_probs=207.7
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
.++|...+.||+|+||.||+|.+.... .....||+|.+.... ..+.+.+|+.+++.++||||+++++++.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 86 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHK--GEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEP-- 86 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTT--CCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSSS--
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCC--CCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCCC--
Confidence 457899999999999999999876543 234579999987653 3457889999999999999999999986543
Q ss_pred CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecc
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 240 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 240 (426)
.++||||+++++|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 87 ---~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 159 (281)
T 3cc6_A 87 ---TWIIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGL 159 (281)
T ss_dssp ---CEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCG
T ss_pred ---CEEEEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCC
Confidence 289999999999999996432 3489999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014363 241 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAK 319 (426)
Q Consensus 241 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 319 (426)
+........ .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.............
T Consensus 160 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~---------- 228 (281)
T 3cc6_A 160 SRYIEDEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE---------- 228 (281)
T ss_dssp GGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHH----------
T ss_pred Ccccccccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHh----------
Confidence 986543321 11233467889999999999999999999999999999998 999997554332221110
Q ss_pred hhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhh
Q 014363 320 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 373 (426)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~ 373 (426)
... ....+..+++.+.+++.+||+.||++|||+.|++++|+.+....
T Consensus 229 ---~~~----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 275 (281)
T 3cc6_A 229 ---KGD----RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME 275 (281)
T ss_dssp ---HTC----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ---cCC----CCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhh
Confidence 000 01112234568999999999999999999999999999887543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-46 Score=347.76 Aligned_cols=247 Identities=29% Similarity=0.457 Sum_probs=201.6
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-----CCHHHHHHHHHHHhhcCCCCccceEeEEEccC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-----GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 158 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 158 (426)
.++|.+.+.||+|+||.||+|.+..++. .||+|.+... .....+.+|+.+++.++||||+++++++.+..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 82 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT 82 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCC-----EEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCc-----EEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCC
Confidence 4679999999999999999999877654 7899987533 23456889999999999999999999998765
Q ss_pred CCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeee
Q 014363 159 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 238 (426)
Q Consensus 159 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 238 (426)
..++||||+++++|.+++.... .+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+||
T Consensus 83 ----~~~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Df 153 (279)
T 3fdn_A 83 ----RVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADF 153 (279)
T ss_dssp ----EEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSC
T ss_pred ----EEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEec
Confidence 4599999999999999986543 489999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014363 239 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 318 (426)
Q Consensus 239 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 318 (426)
|++....... .....||+.|+|||++.+..++.++||||||+++|+|++|..||...........+.
T Consensus 154 g~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--------- 220 (279)
T 3fdn_A 154 GWSVHAPSSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS--------- 220 (279)
T ss_dssp CEESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH---------
T ss_pred cccccCCccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHH---------
Confidence 9986543321 234679999999999999999999999999999999999999997654322111110
Q ss_pred hhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014363 319 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMV 366 (426)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L 366 (426)
. ....++..++..+.+|+.+||+.||++|||+.|++++-
T Consensus 221 ----~-----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~ 259 (279)
T 3fdn_A 221 ----R-----VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHP 259 (279)
T ss_dssp ----H-----TCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred ----h-----CCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 0 01112223456789999999999999999999999973
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-46 Score=370.87 Aligned_cols=247 Identities=26% Similarity=0.406 Sum_probs=205.2
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-----CCHHHHHHHHHHHhhcCCCCccceEeEEEccC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-----GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 158 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 158 (426)
.++|.+.+.||+|+||.||+|.+..++. .||+|.+... .....+.+|+.+|+.++||||+++++++.+..
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~-----~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~ 89 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGH-----KVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPS 89 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCC-----EEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCC-----EEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 4689999999999999999999876654 8999998543 23457889999999999999999999998765
Q ss_pred CCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeee
Q 014363 159 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 238 (426)
Q Consensus 159 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 238 (426)
..|+||||+++|+|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 90 ----~~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DF 160 (476)
T 2y94_A 90 ----DIFMVMEYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADF 160 (476)
T ss_dssp ----EEEEEEECCSSEEHHHHTTSS--SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred ----EEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEec
Confidence 459999999999999999754 3499999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCchhhccCCC-CCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh
Q 014363 239 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRL-AARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 317 (426)
Q Consensus 239 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 317 (426)
|++....... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||..........
T Consensus 161 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~----------- 226 (476)
T 2y94_A 161 GLSNMMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFK----------- 226 (476)
T ss_dssp SSCEECCTTC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHH-----------
T ss_pred cchhhccccc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHH-----------
Confidence 9998765432 2335689999999999988776 679999999999999999999998654322111
Q ss_pred hhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 318 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.+.+... ..+..++..+.+|+.+||+.||++|||+.||++|
T Consensus 227 -----~i~~~~~--~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 227 -----KICDGIF--YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp -----HHHTTCC--CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred -----HHhcCCc--CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 1111111 1122345688999999999999999999999986
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=368.74 Aligned_cols=266 Identities=23% Similarity=0.293 Sum_probs=198.2
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc----CCHHHHHHHHHHHhhcCCCCccceEeEEEccCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR----GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
.++|++++.||+|+||.||+|.+..++. .||+|++... ...+.+.+|+.+|+.++||||+++++++.....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~-----~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 135 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDR-----NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKT 135 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTE-----EEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCS
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCC-----EEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCc
Confidence 5789999999999999999999876653 7999998643 234567899999999999999999999976542
Q ss_pred --CCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEee
Q 014363 160 --RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 237 (426)
Q Consensus 160 --~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~D 237 (426)
.....||||||+++ +|.+.+.. .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 136 ~~~~~~~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~D 207 (464)
T 3ttj_A 136 LEEFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD 207 (464)
T ss_dssp TTTCCEEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECC
T ss_pred cccCCeEEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEE
Confidence 22357999999966 56666643 288999999999999999999998 999999999999999999999999
Q ss_pred ecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHh-Hh----
Q 014363 238 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQW-VK---- 312 (426)
Q Consensus 238 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~-~~---- 312 (426)
||+++..... ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.........+.. ..
T Consensus 208 FG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~ 284 (464)
T 3ttj_A 208 FGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 284 (464)
T ss_dssp CCCC-----C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCH
T ss_pred EEeeeecCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 9999865432 123457899999999999999999999999999999999999999987543322111110 00
Q ss_pred hhhhh-hhhhhhhcCCc---------------C---CCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 313 PYLSD-AKQFRQIVDPR---------------L---EGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 313 ~~~~~-~~~~~~~~~~~---------------~---~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
..+.. .......+... + ........+..+.+|+.+||+.||++|||++|+++|
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 285 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000 00011111100 0 001112236789999999999999999999999986
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=360.93 Aligned_cols=251 Identities=24% Similarity=0.389 Sum_probs=195.1
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCC--CCccceEeEEEcc
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEH--QNLVKLVGYCADD 157 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~H--pnIv~~~~~~~~~ 157 (426)
.++|++.+.||+|+||.||+|.+... ..||+|.+.... ..+.+.+|+.+|..++| |||+++++++.+.
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~ 81 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKK------QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 81 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTS------CEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCC------CEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeC
Confidence 45699999999999999999986542 379999886443 23567899999999976 9999999999876
Q ss_pred CCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEee
Q 014363 158 DERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 237 (426)
Q Consensus 158 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~D 237 (426)
. ..|+|||+ .+++|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+|||++ ++.+||+|
T Consensus 82 ~----~~~lv~e~-~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~D 150 (343)
T 3dbq_A 82 Q----YIYMVMEC-GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLID 150 (343)
T ss_dssp S----EEEEEECC-CSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECC
T ss_pred C----EEEEEEeC-CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEee
Confidence 5 45999995 588999999754 3489999999999999999999998 999999999999997 57899999
Q ss_pred ecccccCCCCCceeeeeeeecCcccCCchhhcc-----------CCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHH
Q 014363 238 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT-----------GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQK 306 (426)
Q Consensus 238 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~ 306 (426)
||++...............+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.......
T Consensus 151 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--- 227 (343)
T 3dbq_A 151 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI--- 227 (343)
T ss_dssp CSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH---
T ss_pred cccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH---
Confidence 999987654433333445689999999999865 678899999999999999999999997543211
Q ss_pred HHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014363 307 LLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMV 366 (426)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L 366 (426)
..+...+++.....++...+..+.+|+.+||+.||++|||+.|++++.
T Consensus 228 ------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 228 ------------SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp ------------HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred ------------HHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence 111222233333333333456789999999999999999999999874
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=380.28 Aligned_cols=261 Identities=23% Similarity=0.419 Sum_probs=205.8
Q ss_pred CCCCcc-eecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 86 NFSRSV-VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 86 ~y~~~~-~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
++.+.. .||+|+||.||+|.++... ....||+|.+.... ..+.+.+|+.+|+.++|||||++++++.++
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~---~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~---- 408 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRK---KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE---- 408 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSS---CEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESS----
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCC---CcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccC----
Confidence 334444 7999999999999886432 23579999987542 457899999999999999999999999763
Q ss_pred ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccc
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 241 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 241 (426)
..++||||+++|+|.+++... ...+++..++.|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||++
T Consensus 409 -~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla 483 (613)
T 2ozo_A 409 -ALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLS 483 (613)
T ss_dssp -SEEEEEECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTT
T ss_pred -CeEEEEEeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCc
Confidence 259999999999999999754 34589999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCc-eeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014363 242 RLGPSEGF-THVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAK 319 (426)
Q Consensus 242 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 319 (426)
+....... ........+++.|+|||++.+..++.++|||||||++|||++ |..||...........+.
T Consensus 484 ~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~---------- 553 (613)
T 2ozo_A 484 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE---------- 553 (613)
T ss_dssp TTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHH----------
T ss_pred ccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH----------
Confidence 87543221 111223346789999999999999999999999999999998 999998755432211110
Q ss_pred hhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhhcc
Q 014363 320 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASAE 375 (426)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~~~ 375 (426)
.......+..++..+.+||.+||+.||++||++.+|++.|+.+......
T Consensus 554 -------~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~ 602 (613)
T 2ozo_A 554 -------QGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 602 (613)
T ss_dssp -------TTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSC
T ss_pred -------cCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcc
Confidence 0111122334667899999999999999999999999999998766543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=363.90 Aligned_cols=276 Identities=24% Similarity=0.316 Sum_probs=214.4
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc---CCHHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR---GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
.++|.+.++||+|+||.||+|.+..++. .||+|.+... ...+.+.+|+.+|+.++||||+++++++.+....
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 82 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGD-----LFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTR 82 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCC-----EEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTC
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCc-----EEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCC
Confidence 3578999999999999999999887654 8999998653 2456788999999999999999999999876533
Q ss_pred CceEEEEEeeCCCCChhhhccCCCC-CccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEe----CCCCCeeE
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSE-TILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL----DEQWNAKL 235 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~-~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl----~~~~~~kl 235 (426)
..++||||+++|+|.+++..... ..+++..++.++.|++.||+|||++ +|+||||||+|||+ +.++.+||
T Consensus 83 --~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL 157 (396)
T 4eut_A 83 --HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKL 157 (396)
T ss_dssp --CEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEE
T ss_pred --eeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEE
Confidence 45999999999999999975432 2389999999999999999999998 99999999999999 77888999
Q ss_pred eeecccccCCCCCceeeeeeeecCcccCCchhhcc--------CCCCCchhhHHHHHHHHHHHhCCCCCCCCCchh-hHH
Q 014363 236 SDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT--------GRLAARSDVWSYGVFLYELITGRRPIDRNRPRS-EQK 306 (426)
Q Consensus 236 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslGvil~elltg~~p~~~~~~~~-~~~ 306 (426)
+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|..||....... ...
T Consensus 158 ~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~ 234 (396)
T 4eut_A 158 TDFGAARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE 234 (396)
T ss_dssp CCGGGCEECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHH
T ss_pred ecCCCceEccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHH
Confidence 9999998764432 1234679999999999875 567889999999999999999999996533211 111
Q ss_pred HHH-hHhhhhhh-hhhhhhhc--------CCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 014363 307 LLQ-WVKPYLSD-AKQFRQIV--------DPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 372 (426)
Q Consensus 307 ~~~-~~~~~~~~-~~~~~~~~--------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~ 372 (426)
... ........ ........ ...........++..+.+++.+||+.||++||+++|+++.+..++..
T Consensus 235 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 235 VMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp HHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred HHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 111 11100000 00000000 01112234578889999999999999999999999999999998765
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=349.00 Aligned_cols=265 Identities=29% Similarity=0.460 Sum_probs=205.3
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC---HHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG---HKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
..+|...+.||+|+||.||+|.+.... .....+++|.+..... .+.+.+|+.++++++||||+++++++.+.+.
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~- 100 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDND--GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG- 100 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-------CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS-
T ss_pred ceehhhcceeeecCCceEEEEEEecCC--CceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCC-
Confidence 346888899999999999999876543 2345689998865443 3568899999999999999999999765432
Q ss_pred CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecc
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 240 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 240 (426)
..++||||+++|+|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 101 --~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~ 174 (298)
T 3f66_A 101 --SPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGL 174 (298)
T ss_dssp --CCEEEEECCTTCBHHHHHHCTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGG
T ss_pred --ceEEEEeCCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccc
Confidence 2489999999999999997533 4489999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCc--eeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhh
Q 014363 241 ARLGPSEGF--THVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSD 317 (426)
Q Consensus 241 a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 317 (426)
+........ ........||+.|+|||++.+..++.++||||||+++|+|++ |.+||.............
T Consensus 175 a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~-------- 246 (298)
T 3f66_A 175 ARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-------- 246 (298)
T ss_dssp GCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHH--------
T ss_pred cccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh--------
Confidence 986543221 112334568889999999999999999999999999999999 556665443322111100
Q ss_pred hhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhhc
Q 014363 318 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASA 374 (426)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~~ 374 (426)
. ......+..++..+.+++.+||+.||++|||+.|+++.|+.+.....
T Consensus 247 -----~----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 294 (298)
T 3f66_A 247 -----Q----GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294 (298)
T ss_dssp -----T----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred -----c----CCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 0 00111122345679999999999999999999999999999887543
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=349.85 Aligned_cols=266 Identities=23% Similarity=0.305 Sum_probs=199.8
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC----HHHHHHHHHHHhhcCCCCccceEeEEEccCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG----HKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
.++|+.++.||+|+||.||+|.+..++. .||+|.+..... .+.+.+|+.+++.++||||+++++++.+..
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 75 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQ-----IVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKR- 75 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCC-----EEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCc-----EEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCC-
Confidence 3679999999999999999999877654 799998865443 345779999999999999999999998765
Q ss_pred CCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeec
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 239 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 239 (426)
..++||||+++++|.+++... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 76 ---~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg 147 (311)
T 4agu_A 76 ---RLHLVFEYCDHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFG 147 (311)
T ss_dssp ---EEEEEEECCSEEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred ---eEEEEEEeCCCchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCC
Confidence 459999999999999988644 3489999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhh-h---
Q 014363 240 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKP-Y--- 314 (426)
Q Consensus 240 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~-~--- 314 (426)
++....... .......||+.|+|||++.+ ..++.++||||||+++|+|++|..||...........+..... .
T Consensus 148 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 225 (311)
T 4agu_A 148 FARLLTGPS--DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPR 225 (311)
T ss_dssp TCEECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH
T ss_pred CchhccCcc--cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccc
Confidence 998654322 12334679999999999876 5689999999999999999999999987654433322211100 0
Q ss_pred ----hhhhhhhhhhcCCcCCCcc-----cHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 315 ----LSDAKQFRQIVDPRLEGKY-----SLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 315 ----~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
......+.....+...... ...++..+.+|+.+||+.||++|||++|++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 226 HQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp HHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000000000000000000 01345678999999999999999999999986
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-46 Score=356.11 Aligned_cols=251 Identities=26% Similarity=0.377 Sum_probs=194.7
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC------CHHHHHHHHHHHhhcCCCCccceEeEEEcc
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG------GHKEWMTEVNFLGIVEHQNLVKLVGYCADD 157 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~------~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 157 (426)
.++|++.+.||+|+||.||+|..... ......||+|.+.... ....+.+|+.+|+.++||||+++++++.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~--~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 93 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTG--ANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG 93 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSS--TTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEecc--CCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC
Confidence 35799999999999999999987531 1223489999986542 334578899999999999999999999876
Q ss_pred CCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEee
Q 014363 158 DERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 237 (426)
Q Consensus 158 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~D 237 (426)
+. .|+||||+++++|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|
T Consensus 94 ~~----~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~D 164 (327)
T 3a62_A 94 GK----LYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTD 164 (327)
T ss_dssp SC----EEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECC
T ss_pred CE----EEEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEe
Confidence 53 59999999999999998643 3488999999999999999999998 999999999999999999999999
Q ss_pred ecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh
Q 014363 238 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 317 (426)
Q Consensus 238 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 317 (426)
||+++...... ......+||+.|+|||++.+..++.++||||||+++|+|++|..||..........
T Consensus 165 fg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~----------- 231 (327)
T 3a62_A 165 FGLCKESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTID----------- 231 (327)
T ss_dssp CSCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-----------
T ss_pred CCcccccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHH-----------
Confidence 99997543221 12345679999999999999999999999999999999999999997654321111
Q ss_pred hhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 014363 318 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRP-----KMSEVLEM 365 (426)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~ 365 (426)
.+.... ..++..++..+.+++.+||+.||++|| ++.|+++|
T Consensus 232 -----~i~~~~--~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 232 -----KILKCK--LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp -----HHHHTC--CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred -----HHHhCC--CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 111100 112233567899999999999999999 78899886
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=346.68 Aligned_cols=268 Identities=19% Similarity=0.279 Sum_probs=207.9
Q ss_pred HhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCc
Q 014363 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 162 (426)
Q Consensus 83 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~ 162 (426)
..++|...+.||+|+||.||+|.+..++ ..||+|.+........+.+|+.++..++|++++..++++.....
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~--- 78 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAG-----EEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGD--- 78 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTT-----EEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETT---
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCC-----ceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCC---
Confidence 3578999999999999999999976654 38999987766666678999999999999998888877755443
Q ss_pred eEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEe---CCCCCeeEeeec
Q 014363 163 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL---DEQWNAKLSDFG 239 (426)
Q Consensus 163 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl---~~~~~~kl~DFG 239 (426)
..++||||+ +++|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+|||+ +.++.+||+|||
T Consensus 79 ~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg 153 (296)
T 4hgt_A 79 YNVMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFG 153 (296)
T ss_dssp EEEEEEECC-CCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCT
T ss_pred ceEEEEEcc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCc
Confidence 469999999 999999987433 3489999999999999999999998 99999999999999 788999999999
Q ss_pred ccccCCCCCce-----eeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhh-
Q 014363 240 LARLGPSEGFT-----HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKP- 313 (426)
Q Consensus 240 la~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~- 313 (426)
++......... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.................
T Consensus 154 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 233 (296)
T 4hgt_A 154 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK 233 (296)
T ss_dssp TCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH
T ss_pred cceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcc
Confidence 99865443221 112356799999999999999999999999999999999999999976543322221111100
Q ss_pred hhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhhc
Q 014363 314 YLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASA 374 (426)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~~ 374 (426)
..... . .. ....++..+.+++.+||+.||++|||+++|++.|+++.....
T Consensus 234 ~~~~~--~-~~--------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~ 283 (296)
T 4hgt_A 234 KMSTP--I-EV--------LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp HHHSC--H-HH--------HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred cccch--h-hh--------hhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence 00000 0 00 001234689999999999999999999999999999887643
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=364.25 Aligned_cols=247 Identities=25% Similarity=0.332 Sum_probs=195.0
Q ss_pred CcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC--CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCceEEE
Q 014363 89 RSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLL 166 (426)
Q Consensus 89 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~~~l 166 (426)
..+.||+|+||.||+|.+..++. .||+|.+.... ..+.+.+|+.+|..++||||+++++++.+.. ..+|
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~-----~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~----~~~l 163 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGL-----KLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKN----DIVL 163 (373)
T ss_dssp EEEECC-----CEEEEEETTTCC-----EEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS----EEEE
T ss_pred cceEEecCcCEEEEEEEEcCCCc-----EEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECC----EEEE
Confidence 35689999999999999876654 79999986543 4467899999999999999999999998765 4599
Q ss_pred EEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEe--CCCCCeeEeeecccccC
Q 014363 167 VYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL--DEQWNAKLSDFGLARLG 244 (426)
Q Consensus 167 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl--~~~~~~kl~DFGla~~~ 244 (426)
||||+++++|.+++.... ..+++..++.++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+++..
T Consensus 164 v~E~~~~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~ 239 (373)
T 2x4f_A 164 VMEYVDGGELFDRIIDES-YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRY 239 (373)
T ss_dssp EEECCTTCEEHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEEC
T ss_pred EEeCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceec
Confidence 999999999999886432 3589999999999999999999998 99999999999999 66788999999999876
Q ss_pred CCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhh
Q 014363 245 PSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQI 324 (426)
Q Consensus 245 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (426)
..... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.......... .....
T Consensus 240 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~--~i~~~----------- 303 (373)
T 2x4f_A 240 KPREK---LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLN--NILAC----------- 303 (373)
T ss_dssp CTTCB---CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH--HHHHT-----------
T ss_pred CCccc---cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHhc-----------
Confidence 54321 234579999999999998889999999999999999999999997654321111 10000
Q ss_pred cCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 325 VDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 325 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
...+.......++..+.+||.+||+.||++|||+.|++++
T Consensus 304 -~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 304 -RWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp -CCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -cCCCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0001111112345789999999999999999999999985
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=362.80 Aligned_cols=264 Identities=28% Similarity=0.456 Sum_probs=199.6
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCc
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 162 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~ 162 (426)
.|...+.||+|+||.||+|.+.... .....+|+|.+.... ..+.+.+|+.+++.++||||+++++++.+...
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~--- 164 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDND--GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG--- 164 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETT--TEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSS---
T ss_pred eeecCcEeeeCCCeEEEEEEEECCC--CcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCC---
Confidence 4667789999999999999876432 234578999886543 34578899999999999999999999765432
Q ss_pred eEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccc
Q 014363 163 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 242 (426)
Q Consensus 163 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 242 (426)
..++||||+++|+|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~ 240 (373)
T 3c1x_A 165 SPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLAR 240 (373)
T ss_dssp CCEEEEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred CeEEEEECCCCCCHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccccc
Confidence 2489999999999999997543 3488999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCCCce--eeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014363 243 LGPSEGFT--HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAK 319 (426)
Q Consensus 243 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 319 (426)
........ .......+|+.|+|||++.+..++.++||||||+++|||++ |.+||.............
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~---------- 310 (373)
T 3c1x_A 241 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL---------- 310 (373)
T ss_dssp -----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHH----------
T ss_pred cccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHH----------
Confidence 65432211 11234567889999999999999999999999999999999 777886544322111110
Q ss_pred hhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhhcc
Q 014363 320 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASAE 375 (426)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~~~ 375 (426)
.. .....+..++..+.+++.+||+.||++|||+.|+++.|+.+......
T Consensus 311 ------~~-~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~ 359 (373)
T 3c1x_A 311 ------QG-RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 359 (373)
T ss_dssp ------TT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred ------cC-CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccc
Confidence 00 00111223556899999999999999999999999999999876543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=346.43 Aligned_cols=250 Identities=24% Similarity=0.403 Sum_probs=200.9
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
.|.+.+.||+|+||.||+|.+..++. .|++|.+.... ..+.+.+|+.+++.++||||+++++++.......
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~-----~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTV-----EVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK 101 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCC-----EEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSC
T ss_pred eEEeeeeccCCCCeEEEEeEecCCce-----EEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCC
Confidence 47778899999999999999876654 78999876432 3356889999999999999999999998765444
Q ss_pred ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCC--eEeccCCCCceEeC-CCCCeeEeee
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQ--IIVRDFKSSNILLD-EQWNAKLSDF 238 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~--iiHrDlkp~NILl~-~~~~~kl~DF 238 (426)
...++||||+++++|.+++... ..+++..++.++.|++.||.|||+. + |+||||||+|||++ .++.+||+||
T Consensus 102 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Df 176 (290)
T 1t4h_A 102 KCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDL 176 (290)
T ss_dssp EEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCT
T ss_pred ceEEEEEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeC
Confidence 5679999999999999999653 3489999999999999999999998 7 99999999999997 7899999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014363 239 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 318 (426)
Q Consensus 239 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 318 (426)
|++....... .....||+.|+|||++. +.++.++||||||+++|+|++|..||......... ..
T Consensus 177 g~~~~~~~~~----~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--~~--------- 240 (290)
T 1t4h_A 177 GLATLKRASF----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI--YR--------- 240 (290)
T ss_dssp TGGGGCCTTS----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH--HH---------
T ss_pred CCcccccccc----cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHH--HH---------
Confidence 9997654332 23457999999999876 56899999999999999999999999764332111 11
Q ss_pred hhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 319 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.+........++...++.+.+++.+||+.||++|||+.|++++
T Consensus 241 ----~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 241 ----RVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp ----HHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ----HHhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1111111111222334679999999999999999999999985
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=345.95 Aligned_cols=264 Identities=24% Similarity=0.417 Sum_probs=210.4
Q ss_pred CCCCCcc-eecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 85 KNFSRSV-VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 85 ~~y~~~~-~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
++|.+.. .||+|+||.||+|.+.... ....||+|.+.... ..+.+.+|+.++..++||||+++++++...
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--- 82 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRK---KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE--- 82 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS---
T ss_pred HHhhhhhccccccCceeEEEeEeccCC---CcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecCC---
Confidence 4566665 8999999999999875432 23479999987643 345688999999999999999999999443
Q ss_pred CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecc
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 240 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 240 (426)
..++||||+++++|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 83 --~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~ 156 (287)
T 1u59_A 83 --ALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGL 156 (287)
T ss_dssp --SEEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTT
T ss_pred --CcEEEEEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccc
Confidence 259999999999999999744 34589999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCce-eeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014363 241 ARLGPSEGFT-HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDA 318 (426)
Q Consensus 241 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 318 (426)
+......... .......||+.|+|||++.+..++.++||||||+++|+|++ |..||...........+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~--------- 227 (287)
T 1u59_A 157 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE--------- 227 (287)
T ss_dssp CEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH---------
T ss_pred eeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHh---------
Confidence 9876533221 12233457899999999998899999999999999999998 999997654322111110
Q ss_pred hhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhhccCC
Q 014363 319 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASAEAG 377 (426)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~~~~~ 377 (426)
. ......+..++..+.+++.+||+.||++||++.+++++|+.+........
T Consensus 228 ----~----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~ 278 (287)
T 1u59_A 228 ----Q----GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 278 (287)
T ss_dssp ----T----TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTC
T ss_pred ----c----CCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcc
Confidence 0 01112233456789999999999999999999999999999987765543
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=347.43 Aligned_cols=264 Identities=27% Similarity=0.404 Sum_probs=208.2
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC---HHHHHHHHHHHhhcCCCCccceEeEEEccCCCCc
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG---HKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 162 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~ 162 (426)
.|...++||+|+||.||+|.+.... .....+|+|.+..... .+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~-- 97 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQA--QNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGL-- 97 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSS--SCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC--
T ss_pred EEccCceeccCCCceEEEEEEecCC--CceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCC--
Confidence 4566689999999999999876543 2345789999875443 35678999999999999999999999765532
Q ss_pred eEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccc
Q 014363 163 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 242 (426)
Q Consensus 163 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 242 (426)
.++||||+.+|+|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.
T Consensus 98 -~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 172 (298)
T 3pls_A 98 -PHVLLPYMCHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLAR 172 (298)
T ss_dssp -CEEEECCCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSC
T ss_pred -cEEEEecccCCCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcc
Confidence 389999999999999997533 4589999999999999999999998 99999999999999999999999999997
Q ss_pred cCCCCCc--eeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCC-CCCCCchhhHHHHHhHhhhhhhhh
Q 014363 243 LGPSEGF--THVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRP-IDRNRPRSEQKLLQWVKPYLSDAK 319 (426)
Q Consensus 243 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~ 319 (426)
....... ........||+.|+|||.+.+..++.++||||||+++|+|++|..| |.............
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~---------- 242 (298)
T 3pls_A 173 DILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA---------- 242 (298)
T ss_dssp TTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHH----------
T ss_pred cccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhh----------
Confidence 5543221 1122345688999999999999999999999999999999995555 44333222111110
Q ss_pred hhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhhcc
Q 014363 320 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASAE 375 (426)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~~~ 375 (426)
.......+..++..+.+++.+||+.||++|||+.++++.|+++......
T Consensus 243 -------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~ 291 (298)
T 3pls_A 243 -------QGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291 (298)
T ss_dssp -------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred -------cCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 0111112233456899999999999999999999999999999877544
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=351.54 Aligned_cols=263 Identities=24% Similarity=0.404 Sum_probs=208.2
Q ss_pred hCCCCCcc-eecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccC
Q 014363 84 TKNFSRSV-VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 158 (426)
Q Consensus 84 ~~~y~~~~-~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 158 (426)
.++|.+.+ .||+|+||.||+|.+.... ....|++|.+.... ..+.+.+|+.+++.++||||+++++++.. +
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~ 90 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKK---VVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-E 90 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSS---SEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-S
T ss_pred chhhhhccCccccccCeeeEeeeecCCC---ceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECC-C
Confidence 45678777 9999999999999765322 34589999986543 24578899999999999999999999943 2
Q ss_pred CCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeee
Q 014363 159 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 238 (426)
Q Consensus 159 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 238 (426)
..++||||+++++|.+++.... .+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+||
T Consensus 91 ----~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Df 161 (291)
T 1xbb_A 91 ----SWMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDF 161 (291)
T ss_dssp ----SEEEEEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCC
T ss_pred ----CcEEEEEeCCCCCHHHHHHhCc--CCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccC
Confidence 3589999999999999997543 489999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCce-eeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhh
Q 014363 239 GLARLGPSEGFT-HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLS 316 (426)
Q Consensus 239 Gla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 316 (426)
|++......... .......+++.|+|||++.+..++.++||||||+++|+|++ |..||...........+.
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~------- 234 (291)
T 1xbb_A 162 GLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE------- 234 (291)
T ss_dssp TTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-------
T ss_pred CcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-------
Confidence 999876543322 12223456789999999998889999999999999999999 999997654322111110
Q ss_pred hhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhhccC
Q 014363 317 DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASAEA 376 (426)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~~~~ 376 (426)
.......+..++..+.+++.+||+.||++||++.++++.|+.++......
T Consensus 235 ----------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~ 284 (291)
T 1xbb_A 235 ----------KGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNE 284 (291)
T ss_dssp ----------TTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHHH
T ss_pred ----------cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhhc
Confidence 01111223345678999999999999999999999999999998765443
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-46 Score=357.89 Aligned_cols=257 Identities=23% Similarity=0.287 Sum_probs=200.4
Q ss_pred HHHhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-------CCHHHHHHHHHHHhhcCCCCccceEeE
Q 014363 81 KSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-------GGHKEWMTEVNFLGIVEHQNLVKLVGY 153 (426)
Q Consensus 81 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-------~~~~~~~~E~~~l~~l~HpnIv~~~~~ 153 (426)
....++|.+.+.||+|+||.||+|.+..++. .||+|.+... ...+.+.+|+.+++.++||||++++++
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 96 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRA-----IRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEV 96 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEETTTCC-----EEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hhhhhheeecceeeecCCeEEEEEEECCCCc-----eEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehh
Confidence 3456789999999999999999999876654 7899987532 234678899999999999999999999
Q ss_pred EEccCCCCceEEEEEeeCCCCChhhhccCC--------------------------------------CCCccCHHHHHH
Q 014363 154 CADDDERGIQRLLVYEYMPNGSVDQYLSPK--------------------------------------SETILTWAMRLK 195 (426)
Q Consensus 154 ~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~--------------------------------------~~~~~~~~~~~~ 195 (426)
+.+.. ..++||||+++|+|.+++... ....+++..++.
T Consensus 97 ~~~~~----~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (345)
T 3hko_A 97 YEDEQ----YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISN 172 (345)
T ss_dssp EECSS----EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHH
T ss_pred hccCC----eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHH
Confidence 98765 459999999999999998521 012356788899
Q ss_pred HHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCC--CeeEeeecccccCCCCC--ceeeeeeeecCcccCCchhhcc-
Q 014363 196 IAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW--NAKLSDFGLARLGPSEG--FTHVSTAVVGTMGYAAPEYVQT- 270 (426)
Q Consensus 196 i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~--~~kl~DFGla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~- 270 (426)
++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||++....... .........||+.|+|||++.+
T Consensus 173 i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 249 (345)
T 3hko_A 173 IMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTT 249 (345)
T ss_dssp HHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCS
T ss_pred HHHHHHHHHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccC
Confidence 999999999999998 999999999999998776 89999999998643211 1112345679999999999875
Q ss_pred -CCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCCc--CCCcccHHHHHHHHHHHHh
Q 014363 271 -GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPR--LEGKYSLRLVSKLSHVANL 347 (426)
Q Consensus 271 -~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~ 347 (426)
..++.++||||||+++|+|++|..||.......... .++... ........++..+.+|+.+
T Consensus 250 ~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~li~~ 313 (345)
T 3hko_A 250 NESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTIS----------------QVLNKKLCFENPNYNVLSPLARDLLSN 313 (345)
T ss_dssp SSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----------------HHHHCCCCTTSGGGGGSCHHHHHHHHH
T ss_pred CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHH----------------HHHhcccccCCcccccCCHHHHHHHHH
Confidence 678999999999999999999999997654322111 111111 1111112345789999999
Q ss_pred ccccCCCCCCCHHHHHHH
Q 014363 348 CLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 348 cl~~dp~~RPs~~eil~~ 365 (426)
||+.||++|||+.+++++
T Consensus 314 ~l~~~p~~Rps~~~~l~h 331 (345)
T 3hko_A 314 LLNRNVDERFDAMRALQH 331 (345)
T ss_dssp HSCSCTTTSCCHHHHHHS
T ss_pred HcCCChhHCCCHHHHhcC
Confidence 999999999999999986
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=344.70 Aligned_cols=254 Identities=25% Similarity=0.389 Sum_probs=204.7
Q ss_pred HhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCCccceEeEEEccCC
Q 014363 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 83 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
..++|++.+.||+|+||.||+|.+..++. .|++|.+.... ..+.+.+|+.+++.++||||+++++++.+..
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 78 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEE-----AVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN- 78 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCC-----EEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT-
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCc-----EEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCC-
Confidence 34679999999999999999999876554 79999885432 3467889999999999999999999998765
Q ss_pred CCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeec
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 239 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 239 (426)
..|+||||+++++|.+++... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 79 ---~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg 150 (276)
T 2yex_A 79 ---IQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFG 150 (276)
T ss_dssp ---EEEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred ---EEEEEEEecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCC
Confidence 459999999999999999654 3489999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCchhhccCCC-CCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014363 240 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRL-AARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 318 (426)
Q Consensus 240 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 318 (426)
++................||+.|+|||++.+..+ +.++||||||+++|+|++|..||......... ...+..
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~------ 223 (276)
T 2yex_A 151 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWKE------ 223 (276)
T ss_dssp TCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH-HHHHHT------
T ss_pred CccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH-HHHhhh------
Confidence 9986543332233345679999999999987775 67899999999999999999999765432111 111110
Q ss_pred hhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 319 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
..........++..+.+++.+||+.||++|||+.|++++
T Consensus 224 --------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 224 --------KKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp --------TCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --------cccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 000001112345688999999999999999999999875
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-46 Score=357.76 Aligned_cols=270 Identities=17% Similarity=0.216 Sum_probs=199.6
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC-------------HHHHHHHHHHHhhcCCCCccce
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG-------------HKEWMTEVNFLGIVEHQNLVKL 150 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~-------------~~~~~~E~~~l~~l~HpnIv~~ 150 (426)
.++|.+.+.||+|+||.||+|.+...+ .....+++|.+..... ...+.+|+.++..++||||+++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~ 113 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKP--EKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF 113 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSC--GGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCC--CccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence 357999999999999999999987622 1234688888765431 2346678889999999999999
Q ss_pred EeEEEccCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCC
Q 014363 151 VGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQ 230 (426)
Q Consensus 151 ~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~ 230 (426)
++++.+........|+||||+ +++|.+++.... .+++..++.|+.||+.||+|||++ +|+||||||+|||++.+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYK 187 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESS
T ss_pred ecccccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccC
Confidence 999988543344679999999 999999997543 599999999999999999999998 99999999999999888
Q ss_pred C--CeeEeeecccccCCCCCc-----eeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchh
Q 014363 231 W--NAKLSDFGLARLGPSEGF-----THVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRS 303 (426)
Q Consensus 231 ~--~~kl~DFGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~ 303 (426)
+ .+||+|||+++....... ........||+.|+|||++.+..++.++|||||||++|||++|..||.......
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~ 267 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP 267 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence 7 999999999986542211 111134579999999999999999999999999999999999999996432211
Q ss_pred hHHHHHhHhhhhhh-hhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHh
Q 014363 304 EQKLLQWVKPYLSD-AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 369 (426)
Q Consensus 304 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~ 369 (426)
.... ......... ......... ...++..+.+++.+||+.||++|||+++|++.|+.+
T Consensus 268 ~~~~-~~~~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 268 VAVQ-TAKTNLLDELPQSVLKWAP-------SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp HHHH-HHHHHHHHTTTHHHHHHSC-------TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred HHHH-HHHHhhcccccHHHHhhcc-------ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 1111 100000000 000001000 012456899999999999999999999999999754
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=360.17 Aligned_cols=253 Identities=23% Similarity=0.347 Sum_probs=202.5
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhc-CCCCccceEeEEEccCCCCc
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDERGI 162 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~~~~ 162 (426)
.++|+..+.||+|+||.||+|.++.++ ..||+|.+.... ....+|++++.++ +||||+++++++.+..
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~~avK~~~~~~--~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~---- 89 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATN-----MEFAVKIIDKSK--RDPTEEIEILLRYGQHPNIITLKDVYDDGK---- 89 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTT-----EEEEEEEEETTT--CCCHHHHHHHHHHTTSTTBCCEEEEEECSS----
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCC-----CEEEEEEEEccc--CChHHHHHHHHHhcCCCCcCeEEEEEEcCC----
Confidence 567999999999999999999987655 389999986543 2356799999888 8999999999998765
Q ss_pred eEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCC-C---CeeEeee
Q 014363 163 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQ-W---NAKLSDF 238 (426)
Q Consensus 163 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~-~---~~kl~DF 238 (426)
..|+||||++||+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||+..+ + .+||+||
T Consensus 90 ~~~lv~E~~~gg~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Df 164 (342)
T 2qr7_A 90 YVYVVTELMKGGELLDKILRQK--FFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDF 164 (342)
T ss_dssp EEEEEECCCCSCBHHHHHHTCT--TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCC
T ss_pred EEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEEC
Confidence 4599999999999999987543 489999999999999999999998 99999999999998443 3 4999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014363 239 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 318 (426)
Q Consensus 239 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 318 (426)
|++........ .....+||+.|+|||++.+..|+.++|||||||++|+|++|..||..........+...+..
T Consensus 165 g~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~----- 237 (342)
T 2qr7_A 165 GFAKQLRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGS----- 237 (342)
T ss_dssp TTCEECBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHH-----
T ss_pred CCcccCcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHcc-----
Confidence 99986543321 23356899999999999888899999999999999999999999976433222222221110
Q ss_pred hhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 319 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
-...+...+...++..+.+|+.+||..||++|||+.++++|
T Consensus 238 ------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 238 ------GKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp ------CCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred ------CCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00111112223456789999999999999999999999987
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=352.69 Aligned_cols=256 Identities=23% Similarity=0.424 Sum_probs=202.7
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCC--CcceEEEEEEcccc--CCHHHHHHHHHHHhhcCCCCccceEeEEEccCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDP--SQKVEVAVKQLGRR--GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~--~~~~~va~K~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
.++|...+.||+|+||.||+|.+...+.. .....|++|.+... ...+.+.+|+.+++.++||||+++++++.+...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 35788999999999999999998765421 22357899988543 345678999999999999999999999987664
Q ss_pred CCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCC-------
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWN------- 232 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~------- 232 (426)
. ++||||+++|+|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.
T Consensus 87 ~----~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~ 158 (289)
T 4fvq_A 87 N----ILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPP 158 (289)
T ss_dssp C----EEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCC
T ss_pred C----EEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccc
Confidence 4 89999999999999997543 3489999999999999999999998 9999999999999998887
Q ss_pred -eeEeeecccccCCCCCceeeeeeeecCcccCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCC-CCCCCchhhHHHHH
Q 014363 233 -AKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRP-IDRNRPRSEQKLLQ 309 (426)
Q Consensus 233 -~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p-~~~~~~~~~~~~~~ 309 (426)
+||+|||++..... .....||+.|+|||++.+ ..++.++||||||+++|+|++|..| |............
T Consensus 159 ~~kl~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~- 231 (289)
T 4fvq_A 159 FIKLSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY- 231 (289)
T ss_dssp EEEECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH-
T ss_pred eeeeccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh-
Confidence 99999999875432 123568999999999987 6789999999999999999996554 4432221111100
Q ss_pred hHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 014363 310 WVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 372 (426)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~ 372 (426)
. . ...+. ...+..+.+++.+||+.||++|||+.+++++|+.+...
T Consensus 232 --~----~--------~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p 276 (289)
T 4fvq_A 232 --E----D--------RHQLP----APKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276 (289)
T ss_dssp --H----T--------TCCCC----CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred --h----c--------cCCCC----CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 0 0 01111 11235688999999999999999999999999987653
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=352.20 Aligned_cols=251 Identities=25% Similarity=0.345 Sum_probs=204.2
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC--------CHHHHHHHHHHHhhcCCCCccceEeEEE
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--------GHKEWMTEVNFLGIVEHQNLVKLVGYCA 155 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~--------~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 155 (426)
.++|.+.+.||+|+||.||+|.+..++. .||+|.+.... ..+.+.+|+.++..++||||+++++++.
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 85 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGL-----EYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYE 85 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCC-----EEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCe-----EEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 4579999999999999999999876654 78999885432 3567899999999999999999999998
Q ss_pred ccCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCC----
Q 014363 156 DDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW---- 231 (426)
Q Consensus 156 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~---- 231 (426)
+.. ..++||||+++++|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++
T Consensus 86 ~~~----~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~ 156 (321)
T 2a2a_A 86 NRT----DVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIP 156 (321)
T ss_dssp CSS----EEEEEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSC
T ss_pred cCC----EEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcC
Confidence 765 459999999999999999754 3489999999999999999999998 999999999999999888
Q ss_pred CeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhH
Q 014363 232 NAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWV 311 (426)
Q Consensus 232 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~ 311 (426)
.+||+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||...........+
T Consensus 157 ~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i--- 230 (321)
T 2a2a_A 157 HIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI--- 230 (321)
T ss_dssp CEEECCCTTCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH---
T ss_pred CEEEccCccceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHH---
Confidence 79999999998665432 123457999999999999999999999999999999999999999765332111110
Q ss_pred hhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 312 KPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.. . ............+..+.+++.+||+.||++|||+.|++++
T Consensus 231 ~~---~--------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 231 TS---V--------SYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp HT---T--------CCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred Hh---c--------ccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 0 0000001112245678999999999999999999999985
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-45 Score=343.99 Aligned_cols=266 Identities=19% Similarity=0.275 Sum_probs=211.1
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCce
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQ 163 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~ 163 (426)
.++|...+.||+|+||.||+|.+..++ ..||+|.+........+.+|+.++..++|++++..++++..... .
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~---~ 79 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAG-----EEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGD---Y 79 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTT-----EEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETT---E
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCC-----cEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCC---c
Confidence 568999999999999999999976654 38999998777666789999999999999988887777655433 4
Q ss_pred EEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEe---CCCCCeeEeeecc
Q 014363 164 RLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL---DEQWNAKLSDFGL 240 (426)
Q Consensus 164 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl---~~~~~~kl~DFGl 240 (426)
.++||||+ +++|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||+ +.++.+||+|||+
T Consensus 80 ~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 154 (296)
T 3uzp_A 80 NVMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGL 154 (296)
T ss_dssp EEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTT
T ss_pred eEEEEEec-CCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCC
Confidence 69999999 999999997332 3489999999999999999999998 99999999999999 4888999999999
Q ss_pred cccCCCCCcee-----eeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhh-h
Q 014363 241 ARLGPSEGFTH-----VSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKP-Y 314 (426)
Q Consensus 241 a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~-~ 314 (426)
+.......... ......||+.|+|||++.+..++.++||||||+++|+|++|..||................. .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 234 (296)
T 3uzp_A 155 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK 234 (296)
T ss_dssp CEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccc
Confidence 98654432211 12356799999999999999999999999999999999999999986443222211111110 0
Q ss_pred hhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhh
Q 014363 315 LSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 373 (426)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~ 373 (426)
.... . . .....++..+.+++.+||+.||++|||+.+|++.|+.+....
T Consensus 235 ~~~~--~-~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 282 (296)
T 3uzp_A 235 MSTP--I-E--------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp HHSC--H-H--------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred cCCc--h-H--------HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence 0000 0 0 001123468999999999999999999999999999987664
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-46 Score=362.15 Aligned_cols=243 Identities=29% Similarity=0.373 Sum_probs=191.5
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-----CHHHHHHHHHH-HhhcCCCCccceEeEEEcc
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-----GHKEWMTEVNF-LGIVEHQNLVKLVGYCADD 157 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-----~~~~~~~E~~~-l~~l~HpnIv~~~~~~~~~ 157 (426)
.++|+.+++||+|+||.||+|.++.++. .||+|.+.... ....+..|..+ ++.++||||+++++++.+.
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~-----~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~ 111 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEV-----FYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA 111 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCC-----EEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECS
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCC-----EEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeC
Confidence 4579999999999999999999887654 89999986442 23456677776 5678999999999999886
Q ss_pred CCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEee
Q 014363 158 DERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 237 (426)
Q Consensus 158 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~D 237 (426)
+ ..|+||||++||+|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.+|.+||+|
T Consensus 112 ~----~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~D 182 (373)
T 2r5t_A 112 D----KLYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTD 182 (373)
T ss_dssp S----EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECC
T ss_pred C----EEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEee
Confidence 5 469999999999999998653 3488999999999999999999998 999999999999999999999999
Q ss_pred ecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh
Q 014363 238 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 317 (426)
Q Consensus 238 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 317 (426)
||+++...... ......+||+.|+|||++.+..|+.++|||||||++|||++|..||.........
T Consensus 183 FG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~------------ 248 (373)
T 2r5t_A 183 FGLCKENIEHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY------------ 248 (373)
T ss_dssp CCBCGGGBCCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHH------------
T ss_pred CccccccccCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHH------------
Confidence 99998633221 1234578999999999999999999999999999999999999999764322111
Q ss_pred hhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHH
Q 014363 318 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMS 360 (426)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ 360 (426)
..++...+ .++..++..+.+||.+||+.||++||++.
T Consensus 249 ----~~i~~~~~--~~~~~~~~~~~~li~~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 249 ----DNILNKPL--QLKPNITNSARHLLEGLLQKDRTKRLGAK 285 (373)
T ss_dssp ----HHHHHSCC--CCCSSSCHHHHHHHHHHTCSSGGGSTTTT
T ss_pred ----HHHHhccc--CCCCCCCHHHHHHHHHHcccCHHhCCCCC
Confidence 11111111 12223557899999999999999999985
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-46 Score=364.36 Aligned_cols=250 Identities=24% Similarity=0.389 Sum_probs=195.1
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcC--CCCccceEeEEEccC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVE--HQNLVKLVGYCADDD 158 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~--HpnIv~~~~~~~~~~ 158 (426)
.+|.+.+.||+|+||.||+|.+.. + ..||+|.+.... ..+.+.+|+.+|..++ ||||+++++++....
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~-----~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~ 129 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEK-K-----QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 129 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTT-C-----CEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred CceEEEEEEccCCCeEEEEEEcCC-C-----CEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCC
Confidence 459999999999999999998654 2 379999886443 2356889999999996 599999999998765
Q ss_pred CCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeee
Q 014363 159 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 238 (426)
Q Consensus 159 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 238 (426)
..|+||| +.+++|.+++.... .+++..++.++.||+.||.|||++ +|+||||||+|||++ ++.+||+||
T Consensus 130 ----~~~lv~E-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DF 198 (390)
T 2zmd_A 130 ----YIYMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDF 198 (390)
T ss_dssp ----EEEEEEE-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCC
T ss_pred ----EEEEEEe-cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEec
Confidence 4699999 55889999997543 488899999999999999999998 999999999999996 579999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCchhhcc-----------CCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHH
Q 014363 239 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT-----------GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKL 307 (426)
Q Consensus 239 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~ 307 (426)
|+++..............+||+.|+|||++.+ ..++.++|||||||++|||++|..||.......
T Consensus 199 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~---- 274 (390)
T 2zmd_A 199 GIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI---- 274 (390)
T ss_dssp SSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH----
T ss_pred CccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH----
Confidence 99987654332223345689999999999875 368899999999999999999999997543211
Q ss_pred HHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014363 308 LQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMV 366 (426)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L 366 (426)
..+..++++.....++...+..+.+|+.+||+.||++|||+.|++++-
T Consensus 275 -----------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp 322 (390)
T 2zmd_A 275 -----------SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 322 (390)
T ss_dssp -----------HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred -----------HHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence 111222222222222223356789999999999999999999999873
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=366.20 Aligned_cols=251 Identities=23% Similarity=0.339 Sum_probs=192.9
Q ss_pred HHhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----------CHHHHHHHHHHHhhcCCCCccceE
Q 014363 82 SATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----------GHKEWMTEVNFLGIVEHQNLVKLV 151 (426)
Q Consensus 82 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----------~~~~~~~E~~~l~~l~HpnIv~~~ 151 (426)
...++|...+.||+|+||.||+|.+..++. .||+|.+.... ....+.+|+.+|++++||||++++
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~ 206 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCK-----KVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIK 206 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCC-----EEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCC
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCc-----EEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEE
Confidence 346789999999999999999999887654 89999885432 123578999999999999999999
Q ss_pred eEEEccCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCC
Q 014363 152 GYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW 231 (426)
Q Consensus 152 ~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~ 231 (426)
+++... ..|+||||+++|+|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++
T Consensus 207 ~~~~~~-----~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~ 276 (419)
T 3i6u_A 207 NFFDAE-----DYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQE 276 (419)
T ss_dssp EEEESS-----EEEEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSS
T ss_pred EEEecC-----ceEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCC
Confidence 998643 358999999999999998654 3489999999999999999999998 999999999999997544
Q ss_pred ---CeeEeeecccccCCCCCceeeeeeeecCcccCCchhhcc---CCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhH
Q 014363 232 ---NAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT---GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQ 305 (426)
Q Consensus 232 ---~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~ 305 (426)
.+||+|||+++..... ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.........
T Consensus 277 ~~~~~kl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~ 353 (419)
T 3i6u_A 277 EDCLIKITDFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL 353 (419)
T ss_dssp SSCCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCH
T ss_pred CcceEEEeecccceecCCC---ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHH
Confidence 5999999999875432 22345789999999999853 56788999999999999999999999754322111
Q ss_pred HHHHhHhhhhhhhhhhhhhcCCcCC--CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 306 KLLQWVKPYLSDAKQFRQIVDPRLE--GKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
... +...... ......++..+.+|+.+||+.||++|||+.|+++|
T Consensus 354 --~~~-------------i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 354 --KDQ-------------ITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp --HHH-------------HHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred --HHH-------------HhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 000 0000000 00011245789999999999999999999999986
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-46 Score=357.10 Aligned_cols=242 Identities=24% Similarity=0.361 Sum_probs=201.6
Q ss_pred HhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----------CHHHHHHHHHHHhhcCCCCccceEe
Q 014363 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----------GHKEWMTEVNFLGIVEHQNLVKLVG 152 (426)
Q Consensus 83 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----------~~~~~~~E~~~l~~l~HpnIv~~~~ 152 (426)
..++|...+.||+|+||.||+|.+..++ ..||+|.+.... ....+.+|+.+|+.++||||+++++
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~ 96 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKN-----KEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLD 96 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTT-----EEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEE
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCC-----cEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 4568999999999999999999987665 389999886543 2345778999999999999999999
Q ss_pred EEEccCCCCceEEEEEeeCCCC-ChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCC
Q 014363 153 YCADDDERGIQRLLVYEYMPNG-SVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW 231 (426)
Q Consensus 153 ~~~~~~~~~~~~~lv~E~~~~g-~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~ 231 (426)
++.+.. ..++||||+.+| +|.+++.... .+++..++.|+.||+.||.|||++ +|+||||||+|||++.++
T Consensus 97 ~~~~~~----~~~lv~e~~~~g~~l~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~ 167 (335)
T 3dls_A 97 IFENQG----FFQLVMEKHGSGLDLFAFIDRHP--RLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDF 167 (335)
T ss_dssp EEECSS----EEEEEEECCTTSCBHHHHHHTCC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTS
T ss_pred EEeeCC----EEEEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCC
Confidence 998765 459999999766 9999997543 489999999999999999999998 999999999999999999
Q ss_pred CeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCC-CCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHh
Q 014363 232 NAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRL-AARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQW 310 (426)
Q Consensus 232 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~ 310 (426)
.+||+|||++........ ....+||+.|+|||++.+..+ +.++||||||+++|+|++|..||.....
T Consensus 168 ~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------- 235 (335)
T 3dls_A 168 TIKLIDFGSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE--------- 235 (335)
T ss_dssp CEEECCCTTCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG---------
T ss_pred cEEEeecccceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH---------
Confidence 999999999987654322 234679999999999988887 7899999999999999999999964211
Q ss_pred HhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 311 VKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
....... .+..++..+.+|+.+||+.||++|||+.+++++
T Consensus 236 -------------~~~~~~~--~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 236 -------------TVEAAIH--PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp -------------GTTTCCC--CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred -------------HHhhccC--CCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111111 111245689999999999999999999999997
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=356.60 Aligned_cols=260 Identities=15% Similarity=0.173 Sum_probs=206.4
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhcC---CCCccceEeEEEccCCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVE---HQNLVKLVGYCADDDER 160 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l~---HpnIv~~~~~~~~~~~~ 160 (426)
.++|.+.+.||+|+||.||+|.+...........||+|.+... ....+..|+.++..++ |+||+++++++...+.
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~- 141 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNG- 141 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSC-
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCC-
Confidence 5679999999999999999997554444445568999998654 4567888999888886 9999999999988764
Q ss_pred CceEEEEEeeCCCCChhhhccCC---CCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCC--------
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPK---SETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE-------- 229 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~---~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~-------- 229 (426)
.||||||+++|+|.+++... ....+++..++.|+.||+.||+|||++ +|+||||||+||||+.
T Consensus 142 ---~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 142 ---SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp ---EEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC---
T ss_pred ---cEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCcccc
Confidence 49999999999999999631 234599999999999999999999998 9999999999999998
Q ss_pred ---CCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHH
Q 014363 230 ---QWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQK 306 (426)
Q Consensus 230 ---~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~ 306 (426)
++.+||+|||+++..............+||+.|+|||++.+..|+.++|||||||++|||++|+.||.......
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--- 292 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE--- 292 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE---
T ss_pred ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc---
Confidence 89999999999975432222333456789999999999999999999999999999999999999995322100
Q ss_pred HHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCC-CCHHHHHHHHHHhHhhh
Q 014363 307 LLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTR-PKMSEVLEMVNKIVDAS 373 (426)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R-Ps~~eil~~L~~~~~~~ 373 (426)
.. ....+.. + ...+.+.+++..||+.+|.+| |+++++.+.|+..+...
T Consensus 293 ------------~~----~~~~~~~-~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 293 ------------CK----PEGLFRR-L--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp ------------EE----ECSCCTT-C--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred ------------ee----echhccc-c--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence 00 1111111 1 135577889999999999999 68889988898887653
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-45 Score=348.03 Aligned_cols=262 Identities=21% Similarity=0.291 Sum_probs=203.3
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhcC-CCCccceEeEEEccCCCCc
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVE-HQNLVKLVGYCADDDERGI 162 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~~~~~~~~ 162 (426)
.++|++.+.||+|+||.||+|.+..++. .||+|.+... ..+.+.+|+.++..++ ||||+++++++.+....
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vavK~~~~~-~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~-- 106 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNE-----KVVVKILKPV-KKKKIKREIKILENLRGGPNIITLADIVKDPVSR-- 106 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCC-----EEEEEEECSC-CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC--
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCc-----EEEEEEeccc-chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCC--
Confidence 3579999999999999999999876654 8999998643 4578899999999997 99999999999875433
Q ss_pred eEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCC-CeeEeeeccc
Q 014363 163 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW-NAKLSDFGLA 241 (426)
Q Consensus 163 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~-~~kl~DFGla 241 (426)
..++||||+++++|.+++.. +++..++.++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||++
T Consensus 107 ~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a 178 (330)
T 3nsz_A 107 TPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLA 178 (330)
T ss_dssp CEEEEEECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred ceEEEEeccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCc
Confidence 45999999999999999842 88899999999999999999998 999999999999999776 8999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhh-h--
Q 014363 242 RLGPSEGFTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS-D-- 317 (426)
Q Consensus 242 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~-- 317 (426)
........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||......... +......... .
T Consensus 179 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~-l~~~~~~~~~~~~~ 254 (330)
T 3nsz_A 179 EFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ-LVRIAKVLGTEDLY 254 (330)
T ss_dssp EECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH-HHHHHHHHCHHHHH
T ss_pred eEcCCCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHH-HHHHHHhcCCchhh
Confidence 86554321 234579999999999877 67899999999999999999999999654433221 1111100000 0
Q ss_pred ----------hhhhhhhcCC--------cCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 318 ----------AKQFRQIVDP--------RLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 318 ----------~~~~~~~~~~--------~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
...+...... .........++..+.+||.+||+.||++|||++|+++|
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 255 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred hHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0000111100 01111122256789999999999999999999999986
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=354.09 Aligned_cols=259 Identities=28% Similarity=0.474 Sum_probs=206.6
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc---CCHHHHHHHHHHHhhc-CCCCccceEeEEEccCCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR---GGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDER 160 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~---~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~~ 160 (426)
++|...+.||+|+||.||+|.+..++. ...+++|.+... ...+.+.+|+.++..+ +||||+++++++.+.+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~-- 99 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGL---RMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG-- 99 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTE---EEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT--
T ss_pred HHccceeeeecCCCceEEEEEEccCCc---ccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC--
Confidence 578999999999999999999876542 224588887543 2445788999999999 9999999999998765
Q ss_pred CceEEEEEeeCCCCChhhhccCCC--------------CCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceE
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKS--------------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNIL 226 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NIL 226 (426)
..|+||||+++|+|.+++.... ...+++..++.++.||+.||.|||++ +|+||||||+|||
T Consensus 100 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl 174 (327)
T 1fvr_A 100 --YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNIL 174 (327)
T ss_dssp --EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred --ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEE
Confidence 4599999999999999997543 23589999999999999999999998 9999999999999
Q ss_pred eCCCCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhH
Q 014363 227 LDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQ 305 (426)
Q Consensus 227 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~ 305 (426)
++.++.+||+|||++..... ........+++.|+|||++.+..++.++||||||+++|+|++ |..||.......
T Consensus 175 ~~~~~~~kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~-- 249 (327)
T 1fvr_A 175 VGENYVAKIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-- 249 (327)
T ss_dssp ECGGGCEEECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--
T ss_pred EcCCCeEEEcccCcCccccc---cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH--
Confidence 99999999999999974322 111233467889999999998889999999999999999998 999997654321
Q ss_pred HHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhh
Q 014363 306 KLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 373 (426)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~ 373 (426)
+... +........+..++..+.+|+.+||+.||++|||+.+++++|+.+....
T Consensus 250 -~~~~--------------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 302 (327)
T 1fvr_A 250 -LYEK--------------LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302 (327)
T ss_dssp -HHHH--------------GGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred -HHHH--------------hhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence 1110 0001111222345578999999999999999999999999999988654
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=381.31 Aligned_cols=257 Identities=26% Similarity=0.447 Sum_probs=208.5
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCc
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 162 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~ 162 (426)
.++|.+.+.||+|+||.||+|.+... ..||+|.+.... ..+.|.+|+.+|+.++||||+++++++.+ ..
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~------~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~--- 335 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGT------TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP--- 335 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTT------EEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS---
T ss_pred hhhhhhheecccCCCeEEEEEEECCC------ceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-cc---
Confidence 45688889999999999999998753 269999987543 55789999999999999999999999865 22
Q ss_pred eEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccc
Q 014363 163 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 242 (426)
Q Consensus 163 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 242 (426)
.||||||+++|+|.+++.......+++..++.|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++
T Consensus 336 -~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 411 (535)
T 2h8h_A 336 -IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLAR 411 (535)
T ss_dssp -CEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTT
T ss_pred -ceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccce
Confidence 48999999999999999754334589999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhh
Q 014363 243 LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 321 (426)
Q Consensus 243 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (426)
....... .......++..|+|||++.++.++.++|||||||+||||++ |..||......... ..+.
T Consensus 412 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~---~~i~--------- 478 (535)
T 2h8h_A 412 LIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL---DQVE--------- 478 (535)
T ss_dssp TCCCHHH-HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHH---HHHH---------
T ss_pred ecCCCce-ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHHH---------
Confidence 6543211 11123456789999999999999999999999999999999 99999765432111 1110
Q ss_pred hhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 014363 322 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 372 (426)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~ 372 (426)
.......+..++..+.+||.+||+.||++|||+++|++.|+.+...
T Consensus 479 -----~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 479 -----RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp -----TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred -----cCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 0111112234567899999999999999999999999999987644
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-46 Score=354.92 Aligned_cols=250 Identities=26% Similarity=0.385 Sum_probs=180.2
Q ss_pred cceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhcC-CCCccceEeEEEccCCCCceEEEEE
Q 014363 90 SVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVE-HQNLVKLVGYCADDDERGIQRLLVY 168 (426)
Q Consensus 90 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~~~~~~~~~~~lv~ 168 (426)
.+.||+|+||.||+|.+..++. .||+|.+... ....+.+|+.++..+. ||||+++++++.+.. ..|+||
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~-----~vavK~~~~~-~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~----~~~lv~ 85 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQ-----AFAVKIISKR-MEANTQKEITALKLCEGHPNIVKLHEVFHDQL----HTFLVM 85 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCC-----EEEEEEEEGG-GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS----EEEEEE
T ss_pred CCccccCCCeEEEEEEECCCCC-----EEEEEEEChh-hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCC----EEEEEE
Confidence 4789999999999999877654 8999998654 3467789999999996 999999999998765 459999
Q ss_pred eeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCC---CeeEeeecccccCC
Q 014363 169 EYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW---NAKLSDFGLARLGP 245 (426)
Q Consensus 169 E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~---~~kl~DFGla~~~~ 245 (426)
||+++|+|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||++....
T Consensus 86 e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~ 160 (325)
T 3kn6_A 86 ELLNGGELFERIKKK--KHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP 160 (325)
T ss_dssp CCCCSCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECC
T ss_pred EccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecC
Confidence 999999999999754 3489999999999999999999998 999999999999997765 79999999998654
Q ss_pred CCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhc
Q 014363 246 SEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIV 325 (426)
Q Consensus 246 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (426)
... ......+||+.|+|||++.+..++.++||||||+++|+|++|..||.......... ........+.
T Consensus 161 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~---------~~~~~~~~i~ 229 (325)
T 3kn6_A 161 PDN--QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCT---------SAVEIMKKIK 229 (325)
T ss_dssp C------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CC---------CHHHHHHHHT
T ss_pred CCC--CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccc---------cHHHHHHHHH
Confidence 432 22345678999999999999999999999999999999999999997543211000 0001111111
Q ss_pred CCcC--CCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 326 DPRL--EGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 326 ~~~~--~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.... .......++..+.+|+.+||+.||++|||+.|++++
T Consensus 230 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 230 KGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp TTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred cCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 1111 111112456789999999999999999999999875
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=346.66 Aligned_cols=272 Identities=24% Similarity=0.371 Sum_probs=204.6
Q ss_pred HHhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhc--CCCCccceEeEEEccCC
Q 014363 82 SATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIV--EHQNLVKLVGYCADDDE 159 (426)
Q Consensus 82 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l--~HpnIv~~~~~~~~~~~ 159 (426)
...++|++.+.||+|+||.||+|.+.+ ..||+|.+.... ...+..|.+++..+ +||||+++++++.+...
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~vavK~~~~~~-~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWRG-------EKVAVKVFFTTE-EASWFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEETT-------EEEEEEEEEGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred ccccceEEEeEeecCCCeEEEEEEECC-------ceEEEEEEeccc-cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 345689999999999999999998752 379999985443 34455666666554 99999999999987754
Q ss_pred CCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCC-----CCCeEeccCCCCceEeCCCCCee
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGM-----DFQIIVRDFKSSNILLDEQWNAK 234 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~-----~~~iiHrDlkp~NILl~~~~~~k 234 (426)
.....++||||+++|+|.+++... .+++..++.++.|++.||.|||++. ..+|+||||||+|||++.++.+|
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 182 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCC 182 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred CCCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEE
Confidence 334679999999999999999643 3899999999999999999999741 23899999999999999999999
Q ss_pred EeeecccccCCCCCcee--eeeeeecCcccCCchhhccCCCCCc------hhhHHHHHHHHHHHhC----------CCCC
Q 014363 235 LSDFGLARLGPSEGFTH--VSTAVVGTMGYAAPEYVQTGRLAAR------SDVWSYGVFLYELITG----------RRPI 296 (426)
Q Consensus 235 l~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------~DvwslGvil~elltg----------~~p~ 296 (426)
|+|||++.......... ......||+.|+|||++.+..+... +|||||||++|||++| ..||
T Consensus 183 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~ 262 (337)
T 3mdy_A 183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY 262 (337)
T ss_dssp ECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccH
Confidence 99999997654332111 1224579999999999988776665 9999999999999999 6666
Q ss_pred CCCCchhhH--HHHHhHhhhhhhhhhhhhhcCCcCCCcc-cHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhh
Q 014363 297 DRNRPRSEQ--KLLQWVKPYLSDAKQFRQIVDPRLEGKY-SLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 373 (426)
Q Consensus 297 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~ 373 (426)
......... ...... ......+.....+ ...++..+.+|+.+||+.||++|||+.||+++|+.+.+..
T Consensus 263 ~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 263 HDLVPSDPSYEDMREIV---------CIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp TTTSCSSCCHHHHHHHH---------TTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred hhhcCCCCchhhhHHHH---------hhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 543221110 000000 0001111111111 2367889999999999999999999999999999987653
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=348.43 Aligned_cols=269 Identities=26% Similarity=0.400 Sum_probs=209.7
Q ss_pred HHHhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhh--cCCCCccceEeEEEccC
Q 014363 81 KSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGI--VEHQNLVKLVGYCADDD 158 (426)
Q Consensus 81 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~--l~HpnIv~~~~~~~~~~ 158 (426)
....++|.+.+.||+|+||.||+|.+.+ ..||+|.+... ....+.+|++++.. ++||||+++++++....
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~-~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~ 109 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKWRG-------EEVAVKIFSSR-EERSWFREAEIYQTVMLRHENILGFIAADNKDN 109 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEETT-------EEEEEEEECGG-GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEEcC-------ccEEEEEeCch-hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence 3456789999999999999999998742 37999998654 34567889999887 79999999999998876
Q ss_pred CCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhc--------cCCCCCeEeccCCCCceEeCCC
Q 014363 159 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLH--------EGMDFQIIVRDFKSSNILLDEQ 230 (426)
Q Consensus 159 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH--------~~~~~~iiHrDlkp~NILl~~~ 230 (426)
......++||||+++|+|.+++... .+++..++.++.|++.||.||| +. +|+||||||+|||++.+
T Consensus 110 ~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~ 183 (342)
T 1b6c_B 110 GTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKN 183 (342)
T ss_dssp SSCCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTT
T ss_pred CccceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCC
Confidence 4333569999999999999999653 3899999999999999999999 77 99999999999999999
Q ss_pred CCeeEeeecccccCCCCCcee--eeeeeecCcccCCchhhccCC------CCCchhhHHHHHHHHHHHhC----------
Q 014363 231 WNAKLSDFGLARLGPSEGFTH--VSTAVVGTMGYAAPEYVQTGR------LAARSDVWSYGVFLYELITG---------- 292 (426)
Q Consensus 231 ~~~kl~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslGvil~elltg---------- 292 (426)
+.+||+|||++.......... ......||+.|+|||++.+.. ++.++||||||+++|||++|
T Consensus 184 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~ 263 (342)
T 1b6c_B 184 GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 263 (342)
T ss_dssp SCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred CCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccc
Confidence 999999999997654432211 223457999999999988753 33689999999999999999
Q ss_pred CCCCCCCCchhh--HHHHHhHhhhhhhhhhhhhhcCCcCCCc-ccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHh
Q 014363 293 RRPIDRNRPRSE--QKLLQWVKPYLSDAKQFRQIVDPRLEGK-YSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 369 (426)
Q Consensus 293 ~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~ 369 (426)
..||........ ..+.... ......+.+... .....+..+.+|+.+||+.||++|||+.+|+++|+.+
T Consensus 264 ~~p~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i 334 (342)
T 1b6c_B 264 QLPYYDLVPSDPSVEEMRKVV---------CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334 (342)
T ss_dssp CCTTTTTSCSSCCHHHHHHHH---------TTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCccccCcCcccHHHHHHHH---------HHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 778865432111 1111000 001111222211 1236778899999999999999999999999999998
Q ss_pred Hhh
Q 014363 370 VDA 372 (426)
Q Consensus 370 ~~~ 372 (426)
...
T Consensus 335 ~~~ 337 (342)
T 1b6c_B 335 SQQ 337 (342)
T ss_dssp HHT
T ss_pred HHH
Confidence 765
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=348.53 Aligned_cols=264 Identities=22% Similarity=0.365 Sum_probs=198.8
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-----CHHHHHHHHHHHhhcCCCCccceEeEEEccC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 158 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 158 (426)
.++|.+.+.||+|+||.||+|....++. .||+|.+.... ....+.+|+.+++.++||||+++++++.+..
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 105 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGV-----PVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN 105 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCC-----EEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCc-----eEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 4579999999999999999999876543 89999886422 2356889999999999999999999998765
Q ss_pred CCCceEEEEEeeCCCCChhhhccCC--CCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEe
Q 014363 159 ERGIQRLLVYEYMPNGSVDQYLSPK--SETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLS 236 (426)
Q Consensus 159 ~~~~~~~lv~E~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~ 236 (426)
..++||||+++++|.+++... ....+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+
T Consensus 106 ----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~ 178 (310)
T 2wqm_A 106 ----ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLG 178 (310)
T ss_dssp ----EEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEEC
T ss_pred ----cEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEE
Confidence 459999999999999998631 234589999999999999999999998 99999999999999999999999
Q ss_pred eecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhh
Q 014363 237 DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS 316 (426)
Q Consensus 237 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 316 (426)
|||++....... .......|++.|+|||++.+..++.++||||||+++|+|++|..||........ .+...
T Consensus 179 Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~------ 249 (310)
T 2wqm_A 179 DLGLGRFFSSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-SLCKK------ 249 (310)
T ss_dssp CC--------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHH-HHHHH------
T ss_pred eccceeeecCCC--ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHH-HHHHH------
Confidence 999997654322 122345799999999999999999999999999999999999999975432211 11110
Q ss_pred hhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhhcc
Q 014363 317 DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASAE 375 (426)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~~~ 375 (426)
+............++..+.+++.+||+.||++|||+.+|++.|+.+......
T Consensus 250 -------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~ 301 (310)
T 2wqm_A 250 -------IEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS 301 (310)
T ss_dssp -------HHTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred -------hhcccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence 0011111111123556899999999999999999999999999999876544
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=371.82 Aligned_cols=252 Identities=25% Similarity=0.349 Sum_probs=205.8
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-----CCHHHHHHHHHHHhhcCCCCccceEeEEEccCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-----GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
++|...++||+|+||.||+|.++.++. .||+|.+... .....+.+|+.+|..++||||+++++++.+..
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~-----~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~- 258 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGK-----LYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKT- 258 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCC-----EEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCc-----EEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCC-
Confidence 578889999999999999999876654 8999998543 34567889999999999999999999998765
Q ss_pred CCceEEEEEeeCCCCChhhhccCCC--CCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEee
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPKS--ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 237 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~D 237 (426)
..|+||||++||+|.+++.... ...+++..++.++.||+.||.|||++ +|+||||||+|||++.+|.+||+|
T Consensus 259 ---~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~D 332 (543)
T 3c4z_A 259 ---DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISD 332 (543)
T ss_dssp ---EEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECC
T ss_pred ---EEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEee
Confidence 4599999999999999986543 34599999999999999999999998 999999999999999999999999
Q ss_pred ecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchh-hHHHHHhHhhhhh
Q 014363 238 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRS-EQKLLQWVKPYLS 316 (426)
Q Consensus 238 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~-~~~~~~~~~~~~~ 316 (426)
||+++....... .....+||+.|+|||++.+..|+.++|||||||++|||++|..||....... ...+..
T Consensus 333 FGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~------- 403 (543)
T 3c4z_A 333 LGLAVELKAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ------- 403 (543)
T ss_dssp CTTCEECCTTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHH-------
T ss_pred cceeeeccCCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHH-------
Confidence 999987654321 2334689999999999999999999999999999999999999997653211 111111
Q ss_pred hhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCH-----HHHHHH
Q 014363 317 DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKM-----SEVLEM 365 (426)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~-----~eil~~ 365 (426)
.+.... ..++..++..+.+||.+||+.||++||++ ++|++|
T Consensus 404 ------~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 404 ------RVLEQA--VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp ------HHHHCC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred ------HHhhcc--cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 111111 12233456789999999999999999965 677764
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=343.13 Aligned_cols=251 Identities=22% Similarity=0.341 Sum_probs=203.1
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
.++|++.+.||+|+||.||+|.+..++. .||+|.+.... ..+.+.+|+.+++.++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 78 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGL-----EFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEES- 78 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCC-----EEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCc-----eEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCC-
Confidence 5689999999999999999999877654 79999886543 2356789999999999999999999998765
Q ss_pred CCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCC---eeEe
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWN---AKLS 236 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~---~kl~ 236 (426)
..++||||+++++|.+++... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++. +||+
T Consensus 79 ---~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~ 150 (284)
T 3kk8_A 79 ---FHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLA 150 (284)
T ss_dssp ---EEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEEC
T ss_pred ---EEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEe
Confidence 459999999999998888644 3489999999999999999999998 9999999999999986655 9999
Q ss_pred eecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhh
Q 014363 237 DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS 316 (426)
Q Consensus 237 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 316 (426)
|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||...........+. .
T Consensus 151 Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~---~--- 221 (284)
T 3kk8_A 151 DFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK---A--- 221 (284)
T ss_dssp CCTTCEECCSSC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---H---
T ss_pred eceeeEEcccCc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHH---h---
Confidence 999997655432 1234679999999999999999999999999999999999999997644322111110 0
Q ss_pred hhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 317 DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
... .........+++.+.+++.+||+.||++|||+.|++++
T Consensus 222 ------~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 222 ------GAY--DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp ------TCC--CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ------ccc--cCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 000 00111112345689999999999999999999999986
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=342.07 Aligned_cols=250 Identities=22% Similarity=0.330 Sum_probs=202.0
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc--CCHHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR--GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
.++|.+.+.||+|+||.||+|.+..++. .+++|.+... ...+.+.+|+.+++.++||||+++++++.+..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--- 79 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRI-----RRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNT--- 79 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCC-----EEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS---
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCc-----EEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCC---
Confidence 4579999999999999999999877654 7889987543 35678899999999999999999999998765
Q ss_pred ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEe---CCCCCeeEeee
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL---DEQWNAKLSDF 238 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl---~~~~~~kl~DF 238 (426)
..++||||+++++|.+++... ..+++..++.++.|++.||.|||++ +|+||||||+|||+ +.++.+||+||
T Consensus 80 -~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Df 153 (277)
T 3f3z_A 80 -DIYLVMELCTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDF 153 (277)
T ss_dssp -EEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred -eEEEEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEec
Confidence 459999999999999988654 3489999999999999999999998 99999999999999 78899999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014363 239 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 318 (426)
Q Consensus 239 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 318 (426)
|++....... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||...........+. . .
T Consensus 154 g~~~~~~~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~--~----~- 222 (277)
T 3f3z_A 154 GLAARFKPGK---MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIR--E----G- 222 (277)
T ss_dssp TTCEECCTTS---CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--H----C-
T ss_pred ccceeccCcc---chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHH--h----C-
Confidence 9998655432 2234579999999998865 48999999999999999999999997654322111100 0 0
Q ss_pred hhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 319 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
...........++..+.+++.+||+.||++|||+.+++++
T Consensus 223 -------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 223 -------TFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp -------CCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred -------CCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000001245789999999999999999999999985
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=352.46 Aligned_cols=264 Identities=24% Similarity=0.316 Sum_probs=203.3
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC--CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
.++|...+.||+|+||.||+|....++. .||+|.+.... ..+.+.+|+.+++.++||||+++++++.......
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGH-----FYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAK 102 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCC-----EEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCc-----EEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCC
Confidence 4579999999999999999999866554 89999875432 3457889999999999999999999997544334
Q ss_pred ceEEEEEeeCCCCChhhhccCC--CCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeec
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPK--SETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 239 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 239 (426)
...++||||+++|+|.+++... ....+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 103 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg 179 (317)
T 2buj_A 103 HEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLG 179 (317)
T ss_dssp EEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCS
T ss_pred ceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecC
Confidence 4679999999999999988642 234589999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCcee-------eeeeeecCcccCCchhhccCC---CCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHH
Q 014363 240 LARLGPSEGFTH-------VSTAVVGTMGYAAPEYVQTGR---LAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQ 309 (426)
Q Consensus 240 la~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~ 309 (426)
++.......... ......||+.|+|||++.+.. ++.++||||||+++|+|++|..||.......
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------ 253 (317)
T 2buj_A 180 SMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG------ 253 (317)
T ss_dssp SCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT------
T ss_pred cchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc------
Confidence 987543210000 011345799999999987654 6899999999999999999999995311000
Q ss_pred hHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhH
Q 014363 310 WVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIV 370 (426)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~ 370 (426)
..................++..+.+++.+||+.||++|||+.+++++|+.+.
T Consensus 254 ---------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 254 ---------DSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp ---------SCHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred ---------chhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 0000000001111112235578999999999999999999999999998764
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=346.01 Aligned_cols=255 Identities=24% Similarity=0.399 Sum_probs=206.9
Q ss_pred HhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhcCCCCccceEeEEEccC----
Q 014363 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQNLVKLVGYCADDD---- 158 (426)
Q Consensus 83 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~---- 158 (426)
..++|+..+.||+|+||.||+|.+..++. .|++|.+.... +.+.+|+.+++.++||||+++++++....
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vavK~~~~~~--~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGK-----TYVIKRVKYNN--EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPE 81 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCC-----EEEEEEEECCS--GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCe-----EEEEEEecccc--HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence 34679999999999999999999876544 79999886543 46789999999999999999999886421
Q ss_pred --------CCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCC
Q 014363 159 --------ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQ 230 (426)
Q Consensus 159 --------~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~ 230 (426)
......++||||+++++|.+++.......+++..++.++.|++.||.|||++ +|+||||||+|||++.+
T Consensus 82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~ 158 (284)
T 2a19_B 82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDT 158 (284)
T ss_dssp -------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEET
T ss_pred cccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCC
Confidence 1123469999999999999999755445689999999999999999999998 99999999999999999
Q ss_pred CCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHh
Q 014363 231 WNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQW 310 (426)
Q Consensus 231 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~ 310 (426)
+.+||+|||++........ .....||+.|+|||++.+..++.++||||||+++|+|++|..|+... ...
T Consensus 159 ~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-----~~~--- 227 (284)
T 2a19_B 159 KQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-----SKF--- 227 (284)
T ss_dssp TEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-----HHH---
T ss_pred CCEEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-----HHH---
Confidence 9999999999987654321 23457999999999999999999999999999999999999886311 000
Q ss_pred HhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 014363 311 VKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 372 (426)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~ 372 (426)
...+....+.. .++..+.+++.+||+.||++|||+.|++++|..+...
T Consensus 228 ----------~~~~~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 228 ----------FTDLRDGIISD----IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp ----------HHHHHTTCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred ----------HHHhhcccccc----cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 11111111222 2346788999999999999999999999999887543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=354.06 Aligned_cols=264 Identities=27% Similarity=0.406 Sum_probs=202.0
Q ss_pred CHHHHHHHhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-CCHHHHHHHHHHHhhc-CCCCccceEeE
Q 014363 76 TIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-GGHKEWMTEVNFLGIV-EHQNLVKLVGY 153 (426)
Q Consensus 76 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~~~~~ 153 (426)
++.++....++|.+.+.||+|+||.||+|.+..++. .||+|.+... .....+.+|+.++..+ +||||++++++
T Consensus 15 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 89 (326)
T 2x7f_A 15 DLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQ-----LAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGA 89 (326)
T ss_dssp -CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCC-----EEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEE
T ss_pred cchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCC-----eEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeE
Confidence 333444457889999999999999999999876554 7999988544 3456789999999999 89999999999
Q ss_pred EEccCCC--CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCC
Q 014363 154 CADDDER--GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW 231 (426)
Q Consensus 154 ~~~~~~~--~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~ 231 (426)
+...... ....++||||+++|+|.+++.......+++..++.++.||+.||.|||++ +|+||||||+|||++.++
T Consensus 90 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~ 166 (326)
T 2x7f_A 90 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENA 166 (326)
T ss_dssp EEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTC
T ss_pred EeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCC
Confidence 9874311 23569999999999999999765445689999999999999999999998 999999999999999999
Q ss_pred CeeEeeecccccCCCCCceeeeeeeecCcccCCchhhc-----cCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHH
Q 014363 232 NAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQ-----TGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQK 306 (426)
Q Consensus 232 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~ 306 (426)
.+||+|||++....... .......||+.|+|||++. +..++.++||||||+++|+|++|..||..........
T Consensus 167 ~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~ 244 (326)
T 2x7f_A 167 EVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF 244 (326)
T ss_dssp CEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred CEEEeeCcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHH
Confidence 99999999997654321 1123457999999999987 5668999999999999999999999997654321111
Q ss_pred HHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 307 LLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.. .....+. .....++..+.+++.+||..||++||++.+++++
T Consensus 245 ~~-------------~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 245 LI-------------PRNPAPR---LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp HH-------------HHSCCCC---CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred Hh-------------hcCcccc---CCccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 10 0000011 1112245689999999999999999999999985
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=350.27 Aligned_cols=257 Identities=22% Similarity=0.357 Sum_probs=204.4
Q ss_pred HHHHhCCCCCc-ceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhc-CCCCccceEeE
Q 014363 80 LKSATKNFSRS-VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIV-EHQNLVKLVGY 153 (426)
Q Consensus 80 ~~~~~~~y~~~-~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l-~HpnIv~~~~~ 153 (426)
.....+.|.+. +.||+|+||.||+|.+..++. .||+|.+.... ....+.+|+.++..+ .||||++++++
T Consensus 23 ~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~ 97 (327)
T 3lm5_A 23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQ-----EYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV 97 (327)
T ss_dssp HHHHHHHEEEEEEEEEEETTEEEEEEEETTTCC-----EEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred HHhhhhEEeeccceeCCCCCeEEEEEEECCCCC-----EEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 34456677777 899999999999999876654 89999886432 356789999999999 56999999999
Q ss_pred EEccCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCC---C
Q 014363 154 CADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE---Q 230 (426)
Q Consensus 154 ~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~---~ 230 (426)
+.+.. ..++||||+++|+|.+++.......+++..++.++.|++.||+|||++ +|+||||||+|||++. +
T Consensus 98 ~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~ 170 (327)
T 3lm5_A 98 YENTS----EIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPL 170 (327)
T ss_dssp EECSS----EEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTB
T ss_pred EEeCC----eEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCC
Confidence 98765 459999999999999999766556799999999999999999999998 9999999999999987 7
Q ss_pred CCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHh
Q 014363 231 WNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQW 310 (426)
Q Consensus 231 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~ 310 (426)
+.+||+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||...........+.
T Consensus 171 ~~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~- 246 (327)
T 3lm5_A 171 GDIKIVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNIS- 246 (327)
T ss_dssp CCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-
T ss_pred CcEEEeeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHH-
Confidence 899999999998664322 1234679999999999999999999999999999999999999997654322111110
Q ss_pred HhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 311 VKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
. ............++..+.+++.+||+.||++|||+++++++
T Consensus 247 ------------~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 247 ------------Q-VNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp ------------H-TCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred ------------h-cccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 0 01111111222356789999999999999999999999986
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=353.00 Aligned_cols=284 Identities=25% Similarity=0.398 Sum_probs=202.1
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHH--HhhcCCCCccceEeEEEccC-CC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNF--LGIVEHQNLVKLVGYCADDD-ER 160 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~--l~~l~HpnIv~~~~~~~~~~-~~ 160 (426)
.++|.+.+.||+|+||.||+|...+ ..||+|.+.... ...+..|.++ +..++||||+++++++.... ..
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~-~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 83 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSLDE-------RPVAVKVFSFAN-RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADG 83 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETT-------EEEEEEEEEGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTS
T ss_pred hHHhheeeecccCCCeEEEEEEECC-------eEEEEEEeeccc-hhhHHHHHHHHHHHhccCcchhhheecccccccCC
Confidence 4689999999999999999997632 379999986443 3445555555 44589999999998765422 22
Q ss_pred CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCC------CCCeEeccCCCCceEeCCCCCee
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGM------DFQIIVRDFKSSNILLDEQWNAK 234 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~------~~~iiHrDlkp~NILl~~~~~~k 234 (426)
....++||||+++|+|.+++.... .++..++.++.||+.||.|||+.. ..+|+||||||+|||++.++.+|
T Consensus 84 ~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 84 RMEYLLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp CEEEEEEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred CceEEEEEecCCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEE
Confidence 335689999999999999996543 688999999999999999999752 12899999999999999999999
Q ss_pred EeeecccccCCCCCc------eeeeeeeecCcccCCchhhcc-------CCCCCchhhHHHHHHHHHHHhCCCCCCCCCc
Q 014363 235 LSDFGLARLGPSEGF------THVSTAVVGTMGYAAPEYVQT-------GRLAARSDVWSYGVFLYELITGRRPIDRNRP 301 (426)
Q Consensus 235 l~DFGla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslGvil~elltg~~p~~~~~~ 301 (426)
|+|||++........ ........||+.|+|||++.+ ..++.++|||||||++|||++|..||.....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 999999986543211 112234579999999999886 3466789999999999999999777643322
Q ss_pred hhh-HHHHHhHhhhhhhhhhhhhh-----cCCcCCCc--ccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhh
Q 014363 302 RSE-QKLLQWVKPYLSDAKQFRQI-----VDPRLEGK--YSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 373 (426)
Q Consensus 302 ~~~-~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~--~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~ 373 (426)
... .................... ..+.+... ....++..+.+||.+||+.||++|||++|+++.|+.++..+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~ 320 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIW 320 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCC
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHH
Confidence 111 00000000000000000010 11111111 12246778999999999999999999999999999999877
Q ss_pred ccCCC
Q 014363 374 AEAGS 378 (426)
Q Consensus 374 ~~~~~ 378 (426)
.....
T Consensus 321 ~~~~~ 325 (336)
T 3g2f_A 321 ERNKS 325 (336)
T ss_dssp CC---
T ss_pred Hhccc
Confidence 65443
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=341.96 Aligned_cols=253 Identities=22% Similarity=0.297 Sum_probs=201.5
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc------CCHHHHHHHHHHHhhcCCCCccceEeEEEcc
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR------GGHKEWMTEVNFLGIVEHQNLVKLVGYCADD 157 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~------~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 157 (426)
.++|.+.+.||+|+||.||+|.+..++. .+++|.+... .....+.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~-----~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 78 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLC-----RRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNE 78 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCC-----EEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCc-----EEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcC
Confidence 5789999999999999999999766554 7999988643 2346789999999999999999999998654
Q ss_pred CCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEee
Q 014363 158 DERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 237 (426)
Q Consensus 158 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~D 237 (426)
... ..|+||||++++ |.+++.......+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|
T Consensus 79 ~~~--~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~d 152 (305)
T 2wtk_C 79 EKQ--KMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISA 152 (305)
T ss_dssp -----CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred CCC--eEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeec
Confidence 432 459999999876 77777655556699999999999999999999998 999999999999999999999999
Q ss_pred ecccccCCCCCceeeeeeeecCcccCCchhhccCC--CCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhh
Q 014363 238 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGR--LAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYL 315 (426)
Q Consensus 238 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 315 (426)
||++................||+.|+|||++.+.. ++.++||||||+++|+|++|..||........... +.
T Consensus 153 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---i~--- 226 (305)
T 2wtk_C 153 LGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFEN---IG--- 226 (305)
T ss_dssp CTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HH---
T ss_pred cccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH---Hh---
Confidence 99998765433333344567999999999987644 37799999999999999999999976432211110 00
Q ss_pred hhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 316 SDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.. .. ..+..++..+.+++.+||+.||++|||+.|++++
T Consensus 227 -------~~-~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 227 -------KG-SY----AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp -------HC-CC----CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -------cC-CC----CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 00 1122345688899999999999999999999987
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=342.34 Aligned_cols=246 Identities=25% Similarity=0.421 Sum_probs=203.9
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-----CCHHHHHHHHHHHhhcCCCCccceEeEEEccC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-----GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 158 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 158 (426)
.++|.+.+.||+|+||.||+|.+..++ ..|++|.+... .....+.+|+.+++.++||||+++++++.+..
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 87 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNK-----FIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRK 87 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTT-----EEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCC-----cEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCC
Confidence 357999999999999999999987654 37999988532 23467889999999999999999999998765
Q ss_pred CCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeee
Q 014363 159 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 238 (426)
Q Consensus 159 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 238 (426)
..++||||+++++|.+++.... .+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+||
T Consensus 88 ----~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Df 158 (284)
T 2vgo_A 88 ----RIYLMLEFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADF 158 (284)
T ss_dssp ----EEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCC
T ss_pred ----EEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecc
Confidence 4599999999999999986543 489999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014363 239 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 318 (426)
Q Consensus 239 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 318 (426)
|++....... .....|++.|+|||++.+..++.++||||||+++|+|++|..||..........
T Consensus 159 g~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~------------ 222 (284)
T 2vgo_A 159 GWSVHAPSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHR------------ 222 (284)
T ss_dssp TTCEECSSSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------------
T ss_pred cccccCcccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHH------------
Confidence 9987654322 234679999999999999999999999999999999999999997643321111
Q ss_pred hhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 319 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.+.... ..++..++..+.+++.+||+.||++|||+.+++++
T Consensus 223 ----~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 223 ----RIVNVD--LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp ----HHHTTC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred ----HHhccc--cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 111111 11223355788999999999999999999999986
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=344.91 Aligned_cols=250 Identities=25% Similarity=0.372 Sum_probs=196.0
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
++|...+.||+|+||.||+|....++. .+++|.+.... ..+.+.+|+.+|+.++||||+++++++.+..
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--- 93 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGL-----ERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYH--- 93 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCC-----EEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS---
T ss_pred hheeecceeccCCCeEEEEEEEccCCc-----eEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCC---
Confidence 478999999999999999999876654 78999875443 4578899999999999999999999998765
Q ss_pred ceEEEEEeeCCCCChhhhccCC--CCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEe---CCCCCeeEe
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPK--SETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL---DEQWNAKLS 236 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl---~~~~~~kl~ 236 (426)
..++||||+++|+|.+++... ....+++..++.++.|++.||+|||++ +|+||||||+|||+ +.++.+||+
T Consensus 94 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~ 169 (285)
T 3is5_A 94 -NMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKII 169 (285)
T ss_dssp -EEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEEC
T ss_pred -eEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEE
Confidence 459999999999999988532 124589999999999999999999998 99999999999999 556789999
Q ss_pred eecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhh
Q 014363 237 DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS 316 (426)
Q Consensus 237 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 316 (426)
|||++....... ......||+.|+|||++. +.++.++||||||+++|+|++|..||..............
T Consensus 170 Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~------ 239 (285)
T 3is5_A 170 DFGLAELFKSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATY------ 239 (285)
T ss_dssp CCCCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------
T ss_pred eeecceecCCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhcc------
Confidence 999997654321 234567999999999875 5689999999999999999999999986543222211110
Q ss_pred hhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 317 DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
...... ......++.+.+++.+||+.||++|||+.|++++
T Consensus 240 --------~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 240 --------KEPNYA-VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp --------CCCCCC-C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred --------CCcccc-cccCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000 0001134678899999999999999999999975
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=355.46 Aligned_cols=247 Identities=31% Similarity=0.420 Sum_probs=198.4
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-----CHHHHHHHHHHHhhcCCCCccceEeEEEccCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
+.|...+.||+|+||.||+|.+..++ ..||+|.+.... ..+.+.+|+.+|+.++||||+++++++.+..
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~- 127 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNS-----EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH- 127 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTT-----EEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-
T ss_pred hheeeeeEEccCCCEEEEEEEEccCC-----eEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC-
Confidence 45889999999999999999976654 389999986432 2246889999999999999999999998765
Q ss_pred CCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeec
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 239 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 239 (426)
..++||||++ |+|.+++... ...+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 128 ---~~~lv~e~~~-g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG 199 (348)
T 1u5q_A 128 ---TAWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFG 199 (348)
T ss_dssp ---EEEEEEECCS-EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCT
T ss_pred ---eEEEEEecCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeecc
Confidence 4599999996 6787777532 23589999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCchhhc---cCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhh
Q 014363 240 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQ---TGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS 316 (426)
Q Consensus 240 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 316 (426)
++..... .....||+.|+|||++. ++.++.++|||||||++|||++|..||......... ...
T Consensus 200 ~a~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~--~~~------ 265 (348)
T 1u5q_A 200 SASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL--YHI------ 265 (348)
T ss_dssp TCBSSSS------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH--HHH------
T ss_pred CceecCC------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH--HHH------
Confidence 9986543 23467999999999885 567899999999999999999999999764322111 100
Q ss_pred hhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014363 317 DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVN 367 (426)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~ 367 (426)
.....+. .....++..+.+|+.+||+.||++|||+.+++++..
T Consensus 266 -----~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~ 308 (348)
T 1u5q_A 266 -----AQNESPA---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 308 (348)
T ss_dssp -----HHSCCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred -----HhcCCCC---CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence 0000111 111234567899999999999999999999998743
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=350.30 Aligned_cols=265 Identities=25% Similarity=0.385 Sum_probs=195.8
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC---HHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG---HKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
++|...+.||+|+||.||+|.+..++. .||+|.+..... ...+.+|+.+++.++||||+++++++.+...
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-- 74 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDN-----LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKS-- 74 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCC-----EEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSC--
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCc-----EEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCE--
Confidence 578999999999999999999876654 799998864432 1245679999999999999999999987664
Q ss_pred ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccc
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 241 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 241 (426)
.++||||++ |+|.+++.... ..+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 75 --~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a 147 (324)
T 3mtl_A 75 --LTLVFEYLD-KDLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLA 147 (324)
T ss_dssp --EEEEEECCS-EEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEE
T ss_pred --EEEEecccc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCccc
Confidence 499999996 58988886543 3589999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhh-------
Q 014363 242 RLGPSEGFTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKP------- 313 (426)
Q Consensus 242 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~------- 313 (426)
....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+.....
T Consensus 148 ~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 225 (324)
T 3mtl_A 148 RAKSIPT--KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETW 225 (324)
T ss_dssp ECC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred ccccCCc--cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhc
Confidence 8654321 12334578999999999876 5689999999999999999999999987654332222111000
Q ss_pred -hhhhhhhhhhhcCCcCCCc----ccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 314 -YLSDAKQFRQIVDPRLEGK----YSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 314 -~~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.......+.....+..... ....++..+.+|+.+||+.||++|||++|++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 226 PGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp TTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000000111100100000 011245678999999999999999999999986
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-45 Score=341.37 Aligned_cols=250 Identities=26% Similarity=0.379 Sum_probs=200.2
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC--------CHHHHHHHHHHHhhcCCCCccceEeEEEc
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--------GHKEWMTEVNFLGIVEHQNLVKLVGYCAD 156 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~--------~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 156 (426)
++|.+.+.||+|+||.||+|.+..++. .+++|.+.... ..+.+.+|+.+++.++||||+++++++.+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 79 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGK-----EYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFEN 79 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCC-----EEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCC-----eeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecC
Confidence 468999999999999999999886554 78999875432 35678999999999999999999999987
Q ss_pred cCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCC----C
Q 014363 157 DDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW----N 232 (426)
Q Consensus 157 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~----~ 232 (426)
.. ..++||||+++++|.+++... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++ .
T Consensus 80 ~~----~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~ 150 (283)
T 3bhy_A 80 KT----DVVLILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPR 150 (283)
T ss_dssp SS----EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCC
T ss_pred CC----eEEEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCc
Confidence 65 459999999999999999643 3489999999999999999999998 999999999999998877 7
Q ss_pred eeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHh
Q 014363 233 AKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK 312 (426)
Q Consensus 233 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~ 312 (426)
+||+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||...........+..
T Consensus 151 ~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-- 225 (283)
T 3bhy_A 151 IKLIDFGIAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISA-- 225 (283)
T ss_dssp EEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT--
T ss_pred eEEEecccceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHh--
Confidence 9999999998654322 12345799999999999999999999999999999999999999976543211111000
Q ss_pred hhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 313 PYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.............+..+.+++.+||+.||++|||+.|++++
T Consensus 226 ------------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 226 ------------VNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp ------------TCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred ------------cccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 00000101112245678999999999999999999999985
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=358.05 Aligned_cols=265 Identities=26% Similarity=0.358 Sum_probs=203.8
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
.++|...+.||+|+||.||+|.+..++. .||+|.+.... ..+.+.+|+.++..++||||+++++++.+..
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 104 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGL-----VMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-- 104 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCC-----EEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETT--
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCc-----EEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECC--
Confidence 3579999999999999999999886654 79999886543 2356889999999999999999999998765
Q ss_pred CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecc
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 240 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 240 (426)
..++||||+++++|.+++.... .+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||+
T Consensus 105 --~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 178 (360)
T 3eqc_A 105 --EISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGV 178 (360)
T ss_dssp --EEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCC
T ss_pred --EEEEEEECCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHh--CCEEcCCccHHHEEECCCCCEEEEECCC
Confidence 4599999999999999996543 489999999999999999999973 1799999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHh--------
Q 014363 241 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK-------- 312 (426)
Q Consensus 241 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~-------- 312 (426)
+...... ......||+.|+|||++.+..++.++||||||+++|+|++|..||................
T Consensus 179 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 254 (360)
T 3eqc_A 179 SGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP 254 (360)
T ss_dssp CHHHHHH----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------
T ss_pred Ccccccc----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCC
Confidence 8654221 1234679999999999999999999999999999999999999998655433221110000
Q ss_pred ------------------hhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 313 ------------------PYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 313 ------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
+..........+............++..+.+|+.+||+.||++|||++|+++|
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 255 PRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp -------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 00000000111111111111122345689999999999999999999999987
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=352.82 Aligned_cols=264 Identities=21% Similarity=0.300 Sum_probs=193.1
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC----HHHHHHHHHHHhhcCCCCccceEeEEEccCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG----HKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
.++|.+.+.||+|+||.||+|.+..++ ..||+|.+..... .+.+.+|+.+++.++||||+++++++.+..
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 106 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTN-----ETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNH- 106 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTT-----EEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETT-
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCC-----ceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCC-
Confidence 568999999999999999999977655 3899999864432 345679999999999999999999998765
Q ss_pred CCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEe-----CCCCCee
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL-----DEQWNAK 234 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl-----~~~~~~k 234 (426)
..++||||++ |+|.+++.... .+++..++.|+.||+.||.|||++ +|+||||||+|||+ +.++.+|
T Consensus 107 ---~~~lv~e~~~-~~L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~k 177 (329)
T 3gbz_A 107 ---RLHLIFEYAE-NDLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLK 177 (329)
T ss_dssp ---EEEEEEECCS-EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEE
T ss_pred ---EEEEEEecCC-CCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEE
Confidence 4599999997 59999987544 389999999999999999999998 99999999999999 4555699
Q ss_pred EeeecccccCCCCCceeeeeeeecCcccCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhh
Q 014363 235 LSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKP 313 (426)
Q Consensus 235 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~ 313 (426)
|+|||++....... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||...........+.....
T Consensus 178 l~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 255 (329)
T 3gbz_A 178 IGDFGLARAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLG 255 (329)
T ss_dssp ECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred ECcCCCccccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhC
Confidence 99999998654321 123345789999999998874 489999999999999999999999976543322111110000
Q ss_pred hhhhhhhhh------hhc--CCcCCC-----cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 314 YLSDAKQFR------QIV--DPRLEG-----KYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 314 ~~~~~~~~~------~~~--~~~~~~-----~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
........ ... .+.... .....++..+.+|+.+||+.||++|||+.|+++|
T Consensus 256 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 256 -LPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp -CCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -CCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 00000000 000 000000 0111245788999999999999999999999985
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-46 Score=347.40 Aligned_cols=255 Identities=25% Similarity=0.367 Sum_probs=202.8
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
.++|+..+.||+|+||.||+|.+..++. .|++|.+.... ..+.+.+|+.+++.++||||+++++++.+...
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 79 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGK-----ILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTN 79 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCC-----EEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGG
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCc-----EEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCC
Confidence 4678999999999999999999876654 78999886432 33568899999999999999999998875433
Q ss_pred CCceEEEEEeeCCCCChhhhccCCC--CCccCHHHHHHHHHHHHHHHHHhccCCCCC-----eEeccCCCCceEeCCCCC
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPKS--ETILTWAMRLKIAQDAARGLAYLHEGMDFQ-----IIVRDFKSSNILLDEQWN 232 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~-----iiHrDlkp~NILl~~~~~ 232 (426)
. ..++||||+++++|.+++.... ...+++..++.++.|++.||+|||+. + |+||||||+|||++.++.
T Consensus 80 ~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~ 154 (279)
T 2w5a_A 80 T--TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQN 154 (279)
T ss_dssp T--EEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSC
T ss_pred c--eEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCC
Confidence 2 5699999999999999986422 23489999999999999999999998 7 999999999999999999
Q ss_pred eeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHh
Q 014363 233 AKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK 312 (426)
Q Consensus 233 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~ 312 (426)
+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|+|++|..||......... ..+.
T Consensus 155 ~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~i~ 229 (279)
T 2w5a_A 155 VKLGDFGLARILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELA---GKIR 229 (279)
T ss_dssp EEECCCCHHHHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHH
T ss_pred EEEecCchheeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHH---HHHh
Confidence 99999999986543221 123457899999999999989999999999999999999999999865432111 1100
Q ss_pred hhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014363 313 PYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVN 367 (426)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~ 367 (426)
.-... ..+..++..+.+++.+||+.||++|||+.||++++.
T Consensus 230 ----------~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 230 ----------EGKFR----RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp ----------HTCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred ----------hcccc----cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 00001 122235578999999999999999999999999764
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=341.05 Aligned_cols=249 Identities=27% Similarity=0.437 Sum_probs=183.4
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-----CCHHHHHHHHHHHhhcCCCCccceEeEEEccC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-----GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 158 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 158 (426)
.++|.+.+.||+|+||.||+|.+..++. .|++|.+... ...+.+.+|+.++..++||||+++++++.+..
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 84 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGL-----EVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSN 84 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCC-----EEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSS
T ss_pred cccceeeeeecCCCceEEEEEEEccCCc-----eEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCC
Confidence 4679999999999999999999866554 7999988543 23467889999999999999999999998765
Q ss_pred CCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeee
Q 014363 159 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 238 (426)
Q Consensus 159 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 238 (426)
..++||||+++++|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+||
T Consensus 85 ----~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~df 156 (278)
T 3cok_A 85 ----YVYLVLEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADF 156 (278)
T ss_dssp ----EEEEEEECCTTEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCC
T ss_pred ----eEEEEEecCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEee
Confidence 4599999999999999997542 4589999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014363 239 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 318 (426)
Q Consensus 239 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 318 (426)
|++........ ......||+.|+|||++.+..++.++||||||+++|+|++|..||........
T Consensus 157 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------------- 220 (278)
T 3cok_A 157 GLATQLKMPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-------------- 220 (278)
T ss_dssp TTCEECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------------
T ss_pred cceeeccCCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH--------------
Confidence 99986543221 12346799999999999988899999999999999999999999975432211
Q ss_pred hhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 319 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
......... ..+..++..+.+++.+||+.||++|||+.+++++
T Consensus 221 --~~~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 221 --LNKVVLADY--EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp -----CCSSCC--CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred --HHHHhhccc--CCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 011111111 1223355688999999999999999999999985
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=347.68 Aligned_cols=260 Identities=20% Similarity=0.257 Sum_probs=198.0
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC-----HHHHHHHHHHHhhcCCCCccceEeEEEccC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG-----HKEWMTEVNFLGIVEHQNLVKLVGYCADDD 158 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~-----~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 158 (426)
.++|.+.+.||+|+||.||+|.+..++ ..||+|.+..... .+.+.+|+.++..++||||+++++++.+..
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~ 107 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRE-----RIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDG 107 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTT-----EEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCC-----eEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCC
Confidence 578999999999999999999977654 3899999865421 356889999999999999999999998765
Q ss_pred CCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeee
Q 014363 159 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 238 (426)
Q Consensus 159 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 238 (426)
..|+||||+++++|.+++... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+||
T Consensus 108 ----~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Df 178 (309)
T 2h34_A 108 ----QLYVDMRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDF 178 (309)
T ss_dssp ----EEEEEEECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSC
T ss_pred ----eEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecC
Confidence 459999999999999999753 3489999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014363 239 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 318 (426)
Q Consensus 239 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 318 (426)
|++........ .......||+.|+|||++.+..++.++||||||+++|+|++|..||...... ....... .
T Consensus 179 g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~~----~- 249 (309)
T 2h34_A 179 GIASATTDEKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS---VMGAHIN----Q- 249 (309)
T ss_dssp CC-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH---HHHHHHH----S-
T ss_pred ccCcccccccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH---HHHHHhc----c-
Confidence 99976543321 1223457999999999999999999999999999999999999999764321 1111000 0
Q ss_pred hhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHHHHhHhhh
Q 014363 319 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRP-KMSEVLEMVNKIVDAS 373 (426)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-s~~eil~~L~~~~~~~ 373 (426)
.. .........++..+.+++.+||+.||++|| +++++++.|+..+...
T Consensus 250 -----~~--~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 250 -----AI--PRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp -----CC--CCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred -----CC--CCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 00 001112233456899999999999999999 9999999998876443
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-45 Score=377.22 Aligned_cols=252 Identities=25% Similarity=0.423 Sum_probs=200.7
Q ss_pred ceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCceEEE
Q 014363 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLL 166 (426)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~~~l 166 (426)
+.||+|+||.||+|.+.... ..+.||+|.+.... ..+.+.+|+.+|..++|||||++++++.+.. .++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-----~~l 446 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKK---VVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAES-----WML 446 (635)
T ss_dssp EEEEECSSEEEEEEEEECSS---CEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESSS-----EEE
T ss_pred CEeccCCCEEEEEEEEcCCC---cceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-----EEE
Confidence 47999999999999765432 34579999986542 2467899999999999999999999996532 489
Q ss_pred EEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccCCC
Q 014363 167 VYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPS 246 (426)
Q Consensus 167 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 246 (426)
||||+++|+|.+++... ..+++..++.|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++....
T Consensus 447 v~E~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 521 (635)
T 4fl3_A 447 VMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 521 (635)
T ss_dssp EEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC
T ss_pred EEEccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCcccccc
Confidence 99999999999999654 3489999999999999999999998 999999999999999999999999999987654
Q ss_pred CCc-eeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhh
Q 014363 247 EGF-THVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQI 324 (426)
Q Consensus 247 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (426)
... ........||+.|+|||++.+..++.++|||||||++|||++ |..||...........+
T Consensus 522 ~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i---------------- 585 (635)
T 4fl3_A 522 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML---------------- 585 (635)
T ss_dssp -------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH----------------
T ss_pred CccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----------------
Confidence 321 122234457889999999999999999999999999999998 99999765432211111
Q ss_pred cCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 014363 325 VDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 372 (426)
Q Consensus 325 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~ 372 (426)
........+..++..+.+||.+||+.||++||++.+|++.|+++...
T Consensus 586 -~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 586 -EKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp -HTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred -HcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 11111223334667899999999999999999999999999987654
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=345.15 Aligned_cols=253 Identities=28% Similarity=0.415 Sum_probs=202.8
Q ss_pred HhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCc
Q 014363 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 162 (426)
Q Consensus 83 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~ 162 (426)
..++|...+.||+|+||.||+|.+..++. .||+|.+......+.+.+|+.++..++||||+++++++.+..
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~-----~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 97 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQ-----IVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNT---- 97 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCC-----EEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEETT----
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCC-----EEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCC----
Confidence 35689999999999999999999876554 899999987777788999999999999999999999998765
Q ss_pred eEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccc
Q 014363 163 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 242 (426)
Q Consensus 163 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 242 (426)
..|+||||+++++|.+++... ...+++..++.++.|++.||.|||+. +++|+||||+|||++.++.+||+|||++.
T Consensus 98 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 173 (314)
T 3com_A 98 DLWIVMEYCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAG 173 (314)
T ss_dssp EEEEEEECCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEeecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccch
Confidence 459999999999999998632 23489999999999999999999998 99999999999999999999999999997
Q ss_pred cCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhh
Q 014363 243 LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFR 322 (426)
Q Consensus 243 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (426)
...... .......||+.|+|||++.+..++.++||||||+++|+|++|..||............ .
T Consensus 174 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-------------~ 238 (314)
T 3com_A 174 QLTDTM--AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMI-------------P 238 (314)
T ss_dssp ECBTTB--SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-------------H
T ss_pred hhhhhc--cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-------------h
Confidence 654321 1123457999999999999999999999999999999999999999764432111100 0
Q ss_pred hhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 323 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
. ........+..++..+.+++.+||+.||++|||+.+++++
T Consensus 239 ~--~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 239 T--NPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp H--SCCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred c--CCCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0 0001111223345789999999999999999999999985
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-45 Score=354.79 Aligned_cols=265 Identities=25% Similarity=0.323 Sum_probs=198.3
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
.++|...+.||+|+||.||+|.+..++. .||+|.+.... ..+.+.+|+.+|+.++||||+++++++.....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 98 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGA-----KVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDET 98 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCC-----EEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSS
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCC-----EEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCc
Confidence 4689999999999999999999876654 89999985432 23567899999999999999999999976532
Q ss_pred C--CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEee
Q 014363 160 R--GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 237 (426)
Q Consensus 160 ~--~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~D 237 (426)
. ....|+||||+ +++|.+++... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 99 ~~~~~~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~D 171 (367)
T 1cm8_A 99 LDDFTDFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILD 171 (367)
T ss_dssp TTTCCCCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECC
T ss_pred cccCceEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEe
Confidence 1 12459999999 88999998653 489999999999999999999998 999999999999999999999999
Q ss_pred ecccccCCCCCceeeeeeeecCcccCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhh---
Q 014363 238 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKP--- 313 (426)
Q Consensus 238 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~--- 313 (426)
||+++..... ....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.........+.....
T Consensus 172 fg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~ 246 (367)
T 1cm8_A 172 FGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP 246 (367)
T ss_dssp CTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred eecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 9999875432 234679999999999887 6799999999999999999999999986543322111110000
Q ss_pred -----hhhh--hhhhhhhcCCcCC---CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 314 -----YLSD--AKQFRQIVDPRLE---GKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 314 -----~~~~--~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.+.. ...+...+..... .......++.+.+|+.+||+.||++|||+.|+++|
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 247 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 0000 0000000000000 11122346789999999999999999999999996
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=360.39 Aligned_cols=265 Identities=18% Similarity=0.271 Sum_probs=208.5
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhcCCCCcc-ceEeEEEccCCCCc
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQNLV-KLVGYCADDDERGI 162 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l~HpnIv-~~~~~~~~~~~~~~ 162 (426)
.++|.++++||+|+||.||+|.+..++. .||+|.+........+..|+.++..|+|++++ .+..++.+..
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~-----~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~---- 76 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNE-----EVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGD---- 76 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCC-----EEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETT----
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCc-----EEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCC----
Confidence 4689999999999999999999876554 89999887766667899999999999875544 4444444433
Q ss_pred eEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEe---CCCCCeeEeeec
Q 014363 163 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL---DEQWNAKLSDFG 239 (426)
Q Consensus 163 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl---~~~~~~kl~DFG 239 (426)
..+|||||+ +++|.+++.... ..+++..++.|+.||+.||+|||++ +|+||||||+|||| +.++.+||+|||
T Consensus 77 ~~~lvme~~-g~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFG 151 (483)
T 3sv0_A 77 YNVLVMDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFG 151 (483)
T ss_dssp EEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCT
T ss_pred EEEEEEECC-CCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCC
Confidence 459999999 999999997433 3499999999999999999999998 99999999999999 688999999999
Q ss_pred ccccCCCCCce-----eeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhh
Q 014363 240 LARLGPSEGFT-----HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPY 314 (426)
Q Consensus 240 la~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 314 (426)
+++........ .......||+.|+|||++.+..++.++|||||||+||||++|..||..............+...
T Consensus 152 la~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~ 231 (483)
T 3sv0_A 152 LAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 231 (483)
T ss_dssp TCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHH
T ss_pred cceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhc
Confidence 99876543221 1123568999999999999999999999999999999999999999876543333222221110
Q ss_pred hhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 014363 315 LSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 372 (426)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~ 372 (426)
.. ...... ....++.++.+|+.+||+.||++||++.+|++.|+.++..
T Consensus 232 ~~-~~~~~~---------l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~ 279 (483)
T 3sv0_A 232 KV-ATSIEA---------LCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR 279 (483)
T ss_dssp HH-HSCHHH---------HHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred cc-cccHHH---------HhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence 00 000000 0112356899999999999999999999999999988754
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=380.64 Aligned_cols=249 Identities=25% Similarity=0.408 Sum_probs=206.8
Q ss_pred HhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-----CCHHHHHHHHHHHhhc-CCCCccceEeEEEc
Q 014363 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-----GGHKEWMTEVNFLGIV-EHQNLVKLVGYCAD 156 (426)
Q Consensus 83 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-----~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~ 156 (426)
..++|+++++||+|+||.||+|.++.++. .||+|.+... ...+.+..|..+|..+ +||||+++++++.+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~-----~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~ 413 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDE-----LYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT 413 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCC-----EEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBC
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCc-----EEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEe
Confidence 35689999999999999999999887654 7999998632 3456788999999988 79999999999887
Q ss_pred cCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEe
Q 014363 157 DDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLS 236 (426)
Q Consensus 157 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~ 236 (426)
.+ .+||||||++||+|.+++.... .+++..++.|+.||+.||+|||++ +|+||||||+||||+.+|.+||+
T Consensus 414 ~~----~~~lV~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~ 484 (674)
T 3pfq_A 414 MD----RLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIA 484 (674)
T ss_dssp SS----EEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEEC
T ss_pred CC----EEEEEEeCcCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEe
Confidence 65 4699999999999999997543 489999999999999999999998 99999999999999999999999
Q ss_pred eecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhh
Q 014363 237 DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS 316 (426)
Q Consensus 237 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 316 (426)
|||+++....... .....+||+.|+|||++.+..|+.++|||||||+||||++|..||....... +
T Consensus 485 DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~---~--------- 550 (674)
T 3pfq_A 485 DFGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---L--------- 550 (674)
T ss_dssp CCTTCEECCCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---H---------
T ss_pred ecceeeccccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHH---H---------
Confidence 9999986433322 2446789999999999999999999999999999999999999997653321 1
Q ss_pred hhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCH-----HHHHHH
Q 014363 317 DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKM-----SEVLEM 365 (426)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~-----~eil~~ 365 (426)
+..++...+ .++..++.++.+||.+||+.||++||++ +||++|
T Consensus 551 ----~~~i~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 551 ----FQSIMEHNV--AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp ----HHHHHSSCC--CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred ----HHHHHhCCC--CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 112222211 2334567789999999999999999997 777765
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=353.20 Aligned_cols=266 Identities=25% Similarity=0.390 Sum_probs=200.4
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC----HHHHHHHHHHHhhcCCCCccceEeEEEccCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG----HKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
.++|+..+.||+|+||.||+|.+..++. .||+|.+..... .+.+.+|+.+++.++||||+++++++.+..
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 97 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGR-----IVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKK- 97 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCC-----EEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCc-----eEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCC-
Confidence 4579999999999999999999877654 799998754432 345779999999999999999999998765
Q ss_pred CCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeec
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 239 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 239 (426)
..++||||+++++|.+++.... .+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 98 ---~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg 169 (331)
T 4aaa_A 98 ---RWYLVFEFVDHTILDDLELFPN--GLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFG 169 (331)
T ss_dssp ---EEEEEEECCSEEHHHHHHHSTT--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCT
T ss_pred ---EEEEEEecCCcchHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCC
Confidence 4599999999999988875433 389999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhH-hh----
Q 014363 240 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWV-KP---- 313 (426)
Q Consensus 240 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~-~~---- 313 (426)
++....... .......||+.|+|||++.+. .++.++||||||+++|+|++|..||...........+... ..
T Consensus 170 ~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 247 (331)
T 4aaa_A 170 FARTLAAPG--EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPR 247 (331)
T ss_dssp TC--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH
T ss_pred CceeecCCc--cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChh
Confidence 997654322 123345799999999998875 6899999999999999999999999865543222111100 00
Q ss_pred ---hhhhhhhhhhhcCCcCCCcc-----cHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 314 ---YLSDAKQFRQIVDPRLEGKY-----SLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 314 ---~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.+...........+.+.... ...++..+.+|+.+||+.||++|||+.|++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 248 HQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp HHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred hhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000111111111111111 11346789999999999999999999999986
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=351.24 Aligned_cols=248 Identities=23% Similarity=0.379 Sum_probs=204.2
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-----CHHHHHHHHHHHhhcCCCCccceEeEEEccC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 158 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 158 (426)
.++|.+.+.||+|+||.||+|.+..++. .+++|.+.... ..+.+.+|+.+++.++||||+++++++.+.+
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~-----~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 114 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKE-----VFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND 114 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCC-----EEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCC-----EEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 4679999999999999999999877654 78999875432 3456889999999999999999999998765
Q ss_pred CCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeee
Q 014363 159 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 238 (426)
Q Consensus 159 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 238 (426)
..|+||||+++++|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+||
T Consensus 115 ----~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Df 185 (335)
T 2owb_A 115 ----FVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDF 185 (335)
T ss_dssp ----EEEEEECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCC
T ss_pred ----eEEEEEecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeec
Confidence 459999999999999988643 3489999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014363 239 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 318 (426)
Q Consensus 239 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 318 (426)
|++........ ......||+.|+|||++.+..++.++||||||+++|+|++|..||...........+.
T Consensus 186 g~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--------- 254 (335)
T 2owb_A 186 GLATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK--------- 254 (335)
T ss_dssp TTCEECCSTTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH---------
T ss_pred cCceecccCcc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHh---------
Confidence 99986643321 1234679999999999999999999999999999999999999997643221111000
Q ss_pred hhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 319 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
. .... .+..++..+.+|+.+||+.||++|||+.|++++
T Consensus 255 ----~-~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 255 ----K-NEYS----IPKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp ----H-TCCC----CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ----c-CCCC----CCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 0011 122345678999999999999999999999986
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=349.91 Aligned_cols=266 Identities=25% Similarity=0.316 Sum_probs=197.0
Q ss_pred HHhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-------CHHHHHHHHHHHhhcCCCCccceEeEE
Q 014363 82 SATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-------GHKEWMTEVNFLGIVEHQNLVKLVGYC 154 (426)
Q Consensus 82 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-------~~~~~~~E~~~l~~l~HpnIv~~~~~~ 154 (426)
...++|...+.||+|+||.||+|.+..++. .||+|.+.... ....+.+|+.+++.++||||+++++++
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 81 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQ-----IVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF 81 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCS-----EEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCc-----EEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEE
Confidence 346789999999999999999999876544 79999886432 124678999999999999999999999
Q ss_pred EccCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCee
Q 014363 155 ADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAK 234 (426)
Q Consensus 155 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~k 234 (426)
.+.... ++||||+++ +|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+|
T Consensus 82 ~~~~~~----~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~k 152 (346)
T 1ua2_A 82 GHKSNI----SLVFDFMET-DLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLK 152 (346)
T ss_dssp CCTTCC----EEEEECCSE-EHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEE
T ss_pred eeCCce----EEEEEcCCC-CHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEE
Confidence 876644 999999975 8888886543 4588899999999999999999998 999999999999999999999
Q ss_pred EeeecccccCCCCCceeeeeeeecCcccCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhh
Q 014363 235 LSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKP 313 (426)
Q Consensus 235 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~ 313 (426)
|+|||++....... .......||+.|+|||++.+. .++.++|||||||++|+|++|.+||.......... .....
T Consensus 153 l~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~--~i~~~ 228 (346)
T 1ua2_A 153 LADFGLAKSFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLT--RIFET 228 (346)
T ss_dssp ECCCGGGSTTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHHHH
T ss_pred EEecccceeccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHH--HHHHH
Confidence 99999998654332 123346799999999998764 58899999999999999999999997654322211 11110
Q ss_pred hhhh-hhh------hhhhcCCcCCCcc-----cHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 314 YLSD-AKQ------FRQIVDPRLEGKY-----SLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 314 ~~~~-~~~------~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.... ... ..+.......... ....+..+.+||.+||+.||++|||+.|++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 229 LGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp HCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0000 000 0000000000000 12345789999999999999999999999997
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-45 Score=343.24 Aligned_cols=248 Identities=23% Similarity=0.377 Sum_probs=203.9
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-----CHHHHHHHHHHHhhcCCCCccceEeEEEccC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 158 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 158 (426)
.++|...+.||+|+||.||+|.+..++. .+++|.+.... ..+.+.+|+.+++.++||||+++++++.+.+
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~-----~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 88 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKE-----VFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND 88 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCC-----EEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCc-----eEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCC
Confidence 4578999999999999999999877654 78999875432 3456789999999999999999999998765
Q ss_pred CCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeee
Q 014363 159 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 238 (426)
Q Consensus 159 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 238 (426)
..++||||+++++|.+++... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+||
T Consensus 89 ----~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~df 159 (294)
T 2rku_A 89 ----FVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDF 159 (294)
T ss_dssp ----EEEEEEECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCC
T ss_pred ----EEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEec
Confidence 459999999999999988643 3489999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014363 239 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 318 (426)
Q Consensus 239 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 318 (426)
|++........ ......||+.|+|||++.+..++.++||||||+++|+|++|..||..........
T Consensus 160 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~------------ 225 (294)
T 2rku_A 160 GLATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL------------ 225 (294)
T ss_dssp TTCEECCSTTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------------
T ss_pred cCceecccCcc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------------
Confidence 99986543321 1234679999999999998889999999999999999999999997654221111
Q ss_pred hhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 319 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.+.... ...+..++..+.+++.+||+.||++|||+.|++++
T Consensus 226 ----~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 226 ----RIKKNE--YSIPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp ----HHHTTC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ----HHhhcc--CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 010100 01222345678999999999999999999999986
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=343.50 Aligned_cols=250 Identities=28% Similarity=0.429 Sum_probs=205.5
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
.+.|...+.||+|+||.||+|.+..++. .|++|.+.... ..+.+.+|+.++..++||||+++++++.+..
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 93 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQK-----VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT-- 93 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCC-----EEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCc-----EEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC--
Confidence 3568999999999999999999876554 79999885432 4567899999999999999999999998765
Q ss_pred CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecc
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 240 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 240 (426)
..++||||+++++|.+++.. ..+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 94 --~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~ 165 (303)
T 3a7i_A 94 --KLWIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGV 165 (303)
T ss_dssp --EEEEEEECCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred --eEEEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeeccc
Confidence 45999999999999999964 3489999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhh
Q 014363 241 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 320 (426)
Q Consensus 241 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (426)
+....... .......||+.|+|||++.+..++.++||||||+++|+|++|..||...........+
T Consensus 166 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~------------ 231 (303)
T 3a7i_A 166 AGQLTDTQ--IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLI------------ 231 (303)
T ss_dssp CEECBTTB--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH------------
T ss_pred ceecCccc--cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHh------------
Confidence 97654332 1123467999999999999999999999999999999999999999765432211110
Q ss_pred hhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014363 321 FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVN 367 (426)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~ 367 (426)
.....+.+ ...++..+.+++.+||+.||++|||+.+++++..
T Consensus 232 -~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~ 273 (303)
T 3a7i_A 232 -PKNNPPTL----EGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKF 273 (303)
T ss_dssp -HHSCCCCC----CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHH
T ss_pred -hcCCCCCC----ccccCHHHHHHHHHHcCCChhhCcCHHHHhhChh
Confidence 01111112 2234567899999999999999999999998743
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=354.00 Aligned_cols=273 Identities=16% Similarity=0.242 Sum_probs=207.8
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCC---cceEEEEEEccccCCHHHHHHHHHHHhhcCCCCccc------------
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPS---QKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQNLVK------------ 149 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~---~~~~va~K~~~~~~~~~~~~~E~~~l~~l~HpnIv~------------ 149 (426)
++|.+.+.||+|+||.||+|.+..+.... ....||+|.+... +.+.+|+.++..++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 118 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD---GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLA 118 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT---STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCS
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc---chHHHHHHHHHHhcccchhhhhhhhccCCccC
Confidence 57999999999999999999987642111 2347999998654 46889999999999999887
Q ss_pred ---eEeEEEccCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceE
Q 014363 150 ---LVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNIL 226 (426)
Q Consensus 150 ---~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NIL 226 (426)
+++++...+. ..|+||||+ +++|.+++.......+++..++.|+.||+.||.|||++ +|+||||||+|||
T Consensus 119 i~~~~~~~~~~~~---~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl 191 (352)
T 2jii_A 119 IPTCMGFGVHQDK---YRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIF 191 (352)
T ss_dssp CCCCCEEEEETTT---EEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEE
T ss_pred ccchhhccccCCc---EEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEE
Confidence 6677765332 469999999 99999999865445699999999999999999999998 9999999999999
Q ss_pred eCCCC--CeeEeeecccccCCCCCce-----eeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCC
Q 014363 227 LDEQW--NAKLSDFGLARLGPSEGFT-----HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRN 299 (426)
Q Consensus 227 l~~~~--~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~ 299 (426)
++.++ .+||+|||+++........ .......||+.|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 99998 8999999999765432111 0113357999999999999989999999999999999999999999765
Q ss_pred CchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhhc
Q 014363 300 RPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASA 374 (426)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~~ 374 (426)
...... ........... ...+..... ....++..+.+|+.+||+.||++|||+++|++.|+.++....
T Consensus 272 ~~~~~~-~~~~~~~~~~~---~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 272 LPNTED-IMKQKQKFVDK---PGPFVGPCG---HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp TTCHHH-HHHHHHHHHHS---CCCEECTTS---CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred CcCHHH-HHHHHHhccCC---hhhhhhhcc---ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence 422211 11111100000 000111000 011235789999999999999999999999999999887653
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-45 Score=345.82 Aligned_cols=267 Identities=25% Similarity=0.324 Sum_probs=195.3
Q ss_pred hCCCCCc-ceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC--CHHHHHHHHHHHhhc-CCCCccceEeEEEccCC
Q 014363 84 TKNFSRS-VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--GHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDE 159 (426)
Q Consensus 84 ~~~y~~~-~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~ 159 (426)
.+.|.+. ++||+|+||.||+|.+..++. .||+|.+.... ....+.+|+.++.++ +||||+++++++.+.+
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~- 84 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQ-----EYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEED- 84 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCC-----EEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT-
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCc-----EEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC-
Confidence 3567774 789999999999998765543 89999986543 456789999999985 7999999999998765
Q ss_pred CCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCC---eeEe
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWN---AKLS 236 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~---~kl~ 236 (426)
..|+||||+++|+|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++. +||+
T Consensus 85 ---~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~ 156 (316)
T 2ac3_A 85 ---RFYLVFEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKIC 156 (316)
T ss_dssp ---EEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEEC
T ss_pred ---EEEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEE
Confidence 459999999999999999654 3489999999999999999999998 9999999999999988776 9999
Q ss_pred eecccccCCCCCc-----eeeeeeeecCcccCCchhhcc-----CCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHH
Q 014363 237 DFGLARLGPSEGF-----THVSTAVVGTMGYAAPEYVQT-----GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQK 306 (426)
Q Consensus 237 DFGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~ 306 (426)
|||++........ .......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||..........
T Consensus 157 Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~ 236 (316)
T 2ac3_A 157 DFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGW 236 (316)
T ss_dssp CTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC
T ss_pred EccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccc
Confidence 9999876532211 111224569999999999875 558899999999999999999999997654321000
Q ss_pred HHHhHhhhhhhhhhhhhhcCCcCCCc--ccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 307 LLQWVKPYLSDAKQFRQIVDPRLEGK--YSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
......+. ........+........ ....++..+.+|+.+||+.||++|||+.|++++
T Consensus 237 ~~~~~~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 237 DRGEACPA-CQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp ----CCHH-HHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cccccchh-HHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 00000000 00000011111111000 001245689999999999999999999999986
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-45 Score=361.75 Aligned_cols=202 Identities=29% Similarity=0.394 Sum_probs=165.3
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
.++|.+.+.||+|+||.||+|.+..++ ..||+|++.... ..+.+.+|+.+|+.++||||+++++++.....
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~-----~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 99 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTE-----KNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDL 99 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTT-----EEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCT
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCC-----cEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCC
Confidence 468999999999999999999987665 389999986532 33578899999999999999999999876532
Q ss_pred -CCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeee
Q 014363 160 -RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 238 (426)
Q Consensus 160 -~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 238 (426)
.....|+||||++ ++|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 100 ~~~~~~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DF 173 (432)
T 3n9x_A 100 LKFDELYIVLEIAD-SDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDF 173 (432)
T ss_dssp TTCCCEEEEEECCS-EEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCC
T ss_pred CcCCeEEEEEecCC-cCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccC
Confidence 1124699999995 6999999654 3489999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCce--------------------eeeeeeecCcccCCchhh-ccCCCCCchhhHHHHHHHHHHHhCCCCC
Q 014363 239 GLARLGPSEGFT--------------------HVSTAVVGTMGYAAPEYV-QTGRLAARSDVWSYGVFLYELITGRRPI 296 (426)
Q Consensus 239 Gla~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslGvil~elltg~~p~ 296 (426)
|+++........ ......+||+.|+|||++ ....|+.++|||||||++|||++|..||
T Consensus 174 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 174 GLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp TTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred CCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 999876432211 123567899999999986 5566999999999999999999854444
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=366.58 Aligned_cols=250 Identities=23% Similarity=0.361 Sum_probs=198.1
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc----CCHHHHHHHHHHHhhcCCCCccceEeEEEccCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR----GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
.++|..++.||+|+||.||+|.++.++. .+|+|.+... .....+.+|+.+|+.++||||+++++++.+..
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~-----~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~- 109 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHV-----ERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKR- 109 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCC-----EEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSS-
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCc-----EEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC-
Confidence 4579999999999999999999876654 7899988643 23567899999999999999999999998765
Q ss_pred CCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCC---CCeeEe
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQ---WNAKLS 236 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~---~~~kl~ 236 (426)
..|+|||||++|+|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.. +.+||+
T Consensus 110 ---~~~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~ 181 (494)
T 3lij_A 110 ---NYYLVMECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIV 181 (494)
T ss_dssp ---EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred ---EEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEE
Confidence 459999999999999888644 3489999999999999999999998 99999999999999764 459999
Q ss_pred eecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhh
Q 014363 237 DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS 316 (426)
Q Consensus 237 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 316 (426)
|||++....... .....+||+.|+|||++. +.|+.++|||||||++|+|++|..||...........+...
T Consensus 182 DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~----- 252 (494)
T 3lij_A 182 DFGLSAVFENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKG----- 252 (494)
T ss_dssp CCTTCEECBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-----
T ss_pred ECCCCeECCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-----
Confidence 999998654322 234467999999999886 57999999999999999999999999865432211111100
Q ss_pred hhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 317 DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
...........++..+.+|+.+||+.||++|||+.|+++|
T Consensus 253 ---------~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 253 ---------KYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp ---------CCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred ---------CCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 0000111112345789999999999999999999999986
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-45 Score=356.81 Aligned_cols=274 Identities=21% Similarity=0.293 Sum_probs=201.1
Q ss_pred HHHhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhcCCCCccceEeEEEccCC-
Q 014363 81 KSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE- 159 (426)
Q Consensus 81 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~- 159 (426)
....++|...+.||+|+||.||+|.+..++. .||+|.+.... ....+|+.+|+.++||||+++++++.....
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~-----~vAiK~~~~~~--~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 75 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGK-----RFALKKVLQDP--RYKNRELDIMKVLDHVNIIKLVDYFYTTGDE 75 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCC-----EEEEEEEECCT--TSCCHHHHHHTTCCCTTBCCEEEEEEEC---
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCC-----EEEEEEEecCc--chHHHHHHHHHHcCCCCccchhheeeecCcc
Confidence 3456789999999999999999999876654 89999886543 233589999999999999999999865431
Q ss_pred ---------------------------------CCceEEEEEeeCCCCChhhhccC--CCCCccCHHHHHHHHHHHHHHH
Q 014363 160 ---------------------------------RGIQRLLVYEYMPNGSVDQYLSP--KSETILTWAMRLKIAQDAARGL 204 (426)
Q Consensus 160 ---------------------------------~~~~~~lv~E~~~~g~L~~~l~~--~~~~~~~~~~~~~i~~~i~~aL 204 (426)
.....++||||++ |+|.+.+.. .....+++..++.++.||+.||
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL 154 (383)
T 3eb0_A 76 EPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAV 154 (383)
T ss_dssp ----------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Confidence 2234689999997 577776642 1234589999999999999999
Q ss_pred HHhccCCCCCeEeccCCCCceEeC-CCCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccC-CCCCchhhHHH
Q 014363 205 AYLHEGMDFQIIVRDFKSSNILLD-EQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSY 282 (426)
Q Consensus 205 ~~LH~~~~~~iiHrDlkp~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvwsl 282 (426)
.|||++ +|+||||||+|||++ .++.+||+|||++....... ......||+.|+|||++.+. .++.++|||||
T Consensus 155 ~~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl 228 (383)
T 3eb0_A 155 GFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSI 228 (383)
T ss_dssp HHHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHH
T ss_pred HHHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhH
Confidence 999998 999999999999997 68899999999998654332 12345789999999988765 48999999999
Q ss_pred HHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh-hhhhh-------hhcCCcCC-----CcccHHHHHHHHHHHHhcc
Q 014363 283 GVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD-AKQFR-------QIVDPRLE-----GKYSLRLVSKLSHVANLCL 349 (426)
Q Consensus 283 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~-------~~~~~~~~-----~~~~~~~~~~l~~li~~cl 349 (426)
||++|+|++|..||.+........ ..+...... ...+. ...-+.+. ..++...+..+.+|+.+||
T Consensus 229 G~il~ell~g~~pf~~~~~~~~~~--~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 306 (383)
T 3eb0_A 229 GCVFGELILGKPLFSGETSIDQLV--RIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQIL 306 (383)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHH--HHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHC
T ss_pred HHHHHHHHhCCCCCCCCChHHHHH--HHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHc
Confidence 999999999999998654332221 111100000 00000 00001110 1122235678999999999
Q ss_pred ccCCCCCCCHHHHHHH--HHHhH
Q 014363 350 VKNARTRPKMSEVLEM--VNKIV 370 (426)
Q Consensus 350 ~~dp~~RPs~~eil~~--L~~~~ 370 (426)
+.||++|||+.|+++| ++.+.
T Consensus 307 ~~dP~~R~t~~e~l~hp~f~~~~ 329 (383)
T 3eb0_A 307 RYEPDLRINPYEAMAHPFFDHLR 329 (383)
T ss_dssp CSSGGGSCCHHHHHTSGGGHHHH
T ss_pred cCChhhCCCHHHHhcCHHHHHHH
Confidence 9999999999999976 44443
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-45 Score=367.47 Aligned_cols=250 Identities=25% Similarity=0.376 Sum_probs=204.0
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-----CCHHHHHHHHHHHhhcCCCCccceEeEEEccC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-----GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 158 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 158 (426)
.++|...++||+|+||.||+|.+..++. .||+|.+... ...+.+.+|+.+|+.++||||+++++++.+..
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 99 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQ-----ECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKG 99 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCC-----EEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCC-----EEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 4579999999999999999999876654 8999988532 34567899999999999999999999998765
Q ss_pred CCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEe---CCCCCeeE
Q 014363 159 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL---DEQWNAKL 235 (426)
Q Consensus 159 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl---~~~~~~kl 235 (426)
..|+||||+.+|+|.+++.... .+++..++.++.||+.||.|||++ +|+||||||+|||+ +.++.+||
T Consensus 100 ----~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl 170 (484)
T 3nyv_A 100 ----YFYLVGEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRI 170 (484)
T ss_dssp ----EEEEEECCCCSCBHHHHHHTCS--CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEE
T ss_pred ----EEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEE
Confidence 4599999999999999986543 489999999999999999999998 99999999999999 56789999
Q ss_pred eeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhh
Q 014363 236 SDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYL 315 (426)
Q Consensus 236 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 315 (426)
+|||++....... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||...........+. .
T Consensus 171 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~---~-- 241 (484)
T 3nyv_A 171 IDFGLSTHFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVE---K-- 241 (484)
T ss_dssp CCTTHHHHBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---H--
T ss_pred EeeeeeEEccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH---c--
Confidence 9999998765432 1234579999999999875 79999999999999999999999998654322111110 0
Q ss_pred hhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 316 SDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
. ...........++..+.+|+.+||+.||++|||+.|+++|
T Consensus 242 -------~--~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 242 -------G--KYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp -------C--CCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -------C--CCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 0 0000111112356789999999999999999999999987
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=366.49 Aligned_cols=249 Identities=25% Similarity=0.382 Sum_probs=200.7
Q ss_pred HhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc---------------CCHHHHHHHHHHHhhcCCCCc
Q 014363 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR---------------GGHKEWMTEVNFLGIVEHQNL 147 (426)
Q Consensus 83 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~---------------~~~~~~~~E~~~l~~l~HpnI 147 (426)
..++|.+++.||+|+||.||+|.++.++. .+|+|.+... ...+.+.+|+.+|+.++||||
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~-----~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni 108 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHS-----EKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNI 108 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCC-----EEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTB
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCc-----EEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCC
Confidence 35689999999999999999999887654 7899987543 234578899999999999999
Q ss_pred cceEeEEEccCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEe
Q 014363 148 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL 227 (426)
Q Consensus 148 v~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl 227 (426)
+++++++.+.. ..|+|||||++|+|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+|||+
T Consensus 109 v~~~~~~~~~~----~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~ 179 (504)
T 3q5i_A 109 IKLFDVFEDKK----YFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILL 179 (504)
T ss_dssp CCEEEEEECSS----EEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred CeEEEEEEcCC----EEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEE
Confidence 99999998765 459999999999999988643 3489999999999999999999998 99999999999999
Q ss_pred CCCC---CeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhh
Q 014363 228 DEQW---NAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSE 304 (426)
Q Consensus 228 ~~~~---~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~ 304 (426)
+.++ .+||+|||++....... .....+||+.|+|||++. +.|+.++|||||||++|+|++|..||........
T Consensus 180 ~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 255 (504)
T 3q5i_A 180 ENKNSLLNIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDI 255 (504)
T ss_dssp SSTTCCSSEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred ecCCCCccEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 8776 69999999998765432 133467999999999887 5699999999999999999999999986543221
Q ss_pred HHHHHhHhhhhhhhhhhhhhcCCcCCCc--ccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 305 QKLLQWVKPYLSDAKQFRQIVDPRLEGK--YSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
...+. ....... ....++..+.+|+.+||+.||++|||+.|++++
T Consensus 256 ~~~i~----------------~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 256 IKKVE----------------KGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HHHHH----------------HCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHH----------------cCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 11111 0000000 001245789999999999999999999999986
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=342.94 Aligned_cols=261 Identities=25% Similarity=0.362 Sum_probs=200.0
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-----CCHHHHHHHHHHHhhcCCCCccceEeEEEccC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-----GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 158 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 158 (426)
.++|+..+.||+|+||.||+|.+.... .....|++|.+... ...+.+.+|+.++..++||||+++++++.+..
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 94 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPS--GKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP 94 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTT--SCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCC--CceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC
Confidence 357999999999999999999875432 22346899987643 23457889999999999999999999997654
Q ss_pred CCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeee
Q 014363 159 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 238 (426)
Q Consensus 159 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 238 (426)
.++||||+++++|.+++... ...+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+||
T Consensus 95 -----~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Df 165 (291)
T 1u46_A 95 -----MKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDF 165 (291)
T ss_dssp -----CEEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCC
T ss_pred -----ceeeEecccCCCHHHHHHhc-cCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccc
Confidence 38999999999999998743 24489999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCce-eeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhh
Q 014363 239 GLARLGPSEGFT-HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLS 316 (426)
Q Consensus 239 Gla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 316 (426)
|++......... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||......... .
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~---~------- 235 (291)
T 1u46_A 166 GLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL---H------- 235 (291)
T ss_dssp TTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH---H-------
T ss_pred cccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHH---H-------
Confidence 999876543322 22334567889999999998889999999999999999999 99999765432111 1
Q ss_pred hhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHh
Q 014363 317 DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVD 371 (426)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~ 371 (426)
.+.........+..++..+.+++.+||+.||++|||+.+++++|+++..
T Consensus 236 ------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 236 ------KIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp ------HHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred ------HHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 1111111111223456789999999999999999999999999987753
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=355.46 Aligned_cols=269 Identities=20% Similarity=0.238 Sum_probs=204.9
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-CHHHHHHHHHHHhhcC--------CCCccceEeEE
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-GHKEWMTEVNFLGIVE--------HQNLVKLVGYC 154 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~E~~~l~~l~--------HpnIv~~~~~~ 154 (426)
.++|.+.+.||+|+||.||+|.+..++ ..||+|.+.... ..+.+.+|+.+|+.++ ||||+++++++
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~ 110 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGK-----KFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDF 110 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTT-----EEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCC-----eEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecce
Confidence 468999999999999999999877654 489999986543 3457889999999985 78899999999
Q ss_pred EccCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCC---
Q 014363 155 ADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW--- 231 (426)
Q Consensus 155 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~--- 231 (426)
......+...|+||||+ +++|.+++.......+++..++.|+.||+.||+|||+++ +|+||||||+|||++.++
T Consensus 111 ~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~ 187 (397)
T 1wak_A 111 KISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYI 187 (397)
T ss_dssp EEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHH
T ss_pred eecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhh
Confidence 85443344679999999 666766665554456999999999999999999999841 899999999999999775
Q ss_pred ----------------------------------------------CeeEeeecccccCCCCCceeeeeeeecCcccCCc
Q 014363 232 ----------------------------------------------NAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAP 265 (426)
Q Consensus 232 ----------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aP 265 (426)
.+||+|||++...... .....||+.|+||
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aP 262 (397)
T 1wak_A 188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSL 262 (397)
T ss_dssp HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCH
T ss_pred hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCC
Confidence 7999999999865432 2345799999999
Q ss_pred hhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhh---HHHHHhHhhhhhh--------hhhhhhhcCC-------
Q 014363 266 EYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSE---QKLLQWVKPYLSD--------AKQFRQIVDP------- 327 (426)
Q Consensus 266 E~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~---~~~~~~~~~~~~~--------~~~~~~~~~~------- 327 (426)
|++.+..++.++|||||||++|+|++|..||........ ..........+.. ..........
T Consensus 263 E~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 342 (397)
T 1wak_A 263 EVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHI 342 (397)
T ss_dssp HHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSC
T ss_pred hhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccc
Confidence 999999999999999999999999999999976543221 1111111000000 0000000000
Q ss_pred ---cC---------CCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 328 ---RL---------EGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 328 ---~~---------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.. ....+...+..+.+||.+||+.||++|||+.|+++|
T Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 343 TKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred cccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 00 012356778899999999999999999999999985
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=345.54 Aligned_cols=272 Identities=22% Similarity=0.311 Sum_probs=202.1
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
.++|.+.+.||+|+||.||+|.+..++. .||+|.+.... ....+.+|+.+++.++||||+++++++.+...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 90 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQ-----KVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAS 90 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCC-----EEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCC-----EEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccc
Confidence 4689999999999999999999876654 89999885443 23468899999999999999999999987542
Q ss_pred C----CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeE
Q 014363 160 R----GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKL 235 (426)
Q Consensus 160 ~----~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl 235 (426)
. ....|+||||+++ +|.+.+.... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||
T Consensus 91 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl 165 (351)
T 3mi9_A 91 PYNRCKGSIYLVFDFCEH-DLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKL 165 (351)
T ss_dssp ------CEEEEEEECCSE-EHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEE
T ss_pred ccccCCceEEEEEeccCC-CHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEE
Confidence 1 2356999999975 7777665433 3489999999999999999999998 9999999999999999999999
Q ss_pred eeecccccCCCCCc--eeeeeeeecCcccCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHh
Q 014363 236 SDFGLARLGPSEGF--THVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK 312 (426)
Q Consensus 236 ~DFGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~ 312 (426)
+|||++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+....
T Consensus 166 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~ 245 (351)
T 3mi9_A 166 ADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 245 (351)
T ss_dssp CCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred ccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 99999986542211 122345678999999998876 458999999999999999999999998765433322222111
Q ss_pred hh-----hhhhh---hhhhhcC-CcCCCcccHH-----HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 313 PY-----LSDAK---QFRQIVD-PRLEGKYSLR-----LVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 313 ~~-----~~~~~---~~~~~~~-~~~~~~~~~~-----~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.. +.... ....... .......... .++.+.+|+.+||+.||++|||++|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 246 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp CCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 00 00000 0000000 0000001111 14568899999999999999999999996
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=347.21 Aligned_cols=279 Identities=24% Similarity=0.383 Sum_probs=210.8
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC--HHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG--HKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
.++|++++.||+|+||.||+|.+... .......||+|.+..... .+.+.+|+.+++.++||||+++++++...+..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~- 117 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPL-QDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR- 117 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTT-SSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-----
T ss_pred HHHceeeeeeccCCCeEEEEEEeccc-cCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC-
Confidence 35688999999999999999986432 123345899999865443 35788999999999999999999998765432
Q ss_pred ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccc
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 241 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 241 (426)
..++||||+++++|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 118 -~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~ 192 (326)
T 2w1i_A 118 -NLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLT 192 (326)
T ss_dssp -CCEEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred -ceEEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcch
Confidence 3489999999999999997543 3489999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCce-eeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhh---h
Q 014363 242 RLGPSEGFT-HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS---D 317 (426)
Q Consensus 242 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~ 317 (426)
......... .......++..|+|||++.+..++.++||||||+++|+|++|..||..... ........... .
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~----~~~~~~~~~~~~~~~ 268 (326)
T 2w1i_A 193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA----EFMRMIGNDKQGQMI 268 (326)
T ss_dssp EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH----HHHHHHCTTCCTHHH
T ss_pred hhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHH----HHHHhhccccchhhh
Confidence 876543321 112334678889999999988899999999999999999999999863211 00000000000 0
Q ss_pred hhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhh
Q 014363 318 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 373 (426)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~ 373 (426)
...+.+.+........+..++..+.+++.+||+.||++|||+.||++.|+.+.+..
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l 324 (326)
T 2w1i_A 269 VFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324 (326)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 00111111111111223345678999999999999999999999999999987653
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=357.69 Aligned_cols=264 Identities=21% Similarity=0.275 Sum_probs=203.2
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-CHHHHHHHHHHHhhc------CCCCccceEeEEEc
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-GHKEWMTEVNFLGIV------EHQNLVKLVGYCAD 156 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~E~~~l~~l------~HpnIv~~~~~~~~ 156 (426)
..+|++.++||+|+||.||+|.+..++ ..||+|.+.... ....+.+|+.++..+ +|+||+++++++..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~-----~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~ 170 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVH-----QHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF 170 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTT-----EEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCC-----cEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc
Confidence 457999999999999999999987654 389999987543 235677888888887 57799999999987
Q ss_pred cCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCC--ee
Q 014363 157 DDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWN--AK 234 (426)
Q Consensus 157 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~--~k 234 (426)
.. ..++||||+. ++|.+++.......+++..++.|+.||+.||+|||++ +|+||||||+|||++.++. +|
T Consensus 171 ~~----~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vk 242 (429)
T 3kvw_A 171 RN----HICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIK 242 (429)
T ss_dssp TT----EEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEE
T ss_pred CC----eEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceE
Confidence 65 4599999995 6999998766655699999999999999999999998 9999999999999999987 99
Q ss_pred EeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHh--
Q 014363 235 LSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK-- 312 (426)
Q Consensus 235 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~-- 312 (426)
|+|||++...... ....+||+.|+|||++.+..++.++|||||||++|||++|..||...........+....
T Consensus 243 L~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~ 317 (429)
T 3kvw_A 243 VIDFGSSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGM 317 (429)
T ss_dssp ECCCTTCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred EeecccceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC
Confidence 9999999765432 234679999999999999999999999999999999999999998654432221111100
Q ss_pred ---hhhhhhhhhhhhcCCc--------------------------------CCCcc----cHHHHHHHHHHHHhccccCC
Q 014363 313 ---PYLSDAKQFRQIVDPR--------------------------------LEGKY----SLRLVSKLSHVANLCLVKNA 353 (426)
Q Consensus 313 ---~~~~~~~~~~~~~~~~--------------------------------~~~~~----~~~~~~~l~~li~~cl~~dp 353 (426)
..+.........++.. ....+ ....++.+.+||.+||+.||
T Consensus 318 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP 397 (429)
T 3kvw_A 318 PSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDP 397 (429)
T ss_dssp CCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSST
T ss_pred CCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCCh
Confidence 0000000011111100 00000 00124678999999999999
Q ss_pred CCCCCHHHHHHH
Q 014363 354 RTRPKMSEVLEM 365 (426)
Q Consensus 354 ~~RPs~~eil~~ 365 (426)
++|||+.|+++|
T Consensus 398 ~~Rpta~e~L~H 409 (429)
T 3kvw_A 398 AVRMTPGQALRH 409 (429)
T ss_dssp TTSCCHHHHHTS
T ss_pred hhCCCHHHHhCC
Confidence 999999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=348.19 Aligned_cols=261 Identities=25% Similarity=0.322 Sum_probs=188.1
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC--CHHHHHHHHHHHhhcC-CCCccceEeEEEccC--
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--GHKEWMTEVNFLGIVE-HQNLVKLVGYCADDD-- 158 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~E~~~l~~l~-HpnIv~~~~~~~~~~-- 158 (426)
..+|.+.++||+|+||.||+|.+..++. .||+|.+.... ..+.+.+|+.++..+. ||||+++++++....
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 101 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGR-----EYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEE 101 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCC-----EEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTT
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCc-----EEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccc
Confidence 3579999999999999999999876654 79999875443 3456889999999995 999999999995322
Q ss_pred --CCCceEEEEEeeCCCCChhhhccCC-CCCccCHHHHHHHHHHHHHHHHHhccCCCCC--eEeccCCCCceEeCCCCCe
Q 014363 159 --ERGIQRLLVYEYMPNGSVDQYLSPK-SETILTWAMRLKIAQDAARGLAYLHEGMDFQ--IIVRDFKSSNILLDEQWNA 233 (426)
Q Consensus 159 --~~~~~~~lv~E~~~~g~L~~~l~~~-~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~--iiHrDlkp~NILl~~~~~~ 233 (426)
......++||||+. |+|.+++... ....+++..++.++.||+.||.|||+. + |+||||||+|||++.++.+
T Consensus 102 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~ 177 (337)
T 3ll6_A 102 SDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTI 177 (337)
T ss_dssp STTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCE
T ss_pred cccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCE
Confidence 22335799999995 7898888541 234599999999999999999999998 7 9999999999999999999
Q ss_pred eEeeecccccCCCCCcee----------eeeeeecCcccCCchhh---ccCCCCCchhhHHHHHHHHHHHhCCCCCCCCC
Q 014363 234 KLSDFGLARLGPSEGFTH----------VSTAVVGTMGYAAPEYV---QTGRLAARSDVWSYGVFLYELITGRRPIDRNR 300 (426)
Q Consensus 234 kl~DFGla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslGvil~elltg~~p~~~~~ 300 (426)
||+|||++.......... ......||+.|+|||++ .+..++.++||||||+++|+|++|..||....
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 257 (337)
T 3ll6_A 178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA 257 (337)
T ss_dssp EBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred EEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh
Confidence 999999998654322111 11245699999999998 56678899999999999999999999996432
Q ss_pred chhhHHHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhh
Q 014363 301 PRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 373 (426)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~ 373 (426)
... ++............+..+.+|+.+||+.||++|||+.|++++|..+....
T Consensus 258 ~~~--------------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~ 310 (337)
T 3ll6_A 258 KLR--------------------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310 (337)
T ss_dssp ----------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HHH--------------------hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 210 00000111111122345889999999999999999999999999887653
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=349.02 Aligned_cols=255 Identities=24% Similarity=0.354 Sum_probs=203.8
Q ss_pred HHHHHHhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC----------HHHHHHHHHHHhhc-CCCC
Q 014363 78 AELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG----------HKEWMTEVNFLGIV-EHQN 146 (426)
Q Consensus 78 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~----------~~~~~~E~~~l~~l-~Hpn 146 (426)
.......++|.+.+.||+|+||.||+|.+..++. .||+|++..... .+.+.+|+.++..+ +|||
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~-----~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~ 161 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGH-----EFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCC-----EEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTT
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECCCCc-----EEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 3344556789999999999999999999876554 899998854321 34578999999999 8999
Q ss_pred ccceEeEEEccCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceE
Q 014363 147 LVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNIL 226 (426)
Q Consensus 147 Iv~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NIL 226 (426)
|+++++++.... ..|+||||+++++|.+++... ..+++..++.++.||+.||.|||+. ||+||||||+|||
T Consensus 162 iv~~~~~~~~~~----~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl 232 (365)
T 2y7j_A 162 IITLIDSYESSS----FMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENIL 232 (365)
T ss_dssp BCCEEEEEEBSS----EEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred EeEEEEEEeeCC----EEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEE
Confidence 999999998755 459999999999999998643 3489999999999999999999998 9999999999999
Q ss_pred eCCCCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhcc------CCCCCchhhHHHHHHHHHHHhCCCCCCCCC
Q 014363 227 LDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT------GRLAARSDVWSYGVFLYELITGRRPIDRNR 300 (426)
Q Consensus 227 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslGvil~elltg~~p~~~~~ 300 (426)
++.++.+||+|||++....... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||....
T Consensus 233 ~~~~~~ikl~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~ 309 (365)
T 2y7j_A 233 LDDNMQIRLSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR 309 (365)
T ss_dssp ECTTCCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ECCCCCEEEEecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC
Confidence 9999999999999998765432 1234689999999999864 358899999999999999999999997643
Q ss_pred chhhHHHHHhHhhhhhhhhhhhhhcCCcCCCcc--cHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 301 PRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKY--SLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
..... ..+. ........ ....+..+.+++.+||+.||++|||+.|++++
T Consensus 310 ~~~~~---~~i~-------------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 310 QILML---RMIM-------------EGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp HHHHH---HHHH-------------HTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHH---HHHH-------------hCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 22111 1110 00000000 01234678999999999999999999999985
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=364.99 Aligned_cols=250 Identities=24% Similarity=0.366 Sum_probs=201.3
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccc----cCCHHHHHHHHHHHhhcCCCCccceEeEEEccCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGR----RGGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~----~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
.++|.+.+.||+|+||.||+|.+..++. .||+|.+.. ......+.+|+.+|+.++||||+++++++.+..
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~- 94 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQ-----EYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSS- 94 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCC-----EEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCC-----EEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCC-
Confidence 4579999999999999999999876654 799998743 235667899999999999999999999998765
Q ss_pred CCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeC---CCCCeeEe
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLD---EQWNAKLS 236 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~---~~~~~kl~ 236 (426)
..|+||||+++|+|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+|||++ .++.+||+
T Consensus 95 ---~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~ 166 (486)
T 3mwu_A 95 ---SFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKII 166 (486)
T ss_dssp ---EEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEEC
T ss_pred ---EEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEE
Confidence 459999999999999988644 3489999999999999999999998 999999999999995 45679999
Q ss_pred eecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhh
Q 014363 237 DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS 316 (426)
Q Consensus 237 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 316 (426)
|||++....... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||...........+. .
T Consensus 167 Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~---~--- 236 (486)
T 3mwu_A 167 DFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVE---T--- 236 (486)
T ss_dssp SCSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---H---
T ss_pred ECCcCeECCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---h---
Confidence 999998654332 2334679999999999875 59999999999999999999999997654322111110 0
Q ss_pred hhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 317 DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
. ...........++..+.+||.+||+.||++|||+.|++++
T Consensus 237 ------~--~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 237 ------G--KYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp ------T--CCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred ------C--CCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 0000111112356789999999999999999999999997
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=350.60 Aligned_cols=276 Identities=21% Similarity=0.269 Sum_probs=201.3
Q ss_pred CHHHHHHHhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC-------------HHHHHHHHHHHhhc
Q 014363 76 TIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG-------------HKEWMTEVNFLGIV 142 (426)
Q Consensus 76 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~-------------~~~~~~E~~~l~~l 142 (426)
.+.++....++|.+.+.||+|+||.||+|.+..+ ..||+|.+..... .+.+.+|+.+++.+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 86 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEG------IPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHF 86 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTS------CEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCC------CeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhC
Confidence 3567788899999999999999999999986542 3799998854321 26789999999999
Q ss_pred CCCCccceEeEEEccC-CCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCC
Q 014363 143 EHQNLVKLVGYCADDD-ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFK 221 (426)
Q Consensus 143 ~HpnIv~~~~~~~~~~-~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlk 221 (426)
+||||+++++++.... ......|+||||++ |+|.+++... ...+++..++.++.||+.||.|||++ +|+|||||
T Consensus 87 ~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlk 161 (362)
T 3pg1_A 87 HHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLH 161 (362)
T ss_dssp CCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCC
T ss_pred CCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCC
Confidence 9999999999986643 22346799999997 6888887643 34589999999999999999999998 99999999
Q ss_pred CCceEeCCCCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCC
Q 014363 222 SSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNR 300 (426)
Q Consensus 222 p~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~ 300 (426)
|+|||++.++.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||....
T Consensus 162 p~NIl~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 238 (362)
T 3pg1_A 162 PGNILLADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST 238 (362)
T ss_dssp GGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred hHHEEEcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999997543321 2334679999999999877 678999999999999999999999998654
Q ss_pred chhhHHHH-HhHhh-hhh-----hhhhhhhhcCCcCC---C----cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 301 PRSEQKLL-QWVKP-YLS-----DAKQFRQIVDPRLE---G----KYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 301 ~~~~~~~~-~~~~~-~~~-----~~~~~~~~~~~~~~---~----~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.......+ ..... ... .............. . ......++.+.+|+.+||+.||++|||+.|+++|
T Consensus 239 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 239 FYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 33222111 10000 000 00001111111110 0 0111235678999999999999999999999986
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=342.59 Aligned_cols=244 Identities=20% Similarity=0.285 Sum_probs=196.2
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhc-CCCCccceEeEEEccC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIV-EHQNLVKLVGYCADDD 158 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~ 158 (426)
.++|.+.+.||+|+||.||+|.+..++. .||+|.+.... ....+.+|+.++..+ +||||+++++++.+.+
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~ 84 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGC-----IYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDD 84 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCC-----EEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETT
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCc-----eEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCC
Confidence 5679999999999999999999876554 89999886432 345678999999999 9999999999998766
Q ss_pred CCCceEEEEEeeCCCCChhhhccCCCC--CccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCC------
Q 014363 159 ERGIQRLLVYEYMPNGSVDQYLSPKSE--TILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQ------ 230 (426)
Q Consensus 159 ~~~~~~~lv~E~~~~g~L~~~l~~~~~--~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~------ 230 (426)
..++||||+++++|.+++..... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.+
T Consensus 85 ----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~ 157 (289)
T 1x8b_A 85 ----HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAA 157 (289)
T ss_dssp ----EEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC--------
T ss_pred ----eEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccc
Confidence 45999999999999999965321 4489999999999999999999998 99999999999999844
Q ss_pred -------------CCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCC
Q 014363 231 -------------WNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPI 296 (426)
Q Consensus 231 -------------~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~ 296 (426)
..+||+|||++....... ...||+.|+|||++.+. .++.++||||||+++|+|++|.+|+
T Consensus 158 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~ 231 (289)
T 1x8b_A 158 SEEGDEDDWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLP 231 (289)
T ss_dssp ------------CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred ccccccccccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCC
Confidence 479999999998765432 24599999999998866 5668999999999999999998876
Q ss_pred CCCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 297 DRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
..... . ..+.... ....+..++..+.+++.+||+.||++|||+.|++++
T Consensus 232 ~~~~~-----~--------------~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 232 RNGDQ-----W--------------HEIRQGR-LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp SSSHH-----H--------------HHHHTTC-CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred cchhH-----H--------------HHHHcCC-CCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 43210 0 0011111 111222355789999999999999999999999986
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=348.58 Aligned_cols=266 Identities=24% Similarity=0.287 Sum_probs=194.2
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
.++|...+.||+|+||.||+|.+..++ ..||+|.+.... ..+.+.+|+.+++.++||||+++++++.....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 98 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILE-----RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKS 98 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTT-----EEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCS
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCC-----ceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccc
Confidence 468999999999999999999977654 379999986532 23467899999999999999999999976542
Q ss_pred --CCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEee
Q 014363 160 --RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 237 (426)
Q Consensus 160 --~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~D 237 (426)
.....|+||||++ ++|.+++.. .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|
T Consensus 99 ~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~D 170 (371)
T 2xrw_A 99 LEEFQDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD 170 (371)
T ss_dssp TTTCCEEEEEEECCS-EEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECC
T ss_pred cccccceEEEEEcCC-CCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEE
Confidence 2235699999996 478888752 388999999999999999999998 999999999999999999999999
Q ss_pred ecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhH-h----
Q 014363 238 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWV-K---- 312 (426)
Q Consensus 238 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~-~---- 312 (426)
||++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+... .
T Consensus 171 fg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 247 (371)
T 2xrw_A 171 FGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCP 247 (371)
T ss_dssp CCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCH
T ss_pred eecccccccc---cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 9999865432 1233468999999999999999999999999999999999999999865432211111000 0
Q ss_pred hhhhh-hhh---------------hhhhcCCcC---CCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 313 PYLSD-AKQ---------------FRQIVDPRL---EGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 313 ~~~~~-~~~---------------~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
..+.. ... +........ ........+..+.+|+.+||+.||++|||++|+++|
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 248 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 00000 000 000000000 011123447789999999999999999999999997
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=350.32 Aligned_cols=270 Identities=22% Similarity=0.301 Sum_probs=203.1
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC---HHHHHHHHHHHhhcCCCCccceEeEEEccC-C
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG---HKEWMTEVNFLGIVEHQNLVKLVGYCADDD-E 159 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~-~ 159 (426)
.++|++++.||+|+||.||+|.+..++ ..||+|.+..... .+.+.+|+.+|..++||||+++++++.... .
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 100 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNK-----VRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE 100 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTT-----EEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTT
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCC-----eEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCcc
Confidence 468999999999999999999977654 4799999865432 356889999999999999999999997654 2
Q ss_pred CCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeec
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 239 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 239 (426)
.....|+||||++ |+|.+++... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 101 ~~~~~~iv~e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg 173 (364)
T 3qyz_A 101 QMKDVYIVQDLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFG 173 (364)
T ss_dssp TCCCEEEEEECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred ccceEEEEEcccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCc
Confidence 2234699999996 5999988643 389999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCc-eeeeeeeecCcccCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHh-hh--
Q 014363 240 LARLGPSEGF-THVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK-PY-- 314 (426)
Q Consensus 240 la~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~-~~-- 314 (426)
++........ .......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+.... ..
T Consensus 174 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 253 (364)
T 3qyz_A 174 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 253 (364)
T ss_dssp TCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCH
T ss_pred ceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 9986543211 111234689999999998764 458999999999999999999999998765433322211100 00
Q ss_pred -----hhhh--hhhhhhcCCcCCC---cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 315 -----LSDA--KQFRQIVDPRLEG---KYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 315 -----~~~~--~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.... ............. .....++..+.+|+.+||+.||++|||+.|++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 0000000000000 0112245688999999999999999999999986
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=343.42 Aligned_cols=250 Identities=23% Similarity=0.341 Sum_probs=201.6
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC--CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
.++|...+.||+|+||.||+|.+..++. .||+|.+.... ..+.+.+|+.+++.++||||+++++++.+..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--- 79 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGK-----LFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTT--- 79 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCC-----EEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSS---
T ss_pred hccceeeeeccCCCCceEEEEEECCCCC-----EEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCC---
Confidence 4579999999999999999999876554 79999886543 3456889999999999999999999998765
Q ss_pred ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEe---CCCCCeeEeee
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL---DEQWNAKLSDF 238 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl---~~~~~~kl~DF 238 (426)
..|+||||+++++|.+++... ..+++..++.++.|++.||.|||++ +|+||||||+|||+ +.++.+||+||
T Consensus 80 -~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Df 153 (304)
T 2jam_A 80 -HYYLVMQLVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDF 153 (304)
T ss_dssp -EEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSC
T ss_pred -EEEEEEEcCCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccC
Confidence 459999999999999988643 3489999999999999999999998 99999999999999 78889999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014363 239 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 318 (426)
Q Consensus 239 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 318 (426)
|++...... ......||+.|+|||++.+..++.++||||||+++|+|++|..||......... ..+.. .
T Consensus 154 g~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~i~~---~- 222 (304)
T 2jam_A 154 GLSKMEQNG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLF---EKIKE---G- 222 (304)
T ss_dssp STTCCCCCB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---HHHHH---C-
T ss_pred CcceecCCC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHH---HHHHc---C-
Confidence 999754322 123457999999999999999999999999999999999999999764332111 11100 0
Q ss_pred hhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 319 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
...........++..+.+++.+||+.||++|||+.|++++
T Consensus 223 -------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 223 -------YYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp -------CCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred -------CCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0011111222355789999999999999999999999986
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-44 Score=337.21 Aligned_cols=252 Identities=23% Similarity=0.356 Sum_probs=198.6
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC--CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCc
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 162 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~ 162 (426)
.+|....+||+|+||.||+|.+..++. .||+|.+.... ..+.+.+|+.+++.++||||+++++++.+.+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---- 92 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQV-----RIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENG---- 92 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCC-----EEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETT----
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCe-----EEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCC----
Confidence 356666799999999999999876654 79999886543 3467889999999999999999999998765
Q ss_pred eEEEEEeeCCCCChhhhccCCC-CCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCC-CCCeeEeeecc
Q 014363 163 QRLLVYEYMPNGSVDQYLSPKS-ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE-QWNAKLSDFGL 240 (426)
Q Consensus 163 ~~~lv~E~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~-~~~~kl~DFGl 240 (426)
..++||||+++++|.+++.... ...+++..++.++.|++.||.|||++ +|+||||||+|||++. ++.+||+|||+
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~ 169 (295)
T 2clq_A 93 FIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGT 169 (295)
T ss_dssp EEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTT
T ss_pred cEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeeccc
Confidence 4599999999999999987542 23467889999999999999999998 9999999999999987 89999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCchhhccCC--CCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014363 241 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGR--LAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 318 (426)
Q Consensus 241 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 318 (426)
+....... .......||+.|+|||++.+.. ++.++||||||+++|+|++|..||.............
T Consensus 170 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--------- 238 (295)
T 2clq_A 170 SKRLAGIN--PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKV--------- 238 (295)
T ss_dssp CEESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHH---------
T ss_pred ccccCCCC--CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhh---------
Confidence 98654321 1233467999999999987654 7889999999999999999999996433221111000
Q ss_pred hhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 319 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
...... ...+..++..+.+++.+||+.||++||++.+++++
T Consensus 239 --~~~~~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 239 --GMFKVH----PEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp --HHHCCC----CCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred --cccccc----ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000011 12233456788999999999999999999999875
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=344.91 Aligned_cols=261 Identities=26% Similarity=0.430 Sum_probs=185.8
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
.++|.+.+.||+|+||.||+|.+..++. .||+|.+.... ..+.+.+|+.++..++||||+++++++...+.
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~- 87 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKE-----KVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE- 87 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----C-----EEEEECCC----------------CCCCCCCTTBCCEEEEEESSSC-
T ss_pred hhhhhhhheeccccceEEEEEEECCCCc-----EEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCC-
Confidence 5689999999999999999998765443 79999886432 34568899999999999999999999988764
Q ss_pred CceEEEEEeeCCCCChhhhccC------CCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCee
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSP------KSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAK 234 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~------~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~k 234 (426)
.++||||+++++|.+++.. .....+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+|
T Consensus 88 ---~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~k 161 (303)
T 2vwi_A 88 ---LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQ 161 (303)
T ss_dssp ---EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEE
T ss_pred ---cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEE
Confidence 4999999999999999863 1234589999999999999999999998 999999999999999999999
Q ss_pred EeeecccccCCCCCc---eeeeeeeecCcccCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHh
Q 014363 235 LSDFGLARLGPSEGF---THVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQW 310 (426)
Q Consensus 235 l~DFGla~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~ 310 (426)
|+|||++........ ........||+.|+|||++.+ ..++.++||||||+++|+|++|..||............
T Consensus 162 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-- 239 (303)
T 2vwi_A 162 IADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLT-- 239 (303)
T ss_dssp ECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH--
T ss_pred EEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHH--
Confidence 999999976543211 112234679999999999876 56899999999999999999999999865443221110
Q ss_pred Hhhhhhhhhhhh-hhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 311 VKPYLSDAKQFR-QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 311 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
... ...... ...+.. ....++..+.+++.+||+.||++|||+.+++++
T Consensus 240 ~~~---~~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 240 LQN---DPPSLETGVQDKE----MLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp HTS---SCCCTTC-----C----CCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hcc---CCCccccccccch----hhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 000 000000 000111 112244678999999999999999999999985
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=343.93 Aligned_cols=251 Identities=24% Similarity=0.342 Sum_probs=196.4
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----------CHHHHHHHHHHHhhcCCCCccceEeE
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----------GHKEWMTEVNFLGIVEHQNLVKLVGY 153 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----------~~~~~~~E~~~l~~l~HpnIv~~~~~ 153 (426)
.++|.+.+.||+|+||.||+|.+..++ ..||+|.+.... ....+.+|+.+|+.++||||++++++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 83 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTC-----KKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF 83 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTT-----EEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCC-----cEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeE
Confidence 467999999999999999999987654 389999885432 22357899999999999999999999
Q ss_pred EEccCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCC-
Q 014363 154 CADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWN- 232 (426)
Q Consensus 154 ~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~- 232 (426)
+.... .|+||||+++++|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.
T Consensus 84 ~~~~~-----~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~ 153 (322)
T 2ycf_A 84 FDAED-----YYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEED 153 (322)
T ss_dssp EESSS-----EEEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSS
T ss_pred EcCCc-----eEEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCC
Confidence 87643 49999999999999998654 3489999999999999999999998 9999999999999987665
Q ss_pred --eeEeeecccccCCCCCceeeeeeeecCcccCCchhhc---cCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHH
Q 014363 233 --AKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQ---TGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKL 307 (426)
Q Consensus 233 --~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~ 307 (426)
+||+|||++....... ......||+.|+|||++. ...++.++||||||+++|+|++|..||.........
T Consensus 154 ~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-- 228 (322)
T 2ycf_A 154 CLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL-- 228 (322)
T ss_dssp CCEEECCCTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCH--
T ss_pred CeEEEccCccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHH--
Confidence 9999999998654321 123457999999999874 467899999999999999999999999754332111
Q ss_pred HHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 308 LQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
...... . ...........++..+.+++.+||+.||++|||+.+++++
T Consensus 229 ~~~~~~----~-------~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 229 KDQITS----G-------KYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp HHHHHH----T-------CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHh----C-------ccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 000000 0 0000000011245688999999999999999999999864
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=355.02 Aligned_cols=265 Identities=25% Similarity=0.335 Sum_probs=197.5
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhcCCCCccceEeEEEccCC--CCc
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE--RGI 162 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~--~~~ 162 (426)
.+|...++||+|+||.||+|.+..++. .||+|.+.... ..+.+|+++|+.++|||||++++++..... ...
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~-----~vaiK~~~~~~--~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~ 126 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGE-----LVAIKKVLQDK--RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 126 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCC-----EEEEEEEECCT--TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCc-----EEEEEEecccc--hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence 468899999999999999999876554 89999886543 234579999999999999999999865332 223
Q ss_pred eEEEEEeeCCCCChhhhccC--CCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCC-CCeeEeeec
Q 014363 163 QRLLVYEYMPNGSVDQYLSP--KSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQ-WNAKLSDFG 239 (426)
Q Consensus 163 ~~~lv~E~~~~g~L~~~l~~--~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~-~~~kl~DFG 239 (426)
.+++||||+++ +|.+++.. .....+++..++.++.||+.||+|||++ +|+||||||+||||+.+ +.+||+|||
T Consensus 127 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG 202 (420)
T 1j1b_A 127 YLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFG 202 (420)
T ss_dssp EEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccch
Confidence 46799999975 66655532 1234589999999999999999999998 99999999999999965 568999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhh-h
Q 014363 240 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS-D 317 (426)
Q Consensus 240 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~ 317 (426)
+++...... .....+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+..... .+...+...-. .
T Consensus 203 ~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~--~l~~i~~~lg~p~ 277 (420)
T 1j1b_A 203 SAKQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEIIKVLGTPT 277 (420)
T ss_dssp TCEECCTTC---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCSCC
T ss_pred hhhhcccCC---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCC
Confidence 998654322 12346799999999998765 78999999999999999999999998654322 12111111000 0
Q ss_pred hhhhhhh-------cCCcCCC-----cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 318 AKQFRQI-------VDPRLEG-----KYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 318 ~~~~~~~-------~~~~~~~-----~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
...+... ..+.+.. .+....+.++.+|+.+||+.||++|||+.|+++|
T Consensus 278 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 278 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 0111111 0011110 0122346789999999999999999999999986
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=351.62 Aligned_cols=256 Identities=26% Similarity=0.352 Sum_probs=201.3
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc------CCHHHHHHHHHHHhhc-CCCCccceEeEEEc
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR------GGHKEWMTEVNFLGIV-EHQNLVKLVGYCAD 156 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~------~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~ 156 (426)
.++|.+.+.||+|+||.||+|...... .....||+|.+... ...+.+.+|+.+|..+ +||||+++++++.+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 130 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGH--DTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 130 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSST--TTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccC--CCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee
Confidence 357999999999999999999875311 12348999987542 2445678899999999 79999999999987
Q ss_pred cCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEe
Q 014363 157 DDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLS 236 (426)
Q Consensus 157 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~ 236 (426)
.. ..++||||+++|+|.+++.... .+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+
T Consensus 131 ~~----~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~ 201 (355)
T 1vzo_A 131 ET----KLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLT 201 (355)
T ss_dssp TT----EEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEES
T ss_pred Cc----eEEEEeecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEe
Confidence 65 4599999999999999996543 489999999999999999999998 99999999999999999999999
Q ss_pred eecccccCCCCCceeeeeeeecCcccCCchhhccC--CCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhH-HHHHhHhh
Q 014363 237 DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG--RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQ-KLLQWVKP 313 (426)
Q Consensus 237 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~-~~~~~~~~ 313 (426)
|||+++....... ......+||+.|+|||++.+. .++.++|||||||++|+|++|..||......... .+...
T Consensus 202 DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~--- 277 (355)
T 1vzo_A 202 DFGLSKEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR--- 277 (355)
T ss_dssp CSSEEEECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHH---
T ss_pred eCCCCeecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHH---
Confidence 9999986543221 123346799999999999863 4789999999999999999999999754322111 11110
Q ss_pred hhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHHH
Q 014363 314 YLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRP-----KMSEVLEMV 366 (426)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~L 366 (426)
+.. ....++..++..+.+||.+||+.||++|| +++|++++.
T Consensus 278 ----------~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 278 ----------ILK--SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp ----------HHH--CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred ----------Hhc--cCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 000 01122334557889999999999999999 999999874
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=334.88 Aligned_cols=247 Identities=24% Similarity=0.372 Sum_probs=194.2
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-----CCHHHHHHHHHHHhhcCCCCccceEeEEEccC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-----GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 158 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 158 (426)
.++|.+.+.||+|+||.||+|.+..++. .|++|.+... ...+.+.+|+.+++.++||||+++++++.+..
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 84 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGH-----KVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPT 84 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCC-----EEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCc-----eEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 4689999999999999999999876544 7999988543 23457889999999999999999999998765
Q ss_pred CCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeee
Q 014363 159 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 238 (426)
Q Consensus 159 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 238 (426)
..++||||+++++|.+++.... .+++..++.++.|++.||.|||++ +|+|+||||+|||++.++.+||+||
T Consensus 85 ----~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~df 155 (276)
T 2h6d_A 85 ----DFFMVMEYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADF 155 (276)
T ss_dssp ----EEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCC
T ss_pred ----eEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeec
Confidence 4599999999999999996543 489999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCchhhccCCC-CCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh
Q 014363 239 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRL-AARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 317 (426)
Q Consensus 239 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 317 (426)
|++....... ......||+.|+|||++.+..+ +.++||||||+++|+|++|..||........ .....
T Consensus 156 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~~~~~----- 224 (276)
T 2h6d_A 156 GLSNMMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTL---FKKIR----- 224 (276)
T ss_dssp CGGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHH-----
T ss_pred ccccccCCCc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH---HHHhh-----
Confidence 9998654322 1234579999999999987765 5799999999999999999999976432211 11100
Q ss_pred hhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 318 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.. .. ..+..++..+.+++.+||+.||++|||+.+++++
T Consensus 225 -----~~-~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 225 -----GG-VF----YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp -----HC-CC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -----cC-cc----cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00 00 1122345678999999999999999999999986
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-44 Score=347.59 Aligned_cols=265 Identities=25% Similarity=0.341 Sum_probs=185.4
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
.++|..++.||+|+||.||+|.+..++ ..||+|++.... ..+.+.+|+.+|+.++||||+++++++.....
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 102 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTG-----LRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 102 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTT-----EEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCC-----CEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCc
Confidence 468999999999999999999977655 389999986532 23567899999999999999999999976421
Q ss_pred C--CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEee
Q 014363 160 R--GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 237 (426)
Q Consensus 160 ~--~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~D 237 (426)
. ....|+||||+ +++|.+++.. ..+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|
T Consensus 103 ~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~D 175 (367)
T 2fst_X 103 LEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILD 175 (367)
T ss_dssp GGGCCCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred cccCCeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEee
Confidence 1 12359999999 7899998864 3489999999999999999999998 999999999999999999999999
Q ss_pred ecccccCCCCCceeeeeeeecCcccCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhh---
Q 014363 238 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKP--- 313 (426)
Q Consensus 238 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~--- 313 (426)
||+++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+.....
T Consensus 176 FG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~ 250 (367)
T 2fst_X 176 FGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 250 (367)
T ss_dssp --------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCC
T ss_pred cccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 9999864432 334689999999999877 6789999999999999999999999987554322221111000
Q ss_pred --hhhh--hhhhhhh---cCCcCCCccc---HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 314 --YLSD--AKQFRQI---VDPRLEGKYS---LRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 314 --~~~~--~~~~~~~---~~~~~~~~~~---~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.+.. ....... +.......+. ...++.+.+|+.+||+.||++|||+.|+++|
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 251 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0000 0000000 0000000110 1235678999999999999999999999987
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=353.59 Aligned_cols=272 Identities=22% Similarity=0.304 Sum_probs=186.3
Q ss_pred CCCCC-cceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCce
Q 014363 85 KNFSR-SVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQ 163 (426)
Q Consensus 85 ~~y~~-~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~ 163 (426)
+.|.+ .++||+|+||.||+|.+++.. ....||+|.+........+.+|+.+|+.++||||+++++++...... .
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~---~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~--~ 94 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGK---DDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADR--K 94 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSS---CCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTT--E
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCC---CCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCC--e
Confidence 34665 458999999999999976432 22479999998777677899999999999999999999999765433 5
Q ss_pred EEEEEeeCCCCChhhhccCC-------CCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEe----CCCCC
Q 014363 164 RLLVYEYMPNGSVDQYLSPK-------SETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL----DEQWN 232 (426)
Q Consensus 164 ~~lv~E~~~~g~L~~~l~~~-------~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl----~~~~~ 232 (426)
.|+||||+. ++|.+++... ....+++..++.|+.||+.||.|||++ +|+||||||+|||| +.++.
T Consensus 95 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~ 170 (405)
T 3rgf_A 95 VWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGR 170 (405)
T ss_dssp EEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTC
T ss_pred EEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCc
Confidence 699999996 5887777421 122489999999999999999999998 99999999999999 77889
Q ss_pred eeEeeecccccCCCCCc-eeeeeeeecCcccCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCchh-------
Q 014363 233 AKLSDFGLARLGPSEGF-THVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRS------- 303 (426)
Q Consensus 233 ~kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~------- 303 (426)
+||+|||+++....... .......+||+.|+|||++.+. .++.++|||||||++|+|++|..||.......
T Consensus 171 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~ 250 (405)
T 3rgf_A 171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYH 250 (405)
T ss_dssp EEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCC
T ss_pred EEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccch
Confidence 99999999986543211 1223456899999999998874 48999999999999999999999997544311
Q ss_pred hHHHHHhHhhh-------hhhh------hhh-hhhcCCcCCCccc--------HHHHHHHHHHHHhccccCCCCCCCHHH
Q 014363 304 EQKLLQWVKPY-------LSDA------KQF-RQIVDPRLEGKYS--------LRLVSKLSHVANLCLVKNARTRPKMSE 361 (426)
Q Consensus 304 ~~~~~~~~~~~-------~~~~------~~~-~~~~~~~~~~~~~--------~~~~~~l~~li~~cl~~dp~~RPs~~e 361 (426)
...+....... +... ... ..+.......... ...+..+.+||.+||+.||++|||++|
T Consensus 251 ~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e 330 (405)
T 3rgf_A 251 HDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQ 330 (405)
T ss_dssp HHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence 01111110000 0000 000 0000000000000 001457889999999999999999999
Q ss_pred HHHH
Q 014363 362 VLEM 365 (426)
Q Consensus 362 il~~ 365 (426)
+++|
T Consensus 331 ~L~h 334 (405)
T 3rgf_A 331 AMQD 334 (405)
T ss_dssp HHTS
T ss_pred HhcC
Confidence 9997
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=340.87 Aligned_cols=252 Identities=24% Similarity=0.381 Sum_probs=197.9
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc--CCHHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR--GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
.++|++.+.||+|+||.||+|.+..++. .+++|.+... ...+.+.+|+.++..++||||+++++++.+..
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~-----~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--- 89 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGA-----LAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDG--- 89 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCC-----EEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC----
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCc-----EEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCC---
Confidence 4689999999999999999999876554 7899987543 34577899999999999999999999998765
Q ss_pred ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccc
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 241 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 241 (426)
..++||||+++++|.+++.... ..+++..++.++.|++.||.|||++ +++||||||+|||++.++.+||+|||++
T Consensus 90 -~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 164 (302)
T 2j7t_A 90 -KLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVS 164 (302)
T ss_dssp -CEEEEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHH
T ss_pred -eEEEEEEeCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCC
Confidence 3599999999999999886432 3489999999999999999999998 9999999999999999999999999987
Q ss_pred ccCCCCCceeeeeeeecCcccCCchhhc-----cCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhh
Q 014363 242 RLGPSEGFTHVSTAVVGTMGYAAPEYVQ-----TGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS 316 (426)
Q Consensus 242 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 316 (426)
...... ........||+.|+|||++. +..++.++||||||+++|+|++|..||.......... ...
T Consensus 165 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--~~~----- 235 (302)
T 2j7t_A 165 AKNLKT--LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL--KIA----- 235 (302)
T ss_dssp HHHHHH--HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH--HHH-----
T ss_pred cccccc--ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHH--HHh-----
Confidence 532111 01123457999999999884 5678999999999999999999999997654321110 000
Q ss_pred hhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 317 DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
. ........+..++..+.+++.+||+.||++|||+.+++++
T Consensus 236 ------~--~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 236 ------K--SDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp ------H--SCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred ------c--cCCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0 0000111223455789999999999999999999999875
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=346.60 Aligned_cols=262 Identities=20% Similarity=0.299 Sum_probs=202.5
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC-------------------HHHHHHHHHHHhhcCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG-------------------HKEWMTEVNFLGIVEH 144 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~-------------------~~~~~~E~~~l~~l~H 144 (426)
.++|.+.+.||+|+||.||+|.+ + ...||+|.+..... .+.+.+|+.++..++|
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 102 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--D-----NKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKN 102 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--T-----TEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--C-----CceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCC
Confidence 46899999999999999999997 2 23899998854321 1788999999999999
Q ss_pred CCccceEeEEEccCCCCceEEEEEeeCCCCChhhh------ccCCCCCccCHHHHHHHHHHHHHHHHHhcc-CCCCCeEe
Q 014363 145 QNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQY------LSPKSETILTWAMRLKIAQDAARGLAYLHE-GMDFQIIV 217 (426)
Q Consensus 145 pnIv~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~------l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~-~~~~~iiH 217 (426)
|||+++++++.+.+ ..++||||+++|+|.++ +.......+++..++.++.|++.||.|||+ + +|+|
T Consensus 103 ~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H 175 (348)
T 2pml_X 103 EYCLTCEGIITNYD----EVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICH 175 (348)
T ss_dssp TTBCCCSEEEESSS----EEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEEC
T ss_pred CCcceEEEEEeeCC----eEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEee
Confidence 99999999998865 45999999999999999 665445679999999999999999999998 7 9999
Q ss_pred ccCCCCceEeCCCCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccC-CCCC-chhhHHHHHHHHHHHhCCCC
Q 014363 218 RDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG-RLAA-RSDVWSYGVFLYELITGRRP 295 (426)
Q Consensus 218 rDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DvwslGvil~elltg~~p 295 (426)
|||||+|||++.++.+||+|||++...... ......||+.|+|||++.+. .++. ++||||||+++|+|++|..|
T Consensus 176 ~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p 251 (348)
T 2pml_X 176 RDVKPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251 (348)
T ss_dssp CCCCGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCS
T ss_pred cCCChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999865432 23456799999999999877 6666 99999999999999999999
Q ss_pred CCCCCchhhHHHHHhHhhh-hhhhh---hhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 296 IDRNRPRSEQKLLQWVKPY-LSDAK---QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~-~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
|....... .....+... ..... .................++..+.+|+.+||+.||++|||+.|++++
T Consensus 252 f~~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 252 FSLKISLV--ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp SCCSSCSH--HHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCCCCcHH--HHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 98654411 111111000 00000 0000000000000113456789999999999999999999999985
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-45 Score=354.78 Aligned_cols=257 Identities=13% Similarity=0.080 Sum_probs=183.1
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-----CHHHHHHHHHHHhhc--CCCCccceE------
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-----GHKEWMTEVNFLGIV--EHQNLVKLV------ 151 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-----~~~~~~~E~~~l~~l--~HpnIv~~~------ 151 (426)
.+|...+.||+|+||.||+|.+..++ ..||+|.+.... ..+.+.+|+.++..| +||||++++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p 136 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERL-----EDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLP 136 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTT-----EEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCC
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCC-----ceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEee
Confidence 45888999999999999999987654 389999987644 234567785555555 699988755
Q ss_pred -eEEEccCCC-------------CceEEEEEeeCCCCChhhhccCCCCCccCHHHH------HHHHHHHHHHHHHhccCC
Q 014363 152 -GYCADDDER-------------GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMR------LKIAQDAARGLAYLHEGM 211 (426)
Q Consensus 152 -~~~~~~~~~-------------~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~------~~i~~~i~~aL~~LH~~~ 211 (426)
+++...... ....||||||++ |+|.+++.... ..+++..+ +.++.||+.||+|||++
T Consensus 137 ~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~- 213 (371)
T 3q60_A 137 SDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQSK- 213 (371)
T ss_dssp CEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT-
T ss_pred ehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHHHHC-
Confidence 455433321 134699999998 89999997532 22444555 67889999999999998
Q ss_pred CCCeEeccCCCCceEeCCCCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhcc--CCCCCchhhHHHHHHHHHH
Q 014363 212 DFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT--GRLAARSDVWSYGVFLYEL 289 (426)
Q Consensus 212 ~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~el 289 (426)
+|+||||||+|||++.++.+||+|||+++..... .....||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 214 --~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~el 286 (371)
T 3q60_A 214 --GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRV 286 (371)
T ss_dssp --TEEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHH
T ss_pred --CCccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHH
Confidence 9999999999999999999999999999865421 224567799999999987 6799999999999999999
Q ss_pred HhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 290 ITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 290 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
++|..||....+...... . ...................++..+.+|+.+||+.||++|||+.+++++
T Consensus 287 ltg~~Pf~~~~~~~~~~~--------~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 287 WCLFLPFGLVTPGIKGSW--------K-RPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp HHSSCSTTBCCTTCTTCC--------C-BCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred HhCCCCCCCcCcccccch--------h-hhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 999999976533211100 0 000000001111111112456789999999999999999999999875
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=340.88 Aligned_cols=265 Identities=19% Similarity=0.261 Sum_probs=204.1
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-CHHHHHHHHHHHhhcCCCC------ccceEeEEEc
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-GHKEWMTEVNFLGIVEHQN------LVKLVGYCAD 156 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~E~~~l~~l~Hpn------Iv~~~~~~~~ 156 (426)
.++|.+.+.||+|+||.||+|.+... ....||+|.+.... ..+.+.+|+.++..++|+| |+++++++.+
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~----~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~ 88 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKA----GGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH 88 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTT----TTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCC----CCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc
Confidence 46899999999999999999987332 12489999986543 3456789999999987654 9999999987
Q ss_pred cCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCC-------
Q 014363 157 DDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE------- 229 (426)
Q Consensus 157 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~------- 229 (426)
.+ ..++||||+ +++|.+++.......+++..++.++.|++.||+|||++ +|+||||||+|||++.
T Consensus 89 ~~----~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~ 160 (339)
T 1z57_A 89 HG----HICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAY 160 (339)
T ss_dssp TT----EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEE
T ss_pred CC----cEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEecccccccc
Confidence 66 459999999 88999999766655689999999999999999999998 9999999999999987
Q ss_pred ------------CCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCC
Q 014363 230 ------------QWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPID 297 (426)
Q Consensus 230 ------------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~ 297 (426)
++.+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|||++|..||.
T Consensus 161 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 235 (339)
T 1z57_A 161 NPKIKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFP 235 (339)
T ss_dssp C----CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CCccccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 678999999999865432 234579999999999999999999999999999999999999998
Q ss_pred CCCchhhHHHHHhHhhhhhh-----h--------------------hhhhhhcCCc-CCCcccHHHHHHHHHHHHhcccc
Q 014363 298 RNRPRSEQKLLQWVKPYLSD-----A--------------------KQFRQIVDPR-LEGKYSLRLVSKLSHVANLCLVK 351 (426)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~-----~--------------------~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~ 351 (426)
..........+......... . ........+. .........+..+.+|+.+||+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 315 (339)
T 1z57_A 236 THDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEY 315 (339)
T ss_dssp CSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred CCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCc
Confidence 76543322222111100000 0 0000000000 00111234678899999999999
Q ss_pred CCCCCCCHHHHHHH
Q 014363 352 NARTRPKMSEVLEM 365 (426)
Q Consensus 352 dp~~RPs~~eil~~ 365 (426)
||++|||+.|++++
T Consensus 316 dP~~Rpt~~ell~h 329 (339)
T 1z57_A 316 DPAKRITLREALKH 329 (339)
T ss_dssp STTTSCCHHHHTTS
T ss_pred CcccccCHHHHhcC
Confidence 99999999999986
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=358.38 Aligned_cols=245 Identities=17% Similarity=0.227 Sum_probs=189.1
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-----CCHHHHHHHH---HHHhhcCCCCccceE----
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-----GGHKEWMTEV---NFLGIVEHQNLVKLV---- 151 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-----~~~~~~~~E~---~~l~~l~HpnIv~~~---- 151 (426)
.++|...+.||+|+||.||+|.+..++. .||+|.+... ...+.+.+|+ .+|+.++|||||+++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~ 146 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGE-----SFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI 146 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCC-----EEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBC
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCc-----EEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhh
Confidence 4578889999999999999999765544 8999998532 2346788999 455556899999998
Q ss_pred ---eEEEccCC----------CC---ceEEEEEeeCCCCChhhhccCCC-----CCccCHHHHHHHHHHHHHHHHHhccC
Q 014363 152 ---GYCADDDE----------RG---IQRLLVYEYMPNGSVDQYLSPKS-----ETILTWAMRLKIAQDAARGLAYLHEG 210 (426)
Q Consensus 152 ---~~~~~~~~----------~~---~~~~lv~E~~~~g~L~~~l~~~~-----~~~~~~~~~~~i~~~i~~aL~~LH~~ 210 (426)
+++.+.+. .. ...||||||+ +|+|.+++.... ...+++..++.|+.||+.||+|||++
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 225 (377)
T 3byv_A 147 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY 225 (377)
T ss_dssp CCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred hhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC
Confidence 66665432 00 1258999999 689999996431 12345688889999999999999998
Q ss_pred CCCCeEeccCCCCceEeCCCCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccC-----------CCCCchhh
Q 014363 211 MDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG-----------RLAARSDV 279 (426)
Q Consensus 211 ~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv 279 (426)
+|+||||||+|||++.++.+||+|||+++.... .....+| +.|+|||++.+. .++.++||
T Consensus 226 ---~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Dv 296 (377)
T 3byv_A 226 ---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDA 296 (377)
T ss_dssp ---TEECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHH
T ss_pred ---CeecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhH
Confidence 999999999999999999999999999986432 2345678 999999999887 89999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCH
Q 014363 280 WSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKM 359 (426)
Q Consensus 280 wslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~ 359 (426)
|||||++|||++|..||....... ....+... . ..++..+.+|+.+||+.||++|||+
T Consensus 297 wSlG~il~elltg~~Pf~~~~~~~----------------~~~~~~~~-~-----~~~~~~~~~li~~~L~~dp~~Rpt~ 354 (377)
T 3byv_A 297 WALGLVIYWIWCADLPITKDAALG----------------GSEWIFRS-C-----KNIPQPVRALLEGFLRYPKEDRLLP 354 (377)
T ss_dssp HHHHHHHHHHHHSSCCC------C----------------CSGGGGSS-C-----CCCCHHHHHHHHHHTCSSGGGCCCH
T ss_pred HHHHHHHHHHHHCCCCCccccccc----------------chhhhhhh-c-----cCCCHHHHHHHHHHcCCCchhCCCH
Confidence 999999999999999996532211 01111110 0 1245689999999999999999999
Q ss_pred HHHHHH
Q 014363 360 SEVLEM 365 (426)
Q Consensus 360 ~eil~~ 365 (426)
.|++++
T Consensus 355 ~e~l~h 360 (377)
T 3byv_A 355 LQAMET 360 (377)
T ss_dssp HHHHTS
T ss_pred HHHhhC
Confidence 999974
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=349.41 Aligned_cols=269 Identities=20% Similarity=0.300 Sum_probs=204.8
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-CHHHHHHHHHHHhhcC-----------CCCccceE
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-GHKEWMTEVNFLGIVE-----------HQNLVKLV 151 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~E~~~l~~l~-----------HpnIv~~~ 151 (426)
.++|.+.+.||+|+||.||+|.+..++ ..||+|.+.... ..+.+.+|+.++..++ ||||++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~ 92 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNN-----THVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL 92 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTT-----EEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCC-----cEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHH
Confidence 358999999999999999999976654 389999987543 3456789999999886 89999999
Q ss_pred eEEEccCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeC---
Q 014363 152 GYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLD--- 228 (426)
Q Consensus 152 ~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~--- 228 (426)
+++......+...++||||+ +++|.+++.......+++..++.++.||+.||+|||++ .+|+||||||+|||++
T Consensus 93 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~--~~ivH~Dikp~NIll~~~~ 169 (373)
T 1q8y_A 93 DHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVD 169 (373)
T ss_dssp EEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEE
T ss_pred HHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChHHeEEeccC
Confidence 99987665555679999999 89999999765555699999999999999999999984 2899999999999994
Q ss_pred ---CCCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchh--
Q 014363 229 ---EQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRS-- 303 (426)
Q Consensus 229 ---~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~-- 303 (426)
..+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.......
T Consensus 170 ~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 244 (373)
T 1q8y_A 170 SPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 244 (373)
T ss_dssp TTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred CCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccC
Confidence 4457999999999865432 234579999999999999999999999999999999999999997544221
Q ss_pred --hHHHHHhHhhh-------hhhhhhhhhhcCC-------------------cCCCcccHHHHHHHHHHHHhccccCCCC
Q 014363 304 --EQKLLQWVKPY-------LSDAKQFRQIVDP-------------------RLEGKYSLRLVSKLSHVANLCLVKNART 355 (426)
Q Consensus 304 --~~~~~~~~~~~-------~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~l~~li~~cl~~dp~~ 355 (426)
...+....... +..........+. .....++...+..+.+||.+||+.||++
T Consensus 245 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 324 (373)
T 1q8y_A 245 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK 324 (373)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred ChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccc
Confidence 11111111000 0000000000000 0011245678899999999999999999
Q ss_pred CCCHHHHHHH
Q 014363 356 RPKMSEVLEM 365 (426)
Q Consensus 356 RPs~~eil~~ 365 (426)
|||+.|++++
T Consensus 325 Rpt~~ell~h 334 (373)
T 1q8y_A 325 RADAGGLVNH 334 (373)
T ss_dssp CBCHHHHHTC
T ss_pred cCCHHHHhhC
Confidence 9999999986
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=343.84 Aligned_cols=258 Identities=20% Similarity=0.279 Sum_probs=178.8
Q ss_pred hCCCCCcc-eecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHH-HHHhhcCCCCccceEeEEEccCCCC
Q 014363 84 TKNFSRSV-VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEV-NFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 84 ~~~y~~~~-~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~-~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
.++|.+.+ +||+|+||.||+|.++.++. .||+|.+... ....+|+ ..+..+.||||+++++++.......
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~-----~vavK~~~~~---~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 98 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQ-----KCALKLLYDS---PKARQEVDHHWQASGGPHIVCILDVYENMHHGK 98 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCC-----EEEEEEEESS---HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCC-----EEEEEEecCc---HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCC
Confidence 46788854 69999999999999886654 8999998653 2233343 4456679999999999998754444
Q ss_pred ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCC---CCCeeEeee
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE---QWNAKLSDF 238 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~---~~~~kl~DF 238 (426)
...++||||+++|+|.+++.......+++..++.++.||+.||.|||++ +|+||||||+|||++. ++.+||+||
T Consensus 99 ~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Df 175 (336)
T 3fhr_A 99 RCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDF 175 (336)
T ss_dssp EEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred ceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEecc
Confidence 4579999999999999999876656799999999999999999999998 9999999999999976 455999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014363 239 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 318 (426)
Q Consensus 239 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 318 (426)
|++....... .....||+.|+|||++.+..++.++||||||+++|+|++|..||............. .
T Consensus 176 g~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~---~----- 243 (336)
T 3fhr_A 176 GFAKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK---R----- 243 (336)
T ss_dssp TTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------
T ss_pred ccceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHH---H-----
Confidence 9998654321 234678999999999988889999999999999999999999997543221100000 0
Q ss_pred hhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014363 319 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMV 366 (426)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L 366 (426)
.. ..............++..+.+|+.+||+.||++|||+.|++++-
T Consensus 244 -~~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 289 (336)
T 3fhr_A 244 -RI-RLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHP 289 (336)
T ss_dssp ---------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred -hh-hccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 00 00000111111123567899999999999999999999999963
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=370.74 Aligned_cols=260 Identities=22% Similarity=0.391 Sum_probs=206.6
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC---HHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG---HKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
.++|.+.+.||+|+||.||+|.+...+. ....||+|.+..... .+.+.+|+.+|+.++||||+++++++.+. .
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-~- 464 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPEN--PAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN-P- 464 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSS--CCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-S-
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCC--ccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC-c-
Confidence 4678899999999999999999875432 345789998865432 35788999999999999999999998543 2
Q ss_pred CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecc
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 240 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 240 (426)
.|+||||+++|+|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 465 ---~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~ 537 (656)
T 2j0j_A 465 ---VWIIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGL 537 (656)
T ss_dssp ---CEEEEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCC
T ss_pred ---eEEEEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCC
Confidence 389999999999999997443 3489999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014363 241 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAK 319 (426)
Q Consensus 241 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 319 (426)
++....... .......||+.|+|||++.+..++.++||||||+++|||++ |..||......... ..+.
T Consensus 538 a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~---~~i~------- 606 (656)
T 2j0j_A 538 SRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI---GRIE------- 606 (656)
T ss_dssp CCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH---HHHH-------
T ss_pred CeecCCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHH---HHHH-------
Confidence 987644321 12234567889999999999999999999999999999997 99999765432211 1110
Q ss_pred hhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 014363 320 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 372 (426)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~ 372 (426)
.. .....+..++..+.+++.+||+.||++|||+.+|++.|+.+++.
T Consensus 607 ---~~----~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 607 ---NG----ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp ---HT----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---cC----CCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 00 01112234567899999999999999999999999999998754
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=354.63 Aligned_cols=266 Identities=24% Similarity=0.336 Sum_probs=195.7
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhcCCCCccceEeEEEccCC--CC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE--RG 161 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~--~~ 161 (426)
..+|...++||+|+||.||+|.+..++ .+|+|++.... ....+|+.+|+.++||||+++++++..... ..
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~------~~aikk~~~~~--~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 110 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESD------EVAIKKVLQDK--RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDE 110 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTE------EEEEEEEECCT--TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSC
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCC------eEEEEEEecCc--chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCc
Confidence 347999999999999999999987654 47777765432 223479999999999999999999976542 22
Q ss_pred ceEEEEEeeCCCCChhhhcc-CCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeC-CCCCeeEeeec
Q 014363 162 IQRLLVYEYMPNGSVDQYLS-PKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLD-EQWNAKLSDFG 239 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~-~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~-~~~~~kl~DFG 239 (426)
...++||||++++.+..... ......+++..++.++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||
T Consensus 111 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG 187 (394)
T 4e7w_A 111 VFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFG 187 (394)
T ss_dssp EEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence 34689999997754433321 11234589999999999999999999998 999999999999998 79999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhh-h
Q 014363 240 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS-D 317 (426)
Q Consensus 240 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~ 317 (426)
+++....... .....||+.|+|||++.+. .|+.++|||||||++|||++|..||.+........ ........ .
T Consensus 188 ~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~--~i~~~~g~p~ 262 (394)
T 4e7w_A 188 SAKILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLV--EIIKVLGTPS 262 (394)
T ss_dssp TCEECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHHHHHCCCC
T ss_pred CcccccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHHhCCCC
Confidence 9987543321 2346789999999998765 58999999999999999999999998754332211 11110000 0
Q ss_pred hhhhhh----hcC---CcCC-----CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 318 AKQFRQ----IVD---PRLE-----GKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 318 ~~~~~~----~~~---~~~~-----~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
...+.. ... +... ..+....+.++.+|+.+||+.||++|||+.|+++|
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 263 REQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 000000 000 0000 01122355789999999999999999999999986
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=334.31 Aligned_cols=252 Identities=26% Similarity=0.364 Sum_probs=202.3
Q ss_pred HhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-----------CHHHHHHHHHHHhhcC-CCCccce
Q 014363 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-----------GHKEWMTEVNFLGIVE-HQNLVKL 150 (426)
Q Consensus 83 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-----------~~~~~~~E~~~l~~l~-HpnIv~~ 150 (426)
..++|...+.||+|+||.||+|.++.++ ..||+|.+.... ..+.+.+|+.++.++. ||||+++
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~ 89 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTC-----KEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQL 89 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTT-----EEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcC-----ceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeee
Confidence 3568999999999999999999987654 389999985432 1345789999999995 9999999
Q ss_pred EeEEEccCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCC
Q 014363 151 VGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQ 230 (426)
Q Consensus 151 ~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~ 230 (426)
++++.+.. ..++||||+++++|.+++... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.+
T Consensus 90 ~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~ 160 (298)
T 1phk_A 90 KDTYETNT----FFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDD 160 (298)
T ss_dssp EEEEECSS----EEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTT
T ss_pred eeeeccCC----eEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCC
Confidence 99998755 459999999999999999653 3489999999999999999999998 99999999999999999
Q ss_pred CCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhc------cCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhh
Q 014363 231 WNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQ------TGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSE 304 (426)
Q Consensus 231 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~ 304 (426)
+.+||+|||++....... ......||+.|+|||++. ...++.++||||||+++|+|++|..||........
T Consensus 161 ~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~ 237 (298)
T 1phk_A 161 MNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM 237 (298)
T ss_dssp CCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred CcEEEecccchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHH
Confidence 999999999998655432 123457999999999885 45688999999999999999999999976433211
Q ss_pred HHHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 305 QKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
...+ .. . ...........++..+.+++.+||+.||++|||+.|++++
T Consensus 238 ~~~~---~~---------~--~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 238 LRMI---MS---------G--NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp HHHH---HH---------T--CCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHH---hc---------C--CcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 1110 00 0 0001111112356789999999999999999999999875
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=341.82 Aligned_cols=273 Identities=22% Similarity=0.280 Sum_probs=192.4
Q ss_pred HHHHHhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-CHHHHHHHHHHHhhcCCCCccceEeEEEcc
Q 014363 79 ELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-GHKEWMTEVNFLGIVEHQNLVKLVGYCADD 157 (426)
Q Consensus 79 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 157 (426)
......++|.+.+.||+|+||.||+|.+..++. .||+|.+.... ....+.+|+..+..++||||+++++++...
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~ 91 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGM-----SVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTL 91 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCC-----EEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEE
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCC-----EEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhcc
Confidence 345567899999999999999999999876654 79999875443 345677888999999999999999999764
Q ss_pred CC---CCceEEEEEeeCCCCChhhhccC--CCCCccCHHHHHHHHHHHHHHHHHhc--cCCCCCeEeccCCCCceEeCC-
Q 014363 158 DE---RGIQRLLVYEYMPNGSVDQYLSP--KSETILTWAMRLKIAQDAARGLAYLH--EGMDFQIIVRDFKSSNILLDE- 229 (426)
Q Consensus 158 ~~---~~~~~~lv~E~~~~g~L~~~l~~--~~~~~~~~~~~~~i~~~i~~aL~~LH--~~~~~~iiHrDlkp~NILl~~- 229 (426)
.. .....++||||+++ +|.+.+.. .....+++..++.++.|++.||.||| +. +|+||||||+|||++.
T Consensus 92 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~ 167 (360)
T 3e3p_A 92 GERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEA 167 (360)
T ss_dssp CSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETT
T ss_pred ccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCC
Confidence 32 22346899999976 44433321 22345889999999999999999999 77 9999999999999996
Q ss_pred CCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCC-CCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHH
Q 014363 230 QWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGR-LAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLL 308 (426)
Q Consensus 230 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~ 308 (426)
++.+||+|||++....... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||...........
T Consensus 168 ~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~- 243 (360)
T 3e3p_A 168 DGTLKLCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHE- 243 (360)
T ss_dssp TTEEEECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-
T ss_pred CCcEEEeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHH-
Confidence 8999999999998665432 123457899999999986654 89999999999999999999999987543322211
Q ss_pred HhHhhhhhhhhhhhhhcCCcC----------------CCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 309 QWVKPYLSDAKQFRQIVDPRL----------------EGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
...............+++.. ........+..+.+|+.+||+.||++|||+.|+++|
T Consensus 244 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 244 -IVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp -HHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred -HHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 11100000000000000000 001111256789999999999999999999999986
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=336.33 Aligned_cols=252 Identities=24% Similarity=0.334 Sum_probs=184.9
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCH----HHHHHHHHHHhhcCCCCccceEeEEEccCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGH----KEWMTEVNFLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~----~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
.++|+..+.||+|+||.||+|.+..++ ..||+|.+...... +.+.++...++.++||||+++++++.+...
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~ 80 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSG-----QIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGD 80 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTT-----EEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSS
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCC-----eEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCC
Confidence 467999999999999999999987654 38999998654322 223455556888899999999999987653
Q ss_pred CCceEEEEEeeCCCCChhhhccC--CCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEee
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSP--KSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 237 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~--~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~D 237 (426)
.++||||++ |+|.+++.. .....+++..++.++.|++.||.|||++ .+|+||||||+|||++.++.+||+|
T Consensus 81 ----~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~D 153 (290)
T 3fme_A 81 ----VWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCD 153 (290)
T ss_dssp ----EEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCC
T ss_pred ----EEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEee
Confidence 499999996 588777643 1234599999999999999999999973 2899999999999999999999999
Q ss_pred ecccccCCCCCceeeeeeeecCcccCCchhh----ccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhh
Q 014363 238 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYV----QTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKP 313 (426)
Q Consensus 238 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~ 313 (426)
||++....... ......||+.|+|||++ .+..++.++||||||+++|+|++|..||......... +..
T Consensus 154 fg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~---- 225 (290)
T 3fme_A 154 FGISGYLVDDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQ-LKQ---- 225 (290)
T ss_dssp C------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHH-HHH----
T ss_pred cCCcccccccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHH-HHH----
Confidence 99997654322 12335799999999996 4567889999999999999999999999754332111 111
Q ss_pred hhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 314 YLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.............++..+.+++.+||+.||++|||+.|++++
T Consensus 226 ----------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 226 ----------VVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp ----------HHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred ----------HhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 111111111122345789999999999999999999999985
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=344.64 Aligned_cols=257 Identities=22% Similarity=0.370 Sum_probs=197.3
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
.++|.+.+.||+|+||.||+|.+.. .+++|.+.... ..+.+.+|+.+++.++||||+++++++.+...
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~--------~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG--------EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH 103 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS--------SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC--------eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence 5689999999999999999998754 37888875432 33567889999999999999999999987663
Q ss_pred CCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeec
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 239 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 239 (426)
.++||||+++++|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++ ++.+||+|||
T Consensus 104 ----~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg 174 (319)
T 2y4i_B 104 ----LAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFG 174 (319)
T ss_dssp ----EEEECBCCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCS
T ss_pred ----eEEEeecccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecC
Confidence 599999999999999997543 3589999999999999999999998 999999999999998 6799999999
Q ss_pred ccccCCCCC---ceeeeeeeecCcccCCchhhcc---------CCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHH
Q 014363 240 LARLGPSEG---FTHVSTAVVGTMGYAAPEYVQT---------GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKL 307 (426)
Q Consensus 240 la~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~ 307 (426)
++....... .........||+.|+|||++.+ ..++.++||||||+++|+|++|..||...........
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~ 254 (319)
T 2y4i_B 175 LFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQ 254 (319)
T ss_dssp CCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHH
T ss_pred CccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 987543211 1111234569999999999874 3578899999999999999999999976543221111
Q ss_pred HHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhh
Q 014363 308 LQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 373 (426)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~ 373 (426)
. .....+.. ....++..+.+++.+||..||++|||+.++++.|+.+....
T Consensus 255 ~-------------~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 255 M-------------GTGMKPNL---SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp H-------------HTTCCCCC---CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred h-------------ccCCCCCC---CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 0 00011111 11124457899999999999999999999999998876554
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=333.75 Aligned_cols=257 Identities=23% Similarity=0.364 Sum_probs=195.1
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-CHHHHHHHHHHHhhcCCCCccceEeEEEccCC---
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE--- 159 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~--- 159 (426)
.++|+..+.||+|+||.||+|.+..++. .||+|.+.... ..+.+.+|+.+++.++||||+++++++.+...
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSR-----YYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVK 79 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCC-----EEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCe-----EEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhh
Confidence 4579999999999999999999876554 79999885432 34568899999999999999999999876431
Q ss_pred ------CCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCe
Q 014363 160 ------RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNA 233 (426)
Q Consensus 160 ------~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~ 233 (426)
.....|+||||+++|+|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+
T Consensus 80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~ 155 (303)
T 1zy4_A 80 PMTAVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNV 155 (303)
T ss_dssp ------CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCE
T ss_pred hhcccccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCE
Confidence 1346799999999999999997533 4578899999999999999999998 99999999999999999999
Q ss_pred eEeeecccccCCCCC------------ceeeeeeeecCcccCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCC
Q 014363 234 KLSDFGLARLGPSEG------------FTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNR 300 (426)
Q Consensus 234 kl~DFGla~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~ 300 (426)
||+|||++....... .........||+.|+|||++.+. .++.++||||||+++|+|++ ||....
T Consensus 156 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~ 232 (303)
T 1zy4_A 156 KIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM 232 (303)
T ss_dssp EECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH
T ss_pred EEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch
Confidence 999999997654211 01122346799999999998764 68999999999999999998 553211
Q ss_pred chhhHHHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 301 PRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
......... .. ........+....+..+.+++.+||+.||++|||+.+++++
T Consensus 233 --~~~~~~~~~----------~~-~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 233 --ERVNILKKL----------RS-VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp --HHHHHHHHH----------HS-TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred --hHHHHHHhc----------cc-cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 111111100 00 11122233444556778999999999999999999999985
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=342.85 Aligned_cols=252 Identities=24% Similarity=0.387 Sum_probs=193.8
Q ss_pred HhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcC--CCCccceEeEEEc
Q 014363 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVE--HQNLVKLVGYCAD 156 (426)
Q Consensus 83 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~--HpnIv~~~~~~~~ 156 (426)
..++|.+.+.||+|+||.||+|.+..+ ..||+|.+.... ..+.+.+|+.++..++ ||||+++++++.+
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~ 99 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNEKK------QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 99 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTTC------CEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC
T ss_pred ccceEEEEEEecCCCCEEEEEEEcCCC------cEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec
Confidence 356799999999999999999987542 379999885433 2356889999999997 5999999999987
Q ss_pred cCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEe
Q 014363 157 DDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLS 236 (426)
Q Consensus 157 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~ 236 (426)
.. ..|+||| +.+++|.+++.... .+++..++.++.|++.||.|||++ +|+||||||+|||+++ +.+||+
T Consensus 100 ~~----~~~lv~e-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~ 168 (313)
T 3cek_A 100 DQ----YIYMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLI 168 (313)
T ss_dssp SS----EEEEEEC-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEEC
T ss_pred CC----EEEEEEe-cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEe
Confidence 65 4599999 55889999997543 489999999999999999999998 9999999999999964 799999
Q ss_pred eecccccCCCCCceeeeeeeecCcccCCchhhcc-----------CCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhH
Q 014363 237 DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT-----------GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQ 305 (426)
Q Consensus 237 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~ 305 (426)
|||++................||+.|+|||++.+ ..++.++||||||+++|+|++|..||........
T Consensus 169 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~- 247 (313)
T 3cek_A 169 DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS- 247 (313)
T ss_dssp CCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH-
T ss_pred eccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHH-
Confidence 9999986654332222345679999999999875 4688899999999999999999999975433211
Q ss_pred HHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014363 306 KLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMV 366 (426)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L 366 (426)
......++.....++...+..+.+++.+||+.||++|||+.|++++-
T Consensus 248 --------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 294 (313)
T 3cek_A 248 --------------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 294 (313)
T ss_dssp --------------HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred --------------HHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence 11122222222222233456899999999999999999999999873
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=339.47 Aligned_cols=271 Identities=25% Similarity=0.331 Sum_probs=203.2
Q ss_pred HhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhc---CCCCccceEeEEE
Q 014363 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIV---EHQNLVKLVGYCA 155 (426)
Q Consensus 83 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l---~HpnIv~~~~~~~ 155 (426)
..++|.+.+.||+|+||.||+|.+.... ...||+|.+.... ....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~ 84 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNG----GRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCT 84 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTT----TEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEE
T ss_pred chhceeeeeeecccccEEEEEEEecCCC----CEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeee
Confidence 3578999999999999999999985221 2378999875332 234677888888777 8999999999987
Q ss_pred ccC-CCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCee
Q 014363 156 DDD-ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAK 234 (426)
Q Consensus 156 ~~~-~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~k 234 (426)
... ......++||||++ |+|.+++.......+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~k 160 (326)
T 1blx_A 85 VSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIK 160 (326)
T ss_dssp EEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEE
T ss_pred ecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEE
Confidence 321 12335699999997 6999999766555689999999999999999999998 999999999999999999999
Q ss_pred EeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhh
Q 014363 235 LSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPY 314 (426)
Q Consensus 235 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 314 (426)
|+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||...........+.....
T Consensus 161 l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~- 236 (326)
T 1blx_A 161 LADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG- 236 (326)
T ss_dssp ECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC-
T ss_pred EecCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcC-
Confidence 99999997654221 22346799999999999999999999999999999999999999986543322111110000
Q ss_pred hhhhhhhh-------hhcC---CcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 315 LSDAKQFR-------QIVD---PRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 315 ~~~~~~~~-------~~~~---~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
........ .... ......+...++..+.+|+.+||+.||++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00000000 0000 000011222356788999999999999999999999975
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=343.10 Aligned_cols=267 Identities=22% Similarity=0.235 Sum_probs=202.2
Q ss_pred HhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-CHHHHHHHHHHHhhcC-CC-----CccceEeEEE
Q 014363 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-GHKEWMTEVNFLGIVE-HQ-----NLVKLVGYCA 155 (426)
Q Consensus 83 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~E~~~l~~l~-Hp-----nIv~~~~~~~ 155 (426)
..++|.+.+.||+|+||.||+|.+..++ ..||+|.+.... ....+..|+.++..++ |+ +|+++++++.
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~ 126 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQ-----EWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM 126 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTT-----EEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCC-----cEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec
Confidence 4678999999999999999999987654 379999987543 2356778999988884 55 4999999998
Q ss_pred ccCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeC--CCCCe
Q 014363 156 DDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLD--EQWNA 233 (426)
Q Consensus 156 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~--~~~~~ 233 (426)
... ..|+||||++ |+|.+++.......+++..++.++.|++.||.|||.+ ..+|+||||||+|||++ .++.+
T Consensus 127 ~~~----~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~ 200 (382)
T 2vx3_A 127 FRN----HLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAI 200 (382)
T ss_dssp ETT----EEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCE
T ss_pred cCC----ceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcE
Confidence 765 4599999995 5999999766555689999999999999999999953 23999999999999994 57789
Q ss_pred eEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhh
Q 014363 234 KLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKP 313 (426)
Q Consensus 234 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~ 313 (426)
||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|..||...........+.....
T Consensus 201 kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~ 275 (382)
T 2vx3_A 201 KIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLG 275 (382)
T ss_dssp EECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred EEEeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 99999999876432 2346799999999999999999999999999999999999999986544322211111000
Q ss_pred -----hhhhhhhhhhhcCCcC-----------------------------------------CCcccHHHHHHHHHHHHh
Q 014363 314 -----YLSDAKQFRQIVDPRL-----------------------------------------EGKYSLRLVSKLSHVANL 347 (426)
Q Consensus 314 -----~~~~~~~~~~~~~~~~-----------------------------------------~~~~~~~~~~~l~~li~~ 347 (426)
.+.........+.... ...........+.+||.+
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~ 355 (382)
T 2vx3_A 276 IPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILR 355 (382)
T ss_dssp SCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHH
T ss_pred CCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHH
Confidence 0000000000000000 001122344688999999
Q ss_pred ccccCCCCCCCHHHHHHH
Q 014363 348 CLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 348 cl~~dp~~RPs~~eil~~ 365 (426)
||+.||++|||++|+++|
T Consensus 356 mL~~dP~~Rpta~e~L~h 373 (382)
T 2vx3_A 356 MLDYDPKTRIQPYYALQH 373 (382)
T ss_dssp HTCSCTTTSCCHHHHTTS
T ss_pred hcCCChhhCCCHHHHhcC
Confidence 999999999999999986
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=337.93 Aligned_cols=270 Identities=20% Similarity=0.303 Sum_probs=194.5
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC--CHHHHHHHHHHHhhcCCCCccceEeEEEccC---
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--GHKEWMTEVNFLGIVEHQNLVKLVGYCADDD--- 158 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~--- 158 (426)
.++|...+.||+|+||.||+|.+..++ ..||+|.+.... ..+.+.+|+.+++.++||||+++++++....
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCD-----KRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQL 84 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTT-----EEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBC
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCC-----eEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccc
Confidence 468999999999999999999987654 389999886443 3457889999999999999999999985432
Q ss_pred -------CCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeC-CC
Q 014363 159 -------ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLD-EQ 230 (426)
Q Consensus 159 -------~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~-~~ 230 (426)
......|+||||++ |+|.+++.. ..+++..++.++.|++.||+|||++ +|+||||||+|||++ ++
T Consensus 85 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~ 157 (320)
T 2i6l_A 85 TDDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTED 157 (320)
T ss_dssp CC----CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTT
T ss_pred ccccccccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCC
Confidence 12236799999997 699999864 3489999999999999999999998 999999999999997 56
Q ss_pred CCeeEeeecccccCCCCCc-eeeeeeeecCcccCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHH
Q 014363 231 WNAKLSDFGLARLGPSEGF-THVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLL 308 (426)
Q Consensus 231 ~~~kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~ 308 (426)
+.+||+|||++........ ........||+.|+|||++.+ ..++.++||||||+++|+|++|..||...........+
T Consensus 158 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 237 (320)
T 2i6l_A 158 LVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI 237 (320)
T ss_dssp TEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 7899999999986543211 111234567999999998865 67899999999999999999999999865533221111
Q ss_pred HhHhhhhhh--hhhh--------hhhcC-CcCC-CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 309 QWVKPYLSD--AKQF--------RQIVD-PRLE-GKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 309 ~~~~~~~~~--~~~~--------~~~~~-~~~~-~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
....+.... ...+ ..... +... ......++..+.+++.+||+.||++|||++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 238 LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp HHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 100000000 0000 00000 0000 00112346789999999999999999999999986
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=341.03 Aligned_cols=264 Identities=23% Similarity=0.353 Sum_probs=198.5
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
.++|...+.||+|+||.||+|.+..++. .||+|.+.... ..+.+.+|+.+++.++||||+++++++.....
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 115 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGE-----KVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASS 115 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTE-----EEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCC-----EEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCC
Confidence 4689999999999999999999876553 89999986543 23567899999999999999999999987653
Q ss_pred CC--ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEee
Q 014363 160 RG--IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 237 (426)
Q Consensus 160 ~~--~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~D 237 (426)
.. ...|+||||+. ++|.+++.. .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 116 ~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~D 187 (371)
T 4exu_A 116 LRNFYDFYLVMPFMQ-TDLQKIMGM----EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILD 187 (371)
T ss_dssp STTCCCCEEEEECCC-EEHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECS
T ss_pred cccceeEEEEEcccc-ccHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEe
Confidence 21 12389999996 688888742 389999999999999999999998 999999999999999999999999
Q ss_pred ecccccCCCCCceeeeeeeecCcccCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhh---
Q 014363 238 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKP--- 313 (426)
Q Consensus 238 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~--- 313 (426)
||++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+.....
T Consensus 188 fg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~ 262 (371)
T 4exu_A 188 FGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG 262 (371)
T ss_dssp TTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred cCcccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Confidence 9999855432 234678999999999887 6789999999999999999999999986543322111110000
Q ss_pred --h---hhh--hhhhhhhcCCcCCCcc---cHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 314 --Y---LSD--AKQFRQIVDPRLEGKY---SLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 314 --~---~~~--~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
. +.. .......+.......+ ...++..+.+|+.+||+.||++|||+.|++++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 263 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0 000 0000001111111111 11246789999999999999999999999986
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-44 Score=344.49 Aligned_cols=270 Identities=24% Similarity=0.319 Sum_probs=200.4
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC---HHHHHHHHHHHhhcCCCCccceEeEEEccC-C
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG---HKEWMTEVNFLGIVEHQNLVKLVGYCADDD-E 159 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~-~ 159 (426)
.++|.+.+.||+|+||.||+|.+..++ ..||+|.+..... ...+.+|+.+++.++||||+++++++.... .
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 84 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTG-----EIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFE 84 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTT-----EEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCST
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCC-----cEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccC
Confidence 468999999999999999999987654 3899999864432 346789999999999999999999887542 1
Q ss_pred CCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeec
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 239 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 239 (426)
.....|+||||++ ++|.+++... .+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 85 ~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg 157 (353)
T 2b9h_A 85 NFNEVYIIQELMQ-TDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFG 157 (353)
T ss_dssp TCCCEEEEECCCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCT
T ss_pred ccceEEEEEeccC-ccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecc
Confidence 1235699999996 6899988643 489999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCcee--------eeeeeecCcccCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHh
Q 014363 240 LARLGPSEGFTH--------VSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQW 310 (426)
Q Consensus 240 la~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~ 310 (426)
++.......... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+..
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 237 (353)
T 2b9h_A 158 LARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFG 237 (353)
T ss_dssp TCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Confidence 998654322111 1223578999999998765 6789999999999999999999999986543322211110
Q ss_pred Hhhhhh--------hhhhhhhhcCC--cC-CC---cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 311 VKPYLS--------DAKQFRQIVDP--RL-EG---KYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 311 ~~~~~~--------~~~~~~~~~~~--~~-~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
...... ......+.... .. .. .....++..+.+|+.+||+.||++|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000 00000000000 00 00 0112355788999999999999999999999986
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=337.99 Aligned_cols=265 Identities=21% Similarity=0.282 Sum_probs=202.0
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-CHHHHHHHHHHHhhcCCCC------ccceEeEEEc
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-GHKEWMTEVNFLGIVEHQN------LVKLVGYCAD 156 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~E~~~l~~l~Hpn------Iv~~~~~~~~ 156 (426)
.++|.+.+.||+|+||.||+|.+...+ ...||+|.+.... ..+.+.+|+.+++.++|++ ++.+++++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 93 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARG----KSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF 93 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTT----TEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCC----ceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee
Confidence 468999999999999999999986543 2479999986543 3456788999999997766 8999999887
Q ss_pred cCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEe---------
Q 014363 157 DDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL--------- 227 (426)
Q Consensus 157 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl--------- 227 (426)
.. ..++||||+ +++|.+++.......+++..++.++.||+.||+|||++ +|+||||||+|||+
T Consensus 94 ~~----~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~ 165 (355)
T 2eu9_A 94 HG----HMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLY 165 (355)
T ss_dssp TT----EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEE
T ss_pred CC----eEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccc
Confidence 65 459999999 66777777655545699999999999999999999998 99999999999999
Q ss_pred ----------CCCCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCC
Q 014363 228 ----------DEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPID 297 (426)
Q Consensus 228 ----------~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~ 297 (426)
+.++.+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|||++|..||.
T Consensus 166 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 240 (355)
T 2eu9_A 166 NEHKSCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQ 240 (355)
T ss_dssp CCC-CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCC
Confidence 56789999999999864432 234679999999999999999999999999999999999999998
Q ss_pred CCCchhhHHHHHhHhhhhhh-----h--------------------hhhhhhcCC-cCCCcccHHHHHHHHHHHHhcccc
Q 014363 298 RNRPRSEQKLLQWVKPYLSD-----A--------------------KQFRQIVDP-RLEGKYSLRLVSKLSHVANLCLVK 351 (426)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~-----~--------------------~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~ 351 (426)
..........+......... . ........+ ..........+..+.+|+.+||+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 320 (355)
T 2eu9_A 241 THENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEF 320 (355)
T ss_dssp CSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred CCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcC
Confidence 65543222221111000000 0 000000000 000011224567899999999999
Q ss_pred CCCCCCCHHHHHHH
Q 014363 352 NARTRPKMSEVLEM 365 (426)
Q Consensus 352 dp~~RPs~~eil~~ 365 (426)
||++|||+.|++++
T Consensus 321 dP~~Rpt~~e~l~h 334 (355)
T 2eu9_A 321 DPAQRITLAEALLH 334 (355)
T ss_dssp STTTSCCHHHHTTS
T ss_pred ChhhCcCHHHHhcC
Confidence 99999999999976
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=330.12 Aligned_cols=251 Identities=24% Similarity=0.358 Sum_probs=200.1
Q ss_pred HhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc----CCHHHHHHHHHHHhhcCCCCccceEeEEEccC
Q 014363 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR----GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 158 (426)
Q Consensus 83 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 158 (426)
..++|.+.+.||+|+||.||+|.+..++. .|++|.+... ...+.+.+|+.+++.++||||+++++++.+..
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~-----~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 94 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQ-----EYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSS 94 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCC-----EEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCc-----EEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCC
Confidence 45689999999999999999999876544 7999987533 24567899999999999999999999998765
Q ss_pred CCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCC---CCeeE
Q 014363 159 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQ---WNAKL 235 (426)
Q Consensus 159 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~---~~~kl 235 (426)
..++||||+++++|.+++.... .+++..++.++.|++.||.|||++ +|+||||||+|||++.+ +.+||
T Consensus 95 ----~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL 165 (287)
T 2wei_A 95 ----SFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKI 165 (287)
T ss_dssp ----EEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred ----eEEEEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEE
Confidence 4599999999999998886433 489999999999999999999998 99999999999999754 46999
Q ss_pred eeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhh
Q 014363 236 SDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYL 315 (426)
Q Consensus 236 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 315 (426)
+|||++........ .....||+.|+|||++.+ .++.++||||||+++|+|++|..||...........+ ..
T Consensus 166 ~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~---~~-- 236 (287)
T 2wei_A 166 IDFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV---ET-- 236 (287)
T ss_dssp CSTTGGGTBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HH--
T ss_pred eccCcceeecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH---Hc--
Confidence 99999986543221 233468999999998865 5899999999999999999999999765432211110 00
Q ss_pred hhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 316 SDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
. .. .........++..+.+++.+||+.||++|||+.|++++
T Consensus 237 --~-----~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 237 --G-----KY--AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp --C-----CC--CCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred --C-----CC--CCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 0 00 00000112345689999999999999999999999986
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=336.10 Aligned_cols=264 Identities=23% Similarity=0.326 Sum_probs=198.4
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
.++|...+.||+|+||.||+|.+..++ ..||+|.+.... ..+.+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 97 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSG-----EKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASS 97 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTT-----EEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCC-----CEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccc
Confidence 467999999999999999999987654 389999986543 23567899999999999999999999987543
Q ss_pred C--CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEee
Q 014363 160 R--GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 237 (426)
Q Consensus 160 ~--~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~D 237 (426)
. ....|+||||++ ++|.+++.. .+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|
T Consensus 98 ~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~D 169 (353)
T 3coi_A 98 LRNFYDFYLVMPFMQ-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILD 169 (353)
T ss_dssp GGGCCCCEEEEECCS-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECS
T ss_pred cccceeEEEEecccc-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEee
Confidence 2 113489999996 689888743 389999999999999999999998 999999999999999999999999
Q ss_pred ecccccCCCCCceeeeeeeecCcccCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhh---
Q 014363 238 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKP--- 313 (426)
Q Consensus 238 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~--- 313 (426)
||++...... .....||+.|+|||++.+ ..++.++||||||+++|+|++|..||...........+.....
T Consensus 170 fg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~ 244 (353)
T 3coi_A 170 FGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG 244 (353)
T ss_dssp TTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCC
T ss_pred cccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 9999764322 234578999999999877 6789999999999999999999999986543222111100000
Q ss_pred -----hhhhh--hhhhhhcCCcCC---CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 314 -----YLSDA--KQFRQIVDPRLE---GKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 314 -----~~~~~--~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.+... ......+..... .......+..+.+|+.+||+.||++|||+.|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 245 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00000 000000000000 11122456789999999999999999999999986
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=336.87 Aligned_cols=243 Identities=26% Similarity=0.446 Sum_probs=192.0
Q ss_pred HHHhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC--------CHHHHHHHHHHHhhc----CCCCcc
Q 014363 81 KSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--------GHKEWMTEVNFLGIV----EHQNLV 148 (426)
Q Consensus 81 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~--------~~~~~~~E~~~l~~l----~HpnIv 148 (426)
....++|.+.+.||+|+||.||+|.+..++. .||+|.+.... ....+.+|+.++..+ +||||+
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~ 101 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRL-----QVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVI 101 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCC-----EEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBC
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCe-----EEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCee
Confidence 3446789999999999999999998766543 89999986542 223456799999998 899999
Q ss_pred ceEeEEEccCCCCceEEEEEee-CCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEe
Q 014363 149 KLVGYCADDDERGIQRLLVYEY-MPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL 227 (426)
Q Consensus 149 ~~~~~~~~~~~~~~~~~lv~E~-~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl 227 (426)
++++++.+.+.. ++|||| +.+++|.+++.... .+++..++.++.||+.||.|||++ +|+||||||+|||+
T Consensus 102 ~~~~~~~~~~~~----~~v~e~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~ 172 (312)
T 2iwi_A 102 RLLDWFETQEGF----MLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILI 172 (312)
T ss_dssp CEEEEC-----C----EEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEE
T ss_pred eEEEEEecCCeE----EEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEE
Confidence 999999876543 899999 78999999997533 489999999999999999999998 99999999999999
Q ss_pred C-CCCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCC-CchhhHHHHHHHHHHHhCCCCCCCCCchhhH
Q 014363 228 D-EQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLA-ARSDVWSYGVFLYELITGRRPIDRNRPRSEQ 305 (426)
Q Consensus 228 ~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGvil~elltg~~p~~~~~~~~~~ 305 (426)
+ .++.+||+|||++....... .....||+.|+|||++.+..+. .++||||||+++|+|++|..||....
T Consensus 173 ~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----- 243 (312)
T 2iwi_A 173 DLRRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ----- 243 (312)
T ss_dssp ETTTTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----
T ss_pred eCCCCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-----
Confidence 9 88999999999998765432 2345799999999999877765 48999999999999999999996421
Q ss_pred HHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 306 KLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
... .. . ..++..++..+.+++.+||+.||++|||+.|++++
T Consensus 244 ~~~-------------~~--~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 244 EIL-------------EA--E----LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp HHH-------------HT--C----CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred HHh-------------hh--c----cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 00 0 01222345688999999999999999999999986
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=338.05 Aligned_cols=242 Identities=24% Similarity=0.447 Sum_probs=198.1
Q ss_pred HHhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC--------CHHHHHHHHHHHhhcC--CCCccceE
Q 014363 82 SATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--------GHKEWMTEVNFLGIVE--HQNLVKLV 151 (426)
Q Consensus 82 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~--------~~~~~~~E~~~l~~l~--HpnIv~~~ 151 (426)
...++|.+.+.||+|+||.||+|.+..++ ..||+|.+.... ....+.+|+.+++.++ ||||++++
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~ 114 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDN-----LPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 114 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTT-----EEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEE
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCC-----cEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEE
Confidence 34678999999999999999999977654 489999886442 2245678999999996 59999999
Q ss_pred eEEEccCCCCceEEEEEeeCCC-CChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeC-C
Q 014363 152 GYCADDDERGIQRLLVYEYMPN-GSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLD-E 229 (426)
Q Consensus 152 ~~~~~~~~~~~~~~lv~E~~~~-g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~-~ 229 (426)
+++.+.. ..++||||+.+ ++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++ +
T Consensus 115 ~~~~~~~----~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~ 185 (320)
T 3a99_A 115 DWFERPD----SFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLN 185 (320)
T ss_dssp EEEECSS----EEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETT
T ss_pred EEEecCC----cEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCC
Confidence 9998765 45999999976 8999998653 3489999999999999999999998 999999999999998 7
Q ss_pred CCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCC-CCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHH
Q 014363 230 QWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRL-AARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLL 308 (426)
Q Consensus 230 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~ 308 (426)
++.+||+|||++....... .....||+.|+|||++.+..+ +.++||||||+++|+|++|..||.... ...
T Consensus 186 ~~~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-----~~~ 256 (320)
T 3a99_A 186 RGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EII 256 (320)
T ss_dssp TTEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HHH
T ss_pred CCCEEEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-----hhh
Confidence 8899999999998765432 234579999999999987776 678999999999999999999996421 000
Q ss_pred HhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 309 QWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.. .. .++..++..+.+|+.+||+.||++|||+.||+++
T Consensus 257 -------------~~--~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 257 -------------RG--QV----FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp -------------HC--CC----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -------------cc--cc----cccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 00 0112245688999999999999999999999985
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-43 Score=334.05 Aligned_cols=252 Identities=30% Similarity=0.447 Sum_probs=176.7
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC---HHHHHHHHH-HHhhcCCCCccceEeEEEccCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG---HKEWMTEVN-FLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~E~~-~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
.++|...+.||+|+||.||+|.+..++ ..||+|.+..... ...+..|+. +++.++||||+++++++.+.+
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~- 94 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSG-----QIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREG- 94 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTT-----EEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSS-
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCC-----CEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCC-
Confidence 367899999999999999999987654 3899999865432 234556665 777789999999999998765
Q ss_pred CCceEEEEEeeCCCCChhhhccC---CCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEe
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSP---KSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLS 236 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~---~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~ 236 (426)
..++||||+++ +|.+++.. .....+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.+||+
T Consensus 95 ---~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~ 168 (327)
T 3aln_A 95 ---DCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLC 168 (327)
T ss_dssp ---EEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEEC
T ss_pred ---ceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEc
Confidence 45999999975 78777652 1234589999999999999999999983 389999999999999999999999
Q ss_pred eecccccCCCCCceeeeeeeecCcccCCchhh----ccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHh
Q 014363 237 DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYV----QTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK 312 (426)
Q Consensus 237 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~ 312 (426)
|||++....... ......||+.|+|||++ .+..++.++||||||+++|+|++|..||........
T Consensus 169 Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-------- 237 (327)
T 3aln_A 169 DFGISGQLVDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-------- 237 (327)
T ss_dssp CCSSSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------
T ss_pred cCCCceeccccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH--------
Confidence 999997654321 12334799999999998 456789999999999999999999999975422100
Q ss_pred hhhhhhhhhhhhcC---CcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 313 PYLSDAKQFRQIVD---PRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 313 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
....+.. +.+.......++..+.+|+.+||+.||++|||+.+|+++
T Consensus 238 -------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 238 -------QLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp ---------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred -------HHHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 0011111 111111122356789999999999999999999999875
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=342.58 Aligned_cols=252 Identities=22% Similarity=0.289 Sum_probs=185.1
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhc-CCCCccceEeEEEccCCCCce
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDERGIQ 163 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~~~~~ 163 (426)
+.|...++||+|+||+||.+.... ...||+|++... ..+.+.+|+.+|..+ +||||+++++++.+.. .
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~------g~~vAvK~~~~~-~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~----~ 83 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQ------GRPVAVKRMLID-FCDIALMEIKLLTESDDHPNVIRYYCSETTDR----F 83 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESS------SSEEEEEEEEGG-GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSS----E
T ss_pred heeeccCeEeeCCCeEEEEEEEEC------CeEEEEEEEcHH-HHHHHHHHHHHHHhccCCCCcCeEEEEEecCC----e
Confidence 345567889999999998654332 238999988654 345678999999886 8999999999988765 4
Q ss_pred EEEEEeeCCCCChhhhccCCCCCc-----cCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCC--------
Q 014363 164 RLLVYEYMPNGSVDQYLSPKSETI-----LTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQ-------- 230 (426)
Q Consensus 164 ~~lv~E~~~~g~L~~~l~~~~~~~-----~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~-------- 230 (426)
.|+|||||+ |+|.+++....... ..+..++.++.||+.||+|||++ +|+||||||+|||++.+
T Consensus 84 ~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~ 159 (434)
T 2rio_A 84 LYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQ 159 (434)
T ss_dssp EEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCT
T ss_pred EEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccc
Confidence 599999995 69999997553211 12334578999999999999998 99999999999999654
Q ss_pred -----CCeeEeeecccccCCCCCce--eeeeeeecCcccCCchhhcc-------CCCCCchhhHHHHHHHHHHHh-CCCC
Q 014363 231 -----WNAKLSDFGLARLGPSEGFT--HVSTAVVGTMGYAAPEYVQT-------GRLAARSDVWSYGVFLYELIT-GRRP 295 (426)
Q Consensus 231 -----~~~kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslGvil~ellt-g~~p 295 (426)
+.+||+|||++......... .......||+.|+|||++.+ ..++.++|||||||++|||++ |..|
T Consensus 160 ~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~P 239 (434)
T 2rio_A 160 TGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239 (434)
T ss_dssp TCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCT
T ss_pred cCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCC
Confidence 47999999999876543211 11234689999999999876 568999999999999999999 9999
Q ss_pred CCCCCchhhHHHHHhHhhhhhhhhhhhhhc-CCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 296 IDRNRPRSEQKLLQWVKPYLSDAKQFRQIV-DPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
|........ .... ... .+.........++.++.+|+.+||+.||++|||+.+|++|
T Consensus 240 f~~~~~~~~-~i~~-------------~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 240 FGDKYSRES-NIIR-------------GIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp TCSTTTHHH-HHHH-------------TCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCchhhHH-HHhc-------------CCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 975433211 1100 000 1111222345678899999999999999999999999874
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=326.61 Aligned_cols=251 Identities=28% Similarity=0.395 Sum_probs=178.6
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCH----HHHHHHHHHHhhcCCCCccceEeEEEccCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGH----KEWMTEVNFLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~----~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
.++|+..+.||+|+||.||+|.+..++. .||+|.+...... +.+.++..+++.++||||+++++++.+.+
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~- 97 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGH-----VIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNT- 97 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCC-----EEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS-
T ss_pred hccccccceeeecCCeeEEEEEEecCCe-----EEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC-
Confidence 4578899999999999999999876554 8999998655432 22344556788889999999999998765
Q ss_pred CCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhcc-CCCCCeEeccCCCCceEeCCCCCeeEeee
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHE-GMDFQIIVRDFKSSNILLDEQWNAKLSDF 238 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~-~~~~~iiHrDlkp~NILl~~~~~~kl~DF 238 (426)
..++||||+ ++.+..+.... ...+++..++.++.|++.||.|||+ . +|+||||||+|||++.++.+||+||
T Consensus 98 ---~~~lv~e~~-~~~~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~df 169 (318)
T 2dyl_A 98 ---DVFIAMELM-GTCAEKLKKRM-QGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDF 169 (318)
T ss_dssp ---EEEEEECCC-SEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCC
T ss_pred ---cEEEEEecc-CCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEEC
Confidence 459999999 55665555422 3458999999999999999999997 5 8999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCchhhc-----cCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhh
Q 014363 239 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQ-----TGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKP 313 (426)
Q Consensus 239 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~ 313 (426)
|++....... ......||+.|+|||++. ...++.++||||||+++|+|++|..||......... +...
T Consensus 170 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~--- 242 (318)
T 2dyl_A 170 GISGRLVDDK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEV-LTKV--- 242 (318)
T ss_dssp TTC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH-HHHH---
T ss_pred CCchhccCCc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHH-HHHH---
Confidence 9997654322 123457999999999984 456889999999999999999999999764322111 1000
Q ss_pred hhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 314 YLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
. ....+.+. ....++..+.+++.+||+.||++||++.+|+++
T Consensus 243 -~-------~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 243 -L-------QEEPPLLP--GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp -H-------HSCCCCCC--SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred -h-------ccCCCCCC--ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 0 00001111 111245689999999999999999999999885
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-42 Score=339.08 Aligned_cols=251 Identities=24% Similarity=0.296 Sum_probs=183.5
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhc-CCCCccceEeEEEccCCCCc
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDERGI 162 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~~~~ 162 (426)
..+|...++||+|+||+||......+ ..||+|++.... ...+.+|+.+|+.+ +|||||++++++.+..
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~------~~vAvK~~~~~~-~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~---- 91 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDN------RDVAVKRILPEC-FSFADREVQLLRESDEHPNVIRYFCTEKDRQ---- 91 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSS------SEEEEEEECTTT-EEECHHHHHHHHHSCCCTTBCCEEEEEEETT----
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCC------eEEEEEEECHHH-HHHHHHHHHHHHhccCCCCcCeEEEEEecCC----
Confidence 34688899999999999654332222 379999986543 23467899999999 8999999999998765
Q ss_pred eEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCC-----CCCeeEee
Q 014363 163 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE-----QWNAKLSD 237 (426)
Q Consensus 163 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~-----~~~~kl~D 237 (426)
..|||||||+ |+|.+++..... .+.+..++.++.||+.||.|||++ +|+||||||+|||++. ...+||+|
T Consensus 92 ~~~lv~E~~~-g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~D 166 (432)
T 3p23_A 92 FQYIAIELCA-ATLQEYVEQKDF-AHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISD 166 (432)
T ss_dssp EEEEEEECCS-EEHHHHHHSSSC-CCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECC
T ss_pred EEEEEEECCC-CCHHHHHHhcCC-CccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEec
Confidence 4599999995 699999975542 244455678999999999999998 9999999999999953 33578999
Q ss_pred ecccccCCCCCc-eeeeeeeecCcccCCchhhc---cCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHh
Q 014363 238 FGLARLGPSEGF-THVSTAVVGTMGYAAPEYVQ---TGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVK 312 (426)
Q Consensus 238 FGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~ 312 (426)
||+++....... .......+||+.|+|||++. ...++.++|||||||++|||++ |..||............
T Consensus 167 FG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~---- 242 (432)
T 3p23_A 167 FGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILL---- 242 (432)
T ss_dssp TTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHT----
T ss_pred ccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHh----
Confidence 999986643221 12234567999999999987 4567889999999999999999 99999654322111100
Q ss_pred hhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 313 PYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
..... ............+.+||.+||+.||++|||+.||++|
T Consensus 243 ----------~~~~~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 243 ----------GACSL-DCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp ----------TCCCC-TTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ----------ccCCc-cccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 00000 0001122456678899999999999999999999864
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=316.36 Aligned_cols=233 Identities=21% Similarity=0.291 Sum_probs=183.0
Q ss_pred hCCCCCc-ceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHH-hhcCCCCccceEeEEEccCCCC
Q 014363 84 TKNFSRS-VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFL-GIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 84 ~~~y~~~-~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l-~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
.++|... ++||+|+||.||+|.+..++. .||+|.+... ..+.+|+.++ +.++||||+++++++.......
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~---~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 87 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQE-----KFALKMLQDC---PKARREVELHWRASQCPHIVRIVDVYENLYAGR 87 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCC-----EEEEEEEECS---HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCc-----EEEEEEeccc---HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCC
Confidence 4567776 789999999999999876654 8999998643 5678899988 5569999999999987633223
Q ss_pred ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCC---CCCeeEeee
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE---QWNAKLSDF 238 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~---~~~~kl~DF 238 (426)
...++||||+++|+|.+++.......+++..++.++.|++.||.|||++ +|+||||||+|||++. ++.+||+||
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Df 164 (299)
T 3m2w_A 88 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDF 164 (299)
T ss_dssp EEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred ceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEecc
Confidence 3569999999999999999876656799999999999999999999998 9999999999999998 788999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014363 239 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 318 (426)
Q Consensus 239 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 318 (426)
|++.... +..++.++|||||||++|+|++|..||......... .
T Consensus 165 g~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~------------~ 208 (299)
T 3m2w_A 165 GFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS------------P 208 (299)
T ss_dssp TTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------------------C
T ss_pred ccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh------------H
Confidence 9986432 245678999999999999999999999754321100 0
Q ss_pred hhhhhhcCCcCCCccc----HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 319 KQFRQIVDPRLEGKYS----LRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 319 ~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.....+..... ..+ ..++..+.+++.+||+.||++|||+.|++++
T Consensus 209 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 209 GMKTRIRMGQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp CSCCSSCTTCC--SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHhhccc--cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 00000000000 111 2346789999999999999999999999997
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=316.14 Aligned_cols=231 Identities=14% Similarity=0.147 Sum_probs=182.2
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC-----HHHHHHHHHHHhhcCCCCccceEeEEEccC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG-----HKEWMTEVNFLGIVEHQNLVKLVGYCADDD 158 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~-----~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 158 (426)
.++|.+.+.||+|+||.||+|.+...+ ..||+|.+..... .+.+.+|+.++..++||||+++++++.+.+
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~ 104 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALD-----RQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRA 104 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTT-----EEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCC-----ceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECC
Confidence 367999999999999999999987654 3899999975532 257899999999999999999999998765
Q ss_pred CCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeee
Q 014363 159 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 238 (426)
Q Consensus 159 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 238 (426)
..|+||||++|++|.+++... .....+..|+.|++.||+|||++ ||+||||||+|||++.+|.+||+++
T Consensus 105 ----~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~ 173 (286)
T 3uqc_A 105 ----GGLVVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYP 173 (286)
T ss_dssp ----EEEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSC
T ss_pred ----cEEEEEEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEec
Confidence 459999999999999999542 34556888999999999999998 9999999999999999999999854
Q ss_pred cccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014363 239 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 318 (426)
Q Consensus 239 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 318 (426)
| |++ .++.++|||||||++|+|++|+.||..........
T Consensus 174 ~----------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~------------ 212 (286)
T 3uqc_A 174 A----------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA------------ 212 (286)
T ss_dssp C----------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE------------
T ss_pred c----------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH------------
Confidence 3 333 36889999999999999999999998654321000
Q ss_pred hhhhhhcCCcCC--CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhh
Q 014363 319 KQFRQIVDPRLE--GKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 373 (426)
Q Consensus 319 ~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~ 373 (426)
........... ......++..+.+++.+||+.||++| |+.|+++.|+.+....
T Consensus 213 -~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 213 -PAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp -ECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred -HHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 00000000000 01112355789999999999999999 9999999999876543
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=351.15 Aligned_cols=245 Identities=24% Similarity=0.328 Sum_probs=194.4
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC---HHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG---HKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
.++|.+.+.||+|+||.||+|.+.... ...|++|.+..... ...+.+|+.+|..++||||+++++++...+..
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~----~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 154 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVN----GRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRH 154 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGT----TEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTT
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCC----CcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCC
Confidence 478999999999999999999986421 24799999865433 34678999999999999999999999876653
Q ss_pred Cc-eEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeec
Q 014363 161 GI-QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 239 (426)
Q Consensus 161 ~~-~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 239 (426)
+. ..||||||++|++|.+++.. .+++..++.|+.||+.||.|||++ +|+||||||+|||++.+ .+||+|||
T Consensus 155 ~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG 226 (681)
T 2pzi_A 155 GDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLG 226 (681)
T ss_dssp SCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCT
T ss_pred CCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecc
Confidence 22 25999999999999988754 489999999999999999999998 99999999999999986 89999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014363 240 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 319 (426)
Q Consensus 240 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 319 (426)
+++..... ....||+.|+|||++.++ ++.++|||||||++|+|++|..||......
T Consensus 227 ~a~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~----------------- 282 (681)
T 2pzi_A 227 AVSRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVD----------------- 282 (681)
T ss_dssp TCEETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECS-----------------
T ss_pred cchhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccc-----------------
Confidence 99876542 345799999999998765 488999999999999999999887642110
Q ss_pred hhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCC-HHHHHHHHHHhHh
Q 014363 320 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPK-MSEVLEMVNKIVD 371 (426)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-~~eil~~L~~~~~ 371 (426)
...........+..+.+||.+||+.||++||+ ++++...|..++.
T Consensus 283 -------~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 328 (681)
T 2pzi_A 283 -------GLPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR 328 (681)
T ss_dssp -------SCCTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred -------cccccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence 00011111234568899999999999999995 5666666766553
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=348.50 Aligned_cols=273 Identities=26% Similarity=0.384 Sum_probs=202.2
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCCccceEeEEEccCC-
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE- 159 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~- 159 (426)
.++|.+.+.||+|+||.||+|.+..++. .||+|.+.... ..+.+.+|+.++..++||||+++++++.....
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~-----~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~ 87 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGE-----QVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKL 87 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTC-----CEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCC
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCc-----EEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccc
Confidence 3689999999999999999998766544 79999886543 24568899999999999999999998765211
Q ss_pred -CCceEEEEEeeCCCCChhhhccCCCC-CccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCC---ee
Q 014363 160 -RGIQRLLVYEYMPNGSVDQYLSPKSE-TILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWN---AK 234 (426)
Q Consensus 160 -~~~~~~lv~E~~~~g~L~~~l~~~~~-~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~---~k 234 (426)
.....|+||||+++|+|.+++..... ..+++..++.|+.|++.||+|||+. +|+||||||+|||++.++. +|
T Consensus 88 ~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vK 164 (676)
T 3qa8_A 88 APNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHK 164 (676)
T ss_dssp CTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEE
T ss_pred cCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEE
Confidence 12245899999999999999976432 3588899999999999999999998 9999999999999997765 99
Q ss_pred EeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhh
Q 014363 235 LSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPY 314 (426)
Q Consensus 235 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 314 (426)
|+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||...... ..|....
T Consensus 165 L~DFG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-----~~~~~~i 236 (676)
T 3qa8_A 165 IIDLGYAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-----VQWHGKV 236 (676)
T ss_dssp ECSCCCCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-----HHSSTTC
T ss_pred Eccccccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-----hhhhhhh
Confidence 99999998765432 234468999999999999999999999999999999999999999754221 1111100
Q ss_pred hhhhhh---hhhhcC--------CcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHH-----HHHHHHhHhh
Q 014363 315 LSDAKQ---FRQIVD--------PRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEV-----LEMVNKIVDA 372 (426)
Q Consensus 315 ~~~~~~---~~~~~~--------~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei-----l~~L~~~~~~ 372 (426)
...... ...... ..........++..+.+++.+||..||++|||+.|+ ++.++.+...
T Consensus 237 ~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~ 310 (676)
T 3qa8_A 237 REKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSL 310 (676)
T ss_dssp C------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCC
T ss_pred hcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhc
Confidence 000000 000000 011123445678899999999999999999999984 4556665543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=327.74 Aligned_cols=244 Identities=16% Similarity=0.209 Sum_probs=182.2
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-----CHHHHHHHHHHHhhcCC-CCcc---------c
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-----GHKEWMTEVNFLGIVEH-QNLV---------K 149 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-----~~~~~~~E~~~l~~l~H-pnIv---------~ 149 (426)
.+|...++||+|+||.||+|.+..++. .||+|++.... ..+.+.+|+.++..+.| +|+. .
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~-----~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~ 152 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGE-----SFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIF 152 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCC-----EEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCC
T ss_pred eeEEEecccccCCCEEEEEEEecCCCC-----ceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhccccc
Confidence 457788899999999999999887654 89999886332 24678899999999987 3211 1
Q ss_pred ------------eEeEEEccC-CCCceEEEEEeeCCCCChhhhcc-----CCCCCccCHHHHHHHHHHHHHHHHHhccCC
Q 014363 150 ------------LVGYCADDD-ERGIQRLLVYEYMPNGSVDQYLS-----PKSETILTWAMRLKIAQDAARGLAYLHEGM 211 (426)
Q Consensus 150 ------------~~~~~~~~~-~~~~~~~lv~E~~~~g~L~~~l~-----~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~ 211 (426)
++.++.... ......+++|+++ +++|.+++. ......+++..++.|+.||+.||+|||++
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~- 230 (413)
T 3dzo_A 153 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY- 230 (413)
T ss_dssp CCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT-
T ss_pred chhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 111111111 0112347777776 789999884 23345688999999999999999999998
Q ss_pred CCCeEeccCCCCceEeCCCCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhh----------ccCCCCCchhhHH
Q 014363 212 DFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYV----------QTGRLAARSDVWS 281 (426)
Q Consensus 212 ~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Dvws 281 (426)
+|+||||||+||||+.++.+||+|||+++..... ....+| +.|+|||++ .+..++.++||||
T Consensus 231 --~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwS 302 (413)
T 3dzo_A 231 --GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWT 302 (413)
T ss_dssp --TEECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHH
T ss_pred --CcccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHH
Confidence 9999999999999999999999999998864321 345678 999999998 4555888999999
Q ss_pred HHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHH
Q 014363 282 YGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSE 361 (426)
Q Consensus 282 lGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~e 361 (426)
|||++|||++|+.||....... ....++... . .++..+.+|+.+||+.||++||++.+
T Consensus 303 lGvil~elltg~~Pf~~~~~~~----------------~~~~~~~~~--~----~~~~~~~~li~~~l~~dP~~Rpt~~~ 360 (413)
T 3dzo_A 303 LGLAIYWIWCADLPNTDDAALG----------------GSEWIFRSC--K----NIPQPVRALLEGFLRYPKEDRLLPLQ 360 (413)
T ss_dssp HHHHHHHHHHSSCCCCTTGGGS----------------CSGGGGSSC--C----CCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHHHHCCCCCCCcchhh----------------hHHHHHhhc--c----cCCHHHHHHHHHHccCChhhCcCHHH
Confidence 9999999999999997543211 111111110 1 23478999999999999999999888
Q ss_pred HHHH
Q 014363 362 VLEM 365 (426)
Q Consensus 362 il~~ 365 (426)
++++
T Consensus 361 ~l~~ 364 (413)
T 3dzo_A 361 AMET 364 (413)
T ss_dssp HTTS
T ss_pred HHhC
Confidence 8654
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=313.19 Aligned_cols=245 Identities=18% Similarity=0.203 Sum_probs=184.5
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----------CHHHHHHHHHHHhhcC---------C
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----------GHKEWMTEVNFLGIVE---------H 144 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----------~~~~~~~E~~~l~~l~---------H 144 (426)
.++|.+.+.||+|+||.||+|.+.+ ..||+|.+.... ..+.+.+|+.+|+.++ |
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~-------~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h 91 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIADH-------TPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRT 91 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEETT-------EEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBC
T ss_pred cccchheeeecccCceEEEEEEeCC-------ceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccC
Confidence 4578999999999999999998732 489999986542 2367889999999885 8
Q ss_pred CCccceEeEEEccC--------------------------CCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHH
Q 014363 145 QNLVKLVGYCADDD--------------------------ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQ 198 (426)
Q Consensus 145 pnIv~~~~~~~~~~--------------------------~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~ 198 (426)
||||++++++...+ ......||||||+++|++.+.+.. ..+++..++.|+.
T Consensus 92 ~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~ 168 (336)
T 2vuw_A 92 EGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILH 168 (336)
T ss_dssp CCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHH
T ss_pred CchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHH
Confidence 88888877654211 002356999999999977666643 3489999999999
Q ss_pred HHHHHHHHhc-cCCCCCeEeccCCCCceEeCCCC--------------------CeeEeeecccccCCCCCceeeeeeee
Q 014363 199 DAARGLAYLH-EGMDFQIIVRDFKSSNILLDEQW--------------------NAKLSDFGLARLGPSEGFTHVSTAVV 257 (426)
Q Consensus 199 ~i~~aL~~LH-~~~~~~iiHrDlkp~NILl~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~~ 257 (426)
||+.||+||| ++ +|+||||||+||||+.++ .+||+|||+++.... ...+
T Consensus 169 qi~~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~ 238 (336)
T 2vuw_A 169 QLTASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVV 238 (336)
T ss_dssp HHHHHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEE
T ss_pred HHHHHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEE
Confidence 9999999999 88 999999999999999887 899999999986543 2358
Q ss_pred cCcccCCchhhccCCCCCchhhHHHHHH-HHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhh-hcCCcCCCcccH
Q 014363 258 GTMGYAAPEYVQTGRLAARSDVWSYGVF-LYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQ-IVDPRLEGKYSL 335 (426)
Q Consensus 258 gt~~y~aPE~~~~~~~~~~~DvwslGvi-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 335 (426)
||+.|+|||++.+.. +.++||||||++ .+++++|..||... .|...... ..... ............
T Consensus 239 gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~---------~~~~~~~~--~~~~~~~~~~~~~~~~~~ 306 (336)
T 2vuw_A 239 FCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV---------LWLHYLTD--KMLKQMTFKTKCNTPAMK 306 (336)
T ss_dssp CCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH---------HHHHHHHH--HHHHTCCCSSCCCSHHHH
T ss_pred EeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch---------hhhhHHHH--hhhhhhccCcccchhhhh
Confidence 999999999998665 889999998777 77888899988421 01000000 00000 011111222345
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHH-HH
Q 014363 336 RLVSKLSHVANLCLVKNARTRPKMSEVL-EM 365 (426)
Q Consensus 336 ~~~~~l~~li~~cl~~dp~~RPs~~eil-~~ 365 (426)
.+++++.+||.+||+.| |+.|++ +|
T Consensus 307 ~~s~~~~dli~~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 307 QIKRKIQEFHRTMLNFS-----SATDLLCQH 332 (336)
T ss_dssp HHHHHHHHHHHHGGGSS-----SHHHHHHHC
T ss_pred hcCHHHHHHHHHHhccC-----CHHHHHhcC
Confidence 68899999999999976 999998 65
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.9e-34 Score=291.47 Aligned_cols=183 Identities=17% Similarity=0.110 Sum_probs=125.4
Q ss_pred ecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC------------CHHHHHHHHHHHhhc-CCCCccceEeEEEccCC
Q 014363 93 IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG------------GHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDE 159 (426)
Q Consensus 93 lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~------------~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~ 159 (426)
++.|++|.+..++....++ .+++|.+.... ..++|.+|+++|+++ .|+||+++++++.++.
T Consensus 242 ~~~~~~~~h~~~rr~~fg~-----~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~- 315 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGE-----DYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQ- 315 (569)
T ss_dssp -C--------CCEEEEECS-----SEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSS-
T ss_pred cccCCcccccccccccccc-----eeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECC-
Confidence 4556666555544332232 57888875432 234689999999999 7999999999998876
Q ss_pred CCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeec
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 239 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 239 (426)
+.||||||++|++|.++|...+ .++.. .|+.||+.||+|||++ |||||||||+||||+.+|++||+|||
T Consensus 316 ---~~yLVMEyv~G~~L~d~i~~~~--~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFG 384 (569)
T 4azs_A 316 ---SGWLVMEKLPGRLLSDMLAAGE--EIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFG 384 (569)
T ss_dssp ---EEEEEEECCCSEEHHHHHHTTC--CCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCT
T ss_pred ---EEEEEEecCCCCcHHHHHHhCC--CCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecc
Confidence 4599999999999999997654 36654 5889999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCC
Q 014363 240 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRP 295 (426)
Q Consensus 240 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p 295 (426)
+|+...... ....+.+||+.|||||++.+ .+..++|+||+|+++++|.++..+
T Consensus 385 lAr~~~~~~--~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 385 SIVTTPQDC--SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp TEESCC-----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred cCeeCCCCC--ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 998765432 22345789999999999875 567789999999998887665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.2e-30 Score=260.83 Aligned_cols=183 Identities=19% Similarity=0.264 Sum_probs=140.6
Q ss_pred CCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----------CHHHHHHHHHHHhhcCCCCccceEeEEEcc
Q 014363 88 SRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----------GHKEWMTEVNFLGIVEHQNLVKLVGYCADD 157 (426)
Q Consensus 88 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----------~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 157 (426)
...++||+|+||.||+|..... .+++|...... ..+.+.+|+++|++++||||+++..++.+.
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~~~-------~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~ 411 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYLDF-------DVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDL 411 (540)
T ss_dssp ---------CCEEEEEEECSSC-------EEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEET
T ss_pred CCCCEEeeCCCEEEEEEEECCC-------eEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeC
Confidence 4466899999999999954432 57777653321 123478999999999999999655555555
Q ss_pred CCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEee
Q 014363 158 DERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 237 (426)
Q Consensus 158 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~D 237 (426)
+.. ||||||+++++|.+++.. ++.++.|++.||+|||++ +|+||||||+|||++. .+||+|
T Consensus 412 ~~~----~lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~D 472 (540)
T 3en9_A 412 DNK----RIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIID 472 (540)
T ss_dssp TTT----EEEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECC
T ss_pred Ccc----EEEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEE
Confidence 443 999999999999999964 458999999999999998 9999999999999999 999999
Q ss_pred ecccccCCCCCcee-----eeeeeecCcccCCchhhcc--CCCCCchhhHHHHHHHHHHHhCCCCC
Q 014363 238 FGLARLGPSEGFTH-----VSTAVVGTMGYAAPEYVQT--GRLAARSDVWSYGVFLYELITGRRPI 296 (426)
Q Consensus 238 FGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~elltg~~p~ 296 (426)
||+++......... .....+||+.|||||++.. ..|+...|+|+..+-.++.+.++.+|
T Consensus 473 FGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 473 FGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 99998765432111 1235789999999999987 56888899999999999888877766
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-25 Score=210.62 Aligned_cols=149 Identities=14% Similarity=0.072 Sum_probs=117.1
Q ss_pred HHHHhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC--------------------CHHHHHHHHHHH
Q 014363 80 LKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--------------------GHKEWMTEVNFL 139 (426)
Q Consensus 80 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~--------------------~~~~~~~E~~~l 139 (426)
+......|...+.||+|+||.||+|.+ .++ ..||+|.+.... ....+.+|+.+|
T Consensus 85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g-----~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l 158 (282)
T 1zar_A 85 LVRSGKVDAIGKLMGEGKESAVFNCYS-EKF-----GECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRAL 158 (282)
T ss_dssp HHHTTSCSEEEEEEEECSSEEEEEEEE-TTT-----EEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHH
T ss_pred HHhCCeEEEecCEeccCCCceEEEEEe-CCC-----CEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHH
Confidence 334455677789999999999999998 333 379999985322 134588999999
Q ss_pred hhcCCCCccceEeEEEccCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEecc
Q 014363 140 GIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRD 219 (426)
Q Consensus 140 ~~l~HpnIv~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrD 219 (426)
+.++ | +++++++... . .|+||||++|++|.+ +.. .....++.|++.||.|||+. +|+|||
T Consensus 159 ~~l~--~-~~v~~~~~~~-~----~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~---giiHrD 218 (282)
T 1zar_A 159 QKLQ--G-LAVPKVYAWE-G----NAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHR---GIVHGD 218 (282)
T ss_dssp HHTT--T-SSSCCEEEEE-T----TEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred Hhcc--C-CCcCeEEecc-c----eEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHC---CCEeCC
Confidence 9999 4 6666655432 2 289999999999998 531 12346999999999999998 999999
Q ss_pred CCCCceEeCCCCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhcc
Q 014363 220 FKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT 270 (426)
Q Consensus 220 lkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 270 (426)
|||+|||++ ++.+||+|||+++ .+..|+|||++..
T Consensus 219 lkp~NILl~-~~~vkl~DFG~a~---------------~~~~~~a~e~l~r 253 (282)
T 1zar_A 219 LSQYNVLVS-EEGIWIIDFPQSV---------------EVGEEGWREILER 253 (282)
T ss_dssp CSTTSEEEE-TTEEEECCCTTCE---------------ETTSTTHHHHHHH
T ss_pred CCHHHEEEE-CCcEEEEECCCCe---------------ECCCCCHHHHHHH
Confidence 999999999 9999999999986 3456789998753
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=1.1e-21 Score=180.95 Aligned_cols=135 Identities=17% Similarity=0.090 Sum_probs=103.0
Q ss_pred CCCcceecccCcEEEEEEEEcCCCCCCcceE--EEEEEccccCC--------------------------HHHHHHHHHH
Q 014363 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVE--VAVKQLGRRGG--------------------------HKEWMTEVNF 138 (426)
Q Consensus 87 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~--va~K~~~~~~~--------------------------~~~~~~E~~~ 138 (426)
|.+.+.||+|+||.||+|.+..++ .. ||+|.+..... ...+.+|+.+
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g-----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 123 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDG-----KPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRN 123 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETT-----EEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCC-----cEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHH
Confidence 667889999999999999874333 26 99998643210 1257889999
Q ss_pred HhhcCCCCc--cceEeEEEccCCCCceEEEEEeeCCC-C----ChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhc-cC
Q 014363 139 LGIVEHQNL--VKLVGYCADDDERGIQRLLVYEYMPN-G----SVDQYLSPKSETILTWAMRLKIAQDAARGLAYLH-EG 210 (426)
Q Consensus 139 l~~l~HpnI--v~~~~~~~~~~~~~~~~~lv~E~~~~-g----~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH-~~ 210 (426)
|..+.|++| +.++++ . . .+|||||+.+ | +|.++... .++..+..++.|++.||.||| +.
T Consensus 124 l~~l~~~~i~~p~~~~~--~--~----~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~ 190 (258)
T 1zth_A 124 LERAKEAGVSVPQPYTY--M--K----NVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEA 190 (258)
T ss_dssp HHHHHHTTCCCCCEEEE--E--T----TEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTS
T ss_pred HHHHHhCCCCCCeEEEc--C--C----CEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHC
Confidence 999988864 444442 2 2 2899999942 3 66665432 234567789999999999999 87
Q ss_pred CCCCeEeccCCCCceEeCCCCCeeEeeecccccC
Q 014363 211 MDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLG 244 (426)
Q Consensus 211 ~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 244 (426)
+|+||||||+|||++. .++|+|||+|...
T Consensus 191 ---givHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 191 ---ELVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp ---CEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred ---CEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 9999999999999998 9999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.73 E-value=6.6e-18 Score=162.40 Aligned_cols=135 Identities=15% Similarity=0.076 Sum_probs=98.2
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----------------CHHH--------HHHHHHHHhh
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----------------GHKE--------WMTEVNFLGI 141 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----------------~~~~--------~~~E~~~l~~ 141 (426)
-|++...||+|+||.||+|....+ ..||+|+++... .... ...|...|.+
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G------~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~r 169 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKG------KQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKA 169 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTC------CEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEecCEeeeCCceEEEEEECCCC------CEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHH
Confidence 389999999999999999986543 379999864210 1111 2356777777
Q ss_pred cCCCCccceEeEEEccCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCC
Q 014363 142 VEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFK 221 (426)
Q Consensus 142 l~HpnIv~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlk 221 (426)
+.+.++.-..-+..... +|||||++|++|.++... + ....++.|++.+|.|||+. ||||||||
T Consensus 170 L~~~gv~vp~p~~~~~~------~LVME~i~G~~L~~l~~~------~--~~~~l~~qll~~l~~lH~~---gIVHrDLK 232 (397)
T 4gyi_A 170 LYEEGFPVPEPIAQSRH------TIVMSLVDALPMRQVSSV------P--DPASLYADLIALILRLAKH---GLIHGDFN 232 (397)
T ss_dssp HHHTTCSCCCEEEEETT------EEEEECCSCEEGGGCCCC------S--CHHHHHHHHHHHHHHHHHT---TEECSCCS
T ss_pred HHhcCCCCCeeeeccCc------eEEEEecCCccHhhhccc------H--HHHHHHHHHHHHHHHHHHC---CCcCCCCC
Confidence 75544432221222221 799999999998776532 1 2346789999999999998 99999999
Q ss_pred CCceEeCCCCC----------eeEeeeccccc
Q 014363 222 SSNILLDEQWN----------AKLSDFGLARL 243 (426)
Q Consensus 222 p~NILl~~~~~----------~kl~DFGla~~ 243 (426)
|.|||++++|. +.|+||+-+..
T Consensus 233 p~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 233 EFNILIREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp TTSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred HHHEEEeCCCCcccccccccceEEEEeCCccc
Confidence 99999988773 89999997754
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.44 E-value=2.6e-13 Score=124.89 Aligned_cols=145 Identities=16% Similarity=0.107 Sum_probs=110.6
Q ss_pred HHHHhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc--CCHHHHHHHHHHHhhc-CCCCccceEeEEEc
Q 014363 80 LKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR--GGHKEWMTEVNFLGIV-EHQNLVKLVGYCAD 156 (426)
Q Consensus 80 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~ 156 (426)
+......|.....+|.|+.+.||++...+ ..+++|..... .....+.+|+.+|+.+ .+.++.++++++.+
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~~-------~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~ 81 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVGEN-------ENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH 81 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEECSS-------CEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE
T ss_pred HHHHhccceeEeeccCCCCCeEEEEECCC-------CcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEec
Confidence 34456788888889999999999986432 27889987642 2345688999999999 46788899998876
Q ss_pred cCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccC--------------------------
Q 014363 157 DDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEG-------------------------- 210 (426)
Q Consensus 157 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~-------------------------- 210 (426)
.+ ..|+||||++|.+|.+.+... .....++.+++++|..||+.
T Consensus 82 ~~----~~~lv~e~i~G~~l~~~~~~~-------~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (263)
T 3tm0_A 82 DG----WSNLLMSEADGVLCSEEYEDE-------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDL 150 (263)
T ss_dssp TT----EEEEEEECCSSEEHHHHCCTT-------TCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTC
T ss_pred CC----ceEEEEEecCCeehhhccCCc-------ccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccc
Confidence 54 459999999999998764211 12236788999999999971
Q ss_pred ------------------------------CCCCeEeccCCCCceEeCCCCCeeEeeecccc
Q 014363 211 ------------------------------MDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 242 (426)
Q Consensus 211 ------------------------------~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 242 (426)
....++|+|++|.|||++++..+.|+||+.+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 151 ADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 01359999999999999876556799998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.29 E-value=4.5e-12 Score=116.06 Aligned_cols=137 Identities=14% Similarity=0.062 Sum_probs=95.8
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhcCCCC--ccceEeEEEccCCCCc
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQN--LVKLVGYCADDDERGI 162 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l~Hpn--Iv~~~~~~~~~~~~~~ 162 (426)
..|....+.+.|..+.||++...++. .+++|..... ....+..|+.+++.+.+.+ +.+++++..+.+
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~------~~vlK~~~~~-~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~---- 88 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRP------VLFVKTDLSG-ALNELQDEAARLSWLATTGVPCAAVLDVVTEAG---- 88 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSC------CEEEEEECSC-TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSS----
T ss_pred CCCceEecccCCCCceEEEEecCCCC------eEEEEeCCcc-cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCC----
Confidence 34444333345666999998643221 5788886544 3356789999999995444 566888776653
Q ss_pred eEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCC-------------------------------
Q 014363 163 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGM------------------------------- 211 (426)
Q Consensus 163 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~------------------------------- 211 (426)
..++||||++|.+|. ... ... ..++.+++..|..||...
T Consensus 89 ~~~~v~e~i~G~~l~--~~~-----~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (264)
T 1nd4_A 89 RDWLLLGEVPGQDLL--SSH-----LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDL 158 (264)
T ss_dssp CEEEEEECCSSEETT--TSC-----CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSC
T ss_pred CCEEEEEecCCcccC--cCc-----CCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhh
Confidence 249999999998884 221 111 256778888888888641
Q ss_pred ------------------------CCCeEeccCCCCceEeCCCCCeeEeeecccc
Q 014363 212 ------------------------DFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 242 (426)
Q Consensus 212 ------------------------~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 242 (426)
...++|+|++|.|||+++++.+.|+|||.+.
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 159 DEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp CGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1139999999999999877667799999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.25 E-value=3.7e-11 Score=115.77 Aligned_cols=145 Identities=14% Similarity=0.187 Sum_probs=106.1
Q ss_pred CCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcc--ccC---CHHHHHHHHHHHhhcC--CCCccceEeEEEccCCC
Q 014363 88 SRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLG--RRG---GHKEWMTEVNFLGIVE--HQNLVKLVGYCADDDER 160 (426)
Q Consensus 88 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~--~~~---~~~~~~~E~~~l~~l~--HpnIv~~~~~~~~~~~~ 160 (426)
..++.|+.|.++.||++...+. .+++|... ... ....+.+|+.+++.|. +..+++++.++.+....
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~~~-------~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~ 113 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTPGQ-------TYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVI 113 (359)
T ss_dssp CEEEECCC-CCSCEEEEECSSC-------EEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTT
T ss_pred ceEEEcCCcccceEEEEEECCc-------eEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCcc
Confidence 3467899999999999875431 57777765 221 2346789999999996 45688999888765332
Q ss_pred CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCC-----------------------------
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGM----------------------------- 211 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~----------------------------- 211 (426)
+ ..|+||||++|..+.+... ..++......++.+++.+|..||...
T Consensus 114 g-~~~~vme~v~G~~l~~~~~----~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (359)
T 3dxp_A 114 G-RAFYIMEFVSGRVLWDQSL----PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKL 188 (359)
T ss_dssp S-SCEEEEECCCCBCCCCTTC----TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHH
T ss_pred C-CeEEEEEecCCeecCCCcc----ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHh
Confidence 2 2489999999988854221 12677888889999999999999720
Q ss_pred --------------------------CCCeEeccCCCCceEeCCCCC--eeEeeecccccC
Q 014363 212 --------------------------DFQIIVRDFKSSNILLDEQWN--AKLSDFGLARLG 244 (426)
Q Consensus 212 --------------------------~~~iiHrDlkp~NILl~~~~~--~kl~DFGla~~~ 244 (426)
...++|+|+++.|||++.++. +.|+||+.+...
T Consensus 189 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 189 SETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred cCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 247999999999999997753 689999988653
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.15 E-value=2.6e-11 Score=114.03 Aligned_cols=186 Identities=20% Similarity=0.216 Sum_probs=121.5
Q ss_pred cceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhc-CCCC--ccceEeEEEccCCCCceEEE
Q 014363 90 SVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIV-EHQN--LVKLVGYCADDDERGIQRLL 166 (426)
Q Consensus 90 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l-~Hpn--Iv~~~~~~~~~~~~~~~~~l 166 (426)
++.++.|.+..||++. . .+++|..........+.+|+.+|+.+ .+.. +.+++.+....... ...|+
T Consensus 25 i~~~~~G~~n~v~~v~----~------~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~-~~~~~ 93 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----R------DFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETY-QMSFA 93 (304)
T ss_dssp CCEEEECSSEEEEEST----T------SEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSC-SCSCE
T ss_pred eEecCCCCcceEEEEC----C------EEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCC-CcceE
Confidence 4578999999999853 1 46777755443456788999999888 3333 44555443332211 12388
Q ss_pred EEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccC------------------------------------
Q 014363 167 VYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEG------------------------------------ 210 (426)
Q Consensus 167 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~------------------------------------ 210 (426)
|||+++|.+|.+... ..++......++.+++..|..||+.
T Consensus 94 vm~~i~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (304)
T 3sg8_A 94 GFTKIKGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQ 169 (304)
T ss_dssp EEECCCCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHH
T ss_pred EEcccCCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCccc
Confidence 999999988865332 1256677778888888888888851
Q ss_pred -------------------CCCCeEeccCCCCceEeCC--CCCeeEeeecccccCCCCCceeeeeeeecCccc---CCch
Q 014363 211 -------------------MDFQIIVRDFKSSNILLDE--QWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGY---AAPE 266 (426)
Q Consensus 211 -------------------~~~~iiHrDlkp~NILl~~--~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y---~aPE 266 (426)
....++|+|++|.|||+++ +..+.|+||+.+....... . ......+ ..|+
T Consensus 170 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~-D-----l~~~~~~~~~~~~~ 243 (304)
T 3sg8_A 170 MKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN-D-----FISLMEDDEEYGME 243 (304)
T ss_dssp HHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH-H-----HHTTCCTTTSCCHH
T ss_pred HHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH-H-----HHHHHhhccccCHH
Confidence 1135899999999999988 4567899999987543211 0 0011111 2333
Q ss_pred hhcc-----CCC---------CCchhhHHHHHHHHHHHhCCCCC
Q 014363 267 YVQT-----GRL---------AARSDVWSYGVFLYELITGRRPI 296 (426)
Q Consensus 267 ~~~~-----~~~---------~~~~DvwslGvil~elltg~~p~ 296 (426)
.... +.. ....+.|++|.++|.+.+|..+|
T Consensus 244 ~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 244 FVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 2211 111 12268999999999999998776
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.61 E-value=2.8e-07 Score=86.44 Aligned_cols=138 Identities=18% Similarity=0.159 Sum_probs=92.2
Q ss_pred CcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhcCCC---CccceEeEEEccCCCCceEE
Q 014363 89 RSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQ---NLVKLVGYCADDDERGIQRL 165 (426)
Q Consensus 89 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l~Hp---nIv~~~~~~~~~~~~~~~~~ 165 (426)
.++.++.|....||+. + . .+.+|..........+..|+.+|..|.+. .+.+++.+..... + ..|
T Consensus 23 ~v~~l~~G~~n~v~~v---g-~------~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~--g-~~~ 89 (306)
T 3tdw_A 23 SVESLGEGFRNYAILV---N-G------DWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSD--G-NPF 89 (306)
T ss_dssp CEEEEEECSSEEEEEE---T-T------TEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTT--S-CEE
T ss_pred eeeecCCCcceeEEEE---C-C------EEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCC--C-ceE
Confidence 3457888999999987 1 1 36677643333345788999999999653 3667777765322 1 348
Q ss_pred EEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccC-----------------------------------
Q 014363 166 LVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEG----------------------------------- 210 (426)
Q Consensus 166 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~----------------------------------- 210 (426)
+||||++|..|.+..-. .++......++.+++..|..||+.
T Consensus 90 ~v~e~i~G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~ 165 (306)
T 3tdw_A 90 VGYRKVQGQILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLD 165 (306)
T ss_dssp EEEECCCSEECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSC
T ss_pred EEEeccCCeECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccc
Confidence 99999999888763211 134444445555555555555532
Q ss_pred ----------------------CCCCeEeccCCCCceEeCC---CCCe-eEeeeccccc
Q 014363 211 ----------------------MDFQIIVRDFKSSNILLDE---QWNA-KLSDFGLARL 243 (426)
Q Consensus 211 ----------------------~~~~iiHrDlkp~NILl~~---~~~~-kl~DFGla~~ 243 (426)
....++|+|++|.|||++. ++.+ .|+||+.+..
T Consensus 166 ~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 166 ESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred hhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1235799999999999987 4554 8999998754
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.53 E-value=3.7e-07 Score=83.77 Aligned_cols=135 Identities=20% Similarity=0.124 Sum_probs=91.6
Q ss_pred eecccCcE-EEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhcC-CCCccceEeEEEccCCCCceEEEEEe
Q 014363 92 VIGEGGFG-CVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVE-HQNLVKLVGYCADDDERGIQRLLVYE 169 (426)
Q Consensus 92 ~lG~G~~g-~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~~~~~~~~~~~lv~E 169 (426)
.+..|..| .||+......+. .+.+|..... ....+..|..+|+.|. +--+.++++++.+.+ ..|+|||
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~-----~~~lk~~~~~-~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~----~~~lvme 100 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAP-----ELFLKHGKGS-VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPD----DAWLLTT 100 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCC-----CEEEEEEETH-HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETT----EEEEEEE
T ss_pred EccCCCcCCeEEEEEecCCCe-----EEEEEECCCC-CHhHHHHHHHHHHHhccCCCcCeEEEEEEECC----eEEEEEE
Confidence 35556555 689876544332 4677765432 3456788999999883 334778888887765 3499999
Q ss_pred eCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccC---------------------------------------
Q 014363 170 YMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEG--------------------------------------- 210 (426)
Q Consensus 170 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~--------------------------------------- 210 (426)
+++|.++.+..... ......+..+++..|.-||..
T Consensus 101 ~l~G~~~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (272)
T 4gkh_A 101 AIPGKTAFQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGW 174 (272)
T ss_dssp CCCSEEHHHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTC
T ss_pred eeCCccccccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccch
Confidence 99998887654321 112234555666666666621
Q ss_pred ----------------CCCCeEeccCCCCceEeCCCCCeeEeeecccc
Q 014363 211 ----------------MDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 242 (426)
Q Consensus 211 ----------------~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 242 (426)
....++|+|+.+.|||++.++.+-|+||+.+.
T Consensus 175 ~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 175 PVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp CHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 01238999999999999987777899999875
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.48 E-value=8.3e-07 Score=84.98 Aligned_cols=88 Identities=8% Similarity=0.018 Sum_probs=56.0
Q ss_pred ccee-cccCcEEEEEEEEcCCCC-CCcceEEEEEEccccC-----CHHHHHHHHHHHhhcC-C--CCccceEeEEEccCC
Q 014363 90 SVVI-GEGGFGCVYKGLIKNSED-PSQKVEVAVKQLGRRG-----GHKEWMTEVNFLGIVE-H--QNLVKLVGYCADDDE 159 (426)
Q Consensus 90 ~~~l-G~G~~g~Vy~~~~~~~~~-~~~~~~va~K~~~~~~-----~~~~~~~E~~~l~~l~-H--pnIv~~~~~~~~~~~ 159 (426)
.+.| +.|....+|+.......+ ......+.+|...... ....+.+|+.+|+.|. + -.+.+++.++.+...
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 888899999876530000 0002357777764332 1256789999999883 3 357888888765432
Q ss_pred CCceEEEEEeeCCCCChhh
Q 014363 160 RGIQRLLVYEYMPNGSVDQ 178 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~ 178 (426)
.+ ..|+||||++|..+.+
T Consensus 105 ~g-~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 105 LG-TPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TS-SCEEEEECCCCBCCCB
T ss_pred cC-CceEEEEecCCCChhh
Confidence 12 2389999999877764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.33 E-value=3.4e-06 Score=82.00 Aligned_cols=74 Identities=14% Similarity=0.029 Sum_probs=47.5
Q ss_pred cceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc---------CCHHHHHHHHHHHhhcCC--C-CccceEeEEEcc
Q 014363 90 SVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR---------GGHKEWMTEVNFLGIVEH--Q-NLVKLVGYCADD 157 (426)
Q Consensus 90 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~---------~~~~~~~~E~~~l~~l~H--p-nIv~~~~~~~~~ 157 (426)
.+.||.|.++.||++.....+ ..+++|..... .....+..|+++|..+.. | .+.+++.+. .
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~-----~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~ 107 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHD-----RALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--T 107 (397)
T ss_dssp EEECCSSSSEEEEEEEC---------CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--T
T ss_pred EEECCCCceEEEEEEEECCCC-----cEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--C
Confidence 567999999999999654322 26888865321 123456789999988732 3 345666542 2
Q ss_pred CCCCceEEEEEeeCCCC
Q 014363 158 DERGIQRLLVYEYMPNG 174 (426)
Q Consensus 158 ~~~~~~~~lv~E~~~~g 174 (426)
+.. ++||||+++.
T Consensus 108 ~~~----~lvmE~l~g~ 120 (397)
T 2olc_A 108 EMA----VTVMEDLSHL 120 (397)
T ss_dssp TTT----EEEECCCTTS
T ss_pred Ccc----EEEEEeCCCc
Confidence 222 8999999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.18 E-value=1.3e-05 Score=75.73 Aligned_cols=30 Identities=20% Similarity=0.244 Sum_probs=27.4
Q ss_pred CCeEeccCCCCceEeCCCCCeeEeeecccc
Q 014363 213 FQIIVRDFKSSNILLDEQWNAKLSDFGLAR 242 (426)
Q Consensus 213 ~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 242 (426)
..++|+|+.+.|||++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 489999999999999888899999999774
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.98 E-value=4.3e-05 Score=71.53 Aligned_cols=139 Identities=14% Similarity=0.098 Sum_probs=87.8
Q ss_pred CCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhcC---CCCccceEeEEEccCCCCceE
Q 014363 88 SRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVE---HQNLVKLVGYCADDDERGIQR 164 (426)
Q Consensus 88 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l~---HpnIv~~~~~~~~~~~~~~~~ 164 (426)
...+.|+.|.+..+|+....+ ..+.+|..... ....+..|+..|+.|. ...+++++++....+ ..
T Consensus 39 ~~~~~l~gG~~n~~y~v~~~~-------~~~vlK~~~~~-~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g----~~ 106 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLINDEV-------QTVFVKINERS-YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQG----HS 106 (312)
T ss_dssp CEEEEECCSSSSEEEEEESSS-------CEEEEEEEEGG-GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSS----EE
T ss_pred eeeEEeCCccceeeeEEEECC-------CeEEEEeCCcc-cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCC----ce
Confidence 345679999999999986421 26778876533 3567889999999883 356888888876543 35
Q ss_pred EEEEeeCCCCChhhh-----------ccCCCC-C-------------------ccCHHHHH---HHH-------------
Q 014363 165 LLVYEYMPNGSVDQY-----------LSPKSE-T-------------------ILTWAMRL---KIA------------- 197 (426)
Q Consensus 165 ~lv~E~~~~g~L~~~-----------l~~~~~-~-------------------~~~~~~~~---~i~------------- 197 (426)
|+||||++|..+..- |+.... . .-+|.... ++.
T Consensus 107 ~lvme~l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~ 186 (312)
T 3jr1_A 107 FLLLEALNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIF 186 (312)
T ss_dssp EEEEECCCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCC
T ss_pred EEEEEeccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCCh
Confidence 999999998765311 111110 0 01343321 011
Q ss_pred ---HHHHHHH-HHhcc-CCCCCeEeccCCCCceEeCCCCCeeEeeec
Q 014363 198 ---QDAARGL-AYLHE-GMDFQIIVRDFKSSNILLDEQWNAKLSDFG 239 (426)
Q Consensus 198 ---~~i~~aL-~~LH~-~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 239 (426)
..++..+ ..|.. ...+.++|+|+.+.|||++.++ +.|.||+
T Consensus 187 ~~~~~l~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 187 GNIDLIVQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp SCHHHHHHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHHHHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 1122222 23421 1245899999999999999887 8899984
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.85 E-value=7.6e-05 Score=70.00 Aligned_cols=161 Identities=11% Similarity=0.100 Sum_probs=86.9
Q ss_pred ccCHHHHHHHhCCCCC-----cceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhcCCCC--
Q 014363 74 EFTIAELKSATKNFSR-----SVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQN-- 146 (426)
Q Consensus 74 ~~~~~~~~~~~~~y~~-----~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l~Hpn-- 146 (426)
.++.+++......|.. .+.|+.|....+|+....+. .+.+|..........+..|+.++..|...+
T Consensus 6 ~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-------~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~ 78 (322)
T 2ppq_A 6 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-------PLILTLYEKRVEKNDLPFFLGLMQHLAAKGLS 78 (322)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-------CEEEEEECC---CCHHHHHHHHHHHHHHTTCC
T ss_pred cCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-------cEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCC
Confidence 3556677777666765 24566788889999875432 467887765333456778888888773212
Q ss_pred ccceEeEEEccCC---CCceEEEEEeeCCCCChhhh--------------cc----CCCC------CccCHHHHHH----
Q 014363 147 LVKLVGYCADDDE---RGIQRLLVYEYMPNGSVDQY--------------LS----PKSE------TILTWAMRLK---- 195 (426)
Q Consensus 147 Iv~~~~~~~~~~~---~~~~~~lv~E~~~~g~L~~~--------------l~----~~~~------~~~~~~~~~~---- 195 (426)
+.+++... +... .....+++|+|++|..+... ++ .... ....|...+.
T Consensus 79 vP~~~~~~-~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~ 157 (322)
T 2ppq_A 79 CPLPLPRK-DGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEE 157 (322)
T ss_dssp CCCBCCBT-TCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGG
T ss_pred CCcccCCC-CCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHH
Confidence 33333210 0000 01135899999988654220 00 0000 0011222100
Q ss_pred --------HHHHHHHHHHHhcc----CCCCCeEeccCCCCceEeCCCCCeeEeeecccc
Q 014363 196 --------IAQDAARGLAYLHE----GMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 242 (426)
Q Consensus 196 --------i~~~i~~aL~~LH~----~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 242 (426)
+...+...+..+.. ....+++|+|+.+.|||++.++.+.|+||+.+.
T Consensus 158 ~~~~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 158 RADEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp GGGGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHhhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 00113334444432 123479999999999999987656899998774
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.76 E-value=0.00011 Score=71.72 Aligned_cols=76 Identities=13% Similarity=0.150 Sum_probs=46.2
Q ss_pred CCeEeccCCCCceEeCCCCCeeEeeecccccCCCCCceeeeeeeec--CcccCCchhhccCC---CCCchhhHHHHHHHH
Q 014363 213 FQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVG--TMGYAAPEYVQTGR---LAARSDVWSYGVFLY 287 (426)
Q Consensus 213 ~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~---~~~~~DvwslGvil~ 287 (426)
..++|+|++|.|||++.++ ++|+||+.+......- .. . ...+ ...|++|+...... -....++..+...+|
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~-Dl-a-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGF-DI-G-AYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHH-HH-H-HHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHH-HH-H-HHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 3899999999999999876 9999999887543210 00 0 0000 13455665443111 111345557777777
Q ss_pred HHHhC
Q 014363 288 ELITG 292 (426)
Q Consensus 288 elltg 292 (426)
+.+.+
T Consensus 308 ~~y~~ 312 (420)
T 2pyw_A 308 NLFNK 312 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 77765
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.71 E-value=0.00015 Score=67.41 Aligned_cols=73 Identities=8% Similarity=0.115 Sum_probs=45.1
Q ss_pred CCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-CHHHHHHHHHHHhhcCCCCc-cceEeEEEccCCCCceE
Q 014363 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-GHKEWMTEVNFLGIVEHQNL-VKLVGYCADDDERGIQR 164 (426)
Q Consensus 87 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~E~~~l~~l~HpnI-v~~~~~~~~~~~~~~~~ 164 (426)
+.-++.|+.|....+|++ . .+.+|...... ......+|+.+++.+..-++ .++++++.+ ..
T Consensus 20 ~~~i~~l~gG~tN~~~~~-----~------~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~~~--~~---- 82 (301)
T 3dxq_A 20 YTGPLERLGGLTNLVFRA-----G------DLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVDPA--TG---- 82 (301)
T ss_dssp CCSCEEEESCSSEEEEEE-----T------TEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEECTT--TC----
T ss_pred ccceeEcCCcccccccee-----e------eEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEECC--CC----
Confidence 334678999999999998 1 36677664321 11123578888887743233 566654322 22
Q ss_pred EEEEeeC-CCCCh
Q 014363 165 LLVYEYM-PNGSV 176 (426)
Q Consensus 165 ~lv~E~~-~~g~L 176 (426)
++|+||+ +|.+|
T Consensus 83 ~~v~e~i~~g~~l 95 (301)
T 3dxq_A 83 VMVTRYIAGAQTM 95 (301)
T ss_dssp CEEEECCTTCEEC
T ss_pred EEEEeecCCCccC
Confidence 6899999 66555
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.65 E-value=0.00044 Score=63.76 Aligned_cols=77 Identities=14% Similarity=0.136 Sum_probs=54.2
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC--CHHHHHHHHHHHhhcCC---CCccceEeEEEccCCC
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--GHKEWMTEVNFLGIVEH---QNLVKLVGYCADDDER 160 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~E~~~l~~l~H---pnIv~~~~~~~~~~~~ 160 (426)
....+..+|.|..+.||+....++. .+.+|...... ....+..|+..|+.|.- -.+.+++++. ..
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~------~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~~-- 85 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGT------PLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD--DR-- 85 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSC------EEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--TT--
T ss_pred CeEEEEecCCCCCeEEEEEEECCCC------EEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc--Cc--
Confidence 4556678999999999999876543 68888764332 23467899999998842 2356666542 22
Q ss_pred CceEEEEEeeCCCCCh
Q 014363 161 GIQRLLVYEYMPNGSV 176 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L 176 (426)
++||||++++..
T Consensus 86 ----~lv~e~l~~~~~ 97 (288)
T 3f7w_A 86 ----TLAMEWVDERPP 97 (288)
T ss_dssp ----EEEEECCCCCCC
T ss_pred ----eEEEEeecccCC
Confidence 799999987654
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.64 E-value=0.00024 Score=69.68 Aligned_cols=79 Identities=14% Similarity=0.163 Sum_probs=50.4
Q ss_pred cceecccCcEEEEEEEEcCCCCC--CcceEEEEEEccccCCHHHHHHHHHHHhhcCCCC-ccceEeEEEccCCCCceEEE
Q 014363 90 SVVIGEGGFGCVYKGLIKNSEDP--SQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQN-LVKLVGYCADDDERGIQRLL 166 (426)
Q Consensus 90 ~~~lG~G~~g~Vy~~~~~~~~~~--~~~~~va~K~~~~~~~~~~~~~E~~~l~~l~Hpn-Iv~~~~~~~~~~~~~~~~~l 166 (426)
++.|+.|....||++...+.... .....+.+|+.........+..|+.++..|...+ ..++++.+. + .+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~------g~ 149 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFS--G------GR 149 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T------EE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C------CE
Confidence 45688888899999976532100 0123677887743222256778999999884333 467776553 1 47
Q ss_pred EEeeCCCCCh
Q 014363 167 VYEYMPNGSV 176 (426)
Q Consensus 167 v~E~~~~g~L 176 (426)
||||++|.+|
T Consensus 150 v~e~l~G~~l 159 (429)
T 1nw1_A 150 LEEYIPSRPL 159 (429)
T ss_dssp EECCCCEEEC
T ss_pred EEEEeCCccc
Confidence 9999987554
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.61 E-value=0.00024 Score=67.03 Aligned_cols=32 Identities=31% Similarity=0.477 Sum_probs=27.8
Q ss_pred CCeEeccCCCCceEeCCC----CCeeEeeecccccC
Q 014363 213 FQIIVRDFKSSNILLDEQ----WNAKLSDFGLARLG 244 (426)
Q Consensus 213 ~~iiHrDlkp~NILl~~~----~~~kl~DFGla~~~ 244 (426)
..++|+|+.+.|||++.+ +.+.|+||+.+...
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 489999999999999874 67999999988654
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.45 E-value=0.002 Score=60.40 Aligned_cols=158 Identities=11% Similarity=0.072 Sum_probs=85.5
Q ss_pred cCHHHHHHHhCCCC-----CcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-CCHHHHHHHHHHHhhcCCC--C
Q 014363 75 FTIAELKSATKNFS-----RSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-GGHKEWMTEVNFLGIVEHQ--N 146 (426)
Q Consensus 75 ~~~~~~~~~~~~y~-----~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~E~~~l~~l~Hp--n 146 (426)
++.+.+......|. .+..|+ |....||++...++ ..+.+|..... .....+..|..++..|... .
T Consensus 11 l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g------~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~ 83 (328)
T 1zyl_A 11 LHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDR------RRFVVKFYRPERWTADQILEEHQFALQLVNDEVP 83 (328)
T ss_dssp CCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTC------CCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCS
T ss_pred CCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCC------CEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCe
Confidence 34444444444342 234577 88889998754332 14788887633 3456778899888888322 2
Q ss_pred ccceEeEEEccCC---CCceEEEEEeeCCCCChhh-----h---------c----cCCC---CCccCHHHH---------
Q 014363 147 LVKLVGYCADDDE---RGIQRLLVYEYMPNGSVDQ-----Y---------L----SPKS---ETILTWAMR--------- 193 (426)
Q Consensus 147 Iv~~~~~~~~~~~---~~~~~~lv~E~~~~g~L~~-----~---------l----~~~~---~~~~~~~~~--------- 193 (426)
+++++.. +... .....++||+|++|..+.. + + .... ....++...
T Consensus 84 vp~~~~~--~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 161 (328)
T 1zyl_A 84 VAAPVAF--NGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFE 161 (328)
T ss_dssp BCCCCCB--TTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHH
T ss_pred ecceeec--CCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHh
Confidence 4445443 1110 0124578999998755421 0 0 0000 011111110
Q ss_pred -------------HHHHHHHHHHHHHhcc-CCCCCeEeccCCCCceEeCCCCCeeEeeeccccc
Q 014363 194 -------------LKIAQDAARGLAYLHE-GMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL 243 (426)
Q Consensus 194 -------------~~i~~~i~~aL~~LH~-~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 243 (426)
...+..++..+.-+-. .....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 162 DATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp TCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hcCcCCHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1112222222322211 1234789999999999999 4 899999988754
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.30 E-value=0.0016 Score=64.25 Aligned_cols=74 Identities=14% Similarity=0.113 Sum_probs=46.1
Q ss_pred cceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-CHHHHHHHHHHHhhcCCCCc-cceEeEEEccCCCCceEEEE
Q 014363 90 SVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-GHKEWMTEVNFLGIVEHQNL-VKLVGYCADDDERGIQRLLV 167 (426)
Q Consensus 90 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~E~~~l~~l~HpnI-v~~~~~~~~~~~~~~~~~lv 167 (426)
++.|+.|-...+|++...+. ...+.+|+..... ..-.-..|+.++..|...++ .++++++. + .+|
T Consensus 113 i~~lsgG~tN~~y~v~~~~~-----~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~------G~v 179 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSK-----QAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT--N------GRI 179 (458)
T ss_dssp EEEECC--CEEEEEEEETTT-----TEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T------EEE
T ss_pred EEEcCCCeEeEEEEEEECCC-----CceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C------eEE
Confidence 45688888899999876541 1257777764321 11122589999999965444 57777662 1 359
Q ss_pred EeeCCCCCh
Q 014363 168 YEYMPNGSV 176 (426)
Q Consensus 168 ~E~~~~g~L 176 (426)
|||++|.+|
T Consensus 180 ~e~I~G~~l 188 (458)
T 2qg7_A 180 EEFMDGYAL 188 (458)
T ss_dssp EECCCSEEC
T ss_pred EEeeCCccC
Confidence 999988555
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.26 E-value=0.0012 Score=63.46 Aligned_cols=145 Identities=14% Similarity=0.159 Sum_probs=80.9
Q ss_pred cceecccCcEEEEEEEEcCCCC--CCcceEEEEEEcccc-CCHHHHHHHHHHHhhcC-CCCccceEeEEEccCCCCceEE
Q 014363 90 SVVIGEGGFGCVYKGLIKNSED--PSQKVEVAVKQLGRR-GGHKEWMTEVNFLGIVE-HQNLVKLVGYCADDDERGIQRL 165 (426)
Q Consensus 90 ~~~lG~G~~g~Vy~~~~~~~~~--~~~~~~va~K~~~~~-~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~~~~~~~~~~~ 165 (426)
++.|..|-...+|++...+... ......+.+++.... .....+.+|..+++.|. +.-..++++++.+ .
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~--------g 126 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE--------G 126 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT--------E
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC--------c
Confidence 3457778888899987642100 011236777775332 23456679999998883 3334677766532 3
Q ss_pred EEEeeCCCCChhhh-c----------------cCCC---CCcc--CHHHHHHHHHHHHH-------------------HH
Q 014363 166 LVYEYMPNGSVDQY-L----------------SPKS---ETIL--TWAMRLKIAQDAAR-------------------GL 204 (426)
Q Consensus 166 lv~E~~~~g~L~~~-l----------------~~~~---~~~~--~~~~~~~i~~~i~~-------------------aL 204 (426)
+||||++|..|..- + +... .... -+.++..+..++.. .+
T Consensus 127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~ 206 (379)
T 3feg_A 127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM 206 (379)
T ss_dssp EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence 79999998665421 1 0000 1111 23444444433321 12
Q ss_pred HHhc----c-CCCCCeEeccCCCCceEeCCC----CCeeEeeecccc
Q 014363 205 AYLH----E-GMDFQIIVRDFKSSNILLDEQ----WNAKLSDFGLAR 242 (426)
Q Consensus 205 ~~LH----~-~~~~~iiHrDlkp~NILl~~~----~~~kl~DFGla~ 242 (426)
..|. . .....++|+|+.+.|||++.+ +.+.|+||..+.
T Consensus 207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 2221 1 123479999999999999876 789999998875
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.23 E-value=0.00065 Score=59.16 Aligned_cols=101 Identities=12% Similarity=0.025 Sum_probs=64.0
Q ss_pred CChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccCCCCCceeee
Q 014363 174 GSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVS 253 (426)
Q Consensus 174 g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 253 (426)
-+|.+.|... +.++++.++|.++.|.+.+|.-+-.+. .-..+=+-|..|+|..+|.|-+.+ +.+.
T Consensus 33 vSL~eIL~~~-~~PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 33 LSLEEILRLY-NQPINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred ccHHHHHHHc-CCCcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc-----------
Confidence 4788888654 356999999999999999987762110 101223346899999999887764 2111
Q ss_pred eeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCC
Q 014363 254 TAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGR 293 (426)
Q Consensus 254 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~ 293 (426)
.....+.+||... ...+.+.=|||||++||..+--.
T Consensus 98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDyg 133 (229)
T 2yle_A 98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYG 133 (229)
T ss_dssp ------------CCSS-SSSCHHHHHHHHHHHHHHHHTTT
T ss_pred ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcC
Confidence 1223466888653 34467889999999999998733
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.13 E-value=0.0013 Score=62.97 Aligned_cols=79 Identities=11% Similarity=0.089 Sum_probs=44.0
Q ss_pred cceecccCcEEEEEEEEcCCC---CCCcceEEEEEEccccCC-HHHHHHHHHHHhhcCCCC-ccceEeEEEccCCCCceE
Q 014363 90 SVVIGEGGFGCVYKGLIKNSE---DPSQKVEVAVKQLGRRGG-HKEWMTEVNFLGIVEHQN-LVKLVGYCADDDERGIQR 164 (426)
Q Consensus 90 ~~~lG~G~~g~Vy~~~~~~~~---~~~~~~~va~K~~~~~~~-~~~~~~E~~~l~~l~Hpn-Iv~~~~~~~~~~~~~~~~ 164 (426)
.+.|+.|..-.+|++...+.. .......+.+|....... ......|+.++..|...+ +.++++.+ .+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~------ 109 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--NG------ 109 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT------
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--CC------
Confidence 346778888899998754310 000112577777644221 112467888888884333 45777554 22
Q ss_pred EEEEeeCCCCCh
Q 014363 165 LLVYEYMPNGSV 176 (426)
Q Consensus 165 ~lv~E~~~~g~L 176 (426)
++||||++|..+
T Consensus 110 ~~v~e~i~G~~l 121 (369)
T 3c5i_A 110 GRIEEWLYGDPL 121 (369)
T ss_dssp EEEEECCCSEEC
T ss_pred cEEEEEecCCcC
Confidence 689999988554
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.74 E-value=0.0076 Score=56.85 Aligned_cols=31 Identities=16% Similarity=0.316 Sum_probs=27.8
Q ss_pred CCeEeccCCCCceEeCCCCCeeEeeeccccc
Q 014363 213 FQIIVRDFKSSNILLDEQWNAKLSDFGLARL 243 (426)
Q Consensus 213 ~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 243 (426)
..++|+|+.+.|||++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4799999999999999888899999987764
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.89 E-value=0.041 Score=53.44 Aligned_cols=79 Identities=9% Similarity=0.060 Sum_probs=47.5
Q ss_pred cceecccCcEEEEEEEEcCCCCC--CcceEEEEEEccccC-CHHHHHHHHHHHhhcC-CCCccceEeEEEccCCCCceEE
Q 014363 90 SVVIGEGGFGCVYKGLIKNSEDP--SQKVEVAVKQLGRRG-GHKEWMTEVNFLGIVE-HQNLVKLVGYCADDDERGIQRL 165 (426)
Q Consensus 90 ~~~lG~G~~g~Vy~~~~~~~~~~--~~~~~va~K~~~~~~-~~~~~~~E~~~l~~l~-HpnIv~~~~~~~~~~~~~~~~~ 165 (426)
++.|..|-...+|+......... .....+.+++..... ..-...+|..+++.|. +.-..++++.+ .+ +
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~------~ 146 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF--PE------G 146 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TT------E
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc--CC------C
Confidence 45677788888999886532110 012367777754322 1123468999988884 33355666543 22 7
Q ss_pred EEEeeCCCCCh
Q 014363 166 LVYEYMPNGSV 176 (426)
Q Consensus 166 lv~E~~~~g~L 176 (426)
+||||++|..|
T Consensus 147 ~I~efI~G~~l 157 (424)
T 3mes_A 147 RIEEFIDGEPL 157 (424)
T ss_dssp EEEECCCSEEC
T ss_pred EEEEEeCCccC
Confidence 89999998664
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.92 E-value=0.098 Score=50.38 Aligned_cols=29 Identities=31% Similarity=0.387 Sum_probs=24.7
Q ss_pred CeEeccCCCCceEe------CCCCCeeEeeecccc
Q 014363 214 QIIVRDFKSSNILL------DEQWNAKLSDFGLAR 242 (426)
Q Consensus 214 ~iiHrDlkp~NILl------~~~~~~kl~DFGla~ 242 (426)
.++|+|+.+.|||+ +++..++++||.+|.
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 46799999999999 456779999998875
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=89.75 E-value=1.1 Score=38.84 Aligned_cols=116 Identities=8% Similarity=0.017 Sum_probs=76.5
Q ss_pred CCCCccceEeEEEccCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCC
Q 014363 143 EHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKS 222 (426)
Q Consensus 143 ~HpnIv~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp 222 (426)
.||+.+.. .+-.+++ -++..|-.......+-.- ..++....+.++.+|+....+++. =+|--|.|
T Consensus 43 ~~~~Fl~~-~I~e~eD------~v~~~y~~~~~~~~f~~i---k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P 107 (215)
T 4ann_A 43 HSPYFIDA-ELTELRD------SFQIHYDINDNHTPFDNI---KSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAP 107 (215)
T ss_dssp CCTTBCCE-EEEECSS------EEEEEECCCTTSEEGGGG---GGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSG
T ss_pred cCCcccce-EEEEccc------EEEEEEEcCcccCCHHHH---HhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEec
Confidence 68888876 3444444 244555433333333221 227788899999999988877764 46788999
Q ss_pred CceEeCCCCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCC
Q 014363 223 SNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPID 297 (426)
Q Consensus 223 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~ 297 (426)
+||+++.++.+++.-.|+-..+.+ . ..+...=+-.+=+++..+++++..|+
T Consensus 108 ~NL~f~~~~~p~i~~RGik~~l~P-------------------~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 108 DELFFTRDGLPIAKTRGLQNVVDP-------------------L-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp GGEEECTTSCEEESCCEETTTBSC-------------------C-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred ceEEEcCCCCEEEEEccCccCCCC-------------------C-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999999999998887543221 1 11111122367788999999998884
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=87.36 E-value=1.4 Score=38.25 Aligned_cols=80 Identities=11% Similarity=0.113 Sum_probs=58.8
Q ss_pred cCHHHHHHHHHHHHHHHH-HhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccCCCCCceeeeeeeecCcccCCch
Q 014363 188 LTWAMRLKIAQDAARGLA-YLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPE 266 (426)
Q Consensus 188 ~~~~~~~~i~~~i~~aL~-~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE 266 (426)
++...++.++.+|+.... +++. -+|--|.|+||+++.++.++|.-.|+-..+++.. +.+
T Consensus 82 ~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~NL~f~~~~~p~i~hRGi~~~lpP~e--------------~~e- 141 (219)
T 4ano_A 82 TTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPENLMFNRALEPFFLHVGVKESLPPDE--------------WDD- 141 (219)
T ss_dssp SCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGGEEECTTCCEEESCCEETTTBSSCS--------------CCH-
T ss_pred cCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCceEEEeCCCcEEEEEcCCcccCCCCC--------------CCH-
Confidence 677888999999988777 6664 4677899999999999999999888754322110 112
Q ss_pred hhccCCCCCchhh-HHHHHHHHHHHhCCCCCC
Q 014363 267 YVQTGRLAARSDV-WSYGVFLYELITGRRPID 297 (426)
Q Consensus 267 ~~~~~~~~~~~Dv-wslGvil~elltg~~p~~ 297 (426)
.|. -.+=+++..++.++..|+
T Consensus 142 ----------e~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 142 ----------ERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp ----------HHHHHHHHHHHHHHTTCSSCHH
T ss_pred ----------HHHHHHHHHHHHHHHcCCCCHH
Confidence 233 267788888999888774
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=84.61 E-value=0.11 Score=50.97 Aligned_cols=60 Identities=8% Similarity=0.075 Sum_probs=16.7
Q ss_pred CcceecccCcEEEEEEEEcCCCCCCcceEEEE------EEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEc
Q 014363 89 RSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAV------KQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCAD 156 (426)
Q Consensus 89 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~------K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 156 (426)
..+.|| ||.||+|.+..... .||+ |...... ....+.+|..++..++|||+++.++|...
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~-----~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHM-----PVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp STTTSS---BCCC---------C-----CBGGGC-----------------------------------CBCCCEEEE
T ss_pred ccccCC---chhhhcccccccCC-----chhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 345666 99999998865322 3455 5543322 23467889999999999999999988764
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 426 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-68 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-65 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-63 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-62 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-62 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 6e-62 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-61 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-61 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-61 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-61 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-61 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-60 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-60 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-60 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 6e-60 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-58 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-58 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-58 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-57 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-56 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-56 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-56 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 9e-56 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-55 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-55 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-55 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 8e-55 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-53 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-52 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-52 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-51 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-50 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-49 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-48 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-46 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-46 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-45 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-45 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 7e-45 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-44 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-44 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-43 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-43 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-43 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 9e-43 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-42 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-40 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-40 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-40 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-40 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-39 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-39 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-38 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-37 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-36 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 7e-35 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-34 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-32 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-31 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-30 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-29 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 8e-28 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-18 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (549), Expect = 4e-68
Identities = 77/285 (27%), Positives = 119/285 (41%), Gaps = 36/285 (12%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL----GRRGGHKEWMTEVNFLGIVEHQNL 147
IG G FG VYKG +VAVK L + + EV L H N+
Sbjct: 15 RIGSGSFGTVYKGKWHG--------DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 66
Query: 148 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYL 207
+ +GY Q +V ++ S+ +L ET + IA+ A+G+ YL
Sbjct: 67 LLFMGYSTAP-----QLAIVTQWCEGSSLYHHLH-IIETKFEMIKLIDIARQTAQGMDYL 120
Query: 208 HEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEY 267
H II RD KS+NI L E K+ DFGLA + +H + G++ + APE
Sbjct: 121 H---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 177
Query: 268 VQT---GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQI 324
++ + +SDV+++G+ LYEL+TG+ P R + + R
Sbjct: 178 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG-----------RGY 226
Query: 325 VDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 369
+ P L K + + CL K RP ++L + +
Sbjct: 227 LSPDLS-KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL 270
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 209 bits (534), Expect = 1e-65
Identities = 77/312 (24%), Positives = 142/312 (45%), Gaps = 43/312 (13%)
Query: 75 FTIAELKSATKNFSRSV---------VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGR 125
FT + A + F++ + VIG G FG V G +K +++ VA+K L
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLK--LPGKREIFVAIKTLKS 64
Query: 126 ---RGGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSP 182
+++++E + +G +H N++ L G +++ E+M NGS+D +L
Sbjct: 65 GYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPV----MIITEFMENGSLDSFLRQ 120
Query: 183 KSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 242
T + + + A G+ YL D + RD + NIL++ K+SDFGL+R
Sbjct: 121 NDGQF-TVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSR 176
Query: 243 LGPSEGFTHVSTAVVG---TMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDR 298
+ T+ +G + + APE +Q + + SDVWSYG+ ++E+++ G RP
Sbjct: 177 FLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD 236
Query: 299 NRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPK 358
+ Q ++ ++ D RL + S L + C K+ RPK
Sbjct: 237 ---MTNQDVINAIEQ------------DYRLP--PPMDCPSALHQLMLDCWQKDRNHRPK 279
Query: 359 MSEVLEMVNKIV 370
+++ ++K++
Sbjct: 280 FGQIVNTLDKMI 291
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 4e-63
Identities = 72/285 (25%), Positives = 116/285 (40%), Gaps = 36/285 (12%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGR-RGGHKEWMTEVNFLGIVEHQNLVKL 150
+G G FG V+ G +VAVK L + ++ E N + ++HQ LV+L
Sbjct: 20 RLGAGQFGEVWMGYYNGHT------KVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL 73
Query: 151 VGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEG 210
+ ++ EYM NGS+ +L S LT L +A A G+A++ E
Sbjct: 74 YAVVTQEP-----IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE- 127
Query: 211 MDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT 270
I RD +++NIL+ + + K++DFGLARL + + APE +
Sbjct: 128 --RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAINY 184
Query: 271 GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSE--QKLLQWVKPYLSDAKQFRQIVDPR 328
G +SDVWS+G+ L E++T R E Q L + + D
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD----------- 233
Query: 329 LEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 373
+L + LC + RP + ++ A+
Sbjct: 234 -------NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (508), Expect = 3e-62
Identities = 71/289 (24%), Positives = 128/289 (44%), Gaps = 32/289 (11%)
Query: 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-GHKEWMTEVNFLGIVE 143
+ IG G FG V+ G N + +VA+K + ++++ E + +
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKD------KVAIKTIREGAMSEEDFIEEAEVMMKLS 58
Query: 144 HQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARG 203
H LV+L G C + LV+E+M +G + Y + L + D G
Sbjct: 59 HPKLVQLYGVCLEQAPI----CLVFEFMEHGCLSDY-LRTQRGLFAAETLLGMCLDVCEG 113
Query: 204 LAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYA 263
+AYL E +I RD + N L+ E K+SDFG+ R + +T ST + +A
Sbjct: 114 MAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-STGTKFPVKWA 169
Query: 264 APEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQ 323
+PE R +++SDVWS+GV ++E+ + + NR SE +++ + +
Sbjct: 170 SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVEDI-------STGFR 220
Query: 324 IVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 372
+ PRL + ++++ C + RP S +L + +I ++
Sbjct: 221 LYKPRLASTHVYQIMNH-------CWKERPEDRPAFSRLLRQLAEIAES 262
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (508), Expect = 5e-62
Identities = 64/278 (23%), Positives = 113/278 (40%), Gaps = 33/278 (11%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR----GGHKEWMTEVNFLGIVEHQNL 147
IG G F VYKGL D VEVA +L R + + E L ++H N+
Sbjct: 16 EIGRGSFKTVYKGL-----DTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 148 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYL 207
V+ + +LV E M +G++ YL K ++ + + +GL +L
Sbjct: 71 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL--KRFKVMKIKVLRSWCRQILKGLQFL 128
Query: 208 HEGMDFQIIVRDFKSSNILL-DEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPE 266
H II RD K NI + + K+ D GLA L + + AV+GT + APE
Sbjct: 129 HT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA----SFAKAVIGTPEFMAPE 183
Query: 267 YVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVD 326
+ + DV+++G+ + E+ T P + ++ +R++
Sbjct: 184 MYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ---------------IYRRVTS 227
Query: 327 PRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 364
+ + ++ + C+ +N R + ++L
Sbjct: 228 GVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 6e-62
Identities = 81/305 (26%), Positives = 135/305 (44%), Gaps = 33/305 (10%)
Query: 70 SNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGR---R 126
++ I S +F+ VIG G FGCVY G + +++ +K+ AVK L R
Sbjct: 15 QAVQHVVIGP-SSLIVHFNE--VIGRGHFGCVYHGTLLDND--GKKIHCAVKSLNRITDI 69
Query: 127 GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSET 186
G +++TE + H N++ L+G C + L+V YM +G + ++ ++
Sbjct: 70 GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS---PLVVLPYMKHGDLRNFIRNETHN 126
Query: 187 ILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPS 246
T + A+G+ +L + + RD + N +LDE++ K++DFGLAR
Sbjct: 127 -PTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 182
Query: 247 EGF--THVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSE 304
+ F H T + + A E +QT + +SDVWS+GV L+EL+T P P +
Sbjct: 183 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPD 237
Query: 305 QKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 364
L R+++ P L V C A RP SE++
Sbjct: 238 VNTFDITVYLLQG----RRLLQPEY-------CPDPLYEVMLKCWHPKAEMRPSFSELVS 286
Query: 365 MVNKI 369
++ I
Sbjct: 287 RISAI 291
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 199 bits (507), Expect = 2e-61
Identities = 72/318 (22%), Positives = 118/318 (37%), Gaps = 48/318 (15%)
Query: 77 IAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL---GRRGGHKEWM 133
+ L+ N IGEG FG V++ VAVK L ++
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64
Query: 134 TEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYL------------- 180
E + ++ N+VKL+G CA L++EYM G ++++L
Sbjct: 65 REAALMAEFDNPNIVKLLGVCAVGKPM----CLLFEYMAYGDLNEFLRSMSPHTVCSLSH 120
Query: 181 ---------SPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW 231
S L+ A +L IA+ A G+AYL E + + RD + N L+ E
Sbjct: 121 SDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENM 177
Query: 232 NAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT 291
K++DFGL+R S + + + PE + R SDVW+YGV L+E+ +
Sbjct: 178 VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 237
Query: 292 GRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVK 351
E + D + +L ++ LC K
Sbjct: 238 YGLQPYYGMAHEE---------------VIYYVRDGNIL-ACPENCPLELYNLMRLCWSK 281
Query: 352 NARTRPKMSEVLEMVNKI 369
RP + ++ ++
Sbjct: 282 LPADRPSFCSIHRILQRM 299
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (503), Expect = 2e-61
Identities = 65/278 (23%), Positives = 113/278 (40%), Gaps = 34/278 (12%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQNLVKLV 151
IG+G FG V G + ++ VAVK + + ++ E + + + H NLV+L+
Sbjct: 14 TIGKGEFGDVMLGDYRGNK-------VAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLL 66
Query: 152 GYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGM 211
G ++ +V EYM GS+ YL + ++L LK + D + YL
Sbjct: 67 GVIVEEKGG---LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG-- 121
Query: 212 DFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG 271
+ RD + N+L+ E AK+SDFGL + S + + APE ++
Sbjct: 122 -NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALREK 175
Query: 272 RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEG 331
+ + +SDVWS+G+ L+E+ + R P + + +
Sbjct: 176 KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV------------VPRVEKGYKMDAPD 223
Query: 332 KYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 369
+ V C +A RP ++ E + I
Sbjct: 224 GCP----PAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (508), Expect = 2e-61
Identities = 72/315 (22%), Positives = 122/315 (38%), Gaps = 48/315 (15%)
Query: 79 ELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL---GRRGGHKEWMTE 135
ELK +F + +G G G V+K + +A K + + + + E
Sbjct: 2 ELK--DDDFEKISELGAGNGGVVFKV-----SHKPSGLVMARKLIHLEIKPAIRNQIIRE 54
Query: 136 VNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLK 195
+ L +V G D E + E+M GS+DQ L K + + K
Sbjct: 55 LQVLHECNSPYIVGFYGAFYSDGEI----SICMEHMDGGSLDQVL--KKAGRIPEQILGK 108
Query: 196 IAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTA 255
++ +GL YL E I+ RD K SNIL++ + KL DFG++ ++ +
Sbjct: 109 VSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANS 162
Query: 256 VVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWV---- 311
VGT Y +PE +Q + +SD+WS G+ L E+ GR PI + + +
Sbjct: 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGD 222
Query: 312 ----------------------KPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCL 349
+P ++ + IV+ S + N CL
Sbjct: 223 AAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCL 282
Query: 350 VKNARTRPKMSEVLE 364
+KN R + +++
Sbjct: 283 IKNPAERADLKQLMV 297
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 3e-61
Identities = 67/298 (22%), Positives = 122/298 (40%), Gaps = 28/298 (9%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWM-TEVNFLGIVEHQNLVKL 150
IG+G FG V++G + E VAVK R + E+ ++ H+N++
Sbjct: 10 SIGKGRFGEVWRGKWRGEE-------VAVKIFSSREERSWFREAEIYQTVMLRHENILGF 62
Query: 151 VGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEG 210
+ D+ Q LV +Y +GS+ YL+ + +T +K+A A GLA+LH
Sbjct: 63 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHME 119
Query: 211 MDFQ-----IIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFT--HVSTAVVGTMGYA 263
+ I RD KS NIL+ + ++D GLA S T VGT Y
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179
Query: 264 APEYVQT------GRLAARSDVWSYGVFLYELITGRRPIDRNRP-RSEQKLLQWVKPYLS 316
APE + R+D+++ G+ +E+ + + L P +
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239
Query: 317 DAKQF--RQIVDPRLEGKY-SLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVD 371
+ ++ Q + P + ++ S + ++ + C N R + + ++++
Sbjct: 240 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 5e-61
Identities = 64/288 (22%), Positives = 120/288 (41%), Gaps = 36/288 (12%)
Query: 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-GHKEWMTEVNFLGIVE 143
K+ + +G G FG V G + +VA+K + E++ E + +
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQY------DVAIKMIKEGSMSEDEFIEEAKVMMNLS 57
Query: 144 HQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARG 203
H+ LV+L G C ++ EYM NG + YL L++ +D
Sbjct: 58 HEKLVQLYGVCTKQRPI----FIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEA 112
Query: 204 LAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYA 263
+ YL Q + RD + N L+++Q K+SDFGL+R + +T S + ++
Sbjct: 113 MEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS-SVGSKFPVRWS 168
Query: 264 APEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSE--QKLLQWVKPYLSDAKQF 321
PE + + +++SD+W++GV ++E+ + + SE + + Q ++ Y
Sbjct: 169 PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY------- 221
Query: 322 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 369
P L + K+ + C + A RP +L + +
Sbjct: 222 ----RPHLASE-------KVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 1e-60
Identities = 68/302 (22%), Positives = 111/302 (36%), Gaps = 42/302 (13%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL---GRRGGHKEWMTEVNFLG-IVEHQNL 147
+G G FG V + + VAVK L + M+E+ L + H N+
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 148 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPK----------------SETILTWA 191
V L+G C L++ EY G + +L K E L
Sbjct: 90 VNLLGACTIGGPT----LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145
Query: 192 MRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTH 251
L + A+G+A+L I RD + NILL K+ DFGLAR ++
Sbjct: 146 DLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202
Query: 252 VSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWV 311
V + + APE + SDVWSYG+FL+EL + P
Sbjct: 203 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS------- 255
Query: 312 KPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVD 371
+F +++ +++ + C + RP ++++++ K +
Sbjct: 256 --------KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307
Query: 372 AS 373
S
Sbjct: 308 ES 309
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 2e-60
Identities = 66/291 (22%), Positives = 132/291 (45%), Gaps = 29/291 (9%)
Query: 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL---GRRGGHKEWMTEVNFLGIV 142
+R VIG G FG VYKG++K S ++V VA+K L +++ E +G
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTS-SGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 143 EHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAAR 202
H N+++L G + +++ EYM NG++D++ + + + + + + A
Sbjct: 67 SHHNIIRLEGVISKYKPM----MIITEYMENGALDKF-LREKDGEFSVLQLVGMLRGIAA 121
Query: 203 GLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEG-FTHVSTAVVGTMG 261
G+ YL + RD + NIL++ K+SDFGL+R+ + T+ ++ +
Sbjct: 122 GMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178
Query: 262 YAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 321
+ APE + + + SDVWS+G+ ++E++T E
Sbjct: 179 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE----------------V 222
Query: 322 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 372
+ ++ + S + + C + RPK ++++ +++K++ A
Sbjct: 223 MKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 4e-60
Identities = 66/299 (22%), Positives = 110/299 (36%), Gaps = 47/299 (15%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR---GGHKEWMTEVNFLG-IVEHQNL 147
V+G G FG V ++VAVK L + + M+E+ + + H+N+
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103
Query: 148 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSE---------------------T 186
V L+G C L++EY G + YL K E
Sbjct: 104 VNLLGACTLSG----PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 159
Query: 187 ILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPS 246
+LT+ L A A+G+ +L + RD + N+L+ K+ DFGLAR S
Sbjct: 160 VLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 216
Query: 247 EGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQK 306
+ V + + APE + G +SDVWSYG+ L+E+ + P
Sbjct: 217 DSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA-- 274
Query: 307 LLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365
F +++ + ++ + C ++R RP +
Sbjct: 275 -------------NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 6e-60
Identities = 65/297 (21%), Positives = 133/297 (44%), Gaps = 35/297 (11%)
Query: 79 ELKSATKNFS-RSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL---GRRGGHKEWMT 134
+L N + +G G FG V +G+ + + +++VA+K L + +E M
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKK---QIDVAIKVLKQGTEKADTEEMMR 58
Query: 135 EVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRL 194
E + +++ +V+L+G C + +LV E G + ++L K E + +
Sbjct: 59 EAQIMHQLDNPYIVRLIGVC-----QAEALMLVMEMAGGGPLHKFLVGKREE-IPVSNVA 112
Query: 195 KIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR-LGPSEGFTHVS 253
++ + G+ YL + + RD + N+LL + AK+SDFGL++ LG + +
Sbjct: 113 ELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 169
Query: 254 TAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVK 312
+A + + APE + + ++RSDVWSYGV ++E ++ G++P + +++ +++
Sbjct: 170 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK---MKGPEVMAFIE 226
Query: 313 PYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 369
Q + +L + + C + RP V + +
Sbjct: 227 ----------QGKRMECPPECP----PELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 191 bits (486), Expect = 1e-58
Identities = 65/307 (21%), Positives = 122/307 (39%), Gaps = 35/307 (11%)
Query: 64 SMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL 123
+M N ++ + + + +G G +G VY+G + VAVK L
Sbjct: 1 AMDPSSPNYDKWEMER-----TDITMKHKLGGGQYGEVYEG-----VWKKYSLTVAVKTL 50
Query: 124 GR-RGGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSP 182
+E++ E + ++H NLV+L+G C + I E+M G++ YL
Sbjct: 51 KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII----TEFMTYGNLLDYLRE 106
Query: 183 KSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 242
+ ++ + L +A + + YL + I RD + N L+ E K++DFGL+R
Sbjct: 107 CNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSR 163
Query: 243 LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPR 302
L + + + APE + + + +SDVW++GV L+E+ T
Sbjct: 164 LMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-- 220
Query: 303 SEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEV 362
D Q ++++ + K+ + C N RP +E+
Sbjct: 221 --------------DLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 266
Query: 363 LEMVNKI 369
+ +
Sbjct: 267 HQAFETM 273
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 2e-58
Identities = 70/291 (24%), Positives = 111/291 (38%), Gaps = 34/291 (11%)
Query: 82 SATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGR----RGGHKEWMTEVN 137
S +++ IG G +G K S + K+L + ++EVN
Sbjct: 1 SRAEDYEVLYTIGTGSYGRCQKI-----RRKSDGKILVWKELDYGSMTEAEKQMLVSEVN 55
Query: 138 FLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYL--SPKSETILTWAMRLK 195
L ++H N+V+ D + +V EY G + + K L L+
Sbjct: 56 LLRELKHPNIVRYYDRIIDRTNTTL--YIVMEYCEGGDLASVITKGTKERQYLDEEFVLR 113
Query: 196 IAQDAARGLAYLHEGMD--FQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVS 253
+ L H D ++ RD K +N+ LD + N KL DFGLAR+ + T +
Sbjct: 114 VMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD--TSFA 171
Query: 254 TAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKP 313
A VGT Y +PE + +SD+WS G LYEL P
Sbjct: 172 KAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF-------------- 217
Query: 314 YLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 364
S + +I + + + R +L+ + L RP + E+LE
Sbjct: 218 --SQKELAGKIREGKFR-RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 4e-58
Identities = 68/296 (22%), Positives = 113/296 (38%), Gaps = 32/296 (10%)
Query: 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL-GRRGGHKEWMTEVNFLGIVE 143
++ V +G+G FG V+ G + VA+K L + ++ E + +
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTT------RVAIKTLKPGTMSPEAFLQEAQVMKKLR 70
Query: 144 HQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARG 203
H+ LV+L +++ +V EYM GS+ +L ++ L + +A A G
Sbjct: 71 HEKLVQLYAVVSEEP-----IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 125
Query: 204 LAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYA 263
+AY+ + RD +++NIL+ E K++DFGLARL +T + +
Sbjct: 126 MAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA-RQGAKFPIKWT 181
Query: 264 APEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQ 323
APE GR +SDVWS+G+ L EL T R E
Sbjct: 182 APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV----------------LD 225
Query: 324 IVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDASAEAGSP 379
V+ L + C K RP + + ++ P
Sbjct: 226 QVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 281
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (477), Expect = 1e-57
Identities = 73/297 (24%), Positives = 119/297 (40%), Gaps = 48/297 (16%)
Query: 73 KEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL-----GRRG 127
+++ + ++F +G+G FG VY + K +A+K L + G
Sbjct: 1 RQWAL-------EDFEIGRPLGKGKFGNVYLA-----REKQSKFILALKVLFKAQLEKAG 48
Query: 128 GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETI 187
+ EV + H N+++L GY D + + EY P G+V + L + +
Sbjct: 49 VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL----ILEYAPLGTVYREL--QKLSK 102
Query: 188 LTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSE 247
+ A L+Y H ++I RD K N+LL K++DFG + PS
Sbjct: 103 FDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159
Query: 248 GFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKL 307
T + GT+ Y PE ++ + D+WS GV YE + G+ P + N + K
Sbjct: 160 RRTTL----CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR 215
Query: 308 LQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 364
+ V+ F V L+S+ L N RP + EVLE
Sbjct: 216 ISRVEF------TFPDFVTEGAR-----DLISR-------LLKHNPSQRPMLREVLE 254
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 1e-56
Identities = 71/286 (24%), Positives = 125/286 (43%), Gaps = 29/286 (10%)
Query: 87 FSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL---GRRGGHKEWMTEVNFLGIVE 143
F + V+G G FG VYKGL E K+ VA+K+L +KE + E + V+
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWI-PEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69
Query: 144 HQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARG 203
+ ++ +L+G C + L+ + MP G + Y + + + L A+G
Sbjct: 70 NPHVCRLLGICLTSTVQ-----LITQLMPFGCLLDY-VREHKDNIGSQYLLNWCVQIAKG 123
Query: 204 LAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYA 263
+ YL D +++ RD + N+L+ + K++DFGLA+L +E + + + +
Sbjct: 124 MNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 180
Query: 264 APEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQ 323
A E + +SDVWSYGV ++EL+T P SE
Sbjct: 181 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----------------ISS 224
Query: 324 IVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 369
I++ + + C + +A +RPK E++ +K+
Sbjct: 225 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 2e-56
Identities = 61/284 (21%), Positives = 114/284 (40%), Gaps = 33/284 (11%)
Query: 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR---GGHKEWMTEVNFLGI 141
+++ +GEG +G V + + VAVK + + + E+ +
Sbjct: 5 EDWDLVQTLGEGAYGEVQLA-----VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKM 59
Query: 142 VEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAA 201
+ H+N+VK G+ + + + L EY G + + + + + +
Sbjct: 60 LNHENVVKFYGHRREGNIQ----YLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLM 113
Query: 202 RGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMG 261
G+ YLH I RD K N+LLDE+ N K+SDFGLA + + + GT+
Sbjct: 114 AGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 170
Query: 262 YAAPEYVQTGRLAAR-SDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 320
Y APE ++ A DVWS G+ L ++ G P D+ ++
Sbjct: 171 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD---------------SCQE 215
Query: 321 FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 364
+ + + ++ S + + LV+N R + ++ +
Sbjct: 216 YSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 3e-56
Identities = 62/284 (21%), Positives = 115/284 (40%), Gaps = 36/284 (12%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL----GRRGGHKEWMTEVNFLGIVEHQNL 147
+G G FG V KG + + VAVK L E + E N + +++ +
Sbjct: 14 ELGSGNFGTVKKGYYQMKKV---VKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 148 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYL 207
V+++G C + +LV E G +++YL + +++ + G+ YL
Sbjct: 71 VRMIGICEAES-----WMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYL 123
Query: 208 HEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR-LGPSEGFTHVSTAVVGTMGYAAPE 266
+ + RD + N+LL Q AK+SDFGL++ L E + T + + APE
Sbjct: 124 E---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180
Query: 267 YVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS-DAKQFRQIV 325
+ + +++SDVWS+GV ++E + + PY + ++
Sbjct: 181 CINYYKFSSKSDVWSFGVLMWEAFSYGQK-----------------PYRGMKGSEVTAML 223
Query: 326 DPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 369
+ ++ + NLC + RP + V +
Sbjct: 224 EKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 9e-56
Identities = 74/305 (24%), Positives = 129/305 (42%), Gaps = 47/305 (15%)
Query: 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL---GRRGGHKEWMTEVNFLG- 140
+ VIGEG FG V K IK +++ A+K++ + H+++ E+ L
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKD---GLRMDAAIKRMKEYASKDDHRDFAGELEVLCK 66
Query: 141 IVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYL--------------SPKSET 186
+ H N++ L+G C L EY P+G++ +L + + +
Sbjct: 67 LGHHPNIINLLGACEHRGYL----YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 122
Query: 187 ILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPS 246
L+ L A D ARG+ YL + Q I RD + NIL+ E + AK++DFGL+R
Sbjct: 123 TLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEV 179
Query: 247 EGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQK 306
T + + A E + SDVWSYGV L+E+++ + +
Sbjct: 180 Y---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG--MTCAE 234
Query: 307 LLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMV 366
L + + RLE L ++ + C + RP +++L +
Sbjct: 235 LYEKLPQ------------GYRLE--KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 280
Query: 367 NKIVD 371
N++++
Sbjct: 281 NRMLE 285
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (464), Expect = 1e-55
Identities = 65/293 (22%), Positives = 111/293 (37%), Gaps = 36/293 (12%)
Query: 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL-----GRRGGHKEWMTEVNFL 139
K+ +G+G FG V +G + V VAVK L + +++ EVN +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWD--APSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAM 65
Query: 140 GIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQD 199
++H+NL++L G + +V E P GS+ K + + A
Sbjct: 66 HSLDHRNLIRLYGVVLTPPMK-----MVTELAPLGSLLDR-LRKHQGHFLLGTLSRYAVQ 119
Query: 200 AARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHV-STAVVG 258
A G+ YL + I RD + N+LL + K+ DFGL R P +V
Sbjct: 120 VAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 176
Query: 259 TMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPY--LS 316
+ APE ++T + SD W +GV L+E+ T + P+ L+
Sbjct: 177 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE-----------------PWIGLN 219
Query: 317 DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 369
++ +I + +V C RP + + + +
Sbjct: 220 GSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (464), Expect = 3e-55
Identities = 69/301 (22%), Positives = 118/301 (39%), Gaps = 39/301 (12%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL---GRRGGHKEWMTEVNFLG-IVEHQNL 147
+G G FG V + + + VAVK L H+ M+E+ L I H N+
Sbjct: 20 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 79
Query: 148 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPK--------------SETILTWAMR 193
V L+G C +++ E+ G++ YL K + LT
Sbjct: 80 VNLLGACTKPGGP---LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 136
Query: 194 LKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVS 253
+ + A+G+ +L + I RD + NILL E+ K+ DFGLAR +
Sbjct: 137 ICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 193
Query: 254 TAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKP 313
+ + APE + +SDVWS+GV L+E+ + P K+ +
Sbjct: 194 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKIDEEF-- 246
Query: 314 YLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 373
++ ++ R + ++ C RP SE++E + ++ A+
Sbjct: 247 ----CRRLKEGTRMRAPDYTT----PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 298
Query: 374 A 374
A
Sbjct: 299 A 299
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 183 bits (465), Expect = 4e-55
Identities = 73/289 (25%), Positives = 105/289 (36%), Gaps = 44/289 (15%)
Query: 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGH-----KEWMTEVNF 138
K FS IG G FG VY D VA+K++ G ++ + EV F
Sbjct: 14 EKLFSDLREIGHGSFGAVYFA-----RDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRF 68
Query: 139 LGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQ 198
L + H N ++ G + LV EY + D + L +
Sbjct: 69 LQKLRHPNTIQYRGCYLREHTA----WLVMEYCLGSASDLLE--VHKKPLQEVEIAAVTH 122
Query: 199 DAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVG 258
A +GLAYLH +I RD K+ NILL E KL DFG A + + VG
Sbjct: 123 GALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSAS------IMAPANSFVG 173
Query: 259 TMGYAAPEYVQT---GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYL 315
T + APE + G+ + DVWS G+ EL + P+ +
Sbjct: 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN----------------M 217
Query: 316 SDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 364
+ I S + + CL K + RP +L+
Sbjct: 218 NAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 8e-55
Identities = 69/280 (24%), Positives = 115/280 (41%), Gaps = 37/280 (13%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL--GRRGGHKEWMTEVNFLGIVEHQNLVK 149
+G+G FG VYK ++ V A K + +++M E++ L +H N+VK
Sbjct: 19 ELGDGAFGKVYKA-----QNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 73
Query: 150 LVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHE 209
L+ ++ ++ E+ G+VD + + E LT + + + L YLH+
Sbjct: 74 LLDAFYYENNL----WILIEFCAGGAVDAVM-LELERPLTESQIQVVCKQTLDALNYLHD 128
Query: 210 GMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQ 269
+II RD K+ NIL + KL+DFG++ + +GT + APE V
Sbjct: 129 ---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRRDSFIGTPYWMAPEVVM 183
Query: 270 TGRLA-----ARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQI 324
++DVWS G+ L E+ P P + LL+ K + +
Sbjct: 184 CETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP--MRVLLKIAK------SEPPTL 235
Query: 325 VDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 364
P + K CL KN R S++L+
Sbjct: 236 AQPSRWSSNFKDFLKK-------CLEKNVDARWTTSQLLQ 268
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 1e-53
Identities = 62/298 (20%), Positives = 125/298 (41%), Gaps = 34/298 (11%)
Query: 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL---GRRGGHKEWMTEVNFLGI 141
+ + S +G+G FG VY+G+ K + VA+K + E++ E + +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 142 VEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETI--------LTWAMR 193
++V+L+G + L++ E M G + YL + + +
Sbjct: 80 FNCHHVVRLLGVVSQGQPT----LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 135
Query: 194 LKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVS 253
+++A + A G+AYL+ + + RD + N ++ E + K+ DFG+ R +
Sbjct: 136 IQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 192
Query: 254 TAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKP 313
+ + + +PE ++ G SDVWS+GV L+E+ T +
Sbjct: 193 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG-------------- 238
Query: 314 YLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVD 371
LS+ + R +++ L K L + +C N + RP E++ + + ++
Sbjct: 239 -LSNEQVLRFVMEGGLLDKPD-NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 3e-52
Identities = 71/295 (24%), Positives = 116/295 (39%), Gaps = 42/295 (14%)
Query: 76 TIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL--GRRGGHKEWM 133
+I + K ++R IG+G G VY D + EVA++Q+ ++ + +
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTA-----MDVATGQEVAIRQMNLQQQPKKELII 65
Query: 134 TEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMR 193
E+ + ++ N+V + DE +V EY+ GS+ ++
Sbjct: 66 NEILVMRENKNPNIVNYLDSYLVGDEL----WVVMEYLAGGSLTDVVTETCMD---EGQI 118
Query: 194 LKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVS 253
+ ++ + L +LH Q+I RD KS NILL + KL+DFG E
Sbjct: 119 AAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-- 173
Query: 254 TAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKP 313
+ +VGT + APE V + D+WS G+ E+I G P P
Sbjct: 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP------------ 221
Query: 314 YLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVA----NLCLVKNARTRPKMSEVLE 364
+ I G L+ KLS + N CL + R E+L+
Sbjct: 222 ----LRALYLIA---TNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 7e-52
Identities = 59/284 (20%), Positives = 116/284 (40%), Gaps = 33/284 (11%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL---GRRGGHKEWMTEVNFLGIVEHQNLV 148
IGEG FG V++G+ + E+P + VA+K ++++ E + +H ++V
Sbjct: 14 CIGEGQFGDVHQGIYMSPENP--ALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 71
Query: 149 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLH 208
KL+G ++ ++ E G + + + L A + A + LAYL
Sbjct: 72 KLIGVITEN-----PVWIIMELCTLGELRSF-LQVRKYSLDLASLILYAYQLSTALAYLE 125
Query: 209 EGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYV 268
+ + RD + N+L+ KL DFGL+R + ++ + + APE +
Sbjct: 126 S---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST-YYKASKGKLPIKWMAPESI 181
Query: 269 QTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDP 327
R + SDVW +GV ++E++ G +P + ++ + P
Sbjct: 182 NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL-----PMPPNCPP 236
Query: 328 RLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVD 371
L + C + RP+ +E+ ++ I++
Sbjct: 237 TLY------------SLMTKCWAYDPSRRPRFTELKAQLSTILE 268
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 171 bits (435), Expect = 3e-51
Identities = 70/287 (24%), Positives = 115/287 (40%), Gaps = 35/287 (12%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL-----GRRGGHKEWMTEVNFLGIVEHQN 146
++G GG V+ D +VAVK L + + E + H
Sbjct: 14 ILGFGGMSEVHLA-----RDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68
Query: 147 LVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAY 206
+V + + G +V EY+ ++ + +E +T +++ DA + L +
Sbjct: 69 IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV--HTEGPMTPKRAIEVIADACQALNF 126
Query: 207 LHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR-LGPSEGFTHVSTAVVGTMGYAAP 265
H+ II RD K +NI++ K+ DFG+AR + S + AV+GT Y +P
Sbjct: 127 SHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183
Query: 266 EYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIV 325
E + + ARSDV+S G LYE++TG P + S Q V
Sbjct: 184 EQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD----------------SPVSVAYQHV 227
Query: 326 --DPRLEGKYSLRLVSKLSHVANLCLVKNARTRPK-MSEVLEMVNKI 369
DP L + L V L KN R + +E+ + ++
Sbjct: 228 REDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 2e-50
Identities = 69/303 (22%), Positives = 124/303 (40%), Gaps = 43/303 (14%)
Query: 92 VIGEGGFGCVYKGLIK--NSEDPSQKVEVAVKQL---GRRGGHKEWMTEVNFLG-IVEHQ 145
+GEG FG V + + P++ +VAVK L + ++E+ + I +H+
Sbjct: 20 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 79
Query: 146 NLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYL--------------SPKSETILTWA 191
N++ L+G C D ++ EY G++ +YL S E L+
Sbjct: 80 NIINLLGACTQDGPL----YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 135
Query: 192 MRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTH 251
+ A ARG+ YL + I RD + N+L+ E K++DFGLAR +
Sbjct: 136 DLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 192
Query: 252 VSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWV 311
+T + + APE + +SDVWS+GV L+E+ T P
Sbjct: 193 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--------- 243
Query: 312 KPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVD 371
++ +++ ++L + C RP +++E +++IV
Sbjct: 244 -------EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296
Query: 372 ASA 374
++
Sbjct: 297 LTS 299
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 2e-49
Identities = 66/288 (22%), Positives = 111/288 (38%), Gaps = 37/288 (12%)
Query: 81 KSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-----GGHKEWMTE 135
K ++F ++GEG F V + + E A+K L +R E
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLA-----RELATSREYAIKILEKRHIIKENKVPYVTRE 58
Query: 136 VNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLK 195
+ + ++H VKL DD++ Y NG + +Y+
Sbjct: 59 RDVMSRLDHPFFVKLYFTFQDDEKL----YFGLSYAKNGELLKYIRKIG--SFDETCTRF 112
Query: 196 IAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTA 255
+ L YLH II RD K NILL+E + +++DFG A++ E + +
Sbjct: 113 YTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS 169
Query: 256 VVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYL 315
VGT Y +PE + SD+W+ G +Y+L+ G P
Sbjct: 170 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG---------------- 213
Query: 316 SDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVL 363
++ F++I+ +LE + + K + LV +A R E+
Sbjct: 214 NEYLIFQKII--KLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEME 259
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 166 bits (422), Expect = 2e-48
Identities = 67/355 (18%), Positives = 126/355 (35%), Gaps = 53/355 (14%)
Query: 68 RPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL--GR 125
+P +K + + ++ +G G FG V++ + + A K +
Sbjct: 15 QPVEIKHDHVLD------HYDIHEELGTGAFGVVHRV-----TERATGNNFAAKFVMTPH 63
Query: 126 RGGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSE 185
+ E+ + ++ H LV L DD+E +++YE+M G + + +
Sbjct: 64 ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEM----VMIYEFMSGGELFEKV-ADEH 118
Query: 186 TILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWN--AKLSDFGLARL 243
++ ++ + +GL ++HE + D K NI+ + + KL DFGL
Sbjct: 119 NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAH 175
Query: 244 GPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRS 303
+ V GT +AAPE + + +D+WS GV Y L++G P
Sbjct: 176 LDPKQSVKV---TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE---- 228
Query: 304 EQKLLQWVKPYLSDAKQFRQIV--DPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSE 361
+D + R + D ++ + L+ + TR + +
Sbjct: 229 ------------NDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQ 276
Query: 362 VLEM--VNKIVDASAEAGSPRRPLRSSTSRETPDHTKTKHKRRIIESKTRESGTL 414
LE + P R + +SR T K K G +
Sbjct: 277 ALEHPWLTPGNA-------PGRDSQIPSSRYTKIRDSIKTKYDAWPEPLPPLGRI 324
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 3e-46
Identities = 74/334 (22%), Positives = 121/334 (36%), Gaps = 34/334 (10%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL---GRRGGHKEWMTEVNFLGIVEHQNLV 148
IGEG +G V D KV VA+K++ + + + E+ L H+N++
Sbjct: 15 YIGEGAYGMVCSA-----YDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 69
Query: 149 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLH 208
+ ++ + + ++ + + L + L+ RGL Y+H
Sbjct: 70 GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH---LSNDHICYFLYQILRGLKYIH 126
Query: 209 EGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTH-VSTAVVGTMGYAAPEY 267
++ RD K SN+LL+ + K+ DFGLAR+ + T V T Y APE
Sbjct: 127 SA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 268 VQTGRLAARS-DVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVD 326
+ + +S D+WS G L E+++ R + + + S I
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243
Query: 327 PRLEGKYSL---------RLVSKLSHVA----NLCLVKNARTRPKMSEVLEM--VNKIVD 371
SL RL A + L N R ++ + L + + D
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 303
Query: 372 ASAEAGSPRRPLRSSTSRETPDHTKTKHKRRIIE 405
S E P E D K K K I E
Sbjct: 304 PSDE---PIAEAPFKFDMELDDLPKEKLKELIFE 334
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 160 bits (405), Expect = 5e-46
Identities = 58/281 (20%), Positives = 106/281 (37%), Gaps = 42/281 (14%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL--GRRGGHKEWMTEVNFLGIVEHQNLVK 149
+G G FG V++ + + K + E++ + + H L+
Sbjct: 36 ELGSGAFGVVHRC-----VEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 90
Query: 150 LVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHE 209
L D E +L+ E++ G + ++ + ++ A + + A GL ++HE
Sbjct: 91 LHDAFEDKYEM----VLILEFLSGGELFDRIA-AEDYKMSEAEVINYMRQACEGLKHMHE 145
Query: 210 GMDFQIIVRDFKSSNILLDEQWNA--KLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEY 267
I+ D K NI+ + + + K+ DFGLA + V T +AAPE
Sbjct: 146 ---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV---TTATAEFAAPEI 199
Query: 268 VQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDP 327
V + +D+W+ GV Y L++G P D + + +
Sbjct: 200 VDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE----------------DDLETLQNVK-- 241
Query: 328 RLEGKYSLRLVSKLSHVA----NLCLVKNARTRPKMSEVLE 364
R + ++ S +S A L K R R + + LE
Sbjct: 242 RCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 158 bits (400), Expect = 1e-45
Identities = 59/278 (21%), Positives = 98/278 (35%), Gaps = 35/278 (12%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR---GGHKEWMTEVNFLGIVEHQNLV 148
V+G G F V ED + VA+K + ++ G E+ L ++H N+V
Sbjct: 16 VLGTGAFSEVILA-----EDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 70
Query: 149 KLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLH 208
L L+ + + G + + + T ++ + YLH
Sbjct: 71 ALDDIYESGGHL----YLIMQLVSGGELFDRI--VEKGFYTERDASRLIFQVLDAVKYLH 124
Query: 209 EGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYV 268
+ ++ LDE +SDFGL+++ E V + GT GY APE +
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVL 181
Query: 269 QTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIV--D 326
+ D WS GV Y L+ G P +DAK F QI+ +
Sbjct: 182 AQKPYSKAVDCWSIGVIAYILLCGYPPFYDE----------------NDAKLFEQILKAE 225
Query: 327 PRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 364
+ Y + + K+ R + L+
Sbjct: 226 YEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 6e-45
Identities = 68/289 (23%), Positives = 106/289 (36%), Gaps = 26/289 (8%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL----GRRGGHKEWMTEVNF---LGIVEH 144
IGEG +G V+K + VA+K++ G G + EV L EH
Sbjct: 14 EIGEGAYGKVFKARDL----KNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEH 69
Query: 145 QNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGL 204
N+V+L C +L + + + YL E + + RGL
Sbjct: 70 PNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 129
Query: 205 AYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAA 264
+LH +++ RD K NIL+ KL+DFGLAR+ T+VV T+ Y A
Sbjct: 130 DFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLWYRA 183
Query: 265 PEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQI 324
PE + A D+WS G E+ + + + + V + R +
Sbjct: 184 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243
Query: 325 VDPR-----LEGKYSLRLVSKLSHVA----NLCLVKNARTRPKMSEVLE 364
PR + + V+ + + CL N R L
Sbjct: 244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 155 bits (392), Expect = 7e-45
Identities = 64/299 (21%), Positives = 101/299 (33%), Gaps = 53/299 (17%)
Query: 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL-----------GRRGGHKEWMT 134
N+ ++G G V + E AVK + + + +
Sbjct: 4 NYEPKEILGRGVSSVVRRC-----IHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLK 58
Query: 135 EVNFLGIV-EHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMR 193
EV+ L V H N+++L + LV++ M G + YL + L+
Sbjct: 59 EVDILRKVSGHPNIIQLKDTYETNTFF----FLVFDLMKKGELFDYL--TEKVTLSEKET 112
Query: 194 LKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVS 253
KI + + LH+ I+ RD K NILLD+ N KL+DFG +
Sbjct: 113 RKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP---GEKL 166
Query: 254 TAVVGTMGYAAPEYVQTGRLAAR------SDVWSYGVFLYELITGRRPIDRNRPRSEQKL 307
V GT Y APE ++ D+WS GV +Y L+ G P
Sbjct: 167 REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR-------- 218
Query: 308 LQWVKPYLSDAKQFRQIV--DPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 364
R I+ + + + + + LV + R E L
Sbjct: 219 --------KQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 4e-44
Identities = 53/276 (19%), Positives = 105/276 (38%), Gaps = 33/276 (11%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-GHKEWMTEVNFLGIVEHQNLVKL 150
+G G FG V++ + S K K + +G E++ L I H+N++ L
Sbjct: 12 DLGRGEFGIVHRC-----VETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHL 66
Query: 151 VGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEG 210
+E ++++E++ + + ++ S L + L +LH
Sbjct: 67 HESFESMEEL----VMIFEFISGLDIFERIN-TSAFELNEREIVSYVHQVCEALQFLHS- 120
Query: 211 MDFQIIVRDFKSSNILLDEQWNA--KLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYV 268
I D + NI+ + ++ K+ +FG AR + Y APE
Sbjct: 121 --HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ---LKPGDNFRLLFTAPEYYAPEVH 175
Query: 269 QTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPR 328
Q ++ +D+WS G +Y L++G P +Q + + + ++ + +
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGINPFLAETN--QQIIENIMNAEYTFDEEAFKEISIE 233
Query: 329 LEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 364
+ V + LVK ++R SE L+
Sbjct: 234 A-----MDFVDR-------LLVKERKSRMTASEALQ 257
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 153 bits (387), Expect = 6e-44
Identities = 51/286 (17%), Positives = 97/286 (33%), Gaps = 31/286 (10%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQNLVKLV 151
IG G FG +Y G D + EVA+K + H + E +++ + +
Sbjct: 14 KIGSGSFGDIYLG-----TDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTI 68
Query: 152 GYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGM 211
+C + + ++V E + D + + + L +A + Y+H
Sbjct: 69 RWCGAEGDY---NVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIHSK- 122
Query: 212 DFQIIVRDFKSSNIL---LDEQWNAKLSDFGLARLGPSEG-----FTHVSTAVVGTMGYA 263
I RD K N L + + DFGLA+ + + GT YA
Sbjct: 123 --NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 264 APEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQ 323
+ + R D+ S G L G P + ++++ + + ++
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS------EKKMS 234
Query: 324 IVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 369
L Y S+ + N C +P S + ++ +
Sbjct: 235 TPIEVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 2e-43
Identities = 70/296 (23%), Positives = 112/296 (37%), Gaps = 42/296 (14%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL-------GRRGGHKEWMTEVNFLGIVEH 144
+GEG F VYK D + VA+K++ + G ++ + E+ L + H
Sbjct: 5 FLGEGQFATVYKA-----RDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH 59
Query: 145 QNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGL 204
N++ L+ LV+++M + +LT + +GL
Sbjct: 60 PNIIGLLDAFGHKSNI----SLVFDFMETDLEVII--KDNSLVLTPSHIKAYMLMTLQGL 113
Query: 205 AYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAA 264
YLH+ I+ RD K +N+LLDE KL+DFGLA+ S + T V T Y A
Sbjct: 114 EYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--THQVVTRWYRA 168
Query: 265 PEYVQTGRLA-ARSDVWSYGVFLYELITGRRPIDRN--------------RPRSEQKLLQ 309
PE + R+ D+W+ G L EL+ + + P EQ
Sbjct: 169 PELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM 228
Query: 310 WVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365
P K F I + L+ + + N R ++ L+M
Sbjct: 229 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQG----LFLFNPCARITATQALKM 280
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 3e-43
Identities = 53/277 (19%), Positives = 95/277 (34%), Gaps = 28/277 (10%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLG-IVEHQNLVKL 150
V+G G G V + + + + A+K L + EV + ++V++
Sbjct: 19 VLGLGINGKVLQI-----FNKRTQEKFALKMLQDC---PKARREVELHWRASQCPHIVRI 70
Query: 151 VGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEG 210
V + L+V E + G + + + + T +I + + YLH
Sbjct: 71 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI 130
Query: 211 MDFQIIVRDFKSSNILLDEQWN---AKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEY 267
I RD K N+L + KL+DFG A+ S T Y APE
Sbjct: 131 ---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT---PCYTPYYVAPEV 184
Query: 268 VQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDP 327
+ + D+WS GV +Y L+ G P N + + K ++
Sbjct: 185 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM----------KTRIRMGQY 234
Query: 328 RLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 364
+ ++ + L R ++E +
Sbjct: 235 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 152 bits (386), Expect = 3e-43
Identities = 65/281 (23%), Positives = 111/281 (39%), Gaps = 42/281 (14%)
Query: 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL-----GRRGGHKEWMTEVNFLG 140
+FS +IG GGFG VY A+K L + G + E L
Sbjct: 5 DFSVHRIIGRGGFGEVYGC-----RKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS 59
Query: 141 IV---EHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIA 197
+V + +V + D+ + + M G + +L + + A A
Sbjct: 60 LVSTGDCPFIVCMSYAFHTPDKL----SFILDLMNGGDLHYHL--SQHGVFSEADMRFYA 113
Query: 198 QDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVV 257
+ GL ++H ++ RD K +NILLDE + ++SD GLA + V
Sbjct: 114 AEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SV 166
Query: 258 GTMGYAAPEYVQTGR-LAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS 316
GT GY APE +Q G + +D +S G L++L+ G P +++ + + ++ + L+
Sbjct: 167 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM---TLT 223
Query: 317 DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRP 357
A + P L L+ L ++ R
Sbjct: 224 MAVELPDSFSPELR-----SLLEG-------LLQRDVNRRL 252
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 9e-43
Identities = 60/280 (21%), Positives = 106/280 (37%), Gaps = 41/280 (14%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL-----GRRGGHKEWMTEVNFLGIV-EHQ 145
++G+G FG V+ E A+K L + M E L + EH
Sbjct: 9 MLGKGSFGKVFLA-----EFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 146 NLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLA 205
L + + EY+ G + ++ +S + A + GL
Sbjct: 64 FLTHMFCTFQTKENLFFV----MEYLNGGDLMYHI--QSCHKFDLSRATFYAAEIILGLQ 117
Query: 206 YLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAP 265
+LH I+ RD K NILLD+ + K++DFG+ + GT Y AP
Sbjct: 118 FLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTPDYIAP 172
Query: 266 EYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIV 325
E + + D WS+GV LYE++ G+ P + E++L ++ D + + +
Sbjct: 173 EILLGQKYNHSVDWWSFGVLLYEMLIGQSPFH---GQDEEELFHSIR---MDNPFYPRWL 226
Query: 326 DPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKM-SEVLE 364
+ + L+ K V+ R + ++ +
Sbjct: 227 EKEAK-----DLLVK-------LFVREPEKRLGVRGDIRQ 254
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 148 bits (374), Expect = 4e-42
Identities = 40/288 (13%), Positives = 87/288 (30%), Gaps = 33/288 (11%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQNLVKLV 151
IGEG FG +++G + +VA+K RR + E ++ + V
Sbjct: 12 RIGEGSFGVIFEG-----TNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 66
Query: 152 GYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGM 211
Y + + LV + + D + A+ + +HE
Sbjct: 67 YYFGQEGLHNV---LVIDLLGPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHE-- 119
Query: 212 DFQIIVRDFKSSNILLDEQWN-----AKLSDFGLARLGPSEG-----FTHVSTAVVGTMG 261
++ RD K N L+ + + DFG+ + + GT
Sbjct: 120 -KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 178
Query: 262 YAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQF 321
Y + + R D+ + G + G P + + ++ + + ++
Sbjct: 179 YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG------EKK 232
Query: 322 RQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 369
+ L + + + P + + +K+
Sbjct: 233 QSTPLRELCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 3e-40
Identities = 61/300 (20%), Positives = 107/300 (35%), Gaps = 29/300 (9%)
Query: 81 KSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLG 140
+ +++ + VIG G FG VY+ + VA+K++ + E+ +
Sbjct: 16 RPQEVSYTDTKVIGNGSFGVVYQA-----KLCDSGELVAIKKV--LQDKRFKNRELQIMR 68
Query: 141 IVEHQNLVKLVGYCADDDERG--IQRLLVYEYMPNGSVDQYLS-PKSETILTWAMRLKIA 197
++H N+V+L + E+ + LV +Y+P +++ L
Sbjct: 69 KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 128
Query: 198 QDAARGLAYLHEGMDFQIIVRDFKSSNILLD-EQWNAKLSDFGLARLGPSEGFTHVSTAV 256
R LAY+H I RD K N+LLD + KL DFG A+ + +
Sbjct: 129 YQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSYI 183
Query: 257 VGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRP------------IDRNRPRSE 304
A + DVWS G L EL+ G+ I +
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 243
Query: 305 QKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 364
++ ++ + P ++ K F QI + R + + + L R E
Sbjct: 244 REQIREMNPNYTEFK-FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 5e-40
Identities = 63/285 (22%), Positives = 98/285 (34%), Gaps = 53/285 (18%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL--------GRRGGHKEWMTEVNFLGIV- 142
++G GGFG VY G S + VA+K + G EV L V
Sbjct: 11 LLGSGGFGSVYSG-----IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 143 -EHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAA 201
+++L+ + D +L+ E L +
Sbjct: 66 SGFSGVIRLLDWFERPD----SFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVL 120
Query: 202 RGLAYLHEGMDFQIIVRDFKSSNILLD-EQWNAKLSDFGLARLGPSEGFTHVSTAVVGTM 260
+ + H ++ RD K NIL+D + KL DFG L +T GT
Sbjct: 121 EAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF----DGTR 173
Query: 261 GYAAPEYVQTGRLAARS-DVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 319
Y+ PE+++ R RS VWS G+ LY+++ G P + + ++
Sbjct: 174 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVF----------- 222
Query: 320 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 364
FRQ V + L+ CL RP E+
Sbjct: 223 -FRQRVSSECQ-----HLIRW-------CLALRPSDRPTFEEIQN 254
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 5e-40
Identities = 61/285 (21%), Positives = 108/285 (37%), Gaps = 43/285 (15%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL--------GRRGGHKEWMTEVNFLGIVE 143
+G G F V K + S ++ A K + R ++ EV+ L ++
Sbjct: 17 ELGSGQFAVVKKC-----REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 144 HQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARG 203
H N++ L + + +L+ E + G + + + LT + + G
Sbjct: 72 HPNVITLHEVYENKTDV----ILILELVAGGELFDF--LAEKESLTEEEATEFLKQILNG 125
Query: 204 LAYLHEGMDFQIIVRDFKSSNILLDEQW----NAKLSDFGLARLGPSEGFTHVSTAVVGT 259
+ YLH QI D K NI+L ++ K+ DFGLA F + + GT
Sbjct: 126 VYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGT 179
Query: 260 MGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 319
+ APE V L +D+WS GV Y L++G P + + + V D
Sbjct: 180 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED-- 237
Query: 320 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLE 364
++ + + + LVK+ + R + + L+
Sbjct: 238 EYFSNTSALAK-----DFIRR-------LLVKDPKKRMTIQDSLQ 270
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 6e-40
Identities = 61/298 (20%), Positives = 118/298 (39%), Gaps = 35/298 (11%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL----GRRGGHKEWMTEVNFLGIVEHQNL 147
IG+G FG V+K +VA+K++ + G + E+ L +++H+N+
Sbjct: 17 KIGQGTFGEVFKA-----RHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71
Query: 148 VKLVGYCADDDERGIQR----LLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARG 203
V L+ C + LV+++ + + + T + ++ Q G
Sbjct: 72 VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK--FTLSEIKRVMQMLLNG 129
Query: 204 LAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL--GPSEGFTHVSTAVVGTMG 261
L Y+H +I+ RD K++N+L+ KL+DFGLAR + T V T+
Sbjct: 130 LYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186
Query: 262 YAAPEYVQTGRLA-ARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS---- 316
Y PE + R D+W G + E+ T + N + + L+ + ++
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246
Query: 317 -------DAKQFRQIVDPRLEGKYSLRLVSKLSHVANL---CLVKNARTRPKMSEVLE 364
++ + + + K L+ + + +L LV + R + L
Sbjct: 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 1e-39
Identities = 60/294 (20%), Positives = 109/294 (37%), Gaps = 29/294 (9%)
Query: 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL----GRRGGHKEWMTEVNFLGI 141
NF + IGEG +G VYK + VA+K++ G + E++ L
Sbjct: 3 NFQKVEKIGEGTYGVVYKA-----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 57
Query: 142 VEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAA 201
+ H N+VKL+ +++ LV+E++ +++ + T + +
Sbjct: 58 LNHPNIVKLLDVIHTENKL----YLVFEFLHQDL-KKFMDASALTGIPLPLIKSYLFQLL 112
Query: 202 RGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMG 261
+GLA+ H ++ RD K N+L++ + KL+DFGLAR + VV
Sbjct: 113 QGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTLWY 168
Query: 262 YAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK--PYLSDAK 319
A + + D+WS G E++T R + + + P
Sbjct: 169 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 228
Query: 320 QFRQIVD-----PRLEGKYSLRLVSKLSHVA----NLCLVKNARTRPKMSEVLE 364
+ D P+ + ++V L + L + R L
Sbjct: 229 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 142 bits (358), Expect = 2e-39
Identities = 65/280 (23%), Positives = 106/280 (37%), Gaps = 46/280 (16%)
Query: 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL-----GRRGGHKEWMTEVNFL 139
++F +G G FG V+ A+K L R + E L
Sbjct: 4 QDFQILRTLGTGSFGRVHLI-----RSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLML 58
Query: 140 GIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQD 199
IV H ++++ G D Q ++ +Y+ G + L + A +
Sbjct: 59 SIVTHPFIIRMWGTFQDAQ----QIFMIMDYIEGGELFSLLRKSQRF--PNPVAKFYAAE 112
Query: 200 AARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGT 259
L YLH II RD K NILLD+ + K++DFG A+ P +T + GT
Sbjct: 113 VCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT-----LCGT 164
Query: 260 MGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 319
Y APE V T D WS+G+ +YE++ G P + + K
Sbjct: 165 PDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS----------------NTMK 208
Query: 320 QFRQIV--DPRLEGKYSLRLVSKLSHVANLCLVKNARTRP 357
+ +I+ + R ++ + LS + ++ R
Sbjct: 209 TYEKILNAELRFPPFFNEDVKDLLSR----LITRDLSQRL 244
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 138 bits (348), Expect = 2e-38
Identities = 54/288 (18%), Positives = 101/288 (35%), Gaps = 31/288 (10%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL----GRRGGHKEWMTEVNFLGIVEHQNL 147
IGEG +G VYK E A+K++ G + E++ L ++H N+
Sbjct: 9 KIGEGTYGVVYKAQNNYGE------TFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 148 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYL 207
VKL +LV+E++ E L G+AY
Sbjct: 63 VKLYDVIHTKKRL----VLVFEHLDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 208 HEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEY 267
H+ +++ RD K N+L++ + K++DFGLAR + +V A
Sbjct: 117 HDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT-HEIVTLWYRAPDVL 172
Query: 268 VQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDP 327
+ + + + D+WS G E++ G + + + + P
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232
Query: 328 RLEGKYSL-------RLVSKLSHVA----NLCLVKNARTRPKMSEVLE 364
+ + +++ + L + L + R + LE
Sbjct: 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 135 bits (341), Expect = 5e-37
Identities = 63/336 (18%), Positives = 119/336 (35%), Gaps = 43/336 (12%)
Query: 53 SVESEARPSYPSMSQRPSNLKEFTIAELKSATKN-FSRSVVIGEGGFGCVYKGLIKNSED 111
V S AR + RP ++ ++ ++ + +G G + V++ +
Sbjct: 2 PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEA-----IN 56
Query: 112 PSQKVEVAVKQLGRRGGHKEWMTEVNFLG-IVEHQNLVKLVGYCADDDERGIQRLLVYEY 170
+ +V VK L + K+ E+ L + N++ L D R LV+E+
Sbjct: 57 ITNNEKVVVKIL-KPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA--LVFEH 113
Query: 171 MPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLD-E 229
+ N Q LT + + L Y H I+ RD K N+++D E
Sbjct: 114 VNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHE 165
Query: 230 QWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRL-AARSDVWSYGVFLYE 288
+L D+GLA V + + PE + ++ D+WS G L
Sbjct: 166 HRKLRLIDWGLAEFYHPG---QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLAS 222
Query: 289 LITGRRPIDRNRPRSEQ-----------KLLQWVKPY-LSDAKQFRQIVDPRLEGKYSLR 336
+I + P +Q L ++ Y + +F I+ ++
Sbjct: 223 MIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERF 282
Query: 337 LVSKLSHVANL--------CLVKNARTRPKMSEVLE 364
+ S+ H+ + L + ++R E +E
Sbjct: 283 VHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 2e-36
Identities = 77/335 (22%), Positives = 122/335 (36%), Gaps = 41/335 (12%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGR----RGGHKEWMTEVNFLGIVEHQNL 147
+G G +G V D +VA+K+L R K E+ L + H+N+
Sbjct: 25 PVGSGAYGAVCSA-----VDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 79
Query: 148 VKLVGYCADDDERGIQR--LLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLA 205
+ L+ D+ LV +M K L + +GL
Sbjct: 80 IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK----LGEDRIQFLVYQMLKGLR 135
Query: 206 YLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAP 265
Y+H II RD K N+ ++E K+ DFGLAR S ++ VV A
Sbjct: 136 YIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADS----EMTGYVVTRWYRAPE 188
Query: 266 EYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLL---------QWVKPYLS 316
+ R D+WS G + E+ITG+ + + K + ++V+ S
Sbjct: 189 VILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 248
Query: 317 DAKQFRQIVDPRLEGKYSLRLVSKLSHVA----NLCLVKNARTRPKMSEVLEM--VNKIV 370
D + P LE K +++ S +A LV +A R E L +
Sbjct: 249 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308
Query: 371 DASAEAGSPRRPLRSSTSRETPDHTKTKHKRRIIE 405
D E P+ + S + D T + KR +
Sbjct: 309 DTEDE---PQVQ-KYDDSFDDVDRTLDEWKRVTYK 339
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 7e-35
Identities = 64/280 (22%), Positives = 105/280 (37%), Gaps = 39/280 (13%)
Query: 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL-----GRRGGHKEWMTEVNFL 139
+F ++G+G FG V + + A+K L + +TE L
Sbjct: 5 NDFDYLKLLGKGTFGKVILV-----REKATGRYYAMKILRKEVIIAKDEVAHTVTESRVL 59
Query: 140 GIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQD 199
H L L D EY G + +L E + T +
Sbjct: 60 QNTRHPFLTALKYAFQTHDRLCFV----MEYANGGELFFHL--SRERVFTEERARFYGAE 113
Query: 200 AARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGT 259
L YLH ++ RD K N++LD+ + K++DFGL + G S+G T GT
Sbjct: 114 IVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGT 168
Query: 260 MGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 319
Y APE ++ D W GV +YE++ GR P + ++L + + L +
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN---QDHERLFELI---LMEEI 222
Query: 320 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKM 359
+F + + P L++ L K+ + R
Sbjct: 223 RFPRTLSPEA-----KSLLAG-------LLKKDPKQRLGG 250
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (321), Expect = 1e-34
Identities = 58/289 (20%), Positives = 99/289 (34%), Gaps = 31/289 (10%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL----GRRGGHKEWMTEVNFLGIVEHQNL 147
IGEG +G V+K ++ VA+K++ G + E+ L ++H+N+
Sbjct: 9 KIGEGTYGTVFKA-----KNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 148 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYL 207
V+L D + + V+E+ + S + +GL +
Sbjct: 64 VRLHDVLHSDKKLTL----VFEFCDQDLKKYFDSCNGDLDPEIVKS--FLFQLLKGLGFC 117
Query: 208 HEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEY 267
H ++ RD K N+L++ KL++FGLAR S VV
Sbjct: 118 H---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-RCYSAEVVTLWYRPPDVL 173
Query: 268 VQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDP 327
+ D+WS G EL RP+ +Q + +Q+ +
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233
Query: 328 RLEGKYSL--------RLVSKLSHVA----NLCLVKNARTRPKMSEVLE 364
Y + +V KL+ L N R E L+
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 2e-32
Identities = 73/346 (21%), Positives = 119/346 (34%), Gaps = 50/346 (14%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGR----RGGHKEWMTEVNFLGIVEHQNL 147
IG G G V D VA+K+L R + K E+ + V H+N+
Sbjct: 24 PIGSGAQGIVCAA-----YDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 148 VKLVGYCADDD--ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLA 205
+ L+ E LV E M + G+
Sbjct: 79 ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-----HERMSYLLYQMLCGIK 133
Query: 206 YLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAP 265
+LH II RD K SNI++ K+ DFGLAR + G + + T V T Y AP
Sbjct: 134 HLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAP 187
Query: 266 EYVQTGRLAARSDVWSYGVFLYELITGRRP----------------IDRNRPRSEQKLLQ 309
E + D+WS G + E++ + + P +KL
Sbjct: 188 EVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247
Query: 310 WVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANL--------CLVKNARTRPKMSE 361
V+ Y+ + ++ + P+L S+ + + LV + R + +
Sbjct: 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 307
Query: 362 VLEM--VNKIVDASAEAGSPRRPLRSSTSRETPDHTKTKHKRRIIE 405
L+ +N D + P P + +HT + K I +
Sbjct: 308 ALQHPYINVWYDPAEVEAPP--PQIYDKQLDEREHTIEEWKELIYK 351
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 2e-31
Identities = 72/363 (19%), Positives = 127/363 (34%), Gaps = 45/363 (12%)
Query: 63 PSMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQ 122
P+ ++ N + + E + +G G +G V D + VAVK+
Sbjct: 2 PTFYRQELNKTIWEVPE------RYQNLSPVGSGAYGSVCAA-----FDTKTGLRVAVKK 50
Query: 123 LGR----RGGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE-RGIQRLLVYEYMPNGSVD 177
L R K E+ L ++H+N++ L+ + + ++ ++
Sbjct: 51 LSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN 110
Query: 178 QYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 237
+ + LT + RGL Y+H II RD K SN+ ++E K+ D
Sbjct: 111 NIVKCQK---LTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILD 164
Query: 238 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRP-- 295
FGLAR E +V+T A + D+WS G + EL+TGR
Sbjct: 165 FGLARHTDDEMTGYVAT----RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 220
Query: 296 ----------IDRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLS-HV 344
I R +LL+ + + P++ + L+ +
Sbjct: 221 GTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDL 280
Query: 345 ANLCLVKNARTRPKMSEVLEM--VNKIVDASAEAGSPRRPLRSSTSRETPDHTKTKHKRR 402
LV ++ R ++ L + D E + P S E+ D + K
Sbjct: 281 LEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD--PY--DQSFESRDLLIDEWKSL 336
Query: 403 IIE 405
+
Sbjct: 337 TYD 339
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 118 bits (296), Expect = 2e-30
Identities = 61/282 (21%), Positives = 99/282 (35%), Gaps = 36/282 (12%)
Query: 41 GSELTSQNVSAISVESEARPSYPSMSQRPSNLKEFTIAELKSATKNFSRSVVIGEGGFGC 100
GSE S + + + + SQ + L +F + +G G FG
Sbjct: 9 GSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIK------------TLGTGSFGR 56
Query: 101 VYKGLIKNSEDPSQKVEVAVKQL-----GRRGGHKEWMTEVNFLGIVEHQNLVKLVGYCA 155
V + A+K L + + + E L V LVKL
Sbjct: 57 VMLV-----KHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 156 DDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQI 215
D+ + V EY+ G + +L + A YLH +
Sbjct: 112 DNSNLYM----VMEYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHS---LDL 162
Query: 216 IVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAA 275
I RD K N+L+D+Q +++DFG A+ +T + GT APE + +
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEIILSKGYNK 217
Query: 276 RSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 317
D W+ GV +YE+ G P ++P + + K
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS 259
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 3e-29
Identities = 60/275 (21%), Positives = 102/275 (37%), Gaps = 35/275 (12%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL------GRRGGHKEWMTEVNFLGIVEHQ 145
V+G G +G V+ + D + A+K L + + TE L +
Sbjct: 31 VLGTGAYGKVFLVRKISGHDTGK--LYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQS 88
Query: 146 -NLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGL 204
LV L + + + +Y+ G + +LS + +
Sbjct: 89 PFLVTLHYAFQTETKLHLI----LDYINGGELFTHLSQRERFTEHEVQI-----YVGEIV 139
Query: 205 AYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAA 264
L II RD K NILLD + L+DFGL++ ++ T + GT+ Y A
Sbjct: 140 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE-TERAYDFCGTIEYMA 198
Query: 265 PEYVQTGRLA--ARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFR 322
P+ V+ G D WS GV +YEL+TG P + + + + L +
Sbjct: 199 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGE--KNSQAEISRRILKSEPPYP 256
Query: 323 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRP 357
Q + + L+ + L+K+ + R
Sbjct: 257 QEMSALAK-----DLIQR-------LLMKDPKKRL 279
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 110 bits (276), Expect = 8e-28
Identities = 55/316 (17%), Positives = 108/316 (34%), Gaps = 51/316 (16%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL-GRRGGHKEWMTEVNFLGIVEHQNL--- 147
+G G F V+ +D VA+K + G + + E+ L V +
Sbjct: 20 KLGWGHFSTVWLA-----KDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74
Query: 148 --------VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQD 199
+KL+ + G+ ++V+E + + + I +I++
Sbjct: 75 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGI-PLIYVKQISKQ 133
Query: 200 AARGLAYLHEGMDFQIIVRDFKSSNILLD-EQWNAKLSDFGLARLGPSEGFTHVSTAVVG 258
GL Y+H II D K N+L++ L +A LG + + T +
Sbjct: 134 LLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191
Query: 259 TMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNR------------------ 300
T Y +PE + +D+WS ++ELITG + +
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELL 251
Query: 301 ---PRSEQKLLQWVKPYLSDAKQFRQIVDPRL---------EGKYSLRLVSKLSHVANLC 348
P + ++ + + + R I + + K+S ++S +
Sbjct: 252 GELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPM 311
Query: 349 LVKNARTRPKMSEVLE 364
L + R R ++
Sbjct: 312 LQLDPRKRADAGGLVN 327
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 79.8 bits (196), Expect = 4e-18
Identities = 31/210 (14%), Positives = 58/210 (27%), Gaps = 38/210 (18%)
Query: 92 VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQL------------GRRGGHKEWMTEVNFL 139
++GEG V+ + E VK R G +
Sbjct: 7 LMGEGKESAVFNCYSEKFG------ECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 140 GIVEHQNLVKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQD 199
E + L KL G Y + N + + + K + ++
Sbjct: 61 ARNEFRALQKLQGLAVPKV---------YAWEGNAVLMELIDAKELYRVRVENPDEVLDM 111
Query: 200 AARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR-LGPSEGFTHVSTAVVG 258
+A + I+ D N+L+ E + DF + +G + V
Sbjct: 112 ILEEVAKFYHRG---IVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGEEGWREILERDVRN 167
Query: 259 TMGYAAPEYVQTGRLAARSDVWSYGVFLYE 288
+ Y + Y D+ S + +
Sbjct: 168 IITYFSRTY------RTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 426 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.58 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.14 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.04 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.55 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.28 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.74 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-58 Score=427.16 Aligned_cols=253 Identities=25% Similarity=0.372 Sum_probs=206.5
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
.++|++++.||+|+||+||+|.++.++. .||+|.+.... ..+.+.+|+.+|++++|||||++++++.+..
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~-----~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~-- 76 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEE-----AVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN-- 76 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCC-----EEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETT--
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCC-----EEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCc--
Confidence 4579999999999999999999887654 79999986443 3356889999999999999999999998876
Q ss_pred CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecc
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 240 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 240 (426)
..|||||||++|+|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 77 --~~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~ 149 (271)
T d1nvra_ 77 --IQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGL 149 (271)
T ss_dssp --EEEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred --eeEEEEeccCCCcHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchh
Confidence 459999999999999999654 3599999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCchhhccCCC-CCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014363 241 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRL-AARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 319 (426)
Q Consensus 241 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 319 (426)
|+..............+||+.|||||++.+..+ +.++|||||||++|||++|+.||.......... ..
T Consensus 150 a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~-~~---------- 218 (271)
T d1nvra_ 150 ATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY-SD---------- 218 (271)
T ss_dssp CEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHH-HH----------
T ss_pred heeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHH-HH----------
Confidence 987654443444556789999999999988876 568999999999999999999997644321111 11
Q ss_pred hhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 320 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.............+++++.+|+.+||+.||++|||++|+++|
T Consensus 219 ----~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 219 ----WKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp ----HHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ----HhcCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 011111111122356788999999999999999999999875
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-57 Score=423.23 Aligned_cols=260 Identities=28% Similarity=0.465 Sum_probs=203.7
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
.++|++.+.||+|+||+||+|.++. .||||.+.... ..+.|.+|+.+|++++|||||++++++.+..
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~~--------~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~- 77 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWHG--------DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQ- 77 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESSS--------EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS-
T ss_pred cccEEEEEEEeeCCCcEEEEEEECC--------EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEeccE-
Confidence 4679999999999999999997543 58999986432 3467889999999999999999999875432
Q ss_pred CCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeec
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 239 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 239 (426)
.+||||||++|+|.+++.... ..+++..++.|+.||+.||+|||++ +||||||||+||||+.++.+||+|||
T Consensus 78 ----~~lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFG 149 (276)
T d1uwha_ 78 ----LAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFG 149 (276)
T ss_dssp ----CEEEEECCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCC
T ss_pred ----EEEEEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEcccc
Confidence 489999999999999996443 3489999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCchhhcc---CCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhh
Q 014363 240 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQT---GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS 316 (426)
Q Consensus 240 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 316 (426)
+|+...............||+.|||||++.+ +.|+.++|||||||++|||+||+.||............ +..
T Consensus 150 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~--~~~--- 224 (276)
T d1uwha_ 150 LATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM--VGR--- 224 (276)
T ss_dssp CSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHH--HHH---
T ss_pred ceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHH--Hhc---
Confidence 9987654333334456789999999999864 35889999999999999999999999865443221111 000
Q ss_pred hhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 014363 317 DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 372 (426)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~ 372 (426)
....+. ....+..+++.+.+|+.+||+.||++|||++||+++|+.+..+
T Consensus 225 ------~~~~p~-~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 225 ------GYLSPD-LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp ------TSCCCC-GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ------CCCCCc-chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 011111 1122334567899999999999999999999999999988754
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-57 Score=418.99 Aligned_cols=245 Identities=29% Similarity=0.460 Sum_probs=206.7
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccc-----cCCHHHHHHHHHHHhhcCCCCccceEeEEEccCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGR-----RGGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~-----~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
++|++++.||+|+||+||+|.++.++. .||+|.+.. ....+.+.+|+.+|+.++|||||++++++.+.+
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~-----~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~- 79 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKF-----ILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT- 79 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCC-----EEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCc-----EEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECC-
Confidence 468999999999999999999887654 899998753 234567899999999999999999999998866
Q ss_pred CCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeec
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 239 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 239 (426)
..|+|||||++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 80 ---~~~ivmEy~~~g~L~~~l~~~~--~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG 151 (263)
T d2j4za1 80 ---RVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG 151 (263)
T ss_dssp ---EEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred ---EEEEEEeecCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccc
Confidence 4599999999999999997543 499999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014363 240 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 319 (426)
Q Consensus 240 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 319 (426)
++....... ....+||+.|||||++.+..|+.++|||||||++|||++|+.||..........
T Consensus 152 ~a~~~~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~------------- 214 (263)
T d2j4za1 152 WSVHAPSSR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYK------------- 214 (263)
T ss_dssp SCSCCCCCC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH-------------
T ss_pred eeeecCCCc----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHH-------------
Confidence 998655432 335689999999999999999999999999999999999999997654322111
Q ss_pred hhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 320 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.+.... ..++..+++++.+|+.+||+.||++|||++|+++|
T Consensus 215 ---~i~~~~--~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 215 ---RISRVE--FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp ---HHHTTC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred ---HHHcCC--CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 111111 11233456789999999999999999999999985
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-57 Score=431.01 Aligned_cols=261 Identities=26% Similarity=0.444 Sum_probs=216.0
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhc-CCCCccceEeEEEccCCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDER 160 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~~ 160 (426)
++|+++++||+|+||+||+|.+...+.....+.||+|.+.... ....+.+|+.+|.++ +|||||++++++.+.+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 5788999999999999999999887777777889999985432 345788999999998 899999999999887754
Q ss_pred CceEEEEEeeCCCCChhhhccCCCC---------------------CccCHHHHHHHHHHHHHHHHHhccCCCCCeEecc
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSE---------------------TILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRD 219 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~---------------------~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrD 219 (426)
|+|||||++|+|.++|..... ..+++..++.|+.||+.||+|||++ +|+|||
T Consensus 117 ----~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRD 189 (325)
T d1rjba_ 117 ----YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRD 189 (325)
T ss_dssp ----EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETT
T ss_pred ----EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecc
Confidence 999999999999999965432 3489999999999999999999998 999999
Q ss_pred CCCCceEeCCCCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCC
Q 014363 220 FKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDR 298 (426)
Q Consensus 220 lkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~ 298 (426)
|||+|||++.++.+||+|||+|+...............||+.|||||++.++.|+.++|||||||++|||+| |..||.+
T Consensus 190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~ 269 (325)
T d1rjba_ 190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 269 (325)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCC
Confidence 999999999999999999999987655444444556789999999999999999999999999999999998 8999976
Q ss_pred CCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 014363 299 NRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNK 368 (426)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~ 368 (426)
...... +. +++........+..+++++.+||.+||+.||++|||++||+++|..
T Consensus 270 ~~~~~~--~~--------------~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 270 IPVDAN--FY--------------KLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp CCCSHH--HH--------------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCHHHH--HH--------------HHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 543211 11 1111112222334466789999999999999999999999999964
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-57 Score=421.78 Aligned_cols=249 Identities=26% Similarity=0.405 Sum_probs=207.7
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc--CCHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCc
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR--GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 162 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~ 162 (426)
++|+..+.||+|+||+||+|.++.++. .||+|.+... ...+.+.+|+.+|+.++|||||++++++.+.+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~-----~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~---- 90 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQ-----EVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD---- 90 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCC-----EEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT----
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCC-----EEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECC----
Confidence 479999999999999999999876654 8999987543 35567899999999999999999999998876
Q ss_pred eEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccc
Q 014363 163 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 242 (426)
Q Consensus 163 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 242 (426)
..|||||||+||+|.+++... .+++..++.++.||+.||+|||++ ||+||||||+|||++.+|.+||+|||+++
T Consensus 91 ~~~ivmEy~~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~ 164 (293)
T d1yhwa1 91 ELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA 164 (293)
T ss_dssp EEEEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEEEecCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhhe
Confidence 459999999999999988643 489999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhh
Q 014363 243 LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFR 322 (426)
Q Consensus 243 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (426)
....... .....+||+.|+|||++.+..|+.++|||||||++|+|++|..||........... ...
T Consensus 165 ~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~--~~~---------- 230 (293)
T d1yhwa1 165 QITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL--IAT---------- 230 (293)
T ss_dssp ECCSTTC--CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH--HHH----------
T ss_pred eeccccc--cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHH--HHh----------
Confidence 7654322 23456899999999999999999999999999999999999999976543221111 000
Q ss_pred hhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 323 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
........+..++..+.+||.+||+.||++|||++|+++|
T Consensus 231 ---~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 231 ---NGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp ---HCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred ---CCCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0011112234466789999999999999999999999886
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.8e-57 Score=423.90 Aligned_cols=259 Identities=24% Similarity=0.434 Sum_probs=214.4
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCc
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 162 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~ 162 (426)
.++|+..+.||+|+||+||+|.++.++ ..||+|.+.... ..++|.+|+.+|++++|||||+++|+|.+.+..
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~-----~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~-- 88 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYS-----LTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF-- 88 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGT-----EEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC--
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCC-----eEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCee--
Confidence 357888899999999999999987654 379999986543 557899999999999999999999999877654
Q ss_pred eEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccc
Q 014363 163 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 242 (426)
Q Consensus 163 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 242 (426)
++|||||++|+|.+++.......+++..++.|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++
T Consensus 89 --~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~ 163 (287)
T d1opja_ 89 --YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSR 163 (287)
T ss_dssp --EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTT
T ss_pred --EEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEcccccee
Confidence 9999999999999999766566799999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhh
Q 014363 243 LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFR 322 (426)
Q Consensus 243 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (426)
....... .......||+.|+|||++.++.|+.++|||||||++|||++|..||....... .+.
T Consensus 164 ~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~--~~~-------------- 226 (287)
T d1opja_ 164 LMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVY-------------- 226 (287)
T ss_dssp TCCSSSS-EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHH--------------
T ss_pred ecCCCCc-eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH--HHH--------------
Confidence 7654432 22344578999999999999999999999999999999999777664332211 111
Q ss_pred hhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHh
Q 014363 323 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVD 371 (426)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~ 371 (426)
+.+........+..+++.+.+|+.+||+.||++|||++||++.|+.+..
T Consensus 227 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 227 ELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred HHHhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1111112223334566789999999999999999999999999987653
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-57 Score=416.25 Aligned_cols=256 Identities=26% Similarity=0.486 Sum_probs=199.3
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCce
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQ 163 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~ 163 (426)
++|+.++.||+|+||+||+|.+.++. .||||.+.... ..++|.+|+.++++++|||||+++|++.+.+..
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~------~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~--- 75 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKD------KVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI--- 75 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTE------EEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC---
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCC------EEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCce---
Confidence 46888999999999999999987532 69999987544 567899999999999999999999999877654
Q ss_pred EEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccccc
Q 014363 164 RLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL 243 (426)
Q Consensus 164 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 243 (426)
++|||||++|+|.+++.... ..+++..++.|+.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 76 -~lv~E~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~ 150 (263)
T d1sm2a_ 76 -CLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRF 150 (263)
T ss_dssp -EEEEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC----
T ss_pred -EEEEEecCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchhee
Confidence 99999999999999987543 4589999999999999999999998 999999999999999999999999999987
Q ss_pred CCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhC-CCCCCCCCchhhHHHHHhHhhhhhhhhhhh
Q 014363 244 GPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITG-RRPIDRNRPRSEQKLLQWVKPYLSDAKQFR 322 (426)
Q Consensus 244 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (426)
...... .......||+.|+|||++.+..|+.++|||||||++|||+|+ .+||...... .+...+.
T Consensus 151 ~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~---~~~~~i~---------- 216 (263)
T d1sm2a_ 151 VLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---EVVEDIS---------- 216 (263)
T ss_dssp ---------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH---HHHHHHH----------
T ss_pred ccCCCc-eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH---HHHHHHH----------
Confidence 654332 223346799999999999999999999999999999999995 5555443221 1111111
Q ss_pred hhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 014363 323 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 372 (426)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~ 372 (426)
. ......+..+++++.+|+.+||+.||++|||++||+++|+++.++
T Consensus 217 ~----~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 217 T----GFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp H----TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred h----cCCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 0 011112223457899999999999999999999999999998653
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-57 Score=422.33 Aligned_cols=255 Identities=26% Similarity=0.396 Sum_probs=194.8
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
++|++++.||+|+||+||+|.++.++. .||+|.+.... ..+.+.+|+++|++++|||||++++++.+....
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~-----~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 78 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGK-----ILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNT 78 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCC-----EEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCC-----EEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCC
Confidence 579999999999999999999887664 79999986543 234688999999999999999999999765433
Q ss_pred CceEEEEEeeCCCCChhhhccCC--CCCccCHHHHHHHHHHHHHHHHHhccCC--CCCeEeccCCCCceEeCCCCCeeEe
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPK--SETILTWAMRLKIAQDAARGLAYLHEGM--DFQIIVRDFKSSNILLDEQWNAKLS 236 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~~i~~aL~~LH~~~--~~~iiHrDlkp~NILl~~~~~~kl~ 236 (426)
.+|||||||++|+|.+++... ....+++..++.++.||+.||+|||++. ..+|+||||||+||||+.++.+||+
T Consensus 79 --~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~ 156 (269)
T d2java1 79 --TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLG 156 (269)
T ss_dssp --CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEEC
T ss_pred --EEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEe
Confidence 469999999999999998642 2345999999999999999999999861 1249999999999999999999999
Q ss_pred eecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhh
Q 014363 237 DFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLS 316 (426)
Q Consensus 237 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 316 (426)
|||+++...... ......+||+.|||||++.+..|+.++|||||||++|||++|..||....... +...
T Consensus 157 DFG~a~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~---~~~~------ 225 (269)
T d2java1 157 DFGLARILNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE---LAGK------ 225 (269)
T ss_dssp CHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHH------
T ss_pred eccceeecccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH---HHHH------
Confidence 999998765432 22345789999999999999999999999999999999999999997654322 1111
Q ss_pred hhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 317 DAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
+..... ...+..+++++.+|+.+||+.||++|||++||++|
T Consensus 226 -------i~~~~~-~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 226 -------IREGKF-RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp -------HHHTCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -------HHcCCC-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 111111 11223456789999999999999999999999875
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-57 Score=417.97 Aligned_cols=258 Identities=27% Similarity=0.452 Sum_probs=209.9
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCc
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 162 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~ 162 (426)
.++|++.+.||+|+||.||+|.++++ ..||||++.... ..+.|.+|+.+|++++|||||+++|++.+..
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~------~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~---- 81 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGH------TKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEP---- 81 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTT------EEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS----
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCC------CEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeeccCC----
Confidence 35788899999999999999998643 279999986543 5678999999999999999999999886532
Q ss_pred eEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccc
Q 014363 163 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 242 (426)
Q Consensus 163 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 242 (426)
.|+||||+++|+|.+++.......+++..++.|+.||+.||+|||++ +|+||||||+||||++++.+||+|||+|+
T Consensus 82 -~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~ 157 (272)
T d1qpca_ 82 -IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLAR 157 (272)
T ss_dssp -CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred -eEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceE
Confidence 38999999999999988765545689999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhh
Q 014363 243 LGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFR 322 (426)
Q Consensus 243 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (426)
...... ........||+.|||||++.++.|+.++|||||||++|||+||..|+...... ..+.+.+.
T Consensus 158 ~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~--~~~~~~i~---------- 224 (272)
T d1qpca_ 158 LIEDNE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--PEVIQNLE---------- 224 (272)
T ss_dssp ECSSSC-EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHH----------
T ss_pred EccCCc-cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH--HHHHHHHH----------
Confidence 765433 22334567999999999999999999999999999999999965554432221 11111110
Q ss_pred hhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 014363 323 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 372 (426)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~ 372 (426)
. ......+..+++++.+|+.+||+.||++|||++||++.|+++..+
T Consensus 225 ~----~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 225 R----GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp T----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred h----cCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 1 111122334567899999999999999999999999999988754
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-56 Score=414.05 Aligned_cols=248 Identities=24% Similarity=0.411 Sum_probs=199.9
Q ss_pred CCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCce
Q 014363 88 SRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQ 163 (426)
Q Consensus 88 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~ 163 (426)
+..++||+|+||+||+|.++.++. .||+|.+.... ..+.+.+|+++|++++|||||++++++.+.......
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~-----~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 86 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTV-----EVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 86 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCC-----EEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCe-----EEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCE
Confidence 556689999999999999877654 79999886443 234688999999999999999999999875544456
Q ss_pred EEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCC--eEeccCCCCceEeC-CCCCeeEeeecc
Q 014363 164 RLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQ--IIVRDFKSSNILLD-EQWNAKLSDFGL 240 (426)
Q Consensus 164 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~--iiHrDlkp~NILl~-~~~~~kl~DFGl 240 (426)
+|||||||++|+|.+++... ..+++..++.++.||+.||+|||++ + |+||||||+||||+ +++.+||+|||+
T Consensus 87 ~~ivmE~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGl 161 (270)
T d1t4ha_ 87 IVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGL 161 (270)
T ss_dssp EEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred EEEEEeCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCc
Confidence 79999999999999999654 3489999999999999999999997 6 99999999999996 578999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhh
Q 014363 241 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 320 (426)
Q Consensus 241 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (426)
++...... ....+||+.|||||++.+ .|+.++|||||||++|||++|+.||........ +...
T Consensus 162 a~~~~~~~----~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~--~~~~---------- 224 (270)
T d1t4ha_ 162 ATLKRASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IYRR---------- 224 (270)
T ss_dssp GGGCCTTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HHHH----------
T ss_pred ceeccCCc----cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH--HHHH----------
Confidence 98654322 345789999999998865 699999999999999999999999975433211 1111
Q ss_pred hhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 321 FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
+........++...++++.+|+.+||+.||++|||++|+++|
T Consensus 225 ---i~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 225 ---VTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp ---HTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ---HHcCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 111111112223345678999999999999999999999875
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.7e-56 Score=421.01 Aligned_cols=261 Identities=25% Similarity=0.462 Sum_probs=200.9
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC---HHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG---HKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
++|++.++||+|+||+||+|.++.++. ....||+|.+..... .+.|.+|+.+|++++|||||+++|++.+.+..
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~- 102 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGK--REIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPV- 102 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC-
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCC--EEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE-
Confidence 456777899999999999999876543 234689998865433 35689999999999999999999999877644
Q ss_pred ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccc
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 241 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 241 (426)
|+|||||++|+|.+++.... ..+++..++.|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||++
T Consensus 103 ---~iv~Ey~~~g~L~~~~~~~~-~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla 175 (299)
T d1jpaa_ 103 ---MIITEFMENGSLDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLS 175 (299)
T ss_dssp ---EEEEECCTTEEHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---
T ss_pred ---EEEEEecCCCcceeeecccc-CCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccc
Confidence 99999999999999887543 3589999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCcee---eeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhh
Q 014363 242 RLGPSEGFTH---VSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSD 317 (426)
Q Consensus 242 ~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 317 (426)
+......... ......||+.|||||++.++.|+.++|||||||++|||+| |..||....... +...+.
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~---~~~~i~----- 247 (299)
T d1jpaa_ 176 RFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD---VINAIE----- 247 (299)
T ss_dssp --------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHH-----
T ss_pred eEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH---HHHHHH-----
Confidence 8765432211 1223468999999999999999999999999999999998 899997654322 111111
Q ss_pred hhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 014363 318 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 372 (426)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~ 372 (426)
.......+..++..+.+|+.+||+.||++|||+.||++.|+.++..
T Consensus 248 ---------~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 248 ---------QDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp ---------TTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ---------cCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 1111223344667899999999999999999999999999988754
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-57 Score=420.01 Aligned_cols=250 Identities=24% Similarity=0.368 Sum_probs=204.9
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccc-----cCCHHHHHHHHHHHhhcCCCCccceEeEEEccCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGR-----RGGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~-----~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
++|++++.||+|+||+||+|.++.++. .||+|.+.. ....+.+.+|+.+|++++|||||++++++.+.+
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~-----~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~- 81 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSR-----EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE- 81 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCC-----EEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSS-
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCC-----EEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECC-
Confidence 469999999999999999999887654 799998853 234567899999999999999999999998765
Q ss_pred CCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeec
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 239 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 239 (426)
..|||||||+||+|.+++...+ .+++..++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|||
T Consensus 82 ---~~~ivmEy~~gg~L~~~~~~~~--~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG 153 (288)
T d1uu3a_ 82 ---KLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFG 153 (288)
T ss_dssp ---EEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred ---EEEEEEEccCCCCHHHhhhccC--CCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccc
Confidence 4599999999999999986543 499999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014363 240 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 319 (426)
Q Consensus 240 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 319 (426)
+|+..............+||+.|+|||++.+..|+.++|||||||++|||++|..||.........
T Consensus 154 ~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~-------------- 219 (288)
T d1uu3a_ 154 TAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF-------------- 219 (288)
T ss_dssp TCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--------------
T ss_pred cceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHH--------------
Confidence 998776444334445678999999999999999999999999999999999999999865332111
Q ss_pred hhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014363 320 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMV 366 (426)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L 366 (426)
..+.... ..++..+++.+.+||.+||+.||++|||++|++++.
T Consensus 220 --~~i~~~~--~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~ 262 (288)
T d1uu3a_ 220 --QKIIKLE--YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYG 262 (288)
T ss_dssp --HHHHTTC--CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHH
T ss_pred --HHHHcCC--CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCH
Confidence 1111111 122334567899999999999999999999987653
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-56 Score=425.87 Aligned_cols=264 Identities=26% Similarity=0.359 Sum_probs=205.3
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
.++|++++.||+|+||+||+|.++.++ ..||+|.+.... ....+.+|+.+|+.++|||||+++++|.+..
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~-----~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-- 77 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSG-----LVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-- 77 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTT-----EEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSS--
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCC-----cEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC--
Confidence 467999999999999999999987665 389999986442 2457889999999999999999999998876
Q ss_pred CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhcc-CCCCCeEeccCCCCceEeCCCCCeeEeeec
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHE-GMDFQIIVRDFKSSNILLDEQWNAKLSDFG 239 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~-~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 239 (426)
+.|||||||+||+|.+++...+ .+++..++.++.|++.||+|||+ + +|+||||||+||||+.+|.+||+|||
T Consensus 78 --~~~iVmEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFG 150 (322)
T d1s9ja_ 78 --EISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFG 150 (322)
T ss_dssp --EEEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCC
T ss_pred --EEEEEEEcCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCC
Confidence 4699999999999999997543 49999999999999999999996 5 89999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhH-hh-----
Q 014363 240 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWV-KP----- 313 (426)
Q Consensus 240 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~-~~----- 313 (426)
+|+..... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||........+...... ..
T Consensus 151 la~~~~~~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 226 (322)
T d1s9ja_ 151 VSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAET 226 (322)
T ss_dssp CCHHHHHH----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------
T ss_pred CccccCCC----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccC
Confidence 99865321 234578999999999999999999999999999999999999999765443221110000 00
Q ss_pred --------------------hhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 314 --------------------YLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 314 --------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
..........+.............+.++.+|+.+||+.||++|||++|+++|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 227 PPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp -------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 0000000111111111111112245688999999999999999999999996
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-55 Score=411.28 Aligned_cols=260 Identities=23% Similarity=0.425 Sum_probs=208.7
Q ss_pred CCCCCcce-ecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 85 KNFSRSVV-IGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 85 ~~y~~~~~-lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
++|...+. ||+|+||+||+|.++..+. ...||||.+.... ..+.|.+|+++|++++|||||+++|++.++.
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~---~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~-- 82 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKK---QIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA-- 82 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---C---CEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSS--
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCC---cEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccCe--
Confidence 34556664 9999999999998765432 3479999986543 2357899999999999999999999987542
Q ss_pred CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecc
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 240 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 240 (426)
+|||||||++|+|.+++.... ..+++..++.|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 83 ---~~lvmE~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGl 155 (285)
T d1u59a_ 83 ---LMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGL 155 (285)
T ss_dssp ---EEEEEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTT
T ss_pred ---EEEEEEeCCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchh
Confidence 589999999999999986433 4589999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCce-eeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014363 241 ARLGPSEGFT-HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDA 318 (426)
Q Consensus 241 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 318 (426)
++........ .......||+.|+|||++.++.++.++|||||||++|||+| |..||...........+ .
T Consensus 156 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i---~------ 226 (285)
T d1u59a_ 156 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI---E------ 226 (285)
T ss_dssp CEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHH---H------
T ss_pred hhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHH---H------
Confidence 9876543322 22334578999999999999999999999999999999998 99999865433211111 0
Q ss_pred hhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhh
Q 014363 319 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 373 (426)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~ 373 (426)
.......+..+++++.+||.+||+.||++|||+.+|++.|+......
T Consensus 227 --------~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~ 273 (285)
T d1u59a_ 227 --------QGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273 (285)
T ss_dssp --------TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred --------cCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 01111233456678999999999999999999999999998776543
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-56 Score=415.52 Aligned_cols=251 Identities=26% Similarity=0.383 Sum_probs=204.6
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC--CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCc
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 162 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~ 162 (426)
+.|++++.||+|+||+||+|.++.++. .||+|.+.... ..+.+.+|+++|+.++|||||++++++.+.+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~-----~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~---- 82 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSV-----LAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN---- 82 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCC-----EEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETT----
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCe-----EEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC----
Confidence 468899999999999999999887664 79999986543 4467899999999999999999999998866
Q ss_pred eEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccc
Q 014363 163 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 242 (426)
Q Consensus 163 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 242 (426)
..|||||||++|+|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|.
T Consensus 83 ~~~lvmEy~~~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~ 158 (288)
T d2jfla1 83 NLWILIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSA 158 (288)
T ss_dssp EEEEEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred eEEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhh
Confidence 4599999999999999876432 3599999999999999999999998 99999999999999999999999999997
Q ss_pred cCCCCCceeeeeeeecCcccCCchhhc-----cCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh
Q 014363 243 LGPSEGFTHVSTAVVGTMGYAAPEYVQ-----TGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 317 (426)
Q Consensus 243 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 317 (426)
..... .......+||+.|+|||++. +..|+.++|||||||++|||++|..||...........+ ..
T Consensus 159 ~~~~~--~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i--~~----- 229 (288)
T d2jfla1 159 KNTRT--IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI--AK----- 229 (288)
T ss_dssp ECHHH--HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH--HH-----
T ss_pred ccCCC--cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHH--Hc-----
Confidence 54321 11233568999999999984 456899999999999999999999999765433211110 00
Q ss_pred hhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 318 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
........+..+++++.+||.+||+.||++|||++|+++|
T Consensus 230 --------~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 230 --------SEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp --------SCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred --------CCCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0001112233466789999999999999999999999885
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-55 Score=404.65 Aligned_cols=252 Identities=25% Similarity=0.454 Sum_probs=209.2
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCce
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQ 163 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~ 163 (426)
++|+.+++||+|+||+||+|++++. ..||+|.+.... ..++|.+|+.++++++|||||+++|++.+...
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~------~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~---- 73 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQ------YDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRP---- 73 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTT------EEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSS----
T ss_pred HHCEEeEEEecCCCeEEEEEEECCC------CEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCc----
Confidence 5789999999999999999998643 379999986543 56789999999999999999999999987653
Q ss_pred EEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccccc
Q 014363 164 RLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL 243 (426)
Q Consensus 164 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 243 (426)
+++||||+++|+|.+++.... ..+++..++.++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 74 ~~iv~Ey~~~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~ 149 (258)
T d1k2pa_ 74 IFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRY 149 (258)
T ss_dssp EEEEEECCTTEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCB
T ss_pred eEEEEEccCCCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhhee
Confidence 599999999999999976443 3488999999999999999999998 999999999999999999999999999986
Q ss_pred CCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhhh
Q 014363 244 GPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQFR 322 (426)
Q Consensus 244 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (426)
....... ......||+.|+|||++.+..|+.++|||||||++|||+| |+.||...........+
T Consensus 150 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i-------------- 214 (258)
T d1k2pa_ 150 VLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI-------------- 214 (258)
T ss_dssp CSSSSCC-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHH--------------
T ss_pred ccCCCce-eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHH--------------
Confidence 5543322 2334679999999999999999999999999999999998 89999866433211111
Q ss_pred hhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 014363 323 QIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNK 368 (426)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~ 368 (426)
.. ......+..+++.+.+||.+||+.||++|||++||+++|.+
T Consensus 215 --~~-~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 215 --AQ-GLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp --HT-TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred --Hh-CCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 01 11112233455789999999999999999999999999864
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-55 Score=409.45 Aligned_cols=263 Identities=25% Similarity=0.472 Sum_probs=203.3
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC---HHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG---HKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
+.|+..++||+|+||.||+|.++.++. .....||||.+..... ...|.+|+.+|++++|||||+++|++.+...
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~-~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~-- 83 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSG-KKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP-- 83 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC----CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS--
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCC-EEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCc--
Confidence 468888999999999999999886542 3445799999865443 3468899999999999999999999987664
Q ss_pred ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccc
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 241 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 241 (426)
.++|||||.+++|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+||||+.++.+||+|||++
T Consensus 84 --~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla 157 (283)
T d1mqba_ 84 --MMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLS 157 (283)
T ss_dssp --EEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred --eEEEEEecccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchh
Confidence 499999999999998876443 4599999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCc-eeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhh
Q 014363 242 RLGPSEGF-THVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 320 (426)
Q Consensus 242 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (426)
+....... ........||+.|||||++.++.++.++|||||||++|||++|..|+...... ..+...
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~--~~~~~~---------- 225 (283)
T d1mqba_ 158 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--HEVMKA---------- 225 (283)
T ss_dssp ----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHH----------
T ss_pred hcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH--HHHHHH----------
Confidence 87543321 22233457899999999999999999999999999999999966665433221 111111
Q ss_pred hhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 014363 321 FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 372 (426)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~ 372 (426)
+........+..++..+.+|+.+||+.||++|||+.||++.|+.+++.
T Consensus 226 ----i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 226 ----INDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp ----HHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ----HhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 111122233344667899999999999999999999999999988764
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-55 Score=407.58 Aligned_cols=250 Identities=25% Similarity=0.431 Sum_probs=201.3
Q ss_pred ceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCceEEE
Q 014363 91 VVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLL 166 (426)
Q Consensus 91 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~~~l 166 (426)
++||+|+||+||+|.++... ..+.||+|.+.... ..+.+.+|+.+|++++|||||+++|+|.++. .+|
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~~-----~~l 84 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKK---VVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAES-----WML 84 (277)
T ss_dssp EEEEECSSEEEEEEEEECSS---SEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSS-----EEE
T ss_pred CCcccCCCeEEEEEEEccCC---cCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccCC-----EEE
Confidence 46999999999999876542 34579999986432 2357899999999999999999999986532 489
Q ss_pred EEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccCCC
Q 014363 167 VYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPS 246 (426)
Q Consensus 167 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 246 (426)
|||||++|+|.+++.... .+++..++.|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 85 vmE~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~ 159 (277)
T d1xbba_ 85 VMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 159 (277)
T ss_dssp EEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred EEEcCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhccc
Confidence 999999999999997543 499999999999999999999998 999999999999999999999999999987654
Q ss_pred CCce-eeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhh
Q 014363 247 EGFT-HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQI 324 (426)
Q Consensus 247 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (426)
.... .......||+.|||||++.+..++.++|||||||++|||++ |..||.+.........+
T Consensus 160 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i---------------- 223 (277)
T d1xbba_ 160 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML---------------- 223 (277)
T ss_dssp TCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH----------------
T ss_pred cccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHH----------------
Confidence 4322 22345679999999999999999999999999999999998 89999865432211111
Q ss_pred cCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhH
Q 014363 325 VDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIV 370 (426)
Q Consensus 325 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~ 370 (426)
........+..++.++.+|+.+||+.||++|||+++|++.|+...
T Consensus 224 -~~~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 224 -EKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp -HTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred -HcCCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 011111233446678999999999999999999999998887764
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-55 Score=415.83 Aligned_cols=249 Identities=23% Similarity=0.344 Sum_probs=191.9
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
.+.|++.+.||+|+||+||+|.++.++. .||+|.+.... ..+.+.+|+.+|+.++|||||++++++.+.+
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~-----~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-- 80 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQK-----LVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGG-- 80 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCC-----EEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSS--
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCC-----EEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC--
Confidence 4579999999999999999999887654 79999986442 3346789999999999999999999998765
Q ss_pred CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeC---CCCCeeEee
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLD---EQWNAKLSD 237 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~---~~~~~kl~D 237 (426)
..|||||||+||+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||+. +++.+||+|
T Consensus 81 --~~~lvmE~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~D 153 (307)
T d1a06a_ 81 --HLYLIMQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISD 153 (307)
T ss_dssp --EEEEEECCCCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECC
T ss_pred --EEEEEEeccCCCcHHHhhhcc--cCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEec
Confidence 459999999999999999754 3499999999999999999999998 999999999999994 578999999
Q ss_pred ecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh
Q 014363 238 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 317 (426)
Q Consensus 238 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 317 (426)
||+++...... .....+||+.|||||++.+..|+.++|||||||++|||++|..||..........
T Consensus 154 FG~a~~~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~----------- 219 (307)
T d1a06a_ 154 FGLSKMEDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFE----------- 219 (307)
T ss_dssp C---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-----------
T ss_pred cceeEEccCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHH-----------
Confidence 99998654322 2345789999999999999999999999999999999999999997644322111
Q ss_pred hhhhhhhcC--CcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 318 AKQFRQIVD--PRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 318 ~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.+.. ..........+++++.+|+.+||+.||++|||++|+++|
T Consensus 220 -----~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 220 -----QILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp -----HHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred -----HHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 1111 111122223466789999999999999999999999986
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-55 Score=414.41 Aligned_cols=268 Identities=25% Similarity=0.370 Sum_probs=208.0
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC---HHHHHHHHHHHhhc-CCCCccceEeEEEccCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG---HKEWMTEVNFLGIV-EHQNLVKLVGYCADDDE 159 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~ 159 (426)
.++|++++.||+|+||.||+|.+.......+.+.||+|.+..... .+.+.+|..++.++ +|+|||.+++++.+.+.
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 467999999999999999999998877777888999999865432 34677888888877 78999999998876543
Q ss_pred CCceEEEEEeeCCCCChhhhccCCC--------------CCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCce
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPKS--------------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNI 225 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NI 225 (426)
..++|||||++|+|.+++.... ...+++..++.++.||+.||+|||++ +|+||||||+||
T Consensus 92 ---~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NI 165 (299)
T d1ywna1 92 ---PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNI 165 (299)
T ss_dssp ---CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred ---eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccce
Confidence 2489999999999999986432 23489999999999999999999998 999999999999
Q ss_pred EeCCCCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhC-CCCCCCCCchhh
Q 014363 226 LLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITG-RRPIDRNRPRSE 304 (426)
Q Consensus 226 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg-~~p~~~~~~~~~ 304 (426)
||+.++.+||+|||+|+...............||+.|+|||++.++.++.++|||||||++|||++| ..||........
T Consensus 166 Ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~ 245 (299)
T d1ywna1 166 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 245 (299)
T ss_dssp EECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred eECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence 9999999999999999876544333334557899999999999999999999999999999999996 457765432211
Q ss_pred HHHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhh
Q 014363 305 QKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 373 (426)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~ 373 (426)
+...+ ........+..+++++.+++.+||+.||++|||++||+++|+.++++.
T Consensus 246 --~~~~~--------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~n 298 (299)
T d1ywna1 246 --FCRRL--------------KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 298 (299)
T ss_dssp --HHHHH--------------HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred --HHHHH--------------hcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCC
Confidence 11111 011111223345678999999999999999999999999999987653
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-55 Score=416.42 Aligned_cols=244 Identities=30% Similarity=0.415 Sum_probs=200.5
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-----CHHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
.|+.++.||+|+||+||+|.+..++. .||+|.+.... ..+.+.+|+.+|++++|||||++++++.+.+
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~-----~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~-- 88 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSE-----VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH-- 88 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTE-----EEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT--
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCc-----EEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECC--
Confidence 58999999999999999999877653 79999986543 2246889999999999999999999998865
Q ss_pred CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecc
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 240 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 240 (426)
..|||||||++|+|..++... ..+++..++.++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+
T Consensus 89 --~~~iv~E~~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~ 161 (309)
T d1u5ra_ 89 --TAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGS 161 (309)
T ss_dssp --EEEEEEECCSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTT
T ss_pred --EEEEEEEecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeeccc
Confidence 459999999999998776543 3499999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCchhhcc---CCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh
Q 014363 241 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQT---GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 317 (426)
Q Consensus 241 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 317 (426)
+..... ....+||+.|||||++.+ +.|+.++|||||||++|||++|..||..........
T Consensus 162 a~~~~~------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~----------- 224 (309)
T d1u5ra_ 162 ASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY----------- 224 (309)
T ss_dssp CBSSSS------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-----------
T ss_pred ccccCC------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHH-----------
Confidence 986543 234679999999999864 468999999999999999999999997654321111
Q ss_pred hhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 318 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.+.........+..+++.+.+||.+||+.||++|||++|+++|
T Consensus 225 -----~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 225 -----HIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp -----HHHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred -----HHHhCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 1111111111122356789999999999999999999999885
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.6e-54 Score=415.55 Aligned_cols=252 Identities=21% Similarity=0.357 Sum_probs=207.5
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC--CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
.++|++++.||+|+||.||+|.++.++. .||+|++.... ..+.+.+|+.+|+.++|||||++++++.+.+
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~-----~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~--- 96 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGN-----NFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN--- 96 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTE-----EEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETT---
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCC-----EEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECC---
Confidence 4589999999999999999999876653 89999986543 3456889999999999999999999998865
Q ss_pred ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeC--CCCCeeEeeec
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLD--EQWNAKLSDFG 239 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~--~~~~~kl~DFG 239 (426)
.+|||||||+||+|.+++.... ..+++..++.|+.||+.||+|||++ +|+||||||+|||++ .++.+||+|||
T Consensus 97 -~~~ivmE~~~gg~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG 171 (350)
T d1koaa2 97 -EMVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFG 171 (350)
T ss_dssp -EEEEEECCCCSCBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCT
T ss_pred -EEEEEEEcCCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecc
Confidence 4699999999999999986443 3499999999999999999999998 999999999999995 46789999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014363 240 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 319 (426)
Q Consensus 240 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 319 (426)
+++...... ......||+.|||||++.+..|+.++|||||||++|+|++|..||.+.........+ ..
T Consensus 172 ~a~~~~~~~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i---~~------ 239 (350)
T d1koaa2 172 LTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV---KS------ 239 (350)
T ss_dssp TCEECCTTS---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HH------
T ss_pred hheeccccc---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHH---Hh------
Confidence 998765433 234578999999999999999999999999999999999999999765332111110 00
Q ss_pred hhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 320 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
............+++.+.+||.+||+.||++|||++|+++|
T Consensus 240 -----~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 240 -----CDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp -----TCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred -----CCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00111122223456789999999999999999999999986
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-55 Score=408.19 Aligned_cols=257 Identities=26% Similarity=0.433 Sum_probs=204.0
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCce
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQ 163 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~ 163 (426)
++|++++.||+|+||+||+|.++++. .||+|++.... ..+.|.+|+.+|++++|||||+++|++.+. .
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~------~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~-~---- 85 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTT------RVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE-P---- 85 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTE------EEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-S----
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCC------EEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEecC-C----
Confidence 57999999999999999999986543 69999986554 457899999999999999999999998543 2
Q ss_pred EEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccccc
Q 014363 164 RLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL 243 (426)
Q Consensus 164 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 243 (426)
.++||||+++|+|..++.......+++..++.|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++.
T Consensus 86 ~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~ 162 (285)
T d1fmka3 86 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARL 162 (285)
T ss_dssp CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred eEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhh
Confidence 38999999999999998765445699999999999999999999998 999999999999999999999999999986
Q ss_pred CCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhh
Q 014363 244 GPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQ 323 (426)
Q Consensus 244 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (426)
...... .......||+.|+|||++..+.++.++|||||||++|||++|..|+...... ......+.
T Consensus 163 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~--~~~~~~i~----------- 228 (285)
T d1fmka3 163 IEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQVE----------- 228 (285)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHH-----------
T ss_pred ccCCCc-eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH--HHHHHHHH-----------
Confidence 543322 2234467999999999999999999999999999999999976666443321 11111111
Q ss_pred hcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 014363 324 IVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 372 (426)
Q Consensus 324 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~ 372 (426)
.......+..+++++.+||.+||+.||++|||+++|++.|+.....
T Consensus 229 ---~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 229 ---RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp ---TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred ---hcCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 1111223344667899999999999999999999999999876644
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.1e-54 Score=415.05 Aligned_cols=252 Identities=21% Similarity=0.330 Sum_probs=208.1
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC--CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
.++|++++.||+|+||.||+|.++.++. .||+|.+.... ..+.+.+|+.+|+.++|||||+++++|.+.+
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~-----~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~--- 99 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGR-----VFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY--- 99 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCC-----EEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS---
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCC-----EEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC---
Confidence 3579999999999999999999877654 89999986554 3456789999999999999999999998765
Q ss_pred ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeC--CCCCeeEeeec
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLD--EQWNAKLSDFG 239 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~--~~~~~kl~DFG 239 (426)
.+|||||||+||+|.+++.... ..+++..++.|+.||+.||+|||++ ||+||||||+||||+ .++.+||+|||
T Consensus 100 -~~~ivmE~~~gg~L~~~~~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFG 174 (352)
T d1koba_ 100 -EMVLILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFG 174 (352)
T ss_dssp -EEEEEEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCT
T ss_pred -EEEEEEEcCCCChHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecc
Confidence 4599999999999998876443 3499999999999999999999998 999999999999997 67899999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014363 240 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 319 (426)
Q Consensus 240 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 319 (426)
+|....... ......||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.........+ .
T Consensus 175 la~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i---~------- 241 (352)
T d1koba_ 175 LATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV---K------- 241 (352)
T ss_dssp TCEECCTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH---H-------
T ss_pred cceecCCCC---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---H-------
Confidence 998776543 234568999999999999999999999999999999999999999765432211111 0
Q ss_pred hhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 320 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
. .+..........+++++.+||.+||+.||++|||++|+++|
T Consensus 242 ---~-~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 242 ---R-CDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp ---H-CCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ---h-CCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 01111222223456789999999999999999999999986
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-54 Score=412.36 Aligned_cols=261 Identities=26% Similarity=0.440 Sum_probs=208.5
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc---CCHHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR---GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
.+|+.+++||+|+||+||+|.+..++.. ....||+|.+... ...+.+.+|+.+|++++|||||+++|+|.+..
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~--- 84 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEK-VKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST--- 84 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC-----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS---
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCE-EEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC---
Confidence 4699999999999999999998776543 3446899988543 24568999999999999999999999998753
Q ss_pred ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccc
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 241 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 241 (426)
.+++|||+.+|+|.+++... ...+++..++.|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 85 --~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla 158 (317)
T d1xkka_ 85 --VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLA 158 (317)
T ss_dssp --EEEEEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHH
T ss_pred --eeEEEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccc
Confidence 37899999999999888754 34589999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhh
Q 014363 242 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 320 (426)
Q Consensus 242 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (426)
+...............||+.|+|||++.++.|+.++|||||||++|||+| |..||.+.........+.
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~----------- 227 (317)
T d1xkka_ 159 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE----------- 227 (317)
T ss_dssp HHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHH-----------
T ss_pred eecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-----------
Confidence 97765444444455679999999999999999999999999999999998 888987654332221111
Q ss_pred hhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 014363 321 FRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 372 (426)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~ 372 (426)
.......+..++..+.+|+.+||+.||++|||+.||+++|..+...
T Consensus 228 ------~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 228 ------KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp ------HTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ------cCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 0111122334567899999999999999999999999999887643
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-55 Score=402.84 Aligned_cols=252 Identities=27% Similarity=0.452 Sum_probs=203.3
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCceE
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQR 164 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~~ 164 (426)
++|+.++.||+|+||.||+|.+++ ..||+|.++.....+.+.+|+++|++++|||||+++|++.+... .+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~-------~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~---~~ 76 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYRG-------NKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG---GL 76 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT-------EEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC-----CC
T ss_pred HHeEEeEEEecCCCeEEEEEEECC-------eEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCC---cE
Confidence 467888999999999999999854 27999999888778899999999999999999999999965432 24
Q ss_pred EEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccC
Q 014363 165 LLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLG 244 (426)
Q Consensus 165 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 244 (426)
|+||||+++|+|.+++.......+++..++.|+.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 77 ~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~ 153 (262)
T d1byga_ 77 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 153 (262)
T ss_dssp EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceec
Confidence 8999999999999999765545689999999999999999999998 9999999999999999999999999999865
Q ss_pred CCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhhhhhh
Q 014363 245 PSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQ 323 (426)
Q Consensus 245 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (426)
... .....+|..|+|||++.++.++.++|||||||++|||+| |++||......... ..
T Consensus 154 ~~~-----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~---~~------------- 212 (262)
T d1byga_ 154 SST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV---PR------------- 212 (262)
T ss_dssp -------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHH---HH-------------
T ss_pred CCC-----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHH---HH-------------
Confidence 432 234568999999999999999999999999999999998 78888754332211 11
Q ss_pred hcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHh
Q 014363 324 IVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVD 371 (426)
Q Consensus 324 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~ 371 (426)
+........+..+++++.+|+.+||+.||++|||+.+|+++|+.+..
T Consensus 213 -i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 213 -VEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp -HTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHcCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 11112223344456789999999999999999999999999998764
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-54 Score=412.06 Aligned_cols=248 Identities=27% Similarity=0.368 Sum_probs=208.4
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-----CCHHHHHHHHHHHhhcCCCCccceEeEEEccC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-----GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 158 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 158 (426)
.++|++++.||+|+||.||+|.++.++. .||+|++... ...+.+.+|+.+|+.++|||||++++++.+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~-----~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 78 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGR-----YYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCC-----EEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCC-----EEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccc
Confidence 3579999999999999999999887665 8999998632 34567899999999999999999999999876
Q ss_pred CCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeee
Q 014363 159 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 238 (426)
Q Consensus 159 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 238 (426)
.+|+|||||+||+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.+|.+||+||
T Consensus 79 ----~~~iv~ey~~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DF 149 (337)
T d1o6la_ 79 ----RLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDF 149 (337)
T ss_dssp ----EEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCC
T ss_pred ----ccccceeccCCCchhhhhhccc--CCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeec
Confidence 4599999999999999987543 489999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014363 239 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 318 (426)
Q Consensus 239 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 318 (426)
|+|+...... ......+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.........
T Consensus 150 G~a~~~~~~~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~----------- 216 (337)
T d1o6la_ 150 GLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL----------- 216 (337)
T ss_dssp TTCBCSCCTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-----------
T ss_pred ccccccccCC--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHH-----------
Confidence 9998654432 223457899999999999999999999999999999999999999987543221111
Q ss_pred hhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 014363 319 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPK-----MSEVLEM 365 (426)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~eil~~ 365 (426)
+.... ..++..+++++.+||.+||+.||++||+ ++|+++|
T Consensus 217 -----i~~~~--~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 217 -----ILMEE--IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp -----HHHCC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -----HhcCC--CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 11111 1233346678999999999999999995 8899886
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-54 Score=409.01 Aligned_cols=264 Identities=27% Similarity=0.436 Sum_probs=215.0
Q ss_pred HhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC---HHHHHHHHHHHhhcCCCCccceEeEEEccCC
Q 014363 83 ATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG---HKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 83 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
..++|++++.||+|+||+||+|++++.........||||++..... .+.|.+|+.+|+.++||||+++++++.+...
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence 4678999999999999999999988766666777899999875543 3568999999999999999999999987665
Q ss_pred CCceEEEEEeeCCCCChhhhccCCC----------------------CCccCHHHHHHHHHHHHHHHHHhccCCCCCeEe
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPKS----------------------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIV 217 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~~----------------------~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiH 217 (426)
. ++||||+++|+|.+++.... ...+++..++.|+.|++.||+|||++ +|||
T Consensus 91 ~----~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivH 163 (301)
T d1lufa_ 91 M----CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVH 163 (301)
T ss_dssp C----EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred e----EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEe
Confidence 4 99999999999999985321 23488999999999999999999998 9999
Q ss_pred ccCCCCceEeCCCCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCC-CCC
Q 014363 218 RDFKSSNILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGR-RPI 296 (426)
Q Consensus 218 rDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~-~p~ 296 (426)
|||||+||||+.++.+||+|||+++...............||+.|+|||++.+..|+.++|||||||++|||++|. +||
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence 9999999999999999999999998665443333445678999999999999999999999999999999999985 567
Q ss_pred CCCCchhhHHHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhH
Q 014363 297 DRNRPRSEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIV 370 (426)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~ 370 (426)
....... +... +.+.. ....+..+++++.+|+.+||+.||++|||+.||++.|+++.
T Consensus 244 ~~~~~~e---~~~~-------------v~~~~-~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 244 YGMAHEE---VIYY-------------VRDGN-ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTSCHHH---HHHH-------------HHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCHHH---HHHH-------------HHcCC-CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 6543322 1111 11111 11223345678999999999999999999999999999875
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-54 Score=404.63 Aligned_cols=251 Identities=25% Similarity=0.357 Sum_probs=205.8
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC--------CHHHHHHHHHHHhhcCCCCccceEeEEE
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--------GHKEWMTEVNFLGIVEHQNLVKLVGYCA 155 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~--------~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 155 (426)
.++|++++.||+|+||+||+|.++.++. .||+|.+.... ..+.+.+|+.+|++++|||||++++++.
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~-----~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~ 83 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGL-----QYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE 83 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCC-----EEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCC-----EEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 3579999999999999999999887654 89999885332 3467899999999999999999999998
Q ss_pred ccCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCC----
Q 014363 156 DDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW---- 231 (426)
Q Consensus 156 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~---- 231 (426)
+.. ..|||||||+||+|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++
T Consensus 84 ~~~----~~~iv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~ 154 (293)
T d1jksa_ 84 NKT----DVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKP 154 (293)
T ss_dssp CSS----EEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSC
T ss_pred ECC----EEEEEEEcCCCccccchhcccc--ccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCccc
Confidence 876 4599999999999999996543 499999999999999999999998 999999999999998776
Q ss_pred CeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhH
Q 014363 232 NAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWV 311 (426)
Q Consensus 232 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~ 311 (426)
.+||+|||++....... ......||+.|+|||++.+..|+.++|||||||++|||++|..||.+.........+..
T Consensus 155 ~vkl~DfG~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~- 230 (293)
T d1jksa_ 155 RIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA- 230 (293)
T ss_dssp CEEECCCTTCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHT-
T ss_pred ceEecchhhhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHh-
Confidence 49999999998765432 23456799999999999999999999999999999999999999986543221111100
Q ss_pred hhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 312 KPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
............++..+.+||.+||+.||++|||++|+++|
T Consensus 231 -------------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 231 -------------VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp -------------TCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -------------cCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00011111122355788999999999999999999999985
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-54 Score=401.20 Aligned_cols=260 Identities=22% Similarity=0.383 Sum_probs=200.4
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC---HHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG---HKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
.++|++.+.||+|+||.||+|.+...+. ....||+|.+..... .+.+.+|+.+|++++|||||+++|++.+.
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~--~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--- 80 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPEN--PALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN--- 80 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC----CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS---
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCc--eeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---
Confidence 3578999999999999999999876432 335789998865432 35688999999999999999999999643
Q ss_pred CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecc
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 240 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 240 (426)
..|+||||+++|+|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 81 --~~~iv~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~ 154 (273)
T d1mp8a_ 81 --PVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGL 154 (273)
T ss_dssp --SCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC---
T ss_pred --eEEEEEEeccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchh
Confidence 2499999999999999876433 4589999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014363 241 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSDAK 319 (426)
Q Consensus 241 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 319 (426)
++...... ........||+.|+|||++.+..|+.++|||||||++|||++ |.+||...........+
T Consensus 155 a~~~~~~~-~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i----------- 222 (273)
T d1mp8a_ 155 SRYMEDST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI----------- 222 (273)
T ss_dssp -----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH-----------
T ss_pred heeccCCc-ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHH-----------
Confidence 98654332 222345678999999999999999999999999999999998 89999765543221111
Q ss_pred hhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 014363 320 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 372 (426)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~ 372 (426)
... .....+..+++.+.+||.+||+.||++|||+.||+++|+.+++.
T Consensus 223 -----~~~-~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 223 -----ENG-ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp -----HTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----HcC-CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 110 11123345667899999999999999999999999999988754
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9.6e-54 Score=404.89 Aligned_cols=244 Identities=25% Similarity=0.405 Sum_probs=205.7
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-----CCHHHHHHHHHHHhhcCCCCccceEeEEEccCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-----GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
++|++++.||+|+||+||+|+++.++. .||+|++... ...+.+.+|+.+|+.++|||||++++++.+.+
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~-----~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~- 77 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGR-----YYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ- 77 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCC-----EEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS-
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCC-----EEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCC-
Confidence 579999999999999999999887654 8999998532 34567899999999999999999999998866
Q ss_pred CCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeec
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 239 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 239 (426)
..|+|||||+||+|..++.... .+++..++.++.||+.||+|||++ +|+||||||+||||+.+|.+||+|||
T Consensus 78 ---~~~ivmE~~~gg~l~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG 149 (316)
T d1fota_ 78 ---QIFMIMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFG 149 (316)
T ss_dssp ---EEEEEECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCS
T ss_pred ---eeeeEeeecCCccccccccccc--cccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCc
Confidence 4699999999999999987544 378889999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014363 240 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 319 (426)
Q Consensus 240 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 319 (426)
+|+..... ....+||+.|||||++.+..|+.++|||||||++|+|++|..||..........
T Consensus 150 ~a~~~~~~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~------------- 211 (316)
T d1fota_ 150 FAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYE------------- 211 (316)
T ss_dssp SCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH-------------
T ss_pred cceEeccc-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHH-------------
Confidence 99876532 335789999999999999999999999999999999999999997654322111
Q ss_pred hhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 014363 320 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRP-----KMSEVLEM 365 (426)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~ 365 (426)
.+.... ..++..+++++.+++.+||+.||++|+ |++++++|
T Consensus 212 ---~i~~~~--~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 212 ---KILNAE--LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp ---HHHHCC--CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ---HHHcCC--CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 111111 122334567899999999999999996 89999986
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.3e-53 Score=397.59 Aligned_cols=263 Identities=26% Similarity=0.356 Sum_probs=205.8
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-----CHHHHHHHHHHHhhcCCCCccceEeEEEccC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDD 158 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 158 (426)
.++|++.+.||+|+||+||+|.+..++ +.||+|.+.... ..+.+.+|+.+|+.++|||||++++++...+
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~-----~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~ 80 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLH-----RDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET 80 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTT-----EEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCC-----CEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc
Confidence 357999999999999999999987655 389999986442 2346889999999999999999999998877
Q ss_pred CCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeee
Q 014363 159 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 238 (426)
Q Consensus 159 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 238 (426)
......|||||||+|++|.+++...+ .+++..++.|+.||+.||+|||++ +|+||||||+|||++.++.++|+||
T Consensus 81 ~~~~~~~lvmE~~~g~~L~~~~~~~~--~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~ 155 (277)
T d1o6ya_ 81 PAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDF 155 (277)
T ss_dssp SSSEEEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCC
T ss_pred CCCceEEEEEECCCCCEehhhhcccC--CCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehh
Confidence 66566799999999999999886543 489999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCC-ceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh
Q 014363 239 GLARLGPSEG-FTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD 317 (426)
Q Consensus 239 Gla~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 317 (426)
|.+....... ........+||+.|+|||++.+..|+.++|||||||++|||+||..||.......... ... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~--~~~----~~ 229 (277)
T d1o6ya_ 156 GIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY--QHV----RE 229 (277)
T ss_dssp TTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH--HHH----HC
T ss_pred hhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHH--HHH----hc
Confidence 9987654322 1223445789999999999999999999999999999999999999998654322111 100 00
Q ss_pred hhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHHHHhH
Q 014363 318 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRP-KMSEVLEMVNKIV 370 (426)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-s~~eil~~L~~~~ 370 (426)
.+.........+++.+.+++.+||+.||++|| |++++++.|..+.
T Consensus 230 --------~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 230 --------DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp --------CCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred --------CCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 00011111223567899999999999999999 8999999888764
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-53 Score=406.99 Aligned_cols=256 Identities=21% Similarity=0.266 Sum_probs=205.6
Q ss_pred hCCCCCcc-eecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhc-CCCCccceEeEEEccCCCC
Q 014363 84 TKNFSRSV-VIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 84 ~~~y~~~~-~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~~~ 161 (426)
.++|.+.. +||+|+||+||+|.+..++. .||+|++... ..+.+|+.++.++ +|||||+++++|.+.....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~-----~vAiK~i~~~---~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~ 81 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQE-----KFALKMLQDC---PKARREVELHWRASQCPHIVRIVDVYENLYAGR 81 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCC-----EEEEEEEECS---HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCC-----EEEEEEECCc---HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCC
Confidence 45788764 69999999999999877654 8999998643 5678999987655 8999999999997744334
Q ss_pred ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCC---CCCeeEeee
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE---QWNAKLSDF 238 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~---~~~~kl~DF 238 (426)
..+|||||||+||+|.++|...+...+++..++.|+.||+.||+|||++ +|+||||||+|||++. ++.+||+||
T Consensus 82 ~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DF 158 (335)
T d2ozaa1 82 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDF 158 (335)
T ss_dssp EEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred CEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccccccccc
Confidence 4679999999999999999876656799999999999999999999998 9999999999999975 567999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014363 239 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 318 (426)
Q Consensus 239 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 318 (426)
|+++...... .....+||+.|||||++.+..|+.++|||||||++|+|+||..||.+..........
T Consensus 159 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~---------- 225 (335)
T d2ozaa1 159 GFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM---------- 225 (335)
T ss_dssp TTCEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------------
T ss_pred ceeeeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH----------
Confidence 9998765432 234568999999999999999999999999999999999999999754322111000
Q ss_pred hhhhhhcCCc--CCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 319 KQFRQIVDPR--LEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 319 ~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
...+.... ........+++++.+||.+||+.||++|||+.|+++|
T Consensus 226 --~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 226 --KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp ----CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred --HHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 00111111 1112223567889999999999999999999999986
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-53 Score=402.12 Aligned_cols=266 Identities=26% Similarity=0.420 Sum_probs=217.7
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhc-CCCCccceEeEEEccCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDE 159 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~ 159 (426)
.++|++.++||+|+||.||+|.+.........+.||||++.... ....+.+|+.+++.+ +|||||+++|++.+...
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 35788899999999999999998766556678899999997554 334688999999999 79999999999988764
Q ss_pred CCceEEEEEeeCCCCChhhhccCCC----------------CCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCC
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPKS----------------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSS 223 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~~----------------~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~ 223 (426)
. ++|||||++|+|.+++.... ...+++..++.++.||+.||+|||++ +++||||||+
T Consensus 102 ~----~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~ 174 (311)
T d1t46a_ 102 T----LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAAR 174 (311)
T ss_dssp C----EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGG
T ss_pred E----EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccc
Confidence 4 99999999999999986432 23589999999999999999999998 9999999999
Q ss_pred ceEeCCCCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCch
Q 014363 224 NILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPR 302 (426)
Q Consensus 224 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~ 302 (426)
|||++.++.+||+|||+++..............+||+.|+|||++.++.++.++|||||||++|||+| |.+||......
T Consensus 175 NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~ 254 (311)
T d1t46a_ 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (311)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred cccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999997765544455566789999999999999999999999999999999999 55555443322
Q ss_pred hhHHHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 014363 303 SEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 372 (426)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~ 372 (426)
.. +.+++........+...+..+.+||.+||+.||++|||+.||++.|++++..
T Consensus 255 ~~----------------~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 255 SK----------------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp HH----------------HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HH----------------HHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 11 1111111122222334567899999999999999999999999999987654
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-53 Score=399.75 Aligned_cols=265 Identities=26% Similarity=0.431 Sum_probs=210.5
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCC--CCcceEEEEEEccccCC---HHHHHHHHHHHhhc-CCCCccceEeEEEcc
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSED--PSQKVEVAVKQLGRRGG---HKEWMTEVNFLGIV-EHQNLVKLVGYCADD 157 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~--~~~~~~va~K~~~~~~~---~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~ 157 (426)
.++|.+++.||+|+||.||+|+...... ......||+|.+..... ...+.+|+..+.++ +|||||+++++|.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 3578889999999999999999776543 23456799999976543 35678899999888 899999999999886
Q ss_pred CCCCceEEEEEeeCCCCChhhhccCCC--------------CCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCC
Q 014363 158 DERGIQRLLVYEYMPNGSVDQYLSPKS--------------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSS 223 (426)
Q Consensus 158 ~~~~~~~~lv~E~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~ 223 (426)
+. .++|||||++|+|.++|.... ...+++..++.++.||+.||+|||++ +||||||||+
T Consensus 92 ~~----~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~ 164 (299)
T d1fgka_ 92 GP----LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAAR 164 (299)
T ss_dssp SS----CEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGG
T ss_pred Ce----EEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeeccc
Confidence 64 499999999999999996543 23589999999999999999999998 9999999999
Q ss_pred ceEeCCCCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCch
Q 014363 224 NILLDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPR 302 (426)
Q Consensus 224 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~ 302 (426)
|||++.++.+||+|||+++...............||+.|+|||++.++.|+.++|||||||++|||++ |.+||......
T Consensus 165 NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~ 244 (299)
T d1fgka_ 165 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 244 (299)
T ss_dssp GEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred ceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH
Confidence 99999999999999999987654443334455789999999999999999999999999999999998 78888755432
Q ss_pred hhHHHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 014363 303 SEQKLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 372 (426)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~ 372 (426)
. +...+ ........+..+++++.+||.+||+.||++|||+.||++.|+.++..
T Consensus 245 ~---~~~~i--------------~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 245 E---LFKLL--------------KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp H---HHHHH--------------HTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred H---HHHHH--------------HcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 1 11111 11111223334567899999999999999999999999999988653
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.7e-53 Score=405.53 Aligned_cols=244 Identities=25% Similarity=0.349 Sum_probs=205.2
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-----CCHHHHHHHHHHHhhcCCCCccceEeEEEccCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-----GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
++|++++.||+|+||.||+|.++.++. .||+|.+... ...+.+.+|+.+|+.++|||||++++++.+..
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~-----~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~- 114 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGN-----HYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS- 114 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCC-----EEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCC-----EEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccc-
Confidence 479999999999999999999887655 8999988532 34567899999999999999999999998866
Q ss_pred CCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeec
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 239 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 239 (426)
..++||||+.+|+|.+++.... .+++..++.|+.||+.||.|||++ +||||||||+||||+.+|.+||+|||
T Consensus 115 ---~~~~v~e~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG 186 (350)
T d1rdqe_ 115 ---NLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFG 186 (350)
T ss_dssp ---EEEEEEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred ---ccccccccccccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeece
Confidence 4599999999999999986543 499999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhh
Q 014363 240 LARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAK 319 (426)
Q Consensus 240 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 319 (426)
+|+..... ....+||+.|||||++.+..|+.++|||||||++|||++|..||.+........
T Consensus 187 ~a~~~~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~------------- 248 (350)
T d1rdqe_ 187 FAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE------------- 248 (350)
T ss_dssp TCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-------------
T ss_pred eeeecccc-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHH-------------
Confidence 99876532 235689999999999999999999999999999999999999997654321111
Q ss_pred hhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 014363 320 QFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRP-----KMSEVLEM 365 (426)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~ 365 (426)
.+.... ..++..+++++.+||.+||+.||++|+ |+++|++|
T Consensus 249 ---~i~~~~--~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 249 ---KIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp ---HHHHCC--CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred ---HHhcCC--CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 111111 112234567899999999999999994 89999985
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-53 Score=395.94 Aligned_cols=258 Identities=25% Similarity=0.379 Sum_probs=200.4
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-----CHHHHHHHHHHHhhcCCCCccceEeEEEccCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
++|++.+.||+|+||.||+|.+.... ...+.||+|.+.... ..+.|.+|+.+|++++|||||+++|++.+..
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~--~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~~- 84 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPS--GKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP- 84 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTT--SCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCC--CcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeecc-
Confidence 46889999999999999999876543 244578999886432 2457899999999999999999999997542
Q ss_pred CCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeec
Q 014363 160 RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFG 239 (426)
Q Consensus 160 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 239 (426)
.++||||+++|+|.+++... ...+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 85 ----~~lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfG 156 (273)
T d1u46a_ 85 ----MKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFG 156 (273)
T ss_dssp ----CEEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCT
T ss_pred ----hheeeeeecCcchhhhhhcc-cCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccch
Confidence 38999999999999887643 34599999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCcee-eeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCchhhHHHHHhHhhhhhh
Q 014363 240 LARLGPSEGFTH-VSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELIT-GRRPIDRNRPRSEQKLLQWVKPYLSD 317 (426)
Q Consensus 240 la~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 317 (426)
+++......... ......|+..|+|||++.+..++.++|||||||++|||+| |..||.+..... ..
T Consensus 157 l~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~---~~--------- 224 (273)
T d1u46a_ 157 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---IL--------- 224 (273)
T ss_dssp TCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HH---------
T ss_pred hhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH---HH---------
Confidence 999775443322 2334568889999999999999999999999999999998 899997653322 11
Q ss_pred hhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHh
Q 014363 318 AKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKI 369 (426)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~ 369 (426)
..+.........+..++..+.+|+.+||+.||++|||++||++.|.+.
T Consensus 225 ----~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 225 ----HKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ----HHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----HHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 111122222223344567899999999999999999999999988764
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-52 Score=398.92 Aligned_cols=250 Identities=20% Similarity=0.307 Sum_probs=206.1
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC-HHHHHHHHHHHhhcCCCCccceEeEEEccCCCCc
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG-HKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGI 162 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~ 162 (426)
.++|.+++.||+|+||+||+|.++.++. .||+|.+..... ...+.+|+.+|+.++|||||++++++.+..
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~-----~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~---- 74 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKK-----TYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESME---- 74 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTE-----EEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETT----
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCc-----EEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECC----
Confidence 4689999999999999999999887654 799999976543 345789999999999999999999998866
Q ss_pred eEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCC--CCeeEeeecc
Q 014363 163 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQ--WNAKLSDFGL 240 (426)
Q Consensus 163 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~--~~~kl~DFGl 240 (426)
.+|||||||+||+|.+++...+ ..+++..++.|+.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+
T Consensus 75 ~~~lvmE~~~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~ 150 (321)
T d1tkia_ 75 ELVMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQ 150 (321)
T ss_dssp EEEEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTT
T ss_pred EEEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccch
Confidence 4699999999999999997543 3489999999999999999999998 99999999999999854 4799999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhh
Q 014363 241 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQ 320 (426)
Q Consensus 241 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (426)
++...... ......||+.|+|||.+.+..|+.++|||||||++|+|++|..||..........
T Consensus 151 ~~~~~~~~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~-------------- 213 (321)
T d1tkia_ 151 ARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIE-------------- 213 (321)
T ss_dssp CEECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH--------------
T ss_pred hhccccCC---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHH--------------
Confidence 98765432 2345689999999999999999999999999999999999999997654322111
Q ss_pred hhhhcCCcC--CCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 321 FRQIVDPRL--EGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 321 ~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.+..... .......++.++.+|+.+||+.||++|||++|+++|
T Consensus 214 --~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 214 --NIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp --HHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred --HHHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111111 001111345688999999999999999999999986
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=9.7e-53 Score=405.49 Aligned_cols=249 Identities=25% Similarity=0.374 Sum_probs=201.4
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc-----CCHHHHHHH---HHHHhhcCCCCccceEeEEE
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR-----GGHKEWMTE---VNFLGIVEHQNLVKLVGYCA 155 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~-----~~~~~~~~E---~~~l~~l~HpnIv~~~~~~~ 155 (426)
.++|+++++||+|+||.||+|.++.++. .||+|.+... .....+.+| +.+++.++|||||++++++.
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~-----~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~ 77 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGK-----MYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH 77 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCC-----EEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCC-----EEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEE
Confidence 3579999999999999999999887654 8999988532 223334444 66777789999999999998
Q ss_pred ccCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeE
Q 014363 156 DDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKL 235 (426)
Q Consensus 156 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl 235 (426)
+.+ ..|||||||+||+|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+||||+.+|.+||
T Consensus 78 ~~~----~~~ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl 148 (364)
T d1omwa3 78 TPD----KLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRI 148 (364)
T ss_dssp CSS----EEEEEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEE
T ss_pred ECC----EEEEEEEecCCCcHHHHHHhc--ccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEE
Confidence 866 459999999999999999654 3489999999999999999999998 9999999999999999999999
Q ss_pred eeecccccCCCCCceeeeeeeecCcccCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhh
Q 014363 236 SDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPY 314 (426)
Q Consensus 236 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 314 (426)
+|||+|+...... ....+||+.|+|||++.. ..|+.++|||||||+||||++|+.||..........+..
T Consensus 149 ~DFGla~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~----- 219 (364)
T d1omwa3 149 SDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR----- 219 (364)
T ss_dssp CCCTTCEECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHH-----
T ss_pred eeeceeeecCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-----
Confidence 9999998765432 334689999999999875 568999999999999999999999998654433222211
Q ss_pred hhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 014363 315 LSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPK-----MSEVLEM 365 (426)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~eil~~ 365 (426)
.... ....++..+++++.+||.+||+.||++||| ++|+++|
T Consensus 220 --------~~~~--~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 220 --------MTLT--MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp --------HSSS--CCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred --------hccc--CCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 1111 111222345678999999999999999999 6899876
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1e-52 Score=390.43 Aligned_cols=251 Identities=27% Similarity=0.387 Sum_probs=205.1
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC-----------HHHHHHHHHHHhhcC-CCCccceE
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG-----------HKEWMTEVNFLGIVE-HQNLVKLV 151 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~-----------~~~~~~E~~~l~~l~-HpnIv~~~ 151 (426)
.++|++.+.||+|+||+||+|++..++ +.||+|++..... .+.+.+|+.+|++++ |||||+++
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~-----~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~ 76 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTC-----KEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLK 76 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTT-----EEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred cccCEEceEEecCcCeEEEEEEECCCC-----CEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEE
Confidence 368999999999999999999987654 4899999865421 235789999999996 99999999
Q ss_pred eEEEccCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCC
Q 014363 152 GYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW 231 (426)
Q Consensus 152 ~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~ 231 (426)
+++.+.+ ..|||||||++|+|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++
T Consensus 77 ~~~~~~~----~~~ivmE~~~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~ 147 (277)
T d1phka_ 77 DTYETNT----FFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDM 147 (277)
T ss_dssp EEEECSS----EEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTC
T ss_pred eecccCc----ceEEEEEcCCCchHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCC
Confidence 9998866 459999999999999999654 3599999999999999999999998 999999999999999999
Q ss_pred CeeEeeecccccCCCCCceeeeeeeecCcccCCchhhcc------CCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhH
Q 014363 232 NAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQT------GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQ 305 (426)
Q Consensus 232 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~ 305 (426)
.+||+|||+++...... .....+||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.........
T Consensus 148 ~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~ 224 (277)
T d1phka_ 148 NIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML 224 (277)
T ss_dssp CEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred CeEEccchheeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHH
Confidence 99999999998765432 2345689999999998863 34788999999999999999999999865432211
Q ss_pred HHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 306 KLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
..+. .. ...........+++++.+|+.+||+.||++|||++||++|
T Consensus 225 ~~i~------~~--------~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 225 RMIM------SG--------NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HHHH------HT--------CCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHH------hC--------CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1110 00 0111222233567889999999999999999999999876
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-53 Score=401.01 Aligned_cols=247 Identities=23% Similarity=0.374 Sum_probs=203.8
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccc-----cCCHHHHHHHHHHHh-hcCCCCccceEeEEEccC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGR-----RGGHKEWMTEVNFLG-IVEHQNLVKLVGYCADDD 158 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~-----~~~~~~~~~E~~~l~-~l~HpnIv~~~~~~~~~~ 158 (426)
++|.+++.||+|+||+||+|.++.++. .||+|.+.. ....+.+..|..++. .++|||||++++++.+.+
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~-----~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~ 76 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQ-----FFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE 76 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTE-----EEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCC-----EEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCC
Confidence 578999999999999999999887654 899999853 234456777877765 689999999999998876
Q ss_pred CCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeee
Q 014363 159 ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 238 (426)
Q Consensus 159 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 238 (426)
..|||||||++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 77 ----~~yivmEy~~~g~L~~~i~~~~--~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DF 147 (320)
T d1xjda_ 77 ----NLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADF 147 (320)
T ss_dssp ----EEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCC
T ss_pred ----ceeEEEeecCCCcHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceecccc
Confidence 4599999999999999997543 489999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014363 239 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 318 (426)
Q Consensus 239 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 318 (426)
|+++...... ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.........+.
T Consensus 148 G~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~--------- 216 (320)
T d1xjda_ 148 GMCKENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR--------- 216 (320)
T ss_dssp TTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---------
T ss_pred chhhhccccc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH---------
Confidence 9998654332 22345689999999999999999999999999999999999999998654332111110
Q ss_pred hhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHH-HHHHH
Q 014363 319 KQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMS-EVLEM 365 (426)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~-eil~~ 365 (426)
.. ...++..+++++.+|+.+||+.||++||++. |+++|
T Consensus 217 -------~~--~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~h 255 (320)
T d1xjda_ 217 -------MD--NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 255 (320)
T ss_dssp -------HC--CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred -------cC--CCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence 00 1122334567899999999999999999995 78764
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-52 Score=397.31 Aligned_cols=258 Identities=28% Similarity=0.463 Sum_probs=206.2
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc---CCHHHHHHHHHHHhhc-CCCCccceEeEEEccCCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR---GGHKEWMTEVNFLGIV-EHQNLVKLVGYCADDDER 160 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~---~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~~ 160 (426)
++|++.++||+|+||.||+|.++.++. ...||||.+... ...+.+.+|+++|.++ +|||||+++|++.+.+
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~-- 84 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGL---RMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG-- 84 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTE---EEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT--
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCe---EEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC--
Confidence 478888999999999999999876542 335788887533 2445789999999999 7999999999998866
Q ss_pred CceEEEEEeeCCCCChhhhccCC--------------CCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceE
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPK--------------SETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNIL 226 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~--------------~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NIL 226 (426)
..++||||+++|+|.++|... ....+++..++.++.||+.||.|||++ +|+||||||+|||
T Consensus 85 --~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL 159 (309)
T d1fvra_ 85 --YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNIL 159 (309)
T ss_dssp --EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred --eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEE
Confidence 459999999999999999654 124589999999999999999999998 9999999999999
Q ss_pred eCCCCCeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCC-CCCCCCchhhH
Q 014363 227 LDEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRR-PIDRNRPRSEQ 305 (426)
Q Consensus 227 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~-p~~~~~~~~~~ 305 (426)
++.++.+||+|||+++..... .......||..|+|||.+.++.|+.++|||||||++|||++|.. ||......
T Consensus 160 ~~~~~~~kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~--- 233 (309)
T d1fvra_ 160 VGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--- 233 (309)
T ss_dssp ECGGGCEEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---
T ss_pred EcCCCceEEcccccccccccc---ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHH---
Confidence 999999999999999854432 12234579999999999999999999999999999999999764 66543321
Q ss_pred HHHHhHhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 014363 306 KLLQWVKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 372 (426)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~ 372 (426)
.+...+. .......+..+++++.+||.+||+.||++|||+.||+++|+++++.
T Consensus 234 ~~~~~i~--------------~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 234 ELYEKLP--------------QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp HHHHHGG--------------GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHHHHH--------------hcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 1111111 1111223344667899999999999999999999999999998754
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-52 Score=390.87 Aligned_cols=259 Identities=28% Similarity=0.473 Sum_probs=203.4
Q ss_pred cceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC---CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCceEEE
Q 014363 90 SVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG---GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQRLL 166 (426)
Q Consensus 90 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~~~l 166 (426)
.++||+|+||+||+|.+...+. ....||||.+.... ..+.|.+|+++|++++|||||+++|++.+.+. ..++
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~---~~~l 106 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDG--KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG---SPLV 106 (311)
T ss_dssp EEEEEEETTEEEEEEEECC------CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTT---EEEE
T ss_pred ceEEeecCCeEEEEEEEECCCC--EEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCC---ceEE
Confidence 4689999999999999876432 34568999986433 33568999999999999999999999876442 4599
Q ss_pred EEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecccccCCC
Q 014363 167 VYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARLGPS 246 (426)
Q Consensus 167 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 246 (426)
|||||++|+|.+++.... ..+++..++.++.|++.||.|||+. +|+||||||+||||++++.+||+|||+++....
T Consensus 107 v~E~~~~g~l~~~~~~~~-~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~ 182 (311)
T d1r0pa_ 107 VLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 182 (311)
T ss_dssp EEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTT
T ss_pred EEEEeecCchhhhhcccc-ccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccc
Confidence 999999999999987543 4478889999999999999999998 999999999999999999999999999987644
Q ss_pred CCce--eeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhhhhhhhh
Q 014363 247 EGFT--HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDAKQFRQI 324 (426)
Q Consensus 247 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (426)
.... .......||+.|+|||.+.++.++.++||||||+++|||++|..||...... ......+
T Consensus 183 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~--~~~~~~i------------- 247 (311)
T d1r0pa_ 183 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDITVYL------------- 247 (311)
T ss_dssp TTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHH-------------
T ss_pred cccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH--HHHHHHH-------------
Confidence 3221 1223457899999999999999999999999999999999988887643211 1111110
Q ss_pred cCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhh
Q 014363 325 VDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 373 (426)
Q Consensus 325 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~ 373 (426)
... .....+..+++.+.+||.+||+.||++|||+.||+++|+.++...
T Consensus 248 ~~g-~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~ 295 (311)
T d1r0pa_ 248 LQG-RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 295 (311)
T ss_dssp HTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred HcC-CCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhh
Confidence 000 011122335578999999999999999999999999999998654
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-53 Score=397.88 Aligned_cols=263 Identities=22% Similarity=0.421 Sum_probs=213.2
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCH---HHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGH---KEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~---~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
++|...+.||+|+||+||+|.+...........||||++...... ..+.+|+.++++++|||||+++|++......
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~- 98 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT- 98 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC-
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce-
Confidence 578889999999999999999876544445568999999765433 3578999999999999999999999876654
Q ss_pred ceEEEEEeeCCCCChhhhccCCC--------CCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCe
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKS--------ETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNA 233 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~--------~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~ 233 (426)
++||||+++|+|.+++.... ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+
T Consensus 99 ---~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~ 172 (308)
T d1p4oa_ 99 ---LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTV 172 (308)
T ss_dssp ---EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCE
T ss_pred ---eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceE
Confidence 99999999999999885321 13368899999999999999999998 99999999999999999999
Q ss_pred eEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCC-CCCCCCCchhhHHHHHhHh
Q 014363 234 KLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGR-RPIDRNRPRSEQKLLQWVK 312 (426)
Q Consensus 234 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~-~p~~~~~~~~~~~~~~~~~ 312 (426)
||+|||+++...............||+.|+|||.+.++.++.++||||||+++|||+||. +||.........
T Consensus 173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~------- 245 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL------- 245 (308)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH-------
T ss_pred EEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHH-------
Confidence 999999998765444344445567999999999999999999999999999999999985 677654322111
Q ss_pred hhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHh
Q 014363 313 PYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVD 371 (426)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~ 371 (426)
..+.+.. ....+..++..+.+||.+||+.||++|||+.+|+++|++.++
T Consensus 246 ---------~~i~~~~-~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 246 ---------RFVMEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp ---------HHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred ---------HHHHhCC-CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 1111111 111223456789999999999999999999999999987654
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-52 Score=390.41 Aligned_cols=261 Identities=25% Similarity=0.284 Sum_probs=195.8
Q ss_pred CcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-------CHHHHHHHHHHHhhcCCCCccceEeEEEccCCCC
Q 014363 89 RSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-------GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERG 161 (426)
Q Consensus 89 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-------~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 161 (426)
.+++||+|+||+||+|.++.++. .||+|++.... ..+.+.+|+.+|+.++|||||++++++.+.+..
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~-----~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~- 75 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQ-----IVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI- 75 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCS-----EEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC-
T ss_pred cceEeccCcCeEEEEEEECCCCc-----EEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCce-
Confidence 45789999999999999876654 89999985432 124688999999999999999999999887754
Q ss_pred ceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeeccc
Q 014363 162 IQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLA 241 (426)
Q Consensus 162 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 241 (426)
||||||+.++++..++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 76 ---~ivmE~~~~~~~~~~~~~--~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a 147 (299)
T d1ua2a_ 76 ---SLVFDFMETDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLA 147 (299)
T ss_dssp ---EEEEECCSEEHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred ---eehhhhhcchHHhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccc
Confidence 999999988877766643 34488899999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHh-h----hh
Q 014363 242 RLGPSEGFTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK-P----YL 315 (426)
Q Consensus 242 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~-~----~~ 315 (426)
+....... .....+||+.|+|||++.+. .|+.++|||||||++|||++|..||...........+.... . .+
T Consensus 148 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~ 225 (299)
T d1ua2a_ 148 KSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQW 225 (299)
T ss_dssp STTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred cccCCCcc--cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence 86554321 23346899999999988654 57999999999999999999999997654332211111000 0 00
Q ss_pred hhhhhhhhhcC-CcCCCc----ccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 316 SDAKQFRQIVD-PRLEGK----YSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 316 ~~~~~~~~~~~-~~~~~~----~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
........... ...... .....++.+.+|+.+||+.||++|||++|+++|
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 226 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 00000000000 000000 011245789999999999999999999999986
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-52 Score=391.76 Aligned_cols=275 Identities=24% Similarity=0.359 Sum_probs=203.5
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHH--HHHHHhhcCCCCccceEeEEEccCCCCce
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMT--EVNFLGIVEHQNLVKLVGYCADDDERGIQ 163 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~--E~~~l~~l~HpnIv~~~~~~~~~~~~~~~ 163 (426)
+|...+.||+|+||.||+|++.+ ..||+|.+.... ...+.. |+..+..++|||||++++++.+.+.....
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~~g-------~~vAvK~~~~~~-~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~ 75 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKWRG-------EEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEETT-------EEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred EEEEEEEEeeCCCeEEEEEEECC-------EEEEEEEECccc-hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceE
Confidence 46677899999999999998743 379999986554 334444 45555678999999999999987766567
Q ss_pred EEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccC-----CCCCeEeccCCCCceEeCCCCCeeEeee
Q 014363 164 RLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEG-----MDFQIIVRDFKSSNILLDEQWNAKLSDF 238 (426)
Q Consensus 164 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~-----~~~~iiHrDlkp~NILl~~~~~~kl~DF 238 (426)
+|+|||||++|+|.+++... .+++..++.++.|++.||+|||+. ...+|+||||||+||||+.++.+||+||
T Consensus 76 ~~lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DF 152 (303)
T d1vjya_ 76 LWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEEEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEec
Confidence 89999999999999999754 389999999999999999999962 1249999999999999999999999999
Q ss_pred cccccCCCCCcee--eeeeeecCcccCCchhhccCC------CCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHh
Q 014363 239 GLARLGPSEGFTH--VSTAVVGTMGYAAPEYVQTGR------LAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQW 310 (426)
Q Consensus 239 Gla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~ 310 (426)
|+++......... ......||+.|+|||++.+.. ++.++|||||||+||||+||..||........... ..
T Consensus 153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~-~~ 231 (303)
T d1vjya_ 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY-DL 231 (303)
T ss_dssp TTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTT-TT
T ss_pred CccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchh-hc
Confidence 9998764432221 234578999999999987643 56789999999999999999988754321110000 00
Q ss_pred Hhhhhhhhhhh-hhh----cCCcCCCcc-cHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhh
Q 014363 311 VKPYLSDAKQF-RQI----VDPRLEGKY-SLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 373 (426)
Q Consensus 311 ~~~~~~~~~~~-~~~----~~~~~~~~~-~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~ 373 (426)
. ......... ... .++.+...+ .......+.+|+.+||+.||++|||+.||++.|+++.+..
T Consensus 232 ~-~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 232 V-PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp S-CSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred c-cccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence 0 000000000 111 122222222 2346678999999999999999999999999999887653
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=388.63 Aligned_cols=264 Identities=23% Similarity=0.342 Sum_probs=200.8
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
++|++++.||+|+||+||+|.+..++. .||+|++.... ..+.+.+|+.+|++++|||||++++++.+.+
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~-----~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~-- 74 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGE-----VVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN-- 74 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCC-----EEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETT--
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCC-----EEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccccc--
Confidence 579999999999999999999877654 79999985432 3467899999999999999999999998876
Q ss_pred CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecc
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 240 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 240 (426)
..|+||||+.+ .+.+++.......+++..++.++.||+.||+|||++ +||||||||+|||++.++.+||+|||+
T Consensus 75 --~~~iv~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~ 148 (298)
T d1gz8a_ 75 --KLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGL 148 (298)
T ss_dssp --EEEEEEECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTH
T ss_pred --ceeEEEeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCc
Confidence 45999999965 454555444445699999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCchhhccCC-CCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhh-
Q 014363 241 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGR-LAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA- 318 (426)
Q Consensus 241 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~- 318 (426)
|+...... .......||+.|+|||++.... ++.++|||||||++|+|++|+.||.+...... +...........
T Consensus 149 a~~~~~~~--~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~--~~~i~~~~~~~~~ 224 (298)
T d1gz8a_ 149 ARAFGVPV--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ--LFRIFRTLGTPDE 224 (298)
T ss_dssp HHHHCCCS--BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCT
T ss_pred ceeccCCc--ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHH--HHHHHHhcCCCch
Confidence 98765432 2234468999999999887766 47899999999999999999999976543221 111110000000
Q ss_pred ---hhhhhh------cCCcCCCc---ccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 319 ---KQFRQI------VDPRLEGK---YSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 319 ---~~~~~~------~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
...... ........ ....++..+.+|+.+||+.||++|||++|+++|
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 225 VVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 000000 00000000 011345788999999999999999999999986
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-52 Score=385.40 Aligned_cols=240 Identities=24% Similarity=0.434 Sum_probs=196.3
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC--------CHHHHHHHHHHHhhcC--CCCccceEeE
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--------GHKEWMTEVNFLGIVE--HQNLVKLVGY 153 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~--------~~~~~~~E~~~l~~l~--HpnIv~~~~~ 153 (426)
.++|++.++||+|+||+||+|.+..++. .||+|.+.... ....+.+|+.+|++++ |||||+++++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~-----~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~ 77 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNL-----PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 77 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCC-----EEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCC-----EEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEE
Confidence 4679999999999999999999887654 89999885432 1234678999999996 8999999999
Q ss_pred EEccCCCCceEEEEEeeCCC-CChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCC-CC
Q 014363 154 CADDDERGIQRLLVYEYMPN-GSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE-QW 231 (426)
Q Consensus 154 ~~~~~~~~~~~~lv~E~~~~-g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~-~~ 231 (426)
+.+.+ ..|+||||+.+ +++.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||++. ++
T Consensus 78 ~~~~~----~~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~ 148 (273)
T d1xwsa_ 78 FERPD----SFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRG 148 (273)
T ss_dssp EECSS----EEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTT
T ss_pred EeeCC----eEEEEEEeccCcchHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCC
Confidence 98876 45999999976 6777777543 3489999999999999999999998 9999999999999985 47
Q ss_pred CeeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCC-CCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHh
Q 014363 232 NAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRL-AARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQW 310 (426)
Q Consensus 232 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~ 310 (426)
.+||+|||+++...... ....+||+.|+|||++.+..+ +.++|||||||++|||++|..||.... ....
T Consensus 149 ~vkl~DFG~a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~i~~- 218 (273)
T d1xwsa_ 149 ELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EIIR- 218 (273)
T ss_dssp EEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HHHH-
T ss_pred eEEECccccceeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----HHhh-
Confidence 89999999998654432 345789999999999988776 567999999999999999999996421 1000
Q ss_pred HhhhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 311 VKPYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
. .. .++..+++++.+|+.+||+.||++|||++|+++|
T Consensus 219 ------------~--~~----~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 219 ------------G--QV----FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp ------------C--CC----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ------------c--cc----CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 0 00 1122345789999999999999999999999986
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.9e-50 Score=378.02 Aligned_cols=264 Identities=20% Similarity=0.266 Sum_probs=198.7
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
++|..+++||+|+||+||+|.++.+ ..||+|++.... ..+.+.+|+.+|+.++|||||++++++.+...
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~------~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~- 74 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYG------ETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR- 74 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTS------CEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC-
T ss_pred CCceeccEEecCCCcEEEEEEeCCC------CEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCc-
Confidence 5899999999999999999988643 279999986543 34678999999999999999999999998774
Q ss_pred CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecc
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 240 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 240 (426)
.+++|||+.++.+..+.... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 75 ---~~i~~e~~~~~~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~ 146 (286)
T d1ob3a_ 75 ---LVLVFEHLDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGL 146 (286)
T ss_dssp ---EEEEEECCSEEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTH
T ss_pred ---eeEEEEeehhhhHHHHHhhc--CCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEeccccc
Confidence 49999999887777766543 4599999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHh-----hh
Q 014363 241 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK-----PY 314 (426)
Q Consensus 241 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~-----~~ 314 (426)
+........ ......|++.|+|||.+.+. .++.++|||||||++|||++|+.||...........+.... ..
T Consensus 147 a~~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~ 224 (286)
T d1ob3a_ 147 ARAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKN 224 (286)
T ss_dssp HHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred ceecccCcc--ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhh
Confidence 987654322 23445799999999998764 46899999999999999999999997654322211111000 00
Q ss_pred hhhhhhhhhhc------CCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 315 LSDAKQFRQIV------DPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 315 ~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
+.......... .+..........++.+.+|+.+||+.||++|||++|+++|
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 225 WPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp STTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000000000 0000011222355788999999999999999999999875
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-50 Score=381.22 Aligned_cols=271 Identities=24% Similarity=0.300 Sum_probs=202.6
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhc---CCCCccceEeEEEc
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIV---EHQNLVKLVGYCAD 156 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l---~HpnIv~~~~~~~~ 156 (426)
.++|++++.||+|+||+||+|.+..++ .+.||+|.+.... ....+.+|+.+|+.| +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~----~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~ 81 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNG----GRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV 81 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTT----TEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCC----CEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecc
Confidence 468999999999999999999986543 2368999875432 234577888887776 79999999999865
Q ss_pred cC-CCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeE
Q 014363 157 DD-ERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKL 235 (426)
Q Consensus 157 ~~-~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl 235 (426)
.. ......+++|||++++.+..... .....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||
T Consensus 82 ~~~~~~~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl 157 (305)
T d1blxa_ 82 SRTDRETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKL 157 (305)
T ss_dssp EECSSEEEEEEEEECCSCBHHHHHHH-SCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEE
T ss_pred cccccCceEEEEEEeccCCchhhhhh-ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeee
Confidence 32 23346799999998877654443 3334589999999999999999999998 9999999999999999999999
Q ss_pred eeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhh-
Q 014363 236 SDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPY- 314 (426)
Q Consensus 236 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~- 314 (426)
+|||++...... .......||+.|+|||++.+..|+.++|||||||++|||++|+.||...........+......
T Consensus 158 ~dfg~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 234 (305)
T d1blxa_ 158 ADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 234 (305)
T ss_dssp CSCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred cchhhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCC
Confidence 999998754332 2234578999999999999999999999999999999999999999865543222211111000
Q ss_pred ----hhhhhhh-hhhc---CCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 315 ----LSDAKQF-RQIV---DPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 315 ----~~~~~~~-~~~~---~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
+...... .... .......+....++.+.+|+.+||+.||++|||++|+++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred chhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000000 0000 0000111223456788999999999999999999999986
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=382.24 Aligned_cols=271 Identities=21% Similarity=0.282 Sum_probs=200.3
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCC---HHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGG---HKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
..+|++++.||+|+||+||+|.++.++. .||||++..... .+.+++|+.+|+.++||||+++++++......
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~-----~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~ 81 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKV-----RVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE 81 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCS-----EEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTT
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCc-----EEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecccc
Confidence 3579999999999999999999876654 899999865433 34688999999999999999999999775433
Q ss_pred CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecc
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 240 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 240 (426)
....+++++|+.+|+|.+++... .+++..++.++.||+.||+|||++ +||||||||+||||+.++.+||+|||+
T Consensus 82 ~~~~~~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~ 155 (345)
T d1pmea_ 82 QMKDVYLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGL 155 (345)
T ss_dssp TCCCEEEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ccceEEEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCc
Confidence 22334556667799999999643 389999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCc-eeeeeeeecCcccCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhhh
Q 014363 241 ARLGPSEGF-THVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSDA 318 (426)
Q Consensus 241 a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 318 (426)
+........ .......+||+.|+|||++.. ..++.++||||+||++|+|++|..||......................
T Consensus 156 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (345)
T d1pmea_ 156 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 235 (345)
T ss_dssp CEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH
T ss_pred eeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChh
Confidence 986543221 112345679999999998854 567899999999999999999999997655432222211110000000
Q ss_pred --------hhhhhhc-CCcCC-Cc---ccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 319 --------KQFRQIV-DPRLE-GK---YSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 319 --------~~~~~~~-~~~~~-~~---~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
....... .+... .. .....+.++.+|+.+||+.||++|||++|+++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 236 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000000 01100 00 011234678999999999999999999999987
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.5e-49 Score=369.40 Aligned_cols=264 Identities=19% Similarity=0.276 Sum_probs=201.7
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhcCCCCccceEeEEEccCCCCceE
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDERGIQR 164 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~~~~ 164 (426)
++|++++.||+|+||.||+|.+..++ ..||+|.+......+.+..|+++++.++|+|++..++.+..... ..
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~-----~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~---~~ 78 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAG-----EEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGD---YN 78 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTT-----EEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETT---EE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCC-----CEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCC---EE
Confidence 47999999999999999999987654 38999998776666788999999999988877766655544433 45
Q ss_pred EEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeC---CCCCeeEeeeccc
Q 014363 165 LLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLD---EQWNAKLSDFGLA 241 (426)
Q Consensus 165 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~---~~~~~kl~DFGla 241 (426)
++||||+ +++|.+.+.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++ .+..+||+|||+|
T Consensus 79 ~ivme~~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a 153 (299)
T d1ckia_ 79 VMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 153 (299)
T ss_dssp EEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSC
T ss_pred EEEEEEc-CCchhhhhhhcc-CCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcc
Confidence 8999999 566666654332 3489999999999999999999998 999999999999985 4557999999999
Q ss_pred ccCCCCCce-----eeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhH-hhhh
Q 014363 242 RLGPSEGFT-----HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWV-KPYL 315 (426)
Q Consensus 242 ~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~-~~~~ 315 (426)
+........ .......||+.|||||++.+..++.++|||||||++|||++|..||............... ....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~ 233 (299)
T d1ckia_ 154 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 233 (299)
T ss_dssp EECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHH
T ss_pred eeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccC
Confidence 876433211 1234568999999999999999999999999999999999999999765443322221111 0000
Q ss_pred hhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhh
Q 014363 316 SDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDA 372 (426)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~ 372 (426)
.. ... .....+++++.+++.+||+.||++||++++|.+.|+.+...
T Consensus 234 ~~--~~~---------~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 234 ST--PIE---------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp HS--CHH---------HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred CC--Chh---------HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 00 000 01112456899999999999999999999999988877643
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=371.35 Aligned_cols=272 Identities=21% Similarity=0.298 Sum_probs=198.4
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc----CCHHHHHHHHHHHhhcCCCCccceEeEEEccCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR----GGHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
.++|++++.||+|+||+||+|.+..++. .||||++... ...+.+.+|+.+|+.++||||+++++++.....
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~-----~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~ 83 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQ-----KVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAS 83 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCC-----EEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCC-----EEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccc
Confidence 4689999999999999999999876654 8999987543 234578899999999999999999999866432
Q ss_pred C----CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeE
Q 014363 160 R----GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKL 235 (426)
Q Consensus 160 ~----~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl 235 (426)
. ....|+||||+.++.+..+.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||
T Consensus 84 ~~~~~~~~~~iv~e~~~~~~~~~~~~~~--~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl 158 (318)
T d3blha1 84 PYNRCKGSIYLVFDFCEHDLAGLLSNVL--VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKL 158 (318)
T ss_dssp -------CEEEEEECCCEEHHHHHTCTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEE
T ss_pred cccccCceEEEEEeccCCCccchhhhcc--cccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEe
Confidence 1 22469999999887776555433 3488999999999999999999998 9999999999999999999999
Q ss_pred eeecccccCCCCCce--eeeeeeecCcccCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHh
Q 014363 236 SDFGLARLGPSEGFT--HVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK 312 (426)
Q Consensus 236 ~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~ 312 (426)
+|||+++........ ......+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.........+....
T Consensus 159 ~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~ 238 (318)
T d3blha1 159 ADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 238 (318)
T ss_dssp CCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred eecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhc
Confidence 999999865532211 122345799999999998765 68999999999999999999999997654433322222111
Q ss_pred hhhhh--------hhhhhhhcCCcCCCc-ccH-----HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 313 PYLSD--------AKQFRQIVDPRLEGK-YSL-----RLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 313 ~~~~~--------~~~~~~~~~~~~~~~-~~~-----~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
..... ............... ... ...+.+.+||.+||+.||++|||++|+++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 239 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp CCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 00000 000000000000000 111 123567899999999999999999999987
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.2e-48 Score=372.84 Aligned_cols=262 Identities=20% Similarity=0.267 Sum_probs=201.8
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhcC-CCCccceEeEEEccCCCCce
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVE-HQNLVKLVGYCADDDERGIQ 163 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~~~~~~~~~ 163 (426)
++|+++++||+|+||+||+|++..++ ..||+|++... ..+.+.+|+.+|+.+. ||||+++++++...... .
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~-----~~vAiK~i~~~-~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~--~ 106 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNN-----EKVVVKILKPV-KKKKIKREIKILENLRGGPNIITLADIVKDPVSR--T 106 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTT-----EEEEEEEECSS-CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC--S
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCC-----CEEEEEEECHH-HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCC--c
Confidence 47999999999999999999987655 38999998654 4567899999999995 99999999999865443 4
Q ss_pred EEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCC-CeeEeeecccc
Q 014363 164 RLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW-NAKLSDFGLAR 242 (426)
Q Consensus 164 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~-~~kl~DFGla~ 242 (426)
.++|||||++++|..+.. .+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+|+
T Consensus 107 ~~~v~e~~~~~~L~~~~~-----~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~ 178 (328)
T d3bqca1 107 PALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 178 (328)
T ss_dssp EEEEEECCCSCBGGGTTT-----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCE
T ss_pred eeEEEeecCCCcHHHHhc-----CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccce
Confidence 699999999999987753 389999999999999999999998 999999999999998655 59999999998
Q ss_pred cCCCCCceeeeeeeecCcccCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHH--HhHh-hhhh--
Q 014363 243 LGPSEGFTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLL--QWVK-PYLS-- 316 (426)
Q Consensus 243 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~--~~~~-~~~~-- 316 (426)
...... .....+||+.|+|||.+.+. .++.++|||||||++|+|++|..||........+... .... +...
T Consensus 179 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~ 255 (328)
T d3bqca1 179 FYHPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 255 (328)
T ss_dssp ECCTTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHH
T ss_pred eccCCC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhh
Confidence 765432 13456799999999998765 4799999999999999999999999766543322111 0000 0000
Q ss_pred -------hhhhhhhhcCCc--------CCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 317 -------DAKQFRQIVDPR--------LEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 317 -------~~~~~~~~~~~~--------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
....+....... ........+++++.+||.+||+.||++|||++|+|+|
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 256 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp HHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000011111000 0111122356788999999999999999999999985
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=381.83 Aligned_cols=265 Identities=23% Similarity=0.311 Sum_probs=197.3
Q ss_pred CCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhcCCCCccceEeEEEccC--CCCce
Q 014363 86 NFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEHQNLVKLVGYCADDD--ERGIQ 163 (426)
Q Consensus 86 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~--~~~~~ 163 (426)
+|+.+++||+|+||+||+|+++.++. .||+|++.... ..+.+|+.+|+.++||||++++++|.... ....+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~-----~vAiK~i~~~~--~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~ 93 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGE-----LVAIKKVLQDK--RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCC-----EEEEEEEECCS--SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCC-----EEEEEEECccc--hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceE
Confidence 58888999999999999999887654 89999986543 23458999999999999999999986543 22345
Q ss_pred EEEEEeeCCCCChhhhccC-CCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCC-CeeEeeeccc
Q 014363 164 RLLVYEYMPNGSVDQYLSP-KSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQW-NAKLSDFGLA 241 (426)
Q Consensus 164 ~~lv~E~~~~g~L~~~l~~-~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~-~~kl~DFGla 241 (426)
+|||||||+++.+..+... .....+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++
T Consensus 94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a 170 (350)
T d1q5ka_ 94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSA 170 (350)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTC
T ss_pred EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccch
Confidence 7899999977644433221 2234599999999999999999999998 999999999999999775 8999999999
Q ss_pred ccCCCCCceeeeeeeecCcccCCchhhcc-CCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh-hh
Q 014363 242 RLGPSEGFTHVSTAVVGTMGYAAPEYVQT-GRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD-AK 319 (426)
Q Consensus 242 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~ 319 (426)
....... .....+||+.|+|||.+.+ ..|+.++|||||||++|||++|..||.......... ......... ..
T Consensus 171 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~--~i~~~~g~~~~~ 245 (350)
T d1q5ka_ 171 KQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV--EIIKVLGTPTRE 245 (350)
T ss_dssp EECCTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHH--HHHHHHCCCCHH
T ss_pred hhccCCc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHH--HHHHHhCCChHH
Confidence 8765432 2334689999999998765 568999999999999999999999997654332211 111100000 00
Q ss_pred hhhhh----cC---CcC-----CCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 320 QFRQI----VD---PRL-----EGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 320 ~~~~~----~~---~~~-----~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
..... .+ +.. ........++++.+|+.+||+.||++|||+.|+++|
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 246 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp HHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000 00 000 011122356789999999999999999999999986
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.4e-48 Score=366.06 Aligned_cols=266 Identities=15% Similarity=0.223 Sum_probs=211.3
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhcCC-CCccceEeEEEccCCCCc
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEH-QNLVKLVGYCADDDERGI 162 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l~H-pnIv~~~~~~~~~~~~~~ 162 (426)
.++|++++.||+|+||+||+|++..++ +.||+|.+........+.+|++++..|.| +||+.+++++.+..
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~-----~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~---- 74 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNN-----QQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGL---- 74 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTT-----EEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETT----
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCC-----CEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCC----
Confidence 357999999999999999999987654 38999998776666778999999999965 89999999987765
Q ss_pred eEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCC-----CCCeeEee
Q 014363 163 QRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDE-----QWNAKLSD 237 (426)
Q Consensus 163 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~-----~~~~kl~D 237 (426)
..++||||+ +++|.+++.... ..+++..+..++.|++.||+|||++ ||+||||||+|||++. ++.+||+|
T Consensus 75 ~~~~vme~~-~~~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~D 149 (293)
T d1csna_ 75 HNVLVIDLL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVD 149 (293)
T ss_dssp EEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECC
T ss_pred ccEEEEEec-CCCHHHHHHhhc-cchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcc
Confidence 459999999 789999886543 3589999999999999999999998 9999999999999964 57899999
Q ss_pred ecccccCCCCCce-----eeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHh
Q 014363 238 FGLARLGPSEGFT-----HVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVK 312 (426)
Q Consensus 238 FGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~ 312 (426)
||+|+........ ......+||+.|||||++.+..++.++|||||||++|||++|..||.+............+.
T Consensus 150 FG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~ 229 (293)
T d1csna_ 150 FGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG 229 (293)
T ss_dssp CTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHH
T ss_pred cceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHH
Confidence 9999875432211 12345689999999999999999999999999999999999999998655443332222111
Q ss_pred hhhhhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHHhHhhh
Q 014363 313 PYLSDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEMVNKIVDAS 373 (426)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~~~~~~ 373 (426)
... ......++ ...+++++.+++..|+..+|++||+++.+.+.|++++...
T Consensus 230 ~~~-~~~~~~~l---------~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~ 280 (293)
T d1csna_ 230 EKK-QSTPLREL---------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280 (293)
T ss_dssp HHH-HHSCHHHH---------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred hcc-CCCChHHh---------cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence 100 00001111 1124467999999999999999999999999998887543
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-49 Score=379.21 Aligned_cols=265 Identities=25% Similarity=0.328 Sum_probs=197.9
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
.++|++++.||+|+||+||+|.++.++. .||+|++.... ..+.+.+|+.+|+.++|||||+++++|...+.
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~-----~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~ 91 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGA-----KVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDET 91 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCC-----EEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSS
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCC-----EEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcc
Confidence 5689999999999999999999877654 89999986543 23467899999999999999999999987542
Q ss_pred --CCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEee
Q 014363 160 --RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 237 (426)
Q Consensus 160 --~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~D 237 (426)
....+|+||||+ +.+|..++... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 92 ~~~~~~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~D 164 (346)
T d1cm8a_ 92 LDDFTDFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILD 164 (346)
T ss_dssp TTTCCCCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECC
T ss_pred ccccceEEEEEecc-cccHHHHHHhc---cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhccccccccccc
Confidence 223459999999 67888777533 499999999999999999999998 999999999999999999999999
Q ss_pred ecccccCCCCCceeeeeeeecCcccCCchhhccC-CCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhh--
Q 014363 238 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG-RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPY-- 314 (426)
Q Consensus 238 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~-- 314 (426)
||+++..... .....||+.|+|||++.+. .++.++|||||||++|+|++|..||..................
T Consensus 165 fg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (346)
T d1cm8a_ 165 FGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP 239 (346)
T ss_dssp CTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred ccceeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCc
Confidence 9999876543 2356799999999998764 5689999999999999999999999876433222211110000
Q ss_pred ------hh--hhhhhhhhcCCcCC---CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 315 ------LS--DAKQFRQIVDPRLE---GKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 315 ------~~--~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
.. ........+..... .......++.+.+||.+||+.||++|||++|+++|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 240 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00 00000010100000 11122345678899999999999999999999997
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-48 Score=361.78 Aligned_cols=263 Identities=23% Similarity=0.308 Sum_probs=203.6
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccCCC
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDER 160 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 160 (426)
++|++++.||+|+||+||+|++..++. .||+|++.... ....+.+|+.+|+.++||||+++++++.+..
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~-----~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~-- 74 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHE-----IVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK-- 74 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCC-----EEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS--
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCc-----EEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccccc--
Confidence 579999999999999999999887654 79999985432 2467889999999999999999999998876
Q ss_pred CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeeecc
Q 014363 161 GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDFGL 240 (426)
Q Consensus 161 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 240 (426)
..++|||++.+++|..++... +.+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.
T Consensus 75 --~~~iv~~~~~~~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~ 147 (292)
T d1unla_ 75 --KLTLVFEFCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGL 147 (292)
T ss_dssp --EEEEEEECCSEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred --ceeEEeeeccccccccccccc--cccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecch
Confidence 459999999999998887654 3488999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCceeeeeeeecCcccCCchhhccCC-CCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhhhh--
Q 014363 241 ARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGR-LAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYLSD-- 317 (426)
Q Consensus 241 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-- 317 (426)
++....... ......+++.|+|||++.+.. ++.++|||||||++|||++|+.||......... ...+......
T Consensus 148 a~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~--~~~~~~~~~~~~ 223 (292)
T d1unla_ 148 ARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ--LKRIFRLLGTPT 223 (292)
T ss_dssp CEECCSCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH--HHHHHHHHCCCC
T ss_pred hhcccCCCc--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHH--HHHHHhhcCCCC
Confidence 987654322 233456889999999887665 689999999999999999999997654332221 1111100000
Q ss_pred ---hhhhhhhcC---------CcCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 318 ---AKQFRQIVD---------PRLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 318 ---~~~~~~~~~---------~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
........+ ...........++.+.+|+.+||+.||++|||++|+++|
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 224 EEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000000 000111223455788999999999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=369.01 Aligned_cols=266 Identities=21% Similarity=0.263 Sum_probs=194.0
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
.++|+++++||+|+||+||+|.+..++. .||+|++.... ..+.+.+|+.+|++++|||||+++++|...+.
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~-----~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~ 90 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDR-----NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKT 90 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTE-----EEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCS
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCC-----EEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccc
Confidence 3689999999999999999999876653 89999986543 23457899999999999999999999976542
Q ss_pred --CCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEee
Q 014363 160 --RGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 237 (426)
Q Consensus 160 --~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~D 237 (426)
...++|+|||||.++.+.. +. ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+|++|
T Consensus 91 ~~~~~~~~iv~Ey~~~~l~~~-~~----~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~d 162 (355)
T d2b1pa1 91 LEEFQDVYLVMELMDANLCQV-IQ----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD 162 (355)
T ss_dssp TTTCCEEEEEEECCSEEHHHH-HT----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECC
T ss_pred cccCceeEEEEeccchHHHHh-hh----cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeec
Confidence 2347799999997655544 43 2389999999999999999999998 999999999999999999999999
Q ss_pred ecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHh-Hh----
Q 014363 238 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQW-VK---- 312 (426)
Q Consensus 238 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~-~~---- 312 (426)
||+++..... ......+||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.........+.. ..
T Consensus 163 f~~~~~~~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~ 239 (355)
T d2b1pa1 163 FGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 239 (355)
T ss_dssp CCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred hhhhhccccc---cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCH
Confidence 9998765432 233456899999999999999999999999999999999999999976543222111100 00
Q ss_pred hhhhh-hhhh---------------hhhcCC---cCCCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 313 PYLSD-AKQF---------------RQIVDP---RLEGKYSLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 313 ~~~~~-~~~~---------------~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
..+.. .... ...... ..........++.+.+|+.+||+.||++|||++|||+|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000 0000 001100 01111233567889999999999999999999999987
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-48 Score=368.53 Aligned_cols=255 Identities=27% Similarity=0.360 Sum_probs=201.0
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEcccc------CCHHHHHHHHHHHhhcCC-CCccceEeEEEcc
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRR------GGHKEWMTEVNFLGIVEH-QNLVKLVGYCADD 157 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~------~~~~~~~~E~~~l~~l~H-pnIv~~~~~~~~~ 157 (426)
++|++++.||+|+||+||+|...... .....||+|.+... ...+.+.+|+.+|++++| |||+++++++.+.
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~--~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~ 101 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGH--DTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 101 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSST--TTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred hceEEEEEEecCCCeEEEEEEECccC--CCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC
Confidence 56999999999999999999875421 23348999987532 245678899999999966 8999999999887
Q ss_pred CCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEee
Q 014363 158 DERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSD 237 (426)
Q Consensus 158 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~D 237 (426)
. ..++||||+.+|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 102 ~----~~~~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~D 172 (322)
T d1vzoa_ 102 T----KLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTD 172 (322)
T ss_dssp T----EEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESC
T ss_pred C----ceeeeeecccccHHHHHHHhcc--cccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEee
Confidence 6 4599999999999999997544 378889999999999999999998 999999999999999999999999
Q ss_pred ecccccCCCCCceeeeeeeecCcccCCchhhccC--CCCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhh
Q 014363 238 FGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTG--RLAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYL 315 (426)
Q Consensus 238 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 315 (426)
||+++........ ......|++.|+|||.+.+. .++.++|||||||+||+|++|..||...........+.
T Consensus 173 FG~a~~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~------ 245 (322)
T d1vzoa_ 173 FGLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS------ 245 (322)
T ss_dssp SSEEEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHH------
T ss_pred ccchhhhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------
Confidence 9999866433222 23456799999999998764 46889999999999999999999997654332211110
Q ss_pred hhhhhhhhhcCCcCCCcccHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 014363 316 SDAKQFRQIVDPRLEGKYSLRLVSKLSHVANLCLVKNARTRP-----KMSEVLEM 365 (426)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~ 365 (426)
...... ...++..+++++.+|+.+||+.||++|| |++|+++|
T Consensus 246 ------~~~~~~--~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 246 ------RRILKS--EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp ------HHHHHC--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred ------HhcccC--CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 000000 1112334667899999999999999999 48899875
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-47 Score=364.00 Aligned_cols=266 Identities=23% Similarity=0.326 Sum_probs=197.2
Q ss_pred hCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC----CHHHHHHHHHHHhhcCCCCccceEeEEEccCC
Q 014363 84 TKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG----GHKEWMTEVNFLGIVEHQNLVKLVGYCADDDE 159 (426)
Q Consensus 84 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 159 (426)
.++|++++.||+|+||+||+|.+..++. .||+|++.... ..+.+.+|+.+|+.++|||||++++++.....
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~-----~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~ 91 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGL-----RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 91 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTE-----EEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCC-----EEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccc
Confidence 4689999999999999999999876553 89999986543 23467899999999999999999999875432
Q ss_pred C-CceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEeCCCCCeeEeee
Q 014363 160 R-GIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILLDEQWNAKLSDF 238 (426)
Q Consensus 160 ~-~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 238 (426)
. ....++||+|+.+|+|.+++..+ .+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+|++||
T Consensus 92 ~~~~~~~~i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~df 165 (348)
T d2gfsa1 92 LEEFNDVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDF 165 (348)
T ss_dssp TTTCCCCEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC
T ss_pred cccCceEEEEEeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCcccccccccccccccc
Confidence 1 11225667788899999999643 399999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeeeeecCcccCCchhhccCC-CCCchhhHHHHHHHHHHHhCCCCCCCCCchhhHHHHHhHhhhh--
Q 014363 239 GLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGR-LAARSDVWSYGVFLYELITGRRPIDRNRPRSEQKLLQWVKPYL-- 315 (426)
Q Consensus 239 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~-- 315 (426)
|++...... .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.........+.......
T Consensus 166 g~a~~~~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~ 240 (348)
T d2gfsa1 166 GLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 240 (348)
T ss_dssp ----CCTGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred chhcccCcc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 999754322 33467999999999877654 6889999999999999999999998654332222211110000
Q ss_pred ---h--hhhhhhhhcC--CcCC-Ccc---cHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014363 316 ---S--DAKQFRQIVD--PRLE-GKY---SLRLVSKLSHVANLCLVKNARTRPKMSEVLEM 365 (426)
Q Consensus 316 ---~--~~~~~~~~~~--~~~~-~~~---~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 365 (426)
. .......... .... ..+ ....++.+.+||.+||+.||++|||+.|+++|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 241 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp HHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 0 0000000000 0000 000 11245678999999999999999999999986
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.2e-43 Score=339.63 Aligned_cols=266 Identities=20% Similarity=0.258 Sum_probs=193.2
Q ss_pred CCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC-CHHHHHHHHHHHhhcC-----------CCCccceEe
Q 014363 85 KNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG-GHKEWMTEVNFLGIVE-----------HQNLVKLVG 152 (426)
Q Consensus 85 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~E~~~l~~l~-----------HpnIv~~~~ 152 (426)
++|+++++||+|+||+||+|+++.++. .||||++..+. ..+.+.+|+.+++.++ |+||+++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~-----~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~ 87 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNT-----HVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD 87 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTE-----EEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCC-----EEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEE
Confidence 359999999999999999999876654 89999997653 3456788999988875 578999999
Q ss_pred EEEccCCCCceEEEEEeeCCCCC-hhhhccCCCCCccCHHHHHHHHHHHHHHHHHhcc-CCCCCeEeccCCCCceEeCCC
Q 014363 153 YCADDDERGIQRLLVYEYMPNGS-VDQYLSPKSETILTWAMRLKIAQDAARGLAYLHE-GMDFQIIVRDFKSSNILLDEQ 230 (426)
Q Consensus 153 ~~~~~~~~~~~~~lv~E~~~~g~-L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~-~~~~~iiHrDlkp~NILl~~~ 230 (426)
++...... ..+++|+++..+. ............+++..+..++.||+.||+|||+ . ||+||||||+||||+.+
T Consensus 88 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~ 162 (362)
T d1q8ya_ 88 HFNHKGPN--GVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIV 162 (362)
T ss_dssp EEEEEETT--EEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEE
T ss_pred Eeeecccc--ceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeecc
Confidence 98765544 3356666654433 3333333444568999999999999999999997 5 99999999999999866
Q ss_pred CC------eeEeeecccccCCCCCceeeeeeeecCcccCCchhhccCCCCCchhhHHHHHHHHHHHhCCCCCCCCCchhh
Q 014363 231 WN------AKLSDFGLARLGPSEGFTHVSTAVVGTMGYAAPEYVQTGRLAARSDVWSYGVFLYELITGRRPIDRNRPRSE 304 (426)
Q Consensus 231 ~~------~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~ 304 (426)
+. ++|+|||.+...... ....+||+.|+|||++.+..|+.++|||||||++++|++|+.||........
T Consensus 163 ~~~~~~~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~ 237 (362)
T d1q8ya_ 163 DSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSY 237 (362)
T ss_dssp ETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred CcccccceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccc
Confidence 54 999999999765432 2346799999999999999999999999999999999999999975432211
Q ss_pred ----HHHHHhHhhh-------hhhhhhhhhhcCC-----c--------------CCCcccHHHHHHHHHHHHhccccCCC
Q 014363 305 ----QKLLQWVKPY-------LSDAKQFRQIVDP-----R--------------LEGKYSLRLVSKLSHVANLCLVKNAR 354 (426)
Q Consensus 305 ----~~~~~~~~~~-------~~~~~~~~~~~~~-----~--------------~~~~~~~~~~~~l~~li~~cl~~dp~ 354 (426)
..+...+... ...........+. . .........++.+.+|+.+||+.||+
T Consensus 238 ~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~ 317 (362)
T d1q8ya_ 238 TKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPR 317 (362)
T ss_dssp -CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTT
T ss_pred cchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChh
Confidence 1111111100 0000000000000 0 01123456788999999999999999
Q ss_pred CCCCHHHHHHH
Q 014363 355 TRPKMSEVLEM 365 (426)
Q Consensus 355 ~RPs~~eil~~ 365 (426)
+|||++|+|+|
T Consensus 318 ~Rpta~e~L~H 328 (362)
T d1q8ya_ 318 KRADAGGLVNH 328 (362)
T ss_dssp TCBCHHHHHTC
T ss_pred HCcCHHHHhcC
Confidence 99999999986
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=5.4e-26 Score=198.17 Aligned_cols=161 Identities=15% Similarity=0.119 Sum_probs=117.7
Q ss_pred CCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC--------------------CHHHHHHHHHHHhhcCCCCc
Q 014363 88 SRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--------------------GHKEWMTEVNFLGIVEHQNL 147 (426)
Q Consensus 88 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~--------------------~~~~~~~E~~~l~~l~HpnI 147 (426)
.+.+.||+|+||+||+|.+.++ ..||+|.+.... .......|+..+.++.|+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g------~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v 76 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKF------GECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAV 76 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTT------EEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSS
T ss_pred hhCCEeeeCcceEEEEEECCCC------CEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCc
Confidence 4567999999999999987543 379999764211 01234568899999999999
Q ss_pred cceEeEEEccCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccCCCCCeEeccCCCCceEe
Q 014363 148 VKLVGYCADDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEGMDFQIIVRDFKSSNILL 227 (426)
Q Consensus 148 v~~~~~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~~~~~iiHrDlkp~NILl 227 (426)
+..+++.. . +++|||+++..+.++ +...+..++.|++.||.|||++ +|+||||||+|||+
T Consensus 77 ~~~~~~~~--~------~lvme~~~~~~~~~l---------~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv 136 (191)
T d1zara2 77 PKVYAWEG--N------AVLMELIDAKELYRV---------RVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLV 136 (191)
T ss_dssp CCEEEEET--T------EEEEECCCCEEGGGC---------CCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEE
T ss_pred ceEEEecC--C------EEEEEeeccccccch---------hhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheee
Confidence 99886531 1 799999988665543 2333567899999999999998 99999999999999
Q ss_pred CCCCCeeEeeecccccCCCCCceeeeeeeecCcccCC------chhhccCCCCCchhhHHHHHHH
Q 014363 228 DEQWNAKLSDFGLARLGPSEGFTHVSTAVVGTMGYAA------PEYVQTGRLAARSDVWSYGVFL 286 (426)
Q Consensus 228 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~~DvwslGvil 286 (426)
+++ .++|+|||+|......... .|.. .+.+ ...|+.++|+||+.--+
T Consensus 137 ~~~-~~~liDFG~a~~~~~~~~~----------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 137 SEE-GIWIIDFPQSVEVGEEGWR----------EILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp ETT-EEEECCCTTCEETTSTTHH----------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred eCC-CEEEEECCCcccCCCCCcH----------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 976 4999999999765433211 1111 1111 35688899999986544
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.58 E-value=1.1e-07 Score=84.72 Aligned_cols=146 Identities=16% Similarity=0.112 Sum_probs=95.8
Q ss_pred HHHHHhCCCCCcceecccCcEEEEEEEEcCCCCCCcceEEEEEEccccC--CHHHHHHHHHHHhhcC-CCCccceEeEEE
Q 014363 79 ELKSATKNFSRSVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRG--GHKEWMTEVNFLGIVE-HQNLVKLVGYCA 155 (426)
Q Consensus 79 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~E~~~l~~l~-HpnIv~~~~~~~ 155 (426)
++......|+..+..+-++.+.||+....+. .+.+|...... ....+.+|...+..|. +--+.+++.+..
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~~~~-------~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~ 80 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGENE-------NLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFER 80 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEECSSC-------EEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEeCCC-------eEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEe
Confidence 5566667787766655455578998753222 56777764432 3345788999888773 444677887776
Q ss_pred ccCCCCceEEEEEeeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhccC-------------------------
Q 014363 156 DDDERGIQRLLVYEYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHEG------------------------- 210 (426)
Q Consensus 156 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~~------------------------- 210 (426)
+.+ ..++||++++|.++.+...... . ...++.++++.|..||+.
T Consensus 81 ~~~----~~~lv~~~l~G~~~~~~~~~~~----~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (263)
T d1j7la_ 81 HDG----WSNLLMSEADGVLCSEEYEDEQ----S---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNND 149 (263)
T ss_dssp ETT----EEEEEEECCSSEEHHHHTTTCS----C---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTT
T ss_pred cCC----ceEEEEEecccccccccccccc----c---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHH
Confidence 554 3489999999988866543211 1 122344555555555521
Q ss_pred -------------------------------CCCCeEeccCCCCceEeCCCCCeeEeeecccc
Q 014363 211 -------------------------------MDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 242 (426)
Q Consensus 211 -------------------------------~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 242 (426)
....++|+|+.|.|||+++++.+-|+||+.+.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 150 LADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred hhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 01248999999999999987666799998775
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.14 E-value=6.6e-06 Score=72.32 Aligned_cols=130 Identities=15% Similarity=0.091 Sum_probs=81.3
Q ss_pred eecccCc-EEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhcCC--CCccceEeEEEccCCCCceEEEEE
Q 014363 92 VIGEGGF-GCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEH--QNLVKLVGYCADDDERGIQRLLVY 168 (426)
Q Consensus 92 ~lG~G~~-g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l~H--pnIv~~~~~~~~~~~~~~~~~lv~ 168 (426)
.+..|.. +.||+....+.. .+.+|..... ....+..|+..|+.|.. -.+.+++++..+.+ ..++||
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~------~~vlK~~~~~-~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~----~~~~v~ 85 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRP------VLFVKTDLSG-ALNELQDEAARLSWLATTGVPCAAVLDVVTEAG----RDWLLL 85 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSC------CEEEEEECSC-TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSS----CEEEEE
T ss_pred EcCCcccCCeEEEEEeCCCC------EEEEEeCCcc-CHhHHHHHHHHHHHHHhcCCCCCceeeeccccc----ceEEEE
Confidence 3445553 678988754432 4667765433 34467889998888733 34677787776654 348999
Q ss_pred eeCCCCChhhhccCCCCCccCHHHHHHHHHHHHHHHHHhcc---------------------------------------
Q 014363 169 EYMPNGSVDQYLSPKSETILTWAMRLKIAQDAARGLAYLHE--------------------------------------- 209 (426)
Q Consensus 169 E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~~i~~aL~~LH~--------------------------------------- 209 (426)
++++|.++.+.. .... .++.++...|.-||.
T Consensus 86 ~~i~G~~~~~~~-------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (255)
T d1nd4a_ 86 GEVPGQDLLSSH-------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG 155 (255)
T ss_dssp ECCSSEETTTSC-------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred Eeeecccccccc-------ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhh
Confidence 999987765422 1111 112233333333331
Q ss_pred ------------C----CCCCeEeccCCCCceEeCCCCCeeEeeecccc
Q 014363 210 ------------G----MDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 242 (426)
Q Consensus 210 ------------~----~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 242 (426)
. ....++|+|+.|.|||++++..+-|+||+.+.
T Consensus 156 ~~~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 156 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred hHHHHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 1 12348999999999999987667899998764
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.04 E-value=1.1e-05 Score=76.04 Aligned_cols=76 Identities=16% Similarity=0.105 Sum_probs=47.5
Q ss_pred cceecccCcEEEEEEEEcCCCCCCcceEEEEEEccc------c---CCHHHHHHHHHHHhhc-CC--CCccceEeEEEcc
Q 014363 90 SVVIGEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGR------R---GGHKEWMTEVNFLGIV-EH--QNLVKLVGYCADD 157 (426)
Q Consensus 90 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~------~---~~~~~~~~E~~~l~~l-~H--pnIv~~~~~~~~~ 157 (426)
.+.||.|..-.||++....++ +.+.+|+... + ....+...|++.|..+ .+ ..+++++.+..
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~-----~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~-- 103 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHD-----RALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDT-- 103 (392)
T ss_dssp EEECCSSSSEEEEEEEC---------CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEET--
T ss_pred EEEeCCCceEeEEEEEeCCCC-----eEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcC--
Confidence 447899999999998755433 2677886432 1 1234566788888777 33 35667775533
Q ss_pred CCCCceEEEEEeeCCCCCh
Q 014363 158 DERGIQRLLVYEYMPNGSV 176 (426)
Q Consensus 158 ~~~~~~~~lv~E~~~~g~L 176 (426)
+.. ++|||++++..+
T Consensus 104 ~~~----~lvmE~L~~~~~ 118 (392)
T d2pula1 104 EMA----VTVMEDLSHLKI 118 (392)
T ss_dssp TTT----EEEECCCTTSEE
T ss_pred CCC----EEEEeccCCccc
Confidence 322 799999976543
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.55 E-value=0.00018 Score=67.33 Aligned_cols=80 Identities=14% Similarity=0.145 Sum_probs=52.6
Q ss_pred cceecccCcEEEEEEEEcCCCCC--CcceEEEEEEccccCCHHHHHHHHHHHhhcC-CCCccceEeEEEccCCCCceEEE
Q 014363 90 SVVIGEGGFGCVYKGLIKNSEDP--SQKVEVAVKQLGRRGGHKEWMTEVNFLGIVE-HQNLVKLVGYCADDDERGIQRLL 166 (426)
Q Consensus 90 ~~~lG~G~~g~Vy~~~~~~~~~~--~~~~~va~K~~~~~~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~~~~~~~~~~~l 166 (426)
++.|+.|-.=.+|++........ .....|.+++...........+|..+++.+. +.-..++++++.+ .+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~--------g~ 118 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG--------GR 118 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT--------EE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC--------ce
Confidence 35688788888999887654221 1223466666654444455678999999884 4444578877632 68
Q ss_pred EEeeCCCCChh
Q 014363 167 VYEYMPNGSVD 177 (426)
Q Consensus 167 v~E~~~~g~L~ 177 (426)
||||++|..|.
T Consensus 119 I~efi~g~~l~ 129 (395)
T d1nw1a_ 119 LEEYIPSRPLS 129 (395)
T ss_dssp EECCCCEEECC
T ss_pred EEEEeccccCC
Confidence 99999875553
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.28 E-value=0.00052 Score=61.87 Aligned_cols=157 Identities=10% Similarity=0.007 Sum_probs=84.8
Q ss_pred cCHHHHHHHhCCCCCccee-----cccCcEEEEEEEEcCCCCCCcceEEEEEEccccCCHHHHHHHHHHHhhcCC-----
Q 014363 75 FTIAELKSATKNFSRSVVI-----GEGGFGCVYKGLIKNSEDPSQKVEVAVKQLGRRGGHKEWMTEVNFLGIVEH----- 144 (426)
Q Consensus 75 ~~~~~~~~~~~~y~~~~~l-----G~G~~g~Vy~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~E~~~l~~l~H----- 144 (426)
.+.+++.....+|.++++. ..|---+.|+....++ .+.+|+.......+.+..|+.+|..|..
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-------~yVLri~~~~~~~~~l~~~~~~l~~L~~~g~pv 75 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-------PLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSC 75 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-------CEEEEEECC---CCHHHHHHHHHHHHHHTTCCC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-------cEEEEEcCCCCCHHHHHHHHHHHHhhhhccccc
Confidence 5677888888889876544 3455567898875543 4788887654445566778888887732
Q ss_pred CCccceE-e--EEEccCCCCceEEEEEeeCCCCChhhhcc------------------C----CCCC-c-----------
Q 014363 145 QNLVKLV-G--YCADDDERGIQRLLVYEYMPNGSVDQYLS------------------P----KSET-I----------- 187 (426)
Q Consensus 145 pnIv~~~-~--~~~~~~~~~~~~~lv~E~~~~g~L~~~l~------------------~----~~~~-~----------- 187 (426)
|..+... | +... ......++.+..+......-. . .... .
T Consensus 76 p~pi~~~~g~~~~~~----~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (316)
T d2ppqa1 76 PLPLPRKDGELLGEL----SGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKS 151 (316)
T ss_dssp CCBCCBTTCCSCEEE----TTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHH
T ss_pred cccceecCCCcceee----ecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHH
Confidence 2222110 0 0000 112356677766544322110 0 0000 0
Q ss_pred -----cCHHHHHHHHHHHHHHHHHhcc-CCCCCeEeccCCCCceEeCCCCCeeEeeecccc
Q 014363 188 -----LTWAMRLKIAQDAARGLAYLHE-GMDFQIIVRDFKSSNILLDEQWNAKLSDFGLAR 242 (426)
Q Consensus 188 -----~~~~~~~~i~~~i~~aL~~LH~-~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 242 (426)
.........+..+...+.-.+. ....|+||+|+.++||+++.+...-|+||+.+.
T Consensus 152 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 152 EERADEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp GGGGGGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHhhhhcchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 0000111222233333333332 235689999999999999988777899999875
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.74 E-value=0.0025 Score=57.57 Aligned_cols=135 Identities=13% Similarity=0.113 Sum_probs=73.6
Q ss_pred EEEEEEEEcCCCCCCcceEEEEEEcccc-CCHHHHHHHHHHHhhcCCCCc--cceEeEEEccC---CCCceEEEEEeeCC
Q 014363 99 GCVYKGLIKNSEDPSQKVEVAVKQLGRR-GGHKEWMTEVNFLGIVEHQNL--VKLVGYCADDD---ERGIQRLLVYEYMP 172 (426)
Q Consensus 99 g~Vy~~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~E~~~l~~l~HpnI--v~~~~~~~~~~---~~~~~~~lv~E~~~ 172 (426)
=.||++...++. .+++|..... ...+++..|+..|..|....| +..+. .+.. ..+...+.++++++
T Consensus 36 N~vy~v~~~dg~------~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~--~~g~~~~~~~~~~~~l~~~~~ 107 (325)
T d1zyla1 36 NRVYQFQDEDRR------RFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVA--FNGQTLLNHQGFYFAVFPSVG 107 (325)
T ss_dssp SEEEEECCTTCC------CEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCC--BTTBSCEEETTEEEEEEECCC
T ss_pred ceeEEEEcCCCC------EEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCcee--cCCCeeeeeeeEEEEEEeecC
Confidence 369998765543 5888887544 356778899998888842222 11111 0000 01224588999997
Q ss_pred CCChhhh----c--------------cCC---CCCccCHH----------------------HHHHHHHHHHHHHHHh-c
Q 014363 173 NGSVDQY----L--------------SPK---SETILTWA----------------------MRLKIAQDAARGLAYL-H 208 (426)
Q Consensus 173 ~g~L~~~----l--------------~~~---~~~~~~~~----------------------~~~~i~~~i~~aL~~L-H 208 (426)
|..+... + ... .....+.. .....+.++...+.-+ .
T Consensus 108 G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~ 187 (325)
T d1zyla1 108 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR 187 (325)
T ss_dssp CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred CcCCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhcc
Confidence 7443211 0 000 00111111 1122233333333322 2
Q ss_pred cCCCCCeEeccCCCCceEeCCCCCeeEeeeccccc
Q 014363 209 EGMDFQIIVRDFKSSNILLDEQWNAKLSDFGLARL 243 (426)
Q Consensus 209 ~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 243 (426)
.....++||+|+.+.|||++++ ..++||+-+..
T Consensus 188 ~~~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 188 EDFTVLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp SCSCCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ccCCceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 2334689999999999999753 46899998764
|